Citrus Sinensis ID: 040898
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 337 | 2.2.26 [Sep-21-2011] | |||||||
| Q9SKB2 | 641 | Leucine-rich repeat recep | yes | no | 0.982 | 0.516 | 0.618 | 1e-120 | |
| Q9C7S5 | 1095 | Tyrosine-sulfated glycope | no | no | 0.833 | 0.256 | 0.340 | 6e-44 | |
| Q9M0G7 | 1013 | Leucine-rich repeat recep | no | no | 0.792 | 0.263 | 0.381 | 9e-44 | |
| Q9FZ59 | 1088 | Leucine-rich repeat recep | no | no | 0.807 | 0.25 | 0.373 | 3e-43 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.777 | 0.237 | 0.380 | 4e-43 | |
| Q9SSL9 | 1123 | Leucine-rich repeat recep | no | no | 0.845 | 0.253 | 0.337 | 6e-43 | |
| Q9SYM9 | 355 | Receptor-like serine/thre | no | no | 0.804 | 0.763 | 0.348 | 1e-42 | |
| P93194 | 1109 | Receptor-like protein kin | N/A | no | 0.777 | 0.236 | 0.364 | 7e-42 | |
| Q8LPB4 | 1021 | Phytosulfokine receptor 1 | N/A | no | 0.818 | 0.270 | 0.34 | 1e-41 | |
| Q8L899 | 1207 | Systemin receptor SR160 O | N/A | no | 0.824 | 0.230 | 0.363 | 1e-41 |
| >sp|Q9SKB2|SBIR1_ARATH Leucine-rich repeat receptor-like serine/threonine/tyrosine-protein kinase SOBIR1 OS=Arabidopsis thaliana GN=SOBIR1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 433 bits (1113), Expect = e-120, Method: Compositional matrix adjust.
Identities = 209/338 (61%), Positives = 260/338 (76%), Gaps = 7/338 (2%)
Query: 1 MFSFVLKLILAAVRGGSRDRGPTIFSPLVEK-QDLAFLKKEDCFDSLKKIGSGGWGEVFY 59
+FS + KLI+ A+RG + GP+IFSPL++K +DLAFL+ E+ SL+ IG GG GEVF
Sbjct: 304 VFSVLFKLIIQAIRGSEKPPGPSIFSPLIKKAEDLAFLENEEALASLEIIGRGGCGEVF- 362
Query: 60 KAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119
KAELPGSNGK+IA++K ++ P A EL DE S L+ K+ IRSEI T RHR
Sbjct: 363 KAELPGSNGKIIAVKK-VIQPPKDADELT----DEDSKFLNKKMRQIRSEINTVGHIRHR 417
Query: 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYL 179
N+LPLLAH+ RP CH LVYE+M+ GSLQDIL DV G +EL WPARH+IA GIA+GLEYL
Sbjct: 418 NLLPLLAHVSRPECHYLVYEYMEKGSLQDILTDVQAGNQELMWPARHKIALGIAAGLEYL 477
Query: 180 HMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPES 239
HM H PR+IHRD+KPANVL+DDDMEARISDFG K MPD IT + GT+GY+APE
Sbjct: 478 HMDHNPRIIHRDLKPANVLLDDDMEARISDFGLAKAMPDAVTHITTSHVAGTVGYIAPEF 537
Query: 240 LQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINS 299
QT +DKCDIYSFGV+L +LV+GK P D+FF HT+EM ++KWMRN+I SENP+ AI+
Sbjct: 538 YQTHKFTDKCDIYSFGVILGILVIGKLPSDEFFQHTDEMSLIKWMRNIITSENPSLAIDP 597
Query: 300 KLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337
KL+ G++EQMLLVLK+AC+CTL DP +RP+SKDVR+M
Sbjct: 598 KLMDQGFDEQMLLVLKIACYCTLDDPKQRPNSKDVRTM 635
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Promotes the activation of plant defense and cell death. Functions as an inhibitor/regulator of abscission, probably by regulating membrane trafficking during abscission. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9C7S5|PSYR1_ARATH Tyrosine-sulfated glycopeptide receptor 1 OS=Arabidopsis thaliana GN=PSYR1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 178 bits (451), Expect = 6e-44, Method: Compositional matrix adjust.
Identities = 105/308 (34%), Positives = 166/308 (53%), Gaps = 27/308 (8%)
Query: 30 EKQDLA---FLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAE 86
E +DL LK D F IG GG+G V YKA L NG +A++KL D M E
Sbjct: 787 EVKDLTIFELLKATDNFSQANIIGCGGFGLV-YKATL--DNGTKLAVKKLTGDYGMMEKE 843
Query: 87 LIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSL 146
++E+ ++ +H N++ L + V + +L+Y FM+NGSL
Sbjct: 844 F-------------------KAEVEVLSRAKHENLVALQGYCVHDSARILIYSFMENGSL 884
Query: 147 QDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEAR 206
L++ +G +LDWP R I RG +SGL Y+H P ++HRDIK +N+L+D + +A
Sbjct: 885 DYWLHENPEGPAQLDWPKRLNIMRGASSGLAYMHQICEPHIVHRDIKSSNILLDGNFKAY 944
Query: 207 ISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKF 266
++DFG +L+ +T + +VGT+GY+ PE Q + + D+YSFGV++ L+ GK
Sbjct: 945 VADFGLSRLILPYRTHVTTE-LVGTLGYIPPEYGQAWVATLRGDVYSFGVVMLELLTGKR 1003
Query: 267 PVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPD 326
P+ + F ++V W+ + P ++ L +G EE ML VL +AC C ++P
Sbjct: 1004 PM-EVFRPKMSRELVAWVHTMKRDGKPEEVFDTLLRESGNEEAMLRVLDIACMCVNQNPM 1062
Query: 327 ERPSSKDV 334
+RP+ + V
Sbjct: 1063 KRPNIQQV 1070
|
Tyrosine-sulfated glycopeptide receptor with a serine/threonine-protein kinase activity. Regulates, in response to tyrosine-sulfated glycopeptide binding, a signaling cascade involved in cellular proliferation and plant growth. Not involved in PSK perception. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M0G7|PXL2_ARATH Leucine-rich repeat receptor-like protein kinase PXL2 OS=Arabidopsis thaliana GN=PXL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 177 bits (449), Expect = 9e-44, Method: Compositional matrix adjust.
Identities = 117/307 (38%), Positives = 174/307 (56%), Gaps = 40/307 (13%)
Query: 42 CFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHW 101
C IG G G + YKAE+ S+ ++A++KL A +D+
Sbjct: 698 CIKESNMIGMGATG-IVYKAEMSRSS-TVLAVKKLWRSA---------------ADIEDG 740
Query: 102 KIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILY-DVSQGRREL 160
G E+ + RHRNI+ LL + ++VYEFM NG+L D ++ + GR +
Sbjct: 741 TTGDFVGEVNLLGKLRHRNIVRLLGFLYNDKNMMIVYEFMLNGNLGDAIHGKNAAGRLLV 800
Query: 161 DWPARHRIARGIASGLEYLHM-CHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDG 219
DW +R+ IA G+A GL YLH CH P +IHRDIK N+L+D +++ARI+DFG ++M
Sbjct: 801 DWVSRYNIALGVAHGLAYLHHDCHPP-VIHRDIKSNNILLDANLDARIADFGLARMM--A 857
Query: 220 HAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMD 279
+ TV + G+ GY+APE T + +K DIYS+GV+L L+ G+ P++ FG E +D
Sbjct: 858 RKKETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSYGVVLLELLTGRRPLEPEFG--ESVD 915
Query: 280 MVKWMR-----NVIFSE--NPNRAINSKLLGNG--YEEQMLLVLKLACFCTLKDPDERPS 330
+V+W+R N+ E +PN +GN +E+MLLVL++A CT K P +RPS
Sbjct: 916 IVEWVRRKIRDNISLEEALDPN-------VGNCRYVQEEMLLVLQIALLCTTKLPKDRPS 968
Query: 331 SKDVRSM 337
+DV SM
Sbjct: 969 MRDVISM 975
|
Involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FZ59|PEPR2_ARATH Leucine-rich repeat receptor-like protein kinase PEPR2 OS=Arabidopsis thaliana GN=PEPR2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 176 bits (445), Expect = 3e-43, Method: Compositional matrix adjust.
Identities = 115/308 (37%), Positives = 167/308 (54%), Gaps = 36/308 (11%)
Query: 37 LKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYS 96
L D D IG G G V Y+A L +G+ A++KLI + A + +K++I+
Sbjct: 788 LAATDNLDDKYIIGRGAHG-VVYRASL--GSGEEYAVKKLIFAEHIRANQNMKREIE--- 841
Query: 97 DLLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQG 156
T RHRN++ L +R L++Y++M NGSL D+L+ +QG
Sbjct: 842 ---------------TIGLVRHRNLIRLERFWMRKEDGLMLYQYMPNGSLHDVLHRGNQG 886
Query: 157 RRELDWPARHRIARGIASGLEYLHM-CHRPRLIHRDIKPANVLIDDDMEARISDFGHGKL 215
LDW AR IA GI+ GL YLH CH P +IHRDIKP N+L+D DME I DFG ++
Sbjct: 887 EAVLDWSARFNIALGISHGLAYLHHDCHPP-IIHRDIKPENILMDSDMEPHIGDFGLARI 945
Query: 216 MPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHT 275
+ D + ++ + GT GY+APE+ S + D+YS+GV+L LV GK +D F
Sbjct: 946 LDD--STVSTATVTGTTGYIAPENAYKTVRSKESDVYSYGVVLLELVTGKRALDRSF--P 1001
Query: 276 EEMDMVKWMRNVIFS-----ENPNRAINSK----LLGNGYEEQMLLVLKLACFCTLKDPD 326
E++++V W+R+V+ S + ++ K LL EQ + V LA CT K P+
Sbjct: 1002 EDINIVSWVRSVLSSYEDEDDTAGPIVDPKLVDELLDTKLREQAIQVTDLALRCTDKRPE 1061
Query: 327 ERPSSKDV 334
RPS +DV
Sbjct: 1062 NRPSMRDV 1069
|
Acts as a receptor for PEP defense peptides. Unlike typical immune receptors, senses an endogenous elicitor that potentiates PAMP-inducible plant responses. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 175 bits (444), Expect = 4e-43, Method: Compositional matrix adjust.
Identities = 112/294 (38%), Positives = 165/294 (56%), Gaps = 32/294 (10%)
Query: 49 IGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRS 108
+G G G V YKAE+ G G++IA++KL S E D + R+
Sbjct: 805 LGRGACGTV-YKAEMSG--GEVIAVKKL-----NSRGEGASSD------------NSFRA 844
Query: 109 EIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRE--LDWPARH 166
EI T + RHRNI+ L N +LL+YE+M GSL + + +G + LDW AR+
Sbjct: 845 EISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGE---QLQRGEKNCLLDWNARY 901
Query: 167 RIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVK 226
RIA G A GL YLH RP+++HRDIK N+L+D+ +A + DFG KL+ +++ ++
Sbjct: 902 RIALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSK-SMS 960
Query: 227 CMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRN 286
+ G+ GY+APE T +++KCDIYSFGV+L L+ GK PV + D+V W+R
Sbjct: 961 AVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQPL---EQGGDLVNWVRR 1017
Query: 287 VIFSENPN-RAINSKLLGNGYE--EQMLLVLKLACFCTLKDPDERPSSKDVRSM 337
I + P +++L N +M LVLK+A FCT P RP+ ++V +M
Sbjct: 1018 SIRNMIPTIEMFDARLDTNDKRTVHEMSLVLKIALFCTSNSPASRPTMREVVAM 1071
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SSL9|PEPR1_ARATH Leucine-rich repeat receptor-like protein kinase PEPR1 OS=Arabidopsis thaliana GN=PEPR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 174 bits (442), Expect = 6e-43, Method: Compositional matrix adjust.
Identities = 111/329 (33%), Positives = 175/329 (53%), Gaps = 44/329 (13%)
Query: 17 SRDRGPTIFSPLVEKQDLAFLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKL 76
+++ GP++ L+ K L D + IG G G + Y+A L +GK+ A+++L
Sbjct: 808 TQEEGPSL---LLNK----VLAATDNLNEKYTIGRGAHG-IVYRASL--GSGKVYAVKRL 857
Query: 77 IVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLL 136
+ + + A + + ++ID T + RHRN++ L +R + L+
Sbjct: 858 VFASHIRANQSMMREID------------------TIGKVRHRNLIKLEGFWLRKDDGLM 899
Query: 137 VYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHM-CHRPRLIHRDIKPA 195
+Y +M GSL D+L+ VS LDW AR+ +A G+A GL YLH CH P ++HRDIKP
Sbjct: 900 LYRYMPKGSLYDVLHGVSPKENVLDWSARYNVALGVAHGLAYLHYDCHPP-IVHRDIKPE 958
Query: 196 NVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFG 255
N+L+D D+E I DFG +L+ D + ++ + GT GY+APE+ + D+YS+G
Sbjct: 959 NILMDSDLEPHIGDFGLARLLDD--STVSTATVTGTTGYIAPENAFKTVRGRESDVYSYG 1016
Query: 256 VLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRA----------INSKLLGNG 305
V+L LV K VD F E D+V W+R+ + S N N + +LL +
Sbjct: 1017 VVLLELVTRKRAVDKSF--PESTDIVSWVRSALSSSNNNVEDMVTTIVDPILVDELLDSS 1074
Query: 306 YEEQMLLVLKLACFCTLKDPDERPSSKDV 334
EQ++ V +LA CT +DP RP+ +D
Sbjct: 1075 LREQVMQVTELALSCTQQDPAMRPTMRDA 1103
|
Acts as a receptor for PEP defense peptides. Unlike typical immune receptors, senses an endogenous elicitor that potentiates PAMP-inducible plant responses. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SYM9|Y1853_ARATH Receptor-like serine/threonine-protein kinase At1g78530 OS=Arabidopsis thaliana GN=At1g78530 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 174 bits (440), Expect = 1e-42, Method: Compositional matrix adjust.
Identities = 105/301 (34%), Positives = 159/301 (52%), Gaps = 30/301 (9%)
Query: 36 FLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEY 95
F+KK + +GSGG+G V+ R +I D+ A + + + E
Sbjct: 68 FMKKTHKLSNKDILGSGGFGTVY---------------RLVIDDSTTFAVKRLNRGTSER 112
Query: 96 SDLLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQ 155
H ++ A+ +HRNI+ L + P+ +LL+YE M NGSL L+
Sbjct: 113 DRGFHRELEAM-------ADIKHRNIVTLHGYFTSPHYNLLIYELMPNGSLDSFLH---- 161
Query: 156 GRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKL 215
GR+ LDW +R+RIA G A G+ YLH P +IHRDIK +N+L+D +MEAR+SDFG L
Sbjct: 162 GRKALDWASRYRIAVGAARGISYLHHDCIPHIIHRDIKSSNILLDHNMEARVSDFGLATL 221
Query: 216 MPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHT 275
M ++ + GT GY+APE T + K D+YSFGV+L L+ G+ P DD F
Sbjct: 222 MEPDKTHVST-FVAGTFGYLAPEYFDTGKATMKGDVYSFGVVLLELLTGRKPTDDEF-FE 279
Query: 276 EEMDMVKWMRNVIFSENPNRAINSKLLGNGYE--EQMLLVLKLACFCTLKDPDERPSSKD 333
E +V W++ V+ + I+++L G+ + E+M V +A C +P RP+ +
Sbjct: 280 EGTKLVTWVKGVVRDQREEVVIDNRLRGSSVQENEEMNDVFGIAMMCLEPEPAIRPAMTE 339
Query: 334 V 334
V
Sbjct: 340 V 340
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P93194|RPK1_IPONI Receptor-like protein kinase OS=Ipomoea nil GN=INRPK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 171 bits (433), Expect = 7e-42, Method: Composition-based stats.
Identities = 106/291 (36%), Positives = 158/291 (54%), Gaps = 29/291 (9%)
Query: 49 IGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRS 108
IG G G + YKA L S K+ A++KL+ ++ + + + +R
Sbjct: 822 IGKGAHGTI-YKATL--SPDKVYAVKKLV-----------------FTGIKNGSVSMVR- 860
Query: 109 EIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRI 168
EI T + RHRN++ L +R L++Y +M+NGSL DIL++ + + LDW RH I
Sbjct: 861 EIETIGKVRHRNLIKLEEFWLRKEYGLILYTYMENGSLHDILHETNP-PKPLDWSTRHNI 919
Query: 169 ARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCM 228
A G A GL YLH P ++HRDIKP N+L+D D+E ISDFG KL+ I +
Sbjct: 920 AVGTAHGLAYLHFDCDPAIVHRDIKPMNILLDSDLEPHISDFGIAKLLDQSATSIPSNTV 979
Query: 229 VGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVI 288
GT+GYMAPE+ T S + D+YS+GV+L L+ K +D F E D+V W+R+V
Sbjct: 980 QGTIGYMAPENAFTTVKSRESDVYSYGVVLLELITRKKALDPSF--NGETDIVGWVRSVW 1037
Query: 289 FSENP-----NRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDV 334
+ ++ +L+ + EQ+ L LA C K+ D+RP+ +DV
Sbjct: 1038 TQTGEIQKIVDPSLLDELIDSSVMEQVTEALSLALRCAEKEVDKRPTMRDV 1088
|
Possible role in short-day photoperiod floral induction. Ipomoea nil (taxid: 35883) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8LPB4|PSKR1_DAUCA Phytosulfokine receptor 1 OS=Daucus carota GN=PSKR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 171 bits (432), Expect = 1e-41, Method: Composition-based stats.
Identities = 102/300 (34%), Positives = 158/300 (52%), Gaps = 24/300 (8%)
Query: 37 LKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYS 96
LK F+ IG GG+G V YKA LP +G +AI++L D E
Sbjct: 737 LKSTSSFNQANIIGCGGFGLV-YKATLP--DGTKVAIKRLSGDTGQMDREF--------- 784
Query: 97 DLLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQG 156
++E+ T ++ +H N++ LL + N LL+Y +M NGSL L++ G
Sbjct: 785 ----------QAEVETLSRAQHPNLVHLLGYCNYKNDKLLIYSYMDNGSLDYWLHEKVDG 834
Query: 157 RRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLM 216
LDW R RIARG A GL YLH P ++HRDIK +N+L+ D A ++DFG +L+
Sbjct: 835 PPSLDWKTRLRIARGAAEGLAYLHQSCEPHILHRDIKSSNILLSDTFVAHLADFGLARLI 894
Query: 217 PDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTE 276
+T +VGT+GY+ PE Q + K D+YSFGV+L L+ G+ P+ D
Sbjct: 895 LPYDTHVTTD-LVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGRRPM-DVCKPRG 952
Query: 277 EMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336
D++ W+ + + + + + + E+MLLVL++AC C ++P RP+++ + S
Sbjct: 953 SRDLISWVLQMKTEKRESEIFDPFIYDKDHAEEMLLVLEIACRCLGENPKTRPTTQQLVS 1012
|
Phytosulfokine receptor with a serine/threonine-protein kinase activity. Regulates, in response to phytosulfokine binding, a signaling cascade involved in plant cell differentiation, organogenesis and somatic embryogenesis. Daucus carota (taxid: 4039) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8L899|BRI1_SOLPE Systemin receptor SR160 OS=Solanum peruvianum PE=1 SV=1 | Back alignment and function description |
|---|
Score = 170 bits (431), Expect = 1e-41, Method: Compositional matrix adjust.
Identities = 110/303 (36%), Positives = 170/303 (56%), Gaps = 25/303 (8%)
Query: 36 FLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEY 95
L+ + F + +GSGG+G+V YKA+L +G ++AI+KLI + Q E+
Sbjct: 881 LLEATNGFHNDSLVGSGGFGDV-YKAQL--KDGSVVAIKKLI--------HVSGQGDREF 929
Query: 96 SDLLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQ 155
+ +E+ T + +HRN++PLL + LLVYE+MK GSL+D+L+D +
Sbjct: 930 T-----------AEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKYGSLEDVLHDRKK 978
Query: 156 GRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKL 215
+L+WPAR +IA G A GL +LH P +IHRD+K +NVL+D+++EAR+SDFG +L
Sbjct: 979 TGIKLNWPARRKIAIGAARGLAFLHHNCIPHIIHRDMKSSNVLLDENLEARVSDFGMARL 1038
Query: 216 MPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDF-FGH 274
M ++V + GT GY+ PE Q+ S K D+YS+GV+L L+ GK P D FG
Sbjct: 1039 MSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKQPTDSADFGD 1098
Query: 275 TEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDV 334
+ VK ++ +R + + E ++L LK+AC C +RP+ V
Sbjct: 1099 NNLVGWVKLHAKGKITDVFDRELLKE--DASIEIELLQHLKVACACLDDRHWKRPTMIQV 1156
Query: 335 RSM 337
+M
Sbjct: 1157 MAM 1159
|
Receptor with a serine/threonine-protein kinase activity. Involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. May also regulate, in response to brassinosteroid binding, a signaling cascade involved in plant development. Solanum peruvianum (taxid: 4082) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 337 | ||||||
| 255540437 | 633 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.982 | 0.522 | 0.660 | 1e-126 | |
| 224133744 | 630 | predicted protein [Populus trichocarpa] | 0.982 | 0.525 | 0.647 | 1e-124 | |
| 224119518 | 627 | predicted protein [Populus trichocarpa] | 0.982 | 0.527 | 0.630 | 1e-122 | |
| 356508750 | 636 | PREDICTED: leucine-rich repeat receptor- | 0.982 | 0.520 | 0.642 | 1e-121 | |
| 297822929 | 641 | hypothetical protein ARALYDRAFT_482113 [ | 0.982 | 0.516 | 0.615 | 1e-119 | |
| 15225153 | 641 | putative leucine-rich repeat transmembra | 0.982 | 0.516 | 0.618 | 1e-119 | |
| 16648755 | 641 | At2g31880/F20M17.8 [Arabidopsis thaliana | 0.982 | 0.516 | 0.618 | 1e-118 | |
| 24421095 | 633 | receptor-like protein kinase [Nicotiana | 0.982 | 0.522 | 0.621 | 1e-117 | |
| 356516603 | 631 | PREDICTED: leucine-rich repeat receptor- | 0.982 | 0.524 | 0.621 | 1e-116 | |
| 449440606 | 643 | PREDICTED: leucine-rich repeat receptor- | 0.982 | 0.514 | 0.600 | 1e-114 |
| >gi|255540437|ref|XP_002511283.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223550398|gb|EEF51885.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 456 bits (1172), Expect = e-126, Method: Compositional matrix adjust.
Identities = 224/339 (66%), Positives = 269/339 (79%), Gaps = 8/339 (2%)
Query: 1 MFSFVLKLILAAVRGGSRDRGPTIFSP-LVEK-QDLAFLKKEDCFDSLKKIGSGGWGEVF 58
+FS + KLILA +RGG +D GP IFSP L++K ++LAFL+KED +L+ IG GG GEV
Sbjct: 295 VFSVMFKLILATIRGGGKDSGPAIFSPHLIKKAENLAFLEKEDGLSNLELIGRGGCGEV- 353
Query: 59 YKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118
YKAELPGSNGKMIAI+K IV P AAEL ++D + LL+ K+ IRSEI T Q RH
Sbjct: 354 YKAELPGSNGKMIAIKK-IVQPPRDAAELTEED----TKLLNKKMRQIRSEINTVGQIRH 408
Query: 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEY 178
RN+LPLLAH+ RP+CH LVYEFMKNGSLQDIL DV QG+RELDW ARHRIA G+ASGLEY
Sbjct: 409 RNLLPLLAHVSRPDCHCLVYEFMKNGSLQDILSDVEQGKRELDWLARHRIAIGVASGLEY 468
Query: 179 LHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPE 238
LH H PR+IHRD+KPANVL+DDDMEARI+DFG K MPD + +T + GT+GY+APE
Sbjct: 469 LHTSHSPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDANTHVTTSNVAGTVGYIAPE 528
Query: 239 SLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAIN 298
QT +DKCDIYSFGVLL VLVMGK P D+FF T EM +VKWMRN++ SENP++AI+
Sbjct: 529 YHQTLKFTDKCDIYSFGVLLGVLVMGKLPSDEFFQTTREMSLVKWMRNIMTSENPSQAID 588
Query: 299 SKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337
K+ GNG+EEQMLLVLK+ACFCTL DP +RP+SKD+R M
Sbjct: 589 PKMNGNGFEEQMLLVLKIACFCTLDDPRQRPNSKDIRCM 627
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224133744|ref|XP_002321650.1| predicted protein [Populus trichocarpa] gi|222868646|gb|EEF05777.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 451 bits (1159), Expect = e-124, Method: Compositional matrix adjust.
Identities = 219/338 (64%), Positives = 266/338 (78%), Gaps = 7/338 (2%)
Query: 1 MFSFVLKLILAAVRGGSRDRGPTIFSPLVEK-QDLAFLKKEDCFDSLKKIGSGGWGEVFY 59
+FS + K++LAAV+GG RD GP IFSPL+++ +DLAFL+K+D +L+ IG GG GEV Y
Sbjct: 293 VFSLLFKIVLAAVKGGGRDGGPAIFSPLIKRAEDLAFLEKDDGLANLEVIGKGGCGEV-Y 351
Query: 60 KAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119
KAELPGSNGKMIAI+K I+ P AAEL ++D S LLH K+ I+SEI T RHR
Sbjct: 352 KAELPGSNGKMIAIKK-IIQPPKDAAELTEED----SKLLHKKMRQIQSEINTVGHIRHR 406
Query: 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYL 179
N+LPLLAH+ RP+CH LVYE MKNGSLQD L V++GRRELDW ARHRIA G+ASGLEYL
Sbjct: 407 NLLPLLAHVSRPDCHYLVYELMKNGSLQDALNHVTEGRRELDWLARHRIAVGVASGLEYL 466
Query: 180 HMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPES 239
H+ H PR+IHRD+KPANVL+DD MEARI+DFG K MPD IT + GT+GY+APE
Sbjct: 467 HLSHSPRIIHRDLKPANVLLDDSMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEY 526
Query: 240 LQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINS 299
QT +DKCDIYSFGV+L VLVMGK P D+FF +T EM +VKWMRN++ SENP +AI+
Sbjct: 527 HQTLKFTDKCDIYSFGVVLGVLVMGKLPSDEFFQNTREMSLVKWMRNIMTSENPRQAIDP 586
Query: 300 KLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337
KL+GNG EEQMLLVLK+ACFCT+ DP +RP+SKDVR M
Sbjct: 587 KLMGNGLEEQMLLVLKIACFCTIDDPKQRPNSKDVRCM 624
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224119518|ref|XP_002318094.1| predicted protein [Populus trichocarpa] gi|222858767|gb|EEE96314.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 442 bits (1138), Expect = e-122, Method: Compositional matrix adjust.
Identities = 213/338 (63%), Positives = 268/338 (79%), Gaps = 7/338 (2%)
Query: 1 MFSFVLKLILAAVRGGSRDRGPTIFSPLVEK-QDLAFLKKEDCFDSLKKIGSGGWGEVFY 59
+FS + K++LAAV+GG RD GP IFSPL++K +DLAFL+K++ +L+ IG GG GEVF
Sbjct: 290 VFSLLFKIVLAAVKGGGRDVGPAIFSPLIKKAEDLAFLEKDEGLANLEIIGRGGCGEVF- 348
Query: 60 KAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119
KAELPGSNGKMIA++K I+ P AAEL ++D S +L+ K+ I+SEI T RHR
Sbjct: 349 KAELPGSNGKMIAVKK-IIQPPKDAAELSEED----SKVLNKKMRQIQSEINTVGHIRHR 403
Query: 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYL 179
N+LPLLAH+ RP+CH LVYEFMKNGSLQD+L V++G+RELDW ARH+IA G+ASGLEYL
Sbjct: 404 NLLPLLAHVSRPDCHYLVYEFMKNGSLQDVLNQVTEGKRELDWLARHKIAVGVASGLEYL 463
Query: 180 HMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPES 239
H+ H P++IHRD+KPANVL+DDDMEARI+DFG K MPD IT + GT+GY+APE
Sbjct: 464 HLSHSPQIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAKTHITTSNVAGTVGYIAPEY 523
Query: 240 LQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINS 299
QT ++KCDIYSFGV+L VLVMGK P D FF T E+ +VKWMRN++ SENP++AI+
Sbjct: 524 HQTLKFTEKCDIYSFGVVLGVLVMGKLPSDAFFQSTRELSLVKWMRNIMISENPSQAIDP 583
Query: 300 KLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337
KL+G+G EEQMLLVLK+ACFCT+ DP +RPSSKDVR M
Sbjct: 584 KLIGHGLEEQMLLVLKIACFCTIDDPKQRPSSKDVRCM 621
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356508750|ref|XP_003523117.1| PREDICTED: leucine-rich repeat receptor-like serine/threonine/tyrosine-protein kinase SOBIR1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 440 bits (1132), Expect = e-121, Method: Compositional matrix adjust.
Identities = 217/338 (64%), Positives = 259/338 (76%), Gaps = 7/338 (2%)
Query: 1 MFSFVLKLILAAVRGGSRDRGPTIFSPLVEK-QDLAFLKKEDCFDSLKKIGSGGWGEVFY 59
+FS + KL LA ++G R GP I+SPL++K +DLAFL+KE+ SL+ IG GG GEV Y
Sbjct: 299 VFSLMFKLALALIKGRGRKAGPDIYSPLIKKAEDLAFLEKEEGIASLEIIGRGGCGEV-Y 357
Query: 60 KAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119
KAELPGSNGKMIAI+K IV P AEL ++D S +L+ K+ IRSEI T Q RHR
Sbjct: 358 KAELPGSNGKMIAIKK-IVQPPKDGAELAEED----SKVLNKKMRQIRSEINTVGQIRHR 412
Query: 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYL 179
N+LPLLAH+ RP CH LVYEFMKNGSLQD L V +G ELDW +RH+I+ G+A+GLEYL
Sbjct: 413 NLLPLLAHVSRPECHYLVYEFMKNGSLQDTLSKVERGESELDWLSRHKISLGVAAGLEYL 472
Query: 180 HMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPES 239
HM H PR+IHRD+KPAN+L+DDDMEARI+DFG K MPD IT + GT+GY+APE
Sbjct: 473 HMNHNPRIIHRDLKPANILLDDDMEARIADFGLAKAMPDYKTHITTSNVAGTVGYIAPEY 532
Query: 240 LQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINS 299
Q +DKCDIYS+GV+L VLV+GK P DDFF HTEEM +VKWMR + SENP AINS
Sbjct: 533 HQILKFTDKCDIYSYGVILGVLVIGKLPSDDFFQHTEEMSLVKWMRKTLSSENPKEAINS 592
Query: 300 KLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337
KLLGNGYEEQMLLVLK+ACFCT+ DP ERP+SKDVR M
Sbjct: 593 KLLGNGYEEQMLLVLKIACFCTMDDPKERPNSKDVRCM 630
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297822929|ref|XP_002879347.1| hypothetical protein ARALYDRAFT_482113 [Arabidopsis lyrata subsp. lyrata] gi|297325186|gb|EFH55606.1| hypothetical protein ARALYDRAFT_482113 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 433 bits (1114), Expect = e-119, Method: Compositional matrix adjust.
Identities = 208/338 (61%), Positives = 261/338 (77%), Gaps = 7/338 (2%)
Query: 1 MFSFVLKLILAAVRGGSRDRGPTIFSPLVEK-QDLAFLKKEDCFDSLKKIGSGGWGEVFY 59
+FS + KLI+ A+RG + GP+IFSPL++K +DLAFL+ E+ SL+ IG GG GEVF
Sbjct: 304 VFSVLFKLIIQAIRGSGKPSGPSIFSPLIKKAEDLAFLENEEALASLEIIGRGGCGEVF- 362
Query: 60 KAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119
KAELPGSNGK+IA++K ++ P A EL DE S ++ K+ IRSEI T Q RHR
Sbjct: 363 KAELPGSNGKIIAVKK-VIQPPKDADELT----DEDSKFMNKKMRQIRSEISTVGQIRHR 417
Query: 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYL 179
N+LPLLAH+ RP CH LVYE+M+ GSLQDIL DV G +EL WPARH+IA GIA+GLEYL
Sbjct: 418 NLLPLLAHVSRPECHYLVYEYMEKGSLQDILTDVQAGNQELMWPARHKIALGIAAGLEYL 477
Query: 180 HMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPES 239
HM H PR+IHRD+KPANVL+DDDMEARISDFG K+MPD IT + GT+GY+APE
Sbjct: 478 HMDHNPRIIHRDLKPANVLLDDDMEARISDFGLAKVMPDAVTHITTSNVAGTVGYIAPEF 537
Query: 240 LQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINS 299
QT + KCDIYSFGV+L +LV+GK P D+FF HT+EM ++KWMRN+I SENP+ AI+
Sbjct: 538 YQTHKFTAKCDIYSFGVILGILVIGKLPSDEFFQHTDEMSLIKWMRNIITSENPSLAIDP 597
Query: 300 KLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337
KL+ G++EQMLLVLK+AC+CTL DP +RP+SKDVR+M
Sbjct: 598 KLMEQGFDEQMLLVLKIACYCTLDDPKQRPNSKDVRTM 635
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15225153|ref|NP_180747.1| putative leucine-rich repeat transmembrane protein kinase [Arabidopsis thaliana] gi|75265989|sp|Q9SKB2.1|SBIR1_ARATH RecName: Full=Leucine-rich repeat receptor-like serine/threonine/tyrosine-protein kinase SOBIR1; AltName: Full=Protein EVERSHED; AltName: Full=Protein SUPPRESSOR OF BIR1-1; Flags: Precursor gi|13877675|gb|AAK43915.1|AF370596_1 putative receptor-like protein kinase [Arabidopsis thaliana] gi|4887748|gb|AAD32284.1| putative receptor-like protein kinase [Arabidopsis thaliana] gi|224589537|gb|ACN59302.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|330253505|gb|AEC08599.1| putative leucine-rich repeat transmembrane protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 433 bits (1113), Expect = e-119, Method: Compositional matrix adjust.
Identities = 209/338 (61%), Positives = 260/338 (76%), Gaps = 7/338 (2%)
Query: 1 MFSFVLKLILAAVRGGSRDRGPTIFSPLVEK-QDLAFLKKEDCFDSLKKIGSGGWGEVFY 59
+FS + KLI+ A+RG + GP+IFSPL++K +DLAFL+ E+ SL+ IG GG GEVF
Sbjct: 304 VFSVLFKLIIQAIRGSEKPPGPSIFSPLIKKAEDLAFLENEEALASLEIIGRGGCGEVF- 362
Query: 60 KAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119
KAELPGSNGK+IA++K ++ P A EL DE S L+ K+ IRSEI T RHR
Sbjct: 363 KAELPGSNGKIIAVKK-VIQPPKDADELT----DEDSKFLNKKMRQIRSEINTVGHIRHR 417
Query: 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYL 179
N+LPLLAH+ RP CH LVYE+M+ GSLQDIL DV G +EL WPARH+IA GIA+GLEYL
Sbjct: 418 NLLPLLAHVSRPECHYLVYEYMEKGSLQDILTDVQAGNQELMWPARHKIALGIAAGLEYL 477
Query: 180 HMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPES 239
HM H PR+IHRD+KPANVL+DDDMEARISDFG K MPD IT + GT+GY+APE
Sbjct: 478 HMDHNPRIIHRDLKPANVLLDDDMEARISDFGLAKAMPDAVTHITTSHVAGTVGYIAPEF 537
Query: 240 LQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINS 299
QT +DKCDIYSFGV+L +LV+GK P D+FF HT+EM ++KWMRN+I SENP+ AI+
Sbjct: 538 YQTHKFTDKCDIYSFGVILGILVIGKLPSDEFFQHTDEMSLIKWMRNIITSENPSLAIDP 597
Query: 300 KLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337
KL+ G++EQMLLVLK+AC+CTL DP +RP+SKDVR+M
Sbjct: 598 KLMDQGFDEQMLLVLKIACYCTLDDPKQRPNSKDVRTM 635
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|16648755|gb|AAL25569.1| At2g31880/F20M17.8 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 431 bits (1109), Expect = e-118, Method: Compositional matrix adjust.
Identities = 209/338 (61%), Positives = 259/338 (76%), Gaps = 7/338 (2%)
Query: 1 MFSFVLKLILAAVRGGSRDRGPTIFSPLVEK-QDLAFLKKEDCFDSLKKIGSGGWGEVFY 59
+FS + KLI+ A+RG + GP+IFSPL++K +DLAFL+ E+ SL+ IG GG GEVF
Sbjct: 304 VFSVLFKLIIQAIRGSEKPPGPSIFSPLIKKAEDLAFLENEEALASLEIIGRGGCGEVF- 362
Query: 60 KAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119
KAELPGSNGK+IA++K ++ P A EL DE S L+ K+ IRSEI T RHR
Sbjct: 363 KAELPGSNGKIIAVKK-VIQPPKDADELT----DEDSKFLNKKMRQIRSEINTVGHIRHR 417
Query: 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYL 179
N+LPLLAH+ RP CH LVYE+M+ GSLQDIL DV G +EL WPARH+IA GIA+GLEYL
Sbjct: 418 NLLPLLAHVSRPECHYLVYEYMEKGSLQDILTDVQAGNQELMWPARHKIALGIAAGLEYL 477
Query: 180 HMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPES 239
HM H PR+IHRD KPANVL+DDDMEARISDFG K MPD IT + GT+GY+APE
Sbjct: 478 HMDHNPRIIHRDSKPANVLLDDDMEARISDFGLAKAMPDAVTHITTSHVAGTVGYIAPEF 537
Query: 240 LQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINS 299
QT +DKCDIYSFGV+L +LV+GK P D+FF HT+EM ++KWMRN+I SENP+ AI+
Sbjct: 538 YQTHKFTDKCDIYSFGVILGILVIGKLPSDEFFQHTDEMSLIKWMRNIITSENPSLAIDP 597
Query: 300 KLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337
KL+ G++EQMLLVLK+AC+CTL DP +RP+SKDVR+M
Sbjct: 598 KLMDQGFDEQMLLVLKIACYCTLDDPKQRPNSKDVRTM 635
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|24421095|dbj|BAC07504.2| receptor-like protein kinase [Nicotiana tabacum] | Back alignment and taxonomy information |
|---|
Score = 428 bits (1101), Expect = e-117, Method: Compositional matrix adjust.
Identities = 210/338 (62%), Positives = 263/338 (77%), Gaps = 7/338 (2%)
Query: 1 MFSFVLKLILAAVRGGSRDRGPTIFSPLVEK-QDLAFLKKEDCFDSLKKIGSGGWGEVFY 59
+ S + KL++ VR G D TI+SPL++K +DLAFL+KED SL+ IG GG GEV Y
Sbjct: 296 LLSVLFKLVMFFVRKGKTDGSLTIYSPLIKKAEDLAFLEKEDGVASLEMIGKGGCGEV-Y 354
Query: 60 KAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119
+AELPGSNGK+IAI+K I+ PM AAEL ++D + L+ K+ ++SEI Q RHR
Sbjct: 355 RAELPGSNGKIIAIKK-ILQPPMDAAELAEED----TKALNKKMRQVKSEIQILGQIRHR 409
Query: 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYL 179
N+LPLLAHM RP+CH LVYE+MKNGSLQDIL V++G RELDW RHRIA GIA+GLEYL
Sbjct: 410 NLLPLLAHMPRPDCHYLVYEYMKNGSLQDILQQVTEGTRELDWLGRHRIAVGIATGLEYL 469
Query: 180 HMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPES 239
H+ H +IHRD+KPANVL+DDDMEARI+DFG K +PD H +T + GT+GY+APE
Sbjct: 470 HINHSQCIIHRDLKPANVLLDDDMEARIADFGLAKAVPDAHTHVTTSNVAGTVGYIAPEY 529
Query: 240 LQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINS 299
QT +DKCDIYSFGV+LAVLV+GK P D+FF HT EM +VKW+RNV+ SE+P RAI+
Sbjct: 530 HQTLKFTDKCDIYSFGVVLAVLVIGKLPSDEFFQHTPEMSLVKWLRNVMTSEDPKRAIDP 589
Query: 300 KLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337
KL+G+G+EEQMLLVLK+ACFCTL++P ERP+SKDVR M
Sbjct: 590 KLIGSGFEEQMLLVLKIACFCTLENPKERPNSKDVRCM 627
|
Source: Nicotiana tabacum Species: Nicotiana tabacum Genus: Nicotiana Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356516603|ref|XP_003526983.1| PREDICTED: leucine-rich repeat receptor-like serine/threonine/tyrosine-protein kinase SOBIR1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 426 bits (1094), Expect = e-116, Method: Compositional matrix adjust.
Identities = 210/338 (62%), Positives = 256/338 (75%), Gaps = 7/338 (2%)
Query: 1 MFSFVLKLILAAVRGGSRDRGPTIFSPLVEK-QDLAFLKKEDCFDSLKKIGSGGWGEVFY 59
+FS + KL LA ++G R GP I+SPL++K +DLAFL+KE+ SL+ IG GG GEV Y
Sbjct: 294 VFSLMFKLALALIKGRGRKAGPDIYSPLIKKAEDLAFLEKEEGMASLEIIGRGGCGEV-Y 352
Query: 60 KAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119
KAELPGSNGKMIAI+K I+ P AEL ++D S +L+ K+ IRSEI T Q RHR
Sbjct: 353 KAELPGSNGKMIAIKK-IIQPPKEGAELAEED----SKVLNKKMRQIRSEITTVGQIRHR 407
Query: 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYL 179
N+LPLLAH+ RP CH LVYEFMKNGSL D L V G ELDW +RH+IA G+A+GLEYL
Sbjct: 408 NLLPLLAHVSRPGCHYLVYEFMKNGSLHDTLSKVEVGEFELDWLSRHKIALGVAAGLEYL 467
Query: 180 HMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPES 239
H+ H PR+IHRD+KPAN+L+DDDMEARI+DFG K MPD IT + GT+GY+APE
Sbjct: 468 HLNHNPRIIHRDLKPANILLDDDMEARIADFGLAKAMPDYKTHITTSNVAGTVGYIAPEY 527
Query: 240 LQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINS 299
Q +DKCDIYSFGV+L VLV+GK P +FF HTEEM +VKWMR ++ SENP AI++
Sbjct: 528 HQILKFTDKCDIYSFGVILGVLVIGKLPSHEFFQHTEEMSLVKWMRKILSSENPKEAIDT 587
Query: 300 KLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337
KLLGNGYE+QMLLVLK+ACFCT+ DP ERP+SKDV M
Sbjct: 588 KLLGNGYEDQMLLVLKIACFCTMDDPKERPNSKDVWCM 625
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449440606|ref|XP_004138075.1| PREDICTED: leucine-rich repeat receptor-like serine/threonine/tyrosine-protein kinase SOBIR1-like [Cucumis sativus] gi|449501343|ref|XP_004161343.1| PREDICTED: leucine-rich repeat receptor-like serine/threonine/tyrosine-protein kinase SOBIR1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 418 bits (1075), Expect = e-114, Method: Compositional matrix adjust.
Identities = 203/338 (60%), Positives = 258/338 (76%), Gaps = 7/338 (2%)
Query: 1 MFSFVLKLILAAVRGGSRDRGPTIFSP-LVEKQDLAFLKKEDCFDSLKKIGSGGWGEVFY 59
+FS + KL++AA++GGS++ GP+IF+P L+++ DLAFL++++ SL+ IG GG GEV Y
Sbjct: 296 IFSLLFKLVIAAIKGGSKNSGPSIFAPKLIKRDDLAFLERDNALASLQLIGKGGCGEV-Y 354
Query: 60 KAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119
KAELP +GKM AI+K I P AAELI +E S + K+ I+SEI T + RHR
Sbjct: 355 KAELPEKSGKMFAIKK-ITQPPKDAAELI----EEESRHMSKKMRQIKSEIRTVGEIRHR 409
Query: 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYL 179
N+LPL+AH+ RP+CH LVYE MKNGSLQD+L VS G +ELDW RH IA G+ASGLEYL
Sbjct: 410 NLLPLVAHVPRPDCHYLVYELMKNGSLQDMLNQVSAGVKELDWLTRHNIALGVASGLEYL 469
Query: 180 HMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPES 239
HM H PR+IHRD+KPANVL+DD MEARI+DFG K MPD +T + GT+GY+APE
Sbjct: 470 HMNHTPRIIHRDLKPANVLLDDGMEARIADFGLAKAMPDAQTHMTASNVAGTVGYIAPEY 529
Query: 240 LQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINS 299
QT +DKCDIY FGVLL VLV+GK P D+FF +T+EM +VKWM+NV+ S+NP AI+
Sbjct: 530 HQTLKFTDKCDIYGFGVLLGVLVIGKLPSDEFFQNTDEMSLVKWMKNVMTSDNPRGAIDP 589
Query: 300 KLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337
KLLGNG+EEQMLL LK+ACFCT+ +P ERP+SKDVR M
Sbjct: 590 KLLGNGWEEQMLLALKIACFCTMDNPKERPNSKDVRCM 627
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 337 | ||||||
| TAIR|locus:2045228 | 641 | SOBIR1 "SUPPRESSOR OF BIR1 1" | 0.982 | 0.516 | 0.618 | 7.8e-110 | |
| TAIR|locus:2007918 | 1088 | PEPR2 "PEP1 receptor 2" [Arabi | 0.664 | 0.205 | 0.410 | 8e-44 | |
| TAIR|locus:2207056 | 1095 | PSY1R "PSY1 receptor" [Arabido | 0.670 | 0.206 | 0.350 | 3.1e-43 | |
| TAIR|locus:2139885 | 1013 | AT4G28650 [Arabidopsis thalian | 0.810 | 0.269 | 0.395 | 9.4e-43 | |
| TAIR|locus:2032697 | 1123 | PEPR1 "PEP1 receptor 1" [Arabi | 0.652 | 0.195 | 0.394 | 1.4e-42 | |
| TAIR|locus:2203000 | 355 | AT1G78530 [Arabidopsis thalian | 0.771 | 0.732 | 0.363 | 1.8e-42 | |
| TAIR|locus:2025545 | 1029 | AT1G08590 [Arabidopsis thalian | 0.875 | 0.286 | 0.374 | 4.3e-42 | |
| TAIR|locus:2020417 | 1101 | AT1G17230 [Arabidopsis thalian | 0.670 | 0.205 | 0.403 | 6.8e-42 | |
| UNIPROTKB|Q942F3 | 1121 | P0480C01.18-1 "cDNA clone:J033 | 0.673 | 0.202 | 0.390 | 8.2e-42 | |
| TAIR|locus:2091206 | 991 | IKU2 "HAIKU2" [Arabidopsis tha | 0.848 | 0.288 | 0.370 | 2.2e-41 |
| TAIR|locus:2045228 SOBIR1 "SUPPRESSOR OF BIR1 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1085 (387.0 bits), Expect = 7.8e-110, P = 7.8e-110
Identities = 209/338 (61%), Positives = 260/338 (76%)
Query: 1 MFSFVLKLILAAVRGGSRDRGPTIFSPLVEK-QDLAFLKKEDCFDSLKKIGSGGWGEVFY 59
+FS + KLI+ A+RG + GP+IFSPL++K +DLAFL+ E+ SL+ IG GG GEVF
Sbjct: 304 VFSVLFKLIIQAIRGSEKPPGPSIFSPLIKKAEDLAFLENEEALASLEIIGRGGCGEVF- 362
Query: 60 KAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119
KAELPGSNGK+IA++K ++ P A EL DE S L+ K+ IRSEI T RHR
Sbjct: 363 KAELPGSNGKIIAVKK-VIQPPKDADELT----DEDSKFLNKKMRQIRSEINTVGHIRHR 417
Query: 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYL 179
N+LPLLAH+ RP CH LVYE+M+ GSLQDIL DV G +EL WPARH+IA GIA+GLEYL
Sbjct: 418 NLLPLLAHVSRPECHYLVYEYMEKGSLQDILTDVQAGNQELMWPARHKIALGIAAGLEYL 477
Query: 180 HMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPES 239
HM H PR+IHRD+KPANVL+DDDMEARISDFG K MPD IT + GT+GY+APE
Sbjct: 478 HMDHNPRIIHRDLKPANVLLDDDMEARISDFGLAKAMPDAVTHITTSHVAGTVGYIAPEF 537
Query: 240 LQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINS 299
QT +DKCDIYSFGV+L +LV+GK P D+FF HT+EM ++KWMRN+I SENP+ AI+
Sbjct: 538 YQTHKFTDKCDIYSFGVILGILVIGKLPSDEFFQHTDEMSLIKWMRNIITSENPSLAIDP 597
Query: 300 KLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337
KL+ G++EQMLLVLK+AC+CTL DP +RP+SKDVR+M
Sbjct: 598 KLMDQGFDEQMLLVLKIACYCTLDDPKQRPNSKDVRTM 635
|
|
| TAIR|locus:2007918 PEPR2 "PEP1 receptor 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 433 (157.5 bits), Expect = 8.0e-44, Sum P(2) = 8.0e-44
Identities = 98/239 (41%), Positives = 143/239 (59%)
Query: 106 IRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPAR 165
++ EI T RHRN++ L +R L++Y++M NGSL D+L+ +QG LDW AR
Sbjct: 836 MKREIETIGLVRHRNLIRLERFWMRKEDGLMLYQYMPNGSLHDVLHRGNQGEAVLDWSAR 895
Query: 166 HRIARGIASGLEYLHM-CHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQIT 224
IA GI+ GL YLH CH P +IHRDIKP N+L+D DME I DFG +++ D + ++
Sbjct: 896 FNIALGISHGLAYLHHDCHPP-IIHRDIKPENILMDSDMEPHIGDFGLARILDD--STVS 952
Query: 225 VKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWM 284
+ GT GY+APE+ S + D+YS+GV+L LV GK +D F E++++V W+
Sbjct: 953 TATVTGTTGYIAPENAYKTVRSKESDVYSYGVVLLELVTGKRALDRSF--PEDINIVSWV 1010
Query: 285 RNVI--FSENPNRA---INSKL----LGNGYEEQMLLVLKLACFCTLKDPDERPSSKDV 334
R+V+ + + + A ++ KL L EQ + V LA CT K P+ RPS +DV
Sbjct: 1011 RSVLSSYEDEDDTAGPIVDPKLVDELLDTKLREQAIQVTDLALRCTDKRPENRPSMRDV 1069
|
|
| TAIR|locus:2207056 PSY1R "PSY1 receptor" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 411 (149.7 bits), Expect = 3.1e-43, Sum P(2) = 3.1e-43
Identities = 80/228 (35%), Positives = 136/228 (59%)
Query: 107 RSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARH 166
++E+ ++ +H N++ L + V + +L+Y FM+NGSL L++ +G +LDWP R
Sbjct: 845 KAEVEVLSRAKHENLVALQGYCVHDSARILIYSFMENGSLDYWLHENPEGPAQLDWPKRL 904
Query: 167 RIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVK 226
I RG +SGL Y+H P ++HRDIK +N+L+D + +A ++DFG +L+ +T +
Sbjct: 905 NIMRGASSGLAYMHQICEPHIVHRDIKSSNILLDGNFKAYVADFGLSRLILPYRTHVTTE 964
Query: 227 CMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRN 286
+VGT+GY+ PE Q + + D+YSFGV++ L+ GK P++ F ++V W+
Sbjct: 965 -LVGTLGYIPPEYGQAWVATLRGDVYSFGVVMLELLTGKRPME-VFRPKMSRELVAWVHT 1022
Query: 287 VIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDV 334
+ P ++ L +G EE ML VL +AC C ++P +RP+ + V
Sbjct: 1023 MKRDGKPEEVFDTLLRESGNEEAMLRVLDIACMCVNQNPMKRPNIQQV 1070
|
|
| TAIR|locus:2139885 AT4G28650 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 462 (167.7 bits), Expect = 9.4e-43, P = 9.4e-43
Identities = 119/301 (39%), Positives = 178/301 (59%)
Query: 42 CFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHW 101
C IG G G + YKAE+ S+ ++A++KL SAA DI++ +
Sbjct: 698 CIKESNMIGMGATG-IVYKAEMSRSS-TVLAVKKLW----RSAA-----DIEDGTT---- 742
Query: 102 KIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQ-GRREL 160
G E+ + RHRNI+ LL + ++VYEFM NG+L D ++ + GR +
Sbjct: 743 --GDFVGEVNLLGKLRHRNIVRLLGFLYNDKNMMIVYEFMLNGNLGDAIHGKNAAGRLLV 800
Query: 161 DWPARHRIARGIASGLEYLHM-CHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDG 219
DW +R+ IA G+A GL YLH CH P +IHRDIK N+L+D +++ARI+DFG ++M
Sbjct: 801 DWVSRYNIALGVAHGLAYLHHDCHPP-VIHRDIKSNNILLDANLDARIADFGLARMM--A 857
Query: 220 HAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMD 279
+ TV + G+ GY+APE T + +K DIYS+GV+L L+ G+ P++ FG E +D
Sbjct: 858 RKKETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSYGVVLLELLTGRRPLEPEFG--ESVD 915
Query: 280 MVKWMRNVIFSE-NPNRAINSKLLGN-GY-EEQMLLVLKLACFCTLKDPDERPSSKDVRS 336
+V+W+R I + A++ + GN Y +E+MLLVL++A CT K P +RPS +DV S
Sbjct: 916 IVEWVRRKIRDNISLEEALDPNV-GNCRYVQEEMLLVLQIALLCTTKLPKDRPSMRDVIS 974
Query: 337 M 337
M
Sbjct: 975 M 975
|
|
| TAIR|locus:2032697 PEPR1 "PEP1 receptor 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 421 (153.3 bits), Expect = 1.4e-42, Sum P(2) = 1.4e-42
Identities = 93/236 (39%), Positives = 136/236 (57%)
Query: 109 EIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRI 168
EI T + RHRN++ L +R + L++Y +M GSL D+L+ VS LDW AR+ +
Sbjct: 872 EIDTIGKVRHRNLIKLEGFWLRKDDGLMLYRYMPKGSLYDVLHGVSPKENVLDWSARYNV 931
Query: 169 ARGIASGLEYLHM-CHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKC 227
A G+A GL YLH CH P ++HRDIKP N+L+D D+E I DFG +L+ D + ++
Sbjct: 932 ALGVAHGLAYLHYDCHPP-IVHRDIKPENILMDSDLEPHIGDFGLARLLDD--STVSTAT 988
Query: 228 MVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNV 287
+ GT GY+APE+ + D+YS+GV+L LV K VD F E D+V W+R+
Sbjct: 989 VTGTTGYIAPENAFKTVRGRESDVYSYGVVLLELVTRKRAVDKSF--PESTDIVSWVRSA 1046
Query: 288 IFSENPN----------RAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKD 333
+ S N N + +LL + EQ++ V +LA CT +DP RP+ +D
Sbjct: 1047 LSSSNNNVEDMVTTIVDPILVDELLDSSLREQVMQVTELALSCTQQDPAMRPTMRD 1102
|
|
| TAIR|locus:2203000 AT1G78530 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 420 (152.9 bits), Expect = 1.8e-42, Sum P(2) = 1.8e-42
Identities = 100/275 (36%), Positives = 153/275 (55%)
Query: 62 ELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNI 121
++ GS G R +I D+ A + + + E H ++ A+ ++I +HRNI
Sbjct: 79 DILGSGGFGTVYRLVIDDSTTFAVKRLNRGTSERDRGFHRELEAM-ADI------KHRNI 131
Query: 122 LPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHM 181
+ L + P+ +LL+YE M NGSL L+ GR+ LDW +R+RIA G A G+ YLH
Sbjct: 132 VTLHGYFTSPHYNLLIYELMPNGSLDSFLH----GRKALDWASRYRIAVGAARGISYLHH 187
Query: 182 CHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQ 241
P +IHRDIK +N+L+D +MEAR+SDFG LM ++ + GT GY+APE
Sbjct: 188 DCIPHIIHRDIKSSNILLDHNMEARVSDFGLATLMEPDKTHVST-FVAGTFGYLAPEYFD 246
Query: 242 TETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKL 301
T + K D+YSFGV+L L+ G+ P DD F E +V W++ V+ + I+++L
Sbjct: 247 TGKATMKGDVYSFGVVLLELLTGRKPTDDEF-FEEGTKLVTWVKGVVRDQREEVVIDNRL 305
Query: 302 LGNGYEE--QMLLVLKLACFCTLKDPDERPSSKDV 334
G+ +E +M V +A C +P RP+ +V
Sbjct: 306 RGSSVQENEEMNDVFGIAMMCLEPEPAIRPAMTEV 340
|
|
| TAIR|locus:2025545 AT1G08590 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 456 (165.6 bits), Expect = 4.3e-42, P = 4.3e-42
Identities = 119/318 (37%), Positives = 177/318 (55%)
Query: 28 LVEKQDLAFLKKEDCFDSLKK---IGSGGWGEVFYKAELPGSNGKMIAIRKLIVD-APMS 83
LV Q L F D +K+ IG G G + YKAE+ +A++KL +P +
Sbjct: 697 LVAFQRLCFTAG-DILSHIKESNIIGMGAIG-IVYKAEVMRRPLLTVAVKKLWRSPSPQN 754
Query: 84 AAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKN 143
E Q+ DE D+L E+ RHRNI+ +L ++ ++VYE+M N
Sbjct: 755 DIEDHHQEEDEEDDILR--------EVNLLGGLRHRNIVKILGYVHNEREVMMVYEYMPN 806
Query: 144 GSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHM-CHRPRLIHRDIKPANVLIDDD 202
G+L L+ + DW +R+ +A G+ GL YLH C+ P +IHRDIK N+L+D +
Sbjct: 807 GNLGTALHSKDEKFLLRDWLSRYNVAVGVVQGLNYLHNDCYPP-IIHRDIKSNNILLDSN 865
Query: 203 MEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLV 262
+EARI+DFG K+M H TV + G+ GY+APE T I +K DIYS GV+L LV
Sbjct: 866 LEARIADFGLAKMML--HKNETVSMVAGSYGYIAPEYGYTLKIDEKSDIYSLGVVLLELV 923
Query: 263 MGKFPVDDFFGHTEEMDMVKWMRNVIF-SENPNRAINSKLLGNGYE--EQMLLVLKLACF 319
GK P+D F + +D+V+W+R + +E+ I++ + G+ E+MLL L++A
Sbjct: 924 TGKMPIDPSF--EDSIDVVEWIRRKVKKNESLEEVIDASIAGDCKHVIEEMLLALRIALL 981
Query: 320 CTLKDPDERPSSKDVRSM 337
CT K P +RPS +DV +M
Sbjct: 982 CTAKLPKDRPSIRDVITM 999
|
|
| TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 425 (154.7 bits), Expect = 6.8e-42, Sum P(2) = 6.8e-42
Identities = 96/238 (40%), Positives = 142/238 (59%)
Query: 105 AIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRE--LDW 162
+ R+EI T + RHRNI+ L N +LL+YE+M GSL + L +G + LDW
Sbjct: 841 SFRAEISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQL---QRGEKNCLLDW 897
Query: 163 PARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQ 222
AR+RIA G A GL YLH RP+++HRDIK N+L+D+ +A + DFG KL+ +++
Sbjct: 898 NARYRIALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSK 957
Query: 223 ITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVK 282
++ + G+ GY+APE T +++KCDIYSFGV+L L+ GK PV + D+V
Sbjct: 958 -SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQPL---EQGGDLVN 1013
Query: 283 WMRNVIFSENPN-RAINSKLLGNGYE--EQMLLVLKLACFCTLKDPDERPSSKDVRSM 337
W+R I + P +++L N +M LVLK+A FCT P RP+ ++V +M
Sbjct: 1014 WVRRSIRNMIPTIEMFDARLDTNDKRTVHEMSLVLKIALFCTSNSPASRPTMREVVAM 1071
|
|
| UNIPROTKB|Q942F3 P0480C01.18-1 "cDNA clone:J033069J12, full insert sequence" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 402 (146.6 bits), Expect = 8.2e-42, Sum P(2) = 8.2e-42
Identities = 91/233 (39%), Positives = 140/233 (60%)
Query: 108 SEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHR 167
+E+ T + +HRN++PLL + LLVY++MK GSL+D+L+D + ++L+W AR +
Sbjct: 850 AEMETIGKIKHRNLVPLLGYCKAGEERLLVYDYMKFGSLEDVLHDRKKIGKKLNWEARRK 909
Query: 168 IARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKC 227
IA G A GL +LH P +IHRD+K +NVLID+ +EAR+SDFG +LM ++V
Sbjct: 910 IAVGAARGLAFLHHNCIPHIIHRDMKSSNVLIDEQLEARVSDFGMARLMSVVDTHLSVST 969
Query: 228 MVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDF-FGHTEEMDMVKWMRN 286
+ GT GY+ PE Q+ + K D+YS+GV+L L+ GK P D FG E+ ++V W++
Sbjct: 970 LAGTPGYVPPEYYQSFRCTTKGDVYSYGVVLLELLTGKPPTDSADFG--EDNNLVGWVKQ 1027
Query: 287 VIFSENPNRAINSKLLGN--GYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337
+ + + +LL E ++L LK+AC C P RP+ V +M
Sbjct: 1028 HTKLKITD-VFDPELLKEDPSVELELLEHLKIACACLDDRPSRRPTMLKVMAM 1079
|
|
| TAIR|locus:2091206 IKU2 "HAIKU2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 449 (163.1 bits), Expect = 2.2e-41, P = 2.2e-41
Identities = 114/308 (37%), Positives = 170/308 (55%)
Query: 41 DCFDSLKK---IGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSD 97
+ D +K IG GG G V YK L +G+ +A++ + P S+ E + SD
Sbjct: 666 EIIDEIKSENIIGRGGQGNV-YKVSL--RSGETLAVKHIW--CPESSHESFRSSTAMLSD 720
Query: 98 LLHWKI-GAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQG 156
+ G +E+ T + +H N++ L + + LLVYE+M NGSL + L++ +G
Sbjct: 721 GNNRSNNGEFEAEVATLSNIKHINVVKLFCSITCEDSKLLVYEYMPNGSLWEQLHE-RRG 779
Query: 157 RRELDWPARHRIARGIASGLEYLHM-CHRPRLIHRDIKPANVLIDDDMEARISDFGHGKL 215
+E+ W R +A G A GLEYLH RP +IHRD+K +N+L+D++ RI+DFG K+
Sbjct: 780 EQEIGWRVRQALALGAAKGLEYLHHGLDRP-VIHRDVKSSNILLDEEWRPRIADFGLAKI 838
Query: 216 MPDGHAQ--ITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFG 273
+ Q + + GT+GY+APE T +++K D+YSFGV+L LV GK P++ FG
Sbjct: 839 IQADSVQRDFSAPLVKGTLGYIAPEYAYTTKVNEKSDVYSFGVVLMELVTGKKPLETDFG 898
Query: 274 HTEEMDMVKWMRNVIFSENPNRAINSKLLGNG----YEEQMLLVLKLACFCTLKDPDERP 329
E D+V W+ +V S+ NR + KL+ Y+E L VL +A CT K P RP
Sbjct: 899 --ENNDIVMWVWSV--SKETNREMMMKLIDTSIEDEYKEDALKVLTIALLCTDKSPQARP 954
Query: 330 SSKDVRSM 337
K V SM
Sbjct: 955 FMKSVVSM 962
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 337 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-47 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 8e-41 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 9e-39 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-36 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-33 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-32 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-32 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-32 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 7e-31 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-30 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-28 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 6e-28 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-28 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-24 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-24 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-23 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-23 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-23 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-23 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-22 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-22 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 7e-22 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-21 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-21 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-21 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-21 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-21 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-21 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-20 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-20 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-19 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-19 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-19 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-19 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-18 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-18 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-18 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-18 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-18 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-18 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-18 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-18 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 8e-18 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-17 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-17 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-17 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-17 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-17 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-17 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 7e-17 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 9e-17 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-16 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-16 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-16 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-16 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-16 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-16 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-16 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-16 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-16 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 6e-16 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-15 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-15 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-15 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-15 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-15 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-15 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-15 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-15 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-15 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-15 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-15 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-15 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-15 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-15 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-15 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 6e-15 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 7e-15 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 9e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 9e-15 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-14 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-14 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-14 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-14 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-14 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-14 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-14 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 7e-14 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-14 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 8e-14 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-13 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-13 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-13 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-13 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-13 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-13 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-13 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-13 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-13 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-13 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-13 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 8e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 8e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 9e-13 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-12 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-12 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-12 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-12 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-12 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-12 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-12 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-12 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-12 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-12 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 8e-12 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 8e-12 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 9e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-11 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-11 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-11 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-11 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-11 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-11 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-11 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-11 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 5e-11 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-11 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-11 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 8e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 8e-11 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 9e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 9e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-10 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-10 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-10 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-10 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-10 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-10 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-10 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-10 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-10 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-10 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-10 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-10 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-10 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-10 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-10 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 5e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-10 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-10 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-10 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 8e-10 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 8e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-09 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-09 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-09 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-09 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-09 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-09 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-09 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-09 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-09 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-09 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-09 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-09 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-09 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-09 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 6e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 6e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 8e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 8e-09 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 9e-09 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 9e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 9e-09 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 9e-09 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 9e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-08 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-08 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-08 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-08 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-08 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-08 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-08 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-08 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-08 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-08 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 5e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 6e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 8e-08 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 8e-08 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-07 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-07 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-07 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-07 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-07 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 3e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 6e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 6e-07 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 7e-07 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 7e-07 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 8e-07 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 8e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 8e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-06 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-06 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-06 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-06 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-06 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-06 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-06 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-06 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-06 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-06 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 7e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 8e-06 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-05 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-05 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 8e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 1e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-04 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 7e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 0.002 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 4e-47
Identities = 86/292 (29%), Positives = 135/292 (46%), Gaps = 44/292 (15%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
++ L+K+G G +G+V Y A + GK++AI+ + K+ I + +
Sbjct: 1 YEILEKLGEGSFGKV-YLARDKKT-GKLVAIKVIK-----------KKKIKKDRE----- 42
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDW 162
I EI + +H NI+ L + LV E+ + G L D+L +GR D
Sbjct: 43 --RILREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDE 98
Query: 163 PARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQ 222
AR R I S LEYLH ++HRD+KP N+L+D+D +++DFG + + G
Sbjct: 99 -ARF-YLRQILSALEYLHSKG---IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL 153
Query: 223 ITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVK 282
T VGT YMAPE L + DI+S GV+L L+ GK P F G + +++ K
Sbjct: 154 TT---FVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPP---FPGDDQLLELFK 207
Query: 283 WMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDV 334
+ P S E L+ K KDP++R ++++
Sbjct: 208 KIGKPKPPFPPPEWDIS-------PEAKDLIRK--LLV--KDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 141 bits (359), Expect = 8e-41
Identities = 70/215 (32%), Positives = 102/215 (47%), Gaps = 30/215 (13%)
Query: 49 IGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRS 108
+G GG+G V Y A GK +AI+ + + S E + +
Sbjct: 1 LGEGGFGTV-YLARDKK-TGKKVAIKIIKKEDSSSLLEELLR------------------ 40
Query: 109 EIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRI 168
EI + H NI+ L N LV E+ + GSL+D+L + +L RI
Sbjct: 41 EIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLK---ENEGKLSEDEILRI 97
Query: 169 ARGIASGLEYLHMCHRPRLIHRDIKPANVLID-DDMEARISDFGHGKLMPDGHAQITVKC 227
I GLEYLH +IHRD+KP N+L+D D+ + +++DFG KL+ + +
Sbjct: 98 LLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV 154
Query: 228 MVGTMGYMAPESLQTET-ISDKCDIYSFGVLLAVL 261
GT YMAPE L + S+K DI+S GV+L L
Sbjct: 155 --GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 9e-39
Identities = 86/292 (29%), Positives = 130/292 (44%), Gaps = 44/292 (15%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGA 105
L+K+GSG +G V YKA+ G+ GK++A++ L + K
Sbjct: 4 LRKLGSGSFGTV-YKAKHKGT-GKIVAVKIL-----------------KKRSEKSKKDQT 44
Query: 106 IRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPAR 165
R EI + H NI+ L+ + LV E+ + G L D L G L
Sbjct: 45 ARREIRILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYL--SRGGP--LSEDEA 100
Query: 166 HRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLM--PDGHAQI 223
+IA I GLEY H +IHRD+KP N+L+D++ +I+DFG K +
Sbjct: 101 KKIALQILRGLEY---LHSNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT 157
Query: 224 TVKCMVGTMGYMAPESLQTET-ISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVK 282
VGT YMAPE L K D++S GV+L L+ GK P F +D ++
Sbjct: 158 ----FVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPP----FSGENILDQLQ 209
Query: 283 WMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDV 334
+R ++ + +G EE L C KDP +RP+++++
Sbjct: 210 LIRRILGPPLE---FDEPKWSSGSEE----AKDLIKKCLNKDPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 4e-36
Identities = 83/295 (28%), Positives = 129/295 (43%), Gaps = 49/295 (16%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
+ +K +G G G V YK + GK+ A++K+ VD E KQ
Sbjct: 3 LERVKVLGQGSSGVV-YKVRHKPT-GKIYALKKIHVD---GDEEFRKQ------------ 45
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDW 162
+ E+ T ++ + +V E+M GSL D+L ++
Sbjct: 46 ---LLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLL------KKVGKI 96
Query: 163 PAR--HRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGH 220
P IAR I GL+YLH +IHRDIKP+N+LI+ E +I+DFG K++
Sbjct: 97 PEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVL---- 150
Query: 221 AQITVKCM--VGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEM 278
+C VGT+ YM+PE +Q E+ S DI+S G+ L +GKFP F +
Sbjct: 151 ENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFP----FLPPGQP 206
Query: 279 DMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKD 333
+ M+ + P+ L + + + C KDP +RPS+ +
Sbjct: 207 SFFELMQAICDGPPPS------LPAEEFSPEFRDFISA---CLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 2e-33
Identities = 82/301 (27%), Positives = 120/301 (39%), Gaps = 41/301 (13%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDA--PMSAAELIKQDIDEYSDLLH 100
+ L+K+G G +GEV Y A K++A++ L E ++I + L H
Sbjct: 2 YRILRKLGEGSFGEV-YLARDR----KLVALKVLAKKLESKSKEVERFLREIQILASLNH 56
Query: 101 WKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRREL 160
NI+ L LV E++ GSL+D+L + +
Sbjct: 57 -----------------PPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLS 99
Query: 161 DWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID-DDMEARISDFGHGKLMPDG 219
+ A I I S LEYLH +IHRDIKP N+L+D D ++ DFG KL+PD
Sbjct: 100 ESEALF-ILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155
Query: 220 ----HAQITVKCMVGTMGYMAPESLQ---TETISDKCDIYSFGVLLAVLVMGKFPVDDFF 272
VGT GYMAPE L S DI+S G+ L L+ G P +
Sbjct: 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK 215
Query: 273 GHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSK 332
+ +K + + + ++ + L+ K KDP R SS
Sbjct: 216 NSSATSQTLKIILELPTPSLAS-PLSPSNPELISKAASDLLKK----LLAKDPKNRLSSS 270
Query: 333 D 333
Sbjct: 271 S 271
|
Length = 384 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 2e-32
Identities = 62/222 (27%), Positives = 91/222 (40%), Gaps = 40/222 (18%)
Query: 46 LKKIGSGGWGEVFYKAEL---PGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
KK+G G +GEV YK L +A++ L DA + + L
Sbjct: 4 GKKLGEGAFGEV-YKGTLKGKGDGKEVEVAVKTLKEDA----------SEQQIEEFLR-- 50
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDW 162
E + H NI+ LL ++V E+M G L D L +EL
Sbjct: 51 ------EARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYL--RKNRPKELSL 102
Query: 163 PARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFG------HGKLM 216
A IA G+EYL IHRD+ N L+ +++ +ISDFG
Sbjct: 103 SDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY 159
Query: 217 PDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
++ ++ +MAPESL+ + K D++SFGVLL
Sbjct: 160 KVKGGKLPIR-------WMAPESLKEGKFTSKSDVWSFGVLL 194
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 3e-32
Identities = 85/297 (28%), Positives = 128/297 (43%), Gaps = 57/297 (19%)
Query: 42 CFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHW 101
F+ L+KIG GG+GEV YKA GK +AI+ IK + E + +
Sbjct: 1 LFEILEKIGKGGFGEV-YKA-RHKRTGKEVAIKV------------IKLESKEKKEKII- 45
Query: 102 KIGAIRSEIITANQTRHRNILPLLAHMVRPNCHL------LVYEFMKNGSLQDILYDVSQ 155
+EI + +H NI+ +L +V EF GSL+D+L +
Sbjct: 46 ------NEIQILKKCKHPNIVKYY------GSYLKKDELWIVMEFCSGGSLKDLL-KSTN 92
Query: 156 GRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKL 215
A + + + GLEYLH +IHRDIK AN+L+ D E ++ DFG
Sbjct: 93 QTLTESQIAY--VCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQ 147
Query: 216 MPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHT 275
+ D A+ T MVGT +MAPE + + K DI+S G+ L GK P +
Sbjct: 148 LSDTKARNT---MVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSE-LPPM 203
Query: 276 EEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSK 332
+ + + N N S + LK C K+P++RP+++
Sbjct: 204 KALFKI--ATNG-PPGLRNPEKWSDEFKD--------FLKK---CLQKNPEKRPTAE 246
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 4e-32
Identities = 63/222 (28%), Positives = 95/222 (42%), Gaps = 41/222 (18%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGK---MIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
KK+G G +GEV YK +L G GK +A++ L DA + + L
Sbjct: 4 GKKLGEGAFGEV-YKGKLKGKGGKKKVEVAVKTLKEDA----------SEQQIEEFLR-- 50
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDW 162
E + H N++ LL +V E+M+ G L L + R +L
Sbjct: 51 ------EARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL---RKNRPKLSL 101
Query: 163 PARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFG------HGKLM 216
A IA G+EYL IHRD+ N L+ +++ +ISDFG
Sbjct: 102 SDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY 158
Query: 217 PDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
++ ++ +MAPESL+ + K D++SFGVLL
Sbjct: 159 RKRGGKLPIR-------WMAPESLKEGKFTSKSDVWSFGVLL 193
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 7e-31
Identities = 59/234 (25%), Positives = 98/234 (41%), Gaps = 28/234 (11%)
Query: 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAI 106
+ +G G +G V Y A G+++A++ + + S ++ A+
Sbjct: 6 ELLGRGSFGSV-YLALD-KDTGELMAVKSVEL-----------------SGDSEEELEAL 46
Query: 107 RSEIITANQTRHRNILPLLAHMV--RPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPA 164
EI + +H NI+ N + E++ GSL +L + L P
Sbjct: 47 EREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGK----LPEPV 102
Query: 165 RHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQIT 224
+ R I GL YLH ++HRDIK AN+L+D D +++DFG K + D
Sbjct: 103 IRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG 159
Query: 225 VKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEM 278
+ GT +MAPE ++ E DI+S G + + GK P + +
Sbjct: 160 TGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAAL 213
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 1e-30
Identities = 79/306 (25%), Positives = 127/306 (41%), Gaps = 61/306 (19%)
Query: 47 KKIGSGGWGEVFYKAELPGSNGKMI--AIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIG 104
KK+G G +GEV YK +L G +GK A++ L DA +E D L
Sbjct: 1 KKLGEGAFGEV-YKGKLKGKDGKTTEVAVKTLKEDA----------SEEERKDFL----- 44
Query: 105 AIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDIL-----YDVSQGRRE 159
E + H N++ LL LV E+M+ G L D L S +
Sbjct: 45 ---KEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKST 101
Query: 160 LDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPD- 218
L A IA G+EYL + +HRD+ N L+ +D+ +ISDFG + + D
Sbjct: 102 LSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158
Query: 219 ------GHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL-AVLVMGKFPVDDF 271
++ ++ +MAPESL+ + K D++SFGVLL + +G P
Sbjct: 159 DYYRKKTGGKLPIR-------WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL 211
Query: 272 FGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSS 331
++++++R P +E + +L C DP++RP+
Sbjct: 212 SNE----EVLEYLRKGYRLPKPE---------YCPDE----LYELMLSCWQLDPEDRPTF 254
Query: 332 KDVRSM 337
++
Sbjct: 255 SELVER 260
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 3e-28
Identities = 82/304 (26%), Positives = 133/304 (43%), Gaps = 71/304 (23%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
+ +L+KIG G GEV YKA + ++ AI+K+ + KQ+ +
Sbjct: 21 YKNLEKIGEGASGEV-YKATDRATGKEV-AIKKMRLR---------KQNKE--------- 60
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDW 162
I +EI+ +H NI+ + + +V E+M GSL DI+ Q ++
Sbjct: 61 --LIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIIT---QNFVRMNE 115
Query: 163 PARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQ 222
P + R + GLEYLH + IHRDIK N+L+ D +++DFG AQ
Sbjct: 116 PQIAYVCREVLQGLEYLHSQNV---IHRDIKSDNILLSKDGSVKLADFGFA-------AQ 165
Query: 223 ITV-----KCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEE 277
+T +VGT +MAPE ++ + K DI+S G++ + G+ P
Sbjct: 166 LTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPY--------- 216
Query: 278 MDMVKWMRNVIFSENPNRA---INSKLL-----GNGYEEQMLLVLKLACFCTLKDPDERP 329
E P RA I +K + + + L C +KDP++RP
Sbjct: 217 -----------LREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLN---KCLVKDPEKRP 262
Query: 330 SSKD 333
S+++
Sbjct: 263 SAEE 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 6e-28
Identities = 62/223 (27%), Positives = 93/223 (41%), Gaps = 42/223 (18%)
Query: 46 LKKIGSGGWGEVFYKAEL---PGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
KK+G G +GEV YK L +A++ L A +E + L
Sbjct: 4 GKKLGEGAFGEV-YKGTLKGDGEGTETKVAVKTLKEGA----------SEEEREEFL--- 49
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDW 162
E + H NI+ LL + +V E+M G L D L +L
Sbjct: 50 -----EEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKH---GEKLTL 101
Query: 163 PARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFG-------HGKL 215
++A IA G+EYL +HRD+ N L+ +++ +ISDFG
Sbjct: 102 KDLLQMALQIAKGMEYLE---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYY 158
Query: 216 MPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
G ++ +K +MAPESL+ + K D++SFGVLL
Sbjct: 159 RKRGGGKLPIK-------WMAPESLKDGKFTSKSDVWSFGVLL 194
|
Length = 258 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 6e-28
Identities = 68/229 (29%), Positives = 114/229 (49%), Gaps = 18/229 (7%)
Query: 108 SEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHR 167
SEI + +H NI+ L+ L++E+++ +L ++L R L W R +
Sbjct: 732 SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL-------RNLSWERRRK 784
Query: 168 IARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKC 227
IA GIA L +LH P ++ ++ P ++ID E + +L G KC
Sbjct: 785 IAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL------RLSLPGLLCTDTKC 838
Query: 228 MVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNV 287
+ + Y+APE+ +T+ I++K DIY FG++L L+ GK P D FG +V+W R
Sbjct: 839 FISS-AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGS--IVEWARYC 895
Query: 288 IFSENPNRAINSKLLGNG--YEEQMLLVLKLACFCTLKDPDERPSSKDV 334
+ + I+ + G+ + +++ V+ LA CT DP RP + DV
Sbjct: 896 YSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDV 944
|
Length = 968 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99 bits (250), Expect = 2e-24
Identities = 86/295 (29%), Positives = 135/295 (45%), Gaps = 54/295 (18%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
F L+ IG G +GEV YKA +N +++AI K+I D++E D +
Sbjct: 3 FTLLECIGKGSFGEV-YKAIDKRTN-QVVAI-KVI-------------DLEEAED----E 42
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHL-LVYEFMKNGSLQDILYDVSQGRRELD 161
I I+ EI +Q R I ++ L ++ E+ GS D+L +LD
Sbjct: 43 IEDIQQEIQFLSQCRSPYITKYYGSFLK-GSKLWIIMEYCGGGSCLDLLK-----PGKLD 96
Query: 162 WPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFG-HGKLMPDGH 220
I R + GLEYLH IHRDIK AN+L+ ++ + +++DFG G+L
Sbjct: 97 ETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQL---TS 150
Query: 221 AQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDM 280
VGT +MAPE ++ +K DI+S G+ L G+ P+ D +
Sbjct: 151 TMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSD-------LHP 203
Query: 281 VKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLK--LACFCTLKDPDERPSSKD 333
++ + + + P L GN + + K ++ C KDP ERPS+K+
Sbjct: 204 MRVLFLIPKNNPP------SLEGNKFSKP----FKDFVSL-CLNKDPKERPSAKE 247
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 3e-24
Identities = 83/290 (28%), Positives = 122/290 (42%), Gaps = 40/290 (13%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
+ L ++G+G G V K + I K I A + KQ + E D+LH
Sbjct: 3 LEYLGELGAGNSGVV-SKVLHRPTG--KIMAVKTIRLEINEA--IQKQILREL-DILH-- 54
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDW 162
+ I+ + E+M GSL IL +V E
Sbjct: 55 ------------KCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPE--- 99
Query: 163 PARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQ 222
+IA + GL YLH H+ +IHRD+KP+N+L++ + ++ DFG + + A
Sbjct: 100 RILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA- 156
Query: 223 ITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVK 282
K VGT YMAPE +Q S K DI+S G+ L L G+FP + D +
Sbjct: 157 ---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYP---PENDPPDGIF 210
Query: 283 WMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSK 332
+ I +E P R + K + + L C +KDP ERPS K
Sbjct: 211 ELLQYIVNEPPPRLPSGK-----FSPDFQDFVNL---CLIKDPRERPSYK 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 3e-24
Identities = 63/225 (28%), Positives = 101/225 (44%), Gaps = 38/225 (16%)
Query: 48 KIGSGGWGEVFYKAELPGSNGKMIAIRKLIV-DAPMSAAELIKQDIDEYSDLLHWKIGAI 106
IG G +G V YK L G +AI+++ + A + I Q+ID +L
Sbjct: 7 LIGRGAFGVV-YKG-LNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNL-------- 56
Query: 107 RSEIITANQTRHRNILPLLAHMVRPNCHL-LVYEFMKNGSLQDILYDVSQGRRELDWPAR 165
+H NI+ + + + L ++ E+ +NGSL+ I+ ++ +P
Sbjct: 57 ----------KHPNIVKYIGS-IETSDSLYIILEYAENGSLRQII------KKFGPFP-E 98
Query: 166 HRIARGIA---SGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQ 222
+A + GL YLH +IHRDIK AN+L D +++DFG + D
Sbjct: 99 SLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155
Query: 223 ITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFP 267
+VGT +MAPE ++ S DI+S G + L+ G P
Sbjct: 156 DAS--VVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 1e-23
Identities = 71/226 (31%), Positives = 109/226 (48%), Gaps = 44/226 (19%)
Query: 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIK-QDIDEYSDL 98
++ ++ +++IGSG +G+V YKA + IA +L A ++IK + D++
Sbjct: 2 QEDYELIQRIGSGTYGDV-YKA-------RDIATGEL------VAIKVIKLEPGDDFEI- 46
Query: 99 LHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRR 158
I+ EI + RH NI+ +R + +V E+ GSLQDI Y V R
Sbjct: 47 -------IQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDI-YQV--TRG 96
Query: 159 ELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPD 218
L + R GL YLH + IHRDIK AN+L+ +D + +++DFG
Sbjct: 97 PLSELQIAYVCRETLKGLAYLHETGK---IHRDIKGANILLTEDGDVKLADFGVS----- 148
Query: 219 GHAQITV-----KCMVGTMGYMAPESLQTETISD---KCDIYSFGV 256
AQ+T K +GT +MAPE E KCDI++ G+
Sbjct: 149 --AQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGI 192
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 2e-23
Identities = 78/291 (26%), Positives = 124/291 (42%), Gaps = 43/291 (14%)
Query: 46 LKKIGSGGWGEVFYKAE-LPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIG 104
++ IG G V Y A LP N + +AI+++ +L K +
Sbjct: 6 IEVIGVGATAVV-YAAICLP--NNEKVAIKRI---------DLEKCQTS---------VD 44
Query: 105 AIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDIL-YDVSQGRRELDWP 163
+R E+ +Q H N++ V + LV ++ GSL DI+ +G LD
Sbjct: 45 ELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRG--GLDEA 102
Query: 164 ARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFG-HGKLMPDGHAQ 222
+ + + GLEYLH IHRDIK N+L+ +D +I+DFG L G
Sbjct: 103 IIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT 159
Query: 223 ITV-KCMVGTMGYMAPESLQTETISD-KCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDM 280
V K VGT +MAPE ++ D K DI+SFG+ L G P +
Sbjct: 160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP------- 212
Query: 281 VKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSS 331
+K + + ++ P+ + + ++ L C KDP +RP++
Sbjct: 213 MKVLMLTLQNDPPSLETGADYKKYSKSFRKMISL-----CLQKDPSKRPTA 258
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 96.1 bits (240), Expect = 5e-23
Identities = 75/312 (24%), Positives = 114/312 (36%), Gaps = 66/312 (21%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
F K IG G + V A+ K AI+ L +LIK+ K
Sbjct: 3 FKFGKIIGEGSFSTV-VLAKEK-ETNKEYAIKIL------DKRQLIKEK----------K 44
Query: 103 IGAIRSEIITANQ-TRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELD 161
+ ++ E + H I+ L V E+ NG L + LD
Sbjct: 45 VKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGS----LD 100
Query: 162 WP-ARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGH 220
R A I LEYLH +IHRD+KP N+L+D DM +I+DFG K++
Sbjct: 101 EKCTRFYAAE-ILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156
Query: 221 AQITVKCM------------------VGTMGYMAPESLQTETISDKCDIYSFGVLLAVLV 262
+ + K VGT Y++PE L + D+++ G ++ ++
Sbjct: 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQML 216
Query: 263 MGKFPVDDFFGHTEEMDMVKWM-RNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCT 321
GK P F G E + K + F N + L+ KL
Sbjct: 217 TGKPP---FRGSNEYLTFQKILKLEYSFPPNFP------------PDAKDLIEKL----L 257
Query: 322 LKDPDERPSSKD 333
+ DP +R +
Sbjct: 258 VLDPQDRLGVNE 269
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 5e-23
Identities = 55/184 (29%), Positives = 81/184 (44%), Gaps = 25/184 (13%)
Query: 108 SEIITANQTRH----RNILPLLAH--MVRPNC------HL-LVYEFMKNGSLQDILYDVS 154
+II + H RNIL + H +V+ + L LV E+ G L L
Sbjct: 29 KKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLS--K 86
Query: 155 QGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGK 214
+GR A I LEYLH +I+RD+KP N+L+D D +++DFG K
Sbjct: 87 EGR--FSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAK 141
Query: 215 LMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGH 274
+ ++ GT Y+APE L + D +S GVLL ++ GK P F+
Sbjct: 142 ELSSEGSRTNT--FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP---FYAE 196
Query: 275 TEEM 278
+
Sbjct: 197 DRKE 200
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 1e-22
Identities = 83/302 (27%), Positives = 131/302 (43%), Gaps = 62/302 (20%)
Query: 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLL 99
E+ FD L+K+G G +G V YKA + G+++AI+ + V+ D+ E
Sbjct: 2 EEVFDILEKLGEGSYGSV-YKA-IHKETGQVVAIKVVPVEE----------DLQE----- 44
Query: 100 HWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRE 159
I EI Q I+ + +V E+ GS+ DI + +
Sbjct: 45 ------IIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDI---MKITNKT 95
Query: 160 LDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDG 219
L I GLEYLH + IHRDIK N+L++++ +A+++DFG + D
Sbjct: 96 LTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT 152
Query: 220 HAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMD 279
A+ ++GT +MAPE +Q ++K DI+S G+ + GK P D
Sbjct: 153 MAKR--NTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSD--------- 201
Query: 280 MVKWMRNVIFSENPNRAIN--------SKLLGNGYEEQMLLVLKLACFCTLKDPDERPSS 331
+ MR IF PN+ S N + ++ C +KDP+ERPS+
Sbjct: 202 -IHPMR-AIF-MIPNKPPPTLSDPEKWSPEF-NDFVKK----------CLVKDPEERPSA 247
Query: 332 KD 333
Sbjct: 248 IQ 249
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 1e-22
Identities = 79/301 (26%), Positives = 121/301 (40%), Gaps = 47/301 (15%)
Query: 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLH 100
+ L ++G G G V K L N MI K I P +L KQ
Sbjct: 1 EKIVELSRLGEGAGGSV-TKCRLK--NTGMIFALKTITTDP--NPDLQKQ---------- 45
Query: 101 WKIGAIRSEIITANQTRHRNILPLL-AHMVRPNCHL-LVYEFMKNGSLQDILYDV-SQGR 157
I E+ + I+ A + + + + E+ + GSL I V +G
Sbjct: 46 -----ILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGG 100
Query: 158 RELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFG-HGKLM 216
R + +IA + GL YLH ++IHRDIKP+N+L+ + ++ DFG G+L+
Sbjct: 101 RIGEKVL-GKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156
Query: 217 PDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPV----DDFF 272
T GT YMAPE +Q + S D++S G+ L + +FP +
Sbjct: 157 NSLAGTFT-----GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPL 211
Query: 273 GHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSK 332
G E + + M N + P I + E+ + C KDP RP+
Sbjct: 212 GPIELLSYIVNMPNPELKDEPGNGIK-------WSEEFKDFI---KQCLEKDPTRRPTPW 261
Query: 333 D 333
D
Sbjct: 262 D 262
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 92.7 bits (231), Expect = 7e-22
Identities = 77/298 (25%), Positives = 130/298 (43%), Gaps = 48/298 (16%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
++ L+ IG G +G V K S+GK++ K I M+ E KQ
Sbjct: 2 YEVLETIGKGSFGTV-RKVRRK-SDGKILV-WKEIDYGNMTEKE--KQ------------ 44
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHLL--VYEFMKNGSLQDILYDVSQGRREL 160
+ SE+ + +H NI+ ++ + L V E+ + G L + + + ++E
Sbjct: 45 --QLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQL---IQKCKKER 99
Query: 161 DWPARHRIARGIASGLEYLHMCHR-----PRLIHRDIKPANVLIDDDMEARISDFGHGKL 215
+ I R + L L+ CH ++HRD+KPAN+ +D + ++ DFG K+
Sbjct: 100 KYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159
Query: 216 MPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHT 275
+ GH K VGT YM+PE L + +K DI+S G L+ L P F
Sbjct: 160 L--GHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP----FTAR 213
Query: 276 EEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKD 333
++ + ++ F P R Y ++ V+K DPD+RPS+++
Sbjct: 214 NQLQLASKIKEGKFRRIPYR----------YSSELNEVIK---SMLNVDPDKRPSTEE 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (230), Expect = 2e-21
Identities = 75/317 (23%), Positives = 134/317 (42%), Gaps = 61/317 (19%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
++ + +IG G +G+V YKA G+++A++K+ ++ + + +
Sbjct: 1 YEKIAQIGEGTYGQV-YKAR-NKKTGELVALKKIRME----------NEKEGFP------ 42
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMV---RPNCHLLVYEFMKNGSLQDILYDVSQGRRE 159
I AIR EI + RH NI+ L + + + ++ V+E+M + L +L +
Sbjct: 43 ITAIR-EIKLLQKLRHPNIVRLKEIVTSKGKGSIYM-VFEYMDH-DLTGLLDSPEV---K 96
Query: 160 LDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLM-PD 218
+ + GL+Y H ++HRDIK +N+LI++D +++DFG +
Sbjct: 97 FTESQIKCYMKQLLEGLQY---LHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153
Query: 219 GHAQITVKCMVGTMGYMAPESLQTETISD-KCDIYSFGVLLAVLVMGKFPVDDFFGHTE- 276
A T + V T+ Y PE L T + D++S G +LA L +GK P+ F G TE
Sbjct: 154 NSADYTNR--VITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGK-PI--FQGSTEL 208
Query: 277 -------------------EMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLA 317
+ + W N+ + R + + L+ KL
Sbjct: 209 EQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLL 268
Query: 318 CFCTLKDPDERPSSKDV 334
DP +R S+
Sbjct: 269 TL----DPKKRISADQA 281
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 2e-21
Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 23/203 (11%)
Query: 139 EFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198
EFM GSL I E+ +IA + GL YL+ HR ++HRDIKP+N+L
Sbjct: 83 EFMDCGSLDRIYKKGGPIPVEI----LGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNIL 136
Query: 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
++ + ++ DFG + + A VGT YM+PE +Q + K D++S G+ +
Sbjct: 137 VNSRGQIKLCDFGVSGELINSIADT----FVGTSTYMSPERIQGGKYTVKSDVWSLGISI 192
Query: 259 AVLVMGKFPV----DDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVL 314
L +GKFP D G + M ++ ++ ++ P +L + + E + +
Sbjct: 193 IELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPP------RLPSSDFPEDLRDFV 246
Query: 315 KLACFCTLKDPDERPSSKDVRSM 337
C LKDP ERP+ + + +M
Sbjct: 247 DA---CLLKDPTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 2e-21
Identities = 63/228 (27%), Positives = 97/228 (42%), Gaps = 31/228 (13%)
Query: 49 IGSGGWGEVFYKAELPGSNGKMIAIRK-LIVDAPMSAAELIKQDIDEYSDLLHWKIGAIR 107
+GSG +G V Y+ L +G A+++ + D + E +KQ +
Sbjct: 8 LGSGSFGSV-YEG-LNLDDGDFFAVKEVSLADDGQTGQEAVKQ---------------LE 50
Query: 108 SEIITANQTRHRNILPLLAHMVRPNCHLLVY-EFMKNGSLQDILYDVSQGRRELDWPARH 166
EI ++ +H NI+ L R +L ++ E + GSL +L P
Sbjct: 51 QEIALLSKLQHPNIVQYLG-TEREEDNLYIFLELVPGGSLAKLLKKYGS----FPEPVIR 105
Query: 167 RIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVK 226
R I GLEYLH +HRDIK AN+L+D + +++DFG K + K
Sbjct: 106 LYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAK 159
Query: 227 CMVGTMGYMAPESL-QTETISDKCDIYSFGVLLAVLVMGKFPVDDFFG 273
G+ +MAPE + Q DI+S G + + GK P G
Sbjct: 160 SFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG 207
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 90.6 bits (226), Expect = 4e-21
Identities = 74/297 (24%), Positives = 124/297 (41%), Gaps = 57/297 (19%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGA 105
+K+IG G +G+V Y S+GK+ ++++ + MS E ++D
Sbjct: 5 IKQIGKGSFGKV-YLVR-RKSDGKLYVLKEIDLSN-MSEKE--REDA------------- 46
Query: 106 IRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRE------ 159
+E+ + H NI+ +V E+ G L + + +
Sbjct: 47 -LNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQI 105
Query: 160 LDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDG 219
LDW + + L+YLH +++HRDIKP N+ + + ++ DFG K++
Sbjct: 106 LDWFVQ------LCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVL--S 154
Query: 220 HAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMD 279
K +VGT Y++PE Q + + K DI+S G +L L K P F G
Sbjct: 155 STVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHP---FEGENLLEL 211
Query: 280 MVKWMRNVIFSENPNRAINSKLLGNGYEEQML-LVLKLACFCTL-KDPDERPSSKDV 334
+K ++ I S+ Y ++ LV L L KDP+ERPS +
Sbjct: 212 ALKILKGQY------PPIPSQ-----YSSELRNLVSSL-----LQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 5e-21
Identities = 61/200 (30%), Positives = 93/200 (46%), Gaps = 36/200 (18%)
Query: 139 EFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198
EFM GSL+ G D +AR I SG+ YLH R ++HRDIKP+N+L
Sbjct: 152 EFMDGGSLE--------GTHIADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLL 200
Query: 199 IDDDMEARISDFGHGKLMPDGHAQITVKC--MVGTMGYMAPESLQTET---ISDKC--DI 251
I+ +I+DFG +++ AQ C VGT+ YM+PE + T+ D DI
Sbjct: 201 INSAKNVKIADFGVSRIL----AQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDI 256
Query: 252 YSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQML 311
+S GV + +G+FP FG + D M + S+ P + +
Sbjct: 257 WSLGVSILEFYLGRFP----FGVGRQGDWASLMCAICMSQPPEAPATASREFRHF----- 307
Query: 312 LVLKLACFCTLKDPDERPSS 331
++C C ++P +R S+
Sbjct: 308 ----ISC-CLQREPAKRWSA 322
|
Length = 353 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 5e-21
Identities = 71/221 (32%), Positives = 98/221 (44%), Gaps = 30/221 (13%)
Query: 49 IGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGA-IR 107
+G GG+GEV A + GKM A +KL + +K+ E L KI +
Sbjct: 1 LGKGGFGEVC--ACQVKATGKMYACKKL-------DKKRLKKRKGEQMALNEKKILEKVS 51
Query: 108 SEIITANQTRHRNILPLLAHMVRPNCHL-LVYEFMKNGSLQDILYDVSQGRRELDWPARH 166
S I + LA+ L LV M G L+ +Y+V G
Sbjct: 52 SRFIVS-----------LAYAFETKDDLCLVMTLMNGGDLKYHIYNV--GEPGFPEARAI 98
Query: 167 RIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVK 226
A I GLE+LH + R+++RD+KP NVL+DD RISD G + G +K
Sbjct: 99 FYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIK 152
Query: 227 CMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFP 267
GT GYMAPE LQ E D ++ G L ++ G+ P
Sbjct: 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 2e-20
Identities = 64/215 (29%), Positives = 101/215 (46%), Gaps = 44/215 (20%)
Query: 49 IGSGGWGEVF---YKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGA 105
IG G +G+V Y+ G+ +A++ L D+ + A L E S
Sbjct: 14 IGKGEFGDVMLGDYR-------GQKVAVKCLKDDSTAAQAFL-----AEAS--------- 52
Query: 106 IRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPAR 165
RH N++ LL +++ N +V E+M GSL D L S+GR + +
Sbjct: 53 ------VMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLR--SRGRAVITLAQQ 104
Query: 166 HRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGH--AQI 223
A + G+EYL +HRD+ NVL+ +D+ A++SDFG K G ++
Sbjct: 105 LGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKL 161
Query: 224 TVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
VK + APE+L+ + S K D++SFG+LL
Sbjct: 162 PVK-------WTAPEALREKKFSTKSDVWSFGILL 189
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 3e-20
Identities = 75/288 (26%), Positives = 124/288 (43%), Gaps = 32/288 (11%)
Query: 49 IGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRS 108
IG G +G V+ L + G+M+A++++ EL + + A+RS
Sbjct: 9 IGKGTYGRVYLA--LNVTTGEMMAVKQV---------ELPATIAGRHDSRQKDMVKALRS 57
Query: 109 EIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRI 168
EI T H NI+ L + E++ GS+ L + GR E R
Sbjct: 58 EIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLR--TYGRFEEQL-VRF-F 113
Query: 169 ARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCM 228
+ GL YLH ++HRD+K N+L+D D +ISDFG K D + M
Sbjct: 114 TEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSM 170
Query: 229 VGTMGYMAPE--SLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRN 286
G++ +MAPE ++ S K DI+S G ++ + G+ P D + + M
Sbjct: 171 QGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSD-------EEAIAAMFK 223
Query: 287 VIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDV 334
+ ++ I + N + L ACF +PD RP+++++
Sbjct: 224 -LGNKRSAPPIPPDVSMN--LSPVALDFLNACF--TINPDNRPTAREL 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 7e-20
Identities = 84/295 (28%), Positives = 130/295 (44%), Gaps = 47/295 (15%)
Query: 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLL 99
E+ F L+KIG G +GEVF + K++AI+ + D++E D
Sbjct: 3 EELFTKLEKIGKGSFGEVF--KGIDNRTQKVVAIKII--------------DLEEAED-- 44
Query: 100 HWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRE 159
+I I+ EI +Q + ++ ++ E++ GS D+L
Sbjct: 45 --EIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-----GP 97
Query: 160 LDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDG 219
LD I R I GL+YLH + IHRDIK ANVL+ + E +++DFG + D
Sbjct: 98 LDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD- 153
Query: 220 HAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMD 279
QI VGT +MAPE ++ K DI+S G+ L G+ P H+E
Sbjct: 154 -TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP------HSELHP 206
Query: 280 MVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDV 334
M V+F N N L Y + + ++ C K+P RP++K++
Sbjct: 207 M-----KVLFLIPKN---NPPTLEGNYSKPLKEFVEA---CLNKEPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 1e-19
Identities = 80/288 (27%), Positives = 128/288 (44%), Gaps = 39/288 (13%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKL-IVDAPMSAAELIKQDIDEYSDLLHW 101
F KKIG G + V YKA +G+++A++K+ I + M A+ +QD + DLL
Sbjct: 4 FKIEKKIGKGQFSVV-YKAICL-LDGRVVALKKVQIFE--MMDAK-ARQDCLKEIDLL-- 56
Query: 102 KIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELD 161
Q H N++ LA + N +V E G L ++ + +R +
Sbjct: 57 ------------KQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIP 104
Query: 162 WPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHA 221
+ + S LE HM H R++HRDIKPANV I ++ D G G+
Sbjct: 105 ERTIWKYFVQLCSALE--HM-HSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS--K 159
Query: 222 QITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMV 281
+VGT YM+PE + + K DI+S G LL + + P F+G ++M++
Sbjct: 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP---FYG--DKMNLY 214
Query: 282 KWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERP 329
+ + + P L + Y E++ L C DP++RP
Sbjct: 215 SLCKKIEKCDYP------PLPADHYSEEL---RDLVSRCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-19
Identities = 61/227 (26%), Positives = 113/227 (49%), Gaps = 25/227 (11%)
Query: 49 IGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRS 108
IGSG +G V+ + S+G+++A++++ + + ++++ K+ + + A+
Sbjct: 8 IGSGSFGSVYLG--MNASSGELMAVKQVELPSVSASSKDRKRSM----------LDALAR 55
Query: 109 EIITANQTRHRNILPLLAHMVRPNCHLLVY-EFMKNGSLQDILYDVSQGRRELDWPARHR 167
EI + +H NI+ L + + HL ++ E++ GS+ +L + +
Sbjct: 56 EIALLKELQHENIVQYLGSSLDAD-HLNIFLEYVPGGSVAALLNNYGA----FEETLVRN 110
Query: 168 IARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVK- 226
R I GL YLH +IHRDIK AN+L+D+ +ISDFG K +
Sbjct: 111 FVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNG 167
Query: 227 ---CMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDD 270
+ G++ +MAPE ++ + + K DI+S G L+ ++ GK P D
Sbjct: 168 ARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPD 214
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 1e-19
Identities = 64/240 (26%), Positives = 99/240 (41%), Gaps = 41/240 (17%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
F+ L+ IG G +G+V + KM A++ + KQ E
Sbjct: 2 FELLRVIGKGAFGKVCIVQKR--DTKKMFAMK-----------YMNKQKCVEKG-----S 43
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMV-----RPNCHLLVYEFMKNGSLQDILYDVSQGR 157
+ + +E + H P L ++ N +L+V + + G D+ Y +SQ
Sbjct: 44 VRNVLNERRILQELNH----PFLVNLWYSFQDEENMYLVV-DLLLGG---DLRYHLSQKV 95
Query: 158 RELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMP 217
+ + + I I LEYLH +IHRDIKP N+L+D+ I+DF +
Sbjct: 96 KFSEEQVKFWICE-IVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVT 151
Query: 218 DGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEE 277
+ GT GYMAPE L + S D +S GV + GK P + GH+
Sbjct: 152 PDTLTTS---TSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP---YRGHSRT 205
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 3e-19
Identities = 87/287 (30%), Positives = 127/287 (44%), Gaps = 41/287 (14%)
Query: 49 IGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRS 108
+G GG+GEV A + GK+ A +KL + L K+ E GA+
Sbjct: 1 LGKGGFGEVS--ACQMRATGKLYACKKL------NKKRLKKRKGYE---------GAMVE 43
Query: 109 EIITANQTRHRNILPLLAHMVRPNCHL-LVYEFMKNGSLQDILYDVSQGRRELDWPARHR 167
+ I A H + LA+ + L LV M G L+ +Y+V + P
Sbjct: 44 KRILAKV--HSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACF 101
Query: 168 IARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKC 227
I SGLE+LH + R+I+RD+KP NVL+D+D RISD G + DG Q K
Sbjct: 102 YTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG--QSKTKG 156
Query: 228 MVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNV 287
GT G+MAPE LQ E D ++ GV L ++ + P F E+++
Sbjct: 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGP---FRARGEKVEN------- 206
Query: 288 IFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTL-KDPDERPSSKD 333
E R +N + Y ++ K C L KDP++R +D
Sbjct: 207 --KELKQRILNDSV---TYPDKFSPASKSFCEALLAKDPEKRLGFRD 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 6e-19
Identities = 69/289 (23%), Positives = 123/289 (42%), Gaps = 43/289 (14%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
F+ L KIG G +G V +K + ++ ++ A++++ + M+ E +
Sbjct: 2 FEILNKIGKGSFGVV-FKV-VRKADKRVYAMKQIDLSK-MNRRE---------------R 43
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDW 162
AI + A + I+ + +V E+ +NG L +L Q R L
Sbjct: 44 EEAIDEARVLA-KLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLK--MQRGRPLPE 100
Query: 163 PARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQ 222
R I GL +LH +++HRDIK N+ +D +I D G KL+ D
Sbjct: 101 DQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD--NT 155
Query: 223 ITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVK 282
+VGT Y++PE + + ++K D+++ GV+L GK P D + + ++K
Sbjct: 156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFD---ANNQGALILK 212
Query: 283 WMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSS 331
+R V + Y +Q+ ++ C KD +RP +
Sbjct: 213 IIRGVF-----------PPVSQMYSQQLAQLIDQ---CLTKDYRQRPDT 247
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 1e-18
Identities = 75/297 (25%), Positives = 132/297 (44%), Gaps = 50/297 (16%)
Query: 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLL 99
E F L++IG G +G V++ ++ +++AI+K+ KQ +++ D++
Sbjct: 14 EKLFTDLREIGHGSFGAVYFARDV--RTNEVVAIKKMSYSG--------KQSNEKWQDII 63
Query: 100 HWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRE 159
E+ Q RH N + +R + LV E+ GS DIL + +E
Sbjct: 64 --------KEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQE 114
Query: 160 LDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDG 219
++ A I G GL YLH R IHRDIK N+L+ + +++DFG L+
Sbjct: 115 VEIAA---ICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168
Query: 220 HAQITVKCMVGTMGYMAPE---SLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTE 276
++ VGT +MAPE ++ K D++S G+ L K P+ +
Sbjct: 169 NS------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN------ 216
Query: 277 EMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKD 333
M+ + + ++ +++P L N + + + C K P +RPSS++
Sbjct: 217 -MNAMSALYHIAQNDSPT------LSSNDWSDYFRNFVDS---CLQKIPQDRPSSEE 263
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 1e-18
Identities = 60/230 (26%), Positives = 98/230 (42%), Gaps = 44/230 (19%)
Query: 46 LKKIGSGGWGEVFYKAELPGS-NGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIG 104
+K+G+G +GEV+ G+ NG K + MS ++
Sbjct: 11 ERKLGAGQFGEVWM-----GTWNGTTKVAVKTLKPGTMSPEAFLQ--------------- 50
Query: 105 AIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPA 164
E + RH ++ L A +V E+M GSL D L ++L P
Sbjct: 51 ----EAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKS--GEGKKLRLPQ 104
Query: 165 RHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGH---- 220
+A IA G+ YL IHRD+ N+L+ +++ +I+DFG +L+ D
Sbjct: 105 LVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAR 161
Query: 221 --AQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFP 267
A+ +K + APE+ + K D++SFG+LL +V G+ P
Sbjct: 162 EGAKFPIK-------WTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-18
Identities = 69/225 (30%), Positives = 104/225 (46%), Gaps = 26/225 (11%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
F + +G GG+GEV A + GKM A +KL + IK+ E L
Sbjct: 2 FRQYRVLGKGGFGEVC--ACQVRATGKMYACKKL-------EKKRIKKRKGESMAL---- 48
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDW 162
+E + R ++ L + LV M G L+ +Y + G +
Sbjct: 49 -----NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM--GEAGFEE 101
Query: 163 PARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQ 222
A I GLE LH + R+++RD+KP N+L+DD RISD G +P+G
Sbjct: 102 GRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-- 156
Query: 223 ITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFP 267
T+K VGT+GYMAPE ++ E + D ++ G LL ++ G+ P
Sbjct: 157 -TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-18
Identities = 49/166 (29%), Positives = 88/166 (53%), Gaps = 16/166 (9%)
Query: 105 AIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPA 164
A E + H+N++ LL ++ ++ V E M G+L + L ++GR +
Sbjct: 45 AFLEETAVMTKLHHKNLVRLLGVILHNGLYI-VMELMSKGNLVNFLR--TRGRALVSVIQ 101
Query: 165 RHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDG--HAQ 222
+ + +A G+EYL +L+HRD+ N+L+ +D A++SDFG ++ G +++
Sbjct: 102 LLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSK 158
Query: 223 ITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL-AVLVMGKFP 267
+ VK + APE+L+ + S K D++S+GVLL V G+ P
Sbjct: 159 LPVK-------WTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-18
Identities = 75/303 (24%), Positives = 128/303 (42%), Gaps = 63/303 (20%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
F +K+GSG +GEV+ E N +AI+ ++K D DLL
Sbjct: 8 FTLERKLGSGYFGEVW---EGLWKNRVRVAIK------------ILKSD-----DLLK-- 45
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDW 162
+ E+ + RH++++ L A ++ E M+ GSL L +G+ L
Sbjct: 46 QQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRS-PEGQ-VLPV 103
Query: 163 PARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPD---- 218
+ +A +A G+ YL IHRD+ N+L+ +D+ +++DFG +L+ +
Sbjct: 104 ASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160
Query: 219 -GHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL-AVLVMGKFPVDDFFGHTE 276
+I K + APE+ T S K D++SFG+LL + G+ P H E
Sbjct: 161 SSDKKIPYK-------WTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH-E 212
Query: 277 EMDMVKWMRNVIF---SENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKD 333
D + ++ P Q + + L C+ +P++RPS K
Sbjct: 213 VYDQI--TAGYRMPCPAKCP---------------QEIYKIMLECWA--AEPEDRPSFKA 253
Query: 334 VRS 336
+R
Sbjct: 254 LRE 256
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 2e-18
Identities = 58/219 (26%), Positives = 97/219 (44%), Gaps = 31/219 (14%)
Query: 46 LKKIGSGGWGEVF-YKAELPGSN-GKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKI 103
+K++G G +G+V + + G N G+ +A++ L SD
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHR----------SDF----- 53
Query: 104 GAIRSEIITANQTRHRNILPL--LAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRE-L 160
EI H NI+ + L+ E++ +GSL+D L Q R+ +
Sbjct: 54 ---EREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL----QRHRDQI 106
Query: 161 DWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGH 220
+ + I G++YL R IHRD+ N+L++ + +ISDFG K++P+
Sbjct: 107 NLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDK 163
Query: 221 AQITVKCMVGT-MGYMAPESLQTETISDKCDIYSFGVLL 258
VK + + + APE L+T S D++SFGV L
Sbjct: 164 DYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTL 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 3e-18
Identities = 70/232 (30%), Positives = 106/232 (45%), Gaps = 30/232 (12%)
Query: 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLL 99
E+ F L++IG G +GEV+ + + K + K+I D++E D
Sbjct: 3 EELFTKLERIGKGSFGEVYKGID---NRTKEVVAIKII-------------DLEEAED-- 44
Query: 100 HWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRE 159
+I I+ EI +Q I ++ ++ E++ GS D+L G E
Sbjct: 45 --EIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLL---KPGPLE 99
Query: 160 LDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDG 219
+ A I R I GL+YLH R IHRDIK ANVL+ + + +++DFG + D
Sbjct: 100 ETYIAT--ILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD- 153
Query: 220 HAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDF 271
QI VGT +MAPE ++ K DI+S G+ L G+ P D
Sbjct: 154 -TQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL 204
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 4e-18
Identities = 72/224 (32%), Positives = 103/224 (45%), Gaps = 28/224 (12%)
Query: 49 IGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRS 108
+G GG+GEV A + GKM A +KL + +K+ E LL +I +
Sbjct: 1 LGKGGFGEVC--AVQVKNTGKMYACKKL-------DKKRLKKKSGEKMALLEKEILEKVN 51
Query: 109 EIITANQTRHRNILPLLAHMVRPNCHL-LVYEFMKNGSLQDILYDVSQGRRELDWPARHR 167
N LA+ HL LV M G L+ +Y+V G R L+
Sbjct: 52 SPFIVN----------LAYAFESKTHLCLVMSLMNGGDLKYHIYNV--GERGLEMERVIH 99
Query: 168 IARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKC 227
+ I G+ LH+ H +++RD+KP NVL+DD R+SD G + DG IT +
Sbjct: 100 YSAQITCGI--LHL-HSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT-ITQR- 154
Query: 228 MVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDF 271
GT GYMAPE L+ E S D ++ G + +V G+ P D
Sbjct: 155 -AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDH 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 8e-18
Identities = 65/232 (28%), Positives = 104/232 (44%), Gaps = 30/232 (12%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
++ KK+G G + V YKA G+++AI+K+ + A + I
Sbjct: 2 YEKGKKLGEGTYAVV-YKAR-DKETGRIVAIKKIKLGERKEAKDGINFT----------- 48
Query: 103 IGAIRSEIITANQTRHRNILPLL-AHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELD 161
A+R EI + +H NI+ LL + N +L V+EFM+ L+ ++ D S D
Sbjct: 49 --ALR-EIKLLQELKHPNIIGLLDVFGHKSNINL-VFEFME-TDLEKVIKDKSIVLTPAD 103
Query: 162 WPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHA 221
+ GLEY H ++HRD+KP N+LI D +++DFG + +
Sbjct: 104 IKS---YMLMTLRGLEY---LHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR 157
Query: 222 QITVKCMVGTMGYMAPESL-QTETISDKCDIYSFGVLLAVLVMGK--FPVDD 270
++T V T Y APE L D++S G + A L++ P D
Sbjct: 158 KMT--HQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDS 207
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 1e-17
Identities = 64/234 (27%), Positives = 97/234 (41%), Gaps = 37/234 (15%)
Query: 43 FDSLKKIGSGGWGEVF--YKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLH 100
+ L KIG G +G V+ G+++AI+K IK +
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKL----TGEIVAIKK------------IKLRFESEGI--- 41
Query: 101 WKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHL-LVYEFMKNGSLQDILYDVSQGRRE 159
A+R EI + H NI+ LL + R L LV+EFM D+ + +R
Sbjct: 42 -PKTALR-EIKLLKELNHPNIIKLLD-VFRHKGDLYLVFEFMD----TDLYKLIKDRQRG 94
Query: 160 LDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDG 219
L + GL + CH ++HRD+KP N+LI+ + +++DFG +
Sbjct: 95 LPESLIKSYLYQLLQGLAF---CHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSP 151
Query: 220 HAQITVKCMVGTMGYMAPESLQTETI-SDKCDIYSFGVLLAVLVMGK--FPVDD 270
T V T Y APE L + S DI+S G + A L+ + FP
Sbjct: 152 VRPYTHY--VVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKS 203
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-17
Identities = 76/283 (26%), Positives = 122/283 (43%), Gaps = 37/283 (13%)
Query: 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAI 106
KKIG G + EV+ L + K +A++K+ + M A +QD + DLL
Sbjct: 8 KKIGRGQFSEVYRATCL--LDRKPVALKKVQIFEMMDAKA--RQDCVKEIDLL------- 56
Query: 107 RSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARH 166
Q H N++ L + N +V E G L ++ + +R +
Sbjct: 57 -------KQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVW 109
Query: 167 RIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVK 226
+ + S +E HM H R++HRDIKPANV I ++ D G G+
Sbjct: 110 KYFVQLCSAVE--HM-HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAH 164
Query: 227 CMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRN 286
+VGT YM+PE + + K DI+S G LL + + P F+G ++M++ +
Sbjct: 165 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP---FYG--DKMNLFSLCQK 219
Query: 287 VIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERP 329
+ + P L Y E++ +L C DPD+RP
Sbjct: 220 IEQCDYP------PLPTEHYSEKL---RELVSMCIYPDPDQRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 2e-17
Identities = 65/229 (28%), Positives = 104/229 (45%), Gaps = 43/229 (18%)
Query: 48 KIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIR 107
K+G G +GEV Y+ + +A++ L D M E +K+ A+
Sbjct: 13 KLGGGQYGEV-YEG-VWKKYSLTVAVKTLKEDT-MEVEEFLKE-------------AAVM 56
Query: 108 SEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHR 167
EI +H N++ LL R ++ EFM G+L D L + R+E++
Sbjct: 57 KEI------KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLY 108
Query: 168 IARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPD------GHA 221
+A I+S +EYL + IHRD+ N L+ ++ +++DFG +LM A
Sbjct: 109 MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 165
Query: 222 QITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL---AVLVMGKFP 267
+ +K + APESL S K D+++FGVLL A M +P
Sbjct: 166 KFPIK-------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP 207
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-17
Identities = 67/235 (28%), Positives = 106/235 (45%), Gaps = 38/235 (16%)
Query: 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLL 99
E+ F L++IG G +GEVF + +++AI+ + D++E D
Sbjct: 3 EELFTKLERIGKGSFGEVF--KGIDNRTQQVVAIKII--------------DLEEAED-- 44
Query: 100 HWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDIL----YDVSQ 155
+I I+ EI +Q + ++ ++ E++ GS D+L +D Q
Sbjct: 45 --EIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQ 102
Query: 156 GRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKL 215
L + I GL+YLH + IHRDIK ANVL+ + + +++DFG
Sbjct: 103 IATML---------KEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQ 150
Query: 216 MPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDD 270
+ D QI VGT +MAPE +Q K DI+S G+ L G+ P D
Sbjct: 151 LTD--TQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSD 203
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 3e-17
Identities = 59/229 (25%), Positives = 102/229 (44%), Gaps = 30/229 (13%)
Query: 47 KKIGSGGWGEVF--YKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIG 104
K +G G +G V+ Y + G+ +A++++ D S ++
Sbjct: 8 KLLGQGAFGRVYLCYDVD----TGRELAVKQV--------------PFDPDSPETKKEVN 49
Query: 105 AIRSEIITANQTRHRNILPLLAHMVRPNCHLLVY-EFMKNGSLQDILYDVSQGRRELDWP 163
A+ EI +H I+ +R + L ++ E+M GS++D L + L
Sbjct: 50 ALECEIQLLKNLQHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQL----KAYGALTET 104
Query: 164 ARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQI 223
+ R I G+EYLH ++HRDIK AN+L D ++ DFG K + +
Sbjct: 105 VTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161
Query: 224 T-VKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDF 271
T +K + GT +M+PE + E K D++S G + ++ K P +F
Sbjct: 162 TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEF 210
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 3e-17
Identities = 56/165 (33%), Positives = 83/165 (50%), Gaps = 12/165 (7%)
Query: 105 AIRSEIITANQTRHRNILPLLAHMVRPNCHL-LVYEFMKNGSLQDILYDVSQGRRELDWP 163
A +E Q RH N++ LL +V L +V E+M GSL D L S+GR L
Sbjct: 45 AFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGD 102
Query: 164 ARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQI 223
+ + + +EYL + +HRD+ NVL+ +D A++SDFG K Q
Sbjct: 103 CLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQD 157
Query: 224 TVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL-AVLVMGKFP 267
T K V + APE+L+ + S K D++SFG+LL + G+ P
Sbjct: 158 TGKLPV---KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-17
Identities = 74/291 (25%), Positives = 124/291 (42%), Gaps = 37/291 (12%)
Query: 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAI 106
KKIG G + EV+ L +G +A++K+ + M A + D + DLL
Sbjct: 8 KKIGRGQFSEVYRATCL--LDGVPVALKKVQIFDLMDAKA--RADCIKEIDLL------- 56
Query: 107 RSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARH 166
Q H N++ A + N +V E G L ++ + +R +
Sbjct: 57 -------KQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVW 109
Query: 167 RIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVK 226
+ + S LE++H R++HRDIKPANV I ++ D G G+
Sbjct: 110 KYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAH 164
Query: 227 CMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRN 286
+VGT YM+PE + + K DI+S G LL + + P F+G ++M++ +
Sbjct: 165 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP---FYG--DKMNLYSLCKK 219
Query: 287 VIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337
+ + P L + Y E++ +L C DP++RP V +
Sbjct: 220 IEQCDYP------PLPSDHYSEEL---RQLVNMCINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 4e-17
Identities = 63/261 (24%), Positives = 112/261 (42%), Gaps = 54/261 (20%)
Query: 39 KEDCFDSLKKIGSGGWGEVFYKAEL----PGSNGKMIAIRKLIVDAPMSAAELIKQDIDE 94
+ D +++G G +G+VF E P ++ +++A++ L A A ++D +
Sbjct: 3 QRDTIVLKRELGEGAFGKVF-LGECYHLEPENDKELVAVKTLKETASNDA----RKDFER 57
Query: 95 YSDLLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQD------ 148
+E++T Q H NI+ + ++V+E+M++G L
Sbjct: 58 ------------EAELLTNFQ--HENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHG 103
Query: 149 ----ILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDME 204
L EL +IA IASG+ YL H +HRD+ N L+ D+
Sbjct: 104 PDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160
Query: 205 ARISDFGHGK-------LMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVL 257
+I DFG + GH + ++ +M PES+ + + D++SFGV+
Sbjct: 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIR-------WMPPESIMYRKFTTESDVWSFGVV 213
Query: 258 L-AVLVMGKFPVDDFFGHTEE 277
L + GK P ++G + E
Sbjct: 214 LWEIFTYGKQP---WYGLSNE 231
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 7e-17
Identities = 48/136 (35%), Positives = 72/136 (52%), Gaps = 16/136 (11%)
Query: 136 LVYEFMKNGSLQDILYDVSQG----RRELDWPARHRIARGIASGLEYLHMCHRPRLIHRD 191
LV M G L+ +Y++ R + + A I GLE LH R R+++RD
Sbjct: 77 LVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAE------ITCGLEDLH---RERIVYRD 127
Query: 192 IKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDI 251
+KP N+L+DD RISD G +P+G T++ VGT+GYMAPE ++ E + D
Sbjct: 128 LKPENILLDDYGHIRISDLGLAVEIPEGE---TIRGRVGTVGYMAPEVVKNERYTFSPDW 184
Query: 252 YSFGVLLAVLVMGKFP 267
+ G L+ ++ GK P
Sbjct: 185 WGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 9e-17
Identities = 58/227 (25%), Positives = 96/227 (42%), Gaps = 31/227 (13%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGA 105
KIG G +G+V+ L G+++A++ E+ QD D I
Sbjct: 5 GNKIGGGTFGKVYTAVNL--DTGELMAVK-----------EIRIQDND------PKTIKE 45
Query: 106 IRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPAR 165
I E+ +H N++ V + E+ G+L+++L + R LD
Sbjct: 46 IADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELL----EHGRILDEHVI 101
Query: 166 HRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQI-- 223
+ GL YLH ++HRDIKPAN+ +D + ++ DFG + + +
Sbjct: 102 RVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGE 158
Query: 224 TVKCMVGTMGYMAPESLQTETISDK---CDIYSFGVLLAVLVMGKFP 267
V+ + GT YMAPE + DI+S G ++ + GK P
Sbjct: 159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 1e-16
Identities = 70/299 (23%), Positives = 131/299 (43%), Gaps = 60/299 (20%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
D+ KIG G G V + S G+ +A++K+ +L KQ E LL
Sbjct: 21 LDNFVKIGEGSTGIVCIATDK--STGRQVAVKKM---------DLRKQQRRE---LLF-- 64
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDW 162
+E++ +H NI+ + + + + +V EF++ G+L DI V+ R ++
Sbjct: 65 -----NEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDI---VTHTR--MNE 114
Query: 163 PARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQ 222
+ + L +LH +IHRDIK ++L+ D ++SDFG AQ
Sbjct: 115 EQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFC-------AQ 164
Query: 223 ITV-----KCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEE 277
++ K +VGT +MAPE + + DI+S G+++ +V G+ P +F
Sbjct: 165 VSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPP---YFNEPP- 220
Query: 278 MDMVKWMRNVIFSENP--NRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDV 334
++ M+ + + P + ++ML ++DP +R ++ ++
Sbjct: 221 ---LQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRML----------VRDPAQRATAAEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 1e-16
Identities = 72/241 (29%), Positives = 106/241 (43%), Gaps = 32/241 (13%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
F + +G GG+GEV A + GKM A +KL + IK+ E L +
Sbjct: 2 FRHYRVLGKGGFGEVC--ACQVRATGKMYACKKL-------EKKRIKKRKGEAMALNEKR 52
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDW 162
I + R ++ L + LV M G L+ +Y++ G D
Sbjct: 53 I---------LEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNM--GNPGFDE 101
Query: 163 PARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQ 222
A + GLE L R R+++RD+KP N+L+DD RISD G +P+G
Sbjct: 102 QRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-- 156
Query: 223 ITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVK 282
TV+ VGT+GYMAPE + E + D + G L+ ++ G+ P F E VK
Sbjct: 157 -TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP---FRKRKER---VK 209
Query: 283 W 283
Sbjct: 210 R 210
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-16
Identities = 65/235 (27%), Positives = 106/235 (45%), Gaps = 40/235 (17%)
Query: 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDL 98
K+D F+ + ++G+G G VF + P +I RKLI
Sbjct: 3 KDDDFEKISELGAGNGGVVFKVSHKPSG---LIMARKLI--------------------- 38
Query: 99 LHWKIG-AIRSEIITANQTRHR----NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDV 153
H +I AIR++II Q H I+ + E M GSL +L
Sbjct: 39 -HLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA 97
Query: 154 SQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHG 213
+ ++ +++ + GL YL H+ ++HRD+KP+N+L++ E ++ DFG
Sbjct: 98 GRIPEQI----LGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS 151
Query: 214 KLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPV 268
+ D A VGT YM+PE LQ S + DI+S G+ L + +G++P+
Sbjct: 152 GQLIDSMAN----SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 2e-16
Identities = 60/225 (26%), Positives = 104/225 (46%), Gaps = 30/225 (13%)
Query: 47 KKIGSGGWGEVFYKA--ELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIG 104
K IG G +GEV + +LPG +AI+ L + + D L
Sbjct: 10 KVIGGGEFGEV-CRGRLKLPGKKEIDVAIKTLKAGSSDK----------QRLDFLT---- 54
Query: 105 AIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPA 164
E Q H NI+ L + + +++ E+M+NGSL L + +
Sbjct: 55 ----EASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFL---RENDGKFTVGQ 107
Query: 165 RHRIARGIASGLEYL-HMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQI 223
+ RGIASG++YL M + +HRD+ N+L++ ++ ++SDFG + + D A
Sbjct: 108 LVGMLRGIASGMKYLSEMNY----VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATY 163
Query: 224 TVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL-AVLVMGKFP 267
T K + + APE++ + D++SFG+++ V+ G+ P
Sbjct: 164 TTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-16
Identities = 83/298 (27%), Positives = 131/298 (43%), Gaps = 63/298 (21%)
Query: 33 DLAFLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDI 92
DL+ ++ F+ +++IGSG +G+V YKA + G++ AI+ +IK +
Sbjct: 1 DLSRRNPQEDFELIQRIGSGTYGDV-YKAR-NVNTGELAAIK------------VIKLEP 46
Query: 93 DEYSDLLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYD 152
E + ++ EII +H NI+ +R + + EF GSLQDI Y
Sbjct: 47 GEDFAV-------VQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDI-YH 98
Query: 153 VSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGH 212
V+ E ++R GL YLH + +HRDIK AN+L+ D+ +++DFG
Sbjct: 99 VTGPLSESQIA---YVSRETLQGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGV 152
Query: 213 GKLMPDGHAQITV-----KCMVGTMGYMAPESLQTET---ISDKCDIYSFGVLLAVLVMG 264
AQIT K +GT +MAPE E + CDI++ G+ L
Sbjct: 153 S-------AQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAEL 205
Query: 265 KFPVDDF-------------FGHTEEMDMVKWMRN------VIFSENP-NRAINSKLL 302
+ P+ D F + D +KW + + ++NP R KLL
Sbjct: 206 QPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLL 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 3e-16
Identities = 70/235 (29%), Positives = 117/235 (49%), Gaps = 37/235 (15%)
Query: 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAI 106
K +G G +G+V AEL G+N + AI+ L +++ +D D ++ ++ A+
Sbjct: 1 KVLGKGSFGKVML-AELKGTN-EFFAIKAL-------KKDVVLEDDDVECTMVERRVLAL 51
Query: 107 RSEIITANQTRHRNILPLLAHM---VRPNCHLL-VYEFMKNGSLQDILYDVSQGRRELDW 162
E P L H+ + HL V E++ G D+++ + R +
Sbjct: 52 AWE------------HPFLTHLFCTFQTKEHLFFVMEYLNGG---DLMFHIQSSGRFDEA 96
Query: 163 PARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQ 222
AR A I GL++LH + +I+RD+K NVL+D D +I+DFG K +G +
Sbjct: 97 RARFYAAE-IICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK 152
Query: 223 ITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEE 277
+ C GT Y+APE L+ + ++ D +SFGVLL +++G+ P F G E+
Sbjct: 153 ASTFC--GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP---FHGEDED 202
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 3e-16
Identities = 49/166 (29%), Positives = 81/166 (48%), Gaps = 10/166 (6%)
Query: 105 AIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPA 164
A+R EI + H +I+ +L + L E+M GS+ +L + +
Sbjct: 49 ALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINY 108
Query: 165 RHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDD-MEARISDFGH-GKLMPDGHAQ 222
++ RG++ YLH ++IHRD+K AN+LID RI+DFG +L G
Sbjct: 109 TEQLLRGLS----YLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGA 161
Query: 223 ITVKC-MVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFP 267
+ ++GT+ +MAPE L+ E CD++S G ++ + K P
Sbjct: 162 GEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 4e-16
Identities = 59/226 (26%), Positives = 109/226 (48%), Gaps = 33/226 (14%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
+ +KIG G G V+ ++ + G+ +AI++ M+ + K+++
Sbjct: 21 YTRFEKIGQGASGTVYTAIDV--ATGQEVAIKQ------MNLQQQPKKEL---------- 62
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDW 162
I +EI+ + +H NI+ L + + +V E++ GSL D++ + ++
Sbjct: 63 ---IINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI-- 117
Query: 163 PARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGH-GKLMPDGHA 221
+ R LE+LH +IHRDIK N+L+ D +++DFG ++ P+
Sbjct: 118 ---AAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171
Query: 222 QITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFP 267
+ T MVGT +MAPE + + K DI+S G++ +V G+ P
Sbjct: 172 RST---MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 4e-16
Identities = 70/247 (28%), Positives = 106/247 (42%), Gaps = 42/247 (17%)
Query: 107 RSEIITANQTRH----RNIL-----PLLAHMVRPNCH----LLVYEFMKNGSLQDILYDV 153
++++I NQ R+IL P + + LV E++ G L +L +V
Sbjct: 28 KADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENV 87
Query: 154 SQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHG 213
G + D AR IA I LEYLH +IHRD+KP N+LID + +++DFG
Sbjct: 88 --GSLDEDV-ARIYIAE-IVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLS 140
Query: 214 KL----MPDGHAQITVKC--MVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFP 267
K+ + +VGT Y+APE + + S D +S G +L ++G P
Sbjct: 141 KVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPP 200
Query: 268 VDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDE 327
F G T E IF N I +E + L+ KL DP++
Sbjct: 201 ---FHGETPEE---------IFQNILNGKIEWPEDVEVSDEAIDLISKLLVP----DPEK 244
Query: 328 RPSSKDV 334
R +K +
Sbjct: 245 RLGAKSI 251
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 76.1 bits (188), Expect = 6e-16
Identities = 47/143 (32%), Positives = 69/143 (48%), Gaps = 14/143 (9%)
Query: 139 EFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198
E+ G L IL D G + ++ AR IA + EYLH +I+RD+KP N+L
Sbjct: 73 EYCLGGELWTILRDR--GLFD-EYTARFYIA-CVVLAFEYLH---NRGIIYRDLKPENLL 125
Query: 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
+D + ++ DFG K + G T GT Y+APE + + D +S G+LL
Sbjct: 126 LDSNGYVKLVDFGFAKKLKSGQKTWT---FCGTPEYVAPEIILNKGYDFSVDYWSLGILL 182
Query: 259 AVLVMGKFPVDDFFGHTEEMDMV 281
L+ G+ P FG +E M
Sbjct: 183 YELLTGRPP----FGEDDEDPME 201
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 1e-15
Identities = 64/225 (28%), Positives = 103/225 (45%), Gaps = 26/225 (11%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
F LKK+G G +G V YK + S+ + A++++ + + MS E ++D
Sbjct: 2 FKVLKKLGKGSYGSV-YKVKRL-SDNQFYALKEVDLGS-MSQKE--RED----------A 46
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDW 162
+ IR I A+ H NI+ + N +V E+ G L + + R+ +
Sbjct: 47 VNEIR---ILASVN-HPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPE 102
Query: 163 PARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQ 222
RI + GL+ LH +++HRD+K AN+L+ + +I D G K++ A
Sbjct: 103 QEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMA- 158
Query: 223 ITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFP 267
K +GT YMAPE + S K DI+S G LL + P
Sbjct: 159 ---KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 1e-15
Identities = 41/130 (31%), Positives = 67/130 (51%), Gaps = 10/130 (7%)
Query: 139 EFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198
E M GSL +L + +I+ + GL YL H+ ++HRD+KP+N+L
Sbjct: 79 EHMDGGSLDQVLKKA----GRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNIL 132
Query: 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
++ E ++ DFG + D A VGT YM+PE LQ + + DI+S G+ L
Sbjct: 133 VNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSL 188
Query: 259 AVLVMGKFPV 268
+ +G++P+
Sbjct: 189 VEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-15
Identities = 60/229 (26%), Positives = 104/229 (45%), Gaps = 42/229 (18%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGA 105
L+K+G+G +GEV+ E +N +A++ L M + + +
Sbjct: 11 LRKLGAGQFGEVW---EGLWNNTTPVAVKTLKPGT-MDPKDFLAE--------------- 51
Query: 106 IRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPAR 165
++I+ + RH ++ L A +V E MK GSL + L R L P
Sbjct: 52 --AQIM--KKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQG--GAGRALKLPQL 105
Query: 166 HRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGH----- 220
+A +ASG+ YL + IHRD+ NVL+ ++ +++DFG +++ +
Sbjct: 106 IDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE 162
Query: 221 -AQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFP 267
A+ +K + APE+ S K D++SFG+LL +V G+ P
Sbjct: 163 GAKFPIK-------WTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 1e-15
Identities = 54/198 (27%), Positives = 83/198 (41%), Gaps = 33/198 (16%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKI-- 103
L +IG G G VF + G+ +A++K+ + L I
Sbjct: 5 LGRIGEGAHGIVFKAKDR--ETGETVALKKVALRR------------------LEGGIPN 44
Query: 104 GAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWP 163
A+R EI +H ++ LL + +LV E+M L ++L D R L
Sbjct: 45 QALR-EIKALQACQHPYVVKLLDVFPHGSGFVLVMEYMP-SDLSEVLRDE---ERPLPEA 99
Query: 164 ARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLM-PDGHAQ 222
R + G+ Y H ++HRD+KPAN+LI D +I+DFG +L +
Sbjct: 100 QVKSYMRMLLKGVAY---MHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL 156
Query: 223 ITVKCMVGTMGYMAPESL 240
+ + V T Y APE L
Sbjct: 157 YSHQ--VATRWYRAPELL 172
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 2e-15
Identities = 66/235 (28%), Positives = 105/235 (44%), Gaps = 40/235 (17%)
Query: 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDL 98
K+D F+ + ++G+G G V P +I RKLI
Sbjct: 3 KDDDFERISELGAGNGGVVTKVQHKPS---GLIMARKLI--------------------- 38
Query: 99 LHWKIG-AIRSEIITANQTRHR----NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDV 153
H +I AIR++II Q H I+ + E M GSL +L +
Sbjct: 39 -HLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEA 97
Query: 154 SQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHG 213
+ E+ +++ + GL YL H+ ++HRD+KP+N+L++ E ++ DFG
Sbjct: 98 KRIPEEI----LGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVS 151
Query: 214 KLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPV 268
+ D A VGT YM+PE LQ S + DI+S G+ L L +G++P+
Sbjct: 152 GQLIDSMAN----SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-15
Identities = 62/237 (26%), Positives = 107/237 (45%), Gaps = 58/237 (24%)
Query: 46 LKKIGSGGWGEV---FYKAELPGSNGKMIAIRKL-----IVDAPMSAAELIKQDIDEYSD 97
+KK+G+G +GEV +Y +N +A++ L V A + A L+K
Sbjct: 11 VKKLGAGQFGEVWMGYY------NNSTKVAVKTLKPGTMSVQAFLEEANLMKT------- 57
Query: 98 LLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGR 157
+H ++ L A + + ++ E+M GSL D L G+
Sbjct: 58 ------------------LQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGK 99
Query: 158 RELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMP 217
L P + IA G+ Y+ R IHRD++ ANVL+ + + +I+DFG +++
Sbjct: 100 VLL--PKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIE 154
Query: 218 DGH------AQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL-AVLVMGKFP 267
D A+ +K + APE++ + + K D++SFG+LL ++ GK P
Sbjct: 155 DNEYTAREGAKFPIK-------WTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 2e-15
Identities = 41/136 (30%), Positives = 70/136 (51%), Gaps = 15/136 (11%)
Query: 139 EFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198
E+M GSL D LY + RI + GL++L H +IHRD+KP NVL
Sbjct: 79 EYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVL 135
Query: 199 IDDDMEARISDFG-HGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISD------KCDI 251
++ + + ++ DFG G L+ A + K +G YMAPE +++ + + D+
Sbjct: 136 VNGNGQVKLCDFGVSGNLV----ASLA-KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDV 190
Query: 252 YSFGVLLAVLVMGKFP 267
+S G+ + + +G++P
Sbjct: 191 WSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 3e-15
Identities = 73/239 (30%), Positives = 109/239 (45%), Gaps = 37/239 (15%)
Query: 105 AIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPA 164
A E + RH ++PL A +V +V EFM GSL D L + G+ L P
Sbjct: 47 AFLQEAQIMKKLRHDKLVPLYA-VVSEEPIYIVTEFMGKGSLLDFLKE-GDGKY-LKLPQ 103
Query: 165 RHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGH---- 220
+A IA G+ Y+ R IHRD++ AN+L+ D++ +I+DFG +L+ D
Sbjct: 104 LVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTAR 160
Query: 221 --AQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHTEE 277
A+ +K + APE+ + K D++SFG+LL LV G+ P
Sbjct: 161 QGAKFPIK-------WTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPG------- 206
Query: 278 MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336
M N E R G E + ++KL C KDPDERP+ + ++S
Sbjct: 207 ------MVNREVLEQVERGYRMP-CPQGCPESLHELMKL---CWKKDPDERPTFEYIQS 255
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 3e-15
Identities = 79/302 (26%), Positives = 130/302 (43%), Gaps = 66/302 (21%)
Query: 46 LKKIGSGGWGEV---FYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
+KK+G+G +GEV +Y +AI+ L MS
Sbjct: 11 VKKLGAGQFGEVWMGYYN------GHTKVAIKSL-KQGSMSPE----------------- 46
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDW 162
A +E Q +H ++ L A +V ++ E+M+NGSL D L +G + L
Sbjct: 47 --AFLAEANLMKQLQHPRLVRLYA-VVTQEPIYIITEYMENGSLVDFL-KTPEGIK-LTI 101
Query: 163 PARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGH-- 220
+A IA G+ ++ R IHRD++ AN+L+ + + +I+DFG +L+ D
Sbjct: 102 NKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158
Query: 221 ----AQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHT 275
A+ +K + APE++ T + K D++SFG+LL +V G+ P
Sbjct: 159 AREGAKFPIK-------WTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPG----- 206
Query: 276 EEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVR 335
M N +N R N EE L+ C + P+ERP+ + +R
Sbjct: 207 --------MTNPEVIQNLERGYRMPRPDNCPEELYELMRL----CWKEKPEERPTFEYLR 254
Query: 336 SM 337
S+
Sbjct: 255 SV 256
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 4e-15
Identities = 61/220 (27%), Positives = 87/220 (39%), Gaps = 38/220 (17%)
Query: 47 KKIGSGGWGEVFYKAELPGSNGKMI--AIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIG 104
KK+G G +G V + E S GK+I A++ L D D L
Sbjct: 1 KKLGDGSFGVV-RRGEWSTSGGKVIPVAVKCLKSDKLSDIM----------DDFL----- 44
Query: 105 AIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPA 164
E + H N++ L +V + ++V E GSL D L
Sbjct: 45 ---KEAAIMHSLDHENLIRLYG-VVLTHPLMMVTELAPLGSLLDRLRK--DALGHFLIST 98
Query: 165 RHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQIT 224
A IA+G+ YL R IHRD+ N+L+ D + +I DFG + +P
Sbjct: 99 LCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE---- 151
Query: 225 VKCMVGTM------GYMAPESLQTETISDKCDIYSFGVLL 258
V + APESL+T T S D++ FGV L
Sbjct: 152 -DHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTL 190
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 4e-15
Identities = 62/230 (26%), Positives = 103/230 (44%), Gaps = 40/230 (17%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGA 105
L+++G G +G+V YK EL G N ++ A I +A ++Q+
Sbjct: 10 LEELGEGAFGKV-YKGELTGPNERLSATSVAIKTLKENAEPKVQQEF------------- 55
Query: 106 IRSEIITANQTRHRNILPLLAHMVR--PNCHLLVYEFMKNGSLQDIL------------Y 151
R E + +H NI+ LL + P C L +E++ +G L + L
Sbjct: 56 -RQEAELMSDLQHPNIVCLLGVCTKEQPTCML--FEYLAHGDLHEFLVRNSPHSDVGAES 112
Query: 152 DVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFG 211
+ LD IA IA+G+EYL H +HRD+ N L+ + + +ISDFG
Sbjct: 113 GDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFG 169
Query: 212 HGKLMPDGHAQITVKCM---VGTMGYMAPESLQTETISDKCDIYSFGVLL 258
L D ++ + + + +M PE++ + + DI+SFGV+L
Sbjct: 170 ---LSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVL 216
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 4e-15
Identities = 65/229 (28%), Positives = 103/229 (44%), Gaps = 34/229 (14%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
F + +G GG+GEV A + GKM A ++L + IK+ E L
Sbjct: 2 FRQYRVLGKGGFGEVC--ACQVRATGKMYACKRL-------EKKRIKKRKGESMAL---- 48
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVS----QGRR 158
+E + + ++ L + LV M G L+ +Y++ + R
Sbjct: 49 -----NEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEER 103
Query: 159 ELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPD 218
L + A I GLE LH R ++RD+KP N+L+DD RISD G +P+
Sbjct: 104 ALFYAAE------ILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE 154
Query: 219 GHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFP 267
G +++ VGT+GYMAPE L + + D + G L+ ++ G+ P
Sbjct: 155 GE---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 5e-15
Identities = 72/235 (30%), Positives = 115/235 (48%), Gaps = 37/235 (15%)
Query: 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAI 106
K +G G +G+VF AEL G+N + AI+ L D ++ D D ++ ++ ++
Sbjct: 1 KMLGKGSFGKVFL-AELKGTN-QFFAIKALKKD-------VVLMDDDVECTMVEKRVLSL 51
Query: 107 RSEIITANQTRHRNILPLLAHM---VRPNCHLL-VYEFMKNGSLQDILYDVSQGRRELDW 162
E H P L H+ + +L V E++ G D+++ + Q + D
Sbjct: 52 AWE--------H----PFLTHLYCTFQTKENLFFVMEYLNGG---DLMFHI-QSCHKFDL 95
Query: 163 PARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQ 222
P A I GL++LH +++RD+K N+L+D D +I+DFG K G A+
Sbjct: 96 PRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK 152
Query: 223 ITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEE 277
C GT Y+APE L + + D +SFGVLL +++G+ P F GH EE
Sbjct: 153 TCTFC--GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP---FHGHDEE 202
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 5e-15
Identities = 61/239 (25%), Positives = 104/239 (43%), Gaps = 30/239 (12%)
Query: 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAI 106
+G G +G+V KA GK++AI+K+ + + +Q + +H+ +
Sbjct: 15 AHLGEGTYGKV-EKAY-DTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCG--IHFT--TL 68
Query: 107 RSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARH 166
R E+ N+ +H NI+ L+ V + LV + M L+ ++ + L
Sbjct: 69 R-ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDR----KIRLTESQVK 122
Query: 167 RIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFG------HGKLMPDGH 220
I I +GL LH + +HRD+ PAN+ I+ +I+DFG +
Sbjct: 123 CILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLS 179
Query: 221 AQITVK------CMVGTMGYMAPESLQ-TETISDKCDIYSFGVLLAVLVMGK--FPVDD 270
T++ V T+ Y APE L E D++S G + A L+ GK FP ++
Sbjct: 180 KDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238
|
Length = 335 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (182), Expect = 5e-15
Identities = 81/311 (26%), Positives = 134/311 (43%), Gaps = 62/311 (19%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGA 105
L+K+G G +G V YKA G+++A++K I+ D +E A
Sbjct: 4 LEKLGEGTYGVV-YKARDK-KTGEIVALKK------------IRLDNEEEG----IPSTA 45
Query: 106 IRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPAR 165
+R EI + +H NI+ LL + LV+E+ L+ L + L
Sbjct: 46 LR-EISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYL---DKRPGPLSPNLI 100
Query: 166 HRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITV 225
I + GL Y CH R++HRD+KP N+LI+ D +++DFG + I +
Sbjct: 101 KSIMYQLLRGLAY---CHSHRILHRDLKPQNILINRDGVLKLADFGLARA-----FGIPL 152
Query: 226 KCM---VGTMGYMAPESL-QTETISDKCDIYSFGVLLAVLVMGK--FPVD---------- 269
+ V T+ Y APE L ++ S DI+S G + A ++ GK FP D
Sbjct: 153 RTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIF 212
Query: 270 DFFGH-TEE-----MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQML-LVLKLACFCTL 322
G TEE + + F + P + + L + + + L+ K+ +
Sbjct: 213 QILGTPTEESWPGVTKLPDY--KPTFPKFPPKDLEKVL--PRLDPEGIDLLSKMLQY--- 265
Query: 323 KDPDERPSSKD 333
+P +R S+K+
Sbjct: 266 -NPAKRISAKE 275
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 6e-15
Identities = 69/232 (29%), Positives = 104/232 (44%), Gaps = 34/232 (14%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
F ++KIG G +G V YKA G+++A++K+ +D
Sbjct: 2 FQKVEKIGEGTYG-VVYKAR-NKLTGEVVALKKIRLDTETEGVPST-------------- 45
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDI--LYDVSQGRREL 160
AIR EI + H NI+ LL + N LV+EF+ QD+ D S +
Sbjct: 46 --AIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASPLS-GI 97
Query: 161 DWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGH 220
P + GL + CH R++HRD+KP N+LI+ + +++DFG + G
Sbjct: 98 PLPLIKSYLFQLLQGLAF---CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GV 152
Query: 221 AQITVKCMVGTMGYMAPES-LQTETISDKCDIYSFGVLLAVLVMGK--FPVD 269
T V T+ Y APE L + S DI+S G + A +V + FP D
Sbjct: 153 PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 7e-15
Identities = 63/226 (27%), Positives = 108/226 (47%), Gaps = 33/226 (14%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
+ +KIG G G VF ++ + G+ +AI+++ L KQ E
Sbjct: 21 YTRYEKIGQGASGTVFTAIDV--ATGQEVAIKQI---------NLQKQPKKEL------- 62
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDW 162
I +EI+ + ++ NI+ L + + +V E++ GSL D++ + +D
Sbjct: 63 ---IINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETC-----MDE 114
Query: 163 PARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGH-GKLMPDGHA 221
+ R LE+LH ++IHRDIK NVL+ D +++DFG ++ P+
Sbjct: 115 AQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK 171
Query: 222 QITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFP 267
+ T MVGT +MAPE + + K DI+S G++ +V G+ P
Sbjct: 172 RST---MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 9e-15
Identities = 57/236 (24%), Positives = 94/236 (39%), Gaps = 30/236 (12%)
Query: 39 KEDCFDSLKKIGSGGWGEVFYKA--ELPGSNGKM-IAIRKLIVDAPMSAAELIKQDIDEY 95
KE + +K +GSG +G V YK G K+ +AI+ L + A +
Sbjct: 5 KETELEKIKVLGSGAFGTV-YKGVWIPEGEKVKIPVAIKVLREETSPKANK--------- 54
Query: 96 SDLLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQ 155
I E H +++ LL + L+ + M G L D V
Sbjct: 55 ---------EILDEAYVMASVDHPHVVRLLGICLSSQ-VQLITQLMPLGCLLDY---VRN 101
Query: 156 GRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKL 215
+ + IA G+ YL RL+HRD+ NVL+ +I+DFG KL
Sbjct: 102 HKDNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158
Query: 216 MPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL-AVLVMGKFPVDD 270
+ + + + +MA ES+ + K D++S+GV + ++ G P +
Sbjct: 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEG 214
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 9e-15
Identities = 60/229 (26%), Positives = 97/229 (42%), Gaps = 35/229 (15%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGA 105
+ +G G G V+ L +++A++ + +D EL KQ
Sbjct: 6 QEILGHGNGGTVYKAYHLLT--RRILAVKVIPLDI---TVELQKQ--------------- 45
Query: 106 IRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPAR 165
I SE+ + I+ N + EFM GSL DV R++
Sbjct: 46 IMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSL-----DVY---RKIPEHVL 97
Query: 166 HRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITV 225
RIA + GL YL +++HRD+KP+N+L++ + ++ DFG + + A
Sbjct: 98 GRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIA---- 150
Query: 226 KCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGH 274
K VGT YMAPE + E D++S G+ L +G+FP +
Sbjct: 151 KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKN 199
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 2e-14
Identities = 58/226 (25%), Positives = 109/226 (48%), Gaps = 33/226 (14%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
+ +KIG G G V+ ++ + G+ +AIR+ M+ + K+++
Sbjct: 22 YTRFEKIGQGASGTVYTAMDV--ATGQEVAIRQ------MNLQQQPKKEL---------- 63
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDW 162
I +EI+ + ++ NI+ L + + +V E++ GSL D++ + ++
Sbjct: 64 ---IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI-- 118
Query: 163 PARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGH-GKLMPDGHA 221
+ R LE+LH ++IHRDIK N+L+ D +++DFG ++ P+
Sbjct: 119 ---AAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--- 169
Query: 222 QITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFP 267
Q MVGT +MAPE + + K DI+S G++ ++ G+ P
Sbjct: 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-14
Identities = 61/233 (26%), Positives = 109/233 (46%), Gaps = 31/233 (13%)
Query: 47 KKIGSGGWGEVFYKA-ELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGA 105
K IG+G +GEVF ++PG +AI+ L KQ D
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTL------KPGYTEKQRQD------------ 52
Query: 106 IRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPAR 165
SE Q H NI+ L + + +++ E+M+NG+L L D + ++ +
Sbjct: 53 FLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRD-----HDGEFSSY 107
Query: 166 HRIA--RGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDG-HAQ 222
+ RGIA+G++YL + +HRD+ N+L++ ++E ++SDFG +++ D
Sbjct: 108 QLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGT 164
Query: 223 ITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL-AVLVMGKFPVDDFFGH 274
T + + APE++ + D++SFG+++ V+ G+ P D H
Sbjct: 165 YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH 217
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-14
Identities = 65/229 (28%), Positives = 109/229 (47%), Gaps = 43/229 (18%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGA 105
+KK+G+G +GEV+ + NG K + MS +++
Sbjct: 11 IKKLGNGQFGEVW----MGTWNGNTKVAVKTLKPGTMSPESFLEE--------------- 51
Query: 106 IRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPAR 165
++I+ + RH ++ L A + ++ V E+M GSL D L D +GR L P
Sbjct: 52 --AQIM--KKLRHDKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKD-GEGR-ALKLPNL 104
Query: 166 HRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGH----- 220
+A +A+G+ Y+ R IHRD++ AN+L+ D + +I+DFG +L+ D
Sbjct: 105 VDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQ 161
Query: 221 -AQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFP 267
A+ +K + APE+ + K D++SFG+LL LV G+ P
Sbjct: 162 GAKFPIK-------WTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 2e-14
Identities = 70/260 (26%), Positives = 122/260 (46%), Gaps = 41/260 (15%)
Query: 83 SAAELIK-QDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLL-AHMVRPNCHLLVYEF 140
+AA++I+ + +E D + EI ++ +H NI+ L A+ +L+ EF
Sbjct: 33 AAAKIIQIESEEELEDFM--------VEIDILSECKHPNIVGLYEAYFYENKLWILI-EF 83
Query: 141 MKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200
G+L I+ ++ +G L P + R + L +LH ++IHRD+K N+L+
Sbjct: 84 CDGGALDSIMLELERG---LTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLT 137
Query: 201 DDMEARISDFG-HGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISD-----KCDIYSF 254
D + +++DFG K + T +GT +MAPE + ET D K DI+S
Sbjct: 138 LDGDVKLADFGVSAKNKSTLQKRDT---FIGTPYWMAPEVVACETFKDNPYDYKADIWSL 194
Query: 255 GVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVL 314
G+ L L + P E++ ++ + ++ SE P SK + L
Sbjct: 195 GITLIELAQMEPP-------HHELNPMRVLLKILKSEPPTLDQPSK-----WSSSFNDFL 242
Query: 315 KLACFCTLKDPDERPSSKDV 334
K C +KDPD+RP++ ++
Sbjct: 243 KS---CLVKDPDDRPTAAEL 259
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 3e-14
Identities = 88/310 (28%), Positives = 137/310 (44%), Gaps = 52/310 (16%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
+++L +G G +G V K + + G+++AI+K + E D K
Sbjct: 3 YENLGLVGEGSYGMVM-KCKHKET-GQIVAIKKFL----------------ESEDDKMVK 44
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDW 162
A+R EI Q RH N++ L+ R LV+EF+ + +L D+ + LD
Sbjct: 45 KIAMR-EIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDH----TVLDDLEKYPNGLDE 99
Query: 163 PARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQ 222
+ I G+E+ CH +IHRDIKP N+L+ ++ DFG + +
Sbjct: 100 SRVRKYLFQILRGIEF---CHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV 156
Query: 223 ITVKCMVGTMGYMAPESLQTETISDK-CDIYSFGVLLAVLVMGK--FPVD---DFFGHTE 276
T V T Y APE L +T + DI++ G L+ ++ G+ FP D D H
Sbjct: 157 YTD--YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYH-- 212
Query: 277 EMDMVKWMRNV------IFSENPNRAI-------NSKLLGNGYEEQMLLVLKLACFCTLK 323
++K + N+ IF +NP A + L + + LVL LA C
Sbjct: 213 ---IIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRI 269
Query: 324 DPDERPSSKD 333
DPD+RPSS
Sbjct: 270 DPDDRPSSSQ 279
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-14
Identities = 64/234 (27%), Positives = 104/234 (44%), Gaps = 39/234 (16%)
Query: 105 AIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPA 164
A E + RH ++ L A +V +V E+M GSL D L + + L P
Sbjct: 47 AFLQEAQVMKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLK--GEMGKYLRLPQ 103
Query: 165 RHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGH---- 220
+A IASG+ Y+ R +HRD++ AN+L+ +++ +++DFG +L+ D
Sbjct: 104 LVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 160
Query: 221 --AQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHTEE 277
A+ +K + APE+ + K D++SFG+LL L G+ P + E
Sbjct: 161 QGAKFPIK-------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-NREV 212
Query: 278 MDMV-KWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPS 330
+D V + R E P + L C C K+P+ERP+
Sbjct: 213 LDQVERGYRMPCPPECPES-----------------LHDLMCQCWRKEPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 71.7 bits (175), Expect = 3e-14
Identities = 58/226 (25%), Positives = 108/226 (47%), Gaps = 33/226 (14%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
+ +KIG G G V+ ++ + G+ +AI++ M+ + K+++
Sbjct: 21 YTRFEKIGQGASGTVYTAIDI--ATGQEVAIKQ------MNLQQQPKKEL---------- 62
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDW 162
I +EI+ + ++ NI+ L + + +V E++ GSL D++ + +
Sbjct: 63 ---IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ--- 116
Query: 163 PARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGH-GKLMPDGHA 221
IA L+ L H ++IHRDIK N+L+ D +++DFG ++ P+
Sbjct: 117 -----IAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171
Query: 222 QITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFP 267
+ T MVGT +MAPE + + K DI+S G++ +V G+ P
Sbjct: 172 RST---MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (176), Expect = 4e-14
Identities = 56/219 (25%), Positives = 97/219 (44%), Gaps = 36/219 (16%)
Query: 43 FDSLKKIGSGGWGEVF---YKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLL 99
F+ +K +G+G +G V +K +GK A++ +S A+++K E+
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHK-----GSGKYYALKI------LSKAKIVKLKQVEH---- 47
Query: 100 HWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRE 159
+ +E RH ++ L + LV E++ G L L GR
Sbjct: 48 ------VLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHL--RKSGRFP 99
Query: 160 LDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDG 219
AR A+ + LEYLH +++RD+KP N+L+D D +I+DFG K +
Sbjct: 100 EPV-ARFYAAQ-VVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154
Query: 220 HAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
+ GT Y+APE + ++ D ++ G+L+
Sbjct: 155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILI 188
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 4e-14
Identities = 72/249 (28%), Positives = 118/249 (47%), Gaps = 41/249 (16%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
F L+K+G G + V YK + G+++A++++ +DA
Sbjct: 2 FKQLEKLGEGTYATV-YKG-RNRTTGEIVALKEIHLDAEEGTPST--------------- 44
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDW 162
AIR EI + +H NI+ L + N +LV+E+M L+ + D R LD
Sbjct: 45 --AIR-EISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYM-DTHGVRGALD- 98
Query: 163 PA-----RHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMP 217
P +++ +GIA CH R++HRD+KP N+LI+ E +++DFG +
Sbjct: 99 PNTVKSFTYQLLKGIA-------FCHENRVLHRDLKPQNLLINKRGELKLADFGLARAF- 150
Query: 218 DGHAQITVKCMVGTMGYMAPESLQ-TETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTE 276
G T V T+ Y AP+ L + T S DI+S G ++A ++ G+ P+ F G
Sbjct: 151 -GIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR-PL--FPGTNN 206
Query: 277 EMDMVKWMR 285
E ++K R
Sbjct: 207 EDQLLKIFR 215
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 7e-14
Identities = 63/223 (28%), Positives = 105/223 (47%), Gaps = 45/223 (20%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIK-QDIDEYSDLLHW 101
++ ++++GSG +G+V YKA + + ++A ++IK + D++S
Sbjct: 11 YELIQRVGSGTYGDV-YKA-------------RNLHTGELAAVKIIKLEPGDDFS----- 51
Query: 102 KIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELD 161
I+ EI + +H NI+ + + E+ GSLQDI Y V+ EL
Sbjct: 52 ---LIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDI-YHVTGPLSELQ 107
Query: 162 WPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHA 221
+ R GL YLH + +HRDIK AN+L+ D+ + +++DFG A
Sbjct: 108 IA---YVCRETLQGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVA-------A 154
Query: 222 QITV-----KCMVGTMGYMAPESLQTET---ISDKCDIYSFGV 256
+IT K +GT +MAPE E + CDI++ G+
Sbjct: 155 KITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGI 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 7e-14
Identities = 69/293 (23%), Positives = 127/293 (43%), Gaps = 32/293 (10%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGA 105
L+ +GSG +G V YK + ++A++++ V P A K++ D+ IG
Sbjct: 5 LEHLGSGAFGCV-YKVRKKNNGQNLLALKEINVHNP--AFGKDKRERDK-------SIGD 54
Query: 106 IRSEI-ITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPA 164
I SE+ I Q RH NI+ + + +V + ++ L + + + ++
Sbjct: 55 IVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEER 114
Query: 165 RHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQIT 224
I + L YLH R++HRD+ P N+++ +D + I+DFG L +
Sbjct: 115 IWNIFVQMVLALRYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFG---LAKQKQPESK 169
Query: 225 VKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWM 284
+ +VGT+ Y PE ++ E +K D+++FG +L + + P F T + + +
Sbjct: 170 LTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP----FYSTNMLSLATKI 225
Query: 285 RNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337
++ P Y E + V+ C D + RP V +M
Sbjct: 226 VEAVYEPLPEGM---------YSEDVTDVIT---SCLTPDAEARPDIIQVSAM 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 8e-14
Identities = 65/254 (25%), Positives = 107/254 (42%), Gaps = 74/254 (29%)
Query: 43 FDSLKKIGSGGWGEVF--YKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLH 100
F+ +K IG G +GEV+ + G++ A++ + +++IK++
Sbjct: 3 FEVIKVIGRGAFGEVWLVRDKD----TGQVYAMKV------LRKSDMIKRN--------- 43
Query: 101 WKIGAIRSEIITANQTRHRNIL-----PLLAHMV---RPNCHL-LVYEFMKNGSLQDILY 151
+I +R+E R+IL P + + + HL LV E+M G L ++L
Sbjct: 44 -QIAHVRAE---------RDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLL- 92
Query: 152 DVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFG 211
+ + + AR IA + + L H+ IHRDIKP N+LID D +++DFG
Sbjct: 93 -IRKDVFPEET-ARFYIAELVLA----LDSVHKLGFIHRDIKPDNILIDADGHIKLADFG 146
Query: 212 HGKLMPDGHAQITV-----------------------KCM----VGTMGYMAPESLQTET 244
K M + + VGT Y+APE L+
Sbjct: 147 LCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTP 206
Query: 245 ISDKCDIYSFGVLL 258
+CD +S GV+L
Sbjct: 207 YGLECDWWSLGVIL 220
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 1e-13
Identities = 61/228 (26%), Positives = 103/228 (45%), Gaps = 30/228 (13%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
++ L +G G +G V + G+++AI+K ++ ++ D+ K
Sbjct: 3 YEVLGVVGEGAYGVVLKCRNK--ATGEIVAIKKF-------------KESEDDEDV---K 44
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDW 162
A+R E+ Q RH NI+ L R LV+E+++ L+ + + S G L
Sbjct: 45 KTALR-EVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELL--EASPG--GLPP 99
Query: 163 PARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQ 222
A + + Y CH +IHRDIKP N+L+ + ++ DFG + + A
Sbjct: 100 DAVRSYIWQLLQAIAY---CHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS 156
Query: 223 ITVKCMVGTMGYMAPESLQTETISDK-CDIYSFGVLLAVLVMGK--FP 267
V T Y APE L +T K D+++ G ++A L+ G+ FP
Sbjct: 157 PLTD-YVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFP 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-13
Identities = 63/240 (26%), Positives = 107/240 (44%), Gaps = 39/240 (16%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
F+ ++ +G+G +G+V+ + G++ AI+ ++D E IKQ+I+ H
Sbjct: 8 FELVELVGNGTYGQVYKGRHV--KTGQLAAIK--VMDVTGDEEEEIKQEINMLKKYSH-- 61
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCH------LLVYEFMKNGSLQDILYDVSQG 156
HRNI ++ N LV EF GS+ D++ +
Sbjct: 62 ---------------HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN 106
Query: 157 RRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLM 216
+ +W A I R I GL +LH + ++IHRDIK NVL+ ++ E ++ DFG +
Sbjct: 107 TLKEEWIAY--ICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161
Query: 217 PDGHAQITVKCMVGTMGYMAPESLQTETISD-----KCDIYSFGVLLAVLVMGKFPVDDF 271
+ +GT +MAPE + + D K D++S G+ + G P+ D
Sbjct: 162 DRTVGRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 219
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-13
Identities = 71/255 (27%), Positives = 113/255 (44%), Gaps = 50/255 (19%)
Query: 33 DLAFLKK-EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQD 91
DL+ L+ F+ ++ +G+G +G+V+ + G++ AI+ ++D E IK +
Sbjct: 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHV--KTGQLAAIK--VMDVTEDEEEEIKLE 62
Query: 92 IDEYSDLLHWKIGAIRSEIITANQTRHRNILPLLAHMVR--PNCH----LLVYEFMKNGS 145
I+ H HRNI ++ P H LV EF GS
Sbjct: 63 INMLKKYSH-----------------HRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGS 105
Query: 146 LQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEA 205
+ D++ + + DW A I R I GL +LH +IHRDIK NVL+ ++ E
Sbjct: 106 VTDLVKNTKGNALKEDWIAY--ICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEV 160
Query: 206 RISDFGHGKLMPDGHAQI--TV---KCMVGTMGYMAPESLQTETISD-----KCDIYSFG 255
++ DFG AQ+ TV +GT +MAPE + + D + DI+S G
Sbjct: 161 KLVDFGVS-------AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLG 213
Query: 256 VLLAVLVMGKFPVDD 270
+ + G P+ D
Sbjct: 214 ITAIEMAEGAPPLCD 228
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 1e-13
Identities = 48/168 (28%), Positives = 79/168 (47%), Gaps = 24/168 (14%)
Query: 167 RIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVK 226
+IA I LEYLH + +IHRD+KP+NVLI+ + + ++ DFG + D A+ T+
Sbjct: 107 KIAVSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK-TID 163
Query: 227 CMVGTMGYMAPESLQTET----ISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVK 282
G YMAPE + E K D++S G+ + L G+FP D + +
Sbjct: 164 --AGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSW------KTPFQ 215
Query: 283 WMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPS 330
++ V+ +P +L + + + C K+ ERP+
Sbjct: 216 QLKQVVEEPSP------QLPAEKFSPEFQDFVNK---CLKKNYKERPN 254
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 1e-13
Identities = 81/319 (25%), Positives = 127/319 (39%), Gaps = 67/319 (21%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDA-----PMSAAELIKQDIDEYSD 97
++ L +IG G +G V YKA G+ +A++K+ V P+S + E +
Sbjct: 1 YEELAEIGEGAYGTV-YKARDLN-TGRFVALKKVRVPLSEEGIPLST-------LREIAL 51
Query: 98 LLHWKIGAIRSEIITANQTRHRNILPLL-----AHMVRPNCHLLVYEFMKNGSLQDILYD 152
L H NI+ LL R LV+E + L L
Sbjct: 52 LKQ------------LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSK 98
Query: 153 VSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGH 212
+ L + R + G+++LH HR ++HRD+KP N+L+ D + +I+DFG
Sbjct: 99 CPK--PGLPPETIKDLMRQLLRGVDFLH-SHR--IVHRDLKPQNILVTSDGQVKIADFGL 153
Query: 213 GKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFF 272
++ A +V V T+ Y APE L + + D++S G + A L F F
Sbjct: 154 ARIYSFEMALTSV---VVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL----FRRRPLF 206
Query: 273 GHTEEMDMVK-------------WMRNVI-----FSENPNRAINSKLLGNGYEEQMLLVL 314
T E D + W RNV F R+ S + E LL
Sbjct: 207 RGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLL-K 265
Query: 315 KLACFCTLKDPDERPSSKD 333
K+ F +P +R S+ +
Sbjct: 266 KMLTF----NPHKRISAFE 280
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 2e-13
Identities = 85/314 (27%), Positives = 137/314 (43%), Gaps = 66/314 (21%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGA 105
L KIG G + EV GK AI+ + + +++ ++L +I A
Sbjct: 4 LGKIGEGTFSEVLKAQSR--KTGKYYAIKCMKKHF---------KSLEQVNNLR--EIQA 50
Query: 106 IRSEIITANQTRHRNILPLLAHMV--RPNCHLLVYEFMKNGSLQDI-LYDVSQGRRELDW 162
+R + H NIL L+ + + LV+E M D+ LY++ +GR+
Sbjct: 51 LRR------LSPHPNILRLIEVLFDRKTGRLALVFELM------DMNLYELIKGRKRPLP 98
Query: 163 PAR-HRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHA 221
R + L+ HM HR + HRDIKP N+LI DD +++DFG + + ++
Sbjct: 99 EKRVKSYMYQLLKSLD--HM-HRNGIFHRDIKPENILIKDD-ILKLADFGSCRGI---YS 151
Query: 222 QITVKCMVGTMGYMAPESLQTETI-SDKCDIYSFG-VLLAVLVMGKFPVDDFFGHTEEMD 279
+ + T Y APE L T+ K DI++ G V +L + FP+ F T E+D
Sbjct: 152 KPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSL--FPL---FPGTNELD 206
Query: 280 MVKWMRNVI--------FSENPNRAIN-----------SKLLGNGYEEQMLLVLKLACFC 320
+ + +V+ +R +N KLL N E + L+ KL +
Sbjct: 207 QIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAY- 265
Query: 321 TLKDPDERPSSKDV 334
DPDER ++K
Sbjct: 266 ---DPDERITAKQA 276
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 2e-13
Identities = 44/167 (26%), Positives = 68/167 (40%), Gaps = 23/167 (13%)
Query: 167 RIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVK 226
++ I L YL H +IHRD+KP+N+L+D ++ DFG + D A+
Sbjct: 118 KMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSA 175
Query: 227 CMVGTMGYMAPESLQTETISDKCDI----YSFGVLLAVLVMGKFPVDDFFGHTEEMDMVK 282
G YMAPE + + K DI +S G+ L L G+FP + E +++
Sbjct: 176 ---GCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP---YKNCKTEFEVL- 228
Query: 283 WMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERP 329
I E P ++ + C KD +RP
Sbjct: 229 ---TKILQEEPPSLPPNEGFSPDFCS-------FVDLCLTKDHRKRP 265
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-13
Identities = 61/243 (25%), Positives = 105/243 (43%), Gaps = 50/243 (20%)
Query: 47 KKIGSGGWGEVFYKA--ELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIG 104
+++G G +G+VF L + KM+ K + D ++A ++D ++LL
Sbjct: 11 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAA----RKDFQREAELL----- 61
Query: 105 AIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQD----------ILYDVS 154
+H +I+ + ++V+E+MK+G L IL D
Sbjct: 62 ---------TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQ 112
Query: 155 --QGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGH 212
Q + EL IA IASG+ YL H +HRD+ N L+ ++ +I DFG
Sbjct: 113 PRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGM 169
Query: 213 GKLMPD-------GHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL-AVLVMG 264
+ + GH + ++ +M PES+ + + D++SFGV+L + G
Sbjct: 170 SRDVYSTDYYRVGGHTMLPIR-------WMPPESIMYRKFTTESDVWSFGVILWEIFTYG 222
Query: 265 KFP 267
K P
Sbjct: 223 KQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-13
Identities = 60/232 (25%), Positives = 105/232 (45%), Gaps = 34/232 (14%)
Query: 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLL 99
E F L++IG G +G V++ ++ N +++AI+K+ KQ +++ D++
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDV--RNSEVVAIKKMSYSG--------KQSNEKWQDII 63
Query: 100 HWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRE 159
E+ + RH N + +R + LV E+ GS D+L + +E
Sbjct: 64 --------KEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQE 114
Query: 160 LDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDG 219
++ A + G GL YLH +IHRD+K N+L+ + ++ DFG +M
Sbjct: 115 VEIAA---VTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168
Query: 220 HAQITVKCMVGTMGYMAPE---SLQTETISDKCDIYSFGVLLAVLVMGKFPV 268
+ VGT +MAPE ++ K D++S G+ L K P+
Sbjct: 169 NX------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 3e-13
Identities = 71/281 (25%), Positives = 112/281 (39%), Gaps = 52/281 (18%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGA 105
LK I G +G V+ + S G AI K++ + M A ++
Sbjct: 1 LKPISKGAFGSVYLAKKR--STGDYFAI-KVLKKSDMIAKN---------------QVTN 42
Query: 106 IRSE-IITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPA 164
+++E I Q + L + LV E++ G ++ + G DW A
Sbjct: 43 VKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTL--GGLPEDW-A 99
Query: 165 RHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGK--LMPDGHAQ 222
+ IA + G+E LH + +IHRDIKP N+LID +++DFG + L
Sbjct: 100 KQYIAE-VVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN----- 150
Query: 223 ITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFP-----VDDFFGHTEE 277
K VGT Y+APE++ D +S G ++ + G P D F +
Sbjct: 151 ---KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILS 207
Query: 278 MDMVKWMRNVIFSENP------NRAI----NSKLLGNGYEE 308
+ W V +P NR + +L NGY+E
Sbjct: 208 RR-INWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQE 247
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 47/168 (27%), Positives = 81/168 (48%), Gaps = 16/168 (9%)
Query: 107 RSEIITANQTRHRNILPLLAHMVRPNCHLL-VYEFMKNGSLQDILYDVSQGRRELDWPAR 165
R E + H NI+ LL P L V+E++ +L+++L + G PA
Sbjct: 26 RRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVL--AADGA----LPAG 79
Query: 166 HRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI---DDDMEARISDFGHGKLMPDGH-- 220
R + L+ L H ++HRD+KP N+++ A++ DFG G L+P
Sbjct: 80 -ETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDA 138
Query: 221 --AQITVKC-MVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGK 265
A +T ++GT Y APE L+ E ++ D+Y++G++ + G+
Sbjct: 139 DVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-13
Identities = 72/306 (23%), Positives = 127/306 (41%), Gaps = 58/306 (18%)
Query: 48 KIGSGGWGEVFYKAE----LPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKI 103
++G G +G+VF AE LP + ++A++ L A+E +QD ++LL
Sbjct: 12 ELGEGAFGKVFL-AECHNLLPEQDKMLVAVKAL-----KEASESARQDFQREAELL---- 61
Query: 104 GAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDIL---------YDVS 154
+H++I+ L+V+E+M++G L L
Sbjct: 62 ----------TVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGG 111
Query: 155 QGRR--ELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGH 212
+ +L IA IASG+ YL H +HRD+ N L+ + +I DFG
Sbjct: 112 EDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGM 168
Query: 213 GK-LMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL-AVLVMGKFPVDD 270
+ + + ++ + M+ + +M PES+ + + DI+SFGV+L + GK P
Sbjct: 169 SRDIYSTDYYRVGGRTML-PIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQ 227
Query: 271 FFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPS 330
+TE ++ + R + E P V + C ++P +R
Sbjct: 228 -LSNTEAIECITQGREL---ERPRTCPPE-------------VYAIMQGCWQREPQQRMV 270
Query: 331 SKDVRS 336
KD+ S
Sbjct: 271 IKDIHS 276
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 3e-13
Identities = 69/298 (23%), Positives = 129/298 (43%), Gaps = 50/298 (16%)
Query: 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLL 99
E+ F L +IG G +G V++ +++A++K+ KQ +++ D++
Sbjct: 20 EEIFVGLHEIGHGSFGAVYFATN--SHTNEVVAVKKMSYSG--------KQTNEKWQDII 69
Query: 100 HWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRE 159
E+ Q +H N + ++ + LV E+ GS D+L + +E
Sbjct: 70 --------KEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQE 120
Query: 160 LDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDG 219
++ A I G GL YLH +IHRDIK N+L+ + + +++DFG
Sbjct: 121 VEIAA---ITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA 174
Query: 220 HAQITVKCMVGTMGYMAPE---SLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTE 276
++ VGT +MAPE ++ K D++S G+ L K P+ +
Sbjct: 175 NS------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN------ 222
Query: 277 EMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDV 334
M+ + + ++ +++P L N + + +C K P ERP+S ++
Sbjct: 223 -MNAMSALYHIAQNDSPT------LQSNEWTDSF---RGFVDYCLQKIPQERPASAEL 270
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-13
Identities = 59/222 (26%), Positives = 93/222 (41%), Gaps = 47/222 (21%)
Query: 47 KKIGSGGWGEVFYKAELPGSNGKM-IAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGA 105
+KIG G +G+V YK L G +A++ P Q
Sbjct: 1 EKIGKGNFGDV-YKGVL---KGNTEVAVKTCRSTLPPDLKRKFLQ--------------- 41
Query: 106 IRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPAR 165
E Q H NI+ L+ V+ +V E + GSL L + + L
Sbjct: 42 ---EAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFL---RKKKNRLTVKKL 95
Query: 166 HRIARGIASGLEYLHM--CHRPRLIHRDIKPANVLIDDDMEARISDFG-----HGKL--M 216
+++ A+G+EYL C IHRD+ N L+ ++ +ISDFG G + +
Sbjct: 96 LQMSLDAAAGMEYLESKNC-----IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTV 150
Query: 217 PDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
DG QI +K + APE+L + + D++S+G+LL
Sbjct: 151 SDGLKQIPIK-------WTAPEALNYGRYTSESDVWSYGILL 185
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 4e-13
Identities = 71/300 (23%), Positives = 133/300 (44%), Gaps = 54/300 (18%)
Query: 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLL 99
E F L++IG G +G V++ ++ + +++AI+K+ KQ +++ D++
Sbjct: 24 EKLFTDLREIGHGSFGAVYFARDVRTN--EVVAIKKMSYSG--------KQSNEKWQDII 73
Query: 100 HWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRE 159
E+ + +H N + +R + LV E+ GS D+L + +E
Sbjct: 74 --------KEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQE 124
Query: 160 LDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDG 219
++ A I G GL YLH +IHRDIK N+L+ + + +++DFG +
Sbjct: 125 VEIAA---ITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA 178
Query: 220 HAQITVKCMVGTMGYMAPE---SLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTE 276
++ VGT +MAPE ++ K D++S G+ L K P+ +
Sbjct: 179 NS------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN------ 226
Query: 277 EMDMVKWMRNVIFSENPNRAIN--SKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDV 334
M+ + + ++ +E+P N S N + C K P +RP+S+++
Sbjct: 227 -MNAMSALYHIAQNESPTLQSNEWSDYFRNFVDS-----------CLQKIPQDRPTSEEL 274
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (168), Expect = 4e-13
Identities = 72/323 (22%), Positives = 131/323 (40%), Gaps = 77/323 (23%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQ---DIDEYSDLL 99
+ +K++G G +G V Y A G+++AI+K+ K+ +E +L
Sbjct: 1 YKVIKQLGDGTFGSV-YLARNK-ETGELVAIKKM------------KKKFYSWEECMNLR 46
Query: 100 HWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHL-LVYEFMKNGSLQDILYDV--SQG 156
K ++R H NI+ L + R N L V+E+M+ LY + +
Sbjct: 47 EVK--SLRK------LNEHPNIVKLK-EVFRENDELYFVFEYMEGN-----LYQLMKDRK 92
Query: 157 RRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLM 216
+ I I GL ++H HRD+KP N+L+ +I+DFG +
Sbjct: 93 GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAR-- 147
Query: 217 PDGHAQITVKCM------VGTMGYMAPES-LQTETISDKCDIYSFGVLLAVLVMGK--FP 267
++ V T Y APE L++ + S DI++ G ++A L + FP
Sbjct: 148 -------EIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFP 200
Query: 268 ----VDDFF------GHTEEMDMVKWMR-----NVIFSENPNRAINSKLLGNGYEEQMLL 312
+D + G + D + + F + +++ +L+ N E + L
Sbjct: 201 GSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLH-QLIPNASPEAIDL 259
Query: 313 VLKLACFCTLK-DPDERPSSKDV 334
+ + L+ DP +RP++
Sbjct: 260 IKDM-----LRWDPKKRPTASQA 277
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 5e-13
Identities = 64/244 (26%), Positives = 113/244 (46%), Gaps = 37/244 (15%)
Query: 33 DLAFLKKEDCFDSLKKIGSGGWGEVFY-KAELPGSNGKMIAIRKLIVDAPMSAAELIKQD 91
D++ +K E+ IG+G +GEV + +LPG +AI+ L + KQ
Sbjct: 2 DVSCVKIEEV------IGAGEFGEVCRGRLKLPGKREIFVAIKTL------KSGYTEKQR 49
Query: 92 IDEYSDLLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILY 151
D SE Q H NI+ L + + +++ EFM+NG+L L
Sbjct: 50 RD------------FLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFL- 96
Query: 152 DVSQGRRELDWPARHRIARGIASGLEYL-HMCHRPRLIHRDIKPANVLIDDDMEARISDF 210
Q + + RGIA+G++YL M + +HRD+ N+L++ ++ ++SDF
Sbjct: 97 --RQNDGQFTVIQLVGMLRGIAAGMKYLSEMNY----VHRDLAARNILVNSNLVCKVSDF 150
Query: 211 GHGKLMPDGHAQITVKCMVG---TMGYMAPESLQTETISDKCDIYSFG-VLLAVLVMGKF 266
G + + D + T +G + + APE++ + D++S+G V+ V+ G+
Sbjct: 151 GLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGER 210
Query: 267 PVDD 270
P D
Sbjct: 211 PYWD 214
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 7e-13
Identities = 47/175 (26%), Positives = 77/175 (44%), Gaps = 24/175 (13%)
Query: 168 IARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFG-HGKLMPDGHAQITVK 226
IA L YL + +IHRD+KP+N+L+D + ++ DFG G+L+ D A+ T
Sbjct: 112 IAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLV-DSIAK-TRD 167
Query: 227 CMVGTMGYMAPESLQTETISD---KCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKW 283
G YMAPE + + D++S G+ L + GKFP + +
Sbjct: 168 --AGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKW------NSVFDQ 219
Query: 284 MRNVIFSENPNRAINSKLLGNGYEEQMLL-VLKLACFCTLKDPDERPSSKDVRSM 337
+ V+ + P +L N E + + C +KD +RP K++
Sbjct: 220 LTQVVKGDPP-------ILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 8e-13
Identities = 72/297 (24%), Positives = 136/297 (45%), Gaps = 56/297 (18%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
D+ KIG G G V S+GK++A++K+ +L KQ E
Sbjct: 22 LDNFIKIGEGSTGIVCIAT--VKSSGKLVAVKKM---------DLRKQQRREL------- 63
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDW 162
+ +E++ +H N++ + + + +V EF++ G+L DI V+ R
Sbjct: 64 ---LFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDI---VTHTRMN--- 114
Query: 163 PARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQ 222
+IA + L+ L + H +IHRDIK ++L+ D ++SDFG AQ
Sbjct: 115 --EEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFC-------AQ 165
Query: 223 ITV-----KCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEE 277
++ K +VGT +MAPE + + DI+S G+++ +V G+ P + +
Sbjct: 166 VSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP----YFNEPP 221
Query: 278 MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDV 334
+ +K +R+ + + N S L G+ +++L ++DP +R ++ ++
Sbjct: 222 LKAMKMIRDNLPPKLKNLHKVSPSL-KGFLDRLL----------VRDPAQRATAAEL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 8e-13
Identities = 62/225 (27%), Positives = 105/225 (46%), Gaps = 29/225 (12%)
Query: 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLH 100
+ ++ L KIG G +G VF K G+++AI+K + + D +
Sbjct: 1 EKYEKLSKIGEGSYGVVF-KCR-NRETGQIVAIKKFV---------------ESEDDPVI 43
Query: 101 WKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRREL 160
KI A+R EI Q +H N++ L+ R LV+E+ + +L ++ + R +
Sbjct: 44 KKI-ALR-EIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDH----TVLNELEKNPRGV 97
Query: 161 DWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGH 220
H I + I L+ ++ CH+ IHRD+KP N+LI + ++ DFG +++
Sbjct: 98 P---EHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154
Query: 221 AQITVKCMVGTMGYMAPESLQTET-ISDKCDIYSFGVLLAVLVMG 264
T V T Y APE L +T D+++ G + A L+ G
Sbjct: 155 DDYTD--YVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 9e-13
Identities = 72/236 (30%), Positives = 114/236 (48%), Gaps = 39/236 (16%)
Query: 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAI 106
K +G G +G+V AEL G G+ A++ L D LI D++ ++ ++ A+
Sbjct: 1 KVLGKGSFGKVLL-AELKGK-GEYFAVKALKKDVV-----LIDDDVE--CTMVEKRVLAL 51
Query: 107 RSEIITANQTRHRNILPLLAHMV---RPNCHLL-VYEFMKNGSLQDILYDVS-QGRRELD 161
E P L H+ + HL V EF+ G D+++ + +GR +L
Sbjct: 52 AWEN------------PFLTHLYCTFQTKEHLFFVMEFLNGG---DLMFHIQDKGRFDLY 96
Query: 162 WPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHA 221
+ A I GL++LH +I+RD+K NV++D D +I+DFG K G
Sbjct: 97 RATFY--AAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN 151
Query: 222 QITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEE 277
+ + C GT Y+APE LQ + D +SFGVLL +++G+ P F G E+
Sbjct: 152 RASTFC--GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP---FHGDDED 202
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 1e-12
Identities = 65/231 (28%), Positives = 108/231 (46%), Gaps = 41/231 (17%)
Query: 47 KKIGSGGWGEVFY-KAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGA 105
K IG+G +GEV + +LPG +AI+ L A KQ D
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTL------KAGYTEKQRRD------------ 51
Query: 106 IRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDIL------YDVSQGRRE 159
SE Q H NI+ L + + ++V E+M+NGSL L + V Q
Sbjct: 52 FLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGM 111
Query: 160 LDWPARHRIARGIASGLEYLH-MCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPD 218
L RGIASG++YL M + +HRD+ N+L++ ++ ++SDFG +++ D
Sbjct: 112 L---------RGIASGMKYLSDMGY----VHRDLAARNILVNSNLVCKVSDFGLSRVLED 158
Query: 219 G-HAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL-AVLVMGKFP 267
A T + + + APE++ + D++S+G+++ V+ G+ P
Sbjct: 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 2e-12
Identities = 62/226 (27%), Positives = 103/226 (45%), Gaps = 33/226 (14%)
Query: 36 FLKKEDCFDSLKKIGSGGWGEVFYKAELPGSN--GKMIAIRKLIVDAPMSAAELIKQDID 93
+LKK ++ +G G +G+V P ++ G+M+A++ L + K++I+
Sbjct: 5 YLKK------IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEIN 58
Query: 94 EYSDLLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDV 153
L H I ++ + + Q L L+ E++ GSL+D L
Sbjct: 59 ILKTLYHENI--VKYKGCCSEQGG--KGL------------QLIMEYVPLGSLRDYL--- 99
Query: 154 SQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHG 213
+ +L+ A+ I G+ YLH H IHRD+ NVL+D+D +I DFG
Sbjct: 100 --PKHKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLA 154
Query: 214 KLMPDGHAQITVK-CMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
K +P+GH V+ + + A E L+ S D++SFGV L
Sbjct: 155 KAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTL 200
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 2e-12
Identities = 42/124 (33%), Positives = 62/124 (50%), Gaps = 7/124 (5%)
Query: 136 LVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPA 195
LV E++ GSL+D L + R LD A I G+EYL R +HRD+
Sbjct: 84 LVMEYLPYGSLRDYL---QKHRERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATR 137
Query: 196 NVLIDDDMEARISDFGHGKLMPDGHAQITVK-CMVGTMGYMAPESLQTETISDKCDIYSF 254
N+L++ + +I DFG K++P V+ + + APESL S D++SF
Sbjct: 138 NILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSF 197
Query: 255 GVLL 258
GV+L
Sbjct: 198 GVVL 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 2e-12
Identities = 63/235 (26%), Positives = 102/235 (43%), Gaps = 53/235 (22%)
Query: 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLH 100
F+ ++ IG G +G+V YKA G+++AI+ I+D I +D +E
Sbjct: 6 GIFELVEVIGEGTYGKV-YKARHK-KTGQLVAIK--IMD--------IIEDEEE------ 47
Query: 101 WKIGAIRSEI-ITANQTRHRNILP------LLAHMVRPNCHLLVYEFMKNGSLQDILYDV 153
I+ E I + H NI + LV E GS+ D++ +
Sbjct: 48 ----EIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGL 103
Query: 154 -SQGRR-ELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFG 211
+G+R + +W A I R GL YLH +IHRDIK N+L+ + E ++ DFG
Sbjct: 104 RKKGKRLKEEWIAY--ILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158
Query: 212 HGKLMPDGHAQITVKCM-----VGTMGYMAPESLQTE-----TISDKCDIYSFGV 256
AQ+ +GT +MAPE + + + + D++S G+
Sbjct: 159 VS-------AQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGI 206
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-12
Identities = 63/230 (27%), Positives = 102/230 (44%), Gaps = 41/230 (17%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
DS KIG G G V E GK +A++K+ +L KQ E
Sbjct: 24 LDSFIKIGEGSTGIVCIATE--KHTGKQVAVKKM---------DLRKQQRREL------- 65
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDW 162
+ +E++ H N++ + + + +V EF++ G+L DI V+ R
Sbjct: 66 ---LFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDI---VTHTRMN--- 116
Query: 163 PARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQ 222
+IA S L L H +IHRDIK ++L+ D ++SDFG AQ
Sbjct: 117 --EEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFC-------AQ 167
Query: 223 ITV-----KCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFP 267
++ K +VGT +MAPE + + DI+S G+++ ++ G+ P
Sbjct: 168 VSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 2e-12
Identities = 88/330 (26%), Positives = 129/330 (39%), Gaps = 94/330 (28%)
Query: 47 KKIGSGGWGEVF--YKAELPGSNG-KMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKI 103
K +G G +G+V L G G +A++ L +A S E DLL
Sbjct: 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSS----------ELRDLL---- 51
Query: 104 GAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDIL---------YDVS 154
SE Q H +++ L + LL+ E+ K GSL+ L Y S
Sbjct: 52 ----SEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGS 107
Query: 155 QGRRE---LDWPARHRIARG--------IASGLEYLHMCHRPRLIHRDIKPANVLIDDDM 203
G R LD P + G I+ G++YL +L+HRD+ NVL+ +
Sbjct: 108 DGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARNVLVAEGR 164
Query: 204 EARISDFGHGK-------LMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGV 256
+ +ISDFG + + +I VK +MA ESL + + D++SFGV
Sbjct: 165 KMKISDFGLSRDVYEEDSYVKRSKGRIPVK-------WMAIESLFDHIYTTQSDVWSFGV 217
Query: 257 LLAVLV-MGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGY--------- 306
LL +V +G P P R N LL GY
Sbjct: 218 LLWEIVTLGGNPYPGI--------------------APERLFN--LLKTGYRMERPENCS 255
Query: 307 EEQMLLVLKLACFCTLKDPDERPSSKDVRS 336
EE L+L C ++PD+RP+ D+
Sbjct: 256 EEMYNLMLT----CWKQEPDKRPTFADISK 281
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 3e-12
Identities = 55/217 (25%), Positives = 97/217 (44%), Gaps = 32/217 (14%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
F L ++G GG+G+VF + G+++A+++ M + L K ++E +L +
Sbjct: 3 FQILTQVGQGGYGQVFLAKK--KDTGEIVALKR------MKKSLLFK--LNEVRHVLTER 52
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDW 162
+I+T T+ ++ LL L E++ G + +L ++ +
Sbjct: 53 ------DILT--TTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSED--- 101
Query: 163 PARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQ 222
AR +A + + H IHRD+KP N LID +++DFG K
Sbjct: 102 HARFYMAEMFEA----VDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSK------GI 151
Query: 223 IT-VKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
+T +VG+ YMAPE L+ + D +S G +L
Sbjct: 152 VTYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCML 188
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 3e-12
Identities = 79/297 (26%), Positives = 115/297 (38%), Gaps = 61/297 (20%)
Query: 49 IGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRS 108
+G G +G V+ +L S IAI++ I + Y LH
Sbjct: 16 LGKGTYGIVYAARDL--STQVRIAIKE------------IPERDSRYVQPLH-------E 54
Query: 109 EIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRI 168
EI + +HRNI+ L + E + GSL +L G + +
Sbjct: 55 EIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALL-RSKWGPLKDNEQTIIFY 113
Query: 169 ARGIASGLEYLHMCHRPRLIHRDIKPANVLIDD-DMEARISDFGHGKLMPDGHAQIT--V 225
+ I GL+YLH +++HRDIK NVL++ +ISDFG K + A I
Sbjct: 114 TKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL----AGINPCT 166
Query: 226 KCMVGTMGYMAPESLQTETISDK--------CDIYSFGVLLAVLVMGKFPVDDFFGHTEE 277
+ GT+ YMAPE + DK DI+S G + + GK P +
Sbjct: 167 ETFTGTLQYMAPE------VIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA 220
Query: 278 MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDV 334
M V +F +P I L L CF DPD+R S+ D+
Sbjct: 221 MFKVG-----MFKIHPE--IPESLSAEAKN------FILRCF--EPDPDKRASAHDL 262
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-12
Identities = 74/300 (24%), Positives = 133/300 (44%), Gaps = 62/300 (20%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
++ KIG G G V E +G+ +A++ + +L KQ E
Sbjct: 23 LENYIKIGEGSTGIVCIARE--KHSGRQVAVKMM---------DLRKQQRREL------- 64
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDW 162
+ +E++ +H+N++ + + ++ EF++ G+L DI VSQ R
Sbjct: 65 ---LFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDI---VSQTRLN--- 115
Query: 163 PARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQ 222
+IA S L+ L H +IHRDIK ++L+ D ++SDFG AQ
Sbjct: 116 --EEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFC-------AQ 166
Query: 223 ITV-----KCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEE 277
I+ K +VGT +MAPE + + DI+S G+++ +V G+ P +F +
Sbjct: 167 ISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPP---YFSDSPV 223
Query: 278 MDMVKWMRNVIFSENPNRAINSKLLG---NGYEEQMLLVLKLACFCTLKDPDERPSSKDV 334
M K +R+ P + N+ + + E+ML ++P ER +++++
Sbjct: 224 QAM-KRLRD----SPPPKLKNAHKISPVLRDFLERML----------TREPQERATAQEL 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 4e-12
Identities = 66/225 (29%), Positives = 102/225 (45%), Gaps = 50/225 (22%)
Query: 49 IGSGGWGEVFYKAELPGSNGKMI--AIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAI 106
IG G +G V Y L S+G+ I A++ L I D++E L
Sbjct: 3 IGKGHFGCV-YHGTLIDSDGQKIHCAVKSL---------NRI-TDLEEVEQFL------- 44
Query: 107 RSEIITANQTRHRNILPLLAHMVRPN-CHLLVYEFMKNGSLQDILYDVSQGRRELDWPA- 164
E I H N+L LL + L+V +MK+G L++ + R E P
Sbjct: 45 -KEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFI------RSETHNPTV 97
Query: 165 RHRIARG--IASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPD---- 218
+ I G +A G+EYL + +HRD+ N ++D+ +++DFG + + D
Sbjct: 98 KDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154
Query: 219 -----GHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
A++ VK +MA ESLQT+ + K D++SFGVLL
Sbjct: 155 SVHNHTGAKLPVK-------WMALESLQTQKFTTKSDVWSFGVLL 192
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 4e-12
Identities = 67/239 (28%), Positives = 106/239 (44%), Gaps = 48/239 (20%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
+ ++KIG G +G V YKA G+++A++K+ ++ DE
Sbjct: 1 YQKVEKIGEGTYG-VVYKA-RDKLTGEIVALKKIRLETE-----------DE-------- 39
Query: 103 IG----AIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEF--MKNGSLQDILYDVSQG 156
G AIR EI + H NI+ LL + N LV+EF + D
Sbjct: 40 -GVPSTAIR-EISLLKELNHPNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLD 97
Query: 157 RRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLM 216
+ +++ +GIA CH R++HRD+KP N+LID + +++DFG +
Sbjct: 98 PPLIK-SYLYQLLQGIA-------YCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAF 149
Query: 217 PDGHAQITVKCM---VGTMGYMAPES-LQTETISDKCDIYSFGVLLAVLVMGK--FPVD 269
+ V+ V T+ Y APE L + S DI+S G + A +V + FP D
Sbjct: 150 -----GVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGD 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 4e-12
Identities = 62/230 (26%), Positives = 100/230 (43%), Gaps = 30/230 (13%)
Query: 47 KKIGSGGWGEVF--YKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIG 104
K +G G +GEV+ Y A+ G+ +A++++ D D E S ++
Sbjct: 8 KLLGRGAFGEVYLCYDAD----TGRELAVKQVPFDP----------DSQETSK----EVN 49
Query: 105 AIRSEIITANQTRHRNILPLLAHMVRPNCHLL--VYEFMKNGSLQDILYDVSQGRRELDW 162
A+ EI RH I+ + P L E+M GS++D L + L
Sbjct: 50 ALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL----KAYGALTE 105
Query: 163 PARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQ 222
R R I G+ YLH ++HRDIK AN+L D ++ DFG K +
Sbjct: 106 NVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMS 162
Query: 223 IT-VKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDF 271
T +K + GT +M+PE + E K D++S + ++ K P ++
Sbjct: 163 GTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 5e-12
Identities = 44/104 (42%), Positives = 54/104 (51%), Gaps = 16/104 (15%)
Query: 169 ARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFG----HGKLMPDGHAQIT 224
A I GLE HM H +++RD+KPAN+L+D+ RISD G K P HA
Sbjct: 103 AAEIILGLE--HM-HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--HAS-- 155
Query: 225 VKCMVGTMGYMAPESLQTETISD-KCDIYSFGVLLAVLVMGKFP 267
VGT GYMAPE LQ D D +S G +L L+ G P
Sbjct: 156 ----VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 5e-12
Identities = 64/230 (27%), Positives = 109/230 (47%), Gaps = 39/230 (16%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
+ ++KIG G +G V YK G+++A++K+ ++ S E +
Sbjct: 2 YTKIEKIGEGTYG-VVYKGR-NKKTGQIVAMKKIRLE---SEEEGVPST----------- 45
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGR---RE 159
AIR EI + +H NI+ L +++ + L++EF+ + L+ L + +G+ E
Sbjct: 46 --AIR-EISLLKELQHPNIVCLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAE 101
Query: 160 LDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDG 219
L ++I +GI CH R++HRD+KP N+LID+ +++DFG +
Sbjct: 102 LVKSYLYQILQGIL-------FCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF--- 151
Query: 220 HAQITVKCM---VGTMGYMAPESLQTET-ISDKCDIYSFGVLLAVLVMGK 265
I V+ V T+ Y APE L S DI+S G + A + K
Sbjct: 152 --GIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 6e-12
Identities = 69/288 (23%), Positives = 115/288 (39%), Gaps = 44/288 (15%)
Query: 49 IGSGGWGEVFYKAELPGSNGKMIAIRKLIVD-APMSAAELIKQDIDEYSDLLHWKIGAIR 107
+G G +G V+ + G++IA++++ +D + + AAE + + E DLL
Sbjct: 8 LGKGAYGTVYCGLT---NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLL-------- 56
Query: 108 SEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHR 167
+H NI+ L + N + EF+ GS+ IL L P +
Sbjct: 57 ------KSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFG----PLPEPVFCK 106
Query: 168 IARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQIT--- 224
+ I G+ YLH ++HRDIK NV++ + ++ DFG + + T
Sbjct: 107 YTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSN 163
Query: 225 -VKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKW 283
+K M GT +MAPE + K DI+S G + + GK P+ MD +
Sbjct: 164 MLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLAS-------MDRLAA 216
Query: 284 MRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSS 331
M + + + C +D ERPS+
Sbjct: 217 MFYIGAHRGLMPRLPDSFSAAAID--------FVTSCLTRDQHERPSA 256
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 8e-12
Identities = 59/235 (25%), Positives = 107/235 (45%), Gaps = 41/235 (17%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
++ +KKIG G +G+++ S+ + I+++ +L K + E
Sbjct: 2 YEIIKKIGEGSFGKIYLAKA--KSDSEHCVIKEI---------DLTKMPVKEKE------ 44
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSL-------QDILYDVSQ 155
A + E+I + +H NI+ A +V E+ G L + +L+ Q
Sbjct: 45 --ASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQ 102
Query: 156 GRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDD-MEARISDFGHGK 214
L W + I+ GL+++H +++HRDIK N+ + + M A++ DFG +
Sbjct: 103 ---ILSWFVQ------ISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIAR 150
Query: 215 LMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVD 269
+ D ++ C VGT Y++PE Q ++K DI+S G +L L K P +
Sbjct: 151 QLNDS-MELAYTC-VGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 8e-12
Identities = 52/190 (27%), Positives = 89/190 (46%), Gaps = 18/190 (9%)
Query: 122 LPLLAHMVRPNCHL-LVYEFMKNGSLQDILYDVSQGRRELDWPARHRIAR-GIASGLEYL 179
+P L + + +L LV E+ G L +L ++ + D +A+ +A + +
Sbjct: 63 IPQLQYAFQDKDNLYLVMEYQPGGDLLSLL---NRYEDQFD----EDMAQFYLAELVLAI 115
Query: 180 HMCHRPRLIHRDIKPANVLIDDDMEARISDFGH-GKLMPDGHAQITVKCMVGTMGYMAPE 238
H H+ +HRDIKP NVLID +++DFG +L + + K VGT Y+APE
Sbjct: 116 HSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM--VNSKLPVGTPDYIAPE 173
Query: 239 SLQTETISDK------CDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSEN 292
L T K CD +S GV+ ++ G+ P + +++ + R + F E+
Sbjct: 174 VLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPED 233
Query: 293 PNRAINSKLL 302
P + + L
Sbjct: 234 PKVSSDFLDL 243
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 9e-12
Identities = 39/139 (28%), Positives = 71/139 (51%), Gaps = 19/139 (13%)
Query: 136 LVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPA 195
++ EFM GSL D L ++ L P + IA G+ ++ + IHRD++ A
Sbjct: 77 IITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIE---QRNYIHRDLRAA 131
Query: 196 NVLIDDDMEARISDFGHGKLMPDGH------AQITVKCMVGTMGYMAPESLQTETISDKC 249
N+L+ + +I+DFG +++ D A+ +K + APE++ + + K
Sbjct: 132 NILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK-------WTAPEAINFGSFTIKS 184
Query: 250 DIYSFGVLLA-VLVMGKFP 267
D++SFG+LL ++ G+ P
Sbjct: 185 DVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 1e-11
Identities = 66/233 (28%), Positives = 108/233 (46%), Gaps = 42/233 (18%)
Query: 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAI 106
K +G G +G+V AEL G++ ++ A++ L D +I QD D + ++ A+
Sbjct: 1 KVLGKGSFGKVLL-AELKGTD-ELYAVKVLKKD-------VILQDDDVECTMTEKRVLAL 51
Query: 107 RSEIITANQTRHRNILPLLAHMVRPNC-----HL-LVYEFMKNGSLQDILYDVSQGRREL 160
+H P L + +C L V E++ G D+++ + + R
Sbjct: 52 --------AGKH----PFLTQLH--SCFQTKDRLFFVMEYVNGG---DLMFHIQRSGR-F 93
Query: 161 DWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKL-MPDG 219
D P A I GL++LH +I+RD+K NVL+D + +I+DFG K + G
Sbjct: 94 DEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG 150
Query: 220 HAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGK--FPVDD 270
+T GT Y+APE L + D ++ GVLL ++ G+ F DD
Sbjct: 151 ---VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD 200
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 1e-11
Identities = 67/232 (28%), Positives = 104/232 (44%), Gaps = 43/232 (18%)
Query: 46 LKKIGSGGWGEVFYKAELPGSN-GKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIG 104
LK +G GG+G+VF ++ G++ GK+ A++ L K
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLK------------------------KAT 36
Query: 105 AIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGR------R 158
+R++ TA+ RNIL + H P L+Y F G L IL +S G R
Sbjct: 37 IVRNQKDTAHTKAERNILEAVKH---PFIVDLIYAFQTGGKLYLILEYLSGGELFMHLER 93
Query: 159 E---LDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKL 215
E ++ A ++ I+ LE+LH + +I+RD+KP N+L+D +++DFG K
Sbjct: 94 EGIFMEDTACFYLSE-ISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKE 149
Query: 216 MPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFP 267
C GT+ YMAPE L D +S G L+ ++ G P
Sbjct: 150 SIHEGTVTHTFC--GTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 2e-11
Identities = 68/237 (28%), Positives = 102/237 (43%), Gaps = 53/237 (22%)
Query: 46 LKKIGSGGWGEVFYKAE---LPGSNGKM-IAIRKLIVDAPMSAAELIKQDIDEYSDLLHW 101
K +G G +G+V KAE L N +A++ L A E + SDL+
Sbjct: 17 GKPLGEGAFGQVV-KAEAVGLDNPNETSTVAVKML----KDDATE------KDLSDLV-- 63
Query: 102 KIGAIRSEIITANQT-RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRR-- 158
SE+ +H+NI+ LL + +V E+ +G+L+D L + RR
Sbjct: 64 ------SEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFL----RARRPP 113
Query: 159 ----ELDWPARHR----------IARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDME 204
D P A +A G+E+L + IHRD+ NVL+ +D
Sbjct: 114 GEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLVTEDHV 170
Query: 205 ARISDFGHGKLMPDGHAQ-ITVKCMVGTMGY--MAPESLQTETISDKCDIYSFGVLL 258
+I+DFG L D H K G + MAPE+L + + D++SFGVLL
Sbjct: 171 MKIADFG---LARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLL 224
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 36/95 (37%), Positives = 53/95 (55%), Gaps = 8/95 (8%)
Query: 179 LHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHG-KLMPDGHAQITVKCMVGTMGYMAP 237
+H H+ +HRDIKP NVL+D + R++DFG K+ DG Q +V VGT Y++P
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVA--VGTPDYISP 172
Query: 238 ESLQTE-----TISDKCDIYSFGVLLAVLVMGKFP 267
E LQ +CD +S GV + ++ G+ P
Sbjct: 173 EILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 2e-11
Identities = 65/229 (28%), Positives = 105/229 (45%), Gaps = 44/229 (19%)
Query: 118 HRNILPLLAHMVR-PNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHR----IARGI 172
H+NILP+L + ++Y +M G+L+ L G + +A I
Sbjct: 67 HQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQI 126
Query: 173 ASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGK-LMP-DGHAQITVKCMVG 230
A G+ YLH + +IH+DI N +ID++++ +I+D + L P D H C+
Sbjct: 127 ACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYH------CLGD 177
Query: 231 T----MGYMAPESLQTETISDKCDIYSFGVLLAVLV-MGKFP---VDDFFGHTEEMDMVK 282
+ +MA ESL + S D++SFGVLL L+ +G+ P +D F +M
Sbjct: 178 NENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF-------EMAA 230
Query: 283 WMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSS 331
++++ P N +E L +AC C DP+ERPS
Sbjct: 231 YLKDGYRLAQPI---------NCPDE---LFAVMAC-CWALDPEERPSF 266
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 3e-11
Identities = 57/230 (24%), Positives = 95/230 (41%), Gaps = 37/230 (16%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGA 105
LK++G+G +G V Y G+ K+I + MS E I+
Sbjct: 9 LKELGTGQFGVVKYGK----WRGQYDVAIKMIKEGSMSEDEFIE---------------- 48
Query: 106 IRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPAR 165
E + H ++ L + +V E+M NG L + L + +
Sbjct: 49 ---EAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYL---REHGKRFQPSQL 102
Query: 166 HRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITV 225
+ + + G+ YL + IHRD+ N L+DD ++SDFG + + D +
Sbjct: 103 LEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS- 158
Query: 226 KCMVGT---MGYMAPESLQTETISDKCDIYSFGVLL-AVLVMGKFPVDDF 271
VG+ + + PE L S K D+++FGVL+ V +GK P + F
Sbjct: 159 ---VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERF 205
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 3e-11
Identities = 35/95 (36%), Positives = 52/95 (54%), Gaps = 8/95 (8%)
Query: 179 LHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHG-KLMPDGHAQITVKCMVGTMGYMAP 237
+ H+ +HRDIKP NVL+D + R++DFG +L+ DG Q V VGT Y++P
Sbjct: 115 IDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVA--VGTPDYISP 172
Query: 238 ESLQ-----TETISDKCDIYSFGVLLAVLVMGKFP 267
E LQ +CD +S GV + ++ G+ P
Sbjct: 173 EILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 69/245 (28%), Positives = 106/245 (43%), Gaps = 58/245 (23%)
Query: 45 SLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIG 104
+L +GSG +G+V A + K +AI+KL P +A K+ E L H
Sbjct: 19 NLSPVGSGAYGQVC-SAFDTKTGRK-VAIKKL--SRPFQSAIHAKRTYRELRLLKH---- 70
Query: 105 AIRSEIITANQTRHRNILPLLAHMVRPNCHL-------LVYEFMKNGSLQDILYDVSQGR 157
H N++ LL + P L LV M D L ++ + +
Sbjct: 71 -----------MDHENVIGLL-DVFTPASSLEDFQDVYLVTHLMG----AD-LNNIVKCQ 113
Query: 158 RELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMP 217
+ D + + I GL+Y+H +IHRD+KP+N+ +++D E +I DF
Sbjct: 114 KLSDDHIQF-LVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDF------- 162
Query: 218 DGHAQITVKCM---VGTMGYMAPESL-----QTETISDKCDIYSFGVLLAVLVMGK--FP 267
G A+ T M V T Y APE + +T+ DI+S G ++A L+ GK FP
Sbjct: 163 -GLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTV----DIWSVGCIMAELLTGKTLFP 217
Query: 268 VDDFF 272
D
Sbjct: 218 GSDHI 222
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 3e-11
Identities = 38/112 (33%), Positives = 60/112 (53%), Gaps = 10/112 (8%)
Query: 172 IASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGT 231
+A L++LH +I+RD+KP N+L+D++ +++DFG K D + C GT
Sbjct: 107 LALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC--GT 161
Query: 232 MGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHT--EEMDMV 281
+ YMAPE + + D +SFGVL+ ++ G P F G E M M+
Sbjct: 162 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP---FQGKDRKETMTMI 210
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 3e-11
Identities = 59/237 (24%), Positives = 100/237 (42%), Gaps = 42/237 (17%)
Query: 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAI 106
K +G G +G V + +L +G + + A + +K DI YS+ I
Sbjct: 5 KILGEGEFGSV-MEGQLSQDDGSQLKV----------AVKTMKLDIHTYSE-----IEEF 48
Query: 107 RSEIITANQTRHRNILPLL------AHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRREL 160
SE H N++ L+ + + + +++ FMK+G L L G
Sbjct: 49 LSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPE 108
Query: 161 DWPARH--RIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPD 218
P + + IA G+EYL IHRD+ N ++ +DM ++DFG K +
Sbjct: 109 KLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYS 165
Query: 219 GH-------AQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL-AVLVMGKFP 267
G A++ VK ++A ESL + K D+++FGV + + G+ P
Sbjct: 166 GDYYRQGRIAKMPVK-------WIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 4e-11
Identities = 33/91 (36%), Positives = 49/91 (53%)
Query: 179 LHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPE 238
+H H +IHRDIK AN+L+ + ++ DFG K+ + + GT Y+APE
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE 215
Query: 239 SLQTETISDKCDIYSFGVLLAVLVMGKFPVD 269
+ + S K D++S GVLL L+ K P D
Sbjct: 216 IWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 4e-11
Identities = 70/301 (23%), Positives = 121/301 (40%), Gaps = 51/301 (16%)
Query: 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAI 106
+IG+G +G+V G + + +++L A L Q++ Y +L
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYREL-------- 52
Query: 107 RSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWP-AR 165
H N+L L + +LLV EF G L++ L ++
Sbjct: 53 ----------NHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVL 102
Query: 166 HRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFG--HGKLMPDGHAQI 223
R+A +ASGL +LH IH D+ N + D+ +I D+G + D + I
Sbjct: 103 QRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY--I 157
Query: 224 TVKCMVGTMGYMAPE-------SLQTETISDKCDIYSFGV-LLAVLVMGKFPVDDFFGHT 275
T C + ++APE L + + K +I+S GV + + P D +
Sbjct: 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPD---LS 214
Query: 276 EEMDMVKW--MRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKD 333
+E ++K I P L Y ++ V++ FC L DP+ RP++++
Sbjct: 215 DE-QVLKQVVREQDIKLPKPQ-------LDLKYSDRWYEVMQ---FCWL-DPETRPTAEE 262
Query: 334 V 334
V
Sbjct: 263 V 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 4e-11
Identities = 42/155 (27%), Positives = 70/155 (45%), Gaps = 9/155 (5%)
Query: 105 AIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPA 164
A ++E H NI+ + + ++V E+ G+L + + + LD
Sbjct: 45 AAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQK--RCNSLLD--- 99
Query: 165 RHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDD-DMEARISDFGHGKLMPDGHAQI 223
I L LH H ++HRD+K N+L+D M +I DFG K++
Sbjct: 100 EDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAY 159
Query: 224 TVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
TV VGT Y++PE + + + K DI++ G +L
Sbjct: 160 TV---VGTPCYISPELCEGKPYNQKSDIWALGCVL 191
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 5e-11
Identities = 52/224 (23%), Positives = 96/224 (42%), Gaps = 42/224 (18%)
Query: 59 YKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118
K + ++A++K+ +D ++ ++ EIIT+ Q +H
Sbjct: 19 AKHK---PTNTLVAVKKINLD---------SCSKEDLK--------LLQQEIITSRQLQH 58
Query: 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDV-SQGRRELDWPARHRIARGIASGLE 177
NILP + + + +V M GS +D+L +G EL A I + + + L+
Sbjct: 59 PNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPEL---AIAFILKDVLNALD 115
Query: 178 YLHMCHRPRLIHRDIKPANVLIDDDMEARISDF---------GHGKLMPDGHAQITVKCM 228
Y+H IHR +K +++L+ D + +S G + + + +VK
Sbjct: 116 YIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK-- 170
Query: 229 VGTMGYMAPESLQT--ETISDKCDIYSFGVLLAVLVMGKFPVDD 270
+ +++PE LQ + ++K DIYS G+ L G P D
Sbjct: 171 --NLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 5e-11
Identities = 58/242 (23%), Positives = 108/242 (44%), Gaps = 51/242 (21%)
Query: 47 KKIGSGGWGEVFYKAEL----PGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
+++G G +G+VF AE P + ++A++ L A++ ++D ++LL
Sbjct: 11 RELGEGAFGKVFL-AECYNLCPEQDKILVAVKTL-----KDASDNARKDFHREAELL--- 61
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYD-------VSQ 155
+H +I+ V + ++V+E+MK+G L L +++
Sbjct: 62 -----------TNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAE 110
Query: 156 GR--RELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHG 213
G EL IA+ IA+G+ YL H +HRD+ N L+ +++ +I DFG
Sbjct: 111 GNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMS 167
Query: 214 K-------LMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL-AVLVMGK 265
+ GH + ++ +M PES+ + + D++S GV+L + GK
Sbjct: 168 RDVYSTDYYRVGGHTMLPIR-------WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGK 220
Query: 266 FP 267
P
Sbjct: 221 QP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 5e-11
Identities = 68/319 (21%), Positives = 127/319 (39%), Gaps = 82/319 (25%)
Query: 49 IGSGGWGEVFYKAE----LPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIG 104
IG G +G VF +A LP M+A++ L +A ++ D + L+
Sbjct: 13 IGQGAFGRVF-QARAPGLLPYEPFTMVAVKMLKEEASAD----MQADFQREAALMA---- 63
Query: 105 AIRSEIITANQTRHRNILPLLAHMV--RPNCHLLVYEFMKNGSLQDILYDVS-------- 154
+ H NI+ LL +P C L++E+M G L + L S
Sbjct: 64 ----------EFDHPNIVKLLGVCAVGKPMC--LLFEYMAYGDLNEFLRHRSPRAQCSLS 111
Query: 155 ----------QGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDME 204
L + IA+ +A+G+ YL +HRD+ N L+ ++M
Sbjct: 112 HSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMV 168
Query: 205 ARISDFGHGKLM-------PDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVL 257
+I+DFG + + + I ++ +M PES+ + + D++++GV+
Sbjct: 169 VKIADFGLSRNIYSADYYKASENDAIPIR-------WMPPESIFYNRYTTESDVWAYGVV 221
Query: 258 LAVLVMGKFPVDDFFGHTEEMDMVKWMR--NVIFSENPNRAINSKLLGNGYEEQMLLVLK 315
L + + + ++G E +++ ++R NV+ + + L +
Sbjct: 222 LWEIF--SYGMQPYYGMAHE-EVIYYVRDGNVL---------------SCPDNCPLELYN 263
Query: 316 LACFCTLKDPDERPSSKDV 334
L C K P +RPS +
Sbjct: 264 LMRLCWSKLPSDRPSFASI 282
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 6e-11
Identities = 46/152 (30%), Positives = 72/152 (47%), Gaps = 25/152 (16%)
Query: 118 HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLE 177
H I+ LL ++ EF G++ I+ ++ +G E P I R + LE
Sbjct: 68 HPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTE---PQIQVICRQM---LE 121
Query: 178 YLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCM------VGT 231
L H ++IHRD+K NVL+ D + +++DF G + VK + +GT
Sbjct: 122 ALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADF--------GVSAKNVKTLQRRDSFIGT 173
Query: 232 MGYMAPESLQTETISD-----KCDIYSFGVLL 258
+MAPE + ET+ D K DI+S G+ L
Sbjct: 174 PYWMAPEVVMCETMKDTPYDYKADIWSLGITL 205
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 8e-11
Identities = 43/104 (41%), Positives = 55/104 (52%), Gaps = 16/104 (15%)
Query: 169 ARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFG----HGKLMPDGHAQIT 224
A I GLE++H +++RD+KPAN+L+D+ RISD G K P HA
Sbjct: 103 ATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--HAS-- 155
Query: 225 VKCMVGTMGYMAPESLQTETISD-KCDIYSFGVLLAVLVMGKFP 267
VGT GYMAPE LQ T D D +S G +L L+ G P
Sbjct: 156 ----VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 8e-11
Identities = 46/135 (34%), Positives = 70/135 (51%), Gaps = 11/135 (8%)
Query: 136 LVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPA 195
V E++ G D++Y + Q R P A IA GL +LH +I+RD+K
Sbjct: 78 FVMEYVNGG---DLMYQIQQVGR-FKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLD 130
Query: 196 NVLIDDDMEARISDFGHGKL-MPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSF 254
NV++D + +I+DFG K M DG +T K GT Y+APE + + D ++F
Sbjct: 131 NVMLDSEGHIKIADFGMCKENMWDG---VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAF 187
Query: 255 GVLLAVLVMGKFPVD 269
GVLL ++ G+ P +
Sbjct: 188 GVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 9e-11
Identities = 71/237 (29%), Positives = 107/237 (45%), Gaps = 39/237 (16%)
Query: 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLH 100
D ++ ++KIG G +G V YKA +N + IA++K+ L ++D S
Sbjct: 2 DQYEKVEKIGEGTYG-VVYKARDRVTN-ETIALKKI---------RLEQEDEGVPST--- 47
Query: 101 WKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRREL 160
AIR EI + +H NI+ L + LV+E++ L
Sbjct: 48 ----AIR-EISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-------LDLKKHMDSSP 95
Query: 161 DWPARHRIARG----IASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEA-RISDFGHGKL 215
D+ R+ + I G+ Y CH R++HRD+KP N+LID A +++DFG +
Sbjct: 96 DFAKNPRLIKTYLYQILRGIAY---CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARA 152
Query: 216 MPDGHAQITVKCMVGTMGYMAPES-LQTETISDKCDIYSFGVLLAVLVMGK--FPVD 269
G T V T+ Y APE L + S DI+S G + A +V K FP D
Sbjct: 153 F--GIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGD 207
|
Length = 294 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 9e-11
Identities = 60/232 (25%), Positives = 107/232 (46%), Gaps = 39/232 (16%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
++ L+KIG G +G VF KA+ + +++A++++ +D E +
Sbjct: 2 YEKLEKIGEGTYGTVF-KAKNRET-HEIVALKRVRLD---DDDEGVPSS----------- 45
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDI--LYDVSQGRREL 160
A+R EI + +H+NI+ L + LV+E+ QD+ +D G ++
Sbjct: 46 --ALR-EICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD----QDLKKYFDSCNG--DI 96
Query: 161 DWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGH 220
D + GL + CH ++HRD+KP N+LI+ + E +++DFG + G
Sbjct: 97 DPEIVKSFMFQLLKGLAF---CHSHNVLHRDLKPQNLLINKNGELKLADFGLAR--AFG- 150
Query: 221 AQITVKCM---VGTMGYMAPESLQTETISD-KCDIYSFGVLLAVLVMGKFPV 268
I V+C V T+ Y P+ L + D++S G + A L P+
Sbjct: 151 --IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 1e-10
Identities = 45/143 (31%), Positives = 65/143 (45%), Gaps = 14/143 (9%)
Query: 135 LLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKP 194
V EF+ G D+++ + + RR D A I S L +LH +I+RD+K
Sbjct: 72 FFVMEFVNGG---DLMFHIQKSRR-FDEARARFYAAEITSALMFLH---DKGIIYRDLKL 124
Query: 195 ANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSF 254
NVL+D + +++DFG K T GT Y+APE LQ D ++
Sbjct: 125 DNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAM 182
Query: 255 GVLLAVLVMGKFPV-----DDFF 272
GVLL ++ G P DD F
Sbjct: 183 GVLLYEMLCGHAPFEAENEDDLF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 62/231 (26%), Positives = 108/231 (46%), Gaps = 42/231 (18%)
Query: 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKL--IVDAPMSAAELIKQDIDEYSD 97
+ ++ IGSG +G V + + +GK +AI+K+ D P A K+ + E
Sbjct: 4 GSRYKPIENIGSGAYGVVC--SAIDTRSGKKVAIKKIPHAFDVPTLA----KRTLRELKI 57
Query: 98 LLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHL-----LVYEFMKNGSLQDILYD 152
L H+K H NI+ + ++RP +V + M++ L I++
Sbjct: 58 LRHFK---------------HDNIIAIR-DILRPPGADFKDVYVVMDLMES-DLHHIIH- 99
Query: 153 VSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGH 212
S + R+ + + + GL+Y+H + +IHRD+KP+N+L+++D E RI DFG
Sbjct: 100 -SDQPLTEEH-IRYFLYQ-LLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGM 153
Query: 213 GKLM---PDGHAQITVKCMVGTMGYMAPESLQT-ETISDKCDIYSFGVLLA 259
+ + P H + V T Y APE L + + D++S G + A
Sbjct: 154 ARGLSSSPTEHKYFMTE-YVATRWYRAPELLLSLPEYTTAIDMWSVGCIFA 203
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-10
Identities = 60/219 (27%), Positives = 92/219 (42%), Gaps = 40/219 (18%)
Query: 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAI 106
++IG G +GEVF +G++ A + A S E + D+
Sbjct: 1 ERIGRGNFGEVF--------SGRLRADNTPV--AVKSCRETLPPDLKA----------KF 40
Query: 107 RSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARH 166
E Q H NI+ L+ + +V E ++ G L ++G R L
Sbjct: 41 LQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLR--TEGPR-LKVKELI 97
Query: 167 RIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPD-------G 219
++ A+G+EYL H IHRD+ N L+ + +ISDFG + D G
Sbjct: 98 QMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154
Query: 220 HAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
QI VK + APE+L S + D++SFG+LL
Sbjct: 155 MKQIPVK-------WTAPEALNYGRYSSESDVWSFGILL 186
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 66/248 (26%), Positives = 110/248 (44%), Gaps = 44/248 (17%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
+D ++ IG GG GEV Y A P + +A++K I++D+ E LL +
Sbjct: 4 YDIIRLIGKGGMGEV-YLAYDPVC-SRRVALKK------------IREDLSEN-PLLKKR 48
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQG---RRE 159
+R I A+ H I+P+ + + +++ +L+ +L V Q +E
Sbjct: 49 F--LREAKIAADLI-HPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKE 105
Query: 160 L----DWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKL 215
L A I I + +EY+H ++HRD+KP N+L+ E I D+G
Sbjct: 106 LAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIF 162
Query: 216 --------------MPDG-HAQITVKC-MVGTMGYMAPESLQTETISDKCDIYSFGVLLA 259
+ ++ +T+ +VGT YMAPE L S+ DIY+ GV+L
Sbjct: 163 KKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILY 222
Query: 260 VLVMGKFP 267
++ FP
Sbjct: 223 QMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 1e-10
Identities = 65/236 (27%), Positives = 102/236 (43%), Gaps = 42/236 (17%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSN-GKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHW 101
F+ LK +G+G +G+VF ++ G + GK+ A++ L
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVL------------------------- 36
Query: 102 KIGAIRSEIITANQTR-HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQG---- 156
+ A+ + T TR RN+L + P L Y F L IL VS G
Sbjct: 37 QKAALVQKAKTVEHTRTERNVLEHVRQ--SPFLVTLHYAFQTEAKLHLILDYVSGGEMFT 94
Query: 157 ---RRELDWPARHRIARG-IASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGH 212
+R+ R G I LE+LH + +++RDIK N+L+D + ++DFG
Sbjct: 95 HLYQRDNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGL 151
Query: 213 GKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKC-DIYSFGVLLAVLVMGKFP 267
K + T GT+ YMAPE ++ + K D +S G+L+ L+ G P
Sbjct: 152 SKEFLSEEKERTYS-FCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 1e-10
Identities = 68/261 (26%), Positives = 114/261 (43%), Gaps = 60/261 (22%)
Query: 25 FSPLVEKQDLAFLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSA 84
+ EK +K ED FD +K IG G +GEV + S+ ++ A++ L S
Sbjct: 28 YEKAAEKITKLRMKAED-FDVIKVIGRGAFGEV--QLVRHKSSKQVYAMKLL------SK 78
Query: 85 AELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLLAH-----MVRPNC------ 133
E+IK RS+ + R ++AH +V+ +
Sbjct: 79 FEMIK-----------------RSDSAFFWEERD-----IMAHANSEWIVQLHYAFQDDK 116
Query: 134 HL-LVYEFMKNGSLQDIL--YDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHR 190
+L +V E+M G L +++ YD+ + W + A + L H IHR
Sbjct: 117 YLYMVMEYMPGGDLVNLMSNYDIPE-----KWARFY-----TAEVVLALDAIHSMGFIHR 166
Query: 191 DIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISD--- 247
D+KP N+L+D +++DFG M D + + VGT Y++PE L+++
Sbjct: 167 DVKPDNMLLDKSGHLKLADFGTCMKM-DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYG 225
Query: 248 -KCDIYSFGVLLAVLVMGKFP 267
+CD +S GV L +++G P
Sbjct: 226 RECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 65/234 (27%), Positives = 106/234 (45%), Gaps = 41/234 (17%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
F+ L +IG G +G + Y+A S G+++A++K+ +D + D
Sbjct: 9 FEKLNRIGEGTYG-IVYRARDTTS-GEIVALKKVRMD----------NERDGIP------ 50
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMV--RPNCHLLVYEFMKNGSLQDILYDVSQGRREL 160
I ++R EI RH NI+ L +V + LV E+ + L +L ++ E
Sbjct: 51 ISSLR-EITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSE- 107
Query: 161 DWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGH 220
+ + GL+YLH +IHRD+K +N+L+ D +I+DFG +
Sbjct: 108 --SQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162
Query: 221 AQITVKCMVGTMGYMAPESL-----QTETISDKCDIYSFGVLLAVLVMGK--FP 267
+T K V T+ Y APE L T I D+++ G +LA L+ K P
Sbjct: 163 KPMTPK--VVTLWYRAPELLLGCTTYTTAI----DMWAVGCILAELLAHKPLLP 210
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 1e-10
Identities = 48/181 (26%), Positives = 87/181 (48%), Gaps = 35/181 (19%)
Query: 117 RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDIL-----------YDVSQGRRE-LDWPA 164
+H+NI+ LL + ++ E+ G+L++ L +D+++ E L +
Sbjct: 76 KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135
Query: 165 RHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPD------ 218
A +A G+EYL R IHRD+ NVL+ +D +I+DFG + + D
Sbjct: 136 LVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKK 192
Query: 219 -GHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL-AVLVMGK-----FPVDDF 271
+ ++ VK +MAPE+L + + D++SFG+L+ + +G PV++
Sbjct: 193 TSNGRLPVK-------WMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL 245
Query: 272 F 272
F
Sbjct: 246 F 246
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 42/123 (34%), Positives = 65/123 (52%), Gaps = 17/123 (13%)
Query: 175 GLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGY 234
GL+Y+H +IHRD+KP+NV +++D E RI DFG + D + V T Y
Sbjct: 130 GLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD-----EMTGYVATRWY 181
Query: 235 MAPE-SLQTETISDKCDIYSFGVLLAVLVMGK--FPVDDFFGHTEEMDMVKWMRNVIFSE 291
APE L + DI+S G ++A L+ GK FP +D+ +D +K + V+ +
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDY------IDQLKRIMEVVGTP 235
Query: 292 NPN 294
+P
Sbjct: 236 SPE 238
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 36/91 (39%), Positives = 52/91 (57%), Gaps = 8/91 (8%)
Query: 183 HRPRLIHRDIKPANVLIDDDMEARISDFGHG-KLMPDGHAQITVKCMVGTMGYMAPESLQ 241
H+ +HRDIKP N+L+D + R++DFG KLM DG Q +V VGT Y++PE LQ
Sbjct: 119 HQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA--VGTPDYISPEILQ 176
Query: 242 TET-----ISDKCDIYSFGVLLAVLVMGKFP 267
+CD +S GV + ++ G+ P
Sbjct: 177 AMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-10
Identities = 61/232 (26%), Positives = 99/232 (42%), Gaps = 34/232 (14%)
Query: 47 KKIGSGGWGEVF--YKAELPGSNGKMIAIRKLIVD--APMSAAELIKQDIDEYSDLLHWK 102
K +G G +G V+ Y A+ G+ +A++++ D +P ++ E
Sbjct: 8 KLLGQGAFGRVYLCYDAD----TGRELAVKQVQFDPESPETSKE---------------- 47
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHLL--VYEFMKNGSLQDILYDVSQGRREL 160
+ A+ EI H I+ + P L E M GS++D L + L
Sbjct: 48 VNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL----KSYGAL 103
Query: 161 DWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGK-LMPDG 219
+ R I G+ YLH ++HRDIK AN+L D ++ DFG K L
Sbjct: 104 TENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC 160
Query: 220 HAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDF 271
+ +K + GT +M+PE + E K DI+S G + ++ K P +F
Sbjct: 161 LSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 2e-10
Identities = 69/260 (26%), Positives = 109/260 (41%), Gaps = 50/260 (19%)
Query: 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLH 100
D L+ +G G +GEV+ G +G + ++ + P S +E QD SD L
Sbjct: 6 DSITLLRALGHGAFGEVYE-GLYRGRDGDAVELQVAVKTLPESCSE---QD---ESDFL- 57
Query: 101 WKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRREL 160
E + ++ H+NI+ L+ ++ E M G L+ L + R
Sbjct: 58 -------MEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFL---RENRPRP 107
Query: 161 DWPARHR------IARGIASGLEYLHMCHRPRLIHRDIKPANVLIDD---DMEARISDFG 211
+ P+ AR +A G +YL H IHRDI N L+ A+I+DFG
Sbjct: 108 ERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFG 164
Query: 212 HGKLM-------PDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL-AVLVM 263
+ + G A + +K +M PE+ + K D++SFGVLL + +
Sbjct: 165 MARDIYRASYYRKGGRAMLPIK-------WMPPEAFLDGIFTSKTDVWSFGVLLWEIFSL 217
Query: 264 GKFPVDDFFGHT--EEMDMV 281
G P + G T E M+ V
Sbjct: 218 GYMP---YPGRTNQEVMEFV 234
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (148), Expect = 2e-10
Identities = 85/325 (26%), Positives = 134/325 (41%), Gaps = 81/325 (24%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGA 105
LK IGSG +G V + + G+ +AI+K+ + + DL+ K
Sbjct: 5 LKPIGSGAYGVVC--SAVDKRTGRKVAIKKI---------------SNVFDDLIDAK--R 45
Query: 106 IRSEIITANQTRHRNILPLLAHMVRPNCHL------LVYEFMKNGSLQDILYDVSQGRRE 159
I EI RH NI+ LL ++RP +V E M + L+ V + +
Sbjct: 46 ILREIKLLRHLRHENIIGLL-DILRPPSPEDFNDVYIVTELM-----ETDLHKVIKSPQP 99
Query: 160 LDWPARHR-IARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPD 218
L + I GL+YLH + +IHRD+KP+N+L++ + + +I DFG + +
Sbjct: 100 LT-DDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155
Query: 219 GHAQITVKCM---VGTMGYMAPESL-----QTETISDKCDIYSFGVLLAVLVMGK--FP- 267
+ + V T Y APE L T+ I DI+S G + A L+ K FP
Sbjct: 156 DEDEKGF--LTEYVVTRWYRAPELLLSSSRYTKAI----DIWSVGCIFAELLTRKPLFPG 209
Query: 268 ---VD------DFFGHTEEMDMVKWMRNVIFSENPNRAINS----------KLLGNGYEE 308
+D + G E D+ I SE + S KL E
Sbjct: 210 RDYIDQLNLIVEVLGTPSEEDL-----KFITSEKARNYLKSLPKKPKKPLSKLFPGASPE 264
Query: 309 QMLLVLKLACFCTLKDPDERPSSKD 333
+ L+ K+ F DP +R ++ +
Sbjct: 265 AIDLLEKMLVF----DPKKRITADE 285
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-10
Identities = 33/94 (35%), Positives = 51/94 (54%), Gaps = 8/94 (8%)
Query: 177 EYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMA 236
EYLH +I+RD+KP N+L+D+ +++DFG K +PD + GT Y+A
Sbjct: 132 EYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD-----RTFTLCGTPEYLA 183
Query: 237 PESLQTETISDKCDIYSFGVLLAVLVMGKFPVDD 270
PE +Q++ D ++ GVLL + G P D
Sbjct: 184 PEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD 217
|
Length = 329 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-10
Identities = 62/258 (24%), Positives = 118/258 (45%), Gaps = 48/258 (18%)
Query: 46 LKKIGSGGWGEVFYKAEL--PG-SNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
++++G +G++ YK L PG + +++AI+ L + ++ W
Sbjct: 10 MEELGECAFGKI-YKGHLYLPGMDHAQLVAIKTL----------------KDINNPQQW- 51
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILY------DVSQG 156
G + E + H NI+ LL + + +++E++ G L + L DV
Sbjct: 52 -GEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCS 110
Query: 157 RRE-------LDWPARHRIARGIASGLEYL--HMCHRPRLIHRDIKPANVLIDDDMEARI 207
E LD IA IA+G+EYL H +H+D+ N+LI + + +I
Sbjct: 111 SDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF-----FVHKDLAARNILIGEQLHVKI 165
Query: 208 SDFGHGK-LMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKF 266
SD G + + + ++ K ++ + +M PE++ S DI+SFGV+L + F
Sbjct: 166 SDLGLSREIYSADYYRVQPKSLL-PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIF--SF 222
Query: 267 PVDDFFGHT--EEMDMVK 282
+ ++G + E ++MV+
Sbjct: 223 GLQPYYGFSNQEVIEMVR 240
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-10
Identities = 43/139 (30%), Positives = 63/139 (45%), Gaps = 20/139 (14%)
Query: 136 LVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPA 195
+V EFM+NG L + L Q + +L + + + G+EYL R IHRD+
Sbjct: 76 IVTEFMENGCLLNYL---RQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAAR 129
Query: 196 NVLIDDDMEARISDFGHGKLMPDGH------AQITVKCMVGTMGYMAPESLQTETISDKC 249
N L+ ++SDFG + + D A+ VK + PE S K
Sbjct: 130 NCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVK-------WSPPEVFNFSKYSSKS 182
Query: 250 DIYSFGVLL-AVLVMGKFP 267
D++SFGVL+ V GK P
Sbjct: 183 DVWSFGVLMWEVFTEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 3e-10
Identities = 48/187 (25%), Positives = 86/187 (45%), Gaps = 29/187 (15%)
Query: 102 KIGAIRSEIITANQTRH----RNILPLLAH--MVRPNC------HL-LVYEFMKNGSLQD 148
K+ AI E+I Q +H + +L ++H ++R L ++ E++ G L
Sbjct: 32 KVMAIP-EVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFS 90
Query: 149 ILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARIS 208
L + A I LEYLH +++RD+KP N+L+D + +++
Sbjct: 91 YL----RNSGRFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLT 143
Query: 209 DFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPV 268
DFG K + D + GT Y+APE +Q++ + D ++ G+L+ +++G P
Sbjct: 144 DFGFAKKLRD-----RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPP- 197
Query: 269 DDFFGHT 275
FF
Sbjct: 198 --FFDDN 202
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 3e-10
Identities = 53/236 (22%), Positives = 100/236 (42%), Gaps = 44/236 (18%)
Query: 109 EIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRI 168
EI+ + +H NI+ H + N L+ E+ G+L D + ++ + +
Sbjct: 49 EIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVR----QKGQLFEEEMVL 104
Query: 169 AR--GIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPD--GHAQIT 224
I S + Y+H + ++HRDIK N+ + ++ DFG K++ A+ T
Sbjct: 105 WYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAE-T 160
Query: 225 VKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWM 284
V VGT YM+PE Q + K DI++ G +L L+ +
Sbjct: 161 V---VGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLT--------------------L 197
Query: 285 RNVIFSENPNRAINSKLLGN------GYEEQMLLVLKLACFCTLKDPDERPSSKDV 334
+ + NP + + GN Y +++ ++ +DP++RP++ +V
Sbjct: 198 KRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHS---LLQQDPEKRPTADEV 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 3e-10
Identities = 46/145 (31%), Positives = 73/145 (50%), Gaps = 20/145 (13%)
Query: 137 VYEFMKNGSLQDILYDVSQ-GR-RELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKP 194
V E++ G D++Y + Q G+ +E P A IA GL +LH +I+RD+K
Sbjct: 79 VMEYVNGG---DLMYHIQQVGKFKE---PHAVFYAAEIAIGLFFLH---SKGIIYRDLKL 129
Query: 195 ANVLIDDDMEARISDFGHGK--LMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIY 252
NV++D + +I+DFG K + T + GT Y+APE + + D +
Sbjct: 130 DNVMLDAEGHIKIADFGMCKENIFGG----KTTRTFCGTPDYIAPEIIAYQPYGKSVDWW 185
Query: 253 SFGVLLAVLVMGKFPVDDFFGHTEE 277
+FGVLL ++ G+ P D G E+
Sbjct: 186 AFGVLLYEMLAGQPPFD---GEDED 207
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 3e-10
Identities = 45/146 (30%), Positives = 68/146 (46%), Gaps = 16/146 (10%)
Query: 130 RPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIH 189
RP +V E+M NG L + L + +G+ +W + + +EYL IH
Sbjct: 72 RPIF--IVTEYMANGCLLNYLRE-RKGKLGTEWLLD--MCSDVCEAMEYLE---SNGFIH 123
Query: 190 RDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGT---MGYMAPESLQTETIS 246
RD+ N L+ +D ++SDFG + + D Q T GT + + PE S
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLDD--QYT--SSQGTKFPVKWAPPEVFDYSRFS 179
Query: 247 DKCDIYSFGVLL-AVLVMGKFPVDDF 271
K D++SFGVL+ V GK P + F
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKMPYERF 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 4e-10
Identities = 63/231 (27%), Positives = 104/231 (45%), Gaps = 31/231 (13%)
Query: 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAI 106
K +G G +G+V AEL G++ ++ AI+ L D I QD D + +I A+
Sbjct: 1 KVLGKGSFGKVML-AELKGTD-EVYAIKVLKKDV-------ILQDDDVDCTMTEKRILAL 51
Query: 107 RSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARH 166
+ +H + L + V E++ G D+++ + + R+ D P
Sbjct: 52 AA--------KHPFLTALHCCFQTKDRLFFVMEYVNGG---DLMFQIQRSRK-FDEPRSR 99
Query: 167 RIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVK 226
A + L +LH R +I+RD+K N+L+D + +++DFG K T
Sbjct: 100 FYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTF 156
Query: 227 CMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPV-----DDFF 272
C GT Y+APE LQ D ++ GVL+ ++ G+ P DD F
Sbjct: 157 C--GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 4e-10
Identities = 74/270 (27%), Positives = 118/270 (43%), Gaps = 50/270 (18%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
+ L+ +G G +G V + G+ +AI+K++ P S L K+ E L H
Sbjct: 12 YVDLQPVGMGAFGLVCSARDQ--LTGQNVAIKKIM--KPFSTPVLAKRTYRELKLLKH-- 65
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHL-LVYEFMKNGSLQDILYDVSQGRRELD 161
RH NI+ L + P + V E + L +L R L+
Sbjct: 66 -------------LRHENIISLSDIFISPLEDIYFVTELLGT-DLHRLLTS-----RPLE 106
Query: 162 WPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHA 221
I GL+Y+H ++HRD+KP+N+LI+++ + +I DFG ++
Sbjct: 107 KQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQ---DP 160
Query: 222 QITVKCMVGTMGYMAPESLQT-ETISDKCDIYSFGVLLAVLVMGK--FP----VDDFFGH 274
Q+T V T Y APE + T + + DI+S G + A ++ GK FP V+ F
Sbjct: 161 QMT--GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSII 218
Query: 275 TE-----EMDMVKWMRNVIFSENPNRAINS 299
T+ D++ N I SEN R + S
Sbjct: 219 TDLLGTPPDDVI----NTICSENTLRFVQS 244
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 4e-10
Identities = 72/268 (26%), Positives = 115/268 (42%), Gaps = 50/268 (18%)
Query: 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLH 100
D FD + +IG G +G+V YKA G+++A++K+ +D
Sbjct: 7 DKFDIIGQIGEGTYGQV-YKAR-DKDTGELVALKKVRLDNEKEG---------------- 48
Query: 101 WKIGAIRSEIITANQTRHRNILPL----------LAHMVRPNCHLLVYEFMKN---GSLQ 147
+ I AIR EI Q HRNI+ L L LV+E+M + G L+
Sbjct: 49 FPITAIR-EIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLE 107
Query: 148 DILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARI 207
L S+ I + LE L+ CH+ +HRDIK +N+L+++ + ++
Sbjct: 108 SGLVHFSE----------DHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKL 157
Query: 208 SDFGHGKLM-PDGHAQITVKCMVGTMGYMAPE-SLQTETISDKCDIYSFGVLLAVLVMGK 265
+DFG +L + T K V T+ Y PE L E D++S G +L L
Sbjct: 158 ADFGLARLYNSEESRPYTNK--VITLWYRPPELLLGEERYGPAIDVWSCGCILGEL---- 211
Query: 266 FPVDDFFGHTEEMDMVKWMRNVIFSENP 293
F F +E+ ++ + + S P
Sbjct: 212 FTKKPIFQANQELAQLELISRLCGSPCP 239
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 4e-10
Identities = 76/272 (27%), Positives = 121/272 (44%), Gaps = 37/272 (13%)
Query: 3 SFVLKLILAAVRGGSR-DRGPTIFSPLVEKQDLAFLKKEDCFDSLKKIGSGGWGEVFYKA 61
S VL L A+R D + +V K +K ED +D +K IG G +GEV +
Sbjct: 5 SLVLDLDFPALRKNKNIDNFLNRYEKIVRKIRKLQMKAED-YDVVKVIGRGAFGEV--QL 61
Query: 62 ELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNI 121
S+ K+ A++ L S E+IK+ + W+ R + AN +
Sbjct: 62 VRHKSSQKVYAMKLL------SKFEMIKRSDSAF----FWEE---RDIMAFANSPW---V 105
Query: 122 LPLLAHMVRPNCHLLVYEFMKNGSLQDIL--YDVSQGRRELDWPARHRIARGIASGLEYL 179
+ L +V E+M G L +++ YDV + W A+ A + + L
Sbjct: 106 VQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE-----KW-AKFYTAEVVLA----L 155
Query: 180 HMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPES 239
H LIHRD+KP N+L+D +++DFG M D + VGT Y++PE
Sbjct: 156 DAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM-DETGMVRCDTAVGTPDYISPEV 214
Query: 240 LQTET----ISDKCDIYSFGVLLAVLVMGKFP 267
L+++ +CD +S GV L +++G P
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 5e-10
Identities = 41/141 (29%), Positives = 63/141 (44%), Gaps = 31/141 (21%)
Query: 135 LLVYEFMKNGSLQDILYDVSQGRRE-------LDWPARHRI---ARGIASGLEYLHMCHR 184
L+V E M G L+ L + RR L P + A IA G+ YL
Sbjct: 85 LVVMELMAKGDLKSYL----RSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK- 139
Query: 185 PRLIHRDIKPANVLIDDDMEARISDFGHGKLM-------PDGHAQITVKCMVGTMGYMAP 237
+HRD+ N ++ +D+ +I DFG + + G + V+ +MAP
Sbjct: 140 --FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-------WMAP 190
Query: 238 ESLQTETISDKCDIYSFGVLL 258
ESL+ + K D++SFGV+L
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVL 211
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 5e-10
Identities = 59/234 (25%), Positives = 104/234 (44%), Gaps = 31/234 (13%)
Query: 108 SEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHR 167
+E +T Q H NI+ L + R N ++V E+M NG+L L + +L
Sbjct: 55 AEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFL---RKHEGQLVAGQLMG 111
Query: 168 IARGIASGLEYL-HMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVK 226
+ G+ASG++YL M + +H+ + VL++ D+ +IS F + ++
Sbjct: 112 MLPGLASGMKYLSEMGY----VHKGLAAHKVLVNSDLVCKISGFRRL---QEDKSEAIYT 164
Query: 227 CMVG--TMGYMAPESLQTETISDKCDIYSFGVLL-AVLVMGKFPVDDFFGHTEEMDMVKW 283
M G + + APE++Q S D++SFG+++ V+ G+ P D G D++K
Sbjct: 165 TMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ----DVIKA 220
Query: 284 MRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337
+ + P +L L L C+ K+ ERP + S+
Sbjct: 221 VEDGFRLPAPRNC-----------PNLLHQLMLDCW--QKERGERPRFSQIHSI 261
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 5e-10
Identities = 44/135 (32%), Positives = 71/135 (52%), Gaps = 11/135 (8%)
Query: 136 LVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPA 195
V E++ G D++Y + Q + P A I+ GL +LH R +I+RD+K
Sbjct: 78 FVMEYVNGG---DLMYHIQQVGK-FKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLD 130
Query: 196 NVLIDDDMEARISDFGHGK-LMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSF 254
NV++D + +I+DFG K M DG +T + GT Y+APE + + D +++
Sbjct: 131 NVMLDSEGHIKIADFGMCKEHMVDG---VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAY 187
Query: 255 GVLLAVLVMGKFPVD 269
GVLL ++ G+ P D
Sbjct: 188 GVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 5e-10
Identities = 58/228 (25%), Positives = 101/228 (44%), Gaps = 36/228 (15%)
Query: 37 LKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELI-KQDIDEY 95
L E+ ++ + ++G G +G+V YKA+ K + ++AA++I + +E
Sbjct: 1 LNPEEFWEIIGELGDGAFGKV-YKAQ-----NKETGV--------LAAAKVIDTKSEEEL 46
Query: 96 SDLLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQ 155
D + EI H NI+ LL N ++ EF G++ ++ ++
Sbjct: 47 EDYM--------VEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL-- 96
Query: 156 GRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKL 215
R L P + + L YLH ++IHRD+K N+L D + +++DFG
Sbjct: 97 -ERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSA- 151
Query: 216 MPDGHAQITVKCMVGTMGYMAPESLQTETISD-----KCDIYSFGVLL 258
+ +GT +MAPE + ET D K D++S G+ L
Sbjct: 152 -KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITL 198
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 5e-10
Identities = 56/226 (24%), Positives = 99/226 (43%), Gaps = 30/226 (13%)
Query: 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVD--APMSAAELIKQDIDEYSDLLHWKIG 104
K +G G +G V+ ++ G+ +A +++ D +P ++ E +
Sbjct: 8 KLLGQGAFGRVYLCYDV--DTGRELAAKQVQFDPESPETSKE----------------VS 49
Query: 105 AIRSEIITANQTRHRNILPLLAHMV-RPNCHLLVY-EFMKNGSLQDILYDVSQGRRELDW 162
A+ EI +H I+ + R L ++ E+M GS++D L + L
Sbjct: 50 ALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL----KAYGALTE 105
Query: 163 PARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGK-LMPDGHA 221
+ R I G+ YLH ++HRDIK AN+L D ++ DFG K L +
Sbjct: 106 SVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMS 162
Query: 222 QITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFP 267
++ + GT +M+PE + E K D++S G + ++ K P
Sbjct: 163 GTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 8e-10
Identities = 65/252 (25%), Positives = 111/252 (44%), Gaps = 44/252 (17%)
Query: 43 FDSLKKIGSGGWGEVFYKAE-LPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHW 101
++ IG G +G V YKA+ G +GK AI+K K D ++Y+ +
Sbjct: 2 YEIEGCIGRGTYGRV-YKAKRKNGKDGKEYAIKK------------FKGDKEQYTGI--- 45
Query: 102 KIGAIRSEIITANQTRHRNILPL----LAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGR 157
A R EI + +H N++ L L H + L++++ ++ Q I + R
Sbjct: 46 SQSACR-EIALLRELKHENVVSLVEVFLEHADK--SVYLLFDYAEHDLWQIIKFHRQAKR 102
Query: 158 RELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEAR----ISDFGHG 213
+ + I +G+ YLH ++HRD+KPAN+L+ + R I D G
Sbjct: 103 VSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLA 159
Query: 214 KLMPDGHAQI-TVKCMVGTMGYMAPESL-----QTETISDKCDIYSFGVLLAVLVMGKFP 267
+L + + +V T+ Y APE L T+ I DI++ G + A L+ + P
Sbjct: 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAI----DIWAIGCIFAELLTLE-P 214
Query: 268 VDDFFGHTEEMD 279
+ F G ++
Sbjct: 215 I--FKGREAKIK 224
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 8e-10
Identities = 62/261 (23%), Positives = 115/261 (44%), Gaps = 49/261 (18%)
Query: 46 LKKIGSGGWGEVFYKAEL----PGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHW 101
++++G +G+V YK L PG + +AI+ L A E K
Sbjct: 10 MEELGEDRFGKV-YKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKH----------- 57
Query: 102 KIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILY---------- 151
E + ++ +H NI+ LL + + +++ + + L + L
Sbjct: 58 -------EAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGS 110
Query: 152 --DVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISD 209
D + L+ I IA+G+E+L H ++H+D+ NVL+ D + +ISD
Sbjct: 111 TDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISD 167
Query: 210 FGHGKLMPDGHAQITVKCMVGTM---GYMAPESLQTETISDKCDIYSFGVLL-AVLVMGK 265
G L + +A K M ++ +M+PE++ S DI+S+GV+L V G
Sbjct: 168 LG---LFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGL 224
Query: 266 FPVDDFFGHTEEMDMVKWMRN 286
P + G++ + D+++ +RN
Sbjct: 225 QP---YCGYSNQ-DVIEMIRN 241
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 1e-09
Identities = 61/236 (25%), Positives = 103/236 (43%), Gaps = 48/236 (20%)
Query: 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLH 100
D + LK++GSG +G V L G +AI+KL P + K+ E L H
Sbjct: 15 DRYRDLKQVGSGAYGTVCSA--LDRRTGAKVAIKKLY--RPFQSELFAKRAYRELRLLKH 70
Query: 101 WK----IGAIRSEIITANQT--RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVS 154
K IG + ++ T + + R + ++ M L+ +E + +Q ++Y
Sbjct: 71 MKHENVIGLL--DVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQ-- 126
Query: 155 QGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGK 214
+ GL+Y+H +IHRD+KP N+ +++D E +I DFG +
Sbjct: 127 -----------------MLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 166
Query: 215 LMPDGHAQITVKCMVGTMGYMAPESL-----QTETISDKCDIYSFGVLLAVLVMGK 265
+ V T Y APE + T+T+ DI+S G ++A ++ GK
Sbjct: 167 -----QTDSEMTGYVVTRWYRAPEVILNWMHYTQTV----DIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 61/241 (25%), Positives = 107/241 (44%), Gaps = 38/241 (15%)
Query: 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLH 100
D ++ ++ IG G +G+V+ +G + A++ I+D P+S D+DE
Sbjct: 22 DTWEIIETIGKGTYGKVYKVTN--KKDGSLAAVK--ILD-PIS-------DVDE------ 63
Query: 101 WKIGAIRSEI-ITANQTRHRNILPLLAHMVRPNCHL-----LVYEFMKNGSLQDILYDVS 154
I +E I + H N++ + + + LV E GS+ +++ +
Sbjct: 64 ----EIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLL 119
Query: 155 QGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGK 214
+ LD I G GL++LH R+IHRD+K N+L+ + ++ DFG
Sbjct: 120 ICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSA 176
Query: 215 LMPDGHAQITVKCMVGTMGYMAPESLQTETISD-----KCDIYSFGVLLAVLVMGKFPVD 269
+ ++ VGT +MAPE + E D +CD++S G+ L G P+
Sbjct: 177 QLTS--TRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLF 234
Query: 270 D 270
D
Sbjct: 235 D 235
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 34/104 (32%), Positives = 60/104 (57%), Gaps = 11/104 (10%)
Query: 167 RIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVK 226
+ A +A+G++YL + IHRD+ NVL+ +++ ++I+DFG + ++ VK
Sbjct: 123 QFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLASKIADFGLSR-----GEEVYVK 174
Query: 227 CMVGTMG--YMAPESLQTETISDKCDIYSFGVLL-AVLVMGKFP 267
+G + +MA ESL + K D++SFGVLL ++ +G P
Sbjct: 175 KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTP 218
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 1e-09
Identities = 44/149 (29%), Positives = 65/149 (43%), Gaps = 17/149 (11%)
Query: 115 QTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIAS 174
Q H I+ L+ +LV E G L L + RRE+ +A +A
Sbjct: 52 QLDHPCIVRLIGVCKGEPL-MLVMELAPLGPLLKYL----KKRREIPVSDLKELAHQVAM 106
Query: 175 GLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMG- 233
G+ YL H +HRD+ NVL+ + +A+ISDFG + + G T G
Sbjct: 107 GMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT----TAGR 159
Query: 234 ----YMAPESLQTETISDKCDIYSFGVLL 258
+ APE + S K D++S+GV L
Sbjct: 160 WPLKWYAPECINYGKFSSKSDVWSYGVTL 188
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-09
Identities = 45/149 (30%), Positives = 65/149 (43%), Gaps = 34/149 (22%)
Query: 136 LVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMC----------HRP 185
LV+EFM++G L D L R RG S L MC
Sbjct: 76 LVFEFMEHGCLSDYL----------------RAQRGKFSQETLLGMCLDVCEGMAYLESS 119
Query: 186 RLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGT---MGYMAPESLQT 242
+IHRD+ N L+ ++ ++SDFG + + D Q T GT + + +PE
Sbjct: 120 NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD--QYTSS--TGTKFPVKWSSPEVFSF 175
Query: 243 ETISDKCDIYSFGVLL-AVLVMGKFPVDD 270
S K D++SFGVL+ V GK P ++
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFSEGKTPYEN 204
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 46/195 (23%), Positives = 88/195 (45%), Gaps = 44/195 (22%)
Query: 30 EKQDLAFLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIK 89
++ + F + ++ L KIG G +GEVF KA +++A++K++++
Sbjct: 1 DQYEFPFCDEVSKYEKLAKIGQGTFGEVF-KAR-HKKTKQIVALKKVLMENEKEG----- 53
Query: 90 QDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCH-------------LL 136
+ I A+R EI +H N++ L+ C L
Sbjct: 54 -----------FPITALR-EIKILQLLKHENVVNLIE-----ICRTKATPYNRYKGSFYL 96
Query: 137 VYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPAN 196
V+EF ++ D+ +S + ++ + + +GL Y+H R +++HRD+K AN
Sbjct: 97 VFEFCEH----DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAAN 149
Query: 197 VLIDDDMEARISDFG 211
+LI D +++DFG
Sbjct: 150 ILITKDGILKLADFG 164
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 71/297 (23%), Positives = 133/297 (44%), Gaps = 52/297 (17%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
+ L+ IG G +G V+ +P G+++A++ + +D P D+ SD
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVP--TGRVVALKIINLDTPD----------DDVSD----- 45
Query: 103 IGAIRSEIITANQTRH---RNILPLL-AHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRR 158
I+ E+ +Q R NI +++ P ++ E+ + GS++ ++
Sbjct: 46 ---IQREVALLSQLRQSQPPNITKYYGSYLKGPRL-WIIMEYAEGGSVRTLMK-----AG 96
Query: 159 ELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPD 218
+ I R + L+Y+H + +IHRDIK AN+L+ + ++ DFG L+
Sbjct: 97 PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153
Query: 219 GHAQITVKCMVGTMGYMAPESLQTETISD-KCDIYSFGVLLAVLVMGKFPVDDFFGHTEE 277
++ + VGT +MAPE + D K DI+S G+ + + G P D
Sbjct: 154 NSSKRST--FVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSD------- 204
Query: 278 MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDV 334
+D + M + S+ P +L NGY + + + C ++P ER S++++
Sbjct: 205 VDAFRAMMLIPKSKPP------RLEDNGYSKLL---REFVAACLDEEPKERLSAEEL 252
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 2e-09
Identities = 68/255 (26%), Positives = 110/255 (43%), Gaps = 66/255 (25%)
Query: 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLH 100
D ++ L+KIG G +G+V YKA + GK++A++K + ++DE
Sbjct: 1 DAYEKLEKIGEGTYGKV-YKAR-DKNTGKLVALKK------------TRLEMDE------ 40
Query: 101 WKIGAIRSEIITANQTRHRNILPLLA---HMVRPNCHLLVYEFMKNGSLQDILYDV---- 153
E I R ++L +L+ ++VR LL E ++ + + LY V
Sbjct: 41 --------EGIPPTALREISLLQMLSESIYIVR----LLDVEHVEEKNGKPSLYLVFEYL 88
Query: 154 ---------SQGR---RELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDD 201
S GR R L + G+ + CH+ ++HRD+KP N+L+D
Sbjct: 89 DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAH---CHKHGVMHRDLKPQNLLVDK 145
Query: 202 DMEA-RISDFGHGKLMPDGHAQITVKCM---VGTMGYMAPES-LQTETISDKCDIYSFGV 256
+I+D G G+ I VK + T+ Y APE L + S DI+S G
Sbjct: 146 QKGLLKIADLGLGRAF-----SIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGC 200
Query: 257 LLAVLVMGK--FPVD 269
+ A + + FP D
Sbjct: 201 IFAEMSRKQPLFPGD 215
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 70/314 (22%), Positives = 132/314 (42%), Gaps = 58/314 (18%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
++ + +IG G +G+V +KA + G+ +A++++ V L I E + L H +
Sbjct: 3 YECVAEIGEGAYGKV-FKARDLKNGGRFVALKRVRVQTGEEGMPL--STIREVAVLRHLE 59
Query: 103 I----GAIR-SEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNG----SLQDILYDV 153
+R ++ T ++T L L+ V + + + + G +++D+++ +
Sbjct: 60 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 119
Query: 154 SQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHG 213
+G L++LH R++HRD+KP N+L+ + +++DFG
Sbjct: 120 LRG-------------------LDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLA 157
Query: 214 KLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLA------VLVMGKFP 267
++ Q+ + +V T+ Y APE L + + D++S G + A L G
Sbjct: 158 RIYS---FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 214
Query: 268 VD------DFFGHTEEMDMVKWMRNV-----IFSENPNRAINSKLLGNGYEEQMLLVLKL 316
VD D G E D W R+V F + I K + + E L+LK
Sbjct: 215 VDQLGKILDVIGLPGEED---WPRDVALPRQAFHSKSAQPI-EKFVTDIDELGKDLLLKC 270
Query: 317 ACFCTLKDPDERPS 330
F K +
Sbjct: 271 LTFNPAKRISAYSA 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 49/163 (30%), Positives = 79/163 (48%), Gaps = 15/163 (9%)
Query: 135 LLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKP 194
LV E++ G D+++ + + R+ + AR A I L +LH +I+RD+K
Sbjct: 72 FLVIEYVNGG---DLMFHMQRQRKLPEEHARFYAAE-ICIALNFLH---ERGIIYRDLKL 124
Query: 195 ANVLIDDDMEARISDFGHGK--LMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIY 252
NVL+D D +++D+G K L P T GT Y+APE L+ E D +
Sbjct: 125 DNVLLDADGHIKLTDYGMCKEGLGPGD----TTSTFCGTPNYIAPEILRGEEYGFSVDWW 180
Query: 253 SFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNR 295
+ GVL+ ++ G+ P D +M+ ++ VI E P R
Sbjct: 181 ALGVLMFEMMAGRSPF-DIITDNPDMNTEDYLFQVIL-EKPIR 221
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 3e-09
Identities = 55/242 (22%), Positives = 94/242 (38%), Gaps = 53/242 (21%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGA 105
+ +G G +GEVF K I + + + L K DE
Sbjct: 10 ITTLGRGEFGEVFL--------AKAKGIEEEGGETLVLVKALQKTK-DENLQS------E 54
Query: 106 IRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWP-- 163
R E+ + H+N++ LL H ++ E+ G L+ L ++ + E P
Sbjct: 55 FRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLR-ATKSKDEKLKPPP 113
Query: 164 ----ARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGK----- 214
+ + IA G+++L R +HRD+ N L+ E ++S K
Sbjct: 114 LSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNS 170
Query: 215 --------LMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL-AVLVMGK 265
L+P + ++APE++Q + S K D++SFGVL+ V G+
Sbjct: 171 EYYKLRNALIP--------------LRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGE 216
Query: 266 FP 267
P
Sbjct: 217 LP 218
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 3e-09
Identities = 61/230 (26%), Positives = 104/230 (45%), Gaps = 29/230 (12%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSN-GKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHW 101
F+ L+ +G+G +G+VF ++ G + GK+ A++ L A + K E++
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVL-----KKATIVQKAKTAEHT----- 51
Query: 102 KIGAIRSEIITANQTRHRNILPLLAHMVRPNCHL-LVYEFMKNGSLQDILYDVSQGRREL 160
R+E R L L + + + L L+ +++ G L LY +
Sbjct: 52 -----RTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLY--QREHFTE 104
Query: 161 DWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGK-LMPDG 219
R IA I L++LH + +I+RDIK N+L+D + ++DFG K + +
Sbjct: 105 S-EVRVYIAE-IVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE 159
Query: 220 HAQITVKCMVGTMGYMAPESLQTETI--SDKCDIYSFGVLLAVLVMGKFP 267
+ C GT+ YMAPE ++ + D +S GVL L+ G P
Sbjct: 160 EERAYSFC--GTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 3e-09
Identities = 71/310 (22%), Positives = 124/310 (40%), Gaps = 67/310 (21%)
Query: 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAI 106
+ +G G +G V +A+L +G + A +++K DI SD I
Sbjct: 5 RMLGKGEFGSV-REAQLKSEDGSFQKV----------AVKMLKADIFSSSD-----IEEF 48
Query: 107 RSEIITANQTRHRNILPLLAHMVRPNCH------LLVYEFMKNGSLQDILYDVSQGRREL 160
E + H N++ L+ +R +++ FMK+G L L G
Sbjct: 49 LREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPF 108
Query: 161 DWPARH--RIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPD 218
P + R IASG+EYL IHRD+ N +++++M ++DFG K +
Sbjct: 109 TLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYS 165
Query: 219 GH-------AQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL-AVLVMGKFPVDD 270
G +++ VK ++A ESL + D+++FGV + ++ G+ P
Sbjct: 166 GDYYRQGCASKLPVK-------WLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP--- 215
Query: 271 FFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQ----MLLVLKLACFCTLKDPD 326
++ N I + L+ +Q + V +L C C +P
Sbjct: 216 ------------------YAGVENSEIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPK 257
Query: 327 ERPSSKDVRS 336
RPS + +R
Sbjct: 258 CRPSFQHLRD 267
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 56.8 bits (138), Expect = 4e-09
Identities = 65/246 (26%), Positives = 111/246 (45%), Gaps = 61/246 (24%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
++ L+K+G G +G V+ KA + +++A++K I DA +A D
Sbjct: 9 YEILQKLGKGAYGIVW-KA-IDRRTKEVVALKK-IFDAFRNA-----TD----------- 49
Query: 103 IGAIRS--EIITANQTR-HRNILPLLAHMVRPNCH--LLVYEFM--------KNGSLQDI 149
A R+ EI+ + H NI+ LL + N LV+E+M + L+D+
Sbjct: 50 --AQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDV 107
Query: 150 LYDVSQGRRELDWPARHR--IARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARI 207
H+ I + L+Y+H +IHRD+KP+N+L++ D ++
Sbjct: 108 ----------------HKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKL 148
Query: 208 SDFGHGKL---MPDGHAQITVKCMVGTMGYMAPESLQTETISDK-CDIYSFGVLLAVLVM 263
+DFG + + + + V T Y APE L T K D++S G +L +++
Sbjct: 149 ADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLL 208
Query: 264 GK--FP 267
GK FP
Sbjct: 209 GKPLFP 214
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 4e-09
Identities = 69/243 (28%), Positives = 107/243 (44%), Gaps = 44/243 (18%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDI---DEYSDLL 99
F L +G G +G+V AE + G++ AI+ L K DI DE
Sbjct: 1 FRCLAVLGRGHFGKVLL-AEYKKT-GELYAIKALK-----------KGDIIARDE----- 42
Query: 100 HWKIGAIRSE---IITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQ-DILYDVSQ 155
+ ++ E TAN RH ++ L A + V E+ G L I DV
Sbjct: 43 ---VESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFS 99
Query: 156 GRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKL 215
R + + A + GL+YLH ++++RD+K N+L+D + +I+DFG K
Sbjct: 100 EPRAVFYAAC------VVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKE 150
Query: 216 -MPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGH 274
M G T GT ++APE L + + D + GVL+ +++G+ P F G
Sbjct: 151 GM--GFGDRT-STFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP---FPGD 204
Query: 275 TEE 277
EE
Sbjct: 205 DEE 207
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 4e-09
Identities = 34/97 (35%), Positives = 53/97 (54%), Gaps = 7/97 (7%)
Query: 172 IASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKL-MPDGHAQITVKCMVG 230
I S L YLH C +++RD+K N+++D D +I+DFG K + DG T+K G
Sbjct: 104 IVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA---TMKTFCG 157
Query: 231 TMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFP 267
T Y+APE L+ D + GV++ ++ G+ P
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 4e-09
Identities = 36/126 (28%), Positives = 61/126 (48%), Gaps = 5/126 (3%)
Query: 135 LLVYEFMKNGSLQDILYDVSQGRRELDWPARH--RIARGIASGLEYLHMCHRPRLIHRDI 192
+++ FMK+G L L G P + + IASG+EYL IHRD+
Sbjct: 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDL 138
Query: 193 KPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIY 252
N +++++M ++DFG K + +G + + ++A ESL + K D++
Sbjct: 139 AARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVW 198
Query: 253 SFGVLL 258
SFGV +
Sbjct: 199 SFGVTM 204
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 5e-09
Identities = 45/141 (31%), Positives = 72/141 (51%), Gaps = 23/141 (16%)
Query: 136 LVYEFMKNGSLQDIL--YDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIK 193
+V E+M G L +++ YDV + W AR A + + L H IHRD+K
Sbjct: 120 MVMEYMPGGDLVNLMSNYDVPE-----KW-ARFYTAEVVLA----LDAIHSMGFIHRDVK 169
Query: 194 PANVLIDDDMEARISDFGHG-KLMPDGHAQITVKC--MVGTMGYMAPESLQTET----IS 246
P N+L+D +++DFG K+ +G V+C VGT Y++PE L+++
Sbjct: 170 PDNMLLDKSGHLKLADFGTCMKMNKEG----MVRCDTAVGTPDYISPEVLKSQGGDGYYG 225
Query: 247 DKCDIYSFGVLLAVLVMGKFP 267
+CD +S GV L +++G P
Sbjct: 226 RECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 5e-09
Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 16/204 (7%)
Query: 65 GSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPL 124
G+ GK+I +R+ A +++K+++ D ++ +E TRH + L
Sbjct: 6 GTFGKVILVREK-ASGKYYAMKILKKEVIIAKD----EVAHTLTESRVLKNTRHPFLTSL 60
Query: 125 LAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHR 184
+ V E++ G L + +S+ R + R A I S L+YLH
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGEL---FFHLSRERVFSEDRTRFYGAE-IVSALDYLH---S 113
Query: 185 PRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQ-ITVKCMVGTMGYMAPESLQTE 243
++++RD+K N+++D D +I+DFG L +G T+K GT Y+APE L+
Sbjct: 114 GKIVYRDLKLENLMLDKDGHIKITDFG---LCKEGITDAATMKTFCGTPEYLAPEVLEDN 170
Query: 244 TISDKCDIYSFGVLLAVLVMGKFP 267
D + GV++ ++ G+ P
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 5e-09
Identities = 71/264 (26%), Positives = 110/264 (41%), Gaps = 48/264 (18%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSN-GKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHW 101
F+ LK +G+G +G+VF ++ G + GK+ A++ L
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVL------------------------- 36
Query: 102 KIGAIRSEIITANQTR-HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRREL 160
K I + T TR R +L + P L Y F + L IL ++ G
Sbjct: 37 KKATIVQKAKTTEHTRTERQVLEHIRQ--SPFLVTLHYAFQTDTKLHLILDYINGGELFT 94
Query: 161 DWPARHRIARG--------IASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGH 212
R R I LE+LH + +I+RDIK N+L+D + ++DFG
Sbjct: 95 HLSQRERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGL 151
Query: 213 GK-LMPDGHAQITVKCMVGTMGYMAPESLQ-TETISDKC-DIYSFGVLLAVLVMGKFPVD 269
K D + C GT+ YMAP+ ++ + DK D +S GVL+ L+ G P
Sbjct: 152 SKEFHEDEVERAYSFC--GTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP-- 207
Query: 270 DFFGHTEEMDMVKWMRNVIFSENP 293
F E+ + R ++ SE P
Sbjct: 208 -FTVDGEKNSQAEISRRILKSEPP 230
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 5e-09
Identities = 34/96 (35%), Positives = 51/96 (53%), Gaps = 7/96 (7%)
Query: 172 IASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLM-PDGHAQITVKCMVG 230
I GL+YLH ++HRDIKP N+L++ + +I DFG ++ PD +T + V
Sbjct: 112 ILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQE--VV 166
Query: 231 TMGYMAPESLQTET-ISDKCDIYSFGVLLAVLVMGK 265
T Y APE L + DI+S G + A L+ +
Sbjct: 167 TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 5e-09
Identities = 34/97 (35%), Positives = 53/97 (54%), Gaps = 7/97 (7%)
Query: 172 IASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHA-QITVKCMVG 230
I S LEYLH +++RDIK N+++D D +I+DFG L +G + T+K G
Sbjct: 104 IVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFG---LCKEGISDGATMKTFCG 157
Query: 231 TMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFP 267
T Y+APE L+ D + GV++ ++ G+ P
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 5e-09
Identities = 32/104 (30%), Positives = 57/104 (54%), Gaps = 11/104 (10%)
Query: 167 RIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVK 226
A +A G++YL + + IHRD+ N+L+ ++ A+I+DFG + ++ VK
Sbjct: 116 HFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVK 167
Query: 227 CMVGTMG--YMAPESLQTETISDKCDIYSFGVLL-AVLVMGKFP 267
+G + +MA ESL + D++S+GVLL ++ +G P
Sbjct: 168 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 211
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 5e-09
Identities = 64/239 (26%), Positives = 107/239 (44%), Gaps = 38/239 (15%)
Query: 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDE--YSDLLHWKIG 104
K +G G +G+V + K + K+ A +++K D E SDL+
Sbjct: 24 KPLGEGCFGQVVMAEAIGLDKEKPNRVTKV-------AVKMLKSDATEKDLSDLI----- 71
Query: 105 AIRSEIITANQT-RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDIL-----------YD 152
SE+ +H+NI+ LL + ++ E+ G+L++ L Y+
Sbjct: 72 ---SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYN 128
Query: 153 VSQGRRE-LDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFG 211
+Q E L + A +A G+EYL + IHRD+ NVL+ +D +I+DFG
Sbjct: 129 PTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFG 185
Query: 212 HGKLMPDGHAQITVKCMVGTM--GYMAPESLQTETISDKCDIYSFGVLL-AVLVMGKFP 267
+ + H K G + +MAPE+L + + D++SFGVLL + +G P
Sbjct: 186 LARDI--HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 242
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 6e-09
Identities = 42/148 (28%), Positives = 73/148 (49%), Gaps = 16/148 (10%)
Query: 136 LVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEY-LHMCHRPRLIHRDIKP 194
V EF+ G D+++ + + R+ P H AR ++ + L+ H +I+RD+K
Sbjct: 73 FVIEFVSGG---DLMFHMQRQRK---LPEEH--ARFYSAEISLALNFLHERGIIYRDLKL 124
Query: 195 ANVLIDDDMEARISDFGHGK--LMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIY 252
NVL+D + +++D+G K + P T GT Y+APE L+ E D +
Sbjct: 125 DNVLLDAEGHIKLTDYGMCKEGIRPGD----TTSTFCGTPNYIAPEILRGEDYGFSVDWW 180
Query: 253 SFGVLLAVLVMGKFPVDDFFGHTEEMDM 280
+ GVL+ ++ G+ P D G ++ D
Sbjct: 181 ALGVLMFEMMAGRSPF-DIVGMSDNPDQ 207
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 6e-09
Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 19/208 (9%)
Query: 65 GSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPL 124
GS K++ +R + + A +++K+++ + + W +++E Q + L
Sbjct: 6 GSYAKVLLVRLKKTER-IYAMKVVKKELVNDDEDIDW----VQTEKHVFEQASNHPFLVG 60
Query: 125 LAHMVRPNCHLL-VYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCH 183
L + L V E++ G D+++ + + R+ + AR A I+ L YLH
Sbjct: 61 LHSCFQTESRLFFVIEYVNGG---DLMFHMQRQRKLPEEHARFYSAE-ISLALNYLH--- 113
Query: 184 RPRLIHRDIKPANVLIDDDMEARISDFGHGK--LMPDGHAQITVKCMVGTMGYMAPESLQ 241
+I+RD+K NVL+D + +++D+G K L P T GT Y+APE L+
Sbjct: 114 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD----TTSTFCGTPNYIAPEILR 169
Query: 242 TETISDKCDIYSFGVLLAVLVMGKFPVD 269
E D ++ GVL+ ++ G+ P D
Sbjct: 170 GEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 8e-09
Identities = 50/167 (29%), Positives = 78/167 (46%), Gaps = 20/167 (11%)
Query: 136 LVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPA 195
LV ++M G L + +GR D A+ IA + + LE+LH + +++RD+KP
Sbjct: 73 LVTDYMSGGEL--FWHLQKEGRFSED-RAKFYIAELVLA-LEHLH---KYDIVYRDLKPE 125
Query: 196 NVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDK-CDIYSF 254
N+L+D + DFG K + T GT Y+APE L E K D +S
Sbjct: 126 NILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSL 183
Query: 255 GVLLAVLVMGKFPVDDFFG-HTEEM------DMVKWMRNVIFSENPN 294
GVL+ + G P F+ T++M V++ +NV+ E
Sbjct: 184 GVLVFEMCCGWSP---FYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQ 227
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 8e-09
Identities = 65/235 (27%), Positives = 103/235 (43%), Gaps = 54/235 (22%)
Query: 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAI 106
K IG G +G+V ++A RKL D A +++++ I
Sbjct: 1 KVIGKGSFGKV------------LLAKRKL--DGKCYAVKVLQKKI-------------- 32
Query: 107 RSEIITANQTRH----RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQG------ 156
++ + +H RN+L L ++ P L Y F L +L V+ G
Sbjct: 33 ---VLNRKEQKHIMAERNVL--LKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHL 87
Query: 157 RRELDWP---ARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHG 213
+RE +P AR A IAS L YLH +++RD+KP N+L+D ++DFG
Sbjct: 88 QRERSFPEPRARFYAAE-IASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFG-- 141
Query: 214 KLMPDGHAQI-TVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFP 267
L +G AQ T GT Y+APE ++ + + D + G +L ++ G P
Sbjct: 142 -LCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 9e-09
Identities = 51/207 (24%), Positives = 84/207 (40%), Gaps = 62/207 (29%)
Query: 164 ARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFG--------H--- 212
AR IA + +E +H + IHRDIKP N+LID D +++DFG H
Sbjct: 103 ARFYIAE-LTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158
Query: 213 -------------------GKLMPDG-----------HAQITVKCMVGTMGYMAPESLQT 242
++ H + +VGT Y+APE L
Sbjct: 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR 218
Query: 243 ETISDKCDIYSFGVLLAVLVMGKFP-VDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKL 301
+ CD +S GV+L +++G+ P + D T ++ ++ W + P++A S+
Sbjct: 219 TGYTQLCDWWSVGVILYEMLVGQPPFLADTPAET-QLKVINWETTLHI---PSQAKLSR- 273
Query: 302 LGNGYEEQMLLVLKLACFCTLKDPDER 328
E L+L+L C ++R
Sbjct: 274 ------EASDLILRLCC-----GAEDR 289
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 9e-09
Identities = 57/232 (24%), Positives = 99/232 (42%), Gaps = 41/232 (17%)
Query: 47 KKIGSGGWGEV----------FYKAELPGSNGK--MIAIRKLIVDAPMSAAELIKQDIDE 94
+K+G G +GEV F P +G+ ++A++ L D +A
Sbjct: 11 EKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTAR--------- 61
Query: 95 YSDLLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYD-- 152
+D L EI ++ ++ NI+ LL V + ++ E+M+NG L L
Sbjct: 62 -NDFL--------KEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQRE 112
Query: 153 -VSQGRRELDWPARHR-----IARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEAR 206
S + P+ +A IASG++YL + +HRD+ N L+ + +
Sbjct: 113 IESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCLVGNHYTIK 169
Query: 207 ISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
I+DFG + + G V + +MA ES+ + D+++FGV L
Sbjct: 170 IADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTL 221
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 9e-09
Identities = 64/250 (25%), Positives = 113/250 (45%), Gaps = 45/250 (18%)
Query: 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLH 100
+ + +L +GSG +G V A G +A++KL P + K+ E L H
Sbjct: 17 ERYQNLSPVGSGAYGSVC--AAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKH 72
Query: 101 WK----IGAIRSEIIT-ANQTRHRNILPLLAHMVRPNCHLLVY-EFMKNGSLQDILYDVS 154
K IG + ++ T A N + L+ H++ + + +V + + + +Q ++Y
Sbjct: 73 MKHENVIGLL--DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ-- 128
Query: 155 QGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGK 214
I GL+Y+H +IHRD+KP+N+ +++D E +I DFG +
Sbjct: 129 -----------------ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 168
Query: 215 LMPDGHAQITVKCMVGTMGYMAPE-SLQTETISDKCDIYSFGVLLAVLVMGK--FPVDDF 271
H + V T Y APE L + DI+S G ++A L+ G+ FP D
Sbjct: 169 -----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD- 222
Query: 272 FGHTEEMDMV 281
H +++ ++
Sbjct: 223 --HIDQLKLI 230
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 9e-09
Identities = 47/179 (26%), Positives = 77/179 (43%), Gaps = 44/179 (24%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGA 105
L K+G G +GEV YKA G+++A++K+++ D I A
Sbjct: 13 LGKLGEGTFGEV-YKAR-QIKTGRVVALKKILMH--------------NEKDGFP--ITA 54
Query: 106 IRSEIITANQTRHRNILPLL--------AHMVRPNCHLLVYEFMK---NGSL--QDILYD 152
+R EI + +H N++PL+ + +V +M +G L +
Sbjct: 55 LR-EIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLT 113
Query: 153 VSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFG 211
SQ + + G+ YLH ++HRDIK AN+LID+ +I+DFG
Sbjct: 114 ESQIKC---------YMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFG 160
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 55.3 bits (134), Expect = 9e-09
Identities = 71/321 (22%), Positives = 138/321 (42%), Gaps = 67/321 (20%)
Query: 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLH 100
D ++ L +I G +G V+ + G+++A++KL ++
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDK--KTGEIVALKKLKMEKEKEG---------------- 46
Query: 101 WKIGAIRSEIITANQTRHRNILPLLAHMVRPNCH--LLVYEFMKNGSLQDILYDVSQGRR 158
+ I ++R EI + +H NI+ + +V N +V E++++ L+ ++ + Q
Sbjct: 47 FPITSLR-EINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFL 104
Query: 159 ELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPD 218
+ + + SG+ +LH ++HRD+K +N+L+++ +I DFG +
Sbjct: 105 Q---SEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158
Query: 219 GHAQITVKCMVGTMGYMAPESL-QTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEE 277
T +V T+ Y APE L + S D++S G + A L+ K P+ F G +E
Sbjct: 159 PLKPYTQ--LVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK-PL--FPGKSEI 213
Query: 278 MDMVK------------W--------MRNVIFSENPNRAINSK-----LLGNGYEEQMLL 312
+ K W + F++ P + K L NG++ L
Sbjct: 214 DQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFD----L 269
Query: 313 VLKLACFCTLKDPDERPSSKD 333
+ +L + DP +R S++D
Sbjct: 270 LNRLLTY----DPAKRISAED 286
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 42/133 (31%), Positives = 67/133 (50%), Gaps = 10/133 (7%)
Query: 136 LVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPA 195
V E+ G L + +S+ R + AR A I S L+YLH +++RD+K
Sbjct: 72 FVMEYANGGEL---FFHLSRERVFSEDRARFYGAE-IVSALDYLHS--EKNVVYRDLKLE 125
Query: 196 NVLIDDDMEARISDFGHGKL-MPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSF 254
N+++D D +I+DFG K + DG T+K GT Y+APE L+ D +
Sbjct: 126 NLMLDKDGHIKITDFGLCKEGIKDG---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 182
Query: 255 GVLLAVLVMGKFP 267
GV++ ++ G+ P
Sbjct: 183 GVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 1e-08
Identities = 43/150 (28%), Positives = 70/150 (46%), Gaps = 16/150 (10%)
Query: 131 PNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHR 190
H+L+ +++K+G L D+L + +L +I R + L LH + +IH
Sbjct: 81 LKGHVLIMDYIKDGDLFDLL----KKEGKLSEAEVKKIIRQLVEALNDLHKHN---IIHN 133
Query: 191 DIKPANVLIDDDME-ARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKC 249
DIK NVL D + + D+G K++ T C GT+ Y +PE ++
Sbjct: 134 DIKLENVLYDRAKDRIYLCDYGLCKIIG------TPSCYDGTLDYFSPEKIKGHNYDVSF 187
Query: 250 DIYSFGVLLAVLVMGKFPVDDFFGHTEEMD 279
D ++ GVL L+ GK P + EE+D
Sbjct: 188 DWWAVGVLTYELLTGKHPFKEDED--EELD 215
|
Length = 267 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 43/165 (26%), Positives = 76/165 (46%), Gaps = 23/165 (13%)
Query: 118 HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIAS--- 174
H NI+ LL L E+ +G+L D L + + + A ++S
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 175 ---------GLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITV 225
G++YL + + IHRD+ N+L+ ++ A+I+DFG + ++ V
Sbjct: 127 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYV 178
Query: 226 KCMVGTMG--YMAPESLQTETISDKCDIYSFGVLL-AVLVMGKFP 267
K +G + +MA ESL + D++S+GVLL ++ +G P
Sbjct: 179 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 223
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 28/92 (30%), Positives = 50/92 (54%), Gaps = 6/92 (6%)
Query: 168 IARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKC 227
+ R GL++LH ++HRD+KP N+L+ + +++DFG ++ Q+ +
Sbjct: 113 LMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLARIYS---CQMALTP 166
Query: 228 MVGTMGYMAPESLQTETISDKCDIYSFGVLLA 259
+V T+ Y APE L T + D++S G + A
Sbjct: 167 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFA 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-08
Identities = 37/128 (28%), Positives = 67/128 (52%), Gaps = 7/128 (5%)
Query: 136 LVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPA 195
L+ EF+ +GSL++ L + + +++ + + A I G++YL + +HRD+
Sbjct: 85 LIMEFLPSGSLKEYL---PRNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAAR 138
Query: 196 NVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGT-MGYMAPESLQTETISDKCDIYSF 254
NVL++ + + +I DFG K + TVK + + + + APE L D++SF
Sbjct: 139 NVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSF 198
Query: 255 GVLLAVLV 262
GV L L+
Sbjct: 199 GVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 47/185 (25%), Positives = 85/185 (45%), Gaps = 43/185 (23%)
Query: 117 RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIAR------ 170
+H+NI+ LL + ++ E+ G+L++ L + RR + IAR
Sbjct: 79 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYL----RARRPPGMEYSYDIARVPDEQM 134
Query: 171 ----------GIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPD-- 218
+A G+EYL + IHRD+ NVL+ ++ +I+DFG + + +
Sbjct: 135 TFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNID 191
Query: 219 -----GHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL-AVLVMG-----KFP 267
+ ++ VK +MAPE+L + + D++SFGVL+ + +G P
Sbjct: 192 YYKKTTNGRLPVK-------WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 244
Query: 268 VDDFF 272
V++ F
Sbjct: 245 VEELF 249
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 32/97 (32%), Positives = 53/97 (54%), Gaps = 6/97 (6%)
Query: 172 IASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQIT--VKCMV 229
I GL+Y+H + ++HRD+KP N+L++ D E +I DFG + + + + V
Sbjct: 114 ILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV 170
Query: 230 GTMGYMAPE-SLQTETISDKCDIYSFGVLLAVLVMGK 265
T Y APE L ++ + D++S G +LA L+ K
Sbjct: 171 ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 2e-08
Identities = 52/173 (30%), Positives = 79/173 (45%), Gaps = 19/173 (10%)
Query: 107 RSEIITANQTRH----RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQG------ 156
+ I+ + +H RN+L L ++ P L Y F L +L V+ G
Sbjct: 30 KKAILKKKEQKHIMAERNVL--LKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHL 87
Query: 157 RRELDWP-ARHRI-ARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGK 214
+RE +P R R A IAS L YLH +I+RD+KP N+L+D ++DFG K
Sbjct: 88 QRERSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK 144
Query: 215 LMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFP 267
+ + C GT Y+APE L+ + D + G +L ++ G P
Sbjct: 145 EGIEHSKTTSTFC--GTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-08
Identities = 45/157 (28%), Positives = 70/157 (44%), Gaps = 19/157 (12%)
Query: 108 SEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHR 167
SE Q H NI+ L+ + +V E + G D L + + + EL +
Sbjct: 41 SEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG---DFLSFLRKKKDELKTKQLVK 97
Query: 168 IARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPD------GHA 221
A A+G+ YL IHRD+ N L+ ++ +ISDFG + D G
Sbjct: 98 FALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK 154
Query: 222 QITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
QI +K + APE+L S + D++S+G+LL
Sbjct: 155 QIPIK-------WTAPEALNYGRYSSESDVWSYGILL 184
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-08
Identities = 62/235 (26%), Positives = 106/235 (45%), Gaps = 51/235 (21%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
+ SLK++GSG +G V + G+ +AI+KL P + K+ E + L H +
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDK--RTGEKVAIKKL--SRPFQSEIFAKRAYRELTLLKHMQ 72
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMV-RPNCH-----LLVYEFMKNGSLQDIL-YDVSQ 155
H N++ LL + LV +M+ LQ I+ + +S+
Sbjct: 73 ---------------HENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHPLSE 116
Query: 156 GRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKL 215
+ + + + GL+Y+H +IHRD+KP N+ +++D E +I DFG +
Sbjct: 117 DKVQY-------LVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR- 165
Query: 216 MPDGHAQITVKCMVGTMGYMAPESL-----QTETISDKCDIYSFGVLLAVLVMGK 265
HA + V T Y APE + +T+ DI+S G ++A ++ GK
Sbjct: 166 ----HADAEMTGYVVTRWYRAPEVILNWMHYNQTV----DIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 67/251 (26%), Positives = 112/251 (44%), Gaps = 47/251 (18%)
Query: 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAA-ELIKQDI--DEYSDLLHWKI 103
K +G G +G+V + I I K + P++ A +++K D + SDL+
Sbjct: 18 KPLGEGCFGQVVM--------AEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLV---- 65
Query: 104 GAIRSEIITANQT-RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDIL-----------Y 151
SE+ +H+NI+ LL + ++ E+ G+L++ L +
Sbjct: 66 ----SEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSF 121
Query: 152 DVSQGRRE-LDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDF 210
D + E L + A +A G+EYL + IHRD+ NVL+ +D +I+DF
Sbjct: 122 DTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVTEDNVMKIADF 178
Query: 211 GHGKLMPDGHAQITVKCMVG---TMGYMAPESLQTETISDKCDIYSFGVLL-AVLVMGK- 265
G L D H K + +MAPE+L + + D++SFGVLL + +G
Sbjct: 179 G---LARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGS 235
Query: 266 ----FPVDDFF 272
PV++ F
Sbjct: 236 PYPGIPVEELF 246
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 2e-08
Identities = 45/165 (27%), Positives = 72/165 (43%), Gaps = 23/165 (13%)
Query: 102 KIGAIRSEIITANQTR---HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRR 158
KIG + +I A + H +++ + +V +V + D+ +++ R
Sbjct: 97 KIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS----DLYTYLTKRSR 152
Query: 159 ELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPD 218
L I + I GL YLH R+IHRD+K N+ I+D + I D
Sbjct: 153 PLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDL-------- 201
Query: 219 GHAQITVKC-----MVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
G AQ V + GT+ APE L + + K DI+S G++L
Sbjct: 202 GAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVL 246
|
Length = 357 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 3e-08
Identities = 44/145 (30%), Positives = 69/145 (47%), Gaps = 15/145 (10%)
Query: 136 LVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPA 195
V +++ G L Y + + R L+ AR A IAS L YLH + +++RD+KP
Sbjct: 73 FVLDYINGGEL---FYHLQRERCFLEPRARFYAAE-IASALGYLHSLN---IVYRDLKPE 125
Query: 196 NVLIDDDMEARISDFGHGK--LMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYS 253
N+L+D ++DFG K + +G T GT Y+APE L + D +
Sbjct: 126 NILLDSQGHIVLTDFGLCKENIEHNG----TTSTFCGTPEYLAPEVLHKQPYDRTVDWWC 181
Query: 254 FGVLLAVLVMGKFPVDDFFGHTEEM 278
G +L ++ G P + +T EM
Sbjct: 182 LGAVLYEMLYGLPPF--YSRNTAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 3e-08
Identities = 45/163 (27%), Positives = 77/163 (47%), Gaps = 16/163 (9%)
Query: 117 RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGL 176
+ NI+ L R LV+E+++ L+ +L ++ G ++ I +
Sbjct: 58 KQENIVELKEAFRRRGKLYLVFEYVEKNMLE-LLEEMPNG------VPPEKVRSYIYQLI 110
Query: 177 EYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDG-HAQITVKCMVGTMGYM 235
+ +H CH+ ++HRDIKP N+LI + ++ DFG + + +G +A T V T Y
Sbjct: 111 KAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTE--YVATRWYR 168
Query: 236 APESLQTETISDKCDIYSFGVLLAVLVMGK--FP----VDDFF 272
+PE L D++S G +L L G+ FP +D F
Sbjct: 169 SPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLF 211
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 3e-08
Identities = 58/238 (24%), Positives = 101/238 (42%), Gaps = 36/238 (15%)
Query: 39 KEDCFDSLKKIGSGGWGEVFYKAELP-GSNGKM-IAIRKLI-VDAPMSAAELIKQDIDEY 95
KE F +K +GSG +G V+ +P G K+ +AI++L +P + E++
Sbjct: 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL------- 57
Query: 96 SDLLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILY---D 152
E + ++ LL + L + + M G L D + D
Sbjct: 58 ------------DEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKD 104
Query: 153 VSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGH 212
+ L+W + IA G+ YL RL+HRD+ NVL+ +I+DFG
Sbjct: 105 NIGSQYLLNWCVQ------IAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGL 155
Query: 213 GKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL-AVLVMGKFPVD 269
KL+ + + + +MA ES+ + + D++S+GV + ++ G P D
Sbjct: 156 AKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 4e-08
Identities = 44/212 (20%), Positives = 95/212 (44%), Gaps = 22/212 (10%)
Query: 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAI 106
+++G G +G V+ + + + + K I ++ E ++ + + + LL
Sbjct: 6 QRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQE--AQLL------- 56
Query: 107 RSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARH 166
++ H I+ A + + ++ E+ + L L ++ + L + +
Sbjct: 57 -------SKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTL---SEN 106
Query: 167 RIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVK 226
++ L +H H+ R++HRD+K N+ + +++ +I DFG +L+ T
Sbjct: 107 QVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT- 164
Query: 227 CMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
GT YM+PE+L+ + K DI+S G +L
Sbjct: 165 -FTGTPYYMSPEALKHQGYDSKSDIWSLGCIL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-08
Identities = 50/177 (28%), Positives = 79/177 (44%), Gaps = 25/177 (14%)
Query: 106 IRSEIITANQTRHRNILPLLAHMVRPNC-----------HL-LVYEFMKNGSLQDILYDV 153
IR ++ R LLA M PN HL +V E+ G D++ +
Sbjct: 33 IRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGG---DLMQKI 89
Query: 154 SQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHG 213
R +L +P + + L H+ H R++HRDIK N+ + + + ++ DFG
Sbjct: 90 KLQRGKL-FPEDTILQWFVQMCLGVQHI-HEKRVLHRDIKSKNIFLTQNGKVKLGDFGSA 147
Query: 214 KLM--PDGHAQITVKCM-VGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFP 267
+L+ P +A C VGT Y+ PE + ++K DI+S G +L L K P
Sbjct: 148 RLLTSPGAYA-----CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 5e-08
Identities = 64/289 (22%), Positives = 109/289 (37%), Gaps = 76/289 (26%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
F +K +G G +GEV RK+ A + L K+D+ LL +
Sbjct: 3 FVKIKTLGIGAFGEV-------------CLARKVDTKALYAMKTLRKKDV-----LLRNQ 44
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDW 162
+ +++E + + ++ L + V +++ G + +L + +L
Sbjct: 45 VAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDL-- 102
Query: 163 PARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFG----------- 211
AR IA + + H+ IHRDIKP N+LID D +++DFG
Sbjct: 103 -ARFYIAELTCA----VESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157
Query: 212 ----------------------------HGKLMP------DGHAQITVKCMVGTMGYMAP 237
+L P H + +VGT Y+AP
Sbjct: 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAP 217
Query: 238 ESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHT---EEMDMVKW 283
E L + CD +S GV+L +++G+ P F T +M ++ W
Sbjct: 218 EVLLRTGYTQLCDWWSVGVILYEMLVGQPP---FLAQTPLETQMKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 5e-08
Identities = 49/170 (28%), Positives = 82/170 (48%), Gaps = 21/170 (12%)
Query: 105 AIRSEIITANQTRHRNILPL--LAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDW 162
AIR E+ +H NI+ L + H R C LV+E++ + L+ L + +
Sbjct: 50 AIR-EVSLLKNLKHANIVTLHDIIHTER--CLTLVFEYLDS-DLKQYLDNCG------NL 99
Query: 163 PARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFG--HGKLMPDGH 220
+ H + + L L CH+ +++HRD+KP N+LI++ E +++DFG K +P
Sbjct: 100 MSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK- 158
Query: 221 AQITVKCMVGTMGYMAPESLQTET-ISDKCDIYSFGVLLAVLVMGK--FP 267
T V T+ Y P+ L T S D++ G +L + G+ FP
Sbjct: 159 ---TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFP 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 6e-08
Identities = 39/128 (30%), Positives = 63/128 (49%), Gaps = 26/128 (20%)
Query: 176 LEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKL--------MPDGH-----AQ 222
LEYLH ++HRD+KP N+LI +++DFG K+ + +GH +
Sbjct: 114 LEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 223 ITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHT-EEM--- 278
K + GT Y+APE + + D ++ G++L ++G P FFG T EE+
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP---FFGDTPEELFGQ 227
Query: 279 ---DMVKW 283
D ++W
Sbjct: 228 VISDDIEW 235
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 8e-08
Identities = 45/175 (25%), Positives = 75/175 (42%), Gaps = 23/175 (13%)
Query: 106 IRSEIITANQTRHRNIL--------PLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGR 157
+ +EI+ + H NIL +M+ +Y FM + +
Sbjct: 210 LENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFD-------WKD 262
Query: 158 RELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMP 217
R L R I + + +EY+H +LIHRDIK N+ ++ D + + DF G MP
Sbjct: 263 RPLLKQTR-AIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDF--GTAMP 316
Query: 218 DGHAQITVKC-MVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKF-PVDD 270
+ VGT+ +PE L + + DI+S G++L ++ F P+ D
Sbjct: 317 FEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGD 371
|
Length = 501 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 8e-08
Identities = 45/162 (27%), Positives = 75/162 (46%), Gaps = 20/162 (12%)
Query: 105 AIRSEI-ITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWP 163
A+ SE+ I ++ H NI+ LL L++ E+ G L + L + L
Sbjct: 84 ALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLR--RKRESFLTLE 141
Query: 164 ARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGK-LMPD---- 218
+ +A G+ +L IHRD+ NVL+ +I DFG + +M D
Sbjct: 142 DLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYV 198
Query: 219 --GHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
G+A++ VK +MAPES+ + + D++S+G+LL
Sbjct: 199 VKGNARLPVK-------WMAPESIFNCVYTFESDVWSYGILL 233
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 1e-07
Identities = 63/239 (26%), Positives = 93/239 (38%), Gaps = 48/239 (20%)
Query: 49 IGSGGWGEVFYKAEL----PGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIG 104
+GSG +GEV+ PGS +A++ L A E + L
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT----------DQEKKEFL----- 47
Query: 105 AIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRE---LD 161
E + H NI+ LL + ++ E M+ G L L D R L
Sbjct: 48 ---KEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLT 104
Query: 162 WPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI-----DDDMEARISDFGHGK-- 214
I +A G YL H IHRD+ N L+ D D +I DFG +
Sbjct: 105 LKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDI 161
Query: 215 -----LMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL-AVLVMGKFP 267
+G + V+ +MAPESL + + D++SFGVL+ +L +G+ P
Sbjct: 162 YKSDYYRKEGEGLLPVR-------WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 1e-07
Identities = 57/236 (24%), Positives = 100/236 (42%), Gaps = 32/236 (13%)
Query: 39 KEDCFDSLKKIGSGGWGEVFYKAELP-GSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSD 97
KE +K +GSG +G V+ +P G K+ K++ + A + E+ D
Sbjct: 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV------EFMD 58
Query: 98 LLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILY---DVS 154
E + H +++ LL + P L V + M +G L D ++ D
Sbjct: 59 -----------EALIMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNI 106
Query: 155 QGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGK 214
+ L+W + IA G+ YL RL+HRD+ NVL+ +I+DFG +
Sbjct: 107 GSQLLLNWCVQ------IAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLAR 157
Query: 215 LMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL-AVLVMGKFPVD 269
L+ + + +MA E + + + D++S+GV + ++ G P D
Sbjct: 158 LLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 31/94 (32%), Positives = 53/94 (56%), Gaps = 17/94 (18%)
Query: 172 IASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLM---PD----GHAQIT 224
+A G+E+L + IHRD+ N+L+ ++ +I DFG + + PD G A++
Sbjct: 182 VARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 225 VKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
+K +MAPES+ + + + D++SFGVLL
Sbjct: 239 LK-------WMAPESIFDKVYTTQSDVWSFGVLL 265
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 74/318 (23%), Positives = 121/318 (38%), Gaps = 68/318 (21%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
F +K +G G G VF L G+ GK+ A+ K+ + E+IK++ K
Sbjct: 3 FKKIKLLGKGDVGRVFL-VRLKGT-GKLFAL-KV-----LDKKEMIKRN----------K 44
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDW 162
+ + +E H + L A LV ++ G L +L G+ +
Sbjct: 45 VKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLL-QRQPGKCLSEE 103
Query: 163 PARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQ 222
AR A + LEYLH+ +++RD+KP N+L+ + +SDF K
Sbjct: 104 VARFYAAE-VLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP 159
Query: 223 I-------------------TVKC--------MVGTMGYMAPESLQTETISDKCDIYSFG 255
+ T VGT Y+APE + + D ++ G
Sbjct: 160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLG 219
Query: 256 VLLAVLVMGKFPVDDFFGHTEEMDMVKWMRN-VIFSENPNRAINSKLLGNGYEEQMLLVL 314
+LL ++ G P F G + ++ V F +P + +++ L LLV
Sbjct: 220 ILLYEMLYGTTP---FKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRK-----LLV- 270
Query: 315 KLACFCTLKDPDERPSSK 332
KDP +R SK
Sbjct: 271 --------KDPSKRLGSK 280
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 40/134 (29%), Positives = 65/134 (48%), Gaps = 13/134 (9%)
Query: 136 LVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPA 195
V +++ G L + + + R L+ AR A +AS + YLH + +I+RD+KP
Sbjct: 73 FVLDYVNGGEL---FFHLQRERCFLEPRARFYAAE-VASAIGYLHSLN---IIYRDLKPE 125
Query: 196 NVLIDDDMEARISDFGHGK--LMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYS 253
N+L+D ++DFG K + P+ T GT Y+APE L+ E D +
Sbjct: 126 NILLDSQGHVVLTDFGLCKEGVEPEE----TTSTFCGTPEYLAPEVLRKEPYDRTVDWWC 181
Query: 254 FGVLLAVLVMGKFP 267
G +L ++ G P
Sbjct: 182 LGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-07
Identities = 65/249 (26%), Positives = 107/249 (42%), Gaps = 40/249 (16%)
Query: 35 AFLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDE 94
+F D ++ ++ IG G +G+VF L NG A++ I+D P+ DIDE
Sbjct: 12 SFPDPSDTWEIIETIGKGTYGKVF--KVLNKKNGSKAAVK--ILD-PI-------HDIDE 59
Query: 95 YSDLLHWKIGAIRSEI-ITANQTRHRNILPLLAHMVRPNCH-----LLVYEFMKNGSLQD 148
I +E I + H N++ + + LV E GS+ D
Sbjct: 60 ----------EIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTD 109
Query: 149 ILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARIS 208
++ + ++ P I GL++LH+ + IHRD+K N+L+ + ++
Sbjct: 110 LVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGVKLV 166
Query: 209 DFG-HGKLMPDGHAQITVKCMVGTMGYMAPESLQTE-----TISDKCDIYSFGVLLAVLV 262
DFG +L + T VGT +MAPE + E T +CD++S G+ L
Sbjct: 167 DFGVSAQLTSTRLRRNT---SVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELG 223
Query: 263 MGKFPVDDF 271
G P+ D
Sbjct: 224 DGDPPLADL 232
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 2e-07
Identities = 67/240 (27%), Positives = 100/240 (41%), Gaps = 46/240 (19%)
Query: 43 FDSLKKIGSGGWGEV--FYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLH 100
+ +LK IGSG G V Y A L + +AI+KL P K+
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVL----DRNVAIKKL--SRPFQNQTHAKR---------- 62
Query: 101 WKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHL-------LVYEFMKNGSLQDILYDV 153
A R E++ H+NI+ LL ++ P L LV E M Q I
Sbjct: 63 ----AYR-ELVLMKCVNHKNIISLL-NVFTPQKSLEEFQDVYLVMELMDANLCQVI---- 112
Query: 154 SQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHG 213
+ ELD + + G+++LH +IHRD+KP+N+++ D +I DFG
Sbjct: 113 ---QMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG-- 164
Query: 214 KLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGK--FPVDDF 271
L + V T Y APE + + DI+S G ++ +V K FP D+
Sbjct: 165 -LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 223
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 32/97 (32%), Positives = 52/97 (53%), Gaps = 9/97 (9%)
Query: 176 LEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFG--HGKLMPDGHAQITVKCMVGTMG 233
L L+ CHR +++HRD+KP N+LI++ E +++DFG K +P T V T+
Sbjct: 114 LRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK----TYSNEVVTLW 169
Query: 234 YMAPESLQTET-ISDKCDIYSFGVLLAVLVMGK--FP 267
Y P+ L T S + D++ G + + G+ FP
Sbjct: 170 YRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFP 206
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 3e-07
Identities = 65/240 (27%), Positives = 99/240 (41%), Gaps = 46/240 (19%)
Query: 43 FDSLKKIGSGGWGEV--FYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLH 100
+ +LK IGSG G V Y A L + +AI+KL P K+
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAILE----RNVAIKKL--SRPFQNQTHAKR---------- 69
Query: 101 WKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHL-------LVYEFMKNGSLQDILYDV 153
A R E++ H+NI+ LL ++ P L +V E M Q I
Sbjct: 70 ----AYR-ELVLMKCVNHKNIIGLL-NVFTPQKSLEEFQDVYIVMELMDANLCQVI---- 119
Query: 154 SQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHG 213
+ ELD + + G+++LH +IHRD+KP+N+++ D +I DFG
Sbjct: 120 ---QMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG-- 171
Query: 214 KLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGK--FPVDDF 271
L + V T Y APE + + DI+S G ++ ++ G FP D
Sbjct: 172 -LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH 230
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 3e-07
Identities = 42/137 (30%), Positives = 68/137 (49%), Gaps = 22/137 (16%)
Query: 158 RELDWPARH----RIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHG 213
E WP R + +A G+++L IHRD+ NVL+ D A+I DFG
Sbjct: 203 TEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLA 259
Query: 214 K-LMPD------GHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL-AVLVMGK 265
+ +M D G+A++ VK +MAPES+ + + D++S+G+LL + +GK
Sbjct: 260 RDIMNDSNYVVKGNARLPVK-------WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGK 312
Query: 266 FPVDDFFGHTEEMDMVK 282
P +++ MVK
Sbjct: 313 SPYPGILVNSKFYKMVK 329
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 3e-07
Identities = 51/218 (23%), Positives = 97/218 (44%), Gaps = 30/218 (13%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGS--NGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLH 100
+ +KKIG G +G KA L S +GK I+++ + + MS E +
Sbjct: 2 YVKVKKIGEGSFG----KAILVKSKEDGKQYVIKEINI-SKMSPKEREES---------- 46
Query: 101 WKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRREL 160
R E+ + +H NI+ +V ++ + G L Y +R +
Sbjct: 47 ------RKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDL----YKKINAQRGV 96
Query: 161 DWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGH 220
+P + + L H+ H +++HRDIK N+ + D ++ DFG +++ +
Sbjct: 97 LFPEDQILDWFVQICLALKHV-HDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL-NST 154
Query: 221 AQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
++ C +GT Y++PE + ++K DI++ G +L
Sbjct: 155 VELARTC-IGTPYYLSPEICENRPYNNKSDIWALGCVL 191
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 3e-07
Identities = 49/164 (29%), Positives = 74/164 (45%), Gaps = 20/164 (12%)
Query: 118 HRNILPLLAHMVRPNCHLLVYEFMKNGSLQD-ILYDVSQGRRELDWPARHRIARGIASGL 176
H NI+P A + N +V FM GS +D I G EL A I +G+ L
Sbjct: 58 HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSEL---AIAYILQGVLKAL 114
Query: 177 EYL-HMCHRPRLIHRDIKPANVLIDDD-------MEARISDFGHGKLMPDGHAQITVKCM 228
+Y+ HM + +HR +K +++LI D + + +S HG+ + H K
Sbjct: 115 DYIHHMGY----VHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHD--FPKYS 168
Query: 229 VGTMGYMAPESLQT--ETISDKCDIYSFGVLLAVLVMGKFPVDD 270
V + +++PE LQ + K DIYS G+ L G P D
Sbjct: 169 VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 4e-07
Identities = 62/296 (20%), Positives = 118/296 (39%), Gaps = 42/296 (14%)
Query: 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAI 106
++IG+G +G+V + + +++L +A Q D Y L
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRIL-------- 52
Query: 107 RSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARH 166
+H NIL L V +LLV+E+ + G L+ L RR
Sbjct: 53 ----------QHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ 102
Query: 167 RIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVK 226
R+A IA+G+ ++H + +H D+ N + D+ ++ D+G G T
Sbjct: 103 RMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETED 159
Query: 227 CMVGTMGYMAPE---SLQTETISDK----CDIYSFGVLLAVLV-MGKFPVDDFFGHTEEM 278
+ ++APE I+ + ++++ GV L L P + H +
Sbjct: 160 DKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQP----YSHLSDR 215
Query: 279 DMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDV 334
+++ N + + + + L Y E+ VL+ FC L P++R ++++V
Sbjct: 216 EVL----NHVIKDQQVKLFKPQ-LELPYSERWYEVLQ---FCWLS-PEKRATAEEV 262
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 5e-07
Identities = 78/316 (24%), Positives = 130/316 (41%), Gaps = 68/316 (21%)
Query: 49 IGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRS 108
IG G +G V + + G+ +AI+K I + SD I
Sbjct: 8 IGKGSYGVVC--SAIDTHTGEKVAIKK------------INDVFEHVSDATR-----ILR 48
Query: 109 EIITANQTRHRNILPLLAHMVRPNCH-----LLVYEFMKNGSLQDILYDVSQGRRELDWP 163
EI RH +I+ + M+ P+ +V+E M++ L+ V + +L P
Sbjct: 49 EIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESD-----LHQVIKANDDLT-P 102
Query: 164 ARHRI-ARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLM-PDGHA 221
H+ + L+Y+H + + HRD+KP N+L + D + +I DFG ++ D
Sbjct: 103 EHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 159
Query: 222 QITVKCMVGTMGYMAPE------SLQTETISDKCDIYSFGVLLAVLVMGK--FP------ 267
I V T Y APE S T I DI+S G + A ++ GK FP
Sbjct: 160 AIFWTDYVATRWYRAPELCGSFFSKYTPAI----DIWSIGCIFAEVLTGKPLFPGKNVVH 215
Query: 268 ----VDDFFGHTEEMDMVKWMRNV-----IFSENPNRAIN-SKLLGNGYEEQMLLVLKLA 317
+ D G T + + +RN + S + + S+ N + L+ +L
Sbjct: 216 QLDLITDLLG-TPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLL 274
Query: 318 CFCTLKDPDERPSSKD 333
F DP +RP++++
Sbjct: 275 AF----DPKDRPTAEE 286
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 6e-07
Identities = 62/281 (22%), Positives = 106/281 (37%), Gaps = 60/281 (21%)
Query: 43 FDSLKKIGSGGWGEV-FYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHW 101
F+SLK IG G +GEV + + G M +RK A++++++
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRK---------ADMLEKE---------- 43
Query: 102 KIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELD 161
++G IR+E + ++ + L+ EF+ G + +L + D
Sbjct: 44 QVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM-------KKD 96
Query: 162 WPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGH- 220
IA + + H+ IHRDIKP N+L+D ++SDFG + H
Sbjct: 97 TLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156
Query: 221 ------------AQITVKCM--------------------VGTMGYMAPESLQTETISDK 248
+ T + M VGT Y+APE +
Sbjct: 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKL 216
Query: 249 CDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIF 289
CD +S GV++ +++G P ++ W +IF
Sbjct: 217 CDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIF 257
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 6e-07
Identities = 63/229 (27%), Positives = 93/229 (40%), Gaps = 40/229 (17%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
+ LK IGSG G V A G +A++KL + + H K
Sbjct: 23 YQQLKPIGSGAQGIVC--AAFDTVLGINVAVKKLS---------------RPFQNQTHAK 65
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHL-------LVYEFMKNGSLQDILYDVSQ 155
A R E++ H+NI+ LL ++ P L LV E M Q I
Sbjct: 66 -RAYR-ELVLLKCVNHKNIISLL-NVFTPQKSLEEFQDVYLVMELMDANLCQVI------ 116
Query: 156 GRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKL 215
ELD + + G+++LH +IHRD+KP+N+++ D +I DFG L
Sbjct: 117 -HMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG---L 169
Query: 216 MPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMG 264
+ V T Y APE + + DI+S G ++ LV G
Sbjct: 170 ARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 6e-07
Identities = 46/160 (28%), Positives = 68/160 (42%), Gaps = 31/160 (19%)
Query: 175 GLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFG--HGKLMPDGHAQITVKCMVGTM 232
GL Y CH+ R++HRD+KP N+LI + E +++DFG K +P T V T+
Sbjct: 115 GLAY---CHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK----TYSNEVVTL 167
Query: 233 GYMAPESLQTET-ISDKCDIYSFGVLLAVLVMGK--FPVDDFFGHTEEMDMVKWMRNVIF 289
Y P+ L T S D++ G + + G+ FP G T+ D + + IF
Sbjct: 168 WYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFP-----GSTDVEDQL----HKIF 218
Query: 290 SENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERP 329
++LG EE V F P P
Sbjct: 219 ----------RVLGTPTEETWPGVSSNPEFKPYSFPFYPP 248
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 7e-07
Identities = 31/94 (32%), Positives = 53/94 (56%), Gaps = 17/94 (18%)
Query: 172 IASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLM---PD----GHAQIT 224
+A G+E+L + IHRD+ N+L+ ++ +I DFG + + PD G A++
Sbjct: 183 VARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 225 VKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
+K +MAPES+ + + + D++SFGVLL
Sbjct: 240 LK-------WMAPESIFDKVYTTQSDVWSFGVLL 266
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 7e-07
Identities = 38/137 (27%), Positives = 64/137 (46%), Gaps = 23/137 (16%)
Query: 135 LLVYEFMKNGSLQDILYDV------SQGRRELDWPARHRIARGIASGLEYLHMCHRPRLI 188
L+V E M +G L+ L + + GR ++A IA G+ YL+ + +
Sbjct: 85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFV 141
Query: 189 HRDIKPANVLIDDDMEARISDFGHGKLMPD-------GHAQITVKCMVGTMGYMAPESLQ 241
HRD+ N ++ D +I DFG + + + G + V+ +MAPESL+
Sbjct: 142 HRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-------WMAPESLK 194
Query: 242 TETISDKCDIYSFGVLL 258
+ D++SFGV+L
Sbjct: 195 DGVFTTSSDMWSFGVVL 211
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 8e-07
Identities = 33/104 (31%), Positives = 59/104 (56%), Gaps = 7/104 (6%)
Query: 172 IASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLM-PDGHAQITVKCMVG 230
I GL+Y+H + ++HRD+KP+N+L++ + + +I DFG ++ P+ + V
Sbjct: 115 ILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVA 171
Query: 231 TMGYMAPE-SLQTETISDKCDIYSFGVLLAVLVMGK--FPVDDF 271
T Y APE L ++ + DI+S G +LA ++ + FP D+
Sbjct: 172 TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY 215
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 8e-07
Identities = 39/142 (27%), Positives = 66/142 (46%), Gaps = 18/142 (12%)
Query: 126 AHMVR-----PNCHL-LVYEFMKNGSLQDILY---DVSQGRRELDWPARHRIARGIASGL 176
A++VR P L LV + GSL D + D +R L+W + IA G+
Sbjct: 69 AYIVRLLGICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ------IAKGM 122
Query: 177 EYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMA 236
YL R++HR++ N+L+ D +I+DFG L+ + + +MA
Sbjct: 123 YYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMA 179
Query: 237 PESLQTETISDKCDIYSFGVLL 258
ES+ + + D++S+GV +
Sbjct: 180 LESILFGRYTHQSDVWSYGVTV 201
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 8e-07
Identities = 26/80 (32%), Positives = 42/80 (52%)
Query: 183 HRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQT 242
H +++HRD+K AN+ + ++ DFG K D + GT Y+APE +
Sbjct: 186 HSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWER 245
Query: 243 ETISDKCDIYSFGVLLAVLV 262
+ S K D++S GV+L L+
Sbjct: 246 KRYSKKADMWSLGVILYELL 265
|
Length = 478 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 59/207 (28%), Positives = 86/207 (41%), Gaps = 16/207 (7%)
Query: 65 GSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPL 124
GS GK++ +RK + + K I S++ H +E Q I+PL
Sbjct: 4 GSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTH-----TLAERTVLAQVNCPFIVPL 58
Query: 125 LAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHR 184
P LV F+ G L + + + R AR A + LE LH +
Sbjct: 59 KFSFQSPEKLYLVLAFINGGEL---FHHLQREGRFDLSRARFYTAE-LLCALENLH---K 111
Query: 185 PRLIHRDIKPANVLIDDDMEARISDFGHGKL-MPDGHAQITVKCMVGTMGYMAPESLQTE 243
+I+RD+KP N+L+D + DFG KL M D GT Y+APE L
Sbjct: 112 FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD---KTNTFCGTPEYLAPELLLGH 168
Query: 244 TISDKCDIYSFGVLLAVLVMGKFPVDD 270
+ D ++ GVLL ++ G P D
Sbjct: 169 GYTKAVDWWTLGVLLYEMLTGLPPFYD 195
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 35/137 (25%), Positives = 64/137 (46%), Gaps = 23/137 (16%)
Query: 135 LLVYEFMKNGSLQDILYDV---SQGRRELDWPARHRI---ARGIASGLEYLHMCHRPRLI 188
L++ E M G L+ L + + P+ ++ A IA G+ YL+ + +
Sbjct: 85 LVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFV 141
Query: 189 HRDIKPANVLIDDDMEARISDFGHGKLMPD-------GHAQITVKCMVGTMGYMAPESLQ 241
HRD+ N ++ +D +I DFG + + + G + V+ +M+PESL+
Sbjct: 142 HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-------WMSPESLK 194
Query: 242 TETISDKCDIYSFGVLL 258
+ D++SFGV+L
Sbjct: 195 DGVFTTYSDVWSFGVVL 211
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 1e-06
Identities = 54/233 (23%), Positives = 97/233 (41%), Gaps = 42/233 (18%)
Query: 47 KKIGSGGWGEV----------FYKAEL----PGSNGKMIAIRKLIVDAPMSAAELIKQDI 92
+K+G G +GEV F + G+ ++A++ L DA +A
Sbjct: 11 EKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNAR------- 63
Query: 93 DEYSDLLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYD 152
+D L EI ++ + NI+ LLA + + ++ E+M+NG L L
Sbjct: 64 ---NDFL--------KEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSR 112
Query: 153 -------VSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEA 205
+ + +A IASG++YL + +HRD+ N L+ +
Sbjct: 113 HEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNCLVGKNYTI 169
Query: 206 RISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
+I+DFG + + G V + +M+ ES+ + D+++FGV L
Sbjct: 170 KIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTL 222
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 67/242 (27%), Positives = 101/242 (41%), Gaps = 52/242 (21%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
+ +LK IGSG G V + G+ +AI+KL P + ++ H K
Sbjct: 18 YQNLKPIGSGAQGIVCAAYDT--VTGQNVAIKKL--SRP-------------FQNVTHAK 60
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHL-------LVYEFMKNGSLQDILYDVSQ 155
A R E++ H+NI+ LL ++ P L LV E M Q I
Sbjct: 61 -RAYR-ELVLMKLVNHKNIIGLL-NVFTPQKSLEEFQDVYLVMELMDANLCQVI------ 111
Query: 156 GRRELDWPARHRIARGIASGLEYLHMC-----HRPRLIHRDIKPANVLIDDDMEARISDF 210
+ +LD R+ S L Y +C H +IHRD+KP+N+++ D +I DF
Sbjct: 112 -QMDLD---HERM-----SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF 162
Query: 211 GHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGK--FPV 268
G L + V T Y APE + + DI+S G ++ ++ G FP
Sbjct: 163 G---LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPG 219
Query: 269 DD 270
D
Sbjct: 220 TD 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 64/260 (24%), Positives = 103/260 (39%), Gaps = 58/260 (22%)
Query: 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLH 100
D F+SLK IG G +GEV + G + A+ K++ A M E + I D+L
Sbjct: 1 DDFESLKVIGRGAFGEV--RLVQKKDTGHIYAM-KILRKADMLEKEQVAH-IRAERDILV 56
Query: 101 WKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRREL 160
GA ++ + Q + RN+ L+ EF+ G + +L +
Sbjct: 57 EADGAWVVKMFYSFQDK-RNLY-------------LIMEFLPGGDMMTLLM-------KK 95
Query: 161 DWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGH 220
D + IA + + H+ IHRDIKP N+L+D ++SDFG + H
Sbjct: 96 DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155
Query: 221 -------------AQITVKCM--------------------VGTMGYMAPESLQTETISD 247
+ + + M VGT Y+APE +
Sbjct: 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNK 215
Query: 248 KCDIYSFGVLLAVLVMGKFP 267
CD +S GV++ +++G P
Sbjct: 216 LCDWWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 49/180 (27%), Positives = 69/180 (38%), Gaps = 39/180 (21%)
Query: 108 SEIITANQTRHRNILPL--------LAHMVRP--NCHLLVY-EFMKNGSLQDILYDVSQG 156
EI HR I+ L MV P C L Y + L+ +
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAIT----- 189
Query: 157 RRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHG-KL 215
I R + L YLH +IHRD+K N+ +D+ A + DFG KL
Sbjct: 190 -----------IQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKL 235
Query: 216 MPDGHAQITVKCM--VGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFG 273
D H T +C GT+ +PE L + K DI+S G++L + + FG
Sbjct: 236 --DAHPD-TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT---LFG 289
|
Length = 392 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 59/263 (22%), Positives = 103/263 (39%), Gaps = 65/263 (24%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
F+S+K IG G +GEV + G + A++K + +E+++++ +
Sbjct: 3 FESIKVIGRGAFGEVRLVQKK--DTGHIYAMKK------LRKSEMLEKE----------Q 44
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDIL--YDVSQGRREL 160
+ +R+E + + ++ L N L+ E++ G + +L D
Sbjct: 45 VAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEE-- 102
Query: 161 DWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFG--------H 212
R IA I + + H+ IHRDIKP N+L+D ++SDFG H
Sbjct: 103 ---TRFYIAETILA----IDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155
Query: 213 --------GKLMPDGHAQITVKCM--------------------VGTMGYMAPESLQTET 244
+P K M VGT Y+APE
Sbjct: 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG 215
Query: 245 ISDKCDIYSFGVLLAVLVMGKFP 267
+ +CD +S GV++ +++G P
Sbjct: 216 YNKECDWWSLGVIMYEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 54/246 (21%), Positives = 96/246 (39%), Gaps = 58/246 (23%)
Query: 42 CFDSLKKIGSGGWGEVFYKAELPGSNGK---------------MIAIRKLIVDAPMSAAE 86
+ ++K+G G +GEV + E G ++A++ L DA +A E
Sbjct: 6 PLNFVEKLGEGQFGEV-HLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARE 64
Query: 87 LIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSL 146
E+ ++ NI LL ++ E+M+NG L
Sbjct: 65 ------------------DFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL 106
Query: 147 QDILY-------DVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI 199
L ++ + L + +A IASG+ YL + +HRD+ N L+
Sbjct: 107 NQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNCLV 163
Query: 200 DDDMEARISDFGHGKLM-------PDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIY 252
+ +I+DFG + + G A + ++ +MA ES+ + K D++
Sbjct: 164 GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIR-------WMAWESVLLGKFTTKSDVW 216
Query: 253 SFGVLL 258
+FGV L
Sbjct: 217 AFGVTL 222
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 2e-06
Identities = 53/197 (26%), Positives = 83/197 (42%), Gaps = 30/197 (15%)
Query: 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAI 106
K+IG+G +G+V G + +++L V A + ++ Y L
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSL-------- 52
Query: 107 RSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRREL---DWP 163
+H N+L L +LLV EF G L+ L S + EL D
Sbjct: 53 ----------QHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLR--SCRKAELMTPDPT 100
Query: 164 ARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFG--HGKLMPDGHA 221
R+A IA GL LH+ H+ IH D+ N L+ D+ +I D+G H K D +
Sbjct: 101 TLQRMACEIALGL--LHL-HKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY- 156
Query: 222 QITVKCMVGTMGYMAPE 238
+T + + ++APE
Sbjct: 157 -VTPDQLWVPLRWIAPE 172
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 61/239 (25%), Positives = 103/239 (43%), Gaps = 34/239 (14%)
Query: 39 KEDCFDSLKKIGSGGWGEVFYKAELP-GSNGKM-IAIRKLIVDAPMSAAELIKQDIDEYS 96
KE +K +GSG +G V+ +P G N K+ +AI+ L + A K+ +DE
Sbjct: 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKAN---KEILDE-- 59
Query: 97 DLLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILY---DV 153
+ + + S + R + L V+ LV + M G L D + D
Sbjct: 60 ---AYVMAGVGSPYVC------RLLGICLTSTVQ-----LVTQLMPYGCLLDYVRENKDR 105
Query: 154 SQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHG 213
+ L+W + IA G+ YL RL+HRD+ NVL+ +I+DFG
Sbjct: 106 IGSQDLLNWCVQ------IAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLA 156
Query: 214 KLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL-AVLVMGKFPVDDF 271
+L+ + + +MA ES+ + + D++S+GV + ++ G P D
Sbjct: 157 RLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI 215
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 59/255 (23%), Positives = 107/255 (41%), Gaps = 37/255 (14%)
Query: 37 LKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYS 96
+K ED F+ ++ +G+G +G V A + +AI++ +++IKQ
Sbjct: 27 MKYED-FNFIRTLGTGSFGRVIL-ATYKNEDFPPVAIKRF------EKSKIIKQK----- 73
Query: 97 DLLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQG 156
++ + SE N H + L + LV EF+ G L
Sbjct: 74 -----QVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL------ 122
Query: 157 RRELDWP--ARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGK 214
RR +P A I EYL + +++RD+KP N+L+D D +++DFG K
Sbjct: 123 RRNKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAK 179
Query: 215 LMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGH 274
++ + GT Y+APE L D ++ G+ + +++G P F+ +
Sbjct: 180 VV-----DTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP---FYAN 231
Query: 275 TEEMDMVKWMRNVIF 289
+ K + +I+
Sbjct: 232 EPLLIYQKILEGIIY 246
|
Length = 340 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 30/98 (30%), Positives = 53/98 (54%), Gaps = 14/98 (14%)
Query: 175 GLEYLHMCHRPRLIHRDIKPANVLID-DDMEARISDFGHGKLM-PD----GHAQITVKCM 228
GL+Y+H + ++HRD+KPANV I+ +D+ +I DFG +++ P G+ +
Sbjct: 126 GLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV-- 180
Query: 229 VGTMGYMAPESLQTETISDKC-DIYSFGVLLAVLVMGK 265
T Y +P L + K D+++ G + A ++ GK
Sbjct: 181 --TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 61/234 (26%), Positives = 101/234 (43%), Gaps = 36/234 (15%)
Query: 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDL 98
K D ++ L+K+G G + V YK + NGK++A++ +I+ +E +
Sbjct: 3 KADSYEKLEKLGEGSYATV-YKGK-SKVNGKLVALK------------VIRLQEEEGTPF 48
Query: 99 LHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRR 158
AIR E +H NI+ L + LV+E++ Q + D G
Sbjct: 49 T-----AIR-EASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYM--DKHPGGL 100
Query: 159 ELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFG--HGKLM 216
+ + GL Y+H + ++HRD+KP N+LI D E +++DFG K +
Sbjct: 101 HPE--NVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSV 155
Query: 217 PDGHAQITVKCMVGTMGYMAPESLQTETISDKC-DIYSFGVLLAVLVMG--KFP 267
P T V T+ Y P+ L T C D++ G + ++ G FP
Sbjct: 156 PSH----TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFP 205
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (116), Expect = 2e-06
Identities = 61/250 (24%), Positives = 104/250 (41%), Gaps = 47/250 (18%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
++ +KKIG+G +GEVF ++ ++ E Y L +
Sbjct: 15 YEVIKKIGNGRFGEVF-----------LVKHKR--------TQEFFCWKAISYRGLKERE 55
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMV-RPNCHL-LVYEFMKNGSLQDILYDVSQGRREL 160
+ E+ + +H+NI+ + + + N L ++ EF G L + + ++
Sbjct: 56 KSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKI 115
Query: 161 DWPARHRIARGIASGLEYLHMC----HRPRLIHRDIKPANVLIDDDME------------ 204
+ A I R + L Y H + R++HRD+KP N+ + +
Sbjct: 116 EEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNL 175
Query: 205 -----ARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETIS--DKCDIYSFGVL 257
A+I DFG K + G + C VGT Y +PE L ET S DK D+++ G +
Sbjct: 176 NGRPIAKIGDFGLSKNI--GIESMAHSC-VGTPYYWSPELLLHETKSYDDKSDMWALGCI 232
Query: 258 LAVLVMGKFP 267
+ L GK P
Sbjct: 233 IYELCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 35/130 (26%), Positives = 52/130 (40%), Gaps = 45/130 (34%)
Query: 183 HRPRLIHRDIKPANVLIDDDMEARISDFG---------HGKLMPDG-------------- 219
H+ IHRDIKP N+LID D +++DFG + K G
Sbjct: 118 HKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLW 177
Query: 220 ----------------------HAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVL 257
H + +VGT Y+APE L + + CD +S GV+
Sbjct: 178 DDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237
Query: 258 LAVLVMGKFP 267
L +++G+ P
Sbjct: 238 LFEMLVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 32/104 (30%), Positives = 56/104 (53%), Gaps = 18/104 (17%)
Query: 172 IASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLM---PD----GHAQIT 224
+A G+E+L + IHRD+ N+L+ ++ +I DFG + + PD G A++
Sbjct: 188 VAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 225 VKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL-AVLVMGKFP 267
+K +MAPE++ + + D++SFGVLL + +G P
Sbjct: 245 LK-------WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 3e-06
Identities = 30/95 (31%), Positives = 45/95 (47%), Gaps = 18/95 (18%)
Query: 172 IASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLM--------PDGHAQI 223
++ G++YL +HRD+ NVL+ A+ISDFG K + H +
Sbjct: 104 VSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKW 160
Query: 224 TVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
VK + APE + S K D++SFGVL+
Sbjct: 161 PVK-------WYAPECMNYYKFSSKSDVWSFGVLM 188
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 3e-06
Identities = 33/101 (32%), Positives = 53/101 (52%), Gaps = 12/101 (11%)
Query: 172 IASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFG--HGKLMPDGHAQITVKCMV 229
I GL Y CHR +++HRD+KP N+LI++ E +++DFG K +P T V
Sbjct: 113 ILRGLAY---CHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK----TYSNEV 165
Query: 230 GTMGYMAPES-LQTETISDKCDIYSFGVLLAVLVMGK--FP 267
T+ Y P+ L + S + D++ G + + G+ FP
Sbjct: 166 VTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFP 206
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 3e-06
Identities = 34/104 (32%), Positives = 55/104 (52%), Gaps = 16/104 (15%)
Query: 175 GLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGY 234
GL+Y+H + ++HRD+KP+N+L++ + + +I DFG + + +T V T Y
Sbjct: 120 GLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTE--YVVTRWY 174
Query: 235 MAPESL-----QTETISDKCDIYSFGVLLAVLVMGK--FPVDDF 271
APE L T I D++S G + A L+ K FP D+
Sbjct: 175 RAPELLLNCSEYTTAI----DVWSVGCIFAELLGRKPLFPGKDY 214
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 7e-06
Identities = 32/98 (32%), Positives = 48/98 (48%), Gaps = 12/98 (12%)
Query: 175 GLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFG--HGKLMPDGHAQITVKCMVGTM 232
GL Y+H ++HRD+KP N+LI E +++DFG K +P T V T+
Sbjct: 115 GLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ----TYSSEVVTL 167
Query: 233 GYMAPESLQTET-ISDKCDIYSFGVLLAVLVMGK--FP 267
Y P+ L T S DI+ G + ++ G+ FP
Sbjct: 168 WYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFP 205
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 8e-06
Identities = 42/164 (25%), Positives = 78/164 (47%), Gaps = 30/164 (18%)
Query: 176 LEYLHMCHRPRLIHRDIKPANVLIDDDMEA-RISDFGHGKLMPDGHAQITVKCMVGTMGY 234
L Y+H + HRD+KP N+LID + ++ DFG K + G ++ C + Y
Sbjct: 183 LAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYIC---SRFY 236
Query: 235 MAPE-SLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENP 293
APE L + D++S G ++A +++G +P+ F G + +V+ +
Sbjct: 237 RAPELMLGATNYTTHIDLWSLGCIIAEMILG-YPI--FSGQSSVDQLVRII--------- 284
Query: 294 NRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337
++LG E+Q+ + + +K PD +P KD++ +
Sbjct: 285 ------QVLGTPTEDQLKEM--NPNYADIKFPDVKP--KDLKKV 318
|
Length = 440 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 1e-05
Identities = 36/158 (22%), Positives = 69/158 (43%), Gaps = 10/158 (6%)
Query: 105 AIRSEIITANQTRHRNILPLLAHMV---RPNCHLLVYEFMKNGSLQDILYDVSQGRRELD 161
++R E++ + H+ P + M+ +LV E G L L S + E+
Sbjct: 37 SVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASGGPLNKFL---SGKKDEIT 93
Query: 162 WPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHA 221
+ ++ G++YL +HRD+ NVL+ + A+ISDFG K + +
Sbjct: 94 VSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDS 150
Query: 222 QITVKCMVG-TMGYMAPESLQTETISDKCDIYSFGVLL 258
+ + + APE + S + D++S+G+ +
Sbjct: 151 YYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITM 188
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 47/175 (26%), Positives = 82/175 (46%), Gaps = 29/175 (16%)
Query: 43 FDSLKKIGSGGWGEVF--YKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLH 100
F +K I G +G+V+ K +N K+ A+ K++ A M ++ Q E L
Sbjct: 6 FVIVKPISRGAFGKVYLGRK----KNNSKLYAV-KVVKKADMINKNMVHQVQAERDAL-- 58
Query: 101 WKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRREL 160
A+ ++ I+ L + N LV E++ G ++ +L+ E+
Sbjct: 59 ----AL---------SKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEM 105
Query: 161 DWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKL 215
A I+ +A L+YLH R +IHRD+KP N+LI ++ +++DFG K+
Sbjct: 106 ---AVKYISE-VALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 39/141 (27%), Positives = 61/141 (43%), Gaps = 7/141 (4%)
Query: 118 HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLE 177
H +L LL VR L K S D+ + R L +AR + S ++
Sbjct: 219 HPAVLALLD--VRVVGGLTCLVLPKYRS--DLYTYLGARLRPLGLAQVTAVARQLLSAID 274
Query: 178 YLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAP 237
Y+H +IHRDIK NVL++ + + DFG + + GT+ AP
Sbjct: 275 YIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAP 331
Query: 238 ESLQTETISDKCDIYSFGVLL 258
E L + + DI+S G+++
Sbjct: 332 EVLAGDPYTPSVDIWSAGLVI 352
|
Length = 461 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 29/91 (31%), Positives = 42/91 (46%), Gaps = 4/91 (4%)
Query: 168 IARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKC 227
I R + ++YLH R+IHRDIK N+ I+ + + DFG P
Sbjct: 187 IERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYG 242
Query: 228 MVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
GT+ APE L + DI+S G++L
Sbjct: 243 WAGTIATNAPELLARDPYGPAVDIWSAGIVL 273
|
Length = 391 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 31/102 (30%), Positives = 53/102 (51%), Gaps = 6/102 (5%)
Query: 172 IASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGK-LMPDGHAQITVKCMVG 230
+A+G+E+L +HRD+ NVLI + +I DFG + +M D + I+
Sbjct: 248 VANGMEFLA---SKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSN-YISKGSTFL 303
Query: 231 TMGYMAPESLQTETISDKCDIYSFGVLL-AVLVMGKFPVDDF 271
+ +MAPES+ + D++SFG+LL + +G P +
Sbjct: 304 PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPEL 345
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 3e-05
Identities = 38/159 (23%), Positives = 72/159 (45%), Gaps = 18/159 (11%)
Query: 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDIL--YDVSQGRRE-------------LDWPA 164
NI+ LL V + ++ E+M+NG L L + + + + +
Sbjct: 80 NIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSS 139
Query: 165 RHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQIT 224
+A IASG++YL + +HRD+ N L+ +++ +I+DFG + + G
Sbjct: 140 LLHVALQIASGMKYLSSLN---FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRI 196
Query: 225 VKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM 263
V + +MA E + + D+++FGV L ++M
Sbjct: 197 QGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 3e-05
Identities = 39/166 (23%), Positives = 74/166 (44%), Gaps = 28/166 (16%)
Query: 172 IASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGT 231
IA L+YLH H ++HRD+K NV + ++ D G +++ + + ++GT
Sbjct: 111 IAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGT 165
Query: 232 MGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSE 291
YM+PE + + K D+++ G + + K + K M ++++
Sbjct: 166 PYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFN-----------AKDMNSLVY-- 212
Query: 292 NPNRAINSKL--LGNGYEEQML-LVLKLACFCTLKDPDERPSSKDV 334
R I KL + Y ++ L+ + K P++RPS K +
Sbjct: 213 ---RIIEGKLPPMPKDYSPELGELIATMLS----KRPEKRPSVKSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 4e-05
Identities = 43/169 (25%), Positives = 74/169 (43%), Gaps = 25/169 (14%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
F ++K IG G +GEV + GK+ A++ L+ +E+ K+D L H
Sbjct: 3 FHTVKVIGKGAFGEVRLVQKK--DTGKIYAMKTLL------KSEMFKKD-----QLAH-- 47
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDW 162
+++E ++ ++ L L+ EF+ G L +L ++
Sbjct: 48 ---VKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDV-- 102
Query: 163 PARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFG 211
R +A + + + H+ IHRDIKP N+LID ++SDFG
Sbjct: 103 -TRFYMAECVLA----IEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFG 146
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 5e-05
Identities = 55/232 (23%), Positives = 92/232 (39%), Gaps = 37/232 (15%)
Query: 47 KKIGSGGWGEVFYKAELPGSNGKMI--AIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIG 104
+ IG G +G+V Y+ + I A++ S E Q
Sbjct: 12 RCIGEGQFGDV-YQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQ-------------- 56
Query: 105 AIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPA 164
E Q H +I+ L+ ++ N +V E G L+ L + LD +
Sbjct: 57 ----EAYIMRQFDHPHIVKLIG-VITENPVWIVMELAPLGELRSYL---QVNKYSLDLAS 108
Query: 165 RHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQIT 224
+ +++ L YL R +HRDI NVL+ ++ DFG + + D +
Sbjct: 109 LILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED---ESY 162
Query: 225 VKCMVGTM--GYMAPESLQTETISDKCDIYSFGVLL-AVLVMGKFPVDDFFG 273
K G + +MAPES+ + D++ FGV + +L++G P F G
Sbjct: 163 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKP---FQG 211
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 8e-05
Identities = 62/275 (22%), Positives = 107/275 (38%), Gaps = 49/275 (17%)
Query: 102 KIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYD-VSQGRREL 160
+ A+++E++ ++ RH NI+ + ++ FM GS +L +G E
Sbjct: 42 HLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSE- 100
Query: 161 DWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGH-GKLMPDG 219
I G GL YLH + IHR+IK +++LI D +S H L+ +G
Sbjct: 101 --ALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNG 155
Query: 220 HAQITV----KCMVGTMGYMAPESLQTET--ISDKCDIYSFGVLLAVLVMGKFPVDDFFG 273
V + + +++PE L+ + + K DIYS G+ L G+ P D
Sbjct: 156 QKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM-- 213
Query: 274 HTEEMDMVK--------WMRNVIFSENPNRAINSKL-LGNGYEEQMLL------------ 312
+M + K F +R NS+ + +G E ++
Sbjct: 214 LRTQMLLQKLKGPPYSPLDIT-TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERL 272
Query: 313 -----------VLKLACFCTLKDPDERPSSKDVRS 336
L C +DP++RPS+ + S
Sbjct: 273 RTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 36/112 (32%), Positives = 55/112 (49%), Gaps = 15/112 (13%)
Query: 131 PNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHR 190
P C + EFM G + I ++ Q +R+++ + R + +GL LH R ++HR
Sbjct: 284 PGC---LEEFMMAG--KKIPDNMPQDKRDIN--VIKGVMRQVLTGLRKLH---RIGIVHR 333
Query: 191 DIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMG--YMAPESL 240
DIKP N+L+ D + +I DFG M G I + G + Y PE L
Sbjct: 334 DIKPENLLVTVDGQVKIIDFGAAVDMCTG---INFNPLYGMLDPRYSPPEEL 382
|
Length = 507 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 4e-04
Identities = 36/146 (24%), Positives = 61/146 (41%), Gaps = 12/146 (8%)
Query: 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYL 179
N++ L ++V + LV + + G L + E + R A + L
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEEC-------VKRWAAEMVVAL 98
Query: 180 HMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPES 239
HR ++ RD+ P N+L+DD +++ F + D V+ M Y APE
Sbjct: 99 DALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----YCAPEV 153
Query: 240 LQTETISDKCDIYSFGVLLAVLVMGK 265
++ CD +S G +L L+ GK
Sbjct: 154 GGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 5e-04
Identities = 24/87 (27%), Positives = 43/87 (49%), Gaps = 3/87 (3%)
Query: 172 IASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGT 231
+A G+E+L +HRD+ NVL+ +I DFG + + ++
Sbjct: 246 VARGMEFLA---SKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302
Query: 232 MGYMAPESLQTETISDKCDIYSFGVLL 258
+ +MAPES+ + D++S+G+LL
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILL 329
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 5e-04
Identities = 27/94 (28%), Positives = 48/94 (51%), Gaps = 17/94 (18%)
Query: 172 IASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPD-------GHAQIT 224
+A G+ +L IHRD+ N+L+ +I DFG + + + G+A++
Sbjct: 223 VAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279
Query: 225 VKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
VK +MAPES+ + + D++S+G+LL
Sbjct: 280 VK-------WMAPESIFNCVYTFESDVWSYGILL 306
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 7e-04
Identities = 48/230 (20%), Positives = 92/230 (40%), Gaps = 49/230 (21%)
Query: 120 NILPLLAH---MVRPNCHL-LVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASG 175
NIL + +V L L+ E+ G L+++L ++L + + +A G
Sbjct: 79 NILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDK----EKDLSFKTKLDMAIDCCKG 134
Query: 176 LEYLHM-CHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGY 234
L L+ ++P ++++ + L+ ++ + +I G K++ + V M Y
Sbjct: 135 LYNLYKYTNKP---YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFK-----NVNFMVY 186
Query: 235 MAPESL----QTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFS 290
+ + L TI D DIYS GV+L + GK P E +
Sbjct: 187 FSYKMLNDIFSEYTIKD--DIYSLGVVLWEIFTGKIPF-------ENLTT---------- 227
Query: 291 ENPNRAINSKLLGNGYEEQMLL--VLKLACF---CTLKDPDERPSSKDVR 335
+ I ++ ++ L L++ C CT D +RP+ K++
Sbjct: 228 ----KEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEIL 273
|
Length = 283 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.002
Identities = 31/107 (28%), Positives = 51/107 (47%), Gaps = 11/107 (10%)
Query: 167 RIARGIASGLEY-----LHMCHRPRLIHRDIKPANVLIDDDMEAR----ISDFGHGKLMP 217
++ RG+ L Y +H H ++HRD+KPAN+L+ + R I+D G +L
Sbjct: 104 QLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163
Query: 218 DGHAQIT-VKCMVGTMGYMAPE-SLQTETISDKCDIYSFGVLLAVLV 262
+ + +V T Y APE L + DI++ G + A L+
Sbjct: 164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 38.0 bits (88), Expect = 0.004
Identities = 44/162 (27%), Positives = 79/162 (48%), Gaps = 15/162 (9%)
Query: 115 QTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIAS 174
Q H++I+ L VR +++V EF++ G L ++ S L P + ++A+ +AS
Sbjct: 60 QVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSD---VLTTPWKFKVAKQLAS 116
Query: 175 GLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITV----KCMVG 230
L YL L+H ++ N+L+ E + G + D ITV +C V
Sbjct: 117 ALSYL---EDKDLVHGNVCTKNILL--AREGIDGECGPFIKLSDPGIPITVLSRQEC-VE 170
Query: 231 TMGYMAPESLQ-TETISDKCDIYSFGVLL-AVLVMGKFPVDD 270
+ ++APE ++ ++ +S D +SFG L + G+ P+ D
Sbjct: 171 RIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKD 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 337 | |||
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.98 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.98 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.91 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.9 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.9 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.9 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.89 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.87 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.86 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.86 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.85 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.84 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.84 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.82 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.82 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.8 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.8 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.78 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.77 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.75 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.75 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.75 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.71 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.69 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.65 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.64 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.63 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.63 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.52 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.48 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.45 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.44 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.42 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.4 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.4 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.37 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.35 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.27 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.26 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.15 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.13 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.1 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.1 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.02 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.94 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.92 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.87 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.8 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.74 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.6 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.55 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.32 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.27 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.27 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.26 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.25 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.15 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.09 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.07 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.05 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.03 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.01 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.87 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.83 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.61 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.58 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.55 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.51 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.49 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.44 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.22 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.17 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.07 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.06 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.97 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.92 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.88 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.57 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.51 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.49 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.27 | |
| PLN02236 | 344 | choline kinase | 96.0 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.9 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.73 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.71 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.16 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.12 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.23 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.15 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 93.68 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 93.44 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 93.38 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 92.11 |
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-51 Score=367.08 Aligned_cols=253 Identities=25% Similarity=0.414 Sum_probs=215.2
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
..+|...+.||+|||+.+|.+.+.. +|..||+|++.+....+.... +.+.+|+++.++|+||
T Consensus 17 ~~~Y~~g~~LGkGgFA~cYe~~~~~--tge~~A~KvVpk~~l~k~~~r----------------eKv~~EIeIHr~L~Hp 78 (592)
T KOG0575|consen 17 SKRYKRGRFLGKGGFARCYEARDLD--TGEVVAVKVVPKKLLKKPKQR----------------EKVLNEIEIHRSLKHP 78 (592)
T ss_pred cceeeeeeeeccCcceEEEEEEEcC--CCcEEEEEEeehHHhcCcchH----------------HHHHHHHHHHHhcCCC
Confidence 3789999999999999999999976 999999999987655544332 6788999999999999
Q ss_pred CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceee
Q 040898 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI 199 (337)
Q Consensus 120 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~ 199 (337)
|||+++++|++.+++|+|+|+|..++|..++ ..+.++++.++..+++||+.|+.|| |+++|+|||||..|+|+
T Consensus 79 nIV~f~~~FEDs~nVYivLELC~~~sL~el~----Krrk~ltEpEary~l~QIv~GlkYL---H~~~IiHRDLKLGNlfL 151 (592)
T KOG0575|consen 79 NIVQFYHFFEDSNNVYIVLELCHRGSLMELL----KRRKPLTEPEARYFLRQIVEGLKYL---HSLGIIHRDLKLGNLFL 151 (592)
T ss_pred cEEeeeeEeecCCceEEEEEecCCccHHHHH----HhcCCCCcHHHHHHHHHHHHHHHHH---HhcCceecccchhheee
Confidence 9999999999999999999999999999998 4567799999999999999999999 78899999999999999
Q ss_pred cCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhh
Q 040898 200 DDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMD 279 (337)
Q Consensus 200 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~ 279 (337)
+++-+|||+|||+|..+..... ...+.+|||.|.|||++.....+..+||||+||++|-||.|++||+.. +
T Consensus 152 ~~~~~VKIgDFGLAt~le~~~E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk-------~ 222 (592)
T KOG0575|consen 152 NENMNVKIGDFGLATQLEYDGE--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK-------T 222 (592)
T ss_pred cCcCcEEecccceeeeecCccc--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc-------h
Confidence 9999999999999998864422 223578999999999999989999999999999999999999999642 2
Q ss_pred HHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 280 MVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
+.+..+.+.......+ ...+....+||.++|+.||.+|||+++||.|
T Consensus 223 vkety~~Ik~~~Y~~P-----------~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 223 VKETYNKIKLNEYSMP-----------SHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred HHHHHHHHHhcCcccc-----------cccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 3333333322222211 1222337899999999999999999999987
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-51 Score=346.15 Aligned_cols=256 Identities=29% Similarity=0.489 Sum_probs=216.0
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
.+.+.++.||.|..|+||++.+.. ++..+|+|.+..+...... ..+.+|+++++..+||+
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~--t~~i~AlK~I~~~~~~~~~------------------~Qi~rEl~il~~~~spy 138 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKP--TGKIYALKVILLNIDPALQ------------------KQILRELEILRSCQSPY 138 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcC--CCeEEEEEeecccCCHHHH------------------HHHHHHHHHHhhCCCCC
Confidence 478899999999999999999987 9999999999655443222 57889999999999999
Q ss_pred cccceeEEEcCC-eeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceee
Q 040898 121 ILPLLAHMVRPN-CHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI 199 (337)
Q Consensus 121 iv~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~ 199 (337)
||.+|+.|..+. ...++|||+++|||++++.. .+.+++....+++.++++||.||| +.++|+||||||+|+|+
T Consensus 139 IV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh--~~~~IIHRDIKPsNlLv 212 (364)
T KOG0581|consen 139 IVGFYGAFYSNGEEISICMEYMDGGSLDDILKR----VGRIPEPVLGKIARAVLRGLSYLH--EERKIIHRDIKPSNLLV 212 (364)
T ss_pred eeeEeEEEEeCCceEEeehhhcCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHh--hccCeeeccCCHHHeee
Confidence 999999999998 59999999999999999954 366999999999999999999995 35899999999999999
Q ss_pred cCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhh
Q 040898 200 DDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMD 279 (337)
Q Consensus 200 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~ 279 (337)
+..|.|||+|||.+..+... ..+...||..|||||.+.+..|+.++||||||+.+.|+.+|+.||... ......
T Consensus 213 NskGeVKicDFGVS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~--~~~~~~ 286 (364)
T KOG0581|consen 213 NSKGEVKICDFGVSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP--NPPYLD 286 (364)
T ss_pred ccCCCEEeccccccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc--CCCCCC
Confidence 99999999999999877655 235578999999999999999999999999999999999999998654 122233
Q ss_pred HHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 280 MVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
..+.+..+...+.+..... ..+.++.+|++.||++||++|||+.++++|
T Consensus 287 ~~~Ll~~Iv~~ppP~lP~~---------~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 287 IFELLCAIVDEPPPRLPEG---------EFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred HHHHHHHHhcCCCCCCCcc---------cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 4444444444333321110 345569999999999999999999999988
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-51 Score=352.27 Aligned_cols=262 Identities=26% Similarity=0.424 Sum_probs=213.3
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
.++.|.+.+.||+|+||.|=++...+ +|+.||||++........... . .....+.+|+++|++|+|
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~--tgk~vAiKIi~krk~~~~s~~----~--------~~~~~v~~EieILkkL~H 235 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKK--TGKQVAIKIINKRKSTGCSRA----I--------AKTRDVQNEIEILKKLSH 235 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcc--cCcEEEeeeeehhhccccccc----c--------cchhhhHHHHHHHHhcCC
Confidence 45569999999999999998888877 999999999977644322110 0 001356789999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
||||+++++|+.....|+||||++||.|.+++ -.+..+.+.....+++|++.|+.|| |++||+||||||+|||
T Consensus 236 P~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~v----v~nk~l~ed~~K~~f~Qll~avkYL---H~~GI~HRDiKPeNIL 308 (475)
T KOG0615|consen 236 PNIVRIKDFFEVPDSSYMVLEYVEGGELFDKV----VANKYLREDLGKLLFKQLLTAVKYL---HSQGIIHRDIKPENIL 308 (475)
T ss_pred CCEEEEeeeeecCCceEEEEEEecCccHHHHH----HhccccccchhHHHHHHHHHHHHHH---HHcCcccccCCcceEE
Confidence 99999999999999999999999999999998 4566788888999999999999999 8889999999999999
Q ss_pred ecCC---CCeEEecccCccccCCCCceeeeecccCCCCccCccccccCC---CCCcccchhhhHHHHHHHhCCCCCCCCC
Q 040898 199 IDDD---MEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTET---ISDKCDIYSFGVLLAVLVMGKFPVDDFF 272 (337)
Q Consensus 199 ~~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~---~~~~~DiwslG~i~~~ll~g~~pf~~~~ 272 (337)
++.+ ..+||+|||++...+... ...+.+|||.|.|||++.+.. ++.++|+|||||++|-+++|.+||.+..
T Consensus 309 l~~~~e~~llKItDFGlAK~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~ 385 (475)
T KOG0615|consen 309 LSNDAEDCLLKITDFGLAKVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEY 385 (475)
T ss_pred eccCCcceEEEecccchhhccccce---ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCccccc
Confidence 9876 789999999999876433 345678999999999997654 3457899999999999999999997654
Q ss_pred CCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 273 GHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
+.. .+.+.+........ +..+....++..+||.+||..||++|||+.|+|+|
T Consensus 386 ~~~---sl~eQI~~G~y~f~----------p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 386 TDP---SLKEQILKGRYAFG----------PLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred CCc---cHHHHHhcCccccc----------ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 432 23333333222211 12344566779999999999999999999999987
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-51 Score=336.79 Aligned_cols=259 Identities=25% Similarity=0.371 Sum_probs=211.9
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
.-.+|+++++||+|+||+||++.+.. +|..+|.|.+.-...... ..+....|+.+|++|+|
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~--~g~l~a~K~i~f~~md~k-----------------~rq~~v~Ei~lLkQL~H 77 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLL--DGKLVALKKIQFGMMDAK-----------------ARQDCVKEISLLKQLNH 77 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeecc--CcchhhhhhcchhhccHH-----------------HHHHHHHHHHHHHhcCC
Confidence 55679999999999999999999988 999999999863332211 12678889999999999
Q ss_pred CCccccee-EEEcCCe-eEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCC-CeEecCCCCC
Q 040898 119 RNILPLLA-HMVRPNC-HLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRP-RLIHRDIKPA 195 (337)
Q Consensus 119 pniv~~~~-~~~~~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~-gi~h~di~~~ 195 (337)
||||++++ .+..++. +++|||+|.+|+|..+++....++..+++..+|+++.|++.||+++|+.... -++||||||.
T Consensus 78 pNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPa 157 (375)
T KOG0591|consen 78 PNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPA 157 (375)
T ss_pred chHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcch
Confidence 99999998 4555555 8999999999999999998888999999999999999999999999652222 3899999999
Q ss_pred ceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCc
Q 040898 196 NVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHT 275 (337)
Q Consensus 196 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~ 275 (337)
|||++++|.+||+|||+++.+..... .....+|||.||+||++.+.+|+.++||||+||++|||..-++||.+.
T Consensus 158 NIFl~~~gvvKLGDfGL~r~l~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~---- 231 (375)
T KOG0591|consen 158 NIFLTANGVVKLGDFGLGRFLSSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD---- 231 (375)
T ss_pred heEEcCCCceeeccchhHhHhcchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc----
Confidence 99999999999999999998765432 223578999999999999999999999999999999999999998653
Q ss_pred hhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhh
Q 040898 276 EEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDV 334 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el 334 (337)
...++++.+.+...++.+ ....++.+..++..|+.+||+.||+.-.+
T Consensus 232 n~~~L~~KI~qgd~~~~p------------~~~YS~~l~~li~~ci~vd~~~RP~t~~~ 278 (375)
T KOG0591|consen 232 NLLSLCKKIEQGDYPPLP------------DEHYSTDLRELINMCIAVDPEQRPDTVPY 278 (375)
T ss_pred cHHHHHHHHHcCCCCCCc------------HHHhhhHHHHHHHHHccCCcccCCCcchH
Confidence 333444444333221111 14456679999999999999999985433
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=334.16 Aligned_cols=205 Identities=28% Similarity=0.487 Sum_probs=182.2
Q ss_pred ccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc
Q 040898 37 LKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT 116 (337)
Q Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 116 (337)
.+..++|...++||+|+||.||++++.. ++..||||.+..+...+.. .+.+..|+.+|+.+
T Consensus 6 ~~~~~~y~~~~~iG~GsfavVykg~h~~--~~~~VAIK~i~~~~l~~k~-----------------~e~L~~Ei~iLkel 66 (429)
T KOG0595|consen 6 MRVVGDYELSREIGSGSFAVVYKGRHKK--SGTEVAIKCIAKKKLNKKL-----------------VELLLSEIKILKEL 66 (429)
T ss_pred ccccccceehhhccCcceEEEEEeEecc--CCceEEeeeehhhccCHHH-----------------HHHHHHHHHHHHhc
Confidence 3466789999999999999999999987 8899999999776432211 15678899999999
Q ss_pred CCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 040898 117 RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPAN 196 (337)
Q Consensus 117 ~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~n 196 (337)
+|||||.+++...+++.+|+|||||+||+|.++++ ..+.+++..+..++.||+.|+++| |+++|+||||||+|
T Consensus 67 ~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~----~~~~l~e~t~r~Fm~QLA~alq~L---~~~~IiHRDLKPQN 139 (429)
T KOG0595|consen 67 KHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIR----RRGRLPEATARHFMQQLASALQFL---HENNIIHRDLKPQN 139 (429)
T ss_pred CCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeccCCcce
Confidence 99999999999999999999999999999999994 445799999999999999999999 78899999999999
Q ss_pred eeecCC------CCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCC
Q 040898 197 VLIDDD------MEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDD 270 (337)
Q Consensus 197 il~~~~------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~ 270 (337)
||++.+ ..+||+|||+++.+...... ...+|+|-|||||++....|+.++|+||+|+++|++++|+.||+.
T Consensus 140 iLLs~~~~~~~~~~LKIADFGfAR~L~~~~~a---~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 140 ILLSTTARNDTSPVLKIADFGFARFLQPGSMA---ETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred EEeccCCCCCCCceEEecccchhhhCCchhHH---HHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 999865 46899999999998755432 346899999999999999999999999999999999999999864
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-49 Score=323.12 Aligned_cols=269 Identities=25% Similarity=0.364 Sum_probs=212.1
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
+.|+.+.++|+|+||.||++++.. +|+-||||++....+...-. .-..||+++|++++|||
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~--TgqIVAIKkF~Esedd~~Vk-----------------KIAlREIrmLKqLkH~N 62 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKD--TGQIVAIKKFVESEDDPVVK-----------------KIALREIRMLKQLKHEN 62 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCC--cccEEEEEeeccCCccHHHH-----------------HHHHHHHHHHHhcccch
Confidence 569999999999999999999977 99999999997665433211 46789999999999999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
+|.++++|.....+++|+|||+..-|.+ ++ ......+.+.+.+++.|++.|+.|+ |+++++||||||+||+++
T Consensus 63 LVnLiEVFrrkrklhLVFE~~dhTvL~e-Le---~~p~G~~~~~vk~~l~Q~l~ai~~c---Hk~n~IHRDIKPENILit 135 (396)
T KOG0593|consen 63 LVNLIEVFRRKRKLHLVFEYCDHTVLHE-LE---RYPNGVPSELVKKYLYQLLKAIHFC---HKNNCIHRDIKPENILIT 135 (396)
T ss_pred HHHHHHHHHhcceeEEEeeecchHHHHH-HH---hccCCCCHHHHHHHHHHHHHHhhhh---hhcCeecccCChhheEEe
Confidence 9999999999999999999998844443 43 4556688999999999999999999 888999999999999999
Q ss_pred CCCCeEEecccCccccCCCCceeeeecccCCCCccCcccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhh
Q 040898 201 DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQT-ETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMD 279 (337)
Q Consensus 201 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~ 279 (337)
.+|.+||+|||+|+.+..... ..+.++.|..|.|||++.| -+|+..+||||+||++.||++|.+-|.+.+.-+....
T Consensus 136 ~~gvvKLCDFGFAR~L~~pgd--~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~ 213 (396)
T KOG0593|consen 136 QNGVVKLCDFGFARTLSAPGD--NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYL 213 (396)
T ss_pred cCCcEEeccchhhHhhcCCcc--hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHH
Confidence 999999999999998764222 2346788999999999988 5799999999999999999999999865433222212
Q ss_pred HHHHHHhhh------ccCCc-------chhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 280 MVKWMRNVI------FSENP-------NRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 280 ~~~~~~~~~------~~~~~-------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
+........ +...+ ...-.+......++.....+.+|+..||+.||.+|+|.+++|.|
T Consensus 214 I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 214 IRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred HHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 222111110 00000 11111222233456666789999999999999999999999987
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-48 Score=326.41 Aligned_cols=256 Identities=25% Similarity=0.326 Sum_probs=209.3
Q ss_pred cccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC
Q 040898 38 KKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR 117 (337)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 117 (337)
...++|++++.||+|+||.||.+.... +++.||+|++.+....... +.+....|..+|..++
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~d--t~kiYAmKvl~K~~iv~~~----------------e~~~~~~Er~IL~~v~ 83 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKD--TGKIYAMKVLKKKKIVEKK----------------EVRHTKAERNILSKIK 83 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcc--cCceeehhhhhhhHhhhhh----------------hHHHHHHHHHHHHhCC
Confidence 367889999999999999999998875 9999999999766543321 2267889999999999
Q ss_pred CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCce
Q 040898 118 HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANV 197 (337)
Q Consensus 118 hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ni 197 (337)
||+||+++-.|++...+|+|+||+.||.|...| ++.+.+++..+.-++..|+.||.|| |++||+|||+||+||
T Consensus 84 hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL----~~eg~F~E~~arfYlaEi~lAL~~L---H~~gIiyRDlKPENI 156 (357)
T KOG0598|consen 84 HPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHL----QREGRFSEDRARFYLAEIVLALGYL---HSKGIIYRDLKPENI 156 (357)
T ss_pred CCcEeeeEEecccCCeEEEEEeccCCccHHHHH----HhcCCcchhHHHHHHHHHHHHHHHH---HhCCeeeccCCHHHe
Confidence 999999999999999999999999999999999 5567799999999999999999999 888999999999999
Q ss_pred eecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchh
Q 040898 198 LIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEE 277 (337)
Q Consensus 198 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~ 277 (337)
|++.+|+++|+|||++........ .....+||+.|+|||++.+..|+.++|.||||+++|+|++|.+||.....
T Consensus 157 LLd~~GHi~LtDFgL~k~~~~~~~--~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~---- 230 (357)
T KOG0598|consen 157 LLDEQGHIKLTDFGLCKEDLKDGD--ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV---- 230 (357)
T ss_pred eecCCCcEEEeccccchhcccCCC--ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH----
Confidence 999999999999999985433222 22347899999999999999999999999999999999999999854321
Q ss_pred hhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCC----ChhhhhcC
Q 040898 278 MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERP----SSKDVRSM 337 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp----s~~ell~~ 337 (337)
.+..+.+.....+ ..+.......++++.++|+.||++|. ++.+|-+|
T Consensus 231 ---~~~~~~I~~~k~~----------~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~H 281 (357)
T KOG0598|consen 231 ---KKMYDKILKGKLP----------LPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRH 281 (357)
T ss_pred ---HHHHHHHhcCcCC----------CCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcC
Confidence 2222222222201 01111333488999999999999996 45555544
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-47 Score=335.49 Aligned_cols=258 Identities=25% Similarity=0.371 Sum_probs=213.8
Q ss_pred ccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc
Q 040898 37 LKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT 116 (337)
Q Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 116 (337)
.+...+|.+++.||.|+|++|+++.++. +++.||||++.+....+... +.-+.+|-..|.+|
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~--t~keYAiKVl~K~~Iike~K----------------vkYV~~Ek~~l~~L 130 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKA--TGKEYAIKVLDKRYIIKEKK----------------VKYVTREKEALTQL 130 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecC--CCceeeHhhhhHHHHHhhcc----------------cchhhHHHHHHHHh
Confidence 5577889999999999999999999987 99999999997765544322 25677888899999
Q ss_pred -CCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCC
Q 040898 117 -RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPA 195 (337)
Q Consensus 117 -~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ 195 (337)
.||.|++++..|.++..+|+|+||+++|+|-++|. +-+.+++.....++.+|+.||.|| |+.||+||||||+
T Consensus 131 ~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~----K~Gsfde~caR~YAAeIldAleyl---H~~GIIHRDlKPE 203 (604)
T KOG0592|consen 131 SGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIK----KYGSFDETCARFYAAEILDALEYL---HSNGIIHRDLKPE 203 (604)
T ss_pred hCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHH----HhCcchHHHHHHHHHHHHHHHHHH---HhcCceeccCChh
Confidence 89999999999999999999999999999999994 446799999999999999999999 7889999999999
Q ss_pred ceeecCCCCeEEecccCccccCCCCce---------ee--eecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhC
Q 040898 196 NVLIDDDMEARISDFGHGKLMPDGHAQ---------IT--VKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMG 264 (337)
Q Consensus 196 nil~~~~~~~~l~dfg~~~~~~~~~~~---------~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g 264 (337)
|||++++++++|+|||.+..+...... .. ....+||..|.+||++.....+..+|+|+|||++|+|+.|
T Consensus 204 NILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG 283 (604)
T KOG0592|consen 204 NILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAG 283 (604)
T ss_pred heeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcC
Confidence 999999999999999999887543222 11 1447899999999999999999999999999999999999
Q ss_pred CCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 265 KFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 265 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.+||..... ...+.+ +...-..- ++..++...+|+.++|..||++|+|+.+|.+|
T Consensus 284 ~PPFra~Ne---yliFqk-I~~l~y~f--------------p~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 284 QPPFRAANE---YLIFQK-IQALDYEF--------------PEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred CCCCccccH---HHHHHH-HHHhcccC--------------CCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 999965322 222222 22111111 11122448899999999999999999999877
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-48 Score=333.81 Aligned_cols=269 Identities=22% Similarity=0.296 Sum_probs=216.1
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC-
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR- 117 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~- 117 (337)
-.++|..+++||.|+||+||++..+. +|..||||+++.+.-... + -.-.||++.|++++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~--~~~~VAIK~MK~Kf~s~e-e-----------------~~nLREvksL~kln~ 67 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKE--TGELVAIKKMKKKFYSWE-E-----------------CMNLREVKSLRKLNP 67 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecC--CCceeeHHHHHhhhccHH-H-----------------HHHHHHHHHHHhcCC
Confidence 35689999999999999999999876 999999999876543211 1 34568999999998
Q ss_pred CCCcccceeEEEcCC-eeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 040898 118 HRNILPLLAHMVRPN-CHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPAN 196 (337)
Q Consensus 118 hpniv~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~n 196 (337)
||||+++.+++.+++ .+|+||||++. +|.++++. .+..+++..+..|+.||++||+|+ |++|+.|||+||+|
T Consensus 68 hpniikL~Evi~d~~~~L~fVfE~Md~-NLYqLmK~---R~r~fse~~irnim~QilqGL~hi---Hk~GfFHRDlKPEN 140 (538)
T KOG0661|consen 68 HPNIIKLKEVIRDNDRILYFVFEFMDC-NLYQLMKD---RNRLFSESDIRNIMYQILQGLAHI---HKHGFFHRDLKPEN 140 (538)
T ss_pred CCcchhhHHHhhccCceEeeeHHhhhh-hHHHHHhh---cCCcCCHHHHHHHHHHHHHHHHHH---HhcCcccccCChhh
Confidence 999999999998877 99999999966 99999975 377899999999999999999999 88899999999999
Q ss_pred eeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccc-cCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCc
Q 040898 197 VLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQ-TETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHT 275 (337)
Q Consensus 197 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~-~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~ 275 (337)
||+.++..+||+|||+|+...... +.+.++.|..|.|||++. ...|+.+.|+|++||+++|+.+-++-|.+...-+
T Consensus 141 iLi~~~~~iKiaDFGLARev~Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~D 217 (538)
T KOG0661|consen 141 ILISGNDVIKIADFGLAREVRSKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEID 217 (538)
T ss_pred eEecccceeEecccccccccccCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHH
Confidence 999999999999999999876554 445688999999999985 5568999999999999999999999987654444
Q ss_pred hhhhHHHHHHhhhccCCcc------------hhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 276 EEMDMVKWMRNVIFSENPN------------RAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
....+++.+........+. ....+.......+....+..+|+..||+.||.+||||.++|+|
T Consensus 218 qi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 218 QIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 4444444332211111111 0001111122334567789999999999999999999999987
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=304.86 Aligned_cols=265 Identities=23% Similarity=0.331 Sum_probs=213.1
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
.+|..++.||+|.||.||++.+.. +|+.||||++........-. ....||++.|+.++|||
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~--t~~~VAIKKIkl~~~kdGi~-----------------~talREIK~Lqel~h~n 62 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTE--TGKRVAIKKIKLGNAKDGIN-----------------RTALREIKLLQELKHPN 62 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecC--CCcEEEEEEeeccccccCcc-----------------HHHHHHHHHHHHccCcc
Confidence 579999999999999999999987 99999999997653321100 46789999999999999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
|+.++++|.....+.+|+||++. +|+..++. +.-.++...+..++.++++|++|+ |.+.|+||||||.|++++
T Consensus 63 Ii~LiD~F~~~~~l~lVfEfm~t-dLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~---H~~~IlHRDlKPnNLLis 135 (318)
T KOG0659|consen 63 IIELIDVFPHKSNLSLVFEFMPT-DLEVVIKD---KNIILSPADIKSYMLMTLKGLAYC---HSKWILHRDLKPNNLLIS 135 (318)
T ss_pred hhhhhhhccCCCceEEEEEeccc-cHHHHhcc---cccccCHHHHHHHHHHHHHHHHHH---HhhhhhcccCCccceEEc
Confidence 99999999999999999999977 99999954 566789999999999999999999 888999999999999999
Q ss_pred CCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhh
Q 040898 201 DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTE-TISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMD 279 (337)
Q Consensus 201 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~ 279 (337)
.+|.+||+|||+++.+........ ..+-|..|.|||++.|. .|+..+|+||.||++.||+-|.+-|.+. ++...
T Consensus 136 ~~g~lKiADFGLAr~f~~p~~~~~--~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~---sDidQ 210 (318)
T KOG0659|consen 136 SDGQLKIADFGLARFFGSPNRIQT--HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGD---SDIDQ 210 (318)
T ss_pred CCCcEEeecccchhccCCCCcccc--cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCC---chHHH
Confidence 999999999999998875544433 33788999999999765 5899999999999999999998776542 22222
Q ss_pred HHHHHHhhhccCCcc--------------hhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 280 MVKWMRNVIFSENPN--------------RAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
+ ..+......+.+. ............+.+..+..+|+.+||.+||.+|+|++|+|+|
T Consensus 211 L-~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 211 L-SKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred H-HHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 3 2232222221111 0111111222455666778999999999999999999999987
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-47 Score=331.31 Aligned_cols=268 Identities=26% Similarity=0.373 Sum_probs=210.8
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..+.|+.+++||+|+||.||++.+.. +|+.||+|++..+......- ....||+.+|++|+|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~--tgkivALKKvr~d~~~~~~~-----------------~t~~REI~ILr~l~H 175 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLE--TGKIVALKKVRFDNEKEGFP-----------------ITAIREIKILRRLDH 175 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecc--cCcEEEEEEeecccCCCcch-----------------HHHHHHHHHHHhcCC
Confidence 67789999999999999999999987 99999999997765332211 456789999999999
Q ss_pred CCcccceeEEEcC--CeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 040898 119 RNILPLLAHMVRP--NCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPAN 196 (337)
Q Consensus 119 pniv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~n 196 (337)
|||+++.+...+. ..+|+|+||+++ +|..++.. ..-.+++.++..++.||+.||.|+ |+.|++|||||.+|
T Consensus 176 pNIikL~eivt~~~~~siYlVFeYMdh-DL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~c---H~~gvlHRDIK~SN 248 (560)
T KOG0600|consen 176 PNIIKLEEIVTSKLSGSIYLVFEYMDH-DLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYC---HSRGVLHRDIKGSN 248 (560)
T ss_pred CcccceeeEEEecCCceEEEEEecccc-hhhhhhcC---CCcccChHHHHHHHHHHHHHHHHH---hhcCeeeccccccc
Confidence 9999999998776 789999999988 88888732 344689999999999999999999 88899999999999
Q ss_pred eeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCCCc
Q 040898 197 VLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTE-TISDKCDIYSFGVLLAVLVMGKFPVDDFFGHT 275 (337)
Q Consensus 197 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~ 275 (337)
||++++|.+||+|||+++++...... ..+..+-|..|.|||++.|. .|+.++|+||.|||+.||++|++.|.+...
T Consensus 249 iLidn~G~LKiaDFGLAr~y~~~~~~-~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tE-- 325 (560)
T KOG0600|consen 249 ILIDNNGVLKIADFGLARFYTPSGSA-PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTE-- 325 (560)
T ss_pred eEEcCCCCEEeccccceeeccCCCCc-ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccH--
Confidence 99999999999999999987655433 24567889999999999876 489999999999999999999999865422
Q ss_pred hhhhHHHHHHhhhccCCcchhhhhcc--------cCC-------chHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 276 EEMDMVKWMRNVIFSENPNRAINSKL--------LGN-------GYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~-------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.+..+.+......+...-....++ ..+ .....+....+|+..||..||.+|.|+.++|++
T Consensus 326 --veQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 326 --VEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred --HHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 222222322221111111000000 000 112223456889999999999999999999874
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=322.95 Aligned_cols=256 Identities=25% Similarity=0.437 Sum_probs=202.8
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
..+|..++.||+|+||.||++.+.+ +|...|||.+....... .+.+.+|+.+|++++||
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~--~g~~~AvK~v~~~~~~~-------------------~~~l~~Ei~iL~~l~~p 74 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKK--TGELMAVKSVELEDSPT-------------------SESLEREIRILSRLNHP 74 (313)
T ss_pred cchhhhhccccCccceEEEEEEecC--CCcceeeeeeecccchh-------------------HHHHHHHHHHHHhCCCC
Confidence 5679999999999999999999986 79999999987652211 16788999999999999
Q ss_pred CcccceeEEEcCC--eeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCce
Q 040898 120 NILPLLAHMVRPN--CHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANV 197 (337)
Q Consensus 120 niv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ni 197 (337)
|||+++|...... .++++|||+++|+|.+++.. ..+ .+++..+..+.+||++||.|| |++|++||||||+||
T Consensus 75 ~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~--~g~-~l~E~~v~~ytr~iL~GL~yl---Hs~g~vH~DiK~~Ni 148 (313)
T KOG0198|consen 75 NIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKR--YGG-KLPEPLVRRYTRQILEGLAYL---HSKGIVHCDIKPANI 148 (313)
T ss_pred CEEeeCCccccccCeeeEeeeeccCCCcHHHHHHH--cCC-CCCHHHHHHHHHHHHHHHHHH---HhCCEeccCcccceE
Confidence 9999999754444 68999999999999999965 222 699999999999999999999 888999999999999
Q ss_pred eecC-CCCeEEecccCccccCC-CCceeeeecccCCCCccCccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCCC
Q 040898 198 LIDD-DMEARISDFGHGKLMPD-GHAQITVKCMVGTMGYMAPESLQTE-TISDKCDIYSFGVLLAVLVMGKFPVDDFFGH 274 (337)
Q Consensus 198 l~~~-~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~ 274 (337)
|++. ++.+||+|||++..... ...........||+.|+|||++... ....++|||||||++.||+||++||... .
T Consensus 149 Ll~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~ 226 (313)
T KOG0198|consen 149 LLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--F 226 (313)
T ss_pred EEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--c
Confidence 9999 79999999999887653 1111122346799999999999853 3345999999999999999999999764 1
Q ss_pred chhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 275 TEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.....+....... ..+ ..++..+....+++.+||..||++|||++++|+|
T Consensus 227 ~~~~~~~~ig~~~---~~P----------~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~h 276 (313)
T KOG0198|consen 227 EEAEALLLIGRED---SLP----------EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEH 276 (313)
T ss_pred chHHHHHHHhccC---CCC----------CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence 1111111111111 011 1222344558999999999999999999999987
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-46 Score=328.69 Aligned_cols=259 Identities=24% Similarity=0.359 Sum_probs=211.8
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++++.||+|+||.||+|.... +|..+|+|++.+....+.. .++.+..|-.+|...++
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~--Tg~iyAmK~LkKS~M~~~~----------------Qv~hV~aERdiL~~~ds 200 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKD--TGEIYAMKILKKSEMLKKN----------------QVEHVRAERDILAEVDS 200 (550)
T ss_pred CcccchhheeeccccceeEEEEEEcc--CCcEEeeecccHHHHHhhh----------------hHHHHHHHHHHhhhcCC
Confidence 56889999999999999999998877 9999999999765443332 23778889999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|.||+++-.|++...+||||||++||++..+| ...+.+++..+..++.+.+.|+..+ |+.|++|+||||+|+|
T Consensus 201 ~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL----~~~~~L~e~~arfYiaE~vlAI~~i---H~~gyIHRDIKPdNlL 273 (550)
T KOG0605|consen 201 PWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLL----MRKDTLTEDWARFYIAETVLAIESI---HQLGYIHRDIKPDNLL 273 (550)
T ss_pred CcEEEEEEEecCCCeeEEEEEecCCccHHHHH----HhcCcCchHHHHHHHHHHHHHHHHH---HHcCcccccCChhhee
Confidence 99999999999999999999999999999999 5567799999999999999999999 7889999999999999
Q ss_pred ecCCCCeEEecccCccccCCCC----------------------ce-----------------------eeeecccCCCC
Q 040898 199 IDDDMEARISDFGHGKLMPDGH----------------------AQ-----------------------ITVKCMVGTMG 233 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~----------------------~~-----------------------~~~~~~~~~~~ 233 (337)
|+..|++||+|||++..+.... .. .-....+|||.
T Consensus 274 iD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPD 353 (550)
T KOG0605|consen 274 IDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPD 353 (550)
T ss_pred ecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCcc
Confidence 9999999999999986442100 00 00112469999
Q ss_pred ccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHH
Q 040898 234 YMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLV 313 (337)
Q Consensus 234 ~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 313 (337)
|+|||++.+..|+..+|.||||||+||||.|.+||........-..+..|.....++.... ...+.
T Consensus 354 YiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~--------------~s~eA 419 (550)
T KOG0605|consen 354 YIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVD--------------LSDEA 419 (550)
T ss_pred ccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCc--------------ccHHH
Confidence 9999999999999999999999999999999999966544444444444443333332221 12448
Q ss_pred HHHHhhhccCCCCCCCC---hhhhhcC
Q 040898 314 LKLACFCTLKDPDERPS---SKDVRSM 337 (337)
Q Consensus 314 ~~li~~~l~~dP~~Rps---~~ell~~ 337 (337)
++||++||. ||++|.. +.||.+|
T Consensus 420 ~DLI~rll~-d~~~RLG~~G~~EIK~H 445 (550)
T KOG0605|consen 420 KDLITRLLC-DPENRLGSKGAEEIKKH 445 (550)
T ss_pred HHHHHHHhc-CHHHhcCcccHHHHhcC
Confidence 899999999 9999986 7777665
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=325.76 Aligned_cols=257 Identities=30% Similarity=0.413 Sum_probs=206.0
Q ss_pred cccccccccccceeccCcceEEEEeEEecCCCCce-EEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHH
Q 040898 36 FLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKM-IAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITAN 114 (337)
Q Consensus 36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~-vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~ 114 (337)
+........+.+.||+|+||+||++.+ .|+. ||+|++......... ...|.+|+.+|.
T Consensus 36 ~~i~~~~l~~~~~iG~G~~g~V~~~~~----~g~~~vavK~~~~~~~~~~~-----------------~~~f~~E~~il~ 94 (362)
T KOG0192|consen 36 EEIDPDELPIEEVLGSGSFGTVYKGKW----RGTDVVAVKIISDPDFDDES-----------------RKAFRREASLLS 94 (362)
T ss_pred eecChHHhhhhhhcccCCceeEEEEEe----CCceeEEEEEecchhcChHH-----------------HHHHHHHHHHHH
Confidence 333455677788899999999998888 6777 999999765433322 168999999999
Q ss_pred hcCCCCcccceeEEEcCC-eeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCC-eEecCC
Q 040898 115 QTRHRNILPLLAHMVRPN-CHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPR-LIHRDI 192 (337)
Q Consensus 115 ~l~hpniv~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~g-i~h~di 192 (337)
.++|||||+++|++.++. ..++||||+++|+|.+++... .+..+++..+..++.||+.|+.|| |+++ |+|+||
T Consensus 95 ~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YL---H~~~~iIHrDL 169 (362)
T KOG0192|consen 95 RLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYL---HSEGPIIHRDL 169 (362)
T ss_pred hCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHH---hcCCCeeeccc
Confidence 999999999999999887 799999999999999999653 467899999999999999999999 6778 999999
Q ss_pred CCCceeecCCC-CeEEecccCccccCCCCceeeeecccCCCCccCccccc--cCCCCCcccchhhhHHHHHHHhCCCCCC
Q 040898 193 KPANVLIDDDM-EARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQ--TETISDKCDIYSFGVLLAVLVMGKFPVD 269 (337)
Q Consensus 193 ~~~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~--~~~~~~~~DiwslG~i~~~ll~g~~pf~ 269 (337)
||+|+|++.++ ++||+|||+++...... ...+...||+.|||||++. ...++.++||||+|+++|||+||..||.
T Consensus 170 K~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~ 247 (362)
T KOG0192|consen 170 KSDNILVDLKGKTLKIADFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFE 247 (362)
T ss_pred ChhhEEEcCCCCEEEECCCccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCC
Confidence 99999999997 99999999998765432 1223357999999999999 5689999999999999999999999997
Q ss_pred CCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 270 DFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
..... . ...........+.. +......+..++.+||+.||+.||++.+++.
T Consensus 248 ~~~~~-~--~~~~v~~~~~Rp~~-------------p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 248 DLAPV-Q--VASAVVVGGLRPPI-------------PKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred CCCHH-H--HHHHHHhcCCCCCC-------------CccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 65431 1 11111111111111 1113444889999999999999999999874
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-46 Score=329.00 Aligned_cols=250 Identities=23% Similarity=0.375 Sum_probs=215.0
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
++|.+.+.||+|+||.||+++.+. +.+.||+|.+.+...... ++..+.+|+++++.++|||
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~--t~~~vAik~i~K~gr~~k-----------------~l~~l~~ev~i~r~lkHpn 62 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKY--TIQVVAIKFIDKSGRNEK-----------------ELKNLRQEVRILRSLKHPN 62 (808)
T ss_pred cchhHHHHhcCCccceeeeccccc--ceeEEEEEEehhcCCchH-----------------HHHHHHHHHHHHHhcCCcc
Confidence 679999999999999999999987 999999999866543211 2267889999999999999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
|+.++++|++...+++|+|||.| +|..++ ...+.++++.+..++.|++.||+|| |+.+|+|+|+||.||++.
T Consensus 63 iv~m~esfEt~~~~~vVte~a~g-~L~~il----~~d~~lpEe~v~~~a~~LVsaL~yL---hs~rilhrd~kPqniLl~ 134 (808)
T KOG0597|consen 63 IVEMLESFETSAHLWVVTEYAVG-DLFTIL----EQDGKLPEEQVRAIAYDLVSALYYL---HSNRILHRDMKPQNILLE 134 (808)
T ss_pred hhhHHHhhcccceEEEEehhhhh-hHHHHH----HhccCCCHHHHHHHHHHHHHHHHHH---HhcCcccccCCcceeeec
Confidence 99999999999999999999977 999999 5677899999999999999999999 788999999999999999
Q ss_pred CCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhH
Q 040898 201 DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDM 280 (337)
Q Consensus 201 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~ 280 (337)
+.+.+|++|||+++....+.. ..+...|||-|||||++.+.+|+..+|+|||||++||+++|++||- ...+
T Consensus 135 ~~~~~KlcdFg~Ar~m~~~t~--vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~-------a~si 205 (808)
T KOG0597|consen 135 KGGTLKLCDFGLARAMSTNTS--VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFY-------ARSI 205 (808)
T ss_pred CCCceeechhhhhhhcccCce--eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCch-------HHHH
Confidence 999999999999998765433 3345679999999999999999999999999999999999999982 3344
Q ss_pred HHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 281 VKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.+..+.+...+... ++.....+.+++..+|.+||..|.|..+++.|
T Consensus 206 ~~Lv~~I~~d~v~~-----------p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 206 TQLVKSILKDPVKP-----------PSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred HHHHHHHhcCCCCC-----------cccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 44555444333322 22455569999999999999999999999987
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-45 Score=313.30 Aligned_cols=273 Identities=27% Similarity=0.407 Sum_probs=217.3
Q ss_pred cccccccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHH
Q 040898 32 QDLAFLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEII 111 (337)
Q Consensus 32 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~ 111 (337)
.+..|---.++|++.+.||.|..++||++.+.+ ++..||||++..+.-... ++.+.+|+.
T Consensus 17 ~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p--~~e~VAIK~inLEkc~~~------------------ld~l~kE~~ 76 (516)
T KOG0582|consen 17 SEKEFPLNAKDYELQEVIGVGASAVVYLARCIP--TNEVVAIKIINLEKCNND------------------LDALRKEVQ 76 (516)
T ss_pred ccccCCCCccceeEEEEEeccceeEeeeeeecc--cCCEEEEEEeehhhhhhh------------------HHHHHHHHH
Confidence 355566677889999999999999999999998 889999999965533221 278899999
Q ss_pred HHHhcCCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 040898 112 TANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRD 191 (337)
Q Consensus 112 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~d 191 (337)
.++.++||||++++..|..+..+|+||.|+.+||+.+.+......+ +++..+..+++++++||.|| |.+|.+|||
T Consensus 77 ~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~G--l~E~~Ia~iLre~LkaL~YL---H~~G~IHRd 151 (516)
T KOG0582|consen 77 TMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDG--LEEASIATILREVLKALDYL---HQNGHIHRD 151 (516)
T ss_pred HhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHcccc--ccHHHHHHHHHHHHHHHHHH---HhcCceecc
Confidence 9999999999999999999999999999999999999998865554 99999999999999999999 888999999
Q ss_pred CCCCceeecCCCCeEEecccCccccCCCCc-eeee-ecccCCCCccCccccc--cCCCCCcccchhhhHHHHHHHhCCCC
Q 040898 192 IKPANVLIDDDMEARISDFGHGKLMPDGHA-QITV-KCMVGTMGYMAPESLQ--TETISDKCDIYSFGVLLAVLVMGKFP 267 (337)
Q Consensus 192 i~~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~-~~~~~~~~~~~PE~~~--~~~~~~~~DiwslG~i~~~ll~g~~p 267 (337)
+|+.|||++.+|.|+|+|||.+..+..+.. .... +...++++|+|||++. ...|+.++||||+|++..||.+|..|
T Consensus 152 vKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aP 231 (516)
T KOG0582|consen 152 VKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAP 231 (516)
T ss_pred cccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCC
Confidence 999999999999999999998766544332 2222 4568999999999953 34589999999999999999999999
Q ss_pred CCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 268 VDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 268 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
|.....- .-.+..+ ...++... .........-.....+..++..||+.||.+|||++++|+|
T Consensus 232 f~k~pPm------kvLl~tL-qn~pp~~~-t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 232 FSKYPPM------KVLLLTL-QNDPPTLL-TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred cccCChH------HHHHHHh-cCCCCCcc-cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 9765431 1111111 11111100 1111111122233368999999999999999999999987
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-45 Score=325.24 Aligned_cols=257 Identities=26% Similarity=0.389 Sum_probs=206.8
Q ss_pred cccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC
Q 040898 38 KKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR 117 (337)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 117 (337)
...++|++.+.||+|+||.|+.+.+.. ++..||+|.+..+........ ..+.+.+|+.+++.+.
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~--t~~~vAiKii~~~~~~~~~~~--------------~~~~i~rEi~~~~~~~ 77 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRL--TGEKVAIKIIDRKKVSSKSQK--------------LDELIKREISILRRLR 77 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeecc--CCCeEEEEEechhcccccccc--------------cchhhHHHHHHHHHhc
Confidence 456789999999999999999998876 889999996655421111000 0145668999999999
Q ss_pred -CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 040898 118 -HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPAN 196 (337)
Q Consensus 118 -hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~n 196 (337)
||||+++++++.....+|+||||+.+|+|.+++. ..+++.+..+..+++|++.|++|+ |+.||+||||||+|
T Consensus 78 ~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~----~~g~l~E~~ar~~F~Qlisav~y~---H~~gi~HRDLK~EN 150 (370)
T KOG0583|consen 78 SHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIV----NKGRLKEDEARKYFRQLISAVAYC---HSRGIVHRDLKPEN 150 (370)
T ss_pred cCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHH----HcCCCChHHHHHHHHHHHHHHHHH---HhCCEeeCCCCHHH
Confidence 9999999999999999999999999999999994 456788899999999999999999 78899999999999
Q ss_pred eeecCC-CCeEEecccCccccCCCCceeeeecccCCCCccCccccccCC-CC-CcccchhhhHHHHHHHhCCCCCCCCCC
Q 040898 197 VLIDDD-MEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTET-IS-DKCDIYSFGVLLAVLVMGKFPVDDFFG 273 (337)
Q Consensus 197 il~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~-~~~DiwslG~i~~~ll~g~~pf~~~~~ 273 (337)
++++.+ +.+||+|||++.... .........+||+.|+|||++.+.. |+ .++||||+|+++|.|++|..||+..
T Consensus 151 illd~~~~~~Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~-- 226 (370)
T KOG0583|consen 151 ILLDGNEGNLKLSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS-- 226 (370)
T ss_pred EEecCCCCCEEEeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc--
Confidence 999999 999999999998874 1112334578999999999999877 75 7899999999999999999999762
Q ss_pred CchhhhHHHHHHhhhccCCcchhhhhcccCCchHHH-HHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 274 HTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQ-MLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
....+...+. ......+. .. +..+..|+.+||..||.+|+|+.+++.|
T Consensus 227 --~~~~l~~ki~---~~~~~~p~-----------~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h 275 (370)
T KOG0583|consen 227 --NVPNLYRKIR---KGEFKIPS-----------YLLSPEARSLIEKMLVPDPSTRITLLEILEH 275 (370)
T ss_pred --cHHHHHHHHh---cCCccCCC-----------CcCCHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence 2222222221 11111111 11 3448999999999999999999999876
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=329.64 Aligned_cols=255 Identities=25% Similarity=0.353 Sum_probs=214.4
Q ss_pred ccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc
Q 040898 37 LKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT 116 (337)
Q Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 116 (337)
....+-|+.++.||.|+.|.|-++++.. ||+..|||++......... ....+.+|+.+|+.+
T Consensus 8 ~~tiGpwkLgkTLG~Gstg~vrlakh~~--TGqlaaiKii~k~~~~s~s----------------~~~~IerEIviMkLi 69 (786)
T KOG0588|consen 8 KNTIGPWKLGKTLGKGSTGCVRLAKHAE--TGQLAAIKIIPKRSELSSS----------------QPAGIEREIVIMKLI 69 (786)
T ss_pred cccccceeccccccCCCCceehhhhccc--ccceeEEEeeccccccccc----------------cccchhhhhHHHHHh
Confidence 3455669999999999999999998876 9999999999766422221 116788999999999
Q ss_pred CCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 040898 117 RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPAN 196 (337)
Q Consensus 117 ~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~n 196 (337)
.|||+++++++|+++..+|+|+||.++|.|.+++ ..++++++.....+++||+.|+.|+ |..+|+|+|+||+|
T Consensus 70 ~HpnVl~LydVwe~~~~lylvlEyv~gGELFdyl----v~kG~l~e~eaa~ff~QIi~gv~yC---H~~~icHRDLKpEN 142 (786)
T KOG0588|consen 70 EHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYL----VRKGPLPEREAAHFFRQILDGVSYC---HAFNICHRDLKPEN 142 (786)
T ss_pred cCCCeeeeeeeeccCceEEEEEEecCCchhHHHH----HhhCCCCCHHHHHHHHHHHHHHHHH---hhhcceeccCCchh
Confidence 9999999999999999999999999999999999 6678899999999999999999999 77799999999999
Q ss_pred eeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCC-CcccchhhhHHHHHHHhCCCCCCCCCCCc
Q 040898 197 VLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETIS-DKCDIYSFGVLLAVLVMGKFPVDDFFGHT 275 (337)
Q Consensus 197 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~-~~~DiwslG~i~~~ll~g~~pf~~~~~~~ 275 (337)
++++..+++||+|||+|..-..+... .+.+|+|.|.+||++.|.+|. .++||||+|+|+|.||+|+.||++ +
T Consensus 143 lLLd~~~nIKIADFGMAsLe~~gklL---eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD----d 215 (786)
T KOG0588|consen 143 LLLDVKNNIKIADFGMASLEVPGKLL---ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD----D 215 (786)
T ss_pred hhhhcccCEeeeccceeecccCCccc---cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC----c
Confidence 99999999999999999875444332 346899999999999999984 789999999999999999999973 3
Q ss_pred hhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 276 EEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
....+...+++..++-+. ..+.+..+|+.+||.+||.+|+|.+||++|
T Consensus 216 Nir~LLlKV~~G~f~MPs--------------~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 216 NIRVLLLKVQRGVFEMPS--------------NISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred cHHHHHHHHHcCcccCCC--------------cCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 334444444443333221 222338899999999999999999999998
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=326.03 Aligned_cols=255 Identities=25% Similarity=0.395 Sum_probs=215.2
Q ss_pred ccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc
Q 040898 37 LKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT 116 (337)
Q Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 116 (337)
.+....|...++||+|+.|.||.+.... +++.||||++......+. +-+..|+.+|+..
T Consensus 269 ~dP~~~y~~~~kigqgaSG~vy~A~~~~--~~~~VaiK~m~l~~Q~~k-------------------eLilnEi~Vm~~~ 327 (550)
T KOG0578|consen 269 GDPRSKYTDFKKIGQGATGGVYVARKIS--TKQEVAIKRMDLRKQPKK-------------------ELLLNEILVMRDL 327 (550)
T ss_pred CChhhhhcchhhhccccccceeeeeecc--CCceEEEEEEEeccCCch-------------------hhhHHHHHHHHhc
Confidence 3477889999999999999999998887 999999999987765544 5688899999999
Q ss_pred CCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 040898 117 RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPAN 196 (337)
Q Consensus 117 ~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~n 196 (337)
.|+|||++++.|...+.+|.||||++||+|.+.+.. ..+++..+..|++.+++||+|| |.+||+|+|||.+|
T Consensus 328 ~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~-----~~~~E~qIA~Icre~l~aL~fL---H~~gIiHrDIKSDn 399 (550)
T KOG0578|consen 328 HHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTK-----TRMTEGQIAAICREILQGLKFL---HARGIIHRDIKSDN 399 (550)
T ss_pred cchHHHHHHHHhcccceeEEEEeecCCCchhhhhhc-----ccccHHHHHHHHHHHHHHHHHH---Hhcceeeeccccce
Confidence 999999999999888999999999999999999843 4489999999999999999999 88999999999999
Q ss_pred eeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCch
Q 040898 197 VLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTE 276 (337)
Q Consensus 197 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~ 276 (337)
|+++.+|.+||+|||++..+..... .....+|||.|||||++....|+.++||||||+++.||+.|.+||-.- ..
T Consensus 400 ILL~~~g~vKltDFGFcaqi~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE---~P 474 (550)
T KOG0578|consen 400 ILLTMDGSVKLTDFGFCAQISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNE---NP 474 (550)
T ss_pred eEeccCCcEEEeeeeeeeccccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCC---Ch
Confidence 9999999999999999988765443 234578999999999999999999999999999999999999998421 11
Q ss_pred hhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 277 EMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
... +..+...+.+.. ...+..+..+.+|+.+||..||.+|+|+.|||+|
T Consensus 475 lrA----lyLIa~ng~P~l--------k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 475 LRA----LYLIATNGTPKL--------KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred HHH----HHHHhhcCCCCc--------CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 111 111222222221 2234455569999999999999999999999998
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=304.65 Aligned_cols=274 Identities=22% Similarity=0.268 Sum_probs=214.4
Q ss_pred ccccccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHH
Q 040898 33 DLAFLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIIT 112 (337)
Q Consensus 33 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 112 (337)
-+-=|+..+.|+++.+|++|+||.||+++++. ++..||+|+++.+.....-. -...||+.+
T Consensus 68 ~l~gCrsv~efe~lnrI~EGtyGiVYRakdk~--t~eIVALKr~kmekek~GFP-----------------ItsLREIni 128 (419)
T KOG0663|consen 68 LLGGCRSVEEFEKLNRIEEGTYGVVYRAKDKK--TDEIVALKRLKMEKEKEGFP-----------------ITSLREINI 128 (419)
T ss_pred cccCcccHHHHHHHhhcccCcceeEEEeccCC--cceeEEeeecccccccCCCc-----------------chhHHHHHH
Confidence 35667788999999999999999999999987 99999999998765322110 346789999
Q ss_pred HHhcCCCCcccceeEEEcC--CeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 040898 113 ANQTRHRNILPLLAHMVRP--NCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHR 190 (337)
Q Consensus 113 l~~l~hpniv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~ 190 (337)
|.+.+|||||.+..+.... +.+|+|||||++ +|..++.+ .+.++...++..++.|++.|++|| |...|+||
T Consensus 129 Ll~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh-DLksl~d~---m~q~F~~~evK~L~~QlL~glk~l---H~~wilHR 201 (419)
T KOG0663|consen 129 LLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH-DLKSLMET---MKQPFLPGEVKTLMLQLLRGLKHL---HDNWILHR 201 (419)
T ss_pred HHhcCCCCeeeeEEEEeccccceeeeeHHHHHh-hHHHHHHh---ccCCCchHHHHHHHHHHHHHHHHH---hhceeEec
Confidence 9999999999999987654 579999999988 99999976 336799999999999999999999 88899999
Q ss_pred CCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccC-CCCCcccchhhhHHHHHHHhCCCCCC
Q 040898 191 DIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTE-TISDKCDIYSFGVLLAVLVMGKFPVD 269 (337)
Q Consensus 191 di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~i~~~ll~g~~pf~ 269 (337)
|+|++|+++++.|.+||+|||+|+.++..... .+..+-|..|.|||++.+. .|+.++|+||+|||+.||+++.+-|.
T Consensus 202 DLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~--~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~ 279 (419)
T KOG0663|consen 202 DLKTSNLLLSHKGILKIADFGLAREYGSPLKP--YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFP 279 (419)
T ss_pred ccchhheeeccCCcEEecccchhhhhcCCccc--CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCC
Confidence 99999999999999999999999998765333 3455689999999999765 58999999999999999999999986
Q ss_pred CCCCCchhhhHHHHHHhhh-----------------ccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChh
Q 040898 270 DFFGHTEEMDMVKWMRNVI-----------------FSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSK 332 (337)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ 332 (337)
+-...+....+...+.-.. ....+......+.... ...+.-.+|+..+|..||.+|.|++
T Consensus 280 G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~---~lse~g~~Lln~llt~dP~kR~tA~ 356 (419)
T KOG0663|consen 280 GKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGAL---SLSEQGFDLLNKLLTYDPGKRITAE 356 (419)
T ss_pred CCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhcccc---ccchhHHHHHHHHhccCccccccHH
Confidence 5433222222222111110 1111111111111100 1346678999999999999999999
Q ss_pred hhhcC
Q 040898 333 DVRSM 337 (337)
Q Consensus 333 ell~~ 337 (337)
|.|+|
T Consensus 357 ~~L~h 361 (419)
T KOG0663|consen 357 DGLKH 361 (419)
T ss_pred Hhhcc
Confidence 99987
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-45 Score=311.80 Aligned_cols=251 Identities=25% Similarity=0.408 Sum_probs=212.5
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
.-+|++.+.||.|+||.|=++.... .|+.||||.+.++.....++. -.+.+|+++|..|+||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~--sgR~VAiKsIrKdkIkdeqDl----------------vhIRREIeIMSsLNHP 113 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHK--SGREVAIKSIRKDKIKDEQDL----------------VHIRREIEIMSSLNHP 113 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhcc--CCcEeehhhhhhhhcccHHHH----------------HHHHHHHHHHhhcCCC
Confidence 3579999999999999998777765 999999999987766555443 6789999999999999
Q ss_pred CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceee
Q 040898 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI 199 (337)
Q Consensus 120 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~ 199 (337)
||+.++++|++.+...+||||..+|.|.+++ ...+.+++.....+++||+.|+.|+ |+++++|+|||.+|||+
T Consensus 114 hII~IyEVFENkdKIvivMEYaS~GeLYDYi----Ser~~LsErEaRhfFRQIvSAVhYC---HknrVvHRDLKLENILL 186 (668)
T KOG0611|consen 114 HIIQIYEVFENKDKIVIVMEYASGGELYDYI----SERGSLSEREARHFFRQIVSAVHYC---HKNRVVHRDLKLENILL 186 (668)
T ss_pred ceeehhhhhcCCceEEEEEEecCCccHHHHH----HHhccccHHHHHHHHHHHHHHHHHH---hhccceecccchhheee
Confidence 9999999999999999999999999999999 5667799999999999999999999 88899999999999999
Q ss_pred cCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCC-CCcccchhhhHHHHHHHhCCCCCCCCCCCchhh
Q 040898 200 DDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETI-SDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEM 278 (337)
Q Consensus 200 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~ 278 (337)
+.++++||+|||++..+...... ..++|+|-|.+||+++|.+| ++.+|.||||+++|-|+.|..||++..
T Consensus 187 D~N~NiKIADFGLSNly~~~kfL---qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D------ 257 (668)
T KOG0611|consen 187 DQNNNIKIADFGLSNLYADKKFL---QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD------ 257 (668)
T ss_pred cCCCCeeeeccchhhhhccccHH---HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch------
Confidence 99999999999999987665433 45789999999999999988 478999999999999999999997642
Q ss_pred hHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 279 DMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
....++++......++. .+....-||++||.+||++|.|+.+|-.|
T Consensus 258 -hk~lvrQIs~GaYrEP~------------~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 258 -HKRLVRQISRGAYREPE------------TPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred -HHHHHHHhhcccccCCC------------CCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 23333443322221111 11125678999999999999999998765
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=323.82 Aligned_cols=252 Identities=27% Similarity=0.392 Sum_probs=207.0
Q ss_pred cccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC
Q 040898 38 KKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR 117 (337)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 117 (337)
-..+.+..++.||+|-||.||.+.+. ...+||+|.+....... +.|.+|+.+|++|+
T Consensus 203 i~r~~l~l~~~LG~G~FG~V~~g~~~---~~~~vavk~ik~~~m~~--------------------~~f~~Ea~iMk~L~ 259 (468)
T KOG0197|consen 203 IPREELKLIRELGSGQFGEVWLGKWN---GSTKVAVKTIKEGSMSP--------------------EAFLREAQIMKKLR 259 (468)
T ss_pred ecHHHHHHHHHhcCCccceEEEEEEc---CCCcccceEEeccccCh--------------------hHHHHHHHHHHhCc
Confidence 34556889999999999999999884 34589999987653221 56779999999999
Q ss_pred CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCce
Q 040898 118 HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANV 197 (337)
Q Consensus 118 hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ni 197 (337)
|+|||++++++..+..+||||||++.|+|.++++. ..+..++....+.++.||++|++|| +++++|||||..+||
T Consensus 260 H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YL---es~~~IHRDLAARNi 334 (468)
T KOG0197|consen 260 HEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYL---ESKNYIHRDLAARNI 334 (468)
T ss_pred ccCeEEEEEEEecCCceEEEEEecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHH---HhCCccchhhhhhhe
Confidence 99999999999999999999999999999999976 5667789999999999999999999 889999999999999
Q ss_pred eecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCch
Q 040898 198 LIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHTE 276 (337)
Q Consensus 198 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~ 276 (337)
||+++..+||+|||+++...+. .........-...|.|||.+....++.+|||||+|++++|++| |+.||+....
T Consensus 335 LV~~~~~vKIsDFGLAr~~~d~-~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn--- 410 (468)
T KOG0197|consen 335 LVDEDLVVKISDFGLARLIGDD-EYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN--- 410 (468)
T ss_pred eeccCceEEEcccccccccCCC-ceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH---
Confidence 9999999999999999954333 2222233345667999999999999999999999999999999 8899876533
Q ss_pred hhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhh
Q 040898 277 EMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVR 335 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 335 (337)
.+.+..+.... .-++++.+++.+.+++..||+.+|++|||++.+.
T Consensus 411 ----~ev~~~le~Gy----------Rlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 411 ----EEVLELLERGY----------RLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred ----HHHHHHHhccC----------cCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 22222221111 1233445667799999999999999999998765
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=316.52 Aligned_cols=277 Identities=35% Similarity=0.609 Sum_probs=226.8
Q ss_pred ccccccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHH
Q 040898 33 DLAFLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIIT 112 (337)
Q Consensus 33 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 112 (337)
--++.+++++|.....||+|+||.||++.-. +++.||||++....... . ..|.+|+.+
T Consensus 67 ~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~---~~~~vAVK~~~~~~~~~-~------------------~eF~~Ei~~ 124 (361)
T KOG1187|consen 67 YDELRKATNNFSESNLIGEGGFGTVYKGVLS---DGTVVAVKRLSSNSGQG-E------------------REFLNEVEI 124 (361)
T ss_pred HHHHHHHHhCCchhcceecCCCeEEEEEEEC---CCCEEEEEEecCCCCcc-h------------------hHHHHHHHH
Confidence 3344558899999999999999999987774 56999999876654432 1 358899999
Q ss_pred HHhcCCCCcccceeEEEcCC-eeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 040898 113 ANQTRHRNILPLLAHMVRPN-CHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRD 191 (337)
Q Consensus 113 l~~l~hpniv~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~d 191 (337)
+.+++|||+++++|+|.+.+ ..++|+||+++|+|.+.+...... +++|..+.+|+.+++.||+|||+.....|+|+|
T Consensus 125 ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrD 202 (361)
T KOG1187|consen 125 LSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRD 202 (361)
T ss_pred HhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCC
Confidence 99999999999999999998 599999999999999999652222 889999999999999999999865555799999
Q ss_pred CCCCceeecCCCCeEEecccCccccCCCCceeeeecc-cCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCC
Q 040898 192 IKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCM-VGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDD 270 (337)
Q Consensus 192 i~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~-~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~ 270 (337)
||++|||++.+...||+|||++...... ....... .||.+|++||.......+.++||||+|+++.|++||+.|.+.
T Consensus 203 iKssNILLD~~~~aKlsDFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~ 280 (361)
T KOG1187|consen 203 IKSSNILLDEDFNAKLSDFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQ 280 (361)
T ss_pred CCHHHeeECCCCCEEccCccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCC
Confidence 9999999999999999999999654431 1111122 799999999999888899999999999999999999988765
Q ss_pred CCCCchhhhHHHHHHhhhccCCcchhhhhccc-CCchH-HHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 271 FFGHTEEMDMVKWMRNVIFSENPNRAINSKLL-GNGYE-EQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
.. ......+..|..............++.+. ..... .+...+..+...|++.+|++||++.++++
T Consensus 281 ~~-~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 281 SR-PRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred CC-CcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 33 12333477777777777677778888776 33332 57777999999999999999999999864
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=314.07 Aligned_cols=270 Identities=19% Similarity=0.232 Sum_probs=202.9
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
++|++.+.||+|+||.||++.+.. +++.||+|++......... ...+.+|+.+++.++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~--~~~~~avK~~~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~~ 61 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKE--TKEIVAIKKFKDSEENEEV-----------------KETTLRELKMLRTLKQEN 61 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECC--CCcEEEEEEEecccccccc-----------------hhhHHHHHHHHHhCCCcc
Confidence 479999999999999999998876 8999999998654322110 146778999999999999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
|+++++++..+...++||||++++++..+. .....+++..+..++.|++.||.|| |+.|++|+||+|+||+++
T Consensus 62 iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~qi~~~L~~l---H~~~i~H~dlkp~Nill~ 134 (287)
T cd07848 62 IVELKEAFRRRGKLYLVFEYVEKNMLELLE----EMPNGVPPEKVRSYIYQLIKAIHWC---HKNDIVHRDIKPENLLIS 134 (287)
T ss_pred ccchhhhEecCCEEEEEEecCCCCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEEc
Confidence 999999999999999999999987776554 2345688899999999999999999 677999999999999999
Q ss_pred CCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhH
Q 040898 201 DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDM 280 (337)
Q Consensus 201 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~ 280 (337)
.++.++|+|||++......... ......+++.|+|||.+.+..++.++|+||+|+++|+|++|.+||............
T Consensus 135 ~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~ 213 (287)
T cd07848 135 HNDVLKLCDFGFARNLSEGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTI 213 (287)
T ss_pred CCCcEEEeeccCcccccccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 9999999999998775432211 112346889999999998888999999999999999999999999754321111111
Q ss_pred HHHHHhh--------hccCCcchhhhhc------ccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 281 VKWMRNV--------IFSENPNRAINSK------LLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 281 ~~~~~~~--------~~~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
....... ...........+. .........+..+.+|+.+||+.||++|||++++|+|
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 214 QKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred HHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 1110000 0000000000000 0000111234569999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=313.88 Aligned_cols=266 Identities=20% Similarity=0.303 Sum_probs=200.8
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
+.++|++.+.||.|+||.||++.+.. +++.||+|.+......... ..+.+|+.+++.++|
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~------------------~~~~~E~~~l~~l~h 62 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKL--TENLVALKEIRLEHEEGAP------------------CTAIREVSLLKNLKH 62 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECC--CCCEEEEEEecccccCCcc------------------hhHHHHHHHHHhCCC
Confidence 45679999999999999999998876 8999999998654322111 356679999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++++.+....++||||+++ +|.+++.. .+..+++..+..++.||+.||.|| |++|++|+||+|+||+
T Consensus 63 ~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~L---H~~~ivH~dlkp~Nil 135 (288)
T cd07871 63 ANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYC---HKRKILHRDLKPQNLL 135 (288)
T ss_pred CCEeeEEEEEcCCCeEEEEEeCCCc-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEE
Confidence 9999999999999999999999976 89888743 234578889999999999999999 7789999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCcccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchh
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQT-ETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEE 277 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~ 277 (337)
++.++.++|+|||++........ ......+++.|+|||.+.+ ..++.++|+||+|+++|+|++|.+||.......
T Consensus 136 ~~~~~~~kl~DfG~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~-- 211 (288)
T cd07871 136 INEKGELKLADFGLARAKSVPTK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKE-- 211 (288)
T ss_pred ECCCCCEEECcCcceeeccCCCc--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--
Confidence 99999999999999876433221 1123457889999999865 557899999999999999999999986532211
Q ss_pred hhHHHHHHhhhccCCcc--------hhhhhccc--------CCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 278 MDMVKWMRNVIFSENPN--------RAINSKLL--------GNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~--------~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.+ ..+.......... ........ ....+....+..+|+.+||+.||++|||++|+++|
T Consensus 212 -~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 212 -EL-HLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred -HH-HHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 11 1111111000000 00000000 00011233568899999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=316.33 Aligned_cols=249 Identities=21% Similarity=0.338 Sum_probs=201.0
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
++|++.+.||+|+||.||++.+.. +++.||+|++......... ....+.+|+.+++.++|||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~--~~~~~aiK~~~~~~~~~~~----------------~~~~~~~E~~~l~~l~hp~ 62 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRI--SEHYYALKVMAIPEVIRLK----------------QEQHVHNEKRVLKEVSHPF 62 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcC--CCCEEEEEEEEHHHHhhhH----------------HHHHHHHHHHHHHhCCCCc
Confidence 479999999999999999998876 8999999998543211111 1156788999999999999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
|+++++++.++...++||||+++++|.+++.. ...+++.....++.|++.||.|| |++|++|+||+|+||+++
T Consensus 63 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~NIli~ 135 (291)
T cd05612 63 IIRLFWTEHDQRFLYMLMEYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYL---HSKEIVYRDLKPENILLD 135 (291)
T ss_pred HhhhHhhhccCCeEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCHHHeEEC
Confidence 99999999999999999999999999999843 44688899999999999999999 778999999999999999
Q ss_pred CCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhH
Q 040898 201 DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDM 280 (337)
Q Consensus 201 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~ 280 (337)
.++.++|+|||++....... ....+++.|+|||.+.+..++.++||||||+++|+|++|..||..... ...
T Consensus 136 ~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~----~~~ 206 (291)
T cd05612 136 KEGHIKLTDFGFAKKLRDRT-----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP----FGI 206 (291)
T ss_pred CCCCEEEEecCcchhccCCc-----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHH
Confidence 99999999999987654321 224589999999999988899999999999999999999999865321 111
Q ss_pred HHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCC-----hhhhhcC
Q 040898 281 VKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPS-----SKDVRSM 337 (337)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~~ 337 (337)
.. ........ .+......+.+|+.+||+.||.+||+ +.++++|
T Consensus 207 ~~---~i~~~~~~-----------~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 207 YE---KILAGKLE-----------FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred HH---HHHhCCcC-----------CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 11 11111110 01112334889999999999999995 9999987
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=308.97 Aligned_cols=256 Identities=27% Similarity=0.389 Sum_probs=202.6
Q ss_pred cccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCc
Q 040898 42 CFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNI 121 (337)
Q Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpni 121 (337)
.|+..+.||+|+||.||++.+.. +++.||+|.+.......... ...+.+|+.++..++||||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~--~~~~~avK~~~~~~~~~~~~----------------~~~~~~E~~il~~l~~~~i 62 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRA--TGKMYACKKLEKKRIKKRKG----------------EAMALNEKRILEKVNSRFV 62 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEec--CCceEEEEEeeHhhhhhhhh----------------HHHHHHHHHHHHhcCCCcE
Confidence 48889999999999999999876 89999999986543221110 0456789999999999999
Q ss_pred ccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecC
Q 040898 122 LPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDD 201 (337)
Q Consensus 122 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~ 201 (337)
+.+.+.+.+++..++++||+++|+|.+.+.. .....+++..+..++.|++.||.|| |+.|++|+||+|+||+++.
T Consensus 63 v~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~iiH~dikp~Nill~~ 137 (285)
T cd05631 63 VSLAYAYETKDALCLVLTIMNGGDLKFHIYN--MGNPGFDEQRAIFYAAELCCGLEDL---QRERIVYRDLKPENILLDD 137 (285)
T ss_pred EEEEEEEccCCeEEEEEEecCCCcHHHHHHh--hCCCCCCHHHHHHHHHHHHHHHHHH---HhCCEEeCCCCHHHEEECC
Confidence 9999999999999999999999999988754 2334588899999999999999999 7789999999999999999
Q ss_pred CCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHH
Q 040898 202 DMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMV 281 (337)
Q Consensus 202 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~ 281 (337)
++.++|+|||++........ .....+++.|+|||.+.+..++.++||||+|+++|+|++|..||.............
T Consensus 138 ~~~~kl~Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~ 214 (285)
T cd05631 138 RGHIRISDLGLAVQIPEGET---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD 214 (285)
T ss_pred CCCEEEeeCCCcEEcCCCCe---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHH
Confidence 99999999999876543221 223568999999999999899999999999999999999999997543321111111
Q ss_pred HHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCC-----hhhhhcC
Q 040898 282 KWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPS-----SKDVRSM 337 (337)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~~ 337 (337)
..... ... .........+.+|+.+||+.||.+||| ++++++|
T Consensus 215 ~~~~~---~~~-----------~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 215 RRVKE---DQE-----------EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred HHhhc---ccc-----------cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 11110 000 011122345889999999999999997 8999886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=305.29 Aligned_cols=272 Identities=23% Similarity=0.346 Sum_probs=211.5
Q ss_pred ccccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHH
Q 040898 35 AFLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITAN 114 (337)
Q Consensus 35 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~ 114 (337)
+.+.....|..++.||+|+||.|+.+.+.. +|..||||++.......... .+..||+++++
T Consensus 16 ~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~--t~~~VAIKKi~~~F~~~~~a-----------------kRtlRElklLr 76 (359)
T KOG0660|consen 16 ELFEIPRYYVLIEPIGRGAYGVVCSAKDKR--TGEKVAIKKILNPFENQIDA-----------------KRTLRELKLLR 76 (359)
T ss_pred eEEeccceecccccccCcceeeEEEEEEcC--CCCEeehhhhhhhhhchHHH-----------------HHHHHHHHHHH
Confidence 445567778889999999999999998876 99999999986443322211 67889999999
Q ss_pred hcCCCCcccceeEEEc-----CCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEe
Q 040898 115 QTRHRNILPLLAHMVR-----PNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIH 189 (337)
Q Consensus 115 ~l~hpniv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h 189 (337)
.++|+||+.+.+++.. -+.+|+|+|+++. +|...+ .++..++...+..++.|++.||+|+ |+.+++|
T Consensus 77 ~~~HeNIi~l~di~~p~~~~~f~DvYiV~elMet-DL~~ii----k~~~~L~d~H~q~f~YQiLrgLKyi---HSAnViH 148 (359)
T KOG0660|consen 77 HLRHENIIGLLDIFRPPSRDKFNDVYLVFELMET-DLHQII----KSQQDLTDDHAQYFLYQILRGLKYI---HSANVIH 148 (359)
T ss_pred HhcCCCcceEEeecccccccccceeEEehhHHhh-HHHHHH----HcCccccHHHHHHHHHHHHHhcchh---hcccccc
Confidence 9999999999998865 3678999999954 898888 4555589999999999999999999 8889999
Q ss_pred cCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCcccc-ccCCCCCcccchhhhHHHHHHHhCCCCC
Q 040898 190 RDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESL-QTETISDKCDIYSFGVLLAVLVMGKFPV 268 (337)
Q Consensus 190 ~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~-~~~~~~~~~DiwslG~i~~~ll~g~~pf 268 (337)
||+||+|++++.++.+||+|||+++...........+..+-|..|.|||++ ....|+.+.||||+|||+.||++|++-|
T Consensus 149 RDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplF 228 (359)
T KOG0660|consen 149 RDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLF 228 (359)
T ss_pred cccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCC
Confidence 999999999999999999999999987654333344667889999999997 4667999999999999999999999998
Q ss_pred CCCCCCchhhhHHHHHHhhhccCCc-----------------chhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCCh
Q 040898 269 DDFFGHTEEMDMVKWMRNVIFSENP-----------------NRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSS 331 (337)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~ 331 (337)
.+... .+..+.+......+.. .....+..+....+.......+|+.+||..||.+|+|+
T Consensus 229 pG~d~----v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita 304 (359)
T KOG0660|consen 229 PGKDY----VHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITA 304 (359)
T ss_pred CCCch----HHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCH
Confidence 65322 1111111111111110 00111111122334555668899999999999999999
Q ss_pred hhhhcC
Q 040898 332 KDVRSM 337 (337)
Q Consensus 332 ~ell~~ 337 (337)
+|+|+|
T Consensus 305 ~eAL~h 310 (359)
T KOG0660|consen 305 EEALAH 310 (359)
T ss_pred HHHhcC
Confidence 999987
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-44 Score=319.90 Aligned_cols=257 Identities=20% Similarity=0.283 Sum_probs=203.3
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
++|++.+.||+|+||.||++.+.. +++.||+|++......... ....+.+|+.++..++|||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~----------------~~~~~~~e~~~l~~~~h~~ 62 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKD--TGEIVALKRMKKSLLFKLN----------------EVRHVLTERDILTTTKSEW 62 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECC--CCCEEEEEEEEHHHHhhhh----------------HHHHHHHHHHHHHhCCCCC
Confidence 469999999999999999999876 8999999998643221111 1156778999999999999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
|+++++++.+++..|+||||+++++|.+++. ....+++..+..++.|++.||.|| |+.|++|+||+|+||+++
T Consensus 63 iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nil~~ 135 (333)
T cd05600 63 LVKLLYAFQDDEYLYLAMEYVPGGDFRTLLN----NLGVLSEDHARFYMAEMFEAVDAL---HELGYIHRDLKPENFLID 135 (333)
T ss_pred CccEEEEEEcCCEEEEEEeCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHEEEC
Confidence 9999999999999999999999999999984 345688899999999999999999 677999999999999999
Q ss_pred CCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhH
Q 040898 201 DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDM 280 (337)
Q Consensus 201 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~ 280 (337)
.++.++|+|||++..... ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...... +.
T Consensus 136 ~~~~~kL~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~----~~ 206 (333)
T cd05600 136 ASGHIKLTDFGLSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN----ET 206 (333)
T ss_pred CCCCEEEEeCcCCccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHH----HH
Confidence 999999999999876543 123456899999999999889999999999999999999999999653221 11
Q ss_pred HHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 281 VKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
...+........... ...........+.+++.+||+.+|.+|||+.++++|
T Consensus 207 ~~~i~~~~~~~~~~~------~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 207 WENLKYWKETLQRPV------YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred HHHHHhccccccCCC------CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 111111000000000 000001234458899999999999999999999986
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=318.52 Aligned_cols=255 Identities=21% Similarity=0.305 Sum_probs=214.5
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
.++|+.++.+|+|+||.++++.+.. +...|++|.+.......... .....|+.+++++.||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~--~~~~~vlK~I~l~~~t~~~r-----------------~~A~~E~~lis~~~hP 63 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKS--DDKLYVLKKINLEKLTEPER-----------------RSAIQEMDLLSKLLHP 63 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhcc--CCceEEEEEEeccccCchhh-----------------HHHHHHHHHHHhccCC
Confidence 5689999999999999999998876 88899999997766543322 4677899999999999
Q ss_pred CcccceeEEEcCCe-eEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 120 NILPLLAHMVRPNC-HLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 120 niv~~~~~~~~~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||.+.+.|..+++ .+|||+||+||+|.+.+.. .++..++++.++.|+.|++.|+.|| |+..|+|||||+.|||
T Consensus 64 ~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~--~k~~~f~E~~i~~~~~Q~~~av~yl---H~~~iLHRDlK~~Nif 138 (426)
T KOG0589|consen 64 NIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKE--QKGVLFPEERILKWFVQILLAVNYL---HENRVLHRDLKCANIF 138 (426)
T ss_pred CeeeeccchhcCCceEEEEEeecCCCCHHHHHHH--HhhccccHHHHHHHHHHHHHHHHHH---Hhhhhhcccchhhhhh
Confidence 99999999999888 9999999999999999976 3467799999999999999999999 6778999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhh
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEM 278 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~ 278 (337)
++.++.|+|+|||++........ ......||+.|++||++.+.+|..++|||||||++|||++-+++|....
T Consensus 139 ltk~~~VkLgDfGlaK~l~~~~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~------ 210 (426)
T KOG0589|consen 139 LTKDKKVKLGDFGLAKILNPEDS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN------ 210 (426)
T ss_pred ccccCceeecchhhhhhcCCchh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc------
Confidence 99999999999999998765541 2245789999999999999999999999999999999999999986542
Q ss_pred hHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 279 DMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
+...+..+.... ..+.+.....++..++..||..+|..|||+.++|.+
T Consensus 211 -m~~Li~ki~~~~----------~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 211 -MSELILKINRGL----------YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -hHHHHHHHhhcc----------CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 222222222111 122233445569999999999999999999999874
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=316.19 Aligned_cols=251 Identities=23% Similarity=0.291 Sum_probs=202.3
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++.+.||+|+||.||++.+.. +++.||+|.+........ .....+.+|+.++++++|
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~----------------~~~~~~~~E~~~l~~l~h 77 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKG--TGEYYAIKCLKKREILKM----------------KQVQHVAQEKSILMELSH 77 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECC--CCCEEEEEEEEHHHHhhh----------------hhHHHHHHHHHHHHhCCC
Confidence 45779999999999999999999876 899999999864321110 112567889999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++.+.+++..++||||+++++|.+++.. ...+++..+..++.|++.||.|| |++|++|+||+|+||+
T Consensus 78 p~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~L---H~~~ivH~dlkp~NIl 150 (329)
T PTZ00263 78 PFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYL---HSKDIIYRDLKPENLL 150 (329)
T ss_pred CCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCHHHEE
Confidence 9999999999999999999999999999999843 45678889999999999999999 7789999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhh
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEM 278 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~ 278 (337)
++.++.++|+|||++....... ....|++.|+|||.+.+..++.++|+||||+++|+|++|..||..... .
T Consensus 151 l~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~----~ 221 (329)
T PTZ00263 151 LDNKGHVKVTDFGFAKKVPDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP----F 221 (329)
T ss_pred ECCCCCEEEeeccCceEcCCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH----H
Confidence 9999999999999987654322 124689999999999998899999999999999999999999854211 1
Q ss_pred hHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCC-----hhhhhcC
Q 040898 279 DMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPS-----SKDVRSM 337 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~~ 337 (337)
...+.+ ....... +......+.+|+.+||+.||++||+ ++++++|
T Consensus 222 ~~~~~i---~~~~~~~-----------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 222 RIYEKI---LAGRLKF-----------PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred HHHHHH---hcCCcCC-----------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 111111 1111100 0012234789999999999999997 6999876
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-45 Score=314.69 Aligned_cols=253 Identities=27% Similarity=0.398 Sum_probs=211.3
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
....|..+++||+|+||.||++.+.. +++.||+|++..+.... +++.+.+|+.++.++++
T Consensus 11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~--t~k~vAiKii~Le~~~d------------------eIediqqei~~Ls~~~~ 70 (467)
T KOG0201|consen 11 PELLYTKLELIGRGSFGEVYKAIDNK--TKKVVAIKIIDLEEAED------------------EIEDIQQEISVLSQCDS 70 (467)
T ss_pred cccccccchhccccccceeeeeeecc--ccceEEEEEechhhcch------------------hhHHHHHHHHHHHhcCc
Confidence 45568889999999999999999987 99999999997665432 23678889999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||.++|+.+..+..++++||||.||++.+.+ ..+..+++..+..++++++.|+.|+ |.++.+|+|||+.||+
T Consensus 71 ~~it~yygsyl~g~~LwiiMey~~gGsv~~lL----~~~~~~~E~~i~~ilre~l~~l~yl---H~~~kiHrDIKaanil 143 (467)
T KOG0201|consen 71 PNITEYYGSYLKGTKLWIIMEYCGGGSVLDLL----KSGNILDEFEIAVILREVLKGLDYL---HSEKKIHRDIKAANIL 143 (467)
T ss_pred chHHhhhhheeecccHHHHHHHhcCcchhhhh----ccCCCCccceeeeehHHHHHHhhhh---hhcceeccccccccee
Confidence 99999999999999999999999999999999 4555568888999999999999999 8889999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhh
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEM 278 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~ 278 (337)
+..+|.++|+|||++.+........ ....|||.|||||++++..|+.++||||||++.+||.+|.+||...+.-...
T Consensus 144 ~s~~g~vkl~DfgVa~ql~~~~~rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl- 220 (467)
T KOG0201|consen 144 LSESGDVKLADFGVAGQLTNTVKRR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL- 220 (467)
T ss_pred EeccCcEEEEecceeeeeechhhcc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE-
Confidence 9999999999999998876543332 5678999999999999989999999999999999999999999775541111
Q ss_pred hHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 279 DMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.-+....+ +..+ ......+++|+..||+.||+.||||.++|+|
T Consensus 221 ------flIpk~~P--P~L~--------~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 221 ------FLIPKSAP--PRLD--------GDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ------EeccCCCC--Cccc--------cccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 00111111 1111 1223348999999999999999999999987
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-44 Score=292.93 Aligned_cols=242 Identities=24% Similarity=0.313 Sum_probs=201.5
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
-++|++++.||.|+||.|-+++.+. +|..+|+|.+......+-.+ ++....|..+|+.+.||
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~--~g~yYAmKvL~k~~vVklKQ----------------veH~~nEk~vL~~v~~P 104 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKH--SGNYYAMKVLDKQKVVKLKQ----------------VEHTHNEKRVLKAVSHP 104 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEcc--CCceeehhhcCHHHHHHHHH----------------HHHHhhHHHHHhhccCc
Confidence 3569999999999999999998876 89999999986654333222 27788899999999999
Q ss_pred CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceee
Q 040898 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI 199 (337)
Q Consensus 120 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~ 199 (337)
+++++++.+.+.+.+|+||||.+||.|..++ .+.+.++++.+.-++.+|+.|+.|| |+.+|++||+||+||++
T Consensus 105 Flv~l~~t~~d~~~lymvmeyv~GGElFS~L----rk~~rF~e~~arFYAAeivlAleyl---H~~~iiYRDLKPENiLl 177 (355)
T KOG0616|consen 105 FLVKLYGTFKDNSNLYMVMEYVPGGELFSYL----RKSGRFSEPHARFYAAEIVLALEYL---HSLDIIYRDLKPENLLL 177 (355)
T ss_pred eeEEEEEeeccCCeEEEEEeccCCccHHHHH----HhcCCCCchhHHHHHHHHHHHHHHH---HhcCeeeccCChHHeee
Confidence 9999999999999999999999999999999 4556799999999999999999999 77899999999999999
Q ss_pred cCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhh
Q 040898 200 DDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMD 279 (337)
Q Consensus 200 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~ 279 (337)
+.+|.+||+|||.+...... .-..+|||.|+|||++...++..++|.||||+++|||+.|.+||..... ..
T Consensus 178 D~~G~iKitDFGFAK~v~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~----~~ 248 (355)
T KOG0616|consen 178 DQNGHIKITDFGFAKRVSGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP----IQ 248 (355)
T ss_pred ccCCcEEEEeccceEEecCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh----HH
Confidence 99999999999999876543 2346899999999999999999999999999999999999999865333 22
Q ss_pred HHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCC
Q 040898 280 MVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERP 329 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp 329 (337)
+.+.+ ...... .++....++.+|+..+|+.|-.+|.
T Consensus 249 iY~KI---~~~~v~-----------fP~~fs~~~kdLl~~LL~vD~t~R~ 284 (355)
T KOG0616|consen 249 IYEKI---LEGKVK-----------FPSYFSSDAKDLLKKLLQVDLTKRF 284 (355)
T ss_pred HHHHH---HhCccc-----------CCcccCHHHHHHHHHHHhhhhHhhh
Confidence 22222 111111 1122233488999999999999993
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-43 Score=311.62 Aligned_cols=264 Identities=22% Similarity=0.372 Sum_probs=203.3
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
.++|++.+.||+|+||.||++.+.. ++..+|+|.+..+..... ...+.+|+.++++++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~~a~k~~~~~~~~~~------------------~~~~~~E~~~l~~l~h~ 63 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKP--SGLIMARKLIHLEIKPAI------------------RNQIIRELQVLHECNSP 63 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECC--CCcEEEEEEeecccCHHH------------------HHHHHHHHHHHHHCCCC
Confidence 4679999999999999999999876 899999999865432111 15688899999999999
Q ss_pred CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceee
Q 040898 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI 199 (337)
Q Consensus 120 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~ 199 (337)
||+++++++..++..++||||+++++|.+++.. ...+++..+..++.|++.|+.|||+ ..+++|+||+|+||++
T Consensus 64 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~ 137 (331)
T cd06649 64 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILV 137 (331)
T ss_pred CCCeEEEEEEECCEEEEEeecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEE
Confidence 999999999999999999999999999999843 3458899999999999999999942 2479999999999999
Q ss_pred cCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhh
Q 040898 200 DDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMD 279 (337)
Q Consensus 200 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~ 279 (337)
+.++.++|+|||++....... .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||..... ..
T Consensus 138 ~~~~~~kl~Dfg~~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~----~~ 209 (331)
T cd06649 138 NSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDA----KE 209 (331)
T ss_pred cCCCcEEEccCcccccccccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH----HH
Confidence 999999999999987653322 1234689999999999988899999999999999999999999964321 11
Q ss_pred HHHHHHhhhccCCc---c---------------------------h----hhhhcccCCchHHHHHHHHHHHhhhccCCC
Q 040898 280 MVKWMRNVIFSENP---N---------------------------R----AINSKLLGNGYEEQMLLVLKLACFCTLKDP 325 (337)
Q Consensus 280 ~~~~~~~~~~~~~~---~---------------------------~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 325 (337)
+............. . . ................++.+|+.+||+.||
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P 289 (331)
T cd06649 210 LEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNP 289 (331)
T ss_pred HHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCc
Confidence 11111100000000 0 0 000000000011234568999999999999
Q ss_pred CCCCChhhhhcC
Q 040898 326 DERPSSKDVRSM 337 (337)
Q Consensus 326 ~~Rps~~ell~~ 337 (337)
++|||+.++++|
T Consensus 290 ~~Rpt~~ell~h 301 (331)
T cd06649 290 AERADLKMLMNH 301 (331)
T ss_pred ccCCCHHHHhcC
Confidence 999999999987
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=315.25 Aligned_cols=261 Identities=23% Similarity=0.359 Sum_probs=198.3
Q ss_pred ccccccccceeccCcceEEEEeEEec---CCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHh
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELP---GSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQ 115 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~ 115 (337)
..++|++.+.||+|+||.||++.+.. ..++..||+|++........ ...+.+|+.++..
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~------------------~~~~~~E~~~l~~ 66 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASE------------------HKALMSELKILIH 66 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHH------------------HHHHHHHHHHHHH
Confidence 56789999999999999999987532 23567899999864322111 1467889999999
Q ss_pred c-CCCCcccceeEEEcC-CeeEEEEEeccCCCHHHHHHHhcCC-------------------------------------
Q 040898 116 T-RHRNILPLLAHMVRP-NCHLLVYEFMKNGSLQDILYDVSQG------------------------------------- 156 (337)
Q Consensus 116 l-~hpniv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~------------------------------------- 156 (337)
+ +||||+++++++... ..++++|||+++|+|.+++......
T Consensus 67 l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (338)
T cd05102 67 IGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLF 146 (338)
T ss_pred hccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccc
Confidence 9 899999999988764 4588999999999999998652210
Q ss_pred ---------------------cccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCCeEEecccCccc
Q 040898 157 ---------------------RRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKL 215 (337)
Q Consensus 157 ---------------------~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~~l~dfg~~~~ 215 (337)
..++++..+..++.||+.||.|| |+.|++|+||||+||+++.++.++|+|||++..
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~L---H~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~ 223 (338)
T cd05102 147 SRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARD 223 (338)
T ss_pred cccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHH---HHCCEECCCCccceEEEcCCCcEEEeecccccc
Confidence 23477788899999999999999 677999999999999999999999999999876
Q ss_pred cCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCchhhhHHHHHHhhhccCCcc
Q 040898 216 MPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHTEEMDMVKWMRNVIFSENPN 294 (337)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (337)
..............+++.|+|||.+.+..++.++||||||+++|+|++ |..||....... ........ .....
T Consensus 224 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~---~~~~~~~~---~~~~~ 297 (338)
T cd05102 224 IYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE---EFCQRLKD---GTRMR 297 (338)
T ss_pred cccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH---HHHHHHhc---CCCCC
Confidence 543322222222345678999999998889999999999999999997 999986532211 11111111 11000
Q ss_pred hhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 295 RAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
.+...+..+.+++.+||+.||++|||+.++++
T Consensus 298 ----------~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 298 ----------APENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred ----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 01122345889999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=308.43 Aligned_cols=268 Identities=21% Similarity=0.288 Sum_probs=199.8
Q ss_pred cccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC
Q 040898 38 KKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR 117 (337)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 117 (337)
++.++|++.+.||+|+||.||++.+.. +++.||+|++......... ..+.+|+.+++.++
T Consensus 2 ~~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~------------------~~~~~E~~~l~~l~ 61 (303)
T cd07869 2 GKADSYEKLEKLGEGSYATVYKGKSKV--NGKLVALKVIRLQEEEGTP------------------FTAIREASLLKGLK 61 (303)
T ss_pred CccccceEeeeEEecCCEEEEEEEECC--CCCEEEEEEeccccccccc------------------hhHHHHHHHHhhCC
Confidence 456889999999999999999999876 8999999998644321111 34667999999999
Q ss_pred CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCce
Q 040898 118 HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANV 197 (337)
Q Consensus 118 hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ni 197 (337)
||||+++++++.++...++||||++ ++|.+++.. ....+++..+..++.|++.||.|| |++|++|+||||+||
T Consensus 62 h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~l---H~~~ivH~dlkp~Ni 134 (303)
T cd07869 62 HANIVLLHDIIHTKETLTLVFEYVH-TDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYI---HQRYILHRDLKPQNL 134 (303)
T ss_pred CCCcCeEEEEEecCCeEEEEEECCC-cCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHE
Confidence 9999999999999999999999996 477777743 345688889999999999999999 778999999999999
Q ss_pred eecCCCCeEEecccCccccCCCCceeeeecccCCCCccCcccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCCCch
Q 040898 198 LIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQT-ETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTE 276 (337)
Q Consensus 198 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~ 276 (337)
+++.++.++|+|||++........ ......+++.|+|||++.+ ..++.++|+||+|+++|+|++|..||......
T Consensus 135 ll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-- 210 (303)
T cd07869 135 LISDTGELKLADFGLARAKSVPSH--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI-- 210 (303)
T ss_pred EECCCCCEEECCCCcceeccCCCc--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH--
Confidence 999999999999999865432211 1123467899999999865 45788999999999999999999999754221
Q ss_pred hhhHHHHHHhhhccCCcc--------hhhhhc-c---cCCchH------HHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 277 EMDMVKWMRNVIFSENPN--------RAINSK-L---LGNGYE------EQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~--------~~~~~~-~---~~~~~~------~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
......+.......... ....+. . ...... .....+.+|+.+||+.||++|||+.++++|
T Consensus 211 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 211 -QDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred -HHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 11111111111000000 000000 0 000000 012457899999999999999999999987
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=311.50 Aligned_cols=274 Identities=28% Similarity=0.368 Sum_probs=206.7
Q ss_pred ccccccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHH
Q 040898 33 DLAFLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIIT 112 (337)
Q Consensus 33 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 112 (337)
+.+=.+.-+.|++++.||+|.||.|-++.+.. +++.||||++.+..-.+......+. ....-.++...+|+.+
T Consensus 89 ~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~--~~~l~AiKil~K~~~~~~~~~~~~~-----a~~~~~~ekv~~EIai 161 (576)
T KOG0585|consen 89 DDQDRKQLNQYELIKEIGSGQYGKVKLARDEV--DGKLYAIKILPKKELRRQYGFPRQP-----AMKLMPIEKVRREIAI 161 (576)
T ss_pred CcccceehhheehhhhhcCCccceEEEEeecC--CCcEEEEEeechhhhhhhccccccc-----ccccCcHHHHHHHHHH
Confidence 34444566779999999999999998888877 9999999999765432211111000 1111123689999999
Q ss_pred HHhcCCCCcccceeEEEcC--CeeEEEEEeccCCCHHHHHHHhcCCccc-CChHHHHHHHHHHHHHHHHHhhCCCCCeEe
Q 040898 113 ANQTRHRNILPLLAHMVRP--NCHLLVYEFMKNGSLQDILYDVSQGRRE-LDWPARHRIARGIASGLEYLHMCHRPRLIH 189 (337)
Q Consensus 113 l~~l~hpniv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~-~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h 189 (337)
|+++.|||||+++++..+. ..+|+|+|||..|.+... ....+ +.+.++++++++++.||.|| |.+||+|
T Consensus 162 lKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~-----p~d~~els~~~Ar~ylrDvv~GLEYL---H~QgiiH 233 (576)
T KOG0585|consen 162 LKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWC-----PPDKPELSEQQARKYLRDVVLGLEYL---HYQGIIH 233 (576)
T ss_pred HHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccC-----CCCcccccHHHHHHHHHHHHHHHHHH---HhcCeec
Confidence 9999999999999998765 578999999988866432 23334 89999999999999999999 8889999
Q ss_pred cCCCCCceeecCCCCeEEecccCccccCCCCc---eeeeecccCCCCccCccccccCC----CCCcccchhhhHHHHHHH
Q 040898 190 RDIKPANVLIDDDMEARISDFGHGKLMPDGHA---QITVKCMVGTMGYMAPESLQTET----ISDKCDIYSFGVLLAVLV 262 (337)
Q Consensus 190 ~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~~~~PE~~~~~~----~~~~~DiwslG~i~~~ll 262 (337)
|||||+|+|++.+|.+||+|||.+..+..+.. ........|||.|+|||...+.. .+.+.||||+|+++|+|+
T Consensus 234 RDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCll 313 (576)
T KOG0585|consen 234 RDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLL 313 (576)
T ss_pred cccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhh
Confidence 99999999999999999999999887632211 11122368999999999987633 356789999999999999
Q ss_pred hCCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 263 MGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 263 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.|+.||... .....+.+.... .+.-+..++..+++.+||.+||.+||+.|.++.+|..|
T Consensus 314 fG~~PF~~~---~~~~l~~KIvn~-------------pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H 372 (576)
T KOG0585|consen 314 FGQLPFFDD---FELELFDKIVND-------------PLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLH 372 (576)
T ss_pred hccCCcccc---hHHHHHHHHhcC-------------cccCCCcccccHHHHHHHHHHhhcChhheeehhhheec
Confidence 999998432 111122221111 11122233556679999999999999999999999776
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=313.61 Aligned_cols=246 Identities=24% Similarity=0.320 Sum_probs=195.9
Q ss_pred ceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCccccee
Q 040898 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLLA 126 (337)
Q Consensus 47 ~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~ 126 (337)
+.||+|+||.||++.+.. +|+.||+|++......... ....+.+|+.++..++||||+++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~--~~~~~aiK~~~~~~~~~~~----------------~~~~~~~e~~~l~~l~hp~i~~~~~ 62 (323)
T cd05571 1 KLLGKGTFGKVILVREKA--TGKYYAMKILKKEVIIAKD----------------EVAHTLTESRVLQNTRHPFLTALKY 62 (323)
T ss_pred CeeeeCCCeEEEEEEECC--CCCEEEEEEEEHHHhhhhH----------------HHHHHHHHHHHHHhCCCCCCCCEEE
Confidence 469999999999998876 8999999998643221111 1146678999999999999999999
Q ss_pred EEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCCeE
Q 040898 127 HMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEAR 206 (337)
Q Consensus 127 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~~ 206 (337)
.+..++..++||||+++++|.+++. ....+++..+..++.||+.||.|| |+.|++|+||||+||+++.++.++
T Consensus 63 ~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~l---H~~~ivHrDlkp~NIll~~~~~~k 135 (323)
T cd05571 63 SFQTHDRLCFVMEYANGGELFFHLS----RERVFSEDRARFYGAEIVSALGYL---HSCDVVYRDLKLENLMLDKDGHIK 135 (323)
T ss_pred EEEcCCEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHH---HhCCeEeCCCCHHHEEECCCCCEE
Confidence 9999999999999999999999884 345688999999999999999999 778999999999999999999999
Q ss_pred EecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHHHHHHh
Q 040898 207 ISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRN 286 (337)
Q Consensus 207 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 286 (337)
|+|||++........ ......|++.|+|||++.+..++.++|+|||||++|+|++|..||..... ......
T Consensus 136 l~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~----~~~~~~--- 206 (323)
T cd05571 136 ITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----EKLFEL--- 206 (323)
T ss_pred EeeCCCCcccccCCC--cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH----HHHHHH---
Confidence 999999865322211 11234689999999999998999999999999999999999999854211 111111
Q ss_pred hhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCC-----ChhhhhcC
Q 040898 287 VIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERP-----SSKDVRSM 337 (337)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 337 (337)
....... .+......+.+++.+||+.||++|| ++.++++|
T Consensus 207 ~~~~~~~-----------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 207 ILMEEIR-----------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred HHcCCCC-----------CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 1111110 0112334588999999999999999 89999987
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-44 Score=284.12 Aligned_cols=256 Identities=26% Similarity=0.360 Sum_probs=212.4
Q ss_pred ccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc
Q 040898 37 LKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT 116 (337)
Q Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 116 (337)
.-+-++|++++.||+|.||.||++...+ ++--||+|++.++.... ..+ -..+.+|+.+...|
T Consensus 18 ~~~l~dfeigr~LgkgkFG~vYlarekk--s~~IvalKVlfKsqi~~------~~v----------~~qlrREiEIqs~L 79 (281)
T KOG0580|consen 18 TWTLDDFEIGRPLGKGKFGNVYLAREKK--SLFIVALKVLFKSQILK------TQV----------EHQLRREIEIQSHL 79 (281)
T ss_pred ccchhhccccccccCCccccEeEeeecc--CCcEEEEeeeeHHHHHH------hcc----------hhhhhheeEeeccc
Confidence 3367789999999999999999999876 89999999986543211 111 16788999999999
Q ss_pred CCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 040898 117 RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPAN 196 (337)
Q Consensus 117 ~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~n 196 (337)
+||||++++++|-+...+|+++||.+.|+|...++. +....+++...+.+..|++.|+.|+ |..+++||||+|+|
T Consensus 80 ~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~--~~~~~f~e~~~a~Yi~q~A~Al~y~---h~k~VIhRdiKpen 154 (281)
T KOG0580|consen 80 RHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQE--GRMKRFDEQRAATYIKQLANALLYC---HLKRVIHRDIKPEN 154 (281)
T ss_pred CCccHHhhhhheeccceeEEEEEecCCchHHHHHHh--cccccccccchhHHHHHHHHHHHHh---ccCCcccCCCCHHH
Confidence 999999999999999999999999999999999964 3556689999999999999999999 88899999999999
Q ss_pred eeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCch
Q 040898 197 VLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTE 276 (337)
Q Consensus 197 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~ 276 (337)
+|++..+.++++|||.+.....+. ....+||..|.|||...+..++..+|+|++|++.||++.|.+||+....+
T Consensus 155 lLlg~~~~lkiAdfGwsV~~p~~k----R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~-- 228 (281)
T KOG0580|consen 155 LLLGSAGELKIADFGWSVHAPSNK----RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS-- 228 (281)
T ss_pred hccCCCCCeeccCCCceeecCCCC----ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH--
Confidence 999999999999999988765332 23467999999999999999999999999999999999999999764322
Q ss_pred hhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 277 EMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
+..+.+...-.. .++.......++|.+|+..+|.+|.+..|+++|
T Consensus 229 --etYkrI~k~~~~--------------~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 229 --ETYKRIRKVDLK--------------FPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred --HHHHHHHHcccc--------------CCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 222222221111 112334448999999999999999999999886
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-44 Score=286.87 Aligned_cols=266 Identities=24% Similarity=0.324 Sum_probs=210.6
Q ss_pred ccccccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHH
Q 040898 33 DLAFLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIIT 112 (337)
Q Consensus 33 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 112 (337)
+.+.+--++||++.++||.|||+.||++.... ++..||+|++.-.+... .+...+|++.
T Consensus 13 ~~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s--~~~~YAlKkI~c~~~~~-------------------~e~~~rEid~ 71 (302)
T KOG2345|consen 13 RGTVIINNKRYRIQRLLGEGGFSFVDLVKGLS--TGHLYALKKILCHSQED-------------------IEEALREIDN 71 (302)
T ss_pred CCcEEEcCceEEEeeeecCCCceeeeeecccC--cccchhhheeeccchHH-------------------HHHHHHHHHH
Confidence 44556678899999999999999999999876 99999999997654211 1678899999
Q ss_pred HHhcCCCCcccceeEEEcC-----CeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCC-
Q 040898 113 ANQTRHRNILPLLAHMVRP-----NCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPR- 186 (337)
Q Consensus 113 l~~l~hpniv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~g- 186 (337)
.+.++|||+++++++...+ ...|++++|...|+|.+.++....++..+++..++.++.+|+.||.+| |...
T Consensus 72 ~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~l---H~~~~ 148 (302)
T KOG2345|consen 72 HRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEAL---HEKEP 148 (302)
T ss_pred HHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHH---hccCC
Confidence 9999999999999876433 458999999999999999998888888999999999999999999999 5555
Q ss_pred -eEecCCCCCceeecCCCCeEEecccCccccCCCCce-------eeeecccCCCCccCccccc---cCCCCCcccchhhh
Q 040898 187 -LIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQ-------ITVKCMVGTMGYMAPESLQ---TETISDKCDIYSFG 255 (337)
Q Consensus 187 -i~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~-------~~~~~~~~~~~~~~PE~~~---~~~~~~~~DiwslG 255 (337)
+.|+||||.||++++++.+++.|||.++...-.... ........|..|.|||++. +...++++||||||
T Consensus 149 ~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLG 228 (302)
T KOG2345|consen 149 PYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLG 228 (302)
T ss_pred cccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhh
Confidence 999999999999999999999999998765422111 1111235789999999985 45578999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhh
Q 040898 256 VLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVR 335 (337)
Q Consensus 256 ~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 335 (337)
|++|.|+.|..||+...+......+.-...++. -+..+..++.+.+++.+||++||.+||++.+++
T Consensus 229 CtLYa~mf~~sPfe~~~~~GgSlaLAv~n~q~s--------------~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll 294 (302)
T KOG2345|consen 229 CTLYAMMFGESPFERIYQQGGSLALAVQNAQIS--------------IPNSSRYSEALHQLIKSMLQVDPNQRPTIPELL 294 (302)
T ss_pred HHHHHHHHcCCcchHHhhcCCeEEEeeeccccc--------------cCCCCCccHHHHHHHHHHhcCCcccCCCHHHHH
Confidence 999999999999975433222211111110111 111122556699999999999999999999998
Q ss_pred c
Q 040898 336 S 336 (337)
Q Consensus 336 ~ 336 (337)
.
T Consensus 295 ~ 295 (302)
T KOG2345|consen 295 S 295 (302)
T ss_pred H
Confidence 5
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=313.86 Aligned_cols=252 Identities=20% Similarity=0.248 Sum_probs=200.5
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++.+.||+|+||.||++.+.. ..+..||+|.+........ .....+.+|+.+++.++|
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~-~~~~~vavK~~~~~~~~~~----------------~~~~~~~~E~~~l~~l~h 90 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKN-EDFPPVAIKRFEKSKIIKQ----------------KQVDHVFSERKILNYINH 90 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEEC-CCCeEEEEEEEEHHHhhhh----------------hhHHHHHHHHHHHHhCCC
Confidence 55679999999999999999988753 2346899998854321111 111567889999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++++.+....++||||+++|+|.+++. ....+++..+..++.|++.||.|| |+.|++|+||+|+||+
T Consensus 91 p~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~----~~~~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDLkp~NIL 163 (340)
T PTZ00426 91 PFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLR----RNKRFPNDVGCFYAAQIVLIFEYL---QSLNIVYRDLKPENLL 163 (340)
T ss_pred CCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHH---HHCCeEccCCCHHHEE
Confidence 999999999999999999999999999999984 344688999999999999999999 7779999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhh
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEM 278 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~ 278 (337)
++.++.++|+|||++....... ....||+.|+|||++.+..++.++|+||+|+++|+|++|..||..... .
T Consensus 164 l~~~~~ikL~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~----~ 234 (340)
T PTZ00426 164 LDKDGFIKMTDFGFAKVVDTRT-----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP----L 234 (340)
T ss_pred ECCCCCEEEecCCCCeecCCCc-----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH----H
Confidence 9999999999999987654321 234689999999999988899999999999999999999999864321 1
Q ss_pred hHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCC-----ChhhhhcC
Q 040898 279 DMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERP-----SSKDVRSM 337 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 337 (337)
.....+ ....... +......+.+++.+||+.||++|+ |+.++++|
T Consensus 235 ~~~~~i---~~~~~~~-----------p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 235 LIYQKI---LEGIIYF-----------PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred HHHHHH---hcCCCCC-----------CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 111111 1111100 011223478999999999999995 89999887
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=316.92 Aligned_cols=257 Identities=26% Similarity=0.372 Sum_probs=202.7
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
++|++.+.||+|+||.||++.+.. +++.||+|++........ .....+..|+.++..++|||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~--~~~~~aiK~~~~~~~~~~----------------~~~~~~~~e~~~l~~~~~~~ 62 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKD--TGQVYAMKVLRKSDMIKR----------------NQIAHVRAERDILADADSPW 62 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECC--CCCEEEEEEEEHHHHhhc----------------cHHHHHHHHHHHHHhcCCCC
Confidence 479999999999999999999876 899999999864321110 11156788999999999999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
|+++++.+.+++..++||||+++++|.+++.. ...+++..+..++.|++.||.|| |+.|++|+||+|+||+++
T Consensus 63 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~L---H~~giiH~Dlkp~NIll~ 135 (350)
T cd05573 63 IVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSV---HKLGFIHRDIKPDNILID 135 (350)
T ss_pred ccchhhheecCCeEEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHeEEC
Confidence 99999999999999999999999999999854 35689999999999999999999 678999999999999999
Q ss_pred CCCCeEEecccCccccCCCC---------------------------ceeeeecccCCCCccCccccccCCCCCcccchh
Q 040898 201 DDMEARISDFGHGKLMPDGH---------------------------AQITVKCMVGTMGYMAPESLQTETISDKCDIYS 253 (337)
Q Consensus 201 ~~~~~~l~dfg~~~~~~~~~---------------------------~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Diws 253 (337)
.++.++|+|||++....... .........||+.|+|||.+.+..++.++||||
T Consensus 136 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 215 (350)
T cd05573 136 ADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWS 215 (350)
T ss_pred CCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEe
Confidence 99999999999987654432 001122346899999999999999999999999
Q ss_pred hhHHHHHHHhCCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCC-hh
Q 040898 254 FGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPS-SK 332 (337)
Q Consensus 254 lG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-~~ 332 (337)
|||++|+|++|..||...... ..... +......... +.....+..+.+++.+||. ||.+||+ +.
T Consensus 216 lG~il~ell~g~~Pf~~~~~~---~~~~~-i~~~~~~~~~----------p~~~~~~~~~~~li~~ll~-dp~~R~~s~~ 280 (350)
T cd05573 216 LGVILYEMLYGFPPFYSDTLQ---ETYNK-IINWKESLRF----------PPDPPVSPEAIDLICRLLC-DPEDRLGSFE 280 (350)
T ss_pred cchhhhhhccCCCCCCCCCHH---HHHHH-HhccCCcccC----------CCCCCCCHHHHHHHHHHcc-ChhhcCCCHH
Confidence 999999999999999654321 11111 1110000000 0000123458899999997 9999999 99
Q ss_pred hhhcC
Q 040898 333 DVRSM 337 (337)
Q Consensus 333 ell~~ 337 (337)
++++|
T Consensus 281 ~ll~h 285 (350)
T cd05573 281 EIKSH 285 (350)
T ss_pred HHhcC
Confidence 99987
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=307.83 Aligned_cols=264 Identities=22% Similarity=0.373 Sum_probs=201.5
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
.++|++.++||+|+||.||++.+.. ++..+|+|.+........ ...+.+|++++++++||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~--~~~~~a~k~~~~~~~~~~------------------~~~~~~E~~~l~~l~h~ 63 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKP--SGLIMARKLIHLEIKPAI------------------RNQIIRELQVLHECNSP 63 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECC--CCcEEEEEEeecccCHHH------------------HHHHHHHHHHHHHCCCC
Confidence 4789999999999999999998876 889999998865432111 14678899999999999
Q ss_pred CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceee
Q 040898 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI 199 (337)
Q Consensus 120 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~ 199 (337)
||+++++++.+++..++||||+++++|.+++.. ...+++..+..++.|++.++.|||+ ..+++|+||+|+||++
T Consensus 64 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili 137 (333)
T cd06650 64 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILV 137 (333)
T ss_pred cccceeEEEEECCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEE
Confidence 999999999999999999999999999999843 3458889999999999999999942 3579999999999999
Q ss_pred cCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhh
Q 040898 200 DDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMD 279 (337)
Q Consensus 200 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~ 279 (337)
+.++.++|+|||++....... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...... .
T Consensus 138 ~~~~~~kL~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~----~ 209 (333)
T cd06650 138 NSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAK----E 209 (333)
T ss_pred cCCCCEEEeeCCcchhhhhhc----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchh----H
Confidence 999999999999987553321 12346889999999999888999999999999999999999998643221 1
Q ss_pred HHHHHHhhhccCCcch----------------------------hhh----hcccCCchHHHHHHHHHHHhhhccCCCCC
Q 040898 280 MVKWMRNVIFSENPNR----------------------------AIN----SKLLGNGYEEQMLLVLKLACFCTLKDPDE 327 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~----------------------------~~~----~~~~~~~~~~~~~~l~~li~~~l~~dP~~ 327 (337)
+............... ... ..............+.+|+.+||+.||++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~ 289 (333)
T cd06650 210 LELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAE 289 (333)
T ss_pred HHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCccc
Confidence 1111000000000000 000 00000000112355889999999999999
Q ss_pred CCChhhhhcC
Q 040898 328 RPSSKDVRSM 337 (337)
Q Consensus 328 Rps~~ell~~ 337 (337)
|||+.|+++|
T Consensus 290 Rpt~~ell~h 299 (333)
T cd06650 290 RADLKQLMVH 299 (333)
T ss_pred CcCHHHHhhC
Confidence 9999999986
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=295.99 Aligned_cols=273 Identities=22% Similarity=0.293 Sum_probs=208.6
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
...|+.+++||+|+||+||++.+.. +|+.||+|++..+..... ......+|+.+++.++|+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~--~g~~VALKkirl~~~~EG-----------------~P~taiREisllk~L~~~ 70 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKR--TGKFVALKKIRLEFEEEG-----------------VPSTAIREISLLKRLSHA 70 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEec--CCCEEEEEEEeccccccC-----------------CCchhhHHHHHHHHhCCC
Confidence 5569999999999999999999987 999999999977654211 014678899999999999
Q ss_pred C-cccceeEEEcCC------eeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 040898 120 N-ILPLLAHMVRPN------CHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDI 192 (337)
Q Consensus 120 n-iv~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di 192 (337)
| |+.+++++.+.+ .+++|+||++. +|..++..........+...+..++.||+.|+.|+ |++||+||||
T Consensus 71 ~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~---H~~~IlHRDL 146 (323)
T KOG0594|consen 71 NHIVRLHDVIHTSNNHRGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFL---HSHGILHRDL 146 (323)
T ss_pred cceEEEEeeeeecccccccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHH---HhCCeecccC
Confidence 9 999999988776 88999999976 99999976544334577789999999999999999 8889999999
Q ss_pred CCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCC
Q 040898 193 KPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTE-TISDKCDIYSFGVLLAVLVMGKFPVDDF 271 (337)
Q Consensus 193 ~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~i~~~ll~g~~pf~~~ 271 (337)
||+||+++++|.+||+|||+++.+..... ..+....|..|.|||++.|. .|+...|+||+|||++||+++++-|.+.
T Consensus 147 KPQNlLi~~~G~lKlaDFGlAra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~ 224 (323)
T KOG0594|consen 147 KPQNLLISSSGVLKLADFGLARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGD 224 (323)
T ss_pred CcceEEECCCCcEeeeccchHHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999986543322 23445688899999999887 6899999999999999999999888664
Q ss_pred CCCchhhhHHHHHHhhhccCCcchh----hhhcc--------cCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 272 FGHTEEMDMVKWMRNVIFSENPNRA----INSKL--------LGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
...+....+...+.......++... ..... .....+....+..+++.+||+.+|.+|.|+..+|+|
T Consensus 225 se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 225 SEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred cHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 4322111222211111111111111 00000 001111222468999999999999999999999987
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=315.72 Aligned_cols=258 Identities=21% Similarity=0.335 Sum_probs=196.2
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
..|++++.||+|+||.||++.+.. +++.||+|++......... ....+.+|+.+++.++|||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~--~~~~~aiK~i~~~~~~~~~----------------~~~~~~~E~~il~~l~h~~ 62 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVD--THALYAMKTLRKKDVLNRN----------------QVAHVKAERDILAEADNEW 62 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECC--CCCEEEEEEEEHHHhhhhH----------------HHHHHHHHHHHHHhcCCCC
Confidence 368999999999999999999876 8999999998653221111 1156888999999999999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
|+++++.+.++...++||||+++|+|.+++.. ...+++..+..++.||+.||.|| |+.|++|+||||+||+++
T Consensus 63 iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~L---H~~givHrDlKp~Nili~ 135 (381)
T cd05626 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESV---HKMGFIHRDIKPDNILID 135 (381)
T ss_pred eeeeEEEEecCCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HhCCeeecCCcHHHEEEC
Confidence 99999999999999999999999999999843 34588889999999999999999 778999999999999999
Q ss_pred CCCCeEEecccCccccCCCCce---------------------------------------------eeeecccCCCCcc
Q 040898 201 DDMEARISDFGHGKLMPDGHAQ---------------------------------------------ITVKCMVGTMGYM 235 (337)
Q Consensus 201 ~~~~~~l~dfg~~~~~~~~~~~---------------------------------------------~~~~~~~~~~~~~ 235 (337)
.++.++|+|||++..+...... .......||+.|+
T Consensus 136 ~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 215 (381)
T cd05626 136 LDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYI 215 (381)
T ss_pred CCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCcccc
Confidence 9999999999987543110000 0001246899999
Q ss_pred CccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHH
Q 040898 236 APESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLK 315 (337)
Q Consensus 236 ~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 315 (337)
|||++.+..++.++|||||||++|+|++|..||....... ....... ....... +........+.+
T Consensus 216 aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~---~~~~i~~---~~~~~~~--------~~~~~~s~~~~d 281 (381)
T cd05626 216 APEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTE---TQLKVIN---WENTLHI--------PPQVKLSPEAVD 281 (381)
T ss_pred CHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHH---HHHHHHc---cccccCC--------CCCCCCCHHHHH
Confidence 9999998889999999999999999999999996532211 1111110 0000000 000012233667
Q ss_pred HHhh--hccCCCCCCCChhhhhcC
Q 040898 316 LACF--CTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 316 li~~--~l~~dP~~Rps~~ell~~ 337 (337)
|+.+ |+..+|..|||+.++++|
T Consensus 282 li~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 282 LITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HHHHHccCcccccCCCCHHHHhcC
Confidence 7777 445666679999999987
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=298.81 Aligned_cols=266 Identities=23% Similarity=0.323 Sum_probs=205.6
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
.=.|+..+++|+|+||.||.+.... ++..||||+...+... -.+|+.+|+.++||
T Consensus 23 ~i~~~~~~liG~GsFg~Vyq~~~~e--~~~~vAIKKv~~d~r~-----------------------knrEl~im~~l~Hp 77 (364)
T KOG0658|consen 23 EISYEAVRLIGSGSFGVVYQAKLRE--TEEEVAIKKVLQDKRY-----------------------KNRELQIMRKLDHP 77 (364)
T ss_pred EEEEEeeEEEeecccceEEEEEEcC--CCceeEEEEecCCCCc-----------------------CcHHHHHHHhcCCc
Confidence 3458899999999999999998876 7999999999776542 23589999999999
Q ss_pred CcccceeEEEcCC-----eeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCC
Q 040898 120 NILPLLAHMVRPN-----CHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKP 194 (337)
Q Consensus 120 niv~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~ 194 (337)
|||++.-+|.... +..+||||++. +|.++++.....+..++...+.-+..||+.||.|| |+.||+||||||
T Consensus 78 NIV~L~~~f~~~~~~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yL---h~~~IcHRDIKP 153 (364)
T KOG0658|consen 78 NIVRLLYFFSSSTESDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYL---HSHGICHRDIKP 153 (364)
T ss_pred CeeeEEEEEEecCCCchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHH---HhcCcccCCCCh
Confidence 9999998875432 34689999988 99999987767778899999999999999999999 778999999999
Q ss_pred CceeecCC-CCeEEecccCccccCCCCceeeeecccCCCCccCccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCC
Q 040898 195 ANVLIDDD-MEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTE-TISDKCDIYSFGVLLAVLVMGKFPVDDFF 272 (337)
Q Consensus 195 ~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~i~~~ll~g~~pf~~~~ 272 (337)
.|+|++.+ |.+||+|||.|..+..+... .....|..|.|||++.|. .|+.+.||||.||++.||+-|++-|.+..
T Consensus 154 qNlLvD~~tg~LKicDFGSAK~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s 230 (364)
T KOG0658|consen 154 QNLLVDPDTGVLKICDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDS 230 (364)
T ss_pred heEEEcCCCCeEEeccCCcceeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCC
Confidence 99999976 89999999999987666544 345678899999999875 58999999999999999999999987644
Q ss_pred CCchhhhHHHHHHh--------hhcc--CCcchhhhhcccCC-chHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 273 GHTEEMDMVKWMRN--------VIFS--ENPNRAINSKLLGN-GYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 273 ~~~~~~~~~~~~~~--------~~~~--~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
+.+....+.+...- +... .............. .......+..+|+.++|.++|.+|.|+.|++.|
T Consensus 231 ~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 231 SVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred HHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 43333233222110 0000 00001111111001 223344568999999999999999999999986
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=313.68 Aligned_cols=262 Identities=23% Similarity=0.277 Sum_probs=197.5
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
.++|++++.||+|+||.||++.+.. +++.||+|.... ..+.+|+.++++++||
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~--~~~~vaiK~~~~-------------------------~~~~~E~~il~~l~Hp 143 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNK--TCEHVVIKAGQR-------------------------GGTATEAHILRAINHP 143 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECC--CCCEEEEechhh-------------------------hhhHHHHHHHHhCCCC
Confidence 4679999999999999999999976 899999996421 3456799999999999
Q ss_pred CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceee
Q 040898 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI 199 (337)
Q Consensus 120 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~ 199 (337)
||+++++++..+...++++|++. ++|..++. ....+++..++.++.||+.||.|| |++|++|+||||+||++
T Consensus 144 nIv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~yl---H~~~IvHrDiKP~NIll 215 (391)
T PHA03212 144 SIIQLKGTFTYNKFTCLILPRYK-TDLYCYLA----AKRNIAICDILAIERSVLRAIQYL---HENRIIHRDIKAENIFI 215 (391)
T ss_pred CCCCEeEEEEECCeeEEEEecCC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCChHhEEE
Confidence 99999999999999999999995 58888773 334688899999999999999999 77799999999999999
Q ss_pred cCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCc----
Q 040898 200 DDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHT---- 275 (337)
Q Consensus 200 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~---- 275 (337)
+.++.++|+|||++......... ......||+.|+|||++.+..++.++|+||||+++|+|++|..||-...+..
T Consensus 216 ~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~ 294 (391)
T PHA03212 216 NHPGDVCLGDFGAACFPVDINAN-KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCD 294 (391)
T ss_pred cCCCCEEEEeCCccccccccccc-ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCc
Confidence 99999999999998653322111 1223568999999999998889999999999999999999998764322111
Q ss_pred hhhhHHHHHHhhhccCC--c---chhhh---------------hcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhh
Q 040898 276 EEMDMVKWMRNVIFSEN--P---NRAIN---------------SKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVR 335 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~--~---~~~~~---------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 335 (337)
....+...+........ + ..... .+.........+..+.+|+.+||+.||++|||+.|+|
T Consensus 295 ~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL 374 (391)
T PHA03212 295 SDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALL 374 (391)
T ss_pred hhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHh
Confidence 01111111111000000 0 00000 0000001112345689999999999999999999999
Q ss_pred cC
Q 040898 336 SM 337 (337)
Q Consensus 336 ~~ 337 (337)
+|
T Consensus 375 ~h 376 (391)
T PHA03212 375 DF 376 (391)
T ss_pred cC
Confidence 87
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=316.05 Aligned_cols=257 Identities=22% Similarity=0.324 Sum_probs=199.5
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
++|++.+.||+|+||.||++.+.. +++.||+|++........ .....+.+|+.++..++|||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~----------------~~~~~~~~E~~il~~l~h~~ 62 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKD--TGHIYAMKKLRKSEMLEK----------------EQVAHVRAERDILAEADNPW 62 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECC--CCCEEEEEEEEHHHhhhh----------------hHHHHHHHHHHHHHhCCCCC
Confidence 479999999999999999999976 899999999864321111 11156778999999999999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
|+++++.+.++...++||||+++|+|.+++.. ...+++..+..++.|++.||.|| |+.|++|+||||+||+++
T Consensus 63 iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~l---H~~~ivH~Dlkp~NIl~~ 135 (364)
T cd05599 63 VVKLYYSFQDENYLYLIMEYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSI---HKLGYIHRDIKPDNLLLD 135 (364)
T ss_pred CcceEEEEEcCCeEEEEECCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeEeccCCHHHeEEC
Confidence 99999999999999999999999999999843 44689999999999999999999 777999999999999999
Q ss_pred CCCCeEEecccCccccCCCCcee------------------------------------eeecccCCCCccCccccccCC
Q 040898 201 DDMEARISDFGHGKLMPDGHAQI------------------------------------TVKCMVGTMGYMAPESLQTET 244 (337)
Q Consensus 201 ~~~~~~l~dfg~~~~~~~~~~~~------------------------------------~~~~~~~~~~~~~PE~~~~~~ 244 (337)
.++.++|+|||++.......... ......||+.|+|||++.+..
T Consensus 136 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 215 (364)
T cd05599 136 AKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG 215 (364)
T ss_pred CCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCC
Confidence 99999999999986543211000 001235899999999999888
Q ss_pred CCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCC
Q 040898 245 ISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKD 324 (337)
Q Consensus 245 ~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 324 (337)
++.++|+|||||++|+|++|..||..... ......+.. ...... . +........+.+++.+|+. +
T Consensus 216 ~~~~~DiwSlG~il~el~~G~~Pf~~~~~----~~~~~~i~~---~~~~~~-~------~~~~~~s~~~~~li~~ll~-~ 280 (364)
T cd05599 216 YNKECDWWSLGVIMYEMLVGYPPFCSDNP----QETYRKIIN---WKETLQ-F------PDEVPLSPEAKDLIKRLCC-E 280 (364)
T ss_pred CCCeeeeecchhHHHHhhcCCCCCCCCCH----HHHHHHHHc---CCCccC-C------CCCCCCCHHHHHHHHHHcc-C
Confidence 99999999999999999999999965322 111111111 000000 0 0000123347889999996 9
Q ss_pred CCCCCC---hhhhhcC
Q 040898 325 PDERPS---SKDVRSM 337 (337)
Q Consensus 325 P~~Rps---~~ell~~ 337 (337)
|.+|++ +.++++|
T Consensus 281 p~~R~~~~~~~~ll~h 296 (364)
T cd05599 281 AERRLGNNGVNEIKSH 296 (364)
T ss_pred HhhcCCCCCHHHHhcC
Confidence 999998 9999986
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=313.47 Aligned_cols=205 Identities=26% Similarity=0.410 Sum_probs=174.1
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
++|++.+.||+|+||+||++.+.. +++.||+|++........ .....+.+|..++..++|||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~----------------~~~~~~~~E~~il~~~~~~~ 62 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKD--TGHVYAMKILRKADMLEK----------------EQVGHIRAERDILVEADSLW 62 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECC--CCCEEEEEEEEHHHHHHh----------------hHHHHHHHHHHHHHhCCCCC
Confidence 479999999999999999998876 899999999864321111 11256778999999999999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
|+++++.+.+....|+||||+++|+|.+++. ....+++..+..++.|++.||.|| |+.|++|+||||+||+++
T Consensus 63 iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~l---H~~givHrDlKp~NILi~ 135 (363)
T cd05628 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM----KKDTLTEEETQFYIAETVLAIDSI---HQLGFIHRDIKPDNLLLD 135 (363)
T ss_pred cceEEEEEecCCeEEEEEcCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHH---HhCCeEecCCCHHHeEEC
Confidence 9999999999999999999999999999984 345689999999999999999999 778999999999999999
Q ss_pred CCCCeEEecccCccccCCCCce---------------------------------eeeecccCCCCccCccccccCCCCC
Q 040898 201 DDMEARISDFGHGKLMPDGHAQ---------------------------------ITVKCMVGTMGYMAPESLQTETISD 247 (337)
Q Consensus 201 ~~~~~~l~dfg~~~~~~~~~~~---------------------------------~~~~~~~~~~~~~~PE~~~~~~~~~ 247 (337)
.++.++|+|||++......... .......||+.|+|||++.+..++.
T Consensus 136 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~ 215 (363)
T cd05628 136 SKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNK 215 (363)
T ss_pred CCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCC
Confidence 9999999999998754321100 0012346899999999999988999
Q ss_pred cccchhhhHHHHHHHhCCCCCCC
Q 040898 248 KCDIYSFGVLLAVLVMGKFPVDD 270 (337)
Q Consensus 248 ~~DiwslG~i~~~ll~g~~pf~~ 270 (337)
++|+|||||++|+|++|..||..
T Consensus 216 ~~DvwSlGvil~ell~G~~Pf~~ 238 (363)
T cd05628 216 LCDWWSLGVIMYEMLIGYPPFCS 238 (363)
T ss_pred chhhhhhHHHHHHHHhCCCCCCC
Confidence 99999999999999999999964
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=316.53 Aligned_cols=257 Identities=22% Similarity=0.321 Sum_probs=196.6
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
++|++++.||+|+||.||++.+.. +++.||+|++........ .....+.+|+.++.+++|||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~--~~~~~aiK~~~~~~~~~~----------------~~~~~~~~E~~il~~l~hp~ 62 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKD--TGKIYAMKTLLKSEMFKK----------------DQLAHVKAERDVLAESDSPW 62 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECC--CCCEEEEEEEEHHHHHHh----------------HHHHHHHHHHHHHHhCCCCC
Confidence 479999999999999999998876 899999999854321111 11256788999999999999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
|+++++++.++...|+||||+++|+|.+++. ....+++..+..++.|++.||.|| |+.|++|+||||+||+++
T Consensus 63 iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~ql~~aL~~L---H~~givHrDlkp~NIll~ 135 (377)
T cd05629 63 VVSLYYSFQDAQYLYLIMEFLPGGDLMTMLI----KYDTFSEDVTRFYMAECVLAIEAV---HKLGFIHRDIKPDNILID 135 (377)
T ss_pred cceEEEEEEcCCeeEEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHEEEC
Confidence 9999999999999999999999999999984 345688899999999999999999 778999999999999999
Q ss_pred CCCCeEEecccCccccCCCCce------------e---------------------------------eeecccCCCCcc
Q 040898 201 DDMEARISDFGHGKLMPDGHAQ------------I---------------------------------TVKCMVGTMGYM 235 (337)
Q Consensus 201 ~~~~~~l~dfg~~~~~~~~~~~------------~---------------------------------~~~~~~~~~~~~ 235 (337)
.++.++|+|||++..+...... . ......||+.|+
T Consensus 136 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 215 (377)
T cd05629 136 RGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYI 215 (377)
T ss_pred CCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCcccc
Confidence 9999999999998633211000 0 001235899999
Q ss_pred CccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHH
Q 040898 236 APESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLK 315 (337)
Q Consensus 236 ~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 315 (337)
|||++.+..++.++|+|||||++|+|++|..||...... .....+... .... . .+........+.+
T Consensus 216 aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~----~~~~~i~~~--~~~~-~-------~p~~~~~s~~~~d 281 (377)
T cd05629 216 APEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSH----ETYRKIINW--RETL-Y-------FPDDIHLSVEAED 281 (377)
T ss_pred CHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHH----HHHHHHHcc--CCcc-C-------CCCCCCCCHHHHH
Confidence 999999888999999999999999999999998643221 111111100 0000 0 0000112334889
Q ss_pred HHhhhccCCCCCC---CChhhhhcC
Q 040898 316 LACFCTLKDPDER---PSSKDVRSM 337 (337)
Q Consensus 316 li~~~l~~dP~~R---ps~~ell~~ 337 (337)
|+.+||. +|.+| +|+.++++|
T Consensus 282 li~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 282 LIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred HHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 9999997 67665 599999986
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=303.35 Aligned_cols=270 Identities=21% Similarity=0.321 Sum_probs=194.5
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc---C
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT---R 117 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l---~ 117 (337)
++|++.+.||+|+||.||++.+.. .++..||+|.+.......... ..+.+|+.+++.+ +
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~-~~~~~vavK~~~~~~~~~~~~-----------------~~~~~e~~~l~~l~~~~ 62 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLK-NGGRFVALKRVRVQTGEEGMP-----------------LSTIREVAVLRHLETFE 62 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcC-CCCeEEEEEEEecccCCCCch-----------------HHHHHHHHHHHhhcccC
Confidence 479999999999999999998753 246889999886543221110 2334455555554 7
Q ss_pred CCCcccceeEEE-----cCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 040898 118 HRNILPLLAHMV-----RPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDI 192 (337)
Q Consensus 118 hpniv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di 192 (337)
||||+++++++. .....++|+||++ ++|.+++.. .....+++..+..++.|++.||.|| |+.|++|+||
T Consensus 63 hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~l---H~~~iiH~dl 136 (290)
T cd07862 63 HPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFL---HSHRVVHRDL 136 (290)
T ss_pred CCCcceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeCCC
Confidence 999999999875 3456899999997 489998854 2334588899999999999999999 7789999999
Q ss_pred CCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCC
Q 040898 193 KPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFF 272 (337)
Q Consensus 193 ~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~ 272 (337)
+|+||+++.++.++|+|||++....... ......+++.|+|||.+.+..++.++|+||+|+++|+|++|.+||....
T Consensus 137 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 213 (290)
T cd07862 137 KPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 213 (290)
T ss_pred CHHHEEEcCCCCEEEccccceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCC
Confidence 9999999999999999999987654331 1223468999999999988889999999999999999999999997543
Q ss_pred CCchhhhHHHHHHhhhccCCcc------hhhhhcc---cCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 273 GHTEEMDMVKWMRNVIFSENPN------RAINSKL---LGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.......+............+. ....... .....+.....+.+++.+||+.||++|||+.++|+|
T Consensus 214 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 214 DVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred HHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 2211111111110000000000 0000000 000112234567899999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=307.87 Aligned_cols=259 Identities=22% Similarity=0.321 Sum_probs=199.7
Q ss_pred cccccceeccCcceEEEEeEEec-CCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc-CCC
Q 040898 42 CFDSLKKIGSGGWGEVFYKAELP-GSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT-RHR 119 (337)
Q Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp 119 (337)
+|++++.||+|+||.||++.+.. ..+++.||+|++......... ...+.+..|+.++..+ .||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~---------------~~~~~~~~e~~~l~~l~~~~ 65 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKA---------------KTVEHTRTERNVLEHVRQSP 65 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhh---------------hHHHHHHHHHHHHHhccCCC
Confidence 58999999999999999987753 247899999998643211110 0114677899999999 599
Q ss_pred CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceee
Q 040898 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI 199 (337)
Q Consensus 120 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~ 199 (337)
||+.+++++..++..++||||+++++|.+++. ....+++..+..++.||+.||.|| |+.|++|+||||+||++
T Consensus 66 ~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivHrDlkp~Nili 138 (332)
T cd05614 66 FLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY----QRDNFSEDEVRFYSGEIILALEHL---HKLGIVYRDIKLENILL 138 (332)
T ss_pred CcccEEEEEecCCEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHH---HHCCcEecCCCHHHeEE
Confidence 99999999999999999999999999999884 344688999999999999999999 77899999999999999
Q ss_pred cCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCC-CCCcccchhhhHHHHHHHhCCCCCCCCCCCchhh
Q 040898 200 DDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTET-ISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEM 278 (337)
Q Consensus 200 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~ 278 (337)
+.++.++|+|||++.......... .....||+.|+|||.+.+.. ++.++||||||+++|+|++|..||..........
T Consensus 139 ~~~~~~kl~DfG~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~ 217 (332)
T cd05614 139 DSEGHVVLTDFGLSKEFLSEEKER-TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS 217 (332)
T ss_pred CCCCCEEEeeCcCCccccccCCCc-cccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH
Confidence 999999999999987653322211 12346899999999997654 7889999999999999999999996533322222
Q ss_pred hHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCC-----ChhhhhcC
Q 040898 279 DMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERP-----SSKDVRSM 337 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 337 (337)
.+...+ ...... .+......+.+++.+||+.||++|| ++.++++|
T Consensus 218 ~~~~~~---~~~~~~-----------~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 218 EVSRRI---LKCDPP-----------FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred HHHHHH---hcCCCC-----------CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 222211 111111 0111233478999999999999999 78899876
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=322.47 Aligned_cols=262 Identities=21% Similarity=0.287 Sum_probs=206.8
Q ss_pred ccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc
Q 040898 37 LKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT 116 (337)
Q Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 116 (337)
....++|++.+.||+|+||+||++.+.. +++.||+|.+......... ...+.+|+..+..+
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~--~g~~vAvK~i~~~~~~~~~-----------------~~~~~~Ei~~l~~~ 88 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVS--DGEPFAVKVVDMEGMSEAD-----------------KNRAQAEVCCLLNC 88 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcC--CCCEEEEEEEecccCCHHH-----------------HHHHHHHHHHHhcC
Confidence 3356789999999999999999998876 8999999998665332211 14567899999999
Q ss_pred CCCCcccceeEEEcCC--------eeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeE
Q 040898 117 RHRNILPLLAHMVRPN--------CHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLI 188 (337)
Q Consensus 117 ~hpniv~~~~~~~~~~--------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~ 188 (337)
+|+|+++++..+.... ..++||||+++|+|.+++.........+++..+..++.|++.||.|+ |+.|++
T Consensus 89 ~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~l---H~~~Ii 165 (496)
T PTZ00283 89 DFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHV---HSKHMI 165 (496)
T ss_pred CCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHH---HhCCEe
Confidence 9999999988764332 36899999999999999976555566789999999999999999999 778999
Q ss_pred ecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCC
Q 040898 189 HRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPV 268 (337)
Q Consensus 189 h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf 268 (337)
|+||||+||+++.++.++|+|||++................||+.|+|||.+.+..++.++||||||+++|+|++|..||
T Consensus 166 HrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf 245 (496)
T PTZ00283 166 HRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPF 245 (496)
T ss_pred cCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 99999999999999999999999987654332222223456899999999999988999999999999999999999998
Q ss_pred CCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 269 DDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.... .............. ..++.....+.+++.+||+.||.+|||+.++++|
T Consensus 246 ~~~~-------~~~~~~~~~~~~~~----------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 246 DGEN-------MEEVMHKTLAGRYD----------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCC-------HHHHHHHHhcCCCC----------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 6421 11111111111110 0111233458899999999999999999999875
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=295.83 Aligned_cols=258 Identities=22% Similarity=0.305 Sum_probs=210.1
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
..|+.+++||+|.-|+||++.... ++..+|+|++.+....+... +.++..|-.+|..++||.
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~--t~~~fAmKVmdK~~l~~rkK----------------l~Ra~tE~eIL~~lDHPF 138 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRG--TNCLFAMKVMDKESLASRKK----------------LKRAQTEREILSLLDHPF 138 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecC--CCceEEEEEecHHHHhhhhH----------------HHHHHHHHHHHHhcCCCc
Confidence 468999999999999999999977 78999999997665433221 267888999999999999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
++.+|..++.++..|++||||+||+|..++++ +.+..+++..+.-++..++.||.|| |-.|||.|||||+|||+.
T Consensus 139 lPTLYa~fet~~~~cl~meyCpGGdL~~Lrqk--Qp~~~fse~~aRFYaAEvl~ALEYL---HmlGivYRDLKPENILvr 213 (459)
T KOG0610|consen 139 LPTLYASFETDKYSCLVMEYCPGGDLHSLRQK--QPGKRFSESAARFYAAEVLLALEYL---HMLGIVYRDLKPENILVR 213 (459)
T ss_pred cchhhheeeccceeEEEEecCCCccHHHHHhh--CCCCccchhhHHHHHHHHHHHHHHH---HhhceeeccCCcceeEEe
Confidence 99999999999999999999999999999876 6667799999999999999999999 778999999999999999
Q ss_pred CCCCeEEecccCccccCCCC-------------------------------c-e----------------------eeee
Q 040898 201 DDMEARISDFGHGKLMPDGH-------------------------------A-Q----------------------ITVK 226 (337)
Q Consensus 201 ~~~~~~l~dfg~~~~~~~~~-------------------------------~-~----------------------~~~~ 226 (337)
++|+|.|+||+++....... . . ....
T Consensus 214 edGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSn 293 (459)
T KOG0610|consen 214 EDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSN 293 (459)
T ss_pred cCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccc
Confidence 99999999999865432100 0 0 0112
Q ss_pred cccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCch
Q 040898 227 CMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGY 306 (337)
Q Consensus 227 ~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (337)
..+||-.|+|||++.|...+.++|.|+||+++|||+.|.-||.+.... ..+...+.+ +. .-+..
T Consensus 294 SFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~---~Tl~NIv~~----~l---------~Fp~~ 357 (459)
T KOG0610|consen 294 SFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNK---ETLRNIVGQ----PL---------KFPEE 357 (459)
T ss_pred ccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCch---hhHHHHhcC----CC---------cCCCC
Confidence 346899999999999999999999999999999999999999764332 222222211 11 11112
Q ss_pred HHHHHHHHHHHhhhccCCCCCCCC----hhhhhcC
Q 040898 307 EEQMLLVLKLACFCTLKDPDERPS----SKDVRSM 337 (337)
Q Consensus 307 ~~~~~~l~~li~~~l~~dP~~Rps----~~ell~~ 337 (337)
+..+..+++||+++|.+||++|.. ++||.+|
T Consensus 358 ~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 358 PEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred CcchhHHHHHHHHHhccChhhhhccccchHHhhcC
Confidence 244455999999999999999999 9999887
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=303.80 Aligned_cols=266 Identities=22% Similarity=0.318 Sum_probs=199.2
Q ss_pred cccccccceeccCcceEEEEeEEec--------------CCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHh
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELP--------------GSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGA 105 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~--------------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 105 (337)
.++|++.++||+|+||.||++.+.. ..++..||+|.+......... ..
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~------------------~~ 65 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNAR------------------ND 65 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHH------------------HH
Confidence 4679999999999999999987532 124557999988654322111 46
Q ss_pred HHHHHHHHHhcCCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcC---------------CcccCChHHHHHHHH
Q 040898 106 IRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQ---------------GRRELDWPARHRIAR 170 (337)
Q Consensus 106 ~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------------~~~~~~~~~~~~i~~ 170 (337)
+.+|+.++..++||||+++++++.+.+..+++|||+++++|.+++..... ....+++..++.++.
T Consensus 66 ~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 145 (304)
T cd05096 66 FLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVAL 145 (304)
T ss_pred HHHHHHHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHH
Confidence 78899999999999999999999999999999999999999999864321 113467788999999
Q ss_pred HHHHHHHHHhhCCCCCeEecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCccc
Q 040898 171 GIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCD 250 (337)
Q Consensus 171 ~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~D 250 (337)
||+.||.|| |+.|++|+||+|+||+++.++.++|+|||++................++..|+|||.+.+..++.++|
T Consensus 146 ~i~~al~~l---H~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 222 (304)
T cd05096 146 QIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASD 222 (304)
T ss_pred HHHHHHHHH---HHCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhh
Confidence 999999999 67799999999999999999999999999987654433222222344578899999998888999999
Q ss_pred chhhhHHHHHHHh--CCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCC
Q 040898 251 IYSFGVLLAVLVM--GKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDER 328 (337)
Q Consensus 251 iwslG~i~~~ll~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 328 (337)
+||||+++|+|++ +..||....... ................ ....++..+..+.+++.+||+.||++|
T Consensus 223 v~slG~~l~el~~~~~~~p~~~~~~~~----~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~li~~cl~~~p~~R 292 (304)
T cd05096 223 VWAFGVTLWEILMLCKEQPYGELTDEQ----VIENAGEFFRDQGRQV------YLFRPPPCPQGLYELMLQCWSRDCRER 292 (304)
T ss_pred hHHHHHHHHHHHHccCCCCCCcCCHHH----HHHHHHHHhhhccccc------cccCCCCCCHHHHHHHHHHccCCchhC
Confidence 9999999999987 567776543221 1111111111000000 000111233458999999999999999
Q ss_pred CChhhhhc
Q 040898 329 PSSKDVRS 336 (337)
Q Consensus 329 ps~~ell~ 336 (337)
||+.+|.+
T Consensus 293 Ps~~~i~~ 300 (304)
T cd05096 293 PSFSDIHA 300 (304)
T ss_pred cCHHHHHH
Confidence 99999865
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=321.95 Aligned_cols=257 Identities=19% Similarity=0.232 Sum_probs=204.3
Q ss_pred cccccccceeccCcceEEEEeEEecCCC-CceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSN-GKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
...|.+.+.||+|++|.||++.+.. + +..||+|.+....... ...+.+|+.++..++|
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~--~~~~~vv~K~~~~~~~~~-------------------~~~~~~E~~~l~~l~H 124 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGS--DPKEKVVAKFVMLNDERQ-------------------AAYARSELHCLAACDH 124 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcC--CCCeEEEEEEcccCCHHH-------------------HHHHHHHHHHHHhCCC
Confidence 3449999999999999999988765 4 6788888764332111 1456779999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++++..++..|+||||+++|+|.+++........++++..+..++.|++.||.|+ |+.|++|+||||+||+
T Consensus 125 pniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~l---H~~~ivHrDlkp~NIl 201 (478)
T PTZ00267 125 FGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEV---HSRKMMHRDLKSANIF 201 (478)
T ss_pred CCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HhCCEEECCcCHHhEE
Confidence 9999999999999999999999999999998865444556788999999999999999999 7789999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhh
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEM 278 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~ 278 (337)
++.++.++|+|||++................||+.|+|||++.+..++.++||||||+++|+|++|..||..... .
T Consensus 202 l~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~----~ 277 (478)
T PTZ00267 202 LMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ----R 277 (478)
T ss_pred ECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH----H
Confidence 999999999999999876543322222345689999999999988899999999999999999999999864211 1
Q ss_pred hHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 279 DMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
............. .+......+.+++.+||+.||++|||+.+++.|
T Consensus 278 ---~~~~~~~~~~~~~----------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 278 ---EIMQQVLYGKYDP----------FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred ---HHHHHHHhCCCCC----------CCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 1122211111110 011223458999999999999999999999864
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=305.99 Aligned_cols=246 Identities=24% Similarity=0.341 Sum_probs=195.5
Q ss_pred ceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCccccee
Q 040898 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLLA 126 (337)
Q Consensus 47 ~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~ 126 (337)
+.||+|+||.||++.+.. +++.||+|++......... ....+.+|+.+++.++||||+++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~--~~~~~avK~~~~~~~~~~~----------------~~~~~~~E~~~l~~l~hp~iv~~~~ 62 (328)
T cd05593 1 KLLGKGTFGKVILVREKA--SGKYYAMKILKKEVIIAKD----------------EVAHTLTESRVLKNTRHPFLTSLKY 62 (328)
T ss_pred CeeeeCCCEEEEEEEECC--CCCEEEEEEEEHHHhhhhh----------------HHHHHHHHHHHHHhCCCCCCcceEE
Confidence 469999999999999876 8999999998654321111 1256778999999999999999999
Q ss_pred EEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCCeE
Q 040898 127 HMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEAR 206 (337)
Q Consensus 127 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~~ 206 (337)
.+..++..++||||+++++|.+.+. ....+++..+..++.||+.||.|| |+.|++|+||||+||+++.++.++
T Consensus 63 ~~~~~~~~~lv~Ey~~~g~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~L---H~~~ivHrDikp~NIll~~~~~~k 135 (328)
T cd05593 63 SFQTKDRLCFVMEYVNGGELFFHLS----RERVFSEDRTRFYGAEIVSALDYL---HSGKIVYRDLKLENLMLDKDGHIK 135 (328)
T ss_pred EEEcCCEEEEEEeCCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHH---HhCCeEecccCHHHeEECCCCcEE
Confidence 9999999999999999999998883 345688999999999999999999 778999999999999999999999
Q ss_pred EecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHHHHHHh
Q 040898 207 ISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRN 286 (337)
Q Consensus 207 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 286 (337)
|+|||++........ ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||..... ... ...
T Consensus 136 L~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~----~~~---~~~ 206 (328)
T cd05593 136 ITDFGLCKEGITDAA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----EKL---FEL 206 (328)
T ss_pred EecCcCCccCCCccc--ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH----HHH---HHH
Confidence 999999865322211 12234689999999999988899999999999999999999999864211 111 111
Q ss_pred hhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCC-----ChhhhhcC
Q 040898 287 VIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERP-----SSKDVRSM 337 (337)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 337 (337)
....... .+......+.+++.+||+.||++|| ++.++++|
T Consensus 207 ~~~~~~~-----------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 207 ILMEDIK-----------FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred hccCCcc-----------CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 1111110 0111234488999999999999997 89999886
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=299.52 Aligned_cols=256 Identities=27% Similarity=0.391 Sum_probs=202.2
Q ss_pred cccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCc
Q 040898 42 CFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNI 121 (337)
Q Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpni 121 (337)
+|++.+.||+|+||.||++.+.. +++.||+|++.......... ...+.+|+.+++.++||||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~----------------~~~~~~E~~~l~~l~h~~i 62 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRA--TGKMYACKKLEKKRIKKRKG----------------EAMALNEKQILEKVNSRFV 62 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcC--CCceEEEEEEehhhhhhhhh----------------HHHHHHHHHHHHhcCCCCE
Confidence 58999999999999999998865 89999999986543211110 1456779999999999999
Q ss_pred ccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecC
Q 040898 122 LPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDD 201 (337)
Q Consensus 122 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~ 201 (337)
+.+++.+.+++..++||||+++++|.+++.. .....+++..+..++.|++.|+.|| |+.|++|+||+|+||++++
T Consensus 63 v~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nil~~~ 137 (285)
T cd05605 63 VSLAYAYETKDALCLVLTLMNGGDLKFHIYN--MGNPGFDEERAVFYAAEITCGLEDL---HRERIVYRDLKPENILLDD 137 (285)
T ss_pred eeeeeeecCCCeEEEEEeccCCCcHHHHHHh--cCcCCCCHHHHHHHHHHHHHHHHHH---HHCCcEecCCCHHHEEECC
Confidence 9999999999999999999999999988754 2335689999999999999999999 6779999999999999999
Q ss_pred CCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHH
Q 040898 202 DMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMV 281 (337)
Q Consensus 202 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~ 281 (337)
++.++|+|||++........ .....+++.|+|||.+.+..++.++|+||+|+++|+|++|..||.............
T Consensus 138 ~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~ 214 (285)
T cd05605 138 YGHIRISDLGLAVEIPEGET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVE 214 (285)
T ss_pred CCCEEEeeCCCceecCCCCc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHH
Confidence 99999999999876543221 123468899999999988889999999999999999999999997532211111111
Q ss_pred HHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCC-----ChhhhhcC
Q 040898 282 KWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERP-----SSKDVRSM 337 (337)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 337 (337)
..+. ... ..........+.+++.+||+.||.+|| ++.++++|
T Consensus 215 ~~~~----~~~----------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 215 RRVK----EDQ----------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred HHhh----hcc----------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 1111 100 011122344588999999999999999 89999886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=308.45 Aligned_cols=246 Identities=25% Similarity=0.324 Sum_probs=194.9
Q ss_pred ceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCccccee
Q 040898 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLLA 126 (337)
Q Consensus 47 ~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~ 126 (337)
+.||+|+||.||++.+.. +|..||+|.+......... ....+.+|+.+++.++||||+++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~----------------~~~~~~~E~~~l~~l~hp~i~~~~~ 62 (323)
T cd05595 1 KLLGKGTFGKVILVREKA--TGRYYAMKILRKEVIIAKD----------------EVAHTVTESRVLQNTRHPFLTALKY 62 (323)
T ss_pred CeeeeCCCEEEEEEEECC--CCCEEEEEEEEHHHhhhhH----------------HHHHHHHHHHHHHhCCCCCCcceee
Confidence 479999999999998876 8999999998654221111 1146678999999999999999999
Q ss_pred EEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCCeE
Q 040898 127 HMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEAR 206 (337)
Q Consensus 127 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~~ 206 (337)
.+..+...|+||||+++++|..++. ....+++..++.++.||+.||.|| |+.|++|+||||+||+++.++.++
T Consensus 63 ~~~~~~~~~lv~E~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~k 135 (323)
T cd05595 63 AFQTHDRLCFVMEYANGGELFFHLS----RERVFTEERARFYGAEIVSALEYL---HSRDVVYRDIKLENLMLDKDGHIK 135 (323)
T ss_pred EEecCCEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHEEEcCCCCEE
Confidence 9999999999999999999988874 344688999999999999999999 778999999999999999999999
Q ss_pred EecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHHHHHHh
Q 040898 207 ISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRN 286 (337)
Q Consensus 207 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 286 (337)
|+|||++........ ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||..... ..... .
T Consensus 136 L~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~----~~~~~---~ 206 (323)
T cd05595 136 ITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----ERLFE---L 206 (323)
T ss_pred ecccHHhccccCCCC--ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH----HHHHH---H
Confidence 999998765322211 11234689999999999988899999999999999999999999864321 11111 1
Q ss_pred hhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCC-----ChhhhhcC
Q 040898 287 VIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERP-----SSKDVRSM 337 (337)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 337 (337)
....... .+......+.+++.+||+.||++|| ++.++++|
T Consensus 207 ~~~~~~~-----------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 207 ILMEEIR-----------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred HhcCCCC-----------CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 1111110 0011234488999999999999998 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=314.75 Aligned_cols=257 Identities=20% Similarity=0.321 Sum_probs=195.9
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
++|++++.||+|+||.||++.+.. +++.||+|++........ .....+.+|+.++++++|||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~--~~~~~aiK~i~~~~~~~~----------------~~~~~~~~E~~il~~~~h~~ 62 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVD--TKALYAMKTLRKKDVLLR----------------NQVAHVKAERDILAEADNEW 62 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECC--CCCEEEEEEEeHHHhhhH----------------HHHHHHHHHHHHHHhCCCCc
Confidence 369999999999999999999876 899999999864321111 11256788999999999999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
|+++++.+.+++..|+||||+++|+|.+++.. ...+++..+..++.||+.||.|| |+.|++|+||||+||+++
T Consensus 63 iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~l---H~~~ivHrDlKp~NILl~ 135 (382)
T cd05625 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESV---HKMGFIHRDIKPDNILID 135 (382)
T ss_pred CCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEC
Confidence 99999999999999999999999999998843 34588889999999999999999 777999999999999999
Q ss_pred CCCCeEEecccCccccCCCCc---------------------------------------------eeeeecccCCCCcc
Q 040898 201 DDMEARISDFGHGKLMPDGHA---------------------------------------------QITVKCMVGTMGYM 235 (337)
Q Consensus 201 ~~~~~~l~dfg~~~~~~~~~~---------------------------------------------~~~~~~~~~~~~~~ 235 (337)
.++.++|+|||++..+..... ........||+.|+
T Consensus 136 ~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 215 (382)
T cd05625 136 RDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYI 215 (382)
T ss_pred CCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccC
Confidence 999999999998753211000 00011236899999
Q ss_pred CccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHH
Q 040898 236 APESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLK 315 (337)
Q Consensus 236 ~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 315 (337)
|||++.+..++.++|+|||||++|+|++|.+||..... ......... ...... .+..........+
T Consensus 216 aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~---~~~~~~i~~---~~~~~~--------~p~~~~~s~~~~~ 281 (382)
T cd05625 216 APEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTP---LETQMKVIN---WQTSLH--------IPPQAKLSPEASD 281 (382)
T ss_pred CHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCH---HHHHHHHHc---cCCCcC--------CCCcccCCHHHHH
Confidence 99999998999999999999999999999999965322 111111110 000000 0001112234677
Q ss_pred HHhhhccCCCCCCCC---hhhhhcC
Q 040898 316 LACFCTLKDPDERPS---SKDVRSM 337 (337)
Q Consensus 316 li~~~l~~dP~~Rps---~~ell~~ 337 (337)
++.+|+ .+|.+|++ +.++++|
T Consensus 282 li~~l~-~~p~~R~~~~~~~ei~~h 305 (382)
T cd05625 282 LIIKLC-RGPEDRLGKNGADEIKAH 305 (382)
T ss_pred HHHHHc-cCHhHcCCCCCHHHHhcC
Confidence 777776 49999998 9999887
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=298.97 Aligned_cols=252 Identities=28% Similarity=0.362 Sum_probs=198.5
Q ss_pred eccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCcccceeEE
Q 040898 49 IGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLLAHM 128 (337)
Q Consensus 49 lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~ 128 (337)
||+|+||+||++.+.. +++.||+|.+......... ....+..|+.+++.+.||||+++.+++
T Consensus 1 lg~G~~g~Vy~~~~~~--~~~~~avK~~~~~~~~~~~----------------~~~~~~~E~~il~~l~~~~i~~~~~~~ 62 (280)
T cd05608 1 LGKGGFGEVSACQMRA--TGKLYACKKLNKKRLKKRK----------------GYEGAMVEKRILAKVHSRFIVSLAYAF 62 (280)
T ss_pred CCCCCceeEEEEEEcc--CCcEEEEEeeeHHHHhhhH----------------HHHHHHHHHHHHHhCCCCcEeeeeEEE
Confidence 7999999999998876 8999999998644321111 114567799999999999999999999
Q ss_pred EcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCCeEEe
Q 040898 129 VRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARIS 208 (337)
Q Consensus 129 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~~l~ 208 (337)
..+...++||||+++++|...+.........+++..+..++.|++.||.|| |+.|++|+||+|+||+++.++.++|+
T Consensus 63 ~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nili~~~~~~~l~ 139 (280)
T cd05608 63 QTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHL---HQRRIIYRDLKPENVLLDNDGNVRIS 139 (280)
T ss_pred cCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCEEEe
Confidence 999999999999999999988865444556789999999999999999999 67799999999999999999999999
Q ss_pred cccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHHHHHHhhh
Q 040898 209 DFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVI 288 (337)
Q Consensus 209 dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 288 (337)
|||.+......... .....+++.|+|||.+.+..++.++|+||+|+++|+|++|..||............. ....
T Consensus 140 dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~---~~~~ 214 (280)
T cd05608 140 DLGLAVELKDGQSK--TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK---QRIL 214 (280)
T ss_pred eCccceecCCCCcc--ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHH---Hhhc
Confidence 99998765443221 123468999999999999899999999999999999999999996533221111111 1111
Q ss_pred ccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCC-----ChhhhhcC
Q 040898 289 FSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERP-----SSKDVRSM 337 (337)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 337 (337)
.... ..++..+..+.+++.+||+.||++|| |++++++|
T Consensus 215 ~~~~-----------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 215 NDSV-----------TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred ccCC-----------CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 1100 01122334588999999999999999 78888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=308.81 Aligned_cols=265 Identities=22% Similarity=0.335 Sum_probs=195.6
Q ss_pred cccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCc
Q 040898 42 CFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNI 121 (337)
Q Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpni 121 (337)
+|++.+.||+|+||.||++.+.. ++..||+|++......... ...+.+|+.+++.++||||
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~-----------------~~~~~~E~~~l~~l~hpni 61 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTH--TGEKVAIKKINDVFEHVSD-----------------ATRILREIKLLRLLRHPDI 61 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECC--CCCEEEEEEechhhccchh-----------------HHHHHHHHHHHHhCCCCCE
Confidence 58999999999999999998876 8999999998643221111 1457789999999999999
Q ss_pred ccceeEEEcC-----CeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 040898 122 LPLLAHMVRP-----NCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPAN 196 (337)
Q Consensus 122 v~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~n 196 (337)
+++++++... ...|+||||+. ++|.+++. ....+++..+..++.|++.||.|| |+.|++|+||||+|
T Consensus 62 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~dlkp~N 133 (338)
T cd07859 62 VEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIK----ANDDLTPEHHQFFLYQLLRALKYI---HTANVFHRDLKPKN 133 (338)
T ss_pred eeecceEeccCCCCCceEEEEEecCC-CCHHHHHH----hcccCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHH
Confidence 9999987543 34799999995 58988883 345689999999999999999999 67799999999999
Q ss_pred eeecCCCCeEEecccCccccCCCCc-eeeeecccCCCCccCcccccc--CCCCCcccchhhhHHHHHHHhCCCCCCCCCC
Q 040898 197 VLIDDDMEARISDFGHGKLMPDGHA-QITVKCMVGTMGYMAPESLQT--ETISDKCDIYSFGVLLAVLVMGKFPVDDFFG 273 (337)
Q Consensus 197 il~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~~~~PE~~~~--~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~ 273 (337)
|+++.++.++|+|||++........ ........+++.|+|||++.+ ..++.++||||||+++|+|++|++||.....
T Consensus 134 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~ 213 (338)
T cd07859 134 ILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV 213 (338)
T ss_pred eEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh
Confidence 9999999999999999875432211 111233568999999999865 5688999999999999999999999965322
Q ss_pred CchhhhHHHHHHhhhccCCcch-----------h---hhh---cccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 274 HTEEMDMVKWMRNVIFSENPNR-----------A---INS---KLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~-----------~---~~~---~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
. .....+........... . ... .......+.....+.+++.+||+.||++|||++|+++
T Consensus 214 ~----~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 214 V----HQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred H----HHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 1 11111111100000000 0 000 0000011122345789999999999999999999998
Q ss_pred C
Q 040898 337 M 337 (337)
Q Consensus 337 ~ 337 (337)
|
T Consensus 290 h 290 (338)
T cd07859 290 D 290 (338)
T ss_pred C
Confidence 7
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=309.85 Aligned_cols=257 Identities=22% Similarity=0.266 Sum_probs=201.1
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
++|++.+.||+|+||.||++.+.. +++.||+|++......... ....+.+|+.+++.++|||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~--~~~~~aiK~~~~~~~~~~~----------------~~~~~~~e~~i~~~~~~~~ 62 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKA--TGDIYAMKVMKKSVLLAQE----------------TVSFFEEERDILSISNSPW 62 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECC--CCCEEEEEEEEHHHhhhhh----------------HHHHHHHHHHHHHhCCCCC
Confidence 469999999999999999998876 8999999998654221111 1156778999999999999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
|+++++.+.++...++||||+++++|.+++.. ....+++..+..++.|++.||.|| |+.|++|+||+|+||+++
T Consensus 63 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~qi~~aL~~l---H~~~i~H~Dlkp~NIll~ 136 (330)
T cd05601 63 IPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNR---YEDQFDEDMAQFYLAELVLAIHSV---HQMGYVHRDIKPENVLID 136 (330)
T ss_pred CcceeeEEecCCeEEEEECCCCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHH---HHCCeEcccCchHheEEC
Confidence 99999999999999999999999999999854 234689999999999999999999 778999999999999999
Q ss_pred CCCCeEEecccCccccCCCCceeeeecccCCCCccCccccc------cCCCCCcccchhhhHHHHHHHhCCCCCCCCCCC
Q 040898 201 DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQ------TETISDKCDIYSFGVLLAVLVMGKFPVDDFFGH 274 (337)
Q Consensus 201 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~------~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~ 274 (337)
.++.++|+|||++......... ......+++.|+|||++. ...++.++||||||+++|+|++|..||......
T Consensus 137 ~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~ 215 (330)
T cd05601 137 RTGHIKLADFGSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA 215 (330)
T ss_pred CCCCEEeccCCCCeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH
Confidence 9999999999998876543322 223346899999999986 455778999999999999999999999653221
Q ss_pred chhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 275 TEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.... ......... ..+..+.....+.+|+.+||+ +|.+|||+.++++|
T Consensus 216 ---~~~~----~i~~~~~~~-------~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 216 ---KTYN----NIMNFQRFL-------KFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred ---HHHH----HHHcCCCcc-------CCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 1111 111100000 000111233448889999998 99999999999987
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=312.83 Aligned_cols=258 Identities=22% Similarity=0.292 Sum_probs=200.9
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++.+.||+|+||.||++.+.. ++..||+|++......... ....+.+|+.+++.++|
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~--~~~~~aiK~~~~~~~~~~~----------------~~~~~~~e~~il~~~~h 102 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKS--SKQVYAMKLLSKFEMIKRS----------------DSAFFWEERDIMAHANS 102 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECC--CCCEEEEEEEEHHHhhhhh----------------hHHHHHHHHHHHHhCCC
Confidence 56789999999999999999998876 8999999998543211110 11456789999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++.+.+++..++||||+++|+|.+++.. ..+++..+..++.|++.||.|| |+.|++|+||+|+||+
T Consensus 103 ~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~L---H~~~ivHrDLkp~NIL 174 (370)
T cd05596 103 EWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAI---HSMGFIHRDVKPDNML 174 (370)
T ss_pred CCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHEE
Confidence 9999999999999999999999999999998843 3478888899999999999999 6779999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccC----CCCCcccchhhhHHHHHHHhCCCCCCCCCCC
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTE----TISDKCDIYSFGVLLAVLVMGKFPVDDFFGH 274 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~----~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~ 274 (337)
++.++.++|+|||++......... ......|++.|+|||++.+. .++.++|+|||||++|+|++|..||.....
T Consensus 175 l~~~~~~kL~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~- 252 (370)
T cd05596 175 LDKSGHLKLADFGTCMKMDANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL- 252 (370)
T ss_pred EcCCCCEEEEeccceeeccCCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH-
Confidence 999999999999998765432211 12335689999999998653 378899999999999999999999865322
Q ss_pred chhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCC--CCChhhhhcC
Q 040898 275 TEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDE--RPSSKDVRSM 337 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~ell~~ 337 (337)
.... ..+........ .+.....+..+.+|+.+||+.+|.+ |+|+.++++|
T Consensus 253 --~~~~----~~i~~~~~~~~-------~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 253 --VGTY----SKIMDHKNSLT-------FPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred --HHHH----HHHHcCCCcCC-------CCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 1111 11111110000 0011123345889999999999998 9999999987
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=303.92 Aligned_cols=244 Identities=24% Similarity=0.312 Sum_probs=193.2
Q ss_pred eccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCcccceeEE
Q 040898 49 IGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLLAHM 128 (337)
Q Consensus 49 lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~ 128 (337)
||+|+||.||++.+.. +++.||+|.+......... ....+.+|+.++.+++||||+++++.+
T Consensus 1 lg~G~~g~Vy~~~~~~--~~~~~aiK~i~~~~~~~~~----------------~~~~~~~E~~~l~~l~h~~iv~~~~~~ 62 (312)
T cd05585 1 IGKGSFGKVMQVRKRD--TQRIYALKTIRKAHIVSRS----------------EVTHTLAERTVLAQVNCPFIVPLKFSF 62 (312)
T ss_pred CCcCCCeEEEEEEECC--CCCEEEEEEEEHHHhhhhh----------------HHHHHHHHHHHHHhCCCCcEeceeeEE
Confidence 7999999999998876 8899999998643211111 125677899999999999999999999
Q ss_pred EcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCCeEEe
Q 040898 129 VRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARIS 208 (337)
Q Consensus 129 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~~l~ 208 (337)
.+++..++||||+++++|.+++. ....+++..+..++.|++.||.|| |+.|++|+||+|+||+++.++.++|+
T Consensus 63 ~~~~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~HrDlkp~Nili~~~~~~kl~ 135 (312)
T cd05585 63 QSPEKLYLVLAFINGGELFHHLQ----REGRFDLSRARFYTAELLCALENL---HKFNVIYRDLKPENILLDYQGHIALC 135 (312)
T ss_pred ecCCeEEEEEcCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHH---HhCCeEeCCCCHHHeEECCCCcEEEE
Confidence 99999999999999999999984 344688999999999999999999 77899999999999999999999999
Q ss_pred cccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHHHHHHhhh
Q 040898 209 DFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVI 288 (337)
Q Consensus 209 dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 288 (337)
|||++........ ......|++.|+|||.+.+..++.++|+||+|+++|+|++|..||..... ... .....
T Consensus 136 Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~----~~~---~~~~~ 206 (312)
T cd05585 136 DFGLCKLNMKDDD--KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV----NEM---YRKIL 206 (312)
T ss_pred ECcccccCccCCC--ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH----HHH---HHHHH
Confidence 9999875332211 12235689999999999998999999999999999999999999864211 111 11111
Q ss_pred ccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCC---ChhhhhcC
Q 040898 289 FSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERP---SSKDVRSM 337 (337)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp---s~~ell~~ 337 (337)
..... .+......+.+++.+||+.||++|| ++.++++|
T Consensus 207 ~~~~~-----------~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 207 QEPLR-----------FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred cCCCC-----------CCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 11110 0112234488999999999999997 47888876
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=310.78 Aligned_cols=261 Identities=21% Similarity=0.293 Sum_probs=201.0
Q ss_pred ccccccccceeccCcceEEEEeEEe---cCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHh
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAEL---PGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQ 115 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~ 115 (337)
..++|++.+.||+|+||.||++.+. ...++..||+|++......... +.+.+|+.++..
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~------------------~~~~~Ei~il~~ 94 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTER------------------EALMSELKVLSY 94 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHH------------------HHHHHHHHHHHH
Confidence 4568999999999999999998753 2236778999998644322111 467789999999
Q ss_pred c-CCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcC---------------------------------------
Q 040898 116 T-RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQ--------------------------------------- 155 (337)
Q Consensus 116 l-~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------------------------------- 155 (337)
+ +||||+++++++..+...++||||+++|+|.+++.....
T Consensus 95 l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 174 (375)
T cd05104 95 LGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPG 174 (375)
T ss_pred hcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCC
Confidence 9 899999999999999999999999999999999864221
Q ss_pred --------------------------------CcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCC
Q 040898 156 --------------------------------GRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDM 203 (337)
Q Consensus 156 --------------------------------~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~ 203 (337)
....+++..+..++.||+.||.|| |+.|++|+||||+||+++.++
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dlkp~Nill~~~~ 251 (375)
T cd05104 175 VSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGR 251 (375)
T ss_pred cccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCchhhEEEECCC
Confidence 112467888999999999999999 677999999999999999999
Q ss_pred CeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCchhhhHHH
Q 040898 204 EARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHTEEMDMVK 282 (337)
Q Consensus 204 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~~~~~~ 282 (337)
.++|+|||++................++..|+|||.+.+..++.++|+||||+++|+|++ |..||....... ....
T Consensus 252 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~---~~~~ 328 (375)
T cd05104 252 ITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS---KFYK 328 (375)
T ss_pred cEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH---HHHH
Confidence 999999999876644332222222335667999999999899999999999999999998 889986543221 1222
Q ss_pred HHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 283 WMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
.+........ +...+..+.+++.+||+.||++|||+.++++
T Consensus 329 ~~~~~~~~~~-------------~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 369 (375)
T cd05104 329 MIKEGYRMLS-------------PECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369 (375)
T ss_pred HHHhCccCCC-------------CCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 2221110000 0112235889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=315.18 Aligned_cols=257 Identities=21% Similarity=0.308 Sum_probs=196.1
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
++|++++.||+|+||.||++.+.. +++.||+|.+........ .....+.+|+.++++++|||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~--~~~~~avK~~~~~~~~~~----------------~~~~~~~~E~~il~~l~h~~ 62 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVD--TNALYAMKTLRKADVLMR----------------NQAAHVKAERDILAEADNEW 62 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECC--CCCEEEEEEEcHHHHHhh----------------hhHHHHHHHHHHHHhCCCCC
Confidence 469999999999999999999876 899999999854321110 11256778999999999999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
|+++++.+.+++..++||||+++|+|.+++. ....+++..+..++.||+.||.|| |++|++|+||||+||+++
T Consensus 63 iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~----~~~~~~~~~~~~~~~qi~~al~~l---H~~~ivHrDlkp~Nill~ 135 (376)
T cd05598 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI----RLGIFEEDLARFYIAELTCAIESV---HKMGFIHRDIKPDNILID 135 (376)
T ss_pred cceEEEEEEcCCEEEEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHH---HHCCeEeCCCCHHHEEEC
Confidence 9999999999999999999999999999984 345688889999999999999999 777999999999999999
Q ss_pred CCCCeEEecccCccccCCCCc-----------------------------------------eeeeecccCCCCccCccc
Q 040898 201 DDMEARISDFGHGKLMPDGHA-----------------------------------------QITVKCMVGTMGYMAPES 239 (337)
Q Consensus 201 ~~~~~~l~dfg~~~~~~~~~~-----------------------------------------~~~~~~~~~~~~~~~PE~ 239 (337)
.++.++|+|||++..+..... ........||+.|+|||+
T Consensus 136 ~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 215 (376)
T cd05598 136 RDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEV 215 (376)
T ss_pred CCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHH
Confidence 999999999998753310000 000012368999999999
Q ss_pred cccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhh
Q 040898 240 LQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACF 319 (337)
Q Consensus 240 ~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 319 (337)
+.+..++.++|||||||++|+|++|..||....... .... +.. ...... ..........+.+++.+
T Consensus 216 ~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---~~~~-i~~---~~~~~~-------~~~~~~~s~~~~~li~~ 281 (376)
T cd05598 216 LLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAE---TQLK-VIN---WETTLH-------IPSQAKLSREASDLILR 281 (376)
T ss_pred HcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHH---HHHH-Hhc---cCcccc-------CCCCCCCCHHHHHHHHH
Confidence 999999999999999999999999999996532211 1111 100 000000 00001122336777777
Q ss_pred hccCCCCCCC---ChhhhhcC
Q 040898 320 CTLKDPDERP---SSKDVRSM 337 (337)
Q Consensus 320 ~l~~dP~~Rp---s~~ell~~ 337 (337)
|+ .+|.+|+ |+.++++|
T Consensus 282 l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 282 LC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred Hh-cCHhhcCCCCCHHHHhCC
Confidence 66 4999999 99999987
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=317.06 Aligned_cols=263 Identities=18% Similarity=0.263 Sum_probs=196.5
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++++.||+|+||.||++.+.. +++.||+|++.... ....+|+.+++.++|
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~--~~~~vAiK~i~~~~-----------------------~~~~~Ei~il~~l~h 118 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICID--TSEKVAIKKVLQDP-----------------------QYKNRELLIMKNLNH 118 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECC--CCCEEEEEEEecCc-----------------------chHHHHHHHHHhcCC
Confidence 45689999999999999999998876 89999999885432 223468999999999
Q ss_pred CCcccceeEEEcC--------CeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 040898 119 RNILPLLAHMVRP--------NCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHR 190 (337)
Q Consensus 119 pniv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~ 190 (337)
|||+++++++... ..+++||||+++ +|.+++......+..+++..++.++.||+.||.|| |+.|++||
T Consensus 119 ~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yL---H~~~IiHr 194 (440)
T PTZ00036 119 INIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYI---HSKFICHR 194 (440)
T ss_pred CCCcceeeeEeecccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCEecC
Confidence 9999998876432 246799999976 78887765555667799999999999999999999 77799999
Q ss_pred CCCCCceeecCCC-CeEEecccCccccCCCCceeeeecccCCCCccCccccccC-CCCCcccchhhhHHHHHHHhCCCCC
Q 040898 191 DIKPANVLIDDDM-EARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTE-TISDKCDIYSFGVLLAVLVMGKFPV 268 (337)
Q Consensus 191 di~~~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~i~~~ll~g~~pf 268 (337)
||||+||+++.++ .++|+|||++......... ....+++.|+|||++.+. .++.++|||||||++|+|++|.+||
T Consensus 195 DLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf 271 (440)
T PTZ00036 195 DLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRS---VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIF 271 (440)
T ss_pred CcCHHHEEEcCCCCceeeeccccchhccCCCCc---ccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 9999999998665 6999999999865433221 234679999999998654 6899999999999999999999999
Q ss_pred CCCCCCchhhhHHHHHHhhhccCCcch---------------hhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhh
Q 040898 269 DDFFGHTEEMDMVKWMRNVIFSENPNR---------------AINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKD 333 (337)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e 333 (337)
.+.... ..+...+... ....... .....+....+...+.++.+|+.+||+.||.+|||+.|
T Consensus 272 ~~~~~~---~~~~~i~~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e 347 (440)
T PTZ00036 272 SGQSSV---DQLVRIIQVL-GTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIE 347 (440)
T ss_pred CCCChH---HHHHHHHHHh-CCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHH
Confidence 653221 1121111111 0000000 00000000011123356899999999999999999999
Q ss_pred hhcC
Q 040898 334 VRSM 337 (337)
Q Consensus 334 ll~~ 337 (337)
+|+|
T Consensus 348 ~l~h 351 (440)
T PTZ00036 348 ALAD 351 (440)
T ss_pred HhCC
Confidence 9987
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=303.06 Aligned_cols=257 Identities=23% Similarity=0.348 Sum_probs=213.8
Q ss_pred cccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC
Q 040898 38 KKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR 117 (337)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 117 (337)
.-...|++.+.||+|.||.||.+.... +|+.+|+|.+......... ....+.+|+.+|+++.
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~--tg~~~A~K~i~k~~~~~~~----------------~~~~v~~Ev~il~~l~ 93 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKS--TGKEVACKVIPKRKLRGKE----------------DREDVRREVAILQQLS 93 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecC--CCceeEEEEeehhhccccc----------------cHHHHHHHHHHHHhcc
Confidence 355679999999999999999998876 8999999999776553322 1157889999999998
Q ss_pred -CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 040898 118 -HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPAN 196 (337)
Q Consensus 118 -hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~n 196 (337)
||||+.+++++++...+++|||+|.||.|.+.+... .+++..+..++.|++.+++|+ |+.|++|+|+||+|
T Consensus 94 ~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~l---H~~gvvHrDlKpEN 165 (382)
T KOG0032|consen 94 GHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYL---HSLGVVHRDLKPEN 165 (382)
T ss_pred CCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHH---HhCCceeccCCHHH
Confidence 999999999999999999999999999999999653 399999999999999999999 77899999999999
Q ss_pred eeecCC----CCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCC
Q 040898 197 VLIDDD----MEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFF 272 (337)
Q Consensus 197 il~~~~----~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~ 272 (337)
+++... +.++++|||++..... .......+||+.|+|||++.+..|+..+|+||+|+++|.|++|.+||....
T Consensus 166 ~L~~~~~~~~~~ik~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~ 242 (382)
T KOG0032|consen 166 LLLASKDEGSGRIKLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGET 242 (382)
T ss_pred eeeccccCCCCcEEEeeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCC
Confidence 999643 4799999999998766 223456789999999999999999999999999999999999999986532
Q ss_pred CCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 273 GHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.. .... .+..... ......++.......+++..||..||.+|+|+.++|+|
T Consensus 243 ~~---~~~~----~i~~~~~-------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 243 EF---EIFL----AILRGDF-------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred hh---HHHH----HHHcCCC-------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 21 1111 1111111 12233445566779999999999999999999999987
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=296.35 Aligned_cols=256 Identities=30% Similarity=0.467 Sum_probs=203.0
Q ss_pred ccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCcc
Q 040898 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNIL 122 (337)
Q Consensus 43 y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv 122 (337)
|++.+.||+|+||+||++.+.. +++.+|+|++.......... ....+|+.++++++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~--~~~~~~~K~~~~~~~~~~~~-----------------~~~~~e~~~~~~l~~~~i~ 61 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKK--NGQKVAVKIIDKSEIEEEER-----------------EENIREIKILRRLRHPNIV 61 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETT--TTEEEEEEEEESTTHHHHHH-----------------HHHHHHHHHHHHHTBTTBC
T ss_pred CEEeEEEEeCCCEEEEEEEECC--CCeEEEEEEecccccccccc-----------------chhhhhhhccccccccccc
Confidence 7899999999999999999976 88899999997765433221 2334599999999999999
Q ss_pred cceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCC
Q 040898 123 PLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDD 202 (337)
Q Consensus 123 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~ 202 (337)
++++++......+++||++++++|.+++. ....++...++.++.|++.||.+| |+.|++|+||+|+||+++.+
T Consensus 62 ~~~~~~~~~~~~~~v~~~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~L---h~~~i~H~dikp~NIl~~~~ 134 (260)
T PF00069_consen 62 QILDVFQDDNYLYIVMEYCPGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYL---HSKGIVHRDIKPENILLDEN 134 (260)
T ss_dssp HEEEEEEESSEEEEEEEEETTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHH---HHTTEEESSBSGGGEEESTT
T ss_pred ccccccccccccccccccccccccccccc----cccccccccccccccccccccccc---cccccccccccccccccccc
Confidence 99999999999999999999999999995 345689999999999999999999 66699999999999999999
Q ss_pred CCeEEecccCccccCCCCceeeeecccCCCCccCccccc-cCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHH
Q 040898 203 MEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQ-TETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMV 281 (337)
Q Consensus 203 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~-~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~ 281 (337)
+.++|+|||.+....... .......+++.|+|||.+. +..++.++|+||||+++++|++|..||.............
T Consensus 135 ~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~ 212 (260)
T PF00069_consen 135 GEVKLIDFGSSVKLSENN--ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIE 212 (260)
T ss_dssp SEEEESSGTTTEESTSTT--SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHH
T ss_pred cccccccccccccccccc--cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhh
Confidence 999999999987642211 2233456899999999998 8889999999999999999999999987641111111121
Q ss_pred HHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 282 KWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
............. .......+.+++.+||+.||++|||+.++++|
T Consensus 213 ~~~~~~~~~~~~~-----------~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 213 KILKRPLPSSSQQ-----------SREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HHHHTHHHHHTTS-----------HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred hcccccccccccc-----------cchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111111000000 00011459999999999999999999999987
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=305.50 Aligned_cols=249 Identities=23% Similarity=0.331 Sum_probs=193.1
Q ss_pred ccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHH---HHHhcCCC
Q 040898 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEII---TANQTRHR 119 (337)
Q Consensus 43 y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~---~l~~l~hp 119 (337)
|++.+.||+|+||.||++.+.. +++.||+|++......... ..+.+.+|.. +++.++||
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~--~~~~~aiK~~~~~~~~~~~----------------~~~~l~~e~~~~~~~~~l~hp 62 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKK--TGELYAIKALKKGDIIARD----------------EVESLMCEKRIFETANSERHP 62 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECC--CCCEEEEEEEEHHHhhhhh----------------HHHHHHHHHHHHHhccccCCC
Confidence 7889999999999999998876 8999999998644211111 1134444544 44667899
Q ss_pred CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceee
Q 040898 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI 199 (337)
Q Consensus 120 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~ 199 (337)
||+++++++.+++..|+||||+++++|...+. ...+++..+..++.|++.||.|| |+.|++|+||+|+||++
T Consensus 63 ~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~l---H~~~ivHrdlkp~Nill 134 (324)
T cd05589 63 FLVNLFACFQTEDHVCFVMEYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYL---HENKIVYRDLKLDNLLL 134 (324)
T ss_pred ChhceeeEEEcCCEEEEEEcCCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHH---HhCCeEecCCCHHHeEE
Confidence 99999999999999999999999999988873 24689999999999999999999 77899999999999999
Q ss_pred cCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhh
Q 040898 200 DDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMD 279 (337)
Q Consensus 200 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~ 279 (337)
+.++.++|+|||++........ ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||..... ..
T Consensus 135 ~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~----~~ 208 (324)
T cd05589 135 DTEGFVKIADFGLCKEGMGFGD--RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE----EE 208 (324)
T ss_pred CCCCcEEeCcccCCccCCCCCC--cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH----HH
Confidence 9999999999998764322211 12235689999999999998899999999999999999999999864321 11
Q ss_pred HHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCC-----ChhhhhcC
Q 040898 280 MVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERP-----SSKDVRSM 337 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 337 (337)
... ........ .+......+.+++.+||+.||.+|| ++.++++|
T Consensus 209 ~~~---~i~~~~~~-----------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 209 VFD---SIVNDEVR-----------YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred HHH---HHHhCCCC-----------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 111 11111110 0011234478999999999999999 67888775
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=305.53 Aligned_cols=251 Identities=23% Similarity=0.303 Sum_probs=196.2
Q ss_pred cccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC-C
Q 040898 42 CFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR-N 120 (337)
Q Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp-n 120 (337)
+|++++.||+|+||.||++.+.. +++.||+|++......... ....+..|..++..+.|+ +
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~--~~~~~avK~~~~~~~~~~~----------------~~~~~~~e~~~l~~~~~~~~ 62 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKG--TDELYAIKILKKDVIIQDD----------------DVECTMVEKRVLALPGKPPF 62 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECC--CCCEEEEEEEEHHHhhhhh----------------HHHHHHHHHHHHHhcCCCCc
Confidence 58999999999999999998876 8899999998653221111 114667788899998765 5
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
|+.+++.+...+..|+||||+++++|.+++. ....+++..+..++.||+.||.|| |++|++|+||+|+||+++
T Consensus 63 i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~----~~~~~~~~~~~~~~~qi~~al~~l---H~~~ivH~dlkp~Nill~ 135 (324)
T cd05587 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ----QVGKFKEPHAVFYAAEIAIGLFFL---HSKGIIYRDLKLDNVMLD 135 (324)
T ss_pred eeeeEEEEEcCCEEEEEEcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHeEEc
Confidence 8888999999999999999999999999884 344588899999999999999999 677999999999999999
Q ss_pred CCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhH
Q 040898 201 DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDM 280 (337)
Q Consensus 201 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~ 280 (337)
.++.++|+|||++........ ......|++.|+|||++.+..++.++|+||+|+++|+|++|..||..... ...
T Consensus 136 ~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~----~~~ 209 (324)
T cd05587 136 AEGHIKIADFGMCKENIFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE----DEL 209 (324)
T ss_pred CCCCEEEeecCcceecCCCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH----HHH
Confidence 999999999998865322211 12235689999999999998899999999999999999999999964321 112
Q ss_pred HHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCCh-----hhhhcC
Q 040898 281 VKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSS-----KDVRSM 337 (337)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~ell~~ 337 (337)
...+.. ..... +......+.+++.+||+.||.+|++. .++++|
T Consensus 210 ~~~i~~---~~~~~-----------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 210 FQSIME---HNVSY-----------PKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred HHHHHc---CCCCC-----------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 111111 11100 01122347899999999999999987 677765
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=307.30 Aligned_cols=252 Identities=26% Similarity=0.411 Sum_probs=195.0
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
.-++|+.++.||+|+||.||++.+.. +++.||+|.+........ ...+.+|+.+++.++|
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~------------------~~~~~~E~~~l~~l~h 131 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRP--TGRLYALKVIYGNHEDTV------------------RRQICREIEILRDVNH 131 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECC--CCCEEEEEEEecCCcHHH------------------HHHHHHHHHHHHhCCC
Confidence 34679999999999999999998876 899999999854432111 1467789999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++++..++..++|+||+++++|.+.. ..++..+..++.||+.||.|| |+.|++|+||+|+||+
T Consensus 132 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlkp~NIl 200 (353)
T PLN00034 132 PNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTH--------IADEQFLADVARQILSGIAYL---HRRHIVHRDIKPSNLL 200 (353)
T ss_pred CCcceeeeEeccCCeEEEEEecCCCCcccccc--------cCCHHHHHHHHHHHHHHHHHH---HHCCEeecCCCHHHEE
Confidence 99999999999999999999999999886532 245677889999999999999 6779999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCcccccc-----CCCCCcccchhhhHHHHHHHhCCCCCCCCCC
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQT-----ETISDKCDIYSFGVLLAVLVMGKFPVDDFFG 273 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-----~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~ 273 (337)
++.++.++|+|||++........ ......|+..|+|||.+.. ...+.++||||||+++|+|++|..||.....
T Consensus 201 l~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~ 278 (353)
T PLN00034 201 INSAKNVKIADFGVSRILAQTMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ 278 (353)
T ss_pred EcCCCCEEEcccccceecccccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999876543221 1123568999999998743 2234689999999999999999999973221
Q ss_pred CchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 274 HTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.. .............. .........+.+|+.+||+.||++|||+.|+++|
T Consensus 279 ~~----~~~~~~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 279 GD----WASLMCAICMSQPP----------EAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred cc----HHHHHHHHhccCCC----------CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11 11111111111110 0111233458999999999999999999999987
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=307.20 Aligned_cols=246 Identities=24% Similarity=0.326 Sum_probs=194.1
Q ss_pred ceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCccccee
Q 040898 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLLA 126 (337)
Q Consensus 47 ~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~ 126 (337)
+.||+|+||.||++.+.. ++..||+|.+......... ....+..|+.++..++||||+++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~--~~~~~a~K~~~~~~~~~~~----------------~~~~~~~e~~~l~~~~hp~i~~~~~ 62 (325)
T cd05594 1 KLLGKGTFGKVILVKEKA--TGRYYAMKILKKEVIVAKD----------------EVAHTLTENRVLQNSRHPFLTALKY 62 (325)
T ss_pred CeeeeCCCEEEEEEEECC--CCCEEEEEEEEHHHhhhhh----------------HHHHHHHHHHHHHhCCCCCCCceEE
Confidence 479999999999998876 8999999998654221111 1145677999999999999999999
Q ss_pred EEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCC-CCeEecCCCCCceeecCCCCe
Q 040898 127 HMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHR-PRLIHRDIKPANVLIDDDMEA 205 (337)
Q Consensus 127 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~-~gi~h~di~~~nil~~~~~~~ 205 (337)
.+..++..++||||+++++|..++. ....+++..+..++.||+.||.|| |+ .|++|+||||+||+++.++.+
T Consensus 63 ~~~~~~~~~lv~E~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~l---H~~~~ivHrDikp~NIll~~~~~~ 135 (325)
T cd05594 63 SFQTHDRLCFVMEYANGGELFFHLS----RERVFSEDRARFYGAEIVSALDYL---HSEKNVVYRDLKLENLMLDKDGHI 135 (325)
T ss_pred EEEcCCEEEEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHH---HhcCCEEecCCCCCeEEECCCCCE
Confidence 9999999999999999999998883 345689999999999999999999 64 699999999999999999999
Q ss_pred EEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHHHHHH
Q 040898 206 RISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMR 285 (337)
Q Consensus 206 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~ 285 (337)
+|+|||++........ ......+++.|+|||++.+..++.++|+||||+++|+|++|..||..... ......+
T Consensus 136 kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~----~~~~~~i- 208 (325)
T cd05594 136 KITDFGLCKEGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----EKLFELI- 208 (325)
T ss_pred EEecCCCCeecCCCCc--ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH----HHHHHHH-
Confidence 9999999865322211 11234689999999999988899999999999999999999999864321 1111111
Q ss_pred hhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCC-----ChhhhhcC
Q 040898 286 NVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERP-----SSKDVRSM 337 (337)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 337 (337)
....... +......+.+++.+||+.||++|+ ++.++++|
T Consensus 209 --~~~~~~~-----------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 209 --LMEEIRF-----------PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred --hcCCCCC-----------CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 1111000 011223488999999999999997 89999986
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=302.45 Aligned_cols=254 Identities=22% Similarity=0.293 Sum_probs=194.9
Q ss_pred ceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc-CCCCcccce
Q 040898 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT-RHRNILPLL 125 (337)
Q Consensus 47 ~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~ 125 (337)
+.||+|+||.||++.+.. +++.||+|.+......... ....+.+|..++..+ +||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~--~~~~~aiK~i~~~~~~~~~----------------~~~~~~~e~~il~~~~~hp~Iv~~~ 62 (329)
T cd05588 1 RVIGRGSYAKVLLVELKK--TRRIYAMKVIKKELVNDDE----------------DIDWVQTEKHVFETASNHPFLVGLH 62 (329)
T ss_pred CeEeeCCCeEEEEEEECC--CCCEEEEEEEEHHHhhhhh----------------HHHHHHHHHHHHHhccCCCCCCceE
Confidence 469999999999999876 8999999998654221111 114577889999888 799999999
Q ss_pred eEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCCe
Q 040898 126 AHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEA 205 (337)
Q Consensus 126 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~ 205 (337)
+++.+.+..|+||||+++++|.+++. ....+++..+..++.|++.||.|| |++|++|+||+|+||+++.++.+
T Consensus 63 ~~~~~~~~~~lv~e~~~~g~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nili~~~~~~ 135 (329)
T cd05588 63 SCFQTESRLFFVIEFVSGGDLMFHMQ----RQRKLPEEHARFYSAEISLALNFL---HERGIIYRDLKLDNVLLDAEGHI 135 (329)
T ss_pred EEEEcCCEEEEEEeCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHeEECCCCCE
Confidence 99999999999999999999998874 345689999999999999999999 77899999999999999999999
Q ss_pred EEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCc-hhhhHHHHH
Q 040898 206 RISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHT-EEMDMVKWM 284 (337)
Q Consensus 206 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~-~~~~~~~~~ 284 (337)
+|+|||++........ ......|++.|+|||++.+..++.++|+||+|+++|+|++|..||+...... .........
T Consensus 136 kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~ 213 (329)
T cd05588 136 KLTDYGMCKEGIRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYL 213 (329)
T ss_pred EECcCccccccccCCC--ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHH
Confidence 9999998864221111 1223568999999999999889999999999999999999999996432211 011111111
Q ss_pred HhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCC------hhhhhcC
Q 040898 285 RNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPS------SKDVRSM 337 (337)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps------~~ell~~ 337 (337)
.+........ .+......+.+++.+||+.||.+||| +.++++|
T Consensus 214 ~~~~~~~~~~----------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 214 FQVILEKQIR----------IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred HHHHHcCCCC----------CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 1111111100 01112334889999999999999997 6788876
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=302.18 Aligned_cols=270 Identities=20% Similarity=0.271 Sum_probs=200.1
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
+.++|.+.+.||+|+||.||++.+.. ++..||+|.+......... ..+.+|+.+++.++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~------------------~~~~~E~~~l~~l~h 63 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSKL--TENLVALKEIRLEHEEGAP------------------CTAIREVSLLKDLKH 63 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEecC--CCCeEEEEEeeccccCCcc------------------hhHHHHHHHHHhCCC
Confidence 45779999999999999999998876 8899999998654322111 345679999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++++..++..++||||+++ +|.+++.. .+..+++..+..++.|++.||.|| |+.|++|+||+|+||+
T Consensus 64 ~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~l---H~~~ivH~dlkp~Nil 136 (309)
T cd07872 64 ANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDD---CGNIMSMHNVKIFLYQILRGLAYC---HRRKVLHRDLKPQNLL 136 (309)
T ss_pred CCcceEEEEEeeCCeEEEEEeCCCC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEE
Confidence 9999999999999999999999976 78877743 334578889999999999999999 7789999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCcccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchh
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQT-ETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEE 277 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~ 277 (337)
++.++.++|+|||++........ ......+++.|+|||.+.+ ..++.++|+||+|+++|+|++|.+||.........
T Consensus 137 l~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~ 214 (309)
T cd07872 137 INERGELKLADFGLARAKSVPTK--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDEL 214 (309)
T ss_pred ECCCCCEEECccccceecCCCcc--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 99999999999999875433221 1123457889999999865 45788999999999999999999999654322111
Q ss_pred hhHHHHHHhhhccCC----cc--------hhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 278 MDMVKWMRNVIFSEN----PN--------RAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~----~~--------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
............... .. ............+.....+.+|+.+||+.||++|||+.|+++|
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 215 HLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred HHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 111111000000000 00 0000000000112234568899999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=311.16 Aligned_cols=247 Identities=23% Similarity=0.307 Sum_probs=202.5
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc-C
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT-R 117 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~ 117 (337)
.-++|.+++.||+|+||.|+++..+. +++.+|||.+++......++. +....|.+++... +
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~--~~e~yAIK~LKK~~Il~~d~V----------------e~~~~EkrI~~la~~ 427 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKG--TNEYYAIKVLKKGDILQRDEV----------------ESLMCEKRIFELANR 427 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcC--CCcEEEEEEeeccceeccccH----------------HHHHHHHHHHHHhcc
Confidence 55789999999999999999999987 899999999988876555443 6777788888777 5
Q ss_pred CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCce
Q 040898 118 HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANV 197 (337)
Q Consensus 118 hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ni 197 (337)
||.+++++..|++...+|+||||+.||++... .....+++..+.-++..|+.||+|| |++||++||||.+||
T Consensus 428 HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~-----~~~~~F~e~rarfyaAev~l~L~fL---H~~~IIYRDlKLdNi 499 (694)
T KOG0694|consen 428 HPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHH-----IHTDVFSEPRARFYAAEVVLGLQFL---HENGIIYRDLKLDNL 499 (694)
T ss_pred CCeEeecccccccCCeEEEEEEecCCCcEEEE-----EecccccHHHHHHHHHHHHHHHHHH---HhcCceeeecchhhe
Confidence 99999999999999999999999999984333 3456799999999999999999999 888999999999999
Q ss_pred eecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchh
Q 040898 198 LIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEE 277 (337)
Q Consensus 198 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~ 277 (337)
|++.+|.+||+|||++..-..... ..++.+|||.|+|||++.+..|+.++|.|||||++||||.|+.||.+. +++
T Consensus 500 LLD~eGh~kiADFGlcKe~m~~g~--~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gd---dEe 574 (694)
T KOG0694|consen 500 LLDTEGHVKIADFGLCKEGMGQGD--RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGD---DEE 574 (694)
T ss_pred EEcccCcEEecccccccccCCCCC--ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCC---CHH
Confidence 999999999999999976432222 335679999999999999999999999999999999999999998643 222
Q ss_pred hhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCCh
Q 040898 278 MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSS 331 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~ 331 (337)
.-+.... ..+...+ --.+.+..++++++|..||++|..+
T Consensus 575 e~FdsI~----~d~~~yP-----------~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 575 EVFDSIV----NDEVRYP-----------RFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHHHHh----cCCCCCC-----------CcccHHHHHHHHHHhccCcccccCC
Confidence 2222221 1111111 1123347889999999999999976
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=309.27 Aligned_cols=258 Identities=21% Similarity=0.300 Sum_probs=199.2
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++.+.||+|+||.||++.+.. +++.+|+|.+......... ....+.+|+.+++.++|
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~--~~~~~aiK~~~~~~~~~~~----------------~~~~~~~e~~i~~~~~h 102 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKS--SQKVYAMKLLSKFEMIKRS----------------DSAFFWEERDIMAFANS 102 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECC--CCCEEEEEEEEHHHhhhhh----------------hHHHHHHHHHHHHhCCC
Confidence 56789999999999999999999876 8999999998542211110 11457789999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++.+.+++..|+||||+++|+|.+++.. ..+++..+..++.||+.||.|| |+.|++|+||||+||+
T Consensus 103 p~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~L---H~~~IvHrDLKp~NIL 174 (370)
T cd05621 103 PWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAI---HSMGLIHRDVKPDNML 174 (370)
T ss_pred CCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHEE
Confidence 9999999999999999999999999999999843 2478888999999999999999 7779999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCC----CCCcccchhhhHHHHHHHhCCCCCCCCCCC
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTET----ISDKCDIYSFGVLLAVLVMGKFPVDDFFGH 274 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~----~~~~~DiwslG~i~~~ll~g~~pf~~~~~~ 274 (337)
++.++.++|+|||++........ .......||+.|+|||++.+.. ++.++|+||+|+++|+|++|..||.....
T Consensus 175 l~~~~~~kL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~- 252 (370)
T cd05621 175 LDKHGHLKLADFGTCMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL- 252 (370)
T ss_pred ECCCCCEEEEecccceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH-
Confidence 99999999999999876543222 1223456999999999987543 67899999999999999999999964321
Q ss_pred chhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCC--CCChhhhhcC
Q 040898 275 TEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDE--RPSSKDVRSM 337 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~ell~~ 337 (337)
..... .+........ .+........+.+++..||..+|.+ |+|+.++++|
T Consensus 253 --~~~~~----~i~~~~~~~~-------~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 253 --VGTYS----KIMDHKNSLN-------FPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred --HHHHH----HHHhCCcccC-------CCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 11111 1111110000 0001122344788999999866544 8999999987
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=302.25 Aligned_cols=246 Identities=24% Similarity=0.308 Sum_probs=193.0
Q ss_pred ceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc-CCCCcccce
Q 040898 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT-RHRNILPLL 125 (337)
Q Consensus 47 ~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~ 125 (337)
+.||+|+||.||++.+.. +++.||+|++........ .....+..|..++..+ +||||++++
T Consensus 1 ~~lg~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~----------------~~~~~~~~e~~~l~~~~~h~~iv~~~ 62 (320)
T cd05590 1 RVLGKGSFGKVMLARLKE--SGRLYAVKVLKKDVILQD----------------DDVECTMTEKRILSLARNHPFLTQLY 62 (320)
T ss_pred CeeeeCCCeEEEEEEEcC--CCCEEEEEEEEHHHHhhc----------------cHHHHHHHHHHHHHhccCCCchhcee
Confidence 479999999999998876 899999999864321111 1114566788888776 799999999
Q ss_pred eEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCCe
Q 040898 126 AHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEA 205 (337)
Q Consensus 126 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~ 205 (337)
+.+...+..|+||||+++++|.+++.. ...+++..+..++.|++.||.|| |+.|++|+||+|+||+++.++.+
T Consensus 63 ~~~~~~~~~~iv~Ey~~~g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~l---H~~~ivH~dlkp~NIli~~~~~~ 135 (320)
T cd05590 63 CCFQTPDRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEITSALMFL---HDKGIIYRDLKLDNVLLDHEGHC 135 (320)
T ss_pred eEEEcCCEEEEEEcCCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeEeCCCCHHHeEECCCCcE
Confidence 999999999999999999999998843 34688999999999999999999 77899999999999999999999
Q ss_pred EEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHHHHHH
Q 040898 206 RISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMR 285 (337)
Q Consensus 206 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~ 285 (337)
+|+|||++........ ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||..... ......+
T Consensus 136 kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~----~~~~~~i- 208 (320)
T cd05590 136 KLADFGMCKEGIFNGK--TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE----DDLFEAI- 208 (320)
T ss_pred EEeeCCCCeecCcCCC--cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH----HHHHHHH-
Confidence 9999999865322211 12234689999999999988899999999999999999999999965321 1121211
Q ss_pred hhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCCh------hhhhcC
Q 040898 286 NVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSS------KDVRSM 337 (337)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~------~ell~~ 337 (337)
....... +......+.+++.+||+.||.+||++ .++++|
T Consensus 209 --~~~~~~~-----------~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 209 --LNDEVVY-----------PTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred --hcCCCCC-----------CCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 1111100 01123458899999999999999998 777776
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=307.04 Aligned_cols=261 Identities=23% Similarity=0.353 Sum_probs=200.5
Q ss_pred ccccccccceeccCcceEEEEeEEec---CCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHh
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELP---GSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQ 115 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~ 115 (337)
..++|++.+.||+|+||.||++.+.. ..++..||+|.+......... ..+.+|+.+++.
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~------------------~~~~~E~~il~~ 97 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDER------------------EALMSELKILSH 97 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHH------------------HHHHHHHHHHHh
Confidence 56689999999999999999988643 224467999998654332211 467789999999
Q ss_pred c-CCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcC---------------------------------------
Q 040898 116 T-RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQ--------------------------------------- 155 (337)
Q Consensus 116 l-~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------------------------------- 155 (337)
+ +||||+++++.+......++||||+++|+|.+++.....
T Consensus 98 l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (374)
T cd05106 98 LGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQG 177 (374)
T ss_pred hccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccc
Confidence 9 899999999999999999999999999999999854211
Q ss_pred ---------------------------CcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCCeEEe
Q 040898 156 ---------------------------GRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARIS 208 (337)
Q Consensus 156 ---------------------------~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~~l~ 208 (337)
...++++..+..++.|++.||.|| |+.|++|+||||+||+++.++.++|+
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yL---H~~giiHrDLkp~Nil~~~~~~~kL~ 254 (374)
T cd05106 178 SDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKIC 254 (374)
T ss_pred cccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHH---HHCCEEeccCchheEEEeCCCeEEEe
Confidence 113467788999999999999999 77899999999999999999999999
Q ss_pred cccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCchhhhHHHHHHhh
Q 040898 209 DFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHTEEMDMVKWMRNV 287 (337)
Q Consensus 209 dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~ 287 (337)
|||++................+++.|+|||++.+..++.++|+||+|+++|+|++ |..||........ ........
T Consensus 255 DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~---~~~~~~~~ 331 (374)
T cd05106 255 DFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK---FYKMVKRG 331 (374)
T ss_pred eceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH---HHHHHHcc
Confidence 9999876544332222222345667999999988889999999999999999997 9999875433211 11111110
Q ss_pred hccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 288 IFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
..... +...+..+.+++.+||+.||.+|||+.++++
T Consensus 332 ~~~~~-------------~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 332 YQMSR-------------PDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred cCccC-------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00000 0011244899999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=291.35 Aligned_cols=258 Identities=23% Similarity=0.356 Sum_probs=202.3
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
++|++.+.||+|++|.||.+.+.. +++.+++|.+.......... .....+.+|+.++++++|||
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~--~~~~~~lk~~~~~~~~~~~~--------------~~~~~~~~e~~~l~~l~~~~ 65 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVD--TGRELAVKQVPFDPDSPETK--------------KEVNALECEIQLLKNLQHER 65 (263)
T ss_pred CcccccceecCCCceEEEEEEEcC--CCcEEEEEEEeecccchhhH--------------HHHHHHHHHHHHHHhCCCCC
Confidence 579999999999999999998865 89999999886543322111 11256788999999999999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
|+++++++.++...++++||+++++|.+.+.. ...+++.....++.|++.|+.+| |+.|++|+||+|+||+++
T Consensus 66 i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~l---H~~~i~H~dl~p~nilv~ 138 (263)
T cd06625 66 IVQYYGCLRDDETLSIFMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYL---HSNMIVHRDIKGANILRD 138 (263)
T ss_pred eeeeEEEEccCCeEEEEEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEc
Confidence 99999999999999999999999999998843 34578889999999999999999 777999999999999999
Q ss_pred CCCCeEEecccCccccCCCCceee-eecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhh
Q 040898 201 DDMEARISDFGHGKLMPDGHAQIT-VKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMD 279 (337)
Q Consensus 201 ~~~~~~l~dfg~~~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~ 279 (337)
.++.++|+|||.+........... .....++..|+|||.+.+..++.++|+||+|+++|++++|+.||..... ...
T Consensus 139 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~ 215 (263)
T cd06625 139 SAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA---MAA 215 (263)
T ss_pred CCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch---HHH
Confidence 999999999999875533211111 1224577889999999988899999999999999999999999864321 111
Q ss_pred HHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 280 MVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
... ....... ...+......+.+++.+||+.+|.+|||+.++++|
T Consensus 216 ~~~----~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 216 IFK----IATQPTN---------PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HHH----HhccCCC---------CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 111 1101000 01111233458899999999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=297.51 Aligned_cols=268 Identities=20% Similarity=0.265 Sum_probs=193.7
Q ss_pred cccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHH---hcCC
Q 040898 42 CFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITAN---QTRH 118 (337)
Q Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~---~l~h 118 (337)
+|++.+.||+|+||.||++.+.. +++.||+|.+.......... ..+.+|+.+++ +++|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~--~~~~~aiK~~~~~~~~~~~~-----------------~~~~~e~~~l~~l~~~~h 61 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPH--SGHFVALKSVRVQTNEDGLP-----------------LSTVREVALLKRLEAFDH 61 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECC--CCcEEEEEEeccCcCCCCCc-----------------hHHHHHHHHHHHhhhcCC
Confidence 58999999999999999999876 89999999886543221100 12334555554 4579
Q ss_pred CCcccceeEEEc-----CCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCC
Q 040898 119 RNILPLLAHMVR-----PNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIK 193 (337)
Q Consensus 119 pniv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~ 193 (337)
|||+++++++.. ....++++|++++ +|.+++.. .....+++..+..++.|++.||.|+ |+.|++|+||+
T Consensus 62 ~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~l---H~~~ivH~dik 135 (288)
T cd07863 62 PNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDK--VPPPGLPAETIKDLMRQFLRGLDFL---HANCIVHRDLK 135 (288)
T ss_pred CCeeeeeeeeccccCCCCceEEEEEccccc-CHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCC
Confidence 999999998754 3457999999975 88888754 2234588999999999999999999 77899999999
Q ss_pred CCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCC
Q 040898 194 PANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFG 273 (337)
Q Consensus 194 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~ 273 (337)
|+||+++.++.++|+|||++........ .....+++.|+|||.+.+..++.++|+||+|+++|+|++|.+||.....
T Consensus 136 p~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~ 212 (288)
T cd07863 136 PENILVTSGGQVKLADFGLARIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE 212 (288)
T ss_pred HHHEEECCCCCEEECccCccccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCH
Confidence 9999999999999999999876543221 1234578899999999888899999999999999999999999864322
Q ss_pred CchhhhHHHHHHhhhccCCcch---------hhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 274 HTEEMDMVKWMRNVIFSENPNR---------AINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
......+............+.. ...........+...+.+.+++.+||+.||++|||+.++++|
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 213 ADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred HHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1111111111100000000000 000000011112344568899999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=309.27 Aligned_cols=260 Identities=25% Similarity=0.364 Sum_probs=209.7
Q ss_pred ccccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHH
Q 040898 35 AFLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITAN 114 (337)
Q Consensus 35 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~ 114 (337)
+|....+...++++||+|+||+||++.+.. .||||.+..+...... .+.|..|+..++
T Consensus 386 ~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-----dVAVK~Lnv~~pt~~q-----------------lqaFKnEVa~lk 443 (678)
T KOG0193|consen 386 EWEIPPEEVLLGERIGSGSFGTVYRGRWHG-----DVAVKLLNVDDPTPEQ-----------------LQAFKNEVAVLK 443 (678)
T ss_pred ccccCHHHhhccceeccccccceeeccccc-----ceEEEEEecCCCCHHH-----------------HHHHHHHHHHHh
Confidence 344456678899999999999999999965 7999999887765542 278999999999
Q ss_pred hcCCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCC
Q 040898 115 QTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKP 194 (337)
Q Consensus 115 ~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~ 194 (337)
+.+|.||+-+.|++..+.. .+|+.+|+|.+|..++.- ....+++.....|++||++|+.|| |.++|+|+|||.
T Consensus 444 kTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv---~etkfdm~~~idIAqQiaqGM~YL---HAK~IIHrDLKS 516 (678)
T KOG0193|consen 444 KTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHV---QETKFDMNTTIDIAQQIAQGMDYL---HAKNIIHRDLKS 516 (678)
T ss_pred hcchhhheeeehhhcCCce-eeeehhccCchhhhhccc---hhhhhhHHHHHHHHHHHHHhhhhh---hhhhhhhhhccc
Confidence 9999999999999988877 999999999999999864 335689999999999999999999 889999999999
Q ss_pred CceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccC---CCCCcccchhhhHHHHHHHhCCCCCCCC
Q 040898 195 ANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTE---TISDKCDIYSFGVLLAVLVMGKFPVDDF 271 (337)
Q Consensus 195 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~---~~~~~~DiwslG~i~~~ll~g~~pf~~~ 271 (337)
.|||+.++++|+|+|||++................+...|+|||++... +|+..+||||+|+++|||++|..||...
T Consensus 517 nNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~ 596 (678)
T KOG0193|consen 517 NNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ 596 (678)
T ss_pred cceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC
Confidence 9999999999999999999876655444444556789999999999643 5889999999999999999999999732
Q ss_pred CCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 272 FGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
..+...... ..+. ...-.......+..++.+|+..||.+++++||++.+||.
T Consensus 597 ~~dqIifmV--------GrG~-----l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 597 NRDQIIFMV--------GRGY-----LMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred ChhheEEEe--------cccc-----cCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 111110000 0000 000011223455567999999999999999999999985
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=302.93 Aligned_cols=250 Identities=23% Similarity=0.289 Sum_probs=194.8
Q ss_pred cceeccCcceEEEEeEEec-CCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCcccc
Q 040898 46 LKKIGSGGWGEVFYKAELP-GSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPL 124 (337)
Q Consensus 46 ~~~lg~G~~g~V~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~ 124 (337)
++.||+|+||.||++.+.. ..+++.||+|.+......... .....+..|+.+++.++||||+++
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~---------------~~~~~~~~E~~il~~l~hp~iv~~ 65 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQ---------------KDTAHTKAERNILEAVKHPFIVDL 65 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhh---------------hhHHHHHHHHHHHHhCCCCchhce
Confidence 4689999999999987753 347899999998643211110 011456789999999999999999
Q ss_pred eeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCC
Q 040898 125 LAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDME 204 (337)
Q Consensus 125 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~ 204 (337)
++.+..++..|+||||+++++|.+++. ....+.+..+..++.|++.||.|| |+.|++|+||+|+||+++.++.
T Consensus 66 ~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nil~~~~~~ 138 (323)
T cd05584 66 IYAFQTGGKLYLILEYLSGGELFMHLE----REGIFMEDTACFYLSEISLALEHL---HQQGIIYRDLKPENILLDAQGH 138 (323)
T ss_pred eeEEecCCeEEEEEeCCCCchHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeEECCCCC
Confidence 999999999999999999999999884 344578888899999999999999 7779999999999999999999
Q ss_pred eEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHHHHH
Q 040898 205 ARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWM 284 (337)
Q Consensus 205 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~ 284 (337)
++|+|||++......... .....+++.|+|||.+.+..++.++||||||+++|+|++|..||..... .. ..
T Consensus 139 ~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~----~~---~~ 209 (323)
T cd05584 139 VKLTDFGLCKESIHEGTV--THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR----KK---TI 209 (323)
T ss_pred EEEeeCcCCeecccCCCc--ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH----HH---HH
Confidence 999999998653322211 1234689999999999988889999999999999999999999865321 11 11
Q ss_pred HhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCC-----ChhhhhcC
Q 040898 285 RNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERP-----SSKDVRSM 337 (337)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 337 (337)
......... .++.....+.+++.+||+.||++|| ++.++++|
T Consensus 210 ~~~~~~~~~-----------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 210 DKILKGKLN-----------LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred HHHHcCCCC-----------CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 111111110 0111234488999999999999999 89998876
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=308.48 Aligned_cols=266 Identities=21% Similarity=0.225 Sum_probs=202.7
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
..+|++++.||.|+||.||++......++..|++|.+... ....+|+.+++.++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~------------------------~~~~~E~~il~~l~h~ 146 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG------------------------KTPGREIDILKTISHR 146 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc------------------------ccHHHHHHHHHhcCCC
Confidence 3469999999999999999987765557889999987532 2345699999999999
Q ss_pred CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceee
Q 040898 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI 199 (337)
Q Consensus 120 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~ 199 (337)
||+++++.+......+++||++. ++|.+++ .....+++..+..++.||+.||.|| |++|++|+||||+||++
T Consensus 147 ~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l----~~~~~l~~~~~~~i~~ql~~aL~~L---H~~givHrDlkp~Nill 218 (392)
T PHA03207 147 AIINLIHAYRWKSTVCMVMPKYK-CDLFTYV----DRSGPLPLEQAITIQRRLLEALAYL---HGRGIIHRDVKTENIFL 218 (392)
T ss_pred CccceeeeEeeCCEEEEEehhcC-CCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHEEE
Confidence 99999999999999999999996 5888887 3445689999999999999999999 67799999999999999
Q ss_pred cCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhh
Q 040898 200 DDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMD 279 (337)
Q Consensus 200 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~ 279 (337)
+.++.++|+|||++................+|+.|+|||++.+..++.++|+|||||++|+|++|..||...........
T Consensus 219 ~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~ 298 (392)
T PHA03207 219 DEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQ 298 (392)
T ss_pred cCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHH
Confidence 99999999999998766544333233345789999999999998999999999999999999999999865433322222
Q ss_pred HHHHHHhhhccCCc--c---hh-------hhhcccCC-ch------HHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 280 MVKWMRNVIFSENP--N---RA-------INSKLLGN-GY------EEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 280 ~~~~~~~~~~~~~~--~---~~-------~~~~~~~~-~~------~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
+............. . .. ........ .. .....++.+++.+||..||.+|||+.|+|.|
T Consensus 299 l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 299 LRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 22222211100000 0 00 00000000 00 0123457889999999999999999999986
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=284.50 Aligned_cols=255 Identities=22% Similarity=0.356 Sum_probs=207.2
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
.+.|++.+.||+|.|+.|+++.+.. +|+.+|+|++..+...... .+.+.+|+.+-+.|+||
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~--tg~~fa~kiin~~k~~~~~-----------------~e~l~rEarIC~~LqHP 70 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKT--TGLEFAAKIINTKKLSARD-----------------FQKLEREARICRKLQHP 70 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhcc--chHHHHHHHhhhhhhcccc-----------------HHHHHHHHHHHHhcCCC
Confidence 4569999999999999999887766 9999999988654332221 16788899999999999
Q ss_pred CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceee
Q 040898 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI 199 (337)
Q Consensus 120 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~ 199 (337)
||++++.........|+|+|++.|++|..-+-. +...++..+...++||+++|.|. |..||+|+|++|+|+++
T Consensus 71 ~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yC---H~n~IvHRDvkP~nllL 143 (355)
T KOG0033|consen 71 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILEALAYC---HSNGIVHRDLKPENLLL 143 (355)
T ss_pred cEeehhhhhcccceeEEEEecccchHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHH---HhcCceeccCChhheee
Confidence 999999999999999999999999999877632 35577888889999999999999 88899999999999999
Q ss_pred cC---CCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCch
Q 040898 200 DD---DMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTE 276 (337)
Q Consensus 200 ~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~ 276 (337)
.. ..-+||+|||++..+..+.. .....|||.|++||+++..+|+..+|||+.|+++|-++.|.+||-+- .
T Consensus 144 ASK~~~A~vKL~~FGvAi~l~~g~~---~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~----~ 216 (355)
T KOG0033|consen 144 ASKAKGAAVKLADFGLAIEVNDGEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE----D 216 (355)
T ss_pred eeccCCCceeecccceEEEeCCccc---cccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCc----c
Confidence 53 44689999999988874332 23478999999999999999999999999999999999999998442 2
Q ss_pred hhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 277 EMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
...+.+.+.+....- .++.++...++.++|+++||..||.+|+|+.|+|+|
T Consensus 217 ~~rlye~I~~g~yd~----------~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 217 QHRLYEQIKAGAYDY----------PSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred HHHHHHHHhccccCC----------CCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 223333333222111 122344555668999999999999999999999987
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=308.92 Aligned_cols=257 Identities=23% Similarity=0.331 Sum_probs=197.3
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
++|++.+.||+|+||.||++.+.. +++.||+|++........ .....+..|..++.+++|||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~----------------~~~~~~~~e~~~l~~l~~~~ 62 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKD--TGHIYAMKILRKADMLEK----------------EQVAHIRAERDILVEADGAW 62 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECC--CCCEEEEEEEEHHHHhhh----------------hhHHHHHHHHHHHHhCCCCC
Confidence 469999999999999999999876 899999999864321111 11256778999999999999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
|+++++.+.+++..|+||||+++|+|.+++. ....+++..+..++.|++.||.|| |+.|++|+||||+||+++
T Consensus 63 iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~~L~~l---H~~givHrDLkp~NIli~ 135 (360)
T cd05627 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM----KKDTLSEEATQFYIAETVLAIDAI---HQLGFIHRDIKPDNLLLD 135 (360)
T ss_pred EeeEEEEEEcCCEEEEEEeCCCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHH---HHCCeEccCCCHHHEEEC
Confidence 9999999999999999999999999999984 345688999999999999999999 778999999999999999
Q ss_pred CCCCeEEecccCccccCCCCce---------------------------------eeeecccCCCCccCccccccCCCCC
Q 040898 201 DDMEARISDFGHGKLMPDGHAQ---------------------------------ITVKCMVGTMGYMAPESLQTETISD 247 (337)
Q Consensus 201 ~~~~~~l~dfg~~~~~~~~~~~---------------------------------~~~~~~~~~~~~~~PE~~~~~~~~~ 247 (337)
.++.++|+|||++......... .......||+.|+|||++.+..++.
T Consensus 136 ~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~ 215 (360)
T cd05627 136 AKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNK 215 (360)
T ss_pred CCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCC
Confidence 9999999999998654321100 0011246899999999999999999
Q ss_pred cccchhhhHHHHHHHhCCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCC
Q 040898 248 KCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDE 327 (337)
Q Consensus 248 ~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~ 327 (337)
++|+|||||++|+|++|..||...... .... ......... .... .......+.+++.+|+. ||.+
T Consensus 216 ~~DiwSlGvilyel~tG~~Pf~~~~~~----~~~~---~i~~~~~~~-~~p~------~~~~s~~~~~li~~l~~-~p~~ 280 (360)
T cd05627 216 LCDWWSLGVIMYEMLIGYPPFCSETPQ----ETYR---KVMNWKETL-VFPP------EVPISEKAKDLILRFCT-DSEN 280 (360)
T ss_pred cceeccccceeeecccCCCCCCCCCHH----HHHH---HHHcCCCce-ecCC------CCCCCHHHHHHHHHhcc-Chhh
Confidence 999999999999999999999653221 1111 111000000 0000 00122347788888775 9999
Q ss_pred CCC---hhhhhcC
Q 040898 328 RPS---SKDVRSM 337 (337)
Q Consensus 328 Rps---~~ell~~ 337 (337)
|++ +.++++|
T Consensus 281 R~~~~~~~ei~~h 293 (360)
T cd05627 281 RIGSNGVEEIKSH 293 (360)
T ss_pred cCCCCCHHHHhcC
Confidence 995 7888877
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=291.98 Aligned_cols=248 Identities=27% Similarity=0.366 Sum_probs=192.0
Q ss_pred eccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCcccceeEE
Q 040898 49 IGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLLAHM 128 (337)
Q Consensus 49 lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~ 128 (337)
||+|+||.||++.+.. +|+.||+|.+..+....... ...+..|+.+++.++||||+++++.+
T Consensus 1 lg~G~~g~Vy~~~~~~--~~~~~a~K~~~~~~~~~~~~----------------~~~~~~E~~il~~l~hp~i~~~~~~~ 62 (277)
T cd05607 1 LGKGGFGEVCAVQVKN--TGKMYACKKLDKKRLKKKSG----------------EKMALLEKEILEKVNSPFIVNLAYAF 62 (277)
T ss_pred CCCCCceEEEEEEEcc--CCcEEEEEEEcHHHhhcchh----------------hHHHHHHHHHHHhcCCCcEEEEEEEE
Confidence 7999999999998876 89999999985432211100 03455689999999999999999999
Q ss_pred EcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCCeEEe
Q 040898 129 VRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARIS 208 (337)
Q Consensus 129 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~~l~ 208 (337)
.++...++||||+++++|.+++.. .....+++..+..++.|++.|+.|| |+.|++|+||+|+||+++.++.++|+
T Consensus 63 ~~~~~~~lv~e~~~g~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~l---H~~~ivH~dikp~Nili~~~~~~~l~ 137 (277)
T cd05607 63 ESKTHLCLVMSLMNGGDLKYHIYN--VGERGLEMERVIHYSAQITCGILHL---HSMDIVYRDMKPENVLLDDQGNCRLS 137 (277)
T ss_pred ecCCeEEEEEecCCCCCHHHHHHh--ccccCCCHHHHHHHHHHHHHHHHHH---HHCCEEEccCChHhEEEcCCCCEEEe
Confidence 999999999999999999988754 2334588888999999999999999 67799999999999999999999999
Q ss_pred cccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHHHHHHhhh
Q 040898 209 DFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVI 288 (337)
Q Consensus 209 dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 288 (337)
|||++........ .....+++.|+|||.+.+..++.++|+||+|+++|+|++|..||............ .....
T Consensus 138 Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~---~~~~~ 211 (277)
T cd05607 138 DLGLAVELKDGKT---ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEEL---KRRTL 211 (277)
T ss_pred eceeeeecCCCce---eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHH---HHHhh
Confidence 9999876544321 22346899999999998888999999999999999999999999754332221111 11111
Q ss_pred ccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhh
Q 040898 289 FSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVR 335 (337)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 335 (337)
...... ........+.+++.+||+.||.+|||++|++
T Consensus 212 ~~~~~~----------~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~ 248 (277)
T cd05607 212 EDEVKF----------EHQNFTEESKDICRLFLAKKPEDRLGSREKN 248 (277)
T ss_pred cccccc----------ccccCCHHHHHHHHHHhccCHhhCCCCccch
Confidence 111000 0012234589999999999999999995443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=300.81 Aligned_cols=246 Identities=22% Similarity=0.313 Sum_probs=192.9
Q ss_pred ceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc-CCCCcccce
Q 040898 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT-RHRNILPLL 125 (337)
Q Consensus 47 ~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~ 125 (337)
+.||+|+||.||++.+.. +++.||+|++......... ....+..|..++..+ +||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~--~~~~~aiK~~~~~~~~~~~----------------~~~~~~~e~~il~~~~~hp~i~~~~ 62 (321)
T cd05591 1 KVLGKGSFGKVMLAELKG--TDEVYAIKVLKKDVILQDD----------------DVDCTMTEKRILALAAKHPFLTALH 62 (321)
T ss_pred CccccCCCeEEEEEEECC--CCCEEEEEEEeHHHhhhhh----------------HHHHHHHHHHHHHhccCCCCcccee
Confidence 469999999999998865 8899999998654221111 114566688888765 899999999
Q ss_pred eEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCCe
Q 040898 126 AHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEA 205 (337)
Q Consensus 126 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~ 205 (337)
+++..++..|+||||+++++|...+. ....+++..+..++.|++.||.|| |+.|++|+||+|+||+++.++.+
T Consensus 63 ~~~~~~~~~~lv~E~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDikp~Nill~~~~~~ 135 (321)
T cd05591 63 CCFQTKDRLFFVMEYVNGGDLMFQIQ----RSRKFDEPRSRFYAAEVTLALMFL---HRHGVIYRDLKLDNILLDAEGHC 135 (321)
T ss_pred eEEEcCCeEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHeEECCCCCE
Confidence 99999999999999999999998884 334688899999999999999999 67799999999999999999999
Q ss_pred EEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHHHHHH
Q 040898 206 RISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMR 285 (337)
Q Consensus 206 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~ 285 (337)
+|+|||++........ ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||..... .....
T Consensus 136 kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~----~~~~~--- 206 (321)
T cd05591 136 KLADFGMCKEGILNGV--TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE----DDLFE--- 206 (321)
T ss_pred EEeecccceecccCCc--cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH----HHHHH---
Confidence 9999998875432221 12234689999999999988899999999999999999999999964321 11111
Q ss_pred hhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCC-------ChhhhhcC
Q 040898 286 NVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERP-------SSKDVRSM 337 (337)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-------s~~ell~~ 337 (337)
......... +......+.+++.+||+.||++|| ++.++++|
T Consensus 207 ~i~~~~~~~-----------p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 207 SILHDDVLY-----------PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred HHHcCCCCC-----------CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 111111110 001223488999999999999999 88899876
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=306.51 Aligned_cols=267 Identities=24% Similarity=0.304 Sum_probs=196.7
Q ss_pred cccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCc
Q 040898 42 CFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNI 121 (337)
Q Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpni 121 (337)
+|++++.||+|+||.||++.+.. +++.||+|++......... ...+.+|+.+++.++||||
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~ni 61 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPR--DGKRVALKKMPNVFQNLVS-----------------CKRVFRELKMLCFFKHDNV 61 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECC--CCCEEEEEeccccccchHH-----------------HHHHHHHHHHHHhCCCCCc
Confidence 48899999999999999998865 8999999988543221110 1467789999999999999
Q ss_pred ccceeEEEcCC-----eeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 040898 122 LPLLAHMVRPN-----CHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPAN 196 (337)
Q Consensus 122 v~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~n 196 (337)
+++++++.... ..|+|+||+.+ +|.+.+ .....+++..+..++.||+.||.|| |+.|++|+||+|+|
T Consensus 62 v~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~----~~~~~l~~~~~~~~~~qi~~aL~~L---H~~~ivH~dlkp~N 133 (372)
T cd07853 62 LSALDILQPPHIDPFEEIYVVTELMQS-DLHKII----VSPQPLSSDHVKVFLYQILRGLKYL---HSAGILHRDIKPGN 133 (372)
T ss_pred CCHhheecCCCccccceEEEEeecccc-CHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCChHH
Confidence 99999998776 78999999964 787777 3445689999999999999999999 77899999999999
Q ss_pred eeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCCCc
Q 040898 197 VLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTE-TISDKCDIYSFGVLLAVLVMGKFPVDDFFGHT 275 (337)
Q Consensus 197 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~ 275 (337)
|+++.++.++|+|||++......... ......+++.|+|||.+.+. .++.++|+||+||++|+|++|+.||.......
T Consensus 134 ili~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 212 (372)
T cd07853 134 LLVNSNCVLKICDFGLARVEEPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ 212 (372)
T ss_pred EEECCCCCEEeccccceeecccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH
Confidence 99999999999999998765432211 11234578899999998774 47889999999999999999999996543211
Q ss_pred hhhhHHHH---------------HHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 276 EEMDMVKW---------------MRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 276 ~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
....+... ................. .........+.+.+|+.+||+.||++|||+.++++|
T Consensus 213 ~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 213 QLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPV-LYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHH-hcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 11111000 00000000000000000 000111224568899999999999999999999986
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=307.08 Aligned_cols=258 Identities=20% Similarity=0.286 Sum_probs=198.3
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++.+.||+|+||.||++.+.. +++.+|+|.+......... ....+.+|..+++.++|
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~--~~~~~aiK~i~~~~~~~~~----------------~~~~~~~e~~i~~~~~h 102 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKS--TRKVYAMKLLSKFEMIKRS----------------DSAFFWEERDIMAFANS 102 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECC--CCcEEEEEEEEHHHhhhhH----------------HHHHHHHHHHHHHhCCC
Confidence 56889999999999999999998876 8999999998543211111 11457789999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++.+.++...++||||+++|+|.+++.. ..+++..+..++.||+.||.|| |+.|++|+||||+||+
T Consensus 103 p~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDLkp~NIl 174 (371)
T cd05622 103 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAI---HSMGFIHRDVKPDNML 174 (371)
T ss_pred CCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHH---HHCCEEeCCCCHHHEE
Confidence 9999999999999999999999999999999843 2478888899999999999999 7789999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCC----CCCcccchhhhHHHHHHHhCCCCCCCCCCC
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTET----ISDKCDIYSFGVLLAVLVMGKFPVDDFFGH 274 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~----~~~~~DiwslG~i~~~ll~g~~pf~~~~~~ 274 (337)
++.++.++|+|||++......... ......||+.|+|||++.+.. ++.++|+||||+++|+|++|..||.....
T Consensus 175 l~~~~~ikL~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~- 252 (371)
T cd05622 175 LDKSGHLKLADFGTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL- 252 (371)
T ss_pred ECCCCCEEEEeCCceeEcCcCCcc-cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH-
Confidence 999999999999998765433211 123456999999999987543 77899999999999999999999864211
Q ss_pred chhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCC--CCChhhhhcC
Q 040898 275 TEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDE--RPSSKDVRSM 337 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~ell~~ 337 (337)
.... ..+........ .+........+.+++..||+.+|.+ |+++.++++|
T Consensus 253 --~~~~----~~i~~~~~~~~-------~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 253 --VGTY----SKIMNHKNSLT-------FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred --HHHH----HHHHcCCCccc-------CCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 1111 11111111000 0011123345889999999844443 7899999986
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=299.78 Aligned_cols=254 Identities=22% Similarity=0.305 Sum_probs=193.8
Q ss_pred ceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc-CCCCcccce
Q 040898 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT-RHRNILPLL 125 (337)
Q Consensus 47 ~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~ 125 (337)
+.||+|+||.||++.+.. +++.||+|++......... ....+.+|..++.++ +||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~----------------~~~~~~~E~~~l~~~~~hp~iv~~~ 62 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKK--TERIYAMKVVKKELVNDDE----------------DIDWVQTEKHVFEQASNHPFLVGLH 62 (329)
T ss_pred CeeeeCCCeEEEEEEECC--CCCEEEEEEEEhhHhcchh----------------HHHHHHHHHHHHHhcCCCCcCCcee
Confidence 479999999999998876 8999999998754322111 114567788888776 899999999
Q ss_pred eEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCCe
Q 040898 126 AHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEA 205 (337)
Q Consensus 126 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~ 205 (337)
+++...+..++||||+++++|..++. ....+++..+..++.|++.||.|| |+.|++|+||||+||+++.++.+
T Consensus 63 ~~~~~~~~~~lv~E~~~~~~L~~~~~----~~~~l~~~~~~~i~~qi~~~l~~l---H~~~ivH~Dikp~Nili~~~~~~ 135 (329)
T cd05618 63 SCFQTESRLFFVIEYVNGGDLMFHMQ----RQRKLPEEHARFYSAEISLALNYL---HERGIIYRDLKLDNVLLDSEGHI 135 (329)
T ss_pred eEEEeCCEEEEEEeCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeCCCCHHHEEECCCCCE
Confidence 99999999999999999999988874 335689999999999999999999 67799999999999999999999
Q ss_pred EEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCch-hhhHHHHH
Q 040898 206 RISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTE-EMDMVKWM 284 (337)
Q Consensus 206 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~-~~~~~~~~ 284 (337)
+|+|||++........ ......|++.|+|||++.+..++.++|+||||+++|+|++|..||........ ........
T Consensus 136 kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~ 213 (329)
T cd05618 136 KLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL 213 (329)
T ss_pred EEeeCCccccccCCCC--ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHH
Confidence 9999999865322111 11235689999999999999999999999999999999999999964222111 11111111
Q ss_pred HhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCCh------hhhhcC
Q 040898 285 RNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSS------KDVRSM 337 (337)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~------~ell~~ 337 (337)
.......... .+......+.+++.+||+.||++|||+ .++++|
T Consensus 214 ~~~i~~~~~~----------~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 214 FQVILEKQIR----------IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred HHHHhcCCCC----------CCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 1111111100 011223347899999999999999994 688876
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=288.68 Aligned_cols=259 Identities=26% Similarity=0.376 Sum_probs=205.1
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
++|++.+.||+|+||.||++.+.. +++.||+|.+.......... ...+.+|+.+++.++|||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~--~~~~~~iK~~~~~~~~~~~~----------------~~~~~~e~~~l~~l~h~~ 63 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLL--DRKPVALKKVQIFEMMDAKA----------------RQDCVKEIDLLKQLNHPN 63 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeC--CCCEEEEEEeeccccCCHHH----------------HHHHHHHHHHHHhCCCcc
Confidence 579999999999999999999876 89999999875432222111 146778999999999999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
|+++++.+...+..++++||+++++|.+++.........+++..+..++.|++.|+.|| |+.|++|+||+|+||+++
T Consensus 64 i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L---H~~~i~H~dl~~~nil~~ 140 (267)
T cd08228 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM---HSRRVMHRDIKPANVFIT 140 (267)
T ss_pred eeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHH---hhCCeeCCCCCHHHEEEc
Confidence 99999999999999999999999999999876555556688899999999999999999 778999999999999999
Q ss_pred CCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhH
Q 040898 201 DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDM 280 (337)
Q Consensus 201 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~ 280 (337)
.++.++|+|||.+......... .....+++.|+|||.+.+..++.++|+||+|+++|+|++|..||..... .....
T Consensus 141 ~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~--~~~~~ 216 (267)
T cd08228 141 ATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM--NLFSL 216 (267)
T ss_pred CCCCEEECccccceeccchhHH--HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc--cHHHH
Confidence 9999999999988765433211 1234578889999999888889999999999999999999999854221 11112
Q ss_pred HHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 281 VKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
...+.. ...+. .........+.+++.+||+.+|++|||+.++++
T Consensus 217 ~~~~~~---~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 217 CQKIEQ---CDYPP---------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred HHHHhc---CCCCC---------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence 221111 11111 011223455899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=299.30 Aligned_cols=253 Identities=23% Similarity=0.275 Sum_probs=194.1
Q ss_pred ceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc-CCCCcccce
Q 040898 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT-RHRNILPLL 125 (337)
Q Consensus 47 ~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~ 125 (337)
+.||+|+||.||++.+.. +++.||+|++......... ....+.+|..++.++ .||||+.++
T Consensus 1 ~~lG~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~----------------~~~~~~~e~~~~~~~~~~~~i~~~~ 62 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKK--NDQIYAMKVVKKELVHDDE----------------DIDWVQTEKHVFEQASSNPFLVGLH 62 (327)
T ss_pred CeeeeCCCeEEEEEEECC--CCCEEEEEEEEHHHhhhhh----------------HHHHHHHHHHHHHhhcCCCCEeeEE
Confidence 479999999999998876 8899999998654322111 125677888888888 699999999
Q ss_pred eEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCCe
Q 040898 126 AHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEA 205 (337)
Q Consensus 126 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~ 205 (337)
+.+.+.+..|+||||+++++|..++. ....+++..+..++.||+.|+.|| |++|++|+||+|+||+++.++.+
T Consensus 63 ~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~l~~~~~~~~~~qi~~al~~l---H~~~ivHrDlkp~Nili~~~~~~ 135 (327)
T cd05617 63 SCFQTTSRLFLVIEYVNGGDLMFHMQ----RQRKLPEEHARFYAAEICIALNFL---HERGIIYRDLKLDNVLLDADGHI 135 (327)
T ss_pred EEEEeCCEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHEEEeCCCCE
Confidence 99999999999999999999998884 334689999999999999999999 67799999999999999999999
Q ss_pred EEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHHHHHH
Q 040898 206 RISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMR 285 (337)
Q Consensus 206 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~ 285 (337)
+|+|||++........ ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||.................
T Consensus 136 kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~ 213 (327)
T cd05617 136 KLTDYGMCKEGLGPGD--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQ 213 (327)
T ss_pred EEeccccceeccCCCC--ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHH
Confidence 9999998865322111 12335689999999999999999999999999999999999999964322211111111111
Q ss_pred hhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCCh------hhhhcC
Q 040898 286 NVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSS------KDVRSM 337 (337)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~------~ell~~ 337 (337)
........ .+...+..+.+++.+||+.||++|+++ .++++|
T Consensus 214 ~~~~~~~~-----------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 214 VILEKPIR-----------IPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred HHHhCCCC-----------CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 11111100 011122347899999999999999985 577765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=295.43 Aligned_cols=260 Identities=25% Similarity=0.377 Sum_probs=202.2
Q ss_pred cccccccceeccCcceEEEEeEEecCC---CCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGS---NGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT 116 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 116 (337)
.++|++.+.||+|++|.||++.+.... +...|++|.+......... ..+.+|+..+..+
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~------------------~~~~~ei~~l~~l 65 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQ------------------QEFRQEAELMSDL 65 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHH------------------HHHHHHHHHHHhc
Confidence 357999999999999999998875421 3367999988644321111 4677899999999
Q ss_pred CCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCC------------cccCChHHHHHHHHHHHHHHHHHhhCCC
Q 040898 117 RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQG------------RRELDWPARHRIARGIASGLEYLHMCHR 184 (337)
Q Consensus 117 ~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------------~~~~~~~~~~~i~~~i~~~l~~l~~~h~ 184 (337)
+||||+++++++.+....++++||+++++|.+++...... ...+++..++.++.|++.||.|| |+
T Consensus 66 ~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~l---H~ 142 (283)
T cd05048 66 QHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYL---SS 142 (283)
T ss_pred CCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHH---Hh
Confidence 9999999999999999999999999999999998653211 14578888999999999999999 77
Q ss_pred CCeEecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-
Q 040898 185 PRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM- 263 (337)
Q Consensus 185 ~gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~- 263 (337)
.|++|+||+|+||++++++.++|+|||++................+++.|+|||.+.+..++.++|+||||+++|+|++
T Consensus 143 ~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~ 222 (283)
T cd05048 143 HHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSY 222 (283)
T ss_pred CCeeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcC
Confidence 7999999999999999999999999999876533322222233456788999999988889999999999999999998
Q ss_pred CCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 264 GKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 264 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
|..||..... .+....+.. ... ...+...+..+.+|+.+||+.||++|||+.+++++
T Consensus 223 g~~p~~~~~~----~~~~~~i~~---~~~----------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 223 GLQPYYGFSN----QEVIEMIRS---RQL----------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred CCCCCCCCCH----HHHHHHHHc---CCc----------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999865422 112221111 110 01122344569999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=301.50 Aligned_cols=251 Identities=22% Similarity=0.301 Sum_probs=195.4
Q ss_pred cccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc-CCCC
Q 040898 42 CFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT-RHRN 120 (337)
Q Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpn 120 (337)
+|++.+.||+|+||.||++.+.. ++..||+|.+.......... ...+..|..++..+ .||+
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~--~~~~~aiK~~~~~~~~~~~~----------------~~~~~~e~~~l~~~~~~~~ 62 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKG--TDELYAIKILKKDVVIQDDD----------------VECTMVEKRVLALSGKPPF 62 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECC--CCCEEEEEEEEHHHhhhhhH----------------HHHHHHHHHHHHhccCCCe
Confidence 58899999999999999998876 88999999986542211111 13455677777766 5889
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
|+.+++.+...+..++||||+++|+|.+.+.. ...+++..+..++.|++.||.|| |+.|++|+||+|+||+++
T Consensus 63 i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~Nill~ 135 (323)
T cd05616 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFL---HSKGIIYRDLKLDNVMLD 135 (323)
T ss_pred EeeEEEEEecCCEEEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCEEecCCCHHHeEEC
Confidence 99999999999999999999999999988843 34588899999999999999999 677999999999999999
Q ss_pred CCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhH
Q 040898 201 DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDM 280 (337)
Q Consensus 201 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~ 280 (337)
.++.++|+|||++........ ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||..... ...
T Consensus 136 ~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~----~~~ 209 (323)
T cd05616 136 SEGHIKIADFGMCKENMWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE----DEL 209 (323)
T ss_pred CCCcEEEccCCCceecCCCCC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH----HHH
Confidence 999999999999875432211 12235689999999999999999999999999999999999999965321 112
Q ss_pred HHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCCh-----hhhhcC
Q 040898 281 VKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSS-----KDVRSM 337 (337)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~ell~~ 337 (337)
...+.. .... .+......+.+++.+||+.||.+|++. .++++|
T Consensus 210 ~~~i~~---~~~~-----------~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 210 FQSIME---HNVA-----------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred HHHHHh---CCCC-----------CCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 111111 1110 011123448899999999999999985 667654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=300.81 Aligned_cols=246 Identities=24% Similarity=0.334 Sum_probs=189.2
Q ss_pred ceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHh-cCCCCcccce
Q 040898 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQ-TRHRNILPLL 125 (337)
Q Consensus 47 ~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~-l~hpniv~~~ 125 (337)
+.||+|+||.||++.+.. +++.||+|.+.......... ...+..|..++.. .+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~----------------~~~~~~e~~~l~~~~~hp~i~~~~ 62 (316)
T cd05592 1 KVLGKGSFGKVMLAELKG--TNEFFAIKALKKDVVLEDDD----------------VECTMVERRVLALAWEHPFLTHLF 62 (316)
T ss_pred CeeeeCCCeEEEEEEECC--CCCEEEEEEEEHHHhhhhhh----------------HHHHHHHHHHHHhccCCCCcccee
Confidence 479999999999998865 88999999986542211110 1334455555554 4899999999
Q ss_pred eEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCCe
Q 040898 126 AHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEA 205 (337)
Q Consensus 126 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~ 205 (337)
+++..+...++||||+++++|.+++. ....+++..+..++.|++.||.|| |+.|++|+||+|+||+++.++.+
T Consensus 63 ~~~~~~~~~~lv~e~~~gg~L~~~~~----~~~~~~~~~~~~~~~qi~~al~~L---H~~~ivH~dlkp~Nill~~~~~~ 135 (316)
T cd05592 63 CTFQTKEHLFFVMEYLNGGDLMFHIQ----SSGRFDEARARFYAAEIICGLQFL---HKKGIIYRDLKLDNVLLDKDGHI 135 (316)
T ss_pred eEEEcCCEEEEEEcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHH---HHCCEEeCCCCHHHeEECCCCCE
Confidence 99999999999999999999999884 334688999999999999999999 67799999999999999999999
Q ss_pred EEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHHHHHH
Q 040898 206 RISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMR 285 (337)
Q Consensus 206 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~ 285 (337)
+|+|||++........ ......||+.|+|||.+.+..++.++|+||||+++|+|++|..||..... ......+
T Consensus 136 kL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~----~~~~~~i- 208 (316)
T cd05592 136 KIADFGMCKENMNGEG--KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE----DELFDSI- 208 (316)
T ss_pred EEccCcCCeECCCCCC--ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH----HHHHHHH-
Confidence 9999999875433221 12235689999999999988899999999999999999999999965321 1111111
Q ss_pred hhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChh-hhhcC
Q 040898 286 NVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSK-DVRSM 337 (337)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~-ell~~ 337 (337)
...... .+......+.+++.+||+.||.+||++. ++++|
T Consensus 209 --~~~~~~-----------~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05592 209 --LNDRPH-----------FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQH 248 (316)
T ss_pred --HcCCCC-----------CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 111100 0111233478999999999999999875 66654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=293.28 Aligned_cols=259 Identities=23% Similarity=0.355 Sum_probs=202.0
Q ss_pred cccccccceeccCcceEEEEeEEecC---CCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPG---SNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT 116 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 116 (337)
.++|.+.+.||+|+||.||++.+... .++..||+|.+........ ...+.+|+.++..+
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~------------------~~~~~~e~~~l~~l 65 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDA------------------RKDFEREAELLTNF 65 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHH------------------HHHHHHHHHHHHhc
Confidence 46799999999999999999877542 3568899998864432211 15678899999999
Q ss_pred CCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhc----------CCcccCChHHHHHHHHHHHHHHHHHhhCCCCC
Q 040898 117 RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVS----------QGRRELDWPARHRIARGIASGLEYLHMCHRPR 186 (337)
Q Consensus 117 ~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~g 186 (337)
+||||+++++++..+...+++|||+++++|.+++.... .....+++..+..++.|++.++.++ |+.|
T Consensus 66 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~l---H~~~ 142 (280)
T cd05049 66 QHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYL---ASQH 142 (280)
T ss_pred CCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHH---hhCC
Confidence 99999999999999999999999999999999996532 1234578889999999999999999 7789
Q ss_pred eEecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CC
Q 040898 187 LIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GK 265 (337)
Q Consensus 187 i~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~ 265 (337)
++|+||+|+||+++.++.++|+|||++................+++.|+|||.+.+..++.++|+||||+++|+|++ |.
T Consensus 143 i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~ 222 (280)
T cd05049 143 FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGK 222 (280)
T ss_pred eeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCC
Confidence 99999999999999999999999999875433222111223345778999999999899999999999999999998 99
Q ss_pred CCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 266 FPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 266 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
.||..... ......+........ .......+.+++.+||+.||++|||+.|+++
T Consensus 223 ~p~~~~~~----~~~~~~~~~~~~~~~-------------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 223 QPWYGLSN----EEVIECITQGRLLQR-------------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CCCCCCCH----HHHHHHHHcCCcCCC-------------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 99854322 112222221111000 1122344899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=291.13 Aligned_cols=256 Identities=29% Similarity=0.408 Sum_probs=201.1
Q ss_pred cccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCc
Q 040898 42 CFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNI 121 (337)
Q Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpni 121 (337)
+|+..+.||+|+||.||++.+.. +++.||+|.+.......... ...+..|+.++++++|+|+
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~--~~~~~avK~~~~~~~~~~~~----------------~~~~~~E~~il~~l~~~~i 62 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRA--TGKMYACKKLEKKRIKKRKG----------------ESMALNEKQILEKVNSRFV 62 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcC--CCceEEEEEEehhhccchHH----------------HHHHHHHHHHHHhCCCCCe
Confidence 47889999999999999999976 89999999986543221110 1456779999999999999
Q ss_pred ccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecC
Q 040898 122 LPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDD 201 (337)
Q Consensus 122 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~ 201 (337)
+.+.+.+.+++..++||||+++++|.+++.. .....+++..+..++.|++.||.|| |+.|++|+||+|+||+++.
T Consensus 63 ~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~--~~~~~l~~~~~~~~~~qi~~~l~~l---H~~~iiH~dikp~Nil~~~ 137 (285)
T cd05630 63 VSLAYAYETKDALCLVLTLMNGGDLKFHIYH--MGEAGFEEGRAVFYAAEICCGLEDL---HQERIVYRDLKPENILLDD 137 (285)
T ss_pred eeeeEEEecCCEEEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHH---HhCCEEeCCCCHHHEEECC
Confidence 9999999999999999999999999998854 2334588899999999999999999 6779999999999999999
Q ss_pred CCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHH
Q 040898 202 DMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMV 281 (337)
Q Consensus 202 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~ 281 (337)
++.++|+|||++........ .....++..|+|||.+.+..++.++|+||+|+++|+|++|..||.............
T Consensus 138 ~~~~~l~Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~ 214 (285)
T cd05630 138 HGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE 214 (285)
T ss_pred CCCEEEeeccceeecCCCcc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHH
Confidence 99999999998876433221 123468999999999998889999999999999999999999997532211111111
Q ss_pred HHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCC-----hhhhhcC
Q 040898 282 KWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPS-----SKDVRSM 337 (337)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~~ 337 (337)
....... .. ........+.+|+.+||+.||++||| +.|+++|
T Consensus 215 ~~~~~~~-~~-------------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 215 RLVKEVQ-EE-------------YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred hhhhhhh-hh-------------cCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 1111100 00 01112334889999999999999999 8999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=296.78 Aligned_cols=266 Identities=19% Similarity=0.278 Sum_probs=199.9
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
+.++|++.+.||.|+||.||++.+.. ++..||+|.+......... ..+.+|+.+++.++|
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~--~~~~vaiK~~~~~~~~~~~------------------~~~~~E~~~l~~l~h 63 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKL--TDNLVALKEIRLEHEEGAP------------------CTAIREVSLLKDLKH 63 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcC--CCcEEEEEEEecccccCch------------------hHHHHHHHHHHhcCC
Confidence 45779999999999999999998865 8899999998654322211 345679999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++++..++..++|+||+++ +|.+++.. ....+++..+..++.|++.||.+| |+.|++|+||+|+||+
T Consensus 64 ~nI~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~l---H~~~i~H~dlkp~Nil 136 (301)
T cd07873 64 ANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDD---CGNSINMHNVKLFLFQLLRGLNYC---HRRKVLHRDLKPQNLL 136 (301)
T ss_pred CCcceEEEEEecCCeEEEEEecccc-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCCHHHEE
Confidence 9999999999999999999999975 88888754 334578899999999999999999 7789999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCCCchh
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTE-TISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEE 277 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~ 277 (337)
++.++.++|+|||++......... .....+++.|+|||.+.+. .++.++|+||||+++|+|++|.+||......
T Consensus 137 ~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~--- 211 (301)
T cd07873 137 INERGELKLADFGLARAKSIPTKT--YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE--- 211 (301)
T ss_pred ECCCCcEEECcCcchhccCCCCCc--ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH---
Confidence 999999999999998754332211 1233568899999998654 4788999999999999999999999653221
Q ss_pred hhHHHHHHhhhccCCcc---h-----hh----hhccc----CCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 278 MDMVKWMRNVIFSENPN---R-----AI----NSKLL----GNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~---~-----~~----~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.....+.......... . .. .+... ....+..+..+.+|+.+||+.||++|||+.|+++|
T Consensus 212 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 212 -EQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred -HHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 1111111111000000 0 00 00000 00111234568899999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=301.13 Aligned_cols=246 Identities=23% Similarity=0.312 Sum_probs=193.4
Q ss_pred ceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc-CCCCcccce
Q 040898 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT-RHRNILPLL 125 (337)
Q Consensus 47 ~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~ 125 (337)
+.||+|+||.||++.+.. +++.||+|++......... ....+.+|..++..+ +||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~----------------~~~~~~~e~~il~~~~~h~~i~~~~ 62 (318)
T cd05570 1 KVLGKGSFGKVLLAELKG--TDELYAVKVLKKDVILQDD----------------DVECTMTEKRVLALAGKHPFLTQLH 62 (318)
T ss_pred CeeeeCCCeEEEEEEECC--CCCEEEEEEEEHHHHhhhh----------------HHHHHHHHHHHHHhccCCCCcccee
Confidence 479999999999998876 8899999998654221111 114566788888877 799999999
Q ss_pred eEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCCe
Q 040898 126 AHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEA 205 (337)
Q Consensus 126 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~ 205 (337)
+++.+.+..++||||+++++|..++. ....+++..+..++.|++.||.|| |+.|++|+||+|+||+++.++.+
T Consensus 63 ~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~~L---H~~~ivH~dlkp~Nill~~~~~~ 135 (318)
T cd05570 63 SCFQTKDRLFFVMEYVNGGDLMFHIQ----RSGRFDEPRARFYAAEIVLGLQFL---HERGIIYRDLKLDNVLLDSEGHI 135 (318)
T ss_pred eEEEcCCEEEEEEcCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHH---HhCCeEccCCCHHHeEECCCCcE
Confidence 99999999999999999999998884 334689999999999999999999 77899999999999999999999
Q ss_pred EEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHHHHHH
Q 040898 206 RISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMR 285 (337)
Q Consensus 206 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~ 285 (337)
+|+|||++......... .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||.... .......+.
T Consensus 136 kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~----~~~~~~~i~ 209 (318)
T cd05570 136 KIADFGMCKEGILGGVT--TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD----EDELFQSIL 209 (318)
T ss_pred EecccCCCeecCcCCCc--ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC----HHHHHHHHH
Confidence 99999988643222111 123458999999999999999999999999999999999999996432 111111111
Q ss_pred hhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCCh-----hhhhcC
Q 040898 286 NVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSS-----KDVRSM 337 (337)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~ell~~ 337 (337)
..... .+......+.+++.+||+.||++|||+ .++++|
T Consensus 210 ---~~~~~-----------~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 210 ---EDEVR-----------YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred ---cCCCC-----------CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 11110 001123458899999999999999999 888876
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=307.36 Aligned_cols=243 Identities=28% Similarity=0.438 Sum_probs=202.6
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
.=+...-++=||+|+.|.||++.. .++.||||++.. .-..+++=|++|+|
T Consensus 122 PFe~IsELeWlGSGaQGAVF~Grl----~netVAVKKV~e--------------------------lkETdIKHLRkLkH 171 (904)
T KOG4721|consen 122 PFEEISELEWLGSGAQGAVFLGRL----HNETVAVKKVRE--------------------------LKETDIKHLRKLKH 171 (904)
T ss_pred CHHHhhhhhhhccCcccceeeeec----cCceehhHHHhh--------------------------hhhhhHHHHHhccC
Confidence 334455688899999999998877 678999998742 22347888999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+.|.|+|....+++||||||..|-|..+| ..+.+++......|..+|+.++.|| |.+.|+|+|||.-|||
T Consensus 172 ~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VL----ka~~~itp~llv~Wsk~IA~GM~YL---H~hKIIHRDLKSPNiL 244 (904)
T KOG4721|consen 172 PNIITFKGVCTQSPCYCIIMEFCAQGQLYEVL----KAGRPITPSLLVDWSKGIAGGMNYL---HLHKIIHRDLKSPNIL 244 (904)
T ss_pred cceeeEeeeecCCceeEEeeeccccccHHHHH----hccCccCHHHHHHHHHHhhhhhHHH---HHhhHhhhccCCCceE
Confidence 99999999999999999999999999999999 5677899999999999999999999 7779999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhh
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEM 278 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~ 278 (337)
|+.+..|||+|||.+......... -.+.||..|||||+++..+.++++||||+|+++|||+||..||.........
T Consensus 245 Is~~d~VKIsDFGTS~e~~~~STk---MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII- 320 (904)
T KOG4721|consen 245 ISYDDVVKISDFGTSKELSDKSTK---MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII- 320 (904)
T ss_pred eeccceEEeccccchHhhhhhhhh---hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeE-
Confidence 999999999999998776544222 2367999999999999999999999999999999999999999654321111
Q ss_pred hHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 279 DMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
+..- ...+.-..++.+++.++-|+++||+-.|++|||++++|.|
T Consensus 321 ----------wGVG-----sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 321 ----------WGVG-----SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLH 364 (904)
T ss_pred ----------Eecc-----CCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence 1111 1112233455667779999999999999999999999986
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=299.84 Aligned_cols=246 Identities=25% Similarity=0.322 Sum_probs=190.6
Q ss_pred ceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc-CCCCcccce
Q 040898 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT-RHRNILPLL 125 (337)
Q Consensus 47 ~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~ 125 (337)
+.||+|+||.||++.+.. ++..||+|.+......... .......|..++..+ +||||++++
T Consensus 1 ~~lg~G~~g~V~~~~~~~--~~~~~avK~~~~~~~~~~~----------------~~~~~~~e~~~l~~~~~~~~i~~~~ 62 (316)
T cd05620 1 KVLGKGSFGKVLLAELKG--KGEYFAVKALKKDVVLIDD----------------DVECTMVEKRVLALAWENPFLTHLY 62 (316)
T ss_pred CeeeeCCCeEEEEEEECC--CCCEEEEEEEEHHHhhhcc----------------hHHHHHHHHHHHHhccCCCCccCee
Confidence 479999999999999876 8999999998653221110 113455577777654 899999999
Q ss_pred eEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCCe
Q 040898 126 AHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEA 205 (337)
Q Consensus 126 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~ 205 (337)
+.+.+++..|+||||+++++|..++.. ...+++..+..++.|++.||.|| |++|++|+||+|+||+++.++.+
T Consensus 63 ~~~~~~~~~~lv~E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivHrDlkp~Nil~~~~~~~ 135 (316)
T cd05620 63 CTFQTKEHLFFVMEFLNGGDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFL---HSKGIIYRDLKLDNVMLDRDGHI 135 (316)
T ss_pred EEEEeCCEEEEEECCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHeEECCCCCE
Confidence 999999999999999999999998843 45688899999999999999999 77899999999999999999999
Q ss_pred EEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHHHHHH
Q 040898 206 RISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMR 285 (337)
Q Consensus 206 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~ 285 (337)
+|+|||++........ ......|++.|+|||.+.+..++.++|+||+|+++|+|++|..||.... .....+.+.
T Consensus 136 kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~----~~~~~~~~~ 209 (316)
T cd05620 136 KIADFGMCKENVFGDN--RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD----EDELFESIR 209 (316)
T ss_pred EeCccCCCeecccCCC--ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC----HHHHHHHHH
Confidence 9999998864322211 1234568999999999999899999999999999999999999986432 112222111
Q ss_pred hhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCCh-hhhhcC
Q 040898 286 NVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSS-KDVRSM 337 (337)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-~ell~~ 337 (337)
. ..... +......+.+++.+||+.||++||++ .++++|
T Consensus 210 ~---~~~~~-----------~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h 248 (316)
T cd05620 210 V---DTPHY-----------PRWITKESKDILEKLFERDPTRRLGVVGNIRGH 248 (316)
T ss_pred h---CCCCC-----------CCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 1 11100 00122348899999999999999998 477765
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=301.46 Aligned_cols=246 Identities=25% Similarity=0.327 Sum_probs=189.7
Q ss_pred ceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHH-HHHHhcCCCCcccce
Q 040898 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEI-ITANQTRHRNILPLL 125 (337)
Q Consensus 47 ~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~-~~l~~l~hpniv~~~ 125 (337)
+.||+|+||.||++.+.. +++.||+|++.......... ...+..|. .+++.++||||++++
T Consensus 1 ~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~----------------~~~~~~e~~~~~~~l~hp~iv~~~ 62 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKA--DGKFYAVKVLQKKAILKKKE----------------QKHIMAERNVLLKNVKHPFLVGLH 62 (323)
T ss_pred CeeeeCCCeEEEEEEECC--CCCEEEEEEEEHHHHhhhhH----------------HHHHHHHHHHHHhhCCCCCCCCee
Confidence 479999999999999876 89999999986532211110 02334444 456788999999999
Q ss_pred eEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCCe
Q 040898 126 AHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEA 205 (337)
Q Consensus 126 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~ 205 (337)
+.+.+++..++||||+++++|..++. ....+++..+..++.||+.||.|| |+.|++|+||+|+||+++.++.+
T Consensus 63 ~~~~~~~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~l---H~~givH~dikp~NIll~~~~~~ 135 (323)
T cd05575 63 YSFQTADKLYFVLDYVNGGELFFHLQ----RERSFPEPRARFYAAEIASALGYL---HSLNIIYRDLKPENILLDSQGHV 135 (323)
T ss_pred EEEEeCCEEEEEEcCCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHH---HHCCeEeCCCCHHHeEECCCCcE
Confidence 99999999999999999999999884 345688899999999999999999 67799999999999999999999
Q ss_pred EEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHHHHHH
Q 040898 206 RISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMR 285 (337)
Q Consensus 206 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~ 285 (337)
+|+|||++........ ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||..... ..+. .
T Consensus 136 kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~----~~~~---~ 206 (323)
T cd05575 136 VLTDFGLCKEGIEHSK--TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT----AEMY---D 206 (323)
T ss_pred EEeccCCCcccccCCC--ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH----HHHH---H
Confidence 9999998865322211 12234689999999999998899999999999999999999999864311 1111 1
Q ss_pred hhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCCh----hhhhcC
Q 040898 286 NVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSS----KDVRSM 337 (337)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~----~ell~~ 337 (337)
........ ..+.....+.+++.+||+.||++||++ .++++|
T Consensus 207 ~i~~~~~~-----------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~ 251 (323)
T cd05575 207 NILNKPLR-----------LKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNH 251 (323)
T ss_pred HHHcCCCC-----------CCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcC
Confidence 11111100 011123448899999999999999998 477765
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=289.98 Aligned_cols=253 Identities=23% Similarity=0.401 Sum_probs=198.7
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
++|++.+.||+|++|.||++.+.. +++.||+|.+..+...... ..+.+|+.++.+++|||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~--~~~~~aiK~~~~~~~~~~~------------------~~~~~E~~~l~~l~h~~ 60 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLL--TRRILAVKVIPLDITVELQ------------------KQIMSELEILYKCDSPY 60 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcC--CCcEEEEEEEecCCChHHH------------------HHHHHHHHHHHhCCCCC
Confidence 468999999999999999998876 8999999988654321111 46778999999999999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
|+++++.+..++..++++||+++++|..+. .+++..+..++.|++.|+.|+ |+.|++|+||+|+||+++
T Consensus 61 iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nill~ 129 (279)
T cd06619 61 IIGFYGAFFVENRISICTEFMDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYL---WSLKILHRDVKPSNMLVN 129 (279)
T ss_pred eeeEEEEEEECCEEEEEEecCCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHH---HHCCEeeCCCCHHHEEEC
Confidence 999999999999999999999999996542 367788899999999999999 677999999999999999
Q ss_pred CCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhH
Q 040898 201 DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDM 280 (337)
Q Consensus 201 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~ 280 (337)
.++.++|+|||++....... .....++..|+|||.+.+..++.++|+||+|+++|+|++|..||............
T Consensus 130 ~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~ 205 (279)
T cd06619 130 TRGQVKLCDFGVSTQLVNSI----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMP 205 (279)
T ss_pred CCCCEEEeeCCcceeccccc----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccch
Confidence 99999999999987654321 12346889999999999888999999999999999999999999754332221111
Q ss_pred HHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 281 VKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
............+ .. ........+.+++.+||+.||++||+++++++|
T Consensus 206 ~~~~~~~~~~~~~-~~--------~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 206 LQLLQCIVDEDPP-VL--------PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HHHHHHHhccCCC-CC--------CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 1111111111000 00 011123348899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=292.92 Aligned_cols=242 Identities=20% Similarity=0.266 Sum_probs=190.5
Q ss_pred ceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCccccee
Q 040898 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLLA 126 (337)
Q Consensus 47 ~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~ 126 (337)
..||+|++|.||++.. +|+.||+|.+......... ..+.+.+|+.++.+++||||+++++
T Consensus 26 ~~i~~g~~~~v~~~~~----~~~~vavK~~~~~~~~~~~----------------~~~~~~~E~~~l~~l~h~nIv~~~g 85 (283)
T PHA02988 26 VLIKENDQNSIYKGIF----NNKEVIIRTFKKFHKGHKV----------------LIDITENEIKNLRRIDSNNILKIYG 85 (283)
T ss_pred eEEeeCCceEEEEEEE----CCEEEEEEeccccccccHH----------------HHHHHHHHHHHHHhcCCCCEEEEee
Confidence 6799999999999877 7899999998654322211 0156788999999999999999999
Q ss_pred EEEc----CCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCC-CCeEecCCCCCceeecC
Q 040898 127 HMVR----PNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHR-PRLIHRDIKPANVLIDD 201 (337)
Q Consensus 127 ~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~-~gi~h~di~~~nil~~~ 201 (337)
++.+ ....++||||+++|+|.+++. +...+++.....++.+++.|+.++ |+ .+++|+||+|+||+++.
T Consensus 86 ~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~----~~~~~~~~~~~~i~~~i~~~l~~l---H~~~~~~Hrdlkp~nill~~ 158 (283)
T PHA02988 86 FIIDIVDDLPRLSLILEYCTRGYLREVLD----KEKDLSFKTKLDMAIDCCKGLYNL---YKYTNKPYKNLTSVSFLVTE 158 (283)
T ss_pred eEEecccCCCceEEEEEeCCCCcHHHHHh----hCCCCChhHHHHHHHHHHHHHHHH---HhcCCCCCCcCChhhEEECC
Confidence 9866 356899999999999999994 345688899999999999999999 54 48889999999999999
Q ss_pred CCCeEEecccCccccCCCCceeeeecccCCCCccCcccccc--CCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhh
Q 040898 202 DMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQT--ETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMD 279 (337)
Q Consensus 202 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~ 279 (337)
++.++|+|||++....... ....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||..... ..
T Consensus 159 ~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~----~~ 229 (283)
T PHA02988 159 NYKLKIICHGLEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT----KE 229 (283)
T ss_pred CCcEEEcccchHhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH----HH
Confidence 9999999999987653321 12457889999999976 6789999999999999999999999975321 11
Q ss_pred HHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 280 MVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
....+ ........ .+...+..+.+++.+||+.||++|||+.++++
T Consensus 230 ~~~~i---~~~~~~~~---------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 230 IYDLI---INKNNSLK---------LPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred HHHHH---HhcCCCCC---------CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 11111 11111000 01123445899999999999999999999985
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=302.84 Aligned_cols=248 Identities=22% Similarity=0.305 Sum_probs=194.1
Q ss_pred cceeccCcceEEEEeEEec-CCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCcccc
Q 040898 46 LKKIGSGGWGEVFYKAELP-GSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPL 124 (337)
Q Consensus 46 ~~~lg~G~~g~V~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~ 124 (337)
++.||+|+||.||++.+.. ..+|+.||+|++........ ....+..|+.++.+++||||+++
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~-----------------~~~~~~~E~~~l~~l~h~niv~~ 63 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVR-----------------DRVRTKMERDILAEVNHPFIVKL 63 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhh-----------------hHHHHHHHHHHHHhCCCCCcccE
Confidence 4689999999999987753 34789999999865322111 01356679999999999999999
Q ss_pred eeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCC
Q 040898 125 LAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDME 204 (337)
Q Consensus 125 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~ 204 (337)
++.+.+++..|+||||+++++|.+++. ....+++..++.++.||+.||.|| |+.|++|+||+|+||+++.++.
T Consensus 64 ~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~ 136 (318)
T cd05582 64 HYAFQTEGKLYLILDFLRGGDLFTRLS----KEVMFTEEDVKFYLAELALALDHL---HSLGIIYRDLKPENILLDEEGH 136 (318)
T ss_pred EEEEEcCCEEEEEEcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHH---HHCCEecCCCCHHHeEECCCCc
Confidence 999999999999999999999999883 345689999999999999999999 6779999999999999999999
Q ss_pred eEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHHHHH
Q 040898 205 ARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWM 284 (337)
Q Consensus 205 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~ 284 (337)
++|+|||++........ ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||..... ....
T Consensus 137 ~kL~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~----~~~~--- 207 (318)
T cd05582 137 IKLTDFGLSKESIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR----KETM--- 207 (318)
T ss_pred EEEeeccCCcccCCCCC--ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH----HHHH---
Confidence 99999999876433321 11235689999999999988889999999999999999999999864321 1111
Q ss_pred HhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCC-----hhhhhcC
Q 040898 285 RNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPS-----SKDVRSM 337 (337)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~~ 337 (337)
......... .+......+.+++.+||+.||++||| +.++++|
T Consensus 208 ~~i~~~~~~-----------~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~ 254 (318)
T cd05582 208 TMILKAKLG-----------MPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRH 254 (318)
T ss_pred HHHHcCCCC-----------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCC
Confidence 111111110 01112344889999999999999999 5557764
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=301.91 Aligned_cols=267 Identities=23% Similarity=0.285 Sum_probs=196.0
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++.+.||+|+||.||++.+.. ++..||+|++......... ...+.+|+.+++.++|
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~-----------------~~~~~~E~~~l~~l~h 79 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTV--LGINVAVKKLSRPFQNQTH-----------------AKRAYRELVLLKCVNH 79 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcC--CCceeEEEEecccccchhH-----------------HHHHHHHHHHHHhCCC
Confidence 45779999999999999999998865 8999999998654322111 1456789999999999
Q ss_pred CCcccceeEEEcCC------eeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 040898 119 RNILPLLAHMVRPN------CHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDI 192 (337)
Q Consensus 119 pniv~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di 192 (337)
|||+++++++.... ..|+||||+++ +|.+.+. ..++...+..++.|++.||.|| |+.|++|+||
T Consensus 80 ~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~L---H~~~ivHrDl 149 (359)
T cd07876 80 KNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHL---HSAGIIHRDL 149 (359)
T ss_pred CCEeeeeeeeccCCCccccceeEEEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHH---HhCCcccCCC
Confidence 99999999886543 47999999976 5666552 2377888999999999999999 7789999999
Q ss_pred CCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCC
Q 040898 193 KPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFF 272 (337)
Q Consensus 193 ~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~ 272 (337)
+|+||+++.++.++|+|||++....... ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||....
T Consensus 150 kp~NIl~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~ 226 (359)
T cd07876 150 KPSNIVVKSDCTLKILDFGLARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTD 226 (359)
T ss_pred CHHHEEECCCCCEEEecCCCccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999987543321 1123468899999999999999999999999999999999999997542
Q ss_pred CCchhhhHHH---------------HHHhhhccCCcc--hhhhh---cc----cCCchHHHHHHHHHHHhhhccCCCCCC
Q 040898 273 GHTEEMDMVK---------------WMRNVIFSENPN--RAINS---KL----LGNGYEEQMLLVLKLACFCTLKDPDER 328 (337)
Q Consensus 273 ~~~~~~~~~~---------------~~~~~~~~~~~~--~~~~~---~~----~~~~~~~~~~~l~~li~~~l~~dP~~R 328 (337)
.......... ............ ..... .. ...........+.+|+.+||+.||++|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R 306 (359)
T cd07876 227 HIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKR 306 (359)
T ss_pred HHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccC
Confidence 2110000000 000000000000 00000 00 000011123458899999999999999
Q ss_pred CChhhhhcC
Q 040898 329 PSSKDVRSM 337 (337)
Q Consensus 329 ps~~ell~~ 337 (337)
||+.|+|+|
T Consensus 307 ~t~~e~l~h 315 (359)
T cd07876 307 ISVDEALRH 315 (359)
T ss_pred CCHHHHhcC
Confidence 999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=290.71 Aligned_cols=255 Identities=24% Similarity=0.330 Sum_probs=198.4
Q ss_pred cccccccceeccCcceEEEEeEEec-CCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELP-GSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
.++|++.+.||+|+||.||++.+.. ...+..||+|.+......... ..+.+|+..+.+++|
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~------------------~~~~~e~~~l~~l~h 65 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQR------------------RGFLAEALTLGQFDH 65 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHH------------------HHHHHHHHHHhcCCC
Confidence 4679999999999999999887642 236788999998765332111 467789999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++++..++..++||||+++++|.+++.. ....+++..++.++.|++.|+.|| |+.|++|+||+|+||+
T Consensus 66 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~i~~al~~l---H~~~iiH~dikp~nil 139 (266)
T cd05064 66 SNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRK---HEGQLVAGQLMGMLPGLASGMKYL---SEMGYVHKGLAAHKVL 139 (266)
T ss_pred CCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHH---HHCCEeeccccHhhEE
Confidence 9999999999999999999999999999999854 234688999999999999999999 6779999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCchh
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHTEE 277 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~ 277 (337)
++.++.++++|||.+......... ......++..|+|||.+.+..++.++|+||+|+++|++++ |..||.....
T Consensus 140 i~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~---- 214 (266)
T cd05064 140 VNSDLVCKISGFRRLQEDKSEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG---- 214 (266)
T ss_pred EcCCCcEEECCCcccccccccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH----
Confidence 999999999999976653222111 1112234567999999998889999999999999999875 9999865422
Q ss_pred hhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 278 MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
....+.+...... ..+...+..+.+++.+||+.+|.+|||+.+|++
T Consensus 215 ~~~~~~~~~~~~~-------------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 215 QDVIKAVEDGFRL-------------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHHHHHCCCCC-------------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 1122222111100 011223345889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=320.34 Aligned_cols=259 Identities=26% Similarity=0.394 Sum_probs=212.7
Q ss_pred ccccccccceeccCcceEEEEeEEec---CCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHh
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELP---GSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQ 115 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~ 115 (337)
+..+....+.||+|+||.||++.... ....+.||||.++.+.....+ ..|.||+.++..
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~------------------~dF~REaeLla~ 545 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQAR------------------QDFRREAELLAE 545 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHH------------------HHHHHHHHHHHh
Confidence 34567788999999999999887643 236688999999877664333 689999999999
Q ss_pred cCCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcC------C----cccCChHHHHHHHHHHHHHHHHHhhCCCC
Q 040898 116 TRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQ------G----RRELDWPARHRIARGIASGLEYLHMCHRP 185 (337)
Q Consensus 116 l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------~----~~~~~~~~~~~i~~~i~~~l~~l~~~h~~ 185 (337)
++|||||+++|++.+++.+++|+||++.|+|.+||..... . ..+++..+.+.|+.||+.|+.|| .++
T Consensus 546 l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YL---s~~ 622 (774)
T KOG1026|consen 546 LQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYL---SSH 622 (774)
T ss_pred ccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHH---HhC
Confidence 9999999999999999999999999999999999976432 1 23478899999999999999999 677
Q ss_pred CeEecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-C
Q 040898 186 RLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-G 264 (337)
Q Consensus 186 gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g 264 (337)
.+||+||-.+|+||.++-.|||+|||+++..-..+-........-..+|||||.+...+++.+|||||+||++||+++ |
T Consensus 623 ~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG 702 (774)
T KOG1026|consen 623 HFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYG 702 (774)
T ss_pred cccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccc
Confidence 899999999999999999999999999987654443333334456789999999999999999999999999999999 8
Q ss_pred CCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhh
Q 040898 265 KFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVR 335 (337)
Q Consensus 265 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 335 (337)
..||.+.... +..+.+++.. .-+++..++..+.+|+..||+.+|.+|||++||=
T Consensus 703 ~QPy~glSn~----EVIe~i~~g~-------------lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 703 KQPYYGLSNQ----EVIECIRAGQ-------------LLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred cCcccccchH----HHHHHHHcCC-------------cccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 9998765332 1222222211 1345566777799999999999999999999973
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=296.12 Aligned_cols=246 Identities=25% Similarity=0.357 Sum_probs=190.7
Q ss_pred ceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHh-cCCCCcccce
Q 040898 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQ-TRHRNILPLL 125 (337)
Q Consensus 47 ~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~-l~hpniv~~~ 125 (337)
+.||+|+||.||++.+.. +++.||+|.+......... .......|..++.. ++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~----------------~~~~~~~e~~~l~~~~~hp~iv~~~ 62 (316)
T cd05619 1 KMLGKGSFGKVFLAELKG--TNQFFAIKALKKDVVLMDD----------------DVECTMVEKRVLSLAWEHPFLTHLY 62 (316)
T ss_pred CeeeeCCCEEEEEEEECC--CCCEEEEEEEEHHHhhhcc----------------hHHHHHHHHHHHHhccCCCcCcceE
Confidence 479999999999998876 8899999998654221111 01344556667765 4999999999
Q ss_pred eEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCCe
Q 040898 126 AHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEA 205 (337)
Q Consensus 126 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~ 205 (337)
+++.+.+..++||||+++|+|.+++.. ...+++..+..++.|++.||.|| |+.|++|+||+|+||+++.++.+
T Consensus 63 ~~~~~~~~~~lv~ey~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~L---H~~~ivHrdikp~Nil~~~~~~~ 135 (316)
T cd05619 63 CTFQTKENLFFVMEYLNGGDLMFHIQS----CHKFDLPRATFYAAEIICGLQFL---HSKGIVYRDLKLDNILLDTDGHI 135 (316)
T ss_pred EEEEeCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HhCCeEeCCCCHHHEEECCCCCE
Confidence 999999999999999999999999843 34688889999999999999999 77899999999999999999999
Q ss_pred EEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHHHHHH
Q 040898 206 RISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMR 285 (337)
Q Consensus 206 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~ 285 (337)
+|+|||++........ ......+++.|+|||.+.+..++.++|+||+|+++|+|++|..||..... ......+.
T Consensus 136 kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~----~~~~~~i~ 209 (316)
T cd05619 136 KIADFGMCKENMLGDA--KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE----EELFQSIR 209 (316)
T ss_pred EEccCCcceECCCCCC--ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH----HHHHHHHH
Confidence 9999998865322211 11234689999999999988899999999999999999999999864321 11211111
Q ss_pred hhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChh-hhhcC
Q 040898 286 NVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSK-DVRSM 337 (337)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~-ell~~ 337 (337)
. ..... +......+.+++.+||+.||.+||++. ++++|
T Consensus 210 ~---~~~~~-----------~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05619 210 M---DNPCY-----------PRWLTREAKDILVKLFVREPERRLGVKGDIRQH 248 (316)
T ss_pred h---CCCCC-----------CccCCHHHHHHHHHHhccCHhhcCCChHHHHcC
Confidence 1 11000 011233478999999999999999996 77765
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=290.44 Aligned_cols=257 Identities=24% Similarity=0.373 Sum_probs=199.6
Q ss_pred cccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC
Q 040898 38 KKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR 117 (337)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 117 (337)
...++|++.+.||+|+||.||++.+.. +++.||+|++........ ..+.+|+.++++++
T Consensus 6 ~~~~~y~~~~~lg~g~~g~vy~~~~~~--~~~~~aik~~~~~~~~~~-------------------~~~~~e~~~l~~~~ 64 (267)
T cd06646 6 NPQHDYELIQRVGSGTYGDVYKARNLH--TGELAAVKIIKLEPGDDF-------------------SLIQQEIFMVKECK 64 (267)
T ss_pred CchhhcchhheeecCCCeEEEEEEECC--CCeEEEEEEEecCccchH-------------------HHHHHHHHHHHhcC
Confidence 356789999999999999999999876 889999999864422111 35667999999999
Q ss_pred CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCce
Q 040898 118 HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANV 197 (337)
Q Consensus 118 hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ni 197 (337)
||||+++++.+..+...++|+||+++++|.+++. ....+++..+..++.|++.++.|+ |+.|++|+|++|+||
T Consensus 65 h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~ni 137 (267)
T cd06646 65 HCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYH----VTGPLSELQIAYVCRETLQGLAYL---HSKGKMHRDIKGANI 137 (267)
T ss_pred CCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHE
Confidence 9999999999999999999999999999999884 345688999999999999999999 677999999999999
Q ss_pred eecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccc---cCCCCCcccchhhhHHHHHHHhCCCCCCCCCCC
Q 040898 198 LIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQ---TETISDKCDIYSFGVLLAVLVMGKFPVDDFFGH 274 (337)
Q Consensus 198 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~ 274 (337)
+++.++.++|+|||++......... .....+++.|+|||.+. ...++.++|+||+|+++|+|++|..||......
T Consensus 138 ll~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~ 215 (267)
T cd06646 138 LLTDNGDVKLADFGVAAKITATIAK--RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPM 215 (267)
T ss_pred EECCCCCEEECcCccceeecccccc--cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchh
Confidence 9999999999999998765332111 12345788999999884 344678899999999999999999998543221
Q ss_pred chhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 275 TEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
...... . ....... . .......+..+.+++.+||+.||++|||++++++|
T Consensus 216 ~~~~~~---~----~~~~~~~----~--~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 216 RALFLM---S----KSNFQPP----K--LKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred hhheee---e----cCCCCCC----C--CccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 110000 0 0000000 0 00011223458999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=280.91 Aligned_cols=259 Identities=27% Similarity=0.399 Sum_probs=208.5
Q ss_pred cccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc-CCCC
Q 040898 42 CFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT-RHRN 120 (337)
Q Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpn 120 (337)
.|+.-+.||+|..+.|-.+.+.. +|..+|+|++...+......- ..+ -.+.-.+|+.+|+++ .||+
T Consensus 18 ~y~pkeilgrgvss~vrRci~k~--t~~e~a~kii~~~at~~~~e~-------~~~----~~EaT~~Ev~ILRqv~GHP~ 84 (411)
T KOG0599|consen 18 KYEPKEILGRGVSSVVRRCIHKE--TGKEFAVKIIDVTATTESGET-------PYE----MREATRQEISILRQVMGHPY 84 (411)
T ss_pred hcChHHHhcccchhhhhhhhhcc--cccceeEEEEEecccccCCcc-------HHH----HHHHHHHHHHHHHHhcCCCc
Confidence 38889999999999997766665 999999999977655433211 111 115677899999998 8999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
|+++.++++.+..+++|+|.++.|.|.+++ .+.-.++++....+++|+++++.|+ |..+|||+|+||+||+++
T Consensus 85 II~l~D~yes~sF~FlVFdl~prGELFDyL----ts~VtlSEK~tR~iMrqlfegVeyl---Ha~~IVHRDLKpENILld 157 (411)
T KOG0599|consen 85 IIDLQDVYESDAFVFLVFDLMPRGELFDYL----TSKVTLSEKETRRIMRQLFEGVEYL---HARNIVHRDLKPENILLD 157 (411)
T ss_pred EEEeeeeccCcchhhhhhhhcccchHHHHh----hhheeecHHHHHHHHHHHHHHHHHH---HHhhhhhcccChhheeec
Confidence 999999999999999999999999999999 4556689999999999999999999 888999999999999999
Q ss_pred CCCCeEEecccCccccCCCCceeeeecccCCCCccCcccccc------CCCCCcccchhhhHHHHHHHhCCCCCCCCCCC
Q 040898 201 DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQT------ETISDKCDIYSFGVLLAVLVMGKFPVDDFFGH 274 (337)
Q Consensus 201 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~------~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~ 274 (337)
++-+++|+|||.++.+..+... ...+|||+|+|||.++. ..|+..+|+|++|+++|-++.|.+||-.
T Consensus 158 dn~~i~isDFGFa~~l~~GekL---relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH---- 230 (411)
T KOG0599|consen 158 DNMNIKISDFGFACQLEPGEKL---RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH---- 230 (411)
T ss_pred cccceEEeccceeeccCCchhH---HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH----
Confidence 9999999999999988766533 34689999999999853 3478889999999999999999999822
Q ss_pred chhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 275 TEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
....-+...+.+.. .. ...+.+.+.+....+|+++||+.||.+|.|+.|+|.|
T Consensus 231 RkQmlMLR~ImeGk---yq-------F~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 231 RKQMLMLRMIMEGK---YQ-------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred HHHHHHHHHHHhcc---cc-------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 11112222222211 11 1123344555668999999999999999999999987
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=289.14 Aligned_cols=256 Identities=26% Similarity=0.364 Sum_probs=200.3
Q ss_pred cccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCc
Q 040898 42 CFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNI 121 (337)
Q Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpni 121 (337)
.|+..+.||.|+||+||++.+.. +++.+|+|.+.......... ...+.+|+.+++.++|+|+
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~--~~~~~aiK~~~~~~~~~~~~----------------~~~~~~E~~il~~l~~~~i 62 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRA--TGKMYACKRLEKKRIKKRKG----------------ESMALNEKQILEKVNSQFV 62 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECC--CCcEEEEEEeehhhhhhhhH----------------HHHHHHHHHHHHHcCCcCc
Confidence 47888999999999999998876 89999999986543221110 1456779999999999999
Q ss_pred ccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecC
Q 040898 122 LPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDD 201 (337)
Q Consensus 122 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~ 201 (337)
+.+.+.+..++..++++||+++++|.+++.. .....+++..+..++.|++.||.|| |+.|++|+||+|+||++++
T Consensus 63 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~ql~~~l~~l---H~~~iiH~dikp~Nili~~ 137 (285)
T cd05632 63 VNLAYAYETKDALCLVLTIMNGGDLKFHIYN--MGNPGFEEERALFYAAEILCGLEDL---HRENTVYRDLKPENILLDD 137 (285)
T ss_pred eeEEEEEecCCEEEEEEEeccCccHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeecCCCHHHEEECC
Confidence 9999999999999999999999999988854 2334689999999999999999999 7789999999999999999
Q ss_pred CCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHH
Q 040898 202 DMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMV 281 (337)
Q Consensus 202 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~ 281 (337)
++.++|+|||++........ .....++..|+|||.+.+..++.++|+||+|+++|+|++|..||......... .
T Consensus 138 ~~~~kl~Dfg~~~~~~~~~~---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~---~ 211 (285)
T cd05632 138 YGHIRISDLGLAVKIPEGES---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR---E 211 (285)
T ss_pred CCCEEEecCCcceecCCCCc---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH---H
Confidence 99999999998865433221 12346899999999998888999999999999999999999999653221111 1
Q ss_pred HHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCC-----hhhhhcC
Q 040898 282 KWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPS-----SKDVRSM 337 (337)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~~ 337 (337)
............ ........+.+|+..||+.||++||| +.+++.|
T Consensus 212 ~~~~~~~~~~~~-----------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 212 EVDRRVLETEEV-----------YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred HHHHhhhccccc-----------cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 111111111000 01112334789999999999999999 7788775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=285.75 Aligned_cols=253 Identities=25% Similarity=0.346 Sum_probs=203.2
Q ss_pred cccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCc
Q 040898 42 CFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNI 121 (337)
Q Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpni 121 (337)
+|.+.+.||+|++|.||++.+.. ++..|++|.+......... ...+.+|+.+++.++|||+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~--~~~~~~~k~~~~~~~~~~~-----------------~~~~~~e~~~l~~l~h~~i 61 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKA--DKRVYAMKQIDLSKMNRRE-----------------REEAIDEARVLAKLDSSYI 61 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcC--CCcEEEEEEeehhhCCHHH-----------------HHHHHHHHHHHHhcCCCCe
Confidence 48899999999999999998876 8999999988654322111 1567889999999999999
Q ss_pred ccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecC
Q 040898 122 LPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDD 201 (337)
Q Consensus 122 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~ 201 (337)
+++++.+.+++..++++||+++++|.+++... ....+++..++.++.+++.|+.+| |+.|++|+||+|+||+++.
T Consensus 62 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~l---H~~~i~h~dl~~~nili~~ 136 (256)
T cd08529 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHL---HSKKILHRDIKSLNLFLDA 136 (256)
T ss_pred ehheeeeccCCEEEEEEEeCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCcceEEEeC
Confidence 99999999999999999999999999998652 345688899999999999999999 6779999999999999999
Q ss_pred CCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHH
Q 040898 202 DMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMV 281 (337)
Q Consensus 202 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~ 281 (337)
++.++|+|||.+......... .....+++.|+|||...+..++.++|+||||+++++|++|..||.... ....
T Consensus 137 ~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~- 209 (256)
T cd08529 137 YDNVKIGDLGVAKLLSDNTNF--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN----QGAL- 209 (256)
T ss_pred CCCEEEcccccceeccCccch--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC----HHHH-
Confidence 999999999988765543221 123457889999999988888999999999999999999999986432 1111
Q ss_pred HHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 282 KWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.........+ .........+.+++.+||+.+|++||++.++++|
T Consensus 210 --~~~~~~~~~~----------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 210 --ILKIIRGVFP----------PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred --HHHHHcCCCC----------CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1111111111 0111233458999999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=287.45 Aligned_cols=257 Identities=25% Similarity=0.358 Sum_probs=201.3
Q ss_pred cccccccceeccCcceEEEEeEEecC-CCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPG-SNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
.++|++.+.||+|+||.||++.+... .+...|++|.+......... ..+.+|+..++.++|
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~------------------~~~~~e~~~l~~l~h 64 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQR------------------LDFLTEASIMGQFDH 64 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHH------------------HHHHHHHHHHHhCCC
Confidence 46799999999999999999988642 24568999988654322111 457789999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++.+..+...++++||+++++|.+++.. ....+++..+..++.|++.|+.+| |+.|++|+||+|+||+
T Consensus 65 ~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~L---h~~~i~H~di~p~nil 138 (266)
T cd05033 65 PNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRE---NDGKFTVGQLVGMLRGIASGMKYL---SEMNYVHRDLAARNIL 138 (266)
T ss_pred CCcceEeEEEecCCceEEEEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCcceEE
Confidence 9999999999999999999999999999999854 234688999999999999999999 7789999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCchh
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHTEE 277 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~ 277 (337)
++.++.++|+|||++................++..|+|||.+.+..++.++|+||||+++|+|++ |..||.....
T Consensus 139 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~---- 214 (266)
T cd05033 139 VNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN---- 214 (266)
T ss_pred EcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH----
Confidence 99999999999999987653222222222345678999999998889999999999999999998 9999855321
Q ss_pred hhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 278 MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
......+........ ....+..+.+++.+||+.+|++|||+.+++++
T Consensus 215 ~~~~~~~~~~~~~~~-------------~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 215 QDVIKAVEDGYRLPP-------------PMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHHHHHcCCCCCC-------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 112222211110000 11223458999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=296.38 Aligned_cols=261 Identities=25% Similarity=0.370 Sum_probs=200.9
Q ss_pred cccc-ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHH
Q 040898 35 AFLK-KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITA 113 (337)
Q Consensus 35 ~~~~-~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l 113 (337)
++++ ++..|+++++||+||.+.||++... +.+.||+|++.....+. ..++.+..|+.+|
T Consensus 354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s---~~~iyalkkv~~~~~D~-----------------qtl~gy~nEI~lL 413 (677)
T KOG0596|consen 354 EIIKVKGREYEILKQIGSGGSSKVFKVLNS---DKQIYALKKVVLLEADN-----------------QTLDGYRNEIALL 413 (677)
T ss_pred eeEEECcchhhHHHhhcCCCcceeeeeecC---CCcchhhhHHHHhhcCH-----------------HHHHHHHHHHHHH
Confidence 4444 7778999999999999999988774 56778887764433221 1237899999999
Q ss_pred Hhc-CCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 040898 114 NQT-RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDI 192 (337)
Q Consensus 114 ~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di 192 (337)
.+| .|.+|+++++|-..++.+|+||||.+. +|...|+. .....+.-.+..+..|++.++.++ |++||||.||
T Consensus 414 ~KLkg~~~IIqL~DYEv~d~~lYmvmE~Gd~-DL~kiL~k---~~~~~~~~~lk~ywkqML~aV~~I---H~~gIVHSDL 486 (677)
T KOG0596|consen 414 NKLKGHDKIIQLYDYEVTDGYLYMVMECGDI-DLNKILKK---KKSIDPDWFLKFYWKQMLLAVKTI---HQHGIVHSDL 486 (677)
T ss_pred HHhcCCceEEEEeeeeccCceEEEEeecccc-cHHHHHHh---ccCCCchHHHHHHHHHHHHHHHHH---HHhceeecCC
Confidence 999 689999999999999999999998755 99999965 222233237888999999999999 7889999999
Q ss_pred CCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCC-----------CCCcccchhhhHHHHHH
Q 040898 193 KPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTET-----------ISDKCDIYSFGVLLAVL 261 (337)
Q Consensus 193 ~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-----------~~~~~DiwslG~i~~~l 261 (337)
||.|+++- .|.+||+|||.+...............+||+.||+||.+.... .+.++||||||||+|+|
T Consensus 487 KPANFLlV-kG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqM 565 (677)
T KOG0596|consen 487 KPANFLLV-KGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQM 565 (677)
T ss_pred CcccEEEE-eeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHH
Confidence 99999886 5789999999999887776666666789999999999985443 45789999999999999
Q ss_pred HhCCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 262 VMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 262 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
+.|+.||+.. .+....+..+..+.. .+..+-..+.++ +.++++.||..||++|||+.++|+|
T Consensus 566 vYgktPf~~~------~n~~aKl~aI~~P~~---~Iefp~~~~~~~-----li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 566 VYGKTPFGQI------INQIAKLHAITDPNH---EIEFPDIPENDE-----LIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred HhcCCchHHH------HHHHHHHHhhcCCCc---cccccCCCCchH-----HHHHHHHHHhcCcccCCCcHHHhcC
Confidence 9999999653 112222222222211 111111111111 8899999999999999999999987
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=312.34 Aligned_cols=266 Identities=24% Similarity=0.303 Sum_probs=208.7
Q ss_pred cccccccccccc-ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHh
Q 040898 27 PLVEKQDLAFLK-KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGA 105 (337)
Q Consensus 27 ~~~~~~~~~~~~-~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 105 (337)
..........+. ..-++++.+.|.+|||+.||+|.+.. .|..||+|++..... .. ...
T Consensus 22 ~~~~~~~G~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~--~~~~~AlKrm~~~de-~~------------------L~~ 80 (738)
T KOG1989|consen 22 QSENYFVGQTFTVGSHRVTVEKVLAEGGFAQVYLAQDVK--GGKKYALKRMYVNDE-EA------------------LNA 80 (738)
T ss_pred ccccCCCceEEEECCEEEEEEEEEccCCcEEEEEEEecC--CCceeeeeeeecCCH-HH------------------HHH
Confidence 333333334444 55578999999999999999999986 559999999876621 11 267
Q ss_pred HHHHHHHHHhcC-CCCcccceeE-EEc------CCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHH
Q 040898 106 IRSEIITANQTR-HRNILPLLAH-MVR------PNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLE 177 (337)
Q Consensus 106 ~~~e~~~l~~l~-hpniv~~~~~-~~~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~ 177 (337)
+.+|+.+|++|. |||||.+++. ... ...++|+||||++|+|-+++.++...+ +++.++++|+.|+++|+.
T Consensus 81 v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~--lte~eVLkIf~dv~~AVa 158 (738)
T KOG1989|consen 81 VKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTR--LTEDEVLKIFYDVCEAVA 158 (738)
T ss_pred HHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhcc--CChHHHHHHHHHHHHHHH
Confidence 889999999995 9999999993 221 245789999999999999998765544 999999999999999999
Q ss_pred HHhhCCCCCeEecCCCCCceeecCCCCeEEecccCccccCCCCce-eee------ecccCCCCccCcccc---ccCCCCC
Q 040898 178 YLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQ-ITV------KCMVGTMGYMAPESL---QTETISD 247 (337)
Q Consensus 178 ~l~~~h~~gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~------~~~~~~~~~~~PE~~---~~~~~~~ 247 (337)
+||.+ +..|+|||||-+|||++.+|..||||||.+.-....... ... -....|+.|++||.+ .+.+.++
T Consensus 159 ~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~e 237 (738)
T KOG1989|consen 159 AMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGE 237 (738)
T ss_pred HHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcc
Confidence 99764 556999999999999999999999999988754333211 000 013479999999987 6888999
Q ss_pred cccchhhhHHHHHHHhCCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCC
Q 040898 248 KCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDE 327 (337)
Q Consensus 248 ~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~ 327 (337)
++|||+|||++|.|+....||++... ..+......-+..+...+.+.+||..||+.||.+
T Consensus 238 KsDIWALGclLYkLCy~t~PFe~sg~--------------------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~ 297 (738)
T KOG1989|consen 238 KSDIWALGCLLYKLCYFTTPFEESGK--------------------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDE 297 (738)
T ss_pred hhHHHHHHHHHHHHHHhCCCcCcCcc--------------------eeEEeccccCCCCccHHHHHHHHHHHHhccCccc
Confidence 99999999999999999999976322 1122222222334567778999999999999999
Q ss_pred CCChhhhhc
Q 040898 328 RPSSKDVRS 336 (337)
Q Consensus 328 Rps~~ell~ 336 (337)
||++.+++.
T Consensus 298 RPnI~Qv~~ 306 (738)
T KOG1989|consen 298 RPNIYQVLE 306 (738)
T ss_pred CCCHHHHHH
Confidence 999999875
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=284.14 Aligned_cols=259 Identities=26% Similarity=0.369 Sum_probs=205.3
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
++|++.+.||+|++|.||++.+.. +++.|++|.+.......... ...+.+|++++++++|+|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~----------------~~~~~~ei~~l~~~~~~~ 63 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLL--DGRVVALKKVQIFEMMDAKA----------------RQDCLKEIDLLKQLDHPN 63 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcC--CCCEEEEEEeecccccchhh----------------HHHHHHHHHHHHhCCCCC
Confidence 579999999999999999998875 89999999886433222111 156788999999999999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
++++++.+..++..++++||+++++|.+++......+..+++..++.++.+++.++.+| |+.|++|+||+|+||+++
T Consensus 64 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---h~~~i~h~dl~p~nil~~ 140 (267)
T cd08224 64 VIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHM---HSKRIMHRDIKPANVFIT 140 (267)
T ss_pred eeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHH---HhCCEecCCcChhhEEEC
Confidence 99999999999999999999999999999876555566789999999999999999999 778999999999999999
Q ss_pred CCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhH
Q 040898 201 DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDM 280 (337)
Q Consensus 201 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~ 280 (337)
.++.++|+|||.+......... .....+++.|.|||.+.+..++.++|+||+|+++|+|++|..||..... +.
T Consensus 141 ~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~ 213 (267)
T cd08224 141 ATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NL 213 (267)
T ss_pred CCCcEEEeccceeeeccCCCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc-----cH
Confidence 9999999999998765433221 1223578889999999888899999999999999999999999854221 11
Q ss_pred HHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 281 VKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
............+ ....+.....+.+++.+||..+|.+|||+.+|++
T Consensus 214 ~~~~~~~~~~~~~---------~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 214 YSLCKKIEKCDYP---------PLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHhhhhcCCCC---------CCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 1111111111000 0011133445899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=286.06 Aligned_cols=259 Identities=26% Similarity=0.371 Sum_probs=204.4
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
++|++.+.||+|++|.||++.+.. ++..+++|.+.......... ...+.+|+.+++.+.|||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~--~~~~~~vK~~~~~~~~~~~~----------------~~~~~~e~~~l~~~~h~~ 63 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLL--DGVPVALKKVQIFDLMDAKA----------------RADCIKEIDLLKQLNHPN 63 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecC--CCceEEEEeeeehhhhhHHH----------------HHHHHHHHHHHHHccCCc
Confidence 469999999999999999998866 89999999876533221111 156778999999999999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
|+++++.+..++..++++||+++++|.+++.........+++..++.++.|++.++.+| |+.|++|+||+|+||+++
T Consensus 64 i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L---H~~~i~H~dl~p~nili~ 140 (267)
T cd08229 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM---HSRRVMHRDIKPANVFIT 140 (267)
T ss_pred hhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEEc
Confidence 99999999999999999999999999999875444556789999999999999999999 778999999999999999
Q ss_pred CCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhH
Q 040898 201 DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDM 280 (337)
Q Consensus 201 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~ 280 (337)
.++.++|+|||.+......... .....++..|+|||.+.+..++.++|+||+|+++|+|++|..||..... .....
T Consensus 141 ~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~ 216 (267)
T cd08229 141 ATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM--NLYSL 216 (267)
T ss_pred CCCCEEECcchhhhccccCCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc--hHHHH
Confidence 9999999999988765433221 1234588899999999888889999999999999999999999854211 11111
Q ss_pred HHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 281 VKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
.+..... ..+. .........+.+++.+||+.||.+|||+.+|++
T Consensus 217 ~~~~~~~---~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 217 CKKIEQC---DYPP---------LPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred hhhhhcC---CCCC---------CCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 1111111 1000 011123445899999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=289.09 Aligned_cols=258 Identities=24% Similarity=0.395 Sum_probs=200.6
Q ss_pred ccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc
Q 040898 37 LKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT 116 (337)
Q Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 116 (337)
....++|++.+.||+|+||.||++.+.. +++.||+|.+........ ..+.+|+.+++.+
T Consensus 5 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~-------------------~~~~~e~~~~~~l 63 (267)
T cd06645 5 RNPQEDFELIQRIGSGTYGDVYKARNVN--TGELAAIKVIKLEPGEDF-------------------AVVQQEIIMMKDC 63 (267)
T ss_pred cCcHHHHHHHHHhCCCCCeEEEEEEEcC--CCcEEEEEEEecCchhHH-------------------HHHHHHHHHHHhC
Confidence 3456789999999999999999998876 899999998865422111 3566789999999
Q ss_pred CCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 040898 117 RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPAN 196 (337)
Q Consensus 117 ~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~n 196 (337)
+||||+++++.+..++..++++||+++++|.+++. ....+++..+..++.|++.++.|| |+.|++|+||+|+|
T Consensus 64 ~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~n 136 (267)
T cd06645 64 KHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYH----VTGPLSESQIAYVSRETLQGLYYL---HSKGKMHRDIKGAN 136 (267)
T ss_pred CCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHH
Confidence 99999999999999999999999999999999884 344688999999999999999999 67799999999999
Q ss_pred eeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccc---cCCCCCcccchhhhHHHHHHHhCCCCCCCCCC
Q 040898 197 VLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQ---TETISDKCDIYSFGVLLAVLVMGKFPVDDFFG 273 (337)
Q Consensus 197 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~ 273 (337)
|+++.++.++|+|||++........ ......+++.|+|||.+. ...++.++|+||||+++|+|++|..||.....
T Consensus 137 ili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~ 214 (267)
T cd06645 137 ILLTDNGHVKLADFGVSAQITATIA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHP 214 (267)
T ss_pred EEECCCCCEEECcceeeeEccCccc--ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccc
Confidence 9999999999999999876543221 112346889999999874 44578899999999999999999999854322
Q ss_pred CchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 274 HTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.. ........ ........ .....+..+.+++.+||+.+|++|||+.++++|
T Consensus 215 ~~---~~~~~~~~----~~~~~~~~------~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 215 MR---ALFLMTKS----NFQPPKLK------DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred hh---hHHhhhcc----CCCCCccc------ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 11 11110000 00000000 000122348899999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=292.07 Aligned_cols=263 Identities=22% Similarity=0.354 Sum_probs=200.0
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
++|++.+.||+|+||.||++.+.. ++..+++|.+..+..... ...+.+|++++++++|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~--~~~~~a~k~~~~~~~~~~------------------~~~~~~E~~~l~~l~h~~ 60 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRP--SGLIMARKLIHLEIKPAI------------------RNQIIRELKVLHECNSPY 60 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcC--CCeEEEEEEeccccCHHH------------------HHHHHHHHHHHHhCCCCC
Confidence 469999999999999999998876 888999998864422111 146778999999999999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
|+++++.+.+++..++++||+++++|.+++.. ...+++..+..++.|++++|.|||+ ..+++|+||+|+||+++
T Consensus 61 iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~ 134 (308)
T cd06615 61 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVN 134 (308)
T ss_pred CCeEEEEEeeCCEEEEEeeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEe
Confidence 99999999999999999999999999999843 3568899999999999999999942 25899999999999999
Q ss_pred CCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhH
Q 040898 201 DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDM 280 (337)
Q Consensus 201 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~ 280 (337)
.++.++|+|||++....... .....+++.|+|||.+.+..++.++|+||+|+++|+|++|..||..... ...
T Consensus 135 ~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~----~~~ 206 (308)
T cd06615 135 SRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA----KEL 206 (308)
T ss_pred cCCcEEEccCCCcccccccc----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch----hhH
Confidence 99999999999886543321 1234678899999999888889999999999999999999999854221 111
Q ss_pred HHHHHhhhccCCcc--------------------hhhhh----cccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 281 VKWMRNVIFSENPN--------------------RAINS----KLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 281 ~~~~~~~~~~~~~~--------------------~~~~~----~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
.............. ..... .............+.+++.+||+.||++|||+.++++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 286 (308)
T cd06615 207 EAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTK 286 (308)
T ss_pred HHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11111000000000 00000 0000000113446899999999999999999999998
Q ss_pred C
Q 040898 337 M 337 (337)
Q Consensus 337 ~ 337 (337)
|
T Consensus 287 ~ 287 (308)
T cd06615 287 H 287 (308)
T ss_pred C
Confidence 6
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=286.22 Aligned_cols=251 Identities=21% Similarity=0.324 Sum_probs=200.1
Q ss_pred cccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCc
Q 040898 42 CFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNI 121 (337)
Q Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpni 121 (337)
+|++.+.||.|+||.||++.+.. ++..+++|.+........ .+.+..|+.+++.++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~--~~~~~~iK~~~~~~~~~~------------------~~~~~~e~~~l~~l~h~~i 60 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVN--SDQKYAMKEIRLPKSSSA------------------VEDSRKEAVLLAKMKHPNI 60 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcC--CCceEEEEEEEcCcchHH------------------HHHHHHHHHHHHhCCCCCc
Confidence 58999999999999999998876 899999999864432111 1456779999999999999
Q ss_pred ccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecC
Q 040898 122 LPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDD 201 (337)
Q Consensus 122 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~ 201 (337)
+++++.+..+...++++||+++++|.+++.. .....+++.....++.|++.|+.+| |+.|++|+||+|+||+++.
T Consensus 61 ~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~i~~al~~l---H~~~i~H~dl~p~nili~~ 135 (255)
T cd08219 61 VAFKESFEADGHLYIVMEYCDGGDLMQKIKL--QRGKLFPEDTILQWFVQMCLGVQHI---HEKRVLHRDIKSKNIFLTQ 135 (255)
T ss_pred ceEEEEEEECCEEEEEEeeCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHH---hhCCcccCCCCcceEEECC
Confidence 9999999999999999999999999998854 2345578899999999999999999 7889999999999999999
Q ss_pred CCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHH
Q 040898 202 DMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMV 281 (337)
Q Consensus 202 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~ 281 (337)
++.++++|||.+......... .....+++.|+|||.+.+..++.++|+||+|+++|+|++|..||..... ....
T Consensus 136 ~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~----~~~~ 209 (255)
T cd08219 136 NGKVKLGDFGSARLLTSPGAY--ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW----KNLI 209 (255)
T ss_pred CCcEEEcccCcceeecccccc--cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH----HHHH
Confidence 999999999998765432211 1234588899999999888899999999999999999999999864211 1111
Q ss_pred HHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 282 KWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
......... ..+......+.+++.+||+.||.+|||+.+++.
T Consensus 210 ---~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 251 (255)
T cd08219 210 ---LKVCQGSYK----------PLPSHYSYELRSLIKQMFKRNPRSRPSATTILS 251 (255)
T ss_pred ---HHHhcCCCC----------CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhh
Confidence 111111110 001122334889999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=302.78 Aligned_cols=266 Identities=21% Similarity=0.293 Sum_probs=202.4
Q ss_pred cccccccccccccceeccCcceEEEEeEEec---CCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHH
Q 040898 34 LAFLKKEDCFDSLKKIGSGGWGEVFYKAELP---GSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEI 110 (337)
Q Consensus 34 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~ 110 (337)
-.+....++|++++.||+|+||.||++.+.. ..++..||+|++......... +.+.+|+
T Consensus 30 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~------------------~~~~~Ei 91 (400)
T cd05105 30 SRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEK------------------QALMSEL 91 (400)
T ss_pred CceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHH------------------HHHHHHH
Confidence 3444467788899999999999999987643 123457999998654332111 5678899
Q ss_pred HHHHhcC-CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcC----------------------------------
Q 040898 111 ITANQTR-HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQ---------------------------------- 155 (337)
Q Consensus 111 ~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------------------------------- 155 (337)
.++..+. ||||+++++++......|+||||+++|+|.+++.....
T Consensus 92 ~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (400)
T cd05105 92 KIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSF 171 (400)
T ss_pred HHHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhh
Confidence 9999995 99999999999999999999999999999998864211
Q ss_pred ----------------------------------------------------------CcccCChHHHHHHHHHHHHHHH
Q 040898 156 ----------------------------------------------------------GRRELDWPARHRIARGIASGLE 177 (337)
Q Consensus 156 ----------------------------------------------------------~~~~~~~~~~~~i~~~i~~~l~ 177 (337)
....+++..+..++.|++.|+.
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~ 251 (400)
T cd05105 172 ENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGME 251 (400)
T ss_pred cccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHH
Confidence 0124677788999999999999
Q ss_pred HHhhCCCCCeEecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHH
Q 040898 178 YLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVL 257 (337)
Q Consensus 178 ~l~~~h~~gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i 257 (337)
|| |+.|++|+||+|+||+++.++.++|+|||++................+++.|+|||.+.+..++.++||||||++
T Consensus 252 ~L---H~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvi 328 (400)
T cd05105 252 FL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGIL 328 (400)
T ss_pred HH---HhCCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHH
Confidence 99 778999999999999999999999999999876543322222223456778999999988889999999999999
Q ss_pred HHHHHh-CCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 258 LAVLVM-GKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 258 ~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
+|+|++ |..||....... .....+.... .. ..+......+.+++.+||+.||++|||+.++.+
T Consensus 329 l~ellt~g~~P~~~~~~~~---~~~~~~~~~~---~~----------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 329 LWEIFSLGGTPYPGMIVDS---TFYNKIKSGY---RM----------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHHHHCCCCCCcccchhH---HHHHHHhcCC---CC----------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 999997 889986532211 1111111110 00 011223345899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=290.69 Aligned_cols=261 Identities=20% Similarity=0.324 Sum_probs=199.2
Q ss_pred ccccccccceeccCcceEEEEeEEec---CCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHh
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELP---GSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQ 115 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~ 115 (337)
..++|++.+.||+|++|.||.+.+.. ..++..||+|.+......... ..+.+|+.+++.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~------------------~~~~~e~~~l~~ 65 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRER------------------IEFLNEASVMKE 65 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHH------------------HHHHHHHHHHHh
Confidence 56789999999999999999887642 235678999987543221110 457789999999
Q ss_pred cCCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCC------cccCChHHHHHHHHHHHHHHHHHhhCCCCCeEe
Q 040898 116 TRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQG------RRELDWPARHRIARGIASGLEYLHMCHRPRLIH 189 (337)
Q Consensus 116 l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h 189 (337)
++||||+++++++..+...++|+||+++++|.+++...... ....++..+..++.|++.||.|| |+.|++|
T Consensus 66 l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~~vH 142 (277)
T cd05062 66 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYL---NANKFVH 142 (277)
T ss_pred CCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHH---HHCCccc
Confidence 99999999999999999999999999999999998653221 23356778899999999999999 6779999
Q ss_pred cCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCC
Q 040898 190 RDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPV 268 (337)
Q Consensus 190 ~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf 268 (337)
+||+|+||++++++.++|+|||++................+++.|+|||.+.+..++.++|+||||+++|+|++ |..||
T Consensus 143 ~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~ 222 (277)
T cd05062 143 RDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY 222 (277)
T ss_pred CCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCC
Confidence 99999999999999999999999876543322222122345678999999988889999999999999999999 78898
Q ss_pred CCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 269 DDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
..... ......... ..... .+......+.+++.+||+.||++|||+.|++++
T Consensus 223 ~~~~~----~~~~~~~~~---~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 223 QGMSN----EQVLRFVME---GGLLD----------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCCCH----HHHHHHHHc---CCcCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 64321 111111111 11100 001123458999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=298.07 Aligned_cols=241 Identities=25% Similarity=0.305 Sum_probs=185.7
Q ss_pred ceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHH-HHHHHhcCCCCcccce
Q 040898 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSE-IITANQTRHRNILPLL 125 (337)
Q Consensus 47 ~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e-~~~l~~l~hpniv~~~ 125 (337)
+.||+|+||.||++.+.. +++.||+|++.......... ...+..| ..+++.++||||++++
T Consensus 1 ~~lg~G~fg~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~----------------~~~~~~e~~~~l~~~~h~~Iv~~~ 62 (325)
T cd05602 1 KVIGKGSFGKVLLARHKA--EEKFYAVKVLQKKAILKKKE----------------EKHIMSERNVLLKNVKHPFLVGLH 62 (325)
T ss_pred CeeeeCCCeEEEEEEECC--CCCEEEEEEEEHHHHHhhhH----------------HHHHHHHHHHHHHhCCCCCCCcee
Confidence 479999999999998876 88999999986432211110 0223333 3457788999999999
Q ss_pred eEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCCe
Q 040898 126 AHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEA 205 (337)
Q Consensus 126 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~ 205 (337)
+.+..++..++||||+++++|.+++.. ...+.+..+..++.||+.||.|| |+.|++|+||||+||+++.++.+
T Consensus 63 ~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~l---H~~giiHrDlkp~Nili~~~~~~ 135 (325)
T cd05602 63 FSFQTADKLYFVLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYL---HSLNIVYRDLKPENILLDSQGHI 135 (325)
T ss_pred EEEEcCCeEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHeEECCCCCE
Confidence 999999999999999999999998843 44577888889999999999999 77899999999999999999999
Q ss_pred EEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHHHHHH
Q 040898 206 RISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMR 285 (337)
Q Consensus 206 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~ 285 (337)
+|+|||++........ ......|++.|+|||++.+..++.++|+||||+++|+|++|.+||..... ......+.
T Consensus 136 kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~~~~i~ 209 (325)
T cd05602 136 VLTDFGLCKENIEHNG--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT----AEMYDNIL 209 (325)
T ss_pred EEccCCCCcccccCCC--CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH----HHHHHHHH
Confidence 9999999875332211 12235689999999999999999999999999999999999999864321 11111111
Q ss_pred hhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChh
Q 040898 286 NVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSK 332 (337)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ 332 (337)
. .... ..+.....+.+++.+||+.||.+||++.
T Consensus 210 ~---~~~~-----------~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (325)
T cd05602 210 N---KPLQ-----------LKPNITNSARHLLEGLLQKDRTKRLGAK 242 (325)
T ss_pred h---CCcC-----------CCCCCCHHHHHHHHHHcccCHHHCCCCC
Confidence 1 1000 0112234488999999999999999987
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=286.46 Aligned_cols=260 Identities=23% Similarity=0.365 Sum_probs=202.7
Q ss_pred cccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCc
Q 040898 42 CFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNI 121 (337)
Q Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpni 121 (337)
+|.+.+.||.|++|.||.+.+.. +++.+++|.+............ .....+.+.+|+.++++++||||
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~--~~~~~~~k~~~~~~~~~~~~~~----------~~~~~~~~~~e~~~l~~l~h~~i 68 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNAS--SGELMAVKQVELPSVSASSKDR----------KRSMLDALAREIALLKELQHENI 68 (267)
T ss_pred CccccceeecCCCeEEEEEEecC--CCcEEEEEEecCCCcccchhHH----------HHHHHHHHHHHHHHHHhcCCCCe
Confidence 58899999999999999998865 7899999988765433221100 01112578889999999999999
Q ss_pred ccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecC
Q 040898 122 LPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDD 201 (337)
Q Consensus 122 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~ 201 (337)
+++++++......++++||+++++|.+++.. ...+++..+..++.|++.|+.++ |+.|++|+||+|+||+++.
T Consensus 69 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~l---H~~~ivH~di~p~nil~~~ 141 (267)
T cd06628 69 VQYLGSSLDADHLNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYL---HNRGIIHRDIKGANILVDN 141 (267)
T ss_pred eeEEEEEEeCCccEEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHH---HhcCcccccCCHHHEEEcC
Confidence 9999999999999999999999999999943 35678889999999999999999 6779999999999999999
Q ss_pred CCCeEEecccCccccCCCCcee----eeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchh
Q 040898 202 DMEARISDFGHGKLMPDGHAQI----TVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEE 277 (337)
Q Consensus 202 ~~~~~l~dfg~~~~~~~~~~~~----~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~ 277 (337)
++.++|+|||.+.......... ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||......
T Consensus 142 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--- 218 (267)
T cd06628 142 KGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL--- 218 (267)
T ss_pred CCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH---
Confidence 9999999999987664321110 111234788899999998888899999999999999999999999753221
Q ss_pred hhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 278 MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.... ....... ...+......+.+++.+||+.||.+||++.++++|
T Consensus 219 ~~~~----~~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 219 QAIF----KIGENAS----------PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred HHHH----HHhccCC----------CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 1111 1111000 01112234458899999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=290.72 Aligned_cols=200 Identities=23% Similarity=0.351 Sum_probs=161.4
Q ss_pred cceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCcccce
Q 040898 46 LKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLL 125 (337)
Q Consensus 46 ~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~ 125 (337)
.++||+|+||.||++.+....+++.||+|.+...... ..+.+|+.+++.++||||++++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~---------------------~~~~~E~~~l~~l~h~niv~~~ 64 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS---------------------MSACREIALLRELKHPNVISLQ 64 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc---------------------HHHHHHHHHHHhcCCCCCccee
Confidence 4689999999999998876567899999988543211 3456799999999999999999
Q ss_pred eEEEc--CCeeEEEEEeccCCCHHHHHHHhcC-----CcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 126 AHMVR--PNCHLLVYEFMKNGSLQDILYDVSQ-----GRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 126 ~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
+.+.. +...++++||+.+ +|.+++..... ....+++..+..++.|++.||.|| |++|++|+||||+||+
T Consensus 65 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~L---H~~~ivHrDlkp~Nil 140 (317)
T cd07868 65 KVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL---HANWVLHRDLKPANIL 140 (317)
T ss_pred eeEecCCCcEEEEEEeccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHH---HhCCEEcCCCCHHHEE
Confidence 98854 4568999999865 88887753211 223588899999999999999999 7789999999999999
Q ss_pred e----cCCCCeEEecccCccccCCCCce-eeeecccCCCCccCccccccC-CCCCcccchhhhHHHHHHHhCCCCCCC
Q 040898 199 I----DDDMEARISDFGHGKLMPDGHAQ-ITVKCMVGTMGYMAPESLQTE-TISDKCDIYSFGVLLAVLVMGKFPVDD 270 (337)
Q Consensus 199 ~----~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~i~~~ll~g~~pf~~ 270 (337)
+ +.++.++|+|||++......... .......+|+.|+|||++.+. .++.++|+||+||++|+|++|.+||..
T Consensus 141 ~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 141 VMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred EecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 9 45678999999999766433211 112235689999999998764 578999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=296.98 Aligned_cols=251 Identities=22% Similarity=0.305 Sum_probs=194.3
Q ss_pred cccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC-CCC
Q 040898 42 CFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR-HRN 120 (337)
Q Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-hpn 120 (337)
+|++.+.||+|+||.||++.+.. +++.||+|++......... ....+..|..++..+. ||+
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~----------------~~~~~~~e~~~l~~~~~~~~ 62 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKG--TDELYAIKILKKDVVIQDD----------------DVECTMVEKRVLALQDKPPF 62 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECC--CCCEEEEEEEEHHHhhhhh----------------HHHHHHHHHHHHHhccCCCc
Confidence 47889999999999999998876 8999999998643221111 1145666888888775 567
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
|+.+++.+.+.+..|+||||+++++|.+++. ....+++..+..++.|++.||.|| |+.|++|+||+|+||+++
T Consensus 63 i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~l---H~~~ivHrDikp~Nill~ 135 (323)
T cd05615 63 LTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQ----QVGKFKEPQAVFYAAEISVGLFFL---HRRGIIYRDLKLDNVMLD 135 (323)
T ss_pred hhheeeEEecCCEEEEEEcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHeEEC
Confidence 8889999999999999999999999999884 345689999999999999999999 677999999999999999
Q ss_pred CCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhH
Q 040898 201 DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDM 280 (337)
Q Consensus 201 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~ 280 (337)
.++.++|+|||++........ ......|++.|+|||.+.+..++.++|+||+|+++|+|++|..||..... ...
T Consensus 136 ~~~~ikL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~----~~~ 209 (323)
T cd05615 136 SEGHIKIADFGMCKEHMVDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE----DEL 209 (323)
T ss_pred CCCCEEEeccccccccCCCCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH----HHH
Confidence 999999999998875332211 12234689999999999988899999999999999999999999865321 111
Q ss_pred HHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCCh-----hhhhcC
Q 040898 281 VKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSS-----KDVRSM 337 (337)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~ell~~ 337 (337)
...+ ....... +......+.+++.+||+.||.+|++. .++++|
T Consensus 210 ~~~i---~~~~~~~-----------p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05615 210 FQSI---MEHNVSY-----------PKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREH 257 (323)
T ss_pred HHHH---HhCCCCC-----------CccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcC
Confidence 1111 1111100 01122347899999999999999984 566654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=298.84 Aligned_cols=264 Identities=21% Similarity=0.246 Sum_probs=196.9
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++.+.||+|+||.||.+.+.. +++.||+|++......... ...+.+|+.+++.++|
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~-----------------~~~~~~E~~~l~~l~h 82 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAI--LERNVAIKKLSRPFQNQTH-----------------AKRAYRELVLMKCVNH 82 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECC--CCcEEEEEEeCccccCchh-----------------HHHHHHHHHHHHhcCC
Confidence 45789999999999999999998876 8999999998654322111 1456789999999999
Q ss_pred CCcccceeEEEcC------CeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 040898 119 RNILPLLAHMVRP------NCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDI 192 (337)
Q Consensus 119 pniv~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di 192 (337)
|||+++++++... ...|+||||+++ +|.+.+.. .+++..+..++.|++.||.|| |++|++|+||
T Consensus 83 ~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~L---H~~~ivH~Dl 152 (364)
T cd07875 83 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHL---HSAGIIHRDL 152 (364)
T ss_pred CCccccceeecccccccccCeEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHH---hhCCeecCCC
Confidence 9999999987543 357999999976 77776632 377888999999999999999 7789999999
Q ss_pred CCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCC
Q 040898 193 KPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFF 272 (337)
Q Consensus 193 ~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~ 272 (337)
+|+||+++.++.++|+|||++........ .....+++.|+|||++.+..++.++|+||||+++|+|++|+.||....
T Consensus 153 kp~NIll~~~~~~kL~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 229 (364)
T cd07875 153 KPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229 (364)
T ss_pred CHHHEEECCCCcEEEEeCCCccccCCCCc---ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999876543321 123468999999999999999999999999999999999999996532
Q ss_pred CCchhhhHHHHHHhhh------------------ccCCcch-----hhhhcc----cCCchHHHHHHHHHHHhhhccCCC
Q 040898 273 GHTEEMDMVKWMRNVI------------------FSENPNR-----AINSKL----LGNGYEEQMLLVLKLACFCTLKDP 325 (337)
Q Consensus 273 ~~~~~~~~~~~~~~~~------------------~~~~~~~-----~~~~~~----~~~~~~~~~~~l~~li~~~l~~dP 325 (337)
. .......+.... ....... ...... ...........+.+|+.+||+.||
T Consensus 230 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP 306 (364)
T cd07875 230 H---IDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA 306 (364)
T ss_pred H---HHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCc
Confidence 1 111111111100 0000000 000000 000011123468899999999999
Q ss_pred CCCCChhhhhcC
Q 040898 326 DERPSSKDVRSM 337 (337)
Q Consensus 326 ~~Rps~~ell~~ 337 (337)
++|||+.++|+|
T Consensus 307 ~~R~t~~e~L~h 318 (364)
T cd07875 307 SKRISVDEALQH 318 (364)
T ss_pred ccCCCHHHHhcC
Confidence 999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=289.92 Aligned_cols=258 Identities=24% Similarity=0.378 Sum_probs=205.3
Q ss_pred cccccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHH
Q 040898 34 LAFLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITA 113 (337)
Q Consensus 34 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l 113 (337)
....+...+|++.+.||+|++|.||++.+.. +++.|++|.+........ ..+.+|+.++
T Consensus 13 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~--~~~~v~ik~~~~~~~~~~-------------------~~~~~e~~~l 71 (296)
T cd06654 13 VSVGDPKKKYTRFEKIGQGASGTVYTAMDVA--TGQEVAIRQMNLQQQPKK-------------------ELIINEILVM 71 (296)
T ss_pred cccCCcccceeeEEEecCCCCeEEEEEEECC--CCcEEEEEEEecCCcchH-------------------HHHHHHHHHH
Confidence 4556678899999999999999999998765 889999998865443221 4677899999
Q ss_pred HhcCCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCC
Q 040898 114 NQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIK 193 (337)
Q Consensus 114 ~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~ 193 (337)
+.+.|||++++++.+..+...++|+||+++++|.+++.. ..+++..+..++.|++.||.|| |+.|++|+||+
T Consensus 72 ~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~L---H~~gi~H~dLk 143 (296)
T cd06654 72 RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFL---HSNQVIHRDIK 143 (296)
T ss_pred HhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCC
Confidence 999999999999999999999999999999999998843 3478889999999999999999 77899999999
Q ss_pred CCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCC
Q 040898 194 PANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFG 273 (337)
Q Consensus 194 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~ 273 (337)
|+||+++.++.++|+|||.+......... .....+++.|+|||.+.+..++.++|+||+|+++|+|++|..||.....
T Consensus 144 p~Nill~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~ 221 (296)
T cd06654 144 SDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP 221 (296)
T ss_pred HHHEEEcCCCCEEECccccchhccccccc--cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999999999999999987764332211 1234578899999999888889999999999999999999999854322
Q ss_pred CchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 274 HTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
........ ....+. ...+......+.+++.+||..||.+|||+.++++|
T Consensus 222 ---~~~~~~~~----~~~~~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 222 ---LRALYLIA----TNGTPE--------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred ---HHhHHHHh----cCCCCC--------CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 11111111 011100 00112233458899999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=301.18 Aligned_cols=264 Identities=23% Similarity=0.253 Sum_probs=196.7
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++.+.||+|+||.||.+.+.. +++.||+|++......... ...+.+|+.+++.++|
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~-----------------~~~~~~E~~~l~~l~h 75 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAV--LDRNVAIKKLSRPFQNQTH-----------------AKRAYRELVLMKCVNH 75 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecC--CCceEEEEEeCCcccChHH-----------------HHHHHHHHHHHHHhCC
Confidence 44679999999999999999998865 8999999998654322111 1456789999999999
Q ss_pred CCcccceeEEEcC------CeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 040898 119 RNILPLLAHMVRP------NCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDI 192 (337)
Q Consensus 119 pniv~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di 192 (337)
|||+++++++... ...+++|||+++ +|.+.+.. .+++..+..++.|++.||.|| |++|++|+||
T Consensus 76 ~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~L---H~~givHrDi 145 (355)
T cd07874 76 KNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHL---HSAGIIHRDL 145 (355)
T ss_pred CchhceeeeeeccccccccceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHH---HhCCcccCCC
Confidence 9999999988643 357999999976 66666632 377888999999999999999 7789999999
Q ss_pred CCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCC
Q 040898 193 KPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFF 272 (337)
Q Consensus 193 ~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~ 272 (337)
||+||+++.++.++|+|||++........ .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||....
T Consensus 146 kp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 222 (355)
T cd07874 146 KPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_pred ChHHEEECCCCCEEEeeCcccccCCCccc---cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999876543321 123468999999999999889999999999999999999999996532
Q ss_pred CCchhhhHHHHHHhhh------------------ccCCcc-hhhhhcc--------cCCchHHHHHHHHHHHhhhccCCC
Q 040898 273 GHTEEMDMVKWMRNVI------------------FSENPN-RAINSKL--------LGNGYEEQMLLVLKLACFCTLKDP 325 (337)
Q Consensus 273 ~~~~~~~~~~~~~~~~------------------~~~~~~-~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dP 325 (337)
. .......+.... ...... ....+.. ...........+.+|+.+||+.||
T Consensus 223 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP 299 (355)
T cd07874 223 Y---IDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 299 (355)
T ss_pred H---HHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCc
Confidence 1 111111111100 000000 0000000 000111223468899999999999
Q ss_pred CCCCChhhhhcC
Q 040898 326 DERPSSKDVRSM 337 (337)
Q Consensus 326 ~~Rps~~ell~~ 337 (337)
++|||+.|+|+|
T Consensus 300 ~~Rps~~ell~h 311 (355)
T cd07874 300 AKRISVDEALQH 311 (355)
T ss_pred hhcCCHHHHhcC
Confidence 999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=285.60 Aligned_cols=247 Identities=25% Similarity=0.330 Sum_probs=191.7
Q ss_pred ceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCccccee
Q 040898 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLLA 126 (337)
Q Consensus 47 ~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~ 126 (337)
+.||+|+||.||++.+.. +++.+|+|.+......... ..+.+|+.+++.++||||+++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~--~~~~~a~k~~~~~~~~~~~------------------~~~~~e~~~l~~l~h~~i~~~~~ 60 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRA--DNTPVAVKSCRETLPPDLK------------------AKFLQEARILKQYSHPNIVRLIG 60 (252)
T ss_pred CccCcccCccEEEEEEec--CCceEEEEecCccCCHHHH------------------HHHHHHHHHHHhCCCCCcceEEE
Confidence 479999999999998876 8999999987644321111 46778999999999999999999
Q ss_pred EEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCCeE
Q 040898 127 HMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEAR 206 (337)
Q Consensus 127 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~~ 206 (337)
++......++|+||+++++|.+++.. ....+++..++.++.|++.||.|| |+.|++|+||+|+||+++.++.++
T Consensus 61 ~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~l---H~~~i~H~dl~p~nil~~~~~~~k 134 (252)
T cd05084 61 VCTQKQPIYIVMELVQGGDFLTFLRT---EGPRLKVKELIQMVENAAAGMEYL---ESKHCIHRDLAARNCLVTEKNVLK 134 (252)
T ss_pred EEcCCCCeEEEEeeccCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHH---HhCCccccccchheEEEcCCCcEE
Confidence 99999999999999999999999843 334578999999999999999999 778999999999999999999999
Q ss_pred EecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCchhhhHHHHHH
Q 040898 207 ISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHTEEMDMVKWMR 285 (337)
Q Consensus 207 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~ 285 (337)
|+|||++.................+..|+|||.+.+..++.++|+||||+++|+|++ |..||..... ........
T Consensus 135 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~----~~~~~~~~ 210 (252)
T cd05084 135 ISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN----QQTREAIE 210 (252)
T ss_pred ECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH----HHHHHHHH
Confidence 999999875443221111111223456999999988889999999999999999998 8888864322 11111111
Q ss_pred hhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 286 NVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
..... ..+...+..+.+++.+||+.||++|||+.++++
T Consensus 211 ~~~~~-------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 211 QGVRL-------------PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred cCCCC-------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 10000 011122345889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=288.15 Aligned_cols=253 Identities=27% Similarity=0.444 Sum_probs=193.6
Q ss_pred cccceeccCcceEEEEeEEe--cCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCc
Q 040898 44 DSLKKIGSGGWGEVFYKAEL--PGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNI 121 (337)
Q Consensus 44 ~~~~~lg~G~~g~V~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpni 121 (337)
.+.+.||.|+||.||.+... ....+..|+||.+........ .+.+.+|+..+++++||||
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~------------------~~~~~~e~~~l~~l~h~ni 63 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEE------------------EEEFLNEIQILRKLRHPNI 63 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHH------------------HHHHHHHHHHHHTHSBTTB
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccccccc------------------ceeeeeccccccccccccc
Confidence 46789999999999999887 445678899999955332221 1578889999999999999
Q ss_pred ccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecC
Q 040898 122 LPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDD 201 (337)
Q Consensus 122 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~ 201 (337)
+++++++...+..++|+||+++|+|.+++.. .....+++..++.++.|++.||.|| |+.+++|++|+++||+++.
T Consensus 64 ~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~--~~~~~~~~~~~~~i~~~i~~~l~~L---h~~~iiH~~l~~~nill~~ 138 (259)
T PF07714_consen 64 VKLYGFCIENEPLFLVMEYCPGGSLDDYLKS--KNKEPLSEQQRLSIAIQIAEALSYL---HSNNIIHGNLSPSNILLDS 138 (259)
T ss_dssp E-EEEEEESSSSEEEEEE--TTEBHHHHHHH--TCTTTSBHHHHHHHHHHHHHHHHHH---HHTTEEEST-SGGGEEEET
T ss_pred ccccccccccccccccccccccccccccccc--ccccccccccccccccccccccccc---ccccccccccccccccccc
Confidence 9999999988889999999999999999976 2356789999999999999999999 6678999999999999999
Q ss_pred CCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCchhhhH
Q 040898 202 DMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHTEEMDM 280 (337)
Q Consensus 202 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~~~~ 280 (337)
++.+||+|||++....................|+|||.+.+..++.++||||||+++||+++ |..||.... ..+.
T Consensus 139 ~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~----~~~~ 214 (259)
T PF07714_consen 139 NGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD----NEEI 214 (259)
T ss_dssp TTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC----HHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc----cccc
Confidence 99999999999887643333323233456778999999988889999999999999999999 679986541 2222
Q ss_pred HHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 281 VKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
...+.+...... +...+..+.+++..||+.||++|||+.++++
T Consensus 215 ~~~~~~~~~~~~-------------~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 215 IEKLKQGQRLPI-------------PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHHHTTEETTS-------------BTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred ccccccccccee-------------ccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 222222211111 1112334889999999999999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=302.21 Aligned_cols=263 Identities=23% Similarity=0.343 Sum_probs=202.4
Q ss_pred cccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC-C--
Q 040898 42 CFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR-H-- 118 (337)
Q Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h-- 118 (337)
+|++++.||+|+||.|-++.+.. +++.||||+++.+...- .....|+.+|..|+ |
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~--T~e~VAIKIiKN~k~f~--------------------~Q~~~Ei~iL~~ln~~d~ 244 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHK--TGEIVAIKIIKNKKRFL--------------------RQAQIEIRILELLNKHDP 244 (586)
T ss_pred EEEEEEEecccccceeEEEEecC--CCcEEEEEeeccChHHH--------------------HHHHHHHHHHHHHhccCC
Confidence 89999999999999999888876 99999999997664322 34556888888886 3
Q ss_pred ---CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCC
Q 040898 119 ---RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPA 195 (337)
Q Consensus 119 ---pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ 195 (337)
-|+|+++++|...+.+|||+|.+.. +|.++++. .+-.+++...+..++.||+++|..| |..||+|+||||+
T Consensus 245 ~~~~n~Vrm~d~F~fr~HlciVfELL~~-NLYellK~--n~f~Glsl~~ir~~~~Qil~~L~~L---~~l~IIHcDLKPE 318 (586)
T KOG0667|consen 245 DDKYNIVRMLDYFYFRNHLCIVFELLST-NLYELLKN--NKFRGLSLPLVRKFAQQILTALLFL---HELGIIHCDLKPE 318 (586)
T ss_pred CCCeeEEEeeeccccccceeeeehhhhh-hHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeeccCChh
Confidence 3999999999999999999999965 99999976 5556699999999999999999999 7779999999999
Q ss_pred ceeecC--CCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCC
Q 040898 196 NVLIDD--DMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFG 273 (337)
Q Consensus 196 nil~~~--~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~ 273 (337)
|||+.. ...|||+|||.+++..... .....+..|.|||++.|.+|+.+.|+||||||++||++|.+-|.+...
T Consensus 319 NILL~~~~r~~vKVIDFGSSc~~~q~v-----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne 393 (586)
T KOG0667|consen 319 NILLKDPKRSRIKVIDFGSSCFESQRV-----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE 393 (586)
T ss_pred heeeccCCcCceeEEecccccccCCcc-----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence 999964 4579999999998765432 256788999999999999999999999999999999999887765322
Q ss_pred CchhhhHHHHHHh--------------hhcc--CCc-----ch-----------------hh------hhcccCCchH-H
Q 040898 274 HTEEMDMVKWMRN--------------VIFS--ENP-----NR-----------------AI------NSKLLGNGYE-E 308 (337)
Q Consensus 274 ~~~~~~~~~~~~~--------------~~~~--~~~-----~~-----------------~~------~~~~~~~~~~-~ 308 (337)
.+...-+.+.... .... ..+ .. .. .......... .
T Consensus 394 ~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~ 473 (586)
T KOG0667|consen 394 YDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKA 473 (586)
T ss_pred HHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccc
Confidence 2111111111100 0000 000 00 00 0000011112 3
Q ss_pred HHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 309 QMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 309 ~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
....+.+++.+||..||.+|+|+.++|+|
T Consensus 474 ~~~~F~dflk~~L~~dP~~R~tp~qal~H 502 (586)
T KOG0667|consen 474 DDKLFIDFLKRCLEWDPAERITPAQALNH 502 (586)
T ss_pred cHHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 44568999999999999999999999988
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=288.34 Aligned_cols=259 Identities=26% Similarity=0.440 Sum_probs=203.9
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
.++|++.+.||+|++|+||++.+.. +++.||+|++......... ..+.+|+.+++.++||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~--~~~~~a~k~~~~~~~~~~~------------------~~~~~E~~~l~~l~h~ 63 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIP--TGTVMAKKVVHIGAKSSVR------------------KQILRELQIMHECRSP 63 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcC--CCcEEEEEEEEecCcchHH------------------HHHHHHHHHHHHcCCC
Confidence 4679999999999999999998876 8999999988654322111 4677899999999999
Q ss_pred CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceee
Q 040898 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI 199 (337)
Q Consensus 120 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~ 199 (337)
||+++++.+......++|+||+++++|.+++. ..+.+++..+..++.+++.++.|||+ ..|++|+||+|+||++
T Consensus 64 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~ 137 (284)
T cd06620 64 YIVSFYGAFLNENNICMCMEFMDCGSLDRIYK----KGGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILV 137 (284)
T ss_pred CcceEeeeEecCCEEEEEEecCCCCCHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEE
Confidence 99999999999999999999999999999884 34468999999999999999999952 3689999999999999
Q ss_pred cCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCc----
Q 040898 200 DDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHT---- 275 (337)
Q Consensus 200 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~---- 275 (337)
+.++.++|+|||++........ ....++..|+|||.+.+..++.++|+||+|+++|++++|..||.......
T Consensus 138 ~~~~~~~l~d~gl~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~ 213 (284)
T cd06620 138 NSRGQIKLCDFGVSGELINSIA----DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQD 213 (284)
T ss_pred CCCCcEEEccCCcccchhhhcc----CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhh
Confidence 9999999999998765432211 23468899999999988888999999999999999999999997543321
Q ss_pred hhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 276 EEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.................+.. ........+.+|+.+||+.||.+|||+.|+++|
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 214 DPMGILDLLQQIVQEPPPRL---------PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred hhhHHHHHHHHHhhccCCCC---------CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 11112222222221111100 001133458899999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=320.31 Aligned_cols=260 Identities=22% Similarity=0.321 Sum_probs=200.5
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++++.||+|+||+||++.+.. ++..+|+|.+......... ...+..|+.++.+++|
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~--tg~~vAlKvIk~~~l~e~~-----------------~~~~~~EI~IL~~L~H 71 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKR--TQEFFCWKAISYRGLKERE-----------------KSQLVIEVNVMRELKH 71 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECC--CCeEEEEEEEeccccCHHH-----------------HHHHHHHHHHHHHcCC
Confidence 34579999999999999999999976 8899999988654332211 1567889999999999
Q ss_pred CCcccceeEEEc--CCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCC----CCCeEecCC
Q 040898 119 RNILPLLAHMVR--PNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCH----RPRLIHRDI 192 (337)
Q Consensus 119 pniv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h----~~gi~h~di 192 (337)
|||++++++|.. ...+|+||||+++++|.+++.........+++..++.++.||+.||.|||... .++|+|+||
T Consensus 72 PNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDL 151 (1021)
T PTZ00266 72 KNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDL 151 (1021)
T ss_pred CCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccC
Confidence 999999998854 45789999999999999999765555567999999999999999999996432 156999999
Q ss_pred CCCceeecC-----------------CCCeEEecccCccccCCCCceeeeecccCCCCccCcccccc--CCCCCcccchh
Q 040898 193 KPANVLIDD-----------------DMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQT--ETISDKCDIYS 253 (337)
Q Consensus 193 ~~~nil~~~-----------------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Diws 253 (337)
+|+|||++. .+.++|+|||++........ .....+|+.|+|||++.+ ..++.++||||
T Consensus 152 KPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWS 228 (1021)
T PTZ00266 152 KPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWA 228 (1021)
T ss_pred cHHHeEeecCccccccccccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHH
Confidence 999999964 34589999999876543221 123468999999999854 44788999999
Q ss_pred hhHHHHHHHhCCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhh
Q 040898 254 FGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKD 333 (337)
Q Consensus 254 lG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e 333 (337)
|||++|+|++|..||..... ....+......... . .......+.+||..||+.+|.+|||+.+
T Consensus 229 LG~ILYELLTGk~PF~~~~~------~~qli~~lk~~p~l-p----------i~~~S~eL~dLI~~~L~~dPeeRPSa~Q 291 (1021)
T PTZ00266 229 LGCIIYELCSGKTPFHKANN------FSQLISELKRGPDL-P----------IKGKSKELNILIKNLLNLSAKERPSALQ 291 (1021)
T ss_pred HHHHHHHHHHCCCCCCcCCc------HHHHHHHHhcCCCC-C----------cCCCCHHHHHHHHHHhcCChhHCcCHHH
Confidence 99999999999999964321 11111111111100 0 0112344889999999999999999999
Q ss_pred hhcC
Q 040898 334 VRSM 337 (337)
Q Consensus 334 ll~~ 337 (337)
+|+|
T Consensus 292 lL~h 295 (1021)
T PTZ00266 292 CLGY 295 (1021)
T ss_pred Hhcc
Confidence 9975
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=289.85 Aligned_cols=258 Identities=22% Similarity=0.353 Sum_probs=198.9
Q ss_pred cccccccceeccCcceEEEEeEEec---CCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELP---GSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT 116 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 116 (337)
..+|.+.+.||+|+||.||++.+.. ..++..+|+|.+....... ...+.+|+.++.++
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~-------------------~~~~~~e~~~l~~l 64 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNA-------------------RKDFHREAELLTNL 64 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHH-------------------HHHHHHHHHHHHhC
Confidence 4579999999999999999987643 2355678899875432111 15678899999999
Q ss_pred CCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhc---------CCcccCChHHHHHHHHHHHHHHHHHhhCCCCCe
Q 040898 117 RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVS---------QGRRELDWPARHRIARGIASGLEYLHMCHRPRL 187 (337)
Q Consensus 117 ~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi 187 (337)
+||||+++++++...+..++++||+++++|.+++.... .....+++..++.++.|++.||.|| |+.|+
T Consensus 65 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~l---H~~~i 141 (288)
T cd05093 65 QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYL---ASQHF 141 (288)
T ss_pred CCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHH---HhCCe
Confidence 99999999999999999999999999999999986432 1223589999999999999999999 77899
Q ss_pred EecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCC
Q 040898 188 IHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKF 266 (337)
Q Consensus 188 ~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~ 266 (337)
+|+||+|+||++++++.++|+|||.+................+++.|+|||.+.+..++.++|+||||+++|+|++ |..
T Consensus 142 ~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~ 221 (288)
T cd05093 142 VHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ 221 (288)
T ss_pred eecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999876543322222223345678999999998889999999999999999998 899
Q ss_pred CCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 267 PVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 267 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
||...... .....+.. ...... ....+..+.+++.+||+.||.+|||+.++++
T Consensus 222 p~~~~~~~----~~~~~i~~---~~~~~~----------~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 222 PWYQLSNN----EVIECITQ---GRVLQR----------PRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred CCCCCCHH----HHHHHHHc---CCcCCC----------CCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 98643221 11111111 111000 0012234899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=295.12 Aligned_cols=259 Identities=22% Similarity=0.257 Sum_probs=195.5
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
++|++.+.||+|+||.||++.+.. +++.||+|.+........ .....+.+|..++..++|||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~----------------~~~~~~~~e~~~l~~~~~~~ 62 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKN--TGQVYAMKILNKWEMLKR----------------AETACFREERDVLVNGDRRW 62 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECC--CCCEEEEEEEEHHHHhhh----------------hhHHHHHHHHHHHHhCCCCC
Confidence 479999999999999999998876 899999999854211111 01145778999999999999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
|+.+++.+.+++..|+||||+++++|.+++.. ....+++..+..++.||+.||.|| |++|++|+||+|+||+++
T Consensus 63 i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nill~ 136 (331)
T cd05597 63 ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSV---HQLGYVHRDIKPDNVLLD 136 (331)
T ss_pred CCceEEEEecCCeEEEEEecCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHH---HhCCeEECCCCHHHEEEC
Confidence 99999999999999999999999999999853 234588899999999999999999 778999999999999999
Q ss_pred CCCCeEEecccCccccCCCCceeeeecccCCCCccCcccccc-----CCCCCcccchhhhHHHHHHHhCCCCCCCCCCCc
Q 040898 201 DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQT-----ETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHT 275 (337)
Q Consensus 201 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-----~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~ 275 (337)
.++.++|+|||++......... ......+++.|+|||++.. ..++.++|+||+|+++|+|++|..||.....
T Consensus 137 ~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~-- 213 (331)
T cd05597 137 KNGHIRLADFGSCLRLLADGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL-- 213 (331)
T ss_pred CCCCEEEEECCceeecCCCCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH--
Confidence 9999999999998665432221 1122458999999999863 3467899999999999999999999864211
Q ss_pred hhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCC--CCCChhhhhcC
Q 040898 276 EEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPD--ERPSSKDVRSM 337 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~--~Rps~~ell~~ 337 (337)
. +.............. .......+..+.+++.+||..+++ .||++.++++|
T Consensus 214 -~----~~~~~i~~~~~~~~~------~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 214 -V----ETYGKIMNHKEHFQF------PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred -H----HHHHHHHcCCCcccC------CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 1 111111111110000 001112334578888887765443 38899999987
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=298.50 Aligned_cols=246 Identities=24% Similarity=0.322 Sum_probs=189.2
Q ss_pred ceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHH-HHHHhcCCCCcccce
Q 040898 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEI-ITANQTRHRNILPLL 125 (337)
Q Consensus 47 ~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~-~~l~~l~hpniv~~~ 125 (337)
+.||+|+||.||++.+.. +|+.+|+|++.......... ...+..|. .+++.++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~----------------~~~~~~e~~~~l~~~~hp~iv~~~ 62 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKL--DGKCYAVKVLQKKIVLNRKE----------------QKHIMAERNVLLKNVKHPFLVGLH 62 (325)
T ss_pred CceeeCCCeEEEEEEECC--CCCEEEEEEEEHHHhhhhhH----------------HHHHHHHHHHHHHhCCCCCCccEE
Confidence 469999999999998876 89999999986542211110 02334444 456778999999999
Q ss_pred eEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCCe
Q 040898 126 AHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEA 205 (337)
Q Consensus 126 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~ 205 (337)
+.+..++..++||||+++++|...+. ....+++..+..++.||+.||.|| |+.|++|+||+|+||+++.++.+
T Consensus 63 ~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~l---H~~givH~Dlkp~NIll~~~~~~ 135 (325)
T cd05604 63 YSFQTTEKLYFVLDFVNGGELFFHLQ----RERSFPEPRARFYAAEIASALGYL---HSINIVYRDLKPENILLDSQGHV 135 (325)
T ss_pred EEEecCCEEEEEEcCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCHHHeEECCCCCE
Confidence 99999999999999999999988873 345688999999999999999999 67799999999999999999999
Q ss_pred EEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHHHHHH
Q 040898 206 RISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMR 285 (337)
Q Consensus 206 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~ 285 (337)
+|+|||++........ ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||..... ... ..
T Consensus 136 kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~----~~~---~~ 206 (325)
T cd05604 136 VLTDFGLCKEGIAQSD--TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV----AEM---YD 206 (325)
T ss_pred EEeecCCcccCCCCCC--CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH----HHH---HH
Confidence 9999999865322211 12235689999999999998899999999999999999999999864311 111 11
Q ss_pred hhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChh----hhhcC
Q 040898 286 NVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSK----DVRSM 337 (337)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~----ell~~ 337 (337)
......... .+.....+.+++.+||+.||++||++. ++++|
T Consensus 207 ~~~~~~~~~-----------~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h 251 (325)
T cd05604 207 NILHKPLVL-----------RPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEH 251 (325)
T ss_pred HHHcCCccC-----------CCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcC
Confidence 111111000 011223478899999999999999875 67665
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=284.42 Aligned_cols=249 Identities=23% Similarity=0.344 Sum_probs=195.1
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
++|++.+.||+|+||.||++... ++..+|+|.+...... . +.+..|+.+++.++|||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~---~~~~~a~K~~~~~~~~-~-------------------~~~~~e~~~l~~l~h~~ 60 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR---AQIKVAIKAINEGAMS-E-------------------EDFIEEAKVMMKLSHPK 60 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec---cCceEEEEecccCCcc-H-------------------HHHHHHHHHHHHCCCCC
Confidence 56899999999999999998764 5668999987543211 1 45677999999999999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
|+++++++......+++|||+++++|.+++.. ....+++..+..++.|++.||.|| |+.|++|+||+|+||+++
T Consensus 61 i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~ni~i~ 134 (256)
T cd05114 61 LVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQ---RQGKLSKDMLLSMCQDVCEGMEYL---ERNSFIHRDLAARNCLVS 134 (256)
T ss_pred ceeEEEEEccCCCEEEEEEcCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHH---HHCCccccccCcceEEEc
Confidence 99999999999999999999999999998853 223578899999999999999999 777999999999999999
Q ss_pred CCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCchhhh
Q 040898 201 DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHTEEMD 279 (337)
Q Consensus 201 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~~~ 279 (337)
.++.++|+|||.+......... ......++..|+|||.+.+..++.++|+||+|+++|+|++ |+.||..... ..
T Consensus 135 ~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~----~~ 209 (256)
T cd05114 135 STGVVKVSDFGMTRYVLDDEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN----YE 209 (256)
T ss_pred CCCeEEECCCCCccccCCCcee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH----HH
Confidence 9999999999988765332211 1122235567999999988889999999999999999999 8999854321 11
Q ss_pred HHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 280 MVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
....+.+. ..... +......+.+++.+||+.||++|||+.++++
T Consensus 210 ~~~~i~~~---~~~~~----------~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 210 VVEMISRG---FRLYR----------PKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHHHHHCC---CCCCC----------CCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 22222111 11100 0011235899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=294.29 Aligned_cols=246 Identities=24% Similarity=0.327 Sum_probs=188.2
Q ss_pred ceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHH-HHHHhcCCCCcccce
Q 040898 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEI-ITANQTRHRNILPLL 125 (337)
Q Consensus 47 ~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~-~~l~~l~hpniv~~~ 125 (337)
+.||+|+||.||++.+.. +++.||+|.+.......... ...+..|. .+++.++||||++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~--~~~~~aiK~~~~~~~~~~~~----------------~~~~~~e~~~~l~~~~h~~iv~~~ 62 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKS--DGSFYAVKVLQKKTILKKKE----------------QNHIMAERNVLLKNLKHPFLVGLH 62 (321)
T ss_pred CeeeeCCCEEEEEEEECC--CCCEEEEEEEEHHHHHHhhH----------------HHHHHHHHHHHHHhCCCCCcccee
Confidence 479999999999999876 89999999986432211110 02334444 467889999999999
Q ss_pred eEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCCe
Q 040898 126 AHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEA 205 (337)
Q Consensus 126 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~ 205 (337)
+.+.+.+..++||||+++++|...+. ....+++..+..++.||+.||.|| |+.|++|+||||+||+++.++.+
T Consensus 63 ~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~l---H~~~ivH~Dlkp~NIll~~~~~~ 135 (321)
T cd05603 63 YSFQTAEKLYFVLDYVNGGELFFHLQ----RERCFLEPRARFYAAEVASAIGYL---HSLNIIYRDLKPENILLDSQGHV 135 (321)
T ss_pred eEEEcCCEEEEEEcCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHH---HHCCeEeccCCHHHeEECCCCCE
Confidence 99999999999999999999988874 344578888999999999999999 77799999999999999999999
Q ss_pred EEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHHHHHH
Q 040898 206 RISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMR 285 (337)
Q Consensus 206 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~ 285 (337)
+|+|||++........ ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||.... ......
T Consensus 136 kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~----~~~~~~--- 206 (321)
T cd05603 136 VLTDFGLCKEGVEPEE--TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD----VSQMYD--- 206 (321)
T ss_pred EEccCCCCccCCCCCC--ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC----HHHHHH---
Confidence 9999998865322111 1223468999999999998889999999999999999999999986431 111111
Q ss_pred hhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChh----hhhcC
Q 040898 286 NVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSK----DVRSM 337 (337)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~----ell~~ 337 (337)
........ .++.....+.+++.+||+.||.+||++. ++++|
T Consensus 207 ~i~~~~~~-----------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 251 (321)
T cd05603 207 NILHKPLQ-----------LPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNH 251 (321)
T ss_pred HHhcCCCC-----------CCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCC
Confidence 11111100 0112233488999999999999999864 66554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=288.37 Aligned_cols=257 Identities=25% Similarity=0.395 Sum_probs=204.2
Q ss_pred ccccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHH
Q 040898 35 AFLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITAN 114 (337)
Q Consensus 35 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~ 114 (337)
++.+...+|++.+.||.|++|.||++.+.. +++.|++|.+........ +.+.+|+.+++
T Consensus 13 ~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~--~~~~v~iK~~~~~~~~~~-------------------~~~~~e~~~l~ 71 (296)
T cd06655 13 SIGDPKKKYTRYEKIGQGASGTVFTAIDVA--TGQEVAIKQINLQKQPKK-------------------ELIINEILVMK 71 (296)
T ss_pred hcCCCcceEEEEEEEecCCCeEEEEEEEcC--CCcEEEEEEEecccCchH-------------------HHHHHHHHHHH
Confidence 445567789999999999999999998866 899999998864432211 45678999999
Q ss_pred hcCCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCC
Q 040898 115 QTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKP 194 (337)
Q Consensus 115 ~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~ 194 (337)
.++|||++++++.+......++|+||+++++|..++.. ..+++..+..++.+++.++.+| |+.|++|+||+|
T Consensus 72 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~L---H~~~i~H~dL~p 143 (296)
T cd06655 72 ELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFL---HANQVIHRDIKS 143 (296)
T ss_pred hcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCH
Confidence 99999999999999999999999999999999998842 3588999999999999999999 777999999999
Q ss_pred CceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCC
Q 040898 195 ANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGH 274 (337)
Q Consensus 195 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~ 274 (337)
+||+++.++.++|+|||++......... .....++..|+|||.+.+..++.++|+||+|+++|++++|..||......
T Consensus 144 ~Nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~ 221 (296)
T cd06655 144 DNVLLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL 221 (296)
T ss_pred HHEEECCCCCEEEccCccchhccccccc--CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999999999999999988765432211 12235788999999998888899999999999999999999998653221
Q ss_pred chhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 275 TEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
..... ... ...+. ...+......+.+++.+||..||.+|||+.++++|
T Consensus 222 ---~~~~~-~~~---~~~~~--------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 222 ---RALYL-IAT---NGTPE--------LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred ---HHHHH-HHh---cCCcc--------cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 11111 110 11000 00111223458899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=289.07 Aligned_cols=269 Identities=22% Similarity=0.315 Sum_probs=201.4
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
++|++.+.||+|++|.||++.+.. +++.||+|++......... ...+.+|+.++++++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~--~~~~~~iK~~~~~~~~~~~-----------------~~~~~~e~~~l~~~~h~~ 61 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRE--TGQIVAIKKFVESEDDPVI-----------------KKIALREIRMLKQLKHPN 61 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECC--CCcEEEEEEEeecccCccc-----------------cHHHHHHHHHHHhCCCCC
Confidence 479999999999999999998865 8999999988654321110 034677999999999999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
++++++.+..+...++|+||+++++|..++ .....+++..+..++.|++.+|.|| |+.|++|+||+|+||+++
T Consensus 62 i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~ql~~~l~~L---H~~~i~H~dl~p~nil~~ 134 (286)
T cd07847 62 LVNLIEVFRRKRKLHLVFEYCDHTVLNELE----KNPRGVPEHLIKKIIWQTLQAVNFC---HKHNCIHRDVKPENILIT 134 (286)
T ss_pred EeeeeeEEeeCCEEEEEEeccCccHHHHHH----hCCCCCCHHHHHHHHHHHHHHHHHH---HHCCceecCCChhhEEEc
Confidence 999999999999999999999998888776 3344689999999999999999999 678999999999999999
Q ss_pred CCCCeEEecccCccccCCCCceeeeecccCCCCccCcccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhh
Q 040898 201 DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQT-ETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMD 279 (337)
Q Consensus 201 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~ 279 (337)
.++.++|+|||++......... .....++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+.........
T Consensus 135 ~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~ 212 (286)
T cd07847 135 KQGQIKLCDFGFARILTGPGDD--YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYL 212 (286)
T ss_pred CCCcEEECccccceecCCCccc--ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 9999999999998876443221 123457788999999876 4578899999999999999999999975433222111
Q ss_pred HHHHHHhhhc-------cCC-cchhhhhccc-----CCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 280 MVKWMRNVIF-------SEN-PNRAINSKLL-----GNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 280 ~~~~~~~~~~-------~~~-~~~~~~~~~~-----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.......... ... ......+... ....+.....+.+|+.+||+.||++|||+.++++|
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 213 IRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred HHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 1111110000 000 0000000000 00112234568999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=298.54 Aligned_cols=265 Identities=24% Similarity=0.329 Sum_probs=196.5
Q ss_pred cccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHh
Q 040898 36 FLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQ 115 (337)
Q Consensus 36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~ 115 (337)
.++-.++|++++.||+|+||.||++.+.. ++..||+|++........ ....+.+|+.+++.
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~-----------------~~~~~~~E~~~l~~ 70 (343)
T cd07878 10 VWEVPERYQNLTPVGSGAYGSVCSAYDTR--LRQKVAVKKLSRPFQSLI-----------------HARRTYRELRLLKH 70 (343)
T ss_pred HhhhhhhhhhheecccCCCeEEEEEEECC--CCCEEEEEEeCchhhhhH-----------------HHHHHHHHHHHHHh
Confidence 34456889999999999999999998876 889999998864321111 01456789999999
Q ss_pred cCCCCcccceeEEEcC------CeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEe
Q 040898 116 TRHRNILPLLAHMVRP------NCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIH 189 (337)
Q Consensus 116 l~hpniv~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h 189 (337)
++||||+++++++... ...|++++++ +++|.+++. ...+++..+..++.|++.||.|| |+.|++|
T Consensus 71 l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~L---H~~~ivH 141 (343)
T cd07878 71 MKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYI---HSAGIIH 141 (343)
T ss_pred cCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeec
Confidence 9999999999887543 4468999988 679988773 34589999999999999999999 7779999
Q ss_pred cCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCcccccc-CCCCCcccchhhhHHHHHHHhCCCCC
Q 040898 190 RDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQT-ETISDKCDIYSFGVLLAVLVMGKFPV 268 (337)
Q Consensus 190 ~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~i~~~ll~g~~pf 268 (337)
+||+|+||+++.++.++|+|||++....... ....+++.|+|||++.+ ..++.++||||||+++|+|++|..||
T Consensus 142 rdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf 216 (343)
T cd07878 142 RDLKPSNVAVNEDCELRILDFGLARQADDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALF 216 (343)
T ss_pred ccCChhhEEECCCCCEEEcCCccceecCCCc-----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCC
Confidence 9999999999999999999999987654321 23468999999999876 56889999999999999999999998
Q ss_pred CCCCCCchhhhHHHHHHhhhccCCcch----------hhhhcc---c----CCchHHHHHHHHHHHhhhccCCCCCCCCh
Q 040898 269 DDFFGHTEEMDMVKWMRNVIFSENPNR----------AINSKL---L----GNGYEEQMLLVLKLACFCTLKDPDERPSS 331 (337)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~---~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~ 331 (337)
....... .+.. +........+.. .....+ . ..........+.+|+.+||+.||++|||+
T Consensus 217 ~~~~~~~---~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~ 292 (343)
T cd07878 217 PGNDYID---QLKR-IMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISA 292 (343)
T ss_pred CCCCHHH---HHHH-HHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCH
Confidence 6432111 1111 111100000000 000000 0 00001112347899999999999999999
Q ss_pred hhhhcC
Q 040898 332 KDVRSM 337 (337)
Q Consensus 332 ~ell~~ 337 (337)
.|+++|
T Consensus 293 ~ell~h 298 (343)
T cd07878 293 SEALAH 298 (343)
T ss_pred HHHhcC
Confidence 999987
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=294.71 Aligned_cols=270 Identities=21% Similarity=0.313 Sum_probs=194.9
Q ss_pred cccceeccC--cceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCc
Q 040898 44 DSLKKIGSG--GWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNI 121 (337)
Q Consensus 44 ~~~~~lg~G--~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpni 121 (337)
++++.||+| ++++||++.+.. +|+.||+|++..+...... ...+.+|+.+++.++||||
T Consensus 1 ~~~~~ig~G~~~~~~v~~~~~~~--~~~~vaiK~~~~~~~~~~~-----------------~~~~~~e~~~l~~l~hpni 61 (327)
T cd08227 1 ELLTVIGRGFEDLMTVNLARYKP--TGEYVTVRRINLEACTNEM-----------------VTFLQGELHVSKLFNHPNI 61 (327)
T ss_pred ChhhhccccccceEEEEEEeecc--cCcEEEEEEechhhccHHH-----------------HHHHHHHHHHHHhcCCCCe
Confidence 367899999 788999988876 9999999998655332211 1467779999999999999
Q ss_pred ccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecC
Q 040898 122 LPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDD 201 (337)
Q Consensus 122 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~ 201 (337)
+++++++..++..++|+||+++++|.+++... ....+++..++.++.|++.||.|| |+.|++|+||+|+||+++.
T Consensus 62 v~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~L---H~~~iiH~dlkp~Nil~~~ 136 (327)
T cd08227 62 VPYRATFIADNELWVVTSFMAYGSAKDLICTH--FMDGMSELAIAYILQGVLKALDYI---HHMGYVHRSVKASHILISV 136 (327)
T ss_pred eeEEEEEEECCEEEEEEeccCCCcHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHH---HHCCEecCCCChhhEEEec
Confidence 99999999999999999999999999998542 234588899999999999999999 7779999999999999999
Q ss_pred CCCeEEecccCccccCCCCcee-----eeecccCCCCccCcccccc--CCCCCcccchhhhHHHHHHHhCCCCCCCCCCC
Q 040898 202 DMEARISDFGHGKLMPDGHAQI-----TVKCMVGTMGYMAPESLQT--ETISDKCDIYSFGVLLAVLVMGKFPVDDFFGH 274 (337)
Q Consensus 202 ~~~~~l~dfg~~~~~~~~~~~~-----~~~~~~~~~~~~~PE~~~~--~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~ 274 (337)
++.+++.||+............ ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||......
T Consensus 137 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 216 (327)
T cd08227 137 DGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPAT 216 (327)
T ss_pred CCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchh
Confidence 9999999998654332111100 0111245677999999875 45889999999999999999999999653221
Q ss_pred chhhhHHHHHHhhhccC---Ccc-------------------------hhhhhcccCCchHHHHHHHHHHHhhhccCCCC
Q 040898 275 TEEMDMVKWMRNVIFSE---NPN-------------------------RAINSKLLGNGYEEQMLLVLKLACFCTLKDPD 326 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~---~~~-------------------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~ 326 (337)
................. ... ..................+.+|+.+||+.||+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~ 296 (327)
T cd08227 217 QMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPD 296 (327)
T ss_pred HHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCch
Confidence 11100000000000000 000 00000000011122345688999999999999
Q ss_pred CCCChhhhhcC
Q 040898 327 ERPSSKDVRSM 337 (337)
Q Consensus 327 ~Rps~~ell~~ 337 (337)
+|||+.++++|
T Consensus 297 ~Rpt~~ell~~ 307 (327)
T cd08227 297 ARPSASTLLNH 307 (327)
T ss_pred hcCCHHHHhcC
Confidence 99999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=286.32 Aligned_cols=257 Identities=23% Similarity=0.351 Sum_probs=200.6
Q ss_pred ccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc
Q 040898 37 LKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT 116 (337)
Q Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 116 (337)
+..++.|++++.||.|++|.||++.+.. ++..+++|.+....... ...+.+|+.+++.+
T Consensus 8 ~~~~~~y~i~~~lg~g~~g~vy~~~~~~--~~~~~~~k~~~~~~~~~-------------------~~~~~~e~~~l~~l 66 (292)
T cd06644 8 LDPNEVWEIIGELGDGAFGKVYKAKNKE--TGALAAAKVIETKSEEE-------------------LEDYMVEIEILATC 66 (292)
T ss_pred cCcchhhhhhheecCCCCeEEEEEEECC--CCceEEEEEeccCCHHH-------------------HHHHHHHHHHHHhC
Confidence 4456889999999999999999998875 88999999986542211 15677899999999
Q ss_pred CCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 040898 117 RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPAN 196 (337)
Q Consensus 117 ~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~n 196 (337)
+||||+++++.+..++..++||||+++++|..++.. ....+++..+..++.|++.++.+| |+.|++|+||+|+|
T Consensus 67 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~l---H~~~i~H~dlkp~N 140 (292)
T cd06644 67 NHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLE---LDRGLTEPQIQVICRQMLEALQYL---HSMKIIHRDLKAGN 140 (292)
T ss_pred CCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHH---hcCCeeecCCCcce
Confidence 999999999999999999999999999999887743 234588999999999999999999 77899999999999
Q ss_pred eeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccc-----cCCCCCcccchhhhHHHHHHHhCCCCCCCC
Q 040898 197 VLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQ-----TETISDKCDIYSFGVLLAVLVMGKFPVDDF 271 (337)
Q Consensus 197 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~-----~~~~~~~~DiwslG~i~~~ll~g~~pf~~~ 271 (337)
|+++.++.++|+|||.+......... .....+++.|+|||.+. ...++.++|+||||+++|+|++|..||...
T Consensus 141 ili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 218 (292)
T cd06644 141 VLLTLDGDIKLADFGVSAKNVKTLQR--RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 218 (292)
T ss_pred EEEcCCCCEEEccCccceeccccccc--cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccc
Confidence 99999999999999987654322111 12345788999999984 344677899999999999999999998653
Q ss_pred CCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 272 FGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
... ... ........+.. .........+.+++.+||+.||++||++.++++|
T Consensus 219 ~~~---~~~----~~~~~~~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 219 NPM---RVL----LKIAKSEPPTL--------SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred cHH---HHH----HHHhcCCCccC--------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 221 111 11111111100 0011223348899999999999999999999986
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=288.85 Aligned_cols=265 Identities=22% Similarity=0.286 Sum_probs=205.1
Q ss_pred ccccccccccccccceeccCcceEEEEeEEec---CCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHH
Q 040898 33 DLAFLKKEDCFDSLKKIGSGGWGEVFYKAELP---GSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSE 109 (337)
Q Consensus 33 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e 109 (337)
++++.-..++|.+.+.||+|+||.||++.+.. ..++..+|+|.+........ .+.+.+|
T Consensus 27 ~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~------------------~~~~~~E 88 (302)
T cd05055 27 DLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSE------------------REALMSE 88 (302)
T ss_pred cccccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHH------------------HHHHHHH
Confidence 55555677889999999999999999987642 23566899998765432111 1467889
Q ss_pred HHHHHhc-CCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeE
Q 040898 110 IITANQT-RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLI 188 (337)
Q Consensus 110 ~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~ 188 (337)
+.+++++ +||||+++++.+...+..++++||+++++|.+++.. .....+++..+..++.|++.++.|+ |++|++
T Consensus 89 ~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~--~~~~~l~~~~~~~i~~~i~~~l~~l---H~~~iv 163 (302)
T cd05055 89 LKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRR--KRESFLTLEDLLSFSYQVAKGMAFL---ASKNCI 163 (302)
T ss_pred HHHHHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHH---HHCCee
Confidence 9999999 799999999999999999999999999999999854 2233489999999999999999999 677999
Q ss_pred ecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCC
Q 040898 189 HRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFP 267 (337)
Q Consensus 189 h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~p 267 (337)
|+||+|+||+++.++.++++|||.+................++..|+|||.+.+..++.++|+||+|+++|+|++ |..|
T Consensus 164 H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p 243 (302)
T cd05055 164 HRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNP 243 (302)
T ss_pred hhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999876544322222223345778999999988889999999999999999998 9999
Q ss_pred CCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 268 VDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 268 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
|...... ..+........... .+......+.+++.+||+.+|++|||+.++++
T Consensus 244 ~~~~~~~---~~~~~~~~~~~~~~-------------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 244 YPGMPVD---SKFYKLIKEGYRMA-------------QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred cCCCCch---HHHHHHHHcCCcCC-------------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 8654321 11111111110000 01112345899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=302.27 Aligned_cols=265 Identities=21% Similarity=0.249 Sum_probs=198.2
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
....|.+.+.||+|+||.||++.+.. +++.||+|.... ..+.+|+.++++++|
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~--~~~~vavK~~~~-------------------------~~~~~E~~iL~~L~H 219 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPD--YPQRVVVKAGWY-------------------------ASSVHEARLLRRLSH 219 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECC--CCCEEEEecccc-------------------------cCHHHHHHHHHHCCC
Confidence 35579999999999999999998876 889999995321 235579999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++++..+...++++|++. ++|.+++.. ....+++..+..++.|++.||.|| |+.|++|+||||+||+
T Consensus 220 pnIv~l~~~~~~~~~~~lv~e~~~-~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yL---H~~gIvHrDLKP~NIL 292 (461)
T PHA03211 220 PAVLALLDVRVVGGLTCLVLPKYR-SDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYI---HGEGIIHRDIKTENVL 292 (461)
T ss_pred CCCCcEEEEEEECCEEEEEEEccC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH---HHCCEEECcCCHHHEE
Confidence 999999999999999999999995 588887743 234689999999999999999999 7789999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCC----
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGH---- 274 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~---- 274 (337)
++.++.++|+|||++................||+.|+|||++.+..++.++|||||||++|+|++|..|+-.....
T Consensus 293 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~ 372 (461)
T PHA03211 293 VNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERR 372 (461)
T ss_pred ECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccC
Confidence 9999999999999987654332222222346899999999999989999999999999999999987654221111
Q ss_pred chhhhHHHHHHhhhccC--Ccch----hh-----------hhcccCCc---hHHHHHHHHHHHhhhccCCCCCCCChhhh
Q 040898 275 TEEMDMVKWMRNVIFSE--NPNR----AI-----------NSKLLGNG---YEEQMLLVLKLACFCTLKDPDERPSSKDV 334 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~--~~~~----~~-----------~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~el 334 (337)
.....+...+....... .+.. .. ........ .......+.+|+++||+.||++|||+.|+
T Consensus 373 ~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~el 452 (461)
T PHA03211 373 PYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAEL 452 (461)
T ss_pred CcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHH
Confidence 11112222222211110 0000 00 00000000 11223468899999999999999999999
Q ss_pred hcC
Q 040898 335 RSM 337 (337)
Q Consensus 335 l~~ 337 (337)
|+|
T Consensus 453 L~h 455 (461)
T PHA03211 453 LRL 455 (461)
T ss_pred hhC
Confidence 987
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=293.54 Aligned_cols=256 Identities=23% Similarity=0.333 Sum_probs=196.3
Q ss_pred ccccccccceeccCcceEEEEeEEecCC--CCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGS--NGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT 116 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 116 (337)
...+|++.+.||+|+||.||++.+.... ....||+|.+......... ..+.+|+.+++.+
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~------------------~~~~~e~~~l~~l 66 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN------------------KEILDEAYVMASV 66 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHH------------------HHHHHHHHHHHhC
Confidence 3456999999999999999999876411 2234899988643321111 4677899999999
Q ss_pred CCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 040898 117 RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPAN 196 (337)
Q Consensus 117 ~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~n 196 (337)
+||||+++++++..+ ..+++++|+++|+|.+++.. ....+++..++.++.|++.||.|| |+.|++|+||+|+|
T Consensus 67 ~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~L---H~~~iiH~dlkp~N 139 (316)
T cd05108 67 DNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYL---EERRLVHRDLAARN 139 (316)
T ss_pred CCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHH---HhcCeeccccchhh
Confidence 999999999988765 56799999999999999854 234578889999999999999999 77899999999999
Q ss_pred eeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCc
Q 040898 197 VLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHT 275 (337)
Q Consensus 197 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~ 275 (337)
|+++.++.++|+|||++.................+..|++||.+.+..++.++|+||||+++|++++ |..||+....
T Consensus 140 ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~-- 217 (316)
T cd05108 140 VLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-- 217 (316)
T ss_pred eEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--
Confidence 9999999999999999987654433222222334678999999998889999999999999999998 9999865321
Q ss_pred hhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 276 EEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
..+........... .++.....+.+++.+||+.||.+|||+.+++.
T Consensus 218 --~~~~~~~~~~~~~~-------------~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~ 263 (316)
T cd05108 218 --SEISSILEKGERLP-------------QPPICTIDVYMIMVKCWMIDADSRPKFRELII 263 (316)
T ss_pred --HHHHHHHhCCCCCC-------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 11222111110000 01112234889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=290.12 Aligned_cols=258 Identities=24% Similarity=0.385 Sum_probs=205.1
Q ss_pred cccccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHH
Q 040898 34 LAFLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITA 113 (337)
Q Consensus 34 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l 113 (337)
+...+..++|++.+.||+|++|.||++.+.. +++.||+|.+........ +.+.+|+.++
T Consensus 12 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~--~~~~vaiK~~~~~~~~~~-------------------~~~~~e~~~l 70 (297)
T cd06656 12 VSVGDPKKKYTRFEKIGQGASGTVYTAIDIA--TGQEVAIKQMNLQQQPKK-------------------ELIINEILVM 70 (297)
T ss_pred cccCChhhhceeeeeeccCCCeEEEEEEECC--CCCEEEEEEEecCccchH-------------------HHHHHHHHHH
Confidence 4456678999999999999999999998865 899999998865432211 4567799999
Q ss_pred HhcCCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCC
Q 040898 114 NQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIK 193 (337)
Q Consensus 114 ~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~ 193 (337)
+.++||||+++++.+..+...++|+||+++++|.+++.. ..+++..+..++.|++.++.+| |+.|++|+||+
T Consensus 71 ~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~L---H~~~i~H~dL~ 142 (297)
T cd06656 71 RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFL---HSNQVIHRDIK 142 (297)
T ss_pred HhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCC
Confidence 999999999999999999999999999999999999843 3478889999999999999999 77799999999
Q ss_pred CCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCC
Q 040898 194 PANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFG 273 (337)
Q Consensus 194 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~ 273 (337)
|+||+++.++.++|+|||.+......... .....+++.|+|||.+.+..++.++|+||+|+++|++++|..||.....
T Consensus 143 p~Nili~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~ 220 (297)
T cd06656 143 SDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220 (297)
T ss_pred HHHEEECCCCCEEECcCccceEccCCccC--cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence 99999999999999999988765432211 1234578889999999888889999999999999999999999854322
Q ss_pred CchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 274 HTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
... .. .......+. ...+......+.+++.+||+.||++|||+.++++|
T Consensus 221 ~~~---~~----~~~~~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 221 LRA---LY----LIATNGTPE--------LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred chh---ee----eeccCCCCC--------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 110 00 000000000 00112233458899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=289.59 Aligned_cols=270 Identities=22% Similarity=0.284 Sum_probs=197.5
Q ss_pred cccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCc
Q 040898 42 CFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNI 121 (337)
Q Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpni 121 (337)
+|++.+.||+|++|.||++.+.. ++..||+|.+......... ...+.+|+.++++++|||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~-----------------~~~~~~e~~~l~~l~h~~i 61 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKK--TGQIVAMKKIRLESEEEGV-----------------PSTAIREISLLKELQHPNI 61 (285)
T ss_pred CceEeeEecccCceEEEEEEECC--CCcEEEEEEeccccccCCc-----------------hHHHHHHHHHHHhcCCCCE
Confidence 58899999999999999998865 8999999988654321110 1456779999999999999
Q ss_pred ccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecC
Q 040898 122 LPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDD 201 (337)
Q Consensus 122 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~ 201 (337)
+++++++.++...++|+||++ ++|.+++.... .+..+++..++.++.|++.||.|| |+.|++|+||+|+||+++.
T Consensus 62 ~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~l---H~~~i~H~dl~p~nil~~~ 136 (285)
T cd07861 62 VCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFC---HSRRVLHRDLKPQNLLIDN 136 (285)
T ss_pred eeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHH---HhCCeeecCCCHHHEEEcC
Confidence 999999999999999999997 58888875422 235688999999999999999999 7789999999999999999
Q ss_pred CCCeEEecccCccccCCCCceeeeecccCCCCccCccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhH
Q 040898 202 DMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTE-TISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDM 280 (337)
Q Consensus 202 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~ 280 (337)
++.++|+|||++........ ......+++.|+|||.+.+. .++.++|+||||+++|+|++|.+||............
T Consensus 137 ~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~ 214 (285)
T cd07861 137 KGVIKLADFGLARAFGIPVR--VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRI 214 (285)
T ss_pred CCcEEECcccceeecCCCcc--cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 99999999999875433211 11233568889999988654 4688999999999999999999998653221111111
Q ss_pred HHHHHhhhcc---CCc-chhhh-------hcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 281 VKWMRNVIFS---ENP-NRAIN-------SKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 281 ~~~~~~~~~~---~~~-~~~~~-------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.......... ... ..... ..............+.+++.+||+.||++|||+.++++|
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 215 FRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 1100000000 000 00000 000000011234457899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=295.15 Aligned_cols=262 Identities=21% Similarity=0.340 Sum_probs=199.3
Q ss_pred ccccccccceeccCcceEEEEeEEec---CCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHh
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELP---GSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQ 115 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~ 115 (337)
..++|++.+.||+|+||.||++.+.. ..+++.||+|++........ ...+.+|+.++.+
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~------------------~~~~~~E~~~~~~ 66 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASE------------------YKALMTELKILIH 66 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHH------------------HHHHHHHHHHHHh
Confidence 45689999999999999999986543 23568899998864432111 1456779999999
Q ss_pred c-CCCCcccceeEEEc-CCeeEEEEEeccCCCHHHHHHHhcCC-------------------------------------
Q 040898 116 T-RHRNILPLLAHMVR-PNCHLLVYEFMKNGSLQDILYDVSQG------------------------------------- 156 (337)
Q Consensus 116 l-~hpniv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~------------------------------------- 156 (337)
+ .||||+++++++.. +..+++++||+++++|.+++......
T Consensus 67 l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (337)
T cd05054 67 IGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSG 146 (337)
T ss_pred hccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccc
Confidence 9 89999999998764 45688999999999999998542210
Q ss_pred --------------------cccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCCeEEecccCcccc
Q 040898 157 --------------------RRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLM 216 (337)
Q Consensus 157 --------------------~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~~l~dfg~~~~~ 216 (337)
..++++..+..++.|++.||.|| |+.|++|+||+|+||+++.++.++|+|||++...
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~l---H~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~ 223 (337)
T cd05054 147 FIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDI 223 (337)
T ss_pred cccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCcceEEEeCCCcEEEeccccchhc
Confidence 23678899999999999999999 6779999999999999999999999999998875
Q ss_pred CCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCchhhhHHHHHHhhhccCCcch
Q 040898 217 PDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHTEEMDMVKWMRNVIFSENPNR 295 (337)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (337)
.............++..|+|||.+.+..++.++|+|||||++|+|++ |..||....... .+...+.......
T Consensus 224 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~---~~~~~~~~~~~~~---- 296 (337)
T cd05054 224 YKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE---EFCRRLKEGTRMR---- 296 (337)
T ss_pred ccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH---HHHHHHhccCCCC----
Confidence 43332222223345678999999999999999999999999999998 999986532221 1111111111000
Q ss_pred hhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 296 AINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 296 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.+......+.+++.+||+.+|++|||+.++++|
T Consensus 297 ---------~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 297 ---------APEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred ---------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 011223458899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=285.22 Aligned_cols=252 Identities=25% Similarity=0.404 Sum_probs=198.2
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++.++||+|++|.||++.+. ++..|++|.+...... .+.+.+|+.+++.++|
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~---~~~~v~iK~~~~~~~~--------------------~~~~~~e~~~l~~l~h 60 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYN---NSTKVAVKTLKPGTMS--------------------VQAFLEEANLMKTLQH 60 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEec---CCceEEEEEccCCchh--------------------HHHHHHHHHHHHhCCC
Confidence 4567999999999999999998764 5678999987543211 1467789999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++.+......++++||+++++|.+++.. .....+++..+..++.|++.|+.|| |+.+++|+||+|+||+
T Consensus 61 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~l~~~l~~L---H~~~i~H~dl~p~nil 135 (261)
T cd05072 61 DKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKS--DEGGKVLLPKLIDFSAQIAEGMAYI---ERKNYIHRDLRAANVL 135 (261)
T ss_pred CCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccccchhhEE
Confidence 9999999999999999999999999999999865 2344578888999999999999999 6779999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCchh
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHTEE 277 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~ 277 (337)
++.++.++|+|||.+......... ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||.....
T Consensus 136 i~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~---- 210 (261)
T cd05072 136 VSESLMCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN---- 210 (261)
T ss_pred ecCCCcEEECCCccceecCCCcee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH----
Confidence 999999999999999876443221 1122345677999999988888999999999999999998 9999864321
Q ss_pred hhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 278 MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
......+.... .. +.....+..+.+++.+||+.+|++|||++++++
T Consensus 211 ~~~~~~~~~~~---~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 211 SDVMSALQRGY---RM----------PRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHHHHHHcCC---CC----------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 11111111110 00 001122345889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=280.12 Aligned_cols=258 Identities=22% Similarity=0.355 Sum_probs=205.5
Q ss_pred cccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCc
Q 040898 42 CFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNI 121 (337)
Q Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpni 121 (337)
+|++.+.||.|++|.||++.+.. ++..+++|.+......... .+.+..|+.+++.++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~--~~~~~~~k~~~~~~~~~~~-----------------~~~~~~e~~~l~~l~~~~i 61 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKS--DGKILVWKEIDYGNMTEKE-----------------KQQLVSEVNILRELKHPNI 61 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecC--CCCEEEEEEEecccCCHHH-----------------HHHHHHHHHHHHhcCCCcc
Confidence 58999999999999999998876 8899999988654332211 1467789999999999999
Q ss_pred ccceeEEEc--CCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCC--CCCeEecCCCCCce
Q 040898 122 LPLLAHMVR--PNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCH--RPRLIHRDIKPANV 197 (337)
Q Consensus 122 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h--~~gi~h~di~~~ni 197 (337)
+++++.+.. +...++++||+++++|.+++.........+++..++.++.|++.++.++|..+ +.+++|+||+|+||
T Consensus 62 ~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~ni 141 (265)
T cd08217 62 VRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANI 141 (265)
T ss_pred ceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHE
Confidence 999997754 45689999999999999999775555677899999999999999999994221 88999999999999
Q ss_pred eecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchh
Q 040898 198 LIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEE 277 (337)
Q Consensus 198 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~ 277 (337)
+++.++.++|+|||.+......... .....+++.|+|||.+.+..++.++|+||||+++++|++|..||.... .
T Consensus 142 li~~~~~~kl~d~g~~~~~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~ 215 (265)
T cd08217 142 FLDANNNVKLGDFGLAKILGHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN----Q 215 (265)
T ss_pred EEecCCCEEEecccccccccCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC----H
Confidence 9999999999999998876544321 123468899999999988888999999999999999999999986532 1
Q ss_pred hhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 278 MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
..+...+...... ..+......+.+++.+||+.+|++|||+.+|++|
T Consensus 216 ~~~~~~~~~~~~~-------------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 216 LQLASKIKEGKFR-------------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred HHHHHHHhcCCCC-------------CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 2222222111110 1112334558999999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=295.32 Aligned_cols=262 Identities=21% Similarity=0.273 Sum_probs=192.8
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
...+|++++.||+|+||.||++.+.. ++..||+|.... .....|+.++++++|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~--~~~~valK~~~~-------------------------~~~~~E~~~l~~l~h 116 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPG--QPDPVVLKIGQK-------------------------GTTLIEAMLLQNVNH 116 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECC--CCceEEEEeCCc-------------------------cccHHHHHHHHhCCC
Confidence 44579999999999999999998865 788999997432 123458899999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++++......++|+|++.+ +|.+++.. ....+++..+..++.||+.||.|| |+.|++|+||||+||+
T Consensus 117 ~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlkp~Nil 189 (357)
T PHA03209 117 PSVIRMKDTLVSGAITCMVLPHYSS-DLYTYLTK---RSRPLPIDQALIIEKQILEGLRYL---HAQRIIHRDVKTENIF 189 (357)
T ss_pred CCCcChhheEEeCCeeEEEEEccCC-cHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEE
Confidence 9999999999999999999999964 78887743 345689999999999999999999 7779999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCC-CCCCCCCch-
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFP-VDDFFGHTE- 276 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~p-f~~~~~~~~- 276 (337)
++.++.++|+|||.+........ .....+++.|+|||.+.+..++.++|+||||+++|+|+++..| |+.......
T Consensus 190 l~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~ 266 (357)
T PHA03209 190 INDVDQVCIGDLGAAQFPVVAPA---FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEE 266 (357)
T ss_pred ECCCCCEEEecCccccccccCcc---cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHH
Confidence 99999999999999875332211 1234689999999999988899999999999999999996544 433211100
Q ss_pred -----hhhHHHHHHhhhccCC-----cch-hhhhcc---------cCC--c--hHHHHHHHHHHHhhhccCCCCCCCChh
Q 040898 277 -----EMDMVKWMRNVIFSEN-----PNR-AINSKL---------LGN--G--YEEQMLLVLKLACFCTLKDPDERPSSK 332 (337)
Q Consensus 277 -----~~~~~~~~~~~~~~~~-----~~~-~~~~~~---------~~~--~--~~~~~~~l~~li~~~l~~dP~~Rps~~ 332 (337)
...+...+........ +.. ...... ... . .......+.+|+.+||+.||++|||+.
T Consensus 267 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~ 346 (357)
T PHA03209 267 YVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAE 346 (357)
T ss_pred HHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHH
Confidence 0111111111100000 000 000000 000 0 001223467799999999999999999
Q ss_pred hhhcC
Q 040898 333 DVRSM 337 (337)
Q Consensus 333 ell~~ 337 (337)
|+|+|
T Consensus 347 e~l~h 351 (357)
T PHA03209 347 EILNY 351 (357)
T ss_pred HHhcC
Confidence 99987
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=281.49 Aligned_cols=253 Identities=22% Similarity=0.302 Sum_probs=199.8
Q ss_pred cccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCc
Q 040898 42 CFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNI 121 (337)
Q Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpni 121 (337)
+|++.+.||.|++|.||.+.+.. +++.+++|++......... .+.+.+|+.+++.++|||+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~--~~~~~~~k~~~~~~~~~~~-----------------~~~~~~e~~~l~~l~~~~i 61 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRT--DGKQYVIKKLNLRNASRRE-----------------RKAAEQEAQLLSQLKHPNI 61 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcC--CCcEEEEEEEehhhcCHHH-----------------HHHHHHHHHHHHhCCCCCe
Confidence 48999999999999999999865 7889999998644322111 1467789999999999999
Q ss_pred ccceeEEEc-CCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 122 LPLLAHMVR-PNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 122 v~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
+++.+.+.. +...++++||+++++|.+++.. .....+++..++.++.+++.++.++ |+.|++|+||+|+||+++
T Consensus 62 ~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~--~~~~~l~~~~~~~~~~~l~~~l~~l---H~~~i~H~di~p~nil~~ 136 (257)
T cd08223 62 VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKE--QKGKLLPENQVVEWFVQIAMALQYL---HEKHILHRDLKTQNVFLT 136 (257)
T ss_pred eeeeeeecCCCCEEEEEecccCCCcHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCchhEEEe
Confidence 999988764 4467999999999999999865 2345689999999999999999999 778999999999999999
Q ss_pred CCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhH
Q 040898 201 DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDM 280 (337)
Q Consensus 201 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~ 280 (337)
.++.++|+|||++........ ......+++.|+|||.+.+..++.++|+||+|++++++++|..||..... ...
T Consensus 137 ~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~----~~~ 210 (257)
T cd08223 137 RTNIIKVGDLGIARVLENQCD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM----NSL 210 (257)
T ss_pred cCCcEEEecccceEEecccCC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH----HHH
Confidence 999999999999876543221 11234578899999999988889999999999999999999999864211 111
Q ss_pred HHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 281 VKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.........+ .........+.+++.+||+.||++|||+.++++|
T Consensus 211 ---~~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 211 ---VYRIIEGKLP----------PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ---HHHHHhcCCC----------CCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1111111110 1112334558999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=291.56 Aligned_cols=253 Identities=22% Similarity=0.305 Sum_probs=210.5
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
.-+=|...+.||+|.|+.|-+++++- +|..||||++.+........ ..+..|++.|+..+|
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVF--TGekVAVKviDKTKlD~~st-----------------~hlfqEVRCMKLVQH 76 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVF--TGEKVAVKVIDKTKLDTLST-----------------GHLFQEVRCMKLVQH 76 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhc--ccceeEEEEecccccchhhh-----------------hHHHHHHHHHHHhcC
Confidence 44569999999999999998888876 99999999998765433221 578889999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
||||++|++..++..+|+|+|.-++|+|.++|.+ ....+.+....+++.||+.|+.|+|+. -+||+||||+|++
T Consensus 77 pNiVRLYEViDTQTKlyLiLELGD~GDl~DyImK---He~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVV 150 (864)
T KOG4717|consen 77 PNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMK---HEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVV 150 (864)
T ss_pred cCeeeeeehhcccceEEEEEEecCCchHHHHHHh---hhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeE
Confidence 9999999999999999999999999999999965 445699999999999999999999554 5999999999987
Q ss_pred ec-CCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCC-CcccchhhhHHHHHHHhCCCCCCCCCCCch
Q 040898 199 ID-DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETIS-DKCDIYSFGVLLAVLVMGKFPVDDFFGHTE 276 (337)
Q Consensus 199 ~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~-~~~DiwslG~i~~~ll~g~~pf~~~~~~~~ 276 (337)
+. +-|-|||.|||++..+..+... +..+|+..|-|||++.|..|+ +++||||||+|+|.|++|++||++......
T Consensus 151 FFEKlGlVKLTDFGFSNkf~PG~kL---~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET 227 (864)
T KOG4717|consen 151 FFEKLGLVKLTDFGFSNKFQPGKKL---TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET 227 (864)
T ss_pred EeeecCceEeeeccccccCCCcchh---hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh
Confidence 75 5789999999999887655433 446899999999999999886 678999999999999999999987544322
Q ss_pred hhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 277 EMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
..-+ -. .....+.....++.+||.+||..||.+|.|.++|..+
T Consensus 228 LTmI----mD--------------CKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 228 LTMI----MD--------------CKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred hhhh----hc--------------ccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 1111 11 1123445677779999999999999999999998753
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=289.64 Aligned_cols=258 Identities=22% Similarity=0.332 Sum_probs=199.9
Q ss_pred ccccccceeccCcceEEEEeEEecC---CCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPG---SNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR 117 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 117 (337)
.+|++.+.||.|+||.||++.+... ..+..||+|++........ .+.+.+|+.++..++
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~------------------~~~~~~e~~~~~~l~ 66 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPL------------------REEFKHEAMMRSRLQ 66 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHH------------------HHHHHHHHHHHhcCC
Confidence 4589999999999999999987542 2467899999875432111 146778999999999
Q ss_pred CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhc------------CCcccCChHHHHHHHHHHHHHHHHHhhCCCC
Q 040898 118 HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVS------------QGRRELDWPARHRIARGIASGLEYLHMCHRP 185 (337)
Q Consensus 118 hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~ 185 (337)
||||+++++++......++++||+++++|.+++.... .....+++..+..++.|++.||.|+ |+.
T Consensus 67 h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~l---H~~ 143 (283)
T cd05091 67 HPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFL---SSH 143 (283)
T ss_pred CCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHH---HHc
Confidence 9999999999999999999999999999999985321 1123578888999999999999999 777
Q ss_pred CeEecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-C
Q 040898 186 RLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-G 264 (337)
Q Consensus 186 gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g 264 (337)
|++|+||||+||++++++.++|+|||++................+++.|+|||.+.+..++.++|+||||+++|+|++ |
T Consensus 144 gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g 223 (283)
T cd05091 144 HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYG 223 (283)
T ss_pred CccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCC
Confidence 999999999999999999999999999876544332222233456778999999988889999999999999999998 8
Q ss_pred CCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 265 KFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 265 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
..||..... ......+.. .... ......+..+.+++.+||+.+|++|||+.+|++
T Consensus 224 ~~p~~~~~~----~~~~~~i~~---~~~~----------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~ 278 (283)
T cd05091 224 LQPYCGYSN----QDVIEMIRN---RQVL----------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHS 278 (283)
T ss_pred CCCCCCCCH----HHHHHHHHc---CCcC----------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 888865322 122222211 1110 011223445889999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=285.07 Aligned_cols=253 Identities=25% Similarity=0.384 Sum_probs=200.6
Q ss_pred cccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC
Q 040898 38 KKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR 117 (337)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 117 (337)
.+..+|++.+.||.|++|.||++.+. .+..+++|.+........ ..+.+|+.+++.++
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~---~~~~~~~k~~~~~~~~~~-------------------~~~~~e~~~l~~l~ 60 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWK---NRVRVAIKILKSDDLLKQ-------------------QDFQKEVQALKRLR 60 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEec---CCCcEEEEeccccchhhH-------------------HHHHHHHHHHhcCC
Confidence 35567999999999999999998886 478899998865432111 45677999999999
Q ss_pred CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCce
Q 040898 118 HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANV 197 (337)
Q Consensus 118 hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ni 197 (337)
||||+++++++.+....++++||+++++|.+++.. ..+..+++..+..++.|++.|+.|| |+.|++|+||+|+||
T Consensus 61 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~i~~al~~l---H~~~i~h~dl~~~ni 135 (261)
T cd05148 61 HKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRS--PEGQVLPVASLIDMACQVAEGMAYL---EEQNSIHRDLAARNI 135 (261)
T ss_pred CcchhheeeeEecCCCeEEEEeecccCCHHHHHhc--CCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccccCcceE
Confidence 99999999999999999999999999999999965 2345688899999999999999999 677999999999999
Q ss_pred eecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCch
Q 040898 198 LIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHTE 276 (337)
Q Consensus 198 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~ 276 (337)
++++++.++|+|||.+.......... ....++..|+|||.+.+..++.++|+||||+++|+|++ |..||.....
T Consensus 136 lv~~~~~~kl~d~g~~~~~~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~--- 210 (261)
T cd05148 136 LVGEDLVCKVADFGLARLIKEDVYLS--SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN--- 210 (261)
T ss_pred EEcCCceEEEccccchhhcCCccccc--cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH---
Confidence 99999999999999987654332111 12345678999999988889999999999999999998 8999865321
Q ss_pred hhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 277 EMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
......... .... ..+...+..+.+++.+||+.||.+|||+.++++
T Consensus 211 -~~~~~~~~~---~~~~----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 211 -HEVYDQITA---GYRM----------PCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred -HHHHHHHHh---CCcC----------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 111111111 1000 011222345889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=281.86 Aligned_cols=256 Identities=28% Similarity=0.450 Sum_probs=203.2
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
.++|++.+.||.|++|.||++.+.. ++..+++|.+....... ...+.+|+.++++++||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~-------------------~~~~~~e~~~l~~~~h~ 60 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIA--TGELVAIKVIKLEPGDD-------------------FEIIQQEISMLKECRHP 60 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecC--CCCEEEEEEEEcCchhh-------------------HHHHHHHHHHHHhCCCC
Confidence 4679999999999999999998865 78899999986543221 15677899999999999
Q ss_pred CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceee
Q 040898 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI 199 (337)
Q Consensus 120 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~ 199 (337)
||+++++.+......+++|||+++++|.+++.. ....+++..+..++.|++.++.+| |+.|++|+||+|+||++
T Consensus 61 ~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~l---h~~~i~h~dl~p~ni~i 134 (262)
T cd06613 61 NIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQV---TRGPLSELQIAYVCRETLKGLAYL---HETGKIHRDIKGANILL 134 (262)
T ss_pred ChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHH---HhCCceecCCChhhEEE
Confidence 999999999999999999999999999998854 225688999999999999999999 77899999999999999
Q ss_pred cCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccC---CCCCcccchhhhHHHHHHHhCCCCCCCCCCCch
Q 040898 200 DDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTE---TISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTE 276 (337)
Q Consensus 200 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~---~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~ 276 (337)
+.++.++|+|||.+........ ......++..|+|||.+.+. .++.++|+||+|+++|+|++|..||......
T Consensus 135 ~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~-- 210 (262)
T cd06613 135 TEDGDVKLADFGVSAQLTATIA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM-- 210 (262)
T ss_pred CCCCCEEECccccchhhhhhhh--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH--
Confidence 9999999999999876543221 11234578889999999776 7888999999999999999999998653221
Q ss_pred hhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 277 EMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
........ ...... ........+..+.+++.+||..+|.+|||+.+++.|
T Consensus 211 -~~~~~~~~----~~~~~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 211 -RALFLISK----SNFPPP------KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred -HHHHHHHh----ccCCCc------cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 11111111 100000 001123344568999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=287.24 Aligned_cols=266 Identities=23% Similarity=0.322 Sum_probs=197.1
Q ss_pred cccccccceeccCcceEEEEeEEec--------------CCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHh
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELP--------------GSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGA 105 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~--------------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 105 (337)
.++|++.+.||+|+||.||++.+.. ..++..+|+|.+......... ..
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~------------------~~ 65 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNAR------------------ND 65 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHH------------------HH
Confidence 4679999999999999999875431 224457899988654321111 46
Q ss_pred HHHHHHHHHhcCCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCC-------cccCChHHHHHHHHHHHHHHHH
Q 040898 106 IRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQG-------RRELDWPARHRIARGIASGLEY 178 (337)
Q Consensus 106 ~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~~i~~~i~~~l~~ 178 (337)
+.+|+.+++.++||||+++++++..+...++++||+++++|.+++...... ...+++..+..++.|++.|+.+
T Consensus 66 ~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~ 145 (296)
T cd05095 66 FLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKY 145 (296)
T ss_pred HHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHH
Confidence 778999999999999999999999999999999999999999998653221 1236677899999999999999
Q ss_pred HhhCCCCCeEecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHH
Q 040898 179 LHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258 (337)
Q Consensus 179 l~~~h~~gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~ 258 (337)
+ |+.|++|+||+|+||+++.++.++|+|||++.................++.|++||...+..++.++|+||||+++
T Consensus 146 l---H~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l 222 (296)
T cd05095 146 L---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTL 222 (296)
T ss_pred H---HHCCeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHH
Confidence 9 6779999999999999999999999999998765433222111223346789999998888899999999999999
Q ss_pred HHHHh--CCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 259 AVLVM--GKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 259 ~~ll~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
|+|++ |..||................... ..... ...+...+..+.+++.+||+.||++|||+.++++
T Consensus 223 ~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~----~~~~~------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 223 WEILTLCKEQPYSQLSDEQVIENTGEFFRDQ----GRQVY------LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHhCCCCCccccChHHHHHHHHHHHhhc----ccccc------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 99998 678886432221111111111100 00000 0001122345889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=287.93 Aligned_cols=263 Identities=24% Similarity=0.331 Sum_probs=202.3
Q ss_pred cccccccccccceeccCcceEEEEeEEecC---CCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHH
Q 040898 36 FLKKEDCFDSLKKIGSGGWGEVFYKAELPG---SNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIIT 112 (337)
Q Consensus 36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 112 (337)
+.-..++|++.+.||+|++|.||++.+... .....+|+|.+........ ...+.+|+.+
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~------------------~~~~~~E~~~ 68 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKD------------------LSDLVSEMEM 68 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHH------------------HHHHHHHHHH
Confidence 334566799999999999999999887642 2447899998865432111 1457789999
Q ss_pred HHhc-CCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhc------------CCcccCChHHHHHHHHHHHHHHHHH
Q 040898 113 ANQT-RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVS------------QGRRELDWPARHRIARGIASGLEYL 179 (337)
Q Consensus 113 l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~~~i~~~i~~~l~~l 179 (337)
+..+ +||||+++++++..+...+++|||+++++|.+++.... .....+++..+..++.|++.||.||
T Consensus 69 l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~L 148 (293)
T cd05053 69 MKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFL 148 (293)
T ss_pred HHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHH
Confidence 9999 89999999999999999999999999999999986532 2345688899999999999999999
Q ss_pred hhCCCCCeEecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHH
Q 040898 180 HMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLA 259 (337)
Q Consensus 180 ~~~h~~gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~ 259 (337)
|+.|++|+||+|+||+++.++.++|+|||.+................++..|+|||.+.+..++.++|+||+|+++|
T Consensus 149 ---H~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 225 (293)
T cd05053 149 ---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLW 225 (293)
T ss_pred ---HHCCccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHH
Confidence 67799999999999999999999999999988765433222222233566799999998888999999999999999
Q ss_pred HHHh-CCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 260 VLVM-GKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 260 ~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
++++ |..||..... ......... ..... .+......+.+|+.+||..||++|||+.++++
T Consensus 226 el~~~g~~p~~~~~~----~~~~~~~~~---~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~ 286 (293)
T cd05053 226 EIFTLGGSPYPGIPV----EELFKLLKE---GYRME----------KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVE 286 (293)
T ss_pred HHhcCCCCCCCCCCH----HHHHHHHHc---CCcCC----------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 9998 8899864321 111111111 11100 01122344889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=283.01 Aligned_cols=258 Identities=24% Similarity=0.389 Sum_probs=202.5
Q ss_pred cccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc-
Q 040898 38 KKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT- 116 (337)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l- 116 (337)
+++++|++.+.||+|++|.||++.+.. +++.+++|.+...... .+.+.+|+.+++++
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~--~~~~~~~k~~~~~~~~--------------------~~~~~~e~~~l~~~~ 60 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKK--TGQLVAIKIMDIIEDE--------------------EEEIKEEYNILRKYS 60 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECC--CCcEEEEEEEecCchh--------------------HHHHHHHHHHHHHhc
Confidence 467899999999999999999998865 7889999988644321 14677899999998
Q ss_pred CCCCcccceeEEEcCC------eeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 040898 117 RHRNILPLLAHMVRPN------CHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHR 190 (337)
Q Consensus 117 ~hpniv~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~ 190 (337)
.||||+++++.+.... ..++|+||+++++|.+++......+..+++..+..++.|++.||.|| |+.|++|+
T Consensus 61 ~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~l---H~~~i~H~ 137 (275)
T cd06608 61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYL---HENKVIHR 137 (275)
T ss_pred CCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHH---hcCCcccC
Confidence 7999999999986544 48999999999999999876554466789999999999999999999 78899999
Q ss_pred CCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccC-----CCCCcccchhhhHHHHHHHhCC
Q 040898 191 DIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTE-----TISDKCDIYSFGVLLAVLVMGK 265 (337)
Q Consensus 191 di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-----~~~~~~DiwslG~i~~~ll~g~ 265 (337)
||+|+||+++.++.++|+|||.+......... .....++..|+|||.+... .++.++|+||||+++|+|++|.
T Consensus 138 ~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~ 215 (275)
T cd06608 138 DIKGQNILLTKNAEVKLVDFGVSAQLDSTLGR--RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215 (275)
T ss_pred CCCHHHEEEccCCeEEECCCccceecccchhh--hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCC
Confidence 99999999999999999999988765432211 1234578899999987542 3677899999999999999999
Q ss_pred CCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 266 FPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 266 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.||...... ..... ......+. ..........+.+++.+||+.||++|||+.++++|
T Consensus 216 ~p~~~~~~~---~~~~~----~~~~~~~~--------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 216 PPLCDMHPM---RALFK----IPRNPPPT--------LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred CCccccchH---HHHHH----hhccCCCC--------CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 998643221 11111 11111110 01112234568899999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=285.43 Aligned_cols=255 Identities=25% Similarity=0.407 Sum_probs=197.5
Q ss_pred cccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc-
Q 040898 38 KKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT- 116 (337)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l- 116 (337)
++.+.|++.+.||+|+||.||++.+.. +++.||+|.+....... ..+..|+.++..+
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~--~~~~~aik~~~~~~~~~--------------------~~~~~e~~~l~~~~ 60 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVK--TGQLAAIKVMDVTGDEE--------------------EEIKQEINMLKKYS 60 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcC--CCcEEEEEEEEcCCccH--------------------HHHHHHHHHHHHhc
Confidence 467889999999999999999998876 89999999986442211 3566788888888
Q ss_pred CCCCcccceeEEEcC------CeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 040898 117 RHRNILPLLAHMVRP------NCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHR 190 (337)
Q Consensus 117 ~hpniv~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~ 190 (337)
+|||++++.+.+... ...++++||+++++|.+++.. .....+++..+..++.|++.|+.|| |+.+++|+
T Consensus 61 ~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~--~~~~~l~~~~~~~~~~qi~~~l~~L---H~~~ivh~ 135 (272)
T cd06637 61 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN--TKGNTLKEEWIAYICREILRGLSHL---HQHKVIHR 135 (272)
T ss_pred CCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHH---HHCCCccC
Confidence 799999999988653 458999999999999999864 2345688999999999999999999 66799999
Q ss_pred CCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccc-----cCCCCCcccchhhhHHHHHHHhCC
Q 040898 191 DIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQ-----TETISDKCDIYSFGVLLAVLVMGK 265 (337)
Q Consensus 191 di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~-----~~~~~~~~DiwslG~i~~~ll~g~ 265 (337)
||+|+||+++.++.++|+|||++........ ......+++.|+|||.+. +..++.++|+||+|+++|+|++|.
T Consensus 136 dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~ 213 (272)
T cd06637 136 DIKGQNVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 213 (272)
T ss_pred CCCHHHEEECCCCCEEEccCCCceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCC
Confidence 9999999999999999999999876533221 112346888999999986 335778999999999999999999
Q ss_pred CCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 266 FPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 266 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.||....... .. . ......... . .....+..+.+|+.+||+.||.+|||+.++++|
T Consensus 214 ~p~~~~~~~~---~~---~-~~~~~~~~~------~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 214 PPLCDMHPMR---AL---F-LIPRNPAPR------L---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred CCccccCHHH---HH---H-HHhcCCCCC------C---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 9986432111 11 0 001010000 0 011123458899999999999999999999987
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=287.00 Aligned_cols=259 Identities=23% Similarity=0.362 Sum_probs=199.7
Q ss_pred ccccccceeccCcceEEEEeEEec--CCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELP--GSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
.+|++.+.||+|+||.||++.... ..++..+++|.+........ ...+.+|+.+++.++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~------------------~~~~~~E~~~l~~l~h 66 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQ------------------WGEFQQEASLMAELHH 66 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHH------------------HHHHHHHHHHHhhCCC
Confidence 568999999999999999987642 23668899999864332111 1457789999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcC-------------CcccCChHHHHHHHHHHHHHHHHHhhCCCC
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQ-------------GRRELDWPARHRIARGIASGLEYLHMCHRP 185 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~ 185 (337)
|||+++++++..+...+++|||+++++|.+++..... ....+++..+..++.|++.||.|| |+.
T Consensus 67 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l---H~~ 143 (283)
T cd05090 67 PNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYL---SSH 143 (283)
T ss_pred CCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHH---Hhc
Confidence 9999999999999999999999999999999853211 123467888899999999999999 677
Q ss_pred CeEecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-C
Q 040898 186 RLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-G 264 (337)
Q Consensus 186 gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g 264 (337)
|++|+||+|+||+++.++.++|+|||++................++..|+|||.+.+..++.++|+||||+++|+|++ |
T Consensus 144 ~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g 223 (283)
T cd05090 144 FFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFG 223 (283)
T ss_pred CeehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCC
Confidence 999999999999999999999999999876544332222233445677999999988889999999999999999998 8
Q ss_pred CCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 265 KFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 265 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
..||.... .....+......... .+...+..+.+++.+||+.||.+||++.+|+++
T Consensus 224 ~~p~~~~~----~~~~~~~~~~~~~~~-------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 224 LQPYYGFS----NQEVIEMVRKRQLLP-------------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred CCCCCCCC----HHHHHHHHHcCCcCC-------------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 88985432 112222222111100 111223458899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=287.45 Aligned_cols=249 Identities=23% Similarity=0.314 Sum_probs=200.8
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
++|++.+.||+|++|.||++.+.. +++.+|+|.+......... ..+.+.+|++++++++|||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~--~~~~~aiK~~~~~~~~~~~----------------~~~~~~~e~~~l~~l~h~~ 62 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKG--SGKYYALKILSKAKIVKLK----------------QVEHVLNEKRILQSIRHPF 62 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcC--CCCEEEEEEEEHHHhhhhh----------------HHHHHHHHHHHHHhCCCCC
Confidence 469999999999999999999876 8899999988643221111 1156788999999999999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
|+++++.+.+++..+++|||+++++|.+++.. ...+++..+..++.|++.+|.+| |+.|++|+||+|+||+++
T Consensus 63 i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~l---H~~~i~H~dl~p~nili~ 135 (290)
T cd05580 63 LVNLYGSFQDDSNLYLVMEYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYL---HSLDIVYRDLKPENLLLD 135 (290)
T ss_pred ccceeeEEEcCCeEEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCEecCCCCHHHEEEC
Confidence 99999999999999999999999999999843 35689999999999999999999 677999999999999999
Q ss_pred CCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhH
Q 040898 201 DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDM 280 (337)
Q Consensus 201 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~ 280 (337)
.++.++|+|||++...... .....+++.|++||.+.+..++.++|+||||+++|+|++|..||..... ...
T Consensus 136 ~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~ 206 (290)
T cd05580 136 SDGYIKITDFGFAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP----IQI 206 (290)
T ss_pred CCCCEEEeeCCCccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH----HHH
Confidence 9999999999998765443 1234588899999999888888999999999999999999999865321 111
Q ss_pred HHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCC-----ChhhhhcC
Q 040898 281 VKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERP-----SSKDVRSM 337 (337)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 337 (337)
.... ...... .+......+.+++.+||+.||.+|+ +++|+++|
T Consensus 207 ~~~~---~~~~~~-----------~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 207 YEKI---LEGKVR-----------FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred HHHH---hcCCcc-----------CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 1111 111100 0011234488999999999999999 88999876
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=284.10 Aligned_cols=256 Identities=21% Similarity=0.376 Sum_probs=199.7
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
++|++++.||+|+||.||++.+.. ++..||+|.+........ ...+.+|+.++++++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~--~~~~~a~k~~~~~~~~~~------------------~~~~~~e~~~l~~~~~~~ 60 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRP--TGVTMAMKEIRLELDESK------------------FNQIIMELDILHKAVSPY 60 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcC--CCcEEEEEEeecccCHHH------------------HHHHHHHHHHHHhcCCCc
Confidence 469999999999999999998865 899999998864422111 146778999999999999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
|+++++.+..++..++|+||+++++|..++.... ....+++..+..++.|++.++.||| ++.|++|+||+|+||+++
T Consensus 61 i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH--~~~~i~H~dl~p~nil~~ 137 (286)
T cd06622 61 IVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLK--EEHNIIHRDVKPTNVLVN 137 (286)
T ss_pred HHhhhhheecCCeEEEEEeecCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHH--hcCCEeeCCCCHHHEEEC
Confidence 9999999999999999999999999998885421 1346899999999999999999994 235999999999999999
Q ss_pred CCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCC------CCCcccchhhhHHHHHHHhCCCCCCCCCCC
Q 040898 201 DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTET------ISDKCDIYSFGVLLAVLVMGKFPVDDFFGH 274 (337)
Q Consensus 201 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~------~~~~~DiwslG~i~~~ll~g~~pf~~~~~~ 274 (337)
.++.++|+|||.+........ ....+++.|+|||.+.+.. ++.++|+||+|+++|+|++|..||......
T Consensus 138 ~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 213 (286)
T cd06622 138 GNGQVKLCDFGVSGNLVASLA----KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA 213 (286)
T ss_pred CCCCEEEeecCCcccccCCcc----ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh
Confidence 999999999998876533221 2235788899999985543 478899999999999999999998643211
Q ss_pred chhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 275 TEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.............. ...++....++.+++.+||+.+|.+||++.++++|
T Consensus 214 ----~~~~~~~~~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 214 ----NIFAQLSAIVDGDP----------PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred ----hHHHHHHHHhhcCC----------CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 11111111111111 11122345568899999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=285.16 Aligned_cols=254 Identities=22% Similarity=0.336 Sum_probs=198.2
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
.+-|++.+.||+|+||.||++.+.. ++..+++|.+....... ...+.+|+.+++.++||
T Consensus 4 ~~~~~i~~~lg~g~~g~v~~~~~~~--~~~~~~~k~~~~~~~~~-------------------~~~~~~e~~~l~~l~h~ 62 (282)
T cd06643 4 EEFWEIIGELGDGAFGKVYKAQNKE--TGVLAAAKVIDTKSEEE-------------------LEDYMVEIDILASCDHP 62 (282)
T ss_pred HHHHHHHhhcccCCCeEEEEEEECC--CCeEEEEEEeCCCCHHH-------------------HHHHHHHHHHHHHCCCC
Confidence 4458999999999999999998865 88899999885432211 14677899999999999
Q ss_pred CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceee
Q 040898 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI 199 (337)
Q Consensus 120 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~ 199 (337)
|++++++.+..++..++|+||+++++|..++.. ...++++..+..++.|++.||.+| |+.|++|+||+|+||++
T Consensus 63 ~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~L---H~~~i~H~dlkp~nili 136 (282)
T cd06643 63 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYL---HENKIIHRDLKAGNILF 136 (282)
T ss_pred CeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCcccEEE
Confidence 999999999999999999999999999988743 345689999999999999999999 67799999999999999
Q ss_pred cCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccc-----cCCCCCcccchhhhHHHHHHHhCCCCCCCCCCC
Q 040898 200 DDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQ-----TETISDKCDIYSFGVLLAVLVMGKFPVDDFFGH 274 (337)
Q Consensus 200 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~-----~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~ 274 (337)
+.++.++|+|||++........ ......+++.|+|||.+. +..++.++|+||+|+++|+|++|.+||......
T Consensus 137 ~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~ 214 (282)
T cd06643 137 TLDGDIKLADFGVSAKNTRTIQ--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM 214 (282)
T ss_pred ccCCCEEEcccccccccccccc--ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH
Confidence 9999999999999865433211 112346888999999973 345678999999999999999999998653221
Q ss_pred chhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 275 TEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
....... ....+... .+...+..+.+++.+||+.||.+|||+.++++|
T Consensus 215 ---~~~~~~~----~~~~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 215 ---RVLLKIA----KSEPPTLA--------QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred ---HHHHHHh----hcCCCCCC--------CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111111 11111000 011123458999999999999999999999986
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=281.89 Aligned_cols=261 Identities=28% Similarity=0.486 Sum_probs=204.3
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
++|++.+.||.|++|+||++.+.. ++..+++|++........ ...+.+|+..++.++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~------------------~~~~~~e~~~l~~l~~~~ 60 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLP--NNEKVAIKRIDLEKCQTS------------------VDELRKEVQAMSQCNHPN 60 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcC--CCcEEEEEEeccCCcchH------------------HHHHHHHHHHHHhcCCCC
Confidence 479999999999999999998765 888999998864432221 156788999999999999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
++++++.+..++..++++|++++++|.+++..... ...+++..+..++.|++.|+.+| |+.|++|+||+|+||+++
T Consensus 61 i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~l---h~~~i~h~~l~p~ni~~~ 136 (267)
T cd06610 61 VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYL---HSNGQIHRDIKAGNILLG 136 (267)
T ss_pred EEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHhEEEc
Confidence 99999999999999999999999999999864222 24688999999999999999999 778999999999999999
Q ss_pred CCCCeEEecccCccccCCCCcee--eeecccCCCCccCccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCCCchh
Q 040898 201 DDMEARISDFGHGKLMPDGHAQI--TVKCMVGTMGYMAPESLQTE-TISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEE 277 (337)
Q Consensus 201 ~~~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~ 277 (337)
+++.++|+|||++.......... ......++..|++||.+... .++.++|+||+|+++|+|++|..||.......
T Consensus 137 ~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-- 214 (267)
T cd06610 137 EDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-- 214 (267)
T ss_pred CCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--
Confidence 99999999999987665433221 11233578899999998766 68899999999999999999999996543211
Q ss_pred hhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 278 MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
....... ...+. . .. .......+..+.+++.+||..||++|||+.++++|
T Consensus 215 -~~~~~~~----~~~~~-~-~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 215 -VLMLTLQ----NDPPS-L-ET---GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred -hHHHHhc----CCCCC-c-CC---ccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 1111111 11100 0 00 00012334558899999999999999999999987
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=281.97 Aligned_cols=258 Identities=24% Similarity=0.345 Sum_probs=199.7
Q ss_pred cccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCc
Q 040898 42 CFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNI 121 (337)
Q Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpni 121 (337)
+|++.+.||+|+||.||++.+. +++.+|+|.+.......... ......+.+|+.+++.++||||
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~---~~~~~avk~~~~~~~~~~~~-------------~~~~~~~~~e~~~l~~l~~~~i 64 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN---QGQLIAVKQVELDTSNVLAA-------------EKEYEKLQEEVDLLKSLKHVNI 64 (265)
T ss_pred CccccceEeccCCeEEEEEEEc---CCCeEEEEEeecCccchhhH-------------HHHHHHHHHHHHHHHhcCCCCE
Confidence 4889999999999999998753 78899999886543221110 0112568889999999999999
Q ss_pred ccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecC
Q 040898 122 LPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDD 201 (337)
Q Consensus 122 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~ 201 (337)
+++++++.+....++++||+++++|.+++.. ..++++..+..++.|++.++.++ |+.|++|+||+|+||+++.
T Consensus 65 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~nil~~~ 137 (265)
T cd06631 65 VQYLGTCLDDNTISIFMEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYL---HNNCVVHRDIKGNNVMLMP 137 (265)
T ss_pred eeEeeEeecCCeEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCcCHHhEEECC
Confidence 9999999999999999999999999999843 34578899999999999999999 6779999999999999999
Q ss_pred CCCeEEecccCccccCCCCc----eeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchh
Q 040898 202 DMEARISDFGHGKLMPDGHA----QITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEE 277 (337)
Q Consensus 202 ~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~ 277 (337)
++.++|+|||.+........ ........++..|+|||.+.+..++.++|+||||+++|+|++|..||......
T Consensus 138 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--- 214 (265)
T cd06631 138 NGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL--- 214 (265)
T ss_pred CCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH---
Confidence 99999999998876432111 11112345788999999999888899999999999999999999999643211
Q ss_pred hhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 278 MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
..... ... ..... ..........+.+++.+||+.+|.+|||+.++++|
T Consensus 215 ~~~~~-~~~---~~~~~--------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 215 AAMFY-IGA---HRGLM--------PRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred HHHHH-hhh---ccCCC--------CCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 11111 000 00000 00111234458899999999999999999999986
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=282.36 Aligned_cols=252 Identities=25% Similarity=0.361 Sum_probs=198.7
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
..+|.+.+.||+|++|.||++.+.. ++..+++|.+..+... ...+.+|+.+++.++||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~--~~~~~~~K~~~~~~~~--------------------~~~~~~e~~~l~~l~h~ 62 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKK--YSLTVAVKTLKEDTME--------------------VEEFLKEAAVMKEIKHP 62 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEec--CCceEEEEEecCCchH--------------------HHHHHHHHHHHHhCCCC
Confidence 3458999999999999999998876 8899999987543210 14577899999999999
Q ss_pred CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceee
Q 040898 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI 199 (337)
Q Consensus 120 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~ 199 (337)
||+++++++..+...++++||+++++|.+++.. .....+++..+..++.|++.+|.+| |+.|++|+||+|+||++
T Consensus 63 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~l~~~~~~~~~~ql~~~l~~l---H~~~i~H~dlkp~nil~ 137 (263)
T cd05052 63 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVNAVVLLYMATQISSAMEYL---EKKNFIHRDLAARNCLV 137 (263)
T ss_pred ChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHH---HhCCEeecccCcceEEE
Confidence 999999999999999999999999999999854 2344588899999999999999999 77899999999999999
Q ss_pred cCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCchhh
Q 040898 200 DDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHTEEM 278 (337)
Q Consensus 200 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~~ 278 (337)
+.++.++|+|||.+......... .......+..|+|||.+.+..++.++|+||||+++|+|++ |..||..... .
T Consensus 138 ~~~~~~kl~df~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~----~ 212 (263)
T cd05052 138 GENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----S 212 (263)
T ss_pred cCCCcEEeCCCccccccccceee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH----H
Confidence 99999999999998765433211 1112234567999999988889999999999999999998 8999864321 1
Q ss_pred hHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 279 DMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
............ ..+...+..+.+++.+||+.||++|||+.++++
T Consensus 213 ~~~~~~~~~~~~-------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 213 QVYELLEKGYRM-------------ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred HHHHHHHCCCCC-------------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 111111111000 001112345889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=284.16 Aligned_cols=251 Identities=29% Similarity=0.450 Sum_probs=201.7
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
++|++.+.||.|++|.||++.+.. +++.|++|.+........ ...+.+|+.+++.++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~------------------~~~~~~e~~~l~~l~h~~ 60 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKR--TNQVVAIKVIDLEEAEDE------------------IEDIQQEIQFLSQCRSPY 60 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECC--CCeEEEEEEeeccccchH------------------HHHHHHHHHHHHHcCCCC
Confidence 479999999999999999998876 899999999865432111 145678999999999999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
++++.+.+.++...++|+||+++++|.+++.. ..+++..++.++.|++.++.+| |+++++|+||+|+||+++
T Consensus 61 i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~l---h~~~i~h~dl~p~ni~i~ 132 (274)
T cd06609 61 ITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYL---HEEGKIHRDIKAANILLS 132 (274)
T ss_pred eeeeeEEEEECCeEEEEEEeeCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEEEC
Confidence 99999999999999999999999999999843 2689999999999999999999 778999999999999999
Q ss_pred CCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhH
Q 040898 201 DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDM 280 (337)
Q Consensus 201 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~ 280 (337)
+++.++|+|||++........ ......+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...... ..
T Consensus 133 ~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~----~~ 206 (274)
T cd06609 133 EEGDVKLADFGVSGQLTSTMS--KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM----RV 206 (274)
T ss_pred CCCCEEEcccccceeeccccc--ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH----HH
Confidence 999999999999877654321 122346788899999999888999999999999999999999999654321 11
Q ss_pred HHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 281 VKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
. ........+.. ... ..+..+.+++.+||..+|++|||++++++|
T Consensus 207 ~---~~~~~~~~~~~------~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 207 L---FLIPKNNPPSL------EGN---KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred H---HHhhhcCCCCC------ccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1 11111111000 000 033458899999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=293.44 Aligned_cols=259 Identities=22% Similarity=0.264 Sum_probs=197.2
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
++|++.+.||+|+||.||++.+.. +++.||+|.+........ .....+..|..++..+.|||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~--~~~~~aiK~~~~~~~~~~----------------~~~~~~~~e~~~l~~~~~~~ 62 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKH--TERIYAMKILNKWEMLKR----------------AETACFREERNVLVNGDCQW 62 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECC--CCCEEEEEEEeHHHHHhh----------------HHHHHHHHHHHHHHhCCCCC
Confidence 479999999999999999998876 889999998854211111 11145777889999999999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
|+.+++.+.+.+..|+||||+++|+|.+++.. ....+++..+..++.|++.||.|+ |+.|++|+||||+||+++
T Consensus 63 i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~~L~~l---H~~~iiHrDlkp~Nill~ 136 (331)
T cd05624 63 ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYIAEMVLAIHSI---HQLHYVHRDIKPDNVLLD 136 (331)
T ss_pred EeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeccCchHHEEEc
Confidence 99999999999999999999999999999854 234688889999999999999999 778999999999999999
Q ss_pred CCCCeEEecccCccccCCCCceeeeecccCCCCccCcccccc-----CCCCCcccchhhhHHHHHHHhCCCCCCCCCCCc
Q 040898 201 DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQT-----ETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHT 275 (337)
Q Consensus 201 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-----~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~ 275 (337)
.++.++|+|||++......... ......|++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||.....
T Consensus 137 ~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~-- 213 (331)
T cd05624 137 MNGHIRLADFGSCLKMNQDGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL-- 213 (331)
T ss_pred CCCCEEEEeccceeeccCCCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH--
Confidence 9999999999998765433221 1123468999999999875 4578899999999999999999999864211
Q ss_pred hhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCC--CCChhhhhcC
Q 040898 276 EEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDE--RPSSKDVRSM 337 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~ell~~ 337 (337)
... ............ ...........+.+++.+||..++++ |++++++++|
T Consensus 214 --~~~---~~~i~~~~~~~~------~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 214 --VET---YGKIMNHEERFQ------FPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred --HHH---HHHHHcCCCccc------CCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 111 111111110000 00111123455888999999876554 5689999876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=282.27 Aligned_cols=251 Identities=23% Similarity=0.346 Sum_probs=195.7
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
.++|++.+.||+|++|.||++.+. .+..+|+|.+...... . +.+.+|+.+++.++||
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~---~~~~~aik~~~~~~~~-~-------------------~~~~~e~~~l~~l~h~ 59 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWR---GQYDVAIKMIKEGSMS-E-------------------DEFIEEAKVMMKLSHE 59 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEec---CCCcEEEEEcCCCccc-H-------------------HHHHHHHHHHhcCCCC
Confidence 356999999999999999988764 3456999987643221 1 4577899999999999
Q ss_pred CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceee
Q 040898 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI 199 (337)
Q Consensus 120 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~ 199 (337)
||+++++++......+++|||+.+++|.+++.. ....+++..++.++.|++.|+.|| |+.|++|+||+|+||++
T Consensus 60 ~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~nili 133 (256)
T cd05113 60 KLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLRE---HGKRFQPSQLLEMCKDVCEGMAYL---ESKQFIHRDLAARNCLV 133 (256)
T ss_pred CeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccccCcceEEE
Confidence 999999999988899999999999999999854 223688999999999999999999 77799999999999999
Q ss_pred cCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCchhh
Q 040898 200 DDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHTEEM 278 (337)
Q Consensus 200 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~~ 278 (337)
+.++.++|+|||.+......... ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||..... .
T Consensus 134 ~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~----~ 208 (256)
T cd05113 134 DDQGCVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN----S 208 (256)
T ss_pred cCCCCEEECCCccceecCCCcee-ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH----H
Confidence 99999999999988765433211 1112235567999999988888999999999999999999 9999865332 1
Q ss_pred hHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 279 DMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.....+........+ ......+.+++.+||+.||.+|||+.++++.
T Consensus 209 ~~~~~~~~~~~~~~~-------------~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 209 ETVEKVSQGLRLYRP-------------HLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHHHHHhcCCCCCCC-------------CCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 111111111110000 0123458999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=287.64 Aligned_cols=267 Identities=21% Similarity=0.294 Sum_probs=201.6
Q ss_pred ccccccccceeccCcceEEEEeEEecCC--------------CCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHH
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGS--------------NGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIG 104 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~--------------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 104 (337)
..++|++.+.||+|+||.||++.+.... .+..||+|.+........ .+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~------------------~~ 64 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNA------------------RE 64 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHH------------------HH
Confidence 3468999999999999999998765411 335689998865543211 15
Q ss_pred hHHHHHHHHHhcCCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcC-------CcccCChHHHHHHHHHHHHHHH
Q 040898 105 AIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQ-------GRRELDWPARHRIARGIASGLE 177 (337)
Q Consensus 105 ~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~i~~~i~~~l~ 177 (337)
.+.+|+.++.+++||||+++++++..+...++++|++++++|.+++..... ....+++..++.++.|++.||.
T Consensus 65 ~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~ 144 (296)
T cd05051 65 DFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMR 144 (296)
T ss_pred HHHHHHHHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHH
Confidence 678899999999999999999999999999999999999999999865331 1236889999999999999999
Q ss_pred HHhhCCCCCeEecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHH
Q 040898 178 YLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVL 257 (337)
Q Consensus 178 ~l~~~h~~gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i 257 (337)
|| |+.|++|+||+|+||+++.++.++|+|||++................+++.|+|||.+.+..++.++||||||++
T Consensus 145 ~L---H~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~ 221 (296)
T cd05051 145 YL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVT 221 (296)
T ss_pred HH---HHcCccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHH
Confidence 99 677999999999999999999999999999876543332222233456778999999988889999999999999
Q ss_pred HHHHHh--CCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhh
Q 040898 258 LAVLVM--GKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVR 335 (337)
Q Consensus 258 ~~~ll~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 335 (337)
+|+|++ +..||..... .................. ....++..+.++.+++.+||+.||.+|||+.+++
T Consensus 222 l~el~~~~~~~p~~~~~~----~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~ 291 (296)
T cd05051 222 LWEILTLCREQPYEHLTD----QQVIENAGHFFRDDGRQI------YLPRPPNCPKDIYELMLECWRRDEEDRPTFREIH 291 (296)
T ss_pred HHHHHhcCCCCCCCCcCh----HHHHHHHHhccccccccc------cCCCccCCCHHHHHHHHHHhccChhcCCCHHHHH
Confidence 999998 6778754322 111111111100000000 0011122334589999999999999999999997
Q ss_pred c
Q 040898 336 S 336 (337)
Q Consensus 336 ~ 336 (337)
+
T Consensus 292 ~ 292 (296)
T cd05051 292 L 292 (296)
T ss_pred H
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=315.20 Aligned_cols=259 Identities=27% Similarity=0.352 Sum_probs=198.0
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
++|++.++||+|+||.||++.+.. +++.||+|++..+....... ...+.+|+.+++.++|||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~--tg~~VAIK~I~~~l~~~e~~----------------~~rflrEi~ILs~L~HPN 63 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPV--CSRRVALKKIREDLSENPLL----------------KKRFLREAKIAADLIHPG 63 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECC--CCcEEEEEEECcccccCHHH----------------HHHHHHHHHHHHhCCCcC
Confidence 689999999999999999998876 89999999987543222110 156888999999999999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCC-------cccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCC
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQG-------RRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIK 193 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~ 193 (337)
|+++++++.+++..+++|||++|++|.+++...... ....+...+..++.||+.||.|| |++|++|+|||
T Consensus 64 IVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yL---Hs~GIIHRDLK 140 (932)
T PRK13184 64 IVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYV---HSKGVLHRDLK 140 (932)
T ss_pred cCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHH---HHCCccccCCc
Confidence 999999999999999999999999999998653221 23345667889999999999999 67799999999
Q ss_pred CCceeecCCCCeEEecccCccccCCCCc----------------eeeeecccCCCCccCccccccCCCCCcccchhhhHH
Q 040898 194 PANVLIDDDMEARISDFGHGKLMPDGHA----------------QITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVL 257 (337)
Q Consensus 194 ~~nil~~~~~~~~l~dfg~~~~~~~~~~----------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i 257 (337)
|+||+++.++.++|+|||++........ ........||+.|+|||.+.+..++.++|+||+|++
T Consensus 141 PeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVI 220 (932)
T PRK13184 141 PDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVI 220 (932)
T ss_pred hheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHH
Confidence 9999999999999999999876521110 001112468999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhh
Q 040898 258 LAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVR 335 (337)
Q Consensus 258 ~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 335 (337)
+|+|++|..||........ .. ...... +... ......+..+.+++.+||+.||++||+..+.+
T Consensus 221 LyELLTG~~PF~~~~~~ki--~~----~~~i~~--P~~~-------~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeL 283 (932)
T PRK13184 221 LYQMLTLSFPYRRKKGRKI--SY----RDVILS--PIEV-------APYREIPPFLSQIAMKALAVDPAERYSSVQEL 283 (932)
T ss_pred HHHHHHCCCCCCCcchhhh--hh----hhhccC--hhhc-------cccccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 9999999999965222110 00 000000 0000 00112334578899999999999998765543
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=282.73 Aligned_cols=266 Identities=25% Similarity=0.369 Sum_probs=201.0
Q ss_pred cccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCc
Q 040898 42 CFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNI 121 (337)
Q Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpni 121 (337)
+|...+.||+|++|.||++.+.. +++.+|+|.+......... .........+.+.+|+.+++.++|||+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~--~~~~~a~K~~~~~~~~~~~---------~~~~~~~~~~~~~~e~~~l~~l~h~~i 70 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVT--TGEMMAVKQVELPATIAGR---------HDSRQKDMVKALRSEIETLKDLDHLNI 70 (272)
T ss_pred ceeecceecccCceEEEEEeecC--CCceeeeeeeechhhhhcc---------cchHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 58899999999999999998865 8999999988543221111 000011122578889999999999999
Q ss_pred ccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecC
Q 040898 122 LPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDD 201 (337)
Q Consensus 122 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~ 201 (337)
+++++++...+..++|+||+++++|.+++.. ...+++..+..++.|++.++.+| |+.|++|+||+|+||+++.
T Consensus 71 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~~~nil~~~ 143 (272)
T cd06629 71 VQYLGFETTEEYLSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAYL---HSKGILHRDLKADNLLVDA 143 (272)
T ss_pred ceEEEEeccCCceEEEEecCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHH---hhCCeeecCCChhhEEEcC
Confidence 9999999999999999999999999999843 35688899999999999999999 7789999999999999999
Q ss_pred CCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCC--CCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhh
Q 040898 202 DMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTET--ISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMD 279 (337)
Q Consensus 202 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~--~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~ 279 (337)
++.++|+|||.+................++..|+|||.+.... ++.++|+||||+++|++++|..||..... ...
T Consensus 144 ~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---~~~ 220 (272)
T cd06629 144 DGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA---IAA 220 (272)
T ss_pred CCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch---HHH
Confidence 9999999999987654322221122345788999999987654 78899999999999999999999853211 111
Q ss_pred HHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 280 MVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
..+.... . ..... ...........+.+++.+||+.+|.+|||+.++++|
T Consensus 221 ~~~~~~~----~-~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 221 MFKLGNK----R-SAPPI----PPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred HHHhhcc----c-cCCcC----CccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 1111000 0 00000 001112234568999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=285.25 Aligned_cols=257 Identities=24% Similarity=0.348 Sum_probs=198.4
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc-C
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT-R 117 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~ 117 (337)
..++|++.+.||+|+||.||++.+.. +++.+++|.+....... ..+..|+.+++.+ +
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~--~~~~~~ik~~~~~~~~~--------------------~~~~~e~~~l~~l~~ 73 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKK--NGSKAAVKILDPIHDID--------------------EEIEAEYNILKALSD 73 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECC--CCceeEEEeeccccchH--------------------HHHHHHHHHHHHHhc
Confidence 77899999999999999999998876 88999999875322110 3466788889998 7
Q ss_pred CCCcccceeEEE-----cCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 040898 118 HRNILPLLAHMV-----RPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDI 192 (337)
Q Consensus 118 hpniv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di 192 (337)
||||+++++++. .+...+++|||+++++|.+++.........+++..++.++.|++.|+.|| |+.+++|+||
T Consensus 74 h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl 150 (286)
T cd06638 74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHL---HVNKTIHRDV 150 (286)
T ss_pred CCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHH---HhCCccccCC
Confidence 999999999873 44678999999999999998865444556788899999999999999999 7779999999
Q ss_pred CCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCcccccc-----CCCCCcccchhhhHHHHHHHhCCCC
Q 040898 193 KPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQT-----ETISDKCDIYSFGVLLAVLVMGKFP 267 (337)
Q Consensus 193 ~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-----~~~~~~~DiwslG~i~~~ll~g~~p 267 (337)
+|+||+++.++.++|+|||++........ ......+++.|+|||.+.. ..++.++|+||+|+++|+|++|..|
T Consensus 151 kp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p 228 (286)
T cd06638 151 KGNNILLTTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPP 228 (286)
T ss_pred CHHhEEECCCCCEEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCC
Confidence 99999999999999999999876543221 1123458899999999753 3478899999999999999999999
Q ss_pred CCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 268 VDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 268 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
|...... ..... ......+ ... ........+.+++.+||+.||.+|||+.|+++|
T Consensus 229 ~~~~~~~---~~~~~----~~~~~~~-~~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 229 LADLHPM---RALFK----IPRNPPP-TLH-------QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred CCCCchh---HHHhh----ccccCCC-ccc-------CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 8653221 11111 0000000 000 001122348899999999999999999999986
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=298.87 Aligned_cols=252 Identities=28% Similarity=0.434 Sum_probs=208.8
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..+.|.-++.||.|+||.||.+.+.. +...||||++....-.+...+ ..+.+|+..|++++|
T Consensus 24 PEklf~dLrEIGHGSFGAVYfArd~~--n~evVAIKKMsySGKQs~EKW----------------qDIlKEVrFL~~l~H 85 (948)
T KOG0577|consen 24 PEKLFSDLREIGHGSFGAVYFARDVR--NSEVVAIKKMSYSGKQSNEKW----------------QDILKEVRFLRQLRH 85 (948)
T ss_pred HHHHHHHHHHhcCCccceeEEeeccC--ccceeeeeeccccccccHHHH----------------HHHHHHHHHHHhccC
Confidence 66779999999999999999999987 999999999876654443332 678899999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
||++.+.|.|....+.|+|||||-| |-.|++.- .+.++.+..+..|+.+.+.||+|| |+++.+|+|||..||+
T Consensus 86 PntieYkgCyLre~TaWLVMEYClG-SAsDlleV---hkKplqEvEIAAi~~gaL~gLaYL---HS~~~IHRDiKAGNIL 158 (948)
T KOG0577|consen 86 PNTIEYKGCYLREHTAWLVMEYCLG-SASDLLEV---HKKPLQEVEIAAITHGALQGLAYL---HSHNRIHRDIKAGNIL 158 (948)
T ss_pred CCcccccceeeccchHHHHHHHHhc-cHHHHHHH---HhccchHHHHHHHHHHHHHHHHHH---HHhhHHhhhccccceE
Confidence 9999999999999999999999955 88888753 446789999999999999999999 7889999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccc---cCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCc
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQ---TETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHT 275 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~ 275 (337)
+++.|.|||+|||.+..... .+.++|||.|||||++. .+.|+-++||||||++..++...++|+-.+..
T Consensus 159 Lse~g~VKLaDFGSAsi~~P------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA-- 230 (948)
T KOG0577|consen 159 LSEPGLVKLADFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-- 230 (948)
T ss_pred ecCCCeeeeccccchhhcCc------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH--
Confidence 99999999999998865432 24578999999999986 34689999999999999999999999644322
Q ss_pred hhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 276 EEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
...+..+.....|. -..+..++.+.+|+..||+.-|.+|||.+++|+|
T Consensus 231 -----MSALYHIAQNesPt---------Lqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 231 -----MSALYHIAQNESPT---------LQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred -----HHHHHHHHhcCCCC---------CCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 11222222222221 1134556679999999999999999999999987
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=285.31 Aligned_cols=260 Identities=22% Similarity=0.317 Sum_probs=200.7
Q ss_pred ccccccccceeccCcceEEEEeEEecC---CCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHh
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPG---SNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQ 115 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~ 115 (337)
..++|++.+.||+|+||.||++.+... .++..|++|.+........ ...+.+|+.++..
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~------------------~~~~~~e~~~l~~ 65 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRE------------------RIEFLNEASVMKE 65 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHH------------------HHHHHHHHHHHHh
Confidence 456899999999999999999887641 2457899999754322111 1457789999999
Q ss_pred cCCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCC------cccCChHHHHHHHHHHHHHHHHHhhCCCCCeEe
Q 040898 116 TRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQG------RRELDWPARHRIARGIASGLEYLHMCHRPRLIH 189 (337)
Q Consensus 116 l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h 189 (337)
++||||+++++++..+...++|+||+++++|.+++...... ...+++..+..++.|++.||.|| |+.|++|
T Consensus 66 ~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H 142 (277)
T cd05032 66 FNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYL---AAKKFVH 142 (277)
T ss_pred CCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHH---HhCCccc
Confidence 99999999999999999999999999999999998653321 23467888999999999999999 7789999
Q ss_pred cCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCC
Q 040898 190 RDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPV 268 (337)
Q Consensus 190 ~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf 268 (337)
+||+|+||+++.++.++|+|||++................++..|+|||.+.+..++.++|+||||+++|++++ |..||
T Consensus 143 ~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 222 (277)
T cd05032 143 RDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPY 222 (277)
T ss_pred cccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCC
Confidence 99999999999999999999999876543322212223346778999999988888999999999999999998 89998
Q ss_pred CCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 269 DDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
..... ........ ...... .+...+..+.+++.+||+.+|++|||+.++++
T Consensus 223 ~~~~~----~~~~~~~~---~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 223 QGLSN----EEVLKFVI---DGGHLD----------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred ccCCH----HHHHHHHh---cCCCCC----------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 64321 12222221 111100 00111345889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=284.49 Aligned_cols=261 Identities=21% Similarity=0.317 Sum_probs=198.9
Q ss_pred ccccccccceeccCcceEEEEeEEecCC---CCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHh
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGS---NGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQ 115 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~ 115 (337)
..++|.+.+.||+|++|.||++.+.... ++..|++|.+......... ..+.+|+.+++.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~------------------~~~~~e~~~l~~ 65 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDE------------------SDFLMEALIMSK 65 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHH------------------HHHHHHHHHHHh
Confidence 3467999999999999999999886422 5678999987544322111 457789999999
Q ss_pred cCCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcC---CcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 040898 116 TRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQ---GRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDI 192 (337)
Q Consensus 116 l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di 192 (337)
++||||+++++++.+....++++||+++++|.+++..... ....+++..+..++.||+.++.|| |+.+++|+||
T Consensus 66 l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~L---H~~~ivH~dl 142 (277)
T cd05036 66 FNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYL---EENHFIHRDI 142 (277)
T ss_pred CCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHH---HHCCEeeccc
Confidence 9999999999999999999999999999999999865332 123578899999999999999999 7779999999
Q ss_pred CCCceeecCCC---CeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCC
Q 040898 193 KPANVLIDDDM---EARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPV 268 (337)
Q Consensus 193 ~~~nil~~~~~---~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf 268 (337)
+|+||+++.++ .++|+|||++.................+..|+|||.+.+..++.++||||||+++|+|++ |..||
T Consensus 143 kp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf 222 (277)
T cd05036 143 AARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPY 222 (277)
T ss_pred chheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCC
Confidence 99999998654 589999999876533222111122234567999999988889999999999999999997 99998
Q ss_pred CCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 269 DDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
..... ......+.. ..... .+...+..+.+++.+||+.+|++|||+.++++|
T Consensus 223 ~~~~~----~~~~~~~~~---~~~~~----------~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 223 PGRTN----QEVMEFVTG---GGRLD----------PPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CCCCH----HHHHHHHHc---CCcCC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 64321 111111111 11100 011123458899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=282.15 Aligned_cols=257 Identities=23% Similarity=0.369 Sum_probs=196.2
Q ss_pred ccccceeccCcceEEEEeEEecC-CCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCc
Q 040898 43 FDSLKKIGSGGWGEVFYKAELPG-SNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNI 121 (337)
Q Consensus 43 y~~~~~lg~G~~g~V~~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpni 121 (337)
|.+.+.||+|+||.||.+..... .++..||+|++..+...... ...+.+|+..++.++||||
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~-----------------~~~~~~e~~~l~~l~h~~i 63 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSE-----------------IEEFLSEAACMKDFDHPNV 63 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHH-----------------HHHHHHHHHHHHhCCCCCe
Confidence 67899999999999999887542 24578999998654322111 1567889999999999999
Q ss_pred ccceeEEEcCCe------eEEEEEeccCCCHHHHHHHhcC--CcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCC
Q 040898 122 LPLLAHMVRPNC------HLLVYEFMKNGSLQDILYDVSQ--GRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIK 193 (337)
Q Consensus 122 v~~~~~~~~~~~------~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~ 193 (337)
+++++.+..... .++++||+++++|..++..... ....+++..+..++.|++.||.|+ |+.|++|+||+
T Consensus 64 v~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~l---H~~~i~H~dlk 140 (273)
T cd05035 64 MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYL---SNRNFIHRDLA 140 (273)
T ss_pred eeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHH---HhCCeeccccc
Confidence 999998765543 7999999999999999865332 234688899999999999999999 67799999999
Q ss_pred CCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCC
Q 040898 194 PANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFF 272 (337)
Q Consensus 194 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~ 272 (337)
|+||++++++.++|+|||++.................+..|++||.+.+..++.++|+||||+++|+|++ |..||....
T Consensus 141 p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~ 220 (273)
T cd05035 141 ARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE 220 (273)
T ss_pred hheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999876543322211122234667999999988889999999999999999999 889986532
Q ss_pred CCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 273 GHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
. ....+.... ..... .+......+.+++.+||+.||++|||+.++++
T Consensus 221 ~----~~~~~~~~~---~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~ 267 (273)
T cd05035 221 N----HEIYDYLRH---GNRLK----------QPEDCLDELYDLMYSCWRADPKDRPTFTKLRE 267 (273)
T ss_pred H----HHHHHHHHc---CCCCC----------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 2 111121111 11110 11122345899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=278.83 Aligned_cols=253 Identities=21% Similarity=0.324 Sum_probs=202.8
Q ss_pred cccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCc
Q 040898 42 CFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNI 121 (337)
Q Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpni 121 (337)
+|+..+.||.|+||.||.+.+.. ++..+++|.+......... ...+.+|+.++++++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~--~~~~~~~k~~~~~~~~~~~-----------------~~~~~~e~~~l~~~~h~~i 61 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTE--DDSLVVWKEVNLTRLSEKE-----------------RRDALNEIVILSLLQHPNI 61 (256)
T ss_pred CceEeeEecccCCceEEEEEEcC--CCcEEEEEEEeecccchhH-----------------HHHHHHHHHHHHhCCCCCe
Confidence 58999999999999999888876 8999999998654322211 1457789999999999999
Q ss_pred ccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecC
Q 040898 122 LPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDD 201 (337)
Q Consensus 122 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~ 201 (337)
+++++++.+.+..++++||+++++|.+++.. .....+++..+..++.|++.++.+| |+.|++|+||+|+||+++.
T Consensus 62 ~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~l---h~~~i~h~dl~p~ni~~~~ 136 (256)
T cd08221 62 IAYYNHFMDDNTLLIEMEYANGGTLYDKIVR--QKGQLFEEEMVLWYLFQIVSAVSYI---HKAGILHRDIKTLNIFLTK 136 (256)
T ss_pred eEEEeEEecCCeEEEEEEecCCCcHHHHHHh--ccccCCCHHHHHHHHHHHHHHHHHH---HhCCccccCCChHhEEEeC
Confidence 9999999999999999999999999999864 2245688999999999999999999 7779999999999999999
Q ss_pred CCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHH
Q 040898 202 DMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMV 281 (337)
Q Consensus 202 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~ 281 (337)
++.++|+|||.+........ ......+++.|.|||.+.+..++.++|+||+|+++|+|++|..||..... .
T Consensus 137 ~~~~kl~d~~~~~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~----~--- 207 (256)
T cd08221 137 AGLIKLGDFGISKILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP----L--- 207 (256)
T ss_pred CCCEEECcCcceEEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH----H---
Confidence 99999999999876544331 12234688999999999888889999999999999999999999864221 1
Q ss_pred HHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 282 KWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
+............ ........+.+++.+||..+|.+|||+.++++|
T Consensus 208 ~~~~~~~~~~~~~----------~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 208 NLVVKIVQGNYTP----------VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred HHHHHHHcCCCCC----------CccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 1111111111110 012233458899999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=285.98 Aligned_cols=265 Identities=24% Similarity=0.330 Sum_probs=201.3
Q ss_pred cccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCc
Q 040898 42 CFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNI 121 (337)
Q Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpni 121 (337)
+|++.+.||.|++|.||++.+.. ++..|++|++......... ...+.+|+.++++++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~--~~~~~~vK~~~~~~~~~~~-----------------~~~~~~e~~~l~~~~~~~i 61 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRE--TGETVALKKVALRRLEGGI-----------------PNQALREIKALQACQHPYV 61 (286)
T ss_pred CceEEeecccCCCcEEEEEEECC--CCceEEEEEEEcccccchh-----------------hHHHHHHHHHHHhCCCCCC
Confidence 58999999999999999999876 7999999998665422211 1467789999999999999
Q ss_pred ccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecC
Q 040898 122 LPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDD 201 (337)
Q Consensus 122 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~ 201 (337)
+++++++..+...++|+||+ +++|.+++.. ....+++..++.++.|++.+|.+| |+.|++|+||+|+||+++.
T Consensus 62 ~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~ni~~~~ 134 (286)
T cd07832 62 VKLLDVFPHGSGFVLVMEYM-PSDLSEVLRD---EERPLPEAQVKSYMRMLLKGVAYM---HANGIMHRDLKPANLLISA 134 (286)
T ss_pred cceeeEEecCCeeEEEeccc-CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCcCHHHEEEcC
Confidence 99999999999999999999 9999998854 235689999999999999999999 6779999999999999999
Q ss_pred CCCeEEecccCccccCCCCceeeeecccCCCCccCccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhH
Q 040898 202 DMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTE-TISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDM 280 (337)
Q Consensus 202 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~ 280 (337)
++.++|+|||.+........ .......++..|+|||.+.+. .++.++|+||+|+++|+|++|.+||..... ....
T Consensus 135 ~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~---~~~~ 210 (286)
T cd07832 135 DGVLKIADFGLARLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND---IEQL 210 (286)
T ss_pred CCcEEEeeeeecccccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH---HHHH
Confidence 99999999999876644322 112234688899999998654 458899999999999999999888754221 1111
Q ss_pred HHHHHhhhccCCcch----------------hhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 281 VKWMRNVIFSENPNR----------------AINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 281 ~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
....... ....... ...........+.....+.+++.+||+.||++|||++++++|
T Consensus 211 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 211 AIVFRTL-GTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred HHHHHHc-CCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 1111110 0000000 000000001112334678999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=286.34 Aligned_cols=259 Identities=21% Similarity=0.340 Sum_probs=200.2
Q ss_pred ccccccccceeccCcceEEEEeEEec---CCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHh
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELP---GSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQ 115 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~ 115 (337)
+..+|.+.+.||+|+||.||++.+.. ..++..+++|.+........ ..+.+|+..+..
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~-------------------~~~~~e~~~l~~ 63 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR-------------------KDFQREAELLTN 63 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHH-------------------HHHHHHHHHHhc
Confidence 34679999999999999999987643 12556688888754322111 457789999999
Q ss_pred cCCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcC------------CcccCChHHHHHHHHHHHHHHHHHhhCC
Q 040898 116 TRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQ------------GRRELDWPARHRIARGIASGLEYLHMCH 183 (337)
Q Consensus 116 l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~l~~~h 183 (337)
++||||+++++++..+...++||||+++++|.+++..... ....+++..++.++.||+.|+.+| |
T Consensus 64 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l---H 140 (291)
T cd05094 64 LQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL---A 140 (291)
T ss_pred CCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHH---H
Confidence 9999999999999999999999999999999999964221 123478899999999999999999 7
Q ss_pred CCCeEecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh
Q 040898 184 RPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM 263 (337)
Q Consensus 184 ~~gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~ 263 (337)
+.|++|+||+|+||+++.++.++|+|||++................++..|+|||.+.+..++.++|+||||+++|+|++
T Consensus 141 ~~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t 220 (291)
T cd05094 141 SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220 (291)
T ss_pred hCCeeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHh
Confidence 88999999999999999999999999999876543322222233456788999999998889999999999999999999
Q ss_pred -CCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 264 -GKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 264 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
|..||..... ....+.+.. ..... .....+..+.+++.+||+.||++|||+.++++
T Consensus 221 ~g~~p~~~~~~----~~~~~~~~~---~~~~~----------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 221 YGKQPWFQLSN----TEVIECITQ---GRVLE----------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred CCCCCCCCCCH----HHHHHHHhC---CCCCC----------CCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 9999855322 111111111 11110 01112345889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=280.01 Aligned_cols=261 Identities=22% Similarity=0.357 Sum_probs=202.3
Q ss_pred cccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCc
Q 040898 42 CFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNI 121 (337)
Q Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpni 121 (337)
+|+..+.||+|++|.||.+.+.. +++.+|+|.+........... .....+.+|+.+++.++||||
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~--~~~~~alk~~~~~~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i 65 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVK--TGTLMAVKQVTYVRNTSSEQE-------------EVVEALRKEIRLMARLNHPHI 65 (268)
T ss_pred CccccceecCcCceEEEEEEEcC--CCcEEEEEEeecccCCchhHH-------------HHHHHHHHHHHHHHHcCCCce
Confidence 48899999999999999988865 899999999865433221110 012578889999999999999
Q ss_pred ccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecC
Q 040898 122 LPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDD 201 (337)
Q Consensus 122 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~ 201 (337)
+++++++.+++..++|+||+++++|.+++.. ..++++..+..++.|++.|+.+| |+.|++|+||+|+||+++.
T Consensus 66 v~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~L---H~~~i~H~~i~~~nil~~~ 138 (268)
T cd06630 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYL---HENQIIHRDVKGANLLIDS 138 (268)
T ss_pred ehhhceeccCCeEEEEEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcC
Confidence 9999999999999999999999999999843 34688899999999999999999 7779999999999999987
Q ss_pred CC-CeEEecccCccccCCCCce--eeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhh
Q 040898 202 DM-EARISDFGHGKLMPDGHAQ--ITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEM 278 (337)
Q Consensus 202 ~~-~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~ 278 (337)
++ .++|+|||.+......... .......++..|+|||.+.+..++.++|+||+|+++|++++|..||.........
T Consensus 139 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~- 217 (268)
T cd06630 139 TGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL- 217 (268)
T ss_pred CCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH-
Confidence 76 5899999998765432111 1112235788999999998888899999999999999999999998643221111
Q ss_pred hHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 279 DMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
........... ....+......+.+++.+||..+|.+|||+.++++|
T Consensus 218 ---~~~~~~~~~~~---------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 218 ---ALIFKIASATT---------APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred ---HHHHHHhccCC---------CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 11111110000 011222344558899999999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=280.93 Aligned_cols=252 Identities=25% Similarity=0.376 Sum_probs=197.4
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++.+.||+|++|.||++.+. ++..||+|.+....... ..+.+|+.++++++|
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~---~~~~v~iK~~~~~~~~~--------------------~~~~~e~~~l~~l~h 60 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWN---NTTPVAVKTLKPGTMDP--------------------KDFLAEAQIMKKLRH 60 (261)
T ss_pred chhheeeEEEecccCCccEEEEEec---CCeEEEEEeeCCCcccH--------------------HHHHHHHHHHHHCCC
Confidence 3567999999999999999998764 45789999986543211 456779999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++++...+..++++||+++++|.+++.. ..+..+++..+..++.|++.|+.+| |+.|++|+||+|+||+
T Consensus 61 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~Nil 135 (261)
T cd05068 61 PKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQG--GAGRALKLPQLIDMAAQVASGMAYL---EAQNYIHRDLAARNVL 135 (261)
T ss_pred CCccceeEEEecCCCeeeeeecccCCcHHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeeccCCcceEE
Confidence 9999999999999999999999999999999854 2234688999999999999999999 7779999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCchh
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHTEE 277 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~ 277 (337)
++.++.++|+|||++......... .......+..|+|||.+.+..++.++|+||||+++|+|++ |..||.....
T Consensus 136 ~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---- 210 (261)
T cd05068 136 VGENNICKVADFGLARVIKEDIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN---- 210 (261)
T ss_pred EcCCCCEEECCcceEEEccCCccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH----
Confidence 999999999999998876532211 1111223457999999988889999999999999999999 9999864321
Q ss_pred hhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 278 MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
......+.... .. .........+.+++.+||+.+|++||++.++++
T Consensus 211 ~~~~~~~~~~~---~~----------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 211 AEVLQQVDQGY---RM----------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHHHHHHcCC---CC----------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 11111111110 00 011122345899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=287.89 Aligned_cols=265 Identities=20% Similarity=0.274 Sum_probs=196.9
Q ss_pred cccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCc
Q 040898 42 CFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNI 121 (337)
Q Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpni 121 (337)
+|++.+.||+|++|.||++.+.. +|..+++|.+......... ...+.+|+.++++++||||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~--~g~~~~~k~~~~~~~~~~~-----------------~~~~~~ei~~l~~l~h~~i 61 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRE--THEIVALKRVRLDDDDEGV-----------------PSSALREICLLKELKHKNI 61 (284)
T ss_pred CceeEEEecccCCeEEEEEEECC--CCcEEEEEEeecccccccC-----------------ccchhHHHHHHHhcCCCCe
Confidence 58999999999999999999876 8999999998654321110 0356679999999999999
Q ss_pred ccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecC
Q 040898 122 LPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDD 201 (337)
Q Consensus 122 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~ 201 (337)
+++++++.+....++++||+++ +|.+++.. ....+++..++.++.||++||.|| |+.|++|+||+|+||+++.
T Consensus 62 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~L---H~~~i~H~dl~~~nil~~~ 134 (284)
T cd07839 62 VRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFC---HSHNVLHRDLKPQNLLINK 134 (284)
T ss_pred eeHHHHhccCCceEEEEecCCC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH---HHCCEecCCCCHHHEEEcC
Confidence 9999999999999999999975 78777643 235689999999999999999999 6779999999999999999
Q ss_pred CCCeEEecccCccccCCCCceeeeecccCCCCccCccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhH
Q 040898 202 DMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTE-TISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDM 280 (337)
Q Consensus 202 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~ 280 (337)
++.++|+|||++......... .....+++.|+|||.+.+. .++.++|+||||+++|+|++|..||..... ....+
T Consensus 135 ~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~--~~~~~ 210 (284)
T cd07839 135 NGELKLADFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQL 210 (284)
T ss_pred CCcEEECccchhhccCCCCCC--cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCC--HHHHH
Confidence 999999999998765432211 1234568899999998764 468899999999999999999888632211 11111
Q ss_pred HHHHHhhhccCCc-----------chhhhhc----ccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 281 VKWMRNVIFSENP-----------NRAINSK----LLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 281 ~~~~~~~~~~~~~-----------~~~~~~~----~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.. +......... ....... ......+.....+.+++.+||+.||.+|||+.++++|
T Consensus 211 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 211 KR-IFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred HH-HHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 11 1111000000 0000000 0001112344568899999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=292.06 Aligned_cols=259 Identities=21% Similarity=0.255 Sum_probs=195.5
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
++|++.+.||+|+||.||++.+.. +++.+|+|.+........ .....+..|..++..++|||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~--~~~~~aiK~~~~~~~~~~----------------~~~~~~~~e~~~l~~~~~~~ 62 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKN--ADKVFAMKILNKWEMLKR----------------AETACFREERDVLVNGDNQW 62 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECC--CCCEEEEEEEeHHHHHHh----------------hHHHHHHHHHHHHhhCCCCC
Confidence 479999999999999999998865 889999999853211111 01145777889999999999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
|+.+++.+.+....++||||+++|+|.+++.. ....+++..+..++.|++.|+.|| |+.|++|+||||+||+++
T Consensus 63 i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~l~~~~~~~~~~qi~~al~~l---H~~~iiHrDlkp~Nili~ 136 (332)
T cd05623 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVIAIDSV---HQLHYVHRDIKPDNILMD 136 (332)
T ss_pred EeeEEEEEecCCEEEEEEeccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHEEEC
Confidence 99999999999999999999999999999854 234588889999999999999999 678999999999999999
Q ss_pred CCCCeEEecccCccccCCCCceeeeecccCCCCccCcccccc-----CCCCCcccchhhhHHHHHHHhCCCCCCCCCCCc
Q 040898 201 DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQT-----ETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHT 275 (337)
Q Consensus 201 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-----~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~ 275 (337)
.++.++|+|||++......... ......||+.|+|||++.+ ..++.++|+||||+++|+|++|..||.....
T Consensus 137 ~~~~~kL~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~-- 213 (332)
T cd05623 137 MNGHIRLADFGSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL-- 213 (332)
T ss_pred CCCCEEEeecchheecccCCcc-eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH--
Confidence 9999999999998654332211 1223468999999999863 4578899999999999999999999864211
Q ss_pred hhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCC--CCChhhhhcC
Q 040898 276 EEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDE--RPSSKDVRSM 337 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~ell~~ 337 (337)
.+............. ...........+.+|+.+||..+|++ |+++.++++|
T Consensus 214 -----~~~~~~i~~~~~~~~------~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 214 -----VETYGKIMNHKERFQ------FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred -----HHHHHHHhCCCcccc------CCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 111111111111000 00111223445788888888654444 7899999987
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=288.20 Aligned_cols=258 Identities=22% Similarity=0.313 Sum_probs=204.0
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
++|++.+.||+|++|.||++.+.. ++..||+|.+.......... ...+..|+..++.++|||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~--~~~~~aiK~~~~~~~~~~~~----------------~~~~~~e~~~l~~l~~~~ 62 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKG--TGKLFALKVLDKKEMIKRNK----------------VKRVLTEQEILATLDHPF 62 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcC--CCcEEEEEEEeccccchHHH----------------HHHHHHHHHHHHhCCCCC
Confidence 469999999999999999998876 89999999987654322111 156788999999999999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
|+++++.+.++...++++||+.+++|.+++.. ..+..+++.....++.|++.+|.|| |+.|++|+||+|+||+++
T Consensus 63 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~l~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nili~ 137 (316)
T cd05574 63 LPTLYASFQTETYLCLVMDYCPGGELFRLLQR--QPGKCLSEEVARFYAAEVLLALEYL---HLLGIVYRDLKPENILLH 137 (316)
T ss_pred chhheeeeecCCEEEEEEEecCCCCHHHHHHh--CCCCccCHHHHHHHHHHHHHHHHHH---HHCCeeccCCChHHeEEc
Confidence 99999999999999999999999999999854 2345689999999999999999999 778999999999999999
Q ss_pred CCCCeEEecccCccccCCCCce---------------------------eeeecccCCCCccCccccccCCCCCcccchh
Q 040898 201 DDMEARISDFGHGKLMPDGHAQ---------------------------ITVKCMVGTMGYMAPESLQTETISDKCDIYS 253 (337)
Q Consensus 201 ~~~~~~l~dfg~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~Diws 253 (337)
.++.++|+|||++......... .......++..|+|||.+.+..++.++|+||
T Consensus 138 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~s 217 (316)
T cd05574 138 ESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWT 217 (316)
T ss_pred CCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHH
Confidence 9999999999987654322110 0011235788899999999888999999999
Q ss_pred hhHHHHHHHhCCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCC---
Q 040898 254 FGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPS--- 330 (337)
Q Consensus 254 lG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps--- 330 (337)
||+++|+|++|..||..... ...+..... .... ..........+.+++.+||..||++|||
T Consensus 218 lG~ll~~l~~g~~pf~~~~~---~~~~~~~~~----~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~ 281 (316)
T cd05574 218 LGILLYEMLYGTTPFKGSNR---DETFSNILK----KEVT---------FPGSPPVSSSARDLIRKLLVKDPSKRLGSKR 281 (316)
T ss_pred HHHHHHHHhhCCCCCCCCch---HHHHHHHhc----CCcc---------CCCccccCHHHHHHHHHHccCCHhHCCCchh
Confidence 99999999999999864322 111111111 0000 0001113456999999999999999999
Q ss_pred -hhhhhcC
Q 040898 331 -SKDVRSM 337 (337)
Q Consensus 331 -~~ell~~ 337 (337)
+.++++|
T Consensus 282 ~~~~ll~~ 289 (316)
T cd05574 282 GAAEIKQH 289 (316)
T ss_pred hHHHHHcC
Confidence 9999986
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=284.66 Aligned_cols=266 Identities=23% Similarity=0.287 Sum_probs=197.1
Q ss_pred cccccccceeccCcceEEEEeEEecC------------CCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHH
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPG------------SNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIR 107 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~------------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 107 (337)
..+|++.+.||+|+||.||++.+... .....||+|.+......... ..+.
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~------------------~~~~ 65 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTAR------------------NDFL 65 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHH------------------HHHH
Confidence 46899999999999999998876421 12345899988654332111 4678
Q ss_pred HHHHHHHhcCCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcC--------CcccCChHHHHHHHHHHHHHHHHH
Q 040898 108 SEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQ--------GRRELDWPARHRIARGIASGLEYL 179 (337)
Q Consensus 108 ~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~i~~~i~~~l~~l 179 (337)
+|++++++++|||++++++++...+..++||||+++++|.+++..... ....+++..++.++.|++.|+.||
T Consensus 66 ~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l 145 (295)
T cd05097 66 KEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL 145 (295)
T ss_pred HHHHHHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHH
Confidence 899999999999999999999999999999999999999999854211 112467888999999999999999
Q ss_pred hhCCCCCeEecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHH
Q 040898 180 HMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLA 259 (337)
Q Consensus 180 ~~~h~~gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~ 259 (337)
|+.|++|+||+|+||+++.++.++|+|||++................++..|+|||.+.+..++.++|+||||+++|
T Consensus 146 ---H~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~ 222 (295)
T cd05097 146 ---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLW 222 (295)
T ss_pred ---HhcCeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHH
Confidence 77899999999999999999999999999987654332222222234567899999998888999999999999999
Q ss_pred HHHh--CCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 260 VLVM--GKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 260 ~ll~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
+|++ +..||........................ ....+..+..+.+++.+||+.||++|||+.++++
T Consensus 223 el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 223 EMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIY----------LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHcCCCCCCcccChHHHHHHHHHhhhhcccccc----------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 9998 56777653221111111111100000000 0001112235999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=280.57 Aligned_cols=251 Identities=26% Similarity=0.419 Sum_probs=196.7
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++.++||+|+||.||++... +++.||+|.+....... ..+.+|+.+++.++|
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~---~~~~~a~K~~~~~~~~~--------------------~~~~~E~~~l~~l~h 60 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYN---GHTKVAIKSLKQGSMSP--------------------EAFLAEANLMKQLQH 60 (260)
T ss_pred chHHceeeeeeccCccceEEeeecC---CCceEEEEEecCCCCcH--------------------HHHHHHHHHHHhcCC
Confidence 4678999999999999999998764 67889999886443211 457779999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
||++++++++. ....++++||+++++|.+++.. ..+..+++..+..++.|++.+|.+| |+.|++|+||+|+||+
T Consensus 61 ~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~i~~al~~L---H~~~i~H~dl~p~ni~ 134 (260)
T cd05067 61 PRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKT--PEGIKLTINKLIDMAAQIAEGMAFI---ERKNYIHRDLRAANIL 134 (260)
T ss_pred cCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHH---hcCCeecccccHHhEE
Confidence 99999999764 5568999999999999998854 3345688899999999999999999 7789999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCchh
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHTEE 277 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~ 277 (337)
++.++.++|+|||.+......... ......++..|+|||.+.+..++.++|+||||+++|++++ |..||.....
T Consensus 135 i~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---- 209 (260)
T cd05067 135 VSETLCCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN---- 209 (260)
T ss_pred EcCCCCEEEccCcceeecCCCCcc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh----
Confidence 999999999999998765432211 1122345678999999988888999999999999999999 9999865322
Q ss_pred hhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 278 MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
......+....... .....+..+.+++.+||+.+|++|||++++++
T Consensus 210 ~~~~~~~~~~~~~~-------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 210 PEVIQNLERGYRMP-------------RPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHHHHHHcCCCCC-------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 11221111111000 01112345999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=296.26 Aligned_cols=245 Identities=22% Similarity=0.268 Sum_probs=186.2
Q ss_pred eccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc---CCCCcccce
Q 040898 49 IGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT---RHRNILPLL 125 (337)
Q Consensus 49 lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l---~hpniv~~~ 125 (337)
||+|+||+||++.+.. +++.||+|++......... .......|..++... .||||+.++
T Consensus 1 lG~G~~g~Vy~~~~~~--~~~~~avK~~~~~~~~~~~----------------~~~~~~~e~~~l~~~~~~~~p~i~~~~ 62 (330)
T cd05586 1 IGKGTFGQVYQVRKKD--TRRIYAMKVLSKKEIVAKK----------------EVAHTIGERNILVRTLLDESPFIVGLK 62 (330)
T ss_pred CCCCCceEEEEEEECC--CCCEEEEEEEeHHHHhhhh----------------HHHHHHHHHHHHHHhccCCCCcCcceE
Confidence 7999999999998876 8999999998543211111 112344455555554 799999999
Q ss_pred eEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCCe
Q 040898 126 AHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEA 205 (337)
Q Consensus 126 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~ 205 (337)
..+.++...|+||||+++++|.+++. ....+++..+..++.||+.||.|| |+.|++|+||+|+||+++.++.+
T Consensus 63 ~~~~~~~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qil~al~~L---H~~~ivHrDlkp~Nili~~~~~~ 135 (330)
T cd05586 63 FSFQTDSDLYLVTDYMSGGELFWHLQ----KEGRFSEDRAKFYIAELVLALEHL---HKYDIVYRDLKPENILLDATGHI 135 (330)
T ss_pred EEEecCCeEEEEEcCCCCChHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHH---HHCCeEeccCCHHHeEECCCCCE
Confidence 99999999999999999999998884 345689999999999999999999 67799999999999999999999
Q ss_pred EEecccCccccCCCCceeeeecccCCCCccCccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHHHHH
Q 040898 206 RISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTE-TISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWM 284 (337)
Q Consensus 206 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~ 284 (337)
+|+|||++........ ......|++.|+|||.+.+. .++.++|+||||+++|+|++|..||..... ... .
T Consensus 136 kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~----~~~---~ 206 (330)
T cd05586 136 ALCDFGLSKANLTDNK--TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT----QQM---Y 206 (330)
T ss_pred EEecCCcCcCCCCCCC--CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH----HHH---H
Confidence 9999999865332221 12235689999999998754 478999999999999999999999854211 111 1
Q ss_pred HhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCC----ChhhhhcC
Q 040898 285 RNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERP----SSKDVRSM 337 (337)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp----s~~ell~~ 337 (337)
........... .......+.+++.+||+.||.+|| ++.++++|
T Consensus 207 ~~i~~~~~~~~----------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 207 RNIAFGKVRFP----------KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred HHHHcCCCCCC----------CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 11111111000 011234478999999999999998 68888876
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=286.79 Aligned_cols=270 Identities=22% Similarity=0.295 Sum_probs=201.6
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
++|++.+.||+|++|.||++.+.. +++.|++|.+........ ....+.+|+.+++.++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~--~~~~v~vK~~~~~~~~~~-----------------~~~~~~~e~~~l~~l~~~~ 61 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKA--TGEIVAIKKFKESEDDED-----------------VKKTALREVKVLRQLRHEN 61 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCC--CCcEEEEehhhhhccccc-----------------chhHHHHHHHHHHhcCCCC
Confidence 479999999999999999998866 789999998865432111 0156788999999999999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
|+++++.+..++..++++||++++.+..+. .....+++..++.++.|++.++.+| |+.|++|+|++|+||+++
T Consensus 62 i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~~i~~~l~~L---H~~~i~H~dl~~~ni~~~ 134 (288)
T cd07833 62 IVNLKEAFRRKGRLYLVFEYVERTLLELLE----ASPGGLPPDAVRSYIWQLLQAIAYC---HSHNIIHRDIKPENILVS 134 (288)
T ss_pred eeehhheEEECCEEEEEEecCCCCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeEEC
Confidence 999999999999999999999987776655 3345588999999999999999999 677999999999999999
Q ss_pred CCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhh
Q 040898 201 DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTE-TISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMD 279 (337)
Q Consensus 201 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~ 279 (337)
+++.++|+|||.+......... ......++..|+|||.+.+. .++.++|+||+|+++|+|++|.+||...........
T Consensus 135 ~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~ 213 (288)
T cd07833 135 ESGVLKLCDFGFARALRARPAS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYL 213 (288)
T ss_pred CCCCEEEEeeecccccCCCccc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9999999999998776543321 12234578889999999887 788999999999999999999999865322111111
Q ss_pred HHHHHHhhh-------ccC-------CcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 280 MVKWMRNVI-------FSE-------NPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 280 ~~~~~~~~~-------~~~-------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
......... ... .+...................+.+++.+||+.+|++|||++++++|
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 214 IQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred HHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 111000000 000 0000000000000111225668999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=285.26 Aligned_cols=255 Identities=24% Similarity=0.413 Sum_probs=200.2
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++.+.||.|++|.||++.+.. ++..+|+|.+....... ...+.+|+.++++++|
T Consensus 3 ~~~~~~i~~~l~~g~~~~v~~~~~~~--~~~~~~iK~~~~~~~~~-------------------~~~~~~e~~~l~~l~h 61 (280)
T cd06611 3 PNDIWEIIGELGDGAFGKVYKAQHKE--TGLFAAAKIIQIESEEE-------------------LEDFMVEIDILSECKH 61 (280)
T ss_pred chhHHHHHHHhcCCCCceEEEEEEcC--CCcEEEEEEEeeCCHHH-------------------HHHHHHHHHHHHhCCC
Confidence 34679999999999999999998865 88999999986442211 1467789999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++.+..+...++||||+++++|.+++.. ....+++..+..++.|++.++.|| |+.|++|+||+|+||+
T Consensus 62 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~l---h~~~i~h~dl~p~nil 135 (280)
T cd06611 62 PNIVGLYEAYFYENKLWILIEFCDGGALDSIMLE---LERGLTEPQIRYVCRQMLEALNFL---HSHKVIHRDLKAGNIL 135 (280)
T ss_pred CceeEEEEEEecCCeEEEEeeccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCChhhEE
Confidence 9999999999999999999999999999998854 234689999999999999999999 7779999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccc-----cCCCCCcccchhhhHHHHHHHhCCCCCCCCCC
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQ-----TETISDKCDIYSFGVLLAVLVMGKFPVDDFFG 273 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~-----~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~ 273 (337)
++.++.++|+|||.+......... .....+++.|++||.+. ...++.++|+||+|+++|+|++|..||.....
T Consensus 136 i~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~ 213 (280)
T cd06611 136 LTLDGDVKLADFGVSAKNKSTLQK--RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP 213 (280)
T ss_pred ECCCCCEEEccCccchhhcccccc--cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH
Confidence 999999999999987664332211 12345788999999974 33467789999999999999999999865422
Q ss_pred CchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 274 HTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
. ..... ......+.. ..+......+.+++..||+.+|.+|||+.++++|
T Consensus 214 ~---~~~~~----~~~~~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 214 M---RVLLK----ILKSEPPTL--------DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred H---HHHHH----HhcCCCCCc--------CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 1 11111 111111000 0011223348899999999999999999999986
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=280.47 Aligned_cols=256 Identities=27% Similarity=0.444 Sum_probs=203.2
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
++|++.+.||+|++|.||++.+.. +++.+++|.+......... ..+.+|+.+++++.|||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~------------------~~~~~e~~~l~~~~~~~ 60 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRP--TGKIMAVKTIRLEINEAIQ------------------KQILRELDILHKCNSPY 60 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcC--CCcEEEEEEEecccChHHH------------------HHHHHHHHHHHHCCCCc
Confidence 468999999999999999998876 8999999988665432111 46778999999999999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCC-CCeEecCCCCCceee
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHR-PRLIHRDIKPANVLI 199 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~-~gi~h~di~~~nil~ 199 (337)
|+++++.+..+...++++||+++++|.+++... ...+++..+..++.|++.++.++ |+ .|++|+||+|+||++
T Consensus 61 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~l---H~~~~i~H~dl~~~ni~~ 134 (265)
T cd06605 61 IVGFYGAFYNNGDISICMEYMDGGSLDKILKEV---QGRIPERILGKIAVAVLKGLTYL---HEKHKIIHRDVKPSNILV 134 (265)
T ss_pred hhhhheeeecCCEEEEEEEecCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHH---cCCCCeecCCCCHHHEEE
Confidence 999999999999999999999999999998542 25688899999999999999999 77 899999999999999
Q ss_pred cCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhh
Q 040898 200 DDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMD 279 (337)
Q Consensus 200 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~ 279 (337)
+.++.++|+|||.+......... ...++..|+|||.+.+..++.++|+||+|+++|+|++|..||....... ..
T Consensus 135 ~~~~~~~l~d~g~~~~~~~~~~~----~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~ 208 (265)
T cd06605 135 NSRGQIKLCDFGVSGQLVNSLAK----TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP--DG 208 (265)
T ss_pred CCCCCEEEeecccchhhHHHHhh----cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc--cc
Confidence 99999999999987655322111 1467889999999998889999999999999999999999986542211 11
Q ss_pred HHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 280 MVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.............+.. ........+.+++.+||..||++|||+.++++|
T Consensus 209 ~~~~~~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 209 IFELLQYIVNEPPPRL---------PSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred HHHHHHHHhcCCCCCC---------ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 1122222211111110 001134458999999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=280.22 Aligned_cols=257 Identities=21% Similarity=0.355 Sum_probs=196.8
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
.+|+..+.||+|++|.||++.+.. ++..|++|++.......... .....+.+|+.++++++|||
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~--~~~~~~~k~~~~~~~~~~~~--------------~~~~~~~~e~~~l~~l~h~~ 65 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVD--TGRELAAKQVQFDPESPETS--------------KEVSALECEIQLLKNLQHER 65 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcC--CCcEEEEEEeecCcCCchhH--------------HHHHHHHHHHHHHHHcCCCC
Confidence 479999999999999999998876 89999999886543221111 01156788999999999999
Q ss_pred cccceeEEEc--CCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 121 ILPLLAHMVR--PNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 121 iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|+++++.+.+ ....++++||+++++|.+++.. ...+++...+.++.|++.++.+| |+.|++|+||+|+||+
T Consensus 66 i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~L---H~~~i~H~~l~p~nil 138 (266)
T cd06651 66 IVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYL---HSNMIVHRDIKGANIL 138 (266)
T ss_pred eeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCCHHHEE
Confidence 9999998865 3678899999999999999843 34578888999999999999999 7789999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCc-eeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchh
Q 040898 199 IDDDMEARISDFGHGKLMPDGHA-QITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEE 277 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~ 277 (337)
++.++.++|+|||++........ ........++..|+|||.+.+..++.++|+||+|+++|++++|..||..... .
T Consensus 139 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~---~ 215 (266)
T cd06651 139 RDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA---M 215 (266)
T ss_pred ECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch---H
Confidence 99999999999998875432111 1111223578889999999988889999999999999999999999865321 1
Q ss_pred hhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 278 MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.... ........ ...+......+.+++ +||..+|++|||+.|+++|
T Consensus 216 ~~~~----~~~~~~~~---------~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 216 AAIF----KIATQPTN---------PQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred HHHH----HHhcCCCC---------CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 1111 11111100 011122334467777 6788899999999999987
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=280.30 Aligned_cols=263 Identities=24% Similarity=0.364 Sum_probs=203.3
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
++|+..+.||.|++|.||++.+.. +++.+|+|.+......... ..+.+|+.+++.++|||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~--~~~~~~~k~~~~~~~~~~~------------------~~~~~e~~~l~~l~h~~ 60 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKN--TGMIFALKTITTDPNPDLQ------------------KQILRELEINKSCKSPY 60 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECC--CCeEEEEEEEecCCchHHH------------------HHHHHHHHHHHhCCCCC
Confidence 468999999999999999999876 8899999988654332111 56788999999999999
Q ss_pred cccceeEEEc--CCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 121 ILPLLAHMVR--PNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 121 iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|+++++++.+ .+..++||||+++++|.+++.........++...+..++.|++.+|.|| |+.|++|+||+|+||+
T Consensus 61 iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~l---H~~~i~H~dl~~~nil 137 (287)
T cd06621 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYL---HSRKIIHRDIKPSNIL 137 (287)
T ss_pred eeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEE
Confidence 9999998754 3478999999999999998876555566788899999999999999999 7789999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCC-chh
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGH-TEE 277 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~-~~~ 277 (337)
++.++.++|+|||++........ ....++..|++||.+.+..++.++|+||||+++|+|++|..||+..... ...
T Consensus 138 ~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~ 213 (287)
T cd06621 138 LTRKGQVKLCDFGVSGELVNSLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGP 213 (287)
T ss_pred EecCCeEEEeecccccccccccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCCh
Confidence 99999999999998765433221 1234678899999998888999999999999999999999999754221 111
Q ss_pred hhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 278 MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.+......... .+ .. .... .........+.+++.+||+.||++|||+.|+++|
T Consensus 214 ~~~~~~~~~~~---~~-~~-~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 214 IELLSYIVNMP---NP-EL-KDEP--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred HHHHHHHhcCC---ch-hh-ccCC--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 12222221111 00 00 0000 0001123558999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=281.40 Aligned_cols=249 Identities=24% Similarity=0.352 Sum_probs=194.7
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
.+|++.+.||+|++|.||++.+. ++..+|+|.+....... +.+.+|+.+++.++|||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~---~~~~~~iK~~~~~~~~~--------------------~~~~~e~~~l~~l~~~~ 60 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR---GKIDVAIKMIREGAMSE--------------------DDFIEEAKVMMKLSHPN 60 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec---CCccEEEEEeccCCCCH--------------------HHHHHHHHHHHhCCCCC
Confidence 45899999999999999998764 56689999875432211 35677999999999999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
|+++++++...+..++|+||+++++|.+++.. ....+++..+..++.|++.++.+| |+.|++|+||+|+||+++
T Consensus 61 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dl~p~ni~i~ 134 (256)
T cd05059 61 LVQLYGVCTKQRPIFIVTEYMANGCLLNYLRE---RKGKLGTEWLLDMCSDVCEAMEYL---ESNGFIHRDLAARNCLVG 134 (256)
T ss_pred EEEEEEEEcCCCceEEEEecCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHH---HHCCcccccccHhhEEEC
Confidence 99999999999999999999999999999854 233688999999999999999999 777999999999999999
Q ss_pred CCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCchhhh
Q 040898 201 DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHTEEMD 279 (337)
Q Consensus 201 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~~~ 279 (337)
.++.++|+|||.+......... ......++..|+|||.+.+..++.++|+||||+++|++++ |..||...... .
T Consensus 135 ~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----~ 209 (256)
T cd05059 135 EDNVVKVSDFGLARYVLDDQYT-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS----E 209 (256)
T ss_pred CCCcEEECCcccceeccccccc-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH----H
Confidence 9999999999988765432111 1111223457999999988889999999999999999999 78998653221 1
Q ss_pred HHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 280 MVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
....+.. ..... .+...+..+.+++.+||+.+|++|||+.++++
T Consensus 210 ~~~~~~~---~~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~ 253 (256)
T cd05059 210 VVESVSA---GYRLY----------RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLS 253 (256)
T ss_pred HHHHHHc---CCcCC----------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 1111111 10000 01113345899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=279.40 Aligned_cols=252 Identities=29% Similarity=0.435 Sum_probs=203.1
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
.++|++.+.||+|++|.||++.+.. +++.+++|.+..... ...+.+|+.+++.++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~--~~~~~~~k~~~~~~~---------------------~~~~~~e~~~~~~l~~~ 58 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKE--TGQVVAIKVVPVEED---------------------LQEIIKEISILKQCDSP 58 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcC--CCcEEEEEEeecHHH---------------------HHHHHHHHHHHHhCCCC
Confidence 4689999999999999999998875 789999998854321 15678899999999999
Q ss_pred CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceee
Q 040898 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI 199 (337)
Q Consensus 120 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~ 199 (337)
||+++++.+.++...|+++||+++++|.+++.. .+..+++..+..++.|++.++.+| |+.|++|+||+|+||++
T Consensus 59 ~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~l---h~~~i~H~dl~~~ni~~ 132 (256)
T cd06612 59 YIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYL---HSNKKIHRDIKAGNILL 132 (256)
T ss_pred cEeeeeeeeecCCcEEEEEecCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCcceEEE
Confidence 999999999999999999999999999999853 345689999999999999999999 67799999999999999
Q ss_pred cCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhh
Q 040898 200 DDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMD 279 (337)
Q Consensus 200 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~ 279 (337)
++++.++|+|||.+......... .....++..|+|||.+.+..++.++|+||+|+++|+|++|..||........
T Consensus 133 ~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~--- 207 (256)
T cd06612 133 NEEGQAKLADFGVSGQLTDTMAK--RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA--- 207 (256)
T ss_pred CCCCcEEEcccccchhcccCccc--cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh---
Confidence 99999999999998776443211 1234578899999999888899999999999999999999999865322110
Q ss_pred HHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 280 MVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.. ........ ...........+.+++.+||+.||++|||+.++++|
T Consensus 208 ~~----~~~~~~~~--------~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 208 IF----MIPNKPPP--------TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred hh----hhccCCCC--------CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 00 00000000 001112234558999999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=295.35 Aligned_cols=272 Identities=21% Similarity=0.280 Sum_probs=205.9
Q ss_pred cccccccccccccccccccceeccCcceEEEEeEEec---CCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHH
Q 040898 28 LVEKQDLAFLKKEDCFDSLKKIGSGGWGEVFYKAELP---GSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIG 104 (337)
Q Consensus 28 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 104 (337)
.....+.+|.-+.++|.+.+.||+|+||.||++.+.. ..++..||+|++........ ..
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~------------------~~ 85 (401)
T cd05107 24 MQLPYDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSE------------------KQ 85 (401)
T ss_pred CCCCCCCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhH------------------HH
Confidence 3344466677788899999999999999999988642 23567899999965432111 14
Q ss_pred hHHHHHHHHHhcC-CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcC----------------------------
Q 040898 105 AIRSEIITANQTR-HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQ---------------------------- 155 (337)
Q Consensus 105 ~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------------------------- 155 (337)
.+.+|+.++..+. ||||+++++.+......++|+||+++|+|.+++.....
T Consensus 86 ~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (401)
T cd05107 86 ALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRK 165 (401)
T ss_pred HHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccc
Confidence 5778999999997 99999999999999999999999999999999864211
Q ss_pred ------------------------------------------------------------------CcccCChHHHHHHH
Q 040898 156 ------------------------------------------------------------------GRRELDWPARHRIA 169 (337)
Q Consensus 156 ------------------------------------------------------------------~~~~~~~~~~~~i~ 169 (337)
....+++..+..++
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 245 (401)
T cd05107 166 SHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFS 245 (401)
T ss_pred cchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHH
Confidence 11235666788899
Q ss_pred HHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcc
Q 040898 170 RGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKC 249 (337)
Q Consensus 170 ~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~ 249 (337)
.|++.||.|| |+.|++|+||+|+||+++.++.++|+|||++................+++.|+|||.+.+..++.++
T Consensus 246 ~qi~~aL~~L---H~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 322 (401)
T cd05107 246 YQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLS 322 (401)
T ss_pred HHHHHHHHHH---hcCCcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHh
Confidence 9999999999 7789999999999999999999999999998764332221111223467889999999888889999
Q ss_pred cchhhhHHHHHHHh-CCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCC
Q 040898 250 DIYSFGVLLAVLVM-GKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDER 328 (337)
Q Consensus 250 DiwslG~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 328 (337)
|+||+|+++|+|++ |..||....... .....+.. .... ..+......+.+++.+||+.+|.+|
T Consensus 323 DvwslGvil~e~l~~g~~P~~~~~~~~---~~~~~~~~---~~~~----------~~p~~~~~~l~~li~~cl~~~P~~R 386 (401)
T cd05107 323 DVWSFGILLWEIFTLGGTPYPELPMNE---QFYNAIKR---GYRM----------AKPAHASDEIYEIMQKCWEEKFEIR 386 (401)
T ss_pred HHHHHHHHHHHHHHcCCCCCCCCCchH---HHHHHHHc---CCCC----------CCCCCCCHHHHHHHHHHcCCChhHC
Confidence 99999999999998 889986532211 11111111 1000 0011223458999999999999999
Q ss_pred CChhhhhc
Q 040898 329 PSSKDVRS 336 (337)
Q Consensus 329 ps~~ell~ 336 (337)
||+.+|++
T Consensus 387 Ps~~ell~ 394 (401)
T cd05107 387 PDFSQLVH 394 (401)
T ss_pred cCHHHHHH
Confidence 99999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=282.92 Aligned_cols=253 Identities=23% Similarity=0.326 Sum_probs=192.9
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCc----eEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHh
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGK----MIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQ 115 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~ 115 (337)
.++|++.+.||+|+||.||++.+.. +++ .+++|.+........ ...+..|+..+..
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~--~~~~~~~~~~~k~~~~~~~~~~------------------~~~~~~~~~~l~~ 65 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIP--EGDSIKIPVAIKTIQDRSGRQT------------------FQEITDHMLAMGS 65 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcC--CCCceeeEEEEeecccccchHH------------------HHHHHHHHHHHhc
Confidence 3579999999999999999998865 454 467777643221110 1456678888999
Q ss_pred cCCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCC
Q 040898 116 TRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPA 195 (337)
Q Consensus 116 l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ 195 (337)
++||||+++++++. +...++++||+++|+|.+++.. ....+++..+..++.|++.|+.|+ |+.|++|+||+|+
T Consensus 66 l~h~~iv~~~~~~~-~~~~~~i~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~l---H~~~iiH~dlkp~ 138 (279)
T cd05111 66 LDHAYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYL---EEHRMVHRNLAAR 138 (279)
T ss_pred CCCCCcceEEEEEC-CCccEEEEEeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHH---HHCCEeccccCcc
Confidence 99999999999875 4567899999999999999853 334688999999999999999999 7779999999999
Q ss_pred ceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCC
Q 040898 196 NVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGH 274 (337)
Q Consensus 196 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~ 274 (337)
||+++.++.++|+|||.+................++..|++||.+.+..++.++|+||||+++|++++ |..||.....
T Consensus 139 nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~- 217 (279)
T cd05111 139 NILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP- 217 (279)
T ss_pred eEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH-
Confidence 99999999999999999876543332222233456778999999988889999999999999999998 9999865322
Q ss_pred chhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 275 TEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
....+.+........+ ......+.+++.+|+..||++|||+.|+++
T Consensus 218 ---~~~~~~~~~~~~~~~~-------------~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 218 ---HEVPDLLEKGERLAQP-------------QICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred ---HHHHHHHHCCCcCCCC-------------CCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 1122222111110000 011234788999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=285.15 Aligned_cols=266 Identities=23% Similarity=0.303 Sum_probs=198.4
Q ss_pred cccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCc
Q 040898 42 CFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNI 121 (337)
Q Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpni 121 (337)
+|++.+.||.|++|.||++.+.. +++.|++|.+..+...... ...+.+|++++++++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~~i 61 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKL--TGEVVALKKIRLDTETEGV-----------------PSTAIREISLLKELNHPNI 61 (284)
T ss_pred CceeeeeecCCCceEEEEEEECC--CCCEEEEEEcccccccccc-----------------chHHHHHHHHHHhcCCCCC
Confidence 48999999999999999998865 8999999988654322110 0457789999999999999
Q ss_pred ccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecC
Q 040898 122 LPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDD 201 (337)
Q Consensus 122 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~ 201 (337)
+++++++.+++..++++||++ ++|..++.. ..+..+++..+..++.|++.|+.|| |+.|++|+||+|+||+++.
T Consensus 62 ~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~--~~~~~l~~~~~~~~~~~i~~~l~~l---h~~~i~H~~l~p~nill~~ 135 (284)
T cd07860 62 VKLLDVIHTENKLYLVFEFLH-QDLKKFMDA--SPLSGIPLPLIKSYLFQLLQGLAFC---HSHRVLHRDLKPQNLLINT 135 (284)
T ss_pred cchhhhcccCCcEEEEeeccc-cCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECC
Confidence 999999999999999999996 588888754 3345688999999999999999999 6779999999999999999
Q ss_pred CCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCC-CCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhH
Q 040898 202 DMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTET-ISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDM 280 (337)
Q Consensus 202 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~ 280 (337)
++.++|+|||++......... .....+++.|+|||.+.+.. ++.++|+||||+++|+|+||..||.... .....
T Consensus 136 ~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~---~~~~~ 210 (284)
T cd07860 136 EGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS---EIDQL 210 (284)
T ss_pred CCCEEEeeccchhhcccCccc--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC---HHHHH
Confidence 999999999988765432211 12234678899999886644 5788999999999999999999986432 22222
Q ss_pred HHHHHhhhccCCc--------------chhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 281 VKWMRNVIFSENP--------------NRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 281 ~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
............. .............+.....+.+++.+||+.||.+|||+.++++|
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 211 FRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 2211111100000 00000000000111233457899999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=283.36 Aligned_cols=257 Identities=24% Similarity=0.371 Sum_probs=199.1
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc-C
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT-R 117 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~ 117 (337)
+.++|++.+.||+|+||.||++.+.. +++.+|+|.+....... ..+.+|+.++..+ +
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~--~~~~~aik~~~~~~~~~--------------------~~~~~e~~~l~~l~~ 77 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKK--DGSLAAVKILDPISDVD--------------------EEIEAEYNILQSLPN 77 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECC--CCCEEEEEEecccccHH--------------------HHHHHHHHHHHHhcC
Confidence 68889999999999999999998876 89999999885432110 3456788888888 8
Q ss_pred CCCcccceeEEEcC-----CeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 040898 118 HRNILPLLAHMVRP-----NCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDI 192 (337)
Q Consensus 118 hpniv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di 192 (337)
|||++++++++... ...++|+||+++++|.+++.........+++..++.++.|++.+|.+| |+.|++|+||
T Consensus 78 h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~ivH~dl 154 (291)
T cd06639 78 HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHL---HNNRIIHRDV 154 (291)
T ss_pred CCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCC
Confidence 99999999988653 358999999999999998865444556789999999999999999999 6779999999
Q ss_pred CCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccC-----CCCCcccchhhhHHHHHHHhCCCC
Q 040898 193 KPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTE-----TISDKCDIYSFGVLLAVLVMGKFP 267 (337)
Q Consensus 193 ~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-----~~~~~~DiwslG~i~~~ll~g~~p 267 (337)
+|+||+++.++.++|+|||.+......... .....++..|+|||.+... .++.++|+||+|+++|+|++|.+|
T Consensus 155 kp~nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p 232 (291)
T cd06639 155 KGNNILLTTEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPP 232 (291)
T ss_pred CHHHEEEcCCCCEEEeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCC
Confidence 999999999999999999998765432211 1224578889999997543 257899999999999999999999
Q ss_pred CCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 268 VDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 268 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
|...... .... .......+. . ...+.....+.+++.+||+.||++|||+.++++|
T Consensus 233 ~~~~~~~---~~~~----~~~~~~~~~-~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 233 LFDMHPV---KTLF----KIPRNPPPT-L-------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred CCCCcHH---HHHH----HHhcCCCCC-C-------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 8653221 1111 111111110 0 0011223458999999999999999999999987
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=290.51 Aligned_cols=263 Identities=21% Similarity=0.310 Sum_probs=197.1
Q ss_pred cccccccccceeccCcceEEEEeEEec---CCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHH
Q 040898 38 KKEDCFDSLKKIGSGGWGEVFYKAELP---GSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITAN 114 (337)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~ 114 (337)
-+.++|++.+.||+|+||.||++.+.. ..+++.||+|.+........ ...+.+|+.++.
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~------------------~~~~~~E~~~l~ 65 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE------------------HRALMSELKILI 65 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHH------------------HHHHHHHHHHHH
Confidence 356789999999999999999987542 23678999999865432211 146778999999
Q ss_pred hc-CCCCcccceeEEEc-CCeeEEEEEeccCCCHHHHHHHhcC-------------------------------------
Q 040898 115 QT-RHRNILPLLAHMVR-PNCHLLVYEFMKNGSLQDILYDVSQ------------------------------------- 155 (337)
Q Consensus 115 ~l-~hpniv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~------------------------------------- 155 (337)
++ .||||+++++++.. +...+++|||+++|+|.+++.....
T Consensus 66 ~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (343)
T cd05103 66 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQ 145 (343)
T ss_pred hccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhcccccccc
Confidence 99 68999999998765 4567899999999999999864211
Q ss_pred --------------------------CcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCCeEEec
Q 040898 156 --------------------------GRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISD 209 (337)
Q Consensus 156 --------------------------~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~~l~d 209 (337)
....+++..+..++.|++.||.|| |+.|++|+||+|+||+++.++.++|+|
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~i~H~dikp~Nil~~~~~~~kl~d 222 (343)
T cd05103 146 SSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICD 222 (343)
T ss_pred ccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCccCeEEEcCCCcEEEEe
Confidence 012367778889999999999999 778999999999999999999999999
Q ss_pred ccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCchhhhHHHHHHhhh
Q 040898 210 FGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHTEEMDMVKWMRNVI 288 (337)
Q Consensus 210 fg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~ 288 (337)
||++................++..|+|||.+.+..++.++|+||||+++|++++ |..||...... ...........
T Consensus 223 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~~~~~ 299 (343)
T cd05103 223 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID---EEFCRRLKEGT 299 (343)
T ss_pred cccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc---HHHHHHHhccC
Confidence 999876533222111122335667999999988889999999999999999997 89998653221 11111111110
Q ss_pred ccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 289 FSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
....+ ......+.+++..||+.||.+|||+.++++|
T Consensus 300 ~~~~~-------------~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 300 RMRAP-------------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred CCCCC-------------CCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 00000 0112348899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=278.90 Aligned_cols=253 Identities=27% Similarity=0.385 Sum_probs=200.9
Q ss_pred ceeccCcceEEEEeEEecC-CCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCcccce
Q 040898 47 KKIGSGGWGEVFYKAELPG-SNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLL 125 (337)
Q Consensus 47 ~~lg~G~~g~V~~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~ 125 (337)
+.||+|+||.||.+.+... ..+..+++|.+........ ...+.+|+..+..++|||+++++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~------------------~~~~~~e~~~l~~~~~~~i~~~~ 62 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEE------------------RKDFLKEARVMKKLGHPNVVRLL 62 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhH------------------HHHHHHHHHHHhhcCCCChheee
Confidence 4799999999999988752 2388999999865543220 15678899999999999999999
Q ss_pred eEEEcCCeeEEEEEeccCCCHHHHHHHhcCC-----cccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 126 AHMVRPNCHLLVYEFMKNGSLQDILYDVSQG-----RRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 126 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
+++.++...++++||+++++|.+++...... ...+++..++.++.|++.|+.+| |++|++|+||+|+||+++
T Consensus 63 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~l---H~~~i~H~di~p~nili~ 139 (262)
T cd00192 63 GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL---ASKKFVHRDLAARNCLVG 139 (262)
T ss_pred eeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHH---HcCCcccCccCcceEEEC
Confidence 9999999999999999999999999653211 46789999999999999999999 778999999999999999
Q ss_pred CCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCchhhh
Q 040898 201 DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHTEEMD 279 (337)
Q Consensus 201 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~~~ 279 (337)
.++.++|+|||.+................+++.|+|||.+....++.++|+||||+++|+|++ |..||..... ..
T Consensus 140 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~~ 215 (262)
T cd00192 140 EDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN----EE 215 (262)
T ss_pred CCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH----HH
Confidence 999999999999887654432222233457889999999988889999999999999999999 6999876421 12
Q ss_pred HHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 280 MVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
....+.. .... ..+...+..+.+++.+||..||.+|||+.+++++
T Consensus 216 ~~~~~~~---~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 216 VLEYLRK---GYRL----------PKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHHHHc---CCCC----------CCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 2222111 1000 1111224458999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=278.70 Aligned_cols=254 Identities=25% Similarity=0.377 Sum_probs=200.5
Q ss_pred cccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCc
Q 040898 42 CFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNI 121 (337)
Q Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpni 121 (337)
+|+..+.||+|++|.||++.+.. ++..|++|.+.......... .....+.+|+.+++.++||||
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~--~~~~~~ik~~~~~~~~~~~~--------------~~~~~~~~e~~~l~~~~h~~i 64 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLD--DGDFFAVKEVSLADDGQTGQ--------------EAVKQLEQEIALLSKLQHPNI 64 (258)
T ss_pred CccccceeeecCCceEEEEEEcC--CCcEEEEEEEEEccccccch--------------HHHHHHHHHHHHHHhcCCCCc
Confidence 58889999999999999998865 88999999886543221110 011567889999999999999
Q ss_pred ccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecC
Q 040898 122 LPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDD 201 (337)
Q Consensus 122 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~ 201 (337)
+++++++.++...++++||+++++|.+++.. ...+++..+..++.|++.++.+| |+.|++|+||+|+||+++.
T Consensus 65 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~~~ni~~~~ 137 (258)
T cd06632 65 VQYLGTEREEDNLYIFLELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYL---HDRNTVHRDIKGANILVDT 137 (258)
T ss_pred hheeeeEecCCeEEEEEEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECC
Confidence 9999999999999999999999999999843 34588899999999999999999 6779999999999999999
Q ss_pred CCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCC-CCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhH
Q 040898 202 DMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTET-ISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDM 280 (337)
Q Consensus 202 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~ 280 (337)
++.++|+|||.+....... ......++..|++||.+.... ++.++|+||+|+++|++++|..||..... ....
T Consensus 138 ~~~~kl~d~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~---~~~~ 211 (258)
T cd06632 138 NGVVKLADFGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG---VAAV 211 (258)
T ss_pred CCCEEEccCccceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH---HHHH
Confidence 9999999999887654332 122345788899999987666 88999999999999999999999876431 1111
Q ss_pred HHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 281 VKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
..... ....+ ..++.....+.+++.+||+.+|.+|||+.++++|
T Consensus 212 ~~~~~---~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 212 FKIGR---SKELP----------PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred HHHHh---cccCC----------CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 11110 00000 0111233458899999999999999999999986
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=278.82 Aligned_cols=248 Identities=23% Similarity=0.297 Sum_probs=191.5
Q ss_pred ceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCccccee
Q 040898 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLLA 126 (337)
Q Consensus 47 ~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~ 126 (337)
+.||+|+||.||++.+....++..+|+|++......... .+.+..|+.+++.++||||+++++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~-----------------~~~~~~e~~~l~~l~h~~i~~~~~ 63 (257)
T cd05116 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPAL-----------------KDELLREANVMQQLDNPYIVRMIG 63 (257)
T ss_pred CcCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHH-----------------HHHHHHHHHHHHhCCCCCcceEEE
Confidence 368999999999987654457899999988644322111 156788999999999999999999
Q ss_pred EEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCCeE
Q 040898 127 HMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEAR 206 (337)
Q Consensus 127 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~~ 206 (337)
++. ....++|+||+++++|.+++.. ...+++..+..++.|++.|+.++ |++|++|+||+|+||+++.++.++
T Consensus 64 ~~~-~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~l---H~~~i~H~dlkp~nill~~~~~~k 135 (257)
T cd05116 64 ICE-AESWMLVMELAELGPLNKFLQK----NKHVTEKNITELVHQVSMGMKYL---EETNFVHRDLAARNVLLVTQHYAK 135 (257)
T ss_pred EEc-CCCcEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCEeecccchhhEEEcCCCeEE
Confidence 875 4567899999999999999843 34688999999999999999999 778999999999999999999999
Q ss_pred EecccCccccCCCCceee-eecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCchhhhHHHHH
Q 040898 207 ISDFGHGKLMPDGHAQIT-VKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHTEEMDMVKWM 284 (337)
Q Consensus 207 l~dfg~~~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~ 284 (337)
|+|||.+........... .....++..|+|||.+....++.++|+||||+++|+|++ |..||..... ......+
T Consensus 136 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~~~~i 211 (257)
T cd05116 136 ISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG----NEVTQMI 211 (257)
T ss_pred ECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHH
Confidence 999999877654332211 112234578999999988888899999999999999998 9999865322 1222222
Q ss_pred HhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 285 RNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
....... .+...+..+.+++.+||+.||++|||+.+|.+
T Consensus 212 ~~~~~~~-------------~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 212 ESGERME-------------CPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred HCCCCCC-------------CCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 2111111 11123345889999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=279.10 Aligned_cols=253 Identities=19% Similarity=0.308 Sum_probs=201.0
Q ss_pred cccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCc
Q 040898 42 CFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNI 121 (337)
Q Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpni 121 (337)
+|++.+.||+|+||.+|.+.+.. +++.|++|.+......... ...+.+|+.+++.++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~--~~~~~~ik~~~~~~~~~~~-----------------~~~~~~e~~~l~~l~~~~i 61 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKE--DGKQYVIKEINISKMSPKE-----------------REESRKEVAVLSNMKHPNI 61 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcC--CCCEEEEEEEEhHhCChHH-----------------HHHHHHHHHHHHhCCCCCe
Confidence 58999999999999999988876 8999999998653221111 1467789999999999999
Q ss_pred ccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecC
Q 040898 122 LPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDD 201 (337)
Q Consensus 122 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~ 201 (337)
+++.+.+...+..++|+||+++++|.+++.. .....+++..+..++.|++.++.++ |+.|++|+||+|+||+++.
T Consensus 62 ~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~l---h~~~i~h~~l~~~nil~~~ 136 (256)
T cd08218 62 VQYQESFEENGNLYIVMDYCEGGDLYKKINA--QRGVLFPEDQILDWFVQICLALKHV---HDRKILHRDIKSQNIFLTK 136 (256)
T ss_pred eeeEeeecCCCeEEEEEecCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHEEEcC
Confidence 9999999999999999999999999998854 2334578889999999999999999 6779999999999999999
Q ss_pred CCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHH
Q 040898 202 DMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMV 281 (337)
Q Consensus 202 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~ 281 (337)
++.++|+|||.+......... .....+++.|+|||.+.+..++.++|+||+|++++++++|..||.... ..+.
T Consensus 137 ~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~----~~~~- 209 (256)
T cd08218 137 DGTIKLGDFGIARVLNSTVEL--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN----MKNL- 209 (256)
T ss_pred CCCEEEeeccceeecCcchhh--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC----HHHH-
Confidence 999999999998765433211 112357888999999988888999999999999999999999985421 1111
Q ss_pred HHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 282 KWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.........+. .+......+.+++.+||+.+|.+||++.++++|
T Consensus 210 --~~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 210 --VLKIIRGSYPP----------VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred --HHHHhcCCCCC----------CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 11111111110 111223458999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=276.69 Aligned_cols=252 Identities=21% Similarity=0.300 Sum_probs=200.1
Q ss_pred cccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCc
Q 040898 42 CFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNI 121 (337)
Q Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpni 121 (337)
+|++.+.||+|++|.||++.+.. +++.+++|.+........ ....+.+|+.+++.++|||+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~-----------------~~~~~~~e~~~l~~~~~~~i 61 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKA--DQKLVIIKQIPVEQMTKD-----------------ERLAAQNECQVLKLLSHPNI 61 (256)
T ss_pred CceEEEEecccCceEEEEEEEcC--CCcEEEEEEEeccccccH-----------------HHHHHHHHHHHHhhCCCCch
Confidence 58999999999999999998876 899999999865432111 11567889999999999999
Q ss_pred ccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecC
Q 040898 122 LPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDD 201 (337)
Q Consensus 122 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~ 201 (337)
+++++.+..++..++|+||+++++|.+++.. .....+++..+..++.+++.++.+| |++|++|+||+|+||+++.
T Consensus 62 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~l---h~~~i~h~dl~~~nil~~~ 136 (256)
T cd08220 62 IEYYENFLEDKALMIVMEYAPGGTLAEYIQK--RCNSLLDEDTILHFFVQILLALHHV---HTKLILHRDLKTQNILLDK 136 (256)
T ss_pred hheeeeEecCCEEEEEEecCCCCCHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcC
Confidence 9999999999999999999999999999965 2344588899999999999999999 7789999999999999986
Q ss_pred CC-CeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhH
Q 040898 202 DM-EARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDM 280 (337)
Q Consensus 202 ~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~ 280 (337)
++ .++|+|||.+......... ....++..|+|||.+.+..++.++|+||+|+++|+|++|..||+.... ...
T Consensus 137 ~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~----~~~ 209 (256)
T cd08220 137 HKMVVKIGDFGISKILSSKSKA---YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL----PAL 209 (256)
T ss_pred CCCEEEEccCCCceecCCCccc---cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch----HHH
Confidence 54 5799999998776443211 224578899999999888889999999999999999999999865321 111
Q ss_pred HHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 281 VKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.... ...... .........+.+++.+||+.||.+|||+.++++|
T Consensus 210 ~~~~---~~~~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 210 VLKI---MSGTFA----------PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred HHHH---HhcCCC----------CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1111 111100 0011123448899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=284.10 Aligned_cols=268 Identities=23% Similarity=0.292 Sum_probs=194.0
Q ss_pred ccc-cccceeccCcceEEEEeEEe--cCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC
Q 040898 41 DCF-DSLKKIGSGGWGEVFYKAEL--PGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR 117 (337)
Q Consensus 41 ~~y-~~~~~lg~G~~g~V~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 117 (337)
++| ++.+.||+|+||.||++... ...++..||+|.+......... ..+.+|+.+++.++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~------------------~~~~~E~~~l~~l~ 64 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNT------------------SGWKKEINILKTLY 64 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHH------------------HHHHHHHHHHHhCC
Confidence 455 99999999999999875432 2347889999988654321111 46778999999999
Q ss_pred CCCcccceeEEEcC--CeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCC
Q 040898 118 HRNILPLLAHMVRP--NCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPA 195 (337)
Q Consensus 118 hpniv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ 195 (337)
||||+++++++... ...+++|||+++++|.+++.. ..+++..++.++.|++.|+.+| |+.|++|+||+|+
T Consensus 65 h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~l---H~~~i~H~dlkp~ 136 (283)
T cd05080 65 HENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYL---HSQHYIHRDLAAR 136 (283)
T ss_pred CCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHH---HHCCeeccccChh
Confidence 99999999987653 468999999999999999843 3489999999999999999999 6779999999999
Q ss_pred ceeecCCCCeEEecccCccccCCCCceee-eecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCC
Q 040898 196 NVLIDDDMEARISDFGHGKLMPDGHAQIT-VKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGH 274 (337)
Q Consensus 196 nil~~~~~~~~l~dfg~~~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~ 274 (337)
||+++.++.++|+|||++........... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||......
T Consensus 137 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~ 216 (283)
T cd05080 137 NVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK 216 (283)
T ss_pred eEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch
Confidence 99999999999999999876644322111 11223556699999998888899999999999999999999998543211
Q ss_pred chhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 275 TEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
. ..........................+.+...+..+.+++..||+.||++|||+.++++
T Consensus 217 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 217 F--EEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred h--hhhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0 00000000000000000000000001111223456899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=283.19 Aligned_cols=258 Identities=22% Similarity=0.336 Sum_probs=197.5
Q ss_pred cccccccceeccCcceEEEEeEEe---cCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAEL---PGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT 116 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 116 (337)
..+|...++||+|+||.||++... ...++..+++|.+....... ...+.+|+..++.+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~-------------------~~~~~~e~~~l~~l 64 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESA-------------------RQDFQREAELLTVL 64 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHH-------------------HHHHHHHHHHHhcC
Confidence 457889999999999999988653 22356788898875432111 15678899999999
Q ss_pred CCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcC-----------CcccCChHHHHHHHHHHHHHHHHHhhCCCC
Q 040898 117 RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQ-----------GRRELDWPARHRIARGIASGLEYLHMCHRP 185 (337)
Q Consensus 117 ~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~ 185 (337)
+||||+++++++.++...++++||+++++|.+++..... ....+++..+..++.|++.|+.|| |+.
T Consensus 65 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L---H~~ 141 (280)
T cd05092 65 QHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYL---ASL 141 (280)
T ss_pred CCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHH---HHC
Confidence 999999999999999999999999999999999865321 113478899999999999999999 677
Q ss_pred CeEecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-C
Q 040898 186 RLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-G 264 (337)
Q Consensus 186 gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g 264 (337)
|++|+||+|+||++++++.++|+|||++................+++.|+|||.+.+..++.++|+||||+++|+|++ |
T Consensus 142 ~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g 221 (280)
T cd05092 142 HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYG 221 (280)
T ss_pred CeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCC
Confidence 999999999999999999999999999875543322222222345678999999998889999999999999999998 8
Q ss_pred CCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 265 KFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 265 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
.+||..... ......... ..... .+...+..+.+++.+||+.||.+|||+.++++
T Consensus 222 ~~p~~~~~~----~~~~~~~~~---~~~~~----------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 222 KQPWYQLSN----TEAIECITQ---GRELE----------RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred CCCCccCCH----HHHHHHHHc---CccCC----------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 999854322 111111111 11100 00112234889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=287.57 Aligned_cols=266 Identities=20% Similarity=0.262 Sum_probs=188.8
Q ss_pred cceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCcccce
Q 040898 46 LKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLL 125 (337)
Q Consensus 46 ~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~ 125 (337)
..+||+|+||.||++.+....++..||+|.+...... ..+.+|+.+++.++||||++++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~---------------------~~~~~E~~~l~~l~h~niv~~~ 64 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS---------------------MSACREIALLRELKHPNVIALQ 64 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc---------------------HHHHHHHHHHHhCCCCCeeeEE
Confidence 3689999999999998766567789999988543211 3466799999999999999999
Q ss_pred eEEEc--CCeeEEEEEeccCCCHHHHHHHhc-----CCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 126 AHMVR--PNCHLLVYEFMKNGSLQDILYDVS-----QGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 126 ~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
+++.. +...++++||+++ +|.+++.... .....+++..+..++.|++.||.|| |+.|++|+||||+||+
T Consensus 65 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~l---H~~~ivH~Dlkp~Nil 140 (317)
T cd07867 65 KVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL---HANWVLHRDLKPANIL 140 (317)
T ss_pred EEEeccCCCeEEEEEeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHH---HhCCEEcCCCCHHHEE
Confidence 98853 5678999999875 7777764321 1233578889999999999999999 7789999999999999
Q ss_pred e----cCCCCeEEecccCccccCCCCce-eeeecccCCCCccCcccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCC
Q 040898 199 I----DDDMEARISDFGHGKLMPDGHAQ-ITVKCMVGTMGYMAPESLQT-ETISDKCDIYSFGVLLAVLVMGKFPVDDFF 272 (337)
Q Consensus 199 ~----~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~i~~~ll~g~~pf~~~~ 272 (337)
+ +.++.++|+|||++......... .......+++.|+|||.+.+ ..++.++|+||+|+++|+|+||.+||....
T Consensus 141 ~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 141 VMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred EccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 9 45678999999999866443221 11223467899999999876 457889999999999999999999996432
Q ss_pred CCch------hhhHHHHHHhhhccCCcc-----------hhhhhc-------------ccCCchHHHHHHHHHHHhhhcc
Q 040898 273 GHTE------EMDMVKWMRNVIFSENPN-----------RAINSK-------------LLGNGYEEQMLLVLKLACFCTL 322 (337)
Q Consensus 273 ~~~~------~~~~~~~~~~~~~~~~~~-----------~~~~~~-------------~~~~~~~~~~~~l~~li~~~l~ 322 (337)
.... ...+...... ....... ...... ............+.+|+.+||+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~ 299 (317)
T cd07867 221 EDIKTSNPFHHDQLDRIFSV-MGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLT 299 (317)
T ss_pred ccccccccccHHHHHHHHHh-cCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhc
Confidence 2110 0001110000 0000000 000000 0000001122347889999999
Q ss_pred CCCCCCCChhhhhcC
Q 040898 323 KDPDERPSSKDVRSM 337 (337)
Q Consensus 323 ~dP~~Rps~~ell~~ 337 (337)
.||++|||+.|+|+|
T Consensus 300 ~dP~~R~t~~e~l~h 314 (317)
T cd07867 300 MDPTKRITSEQALQD 314 (317)
T ss_pred cCcccccCHHHHhcC
Confidence 999999999999987
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=283.78 Aligned_cols=268 Identities=21% Similarity=0.279 Sum_probs=198.2
Q ss_pred cccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC
Q 040898 38 KKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR 117 (337)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 117 (337)
.+-++|++.+.||+|++|.||++.+.. +++.||+|.+......... ..+.+|+.++++++
T Consensus 2 ~~~~~y~~~~~lg~g~~~~vy~~~~~~--~~~~~~iK~~~~~~~~~~~------------------~~~~~E~~~l~~l~ 61 (291)
T cd07844 2 GKLETYKKLDKLGEGSYATVYKGRSKL--TGQLVALKEIRLEHEEGAP------------------FTAIREASLLKDLK 61 (291)
T ss_pred CCccceeEEEEEeecCCeEEEEEEEcC--CCcEEEEEEEecccccCCc------------------hhHHHHHHHHhhCC
Confidence 345789999999999999999998865 8899999998654322111 24567999999999
Q ss_pred CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCce
Q 040898 118 HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANV 197 (337)
Q Consensus 118 hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ni 197 (337)
||||+++++++.+++..++|+||+++ +|.+++.. ....+++..+..++.|+++||.|| |+.|++|+||+|+||
T Consensus 62 h~~i~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~---~~~~~~~~~~~~~~~ql~~al~~l---H~~~i~H~dl~p~ni 134 (291)
T cd07844 62 HANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDD---CGGGLSMHNVRLFLFQLLRGLAYC---HQRRVLHRDLKPQNL 134 (291)
T ss_pred CcceeeEEEEEecCCeEEEEEecCCC-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHH---HhCCeecccCCHHHE
Confidence 99999999999999999999999985 89888753 234688999999999999999999 778999999999999
Q ss_pred eecCCCCeEEecccCccccCCCCceeeeecccCCCCccCcccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCCCch
Q 040898 198 LIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQT-ETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTE 276 (337)
Q Consensus 198 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~ 276 (337)
+++.++.++|+|||.+......... .....++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||.......
T Consensus 135 l~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~- 211 (291)
T cd07844 135 LISERGELKLADFGLARAKSVPSKT--YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE- 211 (291)
T ss_pred EEcCCCCEEECccccccccCCCCcc--ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH-
Confidence 9999999999999988654322111 112346788999999865 457889999999999999999999996543211
Q ss_pred hhhHHHHHHhhhccCCcch----------------hhhhcccCCchHHHH--HHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 277 EMDMVKWMRNVIFSENPNR----------------AINSKLLGNGYEEQM--LLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~--~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
+....+........... ...........+... ..+.+++.+||+.||++|||+.++++|
T Consensus 212 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 212 --DQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred --HHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 11111111110000000 000000000000111 457899999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=286.98 Aligned_cols=264 Identities=23% Similarity=0.323 Sum_probs=200.0
Q ss_pred ccccccccccccceeccCcceEEEEeEEec-----CCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHH
Q 040898 35 AFLKKEDCFDSLKKIGSGGWGEVFYKAELP-----GSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSE 109 (337)
Q Consensus 35 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e 109 (337)
+|.-..++|.+.+.||+|+||.||++.+.. ......+|+|.+........ ...+..|
T Consensus 6 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~------------------~~~~~~E 67 (314)
T cd05099 6 KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKD------------------LADLISE 67 (314)
T ss_pred cccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHH------------------HHHHHHH
Confidence 344455789999999999999999987632 12456789998764432111 1457789
Q ss_pred HHHHHhc-CCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcC------------CcccCChHHHHHHHHHHHHHH
Q 040898 110 IITANQT-RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQ------------GRRELDWPARHRIARGIASGL 176 (337)
Q Consensus 110 ~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l 176 (337)
+.+++.+ +||||+++++++..+...++++||+++++|.+++..... ....+++..+..++.|++.||
T Consensus 68 ~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL 147 (314)
T cd05099 68 MELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGM 147 (314)
T ss_pred HHHHHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHH
Confidence 9999999 699999999999999999999999999999999965321 124578888999999999999
Q ss_pred HHHhhCCCCCeEecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhH
Q 040898 177 EYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGV 256 (337)
Q Consensus 177 ~~l~~~h~~gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~ 256 (337)
.|+ |+.|++|+||+|+||+++.++.++|+|||.+................++..|+|||.+.+..++.++|+||||+
T Consensus 148 ~~l---H~~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~ 224 (314)
T cd05099 148 EYL---ESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGI 224 (314)
T ss_pred HHH---HHCCeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHH
Confidence 999 67899999999999999999999999999987654322211111223456799999998888999999999999
Q ss_pred HHHHHHh-CCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhh
Q 040898 257 LLAVLVM-GKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVR 335 (337)
Q Consensus 257 i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 335 (337)
++|+|++ |..||..... ......+... ... ..+......+.+++.+||+.||++|||+.+++
T Consensus 225 ~l~el~~~g~~p~~~~~~----~~~~~~~~~~---~~~----------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll 287 (314)
T cd05099 225 LMWEIFTLGGSPYPGIPV----EELFKLLREG---HRM----------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLV 287 (314)
T ss_pred HHHHHHhCCCCCCCCCCH----HHHHHHHHcC---CCC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHH
Confidence 9999999 8889854321 1222222111 000 00112233488999999999999999999987
Q ss_pred c
Q 040898 336 S 336 (337)
Q Consensus 336 ~ 336 (337)
+
T Consensus 288 ~ 288 (314)
T cd05099 288 E 288 (314)
T ss_pred H
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=279.35 Aligned_cols=253 Identities=23% Similarity=0.288 Sum_probs=203.5
Q ss_pred cccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCc
Q 040898 42 CFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNI 121 (337)
Q Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpni 121 (337)
+|++.+.||.|+||.||++.+.. ++..|++|.+......... ..+.+.+|+.++++++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~----------------~~~~~~~e~~~l~~l~h~~i 62 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRD--TKKMFAMKYMNKQKCVEKG----------------SVRNVLNERRILQELNHPFL 62 (258)
T ss_pred CceEEEEeccCCCceEEEEEEcc--CCcEEEEEEEehhhhcchh----------------HHHHHHHHHHHHHhCCCCCh
Confidence 58999999999999999998865 8999999998654322211 12578889999999999999
Q ss_pred ccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecC
Q 040898 122 LPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDD 201 (337)
Q Consensus 122 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~ 201 (337)
+++++.+.++...++|+||+++++|.+++.. ..++++..+..++.|++++|.+| |+.|++|+||+|+||++++
T Consensus 63 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~l---h~~~i~h~dl~~~nil~~~ 135 (258)
T cd05578 63 VNLWYSFQDEENMYLVVDLLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYL---HSKGIIHRDIKPDNILLDE 135 (258)
T ss_pred HHHHHhhcCCCeEEEEEeCCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHeEEcC
Confidence 9999999999999999999999999999843 35788999999999999999999 6779999999999999999
Q ss_pred CCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHH
Q 040898 202 DMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMV 281 (337)
Q Consensus 202 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~ 281 (337)
++.++|+|||.+....... ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||...... ....+.
T Consensus 136 ~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~ 211 (258)
T cd05578 136 QGHVHITDFNIATKVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT-IRDQIR 211 (258)
T ss_pred CCCEEEeecccccccCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc-HHHHHH
Confidence 9999999999887654432 112345788899999998888899999999999999999999998754332 111111
Q ss_pred HHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCCh--hhhhcC
Q 040898 282 KWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSS--KDVRSM 337 (337)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~--~ell~~ 337 (337)
..... .. ...++..+..+.+++.+||+.||.+||++ .|+++|
T Consensus 212 ~~~~~----~~----------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~ 255 (258)
T cd05578 212 AKQET----AD----------VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNH 255 (258)
T ss_pred HHhcc----cc----------ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcC
Confidence 11110 00 01111223568899999999999999999 999876
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=280.72 Aligned_cols=251 Identities=27% Similarity=0.427 Sum_probs=201.7
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
.+.|+..++||.|+||.||.+.+.. ++..||+|.+..+..... ...+.+|+.+++.+.||
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~--~~~~vaiK~~~~~~~~~~------------------~~~~~~e~~~l~~l~h~ 62 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNR--TQQVVAIKIIDLEEAEDE------------------IEDIQQEITVLSQCDSP 62 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEcc--CCEEEEEEEEeccccHHH------------------HHHHHHHHHHHHhCCCC
Confidence 3568999999999999999998876 889999998864432111 15678899999999999
Q ss_pred CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceee
Q 040898 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI 199 (337)
Q Consensus 120 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~ 199 (337)
||+++++.+.++...++|+||+++++|.+++.. .++++..+..++.|++.++.++ |+.+++|+||+|+||++
T Consensus 63 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~l---h~~~ivH~dl~p~Nil~ 134 (277)
T cd06640 63 YVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYL---HSEKKIHRDIKAANVLL 134 (277)
T ss_pred CEeeEEEEEEECCEEEEEEecCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHH---HhCCccCcCCChhhEEE
Confidence 999999999999999999999999999998842 3578888999999999999999 77899999999999999
Q ss_pred cCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhh
Q 040898 200 DDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMD 279 (337)
Q Consensus 200 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~ 279 (337)
+.++.++++|||++......... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||.......
T Consensus 135 ~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---- 208 (277)
T cd06640 135 SEQGDVKLADFGVAGQLTDTQIK--RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR---- 208 (277)
T ss_pred cCCCCEEEcccccceeccCCccc--cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh----
Confidence 99999999999998765433211 122357788999999988888999999999999999999999986532211
Q ss_pred HHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 280 MVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
....+. ... ........+..+.+++.+||+.+|.+|||+.++++|
T Consensus 209 ~~~~~~----~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 209 VLFLIP----KNN---------PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred Hhhhhh----cCC---------CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 111010 000 011122344568899999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=279.29 Aligned_cols=256 Identities=23% Similarity=0.323 Sum_probs=189.0
Q ss_pred ceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCccccee
Q 040898 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLLA 126 (337)
Q Consensus 47 ~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~ 126 (337)
+.||+|+||.||++.+....++..+++|.+......... ..+.+|+.++++++||||+++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~------------------~~~~~E~~~l~~l~h~~iv~~~~ 62 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQ------------------MKFLEEAQPYRSLQHSNLLQCLG 62 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHH------------------HHHHHHHHHHHhCCCCCEeeEEE
Confidence 469999999999998765557788999988655432111 35777999999999999999999
Q ss_pred EEEcCCeeEEEEEeccCCCHHHHHHHhcC-CcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCCe
Q 040898 127 HMVRPNCHLLVYEFMKNGSLQDILYDVSQ-GRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEA 205 (337)
Q Consensus 127 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~ 205 (337)
.+.+....++||||+++++|.+++..... .....++..+..++.|++.|+.|+ |+.|++|+||+|+||+++.++.+
T Consensus 63 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~i~H~dlkp~nil~~~~~~~ 139 (269)
T cd05087 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHL---HKNNFIHSDLALRNCLLTADLTV 139 (269)
T ss_pred EEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHH---HHCCEeccccCcceEEEcCCCcE
Confidence 99999999999999999999999865332 223456677888999999999999 67799999999999999999999
Q ss_pred EEecccCccccCCCCceeeeecccCCCCccCccccccC-------CCCCcccchhhhHHHHHHHh-CCCCCCCCCCCchh
Q 040898 206 RISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTE-------TISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHTEE 277 (337)
Q Consensus 206 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-------~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~ 277 (337)
+|+|||.+................++..|+|||++.+. .++.++|+||+|+++|+|++ |..||.......
T Consensus 140 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~-- 217 (269)
T cd05087 140 KIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ-- 217 (269)
T ss_pred EECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH--
Confidence 99999998654333222222234567889999998542 35789999999999999996 999996542211
Q ss_pred hhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 278 MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
........ .......+.. .....+.+.+++..|+ .+|++|||+.+|++
T Consensus 218 -~~~~~~~~-----~~~~~~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 218 -VLTYTVRE-----QQLKLPKPRL----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred -HHHHHhhc-----ccCCCCCCcc----CCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 11111110 0000000000 0112234778889998 68999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=284.72 Aligned_cols=259 Identities=23% Similarity=0.328 Sum_probs=197.6
Q ss_pred cccccccceeccCcceEEEEeEEecC-----CCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHH
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPG-----SNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITAN 114 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~ 114 (337)
.++|.+.+.||+|+||.||++.+... .+...+|+|.+........ ...+.+|+.++.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~------------------~~~~~~e~~~l~ 78 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKD------------------LSDLISEMEMMK 78 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHH------------------HHHHHHHHHHHH
Confidence 46799999999999999999876431 1345799998865422111 145777999999
Q ss_pred hc-CCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcC------------CcccCChHHHHHHHHHHHHHHHHHhh
Q 040898 115 QT-RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQ------------GRRELDWPARHRIARGIASGLEYLHM 181 (337)
Q Consensus 115 ~l-~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~l~~ 181 (337)
.+ +||||+++++++..+...++|+||+++++|.+++..... ....+++..+..++.|++.||.||
T Consensus 79 ~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~l-- 156 (307)
T cd05098 79 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL-- 156 (307)
T ss_pred HhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHH--
Confidence 99 799999999999999999999999999999999965322 123478889999999999999999
Q ss_pred CCCCCeEecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHH
Q 040898 182 CHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVL 261 (337)
Q Consensus 182 ~h~~gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~l 261 (337)
|+.|++|+||+|+||+++.++.++|+|||.+................+++.|+|||.+.+..++.++|+||||+++|+|
T Consensus 157 -H~~gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el 235 (307)
T cd05098 157 -ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 235 (307)
T ss_pred -HHCCcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHH
Confidence 6779999999999999999999999999998765432211111122345689999999888899999999999999999
Q ss_pred Hh-CCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 262 VM-GKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 262 l~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
++ |..||.... .......+.... .. ..+......+.+++.+||+.+|++|||+.++++
T Consensus 236 ~~~g~~p~~~~~----~~~~~~~~~~~~---~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 294 (307)
T cd05098 236 FTLGGSPYPGVP----VEELFKLLKEGH---RM----------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294 (307)
T ss_pred HcCCCCCCCcCC----HHHHHHHHHcCC---CC----------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 98 888885421 122222221111 00 011122345889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=282.06 Aligned_cols=254 Identities=23% Similarity=0.341 Sum_probs=196.4
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCc----eEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHH
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGK----MIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITAN 114 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~ 114 (337)
...+|++.+.||+|+||.||++.+.. ++. .||+|.+......... ..+.+|+.++.
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~--~~~~~~~~va~K~~~~~~~~~~~------------------~~~~~e~~~l~ 64 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIP--DGENVKIPVAIKVLRENTSPKAN------------------KEILDEAYVMA 64 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEec--CCCccceEEEEEEecCCCCHHHH------------------HHHHHHHHHHH
Confidence 34679999999999999999998765 444 5899988654332211 45777899999
Q ss_pred hcCCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCC
Q 040898 115 QTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKP 194 (337)
Q Consensus 115 ~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~ 194 (337)
.+.||||+++++++.. ...+++++|+++|+|.+++.. ....+++..+..++.|++.||.|+ |+.|++|+||+|
T Consensus 65 ~~~~~~i~~~~~~~~~-~~~~l~~~~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~l---H~~~iiH~dlkp 137 (279)
T cd05109 65 GVGSPYVCRLLGICLT-STVQLVTQLMPYGCLLDYVRE---NKDRIGSQDLLNWCVQIAKGMSYL---EEVRLVHRDLAA 137 (279)
T ss_pred hcCCCCCceEEEEEcC-CCcEEEEEcCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHH---HHCCeecccccc
Confidence 9999999999998875 457899999999999998843 234688999999999999999999 778999999999
Q ss_pred CceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCC
Q 040898 195 ANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFG 273 (337)
Q Consensus 195 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~ 273 (337)
+||+++.++.++|+|||++................+++.|+|||...+..++.++|+||||+++|+|++ |..||+....
T Consensus 138 ~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 217 (279)
T cd05109 138 RNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA 217 (279)
T ss_pred ceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 999999999999999999887654332222222345678999999988889999999999999999998 8999864321
Q ss_pred CchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 274 HTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
......+....... .+......+.+++.+||+.||++|||+.++++
T Consensus 218 ----~~~~~~~~~~~~~~-------------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 218 ----REIPDLLEKGERLP-------------QPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred ----HHHHHHHHCCCcCC-------------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 22222222111100 01122345889999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=283.42 Aligned_cols=260 Identities=21% Similarity=0.341 Sum_probs=197.8
Q ss_pred ccccccccceeccCcceEEEEeEEec---CCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHh
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELP---GSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQ 115 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~ 115 (337)
..++|++.+.||+|+||.||++.+.. ...+..||+|.+......... ..+.+|+..++.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~------------------~~~~~e~~~l~~ 65 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER------------------IEFLNEASVMKG 65 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHH------------------HHHHHHHHHHHh
Confidence 56789999999999999999986643 224568999987543321110 356779999999
Q ss_pred cCCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcC------CcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEe
Q 040898 116 TRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQ------GRRELDWPARHRIARGIASGLEYLHMCHRPRLIH 189 (337)
Q Consensus 116 l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h 189 (337)
++||||+++++++..+...+++|||+++|+|.+++..... .....+...+..++.|++.||.|| |++|++|
T Consensus 66 l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~i~H 142 (288)
T cd05061 66 FTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYL---NAKKFVH 142 (288)
T ss_pred CCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHH---HhCCCcC
Confidence 9999999999999999999999999999999999965322 123456677889999999999999 7789999
Q ss_pred cCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCC
Q 040898 190 RDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPV 268 (337)
Q Consensus 190 ~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf 268 (337)
+||+|+||+++.++.++|+|||++................++..|+|||.+.+..++.++|+||+|+++|+|++ |..||
T Consensus 143 ~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~ 222 (288)
T cd05061 143 RDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPY 222 (288)
T ss_pred CCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999875543222222222345677999999988889999999999999999998 78888
Q ss_pred CCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 269 DDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
..... .+..+... ...... ........+.+++.+||+.||++|||+.++++
T Consensus 223 ~~~~~----~~~~~~~~---~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 273 (288)
T cd05061 223 QGLSN----EQVLKFVM---DGGYLD----------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVN 273 (288)
T ss_pred CCCCH----HHHHHHHH---cCCCCC----------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 64321 11111111 111100 00112245999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=283.58 Aligned_cols=251 Identities=28% Similarity=0.425 Sum_probs=200.2
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
.+.|+..+.||+|++|.||++.+.. ++..||+|.+........ ...+.+|+.+++.++||
T Consensus 3 ~~~y~~~~~l~~g~~~~vy~~~~~~--~~~~vaiK~~~~~~~~~~------------------~~~~~~e~~~l~~l~h~ 62 (277)
T cd06642 3 EELFTKLERIGKGSFGEVYKGIDNR--TKEVVAIKIIDLEEAEDE------------------IEDIQQEITVLSQCDSP 62 (277)
T ss_pred HHHHHHHHHhcCCCCeeEEEEEEcC--CCeEEEEEEeccccchHH------------------HHHHHHHHHHHHcCCCC
Confidence 3568899999999999999998865 788999998764432111 15678899999999999
Q ss_pred CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceee
Q 040898 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI 199 (337)
Q Consensus 120 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~ 199 (337)
||+++++.+..++..++|+||+++++|.+++. ...+++..+..++.|++.|+.|+ |+.|++|+||+|+||++
T Consensus 63 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~i~~~l~~l---H~~~ivH~dl~p~ni~i 134 (277)
T cd06642 63 YITRYYGSYLKGTKLWIIMEYLGGGSALDLLK-----PGPLEETYIATILREILKGLDYL---HSERKIHRDIKAANVLL 134 (277)
T ss_pred ccHhhhcccccCCceEEEEEccCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHH---hcCCeeccCCChheEEE
Confidence 99999999999999999999999999999883 24588899999999999999999 77899999999999999
Q ss_pred cCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhh
Q 040898 200 DDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMD 279 (337)
Q Consensus 200 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~ 279 (337)
+.++.++|+|||++........ ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||.......
T Consensus 135 ~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---- 208 (277)
T cd06642 135 SEQGDVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR---- 208 (277)
T ss_pred eCCCCEEEccccccccccCcch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh----
Confidence 9999999999999876543221 1122357888999999988888999999999999999999999986432211
Q ss_pred HHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 280 MVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
..... .....+ .........+.+++.+||+.+|++|||+.++++|
T Consensus 209 ~~~~~---~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 209 VLFLI---PKNSPP----------TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred HHhhh---hcCCCC----------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 11001 000000 0111233458899999999999999999999976
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=284.81 Aligned_cols=263 Identities=22% Similarity=0.328 Sum_probs=201.0
Q ss_pred cccccccccccceeccCcceEEEEeEEec-----CCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHH
Q 040898 36 FLKKEDCFDSLKKIGSGGWGEVFYKAELP-----GSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEI 110 (337)
Q Consensus 36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~ 110 (337)
+.-..++|.+.+.||+|+||.||++.+.. ..++..|++|.+........ ...+.+|+
T Consensus 10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~------------------~~~~~~E~ 71 (304)
T cd05101 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKD------------------LSDLVSEM 71 (304)
T ss_pred ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHH------------------HHHHHHHH
Confidence 33457789999999999999999987532 12456799998764422111 14677899
Q ss_pred HHHHhc-CCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcC------------CcccCChHHHHHHHHHHHHHHH
Q 040898 111 ITANQT-RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQ------------GRRELDWPARHRIARGIASGLE 177 (337)
Q Consensus 111 ~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~ 177 (337)
.++..+ +||||+++++.+......+++|||+++++|.+++..... ....+++..+..++.|++.||.
T Consensus 72 ~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~ 151 (304)
T cd05101 72 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGME 151 (304)
T ss_pred HHHHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHH
Confidence 999999 899999999999999999999999999999999965322 1234677889999999999999
Q ss_pred HHhhCCCCCeEecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHH
Q 040898 178 YLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVL 257 (337)
Q Consensus 178 ~l~~~h~~gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i 257 (337)
|| |+.|++|+||+|+||+++.++.++|+|||.+................+++.|+|||.+.+..++.++|+||||++
T Consensus 152 ~L---H~~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~ 228 (304)
T cd05101 152 YL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVL 228 (304)
T ss_pred HH---HHCCeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHH
Confidence 99 777999999999999999999999999999876644332222222345678999999988889999999999999
Q ss_pred HHHHHh-CCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 258 LAVLVM-GKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 258 ~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
+|++++ |..||.... .......+.. ..... .+......+.+++.+||+.+|.+|||+.++++
T Consensus 229 l~el~~~g~~p~~~~~----~~~~~~~~~~---~~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~ 291 (304)
T cd05101 229 MWEIFTLGGSPYPGIP----VEELFKLLKE---GHRMD----------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVE 291 (304)
T ss_pred HHHHHcCCCCCcccCC----HHHHHHHHHc---CCcCC----------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 999998 788875431 1122222211 11100 01123345889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=279.15 Aligned_cols=251 Identities=27% Similarity=0.440 Sum_probs=195.1
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++.++||+|++|.||++.+. .+..+++|.+....... +.+.+|+.+++.++|
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~---~~~~~~~k~~~~~~~~~--------------------~~~~~E~~~l~~l~~ 60 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWN---GNTKVAVKTLKPGTMSP--------------------ESFLEEAQIMKKLRH 60 (260)
T ss_pred chHHhhhhheeccccCceEEEEEec---CCceeEEEEecCCCCCH--------------------HHHHHHHHHHHhcCC
Confidence 4568999999999999999998664 56779999886543211 357789999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
||++++++++. ....+++|||+++++|.+++.. .....+++..+..++.+++.|+.|| |+.|++|+||+|+||+
T Consensus 61 ~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~al~~l---H~~~i~H~di~p~Nil 134 (260)
T cd05070 61 DKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKD--GEGRALKLPNLVDMAAQVAAGMAYI---ERMNYIHRDLRSANIL 134 (260)
T ss_pred CceEEEEeEEC-CCCcEEEEEecCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCccceEE
Confidence 99999999875 4568999999999999999854 2334588999999999999999999 6779999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCchh
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHTEE 277 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~ 277 (337)
+++++.++|+|||.+.......... .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||.....
T Consensus 135 i~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---- 209 (260)
T cd05070 135 VGDGLVCKIADFGLARLIEDNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN---- 209 (260)
T ss_pred EeCCceEEeCCceeeeeccCccccc-ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH----
Confidence 9999999999999987654332111 112235567999999988889999999999999999999 8899865321
Q ss_pred hhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 278 MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
.+....+... ... ..+...+..+.+++.+||..||.+|||+.++++
T Consensus 210 ~~~~~~~~~~---~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 210 REVLEQVERG---YRM----------PCPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHHHHHHcC---CCC----------CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 1122221111 000 011122345899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=278.56 Aligned_cols=257 Identities=23% Similarity=0.318 Sum_probs=197.8
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
.+|++.+.||+|+||.||.+.+.. ++..|++|.+.......... .....+.+|+.+++.+.|||
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~--~~~~v~ik~~~~~~~~~~~~--------------~~~~~~~~E~~~l~~l~h~~ 65 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDAD--TGRELAVKQVQFDPESPETS--------------KEVNALECEIQLLKNLLHER 65 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcC--CCcEEEEEEeecCcCCcccH--------------HHHHHHHHHHHHHHhcCCCC
Confidence 579999999999999999998865 89999999886432211110 01257788999999999999
Q ss_pred cccceeEEEcC--CeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 121 ILPLLAHMVRP--NCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 121 iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|+++++.+.+. ..+++++||+++++|.+++.. ...+++.....++.|++.+|.++ |+.|++|+||+|+||+
T Consensus 66 i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~l---H~~~i~H~dl~p~nil 138 (265)
T cd06652 66 IVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYL---HSNMIVHRDIKGANIL 138 (265)
T ss_pred eeeEEeEeccCCCceEEEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHEE
Confidence 99999988663 568899999999999998843 23478888999999999999999 7779999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCce-eeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchh
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQ-ITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEE 277 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~ 277 (337)
++.++.++|+|||.+......... .......++..|+|||.+.+..++.++|+||||+++|+|++|..||..... .
T Consensus 139 ~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---~ 215 (265)
T cd06652 139 RDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA---M 215 (265)
T ss_pred ecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch---H
Confidence 999999999999988765322111 111234578899999999888889999999999999999999999864311 1
Q ss_pred hhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 278 MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
... ........ ....++.....+.+++.+|+. +|++|||++++++|
T Consensus 216 ~~~----~~~~~~~~---------~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 216 AAI----FKIATQPT---------NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred HHH----HHHhcCCC---------CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 111 11111110 011123344558889999985 99999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=284.28 Aligned_cols=267 Identities=23% Similarity=0.289 Sum_probs=199.6
Q ss_pred cccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCc
Q 040898 42 CFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNI 121 (337)
Q Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpni 121 (337)
+|++.+.||+|++|.||++.+.. +++.|++|.+............ ...+..|+.+++.++||||
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~--~~~~v~iK~~~~~~~~~~~~~~--------------~~~~~~e~~~l~~~~h~~i 64 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKE--TGRIVAIKKIKLGERKEAKDGI--------------NFTALREIKLLQELKHPNI 64 (298)
T ss_pred CceeeeeeeeccccEEEEEEECC--CCcEEEEEEEeccccccccchh--------------hHHHHHHHHHHhhcCCCCC
Confidence 58899999999999999999876 7899999999765443211111 0456679999999999999
Q ss_pred ccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecC
Q 040898 122 LPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDD 201 (337)
Q Consensus 122 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~ 201 (337)
+++++++.+.+..++||||+ +++|.+++.. ....+++..+..++.||++||.+| |++|++|+||+|+||+++.
T Consensus 65 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~---~~~~~~~~~~~~~~~qi~~al~~l---H~~~i~H~dl~p~nill~~ 137 (298)
T cd07841 65 IGLLDVFGHKSNINLVFEFM-ETDLEKVIKD---KSIVLTPADIKSYMLMTLRGLEYL---HSNWILHRDLKPNNLLIAS 137 (298)
T ss_pred hhhhheeecCCEEEEEEccc-CCCHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeecCCChhhEEEcC
Confidence 99999999999999999999 8899999843 123689999999999999999999 7789999999999999999
Q ss_pred CCCeEEecccCccccCCCCceeeeecccCCCCccCcccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhH
Q 040898 202 DMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQT-ETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDM 280 (337)
Q Consensus 202 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~ 280 (337)
++.++|+|||++......... .....+++.|+|||.+.+ ..++.++|+||+|+++|+|++|.+||...... ..+
T Consensus 138 ~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~---~~~ 212 (298)
T cd07841 138 DGVLKLADFGLARSFGSPNRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI---DQL 212 (298)
T ss_pred CCCEEEccceeeeeccCCCcc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH---HHH
Confidence 999999999998776543221 122346778999998854 45688999999999999999998887543221 111
Q ss_pred HHHHHhhhccCCcch---------hhh-----hcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 281 VKWMRNVIFSENPNR---------AIN-----SKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 281 ~~~~~~~~~~~~~~~---------~~~-----~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
....... ....... ... ..............+.+++.+||+.||++|||+.|+++|
T Consensus 213 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 213 GKIFEAL-GTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred HHHHHHc-CCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 1111110 0000000 000 000000112334568999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=282.76 Aligned_cols=256 Identities=25% Similarity=0.375 Sum_probs=197.2
Q ss_pred ccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc
Q 040898 37 LKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT 116 (337)
Q Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 116 (337)
..+.+.|++.+.||+|+||.||++.+.. +++.+|+|.+...... ...+..|+.+++.+
T Consensus 12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~--~~~~~a~K~~~~~~~~--------------------~~~~~~e~~~l~~~ 69 (282)
T cd06636 12 RDPAGIFELVEVVGNGTYGQVYKGRHVK--TGQLAAIKVMDVTEDE--------------------EEEIKLEINMLKKY 69 (282)
T ss_pred cChhhhhhhheeeccCCCeEEEEEEEcC--CCcEEEEEEEecChHH--------------------HHHHHHHHHHHHHh
Confidence 3467889999999999999999999876 8899999987543210 03566788888888
Q ss_pred -CCCCcccceeEEEc------CCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEe
Q 040898 117 -RHRNILPLLAHMVR------PNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIH 189 (337)
Q Consensus 117 -~hpniv~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h 189 (337)
+|||++++++++.. ....+++|||+++++|.+++.. .....+++..+..++.|++.|+.|| |+.|++|
T Consensus 70 ~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~L---H~~~ivH 144 (282)
T cd06636 70 SHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKN--TKGNALKEDWIAYICREILRGLAHL---HAHKVIH 144 (282)
T ss_pred cCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHH--ccCCCCCHHHHHHHHHHHHHHHHHH---HHCCccc
Confidence 79999999998753 4578999999999999999865 2334578888999999999999999 7779999
Q ss_pred cCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccc-----cCCCCCcccchhhhHHHHHHHhC
Q 040898 190 RDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQ-----TETISDKCDIYSFGVLLAVLVMG 264 (337)
Q Consensus 190 ~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~-----~~~~~~~~DiwslG~i~~~ll~g 264 (337)
+||+|+||+++.++.++|+|||++........ ......+++.|+|||.+. ...++.++|+||||+++|+|++|
T Consensus 145 ~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g 222 (282)
T cd06636 145 RDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222 (282)
T ss_pred CCCCHHHEEECCCCCEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhC
Confidence 99999999999999999999998875532211 112346888999999985 34577899999999999999999
Q ss_pred CCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 265 KFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 265 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
..||...... ..... ........ ......+..+.+++.+||+.||.+|||+.||++|
T Consensus 223 ~~p~~~~~~~---~~~~~----~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 223 APPLCDMHPM---RALFL----IPRNPPPK---------LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred CCCccccCHH---hhhhh----HhhCCCCC---------CcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 9998643211 11111 00000000 0011233458999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=281.12 Aligned_cols=257 Identities=25% Similarity=0.355 Sum_probs=197.0
Q ss_pred cccccceeccCcceEEEEeEEecC---CCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 42 CFDSLKKIGSGGWGEVFYKAELPG---SNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
+|++.+.||+|+||.||++.+... .....+++|.+........ ...+.+|+.+++.++|
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~------------------~~~~~~E~~~l~~l~h 62 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSE------------------LRDLLSEFNLLKQVNH 62 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHH------------------HHHHHHHHHHHhhCCC
Confidence 488999999999999999877531 1335688888765433211 1467789999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcC--------------------CcccCChHHHHHHHHHHHHHHHH
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQ--------------------GRRELDWPARHRIARGIASGLEY 178 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------------~~~~~~~~~~~~i~~~i~~~l~~ 178 (337)
|||+++++.+..+...++++||+++++|.+++..... ....+++..++.++.|++.+|.+
T Consensus 63 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~ 142 (290)
T cd05045 63 PHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQY 142 (290)
T ss_pred CCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999999864321 12357788999999999999999
Q ss_pred HhhCCCCCeEecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHH
Q 040898 179 LHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258 (337)
Q Consensus 179 l~~~h~~gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~ 258 (337)
| |+.|++|+||+|+||++++++.++|+|||++................++..|+|||.+.+..++.++|+||||+++
T Consensus 143 L---H~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l 219 (290)
T cd05045 143 L---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLL 219 (290)
T ss_pred H---HHCCeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHH
Confidence 9 6779999999999999999999999999998765332221111223456789999999888899999999999999
Q ss_pred HHHHh-CCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 259 AVLVM-GKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 259 ~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
|+|++ |..||..... ....+......... .+......+.+++.+||+.+|++|||+.++++
T Consensus 220 ~el~t~g~~p~~~~~~----~~~~~~~~~~~~~~-------------~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 220 WEIVTLGGNPYPGIAP----ERLFNLLKTGYRME-------------RPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHhcCCCCCCCCCH----HHHHHHHhCCCCCC-------------CCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 99998 9999865321 12222221111000 01122345889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=278.48 Aligned_cols=255 Identities=23% Similarity=0.377 Sum_probs=195.2
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHH-HHHhcCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEII-TANQTRHR 119 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~l~~l~hp 119 (337)
++|++.+.||+|+||.||++.+.. +|..||+|++......... ..+..|+. .++.+.||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~--~~~~vaiK~~~~~~~~~~~------------------~~~~~e~~~~~~~~~~~ 60 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVP--TGTIMAVKRIRATVNSQEQ------------------KRLLMDLDISMRSVDCP 60 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcC--CCcEEEEEEEecCCCcHHH------------------HHHHHHHHHHHHHcCCC
Confidence 479999999999999999999876 8999999998654322111 22333444 46667999
Q ss_pred CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCC-CeEecCCCCCcee
Q 040898 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRP-RLIHRDIKPANVL 198 (337)
Q Consensus 120 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~-gi~h~di~~~nil 198 (337)
||+++++++..++..++++||++ ++|.+++......+..+++..++.++.|++.|+.|| |++ +++|+||+|+||+
T Consensus 61 ~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~~i~h~dlkp~nil 136 (283)
T cd06617 61 YTVTFYGALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYL---HSKLSVIHRDVKPSNVL 136 (283)
T ss_pred CeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHH---hhcCCeecCCCCHHHEE
Confidence 99999999999999999999997 589888876544556789999999999999999999 665 9999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCcccccc----CCCCCcccchhhhHHHHHHHhCCCCCCCCCCC
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQT----ETISDKCDIYSFGVLLAVLVMGKFPVDDFFGH 274 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~----~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~ 274 (337)
++.++.++|+|||.+........ .....++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||......
T Consensus 137 ~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 213 (283)
T cd06617 137 INRNGQVKLCDFGISGYLVDSVA---KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP 213 (283)
T ss_pred ECCCCCEEEeecccccccccccc---cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC
Confidence 99999999999999876543221 122457888999998865 44678999999999999999999998643221
Q ss_pred chhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 275 TEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
....... .....+... ....+..+.+++.+||+.+|.+|||+.++++|
T Consensus 214 --~~~~~~~----~~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 214 --FQQLKQV----VEEPSPQLP---------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred --HHHHHHH----HhcCCCCCC---------ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111111 111111000 01123458899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=284.27 Aligned_cols=259 Identities=23% Similarity=0.378 Sum_probs=198.7
Q ss_pred cccccccceeccCcceEEEEeEEec---CCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELP---GSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT 116 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 116 (337)
.++|++.+.||+|+||.||++.+.. ..++..||+|.+......... ..+.+|+.+++.+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~------------------~~~~~ei~~l~~l 65 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ------------------ADFQREAALMAEF 65 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHH------------------HHHHHHHHHHHhc
Confidence 4679999999999999999988643 346788999988654332111 4577899999999
Q ss_pred CCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcC------------------CcccCChHHHHHHHHHHHHHHHH
Q 040898 117 RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQ------------------GRRELDWPARHRIARGIASGLEY 178 (337)
Q Consensus 117 ~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------------------~~~~~~~~~~~~i~~~i~~~l~~ 178 (337)
.||||+++++++.++...++++||+++++|.+++..... ....+++..++.++.|++.||.+
T Consensus 66 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~ 145 (288)
T cd05050 66 DHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAY 145 (288)
T ss_pred CCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999999999964321 12346788899999999999999
Q ss_pred HhhCCCCCeEecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHH
Q 040898 179 LHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258 (337)
Q Consensus 179 l~~~h~~gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~ 258 (337)
+ |+.|++|+||+|+||+++.++.++|+|||.+.................+..|+|||.+.+..++.++|+||||+++
T Consensus 146 l---H~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il 222 (288)
T cd05050 146 L---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVL 222 (288)
T ss_pred H---HhCCeecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHH
Confidence 9 6779999999999999999999999999988754332221111223346679999999888899999999999999
Q ss_pred HHHHh-CCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 259 AVLVM-GKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 259 ~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
|+|++ |..||..... .+....+.. .... ..++..+..+.+++.+||+.||.+|||+.|+++
T Consensus 223 ~el~~~~~~p~~~~~~----~~~~~~~~~---~~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 223 WEIFSYGMQPYYGMAH----EEVIYYVRD---GNVL----------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHhCCCCCCCCCCH----HHHHHHHhc---CCCC----------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 99998 8788754321 111111111 1100 011122345899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=285.17 Aligned_cols=269 Identities=26% Similarity=0.382 Sum_probs=198.9
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
++|++.+.||+|++|.||++.+.. +++.||+|++......... ...+.+|+.+++.++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~--~~~~~~iK~~~~~~~~~~~-----------------~~~~~~e~~~l~~l~h~~ 61 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKE--TGQIVAIKKFLESEDDKMV-----------------KKIAMREIRMLKQLRHEN 61 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECC--CCCEEEEEeHhhccCcchh-----------------hHHHHHHHHHHHhcCCcc
Confidence 479999999999999999998865 7899999988654332210 045677999999999999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
|+++++++..+...++|+||+++++|..+.. ....+++..+..++.|++.++.|| |+.|++|+||+|+||+++
T Consensus 62 i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~L---H~~~i~h~~l~p~ni~~~ 134 (286)
T cd07846 62 LVNLIEVFRRKKRLYLVFEFVDHTVLDDLEK----YPNGLDESRVRKYLFQILRGIEFC---HSHNIIHRDIKPENILVS 134 (286)
T ss_pred hhhHHHhcccCCeEEEEEecCCccHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHEEEC
Confidence 9999999999999999999999988887763 334589999999999999999999 677999999999999999
Q ss_pred CCCCeEEecccCccccCCCCceeeeecccCCCCccCcccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhh
Q 040898 201 DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQT-ETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMD 279 (337)
Q Consensus 201 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~ 279 (337)
.++.++|+|||++......... .....++..|+|||.+.+ ..++.++|+||+|+++|+|++|.+||...........
T Consensus 135 ~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~ 212 (286)
T cd07846 135 QSGVVKLCDFGFARTLAAPGEV--YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYH 212 (286)
T ss_pred CCCcEEEEeeeeeeeccCCccc--cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHH
Confidence 9999999999998765433211 123457888999999865 3467889999999999999999999864321111011
Q ss_pred HHHHHHhhhccC----Ccchhhhhccc---------CCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 280 MVKWMRNVIFSE----NPNRAINSKLL---------GNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 280 ~~~~~~~~~~~~----~~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
............ ........... ....+.....+.+++.+||+.+|++|||+.++++|
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 213 IIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred HHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 110000000000 00000000000 00112334669999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=275.44 Aligned_cols=254 Identities=31% Similarity=0.466 Sum_probs=204.9
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
++|++.+.||.|++|.||++.+.. +++.|++|++........ ...+.+|+..+..++|||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~--~~~~~~vk~~~~~~~~~~------------------~~~~~~e~~~l~~l~~~~ 60 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKP--TGKIYALKKIHVDGDEEF------------------RKQLLRELKTLRSCESPY 60 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcC--CCcEEEEEEeccCcchHH------------------HHHHHHHHHHHHhcCCCC
Confidence 368999999999999999998876 899999999866543211 156788999999999999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCC-CCeEecCCCCCceee
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHR-PRLIHRDIKPANVLI 199 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~-~gi~h~di~~~nil~ 199 (337)
++++++.+..++..++++||+++++|.+++.. ...+++..++.++.|++.++.++ |+ .|++|+||+|+||++
T Consensus 61 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~l---h~~~~~~H~~l~~~ni~~ 133 (264)
T cd06623 61 VVKCYGAFYKEGEISIVLEYMDGGSLADLLKK----VGKIPEPVLAYIARQILKGLDYL---HTKRHIIHRDIKPSNLLI 133 (264)
T ss_pred eeeEEEEEccCCeEEEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---hccCCCccCCCCHHHEEE
Confidence 99999999999999999999999999999953 36689999999999999999999 77 899999999999999
Q ss_pred cCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhh
Q 040898 200 DDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMD 279 (337)
Q Consensus 200 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~ 279 (337)
+.++.++|+|||.+.......... ....++..|+|||.+.+..++.++|+||||+++|+|++|..||...... ....
T Consensus 134 ~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~ 210 (264)
T cd06623 134 NSKGEVKIADFGISKVLENTLDQC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP-SFFE 210 (264)
T ss_pred CCCCCEEEccCccceecccCCCcc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc-CHHH
Confidence 999999999999987764433221 2345788899999998888899999999999999999999998654321 1111
Q ss_pred HHHHHHhhhccCCcchhhhhcccCCchHH-HHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 280 MVKWMRNVIFSENPNRAINSKLLGNGYEE-QMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
. .........+. .... .+..+.+++.+||+.+|++|||+.++++|
T Consensus 211 ~---~~~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 211 L---MQAICDGPPPS----------LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred H---HHHHhcCCCCC----------CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1 22221111110 0111 33458999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=285.43 Aligned_cols=254 Identities=24% Similarity=0.282 Sum_probs=193.3
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCc--eEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc-
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGK--MIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT- 116 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l- 116 (337)
.++|++.+.||+|+||.||++.+.. ++. .+++|.+........ ...+.+|+.++.++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~--~~~~~~~~ik~~~~~~~~~~------------------~~~~~~Ei~~l~~l~ 65 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKK--DGLRMDAAIKRMKEYASKDD------------------HRDFAGELEVLCKLG 65 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEcc--CCceeeEEEEEecccCCHHH------------------HHHHHHHHHHHHHhc
Confidence 3579999999999999999998865 554 457776643221111 14677899999999
Q ss_pred CCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcC------------CcccCChHHHHHHHHHHHHHHHHHhhCCC
Q 040898 117 RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQ------------GRRELDWPARHRIARGIASGLEYLHMCHR 184 (337)
Q Consensus 117 ~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~l~~~h~ 184 (337)
+||||+++++++..++..++++||+++++|.+++..... ....+++..++.++.|++.|+.|| |+
T Consensus 66 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L---H~ 142 (303)
T cd05088 66 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQ 142 (303)
T ss_pred CCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHH---Hh
Confidence 899999999999999999999999999999999864321 123578899999999999999999 77
Q ss_pred CCeEecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-
Q 040898 185 PRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM- 263 (337)
Q Consensus 185 ~gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~- 263 (337)
.|++|+||+|+||+++.++.++|+|||++....... .......+..|+|||.+.+..++.++|+||||+++|+|+|
T Consensus 143 ~gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~ 219 (303)
T cd05088 143 KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL 219 (303)
T ss_pred CCccccccchheEEecCCCcEEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhc
Confidence 899999999999999999999999999886432111 1111224567999999988888999999999999999998
Q ss_pred CCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 264 GKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 264 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
|..||...... +..... ....... .+......+.+++.+||+.+|++|||+.++++
T Consensus 220 g~~p~~~~~~~----~~~~~~---~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 275 (303)
T cd05088 220 GGTPYCGMTCA----ELYEKL---PQGYRLE----------KPLNCDDEVYDLMRQCWREKPYERPSFAQILV 275 (303)
T ss_pred CCCCcccCChH----HHHHHH---hcCCcCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99998643221 111111 1110000 00112334889999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=280.50 Aligned_cols=252 Identities=28% Similarity=0.445 Sum_probs=212.5
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..+-|.++++||+|+||.||++.+.. +|+.+|||++..+.+. ..+.+|+.++.+.+.
T Consensus 31 PEEVFDi~~KLGEGSYGSV~KAIH~E--sG~v~AIK~VPV~sDL---------------------QEIIKEISIMQQC~S 87 (502)
T KOG0574|consen 31 PEEVFDIVGKLGEGSYGSVHKAIHRE--SGHVLAIKKVPVDTDL---------------------QEIIKEISIMQQCKS 87 (502)
T ss_pred hHHHHHHHHHhcCCcchHHHHHHHhc--cCcEEEEEecCccchH---------------------HHHHHHHHHHHHcCC
Confidence 55679999999999999999998875 9999999998765432 567889999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|++|++||.+.....+++|||||..|+..+.++. .+.++.+..+..++++-+++|+|| |...-+|||||..||+
T Consensus 88 ~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YL---H~~~KIHRDIKAGNIL 161 (502)
T KOG0574|consen 88 KYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRA---RRKPLSEQEISAVLRDTLKGLQYL---HDLKKIHRDIKAGNIL 161 (502)
T ss_pred chhhhhhhhhccCCceEeehhhcCCCcHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHH---HHHHHHHhhcccccEE
Confidence 9999999999999999999999999999999864 556799999999999999999999 5557899999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhh
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEM 278 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~ 278 (337)
++-+|..||+|||.+-.+.+.-.. .+...|||.|+|||++..-.|...+||||||++..||..|++||...+.-
T Consensus 162 LNT~G~AKLADFGVAGQLTDTMAK--RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM---- 235 (502)
T KOG0574|consen 162 LNTDGIAKLADFGVAGQLTDTMAK--RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM---- 235 (502)
T ss_pred EcccchhhhhhccccchhhhhHHh--hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc----
Confidence 999999999999999876543222 23568999999999999999999999999999999999999999765441
Q ss_pred hHHHHHHhh-hccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 279 DMVKWMRNV-IFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 279 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
+.+ ..+..+ ...-..++..+.++-+++++||..+|++|.|+.++++|
T Consensus 236 ------RAIFMIPT~P------PPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 236 ------RAIFMIPTKP------PPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred ------ceeEeccCCC------CCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 111 011111 11123455666779999999999999999999999987
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=278.69 Aligned_cols=256 Identities=24% Similarity=0.341 Sum_probs=186.1
Q ss_pred ceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCccccee
Q 040898 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLLA 126 (337)
Q Consensus 47 ~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~ 126 (337)
+.||+|+||.||++..........+++|.+......... ..+.+|+..++.++||||+++++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~------------------~~~~~e~~~~~~l~h~nii~~~~ 62 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQ------------------LLFLQEVQPYRELNHPNVLQCLG 62 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHH------------------HHHHHHHHHHHhCCCCCcceEEE
Confidence 469999999999987655446678888887544321111 45778999999999999999999
Q ss_pred EEEcCCeeEEEEEeccCCCHHHHHHHhcCC-cccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCCe
Q 040898 127 HMVRPNCHLLVYEFMKNGSLQDILYDVSQG-RRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEA 205 (337)
Q Consensus 127 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~ 205 (337)
.+.+....++||||+++++|.+++...... ....++.....++.|++.|+.|| |+.|++|+||+|+||+++.++.+
T Consensus 63 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nill~~~~~~ 139 (269)
T cd05042 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWL---HQADFIHSDLALRNCQLTADLSV 139 (269)
T ss_pred EECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHH---HhcCEecccccHhheEecCCCcE
Confidence 999999999999999999999999653322 23346777889999999999999 77799999999999999999999
Q ss_pred EEecccCccccCCCCceeeeecccCCCCccCccccc-------cCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCchh
Q 040898 206 RISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQ-------TETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHTEE 277 (337)
Q Consensus 206 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~-------~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~ 277 (337)
+|+|||++................+++.|+|||++. ...++.++|+||||+++|+|++ |..||..... .
T Consensus 140 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~---~ 216 (269)
T cd05042 140 KIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD---E 216 (269)
T ss_pred EEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH---H
Confidence 999999886543322222222334567899999874 2356789999999999999999 7888864321 1
Q ss_pred hhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 278 MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
..+........ ...+.. .........+.+++..|+ .||++|||+.+|++
T Consensus 217 ~~~~~~~~~~~-~~~~~~--------~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 217 QVLKQVVREQD-IKLPKP--------QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred HHHHHHhhccC-ccCCCC--------cccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 11111111110 000000 011123344667777888 59999999999976
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=300.18 Aligned_cols=264 Identities=17% Similarity=0.180 Sum_probs=187.2
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc--
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT-- 116 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-- 116 (337)
..++|++++.||+|+||.||++.+.. +++.||||++....... .....|+.++..+
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~--~~~~vAvK~i~~~~~~~--------------------~~~~~e~~~l~~l~~ 184 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRK--RKEYCAVKIVRNVPKYT--------------------RDAKIEIQFMEKVRQ 184 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcC--CCeEEEEEEEecchhhH--------------------HHHHHHHHHHHHHhh
Confidence 46789999999999999999998876 88999999985321110 1233345555544
Q ss_pred ----CCCCcccceeEEEcC-CeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCC-CCeEec
Q 040898 117 ----RHRNILPLLAHMVRP-NCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHR-PRLIHR 190 (337)
Q Consensus 117 ----~hpniv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~-~gi~h~ 190 (337)
.|++++.+++++... ...++|++++ +++|.+++. ....+++..+..++.||+.||.|| |+ .||+|+
T Consensus 185 ~~~~~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~----~~~~l~~~~~~~i~~qi~~aL~yL---H~~~gIiHr 256 (467)
T PTZ00284 185 ADPADRFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIM----KHGPFSHRHLAQIIFQTGVALDYF---HTELHLMHT 256 (467)
T ss_pred cCcccCcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHH---HhcCCeecC
Confidence 455688888888765 5678999988 668888874 335689999999999999999999 54 599999
Q ss_pred CCCCCceeecCCC----------------CeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhh
Q 040898 191 DIKPANVLIDDDM----------------EARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSF 254 (337)
Q Consensus 191 di~~~nil~~~~~----------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Diwsl 254 (337)
||||+||+++.++ .+||+|||.+...... .....+|+.|+|||++.+..++.++|||||
T Consensus 257 DlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSl 331 (467)
T PTZ00284 257 DLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSM 331 (467)
T ss_pred CCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcCCCCcHHHHHHH
Confidence 9999999998765 4999999987543221 123578999999999999999999999999
Q ss_pred hHHHHHHHhCCCCCCCCCCCchhhhHHHHHHhh----------------hccCC------cchhhhhcccC--CchHHHH
Q 040898 255 GVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNV----------------IFSEN------PNRAINSKLLG--NGYEEQM 310 (337)
Q Consensus 255 G~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~----------------~~~~~------~~~~~~~~~~~--~~~~~~~ 310 (337)
||++|+|++|+.||+..........+....... ..... ........... .......
T Consensus 332 Gvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (467)
T PTZ00284 332 GCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRD 411 (467)
T ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhch
Confidence 999999999999997533211111111110000 00000 00000000000 0001123
Q ss_pred HHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 311 LLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 311 ~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
..+.+|+.+||+.||++|||++|+|+|
T Consensus 412 ~~~~dli~~mL~~dP~~R~ta~e~L~H 438 (467)
T PTZ00284 412 DLLCDLIYGLLHYDRQKRLNARQMTTH 438 (467)
T ss_pred HHHHHHHHHhCCcChhhCCCHHHHhcC
Confidence 457899999999999999999999987
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=278.01 Aligned_cols=251 Identities=26% Similarity=0.415 Sum_probs=194.3
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++.++||+|++|.||++.+.. ...||+|.+....... +.+.+|+.+++.++|
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~---~~~valK~~~~~~~~~--------------------~~~~~E~~~l~~l~~ 60 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNG---TTRVAIKTLKPGTMSP--------------------EAFLQEAQVMKKLRH 60 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecC---CceEEEEecccCccCH--------------------HHHHHHHHHHHhCCC
Confidence 35679999999999999999997753 3569999886432211 356779999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++.+. ....+++|||+++++|.+++.. ..+..+++..+..++.|++.||.++ |+.|++|+||+|+||+
T Consensus 61 ~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~aL~~l---H~~~i~H~dl~p~Nil 134 (262)
T cd05071 61 EKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANIL 134 (262)
T ss_pred CCcceEEEEEC-CCCcEEEEEcCCCCcHHHHHhh--ccccCCCHHHHHHHHHHHHHHHHHH---HHCCccccccCcccEE
Confidence 99999999774 4567999999999999999954 2234578889999999999999999 7789999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCchh
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHTEE 277 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~ 277 (337)
++.++.++|+|||.+......... ......++..|+|||...+..++.++|+||||+++|++++ |..||.....
T Consensus 135 l~~~~~~~L~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~---- 209 (262)
T cd05071 135 VGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---- 209 (262)
T ss_pred EcCCCcEEeccCCceeeccccccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh----
Confidence 999999999999998765433221 1122345678999999988889999999999999999999 8888864321
Q ss_pred hhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 278 MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
..... ........ ......+..+.+++.+|++.||++|||+.++++
T Consensus 210 ~~~~~---~~~~~~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 210 REVLD---QVERGYRM----------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHHHH---HHhcCCCC----------CCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 11111 11111000 111233455889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=278.89 Aligned_cols=257 Identities=22% Similarity=0.368 Sum_probs=192.8
Q ss_pred ccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCcc
Q 040898 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNIL 122 (337)
Q Consensus 43 y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv 122 (337)
+.+.+.||+|+||.||++.+........+|+|.+......... .+.+.+|+..++.++||||+
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~~iv 63 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSE-----------------MEDFLSEAVCMKEFDHPNVM 63 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHH-----------------HHHHHHHHHHHHhCCCCCcc
Confidence 3578899999999999998865222346899987654321111 15677899999999999999
Q ss_pred cceeEEEcC------CeeEEEEEeccCCCHHHHHHHhc--CCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCC
Q 040898 123 PLLAHMVRP------NCHLLVYEFMKNGSLQDILYDVS--QGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKP 194 (337)
Q Consensus 123 ~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~ 194 (337)
++++++... ...++++||+++++|.+++.... .....+++.....++.|++.||.|| |++|++|+||+|
T Consensus 64 ~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp 140 (272)
T cd05075 64 RLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYL---SSKSFIHRDLAA 140 (272)
T ss_pred eEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHH---HHCCeeccccch
Confidence 999976432 24689999999999999874322 2334578999999999999999999 677999999999
Q ss_pred CceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCC
Q 040898 195 ANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFG 273 (337)
Q Consensus 195 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~ 273 (337)
+||+++.++.++|+|||++................+++.|++||...+..++.++|+||||+++|+|++ |..||.....
T Consensus 141 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 220 (272)
T cd05075 141 RNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN 220 (272)
T ss_pred hheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 999999999999999999887644332222222345678999999998889999999999999999999 7889864321
Q ss_pred CchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 274 HTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
......+.. ..... ..+.....+.+++.+||+.||.+|||+.++++
T Consensus 221 ----~~~~~~~~~---~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~ 266 (272)
T cd05075 221 ----SEIYDYLRQ---GNRLK----------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRC 266 (272)
T ss_pred ----HHHHHHHHc---CCCCC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 122221211 11100 01122344899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=284.31 Aligned_cols=253 Identities=22% Similarity=0.386 Sum_probs=198.4
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..+.|.....||+|+||.||++.+.. ++..||+|.+....... .+.+.+|+..++.++|
T Consensus 20 ~~~~~~~~~~lg~g~~g~v~~~~~~~--~~~~vaiK~~~~~~~~~-------------------~~~~~~e~~~l~~l~h 78 (292)
T cd06658 20 PREYLDSFIKIGEGSTGIVCIATEKH--TGKQVAVKKMDLRKQQR-------------------RELLFNEVVIMRDYHH 78 (292)
T ss_pred hHHHHhhhhcccCCCCeEEEEEEECC--CCCEEEEEEEecchHHH-------------------HHHHHHHHHHHHhCCC
Confidence 44567778889999999999988865 88999999875432111 1467789999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
||++++++.+..++..++++||+++++|.+++.. ..+++..+..++.||+.++.|| |+.|++|+||+|+||+
T Consensus 79 ~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~L---H~~~ivH~dlkp~Nil 150 (292)
T cd06658 79 ENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQIATVCLSVLRALSYL---HNQGVIHRDIKSDSIL 150 (292)
T ss_pred CcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHH---HHCCEeecCCCHHHEE
Confidence 9999999999999999999999999999998732 3478899999999999999999 7779999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhh
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEM 278 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~ 278 (337)
++.++.++|+|||++......... .....++..|+|||.+.+..++.++|+||+|+++|+|++|..||..... .
T Consensus 151 l~~~~~~kL~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~----~ 224 (292)
T cd06658 151 LTSDGRIKLSDFGFCAQVSKEVPK--RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP----L 224 (292)
T ss_pred EcCCCCEEEccCcchhhccccccc--CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----H
Confidence 999999999999988754332211 1234578899999999888889999999999999999999999864221 1
Q ss_pred hHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 279 DMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
............... ........+.+++.+||..||.+|||+.++++|
T Consensus 225 ~~~~~~~~~~~~~~~-----------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 225 QAMRRIRDNLPPRVK-----------DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHHHHHhcCCCccc-----------cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 111111111000000 011223358899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=276.18 Aligned_cols=253 Identities=23% Similarity=0.303 Sum_probs=205.5
Q ss_pred cccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCc
Q 040898 42 CFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNI 121 (337)
Q Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpni 121 (337)
+|++.+.||.|++|.||++.+.. ++..+++|.+......... ...+.+|+.+++.++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~-----------------~~~~~~e~~~l~~l~~~~i 61 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLS--DNQFYALKEVDLGSMSQKE-----------------REDAVNEIRILASVNHPNI 61 (256)
T ss_pred CceEeeeecCCCceeEEEEEECC--CCCEEEEEEEehhhccHHH-----------------HHHHHHHHHHHHhCCCCCc
Confidence 58999999999999999998865 8899999998654322111 1456779999999999999
Q ss_pred ccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecC
Q 040898 122 LPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDD 201 (337)
Q Consensus 122 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~ 201 (337)
+++.+.+.+....++|+||+++++|.+++......+..+++..++.++.|++.|+.+| |+.|++|+||+|+||+++.
T Consensus 62 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~l---h~~~i~h~~l~~~ni~~~~ 138 (256)
T cd08530 62 ISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL---HEQKILHRDLKSANILLVA 138 (256)
T ss_pred hhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH---hhCCcccCCCCcceEEEec
Confidence 9999999999999999999999999999876544556789999999999999999999 7889999999999999999
Q ss_pred CCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHH
Q 040898 202 DMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMV 281 (337)
Q Consensus 202 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~ 281 (337)
++.++|+|||.+....... .....+++.|+|||.+.+..++.++|+||+|+++++|++|..||..... ..+.
T Consensus 139 ~~~~kl~d~g~~~~~~~~~----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~----~~~~ 210 (256)
T cd08530 139 NDLVKIGDLGISKVLKKNM----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM----QDLR 210 (256)
T ss_pred CCcEEEeeccchhhhccCC----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHH
Confidence 9999999999987765431 1224578899999999988889999999999999999999999865321 1111
Q ss_pred HHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 282 KWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.... .... .........++.+++.+||+.+|++|||+.++++|
T Consensus 211 ~~~~---~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 211 YKVQ---RGKY----------PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred HHHh---cCCC----------CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1111 1111 11122445569999999999999999999999987
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=280.72 Aligned_cols=256 Identities=25% Similarity=0.381 Sum_probs=201.9
Q ss_pred cccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHh
Q 040898 36 FLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQ 115 (337)
Q Consensus 36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~ 115 (337)
+.+..++|++.+.||+|+||.||++.+.. ++..|++|.+....... .+.+.+|+.+++.
T Consensus 14 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~--~~~~v~iK~~~~~~~~~-------------------~~~~~~e~~~l~~ 72 (293)
T cd06647 14 VGDPKKKYTRFEKIGQGASGTVYTAIDVA--TGQEVAIKQMNLQQQPK-------------------KELIINEILVMRE 72 (293)
T ss_pred ccCchhhceeeeEecCCCCeEEEEEEEcC--CCCEEEEEEeccccchH-------------------HHHHHHHHHHHhh
Confidence 34456789999999999999999998765 78899999875332211 1467789999999
Q ss_pred cCCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCC
Q 040898 116 TRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPA 195 (337)
Q Consensus 116 l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ 195 (337)
++|||++++++.+..++..++|+||+++++|.+++.. ..+++..+..++.|++.++.+| |+.|++|+||+|+
T Consensus 73 l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~L---H~~gi~H~dL~p~ 144 (293)
T cd06647 73 NKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFL---HSNQVIHRDIKSD 144 (293)
T ss_pred cCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHH---HhCCEeeccCCHH
Confidence 9999999999999999999999999999999999843 3477888999999999999999 7789999999999
Q ss_pred ceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCc
Q 040898 196 NVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHT 275 (337)
Q Consensus 196 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~ 275 (337)
||+++.++.++|+|||++......... .....+++.|++||.+.+..++.++|+||+|+++|++++|..||.......
T Consensus 145 Nili~~~~~~kL~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~ 222 (293)
T cd06647 145 NILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR 222 (293)
T ss_pred HEEEcCCCCEEEccCcceecccccccc--cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh
Confidence 999999999999999987755433221 123457888999999988888999999999999999999999996432211
Q ss_pred hhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 276 EEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.. ........+. ..........+.+++.+||+.+|.+||++++++.|
T Consensus 223 ~~-------~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 223 AL-------YLIATNGTPE--------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred he-------eehhcCCCCC--------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 0000000000 01112233458899999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=276.92 Aligned_cols=256 Identities=24% Similarity=0.364 Sum_probs=198.0
Q ss_pred cccccccceeccCcceEEEEeEEecC-CCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPG-SNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
.++|++.+.||+|+||.||++.+... ..+..+|+|.+........ ...+.+|+.++++++|
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~------------------~~~~~~e~~~l~~l~h 64 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQ------------------RRDFLSEASIMGQFDH 64 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHH------------------HHHHHHHHHHHHhCCC
Confidence 35799999999999999999987642 2345799998865432111 1467789999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++++..++..+++|||+++++|.+++.. ....+++..+..++.|++.|+.+| |+.|++|+||+|+||+
T Consensus 65 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~l---H~~~i~h~dlkp~nil 138 (267)
T cd05066 65 PNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRK---HDGQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNIL 138 (267)
T ss_pred CCcceEEEEEecCCccEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH---HHCCEeehhhchhcEE
Confidence 9999999999999999999999999999999854 234578899999999999999999 7789999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceee-eecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCch
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQIT-VKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHTE 276 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~ 276 (337)
++.++.++|+|||++........... .....++..|++||.+.+..++.++|+||+|+++|++++ |..||......
T Consensus 139 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~-- 216 (267)
T cd05066 139 VNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ-- 216 (267)
T ss_pred ECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH--
Confidence 99999999999999887654322111 111223567999999988889999999999999999887 99998653221
Q ss_pred hhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 277 EMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
.....+.+.. .. +.....+..+.+++.+|++.+|.+|||+.++++
T Consensus 217 --~~~~~~~~~~---~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 217 --DVIKAIEEGY---RL----------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred --HHHHHHhCCC---cC----------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 1122221111 00 001112345889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=277.96 Aligned_cols=255 Identities=23% Similarity=0.366 Sum_probs=196.6
Q ss_pred ccccccceeccCcceEEEEeEEecCC-CCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGS-NGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
++|++.+.||+|+||.||++.+.... .+..|++|.+........ ...+..|+.+++.+.||
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~------------------~~~~~~e~~~l~~l~h~ 65 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQ------------------RRDFLSEASIMGQFDHP 65 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHH------------------HHHHHHHHHHHHhCCCc
Confidence 56899999999999999999886521 234699998865422111 14678899999999999
Q ss_pred CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceee
Q 040898 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI 199 (337)
Q Consensus 120 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~ 199 (337)
||+++.+++.++...++|+||+++++|.+++.. ....+++..+..++.|++.|+.+| |+.|++|+||+|+||++
T Consensus 66 ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~l~~al~~l---H~~g~~H~dl~p~nili 139 (269)
T cd05065 66 NIIHLEGVVTKSRPVMIITEFMENGALDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYL---SEMNYVHRDLAARNILV 139 (269)
T ss_pred CcceEEEEECCCCceEEEEecCCCCcHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHH---HHCCEeecccChheEEE
Confidence 999999999999999999999999999999854 234588899999999999999999 67799999999999999
Q ss_pred cCCCCeEEecccCccccCCCCceeeeeccc---CCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCc
Q 040898 200 DDDMEARISDFGHGKLMPDGHAQITVKCMV---GTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHT 275 (337)
Q Consensus 200 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~---~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~ 275 (337)
+.++.++|+|||++................ .+..|+|||.+.+..++.++|+||+|+++|++++ |..||.....
T Consensus 140 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~-- 217 (269)
T cd05065 140 NSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-- 217 (269)
T ss_pred cCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH--
Confidence 999999999999987654432221111111 2357999999988889999999999999999887 9999864321
Q ss_pred hhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 276 EEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
.+....+...... +.++..+..+.+++.+||+.+|.+||++.++++
T Consensus 218 --~~~~~~i~~~~~~-------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 218 --QDVINAIEQDYRL-------------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred --HHHHHHHHcCCcC-------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1222222111000 001122344889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=277.10 Aligned_cols=252 Identities=25% Similarity=0.402 Sum_probs=197.3
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++.+.||.|++|.||++.+. .+..+++|.+....... +.+.+|+.+++.++|
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~---~~~~~~vK~~~~~~~~~--------------------~~~~~e~~~l~~l~h 60 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN---GTTKVAVKTLKPGTMSP--------------------EAFLQEAQIMKKLRH 60 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc---CCceEEEEEecCCccCH--------------------HHHHHHHHHHhhCCC
Confidence 4578999999999999999998764 45789999886543211 457789999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++++......++++||+++++|.+++.. .....+++..+..++.+++.|+.+| |+.|++|+||+|+||+
T Consensus 61 ~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~--~~~~~~~~~~~~~~~~~i~~al~~l---h~~~i~h~di~p~nil 135 (261)
T cd05034 61 DKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKS--GEGKKLRLPQLVDMAAQIAEGMAYL---ESRNYIHRDLAARNIL 135 (261)
T ss_pred CCEeeeeeeeecCCceEEEEeccCCCCHHHHHhc--cccCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCcchheEE
Confidence 9999999999998999999999999999999854 2334688999999999999999999 7779999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCchh
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHTEE 277 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~ 277 (337)
++.++.++|+|||.+......... .......+..|+|||.+.+..++.++|+||+|+++|++++ |..||..... .
T Consensus 136 i~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---~ 211 (261)
T cd05034 136 VGENLVCKIADFGLARLIEDDEYT-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN---R 211 (261)
T ss_pred EcCCCCEEECccccceeccchhhh-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---H
Confidence 999999999999998765432111 1112234567999999998889999999999999999998 9999854321 1
Q ss_pred hhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 278 MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
.....+....... .+...+..+.+++.+||+.+|.+|||+.++++
T Consensus 212 -~~~~~~~~~~~~~-------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 212 -EVLEQVERGYRMP-------------RPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred -HHHHHHHcCCCCC-------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 1111111110000 00111345899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=283.73 Aligned_cols=276 Identities=21% Similarity=0.320 Sum_probs=201.0
Q ss_pred ccccccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHH
Q 040898 33 DLAFLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIIT 112 (337)
Q Consensus 33 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 112 (337)
+..+.+..++|++.+.||+|++|.||++.+.. +++.||+|.+.......... ..+.+|+.+
T Consensus 4 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~--~~~~~aik~~~~~~~~~~~~-----------------~~~~~e~~~ 64 (310)
T cd07865 4 EFPFCDEVSKYEKLAKIGQGTFGEVFKARHKK--TKQIVALKKVLMENEKEGFP-----------------ITALREIKI 64 (310)
T ss_pred cCcccchhhheEEEEEeecCCCEEEEEEEECC--CCcEEEEEEEeccCCcCCch-----------------hHHHHHHHH
Confidence 56678888899999999999999999998876 89999999886543221100 345679999
Q ss_pred HHhcCCCCcccceeEEEcCC--------eeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCC
Q 040898 113 ANQTRHRNILPLLAHMVRPN--------CHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHR 184 (337)
Q Consensus 113 l~~l~hpniv~~~~~~~~~~--------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~ 184 (337)
+++++||||+++++++.... ..++|+||+.+ +|.+.+.. ....+++..++.++.|+++||.|| |+
T Consensus 65 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~l---H~ 137 (310)
T cd07865 65 LQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYI---HR 137 (310)
T ss_pred HHhCCCCCccceEEEEecccccccCCCceEEEEEcCCCc-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHH---HH
Confidence 99999999999999876543 45999999965 78877743 334689999999999999999999 67
Q ss_pred CCeEecCCCCCceeecCCCCeEEecccCccccCCCCce--eeeecccCCCCccCccccccC-CCCCcccchhhhHHHHHH
Q 040898 185 PRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQ--ITVKCMVGTMGYMAPESLQTE-TISDKCDIYSFGVLLAVL 261 (337)
Q Consensus 185 ~gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~i~~~l 261 (337)
+|++|+||+|+||+++.++.++|+|||.+......... .......++..|+|||.+.+. .++.++|+||+|+++|+|
T Consensus 138 ~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el 217 (310)
T cd07865 138 NKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEM 217 (310)
T ss_pred CCeeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHH
Confidence 79999999999999999999999999998765432211 111234577889999988654 367899999999999999
Q ss_pred HhCCCCCCCCCCCchhhhHHHHHHhhhcc-----------------CCcchhhhhcccCCchHHHHHHHHHHHhhhccCC
Q 040898 262 VMGKFPVDDFFGHTEEMDMVKWMRNVIFS-----------------ENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKD 324 (337)
Q Consensus 262 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 324 (337)
++|..||...........+.......... ..........+. .......+.+++.+||+.|
T Consensus 218 ~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~---~~~~~~~~~dli~~~l~~~ 294 (310)
T cd07865 218 WTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLK---PYVKDPHALDLIDKLLVLD 294 (310)
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcc---cccCCHHHHHHHHHHhcCC
Confidence 99999986533211111111111000000 000000000000 0011234679999999999
Q ss_pred CCCCCChhhhhcC
Q 040898 325 PDERPSSKDVRSM 337 (337)
Q Consensus 325 P~~Rps~~ell~~ 337 (337)
|.+|||++++++|
T Consensus 295 P~~R~t~~e~l~h 307 (310)
T cd07865 295 PAKRIDADTALNH 307 (310)
T ss_pred hhhccCHHHHhcC
Confidence 9999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=281.42 Aligned_cols=255 Identities=24% Similarity=0.272 Sum_probs=192.6
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc-CCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT-RHR 119 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp 119 (337)
++|++.+.||.|+||.||++.+........+++|.+........ ...+.+|+.++.++ .||
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~------------------~~~~~~E~~~l~~l~~hp 63 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASEND------------------HRDFAGELEVLCKLGHHP 63 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHH------------------HHHHHHHHHHHHhhcCCC
Confidence 57999999999999999998876522234578887653221111 14577899999999 799
Q ss_pred CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcC------------CcccCChHHHHHHHHHHHHHHHHHhhCCCCCe
Q 040898 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQ------------GRRELDWPARHRIARGIASGLEYLHMCHRPRL 187 (337)
Q Consensus 120 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi 187 (337)
||+++++++......++++||+++++|.+++..... ....+++..+..++.|++.|+.+| |+.|+
T Consensus 64 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~l---H~~~i 140 (297)
T cd05089 64 NIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYL---SEKQF 140 (297)
T ss_pred chhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHH---HHCCc
Confidence 999999999999999999999999999999854221 123578889999999999999999 67799
Q ss_pred EecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCC
Q 040898 188 IHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKF 266 (337)
Q Consensus 188 ~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~ 266 (337)
+|+||+|+||+++.++.++|+|||++....... .......+..|+|||.+.+..++.++||||||+++|+|++ |..
T Consensus 141 vH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~ 217 (297)
T cd05089 141 IHRDLAARNVLVGENLASKIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGT 217 (297)
T ss_pred ccCcCCcceEEECCCCeEEECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCC
Confidence 999999999999999999999999876432211 1111223457999999988889999999999999999997 999
Q ss_pred CCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 267 PVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 267 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
||..... .+..... ...... ..+...+..+.+++.+||+.+|.+|||+.++++
T Consensus 218 pf~~~~~----~~~~~~~---~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 270 (297)
T cd05089 218 PYCGMTC----AELYEKL---PQGYRM----------EKPRNCDDEVYELMRQCWRDRPYERPPFAQISV 270 (297)
T ss_pred CCCCCCH----HHHHHHH---hcCCCC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9864322 1111111 110000 001123345889999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=281.45 Aligned_cols=267 Identities=21% Similarity=0.274 Sum_probs=199.7
Q ss_pred cccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC
Q 040898 38 KKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR 117 (337)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 117 (337)
+..++|++.+.||.|++|.||++.+.. +++.+++|.+......... ...+.+|+.++.+++
T Consensus 2 ~~~~~y~~~~~lg~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~-----------------~~~~~~e~~~l~~l~ 62 (293)
T cd07843 2 RSVDEYEKLNRIEEGTYGVVYRARDKK--TGEIVALKKLKMEKEKEGF-----------------PITSLREINILLKLQ 62 (293)
T ss_pred cchhhhhhhhhhcCCCCeEEEEEEECC--CCcEEEEEEEeeccccccc-----------------hhhHHHHHHHHHhcC
Confidence 345679999999999999999998865 8899999998654322110 034667999999999
Q ss_pred CCCcccceeEEEcC--CeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCC
Q 040898 118 HRNILPLLAHMVRP--NCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPA 195 (337)
Q Consensus 118 hpniv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ 195 (337)
||||+++++++... ...|+++||+++ +|.+++.. ....+++..+..++.|++.||.|| |+.|++|+||+|+
T Consensus 63 h~ni~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~L---H~~~i~H~dl~p~ 135 (293)
T cd07843 63 HPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMET---MKQPFLQSEVKCLMLQLLSGVAHL---HDNWILHRDLKTS 135 (293)
T ss_pred CCCEEEEEEEEEecCCCcEEEEehhcCc-CHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeccCCHH
Confidence 99999999998777 889999999975 89888854 223689999999999999999999 6779999999999
Q ss_pred ceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCC-CCCcccchhhhHHHHHHHhCCCCCCCCCCC
Q 040898 196 NVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTET-ISDKCDIYSFGVLLAVLVMGKFPVDDFFGH 274 (337)
Q Consensus 196 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~DiwslG~i~~~ll~g~~pf~~~~~~ 274 (337)
||+++.++.++|+|||++......... .....+++.|+|||.+.+.. ++.++|+||+|+++|+|++|.+||......
T Consensus 136 nili~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~ 213 (293)
T cd07843 136 NLLLNNRGILKICDFGLAREYGSPLKP--YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI 213 (293)
T ss_pred HEEECCCCcEEEeecCceeeccCCccc--cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH
Confidence 999999999999999988766543211 12345788899999986543 588999999999999999999998654321
Q ss_pred chhhhHHHHHHhhhccCCc-----------------chhhhhcccCCchHH--HHHHHHHHHhhhccCCCCCCCChhhhh
Q 040898 275 TEEMDMVKWMRNVIFSENP-----------------NRAINSKLLGNGYEE--QMLLVLKLACFCTLKDPDERPSSKDVR 335 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~--~~~~l~~li~~~l~~dP~~Rps~~ell 335 (337)
. ....... ....... ......... ...+. ....+.+++.+||+.||++|||+.|++
T Consensus 214 ~---~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell 288 (293)
T cd07843 214 D---QLNKIFK-LLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLR-KKFPALSLSDNGFDLLNRLLTYDPAKRISAEDAL 288 (293)
T ss_pred H---HHHHHHH-HhCCCchHHHHHhhccchhcccccccccchhhh-ccccccCCChHHHHHHHHHhccCccccCCHHHHh
Confidence 1 1111111 0000000 000000000 11111 255688999999999999999999999
Q ss_pred cC
Q 040898 336 SM 337 (337)
Q Consensus 336 ~~ 337 (337)
+|
T Consensus 289 ~~ 290 (293)
T cd07843 289 KH 290 (293)
T ss_pred cC
Confidence 86
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=274.37 Aligned_cols=247 Identities=21% Similarity=0.298 Sum_probs=190.4
Q ss_pred eeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCcccceeE
Q 040898 48 KIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLLAH 127 (337)
Q Consensus 48 ~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~ 127 (337)
.||+|+||.||++.+.....+..||+|.+......... +.+.+|+.++++++||||++++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~------------------~~~~~E~~~l~~l~h~~ii~~~~~ 63 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVR------------------DEMMREAEIMHQLDNPYIVRMIGV 63 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHH------------------HHHHHHHHHHHhcCCCCeEEEEEE
Confidence 48999999999987764446677999988654321111 467889999999999999999998
Q ss_pred EEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCCeEE
Q 040898 128 MVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARI 207 (337)
Q Consensus 128 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~~l 207 (337)
+. ....++|+||+++++|.+++.. ....+++..++.++.|++.++.++ |+.|++|+||+|+||+++.++.++|
T Consensus 64 ~~-~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~nil~~~~~~~kl 136 (257)
T cd05115 64 CE-AEALMLVMEMASGGPLNKFLSG---KKDEITVSNVVELMHQVSMGMKYL---EGKNFVHRDLAARNVLLVNQHYAKI 136 (257)
T ss_pred Ec-CCCeEEEEEeCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHH---HhcCeeecccchheEEEcCCCcEEe
Confidence 75 4578999999999999998853 345689999999999999999999 7779999999999999999999999
Q ss_pred ecccCccccCCCCceee-eecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCchhhhHHHHHH
Q 040898 208 SDFGHGKLMPDGHAQIT-VKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHTEEMDMVKWMR 285 (337)
Q Consensus 208 ~dfg~~~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~ 285 (337)
+|||++........... .....++..|+|||.+.+..++.++|+||||+++|++++ |..||..... .+....+.
T Consensus 137 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~~~~~~~~ 212 (257)
T cd05115 137 SDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG----PEVMSFIE 212 (257)
T ss_pred ccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH----HHHHHHHH
Confidence 99999876543322111 111233568999999988888999999999999999996 9999865422 11222121
Q ss_pred hhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 286 NVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
..... ..++.....+.+++.+||+.||++||++.++.+
T Consensus 213 ~~~~~-------------~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 213 QGKRL-------------DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred CCCCC-------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11100 011223445889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=273.81 Aligned_cols=256 Identities=24% Similarity=0.421 Sum_probs=200.9
Q ss_pred cccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCc
Q 040898 42 CFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNI 121 (337)
Q Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpni 121 (337)
+|++.+.||+|++|.||.+.+.. +++.|++|.+........ ....+..|+.+++.++||||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~-----------------~~~~~~~e~~~~~~l~~~~i 61 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLD--TGELMAVKEIRIQDNDPK-----------------TIKEIADEMKVLELLKHPNL 61 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECC--CCcEEEEEEEECcccchH-----------------HHHHHHHHHHHHHhCCCCCh
Confidence 58999999999999999998865 889999999865543211 11678889999999999999
Q ss_pred ccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecC
Q 040898 122 LPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDD 201 (337)
Q Consensus 122 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~ 201 (337)
+++++.+.+.+..++|+||+++++|.+++. .+..+++..+..++.+++.++.+| |+.|++|+||+|+||+++.
T Consensus 62 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~~i~~~l~~l---h~~~i~H~dl~~~nil~~~ 134 (264)
T cd06626 62 VKYYGVEVHREKVYIFMEYCSGGTLEELLE----HGRILDEHVIRVYTLQLLEGLAYL---HSHGIVHRDIKPANIFLDH 134 (264)
T ss_pred hheeeeEecCCEEEEEEecCCCCcHHHHHh----hcCCCChHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECC
Confidence 999999999999999999999999999984 344578889999999999999999 6779999999999999999
Q ss_pred CCCeEEecccCccccCCCCceee--eecccCCCCccCccccccCC---CCCcccchhhhHHHHHHHhCCCCCCCCCCCch
Q 040898 202 DMEARISDFGHGKLMPDGHAQIT--VKCMVGTMGYMAPESLQTET---ISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTE 276 (337)
Q Consensus 202 ~~~~~l~dfg~~~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~---~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~ 276 (337)
++.++|+|||.+........... .....+++.|+|||.+.+.. ++.++|+||+|++++++++|..||......
T Consensus 135 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-- 212 (264)
T cd06626 135 NGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-- 212 (264)
T ss_pred CCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch--
Confidence 99999999999877644322211 11245788999999997766 788999999999999999999999653211
Q ss_pred hhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 277 EMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.... ........+. . +........+.+++.+||+.+|.+|||+.++++|
T Consensus 213 -~~~~---~~~~~~~~~~--~------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 213 -FQIM---FHVGAGHKPP--I------PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred -HHHH---HHHhcCCCCC--C------CcccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 1111 1111111100 0 0011123447899999999999999999999976
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=277.68 Aligned_cols=268 Identities=19% Similarity=0.231 Sum_probs=196.4
Q ss_pred cccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC
Q 040898 38 KKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR 117 (337)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 117 (337)
.+.++|.+.+.||+|+||.||.+.+.. ++..|++|.+..+...... ..+.+|+.+++.++
T Consensus 2 ~~~~~y~~~~~ig~g~~~~v~~~~~~~--~~~~~~iK~~~~~~~~~~~------------------~~~~~e~~~l~~l~ 61 (291)
T cd07870 2 GAATSYLNLEKLGEGSYATVYKGISRI--NGQLVALKVISMKTEEGVP------------------FTAIREASLLKGLK 61 (291)
T ss_pred CccceeEEEEEEEecCCEEEEEEEEcC--CCcEEEEEEecccCcCCCc------------------HHHHHHHHHHHhcC
Confidence 456789999999999999999998876 8899999998654322111 34567999999999
Q ss_pred CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCce
Q 040898 118 HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANV 197 (337)
Q Consensus 118 hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ni 197 (337)
||||+++++++..+...++|+||++ ++|.+++.. ....+++..+..++.|++.||.|| |+.|++|+||+|+||
T Consensus 62 h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~l---H~~~i~H~dlkp~Ni 134 (291)
T cd07870 62 HANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYI---HGQHILHRDLKPQNL 134 (291)
T ss_pred CCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCChHHE
Confidence 9999999999999999999999996 577766632 234577788899999999999999 777999999999999
Q ss_pred eecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCCCch
Q 040898 198 LIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTE-TISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTE 276 (337)
Q Consensus 198 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~ 276 (337)
+++.++.++|+|||++......... .....+++.|+|||.+.+. .++.++|+||||+++|+|++|..||......
T Consensus 135 l~~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~-- 210 (291)
T cd07870 135 LISYLGELKLADFGLARAKSIPSQT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV-- 210 (291)
T ss_pred EEcCCCcEEEeccccccccCCCCCC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH--
Confidence 9999999999999988754322111 1223568899999998654 4788899999999999999999999653221
Q ss_pred hhhHHHHHHhhhccCCc------------chhhhhcccCCch------HHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 277 EMDMVKWMRNVIFSENP------------NRAINSKLLGNGY------EEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
...+.+... ....... ............. ......+.+++.+|+..||++|||+.+++.|
T Consensus 211 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 211 FEQLEKIWT-VLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred HHHHHHHHH-HcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 111111100 0000000 0000000000000 0113457899999999999999999999987
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=275.71 Aligned_cols=250 Identities=29% Similarity=0.447 Sum_probs=193.6
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
.++|++.+.||+|++|.||++.+. .+..+++|.+....... +.+.+|+.+++.++||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~---~~~~~~lK~~~~~~~~~--------------------~~~~~E~~~l~~l~h~ 61 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWN---GTTKVAIKTLKPGTMMP--------------------EAFLQEAQIMKKLRHD 61 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEc---CCceEEEEEcccCCccH--------------------HHHHHHHHHHHhCCCC
Confidence 467999999999999999998775 34569999875433211 4567799999999999
Q ss_pred CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceee
Q 040898 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI 199 (337)
Q Consensus 120 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~ 199 (337)
|++++++++. ....+++|||+++++|.+++.. .....+++..+..++.|++.||.|| |+.|++|+||+|+||++
T Consensus 62 ~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~al~~l---H~~~i~H~dl~~~Nill 135 (260)
T cd05069 62 KLVPLYAVVS-EEPIYIVTEFMGKGSLLDFLKE--GDGKYLKLPQLVDMAAQIADGMAYI---ERMNYIHRDLRAANILV 135 (260)
T ss_pred CeeeEEEEEc-CCCcEEEEEcCCCCCHHHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHH---HhCCEeecccCcceEEE
Confidence 9999998775 4567899999999999999864 2334578889999999999999999 77799999999999999
Q ss_pred cCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCchhh
Q 040898 200 DDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHTEEM 278 (337)
Q Consensus 200 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~~ 278 (337)
++++.++|+|||.+......... ......++..|+|||...+..++.++|+||||+++|+|++ |..||..... .
T Consensus 136 ~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~ 210 (260)
T cd05069 136 GDNLVCKIADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN----R 210 (260)
T ss_pred cCCCeEEECCCccceEccCCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH----H
Confidence 99999999999998765433211 1122345677999999988889999999999999999999 8999864321 1
Q ss_pred hHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 279 DMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
.....+.. .... ..+...+..+.+++.+||+.||++|||+.++++
T Consensus 211 ~~~~~~~~---~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 211 EVLEQVER---GYRM----------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHHHHHc---CCCC----------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 11111111 1000 011123345899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=291.52 Aligned_cols=258 Identities=26% Similarity=0.326 Sum_probs=200.4
Q ss_pred ccccccccceeccCcceEEEEeEEecCCC--CceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSN--GKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT 116 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 116 (337)
..++..+.++||+|+||.||.+....... ...||+|....+..... ..+..+..|.++|+++
T Consensus 155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~----------------~~~~e~m~EArvMr~l 218 (474)
T KOG0194|consen 155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTK----------------EQIKEFMKEARVMRQL 218 (474)
T ss_pred eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccH----------------HHHHHHHHHHHHHHhC
Confidence 55667778999999999999988775322 12289998865332211 1226889999999999
Q ss_pred CCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 040898 117 RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPAN 196 (337)
Q Consensus 117 ~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~n 196 (337)
+||||++++|+......+++|||+|+||+|.+++++ .+..++......++.+.+.||+|| |+++++||||-.+|
T Consensus 219 ~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k---~~~~v~~~ek~~~~~~AA~Gl~YL---h~k~~IHRDIAARN 292 (474)
T KOG0194|consen 219 NHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKK---NKKSLPTLEKLRFCYDAARGLEYL---HSKNCIHRDIAARN 292 (474)
T ss_pred CCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHhHHHHH---HHCCCcchhHhHHH
Confidence 999999999999999999999999999999999964 333689999999999999999999 88899999999999
Q ss_pred eeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCc
Q 040898 197 VLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHT 275 (337)
Q Consensus 197 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~ 275 (337)
+|++.++.+||+|||++..-... ........-..+|+|||.+....++.++||||+|+++||+++ |..||.+....
T Consensus 293 cL~~~~~~vKISDFGLs~~~~~~--~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~- 369 (474)
T KOG0194|consen 293 CLYSKKGVVKISDFGLSRAGSQY--VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY- 369 (474)
T ss_pred heecCCCeEEeCccccccCCcce--eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH-
Confidence 99999999999999998764311 111111235678999999999899999999999999999999 78898765331
Q ss_pred hhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 276 EEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
+....+....... ..+...+.++..++.+|+..||++|||+.++.+
T Consensus 370 ------~v~~kI~~~~~r~---------~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 370 ------EVKAKIVKNGYRM---------PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred ------HHHHHHHhcCccC---------CCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 1122221111111 111133445888888999999999999998864
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=274.74 Aligned_cols=256 Identities=20% Similarity=0.298 Sum_probs=184.8
Q ss_pred ceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCccccee
Q 040898 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLLA 126 (337)
Q Consensus 47 ~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~ 126 (337)
+.||+|+||.||++..........+++|.+......... ..+.+|+..++.++||||+++++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~------------------~~~~~e~~~~~~l~h~~iv~~~~ 62 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQ------------------NEFLQQGDPYRILQHPNILQCLG 62 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHH------------------HHHHHHHHHHhccCCcchhheEE
Confidence 369999999999987665444556777776544322111 56788999999999999999999
Q ss_pred EEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCCeE
Q 040898 127 HMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEAR 206 (337)
Q Consensus 127 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~~ 206 (337)
.+......++||||+++++|.+++..........+...+..++.|++.||.|| |+.+++|+||+|+||+++.++.++
T Consensus 63 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~l---H~~~i~H~dikp~nil~~~~~~~~ 139 (268)
T cd05086 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHM---HKHNFLHSDLALRNCFLTSDLTVK 139 (268)
T ss_pred EecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHH---HHCCeeccCCccceEEEcCCccEE
Confidence 99999999999999999999999965333334567777889999999999999 677999999999999999999999
Q ss_pred EecccCccccCCCCceeeeecccCCCCccCcccccc-------CCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCchhh
Q 040898 207 ISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQT-------ETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHTEEM 278 (337)
Q Consensus 207 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-------~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~~ 278 (337)
|+|||++................++..|+|||++.. ..++.++|+||||+++|+|++ +..||..... ..
T Consensus 140 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~---~~ 216 (268)
T cd05086 140 VGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD---RE 216 (268)
T ss_pred ecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH---HH
Confidence 999998754322211111123457888999999743 235678999999999999997 5678754321 11
Q ss_pred hHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 279 DMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
.......... . ....+.. .....+.+.+++..|+ .+|++|||+.++++
T Consensus 217 ~~~~~~~~~~----~-~~~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 217 VLNHVIKDQQ----V-KLFKPQL----ELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred HHHHHHhhcc----c-ccCCCcc----CCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 1111111110 0 0000100 1112344777888899 67999999999976
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=274.59 Aligned_cols=247 Identities=25% Similarity=0.357 Sum_probs=190.6
Q ss_pred ceeccCcceEEEEeEEecCC-CCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCcccce
Q 040898 47 KKIGSGGWGEVFYKAELPGS-NGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLL 125 (337)
Q Consensus 47 ~~lg~G~~g~V~~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~ 125 (337)
++||+|+||.||++...... ++..+|+|.+........ ...+.+|+.+++.+.|||+++++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~------------------~~~~~~e~~~l~~l~h~~iv~~~ 62 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAG------------------KKEFLREASVMAQLDHPCIVRLI 62 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHH------------------HHHHHHHHHHHHhcCCCCeeeEE
Confidence 47999999999998776533 447899998875543211 14677899999999999999999
Q ss_pred eEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCCe
Q 040898 126 AHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEA 205 (337)
Q Consensus 126 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~ 205 (337)
+++. ....++++||+++++|.+++.. ...+++..+..++.|++.++.+| |+.|++|+||+|+||+++.++.+
T Consensus 63 ~~~~-~~~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~l---h~~~i~H~di~p~nili~~~~~~ 134 (257)
T cd05060 63 GVCK-GEPLMLVMELAPLGPLLKYLKK----RREIPVSDLKELAHQVAMGMAYL---ESKHFVHRDLAARNVLLVNRHQA 134 (257)
T ss_pred EEEc-CCceEEEEEeCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHH---hhcCeeccCcccceEEEcCCCcE
Confidence 9765 4568999999999999999943 33688999999999999999999 77799999999999999999999
Q ss_pred EEecccCccccCCCCceee-eecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCchhhhHHHH
Q 040898 206 RISDFGHGKLMPDGHAQIT-VKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHTEEMDMVKW 283 (337)
Q Consensus 206 ~l~dfg~~~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~~~~~~~ 283 (337)
+|+|||.+........... .....++..|+|||.+.+..++.++|+||||+++|++++ |.+||+.... ......
T Consensus 135 kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~----~~~~~~ 210 (257)
T cd05060 135 KISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG----AEVIAM 210 (257)
T ss_pred EeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH----HHHHHH
Confidence 9999999876643322211 111223467999999988889999999999999999998 9999865432 122222
Q ss_pred HHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 284 MRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
+....... .+...+..+.+++.+||+.+|++|||+.++++
T Consensus 211 ~~~~~~~~-------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 211 LESGERLP-------------RPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred HHcCCcCC-------------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 22111000 11112345889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=272.53 Aligned_cols=255 Identities=22% Similarity=0.360 Sum_probs=205.7
Q ss_pred cccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCc
Q 040898 42 CFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNI 121 (337)
Q Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpni 121 (337)
+|.+.+.||+|++|.||++.+.. ++..+++|++......... ...+.+|++.++.++|||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~-----------------~~~~~~e~~~l~~l~~~~~ 61 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKS--DGKLYVLKEIDLSNMSEKE-----------------REDALNEVKILKKLNHPNI 61 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcC--CCcEEEEEEeecccCChHH-----------------HHHHHHHHHHHHhcCCCCh
Confidence 58899999999999999999865 8999999998655432111 1467789999999999999
Q ss_pred ccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecC
Q 040898 122 LPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDD 201 (337)
Q Consensus 122 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~ 201 (337)
+++.+.+..+...++++|++++++|.+++......+..+++..+..++.+++.++.+| |+.|++|+||+|+||+++.
T Consensus 62 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l---h~~~~~H~dl~~~nil~~~ 138 (258)
T cd08215 62 IKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL---HSRKILHRDIKPQNIFLTS 138 (258)
T ss_pred hheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHH---HhCCEecccCChHHeEEcC
Confidence 9999999999999999999999999999976444457799999999999999999999 6779999999999999999
Q ss_pred CCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHH
Q 040898 202 DMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMV 281 (337)
Q Consensus 202 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~ 281 (337)
++.++|+|||.+........ ......+++.|+|||...+..++.++|+||+|+++++|++|..||..... ....
T Consensus 139 ~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~----~~~~ 212 (258)
T cd08215 139 NGLVKLGDFGISKVLSSTVD--LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL----LELA 212 (258)
T ss_pred CCcEEECCccceeecccCcc--eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH----HHHH
Confidence 99999999999877654431 12234678899999999888899999999999999999999999864321 1111
Q ss_pred HHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 282 KWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
. ........ ..+......+.+++.+||+.+|.+|||+.++|+|
T Consensus 213 ~---~~~~~~~~----------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 213 L---KILKGQYP----------PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred H---HHhcCCCC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1 11111110 0011223458899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=273.61 Aligned_cols=255 Identities=26% Similarity=0.360 Sum_probs=195.5
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
+.++...-..||+|+||.||++.+.. ++..|++|.+....... ...+.+|+.+++.++|
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~--~~~~v~~k~~~~~~~~~-------------------~~~~~~e~~~l~~l~h 64 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLS--TQVRIAIKEIPERDSRY-------------------VQPLHEEIALHSYLKH 64 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecC--CCcEEEEEEecCCCHHH-------------------HHHHHHHHHHHHhcCC
Confidence 44555566789999999999998865 88999999876543211 1467789999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccC--ChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRREL--DWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPAN 196 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~--~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~n 196 (337)
|||+++++++..+...++++||+++++|.+++... ..++ ++..+..++.|++.|+.|| |+.|++|+||+|+|
T Consensus 65 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~l---H~~~i~h~dl~p~n 138 (268)
T cd06624 65 RNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSK---WGPLKDNEQTIIFYTKQILEGLKYL---HDNQIVHRDIKGDN 138 (268)
T ss_pred CCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHh---cccCCCcHHHHHHHHHHHHHHHHHH---HHCCEeecCCCHHH
Confidence 99999999999999999999999999999998642 1234 7788889999999999999 77899999999999
Q ss_pred eeecC-CCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCC--CCCcccchhhhHHHHHHHhCCCCCCCCCC
Q 040898 197 VLIDD-DMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTET--ISDKCDIYSFGVLLAVLVMGKFPVDDFFG 273 (337)
Q Consensus 197 il~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~--~~~~~DiwslG~i~~~ll~g~~pf~~~~~ 273 (337)
|+++. ++.++|+|||.+......... .....+++.|+|||.+.+.. ++.++|+||+|+++|+|++|..||.....
T Consensus 139 il~~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~ 216 (268)
T cd06624 139 VLVNTYSGVVKISDFGTSKRLAGINPC--TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGE 216 (268)
T ss_pred EEEcCCCCeEEEecchhheecccCCCc--cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccC
Confidence 99976 678999999988765432211 12235788999999986543 78899999999999999999999865322
Q ss_pred CchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 274 HTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.... ... ....... ...+....+.+.+++.+||+.+|.+|||+.++++|
T Consensus 217 ~~~~--~~~---~~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 217 PQAA--MFK---VGMFKIH----------PEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred hhhh--Hhh---hhhhccC----------CCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 1110 000 0000000 00112233458899999999999999999999986
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=283.42 Aligned_cols=269 Identities=23% Similarity=0.321 Sum_probs=198.6
Q ss_pred ccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc
Q 040898 37 LKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT 116 (337)
Q Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 116 (337)
+...++|++.+.||+|++|.||++.+.. +|+.||+|.+..+....... ..+.+|+.+++++
T Consensus 3 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~--~~~~vaiK~~~~~~~~~~~~-----------------~~~~~E~~~l~~l 63 (309)
T cd07845 3 CRSVTEFEKLNRIGEGTYGIVYRARDTT--SGEIVALKKVRMDNERDGIP-----------------ISSLREITLLLNL 63 (309)
T ss_pred cccccceeEeeeeeecCCEEEEEEEECC--CCcEEEEEEEEeccCCCCCc-----------------chhhHHHHHHHhC
Confidence 3466789999999999999999999876 89999999986543221100 2355699999999
Q ss_pred CCCCcccceeEEEcC--CeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCC
Q 040898 117 RHRNILPLLAHMVRP--NCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKP 194 (337)
Q Consensus 117 ~hpniv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~ 194 (337)
+|||++++++++... +..++|+||+.+ +|.+++.. ....+++..++.++.|++.|+.+| |+.|++|+||+|
T Consensus 64 ~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~l~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p 136 (309)
T cd07845 64 RHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDN---MPTPFSESQVKCLMLQLLRGLQYL---HENFIIHRDLKV 136 (309)
T ss_pred CCCCCcceEEEEecCCCCeEEEEEecCCC-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCH
Confidence 999999999998755 568999999975 88888754 235689999999999999999999 777999999999
Q ss_pred CceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCcccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCC
Q 040898 195 ANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQT-ETISDKCDIYSFGVLLAVLVMGKFPVDDFFG 273 (337)
Q Consensus 195 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~ 273 (337)
+||+++.++.++|+|||.+......... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|.+||.....
T Consensus 137 ~nil~~~~~~~kL~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~ 214 (309)
T cd07845 137 SNLLLTDKGCLKIADFGLARTYGLPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE 214 (309)
T ss_pred HHEEECCCCCEEECccceeeecCCccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999999999999998776433211 122335778999999865 4578899999999999999999999865322
Q ss_pred CchhhhHHHHHHhhhccCCcch-----------h--hh-hc--ccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 274 HTEEMDMVKWMRNVIFSENPNR-----------A--IN-SK--LLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~-----------~--~~-~~--~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.. ....+........... . .. .. ............+.+++.+||+.||++|||+.++++|
T Consensus 215 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 215 IE----QLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred HH----HHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 11 1111111110000000 0 00 00 0000011124557899999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=267.38 Aligned_cols=262 Identities=23% Similarity=0.348 Sum_probs=211.4
Q ss_pred ccccccc--cccccccc-ceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHH
Q 040898 32 QDLAFLK--KEDCFDSL-KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRS 108 (337)
Q Consensus 32 ~~~~~~~--~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 108 (337)
.++.|-+ ..++|.+- +.||-|-.|.|-.+.++. +++.+|+|++... ...++
T Consensus 50 ~~m~~k~~~itedY~is~qvLG~GinGkV~~C~~k~--T~ekfALKvL~Ds------------------------~KARr 103 (400)
T KOG0604|consen 50 SDMDFKEYSITEDYSISWQVLGAGINGKVVQCVHKR--TQEKFALKVLLDS------------------------PKARR 103 (400)
T ss_pred hhcchhcccchhhheehhhhhccccCCceEEEEecc--chhhhHHHHHhcC------------------------HHHHh
Confidence 3555533 56777765 569999999997676765 9999999988543 45667
Q ss_pred HHHHHHh-cCCCCcccceeEEEcC----CeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCC
Q 040898 109 EIITANQ-TRHRNILPLLAHMVRP----NCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCH 183 (337)
Q Consensus 109 e~~~l~~-l~hpniv~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h 183 (337)
|+++--. ..|||||.+++++++. +++.+|||.++||.|...++. .....+++..+..|++||+.|+.|| |
T Consensus 104 EVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~--~g~~afTErea~eI~~qI~~Av~~l---H 178 (400)
T KOG0604|consen 104 EVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQD--RGDQAFTEREASEIMKQIGLAVRYL---H 178 (400)
T ss_pred HhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHH--cccccchHHHHHHHHHHHHHHHHHH---H
Confidence 7776444 3899999999988653 678899999999999999976 5556799999999999999999999 7
Q ss_pred CCCeEecCCCCCceeecC---CCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHH
Q 040898 184 RPRLIHRDIKPANVLIDD---DMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAV 260 (337)
Q Consensus 184 ~~gi~h~di~~~nil~~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ 260 (337)
+.+|.||||||+|+|.+. +..+||+|||++....... .....+.||.|.|||++..+.|+..+|+||+|+++|-
T Consensus 179 ~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~---~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYI 255 (400)
T KOG0604|consen 179 SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPG---DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYI 255 (400)
T ss_pred hcchhhccCChhheeeecCCCCcceEecccccccccCCCc---cccCCcccccccCHHHhCchhcCCCCCccchhHHHHH
Confidence 789999999999999964 5578999999998755422 2334678999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 261 LVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 261 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
|++|.+||-..++......+...++..... +..+.+...+++.+++|+.+|..+|++|.|++++++|
T Consensus 256 lLCGyPPFYS~hg~aispgMk~rI~~gqy~----------FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 256 LLCGYPPFYSNHGLAISPGMKRRIRTGQYE----------FPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred hhcCCCcccccCCccCChhHHhHhhccCcc----------CCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 999999998777755555554444332211 1234467788889999999999999999999999886
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=276.97 Aligned_cols=249 Identities=29% Similarity=0.366 Sum_probs=193.5
Q ss_pred eccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCcccceeEE
Q 040898 49 IGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLLAHM 128 (337)
Q Consensus 49 lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~ 128 (337)
||+|+||+||++.+.. +++.|++|.+.......... ...+..|+.+++.++|||++++++.+
T Consensus 1 lg~g~~g~vy~~~~~~--~~~~~~ik~~~~~~~~~~~~----------------~~~~~~e~~~l~~l~~~~i~~~~~~~ 62 (277)
T cd05577 1 LGKGGFGEVCACQVKA--TGKMYACKKLDKKRLKKRKG----------------EQMALNEKKILEKVSSRFIVSLAYAF 62 (277)
T ss_pred CCCCCceeEEEEEEcC--CCcEEEEEEEehhhhhhhhh----------------hHHHHHHHHHHHhCCCCCEeeeeeEE
Confidence 6999999999988765 89999999986542211110 14567799999999999999999999
Q ss_pred EcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCCeEEe
Q 040898 129 VRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARIS 208 (337)
Q Consensus 129 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~~l~ 208 (337)
...+..|+|+||+++++|.+++.. .....+++..+..++.|++.++.+| |+.|++|+||+|+||+++.++.++|+
T Consensus 63 ~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~ql~~~l~~l---H~~~i~H~di~p~Nil~~~~~~~~l~ 137 (277)
T cd05577 63 ETKDDLCLVMTLMNGGDLKYHIYN--VGEPGFPEARAIFYAAQIICGLEHL---HQRRIVYRDLKPENVLLDDHGNVRIS 137 (277)
T ss_pred ecCCeEEEEEecCCCCcHHHHHHH--cCcCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEEECCCCCEEEc
Confidence 999999999999999999999854 2234688999999999999999999 77799999999999999999999999
Q ss_pred cccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHHHHHHhhh
Q 040898 209 DFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVI 288 (337)
Q Consensus 209 dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 288 (337)
|||.+....... ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||...........+.... .
T Consensus 138 dfg~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~ 211 (277)
T cd05577 138 DLGLAVELKGGK---KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRT---L 211 (277)
T ss_pred cCcchhhhccCC---ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcc---c
Confidence 999887653321 1123457888999999988888999999999999999999999986543211111111111 0
Q ss_pred ccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCC-----ChhhhhcC
Q 040898 289 FSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERP-----SSKDVRSM 337 (337)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 337 (337)
... ...+......+.+++.+||+.||.+|| ++.++++|
T Consensus 212 -~~~----------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 212 -EMA----------VEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred -ccc----------ccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence 000 001112244588999999999999999 77778876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=277.86 Aligned_cols=260 Identities=23% Similarity=0.344 Sum_probs=199.9
Q ss_pred ccccccccceeccCcceEEEEeEEecCC--CCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGS--NGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT 116 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 116 (337)
..++|++.+.||+|+||.||++.+.... ++..|++|.+........ ...+.+|+.+++.+
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~------------------~~~~~~e~~~l~~l 65 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQ------------------VTLLLQESCLLYGL 65 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHH------------------HHHHHHHHHHHHhC
Confidence 3568999999999999999999886421 368889988754322111 15677899999999
Q ss_pred CCCCcccceeEEEc-CCeeEEEEEeccCCCHHHHHHHhcCC----cccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 040898 117 RHRNILPLLAHMVR-PNCHLLVYEFMKNGSLQDILYDVSQG----RRELDWPARHRIARGIASGLEYLHMCHRPRLIHRD 191 (337)
Q Consensus 117 ~hpniv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~----~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~d 191 (337)
+||||+++++++.. +...+++++|+++++|.+++...... ...+++..++.++.|++.||.|| |+.+++|+|
T Consensus 66 ~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~L---H~~~i~H~d 142 (280)
T cd05043 66 SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYL---HKRGVIHKD 142 (280)
T ss_pred CCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHH---HHCCEeecc
Confidence 99999999998765 56789999999999999998653322 15688999999999999999999 677999999
Q ss_pred CCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCC
Q 040898 192 IKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDD 270 (337)
Q Consensus 192 i~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~ 270 (337)
|+|+||+++.++.++|+|||+++.+.............++..|+|||.+.+..++.++||||||+++|++++ |..||..
T Consensus 143 i~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 222 (280)
T cd05043 143 IAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVE 222 (280)
T ss_pred cCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCc
Confidence 999999999999999999999876543332222222345677999999988889999999999999999999 9999865
Q ss_pred CCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 271 FFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
... .+......... ... .....+..+.+++.+||+.||++|||+.++++
T Consensus 223 ~~~----~~~~~~~~~~~---~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 223 IDP----FEMAAYLKDGY---RLA----------QPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CCH----HHHHHHHHcCC---CCC----------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 322 22222222110 000 01112345899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=279.38 Aligned_cols=257 Identities=21% Similarity=0.289 Sum_probs=196.4
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
++|++.+.||+|+||.||++.+.. +++.|++|.+......... ....+.+|+.+++.++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~--~~~~v~ik~~~~~~~~~~~----------------~~~~~~~e~~~l~~~~~~~ 62 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKE--TRQRFAMKKINKQNLILRN----------------QIQQVFVERDILTFAENPF 62 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECC--CCcEEEEEEeehhhhhhHH----------------HHHHHHHHHHHHHhCCCCC
Confidence 469999999999999999998876 8899999987544221111 1156778999999999999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
|+++++.+..++..++++||+++++|.+++.. ...+++..+..++.|++.|+.|+ |+.|++|+||+|+||+++
T Consensus 63 i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~NIll~ 135 (305)
T cd05609 63 VVSMFCSFETKRHLCMVMEYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYL---HNYGIVHRDLKPDNLLIT 135 (305)
T ss_pred eeeeEEEEecCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCchHHEEEC
Confidence 99999999999999999999999999999843 34688899999999999999999 677999999999999999
Q ss_pred CCCCeEEecccCccccCCCCc-------------eeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCC
Q 040898 201 DDMEARISDFGHGKLMPDGHA-------------QITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFP 267 (337)
Q Consensus 201 ~~~~~~l~dfg~~~~~~~~~~-------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~p 267 (337)
.++.++|+|||++........ ........++..|+|||.+.+..++.++|+||||+++|++++|..|
T Consensus 136 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~p 215 (305)
T cd05609 136 SMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215 (305)
T ss_pred CCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 999999999998763211000 0011123467889999999888899999999999999999999999
Q ss_pred CCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCC---hhhhhcC
Q 040898 268 VDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPS---SKDVRSM 337 (337)
Q Consensus 268 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps---~~ell~~ 337 (337)
|.+.. . .. .............. .....+..+.+++.+||+.||++||| +.++++|
T Consensus 216 f~~~~---~-~~---~~~~~~~~~~~~~~--------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 216 FFGDT---P-EE---LFGQVISDDIEWPE--------GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred CCCCC---H-HH---HHHHHHhcccCCCC--------ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 85321 1 11 11111111100000 00123344899999999999999998 5666664
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=272.18 Aligned_cols=245 Identities=24% Similarity=0.325 Sum_probs=190.5
Q ss_pred ceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCccccee
Q 040898 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLLA 126 (337)
Q Consensus 47 ~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~ 126 (337)
+.||+|++|.||++.. . +++.+|+|.+......... ..+.+|+.+++.++||||+++++
T Consensus 1 ~~ig~g~~g~vy~~~~-~--~~~~~a~K~~~~~~~~~~~------------------~~~~~e~~~l~~l~h~~i~~~~~ 59 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-K--DKTPVAVKTCKEDLPQELK------------------IKFLSEARILKQYDHPNIVKLIG 59 (250)
T ss_pred CccCCCCCceEEEEEe-c--CCcEEEEEecCCcCCHHHH------------------HHHHHHHHHHHhCCCCCcCeEEE
Confidence 4799999999998864 3 6889999988654432111 35778999999999999999999
Q ss_pred EEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCCeE
Q 040898 127 HMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEAR 206 (337)
Q Consensus 127 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~~ 206 (337)
++......++||||+++++|.+++.. ....+++..+..++.|++.++.++ |+.|++|+||+|+||+++.++.++
T Consensus 60 ~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~l---H~~~~~H~dl~p~nili~~~~~~~ 133 (250)
T cd05085 60 VCTQRQPIYIVMELVPGGDFLSFLRK---KKDELKTKQLVKFALDAAAGMAYL---ESKNCIHRDLAARNCLVGENNVLK 133 (250)
T ss_pred EEecCCccEEEEECCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeecccChheEEEcCCCeEE
Confidence 99999999999999999999998853 234578899999999999999999 778999999999999999999999
Q ss_pred EecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCchhhhHHHHHH
Q 040898 207 ISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHTEEMDMVKWMR 285 (337)
Q Consensus 207 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~ 285 (337)
|+|||++.......... .....++..|+|||.+.+..++.++|+||+|+++|++++ |..||...... .....+.
T Consensus 134 l~d~g~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~----~~~~~~~ 208 (250)
T cd05085 134 ISDFGMSRQEDDGIYSS-SGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ----QAREQVE 208 (250)
T ss_pred ECCCccceecccccccc-CCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH----HHHHHHH
Confidence 99999987543322111 111234567999999988889999999999999999998 89998653221 1111111
Q ss_pred hhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 286 NVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
. .... ..+...+..+.+++.+||+.+|++|||+.++++
T Consensus 209 ~---~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 209 K---GYRM----------SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred c---CCCC----------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 1 1000 011122345899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=280.80 Aligned_cols=269 Identities=22% Similarity=0.285 Sum_probs=196.7
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC-CC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR-HR 119 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp 119 (337)
++|++.+.||+|+||.||++.+.. +++.||+|.+......... ...+.+|+.+++.+. ||
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~--~~~~v~lK~~~~~~~~~~~-----------------~~~~~~E~~~l~~l~~~~ 61 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKN--TGKLVALKKTRLEMDEEGI-----------------PPTALREISLLQMLSESI 61 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECC--CCcEEEEEeehhhccccCC-----------------chHHHHHHHHHHHccCCC
Confidence 469999999999999999998875 8999999987654321110 145677999999995 69
Q ss_pred CcccceeEEEcCCe-----eEEEEEeccCCCHHHHHHHhcCC-cccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCC
Q 040898 120 NILPLLAHMVRPNC-----HLLVYEFMKNGSLQDILYDVSQG-RRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIK 193 (337)
Q Consensus 120 niv~~~~~~~~~~~-----~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~ 193 (337)
||+++++++..... .|+++||+++ +|.+++...... ...+++..++.++.||+.||.|| |+.|++|+||+
T Consensus 62 ~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~L---H~~~i~H~dl~ 137 (295)
T cd07837 62 YIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHC---HKHGVMHRDLK 137 (295)
T ss_pred CccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCC
Confidence 99999998876655 8999999986 888887653322 45689999999999999999999 77899999999
Q ss_pred CCceeecC-CCCeEEecccCccccCCCCceeeeecccCCCCccCcccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCC
Q 040898 194 PANVLIDD-DMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQT-ETISDKCDIYSFGVLLAVLVMGKFPVDDF 271 (337)
Q Consensus 194 ~~nil~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~i~~~ll~g~~pf~~~ 271 (337)
|+||+++. ++.++|+|||.+......... .....+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||...
T Consensus 138 ~~nil~~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~ 215 (295)
T cd07837 138 PQNLLVDKQKGLLKIADLGLGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGD 215 (295)
T ss_pred hHHEEEecCCCeEEEeecccceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Confidence 99999998 889999999988755332211 122346788999998865 45688999999999999999999998643
Q ss_pred CCCchhhhHHHHHHhhhccCC---cc----------hhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 272 FGHTEEMDMVKWMRNVIFSEN---PN----------RAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~---~~----------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.. .............+.. +. ....+.......+.....+.+++.+||++||.+|||+.+++.|
T Consensus 216 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 216 SE---LQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred CH---HHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 22 1111111111000000 00 0000000001112344568899999999999999999999987
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=274.67 Aligned_cols=250 Identities=23% Similarity=0.350 Sum_probs=195.6
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
.+|++.+.||+|++|.||++.+. ++..+++|.+....... ..+.+|+.++++++|||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~---~~~~~~~k~~~~~~~~~--------------------~~~~~e~~~l~~l~~~~ 60 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL---EKRKVAIKTIREGAMSE--------------------EDFIEEAQVMMKLSHPK 60 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe---CCCeEEEEECCCCCCCH--------------------HHHHHHHHHHHhCCCCC
Confidence 47899999999999999998774 46789999876432211 45677999999999999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
++++++++......++++||+++++|.+++.. ....+++..++.++.+++.++.+| |+.|++|+||+|+||+++
T Consensus 61 i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~l---H~~~i~h~dl~p~ni~i~ 134 (256)
T cd05112 61 LVQLYGVCTERSPICLVFEFMEHGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYL---ESSNVIHRDLAARNCLVG 134 (256)
T ss_pred eeeEEEEEccCCceEEEEEcCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHH---HHCCccccccccceEEEc
Confidence 99999999999999999999999999998853 334578899999999999999999 677999999999999999
Q ss_pred CCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCchhhh
Q 040898 201 DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHTEEMD 279 (337)
Q Consensus 201 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~~~ 279 (337)
.++.++|+|||.+......... ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||..... ..
T Consensus 135 ~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~----~~ 209 (256)
T cd05112 135 ENQVVKVSDFGMTRFVLDDQYT-SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN----SE 209 (256)
T ss_pred CCCeEEECCCcceeecccCccc-ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH----HH
Confidence 9999999999988755332211 1112234568999999988889999999999999999998 8999864221 11
Q ss_pred HHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 280 MVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
+...+... .... .+ ...+..+.+++.+||+.+|++|||+.+++++
T Consensus 210 ~~~~~~~~---~~~~---~~-------~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 210 VVETINAG---FRLY---KP-------RLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHHHHhCC---CCCC---CC-------CCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 22211111 0100 00 0123458999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=280.79 Aligned_cols=275 Identities=21% Similarity=0.281 Sum_probs=199.2
Q ss_pred cccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCc
Q 040898 42 CFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNI 121 (337)
Q Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpni 121 (337)
+|++.+.||+|++|.||++.+....++..||+|.+......... ....+.+|+.++..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~----------------~~~~~~~e~~~l~~l~h~~i 64 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTG----------------ISQSACREIALLRELKHENV 64 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccC----------------ccHHHHHHHHHHHhcCCCCc
Confidence 48899999999999999998865447899999998764311000 00456779999999999999
Q ss_pred ccceeEEEcC--CeeEEEEEeccCCCHHHHHHHhcCC-cccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 122 LPLLAHMVRP--NCHLLVYEFMKNGSLQDILYDVSQG-RRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 122 v~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
+++++++.+. ...++|+||+++ +|.+++...... ...+++..++.++.|++.|+.|| |+.|++|+||+|+||+
T Consensus 65 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~h~dlkp~Nil 140 (316)
T cd07842 65 VSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYL---HSNWVLHRDLKPANIL 140 (316)
T ss_pred cceEEEEeCCCCceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHH---HhCCEeeCCCCHHHEE
Confidence 9999999888 889999999976 777776543333 33788999999999999999999 7789999999999999
Q ss_pred ecC----CCCeEEecccCccccCCCCc-eeeeecccCCCCccCccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCC
Q 040898 199 IDD----DMEARISDFGHGKLMPDGHA-QITVKCMVGTMGYMAPESLQTE-TISDKCDIYSFGVLLAVLVMGKFPVDDFF 272 (337)
Q Consensus 199 ~~~----~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~i~~~ll~g~~pf~~~~ 272 (337)
++. ++.++|+|||++........ ........+++.|+|||.+.+. .++.++|+||||+++|+|++|.+||....
T Consensus 141 ~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 220 (316)
T cd07842 141 VMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220 (316)
T ss_pred EcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence 999 99999999999886544322 1112234578889999988654 57889999999999999999999997543
Q ss_pred CCch------hhhHHHHHHhhhccCCcc------------h---hhhhcccC-CchH-------HHHHHHHHHHhhhccC
Q 040898 273 GHTE------EMDMVKWMRNVIFSENPN------------R---AINSKLLG-NGYE-------EQMLLVLKLACFCTLK 323 (337)
Q Consensus 273 ~~~~------~~~~~~~~~~~~~~~~~~------------~---~~~~~~~~-~~~~-------~~~~~l~~li~~~l~~ 323 (337)
.... ...+....... ....+. . ........ .... .....+.+++.+||+.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~l-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 299 (316)
T cd07842 221 AKIKKSNPFQRDQLERIFEVL-GTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEY 299 (316)
T ss_pred ccccccchhHHHHHHHHHHHh-CCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcC
Confidence 3220 00111111000 000000 0 00000000 0000 2234588999999999
Q ss_pred CCCCCCChhhhhcC
Q 040898 324 DPDERPSSKDVRSM 337 (337)
Q Consensus 324 dP~~Rps~~ell~~ 337 (337)
||++|||+.++++|
T Consensus 300 ~P~~Rps~~eil~~ 313 (316)
T cd07842 300 DPTKRITAEEALEH 313 (316)
T ss_pred CcccCcCHHHHhcC
Confidence 99999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=276.38 Aligned_cols=251 Identities=28% Similarity=0.439 Sum_probs=199.3
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
.+-|+..+.||.|+||.||++.+.. ++..+|+|.+........ ...+.+|+..+..++||
T Consensus 3 ~~~~~~~~~ig~G~~~~vy~~~~~~--~~~~~aiK~~~~~~~~~~------------------~~~~~~e~~~l~~l~h~ 62 (277)
T cd06641 3 EELFTKLEKIGKGSFGEVFKGIDNR--TQKVVAIKIIDLEEAEDE------------------IEDIQQEITVLSQCDSP 62 (277)
T ss_pred HHhhhhheeEeecCCeEEEEEEECC--CCcEEEEEEeccccchHH------------------HHHHHHHHHHHHhcCCC
Confidence 3458899999999999999988865 889999998754322111 14677899999999999
Q ss_pred CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceee
Q 040898 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI 199 (337)
Q Consensus 120 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~ 199 (337)
||+++++.+..+...++|+||+++++|.+++.. ..+++..+..++.+++.++.++ |+.|++|+||+|+||++
T Consensus 63 ~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~l---h~~~i~h~dl~p~Ni~i 134 (277)
T cd06641 63 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYL---HSEKKIHRDIKAANVLL 134 (277)
T ss_pred CEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHH---ccCCeecCCCCHHhEEE
Confidence 999999999999999999999999999998832 3578999999999999999999 78899999999999999
Q ss_pred cCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhh
Q 040898 200 DDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMD 279 (337)
Q Consensus 200 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~ 279 (337)
+.++.++|+|||++........ ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||...... .
T Consensus 135 ~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~----~ 208 (277)
T cd06641 135 SEHGEVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM----K 208 (277)
T ss_pred CCCCCEEEeecccceecccchh--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH----H
Confidence 9999999999998876543221 112245788899999998888889999999999999999999998653221 1
Q ss_pred HHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 280 MVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
....+ .....+ .........+.+++.+||+.+|.+||++.++++|
T Consensus 209 ~~~~~---~~~~~~----------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 209 VLFLI---PKNNPP----------TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred HHHHH---hcCCCC----------CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11111 111110 0111223448899999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=281.36 Aligned_cols=252 Identities=23% Similarity=0.383 Sum_probs=198.0
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
...|+....||+|+||.||++.+.. +++.||+|.+........ ..+.+|+.++..+.||
T Consensus 20 ~~~~~~~~~ig~g~~g~v~~~~~~~--~~~~v~iK~~~~~~~~~~-------------------~~~~~e~~~l~~l~hp 78 (297)
T cd06659 20 RSLLENYIKIGEGSTGIVCIAREKH--SGRQVAVKMMDLRKQQRR-------------------ELLFNEVVIMRDYQHQ 78 (297)
T ss_pred hhhHHhhhhcCCCCceeEEEEEEcC--CCCEEEEEEEEecccchH-------------------HHHHHHHHHHHhCCCC
Confidence 3456677789999999999998865 889999999854332111 4567799999999999
Q ss_pred CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceee
Q 040898 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI 199 (337)
Q Consensus 120 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~ 199 (337)
|++++++.+..++..++++||+++++|..++.. ..+++..++.++.|++.||.+| |+.|++|+||+|+||++
T Consensus 79 ~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~L---H~~~ivH~dl~p~Nill 150 (297)
T cd06659 79 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-----TRLNEEQIATVCESVLQALCYL---HSQGVIHRDIKSDSILL 150 (297)
T ss_pred chhhhhhheeeCCeEEEEEecCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHeEE
Confidence 999999999999999999999999999987732 3578899999999999999999 77899999999999999
Q ss_pred cCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhh
Q 040898 200 DDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMD 279 (337)
Q Consensus 200 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~ 279 (337)
+.++.++|+|||++......... .....++..|+|||.+.+..++.++|+||+|+++|+|++|..||..... ..
T Consensus 151 ~~~~~~kL~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~----~~ 224 (297)
T cd06659 151 TLDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP----VQ 224 (297)
T ss_pred ccCCcEEEeechhHhhccccccc--ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HH
Confidence 99999999999988654332211 1234588899999999888899999999999999999999999864221 11
Q ss_pred HHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 280 MVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
....+.. ...... .........+.+++.+||+.+|.+|||+.++++|
T Consensus 225 ~~~~~~~---~~~~~~--------~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 225 AMKRLRD---SPPPKL--------KNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHHHHhc---cCCCCc--------cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 1111111 111000 0011223448899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=274.72 Aligned_cols=246 Identities=30% Similarity=0.444 Sum_probs=197.2
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
.++|++.+.||.|++|.||.+.. .++.|++|.+..... . ...+.+|+.+++.++||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~----~~~~v~iK~~~~~~~--~------------------~~~~~~e~~~l~~l~~~ 60 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY----RGQKVAVKCLKDDST--A------------------AQAFLAEASVMTTLRHP 60 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe----cCcEEEEEEeccchh--H------------------HHHHHHHHHHHHhcCCc
Confidence 46799999999999999998876 688999999865432 0 15678899999999999
Q ss_pred CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceee
Q 040898 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI 199 (337)
Q Consensus 120 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~ 199 (337)
||+++++++.+....++|+||+++++|.+++.. .....+++..++.++.|++.++.|| |+.|++|+||+|+||++
T Consensus 61 ~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~l---h~~~i~H~di~p~Nili 135 (256)
T cd05039 61 NLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRS--RGRAVITLAQQLGFALDVCEGMEYL---EEKNFVHRDLAARNVLV 135 (256)
T ss_pred ceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHH---HhCCccchhcccceEEE
Confidence 999999999989999999999999999999854 2333689999999999999999999 77899999999999999
Q ss_pred cCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCchhh
Q 040898 200 DDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHTEEM 278 (337)
Q Consensus 200 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~~ 278 (337)
+.++.++|+|||.+........ ....+..|+|||.+....++.++|+||||+++|++++ |..||..... .
T Consensus 136 ~~~~~~~l~d~g~~~~~~~~~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~ 206 (256)
T cd05039 136 SEDLVAKVSDFGLAKEASQGQD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----K 206 (256)
T ss_pred eCCCCEEEcccccccccccccc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH----H
Confidence 9999999999999876532211 2234567999999988888999999999999999997 9999864321 1
Q ss_pred hHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 279 DMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
......... ... ..+...+..+.+++.+||+.+|.+|||+.++++
T Consensus 207 ~~~~~~~~~---~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 207 DVVPHVEKG---YRM----------EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHHHHHhcC---CCC----------CCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 121111111 000 001122345889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=274.39 Aligned_cols=245 Identities=28% Similarity=0.413 Sum_probs=192.0
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
..+|++.+.||+|++|.||++.. .+..+++|.+..... ...+.+|+.+++.++||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~----~~~~~~~k~~~~~~~---------------------~~~~~~e~~~l~~l~~~ 59 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY----RGNKVAVKCIKNDAT---------------------AQAFLAEASVMTQLRHS 59 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE----cCCcEEEEEeCCCch---------------------HHHHHHHHHHHHhCCCC
Confidence 45799999999999999998866 688899998754321 04577899999999999
Q ss_pred CcccceeEE-EcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 120 NILPLLAHM-VRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 120 niv~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|++++++++ ..+...++++||+++++|.+++.. .....+++..+..++.|++.+|.+| |++|++|+||+|+||+
T Consensus 60 ~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~nil 134 (256)
T cd05082 60 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYL---EANNFVHRDLAARNVL 134 (256)
T ss_pred CeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHH---HhCCEeccccchheEE
Confidence 999999975 455678999999999999999854 2334578899999999999999999 7789999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCchh
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHTEE 277 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~ 277 (337)
++.++.++|+|||.+....... .....+..|+|||.+.+..++.++|+||||+++|+|++ |..||.... .
T Consensus 135 ~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~----~ 205 (256)
T cd05082 135 VSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP----L 205 (256)
T ss_pred EcCCCcEEecCCccceeccccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC----H
Confidence 9999999999999887543221 12234567999999988889999999999999999998 999985421 1
Q ss_pred hhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 278 MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
......+.. .... ...+..+..+.+++.+||+.+|++|||+.++++
T Consensus 206 ~~~~~~~~~---~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 206 KDVVPRVEK---GYKM----------DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHHHHHhc---CCCC----------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 112111111 1000 011122345889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=274.59 Aligned_cols=262 Identities=21% Similarity=0.304 Sum_probs=195.9
Q ss_pred ccccccceeccCcceEEEEeEEe--cCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAEL--PGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..|++++.||+|+||.||++... ...++..||+|.+........ ...+.+|+.+++.++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~------------------~~~~~~e~~~l~~l~h 65 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH------------------IADLKKEIEILRNLYH 65 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHH------------------HHHHHHHHHHHHhCCC
Confidence 45899999999999999988743 234788999999865432211 1467889999999999
Q ss_pred CCcccceeEEEcC--CeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 040898 119 RNILPLLAHMVRP--NCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPAN 196 (337)
Q Consensus 119 pniv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~n 196 (337)
||++++.+++... ...++|+||+++++|.+++.. ....+++..+..++.|++.+|.++ |+.|++|+||+|+|
T Consensus 66 ~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~~i~~aL~~l---H~~gi~H~dlkp~N 139 (284)
T cd05079 66 ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPR---NKNKINLKQQLKYAVQICKGMDYL---GSRQYVHRDLAARN 139 (284)
T ss_pred CCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecccchhe
Confidence 9999999988775 568999999999999999843 223578999999999999999999 77899999999999
Q ss_pred eeecCCCCeEEecccCccccCCCCcee-eeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCC--
Q 040898 197 VLIDDDMEARISDFGHGKLMPDGHAQI-TVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFG-- 273 (337)
Q Consensus 197 il~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~-- 273 (337)
|+++.++.++|+|||++.......... ......++..|+|||.+.+..++.++|+||||+++|+|+++..|+.....
T Consensus 140 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~ 219 (284)
T cd05079 140 VLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLF 219 (284)
T ss_pred EEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchh
Confidence 999999999999999988664432211 11234466779999999888889999999999999999998766422100
Q ss_pred ------CchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 274 ------HTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 274 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
................... .+.....+..+.+|+.+||+.||.+|||+.++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 278 (284)
T cd05079 220 LKMIGPTHGQMTVTRLVRVLEEGKR----------LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278 (284)
T ss_pred hhhcccccccccHHHHHHHHHcCcc----------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 0000001111111100000 0011123456999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=274.47 Aligned_cols=255 Identities=22% Similarity=0.329 Sum_probs=195.8
Q ss_pred ccccccccceeccCcceEEEEeEEecC-CCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPG-SNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR 117 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 117 (337)
..++|.+.+.||+|++|.||++.+... .....|++|........... +.+..|+.+++.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~------------------~~~~~e~~~l~~~~ 65 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVR------------------EKFLQEAYIMRQFD 65 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHH------------------HHHHHHHHHHHhCC
Confidence 356799999999999999999987653 23457899988655432111 46778999999999
Q ss_pred CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCce
Q 040898 118 HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANV 197 (337)
Q Consensus 118 hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ni 197 (337)
||||+++++++.+ ...+++|||+++++|.+++.. ....+++..+..++.|++.|+.+| |+.|++|+||+|+||
T Consensus 66 h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~l---H~~~~~H~dl~p~ni 138 (270)
T cd05056 66 HPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQV---NKYSLDLASLILYSYQLSTALAYL---ESKRFVHRDIAARNV 138 (270)
T ss_pred CCchhceeEEEcC-CCcEEEEEcCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccccChheE
Confidence 9999999998875 457899999999999999854 233588999999999999999999 677999999999999
Q ss_pred eecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCch
Q 040898 198 LIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHTE 276 (337)
Q Consensus 198 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~ 276 (337)
+++.++.++|+|||++......... ......++..|+|||.+.+..++.++|+||||+++|++++ |..||......
T Consensus 139 li~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-- 215 (270)
T cd05056 139 LVSSPDCVKLGDFGLSRYLEDESYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN-- 215 (270)
T ss_pred EEecCCCeEEccCceeeecccccce-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH--
Confidence 9999999999999998765443221 1122234567999999988888999999999999999986 99998654321
Q ss_pred hhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 277 EMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
.....+.. .... ..++..+..+.+++.+|+..+|.+|||+.++++
T Consensus 216 --~~~~~~~~---~~~~----------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 216 --DVIGRIEN---GERL----------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA 260 (270)
T ss_pred --HHHHHHHc---CCcC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11111111 1110 001122345889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=293.22 Aligned_cols=256 Identities=23% Similarity=0.375 Sum_probs=200.2
Q ss_pred ccccc-cccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC
Q 040898 39 KEDCF-DSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR 117 (337)
Q Consensus 39 ~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 117 (337)
..++| +..+.||+|+|-+||++.|.. +|-.||=-.+........ ....+++..|+.+|+.|+
T Consensus 37 p~gRy~k~~evLGrGafKtVYka~De~--~giEVAWnqvk~~d~~q~---------------~~~leR~~~Ev~lLKsL~ 99 (632)
T KOG0584|consen 37 PTGRYLKFDEVLGRGAFKTVYKAFDEE--EGIEVAWNQVKIRDVTQS---------------PEELERLYSEVHLLKSLK 99 (632)
T ss_pred CCCceeehhhhcccccceeeeeccccc--cchhhHHHHHhHHHhhcC---------------hHHHHHHHHHHHHHccCC
Confidence 44555 456789999999999999955 787776444322211111 112278999999999999
Q ss_pred CCCcccceeEEEcCC--eeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCC
Q 040898 118 HRNILPLLAHMVRPN--CHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPA 195 (337)
Q Consensus 118 hpniv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ 195 (337)
||||++++.+|.+.. +..+|+|.+..|+|..++.. .+..+...+..|++||++||.|||+ |...|+|||||.+
T Consensus 100 H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk----~~~vn~kaik~W~RQILkGL~yLHs-~~PPIIHRDLKCD 174 (632)
T KOG0584|consen 100 HPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKK----HRRVNIKAIKSWCRQILKGLVYLHS-QDPPIIHRDLKCD 174 (632)
T ss_pred CCceeeeeeheecCCCceeeeeeecccCCcHHHHHHH----hccCCHHHHHHHHHHHHHHhhhhhc-CCCCccccccccc
Confidence 999999999997764 48899999999999999954 4458888999999999999999988 6788999999999
Q ss_pred ceeecC-CCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCC
Q 040898 196 NVLIDD-DMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGH 274 (337)
Q Consensus 196 nil~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~ 274 (337)
||||++ .|.|||+|+|+|........ ....|||.|||||.+. ..|++.+||||||+.+.||+|+.+||.++..
T Consensus 175 NIFinG~~G~VKIGDLGLAtl~r~s~a----ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n- 248 (632)
T KOG0584|consen 175 NIFVNGNLGEVKIGDLGLATLLRKSHA----KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN- 248 (632)
T ss_pred eEEEcCCcCceeecchhHHHHhhcccc----ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC-
Confidence 999986 58999999999998765543 3368999999999987 7799999999999999999999999976533
Q ss_pred chhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 275 TEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.+.+.+.......+..-...- ...++++|.+||.. .++|||+.|+|+|
T Consensus 249 --~AQIYKKV~SGiKP~sl~kV~------------dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 249 --PAQIYKKVTSGIKPAALSKVK------------DPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred --HHHHHHHHHcCCCHHHhhccC------------CHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 333333332222222211111 12389999999999 9999999999975
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=284.99 Aligned_cols=260 Identities=23% Similarity=0.333 Sum_probs=197.4
Q ss_pred ccccccccceeccCcceEEEEeEEecCC-----CCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHH
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGS-----NGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITA 113 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l 113 (337)
...+|++++.||+|+||.||.+.+.... .+..||+|.+........ ...+.+|+.++
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~------------------~~~~~~E~~~l 71 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKD------------------LSDLVSEMEMM 71 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHH------------------HHHHHHHHHHH
Confidence 4567999999999999999999765311 234689998764322111 15677899999
Q ss_pred Hhc-CCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcC------------CcccCChHHHHHHHHHHHHHHHHHh
Q 040898 114 NQT-RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQ------------GRRELDWPARHRIARGIASGLEYLH 180 (337)
Q Consensus 114 ~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~l~ 180 (337)
+++ +||||+++++++..+...++++||+++++|.+++..... ....+++..+..++.|++.||.||
T Consensus 72 ~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L- 150 (334)
T cd05100 72 KMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL- 150 (334)
T ss_pred HhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHH-
Confidence 999 899999999999999999999999999999999865321 123477888899999999999999
Q ss_pred hCCCCCeEecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHH
Q 040898 181 MCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAV 260 (337)
Q Consensus 181 ~~h~~gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ 260 (337)
|+.|++|+||+|+||+++.++.++|+|||++................++..|+|||.+.+..++.++|+||||+++|+
T Consensus 151 --H~~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e 228 (334)
T cd05100 151 --ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWE 228 (334)
T ss_pred --HHCCeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHH
Confidence 778999999999999999999999999999876543322211122234567999999998889999999999999999
Q ss_pred HHh-CCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 261 LVM-GKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 261 ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
|++ |..||.... .......+.. ..... .+......+.+++.+||+.+|++|||+.++++
T Consensus 229 l~~~g~~p~~~~~----~~~~~~~~~~---~~~~~----------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~ 288 (334)
T cd05100 229 IFTLGGSPYPGIP----VEELFKLLKE---GHRMD----------KPANCTHELYMIMRECWHAVPSQRPTFKQLVE 288 (334)
T ss_pred HHhcCCCCCCCCC----HHHHHHHHHc---CCCCC----------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 998 888885432 1122221111 11100 01112234889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=277.01 Aligned_cols=250 Identities=26% Similarity=0.456 Sum_probs=196.9
Q ss_pred cccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC---C
Q 040898 42 CFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR---H 118 (337)
Q Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h 118 (337)
.|++.+.||+|++|.||++.+.. ++..|++|.+..+..... ...+.+|+.+++.+. |
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~--~~~~~~iK~~~~~~~~~~------------------~~~~~~e~~~l~~l~~~~~ 61 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVP--TGRVVALKIINLDTPDDD------------------VSDIQREVALLSQLRQSQP 61 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcC--CCcEEEEEEecCCCCchh------------------HHHHHHHHHHHHHhccCCC
Confidence 48899999999999999999866 899999998865432211 145667888888886 9
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
||++++++++..+...++++||+++++|.+++.. ..+++..++.++.|++.++.+| |+.|++|+||+|+||+
T Consensus 62 ~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~l---h~~~i~H~dl~p~ni~ 133 (277)
T cd06917 62 PNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYI---HKVGVIHRDIKAANIL 133 (277)
T ss_pred CCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCcCHHHEE
Confidence 9999999999999999999999999999998843 3688999999999999999999 7779999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCcccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchh
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQT-ETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEE 277 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~ 277 (337)
++.++.++|+|||.+......... .....++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||......
T Consensus 134 i~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--- 208 (277)
T cd06917 134 VTNTGNVKLCDFGVAALLNQNSSK--RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF--- 208 (277)
T ss_pred EcCCCCEEEccCCceeecCCCccc--cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh---
Confidence 999999999999998776544321 123468889999998864 45688999999999999999999999653221
Q ss_pred hhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 278 MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
...........+ ..... .....+.+++.+||+.||.+|||+.++++|
T Consensus 209 ----~~~~~~~~~~~~------~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 209 ----RAMMLIPKSKPP------RLEDN---GYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred ----hhhhccccCCCC------CCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 111000000000 00000 123458899999999999999999999875
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=275.03 Aligned_cols=256 Identities=24% Similarity=0.358 Sum_probs=197.0
Q ss_pred cccccccceeccCcceEEEEeEEecC-CCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPG-SNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
.++|+..+.||+|++|.||++.+... .....+++|.+......... ..+..|+.+++.++|
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~------------------~~~~~e~~~l~~l~h 65 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQR------------------QDFLSEASIMGQFSH 65 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHH------------------HHHHHHHHHHhcCCC
Confidence 45789999999999999999988641 12347999988654321111 457789999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
||++++.+++...+..++||||+++++|.+++.. ....+++..+..++.|++.|+.++ |+.|++|+||+|+||+
T Consensus 66 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~l---H~~~i~H~dlkp~Nil 139 (268)
T cd05063 66 HNIIRLEGVVTKFKPAMIITEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYL---SDMNYVHRDLAARNIL 139 (268)
T ss_pred CCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccccchhhEE
Confidence 9999999999999999999999999999999853 335688899999999999999999 6779999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeee-ecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCch
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITV-KCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHTE 276 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~-~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~ 276 (337)
++.++.++|+|||++............ .....+..|+|||.+.+..++.++|+||+|+++|++++ |..||.....
T Consensus 140 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~--- 216 (268)
T cd05063 140 VNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN--- 216 (268)
T ss_pred EcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH---
Confidence 999999999999998765433222111 11223457999999988888999999999999999998 9999854321
Q ss_pred hhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 277 EMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
......+... .... ........+.+++.+||+.+|++||++.++++
T Consensus 217 -~~~~~~i~~~---~~~~----------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 217 -HEVMKAINDG---FRLP----------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred -HHHHHHHhcC---CCCC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 1122222111 0000 01112345889999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=275.88 Aligned_cols=256 Identities=24% Similarity=0.351 Sum_probs=196.4
Q ss_pred ccccccccceeccCcceEEEEeEEecCC--CCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGS--NGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT 116 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 116 (337)
+.++|++.+.||+|+||.||++.+.... ....+++|.+........ ...+.+|+..+..+
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~------------------~~~~~~e~~~l~~l 66 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKA------------------NKEILDEAYVMASV 66 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHH------------------HHHHHHHHHHHHhC
Confidence 3467999999999999999999876511 123688888765533111 15677899999999
Q ss_pred CCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 040898 117 RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPAN 196 (337)
Q Consensus 117 ~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~n 196 (337)
+||||+++++++.. ...++++||+++++|.+++.. ....+++..+..++.|++.|+.|| |+.|++|+||+|+|
T Consensus 67 ~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~L---H~~~i~H~di~p~n 139 (279)
T cd05057 67 DHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRN---HKDNIGSQYLLNWCVQIAKGMSYL---EEKRLVHRDLAARN 139 (279)
T ss_pred CCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHH---HhCCEEecccCcce
Confidence 99999999998887 788999999999999999854 334589999999999999999999 67899999999999
Q ss_pred eeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCc
Q 040898 197 VLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHT 275 (337)
Q Consensus 197 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~ 275 (337)
|+++.++.++|+|||.+................++..|++||.+....++.++|+||+|+++|++++ |..||+....
T Consensus 140 il~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-- 217 (279)
T cd05057 140 VLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA-- 217 (279)
T ss_pred EEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH--
Confidence 9999999999999999887654332222122224567999999988888999999999999999998 9999865422
Q ss_pred hhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 276 EEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
.++...+... ... ..+......+.+++.+||..||++|||+.++++
T Consensus 218 --~~~~~~~~~~---~~~----------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 218 --VEIPDLLEKG---ERL----------PQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred --HHHHHHHhCC---CCC----------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 1222222111 000 000112234889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=271.68 Aligned_cols=247 Identities=23% Similarity=0.317 Sum_probs=196.0
Q ss_pred eccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCcccceeEE
Q 040898 49 IGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLLAHM 128 (337)
Q Consensus 49 lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~ 128 (337)
||.|++|.||++.+.. ++..+++|.+.......... ...+.+|+.+++.++||||+++++.+
T Consensus 1 lg~g~~~~v~~~~~~~--~~~~~~iK~~~~~~~~~~~~----------------~~~~~~e~~~l~~l~h~~i~~~~~~~ 62 (262)
T cd05572 1 LGVGGFGRVELVKVKS--KNRTFALKCVKKRHIVETGQ----------------QEHIFSEKEILEECNHPFIVKLYRTF 62 (262)
T ss_pred CCCCCceEEEEEEECC--CCcEEEEEEEehhcchhhhH----------------HHHHHHHHHHHHhCCCCCEeeeeeeE
Confidence 7999999999999865 79999999986543221111 15678899999999999999999999
Q ss_pred EcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCCeEEe
Q 040898 129 VRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARIS 208 (337)
Q Consensus 129 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~~l~ 208 (337)
.++...++++||+++++|.+++.. ...+++..+..++.|++.||.++ |+.|++|+||+|+||+++.++.++|+
T Consensus 63 ~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~l---H~~~~~h~dl~~~nilv~~~~~~~l~ 135 (262)
T cd05572 63 KDKKYIYMLMEYCLGGELWTILRD----RGLFDEYTARFYIACVVLAFEYL---HNRGIIYRDLKPENLLLDSNGYVKLV 135 (262)
T ss_pred EcCCccEEEEecCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHH---hhCCcccCCCCHHHEEEcCCCCEEEe
Confidence 999999999999999999999843 34588899999999999999999 77899999999999999999999999
Q ss_pred cccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHHHHHHhhh
Q 040898 209 DFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVI 288 (337)
Q Consensus 209 dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 288 (337)
|||.+....... ......+++.|++||.+.+..++.++|+||+|+++|++++|..||.....+ .. .......
T Consensus 136 df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~---~~~~~~~ 207 (262)
T cd05572 136 DFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED--PM---EIYNDIL 207 (262)
T ss_pred eCCcccccCccc---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC--HH---HHHHHHh
Confidence 999987765432 112345788999999998888899999999999999999999999654321 11 1111111
Q ss_pred ccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCC-----hhhhhcC
Q 040898 289 FSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPS-----SKDVRSM 337 (337)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~~ 337 (337)
..... ...+......+.+++.+||+.||++||| +.|+++|
T Consensus 208 ~~~~~---------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~ 252 (262)
T cd05572 208 KGNGK---------LEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH 252 (262)
T ss_pred ccCCC---------CCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence 00000 0011112445899999999999999999 9999986
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=277.59 Aligned_cols=259 Identities=23% Similarity=0.384 Sum_probs=196.9
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC-CC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR-HR 119 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp 119 (337)
++|+..+.||+|+||.||++.+.. +++.+|+|.+........ ...+.+|+.++.++. ||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~--~~~~~aiK~~~~~~~~~~------------------~~~~~~e~~~l~~~~~~~ 63 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKP--SGTIMAVKRIRSTVDEKE------------------QKRLLMDLDVVMRSSDCP 63 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECC--CCCEEEEEEehhccChHH------------------HHHHHHHHHHHHHhcCCC
Confidence 367888999999999999998876 899999999865433211 146778898999985 99
Q ss_pred CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHh-cCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDV-SQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 120 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
||+++++++..+...++++||+.. ++.++.... ......+++..+..++.|++.|++||| ++.|++|+||+|+||+
T Consensus 64 ~iv~~~~~~~~~~~~~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh--~~~~i~H~dlkp~Nil 140 (288)
T cd06616 64 YIVKFYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLK--EELKIIHRDVKPSNIL 140 (288)
T ss_pred CEeeeeeEEecCCcEEEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh--hcCCeeccCCCHHHEE
Confidence 999999999999999999999865 666654321 123456899999999999999999995 2359999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccC---CCCCcccchhhhHHHHHHHhCCCCCCCCCCCc
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTE---TISDKCDIYSFGVLLAVLVMGKFPVDDFFGHT 275 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~---~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~ 275 (337)
++.++.++|+|||++......... ....+++.|+|||.+.+. .++.++|+||+|+++|+|++|..||....
T Consensus 141 ~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--- 214 (288)
T cd06616 141 LDRNGNIKLCDFGISGQLVDSIAK---TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--- 214 (288)
T ss_pred EccCCcEEEeecchhHHhccCCcc---ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc---
Confidence 999999999999998765432211 223578889999998765 68889999999999999999999986542
Q ss_pred hhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 276 EEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.......+......+. ............+.+|+.+||+.||++|||+.++++|
T Consensus 215 ---~~~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 215 ---SVFDQLTQVVKGDPPI------LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred ---hHHHHHhhhcCCCCCc------CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111122211111111 0011112234458999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=273.04 Aligned_cols=251 Identities=23% Similarity=0.399 Sum_probs=194.9
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++.++||+|+||.||++.+. .+..+++|.+...... .+.+.+|+.+++.++|
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~---~~~~~~iK~~~~~~~~--------------------~~~~~~e~~~l~~l~~ 60 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYN---KHTKVAVKTMKPGSMS--------------------VEAFLAEANVMKTLQH 60 (260)
T ss_pred cccceeEEeEecCccceEEEEEEec---CCccEEEEecCCChhH--------------------HHHHHHHHHHHHhcCC
Confidence 4578999999999999999998753 5667999987543110 1467789999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
+||+++++.+.. ...++++||+++++|.+++.. ......++..+..++.|++.||.+| |+.|++|+||+|+||+
T Consensus 61 ~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~aL~~l---H~~~i~H~dl~p~ni~ 134 (260)
T cd05073 61 DKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKS--DEGSKQPLPKLIDFSAQIAEGMAFI---EQRNYIHRDLRAANIL 134 (260)
T ss_pred CCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHh--CCccccCHHHHHHHHHHHHHHHHHH---HhCCccccccCcceEE
Confidence 999999998877 778999999999999999865 2344578888999999999999999 6779999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCchh
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHTEE 277 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~ 277 (337)
++.++.++|+|||.+......... ......++..|+|||.+.+..++.++|+||||+++|++++ |..||.....
T Consensus 135 i~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~---- 209 (260)
T cd05073 135 VSASLVCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---- 209 (260)
T ss_pred EcCCCcEEECCCcceeeccCCCcc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH----
Confidence 999999999999988765432211 1122345677999999988888999999999999999999 8999864321
Q ss_pred hhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 278 MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
......+...... .........+.+++.+||+.+|++|||+.++++
T Consensus 210 ~~~~~~~~~~~~~-------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 210 PEVIRALERGYRM-------------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHHHHHhCCCCC-------------CCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 1122211111000 001122345889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=272.10 Aligned_cols=250 Identities=25% Similarity=0.368 Sum_probs=193.8
Q ss_pred ceeccCcceEEEEeEEec-CCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCcccce
Q 040898 47 KKIGSGGWGEVFYKAELP-GSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLL 125 (337)
Q Consensus 47 ~~lg~G~~g~V~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~ 125 (337)
+.||+|++|.||++.+.. ......||+|.+....... ....+.+|+..+++++||||++++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~------------------~~~~~~~e~~~l~~l~h~~iv~~~ 62 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSD------------------IMDDFLKEAAIMHSLDHENLIRLY 62 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHH------------------HHHHHHHHHHHHhhcCCCCcccee
Confidence 478999999999998864 2233469999886654320 115788899999999999999999
Q ss_pred eEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCCe
Q 040898 126 AHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEA 205 (337)
Q Consensus 126 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~ 205 (337)
+.+.. ...++++||+++++|.+++..... ..+++..++.++.|++.||.+| |+.|++|+||+|+||+++.++.+
T Consensus 63 ~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~l---H~~~i~H~di~p~nil~~~~~~~ 136 (257)
T cd05040 63 GVVLT-HPLMMVTELAPLGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYL---ESKRFIHRDLAARNILLASDDKV 136 (257)
T ss_pred EEEcC-CeEEEEEEecCCCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHH---HhCCccccccCcccEEEecCCEE
Confidence 99888 889999999999999999865221 4689999999999999999999 77899999999999999999999
Q ss_pred EEecccCccccCCCCceeee-ecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCchhhhHHHH
Q 040898 206 RISDFGHGKLMPDGHAQITV-KCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHTEEMDMVKW 283 (337)
Q Consensus 206 ~l~dfg~~~~~~~~~~~~~~-~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~~~~~~~ 283 (337)
+|+|||++............ ....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...... +....
T Consensus 137 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----~~~~~ 212 (257)
T cd05040 137 KIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS----QILKK 212 (257)
T ss_pred EeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH----HHHHH
Confidence 99999998876543222111 12346778999999988889999999999999999999 99998643221 11111
Q ss_pred HHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 284 MRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
+... .... ..+...+..+.+++.+||+.+|++|||+.++++
T Consensus 213 ~~~~---~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 213 IDKE---GERL---------ERPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHhc---CCcC---------CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 1110 0000 001122345889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=307.14 Aligned_cols=259 Identities=23% Similarity=0.345 Sum_probs=205.1
Q ss_pred cccccccceeccCcceEEEEeEEecCCC---CceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSN---GKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT 116 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 116 (337)
..+-+..+.||+|.||.||.+....... ...||+|.+....+.. +...|.+|..+|+.+
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~------------------~~~~Fl~Ea~~m~~f 752 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQ------------------EVSDFLKEALLMSKF 752 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHH------------------HHHHHHHHHHHHhcC
Confidence 4567788999999999999987764221 3458888886554322 226899999999999
Q ss_pred CCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcC---CcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCC
Q 040898 117 RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQ---GRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIK 193 (337)
Q Consensus 117 ~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~ 193 (337)
+||||++++|++.+....++++||+.+|+|..||++.+. +...++....+.++.||++|+.|| +++.+|||||.
T Consensus 753 ~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YL---e~~~fvHRDLA 829 (1025)
T KOG1095|consen 753 DHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYL---ESKHFVHRDLA 829 (1025)
T ss_pred CCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHH---HhCCCcCcchh
Confidence 999999999999999999999999999999999987533 256689999999999999999999 78899999999
Q ss_pred CCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCC
Q 040898 194 PANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFF 272 (337)
Q Consensus 194 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~ 272 (337)
.+|+|++....+||+|||+++......-........-...|||||.+....++.++||||||+++||++| |..||....
T Consensus 830 aRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~ 909 (1025)
T KOG1095|consen 830 ARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRS 909 (1025)
T ss_pred hhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcc
Confidence 9999999999999999999995433322222122234568999999999999999999999999999999 889986643
Q ss_pred CCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 273 GHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
.. +.+........ -..++.+++.+.+++..||+.+|++||++..|++
T Consensus 910 n~-------~v~~~~~~ggR----------L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 910 NF-------EVLLDVLEGGR----------LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred hH-------HHHHHHHhCCc----------cCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 31 11211222221 1223445556889999999999999999999875
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=276.19 Aligned_cols=269 Identities=23% Similarity=0.342 Sum_probs=198.9
Q ss_pred cccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCc
Q 040898 42 CFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNI 121 (337)
Q Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpni 121 (337)
+|++.++||.|++|.||++.+.. ++..||+|.+......... ..+.+|+.++++++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~--~~~~~~iK~~~~~~~~~~~------------------~~~~~E~~~l~~l~h~~i 60 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRT--TGEIVALKEIHLDAEEGTP------------------STAIREISLMKELKHENI 60 (284)
T ss_pred CceEeeeeccCCceEEEEEEECC--CCeEEEEEEecccccccch------------------HHHHHHHHHHHhhcCCCE
Confidence 58999999999999999998865 8999999998654322111 456679999999999999
Q ss_pred ccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecC
Q 040898 122 LPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDD 201 (337)
Q Consensus 122 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~ 201 (337)
+++++.+.+.+..++|+||+++ +|.+++.... ....+++..+..++.|++.||.+| |+.|++|+||+|+||++++
T Consensus 61 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~h~dl~p~ni~~~~ 135 (284)
T cd07836 61 VRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFC---HENRVLHRDLKPQNLLINK 135 (284)
T ss_pred eeeeeeEeeCCcEEEEEecCCc-cHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHH---HHCCeeeCCCCHHHEEECC
Confidence 9999999999999999999986 8888875422 234689999999999999999999 6779999999999999999
Q ss_pred CCCeEEecccCccccCCCCceeeeecccCCCCccCccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhH
Q 040898 202 DMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTE-TISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDM 280 (337)
Q Consensus 202 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~ 280 (337)
++.++|+|||++........ ......+++.|++||.+.+. .++.++|+||||+++|++++|..||............
T Consensus 136 ~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~ 213 (284)
T cd07836 136 RGELKLADFGLARAFGIPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKI 213 (284)
T ss_pred CCcEEEeecchhhhhcCCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Confidence 99999999999875533221 11223567889999988654 4688999999999999999999998654321111111
Q ss_pred HHHHH--------hhhccC---CcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 281 VKWMR--------NVIFSE---NPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 281 ~~~~~--------~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
..... ...... ...............+.....+.+++.+||+.||.+|||+.++++|
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 214 FRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred HHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 11000 000000 0000000000011112334568899999999999999999999986
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=284.68 Aligned_cols=264 Identities=23% Similarity=0.282 Sum_probs=196.4
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++.+.||+|+||.||++.+.. +++.||+|.+......... ...+.+|+.+++.++|
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~-----------------~~~~~~E~~~l~~l~h 74 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTV--TGQNVAIKKLSRPFQNVTH-----------------AKRAYRELVLMKLVNH 74 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECC--CCCEEEEEecCccccChhH-----------------HHHHHHHHHHHHhcCC
Confidence 45779999999999999999998876 8999999988543221111 1456679999999999
Q ss_pred CCcccceeEEEcC------CeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 040898 119 RNILPLLAHMVRP------NCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDI 192 (337)
Q Consensus 119 pniv~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di 192 (337)
|||+++++++... ...|+|+||+++ +|.+.+.. .++...+..++.|++.||.+| |+.|++|+||
T Consensus 75 ~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~ql~~aL~~L---H~~gi~H~dl 144 (353)
T cd07850 75 KNIIGLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM------DLDHERMSYLLYQMLCGIKHL---HSAGIIHRDL 144 (353)
T ss_pred CCCcceeeeeccCCCccccCcEEEEEeccCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHH---HhCCeeeCCC
Confidence 9999999987644 357999999965 88887732 178888999999999999999 7779999999
Q ss_pred CCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCC
Q 040898 193 KPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFF 272 (337)
Q Consensus 193 ~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~ 272 (337)
+|+||+++.++.++|+|||.+........ .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||....
T Consensus 145 kp~Nil~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~ 221 (353)
T cd07850 145 KPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTD 221 (353)
T ss_pred CHHHEEECCCCCEEEccCccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCC
Confidence 99999999999999999999876543321 122457888999999999889999999999999999999999986432
Q ss_pred CCchhhhHHHHHHhhh------------------ccCC-----cc-hhhhhccc----CCchHHHHHHHHHHHhhhccCC
Q 040898 273 GHTEEMDMVKWMRNVI------------------FSEN-----PN-RAINSKLL----GNGYEEQMLLVLKLACFCTLKD 324 (337)
Q Consensus 273 ~~~~~~~~~~~~~~~~------------------~~~~-----~~-~~~~~~~~----~~~~~~~~~~l~~li~~~l~~d 324 (337)
.. ........... .... +. ........ ..........+.+++.+||+.|
T Consensus 222 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 298 (353)
T cd07850 222 HI---DQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVID 298 (353)
T ss_pred HH---HHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCC
Confidence 11 11111110000 0000 00 00000000 0001123456889999999999
Q ss_pred CCCCCChhhhhcC
Q 040898 325 PDERPSSKDVRSM 337 (337)
Q Consensus 325 P~~Rps~~ell~~ 337 (337)
|++|||+.|+|+|
T Consensus 299 P~~R~t~~eiL~~ 311 (353)
T cd07850 299 PEKRISVDDALQH 311 (353)
T ss_pred hhhCcCHHHHhcC
Confidence 9999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=297.31 Aligned_cols=289 Identities=19% Similarity=0.249 Sum_probs=191.1
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
.++|+++++||+|+||+||++.... .++...+.|.+.......... ...+.............+.+|+.++.+++||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~-~~~~~~~~~~~~~~~~~~~~~--~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRA-STEEAEARRGVNSTNQGKPKC--ERLIAKRVKAGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEec-cchhhhhhhccccccccchhh--hhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence 3679999999999999999876643 233333333222111111000 0000111111111235678899999999999
Q ss_pred CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhc-CCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVS-QGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 120 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
||+++++++...+..|++++++.+ +|.+++.... .............++.||+.||.|| |++|++|+||||+||+
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yL---H~~gIiHrDLKP~NIL 299 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYI---HDKKLIHRDIKLENIF 299 (501)
T ss_pred CcCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEE
Confidence 999999999999999999999965 6766664311 1122234566778999999999999 6779999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCC-CCCCCCCCchh
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKF-PVDDFFGHTEE 277 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~-pf~~~~~~~~~ 277 (337)
++.++.++|+|||++..+...... ......|++.|+|||++.+..++.++|||||||++|+|++|.. ||.... ....
T Consensus 300 l~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~-~~~~ 377 (501)
T PHA03210 300 LNCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGG-GKPG 377 (501)
T ss_pred ECCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCC-CCHH
Confidence 999999999999999776443221 1123568999999999999899999999999999999999875 444322 2222
Q ss_pred hhHHHHHHhhhccCC--cc---hhhh---hccc---CCchH------HHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 278 MDMVKWMRNVIFSEN--PN---RAIN---SKLL---GNGYE------EQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~--~~---~~~~---~~~~---~~~~~------~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
..+.+.+........ +. ...+ .... ....+ ....++.+++.+||+.||++|||+.|+|+|
T Consensus 378 ~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 378 KQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 233222221110000 00 0000 0000 00000 112346788999999999999999999986
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=275.22 Aligned_cols=251 Identities=23% Similarity=0.391 Sum_probs=198.0
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
.+|...+.||.|++|.||++.+.. +++.+++|++........ ..+.+|+.+++.+.|||
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~--~~~~~~iK~~~~~~~~~~-------------------~~~~~e~~~l~~~~h~~ 77 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKS--TGRQVAVKKMDLRKQQRR-------------------ELLFNEVVIMRDYQHPN 77 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECC--CCCEEEEEEEeccchhHH-------------------HHHHHHHHHHHHcCCCC
Confidence 457778899999999999988865 889999998753322111 45778999999999999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
++++++++..++..++++||+++++|.+++.. ..+++..+..++.|++.++.+| |++|++|+||+|+||+++
T Consensus 78 vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~l---H~~~i~H~dl~p~Nil~~ 149 (285)
T cd06648 78 IVEMYSSYLVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFL---HAQGVIHRDIKSDSILLT 149 (285)
T ss_pred hheEEEEEEcCCeEEEEEeccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCChhhEEEc
Confidence 99999999999999999999999999998843 4578899999999999999999 778999999999999999
Q ss_pred CCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhH
Q 040898 201 DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDM 280 (337)
Q Consensus 201 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~ 280 (337)
.++.++|+|||.+......... .....+++.|+|||.+.+..++.++|+||+|+++|+|++|..||..... ...
T Consensus 150 ~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~----~~~ 223 (285)
T cd06648 150 SDGRVKLSDFGFCAQVSKEVPR--RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP----LQA 223 (285)
T ss_pred CCCcEEEcccccchhhccCCcc--cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH----HHH
Confidence 9999999999987654332211 1234588899999999888899999999999999999999999854211 111
Q ss_pred HHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 281 VKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
...... ...+... ........+.+++.+||+.+|++|||+.++++|
T Consensus 224 ~~~~~~---~~~~~~~--------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 224 MKRIRD---NLPPKLK--------NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred HHHHHh---cCCCCCc--------ccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 111111 1111000 011123458999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=274.45 Aligned_cols=258 Identities=21% Similarity=0.353 Sum_probs=197.3
Q ss_pred ccccccceeccCcceEEEEeEEecC---CCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPG---SNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR 117 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 117 (337)
++|++.+.||+|+||.||++.+... .+...+++|.+....... ..+.+.+|+.++.+++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~------------------~~~~~~~E~~~l~~l~ 66 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDEN------------------LQSEFRRELDMFRKLS 66 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchH------------------HHHHHHHHHHHHHhcC
Confidence 6799999999999999999987542 245678888875432210 1156788999999999
Q ss_pred CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCC-----cccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 040898 118 HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQG-----RRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDI 192 (337)
Q Consensus 118 hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di 192 (337)
||||+++++++.+....++|+||+++++|.+++...... ...+++..+..++.|++.+|.|| |+.|++|+||
T Consensus 67 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~L---H~~~i~H~dl 143 (275)
T cd05046 67 HKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHL---SNARFVHRDL 143 (275)
T ss_pred CcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHh---hhcCcccCcC
Confidence 999999999999989999999999999999998653311 12589999999999999999999 7789999999
Q ss_pred CCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCC
Q 040898 193 KPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDF 271 (337)
Q Consensus 193 ~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~ 271 (337)
+|+||+++.++.++++|||++........ .......++..|+|||.+.+..++.++|+||||+++|++++ |..||...
T Consensus 144 kp~Nili~~~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~ 222 (275)
T cd05046 144 AARNCLVSSQREVKVSLLSLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGL 222 (275)
T ss_pred ccceEEEeCCCcEEEcccccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 99999999999999999998765432211 11122345677999999888888899999999999999999 78898543
Q ss_pred CCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 272 FGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
.. ............... .....+..+.+++.+||+.||.+|||+.++++
T Consensus 223 ~~----~~~~~~~~~~~~~~~------------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~ 271 (275)
T cd05046 223 SD----EEVLNRLQAGKLELP------------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVS 271 (275)
T ss_pred ch----HHHHHHHHcCCcCCC------------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 21 111111111000000 01112345899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=277.33 Aligned_cols=265 Identities=24% Similarity=0.308 Sum_probs=196.9
Q ss_pred ccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCcc
Q 040898 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNIL 122 (337)
Q Consensus 43 y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv 122 (337)
|++.+.||.|++|.||++.+.. +|..|++|++..+...... ...+.+|+.+++.++|||++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~--~~~~~~ik~~~~~~~~~~~-----------------~~~~~~E~~~l~~l~~~~iv 61 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKL--TGEIVALKKIRLETEDEGV-----------------PSTAIREISLLKELNHPNIV 61 (283)
T ss_pred CchheEecCCCCeEEEEEEEcC--CCCEEEEEEeecccccccc-----------------hhHHHHHHHHHHhcCCCCcc
Confidence 6789999999999999998865 8999999998654322110 03567799999999999999
Q ss_pred cceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCC
Q 040898 123 PLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDD 202 (337)
Q Consensus 123 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~ 202 (337)
++++++.+++..++++||++ ++|.+++... ....+++..+..++.|++.+|.+| |+.+++|+||+|+||+++.+
T Consensus 62 ~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~~L~~l---H~~~~~H~dl~p~nil~~~~ 135 (283)
T cd07835 62 RLLDVVHSENKLYLVFEFLD-LDLKKYMDSS--PLTGLDPPLIKSYLYQLLQGIAYC---HSHRVLHRDLKPQNLLIDRE 135 (283)
T ss_pred CHhheeccCCeEEEEEeccC-cCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeCCCCCHHHEEEcCC
Confidence 99999999999999999996 5899988542 224689999999999999999999 67799999999999999999
Q ss_pred CCeEEecccCccccCCCCceeeeecccCCCCccCccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHH
Q 040898 203 MEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTE-TISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMV 281 (337)
Q Consensus 203 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~ 281 (337)
+.++|+|||.+......... .....+++.|+|||.+.+. .++.++|+||+|+++|+|++|.+||..... .....
T Consensus 136 ~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---~~~~~ 210 (283)
T cd07835 136 GALKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSE---IDQLF 210 (283)
T ss_pred CcEEEeecccccccCCCccc--cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHH
Confidence 99999999998755332211 1223467889999988654 468899999999999999999999864322 11222
Q ss_pred HHHHhhhccCCc--------------chhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 282 KWMRNVIFSENP--------------NRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 282 ~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
...+........ .............+.....+.+++.+||+.||.+|||++++++|
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 211 RIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred HHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 211110000000 00000000001112233568899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=268.62 Aligned_cols=251 Identities=30% Similarity=0.476 Sum_probs=201.7
Q ss_pred cccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCc
Q 040898 42 CFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNI 121 (337)
Q Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpni 121 (337)
+|+..+.||+|++|.||++.+.. ++..+++|++....... ...+.+|+.+++.++|||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~--~~~~~~~k~~~~~~~~~-------------------~~~~~~e~~~l~~l~~~~i 59 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKR--TGKEVAIKVIKLESKEK-------------------KEKIINEIQILKKCKHPNI 59 (253)
T ss_pred CceeeeeeccCCceEEEEEEECC--CCcEEEEEEecccchhH-------------------HHHHHHHHHHHHhCCCCCE
Confidence 48899999999999999998865 78999999986554311 1567789999999999999
Q ss_pred ccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecC
Q 040898 122 LPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDD 201 (337)
Q Consensus 122 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~ 201 (337)
+++.+.+..+...++++||+++++|.+++.. ....+++..+..++.|++.++.+| |+.|++|+||+|+||+++.
T Consensus 60 ~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~l---h~~~i~h~dl~p~ni~i~~ 133 (253)
T cd05122 60 VKYYGSYLKKDELWIVMEFCSGGSLKDLLKS---TNQTLTESQIAYVCKELLKGLEYL---HSNGIIHRDIKAANILLTS 133 (253)
T ss_pred eEEEEEEecCCeEEEEEecCCCCcHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHh---hcCCEecCCCCHHHEEEcc
Confidence 9999999999999999999999999999854 225689999999999999999999 7789999999999999999
Q ss_pred CCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHH
Q 040898 202 DMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMV 281 (337)
Q Consensus 202 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~ 281 (337)
++.++|+|||.+........ .....++..|+|||.+.+..++.++|+||+|+++|+|++|..||...... ....
T Consensus 134 ~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~ 207 (253)
T cd05122 134 DGEVKLIDFGLSAQLSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM---KALF 207 (253)
T ss_pred CCeEEEeecccccccccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH---HHHH
Confidence 99999999998877654332 12345788999999998888899999999999999999999998653211 1111
Q ss_pred HHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 282 KWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
. ... ...+... ........+.+++.+||+.||++|||+.++++|
T Consensus 208 ~-~~~---~~~~~~~--------~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 208 K-IAT---NGPPGLR--------NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred H-HHh---cCCCCcC--------cccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1 110 1110000 001113458999999999999999999999987
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=277.37 Aligned_cols=254 Identities=25% Similarity=0.357 Sum_probs=202.2
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC-CC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR-HR 119 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp 119 (337)
++|++.+.||+|++|.||++.+.. +++.|++|.+.......... ...+.+|..+++++. ||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~--~~~~~~ik~~~~~~~~~~~~----------------~~~~~~e~~~~~~l~~~~ 62 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKE--TNKEYAIKILDKRQLIKEKK----------------VKYVKIEKEVLTRLNGHP 62 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcC--CCCEEEEEEechHhccchHH----------------HHHHHHHHHHHHhcccCC
Confidence 479999999999999999998876 89999999986543221111 146778999999998 99
Q ss_pred CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceee
Q 040898 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI 199 (337)
Q Consensus 120 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~ 199 (337)
||+++++++..++..+++||++++++|.+++.. ...+++..++.++.|++.++.+| |+.|++|+||+|+||++
T Consensus 63 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~L---h~~~~~H~dl~~~ni~i 135 (280)
T cd05581 63 GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYL---HSKGIIHRDLKPENILL 135 (280)
T ss_pred CchhHHHHhcCCceEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCHHHeEE
Confidence 999999999999999999999999999999843 34699999999999999999999 67799999999999999
Q ss_pred cCCCCeEEecccCccccCCCCce------------------eeeecccCCCCccCccccccCCCCCcccchhhhHHHHHH
Q 040898 200 DDDMEARISDFGHGKLMPDGHAQ------------------ITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVL 261 (337)
Q Consensus 200 ~~~~~~~l~dfg~~~~~~~~~~~------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~l 261 (337)
+.++.++|+|||++......... .......++..|+|||...+..++.++|+||||++++++
T Consensus 136 ~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l 215 (280)
T cd05581 136 DKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQM 215 (280)
T ss_pred CCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHH
Confidence 99999999999998765443221 112234578889999999888889999999999999999
Q ss_pred HhCCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCCh----hhhhcC
Q 040898 262 VMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSS----KDVRSM 337 (337)
Q Consensus 262 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~----~ell~~ 337 (337)
++|..||..... ........ . ... ..+......+.+++.+||+.||.+|||+ .++++|
T Consensus 216 ~~g~~p~~~~~~---~~~~~~~~-~---~~~-----------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 216 LTGKPPFRGSNE---YLTFQKIL-K---LEY-----------SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred HhCCCCCCCccH---HHHHHHHH-h---cCC-----------CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 999999875421 11111111 0 000 0111123448899999999999999999 999987
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=267.20 Aligned_cols=275 Identities=20% Similarity=0.291 Sum_probs=204.0
Q ss_pred cccccceeccCcceEEEEeEEecCCCCc--eEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 42 CFDSLKKIGSGGWGEVFYKAELPGSNGK--MIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
.|+.+..||+|+||.||++...+....+ .+|+|++..+.....-+ .+..||+.+++.++||
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS-----------------~SAcREiaL~REl~h~ 87 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGIS-----------------MSACREIALLRELKHP 87 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcC-----------------HHHHHHHHHHHHhcCC
Confidence 4999999999999999999877755544 89999987664321100 4678899999999999
Q ss_pred CcccceeEEEc-CCeeEEEEEeccCCCHHHHHHHhc-CCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCce
Q 040898 120 NILPLLAHMVR-PNCHLLVYEFMKNGSLQDILYDVS-QGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANV 197 (337)
Q Consensus 120 niv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ni 197 (337)
|++.+..++.+ +..+++++||.++ +|...+.-.+ .....++...+..++.||+.|+.|| |+.-++|||+||.||
T Consensus 88 nvi~Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YL---H~NWvlHRDLKPaNI 163 (438)
T KOG0666|consen 88 NVISLVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYL---HSNWVLHRDLKPANI 163 (438)
T ss_pred cchhHHHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHH---hhhheeeccCCcceE
Confidence 99999999877 8899999999988 8888876433 2345789999999999999999999 777899999999999
Q ss_pred eecCC----CCeEEecccCccccCCCCcee-eeecccCCCCccCccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCC
Q 040898 198 LIDDD----MEARISDFGHGKLMPDGHAQI-TVKCMVGTMGYMAPESLQTE-TISDKCDIYSFGVLLAVLVMGKFPVDDF 271 (337)
Q Consensus 198 l~~~~----~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~i~~~ll~g~~pf~~~ 271 (337)
++..+ |.|||+|+|+++.+....... .....+-|..|.|||++.|. .|+.+.|+|++|||+.||+|-.+-|...
T Consensus 164 lvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 164 LVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred EEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 99887 999999999999886654433 23345678899999999876 4899999999999999999999888542
Q ss_pred CCCchh-----hhHHHHHHhhhccCCcchhhh-------------h--cccCCc-hHH-------HHHHHHHHHhhhccC
Q 040898 272 FGHTEE-----MDMVKWMRNVIFSENPNRAIN-------------S--KLLGNG-YEE-------QMLLVLKLACFCTLK 323 (337)
Q Consensus 272 ~~~~~~-----~~~~~~~~~~~~~~~~~~~~~-------------~--~~~~~~-~~~-------~~~~l~~li~~~l~~ 323 (337)
...... .+....+.+++..+......+ . ....+. ... -+....+|+.+||++
T Consensus 244 E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~y 323 (438)
T KOG0666|consen 244 EEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTY 323 (438)
T ss_pred hhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhcc
Confidence 221111 112222222221111100000 0 000000 000 112367899999999
Q ss_pred CCCCCCChhhhhcC
Q 040898 324 DPDERPSSKDVRSM 337 (337)
Q Consensus 324 dP~~Rps~~ell~~ 337 (337)
||.+|+|++++++|
T Consensus 324 DP~kRIta~qAleh 337 (438)
T KOG0666|consen 324 DPIKRITAEQALEH 337 (438)
T ss_pred CchhhccHHHHhcc
Confidence 99999999999987
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=285.48 Aligned_cols=266 Identities=22% Similarity=0.316 Sum_probs=195.5
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++.+.||+|++|.||++.+.. +++.||+|.+........ ...+.+|+.+++.++|
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~--~~~~vaiK~~~~~~~~~~------------------~~~~~~E~~~l~~l~h 62 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKP--TGVKVAIKKISPFEHQTF------------------CQRTLREIKILRRFKH 62 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcC--CCCeEEEEEecccccchh------------------HHHHHHHHHHHHhCCC
Confidence 35789999999999999999998876 899999999854322111 1456779999999999
Q ss_pred CCcccceeEEEcC-----CeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCC
Q 040898 119 RNILPLLAHMVRP-----NCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIK 193 (337)
Q Consensus 119 pniv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~ 193 (337)
|||+++++++... ...++++||+++ +|.+.+. ...+++..++.++.|++.||.+| |+.|++|+||+
T Consensus 63 ~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~L---H~~~ivH~dlk 133 (336)
T cd07849 63 ENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIK-----TQHLSNDHIQYFLYQILRGLKYI---HSANVLHRDLK 133 (336)
T ss_pred CCcCchhheeecccccccceEEEEehhccc-CHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCC
Confidence 9999999876543 357999999975 7877763 24588999999999999999999 77799999999
Q ss_pred CCceeecCCCCeEEecccCccccCCCCcee-eeecccCCCCccCcccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCC
Q 040898 194 PANVLIDDDMEARISDFGHGKLMPDGHAQI-TVKCMVGTMGYMAPESLQT-ETISDKCDIYSFGVLLAVLVMGKFPVDDF 271 (337)
Q Consensus 194 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~i~~~ll~g~~pf~~~ 271 (337)
|+||+++.++.++|+|||++.......... ......+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||...
T Consensus 134 p~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~ 213 (336)
T cd07849 134 PSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGK 213 (336)
T ss_pred HHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999987654322111 1123467889999998754 45788999999999999999999999643
Q ss_pred CCCchhhhHHHHHHhhhccCCcchh-----------h------hhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhh
Q 040898 272 FGHTEEMDMVKWMRNVIFSENPNRA-----------I------NSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDV 334 (337)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~-----------~------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el 334 (337)
.. ......+............ . .........+.....+.+++.+||+.||++|||+.++
T Consensus 214 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~ 289 (336)
T cd07849 214 DY----LHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEA 289 (336)
T ss_pred CH----HHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHH
Confidence 21 1111111111111000000 0 0000000112234568999999999999999999999
Q ss_pred hcC
Q 040898 335 RSM 337 (337)
Q Consensus 335 l~~ 337 (337)
++|
T Consensus 290 l~h 292 (336)
T cd07849 290 LAH 292 (336)
T ss_pred hcC
Confidence 987
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=270.78 Aligned_cols=253 Identities=28% Similarity=0.415 Sum_probs=196.8
Q ss_pred ccccceeccCcceEEEEeEEecCC--CCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 43 FDSLKKIGSGGWGEVFYKAELPGS--NGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 43 y~~~~~lg~G~~g~V~~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
+++.+.||.|+||.||++.+.... .+..+|+|.+........ ...+..|+.++..++|||
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~------------------~~~~~~e~~~l~~l~~~~ 62 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQ------------------IEEFLREARIMRKLDHPN 62 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHH------------------HHHHHHHHHHHHhcCCCc
Confidence 467899999999999999886511 248899999865533211 156778999999999999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
|+++++++.+.+..++++||+++++|.+++.... ...+++..+..++.|++.++.+| |+.|++|+||+|+||+++
T Consensus 63 i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~l---h~~~~~h~dl~~~nil~~ 137 (258)
T smart00219 63 IVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYL---ESKNFIHRDLAARNCLVG 137 (258)
T ss_pred hheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHH---hcCCeeecccccceEEEc
Confidence 9999999999999999999999999999985421 12289999999999999999999 788999999999999999
Q ss_pred CCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCchhhh
Q 040898 201 DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHTEEMD 279 (337)
Q Consensus 201 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~~~ 279 (337)
.++.++|+|||.+........... ....+++.|+|||.+.+..++.++|+||||+++|+|++ |.+||..... ..
T Consensus 138 ~~~~~~l~dfg~~~~~~~~~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~----~~ 212 (258)
T smart00219 138 ENLVVKISDFGLSRDLYDDDYYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN----EE 212 (258)
T ss_pred cCCeEEEcccCCceeccccccccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH----HH
Confidence 999999999999877654322111 12236788999999988888999999999999999998 7888765211 12
Q ss_pred HHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 280 MVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
......... .. ......+..+.+++.+||+.||++|||+.++++
T Consensus 213 ~~~~~~~~~---~~----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 213 VLEYLKKGY---RL----------PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHHhcCC---CC----------CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 222111111 10 001113445889999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=275.61 Aligned_cols=252 Identities=27% Similarity=0.438 Sum_probs=196.9
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|.+.+.||+|++|.||++.+.. +++.|++|.+.......... ...+.+|+.+++.++|
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~--~~~~v~iK~~~~~~~~~~~~----------------~~~~~~Ei~~l~~l~h 74 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVR--TNEVVAIKKMSYSGKQSNEK----------------WQDIIKEVRFLQQLRH 74 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcC--CCcEEEEEEEeccccCcHHH----------------HHHHHHHHHHHHhCCC
Confidence 45679999999999999999998865 89999999886443222111 1467789999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
||++++.+++..+...++|+||+++ ++.+++.. ....+++..+..++.|++.+|.|| |+.|++|+||+|+||+
T Consensus 75 ~niv~~~~~~~~~~~~~lv~e~~~g-~l~~~~~~---~~~~l~~~~~~~~~~ql~~~L~~L---H~~~i~H~dl~p~nIl 147 (307)
T cd06607 75 PNTIEYKGCYLREHTAWLVMEYCLG-SASDILEV---HKKPLQEVEIAAICHGALQGLAYL---HSHERIHRDIKAGNIL 147 (307)
T ss_pred CCEEEEEEEEEeCCeEEEEHHhhCC-CHHHHHHH---cccCCCHHHHHHHHHHHHHHHHHH---HHCCceecCCCcccEE
Confidence 9999999999999999999999975 77776643 234589999999999999999999 7779999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccc---cCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCc
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQ---TETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHT 275 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~ 275 (337)
++.++.++|+|||++...... ....+++.|+|||.+. ...++.++|+||+|+++|+|++|..||.....
T Consensus 148 ~~~~~~~kL~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~-- 219 (307)
T cd06607 148 LTEPGTVKLADFGSASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-- 219 (307)
T ss_pred ECCCCCEEEeecCcceecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH--
Confidence 999999999999988654322 2245788899999874 34578899999999999999999999854311
Q ss_pred hhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 276 EEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
... .........+. .........+.+++.+||+.||.+|||+.++++|
T Consensus 220 --~~~---~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 220 --MSA---LYHIAQNDSPT---------LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred --HHH---HHHHhcCCCCC---------CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 111 11111111100 0011234458999999999999999999999976
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=268.69 Aligned_cols=255 Identities=25% Similarity=0.392 Sum_probs=204.0
Q ss_pred cccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCc
Q 040898 42 CFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNI 121 (337)
Q Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpni 121 (337)
+|...+.||+|++|.||.+.+.. ++..+++|.+........ ..+.+.+|+..+++++||||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~-----------------~~~~~~~e~~~l~~l~~~~i 61 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKD--TGELMAVKSVELSGDSEE-----------------ELEALEREIRILSSLQHPNI 61 (260)
T ss_pred CceeeeEeeecCceEEEEEEECC--CCcEEEEEEeeccccchH-----------------HHHHHHHHHHHHHHcCCCCE
Confidence 48889999999999999998865 899999999865543211 11678889999999999999
Q ss_pred ccceeEEEcC--CeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceee
Q 040898 122 LPLLAHMVRP--NCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI 199 (337)
Q Consensus 122 v~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~ 199 (337)
+++++.+... ...++++||+++++|.+++.. ...+++..++.++.|++.++.+| |+.|++|+|++|+||++
T Consensus 62 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~l---h~~~~~h~dl~p~ni~i 134 (260)
T cd06606 62 VRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKK----FGKLPEPVIRKYTRQILEGLAYL---HSNGIVHRDIKGANILV 134 (260)
T ss_pred eeEEEEEecCCCCeEEEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHEEE
Confidence 9999999888 899999999999999999854 23789999999999999999999 66799999999999999
Q ss_pred cCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhh
Q 040898 200 DDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMD 279 (337)
Q Consensus 200 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~ 279 (337)
+.++.++|+|||.+................++..|+|||.+.+...+.++|+||||+++|+|++|..||..... ..
T Consensus 135 ~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~-- 210 (260)
T cd06606 135 DSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN--PM-- 210 (260)
T ss_pred cCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--hH--
Confidence 99999999999998876554321112335688899999999888899999999999999999999999876431 11
Q ss_pred HHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 280 MVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
............ ...+......+.+++.+||+.||++|||+.++++|
T Consensus 211 --~~~~~~~~~~~~---------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 211 --AALYKIGSSGEP---------PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred --HHHHhccccCCC---------cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 111111100000 01111224559999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=279.72 Aligned_cols=265 Identities=22% Similarity=0.360 Sum_probs=192.7
Q ss_pred cceeccC--cceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCccc
Q 040898 46 LKKIGSG--GWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILP 123 (337)
Q Consensus 46 ~~~lg~G--~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~ 123 (337)
.+.||+| ++|+||.+.+.. +++.||+|.+........ ..+.+.+|+.+++.++||||++
T Consensus 3 ~~~ig~g~~~~~~v~~a~~~~--~~~~vaiK~~~~~~~~~~-----------------~~~~~~~e~~~~~~l~h~niv~ 63 (328)
T cd08226 3 QVEIGRGFCNLTSVYLARHTP--TGTLVTVRITDLENCTEE-----------------HLKALQNEVVLSHFFRHPNIMT 63 (328)
T ss_pred HHHhCCcccCceeEEEEEEcC--CCcEEEEEEeccccCCHH-----------------HHHHHHHHHHHHHhCCCCCcce
Confidence 4567777 999999998876 899999999865432211 1156788999999999999999
Q ss_pred ceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCC
Q 040898 124 LLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDM 203 (337)
Q Consensus 124 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~ 203 (337)
+++++..+...++++||+++++|.+++.... ...+++..+..++.|++.||.|| |+.|++|+||||+||+++.++
T Consensus 64 ~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~l---H~~~ivHrDlkp~Nill~~~~ 138 (328)
T cd08226 64 SWTVFTTGSWLWVISPFMAYGSANSLLKTYF--PEGMSEALIGNILFGALRGLNYL---HQNGYIHRNIKASHILISGDG 138 (328)
T ss_pred EeeeEecCCceEEEEecccCCCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEeCCC
Confidence 9999999999999999999999999886532 33588889999999999999999 677999999999999999999
Q ss_pred CeEEecccCccccCCCCcee--e---eecccCCCCccCccccccC--CCCCcccchhhhHHHHHHHhCCCCCCCCCCCch
Q 040898 204 EARISDFGHGKLMPDGHAQI--T---VKCMVGTMGYMAPESLQTE--TISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTE 276 (337)
Q Consensus 204 ~~~l~dfg~~~~~~~~~~~~--~---~~~~~~~~~~~~PE~~~~~--~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~ 276 (337)
.++++||+.+.......... . .....++..|++||.+.+. .++.++|+||+|+++|+|++|..||........
T Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~ 218 (328)
T cd08226 139 LVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM 218 (328)
T ss_pred cEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH
Confidence 99999997543322111100 0 0112245669999998763 468899999999999999999999975432111
Q ss_pred hhhHHHHHHhhhccCC--------------------------------cchhhhhcccCCchHHHHHHHHHHHhhhccCC
Q 040898 277 EMDMVKWMRNVIFSEN--------------------------------PNRAINSKLLGNGYEEQMLLVLKLACFCTLKD 324 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~--------------------------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 324 (337)
............. ....................+.+|+.+||+.|
T Consensus 219 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d 295 (328)
T cd08226 219 ---LLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQD 295 (328)
T ss_pred ---HHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCC
Confidence 1111100000000 00000001111222345567899999999999
Q ss_pred CCCCCChhhhhcC
Q 040898 325 PDERPSSKDVRSM 337 (337)
Q Consensus 325 P~~Rps~~ell~~ 337 (337)
|++|||+.++++|
T Consensus 296 P~~Rpta~e~l~~ 308 (328)
T cd08226 296 PEKRPSASSLLSH 308 (328)
T ss_pred cccCCCHHHHhhC
Confidence 9999999999987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=277.04 Aligned_cols=266 Identities=23% Similarity=0.270 Sum_probs=194.8
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
++|++.+.||+|++|.||++.+.. +++.|++|.+........ ....+.+|+.++++++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~--~~~~~~iK~~~~~~~~~~-----------------~~~~~~~e~~~l~~l~h~~ 62 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRV--TNETIALKKIRLEQEDEG-----------------VPSTAIREISLLKEMQHGN 62 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecC--CCcEEEEEehhhcccccc-----------------chHHHHHHHHHHHhccCCC
Confidence 579999999999999999998865 899999998855432111 0145677999999999999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
|+++++++.++...++|+||+++ +|.+.+.. ......++..++.++.||+.||.+| |++|++|+||+|+||+++
T Consensus 63 i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~~L---H~~~i~H~dl~p~nill~ 136 (294)
T PLN00009 63 IVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDS--SPDFAKNPRLIKTYLYQILRGIAYC---HSHRVLHRDLKPQNLLID 136 (294)
T ss_pred EeeEEEEEecCCeEEEEEecccc-cHHHHHHh--CCCCCcCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCCcceEEEE
Confidence 99999999999999999999965 78777643 2233467888899999999999999 777999999999999998
Q ss_pred C-CCCeEEecccCccccCCCCceeeeecccCCCCccCcccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhh
Q 040898 201 D-DMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQT-ETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEM 278 (337)
Q Consensus 201 ~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~ 278 (337)
. ++.++|+|||++........ ......+++.|+|||.+.+ ..++.++|+||+|+++|+|++|.+||...... .
T Consensus 137 ~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~---~ 211 (294)
T PLN00009 137 RRTNALKLADFGLARAFGIPVR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI---D 211 (294)
T ss_pred CCCCEEEEcccccccccCCCcc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---H
Confidence 5 55789999999875533211 1123456788999998865 35788999999999999999999998653221 1
Q ss_pred hHHHHHHhhhccCCcch--------h---hhhcccC----CchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 279 DMVKWMRNVIFSENPNR--------A---INSKLLG----NGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~--------~---~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
...+.... ........ . ..+.... ...+.....+.+++.+||+.+|++|||+.++++|
T Consensus 212 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 212 ELFKIFRI-LGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred HHHHHHHH-hCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111110 00000000 0 0000000 0112234458899999999999999999999986
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=284.87 Aligned_cols=267 Identities=22% Similarity=0.320 Sum_probs=198.2
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++.+.||+|++|.||++.+.. ++..|++|++......... ...+.+|+.+++.++|
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~--~~~~valK~~~~~~~~~~~-----------------~~~~~~e~~~l~~l~h 63 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTR--SGKKVAIKKIPHAFDVPTL-----------------AKRTLRELKILRHFKH 63 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcC--CCCEEEEEEeccccccccc-----------------hHHHHHHHHHHHhcCC
Confidence 34789999999999999999998876 8999999998654321110 1456779999999999
Q ss_pred CCcccceeEEEc----CCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCC
Q 040898 119 RNILPLLAHMVR----PNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKP 194 (337)
Q Consensus 119 pniv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~ 194 (337)
|||+++++++.. ....++|+||+. ++|.+++ .....+++..++.++.|++.||.|| |+.|++|+||+|
T Consensus 64 ~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~----~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~dlkp 135 (334)
T cd07855 64 DNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHII----HSDQPLTEEHIRYFLYQLLRGLKYI---HSANVIHRDLKP 135 (334)
T ss_pred CCccCHHHhccccCCCCceEEEEEehhh-hhHHHHh----ccCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCH
Confidence 999999998753 356899999996 5888887 3445589999999999999999999 677999999999
Q ss_pred CceeecCCCCeEEecccCccccCCCCce--eeeecccCCCCccCcccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCC
Q 040898 195 ANVLIDDDMEARISDFGHGKLMPDGHAQ--ITVKCMVGTMGYMAPESLQT-ETISDKCDIYSFGVLLAVLVMGKFPVDDF 271 (337)
Q Consensus 195 ~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~i~~~ll~g~~pf~~~ 271 (337)
+||+++.++.++|+|||++......... .......++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||...
T Consensus 136 ~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 215 (334)
T cd07855 136 SNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGK 215 (334)
T ss_pred HHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCC
Confidence 9999999999999999998765432211 11123467889999999865 45788999999999999999999999653
Q ss_pred CCCchhhhHHHHHHhhhccCCcchh------------hh------hcccCCchHHHHHHHHHHHhhhccCCCCCCCChhh
Q 040898 272 FGHTEEMDMVKWMRNVIFSENPNRA------------IN------SKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKD 333 (337)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~------------~~------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e 333 (337)
..... + ..+..... ..+... .. ........+.....+.+++.+||+.+|++|||+.+
T Consensus 216 ~~~~~---~-~~~~~~~g-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ 290 (334)
T cd07855 216 NYVHQ---L-KLILSVLG-SPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQ 290 (334)
T ss_pred ChHHH---H-HHHHHHhC-CChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 22111 1 11111000 000000 00 00000011233566999999999999999999999
Q ss_pred hhcC
Q 040898 334 VRSM 337 (337)
Q Consensus 334 ll~~ 337 (337)
++.|
T Consensus 291 ~l~~ 294 (334)
T cd07855 291 ALQH 294 (334)
T ss_pred HHhC
Confidence 9976
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=275.36 Aligned_cols=260 Identities=24% Similarity=0.254 Sum_probs=192.7
Q ss_pred ccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC-CCCc
Q 040898 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR-HRNI 121 (337)
Q Consensus 43 y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-hpni 121 (337)
|++.+.||+|++|.||++.+.. ++..||+|++......... ....+|+..+.++. |||+
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~--~~~~~aik~~~~~~~~~~~------------------~~~~~e~~~l~~l~~h~~i 60 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRK--TGKYYAIKCMKKHFKSLEQ------------------VNNLREIQALRRLSPHPNI 60 (282)
T ss_pred CceEeeccccccceEEEEEEcC--CCcEEEEEEehhccCCchh------------------hhHHHHHHHHhhcCCCCCc
Confidence 6789999999999999998876 8899999988654321111 12346888888885 9999
Q ss_pred ccceeEEEcC--CeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceee
Q 040898 122 LPLLAHMVRP--NCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI 199 (337)
Q Consensus 122 v~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~ 199 (337)
+++++++.++ +..++|+||+++ +|.+.+.. ....+++..++.++.|++.||.+| |+.|++|+||+|+||++
T Consensus 61 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~L---H~~~i~H~dl~p~ni~l 133 (282)
T cd07831 61 LRLIEVLFDRKTGRLALVFELMDM-NLYELIKG---RKRPLPEKRVKSYMYQLLKSLDHM---HRNGIFHRDIKPENILI 133 (282)
T ss_pred cceEEEEecCCCCcEEEEEecCCc-cHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHH---HHCCceecccCHHHEEE
Confidence 9999999887 889999999975 77777743 235689999999999999999999 67799999999999999
Q ss_pred cCCCCeEEecccCccccCCCCceeeeecccCCCCccCcccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhh
Q 040898 200 DDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQT-ETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEM 278 (337)
Q Consensus 200 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~ 278 (337)
+. +.++|+|||.+......... ....++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||......+
T Consensus 134 ~~-~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~--- 206 (282)
T cd07831 134 KD-DILKLADFGSCRGIYSKPPY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD--- 206 (282)
T ss_pred cC-CCeEEEecccccccccCCCc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---
Confidence 99 99999999998765433221 22457889999997643 456889999999999999999999996532211
Q ss_pred hHHHHHHhhhccCCc-----------chhhhhcc----cCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 279 DMVKWMRNVIFSENP-----------NRAINSKL----LGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~-----------~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.............. .....+.. .....+..+..+.+++.+||++||++|||+.++++|
T Consensus 207 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 207 -QIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred -HHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 11111111100000 00000000 001112345679999999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=269.94 Aligned_cols=257 Identities=22% Similarity=0.329 Sum_probs=198.3
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
.+|++.+.||+|++|.||++.+.. ++..|++|.+.......... .....+.+|+.++++++|||
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~--------------~~~~~~~~ei~~l~~l~h~~ 65 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDAD--TGRELAVKQVPFDPDSQETS--------------KEVNALECEIQLLKNLRHDR 65 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcC--CCCEEEEEEEecCcccchhh--------------HHHHHHHHHHHHHHHcCCCC
Confidence 579999999999999999998875 89999999875432211110 11257888999999999999
Q ss_pred cccceeEEEcC--CeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 121 ILPLLAHMVRP--NCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 121 iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|+++++.+.+. ...++++||+++++|.+++.. ...+++.....++.|++.|+.+| |+.|++|+||+|+||+
T Consensus 66 i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~L---H~~~i~H~dl~p~ni~ 138 (264)
T cd06653 66 IVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYL---HSNMIVHRDIKGANIL 138 (264)
T ss_pred cceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHEE
Confidence 99999988664 468899999999999999843 34578888999999999999999 7779999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCc-eeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchh
Q 040898 199 IDDDMEARISDFGHGKLMPDGHA-QITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEE 277 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~ 277 (337)
++.++.++|+|||.+........ ........++..|+|||.+.+..++.++|+||||+++|++++|..||..... .
T Consensus 139 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~ 215 (264)
T cd06653 139 RDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA---M 215 (264)
T ss_pred EcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH---H
Confidence 99999999999999876532211 1111234578899999999888889999999999999999999999864311 1
Q ss_pred hhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 278 MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
... . +....... ...+....+.+.+++.+||+ +|..|||+.++++|
T Consensus 216 ~~~---~-~~~~~~~~---------~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 216 AAI---F-KIATQPTK---------PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred HHH---H-HHHcCCCC---------CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 111 1 11111110 01122334558999999999 57999999999987
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=283.70 Aligned_cols=266 Identities=22% Similarity=0.316 Sum_probs=197.2
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
...+|.+.+.||+|++|.||++.+.. ++..||+|.+......... ...+.+|+.+++.++|
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~--~~~~vaiK~~~~~~~~~~~-----------------~~~~~~E~~~l~~l~h 63 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSE--TNEKVAIKKIANAFDNRID-----------------AKRTLREIKLLRHLDH 63 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecC--CCCeEEEEEecccccccch-----------------hHHHHHHHHHHHhcCC
Confidence 45679999999999999999998875 8999999998654221111 1356679999999999
Q ss_pred CCcccceeEEEcC-----CeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCC
Q 040898 119 RNILPLLAHMVRP-----NCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIK 193 (337)
Q Consensus 119 pniv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~ 193 (337)
|||+++++++... ...++++||+. ++|.+++ .....+++..+..++.|++.||.+| |+.|++|+||+
T Consensus 64 ~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~----~~~~~l~~~~~~~i~~qi~~aL~~L---H~~~i~H~dlk 135 (337)
T cd07858 64 ENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQII----RSSQTLSDDHCQYFLYQLLRGLKYI---HSANVLHRDLK 135 (337)
T ss_pred CCccchHHheecccccccCcEEEEEeCCC-CCHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHH---HhCCEecCCCC
Confidence 9999999987644 34799999996 5888887 3445689999999999999999999 77799999999
Q ss_pred CCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCcccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCC
Q 040898 194 PANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQT-ETISDKCDIYSFGVLLAVLVMGKFPVDDFF 272 (337)
Q Consensus 194 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~i~~~ll~g~~pf~~~~ 272 (337)
|+||+++.++.++|+|||++........ ......++..|+|||.+.+ ..++.++|+||||+++|+|++|.+||....
T Consensus 136 p~Nil~~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 213 (337)
T cd07858 136 PSNLLLNANCDLKICDFGLARTTSEKGD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKD 213 (337)
T ss_pred HHHEEEcCCCCEEECcCccccccCCCcc--cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCC
Confidence 9999999999999999999876543321 1123457888999998764 458889999999999999999999996532
Q ss_pred CCchhhhHHHHHHhhhccCCcchh-----------hh------hcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhh
Q 040898 273 GHTEEMDMVKWMRNVIFSENPNRA-----------IN------SKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVR 335 (337)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~-----------~~------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 335 (337)
.... ...+............ .. ........+.....+.+++.+||+.||++|||+.+++
T Consensus 214 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell 289 (337)
T cd07858 214 YVHQ----LKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEAL 289 (337)
T ss_pred hHHH----HHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHH
Confidence 2111 1111110000000000 00 0000001123445689999999999999999999999
Q ss_pred cC
Q 040898 336 SM 337 (337)
Q Consensus 336 ~~ 337 (337)
+|
T Consensus 290 ~h 291 (337)
T cd07858 290 AH 291 (337)
T ss_pred cC
Confidence 87
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=272.13 Aligned_cols=263 Identities=24% Similarity=0.329 Sum_probs=193.2
Q ss_pred cccccccceeccCcceEEEEeEEe--cCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAEL--PGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR 117 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 117 (337)
.++|++.+.||+|+||.||.+... ...++..|++|.+....... ...+.+|+.++..++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~-------------------~~~~~~e~~~l~~l~ 63 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEH-------------------LRDFEREIEILKSLQ 63 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHH-------------------HHHHHHHHHHHHhCC
Confidence 357999999999999999988642 33478899999986442211 146778999999999
Q ss_pred CCCcccceeEEEc--CCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCC
Q 040898 118 HRNILPLLAHMVR--PNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPA 195 (337)
Q Consensus 118 hpniv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ 195 (337)
||||+++++++.. ....++|+||+++++|.+++.. ....+++..++.++.|++.||.|| |+.|++|+||+|+
T Consensus 64 h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~aL~~L---H~~~i~H~dlkp~ 137 (284)
T cd05081 64 HDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQK---HRERLDHRKLLLYASQICKGMEYL---GSKRYVHRDLATR 137 (284)
T ss_pred CCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHH---HHCCceeccCCHh
Confidence 9999999997643 3568999999999999999853 234588999999999999999999 7779999999999
Q ss_pred ceeecCCCCeEEecccCccccCCCCceeeee-cccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCC
Q 040898 196 NVLIDDDMEARISDFGHGKLMPDGHAQITVK-CMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGH 274 (337)
Q Consensus 196 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~-~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~ 274 (337)
||+++.++.++|+|||++............. ...++..|+|||.+.+..++.++|+||||+++|+|++|..|+......
T Consensus 138 nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~ 217 (284)
T cd05081 138 NILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE 217 (284)
T ss_pred hEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh
Confidence 9999999999999999988764432221111 112344599999998888999999999999999999987765321110
Q ss_pred c--------hhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 275 T--------EEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 275 ~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
- ................. ...........+.+++.+||+.+|++|||+.++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 218 FMRMMGNDKQGQMIVYHLIELLKNNG---------RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred hhhhcccccccccchHHHHHHHhcCC---------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 0 00000000000000000 00111223345899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=268.72 Aligned_cols=246 Identities=23% Similarity=0.341 Sum_probs=191.2
Q ss_pred ceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCccccee
Q 040898 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLLA 126 (337)
Q Consensus 47 ~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~ 126 (337)
++||+|++|.||++.+. .++.|++|.+........ ...+..|+.++++++||||+++++
T Consensus 1 ~~lg~g~~g~v~~~~~~---~~~~v~~K~~~~~~~~~~------------------~~~~~~e~~~l~~l~~~~i~~~~~ 59 (251)
T cd05041 1 EKIGKGNFGDVYKGVLK---GNTEVAVKTCRSTLPPDL------------------KRKFLQEAEILKQYDHPNIVKLIG 59 (251)
T ss_pred CccccCCCceEEEEEEe---CCCcEEEEeccccCCHHH------------------HHHHHHHHHHHHhCCCCCeEEEEE
Confidence 47999999999998874 389999998865543211 146778999999999999999999
Q ss_pred EEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCCeE
Q 040898 127 HMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEAR 206 (337)
Q Consensus 127 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~~ 206 (337)
++.+....++|+||+++++|.+++.. ....+++..+..++.+++.++.+| |+++++|+||+|+||+++.++.++
T Consensus 60 ~~~~~~~~~~v~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~~~~~~~l~~l---H~~~i~h~di~p~nili~~~~~~~ 133 (251)
T cd05041 60 VCVQKQPIYIVMELVPGGSLLTFLRK---KKNRLTVKKLLQMSLDAAAGMEYL---ESKNCIHRDLAARNCLVGENNVLK 133 (251)
T ss_pred EEecCCCeEEEEEcCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH---HhCCEehhhcCcceEEEcCCCcEE
Confidence 99999999999999999999999854 234578889999999999999999 778999999999999999999999
Q ss_pred EecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCchhhhHHHHHH
Q 040898 207 ISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHTEEMDMVKWMR 285 (337)
Q Consensus 207 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~ 285 (337)
|+|||.+.................+..|+|||.+.+..++.++|+||||+++|+|++ |..||...... .....+.
T Consensus 134 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~----~~~~~~~ 209 (251)
T cd05041 134 ISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ----QTRERIE 209 (251)
T ss_pred EeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH----HHHHHHh
Confidence 999999876543221111111223566999999988889999999999999999999 78888654221 1111111
Q ss_pred hhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 286 NVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
. .... ..+...+..+.+++.+||+.+|.+|||+.|+++
T Consensus 210 ~----~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 210 S----GYRM---------PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred c----CCCC---------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 1 0000 011122345899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=278.03 Aligned_cols=254 Identities=24% Similarity=0.368 Sum_probs=194.2
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCc----eEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHH
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGK----MIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITAN 114 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~ 114 (337)
+.++|+..+.||+|+||.||++.+.. ++. .+|+|.+......... ..+.+|+.+++
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~--~~~~~~~~vaiK~~~~~~~~~~~------------------~~~~~e~~~~~ 64 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVP--EGETVKIPVAIKILNETTGPKAN------------------VEFMDEALIMA 64 (303)
T ss_pred chhhceeccccccCCCccEEEEEEec--CCCcceeeEEEEeccccCCHHHH------------------HHHHHHHHHHH
Confidence 34669999999999999999998865 443 5788887544321111 35677999999
Q ss_pred hcCCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCC
Q 040898 115 QTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKP 194 (337)
Q Consensus 115 ~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~ 194 (337)
.+.||||+++++++... ..++++||+++|+|.+++.. ....+++..++.++.|++.||.|| |+.|++|+||+|
T Consensus 65 ~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~L---H~~~ivH~dikp 137 (303)
T cd05110 65 SMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYL---EERRLVHRDLAA 137 (303)
T ss_pred hCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHH---hhcCeecccccc
Confidence 99999999999988654 46799999999999999853 234578889999999999999999 778999999999
Q ss_pred CceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCC
Q 040898 195 ANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFG 273 (337)
Q Consensus 195 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~ 273 (337)
+||+++.++.++|+|||++................++..|++||.+.+..++.++|+||||+++|++++ |..||.....
T Consensus 138 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~ 217 (303)
T cd05110 138 RNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT 217 (303)
T ss_pred ceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987654332222222345678999999988889999999999999999998 8899865321
Q ss_pred CchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 274 HTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
........... ... ..+.....+.+++..||..+|++|||+.++++
T Consensus 218 ----~~~~~~~~~~~---~~~----------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~ 263 (303)
T cd05110 218 ----REIPDLLEKGE---RLP----------QPPICTIDVYMVMVKCWMIDADSRPKFKELAA 263 (303)
T ss_pred ----HHHHHHHHCCC---CCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11222221111 000 00112234889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=270.51 Aligned_cols=253 Identities=22% Similarity=0.304 Sum_probs=199.3
Q ss_pred cccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCc
Q 040898 42 CFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNI 121 (337)
Q Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpni 121 (337)
+|++.+.||+|++|.||++.+.. ++..+|+|.+......... .+.+.+|+.+++.++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~-----------------~~~~~~E~~~l~~~~h~~i 61 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKS--DSEHCVIKEIDLTKMPVKE-----------------KEASKKEVILLAKMKHPNI 61 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcC--CCceEEEEEeeHhhccchh-----------------hHHHHHHHHHHHhCCCCCh
Confidence 58999999999999999998876 8899999988553221110 1456789999999999999
Q ss_pred ccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecC
Q 040898 122 LPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDD 201 (337)
Q Consensus 122 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~ 201 (337)
+++++.+..+...++++||+++++|.+++.. .....+++..+..++.|++.++.+| |+.+++|+||+|+||++++
T Consensus 62 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~l---h~~~i~H~dl~~~nil~~~ 136 (257)
T cd08225 62 VTFFASFQENGRLFIVMEYCDGGDLMKRINR--QRGVLFSEDQILSWFVQISLGLKHI---HDRKILHRDIKSQNIFLSK 136 (257)
T ss_pred hhhhheeccCCeEEEEEecCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccccCCHHHEEEcC
Confidence 9999999999999999999999999998854 2334578999999999999999999 6779999999999999998
Q ss_pred CCC-eEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhH
Q 040898 202 DME-ARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDM 280 (337)
Q Consensus 202 ~~~-~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~ 280 (337)
++. ++|+|||.+......... .....+++.|+|||.+.+..++.++|+||+|+++++|++|..||.....
T Consensus 137 ~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------- 207 (257)
T cd08225 137 NGMVAKLGDFGIARQLNDSMEL--AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL------- 207 (257)
T ss_pred CCCeEEecccccchhccCCccc--ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-------
Confidence 864 699999988766433221 1224578899999999888889999999999999999999999854211
Q ss_pred HHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 281 VKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.+........... ...+.....+.+++.+||..+|++|||+.++++|
T Consensus 208 ~~~~~~~~~~~~~----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 208 HQLVLKICQGYFA----------PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred HHHHHHHhcccCC----------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1111111111110 0111223458999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=272.17 Aligned_cols=259 Identities=27% Similarity=0.422 Sum_probs=205.3
Q ss_pred cccccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHH
Q 040898 34 LAFLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITA 113 (337)
Q Consensus 34 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l 113 (337)
++..+..+.|+..+.||+|++|.||.+.+.. ++..+++|.+..... . ...+.+|+.++
T Consensus 12 ~~~~~~~~~~~~~~~l~~g~~~~v~~~~~~~--~~~~~~iK~~~~~~~-~-------------------~~~~~~e~~~l 69 (286)
T cd06614 12 VSEGDPRELYKNLEKIGEGASGEVYKATDRA--TGKEVAIKKMRLRKQ-N-------------------KELIINEILIM 69 (286)
T ss_pred cCCCCccccchHhHhccCCCCeEEEEEEEcc--CCcEEEEEEEecCch-h-------------------HHHHHHHHHHH
Confidence 3344677889999999999999999998865 789999999865433 0 14677899999
Q ss_pred HhcCCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCC
Q 040898 114 NQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIK 193 (337)
Q Consensus 114 ~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~ 193 (337)
+.++|||++++++.+......++++||+++++|.+++.... ..+++..+..++.|++.+|.+| |+.|++|+||+
T Consensus 70 ~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~l---H~~gi~H~dl~ 143 (286)
T cd06614 70 KDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYL---HSQNVIHRDIK 143 (286)
T ss_pred HHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCC
Confidence 99999999999999999999999999999999999996521 3689999999999999999999 77899999999
Q ss_pred CCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCC
Q 040898 194 PANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFG 273 (337)
Q Consensus 194 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~ 273 (337)
|+||+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||.....
T Consensus 144 p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~ 221 (286)
T cd06614 144 SDNILLSKDGSVKLADFGFAAQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP 221 (286)
T ss_pred hhhEEEcCCCCEEECccchhhhhccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999999999999998765543221 11223477889999999888889999999999999999999999864321
Q ss_pred CchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 274 HTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
........ ....+. ..........+.+++.+||+.+|.+|||+.++++|
T Consensus 222 ---~~~~~~~~----~~~~~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 222 ---LRALFLIT----TKGIPP--------LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred ---HHHHHHHH----hcCCCC--------CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11111111 011100 00111233458999999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=271.04 Aligned_cols=243 Identities=26% Similarity=0.413 Sum_probs=190.9
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
++|++.+.||+|+||.||.+.. ++..+|+|.+..... ...+.+|+.+++.++|||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~----~~~~~~iK~~~~~~~---------------------~~~~~~e~~~l~~~~~~~ 60 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY----TGQKVAVKNIKCDVT---------------------AQAFLEETAVMTKLHHKN 60 (254)
T ss_pred HHceeeeeeccCCCCceEeccc----CCCceEEEeecCcch---------------------HHHHHHHHHHHHhCCCCC
Confidence 5699999999999999997654 788899998854321 045778999999999999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
++++++.+..+ ..++++||+++++|.+++.. .....+++..++.++.|++.|+.++ |+.|++|+||+|+||+++
T Consensus 61 i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~qi~~al~~l---H~~~~~H~dl~p~nili~ 134 (254)
T cd05083 61 LVRLLGVILHN-GLYIVMELMSKGNLVNFLRT--RGRALVSVIQLLQFSLDVAEGMEYL---ESKKLVHRDLAARNILVS 134 (254)
T ss_pred cCeEEEEEcCC-CcEEEEECCCCCCHHHHHHh--cCcCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccccCcceEEEc
Confidence 99999988654 57999999999999999865 2334578889999999999999999 778999999999999999
Q ss_pred CCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCchhhh
Q 040898 201 DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHTEEMD 279 (337)
Q Consensus 201 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~~~ 279 (337)
.++.++|+|||.+....... .....+..|+|||.+.+..++.++|+||||+++|+|++ |..||..... ..
T Consensus 135 ~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~----~~ 205 (254)
T cd05083 135 EDGVAKVSDFGLARVGSMGV-----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL----KE 205 (254)
T ss_pred CCCcEEECCCccceeccccC-----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH----HH
Confidence 99999999999887543221 12234567999999988889999999999999999998 9999865322 11
Q ss_pred HHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 280 MVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
....... .... ......+..+.+++.+||+.+|++|||+.++++
T Consensus 206 ~~~~~~~---~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 206 VKECVEK---GYRM----------EPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHHHHhC---CCCC----------CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1111111 1000 001122345889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=271.18 Aligned_cols=263 Identities=22% Similarity=0.388 Sum_probs=200.3
Q ss_pred cccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHh-cCCCC
Q 040898 42 CFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQ-TRHRN 120 (337)
Q Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~-l~hpn 120 (337)
+|++.+.||+|+||.||++.+.. .+++.+|+|.+........... .........+..|+.++.. ++|||
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~-~~~~~~avk~~~~~~~~~~~~~---------~~~~~~~~~~~~e~~~l~~~~~h~~ 70 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKN-NGQNLLALKEINVHNPAFGKDK---------RERDKSIGDIVSEVTIIKEQLRHPN 70 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcC-CCCceeeeeEeecccccccccc---------ccchHHHHHHHHHHHHHhhcCCCCC
Confidence 48899999999999999998753 2578899998865432211000 0001112456678887765 79999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCC-CCCeEecCCCCCceee
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCH-RPRLIHRDIKPANVLI 199 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h-~~gi~h~di~~~nil~ 199 (337)
|+++++++..++..++++||+++++|.+++.........+++..++.++.|++.++.+| | ..|++|+||+|+||++
T Consensus 71 i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---h~~~~i~H~dl~~~nil~ 147 (269)
T cd08528 71 IVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYL---HKEKRIVHRDLTPNNIML 147 (269)
T ss_pred eeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHh---ccCCceeecCCCHHHEEE
Confidence 99999999999999999999999999999876555566789999999999999999999 6 3689999999999999
Q ss_pred cCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhh
Q 040898 200 DDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMD 279 (337)
Q Consensus 200 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~ 279 (337)
+.++.++|+|||.+....... ......++..|++||.+.+..++.++|+||||+++|+|++|..||..... ..
T Consensus 148 ~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~----~~ 220 (269)
T cd08528 148 GEDDKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM----LS 220 (269)
T ss_pred CCCCcEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH----HH
Confidence 999999999999987654432 22334688899999999888889999999999999999999999854211 11
Q ss_pred HHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 280 MVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
.............. .......+.+++.+||+.||++|||+.|+..
T Consensus 221 ~~~~~~~~~~~~~~------------~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~ 265 (269)
T cd08528 221 LATKIVEAVYEPLP------------EGMYSEDVTDVITSCLTPDAEARPDIIQVSA 265 (269)
T ss_pred HHHHHhhccCCcCC------------cccCCHHHHHHHHHHCCCCCccCCCHHHHHH
Confidence 11111111000000 0112344889999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=267.58 Aligned_cols=251 Identities=26% Similarity=0.404 Sum_probs=202.3
Q ss_pred cccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCc
Q 040898 42 CFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNI 121 (337)
Q Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpni 121 (337)
+|++.+.||+|++|.||++.+.. +++.|++|.+........ ..+.+.+|+.++.+++|||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~-----------------~~~~~~~e~~~l~~l~~~~i 61 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLE--TGDFVAIKQISLEKIKEE-----------------ALKSIMQEIDLLKNLKHPNI 61 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcC--CCcEEEEEEecccccCHH-----------------HHHHHHHHHHHHHhCCCCCc
Confidence 58899999999999999998865 788999999876543211 11578889999999999999
Q ss_pred ccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecC
Q 040898 122 LPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDD 201 (337)
Q Consensus 122 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~ 201 (337)
+++++++.+++..++++|++++++|.+++.. ...+++..++.++.|++.++.+| |+.|++|+||+|+||+++.
T Consensus 62 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~ni~i~~ 134 (254)
T cd06627 62 VKYIGSIETSDSLYIILEYAENGSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYL---HEQGVIHRDIKAANILTTK 134 (254)
T ss_pred cEEEEEEEeCCEEEEEEecCCCCcHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHH---hhCCcccCCCCHHHEEECC
Confidence 9999999999999999999999999999843 35689999999999999999999 7789999999999999999
Q ss_pred CCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHH
Q 040898 202 DMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMV 281 (337)
Q Consensus 202 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~ 281 (337)
++.++|+|||.+......... .....++..|+|||...+..++.++|+|++|+++|+|++|..||..... .....
T Consensus 135 ~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~---~~~~~ 209 (254)
T cd06627 135 DGVVKLADFGVATKLNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP---MAALF 209 (254)
T ss_pred CCCEEEeccccceecCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH---HHHHH
Confidence 999999999998876544322 1234578889999999888788999999999999999999999864321 11111
Q ss_pred HHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 282 KWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.. .....+ ..+......+.+++.+||+.+|++|||+.++++|
T Consensus 210 ~~----~~~~~~----------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 210 RI----VQDDHP----------PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred HH----hccCCC----------CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 11 111110 0111223458899999999999999999999976
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=272.62 Aligned_cols=247 Identities=24% Similarity=0.306 Sum_probs=186.8
Q ss_pred ceeccCcceEEEEeEEecCCCCc--eEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc-CCCCccc
Q 040898 47 KKIGSGGWGEVFYKAELPGSNGK--MIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT-RHRNILP 123 (337)
Q Consensus 47 ~~lg~G~~g~V~~~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~ 123 (337)
+.||+|+||.||++.+.. ++. .+++|.+......... ..+.+|+.++..+ .||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~--~~~~~~~~~k~~~~~~~~~~~------------------~~~~~E~~~l~~l~~h~~iv~ 60 (270)
T cd05047 1 DVIGEGNFGQVLKARIKK--DGLRMDAAIKRMKEYASKDDH------------------RDFAGELEVLCKLGHHPNIIN 60 (270)
T ss_pred CcCCCCCCceEEEEEEcC--CCCeeEEEEEEccccCCHHHH------------------HHHHHHHHHHHhhccCCCeee
Confidence 468999999999998865 443 5688877543221111 4677899999999 8999999
Q ss_pred ceeEEEcCCeeEEEEEeccCCCHHHHHHHhcC------------CcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 040898 124 LLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQ------------GRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRD 191 (337)
Q Consensus 124 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~d 191 (337)
+++++...+..+++|||+++++|.+++..... ....+++..+..++.|++.|+.|| |+.|++|+|
T Consensus 61 ~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~l---H~~~i~H~d 137 (270)
T cd05047 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRD 137 (270)
T ss_pred EEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHH---HHCCEeecc
Confidence 99999999999999999999999999864321 123478889999999999999999 677999999
Q ss_pred CCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCC
Q 040898 192 IKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDD 270 (337)
Q Consensus 192 i~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~ 270 (337)
|+|+||+++.++.++|+|||++....... .......+..|+|||.+....++.++|+||||+++|+|++ |..||..
T Consensus 138 ikp~nili~~~~~~kl~dfgl~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~ 214 (270)
T cd05047 138 LAARNILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 214 (270)
T ss_pred cccceEEEcCCCeEEECCCCCccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccc
Confidence 99999999999999999999875322111 1111223567999999988889999999999999999997 9999854
Q ss_pred CCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 271 FFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
... .... .......... ........+.+++.+||+.||.+|||+.+++.
T Consensus 215 ~~~----~~~~---~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 215 MTC----AELY---EKLPQGYRLE----------KPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred cCH----HHHH---HHHhCCCCCC----------CCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 321 1111 1111110000 01112335889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=273.73 Aligned_cols=252 Identities=25% Similarity=0.358 Sum_probs=191.7
Q ss_pred ceeccCcceEEEEeEEec----CCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCcc
Q 040898 47 KKIGSGGWGEVFYKAELP----GSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNIL 122 (337)
Q Consensus 47 ~~lg~G~~g~V~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv 122 (337)
+.||+|++|.||++.+.. ...+..+++|.+........ ...+.+|+.+++.++||||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~------------------~~~~~~e~~~l~~l~h~~i~ 62 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE------------------KKEFLKEAHLMSNFNHPNIV 62 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhh------------------HHHHHHHHHHHHhcCCCCee
Confidence 468999999999987753 12336789998754322111 14677899999999999999
Q ss_pred cceeEEEcCCeeEEEEEeccCCCHHHHHHHhcC---CcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceee
Q 040898 123 PLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQ---GRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI 199 (337)
Q Consensus 123 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~ 199 (337)
++++++..+...++++||+++++|.+++..... ....+++..+..++.|++.++.|+ |+.+++|+||+|+||++
T Consensus 63 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~i~H~dl~p~nil~ 139 (269)
T cd05044 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL---EQMHFIHRDLAARNCLV 139 (269)
T ss_pred eEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHH---HhCCcccCCCChheEEE
Confidence 999999999999999999999999999965332 224478889999999999999999 67799999999999999
Q ss_pred cCCC-----CeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCC
Q 040898 200 DDDM-----EARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFG 273 (337)
Q Consensus 200 ~~~~-----~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~ 273 (337)
+.++ .++|+|||++................++..|+|||.+.+..++.++|+||||+++|+|++ |..||.....
T Consensus 140 ~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~ 219 (269)
T cd05044 140 SEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN 219 (269)
T ss_pred ecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH
Confidence 9877 899999999876543222112222345678999999988889999999999999999998 9999864321
Q ss_pred CchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 274 HTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
.+....+.. .... ......+..+.+++.+||+.+|.+|||+.++++
T Consensus 220 ----~~~~~~~~~---~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 220 ----QEVLQHVTA---GGRL----------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred ----HHHHHHHhc---CCcc----------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 111111111 0000 011223455889999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=284.72 Aligned_cols=253 Identities=23% Similarity=0.334 Sum_probs=209.3
Q ss_pred cccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC
Q 040898 38 KKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR 117 (337)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 117 (337)
...+.|.+.+.||.|-|+.|.++.+.. ++..||+|.+.+........ ..+.+|+++|+.++
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~--t~~~VaiK~idkt~ln~~~~-----------------~k~~rev~imk~l~ 113 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHIL--TGTEVAIKIIDKTQLNPSKR-----------------QKLGREVDIMKSLN 113 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecC--CCceEEEEEehhcccChHHH-----------------HHHHHHHHHHHhcC
Confidence 378889999999999999999999987 89999999887765433321 45889999999999
Q ss_pred CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCce
Q 040898 118 HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANV 197 (337)
Q Consensus 118 hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ni 197 (337)
||||++++.+......+|+||||+.+|.+.+++ .+.+...+..+...+.|++.|++|+ |+++++|+|||++|+
T Consensus 114 HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl----~~~gr~~e~~ar~~F~q~vsaveYc---H~k~ivHrdLk~eNi 186 (596)
T KOG0586|consen 114 HPNIVKLFSVIETEATLYLVMEYASGGELFDYL----VKHGRMKEKEARAKFRQIVSAVEYC---HSKNIVHRDLKAENI 186 (596)
T ss_pred CcceeeeeeeeeecceeEEEEEeccCchhHHHH----HhcccchhhhhhhhhHHHHHHHHHH---hhcceeccccchhhc
Confidence 999999999999999999999999999999999 4455566688999999999999999 889999999999999
Q ss_pred eecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCC-CCcccchhhhHHHHHHHhCCCCCCCCCCCch
Q 040898 198 LIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETI-SDKCDIYSFGVLLAVLVMGKFPVDDFFGHTE 276 (337)
Q Consensus 198 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~ 276 (337)
+++.+-+++|+|||++..+..... ....+|++.|.|||++.+..| ++++|+||+|+++|-|+.|..||++..-
T Consensus 187 lL~~~mnikIaDfgfS~~~~~~~~---lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l--- 260 (596)
T KOG0586|consen 187 LLDENMNIKIADFGFSTFFDYGLM---LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL--- 260 (596)
T ss_pred ccccccceeeeccccceeeccccc---ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc---
Confidence 999999999999999998875433 345789999999999998876 5789999999999999999999975321
Q ss_pred hhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 277 EMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.....+....... .+-....++.++++++|..+|.+|++..++.+|
T Consensus 261 ----k~Lr~rvl~gk~r-----------Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 261 ----KELRPRVLRGKYR-----------IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred ----ccccchheeeeec-----------ccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 1111111111110 111223348899999999999999999998764
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=274.08 Aligned_cols=246 Identities=25% Similarity=0.311 Sum_probs=187.1
Q ss_pred eeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHH---HHHHHhcCCCCcccc
Q 040898 48 KIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSE---IITANQTRHRNILPL 124 (337)
Q Consensus 48 ~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e---~~~l~~l~hpniv~~ 124 (337)
.||+|+||.||++.+.. +++.+|+|.+........... ..+.+| ..++....|||++.+
T Consensus 1 ~lg~G~~g~Vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~i~~~ 62 (279)
T cd05633 1 IIGRGGFGEVYGCRKAD--TGKMYAMKCLDKKRIKMKQGE----------------TLALNERIMLSLVSTGDCPFIVCM 62 (279)
T ss_pred CcccCCCeEEEEEEECC--CCcEEEEEEEEccccccchHH----------------HHHHHHHHHHHHHhhCCCCcEeEE
Confidence 48999999999998875 899999998865533211110 112223 234445589999999
Q ss_pred eeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCC
Q 040898 125 LAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDME 204 (337)
Q Consensus 125 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~ 204 (337)
++.+..++..++||||+++++|.+++. ....+++..+..++.|++.||.|| |+.|++|+||+|+||+++.++.
T Consensus 63 ~~~~~~~~~~~lv~e~~~~~~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~l---H~~~ivH~dikp~Nil~~~~~~ 135 (279)
T cd05633 63 TYAFHTPDKLCFILDLMNGGDLHYHLS----QHGVFSEKEMRFYATEIILGLEHM---HNRFVVYRDLKPANILLDEHGH 135 (279)
T ss_pred EEEEecCCeEEEEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHH---HHCCcCCCCCCHHHEEECCCCC
Confidence 999999999999999999999999884 345689999999999999999999 6779999999999999999999
Q ss_pred eEEecccCccccCCCCceeeeecccCCCCccCccccc-cCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHHHH
Q 040898 205 ARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQ-TETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKW 283 (337)
Q Consensus 205 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~-~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~ 283 (337)
++|+|||++........ ....+++.|+|||.+. +..++.++|+||+|+++|+|++|..||........ ...
T Consensus 136 ~~l~dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~--- 207 (279)
T cd05633 136 VRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEI--- 207 (279)
T ss_pred EEEccCCcceeccccCc----cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-HHH---
Confidence 99999999865433221 2246899999999986 45678899999999999999999999975432211 111
Q ss_pred HHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCC-----ChhhhhcC
Q 040898 284 MRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERP-----SSKDVRSM 337 (337)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 337 (337)
........ ...++.....+.+++.+||+.||.+|| |+.++++|
T Consensus 208 -~~~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 208 -DRMTLTVN----------VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred -HHHhhcCC----------cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 11110000 011122344589999999999999999 69999987
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=269.31 Aligned_cols=244 Identities=21% Similarity=0.315 Sum_probs=188.7
Q ss_pred cccccccee--ccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHh-cC
Q 040898 41 DCFDSLKKI--GSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQ-TR 117 (337)
Q Consensus 41 ~~y~~~~~l--g~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~-l~ 117 (337)
++|++.+.+ |+|+||.||++.+.. ++..+++|.+........ |...... .+
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~--~~~~~~~k~~~~~~~~~~------------------------e~~~~~~~~~ 67 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKP--TQKLFVQKIIKAKNFNAI------------------------EPMVHQLMKD 67 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcC--CCcEEEEEEEehhhcchh------------------------hHHHHHHhhc
Confidence 356777776 999999999998876 899999999864321110 1111111 27
Q ss_pred CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCce
Q 040898 118 HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANV 197 (337)
Q Consensus 118 hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ni 197 (337)
|||++++++.+..++..++||||+++++|.+++.. ...+++..+..++.|++.|+.+| |+.|++|+||+|+||
T Consensus 68 h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~ni 140 (267)
T PHA03390 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDL---HKHNIIHNDIKLENV 140 (267)
T ss_pred CCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCCHHHE
Confidence 99999999999999999999999999999999843 33789999999999999999999 778999999999999
Q ss_pred eecCCC-CeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCch
Q 040898 198 LIDDDM-EARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTE 276 (337)
Q Consensus 198 l~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~ 276 (337)
+++.++ .++|+|||.+....... ...++..|+|||.+.+..++.++|+||+|+++|+|++|..||.......
T Consensus 141 l~~~~~~~~~l~dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~- 213 (267)
T PHA03390 141 LYDRAKDRIYLCDYGLCKIIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE- 213 (267)
T ss_pred EEeCCCCeEEEecCccceecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-
Confidence 999988 99999999887654321 2357889999999998889999999999999999999999997432221
Q ss_pred hhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCC-hhhhhcC
Q 040898 277 EMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPS-SKDVRSM 337 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-~~ell~~ 337 (337)
.....+..... ... ......+..+.+++.+||+.||.+||+ ++++|+|
T Consensus 214 -~~~~~~~~~~~-~~~-----------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 214 -LDLESLLKRQQ-KKL-----------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred -hhHHHHHHhhc-ccC-----------CcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 11111111110 000 111134445899999999999999996 6999987
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=273.82 Aligned_cols=250 Identities=22% Similarity=0.361 Sum_probs=195.6
Q ss_pred cccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCc
Q 040898 42 CFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNI 121 (337)
Q Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpni 121 (337)
.|+....||+|++|.||++.... ++..||+|++....... ...+.+|+.+++.++|||+
T Consensus 21 ~~~~~~~lg~g~~g~v~~~~~~~--~~~~v~iK~~~~~~~~~-------------------~~~~~~e~~~l~~l~h~~i 79 (292)
T cd06657 21 YLDNFIKIGEGSTGIVCIATVKS--SGKLVAVKKMDLRKQQR-------------------RELLFNEVVIMRDYQHENV 79 (292)
T ss_pred HhhhHHHcCCCCCeEEEEEEEcC--CCeEEEEEEecccchhH-------------------HHHHHHHHHHHHhcCCcch
Confidence 35556789999999999988865 89999999875332211 1467789999999999999
Q ss_pred ccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecC
Q 040898 122 LPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDD 201 (337)
Q Consensus 122 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~ 201 (337)
+++++.+..++..++++||+++++|.+++. ...+++..+..++.|++.+++++ |+.|++|+||+|+||+++.
T Consensus 80 v~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~ql~~~l~~l---H~~givH~dl~p~Nilv~~ 151 (292)
T cd06657 80 VEMYNSYLVGDELWVVMEFLEGGALTDIVT-----HTRMNEEQIAAVCLAVLKALSVL---HAQGVIHRDIKSDSILLTH 151 (292)
T ss_pred hheeeEEEeCCEEEEEEecCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECC
Confidence 999999999999999999999999998773 23578899999999999999999 6779999999999999999
Q ss_pred CCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHH
Q 040898 202 DMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMV 281 (337)
Q Consensus 202 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~ 281 (337)
++.++|+|||.+........ ......+++.|+|||.+.+..++.++|+||+|+++|+|++|..||..... ....
T Consensus 152 ~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~----~~~~ 225 (292)
T cd06657 152 DGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP----LKAM 225 (292)
T ss_pred CCCEEEcccccceecccccc--cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHH
Confidence 99999999998765543221 11234578899999999888889999999999999999999999864211 1111
Q ss_pred HHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 282 KWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
............ ........+.+++.+||+.||.+|||+.++++|
T Consensus 226 ~~~~~~~~~~~~-----------~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 226 KMIRDNLPPKLK-----------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred HHHHhhCCcccC-----------CcccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 111111110000 011123347889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=278.57 Aligned_cols=272 Identities=22% Similarity=0.307 Sum_probs=195.5
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++.++||+|++|.||++.+.. +++.+++|++.......... ..+.+|+.+++.++|
T Consensus 6 ~~~~y~~~~~lg~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~-----------------~~~~~e~~~l~~l~h 66 (311)
T cd07866 6 KLRDYEILGKLGEGTFGEVYKARQIK--TGRVVALKKILMHNEKDGFP-----------------ITALREIKILKKLKH 66 (311)
T ss_pred ccccEEEEEEeccCCCEEEEEEEECC--CCcEEEEEEEEeccCCCCcc-----------------hhHHHHHHHHHhcCC
Confidence 46789999999999999999999876 89999999986543322110 345679999999999
Q ss_pred CCcccceeEEEcC--------CeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 040898 119 RNILPLLAHMVRP--------NCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHR 190 (337)
Q Consensus 119 pniv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~ 190 (337)
|||+++++.+... ...++++||+.+ +|...+.. ....+++..+..++.|+++||.|| |+.|++|+
T Consensus 67 ~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~l---H~~~i~H~ 139 (311)
T cd07866 67 PNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLEN---PSVKLTESQIKCYMLQLLEGINYL---HENHILHR 139 (311)
T ss_pred CCccchhhheecccccccccCceEEEEEecCCc-CHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHH---HhCCeecC
Confidence 9999999887443 346999999976 67666532 345689999999999999999999 77899999
Q ss_pred CCCCCceeecCCCCeEEecccCccccCCCCceee---------eecccCCCCccCccccccC-CCCCcccchhhhHHHHH
Q 040898 191 DIKPANVLIDDDMEARISDFGHGKLMPDGHAQIT---------VKCMVGTMGYMAPESLQTE-TISDKCDIYSFGVLLAV 260 (337)
Q Consensus 191 di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~---------~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~i~~~ 260 (337)
||+|+||+++.++.++|+|||++........... .....+++.|+|||.+.+. .++.++|+||+|+++|+
T Consensus 140 dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e 219 (311)
T cd07866 140 DIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAE 219 (311)
T ss_pred CCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHH
Confidence 9999999999999999999999876543221111 1123467889999987654 47889999999999999
Q ss_pred HHhCCCCCCCCCCCchhhhHHHHHHhhhccCCc-------------chhhhhcccCCchHHHHHHHHHHHhhhccCCCCC
Q 040898 261 LVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENP-------------NRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDE 327 (337)
Q Consensus 261 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~ 327 (337)
|++|.+||........................+ .......+ ..........+.+++.+||+.||.+
T Consensus 220 l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~ 298 (311)
T cd07866 220 MFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTL-EERFGKLGPEGLDLLSKLLSLDPYK 298 (311)
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccH-HHHcccCChhHHHHHHHHcccCccc
Confidence 999999986532221111111111000000000 00000000 0011122256889999999999999
Q ss_pred CCChhhhhcC
Q 040898 328 RPSSKDVRSM 337 (337)
Q Consensus 328 Rps~~ell~~ 337 (337)
|||+.+++.|
T Consensus 299 R~t~~ell~~ 308 (311)
T cd07866 299 RLTASDALEH 308 (311)
T ss_pred CcCHHHHhcC
Confidence 9999999986
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=302.95 Aligned_cols=255 Identities=25% Similarity=0.440 Sum_probs=192.5
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
.+|+.++.||+||||.||+++++- +|+.||||++..+.+... ...+.+|++.+.+|+|||
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKl--DGr~YAIKKIpl~~s~~~------------------~skI~rEVk~LArLnHpN 538 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKL--DGREYAIKKIPLKASDKL------------------YSKILREVKLLARLNHPN 538 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecc--cchhhhhhhccCchHHHH------------------HHHHHHHHHHHhhcCCcc
Confidence 458999999999999999999976 999999999987752211 157889999999999999
Q ss_pred cccceeEEEc----------------------------------------------------------------------
Q 040898 121 ILPLLAHMVR---------------------------------------------------------------------- 130 (337)
Q Consensus 121 iv~~~~~~~~---------------------------------------------------------------------- 130 (337)
||+++..|.+
T Consensus 539 VVRYysAWVEs~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~ 618 (1351)
T KOG1035|consen 539 VVRYYSAWVESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDE 618 (1351)
T ss_pred eeeeehhhhccCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCc
Confidence 9999986630
Q ss_pred -----------------------------------------C--------CeeEEEEEeccCCCHHHHHHHhcCCcccCC
Q 040898 131 -----------------------------------------P--------NCHLLVYEFMKNGSLQDILYDVSQGRRELD 161 (337)
Q Consensus 131 -----------------------------------------~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 161 (337)
. ..+||-||||+..+|.+++.. +...-.
T Consensus 619 e~~d~dedg~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~---N~~~~~ 695 (1351)
T KOG1035|consen 619 ENDDSDEDGRNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRR---NHFNSQ 695 (1351)
T ss_pred ccccccccccccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHh---cccchh
Confidence 0 235889999999778777743 111114
Q ss_pred hHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCCeEEecccCccccC----------------CCCceeee
Q 040898 162 WPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMP----------------DGHAQITV 225 (337)
Q Consensus 162 ~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~----------------~~~~~~~~ 225 (337)
....|.++++|++||.|+ |++|++||||||.|||++.++.|||+|||+++... .+......
T Consensus 696 ~d~~wrLFreIlEGLaYI---H~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~ 772 (1351)
T KOG1035|consen 696 RDEAWRLFREILEGLAYI---HDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDL 772 (1351)
T ss_pred hHHHHHHHHHHHHHHHHH---HhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCccc
Confidence 678999999999999999 88899999999999999999999999999998721 01111233
Q ss_pred ecccCCCCccCccccccCC---CCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhccc
Q 040898 226 KCMVGTMGYMAPESLQTET---ISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLL 302 (337)
Q Consensus 226 ~~~~~~~~~~~PE~~~~~~---~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (337)
+..+||.-|+|||++.+.. |+.++|+||||++++||+ +||+. ..+-...+........+.. +.+
T Consensus 773 Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~---yPF~T------sMERa~iL~~LR~g~iP~~---~~f- 839 (1351)
T KOG1035|consen 773 TSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEML---YPFGT------SMERASILTNLRKGSIPEP---ADF- 839 (1351)
T ss_pred ccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHh---ccCCc------hHHHHHHHHhcccCCCCCC---ccc-
Confidence 4578999999999997554 999999999999999998 45643 2222333333322222222 111
Q ss_pred CCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 303 GNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 303 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
+.+....-.++|.+|++.||++||||.|+|+.
T Consensus 840 ---~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 840 ---FDPEHPEEASLIRWLLSHDPSKRPTATELLNS 871 (1351)
T ss_pred ---ccccchHHHHHHHHHhcCCCccCCCHHHHhhc
Confidence 11122225778999999999999999999963
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=272.93 Aligned_cols=263 Identities=24% Similarity=0.335 Sum_probs=199.9
Q ss_pred ccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCcc
Q 040898 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNIL 122 (337)
Q Consensus 43 y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv 122 (337)
|++.+.||+|++|.||++.+.. +++.+++|.+......... ...+.+|+.+++.++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~-----------------~~~~~~e~~~l~~l~~~~i~ 61 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKL--TGEIVAIKKIKLRFESEGI-----------------PKTALREIKLLKELNHPNII 61 (283)
T ss_pred CccceeeecCCCceEEEEEcCC--CCcEEEEEEeccccccchh-----------------HHHHHHHHHHHHHhcCCCcc
Confidence 6788999999999999988865 8999999988655432111 14677799999999999999
Q ss_pred cceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCC
Q 040898 123 PLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDD 202 (337)
Q Consensus 123 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~ 202 (337)
++++++..+...++++||+++ +|.+++.. ....+++..+..++.|++.++.+| |+.|++|+||+|+||+++.+
T Consensus 62 ~~~~~~~~~~~~~~v~e~~~~-~l~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~L---H~~~i~H~dl~p~nili~~~ 134 (283)
T cd05118 62 KLLDVFRHKGDLYLVFEFMDT-DLYKLIKD---RQRGLPESLIKSYLYQLLQGLAFC---HSHGILHRDLKPENLLINTE 134 (283)
T ss_pred hHHHhhccCCCEEEEEeccCC-CHHHHHHh---hcccCCHHHHHHHHHHHHHHHHHH---HHCCeeecCcCHHHEEECCC
Confidence 999999999999999999976 88887754 235689999999999999999999 67799999999999999999
Q ss_pred CCeEEecccCccccCCCCceeeeecccCCCCccCccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHH
Q 040898 203 MEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTE-TISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMV 281 (337)
Q Consensus 203 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~ 281 (337)
+.++|+|||.+....... .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||....... ...
T Consensus 135 ~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~ 209 (283)
T cd05118 135 GVLKLADFGLARSFGSPV--RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID---QLF 209 (283)
T ss_pred CcEEEeeeeeeEecCCCc--ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH---HHH
Confidence 999999999887664432 112234577889999998766 68899999999999999999999986532211 111
Q ss_pred HHHHhhhccCCcc----------------hhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 282 KWMRNVIFSENPN----------------RAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 282 ~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
..... .....+. ............+..+..+.+++.+||+.||.+||++.+++.|
T Consensus 210 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 210 KIFRT-LGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred HHHHH-cCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 11111 0000000 0000000011223456679999999999999999999999986
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=264.80 Aligned_cols=283 Identities=22% Similarity=0.305 Sum_probs=212.2
Q ss_pred ccccccccccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHH
Q 040898 29 VEKQDLAFLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRS 108 (337)
Q Consensus 29 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 108 (337)
.++-+..|++..++|+...+||+|.||.||+++..+ +|+.||+|++..++....- .....+
T Consensus 5 ~~s~~~P~~~~~~~yek~~kigqGtfgeVFkAr~~n--~~kkvalkkvlmeneKeGf-----------------pitalr 65 (376)
T KOG0669|consen 5 KDSMYEPFCDEVSKYEKLAKIGQGTFGEVFKARSKN--TGKKVALKKVLMENEKEGF-----------------PITALR 65 (376)
T ss_pred hhcccCCceecchHHHHHHhcCCchHHHHHHHhhcC--ccchhHHHHHHHhccccCC-----------------cHHHHH
Confidence 344478899999999999999999999999999977 9999999988654322110 145678
Q ss_pred HHHHHHhcCCCCcccceeEEEc--------CCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHh
Q 040898 109 EIITANQTRHRNILPLLAHMVR--------PNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLH 180 (337)
Q Consensus 109 e~~~l~~l~hpniv~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~ 180 (337)
|++++..|+|+|++.+++.|.. ...+|+|+++|++ +|..++.+ ....++...+.+++.++..||.|+
T Consensus 66 eikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~i- 140 (376)
T KOG0669|consen 66 EIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEH-DLAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYI- 140 (376)
T ss_pred HHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhh-hHHHHhcC---ccccccHHHHHHHHHHHHHHHHHH-
Confidence 9999999999999999988743 2458999999988 88888843 335688899999999999999999
Q ss_pred hCCCCCeEecCCCCCceeecCCCCeEEecccCccccCCC--CceeeeecccCCCCccCccccccC-CCCCcccchhhhHH
Q 040898 181 MCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDG--HAQITVKCMVGTMGYMAPESLQTE-TISDKCDIYSFGVL 257 (337)
Q Consensus 181 ~~h~~gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~i 257 (337)
|...|+|||+|+.|++++++|.++|+|||+++.+... ......+.++-|..|.+||.+.|. .|+.+.|+|+.||+
T Consensus 141 --Hr~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCi 218 (376)
T KOG0669|consen 141 --HRNKILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCI 218 (376)
T ss_pred --HHhhHHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHH
Confidence 7779999999999999999999999999999766432 223334556679999999999875 58999999999999
Q ss_pred HHHHHhCCCCCCCCCCCchhhhHHHHHHhhhccCCcc----hhhh----hcccCCchHHH---------HHHHHHHHhhh
Q 040898 258 LAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPN----RAIN----SKLLGNGYEEQ---------MLLVLKLACFC 320 (337)
Q Consensus 258 ~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~----~~~~~~~~~~~---------~~~l~~li~~~ 320 (337)
+.+|+|+.+-+.+.........+......+....+++ +.+. +.+........ .+...+|+..+
T Consensus 219 maeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~l 298 (376)
T KOG0669|consen 219 MAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKL 298 (376)
T ss_pred HHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHH
Confidence 9999999988755433222222222222222222211 0000 00111111111 12567999999
Q ss_pred ccCCCCCCCChhhhhcC
Q 040898 321 TLKDPDERPSSKDVRSM 337 (337)
Q Consensus 321 l~~dP~~Rps~~ell~~ 337 (337)
|..||.+||++.+++.|
T Consensus 299 l~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 299 LKLDPTKRIDADQALNH 315 (376)
T ss_pred hccCcccCcchHhhhch
Confidence 99999999999999986
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=268.11 Aligned_cols=241 Identities=20% Similarity=0.277 Sum_probs=182.3
Q ss_pred ceeccCcceEEEEeEEecC----------CCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc
Q 040898 47 KKIGSGGWGEVFYKAELPG----------SNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT 116 (337)
Q Consensus 47 ~~lg~G~~g~V~~~~~~~~----------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 116 (337)
+.||+|+||.||++..... .....+++|.+....... ...+.+|+.++..+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~-------------------~~~~~~~~~~l~~l 61 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDI-------------------SLAFFETASMMRQV 61 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhH-------------------HHHHHHHHHHHHhC
Confidence 4789999999999875321 123457888764322100 14677789999999
Q ss_pred CCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 040898 117 RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPAN 196 (337)
Q Consensus 117 ~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~n 196 (337)
+||||+++++++..+...++++||+++++|..++.. ....+++..++.++.|++.|+.|| |+.|++|+||+|+|
T Consensus 62 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~dlkp~N 135 (262)
T cd05077 62 SHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYL---EDKDLVHGNVCTKN 135 (262)
T ss_pred CCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHh---hhCCeECCCCCccc
Confidence 999999999999999999999999999999988743 335688899999999999999999 78899999999999
Q ss_pred eeecCCCC-------eEEecccCccccCCCCceeeeecccCCCCccCccccc-cCCCCCcccchhhhHHHHHHH-hCCCC
Q 040898 197 VLIDDDME-------ARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQ-TETISDKCDIYSFGVLLAVLV-MGKFP 267 (337)
Q Consensus 197 il~~~~~~-------~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~-~~~~~~~~DiwslG~i~~~ll-~g~~p 267 (337)
|+++.++. ++++|||.+...... ....++..|+|||.+. +..++.++||||||+++|+|+ +|..|
T Consensus 136 ill~~~~~~~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p 209 (262)
T cd05077 136 ILLAREGIDGECGPFIKLSDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIP 209 (262)
T ss_pred EEEecCCccCCCCceeEeCCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCC
Confidence 99986654 899999987654322 1235778899999886 566889999999999999998 58888
Q ss_pred CCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 268 VDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 268 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
|..... ........ .... . .......+.+++.+||+.||++||++.+|+++
T Consensus 210 ~~~~~~----~~~~~~~~----~~~~--~---------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 210 LKDKTL----AEKERFYE----GQCM--L---------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred CCCcch----hHHHHHHh----cCcc--C---------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 754211 11111100 0000 0 00112458899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=274.01 Aligned_cols=252 Identities=26% Similarity=0.425 Sum_probs=196.4
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
....|...+.||+|+||.||++.+.. ++..+|+|.+.......... ...+.+|+.+++.++|
T Consensus 23 ~~~~f~~~~~lg~G~~~~v~~~~~~~--~~~~valK~~~~~~~~~~~~----------------~~~~~~e~~~l~~l~h 84 (317)
T cd06635 23 PEKLFTDLREIGHGSFGAVYFARDVR--TNEVVAIKKMSYSGKQSNEK----------------WQDIIKEVKFLQRIKH 84 (317)
T ss_pred chhhhhhhheeccCCCeEEEEEEEcC--CCcEEEEEEEecCCCCchHH----------------HHHHHHHHHHHHhCCC
Confidence 44559999999999999999998876 88999999886543222111 1467789999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
||++++++++..+...++|+||+++ +|.+.+.. ...++++..+..++.|++.++.+| |+.|++|+||+|+||+
T Consensus 85 ~~iv~~~~~~~~~~~~~lv~e~~~g-~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~l---H~~~i~H~dL~p~Nil 157 (317)
T cd06635 85 PNSIEYKGCYLREHTAWLVMEYCLG-SASDLLEV---HKKPLQEVEIAAITHGALQGLAYL---HSHNMIHRDIKAGNIL 157 (317)
T ss_pred CCEEEEEEEEeeCCeEEEEEeCCCC-CHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCcccEE
Confidence 9999999999999999999999975 77776643 345688999999999999999999 7779999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccc---cCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCc
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQ---TETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHT 275 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~ 275 (337)
++.++.++|+|||++...... ....+++.|+|||.+. ...++.++|+||+|+++|+|++|..||.....
T Consensus 158 ~~~~~~~kl~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-- 229 (317)
T cd06635 158 LTEPGQVKLADFGSASIASPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-- 229 (317)
T ss_pred ECCCCCEEEecCCCccccCCc------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH--
Confidence 999999999999987654322 2245788899999974 45578899999999999999999999854311
Q ss_pred hhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 276 EEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
......... ...+. .........+.+++.+||+.+|.+|||+.++++|
T Consensus 230 -~~~~~~~~~----~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 277 (317)
T cd06635 230 -MSALYHIAQ----NESPT---------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKH 277 (317)
T ss_pred -HHHHHHHHh----ccCCC---------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhC
Confidence 111111111 11100 0011233458999999999999999999999976
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=288.84 Aligned_cols=255 Identities=22% Similarity=0.333 Sum_probs=205.7
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..+-|+|+..||.|+||.||++.... ++-..|.|.+...+. .+++.+.-|+.+|...+|
T Consensus 30 P~d~WeIiGELGDGAFGKVyKA~nke--t~~lAAaKvIetkse-------------------EELEDylVEIeILa~CdH 88 (1187)
T KOG0579|consen 30 PRDHWEIIGELGDGAFGKVYKAVNKE--TKLLAAAKVIETKSE-------------------EELEDYLVEIEILAECDH 88 (1187)
T ss_pred HHHHHHHHhhhcCccchhhhhhhccc--chhhhhhhhhcccch-------------------hHHhhhhhhhhhhhcCCC
Confidence 55669999999999999999988864 777777787744322 223678889999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|+|+++++.|...+.++++.|||.||-+...+-. -+.++++..+..+++|++.||.|| |+++|+|+|||..|||
T Consensus 89 P~ivkLl~ayy~enkLwiliEFC~GGAVDaimlE---L~r~LtE~QIqvvc~q~ldALn~L---Hs~~iIHRDLKAGNiL 162 (1187)
T KOG0579|consen 89 PVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLE---LGRVLTEDQIQVVCYQVLDALNWL---HSQNIIHRDLKAGNIL 162 (1187)
T ss_pred hHHHHHHHHHhccCceEEEEeecCCchHhHHHHH---hccccchHHHHHHHHHHHHHHHHH---hhcchhhhhccccceE
Confidence 9999999999999999999999999999887743 456799999999999999999999 8889999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCcccc-----ccCCCCCcccchhhhHHHHHHHhCCCCCCCCCC
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESL-----QTETISDKCDIYSFGVLLAVLVMGKFPVDDFFG 273 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~-----~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~ 273 (337)
++-+|.++|+|||.+....... .....+.|||.|||||++ +..+|+.++||||||+++.+|..+.+|..+...
T Consensus 163 ~TldGdirLADFGVSAKn~~t~--qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp 240 (1187)
T KOG0579|consen 163 LTLDGDIRLADFGVSAKNKSTR--QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP 240 (1187)
T ss_pred EEecCcEeeecccccccchhHH--hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch
Confidence 9999999999999886543211 122356899999999997 456789999999999999999999999654322
Q ss_pred CchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 274 HTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
...+..+....++.-.. ++.....+.+++..||..||+.||++.++|+|
T Consensus 241 -------MRVllKiaKSePPTLlq--------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 241 -------MRVLLKIAKSEPPTLLQ--------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred -------HHHHHHHhhcCCCcccC--------cchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 22233333343332221 22334458999999999999999999999987
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=279.11 Aligned_cols=271 Identities=21% Similarity=0.311 Sum_probs=195.9
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc-C
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT-R 117 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~ 117 (337)
..++|++.+.||+|+||.||++.+.. ++..+|+|++......... ...+.+|+.+++++ +
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~--~~~~~~vK~~~~~~~~~~~-----------------~~~~~~E~~~l~~l~~ 65 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRR--TKEVVALKKIFDAFRNATD-----------------AQRTFREIMFLQELGD 65 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcC--CCeEEEEEeeccccCcchh-----------------hhhhhHHHHHHHHhcC
Confidence 45679999999999999999998865 7899999988643221111 13566799999999 9
Q ss_pred CCCcccceeEEEcC--CeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCC
Q 040898 118 HRNILPLLAHMVRP--NCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPA 195 (337)
Q Consensus 118 hpniv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ 195 (337)
||||+++++++... ...++|+||+++ +|..++.. + .+++.....++.|++.||.+| |+.|++|+||+|+
T Consensus 66 h~ni~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~----~-~~~~~~~~~i~~qi~~~L~~L---H~~~i~H~dl~p~ 136 (337)
T cd07852 66 HPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVIRA----N-ILEDVHKRYIMYQLLKALKYI---HSGNVIHRDLKPS 136 (337)
T ss_pred CCCccceeeeeccCCCceEEEEeccccc-CHHHHHhc----C-CCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHH
Confidence 99999999987643 468999999975 89888732 2 678888999999999999999 6779999999999
Q ss_pred ceeecCCCCeEEecccCccccCCCCce---eeeecccCCCCccCcccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCC
Q 040898 196 NVLIDDDMEARISDFGHGKLMPDGHAQ---ITVKCMVGTMGYMAPESLQT-ETISDKCDIYSFGVLLAVLVMGKFPVDDF 271 (337)
Q Consensus 196 nil~~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~i~~~ll~g~~pf~~~ 271 (337)
||+++.++.++|+|||.+......... .......++..|+|||.+.+ ..++.++|+||+|+++|+|++|+.||...
T Consensus 137 nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~ 216 (337)
T cd07852 137 NILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGT 216 (337)
T ss_pred HEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999998765433211 12223457889999998754 45788999999999999999999998643
Q ss_pred CCCchhhhHHHHHHhhh-------ccCCcchhh------hhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 272 FGHTEEMDMVKWMRNVI-------FSENPNRAI------NSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 272 ~~~~~~~~~~~~~~~~~-------~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
................. ......... .........+.....+.+++.+||+.||.+|||+.++++|
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 217 STLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred ChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 22111111100000000 000000000 0000001111234568999999999999999999999976
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=267.50 Aligned_cols=249 Identities=24% Similarity=0.356 Sum_probs=184.2
Q ss_pred ceeccCcceEEEEeEEecC-CCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCcccce
Q 040898 47 KKIGSGGWGEVFYKAELPG-SNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLL 125 (337)
Q Consensus 47 ~~lg~G~~g~V~~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~ 125 (337)
+.||+|+||.||++.+... ..+..+|+|.+....... ....+.+|+.+++.++||||++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~------------------~~~~~~~e~~~l~~l~h~~iv~~~ 62 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLE------------------EVEQFLKEGIIMKDFSHPNVLSLL 62 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHH------------------HHHHHHHHHHHHccCCCCCcceEE
Confidence 4689999999999887542 245679999875322111 115677899999999999999999
Q ss_pred eEEE-cCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCC
Q 040898 126 AHMV-RPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDME 204 (337)
Q Consensus 126 ~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~ 204 (337)
+++. .+...++++||+.+++|.+++.. .....++..+..++.|+++|+.|| |+.+++|+||+|+||+++.++.
T Consensus 63 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlk~~nili~~~~~ 136 (262)
T cd05058 63 GICLPSEGSPLVVLPYMKHGDLRNFIRS---ETHNPTVKDLIGFGLQVAKGMEYL---ASKKFVHRDLAARNCMLDESFT 136 (262)
T ss_pred EEeecCCCCcEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH---HhCCccccccCcceEEEcCCCc
Confidence 9765 45568999999999999999854 223456777888999999999999 6779999999999999999999
Q ss_pred eEEecccCccccCCCCcee--eeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhC-CCCCCCCCCCchhhhHH
Q 040898 205 ARISDFGHGKLMPDGHAQI--TVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMG-KFPVDDFFGHTEEMDMV 281 (337)
Q Consensus 205 ~~l~dfg~~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g-~~pf~~~~~~~~~~~~~ 281 (337)
++|+|||++.......... ......++..|+|||.+.+..++.++|+||||+++|+|++| .+||.... .....
T Consensus 137 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~----~~~~~ 212 (262)
T cd05058 137 VKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD----SFDIT 212 (262)
T ss_pred EEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC----HHHHH
Confidence 9999999987543321111 11123356789999999888899999999999999999995 56664321 11111
Q ss_pred HHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 282 KWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
... ....... .....+..+.+++.+||+.+|++|||+.++++
T Consensus 213 ~~~---~~~~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 213 VYL---LQGRRLL----------QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVS 254 (262)
T ss_pred HHH---hcCCCCC----------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 111 1111000 00112235889999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=280.42 Aligned_cols=265 Identities=25% Similarity=0.336 Sum_probs=200.3
Q ss_pred cccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCc
Q 040898 42 CFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNI 121 (337)
Q Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpni 121 (337)
+|++.+.||+|++|.||++.+.. ++..+++|++......... ...+.+|+.+++.++||||
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~--~~~~~~iK~~~~~~~~~~~-----------------~~~~~~e~~~l~~l~~~~i 61 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKR--TGRKVAIKKISNVFDDLID-----------------AKRILREIKLLRHLRHENI 61 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCC--CCcEEEEEeeccccccchh-----------------hhhHHHHHHHHHhcCCcch
Confidence 58999999999999999998865 7999999998654321110 1567889999999999999
Q ss_pred ccceeEEEcCC-----eeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 040898 122 LPLLAHMVRPN-----CHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPAN 196 (337)
Q Consensus 122 v~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~n 196 (337)
+++.+++.... ..|+++||+++ +|.+++. ....+++..++.++.+++.||.+| |+.|++|+||+|+|
T Consensus 62 ~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~----~~~~l~~~~~~~i~~~l~~~l~~L---H~~gi~H~dlkp~n 133 (330)
T cd07834 62 IGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIK----SPQPLTDDHIQYFLYQILRGLKYL---HSANVIHRDLKPSN 133 (330)
T ss_pred hhhhhhhcccCcccccceEEEecchhh-hHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHH
Confidence 99999987765 78999999975 7888873 444789999999999999999999 77899999999999
Q ss_pred eeecCCCCeEEecccCccccCCCCce-eeeecccCCCCccCccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCCC
Q 040898 197 VLIDDDMEARISDFGHGKLMPDGHAQ-ITVKCMVGTMGYMAPESLQTE-TISDKCDIYSFGVLLAVLVMGKFPVDDFFGH 274 (337)
Q Consensus 197 il~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~ 274 (337)
|+++.++.++|+|||.+......... .......+++.|+|||.+.+. .++.++|+||+|+++|+|++|.+||.....
T Consensus 134 ili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~- 212 (330)
T cd07834 134 ILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDY- 212 (330)
T ss_pred EEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCH-
Confidence 99999999999999998876543210 112234578889999999877 788999999999999999999999865432
Q ss_pred chhhhHHHHHHhhhccCCcchh-----------hh------hcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 275 TEEMDMVKWMRNVIFSENPNRA-----------IN------SKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~-----------~~------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.+....+........+... .. ........+.....+.+++.+||+.+|.+|||++++++|
T Consensus 213 ---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 213 ---IDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred ---HHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1111111111111000000 00 000001112234568999999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=275.08 Aligned_cols=268 Identities=24% Similarity=0.344 Sum_probs=196.9
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++.+.||.|++|.||++.+.. +++.|++|.+......... ...+.+|+.+++.++|
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~--~~~~v~iK~~~~~~~~~~~-----------------~~~~~~e~~~~~~l~h 65 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKD--TGELVALKKVRLDNEKEGF-----------------PITAIREIKILRQLNH 65 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECC--CCcEEEEEEEeecccccCc-----------------hHHHHHHHHHHHhCCC
Confidence 45679999999999999999999876 8899999998654321110 0356679999999999
Q ss_pred CCcccceeEEEcCC----------eeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeE
Q 040898 119 RNILPLLAHMVRPN----------CHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLI 188 (337)
Q Consensus 119 pniv~~~~~~~~~~----------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~ 188 (337)
||++++++++.+.. ..++++||+++ ++...+.. ....+++..+..++.|++.||.|| |+.|++
T Consensus 66 ~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~L---H~~~i~ 138 (302)
T cd07864 66 RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYC---HKKNFL 138 (302)
T ss_pred CCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHH---HhCCee
Confidence 99999999887654 78999999986 77776643 244689999999999999999999 777999
Q ss_pred ecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCcccccc-CCCCCcccchhhhHHHHHHHhCCCC
Q 040898 189 HRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQT-ETISDKCDIYSFGVLLAVLVMGKFP 267 (337)
Q Consensus 189 h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~i~~~ll~g~~p 267 (337)
|+||+|+||++++++.++|+|||.+......... ......++..|+|||.+.+ ..++.++|+||+|+++++|++|++|
T Consensus 139 H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~ 217 (302)
T cd07864 139 HRDIKCSNILLNNKGQIKLADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPI 217 (302)
T ss_pred cCCCCHHHEEECCCCcEEeCcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999998765443221 1122345778999998864 3468899999999999999999999
Q ss_pred CCCCCCCchhhhHHHHHHhhhccCCcchh--h---------hh-----cccCCchHHHHHHHHHHHhhhccCCCCCCCCh
Q 040898 268 VDDFFGHTEEMDMVKWMRNVIFSENPNRA--I---------NS-----KLLGNGYEEQMLLVLKLACFCTLKDPDERPSS 331 (337)
Q Consensus 268 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~---------~~-----~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~ 331 (337)
|...... .....+........+... . +. ..........+..+.+++.+||+.||.+|||+
T Consensus 218 ~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~ 293 (302)
T cd07864 218 FQANQEL----AQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTA 293 (302)
T ss_pred CCCCChH----HHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCH
Confidence 8643221 111111111111110000 0 00 00000111224568999999999999999999
Q ss_pred hhhhcC
Q 040898 332 KDVRSM 337 (337)
Q Consensus 332 ~ell~~ 337 (337)
.++++|
T Consensus 294 ~~il~~ 299 (302)
T cd07864 294 EEALNS 299 (302)
T ss_pred HHHhcC
Confidence 999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=277.34 Aligned_cols=268 Identities=24% Similarity=0.333 Sum_probs=197.0
Q ss_pred ccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc
Q 040898 37 LKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT 116 (337)
Q Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 116 (337)
+..+++|++.+.||.|+||.||++.+.. ++..||+|++......... ...+.+|+.+++.+
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~--~~~~vaiK~~~~~~~~~~~-----------------~~~~~~E~~~l~~l 66 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQL--TGQNVAIKKIMKPFSTPVL-----------------AKRTYRELKLLKHL 66 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECC--CCCEEEEEEecccccccch-----------------hHHHHHHHHHHHhc
Confidence 4578889999999999999999998876 8999999988654321110 14567899999999
Q ss_pred CCCCcccceeEEEc-CCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCC
Q 040898 117 RHRNILPLLAHMVR-PNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPA 195 (337)
Q Consensus 117 ~hpniv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ 195 (337)
+||||+++.+++.. ....++++||+ +++|.+++. ...+++.....++.|+++||.+| |+.|++|+||+|+
T Consensus 67 ~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~-----~~~~~~~~~~~~~~ql~~aL~~L---H~~~iiH~dl~p~ 137 (328)
T cd07856 67 RHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLT-----SRPLEKQFIQYFLYQILRGLKYV---HSAGVVHRDLKPS 137 (328)
T ss_pred CCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHH
Confidence 99999999998865 56789999998 458888873 24578888899999999999999 7789999999999
Q ss_pred ceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCcccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCCC
Q 040898 196 NVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQT-ETISDKCDIYSFGVLLAVLVMGKFPVDDFFGH 274 (337)
Q Consensus 196 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~ 274 (337)
||+++.++.++|+|||.+....... ....+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||......
T Consensus 138 Nili~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~ 212 (328)
T cd07856 138 NILINENCDLKICDFGLARIQDPQM-----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHV 212 (328)
T ss_pred HEeECCCCCEEeCccccccccCCCc-----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999999999999999887543221 22356788999998765 56889999999999999999999998653221
Q ss_pred chhhhHHHHHHhh----h---ccCCcchhhhh------cccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 275 TEEMDMVKWMRNV----I---FSENPNRAINS------KLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 275 ~~~~~~~~~~~~~----~---~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.......+..... . ........... .......+.....+.+++.+||+.+|++|||+.+++.|
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 213 NQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1111111110000 0 00000000000 00000011233568999999999999999999999976
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=272.00 Aligned_cols=267 Identities=22% Similarity=0.332 Sum_probs=197.5
Q ss_pred ccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCcc
Q 040898 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNIL 122 (337)
Q Consensus 43 y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv 122 (337)
|++.+.||.|++|.||++.+.. ++..+++|.+......... ...+.+|+.+++.+.|||++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~--~~~~~~~K~~~~~~~~~~~-----------------~~~~~~e~~~l~~l~~~~i~ 61 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKK--TGELVALKKIRMENEKEGF-----------------PITAIREIKLLQKLRHPNIV 61 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECC--CCeEEEEEEEecccccccc-----------------hHHHHHHHHHHHhccCCCee
Confidence 6789999999999999998875 7899999999765411110 04567799999999999999
Q ss_pred cceeEEEcC--CeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 123 PLLAHMVRP--NCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 123 ~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
++++++... ...++|+||+++ +|.+++.. ....+++..++.++.|++.|+.+| |+.|++|+||+|+||+++
T Consensus 62 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~i~~al~~L---H~~~~~h~dl~p~nil~~ 134 (287)
T cd07840 62 RLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDS---PEVKFTESQIKCYMKQLLEGLQYL---HSNGILHRDIKGSNILIN 134 (287)
T ss_pred eheeeEecCCCCcEEEEeccccc-cHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHH---HHCCceeccCcHHHeEEc
Confidence 999999888 889999999975 88888743 225689999999999999999999 677999999999999999
Q ss_pred CCCCeEEecccCccccCCCCceeeeecccCCCCccCcccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhh
Q 040898 201 DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQT-ETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMD 279 (337)
Q Consensus 201 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~ 279 (337)
+++.++|+|||.+......... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........
T Consensus 135 ~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~ 213 (287)
T cd07840 135 NDGVLKLADFGLARPYTKRNSA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEK 213 (287)
T ss_pred CCCCEEEccccceeeccCCCcc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 9999999999998876544321 1123456788999998765 3578899999999999999999999865432111111
Q ss_pred HHHHHHhhhccCCc-------------chhhhhcccCCchHH-HHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 280 MVKWMRNVIFSENP-------------NRAINSKLLGNGYEE-QMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 280 ~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.............+ ........ ...... ....+.+++.+||+.+|.+|||+.++++|
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 214 IFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRL-REFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred HHHHhCCCchhhccccccchhhhhccccccchhHH-HHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 11111000000000 00000000 000111 24568999999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=268.63 Aligned_cols=264 Identities=24% Similarity=0.344 Sum_probs=195.4
Q ss_pred ccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc---CCC
Q 040898 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT---RHR 119 (337)
Q Consensus 43 y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l---~hp 119 (337)
|++.+.||+|++|.||++.+.. ++..||+|.+.......... ..+.+|+.+++++ +||
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~--~~~~~aiK~~~~~~~~~~~~-----------------~~~~~e~~~l~~l~~~~h~ 61 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLN--TGRFVALKKVRVPLSEEGIP-----------------LSTLREIALLKQLESFEHP 61 (287)
T ss_pred CeEEEEecccCceEEEEEEECC--CCCEEEEEEeccccccchhh-----------------hhHHHHHHHHHHhhccCCC
Confidence 6789999999999999999865 79999999987543321110 2344566655554 699
Q ss_pred CcccceeEEEcCCe-----eEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCC
Q 040898 120 NILPLLAHMVRPNC-----HLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKP 194 (337)
Q Consensus 120 niv~~~~~~~~~~~-----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~ 194 (337)
|++++++.+..... .++++||+++ +|.+++.. .....+++..++.++.|++.||.+| |+.|++|+||+|
T Consensus 62 ~i~~~~~~~~~~~~~~~~~~~l~~e~~~~-~l~~~l~~--~~~~~l~~~~~~~~~~~i~~al~~L---H~~~i~h~~l~~ 135 (287)
T cd07838 62 NIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSK--CPKPGLPPETIKDLMRQLLRGVDFL---HSHRIVHRDLKP 135 (287)
T ss_pred CcceEEEEEeeccCCCCceeEEEehhccc-CHHHHHHH--ccCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeccCCh
Confidence 99999999987766 8999999975 89888754 2223588999999999999999999 677999999999
Q ss_pred CceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCC
Q 040898 195 ANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGH 274 (337)
Q Consensus 195 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~ 274 (337)
+||+++.++.++|+|||.+......... ....++..|+|||.+.+..++.++|+||+|+++|+|++|.+||.....
T Consensus 136 ~nili~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~- 211 (287)
T cd07838 136 QNILVTSDGQVKIADFGLARIYSFEMAL---TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE- 211 (287)
T ss_pred hhEEEccCCCEEEeccCcceeccCCccc---ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh-
Confidence 9999999999999999998776443221 123468889999999988899999999999999999999999865322
Q ss_pred chhhhHHHHHHhhhccCCc----c--------hhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 275 TEEMDMVKWMRNVIFSENP----N--------RAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~----~--------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
................. . ............+.....+.+++.+||+.||.+||++.++++|
T Consensus 212 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 212 --ADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred --HHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 12222222111100000 0 0000000011223445668899999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=270.28 Aligned_cols=240 Identities=18% Similarity=0.266 Sum_probs=180.3
Q ss_pred ceeccCcceEEEEeEEecCC-----CCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCc
Q 040898 47 KKIGSGGWGEVFYKAELPGS-----NGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNI 121 (337)
Q Consensus 47 ~~lg~G~~g~V~~~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpni 121 (337)
+.||+|+||.||++.+.... ....+++|.+..... ...+.+..|+.+++.+.|||+
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~-------------------~~~~~~~~e~~~l~~~~h~~i 61 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHR-------------------NYSESFFEAASMMSQLSHKHL 61 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhH-------------------HHHHHHHHHHHHHHhCCCCCh
Confidence 47999999999998875411 223477776532211 011567789999999999999
Q ss_pred ccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecC
Q 040898 122 LPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDD 201 (337)
Q Consensus 122 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~ 201 (337)
+++++++..+...++||||+++|+|.+++.. .+..+++..+..++.|++.|+.|| |+.|++|+||+|+||+++.
T Consensus 62 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~l---H~~~iiH~dlkp~nili~~ 135 (258)
T cd05078 62 VLNYGVCVCGDESIMVQEYVKFGSLDTYLKK---NKNLINISWKLEVAKQLAWALHFL---EDKGLTHGNVCAKNVLLIR 135 (258)
T ss_pred hheeeEEEeCCCcEEEEecCCCCcHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCccceEEEec
Confidence 9999999998999999999999999999853 233578889999999999999999 7789999999999999987
Q ss_pred CCC--------eEEecccCccccCCCCceeeeecccCCCCccCccccccC-CCCCcccchhhhHHHHHHHhCC-CCCCCC
Q 040898 202 DME--------ARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTE-TISDKCDIYSFGVLLAVLVMGK-FPVDDF 271 (337)
Q Consensus 202 ~~~--------~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~i~~~ll~g~-~pf~~~ 271 (337)
++. ++++|||.+...... ....++..|+|||.+.+. .++.++|+||+|+++|+|++|. .||...
T Consensus 136 ~~~~~~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~ 209 (258)
T cd05078 136 EEDRKTGNPPFIKLSDPGISITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSAL 209 (258)
T ss_pred ccccccCCCceEEecccccccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhc
Confidence 664 689999987654321 223577889999999764 4788999999999999999985 565432
Q ss_pred CCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 272 FGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
.. ......... ... .+......+.+++.+||+.||++|||++++++
T Consensus 210 ~~----~~~~~~~~~----~~~-----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 255 (258)
T cd05078 210 DS----QKKLQFYED----RHQ-----------LPAPKWTELANLINQCMDYEPDFRPSFRAIIR 255 (258)
T ss_pred cH----HHHHHHHHc----ccc-----------CCCCCcHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 11 111111110 000 00111234889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=266.70 Aligned_cols=247 Identities=23% Similarity=0.312 Sum_probs=187.0
Q ss_pred cceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHH-HHHhcCCCCcccc
Q 040898 46 LKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEII-TANQTRHRNILPL 124 (337)
Q Consensus 46 ~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~l~~l~hpniv~~ 124 (337)
++.||.|++|.||++.+.. +++.||+|.+........... ..+..|.. +....+|||++++
T Consensus 1 ~~~l~~g~~~~v~~a~~~~--~~~~vavK~~~~~~~~~~~~~----------------~~~~~e~~~~~~~~~~~~i~~~ 62 (260)
T cd05611 1 LKPISKGAFGSVYLAKKRS--TGDYFAIKVLKKSDMIAKNQV----------------TNVKAERAIMMIQGESPYVAKL 62 (260)
T ss_pred CccCCcCCCeeEEEEEecC--CCCeEEEEEecchhhhHHHHH----------------HHHHHHHHHHhhcCCCCCeeee
Confidence 3679999999999998866 889999998854322111100 12233333 3455689999999
Q ss_pred eeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCC
Q 040898 125 LAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDME 204 (337)
Q Consensus 125 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~ 204 (337)
++.+..++..++++||+++++|.+++. ....+++..+..++.|++.||.|| |+.|++|+||+|+||+++.++.
T Consensus 63 ~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~l---H~~~i~H~dl~p~nil~~~~~~ 135 (260)
T cd05611 63 YYSFQSKDYLYLVMEYLNGGDCASLIK----TLGGLPEDWAKQYIAEVVLGVEDL---HQRGIIHRDIKPENLLIDQTGH 135 (260)
T ss_pred eeeEEcCCeEEEEEeccCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeEECCCCc
Confidence 999999999999999999999999984 334688999999999999999999 7779999999999999999999
Q ss_pred eEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHHHHH
Q 040898 205 ARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWM 284 (337)
Q Consensus 205 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~ 284 (337)
++|+|||.+...... ....+++.|++||.+.+..++.++|+||+|+++|+|++|..||..... .......
T Consensus 136 ~~l~dfg~~~~~~~~------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~ 205 (260)
T cd05611 136 LKLTDFGLSRNGLEN------KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP----DAVFDNI 205 (260)
T ss_pred EEEeecccceecccc------ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH----HHHHHHH
Confidence 999999987654321 234578889999999888889999999999999999999999864321 1111111
Q ss_pred HhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCCh---hhhhcC
Q 040898 285 RNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSS---KDVRSM 337 (337)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~---~ell~~ 337 (337)
....... + .......+..+.+++.+||+.||++|||+ .|+++|
T Consensus 206 ~~~~~~~-~---------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 206 LSRRINW-P---------EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred HhcccCC-C---------CcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 1100000 0 00111234558999999999999999965 688776
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=278.87 Aligned_cols=285 Identities=22% Similarity=0.226 Sum_probs=199.4
Q ss_pred cccccccc-cceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc
Q 040898 38 KKEDCFDS-LKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT 116 (337)
Q Consensus 38 ~~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 116 (337)
+..++|.. .+.||.|+||.||++.+.. +++.||+|.+...............+.... ....+.+|+.+++++
T Consensus 5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~E~~~l~~l 77 (335)
T PTZ00024 5 SISERYIQKGAHLGEGTYGKVEKAYDTL--TGKIVAIKKVKIIEISNDVTKDRQLVGMCG-----IHFTTLRELKIMNEI 77 (335)
T ss_pred ccccchhhhhhcccCCCceeEEEEEECC--CCCeEEEEEeeccccccccccchhhhcccc-----cchhHHHHHHHHHhC
Confidence 34567875 5779999999999998875 899999999865433221100000000000 002467899999999
Q ss_pred CCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 040898 117 RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPAN 196 (337)
Q Consensus 117 ~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~n 196 (337)
+||||+++++++......+++|||++ ++|.+++. ....++......++.|++.||.+| |+.|++|+||+|+|
T Consensus 78 ~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~----~~~~~~~~~~~~~~~ql~~aL~~L---H~~~i~H~dl~~~n 149 (335)
T PTZ00024 78 KHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVD----RKIRLTESQVKCILLQILNGLNVL---HKWYFMHRDLSPAN 149 (335)
T ss_pred CCcceeeeeEEEecCCcEEEEEeccc-cCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHH---HhCCeecccccHHH
Confidence 99999999999999999999999997 58988884 344588899999999999999999 77799999999999
Q ss_pred eeecCCCCeEEecccCccccCCCCc------------eeeeecccCCCCccCccccccC-CCCCcccchhhhHHHHHHHh
Q 040898 197 VLIDDDMEARISDFGHGKLMPDGHA------------QITVKCMVGTMGYMAPESLQTE-TISDKCDIYSFGVLLAVLVM 263 (337)
Q Consensus 197 il~~~~~~~~l~dfg~~~~~~~~~~------------~~~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~i~~~ll~ 263 (337)
|+++.++.++|+|||.+........ ........+++.|+|||.+.+. .++.++|+||||+++|+|++
T Consensus 150 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~t 229 (335)
T PTZ00024 150 IFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT 229 (335)
T ss_pred eEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHh
Confidence 9999999999999999876541110 0111123467789999998764 46889999999999999999
Q ss_pred CCCCCCCCCCCchhhhHHHHHHhhhccCCcch----------hhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhh
Q 040898 264 GKFPVDDFFGHTEEMDMVKWMRNVIFSENPNR----------AINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKD 333 (337)
Q Consensus 264 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e 333 (337)
|.+||...........+............+.. ...+.......+.....+.+++.+||+.+|++|||+++
T Consensus 230 g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~ 309 (335)
T PTZ00024 230 GKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKE 309 (335)
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHH
Confidence 99998654321111111111100000000000 00000000111223456889999999999999999999
Q ss_pred hhcC
Q 040898 334 VRSM 337 (337)
Q Consensus 334 ll~~ 337 (337)
++.|
T Consensus 310 ~l~~ 313 (335)
T PTZ00024 310 ALKH 313 (335)
T ss_pred HhcC
Confidence 9986
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=268.05 Aligned_cols=264 Identities=25% Similarity=0.339 Sum_probs=198.6
Q ss_pred cccccccceeccCcceEEEEeEEec--CCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELP--GSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR 117 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 117 (337)
..+|++.+.||+|+||.||++.... ..++..+|+|.+........ ...+.+|+.+++.+.
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~------------------~~~~~~ei~~l~~l~ 64 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQH------------------RSDFEREIEILRTLD 64 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHH------------------HHHHHHHHHHHHhCC
Confidence 3568899999999999999987642 23688999999875543200 156788999999999
Q ss_pred CCCcccceeEEEc--CCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCC
Q 040898 118 HRNILPLLAHMVR--PNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPA 195 (337)
Q Consensus 118 hpniv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ 195 (337)
||||+++++++.. ....++++||+++++|.+++.. ....+++..+..++.|++.||.+| |+.|++|+||+|+
T Consensus 65 ~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~~~l~~aL~~l---H~~~i~H~dl~p~ 138 (284)
T cd05038 65 HENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQR---HRDQINLKRLLLFSSQICKGMDYL---GSQRYIHRDLAAR 138 (284)
T ss_pred CCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHh---CccccCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHH
Confidence 9999999998877 5678999999999999999854 233588999999999999999999 6779999999999
Q ss_pred ceeecCCCCeEEecccCccccCCCCceeeee-cccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCC
Q 040898 196 NVLIDDDMEARISDFGHGKLMPDGHAQITVK-CMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGH 274 (337)
Q Consensus 196 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~-~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~ 274 (337)
||+++.++.++|+|||.+............. ...++..|++||.+.+..++.++|+||||+++|+|++|..|+......
T Consensus 139 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~ 218 (284)
T cd05038 139 NILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAE 218 (284)
T ss_pred hEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccch
Confidence 9999999999999999988765332221111 223455699999998888899999999999999999999997543221
Q ss_pred chh-------hhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 275 TEE-------MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 275 ~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
... ................ ...+......+.+++.+||+.+|.+|||+.|+++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 219 FLRMIGIAQGQMIVTRLLELLKEGER---------LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred hccccccccccccHHHHHHHHHcCCc---------CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 100 0000001111101000 0111122355899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=279.41 Aligned_cols=269 Identities=22% Similarity=0.325 Sum_probs=199.2
Q ss_pred ccccccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHH
Q 040898 33 DLAFLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIIT 112 (337)
Q Consensus 33 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 112 (337)
..+.+...++|++.+.||+|++|.||++.+.. ++..||+|++......... ...+.+|+.+
T Consensus 7 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~-----------------~~~~~~E~~~ 67 (343)
T cd07880 7 NKTIWEVPDRYRDLKQVGSGAYGTVCSALDRR--TGAKVAIKKLYRPFQSELF-----------------AKRAYRELRL 67 (343)
T ss_pred hhhhhccccceEEEEEeeecCCeEEEEEEECC--CCcEEEEEEecccccchHH-----------------HHHHHHHHHH
Confidence 44566678889999999999999999998866 8999999988543221110 1457789999
Q ss_pred HHhcCCCCcccceeEEEcCC------eeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCC
Q 040898 113 ANQTRHRNILPLLAHMVRPN------CHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPR 186 (337)
Q Consensus 113 l~~l~hpniv~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~g 186 (337)
++.++||||+++++++..+. .+++|+||+ +++|.+++. ...+++..+..++.|++.|+.+| |+.|
T Consensus 68 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~L---H~~g 138 (343)
T cd07880 68 LKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYI---HAAG 138 (343)
T ss_pred HHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHH---HhCC
Confidence 99999999999999887653 358999998 669988873 24588999999999999999999 7789
Q ss_pred eEecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCcccccc-CCCCCcccchhhhHHHHHHHhCC
Q 040898 187 LIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQT-ETISDKCDIYSFGVLLAVLVMGK 265 (337)
Q Consensus 187 i~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~i~~~ll~g~ 265 (337)
++|+||+|+||+++.++.++|+|||++....... ....+++.|++||.+.+ ..++.++|+||||+++|++++|.
T Consensus 139 i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~ 213 (343)
T cd07880 139 IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213 (343)
T ss_pred eecCCCCHHHEEEcCCCCEEEeecccccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999987653321 22356888999999865 45788999999999999999999
Q ss_pred CCCCCCCCCchhhhHHHHHHhhhc----------cCCcchhhh--hcc----cCCchHHHHHHHHHHHhhhccCCCCCCC
Q 040898 266 FPVDDFFGHTEEMDMVKWMRNVIF----------SENPNRAIN--SKL----LGNGYEEQMLLVLKLACFCTLKDPDERP 329 (337)
Q Consensus 266 ~pf~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~--~~~----~~~~~~~~~~~l~~li~~~l~~dP~~Rp 329 (337)
.||...... ....+....... ......... +.. .....+.....+.+++.+||+.||++||
T Consensus 214 ~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~ 290 (343)
T cd07880 214 PLFKGHDHL---DQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRI 290 (343)
T ss_pred CCCCCCCHH---HHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCC
Confidence 998643221 111111110000 000000000 000 0001122334588999999999999999
Q ss_pred ChhhhhcC
Q 040898 330 SSKDVRSM 337 (337)
Q Consensus 330 s~~ell~~ 337 (337)
|+.+++.|
T Consensus 291 t~~~~l~~ 298 (343)
T cd07880 291 TAAEALAH 298 (343)
T ss_pred CHHHHhcC
Confidence 99999976
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=268.99 Aligned_cols=259 Identities=24% Similarity=0.380 Sum_probs=196.7
Q ss_pred cccccceeccCcceEEEEeEEecC-CCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc-CCC
Q 040898 42 CFDSLKKIGSGGWGEVFYKAELPG-SNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT-RHR 119 (337)
Q Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp 119 (337)
+|++.+.||.|+||.||.+.+... .+|..||+|.+.......... ..+.+.+|+.++.++ .||
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~---------------~~~~~~~e~~~l~~l~~~~ 65 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAK---------------TTEHTRTERQVLEHIRQSP 65 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcch---------------HHHHHHHHHHHHHhcccCC
Confidence 488999999999999999887532 378999999986432211100 014567799999999 699
Q ss_pred CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceee
Q 040898 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI 199 (337)
Q Consensus 120 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~ 199 (337)
||+.+++.+..+...++|+||+++++|.+++.. ...+++..+..++.|++.||.+| |+.|++|+||+|+||++
T Consensus 66 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~l---H~~~i~H~dl~p~nil~ 138 (290)
T cd05613 66 FLVTLHYAFQTDTKLHLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHL---HKLGIIYRDIKLENILL 138 (290)
T ss_pred ChhceeeEeecCCeEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHeEE
Confidence 999999999999999999999999999999843 34688889999999999999999 77899999999999999
Q ss_pred cCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccC--CCCCcccchhhhHHHHHHHhCCCCCCCCCCCchh
Q 040898 200 DDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTE--TISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEE 277 (337)
Q Consensus 200 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~ 277 (337)
+.++.++|+|||++......... ......++..|++||.+.+. .++.++|+||+|+++|+|++|..||.........
T Consensus 139 ~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~ 217 (290)
T cd05613 139 DSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ 217 (290)
T ss_pred CCCCCEEEeeCccceeccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccH
Confidence 99999999999998765432211 11234578899999998653 4678899999999999999999998642221111
Q ss_pred hhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCC-----ChhhhhcC
Q 040898 278 MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERP-----SSKDVRSM 337 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 337 (337)
... .........+. +......+.+++.+||+.||.+|| ++.++++|
T Consensus 218 ~~~---~~~~~~~~~~~-----------~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 218 AEI---SRRILKSEPPY-----------PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred HHH---HHHhhccCCCC-----------CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 122 11111111111 111233488999999999999997 78888875
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=268.75 Aligned_cols=248 Identities=24% Similarity=0.354 Sum_probs=193.7
Q ss_pred eccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCcccceeEE
Q 040898 49 IGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLLAHM 128 (337)
Q Consensus 49 lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~ 128 (337)
||.|++|.||++.+.. +++.+++|.+......... ....+.+|+.+++.++||||+++++.+
T Consensus 1 lg~g~~~~vy~~~~~~--~~~~~~~k~~~~~~~~~~~----------------~~~~~~~e~~~l~~~~h~~i~~~~~~~ 62 (265)
T cd05579 1 ISKGAYGRVFLAKKKS--TGDIYAIKVIKKADMIRKN----------------QVDQVLTERDILSQAQSPYVVKLYYSF 62 (265)
T ss_pred CCCCCceEEEEEEECC--CCCEEEEEEecchhhhhhh----------------HHHHHHHHHHHHHhCCCcchhHHHHhe
Confidence 6899999999998865 7999999988654322111 115678899999999999999999999
Q ss_pred EcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCCeEEe
Q 040898 129 VRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARIS 208 (337)
Q Consensus 129 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~~l~ 208 (337)
..+...|+++||+++++|.+++.. ...+++..+..++.|++.+|.+| |+.|++|+||+|+||+++.++.++|+
T Consensus 63 ~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~l---H~~~i~H~di~~~nil~~~~~~~~l~ 135 (265)
T cd05579 63 QGKKNLYLVMEYLPGGDLASLLEN----VGSLDEDVARIYIAEIVLALEYL---HSNGIIHRDLKPDNILIDSNGHLKLT 135 (265)
T ss_pred ecCcEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHcCeecCCCCHHHeEEcCCCCEEEE
Confidence 999999999999999999999854 23689999999999999999999 67799999999999999999999999
Q ss_pred cccCccccCCCCc------eeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHHH
Q 040898 209 DFGHGKLMPDGHA------QITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVK 282 (337)
Q Consensus 209 dfg~~~~~~~~~~------~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~ 282 (337)
|||++........ ........++..|++||.......+.++|+||||+++|++++|..||..... .....
T Consensus 136 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~----~~~~~ 211 (265)
T cd05579 136 DFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP----EEIFQ 211 (265)
T ss_pred ecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH----HHHHH
Confidence 9998775433211 1122234578889999999888889999999999999999999999864321 11111
Q ss_pred HHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCCh---hhhhcC
Q 040898 283 WMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSS---KDVRSM 337 (337)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~---~ell~~ 337 (337)
.. ........ ........+.+++.+||+.+|.+|||+ .++++|
T Consensus 212 ~~---~~~~~~~~---------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 212 NI---LNGKIEWP---------EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred HH---hcCCcCCC---------ccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 11 11010000 000124558999999999999999999 888876
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=267.71 Aligned_cols=257 Identities=23% Similarity=0.364 Sum_probs=193.8
Q ss_pred ccccceeccCcceEEEEeEEec-CCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCc
Q 040898 43 FDSLKKIGSGGWGEVFYKAELP-GSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNI 121 (337)
Q Consensus 43 y~~~~~lg~G~~g~V~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpni 121 (337)
|.+.+.||+|+||.||.+.+.. ..++..+|+|++..+...... .+.+.+|+.+++.++||||
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~~i 63 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSD-----------------IEEFLREAACMKEFDHPNV 63 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHH-----------------HHHHHHHHHHHhcCCCCCc
Confidence 6788999999999999987653 236789999998654332221 1567889999999999999
Q ss_pred ccceeEEEcCC------eeEEEEEeccCCCHHHHHHHhcC--CcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCC
Q 040898 122 LPLLAHMVRPN------CHLLVYEFMKNGSLQDILYDVSQ--GRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIK 193 (337)
Q Consensus 122 v~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~ 193 (337)
+++++++.... ..+++++|+++++|.+++..... ....++...+..++.|++.|+.|+ |+.|++|+||+
T Consensus 64 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~l---H~~~i~H~dik 140 (273)
T cd05074 64 IKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYL---SSKNFIHRDLA 140 (273)
T ss_pred ceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHH---HhCCEeecccc
Confidence 99999876532 24788999999999988754221 223468888999999999999999 67799999999
Q ss_pred CCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCC
Q 040898 194 PANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFF 272 (337)
Q Consensus 194 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~ 272 (337)
|+||+++.++.++|+|||.+................+++.|++||.+....++.++|+||||+++|+|++ |.+||....
T Consensus 141 p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~ 220 (273)
T cd05074 141 ARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE 220 (273)
T ss_pred hhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCC
Confidence 9999999999999999999886543322222222345677999999988888999999999999999999 888886432
Q ss_pred CCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 273 GHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
. .+....+.. ..... ..+.....+.+++.+||+.+|++|||+.++++
T Consensus 221 ~----~~~~~~~~~---~~~~~----------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~ 267 (273)
T cd05074 221 N----SEIYNYLIK---GNRLK----------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD 267 (273)
T ss_pred H----HHHHHHHHc---CCcCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1 122221111 11100 00122345899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=272.49 Aligned_cols=252 Identities=26% Similarity=0.431 Sum_probs=195.6
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
....|...+.||.|++|.||++.+.. ++..+++|.+.......... ...+.+|+.+++.++|
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~----------------~~~~~~e~~~l~~l~h 74 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVR--NSEVVAIKKMSYSGKQSNEK----------------WQDIIKEVRFLQKLRH 74 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcC--CCcEEEEEEEecccccChHH----------------HHHHHHHHHHHHhCCC
Confidence 55669999999999999999999876 88999999886432221111 1456789999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
||++++.+++..+...++|+||+. ++|.+.+.. ...++++..+..++.|++.++.+| |+.|++|+||+|+||+
T Consensus 75 ~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~L---H~~~i~H~dl~p~nil 147 (308)
T cd06634 75 PNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYL---HSHNMIHRDVKAGNIL 147 (308)
T ss_pred CCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHhEE
Confidence 999999999999999999999997 478777643 334588899999999999999999 6779999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccc---cCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCc
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQ---TETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHT 275 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~ 275 (337)
++.++.++|+|||++...... ....+++.|+|||.+. ...++.++|+||||+++|+|++|..||.......
T Consensus 148 ~~~~~~~kl~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~ 221 (308)
T cd06634 148 LSEPGLVKLGDFGSASIMAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 221 (308)
T ss_pred ECCCCcEEECCcccceeecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH
Confidence 999999999999987654322 2245788999999974 3457889999999999999999999985532111
Q ss_pred hhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 276 EEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.... ......+. .........+.+++.+||+.+|++|||+.++++|
T Consensus 222 ---~~~~----~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 222 ---ALYH----IAQNESPA---------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred ---HHHH----HhhcCCCC---------cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 1111 11111100 0011233458899999999999999999999976
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=266.06 Aligned_cols=249 Identities=24% Similarity=0.289 Sum_probs=187.7
Q ss_pred eeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCcccceeE
Q 040898 48 KIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLLAH 127 (337)
Q Consensus 48 ~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~ 127 (337)
.||+|+||.||++.+.. +++.||+|.+..+.......... . ......+.+++...||+|+.+.+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~----~---------~~~~~~~~~~~~~~~~~i~~~~~~ 65 (278)
T cd05606 1 IIGRGGFGEVYGCRKAD--TGKMYAMKCLDKKRIKMKQGETL----A---------LNERIMLSLVSTGDCPFIVCMSYA 65 (278)
T ss_pred CcccCCCeEEEEEEEec--CCCEEEEEEeeccccccchhHHH----H---------HHHHHHHHHHHhCCCCcEeeeeee
Confidence 48999999999998875 89999999987653321110000 0 111223445666789999999999
Q ss_pred EEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCCeEE
Q 040898 128 MVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARI 207 (337)
Q Consensus 128 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~~l 207 (337)
+...+..++|+||+++++|.+++. ....+++..+..++.|++.|+.|| |+.+++|+||+|+||+++.++.++|
T Consensus 66 ~~~~~~~~~v~e~~~g~~L~~~l~----~~~~l~~~~~~~~~~ql~~~l~~l---H~~~i~H~di~p~nili~~~~~~kl 138 (278)
T cd05606 66 FHTPDKLSFILDLMNGGDLHYHLS----QHGVFSEAEMRFYAAEIILGLEHM---HNRFVVYRDLKPANILLDEHGHVRI 138 (278)
T ss_pred eecCCEEEEEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHH---HHCCEEcCCCCHHHEEECCCCCEEE
Confidence 999999999999999999998883 345689999999999999999999 6779999999999999999999999
Q ss_pred ecccCccccCCCCceeeeecccCCCCccCcccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHHHHHHh
Q 040898 208 SDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQT-ETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRN 286 (337)
Q Consensus 208 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 286 (337)
+|||++........ ....++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||........ .......
T Consensus 139 ~dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~-~~~~~~~-- 211 (278)
T cd05606 139 SDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMT-- 211 (278)
T ss_pred ccCcCccccCccCC----cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch-HHHHHHh--
Confidence 99999875533221 23468999999999864 4578999999999999999999999965422111 1111111
Q ss_pred hhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCC-----ChhhhhcC
Q 040898 287 VIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERP-----SSKDVRSM 337 (337)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 337 (337)
. .... ..+...+..+.+++.+||..+|.+|| ++.++++|
T Consensus 212 -~-~~~~----------~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 212 -L-TMAV----------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred -h-ccCC----------CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 0 0000 00111234589999999999999999 99999976
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=278.58 Aligned_cols=265 Identities=22% Similarity=0.316 Sum_probs=192.4
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
.++|.+.+.||.|+||.||++.+.. ++..|++|.+........ ..+.+|+.+++.++||
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~--~~~~v~iK~i~~~~~~~~-------------------~~~~~Ei~~l~~l~h~ 62 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSD--CDKRVAVKKIVLTDPQSV-------------------KHALREIKIIRRLDHD 62 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECC--CCcEEEEEEEecCCCchH-------------------HHHHHHHHHHHhcCCC
Confidence 4789999999999999999998876 899999999865543111 4577799999999999
Q ss_pred CcccceeEEEcC--------------CeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCC
Q 040898 120 NILPLLAHMVRP--------------NCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRP 185 (337)
Q Consensus 120 niv~~~~~~~~~--------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~ 185 (337)
||+++++.+... ...++++||+++ +|.+++. ...+++..++.++.||++|+.|| |+.
T Consensus 63 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~~L---H~~ 133 (342)
T cd07854 63 NIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLE-----QGPLSEEHARLFMYQLLRGLKYI---HSA 133 (342)
T ss_pred cchhhHhhhcccccccccccccccccceEEEEeecccc-cHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHH---HhC
Confidence 999999776543 357899999974 8888773 23588899999999999999999 677
Q ss_pred CeEecCCCCCceeecC-CCCeEEecccCccccCCCCcee-eeecccCCCCccCcccccc-CCCCCcccchhhhHHHHHHH
Q 040898 186 RLIHRDIKPANVLIDD-DMEARISDFGHGKLMPDGHAQI-TVKCMVGTMGYMAPESLQT-ETISDKCDIYSFGVLLAVLV 262 (337)
Q Consensus 186 gi~h~di~~~nil~~~-~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~i~~~ll 262 (337)
|++|+||+|+||+++. ++.++|+|||.+.......... ......++..|+|||.+.+ ..++.++|+||||+++|+|+
T Consensus 134 givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~ 213 (342)
T cd07854 134 NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEML 213 (342)
T ss_pred CcccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHH
Confidence 9999999999999974 5578999999987653321111 1122356888999998754 55788999999999999999
Q ss_pred hCCCCCCCCCCCchhhhHHHHHHhhhccCC----------cchhh-----hhcccCCchHHHHHHHHHHHhhhccCCCCC
Q 040898 263 MGKFPVDDFFGHTEEMDMVKWMRNVIFSEN----------PNRAI-----NSKLLGNGYEEQMLLVLKLACFCTLKDPDE 327 (337)
Q Consensus 263 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~-----~~~~~~~~~~~~~~~l~~li~~~l~~dP~~ 327 (337)
+|..||........ ............. +.... .........+.....+.+++.+||+.||.+
T Consensus 214 ~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 290 (342)
T cd07854 214 TGKPLFAGAHELEQ---MQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMD 290 (342)
T ss_pred hCCCCCCCCCHHHH---HHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchh
Confidence 99999965432111 1111110000000 00000 000000011123356889999999999999
Q ss_pred CCChhhhhcC
Q 040898 328 RPSSKDVRSM 337 (337)
Q Consensus 328 Rps~~ell~~ 337 (337)
|||+.++++|
T Consensus 291 R~t~~ell~h 300 (342)
T cd07854 291 RLTAEEALMH 300 (342)
T ss_pred ccCHHHHhCC
Confidence 9999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=311.20 Aligned_cols=257 Identities=23% Similarity=0.354 Sum_probs=208.2
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
-.-+|+....||.|.||.||.+.+.. +|...|+|-+........ ....+.+|+.++..++|
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~--tGellAvKEI~iq~~~~k-----------------~~~~i~eEm~vlE~lnH 1293 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLD--TGELLAVKEIKIQDSDHK-----------------TFKLIAEEMKVLEGLNH 1293 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCC--ccchhhhhhhhcCccccc-----------------cCcchHHHHHHHHhccC
Confidence 56689999999999999999998887 999999998765543311 11567789999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
||+|+++|+-.+.+..+|.||||.+|+|.+.+ ..+.-.++.....+..|++.|+.|| |++||||+||||.||+
T Consensus 1294 pNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll----~~gri~dE~vt~vyt~qll~gla~L---H~~gIVHRDIK~aNI~ 1366 (1509)
T KOG4645|consen 1294 PNLVRYYGVEVHREKVYIFMEYCEGGSLASLL----EHGRIEDEMVTRVYTKQLLEGLAYL---HEHGIVHRDIKPANIL 1366 (1509)
T ss_pred ccccccCceeecHHHHHHHHHHhccCcHHHHH----HhcchhhhhHHHHHHHHHHHHHHHH---HhcCceecCCCcccee
Confidence 99999999999999999999999999999999 4455577777888999999999999 7889999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCc--eeeeecccCCCCccCccccccC---CCCCcccchhhhHHHHHHHhCCCCCCCCCC
Q 040898 199 IDDDMEARISDFGHGKLMPDGHA--QITVKCMVGTMGYMAPESLQTE---TISDKCDIYSFGVLLAVLVMGKFPVDDFFG 273 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~~~~PE~~~~~---~~~~~~DiwslG~i~~~ll~g~~pf~~~~~ 273 (337)
++.+|.+|++|||.+........ ....+...||+-|||||++.+- ....+.|||||||++.||+||+.||.++..
T Consensus 1367 Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn 1446 (1509)
T KOG4645|consen 1367 LDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN 1446 (1509)
T ss_pred eecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc
Confidence 99999999999999987755421 2223456899999999999654 356789999999999999999999976533
Q ss_pred CchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 274 HTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.+.+.-.......++.| .....+-.+++..||..||++|.++.|+++|
T Consensus 1447 ---e~aIMy~V~~gh~Pq~P-------------~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1447 ---EWAIMYHVAAGHKPQIP-------------ERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred ---hhHHHhHHhccCCCCCc-------------hhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 22222222222222222 2344558999999999999999999999986
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=268.22 Aligned_cols=266 Identities=21% Similarity=0.286 Sum_probs=195.9
Q ss_pred ccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC-CCCc
Q 040898 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR-HRNI 121 (337)
Q Consensus 43 y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-hpni 121 (337)
|++.+.||+|++|+||++.... +++.|++|++......... ....+|+..+..+. |||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~--~~~~~~ik~~~~~~~~~~~------------------~~~~~e~~~l~~~~~h~~i 60 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKE--TGELVAIKKMKKKFYSWEE------------------CMNLREVKSLRKLNEHPNI 60 (283)
T ss_pred CeeheeeccCCceEEEEEEECC--CCcEEEEEEehhhccchhH------------------HHHHHHHHHHHhccCCCCc
Confidence 6789999999999999998865 7899999998654332111 23446888899998 9999
Q ss_pred ccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecC
Q 040898 122 LPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDD 201 (337)
Q Consensus 122 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~ 201 (337)
+++++.+..++..++||||+ +++|.+.+.. ..+..+++..+..++.|++.+|.+| |+.|++|+||+|+||+++.
T Consensus 61 ~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~L---h~~~i~H~dl~~~ni~i~~ 134 (283)
T cd07830 61 VKLKEVFRENDELYFVFEYM-EGNLYQLMKD--RKGKPFSESVIRSIIYQILQGLAHI---HKHGFFHRDLKPENLLVSG 134 (283)
T ss_pred hhHHHHhhcCCcEEEEEecC-CCCHHHHHHh--cccccCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCChhhEEEcC
Confidence 99999999999999999999 7789888754 2234689999999999999999999 6779999999999999999
Q ss_pred CCCeEEecccCccccCCCCceeeeecccCCCCccCccccc-cCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhH
Q 040898 202 DMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQ-TETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDM 280 (337)
Q Consensus 202 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~-~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~ 280 (337)
++.++|+|||.+........ .....++..|+|||.+. ...++.++|+||+|+++++|++|.+||......+.....
T Consensus 135 ~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~ 211 (283)
T cd07830 135 PEVVKIADFGLAREIRSRPP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKI 211 (283)
T ss_pred CCCEEEeecccceeccCCCC---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHH
Confidence 99999999999876543321 12345788899999874 445788999999999999999999998654322221111
Q ss_pred HHHHHhhhcc------------CCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 281 VKWMRNVIFS------------ENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 281 ~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.......... ................+.....+.+++.+||+.||++|||+.|++.|
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 212 CSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred HHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 1110000000 00000000000000111224568999999999999999999999976
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=261.72 Aligned_cols=262 Identities=24% Similarity=0.382 Sum_probs=201.6
Q ss_pred cceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc-CCCCcccc
Q 040898 46 LKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT-RHRNILPL 124 (337)
Q Consensus 46 ~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~ 124 (337)
.+.||+|+|+.|--+.... ++..||||++.+....+. .++.+|+.++.+. .|+||+++
T Consensus 83 ~e~LGeGAyasVqtcv~i~--t~~EYAVKiidKq~gHsR-------------------~RvfREVe~f~~Cqgh~nilqL 141 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQ--TGKEYAVKIIDKQPGHSR-------------------SRVFREVETFYQCQGHKNILQL 141 (463)
T ss_pred HHHhcCccceeeeeeeeec--cchhhhhhhhhcCCchHH-------------------HHHHHHHHHHHHhcCCccHHHH
Confidence 3579999999998788877 999999999977643332 5788999999998 69999999
Q ss_pred eeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCC
Q 040898 125 LAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDME 204 (337)
Q Consensus 125 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~ 204 (337)
+++|+++..+|+|+|.+.||+|-..|. +...+++.++..++++|+.||.+| |++||.|+|+||+||+......
T Consensus 142 iefFEdd~~FYLVfEKm~GGplLshI~----~~~~F~E~EAs~vvkdia~aLdFl---H~kgIAHRDlKPENiLC~~pn~ 214 (463)
T KOG0607|consen 142 IEFFEDDTRFYLVFEKMRGGPLLSHIQ----KRKHFNEREASRVVKDIASALDFL---HTKGIAHRDLKPENILCESPNK 214 (463)
T ss_pred HHHhcccceEEEEEecccCchHHHHHH----HhhhccHHHHHHHHHHHHHHHHHH---hhcCcccccCCccceeecCCCC
Confidence 999999999999999999999999994 455699999999999999999999 8899999999999999976654
Q ss_pred ---eEEecccCccccCCCCce-----eeeecccCCCCccCccccc-----cCCCCCcccchhhhHHHHHHHhCCCCCCCC
Q 040898 205 ---ARISDFGHGKLMPDGHAQ-----ITVKCMVGTMGYMAPESLQ-----TETISDKCDIYSFGVLLAVLVMGKFPVDDF 271 (337)
Q Consensus 205 ---~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~~~~PE~~~-----~~~~~~~~DiwslG~i~~~ll~g~~pf~~~ 271 (337)
+||+||.+.......... ......+|+..|||||++. ...|+.++|.||||+|+|-|++|.+||-+.
T Consensus 215 vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~ 294 (463)
T KOG0607|consen 215 VSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGH 294 (463)
T ss_pred cCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCc
Confidence 699999887654322211 1223467888999999963 234788999999999999999999999765
Q ss_pred CCCchhhh---HHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 272 FGHTEEMD---MVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 272 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.+.+..++ .+...++.++........ ......+...+.+..+|++.+|..|+..|.++..++.|
T Consensus 295 Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkY--eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 295 CGADCGWDRGEVCRVCQNKLFESIQEGKY--EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred cCCcCCccCCCccHHHHHHHHHHHhccCC--cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 54332221 111111111111111000 11123345666778999999999999999999999876
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=264.87 Aligned_cols=236 Identities=20% Similarity=0.311 Sum_probs=183.0
Q ss_pred ceeccCcceEEEEeEEecCCCC----------ceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc
Q 040898 47 KKIGSGGWGEVFYKAELPGSNG----------KMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT 116 (337)
Q Consensus 47 ~~lg~G~~g~V~~~~~~~~~~~----------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 116 (337)
+.||+|+||.||++.+.. ++ ..+++|.+...... ...+.+|+.+++.+
T Consensus 1 ~~lg~G~~~~v~~~~~~~--~~~~~~~~~~~~~~v~~k~~~~~~~~--------------------~~~~~~e~~~l~~l 58 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRV--QSDLDIVGPGQEVSVVLKVLGSDHRD--------------------SLAFFETASLMSQL 58 (259)
T ss_pred CcccccccceEEEEEEec--cCCccccCCccceeeeeeccccchhh--------------------HHHHHHHHHHHHcC
Confidence 479999999999998875 33 34777765433211 15678899999999
Q ss_pred CCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 040898 117 RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPAN 196 (337)
Q Consensus 117 ~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~n 196 (337)
+||||+++++++.. ...++|+||+++++|.+++.. ....+++..+..++.|++.||.|| |++|++|+||+|+|
T Consensus 59 ~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~L---H~~~i~H~dlkp~N 131 (259)
T cd05037 59 SHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHR---EKNNVSLHWKLDVAKQLASALHYL---EDKKLVHGNVCGKN 131 (259)
T ss_pred CCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHH---hhCCeecccCccce
Confidence 99999999999887 778999999999999999854 222688899999999999999999 77899999999999
Q ss_pred eeecCCC-------CeEEecccCccccCCCCceeeeecccCCCCccCccccccC--CCCCcccchhhhHHHHHHHh-CCC
Q 040898 197 VLIDDDM-------EARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTE--TISDKCDIYSFGVLLAVLVM-GKF 266 (337)
Q Consensus 197 il~~~~~-------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~DiwslG~i~~~ll~-g~~ 266 (337)
|+++.++ .++|+|||++...... ....++..|+|||.+.+. .++.++|+||+|+++|++++ |..
T Consensus 132 ill~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~ 205 (259)
T cd05037 132 ILVARYGLNEGYVPFIKLSDPGIPITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEE 205 (259)
T ss_pred EEEecCccccCCceeEEeCCCCcccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCC
Confidence 9999887 7999999998765331 123466789999999776 78899999999999999999 577
Q ss_pred CCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 267 PVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 267 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
||....... ....... ....+.. ....+.+++.+||..+|.+|||+.++++
T Consensus 206 p~~~~~~~~----~~~~~~~--~~~~~~~-------------~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 206 PLSTLSSSE----KERFYQD--QHRLPMP-------------DCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred CcccCCchh----HHHHHhc--CCCCCCC-------------CchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 876543211 1111110 0000000 0145889999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=270.31 Aligned_cols=252 Identities=25% Similarity=0.416 Sum_probs=194.8
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..+.|...+.||+|++|.||++.+.. ++..|++|++.......... ...+.+|+.+++.++|
T Consensus 19 ~~~~~~~~~~lg~g~~g~v~~~~~~~--~~~~v~ik~~~~~~~~~~~~----------------~~~~~~E~~~l~~l~h 80 (313)
T cd06633 19 PEEIFVGLHEIGHGSFGAVYFATNSH--TNEVVAVKKMSYSGKQTNEK----------------WQDIIKEVKFLQQLKH 80 (313)
T ss_pred HHHHhhcceeeccCCCeEEEEEEECC--CCcEEEEEEEeccccCchHH----------------HHHHHHHHHHHHhCCC
Confidence 34458888899999999999998865 89999999986543322211 1457779999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
||++++++++.+....|+++||+.+ +|.+++.. ...++++..+..++.|++.++.|| |+.|++|+||+|+||+
T Consensus 81 ~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~L---H~~gi~H~dl~p~nil 153 (313)
T cd06633 81 PNTIEYKGCYLKEHTAWLVMEYCLG-SASDLLEV---HKKPLQEVEIAAITHGALQGLAYL---HSHNMIHRDIKAGNIL 153 (313)
T ss_pred CCCccEEEEEEeCCEEEEEEecCCC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCChhhEE
Confidence 9999999999999999999999965 77777643 345688999999999999999999 6779999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccc---cCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCc
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQ---TETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHT 275 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~ 275 (337)
++.++.++|+|||.+...... ....++..|+|||.+. ...++.++|+||+|+++|+|++|..||.......
T Consensus 154 i~~~~~~kL~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~ 227 (313)
T cd06633 154 LTEPGQVKLADFGSASKSSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 227 (313)
T ss_pred ECCCCCEEEeecCCCcccCCC------CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 999999999999987543221 2345788899999984 3557889999999999999999999985532211
Q ss_pred hhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 276 EEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
... .......+.. ..+.....+.+++.+||+.+|.+|||+.++++|
T Consensus 228 ---~~~----~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 228 ---ALY----HIAQNDSPTL---------QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ---HHH----HHHhcCCCCC---------CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111 1111111100 011122348899999999999999999999976
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=299.75 Aligned_cols=258 Identities=24% Similarity=0.292 Sum_probs=205.4
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++++.||+|+||.|.+++++. +++.||.|++.+-...+. ...+.|+.|-.+|..-+.
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~--t~~VYAMK~lnK~eMlKr----------------~~tA~F~EERDimv~~ns 134 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKS--TEKVYAMKILNKWEMLKR----------------AETACFREERDIMVFGNS 134 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeec--cccchhHHHhhHHHHhhc----------------hhHHHHHHHhHHHHcCCc
Confidence 67889999999999999999999987 999999999854211111 122788999999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
+=|+.++-.|+++.++|+||||++||+|-.++.+ -..+++..+.-++..|+.||..+ |+.|+|||||||+|||
T Consensus 135 ~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk----~~~~pE~~ArFY~aEiVlAldsl---H~mgyVHRDiKPDNvL 207 (1317)
T KOG0612|consen 135 EWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSK----FDRLPEDWARFYTAEIVLALDSL---HSMGYVHRDIKPDNVL 207 (1317)
T ss_pred HHHHHHHHHhcCccceEEEEecccCchHHHHHhh----cCCChHHHHHHHHHHHHHHHHHH---HhccceeccCCcceeE
Confidence 9999999999999999999999999999999843 33699999999999999999999 7789999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccc----c-CCCCCcccchhhhHHHHHHHhCCCCCCCCCC
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQ----T-ETISDKCDIYSFGVLLAVLVMGKFPVDDFFG 273 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~----~-~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~ 273 (337)
++..|+++|+|||.+-........ .....+|||.|.+||++. + ..|+..+|.||+|+++|||+.|.-||..
T Consensus 208 ld~~GHikLADFGsClkm~~dG~V-~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa--- 283 (1317)
T KOG0612|consen 208 LDKSGHIKLADFGSCLKMDADGTV-RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA--- 283 (1317)
T ss_pred ecccCcEeeccchhHHhcCCCCcE-EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH---
Confidence 999999999999998777644322 335678999999999995 2 4588999999999999999999999832
Q ss_pred CchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCC---hhhhhcC
Q 040898 274 HTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPS---SKDVRSM 337 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps---~~ell~~ 337 (337)
..+.+....+..+..... -+.....++...+||++.+. +|+.|.. ++++-.|
T Consensus 284 ----dslveTY~KIm~hk~~l~-------FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 284 ----DSLVETYGKIMNHKESLS-------FPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred ----HHHHHHHHHHhchhhhcC-------CCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence 233333333333311110 11122355567888887665 8899988 8888766
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=262.11 Aligned_cols=245 Identities=26% Similarity=0.338 Sum_probs=201.2
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|..++.||+|+||.|.+++.+. +++.||+|+++++.....++ ++.-..|-+.|+..+|
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKa--t~k~YAiKIlkKeviiakdE----------------VAHTlTE~RVL~~~~H 227 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKA--TGKLYAIKILKKEVIIAKDE----------------VAHTLTENRVLQNCRH 227 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecc--cCceeehhhhhhhheeehHH----------------hhhhhhHHHHHHhccC
Confidence 45789999999999999999998876 99999999998776554433 2667789999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|.+..+.-.|+.++.+|+||||..||.|.-.+ .....+++....-+-..|+.||.|| |+++||.+|+|.+|.+
T Consensus 228 PFLt~LKYsFQt~drlCFVMeyanGGeLf~HL----srer~FsE~RtRFYGaEIvsAL~YL---Hs~~ivYRDlKLENLl 300 (516)
T KOG0690|consen 228 PFLTSLKYSFQTQDRLCFVMEYANGGELFFHL----SRERVFSEDRTRFYGAEIVSALGYL---HSRNIVYRDLKLENLL 300 (516)
T ss_pred cHHHHhhhhhccCceEEEEEEEccCceEeeeh----hhhhcccchhhhhhhHHHHHHhhhh---hhCCeeeeechhhhhe
Confidence 99999999999999999999999999998887 4456688888888999999999999 7889999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhh
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEM 278 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~ 278 (337)
++++|++||.|||++..-.... ...+..+|||.|+|||++....|+.++|.|.+|+++|||++|+.||..... .
T Consensus 301 LDkDGHIKitDFGLCKE~I~~g--~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh----~ 374 (516)
T KOG0690|consen 301 LDKDGHIKITDFGLCKEEIKYG--DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH----E 374 (516)
T ss_pred eccCCceEeeecccchhccccc--ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch----h
Confidence 9999999999999987532222 233567899999999999999999999999999999999999999853211 1
Q ss_pred hHHHHH--HhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCC
Q 040898 279 DMVKWM--RNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPS 330 (337)
Q Consensus 279 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps 330 (337)
.+.+.+ .++.++ .....+...|+..+|..||++|..
T Consensus 375 kLFeLIl~ed~kFP----------------r~ls~eAktLLsGLL~kdP~kRLG 412 (516)
T KOG0690|consen 375 KLFELILMEDLKFP----------------RTLSPEAKTLLSGLLKKDPKKRLG 412 (516)
T ss_pred HHHHHHHhhhccCC----------------ccCCHHHHHHHHHHhhcChHhhcC
Confidence 122221 112111 122233788999999999999974
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=267.94 Aligned_cols=257 Identities=19% Similarity=0.266 Sum_probs=197.0
Q ss_pred cccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCc
Q 040898 42 CFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNI 121 (337)
Q Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpni 121 (337)
+|.+.+.||+|++|.||++.+.. ++..+++|.+.......... .....+.+|+.+++.++||||
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~--~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~e~~~l~~l~h~~i 64 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKK--AVAEERLKVLKEIPVGELNP--------------NETVQANQEAQLLSKLDHPAI 64 (260)
T ss_pred CceeeeeecCCCCceEEEEEecC--CCCcceEEEeccccccccCc--------------chHHHHHHHHHHHHhCCCCcH
Confidence 58999999999999999998865 55556666654322111000 001345678899999999999
Q ss_pred ccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecC
Q 040898 122 LPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDD 201 (337)
Q Consensus 122 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~ 201 (337)
+++++.+.+....++++||+++++|.+++.........+++..++.++.|++.|+.+| |+.|++|+||+|+||+++.
T Consensus 65 ~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~i~h~~l~~~nili~~ 141 (260)
T cd08222 65 VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYM---HQRRILHRDLKAKNIFLKN 141 (260)
T ss_pred HHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHH---HHcCccccCCChhheEeec
Confidence 9999999999999999999999999999876555667799999999999999999999 7789999999999999975
Q ss_pred CCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHH
Q 040898 202 DMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMV 281 (337)
Q Consensus 202 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~ 281 (337)
+.++|+|||.+......... .....+++.|+|||...+..++.++|+||+|+++|+|++|..||.... ..
T Consensus 142 -~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~----~~--- 211 (260)
T cd08222 142 -NLLKIGDFGVSRLLMGSCDL--ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN----FL--- 211 (260)
T ss_pred -CCEeecccCceeecCCCccc--ccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc----HH---
Confidence 57999999988765432211 123457888999999988888899999999999999999999985321 11
Q ss_pred HHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 282 KWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
...........+ .........+.+++.+||+.||++||++.++++|
T Consensus 212 ~~~~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 212 SVVLRIVEGPTP----------SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred HHHHHHHcCCCC----------CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 111111111111 1112334568899999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=267.63 Aligned_cols=270 Identities=15% Similarity=0.170 Sum_probs=186.7
Q ss_pred ccccccccceeccCcceEEEEeEEecCC-CCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGS-NGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR 117 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 117 (337)
..++|++.+.||+|+||.||++.+.... .+..+++|...........+ ....... .......+...+..+.
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e-----~~~~~~~---~~~~~~~~~~~~~~~~ 81 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVME-----TLVYNNI---YDIDKIALWKNIHNID 81 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhH-----HHHHHhh---hhHHHHHHHHHhccCC
Confidence 3468999999999999999999886511 15566776543332211110 0111000 0012334455667789
Q ss_pred CCCcccceeEEEcCC----eeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCC
Q 040898 118 HRNILPLLAHMVRPN----CHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIK 193 (337)
Q Consensus 118 hpniv~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~ 193 (337)
|+|++++++...... ..+++++++.. ++.+.+.. ....++..+..++.|++.|+.|| |+.+++|||||
T Consensus 82 h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~l---H~~~iiHrDiK 153 (294)
T PHA02882 82 HLGIPKYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYI---HEHGISHGDIK 153 (294)
T ss_pred CCCCCcEEEeeeEecCCceEEEEEEehhcc-CHHHHHHh----hccCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCC
Confidence 999999998765443 34677887744 67666632 23356778899999999999999 77799999999
Q ss_pred CCceeecCCCCeEEecccCccccCCCCce-----eeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCC
Q 040898 194 PANVLIDDDMEARISDFGHGKLMPDGHAQ-----ITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPV 268 (337)
Q Consensus 194 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf 268 (337)
|+||+++.++.++|+|||++..+...... .......+|+.|+|||+..+..++.++||||+|+++|+|++|..||
T Consensus 154 p~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~ 233 (294)
T PHA02882 154 PENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPW 233 (294)
T ss_pred HHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999998765422111 1112246899999999999999999999999999999999999999
Q ss_pred CCCCCCchhhhH--HHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 269 DDFFGHTEEMDM--VKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 269 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
............ .....+....... .+..+..+.+++..|++.+|.+||+..++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 234 KGFGHNGNLIHAAKCDFIKRLHEGKIK------------IKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred CccccchHHHHHhHHHHHHHhhhhhhc------------cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 765332221111 1112222111100 1112355889999999999999999999975
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=280.15 Aligned_cols=264 Identities=24% Similarity=0.364 Sum_probs=197.6
Q ss_pred cccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHh
Q 040898 36 FLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQ 115 (337)
Q Consensus 36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~ 115 (337)
.....++|++.+.||+|++|.||++.+.. +++.||+|++......... ...+.+|+.+++.
T Consensus 10 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~--~~~~~aiK~~~~~~~~~~~-----------------~~~~~~E~~~l~~ 70 (343)
T cd07851 10 VWEVPDRYQNLSPVGSGAYGQVCSAFDTK--TGRKVAIKKLSRPFQSAIH-----------------AKRTYRELRLLKH 70 (343)
T ss_pred eecccCceEEEEEeccCCceEEEEEEECC--CCcEEEEEecccccchhhH-----------------HHHHHHHHHHHHh
Confidence 34456789999999999999999999876 8899999988643211110 1456779999999
Q ss_pred cCCCCcccceeEEEcCCe------eEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEe
Q 040898 116 TRHRNILPLLAHMVRPNC------HLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIH 189 (337)
Q Consensus 116 l~hpniv~~~~~~~~~~~------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h 189 (337)
+.|||++++.+++..... .++|+||+ +++|.+++.. ..+++..++.++.|++.|+.+| |+.|++|
T Consensus 71 l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~L---H~~gi~H 141 (343)
T cd07851 71 MDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYI---HSAGIIH 141 (343)
T ss_pred ccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHH---HHCCeec
Confidence 999999999988765544 89999998 5699998842 4589999999999999999999 7779999
Q ss_pred cCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCcccccc-CCCCCcccchhhhHHHHHHHhCCCCC
Q 040898 190 RDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQT-ETISDKCDIYSFGVLLAVLVMGKFPV 268 (337)
Q Consensus 190 ~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~i~~~ll~g~~pf 268 (337)
+||+|+||+++.++.++|+|||.+...... .....++..|+|||.+.+ ..++.++|+||||+++|++++|..||
T Consensus 142 ~dlkp~Nill~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf 216 (343)
T cd07851 142 RDLKPSNIAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLF 216 (343)
T ss_pred CCCCHHHeEECCCCCEEEcccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999998765432 123457888999999865 35788999999999999999999999
Q ss_pred CCCCCCchhhhHHHHHHhhhccCCcchhhhh--------------ccc----CCchHHHHHHHHHHHhhhccCCCCCCCC
Q 040898 269 DDFFGHTEEMDMVKWMRNVIFSENPNRAINS--------------KLL----GNGYEEQMLLVLKLACFCTLKDPDERPS 330 (337)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps 330 (337)
........ ... +..... ..+...... ... ..........+.+++.+||+.||.+|||
T Consensus 217 ~~~~~~~~---~~~-i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt 291 (343)
T cd07851 217 PGSDHIDQ---LKR-IMNLVG-TPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRIT 291 (343)
T ss_pred CCCChHHH---HHH-HHHhcC-CCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCC
Confidence 64322111 111 111100 000000000 000 0001122456899999999999999999
Q ss_pred hhhhhcC
Q 040898 331 SKDVRSM 337 (337)
Q Consensus 331 ~~ell~~ 337 (337)
+.+|++|
T Consensus 292 ~~ell~h 298 (343)
T cd07851 292 AAEALAH 298 (343)
T ss_pred HHHHhcC
Confidence 9999986
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=267.64 Aligned_cols=240 Identities=19% Similarity=0.252 Sum_probs=180.3
Q ss_pred eeccCcceEEEEeEEec----------------------CCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHh
Q 040898 48 KIGSGGWGEVFYKAELP----------------------GSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGA 105 (337)
Q Consensus 48 ~lg~G~~g~V~~~~~~~----------------------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 105 (337)
.||+|+||.||++.... ......|++|.+...... ....
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-------------------~~~~ 62 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRD-------------------IALA 62 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHH-------------------HHHH
Confidence 69999999999876432 112245788877433211 0145
Q ss_pred HHHHHHHHHhcCCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCC
Q 040898 106 IRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRP 185 (337)
Q Consensus 106 ~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~ 185 (337)
+.+|+.+++.++||||+++++++..+...++||||+++++|..++.. ....+++..+..++.|++.|+.|| |++
T Consensus 63 ~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~l---H~~ 136 (274)
T cd05076 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYL---EDK 136 (274)
T ss_pred HHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH---HcC
Confidence 77788999999999999999999999999999999999999988843 345678899999999999999999 778
Q ss_pred CeEecCCCCCceeecCCC-------CeEEecccCccccCCCCceeeeecccCCCCccCcccccc-CCCCCcccchhhhHH
Q 040898 186 RLIHRDIKPANVLIDDDM-------EARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQT-ETISDKCDIYSFGVL 257 (337)
Q Consensus 186 gi~h~di~~~nil~~~~~-------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~i 257 (337)
|++|+||+|+||+++..+ .++++|||.+...... ....++..|+|||.+.+ ..++.++|+||||++
T Consensus 137 ~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~ 210 (274)
T cd05076 137 NLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTT 210 (274)
T ss_pred CccCCCCCcccEEEeccCcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHH
Confidence 999999999999997643 4799999987543221 12346788999998865 557899999999999
Q ss_pred HHHHH-hCCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 258 LAVLV-MGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 258 ~~~ll-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
+|+++ +|..||....... ......... ..+. .....+.+++.+||+.+|.+|||+.++++
T Consensus 211 l~el~~~g~~p~~~~~~~~----~~~~~~~~~--~~~~-------------~~~~~~~~li~~cl~~~p~~Rps~~~il~ 271 (274)
T cd05076 211 LLEICFDGEVPLKERTPSE----KERFYEKKH--RLPE-------------PSCKELATLISQCLTYEPTQRPSFRTILR 271 (274)
T ss_pred HHHHHhCCCCCccccChHH----HHHHHHhcc--CCCC-------------CCChHHHHHHHHHcccChhhCcCHHHHHH
Confidence 99985 6899986532211 111111100 0000 01123889999999999999999999986
Q ss_pred C
Q 040898 337 M 337 (337)
Q Consensus 337 ~ 337 (337)
.
T Consensus 272 ~ 272 (274)
T cd05076 272 D 272 (274)
T ss_pred h
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=277.07 Aligned_cols=268 Identities=24% Similarity=0.305 Sum_probs=196.1
Q ss_pred cccccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHH
Q 040898 34 LAFLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITA 113 (337)
Q Consensus 34 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l 113 (337)
.+.+...++|++.+.||+|+||.||++.+.. +++.||+|++......... ...+.+|+.++
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~--~~~~vaiK~~~~~~~~~~~-----------------~~~~~~Ei~~l 70 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIH-----------------AKRTYRELRLL 70 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcC--CCeEEEEEEecCcchhhHH-----------------HHHHHHHHHHH
Confidence 3445577889999999999999999998865 8999999988653221110 14567899999
Q ss_pred HhcCCCCcccceeEEEcC------CeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCe
Q 040898 114 NQTRHRNILPLLAHMVRP------NCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRL 187 (337)
Q Consensus 114 ~~l~hpniv~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi 187 (337)
++++||||+++++++... ...+++++++ +++|.+++.. ..+++..++.++.|++.|+.|| |+.|+
T Consensus 71 ~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~L---H~~~i 141 (345)
T cd07877 71 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYI---HSADI 141 (345)
T ss_pred HHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHH---HHCCe
Confidence 999999999999987543 3467888876 6799887732 3588899999999999999999 67799
Q ss_pred EecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCcccccc-CCCCCcccchhhhHHHHHHHhCCC
Q 040898 188 IHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQT-ETISDKCDIYSFGVLLAVLVMGKF 266 (337)
Q Consensus 188 ~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~i~~~ll~g~~ 266 (337)
+|+||+|+||++++++.++|+|||++....... ....++..|+|||.+.+ ..++.++|+||+|+++|+|++|..
T Consensus 142 vH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~ 216 (345)
T cd07877 142 IHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 216 (345)
T ss_pred eecCCChHHEEEcCCCCEEEecccccccccccc-----cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999987643321 23457888999999866 467889999999999999999999
Q ss_pred CCCCCCCCchhhhHHHHHHhhhccCC------c---chhhh-------hcccCCchHHHHHHHHHHHhhhccCCCCCCCC
Q 040898 267 PVDDFFGHTEEMDMVKWMRNVIFSEN------P---NRAIN-------SKLLGNGYEEQMLLVLKLACFCTLKDPDERPS 330 (337)
Q Consensus 267 pf~~~~~~~~~~~~~~~~~~~~~~~~------~---~~~~~-------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps 330 (337)
||...... ............... . ..... ..............+.+++.+||+.||.+|||
T Consensus 217 pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t 293 (345)
T cd07877 217 LFPGTDHI---DQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 293 (345)
T ss_pred CCCCCCHH---HHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCC
Confidence 98543221 111111110000000 0 00000 00000000112445889999999999999999
Q ss_pred hhhhhcC
Q 040898 331 SKDVRSM 337 (337)
Q Consensus 331 ~~ell~~ 337 (337)
+.++++|
T Consensus 294 ~~e~l~h 300 (345)
T cd07877 294 AAQALAH 300 (345)
T ss_pred HHHHhcC
Confidence 9999986
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=280.07 Aligned_cols=262 Identities=23% Similarity=0.322 Sum_probs=210.4
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
+.+...+.++||+|-||+|-++..- .+.+||+|.++..+....+ ..|.+|+++|.+++|
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeve---g~lkVAVK~Lr~~a~~~~r------------------~~F~kEIkiLsqLkh 594 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVE---GPLKVAVKILRPDATKNAR------------------NDFLKEIKILSRLKH 594 (807)
T ss_pred chhheehhhhhcCcccceeEEEEec---CceEEEEeecCcccchhHH------------------HHHHHHHHHHhccCC
Confidence 5567899999999999999776663 4699999999887665443 579999999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||++++++|..++.+++++||++.|+|.+|+...... .+.-.....|+.||+.|++|| .+-++||||+.++|+|
T Consensus 595 PNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYL---es~nfVHrd~a~rNcL 669 (807)
T KOG1094|consen 595 PNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYL---ESLNFVHRDLATRNCL 669 (807)
T ss_pred CCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHH---Hhhchhhcccccccee
Confidence 99999999999999999999999999999999663322 244556677999999999999 6679999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh--CCCCCCCCCCCch
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM--GKFPVDDFFGHTE 276 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~--g~~pf~~~~~~~~ 276 (337)
+++++++||+|||+++-+-.+.........+-..+|+|||.+.-.+++.++|+|++|+++||+++ ...||........
T Consensus 670 v~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v 749 (807)
T KOG1094|consen 670 VDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV 749 (807)
T ss_pred ecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH
Confidence 99999999999999987666655555555667889999999999999999999999999999876 6789876544332
Q ss_pred hhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 277 EMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
..+.... ...+... .....++.++..+.+++.+||..|..+|||++++-.
T Consensus 750 ven~~~~----~~~~~~~------~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 750 VENAGEF----FRDQGRQ------VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred HHhhhhh----cCCCCcc------eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 2222222 2111111 112233455566889999999999999999999854
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=266.61 Aligned_cols=259 Identities=23% Similarity=0.335 Sum_probs=194.9
Q ss_pred cccccceeccCcceEEEEeEEec-CCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc-CCC
Q 040898 42 CFDSLKKIGSGGWGEVFYKAELP-GSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT-RHR 119 (337)
Q Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp 119 (337)
+|++.+.||.|++|.||++.+.. ..++..||+|.+.......... ....+..|+.++.++ .||
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~---------------~~~~~~~E~~~l~~~~~~~ 65 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAK---------------TAEHTRTERQVLEAVRRCP 65 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhh---------------HHHHHHHHHHHHHhccCCc
Confidence 48899999999999999987653 2367899999886432211110 114677899999999 599
Q ss_pred CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceee
Q 040898 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI 199 (337)
Q Consensus 120 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~ 199 (337)
||+.+++.+..+...++|+||+++++|.+++. ....+++..+..++.|++.+|.+| |+.|++|+||+|+||++
T Consensus 66 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~ql~~~l~~l---H~~~~~H~dl~p~nil~ 138 (288)
T cd05583 66 FLVTLHYAFQTDTKLHLILDYVNGGELFTHLY----QREHFTESEVRVYIAEIVLALDHL---HQLGIIYRDIKLENILL 138 (288)
T ss_pred chhhhheeeecCCEEEEEEecCCCCcHHHHHh----hcCCcCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHeEE
Confidence 99999999999999999999999999999884 334688899999999999999999 67799999999999999
Q ss_pred cCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCC--CCCcccchhhhHHHHHHHhCCCCCCCCCCCchh
Q 040898 200 DDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTET--ISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEE 277 (337)
Q Consensus 200 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~--~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~ 277 (337)
+.++.++|+|||++.......... .....++..|++||.+.+.. .+.++|+||+|+++|+|++|..||.........
T Consensus 139 ~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~ 217 (288)
T cd05583 139 DSEGHVVLTDFGLSKEFLAEEEER-AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ 217 (288)
T ss_pred CCCCCEEEEECccccccccccccc-cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchH
Confidence 999999999999887654332111 12235788999999987654 678999999999999999999998532221111
Q ss_pred hhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChh---hhhcC
Q 040898 278 MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSK---DVRSM 337 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~---ell~~ 337 (337)
..+. ........+ ........+.+++.+||+.||++|||+. ++++|
T Consensus 218 ~~~~---~~~~~~~~~-----------~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 218 SEIS---RRILKSKPP-----------FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred HHHH---HHHHccCCC-----------CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 1111 111111111 1111234488999999999999999954 44554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=253.83 Aligned_cols=253 Identities=21% Similarity=0.355 Sum_probs=197.6
Q ss_pred cccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc-CCCC
Q 040898 42 CFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT-RHRN 120 (337)
Q Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpn 120 (337)
+.+++..||.|+-|.||+..... +|...|||.+......... .+++..+.++..- ++|+
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs--~~~iiAVK~M~rt~Nkee~------------------kRILmDldvv~~s~dcpy 152 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRS--TGHIIAVKQMRRTGNKEEN------------------KRILMDLDVVLKSHDCPY 152 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcc--cceEEEEEeecccCCHHHH------------------HHHHHhhhHHhhccCCCe
Confidence 45677889999999999998876 9999999998765443221 5677777776655 6999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
||+.+|+|..+..+++-||.+.. -++.++.. -..++++..+-++...+++||.||.+ ++|++|||+||+|||++
T Consensus 153 IV~c~GyFi~n~dV~IcMelMs~-C~ekLlkr---ik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlD 226 (391)
T KOG0983|consen 153 IVQCFGYFITNTDVFICMELMST-CAEKLLKR---IKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLD 226 (391)
T ss_pred eeeeeeEEeeCchHHHHHHHHHH-HHHHHHHH---hcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEc
Confidence 99999999999999999998744 45555543 44569999999999999999999984 56999999999999999
Q ss_pred CCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccC---CCCCcccchhhhHHHHHHHhCCCCCCCCCCCchh
Q 040898 201 DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTE---TISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEE 277 (337)
Q Consensus 201 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~---~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~ 277 (337)
..|++||+|||.+-.+.++... +...|.+.|||||.+-.. .|+.++||||||++++||.||+.||..... +
T Consensus 227 e~GniKlCDFGIsGrlvdSkAh---trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t---d 300 (391)
T KOG0983|consen 227 ERGNIKLCDFGISGRLVDSKAH---TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT---D 300 (391)
T ss_pred cCCCEEeecccccceeeccccc---ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc---c
Confidence 9999999999999877655433 345699999999998544 588899999999999999999999976432 2
Q ss_pred hhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 278 MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.+.... ++...++.-. .. ...+.++.+++..||+.|+.+||.-.++|+|
T Consensus 301 Fe~ltk---vln~ePP~L~------~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 301 FEVLTK---VLNEEPPLLP------GH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred HHHHHH---HHhcCCCCCC------cc--cCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 222222 2222221110 00 0134458899999999999999999999987
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=304.91 Aligned_cols=257 Identities=26% Similarity=0.452 Sum_probs=195.1
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..+.+...+.||+|+||.||++.+.. ++..||+|++..... ....|+..+++++|
T Consensus 688 ~~~~~~~~~~ig~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~-----------------------~~~~~~~~l~~l~H 742 (968)
T PLN00113 688 ILSSLKEENVISRGKKGASYKGKSIK--NGMQFVVKEINDVNS-----------------------IPSSEIADMGKLQH 742 (968)
T ss_pred HHhhCCcccEEccCCCeeEEEEEECC--CCcEEEEEEccCCcc-----------------------ccHHHHHHHhhCCC
Confidence 34567788899999999999998865 899999998854321 11235778899999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++++.++...++||||+++|+|.+++. .+++..+..++.|++.|++|+|..++.+++|+|++|+||+
T Consensus 743 pnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil 815 (968)
T PLN00113 743 PNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKII 815 (968)
T ss_pred CCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEE
Confidence 999999999999999999999999999999984 2788999999999999999996544789999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhh
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEM 278 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~ 278 (337)
++.++..++. ++........ ....+++.|+|||.+.+..++.++||||+|+++|||+||+.||+...+. ..
T Consensus 816 ~~~~~~~~~~-~~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~--~~ 886 (968)
T PLN00113 816 IDGKDEPHLR-LSLPGLLCTD------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV--HG 886 (968)
T ss_pred ECCCCceEEE-eccccccccC------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC--CC
Confidence 9988877765 4443322111 1235788999999999989999999999999999999999998643221 12
Q ss_pred hHHHHHHhhhccCCcchhhhhccc--CCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 279 DMVKWMRNVIFSENPNRAINSKLL--GNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
...++.+............++... ..........+.+++.+||+.||++|||+.|+++
T Consensus 887 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 946 (968)
T PLN00113 887 SIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLK 946 (968)
T ss_pred cHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHH
Confidence 233333322211111111122211 1223455567889999999999999999999986
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=269.30 Aligned_cols=265 Identities=22% Similarity=0.306 Sum_probs=189.8
Q ss_pred cccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCccc
Q 040898 44 DSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILP 123 (337)
Q Consensus 44 ~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~ 123 (337)
.+++.+|.| |.||.+.+.. +++.||+|++........ ....+.+|+.+++.++||||++
T Consensus 5 ~i~~~~~~~--~~v~~~~~~~--~~~~~avK~~~~~~~~~~-----------------~~~~~~~Ei~~l~~l~h~~i~~ 63 (314)
T cd08216 5 LIGKCFEDL--MIVHLAKHKP--TNTLVAVKKINLDSCSKE-----------------DLKLLQQEIITSRQLQHPNILP 63 (314)
T ss_pred hhhHhhcCC--ceEEEEEecC--CCCEEEEEEEeccccchh-----------------HHHHHHHHHHHHHhcCCcchhh
Confidence 344444444 4455555554 899999999875422111 1157888999999999999999
Q ss_pred ceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCC
Q 040898 124 LLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDM 203 (337)
Q Consensus 124 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~ 203 (337)
+++.+.+++..++++||+++++|.+++... ....+++..+..++.|++.||.|| |++|++|+||+|+||+++.++
T Consensus 64 ~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~~l~~~L~~L---H~~~ivH~dlk~~Nili~~~~ 138 (314)
T cd08216 64 YVTSFIVDSELYVVSPLMAYGSCEDLLKTH--FPEGLPELAIAFILKDVLNALDYI---HSKGFIHRSVKASHILLSGDG 138 (314)
T ss_pred hhheeecCCeEEEEEeccCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCcceEEEecCC
Confidence 999999999999999999999999998652 234578889999999999999999 677999999999999999999
Q ss_pred CeEEecccCccccCCCCc-----eeeeecccCCCCccCcccccc--CCCCCcccchhhhHHHHHHHhCCCCCCCCCCCch
Q 040898 204 EARISDFGHGKLMPDGHA-----QITVKCMVGTMGYMAPESLQT--ETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTE 276 (337)
Q Consensus 204 ~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~~~~PE~~~~--~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~ 276 (337)
.++++||+.+........ ........++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||.......
T Consensus 139 ~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~- 217 (314)
T cd08216 139 KVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ- 217 (314)
T ss_pred ceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence 999999998765432111 011122346778999999865 357889999999999999999999997532211
Q ss_pred hhhHHHHHHhhhc---cCCc----------------chhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 277 EMDMVKWMRNVIF---SENP----------------NRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 277 ~~~~~~~~~~~~~---~~~~----------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
...+....... .... ...................+.+++.+||+.||++|||+.++|+|
T Consensus 218 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 218 --MLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred --HHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 11111110000 0000 00000000111223344678899999999999999999999987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=265.74 Aligned_cols=256 Identities=21% Similarity=0.366 Sum_probs=193.0
Q ss_pred cccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc-
Q 040898 38 KKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT- 116 (337)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l- 116 (337)
-..++|++.+.||+|++|.||++.+.. +++.||+|.+......... ..+.+|+.++..+
T Consensus 12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~--~~~~~avK~~~~~~~~~~~------------------~~~~~e~~~~~~~~ 71 (296)
T cd06618 12 ADLNDLENLGEIGSGTCGQVYKMRFKK--TGHVMAVKQMRRTGNKEEN------------------KRILMDLDVVLKSH 71 (296)
T ss_pred CCcchheeeeEeeccCCeEEEEEEECC--CCeEEEEEEEeccCChHHH------------------HHHHHHHHHHHhcc
Confidence 355779999999999999999998865 7999999998654321111 3445566655555
Q ss_pred CCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCC-CCeEecCCCCC
Q 040898 117 RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHR-PRLIHRDIKPA 195 (337)
Q Consensus 117 ~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~-~gi~h~di~~~ 195 (337)
.||||+++++++.++...++++||+.+ +|.+++.. ....+++..+..++.|++.++.|| |+ .|++|+||+|+
T Consensus 72 ~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~l---H~~~~i~H~dl~p~ 144 (296)
T cd06618 72 DCPYIVKCYGYFITDSDVFICMELMST-CLDKLLKR---IQGPIPEDILGKMTVAIVKALHYL---KEKHGVIHRDVKPS 144 (296)
T ss_pred CCCchHhhheeeecCCeEEEEeeccCc-CHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHH---HhhCCEecCCCcHH
Confidence 599999999999999999999999854 78777644 234688899999999999999999 54 59999999999
Q ss_pred ceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCC----CCCcccchhhhHHHHHHHhCCCCCCCC
Q 040898 196 NVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTET----ISDKCDIYSFGVLLAVLVMGKFPVDDF 271 (337)
Q Consensus 196 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~----~~~~~DiwslG~i~~~ll~g~~pf~~~ 271 (337)
||++++++.++|+|||.+......... ....+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...
T Consensus 145 nill~~~~~~kL~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 221 (296)
T cd06618 145 NILLDASGNVKLCDFGISGRLVDSKAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNC 221 (296)
T ss_pred HEEEcCCCCEEECccccchhccCCCcc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999998765432211 2234678899999987554 778999999999999999999998542
Q ss_pred CCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 272 FGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
... . +..........+... ........+.+++.+||+.||.+|||+.++++|
T Consensus 222 ~~~---~---~~~~~~~~~~~~~~~--------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 222 KTE---F---EVLTKILQEEPPSLP--------PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred hhH---H---HHHHHHhcCCCCCCC--------CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111 1 111111111111000 000123458999999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=268.28 Aligned_cols=267 Identities=24% Similarity=0.305 Sum_probs=198.1
Q ss_pred ccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCcc
Q 040898 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNIL 122 (337)
Q Consensus 43 y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv 122 (337)
|+..+.||+|++|.||.+.... +++.+++|.+......... ...+..|+.+++.++|||++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~--~~~~~~iK~~~~~~~~~~~-----------------~~~~~~e~~~l~~~~~~~i~ 61 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKK--TGEIVALKKIRLDNEEEGI-----------------PSTALREISLLKELKHPNIV 61 (282)
T ss_pred CeeehcccccCcceEEEeeecC--CCcEEEEEEeccccccccc-----------------cHHHHHHHHHHHhcCCCCHH
Confidence 6778999999999999998876 8999999998765421110 04566799999999999999
Q ss_pred cceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCC
Q 040898 123 PLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDD 202 (337)
Q Consensus 123 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~ 202 (337)
++++++.+....++|+||+++ +|.+++... ...+++..+..++.|++.++.+| |+.|++|+||+|+||+++++
T Consensus 62 ~~~~~~~~~~~~~~v~e~~~~-~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~L---H~~~i~H~~l~~~ni~~~~~ 134 (282)
T cd07829 62 KLLDVIHTERKLYLVFEYCDM-DLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAYC---HSHRILHRDLKPQNILINRD 134 (282)
T ss_pred HHHhhhhcCCceEEEecCcCc-CHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCChheEEEcCC
Confidence 999999999999999999975 899998542 14689999999999999999999 67799999999999999999
Q ss_pred CCeEEecccCccccCCCCceeeeecccCCCCccCccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHH
Q 040898 203 MEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTE-TISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMV 281 (337)
Q Consensus 203 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~ 281 (337)
+.++|+|||.+......... ......+..|+|||.+.+. .++.++|+||||++++++++|.+||...........+.
T Consensus 135 ~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~ 212 (282)
T cd07829 135 GVLKLADFGLARAFGIPLRT--YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIF 212 (282)
T ss_pred CCEEEecCCcccccCCCccc--cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH
Confidence 99999999998765433221 1223457789999998766 78889999999999999999999986532211111111
Q ss_pred HHHHhhhc-----------cCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 282 KWMRNVIF-----------SENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 282 ~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
........ .................+.....+.+++.+||..||++||++.++++|
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 213 QILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred HHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 11000000 000000000000001112224569999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=281.60 Aligned_cols=245 Identities=27% Similarity=0.401 Sum_probs=198.9
Q ss_pred eeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCcccceeE
Q 040898 48 KIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLLAH 127 (337)
Q Consensus 48 ~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~ 127 (337)
.||.|+||+||-++|.. +...+|||-+..+.+... ..++.|+.+-++|+|.|||++.|.
T Consensus 582 VLGKGTYG~VYA~RD~~--tqvrIaIKEIpekdsr~~-------------------QPLhEEIaLH~~LrHkNIVrYLGs 640 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMD--TQVRIAIKEIPEKDSREV-------------------QPLHEEIALHSTLRHKNIVRYLGS 640 (1226)
T ss_pred EeecCceeEEEeecccc--ceeEEEeeecccccchhh-------------------ccHHHHHHHHHHHhhHhHHHHhhc
Confidence 69999999999998876 888999998876544221 578889999999999999999999
Q ss_pred EEcCCeeEEEEEeccCCCHHHHHHHhcCCcccC--ChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec-CCCC
Q 040898 128 MVRPNCHLLVYEFMKNGSLQDILYDVSQGRREL--DWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID-DDME 204 (337)
Q Consensus 128 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~--~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~-~~~~ 204 (337)
+..++.+-+.||-.+||||.++++... +++ ++.+..-+.+||++||.|| |...|||||||-+|++++ -+|.
T Consensus 641 ~senGf~kIFMEqVPGGSLSsLLrskW---GPlKDNEstm~fYtkQILeGLkYL---Hen~IVHRDIKGDNVLvNTySGv 714 (1226)
T KOG4279|consen 641 VSENGFFKIFMEQVPGGSLSSLLRSKW---GPLKDNESTMNFYTKQILEGLKYL---HENKIVHRDIKGDNVLVNTYSGV 714 (1226)
T ss_pred cCCCCeEEEEeecCCCCcHHHHHHhcc---CCCccchhHHHHHHHHHHHHhhhh---hhcceeeccccCCcEEEeeccce
Confidence 999999999999999999999997633 344 7888899999999999999 777899999999999996 5889
Q ss_pred eEEecccCccccCCCCceeeeecccCCCCccCccccccC--CCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHHH
Q 040898 205 ARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTE--TISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVK 282 (337)
Q Consensus 205 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~ 282 (337)
+||+|||.+..+...... .....||..|||||++-.+ .|+.++|||||||++.||.||++||-+....... +.+
T Consensus 715 lKISDFGTsKRLAginP~--TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA--MFk 790 (1226)
T KOG4279|consen 715 LKISDFGTSKRLAGINPC--TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA--MFK 790 (1226)
T ss_pred EEecccccchhhccCCcc--ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh--hhh
Confidence 999999998876443322 2356799999999999543 4889999999999999999999999765332211 111
Q ss_pred HHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 283 WMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
..-... -++.+.+.......+|.+|+.+||..|||+.++|+
T Consensus 791 -VGmyKv------------HP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 791 -VGMYKV------------HPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred -hcceec------------CCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 001111 12334566667999999999999999999999985
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=271.95 Aligned_cols=271 Identities=23% Similarity=0.279 Sum_probs=192.5
Q ss_pred cccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc-CCCC
Q 040898 42 CFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT-RHRN 120 (337)
Q Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpn 120 (337)
+|++.+.||+|+||.||++.+.....+..||+|++......... ...+.+|+.+++++ .|||
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~-----------------~~~~~~E~~~l~~l~~h~~ 63 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKIL-----------------AKRALRELKLLRHFRGHKN 63 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchh-----------------HHHHHHHHHHHHHhcCCCC
Confidence 58899999999999999999876323889999998643222110 04567799999998 5999
Q ss_pred cccceeEEEc----CCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 040898 121 ILPLLAHMVR----PNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPAN 196 (337)
Q Consensus 121 iv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~n 196 (337)
|+++++.... ....+++++++. ++|.+.+ .....+++..+..++.|++.||.|| |++|++|+||+|+|
T Consensus 64 iv~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l----~~~~~~~~~~~~~~~~qi~~aL~~L---H~~givH~dlkp~N 135 (332)
T cd07857 64 ITCLYDMDIVFPGNFNELYLYEELME-ADLHQII----RSGQPLTDAHFQSFIYQILCGLKYI---HSANVLHRDLKPGN 135 (332)
T ss_pred hheeeeeeeeccccCCcEEEEEeccc-CCHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHH
Confidence 9999986532 245788889886 5888887 3455689999999999999999999 77899999999999
Q ss_pred eeecCCCCeEEecccCccccCCCCce--eeeecccCCCCccCcccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCC
Q 040898 197 VLIDDDMEARISDFGHGKLMPDGHAQ--ITVKCMVGTMGYMAPESLQT-ETISDKCDIYSFGVLLAVLVMGKFPVDDFFG 273 (337)
Q Consensus 197 il~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~ 273 (337)
|+++.++.++|+|||.+......... .......+++.|+|||.+.+ ..++.++|+||+|+++|++++|.+||.....
T Consensus 136 ili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~ 215 (332)
T cd07857 136 LLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDY 215 (332)
T ss_pred eEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCH
Confidence 99999999999999998765432211 11123468889999998765 4678899999999999999999999865321
Q ss_pred CchhhhHHHH--------HHhhhccCC-----cchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 274 HTEEMDMVKW--------MRNVIFSEN-----PNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 274 ~~~~~~~~~~--------~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.......... ......... ..............+.....+.+++.+||+.||.+|||+.++++|
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 216 VDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 1100000000 000000000 000000000001111224568999999999999999999999976
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=274.98 Aligned_cols=262 Identities=24% Similarity=0.331 Sum_probs=192.6
Q ss_pred cccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC
Q 040898 38 KKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR 117 (337)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 117 (337)
+-.++|.+.+.||+|++|.||++.+.. +++.||+|++......... ...+.+|+.+++.++
T Consensus 12 ~~~~~y~~~~~ig~g~~g~v~~~~~~~--~~~~vaiK~~~~~~~~~~~-----------------~~~~~~e~~~l~~l~ 72 (342)
T cd07879 12 ELPERYTSLKQVGSGAYGSVCSAIDKR--TGEKVAIKKLSRPFQSEIF-----------------AKRAYRELTLLKHMQ 72 (342)
T ss_pred ccccceEEEEEeeecCCeEEEEEEeCC--CCcEEEEEEecCccccccc-----------------hhHHHHHHHHHHhcC
Confidence 334689999999999999999998865 8999999988654221110 145678999999999
Q ss_pred CCCcccceeEEEcC------CeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 040898 118 HRNILPLLAHMVRP------NCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRD 191 (337)
Q Consensus 118 hpniv~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~d 191 (337)
||||+++++++... ...++|+||+.. +|.... . ..+++..+..++.|++.|+.+| |+.|++|+|
T Consensus 73 h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~----~--~~~~~~~~~~~~~qi~~aL~~L---H~~~i~H~d 142 (342)
T cd07879 73 HENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIM----G--HPLSEDKVQYLVYQMLCGLKYI---HSAGIIHRD 142 (342)
T ss_pred CCCccchhheecccccCCCCceEEEEeccccc-CHHHHH----c--CCCCHHHHHHHHHHHHHHHHHH---HHCCcccCC
Confidence 99999999988654 346899999865 776654 1 3588899999999999999999 778999999
Q ss_pred CCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCcccccc-CCCCCcccchhhhHHHHHHHhCCCCCCC
Q 040898 192 IKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQT-ETISDKCDIYSFGVLLAVLVMGKFPVDD 270 (337)
Q Consensus 192 i~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~i~~~ll~g~~pf~~ 270 (337)
|+|+||+++.++.++|+|||++....... ....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||..
T Consensus 143 lkp~NIll~~~~~~kL~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~ 217 (342)
T cd07879 143 LKPGNLAVNEDCELKILDFGLARHADAEM-----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 217 (342)
T ss_pred CCHHHEEECCCCCEEEeeCCCCcCCCCCC-----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999987543221 22356788999999865 4578899999999999999999999964
Q ss_pred CCCCchhhhHHHHHHhhhccCCc-----------ch------hhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhh
Q 040898 271 FFGHTEEMDMVKWMRNVIFSENP-----------NR------AINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKD 333 (337)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~-----------~~------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e 333 (337)
... ...+...+. ......+ .. ...........+.....+.+++.+||+.||.+|||+.+
T Consensus 218 ~~~---~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e 293 (342)
T cd07879 218 KDY---LDQLTQILK-VTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATE 293 (342)
T ss_pred CCH---HHHHHHHHH-hcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 321 111111111 0000000 00 00000000011223445889999999999999999999
Q ss_pred hhcC
Q 040898 334 VRSM 337 (337)
Q Consensus 334 ll~~ 337 (337)
++.|
T Consensus 294 ~l~h 297 (342)
T cd07879 294 ALEH 297 (342)
T ss_pred HhcC
Confidence 9986
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=258.93 Aligned_cols=244 Identities=25% Similarity=0.326 Sum_probs=194.2
Q ss_pred eccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCcccceeEE
Q 040898 49 IGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLLAHM 128 (337)
Q Consensus 49 lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~ 128 (337)
||+|++|.||.+.+.. +++.+++|.+......... ..+.+..|+.+++.++|||++++++.+
T Consensus 1 lg~G~~~~v~~~~~~~--~~~~~~~k~~~~~~~~~~~----------------~~~~~~~e~~~l~~l~h~~i~~~~~~~ 62 (250)
T cd05123 1 LGKGSFGKVLLVRKKD--TGKLYAMKVLKKKKIIKRK----------------EVEHTLTERNILSRINHPFIVKLHYAF 62 (250)
T ss_pred CCCCCceEEEEEEECC--CCcEEEEEEeehhhhcchH----------------HHHHHHHHHHHHHHcCCCcHHHHHHHe
Confidence 6999999999988865 7899999998655432221 115778899999999999999999999
Q ss_pred EcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCCeEEe
Q 040898 129 VRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARIS 208 (337)
Q Consensus 129 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~~l~ 208 (337)
..+...+++|||+++++|.+++.. ...+++..++.++.|+++++.++ |+.+++|+||+|+||+++.++.++|+
T Consensus 63 ~~~~~~~~v~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~l---h~~~~~H~~l~p~ni~~~~~~~~~l~ 135 (250)
T cd05123 63 QTEEKLYLVLEYAPGGELFSHLSK----EGRFSEERARFYAAEIVLALEYL---HSLGIIYRDLKPENILLDADGHIKLT 135 (250)
T ss_pred ecCCeeEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCceecCCCcceEEEcCCCcEEEe
Confidence 999999999999999999999843 34689999999999999999999 66799999999999999999999999
Q ss_pred cccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHHHHHHhhh
Q 040898 209 DFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVI 288 (337)
Q Consensus 209 dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 288 (337)
|||.+........ ......++..|++||...+..++.++|+||||+++|++++|..||..... ..... ...
T Consensus 136 d~~~~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~----~~~~~---~~~ 206 (250)
T cd05123 136 DFGLAKELSSEGS--RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR----KEIYE---KIL 206 (250)
T ss_pred ecCcceecccCCC--cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH----HHHHH---HHh
Confidence 9998876543321 11234578889999999888888999999999999999999999864321 11111 111
Q ss_pred ccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCCh---hhhhcC
Q 040898 289 FSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSS---KDVRSM 337 (337)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~---~ell~~ 337 (337)
..... .+......+.+++.+||..||++|||+ .++++|
T Consensus 207 ~~~~~-----------~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~ 247 (250)
T cd05123 207 KDPLR-----------FPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAH 247 (250)
T ss_pred cCCCC-----------CCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhC
Confidence 11110 011113448899999999999999999 888876
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=280.21 Aligned_cols=264 Identities=20% Similarity=0.325 Sum_probs=201.9
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
++..|..-+.||+|+||.||++.+.. +|+.||||.+......... +...+|++++++++|
T Consensus 11 ~~y~W~~~e~LG~Ga~g~V~rgrnke--tG~~vAvK~~~~~~~~r~~------------------e~~~~EieilkKLnh 70 (732)
T KOG4250|consen 11 ENYLWEMDERLGKGAFGNVYRGRNKE--TGRLVAVKTFNKESSLRPR------------------ERWCREIEILKKLNH 70 (732)
T ss_pred CCcceeehhhhcCCccceeeeecccc--cccchhHHhhhhhcccchH------------------HHHHHHHHHHHHcCc
Confidence 55778899999999999999998876 9999999999887755554 556779999999999
Q ss_pred CCcccceeEEEcCC------eeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 040898 119 RNILPLLAHMVRPN------CHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDI 192 (337)
Q Consensus 119 pniv~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di 192 (337)
||||++.++-++.. ...++||||.+|||...++.- .+...+++..++.++.+++.|+.|| |..||+||||
T Consensus 71 ~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~P-EN~~GLpE~e~l~lL~d~~~al~~L---rEn~IvHRDl 146 (732)
T KOG4250|consen 71 PNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSP-ENAYGLPESEFLDLLSDLVSALRHL---RENGIVHRDL 146 (732)
T ss_pred hhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCc-ccccCCCHHHHHHHHHHHHHHHHHH---HHcCceeccC
Confidence 99999999765543 468999999999999999652 2456799999999999999999999 6679999999
Q ss_pred CCCceeecC--CC--CeEEecccCccccCCCCceeeeecccCCCCccCccccc-cCCCCCcccchhhhHHHHHHHhCCCC
Q 040898 193 KPANVLIDD--DM--EARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQ-TETISDKCDIYSFGVLLAVLVMGKFP 267 (337)
Q Consensus 193 ~~~nil~~~--~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~-~~~~~~~~DiwslG~i~~~ll~g~~p 267 (337)
||.||++.. +| ..||+|||.|+-+..+. ......||+.|++||++. ...|+..+|.||+||++|+..||..|
T Consensus 147 KP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lP 223 (732)
T KOG4250|consen 147 KPGNIVLQIGEDGQSIYKLTDFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELP 223 (732)
T ss_pred CCCcEEEeecCCCceEEeeecccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCC
Confidence 999999953 23 46999999999887665 445678999999999998 47899999999999999999999999
Q ss_pred CCCCCCCchhhhHHHH-HHhhhcc---------CCcchhhhh-cccCCchHHHHHHHHHHHhhhccCCCCCCC
Q 040898 268 VDDFFGHTEEMDMVKW-MRNVIFS---------ENPNRAINS-KLLGNGYEEQMLLVLKLACFCTLKDPDERP 329 (337)
Q Consensus 268 f~~~~~~~~~~~~~~~-~~~~~~~---------~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp 329 (337)
|..+.+......+.-. +...... ..+...... +......+.....+...+..+|..+|++|.
T Consensus 224 F~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 224 FIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred CCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 9876665432222111 1110000 000000000 001112233445577778889999999998
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=274.49 Aligned_cols=251 Identities=20% Similarity=0.287 Sum_probs=202.9
Q ss_pred cccccceeccCcceEEEEeEEecCCC--CceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 42 CFDSLKKIGSGGWGEVFYKAELPGSN--GKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
.....++||.|-||.||.+.-...+. .-.||||.++.+...... +.|..|..+|++++||
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~t------------------ekflqEa~iMrnfdHp 451 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDT------------------EKFLQEASIMRNFDHP 451 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhH------------------HHHHHHHHHHHhCCCc
Confidence 34456789999999999887765433 345888988776554332 6788999999999999
Q ss_pred CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceee
Q 040898 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI 199 (337)
Q Consensus 120 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~ 199 (337)
||++++|++.+. ..++|||.++.|.|..+++. ++..++......++.||+.||.|| |+..+|||||-.+||++
T Consensus 452 hIikLIGv~~e~-P~WivmEL~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYL---eSkrfVHRDIAaRNiLV 524 (974)
T KOG4257|consen 452 HIIKLIGVCVEQ-PMWIVMELAPLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYL---ESKRFVHRDIAARNILV 524 (974)
T ss_pred chhheeeeeecc-ceeEEEecccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHH---Hhhchhhhhhhhhheee
Confidence 999999998865 56999999999999999964 566788899999999999999999 88899999999999999
Q ss_pred cCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCchhh
Q 040898 200 DDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHTEEM 278 (337)
Q Consensus 200 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~~ 278 (337)
....-|||+|||+++......-... +...-..-|++||-++...++.++|||.+|+.+||+++ |..||.+....+-..
T Consensus 525 sSp~CVKLaDFGLSR~~ed~~yYka-S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~ 603 (974)
T KOG4257|consen 525 SSPQCVKLADFGLSRYLEDDAYYKA-SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG 603 (974)
T ss_pred cCcceeeecccchhhhccccchhhc-cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE
Confidence 9999999999999999876644332 23345667999999999999999999999999999888 899997643321110
Q ss_pred hHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhh
Q 040898 279 DMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVR 335 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 335 (337)
.+ ..--..+++++++..+..|+.+||+++|.+||++.++.
T Consensus 604 ~i-----------------EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 604 HI-----------------ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred Ee-----------------cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence 00 00112345566777789999999999999999999875
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=280.35 Aligned_cols=262 Identities=22% Similarity=0.289 Sum_probs=214.6
Q ss_pred cccccccccccccccceeccCcceEEEEeEEecCCCC--ceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHH
Q 040898 32 QDLAFLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNG--KMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSE 109 (337)
Q Consensus 32 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e 109 (337)
.++.-+-..+.....++||+|+||.||.+.+.. .+| -.||||.+....... ..+.|.+|
T Consensus 101 ~~lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~-psgk~V~VAVKclr~d~l~~------------------~mddflrE 161 (1039)
T KOG0199|consen 101 IDLKCLIPEEQIKLYELLGEGSFGVVKRGTWTQ-PSGKHVNVAVKCLRDDSLNA------------------IMDDFLRE 161 (1039)
T ss_pred CCcceeccHHHHHHHHHhcCcceeeEeeccccC-CCCcEEeEEEEeccCCccch------------------hHHHHHHH
Confidence 355566677789999999999999999998875 333 458999987665432 12789999
Q ss_pred HHHHHhcCCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEe
Q 040898 110 IITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIH 189 (337)
Q Consensus 110 ~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h 189 (337)
+..|.+|+|||++++||+..+ ....+|+|.++.|||.+.|.+ .....+-......++.||+.|+.|| ..+++||
T Consensus 162 as~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YL---eskrlvH 235 (1039)
T KOG0199|consen 162 ASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYL---ESKRLVH 235 (1039)
T ss_pred HHHHHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHH---hhhhhhh
Confidence 999999999999999998887 678899999999999999976 4566788889999999999999999 8999999
Q ss_pred cCCCCCceeecCCCCeEEecccCccccCCCCceeeeec-ccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCC
Q 040898 190 RDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKC-MVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFP 267 (337)
Q Consensus 190 ~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~-~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~p 267 (337)
||+-.+|+++.....|||+|||+.+.++.+........ ..-...|+|||.++...++.++|+|++|+++|||++ |..|
T Consensus 236 RDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEeP 315 (1039)
T KOG0199|consen 236 RDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEP 315 (1039)
T ss_pred hhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCC
Confidence 99999999999999999999999999887665544333 234556999999999999999999999999999999 7899
Q ss_pred CCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhh
Q 040898 268 VDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVR 335 (337)
Q Consensus 268 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 335 (337)
|-+..+.. +.+.+... -.-..+..+++++.+++..||..+|.+|||+..|.
T Consensus 316 W~G~~g~q----IL~~iD~~-------------erLpRPk~csedIY~imk~cWah~paDRptFsair 366 (1039)
T KOG0199|consen 316 WVGCRGIQ----ILKNIDAG-------------ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIR 366 (1039)
T ss_pred CCCCCHHH----HHHhcccc-------------ccCCCCCCChHHHHHHHHHhccCCccccccHHHHH
Confidence 97765422 22222110 01123445677899999999999999999999874
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=235.40 Aligned_cols=269 Identities=20% Similarity=0.269 Sum_probs=203.6
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
.+|...++||+|+||+||+++... ++.-||+|++..+.....- ..+..+|+-+++.++|.|
T Consensus 2 ~~ydkmekigegtygtvfkarn~~--t~eivalkrvrlddddegv-----------------pssalreicllkelkhkn 62 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRE--THEIVALKRVRLDDDDEGV-----------------PSSALREICLLKELKHKN 62 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCC--ccceEEEEEEeccCCCCCC-----------------cHHHHHHHHHHHHhhhcc
Confidence 458889999999999999998876 9999999999776543221 157788999999999999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
|++++++.-.++.+-+|+|||+. +|..+... -++.++.+.+..++.|++.+|.+. |++++.|+|+||.|.+++
T Consensus 63 ivrl~dvlhsdkkltlvfe~cdq-dlkkyfds---lng~~d~~~~rsfmlqllrgl~fc---hshnvlhrdlkpqnllin 135 (292)
T KOG0662|consen 63 IVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDS---LNGDLDPEIVRSFMLQLLRGLGFC---HSHNVLHRDLKPQNLLIN 135 (292)
T ss_pred eeehhhhhccCceeEEeHHHhhH-HHHHHHHh---cCCcCCHHHHHHHHHHHHhhhhhh---hhhhhhhccCCcceEEec
Confidence 99999999999999999999966 88888754 345689999999999999999999 888999999999999999
Q ss_pred CCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCC-CCCcccchhhhHHHHHHHh-CCCCCCCCCCCchhh
Q 040898 201 DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTET-ISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHTEEM 278 (337)
Q Consensus 201 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~~ 278 (337)
.+|.+|++|||+++.++-... ..+...-|..|.||.++.|.. |+.+.|+||.||++.|+.. |.+-|.+...++...
T Consensus 136 ~ngelkladfglarafgipvr--cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlk 213 (292)
T KOG0662|consen 136 RNGELKLADFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK 213 (292)
T ss_pred cCCcEEecccchhhhcCCceE--eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHH
Confidence 999999999999988754332 223446789999999998765 7889999999999999998 455555433322222
Q ss_pred hHHHHHHhhhccCCcchh----hhhccc-------CCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 279 DMVKWMRNVIFSENPNRA----INSKLL-------GNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~----~~~~~~-------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.+............+... ..+... ...-|.....-++|+..+|.-+|.+|++++.+++|
T Consensus 214 rif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 214 RIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred HHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 222222111111111100 000000 00112233345788889999999999999999987
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=276.61 Aligned_cols=242 Identities=22% Similarity=0.319 Sum_probs=194.0
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHH-hcC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITAN-QTR 117 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~-~l~ 117 (337)
..+.|++...+|.|+|+.|-++.+.. +++..++|++...... ..+|+.++. .-+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~--t~~~~~vkii~~~~~~-----------------------~~~e~~~~~~~~~ 374 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSP--TDQEPAVKIISKRADD-----------------------NQDEIPISLLVRD 374 (612)
T ss_pred cchhhccccccCCCCccceeeeeccc--cccchhheeccccccc-----------------------cccccchhhhhcC
Confidence 46779999999999999998888876 9999999999766322 223443333 348
Q ss_pred CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCce
Q 040898 118 HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANV 197 (337)
Q Consensus 118 hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ni 197 (337)
||||+++.+.+.++...|+|||.+.|+-+.+.+.. ..... ..+..|+++|+.|+.|| |.+|++|||+||+||
T Consensus 375 h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~----~~~~~-~e~~~w~~~lv~Av~~L---H~~gvvhRDLkp~NI 446 (612)
T KOG0603|consen 375 HPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRS----KPEFC-SEASQWAAELVSAVDYL---HEQGVVHRDLKPGNI 446 (612)
T ss_pred CCcceeecceecCCceeeeeehhccccHHHHHHHh----cchhH-HHHHHHHHHHHHHHHHH---HhcCeeecCCChhhe
Confidence 99999999999999999999999999988777732 22233 67778999999999999 778999999999999
Q ss_pred ee-cCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCch
Q 040898 198 LI-DDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTE 276 (337)
Q Consensus 198 l~-~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~ 276 (337)
|+ +..++++|+|||.+...... ....+-|..|.|||++....|++++|+||||+++|+|++|+.||......
T Consensus 447 L~~~~~g~lrltyFG~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-- 519 (612)
T KOG0603|consen 447 LLDGSAGHLRLTYFGFWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-- 519 (612)
T ss_pred eecCCCCcEEEEEechhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--
Confidence 99 68899999999998876554 23346788999999999999999999999999999999999998654332
Q ss_pred hhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 277 EMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.++...++..... ...++..++|+.+||++||.+||++.+++.|
T Consensus 520 -~ei~~~i~~~~~s----------------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 520 -IEIHTRIQMPKFS----------------ECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred -HHHHHhhcCCccc----------------cccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 2222222211111 3344558999999999999999999999876
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=277.71 Aligned_cols=261 Identities=25% Similarity=0.370 Sum_probs=213.5
Q ss_pred cccccc-ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHH
Q 040898 33 DLAFLK-KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEII 111 (337)
Q Consensus 33 ~~~~~~-~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~ 111 (337)
+++.+. ..+.|++.+.||.|.+|.||++...+ +++..|+|+.....+.. +.+..|..
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~--~~~~aa~kI~~~~~d~d--------------------eEiE~eyn 67 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVK--TGQLAAIKIMDPTEDEE--------------------EEIELEYN 67 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeee--cCceeeeEeecCCcccc--------------------HHHHHHHH
Confidence 444444 77789999999999999999999987 99999999887776543 45566888
Q ss_pred HHHhc-CCCCcccceeEEE-----cCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCC
Q 040898 112 TANQT-RHRNILPLLAHMV-----RPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRP 185 (337)
Q Consensus 112 ~l~~l-~hpniv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~ 185 (337)
+++.+ .|||++.+++++. .++++|||||||.+||..|++++.. +..+.|..+..|++.++.|+.+| |+.
T Consensus 68 il~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HL---H~n 142 (953)
T KOG0587|consen 68 MLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHL---HNN 142 (953)
T ss_pred HHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHH---hhc
Confidence 88887 7999999999985 3578999999999999999998855 77799999999999999999999 777
Q ss_pred CeEecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccC-----CCCCcccchhhhHHHHH
Q 040898 186 RLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTE-----TISDKCDIYSFGVLLAV 260 (337)
Q Consensus 186 gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-----~~~~~~DiwslG~i~~~ 260 (337)
.++|+||+-.||+++.++.|||+|||++..++..... .+...|||.|||||++... .|+..+|+||||++..|
T Consensus 143 kviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~gr--RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIE 220 (953)
T KOG0587|consen 143 KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTVGR--RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIE 220 (953)
T ss_pred ceeeecccCceEEEeccCcEEEeeeeeeeeeeccccc--ccCcCCCcccccceeeecccCCCCCcccccchhhccceeeh
Confidence 8999999999999999999999999999887654332 2356899999999998543 36788999999999999
Q ss_pred HHhCCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 261 LVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 261 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
|-.|.+|+-+++.- ..+..+...++ +....+......+-++|+.||..|-.+||+..++|+|
T Consensus 221 ladG~PPl~DmHPm-------raLF~IpRNPP--------PkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 221 MAEGAPPLCDMHPM-------RALFLIPRNPP--------PKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred hcCCCCCccCcchh-------hhhccCCCCCC--------ccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 99999998665441 11111111111 1223345666779999999999999999999999987
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=254.75 Aligned_cols=262 Identities=23% Similarity=0.410 Sum_probs=206.0
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHH-HHhcC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIIT-ANQTR 117 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-l~~l~ 117 (337)
..++.+-+..||.|+||+|++-.+.+ +|+..|||++........+ .+++.|... ++.-+
T Consensus 62 ~~~~Lqdlg~iG~G~fG~V~KM~hk~--sg~~mAVKrIr~~n~~keq------------------~rll~e~d~~mks~~ 121 (361)
T KOG1006|consen 62 TSDNLQDLGEIGNGAFGTVNKMLHKP--SGKLMAVKRIRSNNIEKEQ------------------KRLLMEHDTVMKSSN 121 (361)
T ss_pred ccchHHHHHHhcCCcchhhhhhhcCc--cCcEEEEEEeeeccchHHH------------------HHHHHHHHHHHhhcC
Confidence 34567788999999999999888876 9999999999887764333 456666654 55558
Q ss_pred CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHH-hcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 040898 118 HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYD-VSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPAN 196 (337)
Q Consensus 118 hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~n 196 (337)
+||||+++|.....+..|+-||.++- ||..+... +..++..+++..+..+.-..+.||.||.+ ...++|||+||+|
T Consensus 122 cp~IVkfyGa~F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSN 198 (361)
T KOG1006|consen 122 CPNIVKFYGALFSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSN 198 (361)
T ss_pred CcHHHHHhhhhhcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhh
Confidence 99999999999999999999999965 77765532 23456779999999999999999999974 4589999999999
Q ss_pred eeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCcccccc--CCCCCcccchhhhHHHHHHHhCCCCCCCCCCC
Q 040898 197 VLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQT--ETISDKCDIYSFGVLLAVLVMGKFPVDDFFGH 274 (337)
Q Consensus 197 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~ 274 (337)
||++..|.+||+|||.+-.+..+... +...|...|+|||.+.. ..|+.++|+||||+++||+.||..||.++..
T Consensus 199 ILldr~G~vKLCDFGIcGqLv~SiAk---T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s- 274 (361)
T KOG1006|consen 199 ILLDRHGDVKLCDFGICGQLVDSIAK---TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS- 274 (361)
T ss_pred eEEecCCCEeeecccchHhHHHHHHh---hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-
Confidence 99999999999999998776554332 34568899999999853 3488999999999999999999999977532
Q ss_pred chhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 275 TEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
..+.+.+.....++.-..+.... .....+.+++..||.+|-+.||+..+++++
T Consensus 275 -----vfeql~~Vv~gdpp~l~~~~~~~-----~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 275 -----VFEQLCQVVIGDPPILLFDKECV-----HYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred -----HHHHHHHHHcCCCCeecCccccc-----ccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 34444555444444333222211 233348999999999999999999999875
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=284.53 Aligned_cols=257 Identities=24% Similarity=0.358 Sum_probs=210.4
Q ss_pred ccccccccceeccCcceEEEEeEEec-CCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELP-GSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR 117 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 117 (337)
......|.+.||.|.||.|+++.-+. .+....||||.++.-...+.+ ..|+.|..+|-+++
T Consensus 627 d~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gytekqr------------------rdFL~EAsIMGQFd 688 (996)
T KOG0196|consen 627 DPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQR------------------RDFLSEASIMGQFD 688 (996)
T ss_pred ChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHH------------------hhhhhhhhhcccCC
Confidence 45567889999999999999876653 346678999999766554432 57999999999999
Q ss_pred CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCce
Q 040898 118 HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANV 197 (337)
Q Consensus 118 hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ni 197 (337)
||||+++.|+....+.+.+|+||+++|+|..||+. +.+.++..++..+++.|+.|++|| .++|+|||||..+||
T Consensus 689 HPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~---~DGqftviQLVgMLrGIAsGMkYL---sdm~YVHRDLAARNI 762 (996)
T KOG0196|consen 689 HPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIASGMKYL---SDMNYVHRDLAARNI 762 (996)
T ss_pred CCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhh---cCCceEeehHHHHHHHHHHHhHHH---hhcCchhhhhhhhhe
Confidence 99999999999999999999999999999999965 456699999999999999999999 888999999999999
Q ss_pred eecCCCCeEEecccCccccCCCCce-eeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCc
Q 040898 198 LIDDDMEARISDFGHGKLMPDGHAQ-ITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHT 275 (337)
Q Consensus 198 l~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~ 275 (337)
|++.+-..|++|||+++.+.+.... .....-.-..+|.|||.+...+++.++||||+|+++||.++ |..||=++..
T Consensus 763 LVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN-- 840 (996)
T KOG0196|consen 763 LVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-- 840 (996)
T ss_pred eeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch--
Confidence 9999999999999999987655421 11111233578999999999999999999999999999988 8899855433
Q ss_pred hhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 276 EEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
++.+..+...-. -+.+.+++..|.+|+..||++|-++||++.+|+.
T Consensus 841 -----QdVIkaIe~gyR----------LPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 841 -----QDVIKAIEQGYR----------LPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVS 886 (996)
T ss_pred -----HHHHHHHHhccC----------CCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence 233332222211 2234456667999999999999999999999975
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=264.43 Aligned_cols=253 Identities=28% Similarity=0.389 Sum_probs=204.0
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..+.|..-+.||+||||.||-+.... +|.-||.|++.++........ .....|-.++.....
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvra--TGKMYAcKkL~KKRiKkr~ge----------------~maLnEk~iL~kV~s 244 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRA--TGKMYACKKLDKKRIKKRKGE----------------TMALNEKQILEKVSS 244 (591)
T ss_pred cccceeeeEEEecccccceeEEEEec--chhhHHHHHHHHHHHHHhhhh----------------HHhhHHHHHHHHhcc
Confidence 56779999999999999997555544 999999999876644332211 467779999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|.||.+--.|++.+.+++|+..++||+|.-.|++ ..+..++++.+.-++.+|+-||.+| |..+||.||+||+|||
T Consensus 245 ~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn--~g~~gF~e~ra~FYAAEi~cGLehl---H~~~iVYRDLKPeNIL 319 (591)
T KOG0986|consen 245 PFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYN--HGNPGFDEQRARFYAAEIICGLEHL---HRRRIVYRDLKPENIL 319 (591)
T ss_pred CcEEEEeeeecCCCceEEEEEeecCCceeEEeec--cCCCCCchHHHHHHHHHHHhhHHHH---HhcceeeccCChhhee
Confidence 9999999999999999999999999999999876 4446799999999999999999999 8889999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhh
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEM 278 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~ 278 (337)
+++.|+++|+|+|++..+..+.. ....+||.+|||||++....|+.+.|.|||||++|+|+.|+.||...-. ..
T Consensus 320 LDd~GhvRISDLGLAvei~~g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke---Kv 393 (591)
T KOG0986|consen 320 LDDHGHVRISDLGLAVEIPEGKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE---KV 393 (591)
T ss_pred eccCCCeEeeccceEEecCCCCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh---hh
Confidence 99999999999999998766553 2346899999999999999999999999999999999999999854211 11
Q ss_pred hHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCCh
Q 040898 279 DMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSS 331 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~ 331 (337)
...+ +.+...... ...+...+++..++...+|+.||++|...
T Consensus 394 k~eE-vdrr~~~~~----------~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 394 KREE-VDRRTLEDP----------EEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred hHHH-HHHHHhcch----------hhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 1111 111111111 11223445568889999999999999754
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=269.06 Aligned_cols=248 Identities=24% Similarity=0.351 Sum_probs=202.6
Q ss_pred cceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCcccce
Q 040898 46 LKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLL 125 (337)
Q Consensus 46 ~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~ 125 (337)
-+.||+|-||+||-+.+.+ +|+.||||++.+.......+ +.+..|+.+|.++.||.||.+.
T Consensus 569 devLGSGQFG~VYgg~hRk--tGrdVAvKvIdKlrFp~kqe-----------------sqlR~EVaILq~l~HPGiV~le 629 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRK--TGRDVAVKVIDKLRFPTKQE-----------------SQLRNEVAILQNLHHPGIVNLE 629 (888)
T ss_pred HhhccCCcceeeecceecc--cCceeeeeeeecccCCCchH-----------------HHHHHHHHHHHhcCCCCeeEEE
Confidence 4789999999999888876 99999999997765443322 5678899999999999999999
Q ss_pred eEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCC---
Q 040898 126 AHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDD--- 202 (337)
Q Consensus 126 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~--- 202 (337)
.-|++.+.++.|||.+.|.-|+..+. ...+.+++..-.-++.||+.||+|| |-++|+|+|+||+||++...
T Consensus 630 ~M~ET~ervFVVMEKl~GDMLEMILS---sEkgRL~er~TkFlvtQIL~ALr~L---H~knIvHCDLKPENVLLas~~~F 703 (888)
T KOG4236|consen 630 CMFETPERVFVVMEKLHGDMLEMILS---SEKGRLPERITKFLVTQILVALRYL---HFKNIVHCDLKPENVLLASASPF 703 (888)
T ss_pred EeecCCceEEEEehhhcchHHHHHHH---hhcccchHHHHHHHHHHHHHHHHHh---hhcceeeccCCchheeeccCCCC
Confidence 99999999999999997755554443 4667799999999999999999999 77899999999999999754
Q ss_pred CCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHHH
Q 040898 203 MEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVK 282 (337)
Q Consensus 203 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~ 282 (337)
..+||+|||.++..+..... ...+|||.|+|||++....|..+-|+||.|+|+|--++|..||++... +.+
T Consensus 704 PQvKlCDFGfARiIgEksFR---rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd------Ind 774 (888)
T KOG4236|consen 704 PQVKLCDFGFARIIGEKSFR---RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED------IND 774 (888)
T ss_pred Cceeeccccceeecchhhhh---hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc------hhH
Confidence 47899999999998765433 346899999999999999999999999999999999999999976422 222
Q ss_pred HHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 283 WMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.++...+-. ..+.+.+......+||..+|+..-++|-|++..|+|
T Consensus 775 QIQNAaFMy----------Pp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 775 QIQNAAFMY----------PPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred Hhhcccccc----------CCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 222211111 122344555568899999999999999999998876
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=254.18 Aligned_cols=226 Identities=21% Similarity=0.228 Sum_probs=177.9
Q ss_pred CcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCcccceeEEEcC
Q 040898 52 GGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLLAHMVRP 131 (337)
Q Consensus 52 G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 131 (337)
|.+|.||++.+.. +++.||+|++..... ..+|...+....||||+++++++.+.
T Consensus 4 g~~~~v~~~~~~~--~~~~~~~K~i~~~~~------------------------~~~~~~~~~~~~~~~i~~~~~~~~~~ 57 (237)
T cd05576 4 GVIDKVLLVMDTR--TQQTFILKGLRKSSE------------------------YSRERLTIIPHCVPNMVCLHKYIVSE 57 (237)
T ss_pred cccceEEEEEEcc--CCcEEEEEeecchhh------------------------hhhHHHHHHhcCCCceeehhhheecC
Confidence 8999999999976 899999999865421 12233444556799999999999999
Q ss_pred CeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCCeEEeccc
Q 040898 132 NCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFG 211 (337)
Q Consensus 132 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~~l~dfg 211 (337)
...+++|||+++++|.+++.. ...+++..+..++.|++.||.++ |+.|++|+||+|+||+++.++.++++|||
T Consensus 58 ~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~~l~df~ 130 (237)
T cd05576 58 DSVFLVLQHAEGGKLWSHISK----FLNIPEECVKRWAAEMVVALDAL---HREGIVCRDLNPNNILLDDRGHIQLTYFS 130 (237)
T ss_pred CeEEEEEecCCCCCHHHHHHH----hcCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHEEEcCCCCEEEeccc
Confidence 999999999999999998843 23588999999999999999999 67799999999999999999999999999
Q ss_pred CccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHHHHHHhhhccC
Q 040898 212 HGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSE 291 (337)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 291 (337)
.+....... ....++..|+|||...+..++.++|+||+|+++|+|++|..|+...... ... .
T Consensus 131 ~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~---------~~~---~- 192 (237)
T cd05576 131 RWSEVEDSC-----DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG---------INT---H- 192 (237)
T ss_pred chhcccccc-----ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh---------ccc---c-
Confidence 876543321 2234567799999998888899999999999999999999886432110 000 0
Q ss_pred CcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCCh-----hhhhcC
Q 040898 292 NPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSS-----KDVRSM 337 (337)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~ell~~ 337 (337)
.. ...++.....+.+++.+||+.||.+|||+ .++++|
T Consensus 193 ~~---------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 234 (237)
T cd05576 193 TT---------LNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSH 234 (237)
T ss_pred cc---------cCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcC
Confidence 00 00111223448899999999999999996 888876
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=258.06 Aligned_cols=260 Identities=20% Similarity=0.295 Sum_probs=197.7
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC-
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH- 118 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h- 118 (337)
.++|.+...+|+|+||.|-.+-+.. ++..||+|+++.-. ++. +...-|+..+.++.+
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~--~~~~vAlKIik~V~-------------kYr-------eAa~iEi~vLqki~~~ 145 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRE--TKEHVALKIIKNVD-------------KYR-------EAALIEIEVLQKINES 145 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecC--CCceehHHHHHHHH-------------HHh-------hHHHHHHHHHHHHHhc
Confidence 7789999999999999996665554 79999999875321 111 566778999998832
Q ss_pred -C----CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCC
Q 040898 119 -R----NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIK 193 (337)
Q Consensus 119 -p----niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~ 193 (337)
| -++.+.++|+-.+..++|+|.+ |-|+.+++.. ++-.+++...+..+.+|+++++++| |+.+++|.|||
T Consensus 146 DP~g~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~--N~y~~fpi~~ir~m~~QL~~sv~fL---h~~kl~HTDLK 219 (415)
T KOG0671|consen 146 DPNGKFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKE--NNYIPFPIDHIRHMGYQLLESVAFL---HDLKLTHTDLK 219 (415)
T ss_pred CCCCceEEEeeehhhhccCceEEEEecc-ChhHHHHhcc--CCccccchHHHHHHHHHHHHHHHHH---HhcceeecCCC
Confidence 2 3567778899999999999998 5599999954 5566788899999999999999999 78899999999
Q ss_pred CCceeec--------------------CCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchh
Q 040898 194 PANVLID--------------------DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYS 253 (337)
Q Consensus 194 ~~nil~~--------------------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Diws 253 (337)
|+||++. .+..|+++|||.++.-.... +..+.|..|.|||++.+..|+.++||||
T Consensus 220 PENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWS 294 (415)
T KOG0671|consen 220 PENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWS 294 (415)
T ss_pred hheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCcee
Confidence 9999994 23468999999988755443 3346889999999999999999999999
Q ss_pred hhHHHHHHHhCCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhc------------------------cc-------
Q 040898 254 FGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSK------------------------LL------- 302 (337)
Q Consensus 254 lG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------------~~------- 302 (337)
+|||++|+.+|..-|..-.. .+...+.+ .++. +.|....... ..
T Consensus 295 iGCIL~ElytG~~LFqtHen-~EHLaMMe---rIlG-p~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~ 369 (415)
T KOG0671|consen 295 IGCILVELYTGETLFQTHEN-LEHLAMME---RILG-PIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLK 369 (415)
T ss_pred eeeEEEEeeccceecccCCc-HHHHHHHH---HhhC-CCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHH
Confidence 99999999999988865432 22222222 2222 1111111111 00
Q ss_pred --CCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 303 --GNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 303 --~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
......+-..+.+|+.+||.+||.+|+|+.|+|+|
T Consensus 370 ~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 370 KYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSH 406 (415)
T ss_pred HHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcC
Confidence 01122344569999999999999999999999987
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=282.50 Aligned_cols=150 Identities=25% Similarity=0.410 Sum_probs=130.4
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
.++|.++++||+|+||.||++.+.. +++.||+|++......... ....+.+|+.++..++||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~--~~~~vAiKvi~~~~~~~~~----------------~~~~~~~E~~~l~~l~hp 64 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKN--NSKLYAVKVVKKADMINKN----------------MVHQVQAERDALALSKSP 64 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECC--CCcEEEEEEEehhhccCHH----------------HHHHHHHHHHHHHhcCCC
Confidence 4679999999999999999999876 8999999998654322111 115677899999999999
Q ss_pred CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceee
Q 040898 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI 199 (337)
Q Consensus 120 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~ 199 (337)
||++++..+......|+||||+.+++|.+++.. ...+++..++.++.||+.||.|| |..||+|+||+|+|||+
T Consensus 65 ~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yL---H~~gIiHrDLKP~NILl 137 (669)
T cd05610 65 FIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYL---HRHGIIHRDLKPDNMLI 137 (669)
T ss_pred CcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HhCCEEeCCccHHHEEE
Confidence 999999999999999999999999999999843 34578889999999999999999 66799999999999999
Q ss_pred cCCCCeEEecccCcc
Q 040898 200 DDDMEARISDFGHGK 214 (337)
Q Consensus 200 ~~~~~~~l~dfg~~~ 214 (337)
+.++.++|+|||++.
T Consensus 138 ~~~g~vkL~DFGls~ 152 (669)
T cd05610 138 SNEGHIKLTDFGLSK 152 (669)
T ss_pred cCCCCEEEEeCCCCc
Confidence 999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=274.35 Aligned_cols=262 Identities=18% Similarity=0.212 Sum_probs=168.7
Q ss_pred ccccccccceeccCcceEEEEeEEecCCC----CceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHH
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSN----GKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITAN 114 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~ 114 (337)
..++|++.+.||+|+||.||++.+.. + +..||+|++........ ... ..+.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~--~~~~~~~~vAvK~~~~~~~~e~---------------------~~~--e~l~ 184 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVN--KQSKKEGKYVLKKATEYGAVEI---------------------WMN--ERVR 184 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcC--CccccCcEEEEEEecccchhHH---------------------HHH--HHHH
Confidence 66789999999999999999999875 6 89999998754321100 000 0111
Q ss_pred hcCCCCcccceeE------EEcCCeeEEEEEeccCCCHHHHHHHhcC----------------CcccCChHHHHHHHHHH
Q 040898 115 QTRHRNILPLLAH------MVRPNCHLLVYEFMKNGSLQDILYDVSQ----------------GRRELDWPARHRIARGI 172 (337)
Q Consensus 115 ~l~hpniv~~~~~------~~~~~~~~lv~e~~~~~~L~~~l~~~~~----------------~~~~~~~~~~~~i~~~i 172 (337)
...+.++..+... ...+...++|+||+++++|.+++..... .........+..++.|+
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~ql 264 (566)
T PLN03225 185 RACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQI 264 (566)
T ss_pred hhchhhHHHHHHhhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHH
Confidence 1111222222111 2456678999999999999998853210 00111234466899999
Q ss_pred HHHHHHHhhCCCCCeEecCCCCCceeecC-CCCeEEecccCccccCCCCceeeeecccCCCCccCccccccC--------
Q 040898 173 ASGLEYLHMCHRPRLIHRDIKPANVLIDD-DMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTE-------- 243 (337)
Q Consensus 173 ~~~l~~l~~~h~~gi~h~di~~~nil~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-------- 243 (337)
+.||.|+ |++||+|+||||+||+++. ++.++|+|||++......... ......+++.|+|||.+...
T Consensus 265 l~aL~yL---H~~gIiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~ 340 (566)
T PLN03225 265 LFALDGL---HSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPS 340 (566)
T ss_pred HHHHHHH---HHCCEEeCcCCHHHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCcc
Confidence 9999999 7789999999999999985 578999999999765433221 12345689999999976322
Q ss_pred --------------CCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCC-----
Q 040898 244 --------------TISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGN----- 304 (337)
Q Consensus 244 --------------~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 304 (337)
.++.++||||+||++|+|+++..|++. ....+...+.. .......+.......
T Consensus 341 ~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~-----~~~~~~~~l~~---~~~~~~~~~~~~~~~~~~~~ 412 (566)
T PLN03225 341 APVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDS-----NLIQFNRQLKR---NDYDLVAWRKLVEPRASPDL 412 (566)
T ss_pred ccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCch-----HHHHHHHHHHh---cCCcHHHHHHhhccccchhh
Confidence 233456999999999999997766432 11111111111 111000000000000
Q ss_pred -----chHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 305 -----GYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 305 -----~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
..........+|+.+||+.||++|||+.++|+|
T Consensus 413 ~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 413 RRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAH 450 (566)
T ss_pred hhhhhhccccchHHHHHHHHHccCCcccCCCHHHHhCC
Confidence 000112235689999999999999999999987
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=257.57 Aligned_cols=259 Identities=26% Similarity=0.379 Sum_probs=188.1
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHH--hcC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITAN--QTR 117 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~--~l~ 117 (337)
....+..+.||+|.||.||++.- +++.||||++....- +.+..|-.+.. .++
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL----~~~~VAVKifp~~~k----------------------qs~~~Ek~Iy~lp~m~ 262 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQL----DNRLVAVKIFPEQEK----------------------QSFQNEKNIYSLPGMK 262 (534)
T ss_pred CCchhhHHHhhcCccceeehhhc----cCceeEEEecCHHHH----------------------HHHHhHHHHHhccCcc
Confidence 44477899999999999998776 679999999854322 44555555544 468
Q ss_pred CCCcccceeEEEcCC----eeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhC------CCCCe
Q 040898 118 HRNILPLLAHMVRPN----CHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMC------HRPRL 187 (337)
Q Consensus 118 hpniv~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~------h~~gi 187 (337)
|+||+++++.-.... .++||++|.+.|+|.+++. ...++|....+++..++.||+|||+. |+.+|
T Consensus 263 h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~-----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~I 337 (534)
T KOG3653|consen 263 HENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLK-----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPI 337 (534)
T ss_pred chhHHHhhchhccCCccccceeEEeeeccCCcHHHHHH-----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCcc
Confidence 999999999765544 7899999999999999994 35699999999999999999999966 45679
Q ss_pred EecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCC-C-----CcccchhhhHHHHHH
Q 040898 188 IHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETI-S-----DKCDIYSFGVLLAVL 261 (337)
Q Consensus 188 ~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~-----~~~DiwslG~i~~~l 261 (337)
+|||||..|||+.++++..|+|||++..+............+||.+|||||++.+.-. . .+.||||+|.++||+
T Consensus 338 aHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi 417 (534)
T KOG3653|consen 338 AHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEI 417 (534)
T ss_pred ccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999988876555544445789999999999965432 1 358999999999999
Q ss_pred HhCCCCCCCCCCCchhhhHH---------HHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChh
Q 040898 262 VMGKFPVDDFFGHTEEMDMV---------KWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSK 332 (337)
Q Consensus 262 l~g~~pf~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ 332 (337)
++...-+...........+. +.++.........+.+... +... .....+.+.+..||..||+.|.|+.
T Consensus 418 ~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~-W~~h--~~~~~l~et~EeCWDhDaeARLTA~ 494 (534)
T KOG3653|consen 418 ASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDA-WRKH--AGMAVLCETIEECWDHDAEARLTAG 494 (534)
T ss_pred HhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhh-hhcC--ccHHHHHHHHHHHcCCchhhhhhhH
Confidence 99653331100000111111 1111111111111111111 1111 3345588999999999999999975
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=268.21 Aligned_cols=248 Identities=23% Similarity=0.305 Sum_probs=207.0
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
+-++++++..||-||||.|=++.... ....+|+|++.+.......+. +.+..|-.+|.+...
T Consensus 418 ~l~dl~~iaTLGvGgFGRVELV~~~~--~~~~fAlKilkK~hIVdtkQq----------------eHv~sEr~Im~~~~s 479 (732)
T KOG0614|consen 418 KLSDLKRIATLGVGGFGRVELVKVNS--QKATFALKILKKKHIVDTKQQ----------------EHVFSERNIMMECRS 479 (732)
T ss_pred chhhhhhhhhcccCccceEEEEEecc--cchHHHHHHHhHhhccchhHH----------------HHHHhHHHHHHhcCc
Confidence 56678899999999999997666643 333589998877766554432 678889999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|.||++|..|.+++.+|++||.|-||.|+..+ ..++.++..+..-++..+++|+.|| |.+||+.|||||+|++
T Consensus 480 ~fIvrLYrTfrd~kyvYmLmEaClGGElWTiL----rdRg~Fdd~tarF~~acv~EAfeYL---H~k~iIYRDLKPENll 552 (732)
T KOG0614|consen 480 DFIVRLYRTFRDSKYVYMLMEACLGGELWTIL----RDRGSFDDYTARFYVACVLEAFEYL---HRKGIIYRDLKPENLL 552 (732)
T ss_pred hHHHHHHHHhccchhhhhhHHhhcCchhhhhh----hhcCCcccchhhhhHHHHHHHHHHH---HhcCceeccCChhhee
Confidence 99999999999999999999999999999999 5667799999999999999999999 8889999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhh
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEM 278 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~ 278 (337)
++.+|.+||.|||.+.....+....+ .+|||.|.|||++.....+.++|.||||+++|||++|.+||.....-....
T Consensus 553 Ld~~Gy~KLVDFGFAKki~~g~KTwT---FcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn 629 (732)
T KOG0614|consen 553 LDNRGYLKLVDFGFAKKIGSGRKTWT---FCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYN 629 (732)
T ss_pred eccCCceEEeehhhHHHhccCCceee---ecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHH
Confidence 99999999999999999877765443 689999999999999999999999999999999999999997755544444
Q ss_pred hHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCC
Q 040898 279 DMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPS 330 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps 330 (337)
.+.+.+..+..+.... ....+|+.++...+|.+|..
T Consensus 630 ~ILkGid~i~~Pr~I~----------------k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 630 LILKGIDKIEFPRRIT----------------KTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred HHHhhhhhhhcccccc----------------hhHHHHHHHHHhcCcHhhhc
Confidence 4444444444332221 12678888999999999976
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=259.91 Aligned_cols=265 Identities=21% Similarity=0.285 Sum_probs=202.3
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
+++|-.+.+||+|||+.||++.|.. ..+.||+|+-..+....... .+.+.....+|..+-+.|+||
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~--EqRYvAvKIHqlNK~WrdEK------------KeNYhKHAcREyrIHKeLDHp 527 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLT--EQRYVAVKIHQLNKNWRDEK------------KENYHKHACREYRIHKELDHP 527 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccc--hhheeeEeeehhccchhhHh------------hhhHHHHHHHHHhhhhccCcc
Confidence 5789999999999999999999987 78889999876654433221 122336788999999999999
Q ss_pred CcccceeEEEc-CCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 120 NILPLLAHMVR-PNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 120 niv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
.||+++++|.- ...+|-|+|||+|.+|.-++ .....++++.+..|+.||+.||.||.+. +..|+|.||||.|||
T Consensus 528 RIVKlYDyfslDtdsFCTVLEYceGNDLDFYL----KQhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNIL 602 (775)
T KOG1151|consen 528 RIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYL----KQHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNIL 602 (775)
T ss_pred eeeeeeeeeeeccccceeeeeecCCCchhHHH----HhhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEE
Confidence 99999999864 56788999999999999999 4566789999999999999999999763 678999999999999
Q ss_pred ec---CCCCeEEecccCccccCCCCce-----eeeecccCCCCccCccccc----cCCCCCcccchhhhHHHHHHHhCCC
Q 040898 199 ID---DDMEARISDFGHGKLMPDGHAQ-----ITVKCMVGTMGYMAPESLQ----TETISDKCDIYSFGVLLAVLVMGKF 266 (337)
Q Consensus 199 ~~---~~~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~~~~PE~~~----~~~~~~~~DiwslG~i~~~ll~g~~ 266 (337)
+- ..|.+||+|||++......... .-.+...||..|+|||.+. ....+.++||||+|+|+|..+.|+.
T Consensus 603 Lv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrK 682 (775)
T KOG1151|consen 603 LVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRK 682 (775)
T ss_pred EecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCC
Confidence 94 4578999999999887643322 1123457999999999984 2346789999999999999999999
Q ss_pred CCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhh
Q 040898 267 PVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVR 335 (337)
Q Consensus 267 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 335 (337)
||+..... .++.+...-+. ..+.. -+..|....+..++|++||++--+.|..+-++-
T Consensus 683 PFGhnqsQ---QdILqeNTIlk---AtEVq------FP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 683 PFGHNQSQ---QDILQENTILK---ATEVQ------FPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred CCCCchhH---HHHHhhhchhc---ceecc------CCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 99753221 12211111111 11111 112233444588999999999999998877764
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=267.31 Aligned_cols=262 Identities=26% Similarity=0.359 Sum_probs=209.9
Q ss_pred CCccccccccccccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHH
Q 040898 25 FSPLVEKQDLAFLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIG 104 (337)
Q Consensus 25 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 104 (337)
++|..++||++-.+ .....+||-|-||.||.+.+++ -.-.||||.++.+.. +++
T Consensus 255 vSPn~DkWEmeRtd----ItMkhKLGGGQYGeVYeGvWKk--yslTvAVKtLKEDtM--------------------eve 308 (1157)
T KOG4278|consen 255 VSPNADKWEMERTD----ITMKHKLGGGQYGEVYEGVWKK--YSLTVAVKTLKEDTM--------------------EVE 308 (1157)
T ss_pred ecCCcchhhccchh----eeeeeccCCCcccceeeeeeec--cceeeehhhhhhcch--------------------hHH
Confidence 45666777765433 5677899999999999999987 778899998865432 127
Q ss_pred hHHHHHHHHHhcCCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCC
Q 040898 105 AIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHR 184 (337)
Q Consensus 105 ~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~ 184 (337)
.|+.|..+|+.+.|||+|+++|+|.....+|||+||+..|+|-++++. ..+...+....+.++.||..|+.|| .+
T Consensus 309 EFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRe--cnr~ev~avvLlyMAtQIsSaMeYL---Ek 383 (1157)
T KOG4278|consen 309 EFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRE--CNRSEVPAVVLLYMATQISSAMEYL---EK 383 (1157)
T ss_pred HHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHH--hchhhcchhHHHHHHHHHHHHHHHH---HH
Confidence 899999999999999999999999999999999999999999999976 5667788899999999999999999 89
Q ss_pred CCeEecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-
Q 040898 185 PRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM- 263 (337)
Q Consensus 185 ~gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~- 263 (337)
++++|+||-.+|+|+.++..||++|||+++......- .......-...|.|||-+....++.++|||++|+++||+.|
T Consensus 384 knFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTY-TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATY 462 (1157)
T KOG4278|consen 384 KNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATY 462 (1157)
T ss_pred hhhhhhhhhhhhccccccceEEeeccchhhhhcCCce-ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhc
Confidence 9999999999999999999999999999998765421 11122234567999999999999999999999999999999
Q ss_pred CCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhh
Q 040898 264 GKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVR 335 (337)
Q Consensus 264 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 335 (337)
|-.||.+... ......+..... -..+..++.-+.+|+..||+.+|.+||+++|+-
T Consensus 463 GMsPYPGidl----SqVY~LLEkgyR-------------M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 463 GMSPYPGIDL----SQVYGLLEKGYR-------------MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred CCCCCCCccH----HHHHHHHhcccc-------------ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence 8899876422 122222211111 111222333478899999999999999999873
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=252.58 Aligned_cols=248 Identities=24% Similarity=0.301 Sum_probs=195.8
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc-C
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT-R 117 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~ 117 (337)
+-.+|.++..||.|+||.|-++.... +...||||++.++.....+++ +--..|-++|... +
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkg--tdELyAiKiLkKDViiQdDDv----------------ectm~EKrvLAL~~k 408 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKG--TDELYAIKILKKDVIIQDDDV----------------ECTMVEKRVLALPGK 408 (683)
T ss_pred eecccceEEEeccCccceeeeecccC--cchhhhhhhhccceeeecCcc----------------cceehhhhheecCCC
Confidence 34569999999999999998888876 889999999988776554433 3334455566555 6
Q ss_pred CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCce
Q 040898 118 HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANV 197 (337)
Q Consensus 118 hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ni 197 (337)
.|.+++++..|++-+.+|+||||+.||+|.-.++ +-+.+.+..+.-++..|+-||-+| |++||+.||||.+||
T Consensus 409 ppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQ----Q~GkFKEp~AvFYAaEiaigLFFL---h~kgIiYRDLKLDNv 481 (683)
T KOG0696|consen 409 PPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ----QVGKFKEPVAVFYAAEIAIGLFFL---HSKGIIYRDLKLDNV 481 (683)
T ss_pred CchHHHHHHHhhhhhheeeEEEEecCchhhhHHH----HhcccCCchhhhhhHHHHHHhhhh---hcCCeeeeeccccce
Confidence 7899999999999999999999999999998884 344577778888999999999999 889999999999999
Q ss_pred eecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchh
Q 040898 198 LIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEE 277 (337)
Q Consensus 198 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~ 277 (337)
+++.+|++||.|||++..--.. ..+....+|||.|+|||++...+|+.++|.||+|+++|||+.|++||++-. +
T Consensus 482 mLd~eGHiKi~DFGmcKEni~~--~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeD---E- 555 (683)
T KOG0696|consen 482 MLDSEGHIKIADFGMCKENIFD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED---E- 555 (683)
T ss_pred EeccCCceEeeecccccccccC--CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCC---H-
Confidence 9999999999999998643222 223346789999999999999999999999999999999999999997532 2
Q ss_pred hhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCCh
Q 040898 278 MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSS 331 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~ 331 (337)
.++...+.+..... +-..+.+...+....|...|.+|...
T Consensus 556 ~elF~aI~ehnvsy--------------PKslSkEAv~ickg~ltK~P~kRLGc 595 (683)
T KOG0696|consen 556 DELFQAIMEHNVSY--------------PKSLSKEAVAICKGLLTKHPGKRLGC 595 (683)
T ss_pred HHHHHHHHHccCcC--------------cccccHHHHHHHHHHhhcCCccccCC
Confidence 22222222222111 11223346778888999999999753
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=272.58 Aligned_cols=255 Identities=26% Similarity=0.362 Sum_probs=208.4
Q ss_pred ccccccccceeccCcceEEEEeEEecCC--CCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGS--NGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT 116 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 116 (337)
+.......++||+|+||+||++.+.+.. -..+||+|++......+.. ..+..|+..|.++
T Consensus 694 kEtelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s------------------~e~LdeAl~masl 755 (1177)
T KOG1025|consen 694 KETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKAS------------------IELLDEALRMASL 755 (1177)
T ss_pred hhhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhh------------------HHHHHHHHHHhcC
Confidence 3444677889999999999999998732 2356888888766554433 5788899999999
Q ss_pred CCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 040898 117 RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPAN 196 (337)
Q Consensus 117 ~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~n 196 (337)
+|||++++++++..+. .-||++|+++|+|.++++. .+..+..+..+.|+.||++|+.|| |.++++||||-.+|
T Consensus 756 dHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YL---e~qrlVHrdLaaRN 828 (1177)
T KOG1025|consen 756 DHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYL---EEQRLVHRDLAARN 828 (1177)
T ss_pred CCchHHHHhhhcccch-HHHHHHhcccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHH---Hhcchhhhhhhhhh
Confidence 9999999999988765 7899999999999999975 566788899999999999999999 88999999999999
Q ss_pred eeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCc
Q 040898 197 VLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHT 275 (337)
Q Consensus 197 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~ 275 (337)
+|+.....+|+.|||++..................+.|+|=|.+.-..++.++||||+|+++||++| |..||++....+
T Consensus 829 VLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e 908 (1177)
T KOG1025|consen 829 VLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE 908 (1177)
T ss_pred eeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH
Confidence 9999999999999999998876655544444445667899999999999999999999999999999 999987754422
Q ss_pred hhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhh
Q 040898 276 EEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVR 335 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 335 (337)
+.+.+.. +. .-+.++.+..++.-++.+||..|+..||+++++.
T Consensus 909 ----I~dlle~----ge---------RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~ 951 (1177)
T KOG1025|consen 909 ----IPDLLEK----GE---------RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELA 951 (1177)
T ss_pred ----hhHHHhc----cc---------cCCCCCCccHHHHHHHHHHhccCcccCccHHHHH
Confidence 1111111 10 1234566777799999999999999999999874
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=257.94 Aligned_cols=315 Identities=21% Similarity=0.227 Sum_probs=200.1
Q ss_pred HHHHHHHHHHhccccCCCCCCCCc-cccccccccccccccccccceeccCcceEEEEeEEec--------------CCCC
Q 040898 4 FVLKLILAAVRGGSRDRGPTIFSP-LVEKQDLAFLKKEDCFDSLKKIGSGGWGEVFYKAELP--------------GSNG 68 (337)
Q Consensus 4 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~--------------~~~~ 68 (337)
.+.++..|++.+.+.-.+-..+.- .+....+.-.-..++|++.++||+|+||.||++.... ...+
T Consensus 107 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~ 186 (507)
T PLN03224 107 RLTALYYLLFSKPNPLFNIWDFYVGAPLADGANSRWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKK 186 (507)
T ss_pred HHHHHHHHhhcCCccccchhHHhhcccccccCCCCccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccC
Confidence 445666778888876544332221 1111111112257889999999999999999886421 2256
Q ss_pred ceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCc-----ccceeEEEc--------CCeeE
Q 040898 69 KMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNI-----LPLLAHMVR--------PNCHL 135 (337)
Q Consensus 69 ~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpni-----v~~~~~~~~--------~~~~~ 135 (337)
+.||||++.........+..+. ........+....|+.++.+++|.++ +++++++.. ....+
T Consensus 187 r~VAVK~l~~~~~~~~~~fl~e-----~~~~~~~~e~~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~ 261 (507)
T PLN03224 187 RRVVLKRVNMDRQGVRQDFLKT-----GTLAKGSAETGMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQW 261 (507)
T ss_pred ceEEEEEecccchhhHHHHHhh-----hhhhhcccchhHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceE
Confidence 7899999865433222111110 00001111345567777777766554 667776643 35679
Q ss_pred EEEEeccCCCHHHHHHHhcC--------------------CcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCC
Q 040898 136 LVYEFMKNGSLQDILYDVSQ--------------------GRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPA 195 (337)
Q Consensus 136 lv~e~~~~~~L~~~l~~~~~--------------------~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ 195 (337)
+|+||+++++|.+++..... .....++..+..++.|++.+|.|+ |+.+++|+||||+
T Consensus 262 LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~l---H~~~ivHrDLKp~ 338 (507)
T PLN03224 262 LVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKL---HRIGIVHRDIKPE 338 (507)
T ss_pred EEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCchH
Confidence 99999999999998864211 012345677889999999999999 6779999999999
Q ss_pred ceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCC--------------------C--CCcccchh
Q 040898 196 NVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTET--------------------I--SDKCDIYS 253 (337)
Q Consensus 196 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~--------------------~--~~~~Diws 253 (337)
||+++.++.++|+|||++......... ......+++.|++||.+.... + ....|+||
T Consensus 339 NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwS 417 (507)
T PLN03224 339 NLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYT 417 (507)
T ss_pred hEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhh
Confidence 999999999999999998654332211 111223578999999985432 1 13479999
Q ss_pred hhHHHHHHHhCCC-CCCCCCCCchhh-----hHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCC--
Q 040898 254 FGVLLAVLVMGKF-PVDDFFGHTEEM-----DMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDP-- 325 (337)
Q Consensus 254 lG~i~~~ll~g~~-pf~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP-- 325 (337)
+||++|+|+++.. ||.......... ....|. ...... ..-+.........++|+++||..+|
T Consensus 418 lGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r-~~~~~~---------~~~~~~d~~s~~~~dLi~~LL~~~~~~ 487 (507)
T PLN03224 418 AGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWR-MYKGQK---------YDFSLLDRNKEAGWDLACKLITKRDQA 487 (507)
T ss_pred HHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHH-hhcccC---------CCcccccccChHHHHHHHHHhccCCCC
Confidence 9999999999875 764321111100 011110 000000 0011122344568999999999766
Q ss_pred -CCCCChhhhhcC
Q 040898 326 -DERPSSKDVRSM 337 (337)
Q Consensus 326 -~~Rps~~ell~~ 337 (337)
.+|+|+.|+|+|
T Consensus 488 ~~~RlSa~eaL~H 500 (507)
T PLN03224 488 NRGRLSVGQALSH 500 (507)
T ss_pred cccCCCHHHHhCC
Confidence 789999999998
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=231.09 Aligned_cols=263 Identities=22% Similarity=0.316 Sum_probs=200.5
Q ss_pred cccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHh
Q 040898 36 FLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQ 115 (337)
Q Consensus 36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~ 115 (337)
-++..++|++.+++|+|.+++||.+.... ++.+++||.+++..- ..+.+|+++|..
T Consensus 33 ~wg~~ddYeivrk~GRGKYSEVFeg~~~~--~~eK~ViKiLKPVkk----------------------kKIkREikIL~n 88 (338)
T KOG0668|consen 33 DWGNQDDYEIVRKVGRGKYSEVFEGINIT--NNEKCVIKILKPVKK----------------------KKIKREIKILQN 88 (338)
T ss_pred eccccchHHHHHHHcCccHhhHhcccccC--CCceEEEeeechHHH----------------------HHHHHHHHHHHh
Confidence 34578889999999999999999999887 899999999865321 678999999999
Q ss_pred cC-CCCcccceeEEEcC--CeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 040898 116 TR-HRNILPLLAHMVRP--NCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDI 192 (337)
Q Consensus 116 l~-hpniv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di 192 (337)
|. ||||++++++..++ +...+++||.++.+...+..+ ++.-.+...+.++++||.|+ |++||.|+|+
T Consensus 89 L~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~t-------l~d~dIryY~~elLkALdyC---HS~GImHRDV 158 (338)
T KOG0668|consen 89 LRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYPT-------LTDYDIRYYIYELLKALDYC---HSMGIMHRDV 158 (338)
T ss_pred ccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHhhh-------hchhhHHHHHHHHHHHHhHH---HhcCcccccC
Confidence 96 99999999998664 567899999999888887744 66677889999999999999 8889999999
Q ss_pred CCCceeecC-CCCeEEecccCccccCCCCceeeeecccCCCCccCccccccC-CCCCcccchhhhHHHHHHHhCCCCCCC
Q 040898 193 KPANVLIDD-DMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTE-TISDKCDIYSFGVLLAVLVMGKFPVDD 270 (337)
Q Consensus 193 ~~~nil~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~i~~~ll~g~~pf~~ 270 (337)
||.|++++. ...++|+|||++.++..+.. .+.+..+..|-.||++... .|+.+-|+|||||++..|+..+.||-.
T Consensus 159 KPhNvmIdh~~rkLrlIDWGLAEFYHp~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFh 235 (338)
T KOG0668|consen 159 KPHNVMIDHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 235 (338)
T ss_pred CcceeeechhhceeeeeecchHhhcCCCce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccC
Confidence 999999985 46799999999998866543 3445678889999998654 478889999999999999999999843
Q ss_pred CCCCchhhhHHHHH------------HhhhccCC----------cchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCC
Q 040898 271 FFGHTEEMDMVKWM------------RNVIFSEN----------PNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDER 328 (337)
Q Consensus 271 ~~~~~~~~~~~~~~------------~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 328 (337)
+.+....+.+.. ......-. ....+........-.-...+..+|+..+|..|..+|
T Consensus 236 --G~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeR 313 (338)
T KOG0668|consen 236 --GHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQER 313 (338)
T ss_pred --CCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccc
Confidence 333332222211 11110000 000111111111111223567899999999999999
Q ss_pred CChhhhhcC
Q 040898 329 PSSKDVRSM 337 (337)
Q Consensus 329 ps~~ell~~ 337 (337)
+|+.|++.|
T Consensus 314 lTakEam~H 322 (338)
T KOG0668|consen 314 LTAKEAMAH 322 (338)
T ss_pred cchHHHhcC
Confidence 999999876
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=235.74 Aligned_cols=241 Identities=29% Similarity=0.414 Sum_probs=190.5
Q ss_pred cceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCcccceeEEEcCC
Q 040898 53 GWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPN 132 (337)
Q Consensus 53 ~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 132 (337)
+||.||++.+.. ++..+++|++........ ...+.+|+..+++++|+|++++++.+....
T Consensus 1 ~~g~v~~~~~~~--~~~~~~~k~~~~~~~~~~------------------~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~ 60 (244)
T smart00220 1 SFGKVYLARDKK--TGKLVAIKVIKKEKIKKK------------------RERILREISILKKLKHPNIVRLYDVFEDED 60 (244)
T ss_pred CceEEEEEEECC--CCcEEEEEEecccccccH------------------HHHHHHHHHHHHhCCCCcHHHHHhheeeCC
Confidence 589999998865 789999999876543221 157788999999999999999999999999
Q ss_pred eeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCCeEEecccC
Q 040898 133 CHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGH 212 (337)
Q Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~~l~dfg~ 212 (337)
..++++|++++++|.+++.. ...+++..++.++.+++.++.+| |+.|++|+||+|+||+++.++.++|+|||.
T Consensus 61 ~~~l~~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~l---h~~~i~h~~i~~~ni~~~~~~~~~l~d~~~ 133 (244)
T smart00220 61 KLYLVMEYCDGGDLFDLLKK----RGRLSEDEARFYARQILSALEYL---HSNGIIHRDLKPENILLDEDGHVKLADFGL 133 (244)
T ss_pred EEEEEEeCCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHH---HHcCeecCCcCHHHeEECCCCcEEEccccc
Confidence 99999999999999999854 22388899999999999999999 667999999999999999999999999999
Q ss_pred ccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHHHHHHhhhccCC
Q 040898 213 GKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSEN 292 (337)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 292 (337)
+....... ......++..|++||...+..++.++|+||+|++++++++|..||..... .....+..........
T Consensus 134 ~~~~~~~~---~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~---~~~~~~~~~~~~~~~~ 207 (244)
T smart00220 134 ARQLDPGG---LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ---LLELFKKIGKPKPPFP 207 (244)
T ss_pred eeeecccc---ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHhccCCCCc
Confidence 88765432 12234578889999999888888999999999999999999999865311 1111111111111000
Q ss_pred cchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 293 PNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.. .......+.+++.+||..+|++||++.++++|
T Consensus 208 ~~-----------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~ 241 (244)
T smart00220 208 PP-----------EWKISPEAKDLIRKLLVKDPEKRLTAEEALQH 241 (244)
T ss_pred cc-----------cccCCHHHHHHHHHHccCCchhccCHHHHhhC
Confidence 00 00023458899999999999999999999976
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=239.09 Aligned_cols=254 Identities=23% Similarity=0.314 Sum_probs=195.7
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc-C
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT-R 117 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~ 117 (337)
.-++|..++.||+|+|+.|-++..++ +.+-||+|+++++-..... .++....|-....+. +
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~--t~qiyamkvvkkel~ndde----------------didwvqtek~vfe~asn 309 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKK--TDQIYAMKVVKKELVNDDE----------------DIDWVQTEKHVFEQASN 309 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcc--cceeeehhhHHHHhcCCcc----------------cchhHHhhHHHHHhccC
Confidence 34679999999999999998888877 9999999998765432221 124566666666665 8
Q ss_pred CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCce
Q 040898 118 HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANV 197 (337)
Q Consensus 118 hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ni 197 (337)
||.+|.++..|++...+++|.||.+||+|.-.+ ++...++++.+.-+...|+.||.|| |+.||+.+|+|.+|+
T Consensus 310 ~pflvglhscfqtesrlffvieyv~ggdlmfhm----qrqrklpeeharfys~ei~lal~fl---h~rgiiyrdlkldnv 382 (593)
T KOG0695|consen 310 NPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM----QRQRKLPEEHARFYSAEICLALNFL---HERGIIYRDLKLDNV 382 (593)
T ss_pred CCeEEehhhhhcccceEEEEEEEecCcceeeeh----hhhhcCcHHHhhhhhHHHHHHHHHH---hhcCeeeeeccccce
Confidence 999999999999999999999999999998877 4556689998999999999999999 888999999999999
Q ss_pred eecCCCCeEEecccCcccc-CCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCch
Q 040898 198 LIDDDMEARISDFGHGKLM-PDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTE 276 (337)
Q Consensus 198 l~~~~~~~~l~dfg~~~~~-~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~ 276 (337)
+++..|++||+|+|++..- ..+. ..+..+|||.|.|||++.+..|..++|.|+||++++||+.|+.||+-...+..
T Consensus 383 lldaeghikltdygmcke~l~~gd---~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~ 459 (593)
T KOG0695|consen 383 LLDAEGHIKLTDYGMCKEGLGPGD---TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNP 459 (593)
T ss_pred EEccCCceeecccchhhcCCCCCc---ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCc
Confidence 9999999999999998642 2222 23457899999999999999999999999999999999999999974333222
Q ss_pred hhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCC
Q 040898 277 EMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPS 330 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps 330 (337)
+.+-...+.++........ .. ..+.....+++..|+.||.+|..
T Consensus 460 d~ntedylfqvilekqiri--pr--------slsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 460 DMNTEDYLFQVILEKQIRI--PR--------SLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred ccchhHHHHHHHhhhcccc--cc--------eeehhhHHHHHHhhcCCcHHhcC
Confidence 2222233333222111100 00 01111455677889999999964
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=262.54 Aligned_cols=265 Identities=24% Similarity=0.324 Sum_probs=207.0
Q ss_pred ccccccccccccceeccCcceEEEEeEEecCC-----CCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHH
Q 040898 35 AFLKKEDCFDSLKKIGSGGWGEVFYKAELPGS-----NGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSE 109 (337)
Q Consensus 35 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e 109 (337)
.|.-..++..+.+.||.|.||.||++.-.... ....||||.+......+.. ..+..|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~------------------~~~~~E 351 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEK------------------KDLMSE 351 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHH------------------HHHHHH
Confidence 44445556678889999999999988654211 2578999998776654322 678889
Q ss_pred HHHHHhc-CCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhc---C---C----c--ccCChHHHHHHHHHHHHHH
Q 040898 110 IITANQT-RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVS---Q---G----R--RELDWPARHRIARGIASGL 176 (337)
Q Consensus 110 ~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~---~----~--~~~~~~~~~~i~~~i~~~l 176 (337)
+.+|+.+ .||||+.+.|.+...+..++|.||+..|+|.++++..+ . . . ..++....+.++.||+.|+
T Consensus 352 l~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GM 431 (609)
T KOG0200|consen 352 LNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGM 431 (609)
T ss_pred HHHHHHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHH
Confidence 9999999 69999999999999999999999999999999998755 0 0 1 2488899999999999999
Q ss_pred HHHhhCCCCCeEecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecc-cCCCCccCccccccCCCCCcccchhhh
Q 040898 177 EYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCM-VGTMGYMAPESLQTETISDKCDIYSFG 255 (337)
Q Consensus 177 ~~l~~~h~~gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~-~~~~~~~~PE~~~~~~~~~~~DiwslG 255 (337)
.|| .+..++|||+-.+||+++++..+|++|||+++.............. .-...|+|||.+....++.++||||+|
T Consensus 432 e~L---~~~~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfG 508 (609)
T KOG0200|consen 432 EYL---ASVPCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFG 508 (609)
T ss_pred HHH---hhCCccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHH
Confidence 999 7889999999999999999999999999999865544333221111 134459999999999999999999999
Q ss_pred HHHHHHHh-CCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhh
Q 040898 256 VLLAVLVM-GKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDV 334 (337)
Q Consensus 256 ~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el 334 (337)
+++||+++ |..||.+... ..++.+.+++...... +..+..++.+++..||+.+|++||++.++
T Consensus 509 I~L~EifsLG~~PYp~~~~---~~~l~~~l~~G~r~~~-------------P~~c~~eiY~iM~~CW~~~p~~RP~F~~~ 572 (609)
T KOG0200|consen 509 ILLWEIFTLGGTPYPGIPP---TEELLEFLKEGNRMEQ-------------PEHCSDEIYDLMKSCWNADPEDRPTFSEC 572 (609)
T ss_pred HHHHHHhhCCCCCCCCCCc---HHHHHHHHhcCCCCCC-------------CCCCCHHHHHHHHHHhCCCcccCCCHHHH
Confidence 99999999 8899876322 2223333333322222 22334558899999999999999999998
Q ss_pred hc
Q 040898 335 RS 336 (337)
Q Consensus 335 l~ 336 (337)
.+
T Consensus 573 ~~ 574 (609)
T KOG0200|consen 573 VE 574 (609)
T ss_pred HH
Confidence 64
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=239.27 Aligned_cols=267 Identities=22% Similarity=0.318 Sum_probs=198.2
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC-
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR- 117 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~- 117 (337)
.+++|.+.++||+|.|++||++-|.. +.+.||+|+.+.... +.+....|+++|++++
T Consensus 76 ~~gRY~v~rKLGWGHFSTVWLawDtq--~~r~VAlKVvKSAqh--------------------YtEaAlDEIklL~~v~~ 133 (590)
T KOG1290|consen 76 NGGRYHVQRKLGWGHFSTVWLAWDTQ--NKRYVALKVVKSAQH--------------------YTEAALDEIKLLQQVRE 133 (590)
T ss_pred cCceEEEEEeccccccceeEEEeecc--CCeEEEEEEEehhhH--------------------HHHHHHHHHHHHHHHHh
Confidence 45899999999999999999999987 899999999753211 1156777999998872
Q ss_pred ----C---CCcccceeEEE----cCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCC
Q 040898 118 ----H---RNILPLLAHMV----RPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPR 186 (337)
Q Consensus 118 ----h---pniv~~~~~~~----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~g 186 (337)
| .+||++++.|. ++..+++|+|++ |.+|-.+|.. ..-..++...+.+|++||+.||.|||. .-|
T Consensus 134 ~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~--s~YrGlpl~~VK~I~~qvL~GLdYLH~--ecg 208 (590)
T KOG1290|consen 134 GDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKY--SNYRGLPLSCVKEICRQVLTGLDYLHR--ECG 208 (590)
T ss_pred cCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHH--hCCCCCcHHHHHHHHHHHHHHHHHHHH--hcC
Confidence 3 37899999885 457899999999 6688888876 344558889999999999999999984 459
Q ss_pred eEecCCCCCceeec------------------------------------------------------------------
Q 040898 187 LIHRDIKPANVLID------------------------------------------------------------------ 200 (337)
Q Consensus 187 i~h~di~~~nil~~------------------------------------------------------------------ 200 (337)
|+|.||||+|||+.
T Consensus 209 IIHTDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l 288 (590)
T KOG1290|consen 209 IIHTDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASL 288 (590)
T ss_pred ccccCCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhh
Confidence 99999999999994
Q ss_pred ------------------------------------------------CC------------------------------
Q 040898 201 ------------------------------------------------DD------------------------------ 202 (337)
Q Consensus 201 ------------------------------------------------~~------------------------------ 202 (337)
.+
T Consensus 289 ~~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~ 368 (590)
T KOG1290|consen 289 AGLEGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSP 368 (590)
T ss_pred cccccccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCc
Confidence 00
Q ss_pred ----------------------CCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHH
Q 040898 203 ----------------------MEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAV 260 (337)
Q Consensus 203 ----------------------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ 260 (337)
-.+||+|||-++++... .+....|..|.+||++.|..|+..+||||++|+++|
T Consensus 369 ~s~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~kh-----FT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FE 443 (590)
T KOG1290|consen 369 SSPGTIASNPLVNPDIPLPECDIRVKIADLGNACWVHKH-----FTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFE 443 (590)
T ss_pred CCccccccccccCCCCCCCccceeEEEeeccchhhhhhh-----hchhhhhhhccCcceeecCCCCCchhHHHHHHHHHH
Confidence 02566777766664332 233467899999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCc--hhhhHHHHHHhhhccCCc--------chhhhhc-----------c---------cCCchHHHH
Q 040898 261 LVMGKFPVDDFFGHT--EEMDMVKWMRNVIFSENP--------NRAINSK-----------L---------LGNGYEEQM 310 (337)
Q Consensus 261 ll~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~--------~~~~~~~-----------~---------~~~~~~~~~ 310 (337)
|.||..-|+...+.. .+.+....+-+.+..-+. .+....+ . .-....+..
T Consensus 444 LaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A 523 (590)
T KOG1290|consen 444 LATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDA 523 (590)
T ss_pred hhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHH
Confidence 999999997544432 222222222222211111 0000000 0 012335666
Q ss_pred HHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 311 LLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 311 ~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.++.+++.-||+.+|++||||.+.|+|
T Consensus 524 ~~fsdFL~PmLef~PeKR~tA~~cl~h 550 (590)
T KOG1290|consen 524 QQFSDFLSPMLEFDPEKRPTAAQCLKH 550 (590)
T ss_pred HHHHHHHHHHHhcCccccccHHHHhcC
Confidence 789999999999999999999999987
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=237.51 Aligned_cols=268 Identities=24% Similarity=0.292 Sum_probs=194.7
Q ss_pred cccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCc
Q 040898 42 CFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNI 121 (337)
Q Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpni 121 (337)
+.+.-+.||.|+||.||.+.|-. +|+.|++|++......-. ...++.+|+++++.++|.|+
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPR--dgrrvalkK~pnvfq~L~-----------------s~krvFre~kmLcfFkHdNV 114 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPR--SGKRVALKKMPNVFQNLA-----------------SCKRVFREIKMLSSFRHDNV 114 (449)
T ss_pred cCCCCCcccccceeEEEeccCCC--CccchhHhhcchHHHHHH-----------------HHHHHHHHHHHHHhhccccH
Confidence 34566789999999999988865 999999999864322111 11688999999999999999
Q ss_pred ccceeEEEcCC-----eeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 040898 122 LPLLAHMVRPN-----CHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPAN 196 (337)
Q Consensus 122 v~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~n 196 (337)
+...+..+-.. ..|.++|.+.. +|...+ -+...++..-++-++.||+.||+|| |+.+|+|+||||.|
T Consensus 115 LSaLDILQPph~dfFqEiYV~TELmQS-DLHKII----VSPQ~Ls~DHvKVFlYQILRGLKYL---HsA~ILHRDIKPGN 186 (449)
T KOG0664|consen 115 LSLLDILQPANPSFFQELYVLTELMQS-DLHKII----VSPQALTPDHVKVFVYQILRGLKYL---HTANILHRDIKPGN 186 (449)
T ss_pred HHHHHhcCCCCchHHHHHHHHHHHHHh-hhhhee----ccCCCCCcchhhhhHHHHHhhhHHH---hhcchhhccCCCcc
Confidence 99998776542 45777887754 777766 5677899999999999999999999 88899999999999
Q ss_pred eeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCCCc
Q 040898 197 VLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTE-TISDKCDIYSFGVLLAVLVMGKFPVDDFFGHT 275 (337)
Q Consensus 197 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~ 275 (337)
.+++.++.+||+|||+++........ ..+...-|..|.+||++.|. .|+.+.||||.||++.|++..+.-|.....-.
T Consensus 187 LLVNSNCvLKICDFGLARvee~d~~~-hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~Piq 265 (449)
T KOG0664|consen 187 LLVNSNCILKICDFGLARTWDQRDRL-NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIE 265 (449)
T ss_pred EEeccCceEEecccccccccchhhhh-hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHH
Confidence 99999999999999999875433222 22344568889999999765 48999999999999999999988875432211
Q ss_pred hhh---------------hHHHHHHhhhccCCcchhhhhccc-CCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 276 EEM---------------DMVKWMRNVIFSENPNRAINSKLL-GNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 276 ~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
... ..++..+...............+. -........+...++..+|..||++|.+.++.+.|
T Consensus 266 QL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~ 343 (449)
T KOG0664|consen 266 QLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQH 343 (449)
T ss_pred HHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence 110 111111111111111111111111 11222334456788899999999999999998865
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=264.23 Aligned_cols=248 Identities=26% Similarity=0.398 Sum_probs=188.0
Q ss_pred ccccceeccCcceEE-EEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc-CCCC
Q 040898 43 FDSLKKIGSGGWGEV-FYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT-RHRN 120 (337)
Q Consensus 43 y~~~~~lg~G~~g~V-~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpn 120 (337)
|...+.+|.|+.|+| |.+.- .|+.||||++..+.. +.+.+|+..++.- +|||
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y----e~R~VAVKrll~e~~----------------------~~A~rEi~lL~eSD~H~N 564 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY----EGREVAVKRLLEEFF----------------------DFAQREIQLLQESDEHPN 564 (903)
T ss_pred eccHHHcccCCCCcEEEEEee----CCceehHHHHhhHhH----------------------HHHHHHHHHHHhccCCCc
Confidence 445567899999886 54444 789999999864432 5788999999998 7999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
|+++++.-.+....|+..|.|.- +|.++++..............+.++.|+++||++| |+-+||||||||.||||+
T Consensus 565 viRyyc~E~d~qF~YIalELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHL---Hsl~iVHRDLkPQNILI~ 640 (903)
T KOG1027|consen 565 VIRYYCSEQDRQFLYIALELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHL---HSLKIVHRDLKPQNILIS 640 (903)
T ss_pred eEEEEeeccCCceEEEEehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHH---HhcccccccCCCceEEEE
Confidence 99999999999999999999955 99999965311111111145688999999999999 556999999999999997
Q ss_pred C---C--CCeEEecccCccccCCCCce-eeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhC-CCCCCCCCC
Q 040898 201 D---D--MEARISDFGHGKLMPDGHAQ-ITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMG-KFPVDDFFG 273 (337)
Q Consensus 201 ~---~--~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g-~~pf~~~~~ 273 (337)
. + ..++|+|||++.....+... .......||-+|+|||++.....+.++|||||||++|+.++| .+||+....
T Consensus 641 ~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~ 720 (903)
T KOG1027|consen 641 VPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE 720 (903)
T ss_pred ccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHH
Confidence 5 3 46799999999987655432 223456799999999999998888899999999999999995 899976422
Q ss_pred CchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 274 HTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
. +.++ ........... ..+.+ +..+||.+|++++|..|||+.++|.|
T Consensus 721 R--~~NI-------l~~~~~L~~L~------~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 721 R--QANI-------LTGNYTLVHLE------PLPDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred h--hhhh-------hcCccceeeec------cCchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 1 1111 11111111100 01111 58899999999999999999999987
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=220.50 Aligned_cols=209 Identities=23% Similarity=0.404 Sum_probs=176.8
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc-C
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT-R 117 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~ 117 (337)
+.++..-+..||+|++|.|=+-++.. +|+..|+|++......... .+..+|+.+..+. .
T Consensus 44 ~ad~L~~i~elGrGayG~vekmrh~~--sg~imAvKri~~tvn~q~q------------------~r~L~dldi~~r~~~ 103 (282)
T KOG0984|consen 44 PADDLVGIEELGRGAYGVVEKMRHIQ--SGTIMAVKRIRATVNSQEQ------------------KRLLMDLDIIMRTVD 103 (282)
T ss_pred chhhhhhhhhhcCCccchhhheeecc--CCeEEEEeeehhhcChHHH------------------HHHHHhhhhhccCCC
Confidence 45556678899999999996667766 9999999999766543222 5667788766554 8
Q ss_pred CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCce
Q 040898 118 HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANV 197 (337)
Q Consensus 118 hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ni 197 (337)
+|.+|.++|.......+++.||.++. ||..+.......+..+++..+-+++..++.||.||| .+..++|||+||+||
T Consensus 104 CPf~V~FyGa~~regdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~--~kL~vIHRDvKPsNi 180 (282)
T KOG0984|consen 104 CPFTVHFYGALFREGDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLH--SKLSVIHRDVKPSNI 180 (282)
T ss_pred CCeEEEeehhhhccccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHH--HHhhhhhccCCcceE
Confidence 99999999999999999999999966 999999888889999999999999999999999998 457899999999999
Q ss_pred eecCCCCeEEecccCccccCCCCceeeeecccCCCCccCcccccc----CCCCCcccchhhhHHHHHHHhCCCCCCCCCC
Q 040898 198 LIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQT----ETISDKCDIYSFGVLLAVLVMGKFPVDDFFG 273 (337)
Q Consensus 198 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~----~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~ 273 (337)
|++..|.+|++|||.+-.+.++... +...|...|+|||.+.. ..|+.++||||||+++.||.+++.||+.+..
T Consensus 181 LIn~~GqVKiCDFGIsG~L~dSiAk---t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t 257 (282)
T KOG0984|consen 181 LINYDGQVKICDFGISGYLVDSIAK---TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT 257 (282)
T ss_pred EEccCCcEEEcccccceeehhhhHH---HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence 9999999999999999877655432 22468888999999853 3588999999999999999999999986543
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=249.82 Aligned_cols=217 Identities=24% Similarity=0.402 Sum_probs=178.3
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
.-|..++.||-|+||+|.++...+ +...||.|.+.+....... .+.....|-.+|...+.+-
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvD--T~~lYAmKTLrKaDVl~rn----------------QvaHVKAERDILAEADn~W 690 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVD--TRALYAMKTLRKADVLMRN----------------QVAHVKAERDILAEADNEW 690 (1034)
T ss_pred cceEEEeeecccccceeEEEeecc--hhhHHHHhhhHHHHHHhhh----------------hhhhhhhhhhhHhhcCCcc
Confidence 457788999999999998887776 8899999988655433322 2367778999999999999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
||+++-.|++++++|+||+|++||++..+|.. -+-+++..+.-++..+..|+.+. |+.|++||||||+||||+
T Consensus 691 VVrLyySFQDkdnLYFVMdYIPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesV---HkmGFIHRDiKPDNILID 763 (1034)
T KOG0608|consen 691 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESV---HKMGFIHRDIKPDNILID 763 (1034)
T ss_pred eEEEEEEeccCCceEEEEeccCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHH---HhccceecccCccceEEc
Confidence 99999999999999999999999999998853 45688888899999999999999 888999999999999999
Q ss_pred CCCCeEEecccCccccC---CCC--------ce-----------------------------eeeecccCCCCccCcccc
Q 040898 201 DDMEARISDFGHGKLMP---DGH--------AQ-----------------------------ITVKCMVGTMGYMAPESL 240 (337)
Q Consensus 201 ~~~~~~l~dfg~~~~~~---~~~--------~~-----------------------------~~~~~~~~~~~~~~PE~~ 240 (337)
.+|++||+|||+++-+. ++. .. ......+||+.|+|||++
T Consensus 764 rdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl 843 (1034)
T KOG0608|consen 764 RDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVL 843 (1034)
T ss_pred cCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHh
Confidence 99999999999987542 000 00 001123599999999999
Q ss_pred ccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHHH
Q 040898 241 QTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVK 282 (337)
Q Consensus 241 ~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~ 282 (337)
....++..+|.||.|+|+|+|+.|++||..............
T Consensus 844 ~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~n 885 (1034)
T KOG0608|consen 844 ARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVIN 885 (1034)
T ss_pred cccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeee
Confidence 999999999999999999999999999965544433333333
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=236.82 Aligned_cols=257 Identities=26% Similarity=0.367 Sum_probs=190.1
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHh--cCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQ--TRH 118 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~--l~h 118 (337)
....+.+.||+|.||+||++.+ .|..||||++..... .+..+|.++.+. |+|
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~w----rGe~VAVKiF~srdE----------------------~SWfrEtEIYqTvmLRH 264 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRW----RGEDVAVKIFSSRDE----------------------RSWFRETEIYQTVMLRH 264 (513)
T ss_pred heeEEEEEecCccccceeeccc----cCCceEEEEecccch----------------------hhhhhHHHHHHHHHhcc
Confidence 4577889999999999999988 899999999965432 344455555554 699
Q ss_pred CCcccceeEEEcC----CeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhC-----CCCCeEe
Q 040898 119 RNILPLLAHMVRP----NCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMC-----HRPRLIH 189 (337)
Q Consensus 119 pniv~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~-----h~~gi~h 189 (337)
+||+.|++.-..+ .+++||++|-+.|||.|+|.. ..++.....+++..++.||++||.. .+..|.|
T Consensus 265 ENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAH 339 (513)
T KOG2052|consen 265 ENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAH 339 (513)
T ss_pred chhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhc
Confidence 9999999865433 357999999999999999943 5688899999999999999999843 3456999
Q ss_pred cCCCCCceeecCCCCeEEecccCccccCCC--CceeeeecccCCCCccCccccccCC----C--CCcccchhhhHHHHHH
Q 040898 190 RDIKPANVLIDDDMEARISDFGHGKLMPDG--HAQITVKCMVGTMGYMAPESLQTET----I--SDKCDIYSFGVLLAVL 261 (337)
Q Consensus 190 ~di~~~nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~~~~~~PE~~~~~~----~--~~~~DiwslG~i~~~l 261 (337)
||||..||++.+++...|+|+|++-..... ......+..+||.+|||||++...- + -..+||||+|.++||+
T Consensus 340 RDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEi 419 (513)
T KOG2052|consen 340 RDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEI 419 (513)
T ss_pred cccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHH
Confidence 999999999999999999999998765543 3344456688999999999985321 1 1358999999999998
Q ss_pred HhC----------CCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCCh
Q 040898 262 VMG----------KFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSS 331 (337)
Q Consensus 262 l~g----------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~ 331 (337)
... ++||.+....+... +.+++..-.....+..+ ..+. ..+....+.++++.||..||.-|.|+
T Consensus 420 arRc~~ggi~eey~~Pyyd~Vp~DPs~---eeMrkVVCv~~~RP~ip-nrW~--s~~~l~~m~klMkeCW~~Np~aRltA 493 (513)
T KOG2052|consen 420 ARRCESGGIVEEYQLPYYDVVPSDPSF---EEMRKVVCVQKLRPNIP-NRWK--SDPALRVMAKLMKECWYANPAARLTA 493 (513)
T ss_pred HHHhhcCCEehhhcCCcccCCCCCCCH---HHHhcceeecccCCCCC-cccc--cCHHHHHHHHHHHHhhcCCchhhhHH
Confidence 753 37776654443332 22232222111111111 1111 12455568999999999999999998
Q ss_pred hhh
Q 040898 332 KDV 334 (337)
Q Consensus 332 ~el 334 (337)
-.+
T Consensus 494 Lri 496 (513)
T KOG2052|consen 494 LRI 496 (513)
T ss_pred HHH
Confidence 654
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.2e-33 Score=243.19 Aligned_cols=267 Identities=19% Similarity=0.262 Sum_probs=204.5
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC-
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH- 118 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h- 118 (337)
.++|++..-.|+|=|++|-.+.+.. .|+.||||++..+.... ..-++|+.+|+.|+.
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~--r~~~vAiKIIRnNE~M~--------------------KtGl~EleiLkKL~~A 488 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQA--RGQEVAIKIIRNNEVMH--------------------KTGLKELEILKKLNDA 488 (752)
T ss_pred cceeEEEeccccceeeeeeeccccC--CCCeeEEEEeecchHHh--------------------hhhhHHHHHHHHhhcc
Confidence 4579999999999999998888866 88899999997764422 345669999999853
Q ss_pred -----CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCC
Q 040898 119 -----RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIK 193 (337)
Q Consensus 119 -----pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~ 193 (337)
-++++++..|...+++|+|+|-+ ..+|.+++..+- .+-.+....+..++.|++.||..|..| |++|+|||
T Consensus 489 D~Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG-~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIK 563 (752)
T KOG0670|consen 489 DPEDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYG-RNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIK 563 (752)
T ss_pred CchhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhC-cccceeehHHHHHHHHHHHHHHHHHhc---CeeecccC
Confidence 38899999999999999999988 459999997643 445578889999999999999999666 99999999
Q ss_pred CCceeecCC-CCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCC
Q 040898 194 PANVLIDDD-MEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFF 272 (337)
Q Consensus 194 ~~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~ 272 (337)
|+|||++.. ..+||||||.+.....+. .+.+.-+..|.|||++.|.+|+...|+||.||++||+.||+..|.+..
T Consensus 564 PDNiLVNE~k~iLKLCDfGSA~~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T 639 (752)
T KOG0670|consen 564 PDNILVNESKNILKLCDFGSASFASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT 639 (752)
T ss_pred ccceEeccCcceeeeccCcccccccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC
Confidence 999999875 457999999988765443 233456677999999999999999999999999999999999997754
Q ss_pred CCchhhhHHHHHHhhh-------------------------------------ccCCcchhhhhcc-----cCCchHHHH
Q 040898 273 GHTEEMDMVKWMRNVI-------------------------------------FSENPNRAINSKL-----LGNGYEEQM 310 (337)
Q Consensus 273 ~~~~~~~~~~~~~~~~-------------------------------------~~~~~~~~~~~~~-----~~~~~~~~~ 310 (337)
.+....-+.+.-..+. ....|.......+ .....+...
T Consensus 640 NN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~ 719 (752)
T KOG0670|consen 640 NNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIV 719 (752)
T ss_pred cHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHH
Confidence 4433322222111000 0000000001111 112234556
Q ss_pred HHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 311 LLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 311 ~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
..+.+|+..||..||.+|.|..++|+|
T Consensus 720 ~~~rdLLdkml~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 720 QQLRDLLDKMLILDPEKRITVNQALKH 746 (752)
T ss_pred HHHHHHHHHHhccChhhcCCHHHHhcC
Confidence 789999999999999999999999987
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=243.79 Aligned_cols=207 Identities=28% Similarity=0.439 Sum_probs=177.2
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC-
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR- 117 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~- 117 (337)
+..+|..++.+|.|+||.||++.++. +...|+||-+.++...-. ..++.. ....+-.|+.+|..++
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~--n~~eVViK~I~KeRIL~D-----tWvrDr------kLGtVp~EIqIla~l~~ 625 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKE--NNYEVVIKMIFKERILVD-----TWVRDR------KLGTVPSEIQILATLNK 625 (772)
T ss_pred ccccceeeeeccccccceEEEeeecc--cceEEEeeehhhhhhhhh-----hhhccc------ccCccchhHHHHHHhhh
Confidence 45679999999999999999999986 688899998876544322 122222 2256778999999997
Q ss_pred --CCCcccceeEEEcCCeeEEEEEec-cCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCC
Q 040898 118 --HRNILPLLAHMVRPNCHLLVYEFM-KNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKP 194 (337)
Q Consensus 118 --hpniv~~~~~~~~~~~~~lv~e~~-~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~ 194 (337)
|+||++++++|++++.+|++||.- ++.+|.+++ ..+..+++.....|++|++.|+++| |++||+|||||-
T Consensus 626 ~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~I----E~kp~m~E~eAk~IFkQV~agi~hl---h~~~ivhrdikd 698 (772)
T KOG1152|consen 626 HSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFI----EFKPRMDEPEAKLIFKQVVAGIKHL---HDQGIVHRDIKD 698 (772)
T ss_pred cCccchhhhhheeecCCeeEEEecCCCCCcchhhhh----hccCccchHHHHHHHHHHHhccccc---cccCceeccccc
Confidence 999999999999999999999974 567899999 5566799999999999999999999 899999999999
Q ss_pred CceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCC-CCcccchhhhHHHHHHHhCCCCCC
Q 040898 195 ANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETI-SDKCDIYSFGVLLAVLVMGKFPVD 269 (337)
Q Consensus 195 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~DiwslG~i~~~ll~g~~pf~ 269 (337)
+|+.++.+|-++|+|||.+.....+.. ....||..|.|||++.|.+| +..-|||+||+++|-++....||-
T Consensus 699 envivd~~g~~klidfgsaa~~ksgpf----d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 699 ENVIVDSNGFVKLIDFGSAAYTKSGPF----DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ccEEEecCCeEEEeeccchhhhcCCCc----ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999999999999999999988766653 34589999999999999887 456899999999999998888873
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-32 Score=227.39 Aligned_cols=270 Identities=24% Similarity=0.317 Sum_probs=200.7
Q ss_pred ccccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHH
Q 040898 35 AFLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITAN 114 (337)
Q Consensus 35 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~ 114 (337)
..+-...+|.-++.+|.|.- .|--+.|.. .+++||+|+........... .+..+|..++.
T Consensus 11 s~ftv~~Ry~nL~p~~~g~~-~v~~a~D~v--~~~~v~ikk~~~pf~n~~~a-----------------kra~rel~l~~ 70 (369)
T KOG0665|consen 11 STFTVPKRYVNLKPIGSGAQ-IVVAAFDQV--LGRPVAIKKLSRPFQNQTHA-----------------KRAYRELKLMK 70 (369)
T ss_pred cceeeeeeeeeecccCCCCc-eEEecchhh--ccCceehhhhcCccccCccc-----------------hhhhhhhhhhh
Confidence 44556778999999999999 443677766 89999999987663321111 57889999999
Q ss_pred hcCCCCcccceeEEEcC------CeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeE
Q 040898 115 QTRHRNILPLLAHMVRP------NCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLI 188 (337)
Q Consensus 115 ~l~hpniv~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~ 188 (337)
.++|+||++++.+|.-. ..+|+|||++.. +|...+. ..++-..+..++.|++.|++|+ |+.||+
T Consensus 71 ~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~-nl~~vi~------~elDH~tis~i~yq~~~~ik~l---hs~~Ii 140 (369)
T KOG0665|consen 71 CVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMDA-NLCQVIL------MELDHETISYILYQMLCGIKHL---HSAGII 140 (369)
T ss_pred hhcccceeeeeeccCccccHHHHHhHHHHHHhhhh-HHHHHHH------HhcchHHHHHHHHHHHHHHHHH---Hhccee
Confidence 99999999999988654 357999999965 8998884 3477789999999999999999 888999
Q ss_pred ecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCC
Q 040898 189 HRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPV 268 (337)
Q Consensus 189 h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf 268 (337)
||||||+||++..++.+|+.|||+++..... ...+..+.+..|.|||++.+..+.+.+||||+||++.||++|..-|
T Consensus 141 hRdLkPsnivv~~~~~lKi~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf 217 (369)
T KOG0665|consen 141 HRDLKPSNIVVNSDCTLKILDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLF 217 (369)
T ss_pred ecccCcccceecchhheeeccchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEe
Confidence 9999999999999999999999998765433 2344567888999999999999999999999999999999999888
Q ss_pred CCCCCCc-----------hhhhHHH----HHHhhhccCCc------chhhhhccc---CCchHHHHHHHHHHHhhhccCC
Q 040898 269 DDFFGHT-----------EEMDMVK----WMRNVIFSENP------NRAINSKLL---GNGYEEQMLLVLKLACFCTLKD 324 (337)
Q Consensus 269 ~~~~~~~-----------~~~~~~~----~~~~~~~~~~~------~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~d 324 (337)
.+-...+ .+..+.. ..+......+. ........+ ....+.......+++.+||..|
T Consensus 218 ~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~ 297 (369)
T KOG0665|consen 218 PGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVID 297 (369)
T ss_pred cCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccC
Confidence 6421100 0001111 11111110000 000000000 1111233456899999999999
Q ss_pred CCCCCChhhhhcC
Q 040898 325 PDERPSSKDVRSM 337 (337)
Q Consensus 325 P~~Rps~~ell~~ 337 (337)
|++|.|++++|+|
T Consensus 298 pe~Risv~daL~H 310 (369)
T KOG0665|consen 298 PEKRISVDDALRH 310 (369)
T ss_pred hhhcccHHHHhcC
Confidence 9999999999998
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=210.69 Aligned_cols=212 Identities=36% Similarity=0.567 Sum_probs=181.2
Q ss_pred eccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCcccceeEE
Q 040898 49 IGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLLAHM 128 (337)
Q Consensus 49 lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~ 128 (337)
||+|++|.||++.+.. +++.+++|.+........ ...+.+|+..++.+.|++++++++++
T Consensus 1 l~~g~~~~v~~~~~~~--~~~~~~~K~~~~~~~~~~------------------~~~~~~e~~~~~~l~~~~i~~~~~~~ 60 (215)
T cd00180 1 LGEGGFGTVYLARDKK--TGKKVAIKIIKKEDSSSL------------------LEELLREIEILKKLNHPNIVKLYGVF 60 (215)
T ss_pred CCcCCceEEEEEEecC--CCcEEEEEEeccccchhH------------------HHHHHHHHHHHHhcCCCCeeeEeeee
Confidence 6899999999998864 699999999876544320 15678899999999999999999999
Q ss_pred EcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecC-CCCeEE
Q 040898 129 VRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDD-DMEARI 207 (337)
Q Consensus 129 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~-~~~~~l 207 (337)
......++++|++++++|.+++.... ..++...++.++.+++.++.++ |+.|++|+||+|.||+++. ++.++|
T Consensus 61 ~~~~~~~~~~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~l---h~~~~~H~dl~~~ni~~~~~~~~~~l 134 (215)
T cd00180 61 EDENHLYLVMEYCEGGSLKDLLKENE---GKLSEDEILRILLQILEGLEYL---HSNGIIHRDLKPENILLDSDNGKVKL 134 (215)
T ss_pred ecCCeEEEEEecCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHhhEEEeCCCCcEEE
Confidence 99999999999999899999985421 4688899999999999999999 7779999999999999999 899999
Q ss_pred ecccCccccCCCCceeeeecccCCCCccCccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHHHHHHh
Q 040898 208 SDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTE-TISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRN 286 (337)
Q Consensus 208 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 286 (337)
+||+.+........ ......+...|++||..... .++.++|+|++|++++++
T Consensus 135 ~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------- 187 (215)
T cd00180 135 ADFGLSKLLTSDKS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------- 187 (215)
T ss_pred ecCCceEEccCCcc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------
Confidence 99999876644321 12234578889999999876 778899999999999998
Q ss_pred hhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 287 VIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
..+.+++.+|++.||.+||++.+++++
T Consensus 188 ------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ------------------------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ------------------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 228899999999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-32 Score=244.13 Aligned_cols=257 Identities=25% Similarity=0.391 Sum_probs=207.7
Q ss_pred cccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC
Q 040898 38 KKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR 117 (337)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 117 (337)
...++|+.+.++|+|+||.||+++++. ++...|+|.++.+..... ..+..|+-+++.-+
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~--s~elaavkvVkLep~dd~-------------------~~iqqei~~~~dc~ 70 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKR--SGELAAVKVVKLEPGDDF-------------------SGIQQEIGMLRDCR 70 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccc--cCchhhheeeeccCCccc-------------------cccccceeeeecCC
Confidence 577889999999999999999999987 999999999988776543 45667899999999
Q ss_pred CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCce
Q 040898 118 HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANV 197 (337)
Q Consensus 118 hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ni 197 (337)
||||+.+++.+.-....++.||||.+|+|++.. ...+++++.++..+++..+++++|| |++|=+|||||-.||
T Consensus 71 h~nivay~gsylr~dklwicMEycgggslQdiy----~~TgplselqiayvcRetl~gl~yl---hs~gk~hRdiKGani 143 (829)
T KOG0576|consen 71 HPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIY----HVTGPLSELQIAYVCRETLQGLKYL---HSQGKIHRDIKGANI 143 (829)
T ss_pred CcChHHHHhhhhhhcCcEEEEEecCCCccccee----eecccchhHHHHHHHhhhhccchhh---hcCCcccccccccce
Confidence 999999999999999999999999999999977 5667899999999999999999999 888999999999999
Q ss_pred eecCCCCeEEecccCccccCCCCceeeeecccCCCCccCcccc---ccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCC
Q 040898 198 LIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESL---QTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGH 274 (337)
Q Consensus 198 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~---~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~ 274 (337)
++++.|.+++.|||.+..++..... .....||+.|+|||+- +...|...+|+|++|++..|+-.-++|-...+.-
T Consensus 144 lltd~gDvklaDfgvsaqitati~K--rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm 221 (829)
T KOG0576|consen 144 LLTDEGDVKLADFGVSAQITATIAK--RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM 221 (829)
T ss_pred eecccCceeecccCchhhhhhhhhh--hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH
Confidence 9999999999999998776543222 2346899999999986 3445889999999999999998888874332221
Q ss_pred chhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 275 TEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.....+ ..+....... +......+.+-+|++.+|..+|++|||++.+|+|
T Consensus 222 ----r~l~Lm---TkS~~qpp~l------kDk~kws~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 222 ----RALFLM---TKSGFQPPTL------KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred ----HHHHHh---hccCCCCCcc------cCCccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence 111111 1111111111 1122334458899999999999999999999876
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=222.36 Aligned_cols=268 Identities=21% Similarity=0.350 Sum_probs=196.9
Q ss_pred ccccccccceeccCcceEEEEeEEec-CCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc-
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELP-GSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT- 116 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l- 116 (337)
..+.|..+++||.|+|++||++.+.. ......||+|.+...+.. .++..|+++|..+
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p---------------------~ri~~El~~L~~~g 92 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP---------------------SRILNELEMLYRLG 92 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc---------------------hHHHHHHHHHHHhc
Confidence 45679999999999999999987764 125788999998766543 4678899999999
Q ss_pred CCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 040898 117 RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPAN 196 (337)
Q Consensus 117 ~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~n 196 (337)
.+.||+.+.+.+..++.+.+|+||+++....+++.. ++...+...++.++.||.++ |+.||+|+||||+|
T Consensus 93 G~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~---h~~GIvHRDiKpsN 162 (418)
T KOG1167|consen 93 GSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHL---HKNGIVHRDIKPSN 162 (418)
T ss_pred cchhhhcchhhhccCCeeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhh---hccCccccCCCccc
Confidence 689999999999999999999999999999998843 66788999999999999999 88999999999999
Q ss_pred eeecC-CCCeEEecccCccccCCCC------------------------------------------ceeeeecccCCCC
Q 040898 197 VLIDD-DMEARISDFGHGKLMPDGH------------------------------------------AQITVKCMVGTMG 233 (337)
Q Consensus 197 il~~~-~~~~~l~dfg~~~~~~~~~------------------------------------------~~~~~~~~~~~~~ 233 (337)
++.+. .+.-.|.|||++....... .........||++
T Consensus 163 FL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~G 242 (418)
T KOG1167|consen 163 FLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPG 242 (418)
T ss_pred cccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCC
Confidence 99985 5678999999987221000 0011123469999
Q ss_pred ccCcccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchh-hhHHHH-----HHhh-hccCC------cc-----
Q 040898 234 YMAPESLQT-ETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEE-MDMVKW-----MRNV-IFSEN------PN----- 294 (337)
Q Consensus 234 ~~~PE~~~~-~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~-~~~~~~-----~~~~-~~~~~------~~----- 294 (337)
|.|||++.. ...+.++|+||.|+|+..++++.+||-....+.+. .++... ++.. ...+. .+
T Consensus 243 fRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~ 322 (418)
T KOG1167|consen 243 FRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIP 322 (418)
T ss_pred CCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccH
Confidence 999999864 44688999999999999999999998432221111 111110 0000 00000 00
Q ss_pred ------hhhh-hccc---------CCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 295 ------RAIN-SKLL---------GNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 295 ------~~~~-~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.... .... .......+..+.+|+++||..||.+|.|++++|+|
T Consensus 323 e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 323 ELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred HHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 0000 0000 00111222368999999999999999999999997
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=215.86 Aligned_cols=257 Identities=19% Similarity=0.257 Sum_probs=195.7
Q ss_pred ccccccceeccCcceEEEEeEEecCC---CCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGS---NGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR 117 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 117 (337)
.|++..-.+.+|.||.||++.+.... +.+.|.+|.+....+.- .+..+..|-.++..+.
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~i------------------Qv~~~L~es~lly~~s 345 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQI------------------QVNLLLQESMLLYGAS 345 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHH------------------HHHHHHHHHHHHhcCc
Confidence 45667777889999999998664321 33456666655443321 1267888999999999
Q ss_pred CCCcccceeEEE-cCCeeEEEEEeccCCCHHHHHHHhcC----CcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 040898 118 HRNILPLLAHMV-RPNCHLLVYEFMKNGSLQDILYDVSQ----GRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDI 192 (337)
Q Consensus 118 hpniv~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di 192 (337)
|||+....++.. +....+.++.+...|+|..|+...+. ..+.++-.+...++.|++.|+.|| |++|++|.||
T Consensus 346 H~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hl---h~~~ViHkDi 422 (563)
T KOG1024|consen 346 HPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHL---HNHGVIHKDI 422 (563)
T ss_pred CCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHH---HhcCcccchh
Confidence 999999999874 45667888999999999999974332 234466678888999999999999 8889999999
Q ss_pred CCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCC
Q 040898 193 KPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDF 271 (337)
Q Consensus 193 ~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~ 271 (337)
-.+|+++++.-.+||+|=.+++.+...+-..-....-+...||+||.+....|++++|+||||+++|||+| |+.||.+.
T Consensus 423 AaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeI 502 (563)
T KOG1024|consen 423 AARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEI 502 (563)
T ss_pred hhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcccc
Confidence 99999999999999999998887544332211122335678999999999999999999999999999999 89998765
Q ss_pred CCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhh
Q 040898 272 FGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVR 335 (337)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 335 (337)
.. .++...+.....-. .+-++++++..++..||..+|++|||++++.
T Consensus 503 DP----fEm~~ylkdGyRla-------------QP~NCPDeLf~vMacCWallpeeRPsf~Qlv 549 (563)
T KOG1024|consen 503 DP----FEMEHYLKDGYRLA-------------QPFNCPDELFTVMACCWALLPEERPSFSQLV 549 (563)
T ss_pred CH----HHHHHHHhccceec-------------CCCCCcHHHHHHHHHHHhcCcccCCCHHHHH
Confidence 33 23333333222111 1235667799999999999999999999985
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-28 Score=204.24 Aligned_cols=201 Identities=30% Similarity=0.485 Sum_probs=169.1
Q ss_pred ccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCcc
Q 040898 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNIL 122 (337)
Q Consensus 43 y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv 122 (337)
|.+.+.||.|++|.||++.... ++..+++|.+....... ....+.+|+..++.++|+|++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~--~~~~~~iK~~~~~~~~~------------------~~~~~~~e~~~~~~~~~~~i~ 60 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKG--TGELVAVKVLKKEKTEK------------------QREEFLREIRILKKLKHPNIV 60 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcC--CCcEEEEEeeccccchH------------------HHHHHHHHHHHHHhCCCCChh
Confidence 6778999999999999998865 78999999987654330 115778899999999999999
Q ss_pred cceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCC
Q 040898 123 PLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDD 202 (337)
Q Consensus 123 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~ 202 (337)
++++.+......++++|++++++|.+++.... ..+++...+.++.+++.++.++ |+.+++|+|++|.||+++.+
T Consensus 61 ~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~l---h~~~i~h~di~~~ni~v~~~ 134 (225)
T smart00221 61 KLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKG---GKLSEEEARFYLRQILEALEYL---HSLGIVHRDLKPENILLGMD 134 (225)
T ss_pred hheeeeecCCceEEEEeccCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCC
Confidence 99999999999999999999999999985421 1178899999999999999999 66799999999999999999
Q ss_pred CCeEEecccCccccCCCCceeeeecccCCCCccCcccc-ccCCCCCcccchhhhHHHHHHHhCCCCCCC
Q 040898 203 MEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESL-QTETISDKCDIYSFGVLLAVLVMGKFPVDD 270 (337)
Q Consensus 203 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~-~~~~~~~~~DiwslG~i~~~ll~g~~pf~~ 270 (337)
+.++|+|||.+......... ......++..|++||.. ....++.++|+|++|+++++|++|+.||..
T Consensus 135 ~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 135 GLVKLADFGLARFIHRDLAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred CCEEEeeCceeeEecCcccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 99999999988876544211 11234577889999998 666677899999999999999999999844
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=203.66 Aligned_cols=256 Identities=20% Similarity=0.303 Sum_probs=189.6
Q ss_pred cccccccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHH
Q 040898 32 QDLAFLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEII 111 (337)
Q Consensus 32 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~ 111 (337)
++++-..=.+.|.+.+.+|+|.||.+-++.+.. +.+.+++|-+....... ..|.+|..
T Consensus 15 ~el~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~--s~t~ivlKavp~p~tt~--------------------~dF~rEfh 72 (378)
T KOG1345|consen 15 EELKKVDLEDVYTINKQLGEGRFGKILLAEHRQ--SKTRIVLKAVPRPQTTQ--------------------ADFVREFH 72 (378)
T ss_pred ccccccchhhhhhHHHHhcccceeeEEeeeccC--CceEEEeeccCcchhhH--------------------HHHHHHhc
Confidence 345555555679999999999999998888876 89999999886654322 56777887
Q ss_pred HHHhc-CCCCcccceeE-EEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEe
Q 040898 112 TANQT-RHRNILPLLAH-MVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIH 189 (337)
Q Consensus 112 ~l~~l-~hpniv~~~~~-~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h 189 (337)
.--.| .|.||+.-+++ |++.+.+++++||++.|+|.+-+ ....+.+.....++.|+++|+.|+ |++++||
T Consensus 73 Y~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv-----~~~GigE~~~K~v~~ql~SAi~fM---HsknlVH 144 (378)
T KOG1345|consen 73 YSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNV-----EAAGIGEANTKKVFAQLLSAIEFM---HSKNLVH 144 (378)
T ss_pred cceeeccchhhhHHHHHHhhcCceEEEeeccCccchhhhhc-----CcccccHHHHHHHHHHHHHHHHHh---hccchhh
Confidence 66666 68899998876 67777888999999999999877 335688899999999999999999 8889999
Q ss_pred cCCCCCceeecC--CCCeEEecccCccccCCCCceeeeecccCCCCccCccccccC-----CCCCcccchhhhHHHHHHH
Q 040898 190 RDIKPANVLIDD--DMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTE-----TISDKCDIYSFGVLLAVLV 262 (337)
Q Consensus 190 ~di~~~nil~~~--~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-----~~~~~~DiwslG~i~~~ll 262 (337)
||||.+|||+.. .-.+||+|||..+..+.-. .....+..|.+||..... ...+.+|+|.+|+++|..+
T Consensus 145 RdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cl 219 (378)
T KOG1345|consen 145 RDLKAENILIFDADFYRVKLCDFGLTRKVGTTV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCL 219 (378)
T ss_pred cccccceEEEecCCccEEEeeecccccccCcee-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeee
Confidence 999999999954 3479999999987654322 223356678899986322 2356789999999999999
Q ss_pred hCCCCCCCC-CCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhh
Q 040898 263 MGKFPVDDF-FGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKD 333 (337)
Q Consensus 263 ~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e 333 (337)
||.+||... ..+........|........ ++. .....+...++.++-|.++|++|=.+.+
T Consensus 220 tG~~PWQka~~~d~~Y~~~~~w~~rk~~~~-------P~~----F~~fs~~a~r~Fkk~lt~~~~drcki~~ 280 (378)
T KOG1345|consen 220 TGKFPWQKASIMDKPYWEWEQWLKRKNPAL-------PKK----FNPFSEKALRLFKKSLTPRFKDRCKIWT 280 (378)
T ss_pred cCCCcchhhhccCchHHHHHHHhcccCccC-------chh----hcccCHHHHHHHHHhcCCcccccchhHH
Confidence 999999743 22334445555544332210 111 1112223677778889999999944433
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-27 Score=236.95 Aligned_cols=197 Identities=16% Similarity=0.186 Sum_probs=137.0
Q ss_pred hcCC-CCcccceeEE-------EcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCC
Q 040898 115 QTRH-RNILPLLAHM-------VRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPR 186 (337)
Q Consensus 115 ~l~h-pniv~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~g 186 (337)
.+.| +||.++++++ .....++.++|++ +++|.+++.. ....+++..+..++.||+.||.|| |++|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~l---H~~g 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAA---HSQG 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHH---HhCC
Confidence 3455 5777777777 2334678888987 5599999953 245589999999999999999999 7789
Q ss_pred eEecCCCCCceeecCCCC-------------------eEEecccCccccCCCCc--------------eeeeecccCCCC
Q 040898 187 LIHRDIKPANVLIDDDME-------------------ARISDFGHGKLMPDGHA--------------QITVKCMVGTMG 233 (337)
Q Consensus 187 i~h~di~~~nil~~~~~~-------------------~~l~dfg~~~~~~~~~~--------------~~~~~~~~~~~~ 233 (337)
|+||||||+|||++..+. ++++|||+++....... ........+|+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 999999999999965444 45555555543211000 000111357888
Q ss_pred ccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHH
Q 040898 234 YMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLV 313 (337)
Q Consensus 234 ~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 313 (337)
|+|||++.+..++.++|||||||++|||++|.+|+... ...+... ..... +.. ........
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~-----~~~~~~~-~~~~~---~~~----------~~~~~~~~ 241 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEK-----SRTMSSL-RHRVL---PPQ----------ILLNWPKE 241 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhH-----HHHHHHH-HHhhc---Chh----------hhhcCHHH
Confidence 99999999999999999999999999999998886421 0111111 11100 000 00111225
Q ss_pred HHHHhhhccCCCCCCCChhhhhcC
Q 040898 314 LKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 314 ~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.+++.+||++||.+|||+.|+++|
T Consensus 242 ~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 242 ASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHHHhCCCChhhCcChHHHhhc
Confidence 678889999999999999999986
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-26 Score=185.86 Aligned_cols=163 Identities=21% Similarity=0.243 Sum_probs=121.3
Q ss_pred CCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCCeEEecccCccccCCCCcee
Q 040898 144 GSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQI 223 (337)
Q Consensus 144 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 223 (337)
|+|.+++.. .+.++++..++.++.|++.||.|| |+++ ||+||+++.++.+++ ||.+.......
T Consensus 1 GsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~l---H~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEV---RGRPLNEEEIWAVCLQCLRALREL---HRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHH---HhcC------CcccEeEcCccceee--ccceEeecccc---
Confidence 689998853 245699999999999999999999 5555 999999999999999 99887654321
Q ss_pred eeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccC
Q 040898 224 TVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLG 303 (337)
Q Consensus 224 ~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (337)
..+++.|+|||++.+..++.++||||+|+++|+|++|..||....... ........... ...+.. .
T Consensus 64 ----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~-~~~~~~-------~ 129 (176)
T smart00750 64 ----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--AILEILLNGMP-ADDPRD-------R 129 (176)
T ss_pred ----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHHHHHHHhc-cCCccc-------c
Confidence 258899999999999999999999999999999999999986432211 11111111111 111100 0
Q ss_pred CchHHHHH--HHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 304 NGYEEQML--LVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 304 ~~~~~~~~--~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
........ .+.+++.+||+.||.+|||+.++++|
T Consensus 130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~ 165 (176)
T smart00750 130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAH 165 (176)
T ss_pred ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHH
Confidence 01112222 58999999999999999999999875
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.8e-24 Score=188.50 Aligned_cols=206 Identities=22% Similarity=0.285 Sum_probs=163.2
Q ss_pred cccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC----
Q 040898 42 CFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR---- 117 (337)
Q Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~---- 117 (337)
+|.+.++||+|+||.||.+.+.... ...+|+|.......... ..+..|..++..+.
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~-~~~~a~K~e~~~~~~~~-------------------~~l~~E~~vl~~l~~~~~ 78 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEK-NKEYAKKLEKKELGSKP-------------------SVLKIEIQVLKKLEKKNG 78 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCC-CeeEEEEEEEecccCCC-------------------ccchhHHHHHHHHhhhcC
Confidence 7999999999999999999987522 45788887765433221 13445666666665
Q ss_pred CCCcccceeEE-EcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 040898 118 HRNILPLLAHM-VRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPAN 196 (337)
Q Consensus 118 hpniv~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~n 196 (337)
.+++..++... ..+...++||+.+ |.+|.++..... ...++..+...++.|++.+|.++ |+.|++||||||.|
T Consensus 79 ~~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~l---H~~G~iHRDiKp~N 152 (322)
T KOG1164|consen 79 PSHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDL---HSKGFIHRDIKPEN 152 (322)
T ss_pred CCCCCEEEEeccCCCceeEEEEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHH---HhcCcccCCcCHHH
Confidence 36888888888 5777889999988 779999875533 56799999999999999999999 77899999999999
Q ss_pred eeecCC-----CCeEEecccCccccC--CCCc----eee--eecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh
Q 040898 197 VLIDDD-----MEARISDFGHGKLMP--DGHA----QIT--VKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM 263 (337)
Q Consensus 197 il~~~~-----~~~~l~dfg~~~~~~--~~~~----~~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~ 263 (337)
+.+... ..++|.|||+++... .... ... .....||.+|+++....+...+.+.|+||++.++.+++.
T Consensus 153 ~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~ 232 (322)
T KOG1164|consen 153 FVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLK 232 (322)
T ss_pred eeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhc
Confidence 999754 468999999998322 1111 111 123459999999999999999999999999999999999
Q ss_pred CCCCCCCCCC
Q 040898 264 GKFPVDDFFG 273 (337)
Q Consensus 264 g~~pf~~~~~ 273 (337)
|..||.....
T Consensus 233 g~LPW~~~~~ 242 (322)
T KOG1164|consen 233 GSLPWEALEM 242 (322)
T ss_pred CCCCCccccc
Confidence 9999966544
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.7e-24 Score=190.03 Aligned_cols=186 Identities=22% Similarity=0.204 Sum_probs=132.0
Q ss_pred CCCCccccccccccccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHh
Q 040898 23 TIFSPLVEKQDLAFLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102 (337)
Q Consensus 23 ~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 102 (337)
+...|++-++.-. -.++|.+.+.||+|+||.||++.+.. .+++.+|||++........... .
T Consensus 3 ~~~~~~~~~~~~~---~~~~Y~~~~~IG~G~fg~Vy~a~~~~-~~~~~vAiK~~~~~~~~~~~~~--------------~ 64 (365)
T PRK09188 3 NIDVPLPGDQIPA---LSARFVETAVLKRDVFSTVERGYFAG-DPGTARAVRRRVSEVPWWSKPL--------------A 64 (365)
T ss_pred CCCCCCccccccc---ccCCceEccEEeecCcEEEEEEEEcC-CCCeEEEEEEecccccccccHH--------------H
Confidence 3444444444222 34569999999999999999987653 2577789998753321000000 0
Q ss_pred HHhHHHHHHHHHhcCCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhC
Q 040898 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMC 182 (337)
Q Consensus 103 ~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~ 182 (337)
...+.+|+.++++++|+|++..+.. ....|+||||++|++|.... ..+ ...++.+++++|.++
T Consensus 65 ~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~LVmE~~~G~~L~~~~----~~~-------~~~~~~~i~~aL~~l--- 127 (365)
T PRK09188 65 RHLAAREIRALKTVRGIGVVPQLLA---TGKDGLVRGWTEGVPLHLAR----PHG-------DPAWFRSAHRALRDL--- 127 (365)
T ss_pred HHHHHHHHHHHHhccCCCCCcEEEE---cCCcEEEEEccCCCCHHHhC----ccc-------hHHHHHHHHHHHHHH---
Confidence 1568899999999999999853322 24579999999999996321 111 146788999999999
Q ss_pred CCCCeEecCC-CCCceeecCCCCeEEecccCccccCCCCceee------eecccCCCCccCccccccC
Q 040898 183 HRPRLIHRDI-KPANVLIDDDMEARISDFGHGKLMPDGHAQIT------VKCMVGTMGYMAPESLQTE 243 (337)
Q Consensus 183 h~~gi~h~di-~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~------~~~~~~~~~~~~PE~~~~~ 243 (337)
|++|++|+|| ||+||+++.++.++|+|||++..+........ .....+++.|++||.+...
T Consensus 128 H~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 128 HRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred HHCCCeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 7789999999 99999999999999999999987654321111 1234578889999998544
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.8e-25 Score=207.50 Aligned_cols=259 Identities=20% Similarity=0.253 Sum_probs=185.9
Q ss_pred cccceeccCcceEEEEeEEecCCCCceEEEEEeccc--CcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCc
Q 040898 44 DSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVD--APMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNI 121 (337)
Q Consensus 44 ~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpni 121 (337)
.....+|.|++|.|+.+.... ....++.|..... ....... ....+..|+-+-..+.|||+
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~--~~~~~~~~~~r~~~~~~~s~~~---------------~~~~i~sE~~i~~~l~h~~~ 383 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRS--DLKSFPEKEFRVRVKPTESERK---------------YNYNITSEFCIGSSLSHPNI 383 (601)
T ss_pred CccceeeecccCceEEEEecC--CCccchhhhhhcccCCcccHHH---------------HhhhhhhheeecccccCCch
Confidence 467889999999776555543 3333334333211 1111110 11236778888899999999
Q ss_pred ccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecC
Q 040898 122 LPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDD 201 (337)
Q Consensus 122 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~ 201 (337)
+.......+....+-.||||+. +|..++. ....+....+-.++.|++.|++|+ |+.|+.|+|+|++|++++.
T Consensus 384 ~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~----~~~~~~~~e~~c~fKqL~~Gv~y~---h~~GiahrdlK~enll~~~ 455 (601)
T KOG0590|consen 384 IETLDIVQEIDGILQSMEYCPY-DLFSLVM----SNGKLTPLEADCFFKQLLRGVKYL---HSMGLAHRDLKLENLLVTE 455 (601)
T ss_pred hhhHHHHhhcccchhhhhcccH-HHHHHHh----cccccchhhhhHHHHHHHHHHHHH---HhcCceeccCccccEEEec
Confidence 8888877777766667999999 9999883 335688889999999999999999 7889999999999999999
Q ss_pred CCCeEEecccCccccCCCCce--eeeecccCCCCccCccccccCCCCC-cccchhhhHHHHHHHhCCCCCCCCCCCchhh
Q 040898 202 DMEARISDFGHGKLMPDGHAQ--ITVKCMVGTMGYMAPESLQTETISD-KCDIYSFGVLLAVLVMGKFPVDDFFGHTEEM 278 (337)
Q Consensus 202 ~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~-~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~ 278 (337)
+|.++|+|||.+..+...... .......|+..|+|||++.+..|.. ..||||.|+++..|.+|+.||......+...
T Consensus 456 ~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~ 535 (601)
T KOG0590|consen 456 NGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF 535 (601)
T ss_pred CCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch
Confidence 999999999998776543332 3334567999999999999888865 5899999999999999999996543332221
Q ss_pred hHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 279 DMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
........ .....-........+...+.++.+||++||.+|.|+.+|++
T Consensus 536 ------~~~~~~~~---~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 536 ------KTNNYSDQ---RNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ------hhhccccc---cccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 00000000 00000011122344456789999999999999999999986
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.1e-24 Score=180.98 Aligned_cols=241 Identities=22% Similarity=0.288 Sum_probs=149.7
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC-
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR- 117 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~- 117 (337)
....+...+.||.|+++.||.+.+.. +++.+|+|+............ +.+.+|.-....+.
T Consensus 10 ~~r~l~~~~~i~~g~~~~v~~v~d~~--t~~~~avkvf~~~~~~~~~~~----------------~~~~~e~l~~~~~~~ 71 (288)
T PF14531_consen 10 RPRTLVRGRIIGKGGFSIVFEVTDVE--TGEEFAVKVFLLPADASANEY----------------EQLKEEQLAITLFPG 71 (288)
T ss_dssp -EEEEEEEEEEEEETTEEEEEEEETT--TTEEEEEEEEEESSTTHTTHH----------------HHHHHHHHGGGGSTT
T ss_pred CceEEEEccccccCCceEEEEEEEcc--CCceEEEEEEecccccchHHH----------------HHHHHHHHHhhhhcc
Confidence 34457788999999999999999976 999999999977763222211 12222222221111
Q ss_pred ---------CCCcccceeEE---------EcC---C-----eeEEEEEeccCCCHHHHHHHh---cCCcccCChHHHHHH
Q 040898 118 ---------HRNILPLLAHM---------VRP---N-----CHLLVYEFMKNGSLQDILYDV---SQGRRELDWPARHRI 168 (337)
Q Consensus 118 ---------hpniv~~~~~~---------~~~---~-----~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i 168 (337)
|-.++-.++.. ... . +.+++|+.+ .++|.+++... ..............+
T Consensus 72 ~~~p~~a~~~~r~l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~l 150 (288)
T PF14531_consen 72 VKNPKEAYRHLRFLVPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSL 150 (288)
T ss_dssp --SHHHHHHHH-B---SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHH
T ss_pred CCCHHHHHHhceEEeeeEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHH
Confidence 11111111111 111 1 236677777 44888876532 222334555667788
Q ss_pred HHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccC-----
Q 040898 169 ARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTE----- 243 (337)
Q Consensus 169 ~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~----- 243 (337)
..|++..+++| |..|++|+||+|+|++++.+|.+.|+||+.....+... .....+..|.|||.....
T Consensus 151 T~Q~I~lvA~L---h~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~-----~~~~~~~~~~PPe~~~~~~~~~~ 222 (288)
T PF14531_consen 151 TVQMIRLVANL---HSYGLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRY-----RCSEFPVAFTPPELESCAGQFGQ 222 (288)
T ss_dssp HHHHHHHHHHH---HHTTEEEST-SGGGEEE-TTS-EEE--GGGEEETTEEE-----EGGGS-TTTS-HHHHHHHTSCHH
T ss_pred HHHHHHHHHHH---hhcceEecccceeeEEEcCCCCEEEcChHHHeecCcee-----eccCCCcccCChhhhhhhcccCc
Confidence 89999999999 77799999999999999999999999998766543321 113455779999987432
Q ss_pred ---CCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhh
Q 040898 244 ---TISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFC 320 (337)
Q Consensus 244 ---~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 320 (337)
.++.+.|.|+||+++|.++++..||+.......... ....|- +.++.+..||..+
T Consensus 223 ~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~---------------------~f~~C~-~~Pe~v~~LI~~l 280 (288)
T PF14531_consen 223 NNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW---------------------DFSRCR-DMPEPVQFLIRGL 280 (288)
T ss_dssp SEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG---------------------GGTTSS----HHHHHHHHHH
T ss_pred ccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc---------------------cchhcC-CcCHHHHHHHHHH
Confidence 467889999999999999999999975422111100 234455 7777899999999
Q ss_pred ccCCCCCC
Q 040898 321 TLKDPDER 328 (337)
Q Consensus 321 l~~dP~~R 328 (337)
|+.||++|
T Consensus 281 L~~~~~~R 288 (288)
T PF14531_consen 281 LQRNPEDR 288 (288)
T ss_dssp T-SSGGGS
T ss_pred ccCCcccC
Confidence 99999988
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.7e-22 Score=177.50 Aligned_cols=264 Identities=30% Similarity=0.409 Sum_probs=195.6
Q ss_pred ccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC-Cc
Q 040898 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR-NI 121 (337)
Q Consensus 43 y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp-ni 121 (337)
|.+.+.||.|+||.||.+.+. ..+++|.+......... ....+.+|...+..+.|+ ++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-----~~~~~k~~~~~~~~~~~----------------~~~~~~~e~~~~~~~~~~~~i 60 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-----KLVALKVLAKKLESKSK----------------EVERFLREIQILASLNHPPNI 60 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-----cEEEEEeechhhccchh----------------HHHHHHHHHHHHHHccCCcce
Confidence 788999999999999988774 67888888665543320 115788899999999988 79
Q ss_pred ccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecC
Q 040898 122 LPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDD 201 (337)
Q Consensus 122 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~ 201 (337)
+++.+.+......+++++++.++++.+++...... ..+.......++.|++.++.++ |..|++|+|++|+||+++.
T Consensus 61 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~---H~~~~~hrd~kp~nil~~~ 136 (384)
T COG0515 61 VKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYL---HSKGIIHRDIKPENILLDR 136 (384)
T ss_pred eeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHeeecC
Confidence 99999998777789999999999999776431111 3688899999999999999999 7779999999999999999
Q ss_pred CC-CeEEecccCccccCCCCcee----eeecccCCCCccCcccccc---CCCCCcccchhhhHHHHHHHhCCCCCCCCCC
Q 040898 202 DM-EARISDFGHGKLMPDGHAQI----TVKCMVGTMGYMAPESLQT---ETISDKCDIYSFGVLLAVLVMGKFPVDDFFG 273 (337)
Q Consensus 202 ~~-~~~l~dfg~~~~~~~~~~~~----~~~~~~~~~~~~~PE~~~~---~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~ 273 (337)
.+ .+++.|||.+.......... ......++..|.+||.+.+ ...+...|+|++|++++++++|..||.....
T Consensus 137 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~ 216 (384)
T COG0515 137 DGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKN 216 (384)
T ss_pred CCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 88 79999999987654433221 2345679999999999987 5778899999999999999999999755433
Q ss_pred CchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 274 HTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
..........+............. ..........+.+++..++..+|..|.+..+...
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~ 274 (384)
T COG0515 217 SSATSQTLKIILELPTPSLASPLS-----PSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274 (384)
T ss_pred cccHHHHHHHHHhcCCcccccccC-----ccccchhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence 111122222222211110000000 0000222345888999999999999999887653
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.7e-24 Score=204.39 Aligned_cols=254 Identities=20% Similarity=0.267 Sum_probs=181.5
Q ss_pred cccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC
Q 040898 38 KKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR 117 (337)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 117 (337)
+...+|...+.||++.|=.|.++.+ ....|+||++-...+.-.-.-+ ..-.+|++ ...++
T Consensus 20 d~~~e~~~~~~LGstRFlKv~r~k~----~eG~vVvKVFvk~~p~~sL~~~---------------~qrL~~ik-~~l~~ 79 (1431)
T KOG1240|consen 20 DLSVECHYVENLGSTRFLKVARAKD----REGLVVVKVFVKQDPTISLRPF---------------KQRLEEIK-FALMK 79 (1431)
T ss_pred cCccceeeecccCchhhhhhhhccC----CCceEEEEEEeccCCCCCchHH---------------HHHHHHHH-HHhhc
Confidence 3333789999999999999988777 4444999998776643322111 22233444 56679
Q ss_pred CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCce
Q 040898 118 HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANV 197 (337)
Q Consensus 118 hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ni 197 (337)
+||.+.+..+.+.++..|+|-+|..+ +|.|.+ ..+.-+...+.+.++.|++.|+..+ |..|++|||||.+||
T Consensus 80 ~pn~lPfqk~~~t~kAAylvRqyvkh-nLyDRl----STRPFL~~iEKkWiaFQLL~al~qc---H~~gVcHGDIKsENI 151 (1431)
T KOG1240|consen 80 APNCLPFQKVLVTDKAAYLVRQYVKH-NLYDRL----STRPFLVLIEKKWIAFQLLKALSQC---HKLGVCHGDIKSENI 151 (1431)
T ss_pred CCcccchHHHHHhhHHHHHHHHHHhh-hhhhhh----ccchHHHHHHHHHHHHHHHHHHHHH---HHcCccccccccceE
Confidence 99999999998899999999999977 999988 3444567788899999999999998 888999999999999
Q ss_pred eecCCCCeEEecccCcccc--CCC---CceeeeecccCCCCccCccccccCC-----------CCCcccchhhhHHHHHH
Q 040898 198 LIDDDMEARISDFGHGKLM--PDG---HAQITVKCMVGTMGYMAPESLQTET-----------ISDKCDIYSFGVLLAVL 261 (337)
Q Consensus 198 l~~~~~~~~l~dfg~~~~~--~~~---~~~~~~~~~~~~~~~~~PE~~~~~~-----------~~~~~DiwslG~i~~~l 261 (337)
|++.=+++.|+||...... ... .......+..+-.+|.|||.+.... .+++-||||+||+++|+
T Consensus 152 LiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaEL 231 (1431)
T KOG1240|consen 152 LITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAEL 231 (1431)
T ss_pred EEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHH
Confidence 9999999999999865432 211 1112223344566899999985411 35678999999999999
Q ss_pred Hh-CCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 262 VM-GKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 262 l~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
++ |.+||+- ..+....... ...++...... +...+++|+..|++.||.+|.|+++.|+
T Consensus 232 f~Eg~PlF~L-------SQL~aYr~~~--~~~~e~~Le~I--------ed~~~Rnlil~Mi~rdPs~RlSAedyL~ 290 (1431)
T KOG1240|consen 232 FLEGRPLFTL-------SQLLAYRSGN--ADDPEQLLEKI--------EDVSLRNLILSMIQRDPSKRLSAEDYLQ 290 (1431)
T ss_pred HhcCCCcccH-------HHHHhHhccC--ccCHHHHHHhC--------cCccHHHHHHHHHccCchhccCHHHHHH
Confidence 99 6888842 1111111110 11111111000 0113899999999999999999999885
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.4e-23 Score=164.73 Aligned_cols=207 Identities=24% Similarity=0.321 Sum_probs=169.7
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..+.|.++++||+|+||.+|.+.... +|..||||.-..+... ..+..|.++.+.|++
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~--~ge~VAiK~Es~~a~h---------------------pqL~yEskvY~iL~~ 69 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISIT--SGEEVAIKLESSKAKH---------------------PQLLYESKVYRILQG 69 (341)
T ss_pred eccceEEEEeecCCchhheeeeeecc--CCceEEEEeecccCCC---------------------cchhHHHHHHHHhcc
Confidence 44569999999999999999999987 9999999986554432 245567888888854
Q ss_pred -CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCce
Q 040898 119 -RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANV 197 (337)
Q Consensus 119 -pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ni 197 (337)
..|..+..+..+...-.+||+.+ |-||++++.-.. ..++.++++-++.|++.-+.|+ |.++++|+||||+|+
T Consensus 70 g~GiP~i~~y~~e~~ynvlVMdLL-GPsLEdLfnfC~---R~ftmkTvLMLaDQml~RiEyv---H~r~fiHRDIKPdNF 142 (341)
T KOG1163|consen 70 GVGIPHIRHYGTEKDYNVLVMDLL-GPSLEDLFNFCS---RRFTMKTVLMLADQMLSRIEYV---HLRNFIHRDIKPDNF 142 (341)
T ss_pred CCCCchhhhhccccccceeeeecc-CccHHHHHHHHh---hhhhHHhHHHHHHHHHHHHHHH---HhhccccccCCccce
Confidence 67888888888888889999998 779999886432 3488999999999999999999 778999999999999
Q ss_pred eec---CCCCeEEecccCccccCCCCce-----eeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCC
Q 040898 198 LID---DDMEARISDFGHGKLMPDGHAQ-----ITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVD 269 (337)
Q Consensus 198 l~~---~~~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~ 269 (337)
+.. ....+.|+|||++..+.+.... .......||.+|.+-....+...+.+.|+-|+|.++.++.-|..||.
T Consensus 143 LMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQ 222 (341)
T KOG1163|consen 143 LMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQ 222 (341)
T ss_pred eeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCccc
Confidence 996 3457899999999877543222 22234568999999888888888999999999999999999999998
Q ss_pred CCCCCc
Q 040898 270 DFFGHT 275 (337)
Q Consensus 270 ~~~~~~ 275 (337)
+....+
T Consensus 223 glka~t 228 (341)
T KOG1163|consen 223 GLKAAT 228 (341)
T ss_pred ccchhh
Confidence 865543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.4e-23 Score=170.75 Aligned_cols=180 Identities=13% Similarity=0.148 Sum_probs=133.6
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
-.++|+..+.+|.|+||.||++.+ ++..+|+|.+.++........ ..... .+.+.+|+..+.++.|
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~----~~~~~iiKvf~~~~~~~~~~~-~~f~~---------g~~~e~Ea~~l~rL~~ 94 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT----DYGKYILKVFAPKVKRTERFL-KSFVK---------GDYYENLIVQTDRVRS 94 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec----CCCcEEEEEechhcCchHHHH-Hhhhh---------hHHHHHHHHHHHHHHH
Confidence 578899999999999999998544 466899999977665443221 10000 1347789999999999
Q ss_pred CCcccceeEEEcC--------CeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 040898 119 RNILPLLAHMVRP--------NCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHR 190 (337)
Q Consensus 119 pniv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~ 190 (337)
|+|..+..++... ...+++|||++|.+|.++.. +++ ....+++.++..+ |..|++|+
T Consensus 95 ~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~l---H~~gi~H~ 159 (232)
T PRK10359 95 EGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESL---HQHGMVSG 159 (232)
T ss_pred CCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHH---HHcCCccC
Confidence 9999999886533 35789999999999988741 222 2456889999999 78899999
Q ss_pred CCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHH
Q 040898 191 DIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLV 262 (337)
Q Consensus 191 di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll 262 (337)
|++|+||+++.+| ++|+|||........... ...+....+..++|+|+||+++..+.
T Consensus 160 Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 160 DPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCChHHEEEeCCC-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 9999999999988 999999977554221100 11233344667899999999876543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.4e-21 Score=162.87 Aligned_cols=204 Identities=25% Similarity=0.337 Sum_probs=169.0
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc-CCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT-RHR 119 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp 119 (337)
-.|.++++||+|+||.+|.+.... ++++||||.-..++.. -.+..|.+..+.| ..+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~--nne~VAIKfEPrkS~A---------------------PQLrdEYr~YKlL~g~~ 84 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLY--NNEPVAIKFEPRKSEA---------------------PQLRDEYRTYKLLGGTE 84 (449)
T ss_pred ccceeccccccCcceeeecccccc--cCceEEEEeccccCCc---------------------chHHHHHHHHHHHcCCC
Confidence 469999999999999999999988 9999999975443321 2455677777777 678
Q ss_pred CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceee
Q 040898 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI 199 (337)
Q Consensus 120 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~ 199 (337)
+|...+-+..++..-.+|+|.+ |-||+|++.- =+..++.+++.-++.|++.-++++ |++.++.|||||+|+||
T Consensus 85 GIP~vYYFGqeG~~NiLVidLL-GPSLEDLFD~---CgR~FSvKTV~miA~Qmi~rie~v---H~k~LIYRDIKPdNFLI 157 (449)
T KOG1165|consen 85 GIPQVYYFGQEGKYNILVIDLL-GPSLEDLFDL---CGRRFSVKTVAMIAKQMITRIEYV---HEKDLIYRDIKPDNFLI 157 (449)
T ss_pred CCCceeeeccccchhhhhhhhh-CcCHHHHHHH---hcCcccHHhHHHHHHHHHHHHHHH---HhcceeecccCccceee
Confidence 9999988888888888999998 6699998753 345689999999999999999999 77899999999999999
Q ss_pred cCC-----CCeEEecccCccccCCCCc-----eeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCC
Q 040898 200 DDD-----MEARISDFGHGKLMPDGHA-----QITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVD 269 (337)
Q Consensus 200 ~~~-----~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~ 269 (337)
... ..+.++|||++..+.+... ....+.-.||.+||+-....|...+.+.|+-|||=++.++|-|..||.
T Consensus 158 Grp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQ 237 (449)
T KOG1165|consen 158 GRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQ 237 (449)
T ss_pred cCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccc
Confidence 753 4589999999988754322 222334569999999999999999999999999999999999999998
Q ss_pred CCCCC
Q 040898 270 DFFGH 274 (337)
Q Consensus 270 ~~~~~ 274 (337)
+.-..
T Consensus 238 GLKA~ 242 (449)
T KOG1165|consen 238 GLKAD 242 (449)
T ss_pred cccCc
Confidence 76443
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.1e-22 Score=161.24 Aligned_cols=159 Identities=16% Similarity=0.121 Sum_probs=111.8
Q ss_pred cceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHH--HHHHh--hhh---hhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 46 LKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAA--ELIKQ--DID---EYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 46 ~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~~--~~~---~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
...||+|++|.||++.+. +|+.||+|++......... ..... ... ...............|+..+..+.+
T Consensus 2 ~~~ig~G~~~~Vy~a~~~---~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 78 (190)
T cd05147 2 NGCISTGKEANVYHATTA---NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVT 78 (190)
T ss_pred CCccccccceEEEEEECC---CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHH
Confidence 578999999999998774 7999999999765322111 00000 000 0000001111344569999999988
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
+++.....+... ..++||||++++++..... ...+++...+..++.|++.+|.++| |+.|++|+||||+||+
T Consensus 79 ~~v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~----~~~~~~~~~~~~i~~qi~~~L~~l~--H~~giiHrDlkP~NIl 150 (190)
T cd05147 79 AGIPCPEPILLK--SHVLVMEFIGDDGWAAPRL----KDAPLSESKARELYLQVIQIMRILY--QDCRLVHADLSEYNLL 150 (190)
T ss_pred CCCCCCcEEEec--CCEEEEEEeCCCCCcchhh----hcCCCCHHHHHHHHHHHHHHHHHHH--HhCCcccCCCCHHHEE
Confidence 877554443222 2389999999877765431 2346888899999999999999995 5679999999999999
Q ss_pred ecCCCCeEEecccCcccc
Q 040898 199 IDDDMEARISDFGHGKLM 216 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~ 216 (337)
++ ++.++|+|||++...
T Consensus 151 i~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 151 YH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred EE-CCcEEEEEccccccC
Confidence 98 578999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-21 Score=188.39 Aligned_cols=210 Identities=22% Similarity=0.271 Sum_probs=170.7
Q ss_pred Ccccccccccccc-ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHH
Q 040898 26 SPLVEKQDLAFLK-KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIG 104 (337)
Q Consensus 26 ~~~~~~~~~~~~~-~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 104 (337)
++.++....+.+. .++.|.|-+.||+|+||.||.+++. +|+.||+|+-.+.+..
T Consensus 682 ~~~~~l~~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~---~~~~~alK~e~P~~~W---------------------- 736 (974)
T KOG1166|consen 682 SRVPKLNPNTEFEVGGEKFCISKEIGEGSYGSVYVATHS---NGKLVALKVEKPPNPW---------------------- 736 (974)
T ss_pred ccccccCccceeeecceeEEEEeeeccccceEEEEeecC---CCcEEEEEeecCCCce----------------------
Confidence 3555666666666 8889999999999999999998886 4999999987666542
Q ss_pred hHHHHHHHHHhcC---CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhh
Q 040898 105 AIRSEIITANQTR---HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHM 181 (337)
Q Consensus 105 ~~~~e~~~l~~l~---hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~ 181 (337)
.|.--.+++.+|+ -+.|..+...+.-.+.-++|+||.+.|+|-++++ ....+++..+.-+..|++..+.+|
T Consensus 737 EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~l-- 810 (974)
T KOG1166|consen 737 EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHL-- 810 (974)
T ss_pred eeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHH--
Confidence 2222344444444 2466667777777788899999999999999994 666789999999999999999999
Q ss_pred CCCCCeEecCCCCCceeec-------CCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhh
Q 040898 182 CHRPRLIHRDIKPANVLID-------DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSF 254 (337)
Q Consensus 182 ~h~~gi~h~di~~~nil~~-------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Diwsl 254 (337)
|..+|+||||||+|+++. .+..++|+|||.+..+.-..........++|-.|-++|...|.+|+..+|.|.|
T Consensus 811 -H~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGl 889 (974)
T KOG1166|consen 811 -HAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGL 889 (974)
T ss_pred -HhcceecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHH
Confidence 777999999999999995 245689999999876654444445566788999999999999999999999999
Q ss_pred hHHHHHHHhCCCC
Q 040898 255 GVLLAVLVMGKFP 267 (337)
Q Consensus 255 G~i~~~ll~g~~p 267 (337)
+.+++.||.|++.
T Consensus 890 Aa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 890 AATVHVMLFGKYM 902 (974)
T ss_pred HHHHHHHHHHHHH
Confidence 9999999999744
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.9e-22 Score=162.33 Aligned_cols=246 Identities=24% Similarity=0.300 Sum_probs=180.8
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
+...++.+|.....|+.|++++ .|..+++|++....-.. .....|..|...++-+.|||
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrw----qgndivakil~vr~~t~-----------------risrdfneefp~lrifshpn 248 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRW----QGNDIVAKILNVREVTA-----------------RISRDFNEEFPALRIFSHPN 248 (448)
T ss_pred hhhhhhhhhccCCCcccccccc----cCcchhhhhhhhhhcch-----------------hhcchhhhhCcceeeecCCc
Confidence 3456677889999999999988 56677778764332111 11157888999999999999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
|+..++.+....+..++..|++.|||..++.. +.+-..+..++.+++.+++.+++|||+.. .-+.---++...++++
T Consensus 249 ilpvlgacnsppnlv~isq~mp~gslynvlhe--~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmid 325 (448)
T KOG0195|consen 249 ILPVLGACNSPPNLVIISQYMPFGSLYNVLHE--QTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMID 325 (448)
T ss_pred hhhhhhhccCCCCceEeeeeccchHHHHHHhc--CccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEec
Confidence 99999999999999999999999999999965 45556778889999999999999997652 2344556888999999
Q ss_pred CCCCeEEe--cccCccccCCCCceeeeecccCCCCccCccccccCCC---CCcccchhhhHHHHHHHhCCCCCCCCCCCc
Q 040898 201 DDMEARIS--DFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETI---SDKCDIYSFGVLLAVLVMGKFPVDDFFGHT 275 (337)
Q Consensus 201 ~~~~~~l~--dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~---~~~~DiwslG~i~~~ll~g~~pf~~~~~~~ 275 (337)
++-+.+|. |--++.+ .......|.|++||.++..+- -.++|+||++++++|+.|...||.+...-.
T Consensus 326 edltarismad~kfsfq---------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspme 396 (448)
T KOG0195|consen 326 EDLTARISMADTKFSFQ---------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPME 396 (448)
T ss_pred chhhhheecccceeeee---------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchh
Confidence 88766554 3222211 123457889999999976553 357899999999999999999997764422
Q ss_pred hhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhh
Q 040898 276 EEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVR 335 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 335 (337)
.. ++-.+..- ....+|.....+.+|+.-|++.||.+||.+..++
T Consensus 397 cg------mkialegl----------rv~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 397 CG------MKIALEGL----------RVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred hh------hhhhhccc----------cccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 22 11111111 1112233334488999999999999999988764
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.1e-20 Score=153.43 Aligned_cols=160 Identities=15% Similarity=0.172 Sum_probs=113.4
Q ss_pred ccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHH--HHHHhh--h-hhh--hhhhHHhHHhHHHHHHHHHhcC
Q 040898 45 SLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAA--ELIKQD--I-DEY--SDLLHWKIGAIRSEIITANQTR 117 (337)
Q Consensus 45 ~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~~~--~-~~~--~~~~~~~~~~~~~e~~~l~~l~ 117 (337)
+.+.||+|++|.||++.+. +|+.||||++......... ...... . ... ............+|...+.++.
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~---~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 77 (190)
T cd05145 1 INGCISTGKEANVYHARTG---DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLY 77 (190)
T ss_pred CCceeecCCCcEEEEEEcC---CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHH
Confidence 4678999999999999874 7999999999876432111 100000 0 000 0011111134567999999999
Q ss_pred CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCC-CCeEecCCCCCc
Q 040898 118 HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHR-PRLIHRDIKPAN 196 (337)
Q Consensus 118 hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~-~gi~h~di~~~n 196 (337)
++++.....+.... .++||||++++++..... ....++......++.|++.++.++ |. .|++|+||+|+|
T Consensus 78 ~~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l----~~~~~~~~~~~~i~~~l~~~l~~l---H~~~givHrDlkP~N 148 (190)
T cd05145 78 EAGVPVPEPILLKK--NVLVMEFIGDDGSPAPRL----KDVPLEEEEAEELYEQVVEQMRRL---YQEAGLVHGDLSEYN 148 (190)
T ss_pred hCCCCCceEEEecC--CEEEEEEecCCCchhhhh----hhccCCHHHHHHHHHHHHHHHHHH---HHhCCEecCCCChhh
Confidence 99886665544433 489999999875544321 223467788899999999999999 55 799999999999
Q ss_pred eeecCCCCeEEecccCccccC
Q 040898 197 VLIDDDMEARISDFGHGKLMP 217 (337)
Q Consensus 197 il~~~~~~~~l~dfg~~~~~~ 217 (337)
|+++ ++.++|+|||++....
T Consensus 149 Ill~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 149 ILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred EEEE-CCCEEEEEcccceecC
Confidence 9999 8899999999987653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.3e-21 Score=166.68 Aligned_cols=191 Identities=21% Similarity=0.282 Sum_probs=133.2
Q ss_pred CCCCcccceeEEEc---------------------------CCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHH
Q 040898 117 RHRNILPLLAHMVR---------------------------PNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIA 169 (337)
Q Consensus 117 ~hpniv~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~ 169 (337)
+|||||++.+.|.+ +...|+||.-++. +|.+++.. ...+.....-++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~-----~~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT-----RHRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc-----CCCchHHHHHHH
Confidence 69999999987743 3567999998876 99999843 224556678899
Q ss_pred HHHHHHHHHHhhCCCCCeEecCCCCCceeec--C--CCCeEEecccCccccCCCCceeeeec----ccCCCCccCccccc
Q 040898 170 RGIASGLEYLHMCHRPRLIHRDIKPANVLID--D--DMEARISDFGHGKLMPDGHAQITVKC----MVGTMGYMAPESLQ 241 (337)
Q Consensus 170 ~~i~~~l~~l~~~h~~gi~h~di~~~nil~~--~--~~~~~l~dfg~~~~~~~~~~~~~~~~----~~~~~~~~~PE~~~ 241 (337)
.|+++|+.|| |++|+.|+|+|.+||++. + -..+.++|||++-.-+....+..... .-|.-..+|||+..
T Consensus 348 aQlLEav~hL---~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHL---HKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHH---HHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 9999999999 888999999999999993 2 34678999998755443322222221 23666789999986
Q ss_pred cCCC------CCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHH
Q 040898 242 TETI------SDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLK 315 (337)
Q Consensus 242 ~~~~------~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 315 (337)
..+. -.++|.|+.|.+.||+++...||-.... ...+.... ++ . -....++.++..+.+
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe--m~L~~r~Y-qe---~----------qLPalp~~vpp~~rq 488 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE--MLLDTRTY-QE---S----------QLPALPSRVPPVARQ 488 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccch--heechhhh-hh---h----------hCCCCcccCChHHHH
Confidence 5442 3578999999999999999999854100 00011000 00 0 011112233344778
Q ss_pred HHhhhccCCCCCCCChh
Q 040898 316 LACFCTLKDPDERPSSK 332 (337)
Q Consensus 316 li~~~l~~dP~~Rps~~ 332 (337)
++...|+.||++|+|..
T Consensus 489 lV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 489 LVFDLLKRDPSKRVSPN 505 (598)
T ss_pred HHHHHhcCCccccCCcc
Confidence 88888999999999964
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.9e-22 Score=179.14 Aligned_cols=230 Identities=23% Similarity=0.287 Sum_probs=178.0
Q ss_pred eeccCcceEEEEeEEecC-CCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC-CCCcccce
Q 040898 48 KIGSGGWGEVFYKAELPG-SNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR-HRNILPLL 125 (337)
Q Consensus 48 ~lg~G~~g~V~~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~ 125 (337)
.+|+|+||.|+++....+ ..|..+|.|.+.+........ .....|..++...+ ||.+++++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~-----------------~~t~~er~il~~~~~~~f~v~lh 63 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDR-----------------THTKQERIILAFVHNTPFLVKLH 63 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccc-----------------cccccHHHHHhhccCCCceeeee
Confidence 379999999998765432 267788888876654432211 12233566677775 99999999
Q ss_pred eEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCCe
Q 040898 126 AHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEA 205 (337)
Q Consensus 126 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~ 205 (337)
..++.+...++++++..+|.|...+ .....+++.........++.++.++ |+.|++++|+|++||+++.+|.+
T Consensus 64 yafqt~~kl~l~ld~~rgg~lft~l----~~~~~f~~~~~~~~~aelaLald~l---h~l~iiyrd~k~enilld~~Ghi 136 (612)
T KOG0603|consen 64 YAFQTDGKLYLILDFLRGGDLFTRL----SKEVMFDELDVAFYLAELALALDHL---HKLGIAYRDYKLENVLLLLEGHI 136 (612)
T ss_pred eeeccccchhHhhhhcccchhhhcc----ccCCchHHHHHHHHHHHHHHHHhhc---chhHHHHhcccccceeecccCcc
Confidence 9999999999999999999888777 4555677788888889999999999 88899999999999999999999
Q ss_pred EEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHHHHHH
Q 040898 206 RISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMR 285 (337)
Q Consensus 206 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~ 285 (337)
++.|||++...-.... .+||..|+|||+++ ....++|.||+|+++++|+||..||.. +.+.
T Consensus 137 ~~tdfglske~v~~~~------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-----------~~~~ 197 (612)
T KOG0603|consen 137 KLTDFGLSKEAVKEKI------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-----------DTMK 197 (612)
T ss_pred ccCCchhhhHhHhhhh------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-----------HHHH
Confidence 9999999876433321 27899999999998 457889999999999999999999865 1222
Q ss_pred hhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCCh
Q 040898 286 NVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSS 331 (337)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~ 331 (337)
.+..... ..+........+++..++..+|.+|.-.
T Consensus 198 ~Il~~~~-----------~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 198 RILKAEL-----------EMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred HHhhhcc-----------CCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 2222111 1233445558888999999999998765
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.3e-19 Score=146.97 Aligned_cols=188 Identities=15% Similarity=0.097 Sum_probs=134.8
Q ss_pred cccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC-CCCcc
Q 040898 44 DSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR-HRNIL 122 (337)
Q Consensus 44 ~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-hpniv 122 (337)
.....|++|+||+||.+.. .+.+++.+.+....-.... +. -..+.+|+++|+++. +++++
T Consensus 5 ~~~~~l~~~~f~~v~~~~~----~~~k~~~~~l~~~~~~~~~------~~---------~~l~~rE~~iL~~L~~~~~vP 65 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG----GERKFVRRDLSAAPWWLRG------VA---------WWLARREALALRQLDGLPRTP 65 (218)
T ss_pred ccceeecCCCcceEEEeec----CCceeeecccccchhhhhh------HH---------HHHHHHHHHHHHhcCCCCCCC
Confidence 4678899999999986554 6778877766433221110 00 035788999999995 57899
Q ss_pred cceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCC-CCCceeecC
Q 040898 123 PLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDI-KPANVLIDD 201 (337)
Q Consensus 123 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di-~~~nil~~~ 201 (337)
+++++ +..+++|+|+.|.+|...+ .. ....++.|++.++.++ |++|++|+|| +|+||+++.
T Consensus 66 ~ll~~----~~~~lvmeyI~G~~L~~~~----~~-------~~~~~~~qi~~~L~~l---H~~GIvHrDL~kp~NILv~~ 127 (218)
T PRK12274 66 RLLHW----DGRHLDRSYLAGAAMYQRP----PR-------GDLAYFRAARRLLQQL---HRCGVAHNDLAKEANWLVQE 127 (218)
T ss_pred EEEEE----cCEEEEEeeecCccHHhhh----hh-------hhHHHHHHHHHHHHHH---HHCcCccCCCCCcceEEEcC
Confidence 99885 3469999999999886543 11 1134778899999999 7789999999 799999999
Q ss_pred CCCeEEecccCccccCCCCce---ee--------eecccCCCCccCccccccC-CCC-CcccchhhhHHHHHHHhCCCCC
Q 040898 202 DMEARISDFGHGKLMPDGHAQ---IT--------VKCMVGTMGYMAPESLQTE-TIS-DKCDIYSFGVLLAVLVMGKFPV 268 (337)
Q Consensus 202 ~~~~~l~dfg~~~~~~~~~~~---~~--------~~~~~~~~~~~~PE~~~~~-~~~-~~~DiwslG~i~~~ll~g~~pf 268 (337)
++.++|+|||++......... .. ......++.++.|+..... ..+ ...+.++.|+-+|.++|+..|+
T Consensus 128 ~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~ 207 (218)
T PRK12274 128 DGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH 207 (218)
T ss_pred CCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence 999999999999865433210 00 0112357777777765433 223 3567888999999999998885
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1e-19 Score=164.83 Aligned_cols=211 Identities=27% Similarity=0.393 Sum_probs=156.3
Q ss_pred HHhcCCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 040898 113 ANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDI 192 (337)
Q Consensus 113 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di 192 (337)
|+++.|.|+.+++|.+.++...+.|.+||..|+|.+.+.. ....+++.....++++|+.|+.|+| ++...+|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh--~s~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLH--NSPIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHh--cCcceeeeee
Confidence 3568999999999999999999999999999999999964 4566888999999999999999996 3344499999
Q ss_pred CCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCC-------CCCcccchhhhHHHHHHHhCC
Q 040898 193 KPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTET-------ISDKCDIYSFGVLLAVLVMGK 265 (337)
Q Consensus 193 ~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-------~~~~~DiwslG~i~~~ll~g~ 265 (337)
+..|++++..-.+||+|||+....................-|.|||.+.+.. .+.+.|+||+|++++|+++..
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 9999999999999999999987664311111111222445589999997642 356789999999999999999
Q ss_pred CCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhh
Q 040898 266 FPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVR 335 (337)
Q Consensus 266 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 335 (337)
.||+.........++...+.. ....+.+...... ......+..++..||..+|.+||+++++-
T Consensus 156 ~~~~~~~~~~~~~eii~~~~~--~~~~~~rP~i~~~-----~e~~~~l~~l~~~cw~e~P~~rPs~~~i~ 218 (484)
T KOG1023|consen 156 GPFDLRNLVEDPDEIILRVKK--GGSNPFRPSIELL-----NELPPELLLLVARCWEEIPEKRPSIEQIR 218 (484)
T ss_pred CccccccccCChHHHHHHHHh--cCCCCcCcchhhh-----hhcchHHHHHHHHhcccChhhCccHHHHH
Confidence 999865443333333333322 0111111111100 02333688999999999999999998874
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=8.1e-19 Score=144.88 Aligned_cols=135 Identities=14% Similarity=0.195 Sum_probs=101.8
Q ss_pred ccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc-----C
Q 040898 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT-----R 117 (337)
Q Consensus 43 y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-----~ 117 (337)
+.-.+.||+|++|.||. +. .++.. +||++........ +.+.+|+.+++.+ .
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp--~~~~k-~IKv~~~~~~~~~-------------------~~~~rEi~~l~~L~~~~~~ 59 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HP--EDAQR-CIKIVYHRGDGGD-------------------KEIRRELKYYAHLSRRLID 59 (210)
T ss_pred cCCcceecCCCceEEEE--CC--CCcCe-EEEEEeccccchH-------------------HHHHHHHHHHHHhhccCCC
Confidence 34567899999999984 33 24554 6888865432111 4678899999999 6
Q ss_pred CCCcccceeEEEcCC---eeE-EEEEe--ccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHH-HHHhhCCCCCeEec
Q 040898 118 HRNILPLLAHMVRPN---CHL-LVYEF--MKNGSLQDILYDVSQGRRELDWPARHRIARGIASGL-EYLHMCHRPRLIHR 190 (337)
Q Consensus 118 hpniv~~~~~~~~~~---~~~-lv~e~--~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l-~~l~~~h~~gi~h~ 190 (337)
||||++++++++++. .++ +|+|| +++++|.+++.. ..+++. ..++.+++.++ .|| |+++|+|+
T Consensus 60 h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yL---h~~~Ivhr 129 (210)
T PRK10345 60 WSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYL---LDNRIVTM 129 (210)
T ss_pred CcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHH---HHCCEeec
Confidence 799999999998874 333 78999 557899999943 235544 35577777777 899 77899999
Q ss_pred CCCCCceeecC----CCCeEEeccc
Q 040898 191 DIKPANVLIDD----DMEARISDFG 211 (337)
Q Consensus 191 di~~~nil~~~----~~~~~l~dfg 211 (337)
||||+||+++. ++.++|+|++
T Consensus 130 DlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 130 ELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred CCCHHHEEEeccCCCCCcEEEEECC
Confidence 99999999974 3479999954
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=9.9e-19 Score=147.85 Aligned_cols=172 Identities=15% Similarity=0.095 Sum_probs=117.5
Q ss_pred ccccccccccccccceeccCcceEEEEeE-EecCCCCceEEEEEecccCcchHH--HHH--Hhhhh-hhhhhhHHhHHhH
Q 040898 33 DLAFLKKEDCFDSLKKIGSGGWGEVFYKA-ELPGSNGKMIAIRKLIVDAPMSAA--ELI--KQDID-EYSDLLHWKIGAI 106 (337)
Q Consensus 33 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~~~vavK~~~~~~~~~~~--~~~--~~~~~-~~~~~~~~~~~~~ 106 (337)
..++.+..--|.+.+.||.|++|.||.+. +.. +|+.||+|++......... ... ..... ............+
T Consensus 20 ~~~~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~--~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 97 (237)
T smart00090 20 LYSLLNRGILSAIGGCISTGKEANVYHALDFDG--SGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWA 97 (237)
T ss_pred HHHHHhcCchHHhCCeeccCcceeEEEEEecCC--CCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHH
Confidence 45566677689999999999999999997 444 8999999998765422110 000 00000 0000000001345
Q ss_pred HHHHHHHHhcCCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCC
Q 040898 107 RSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPR 186 (337)
Q Consensus 107 ~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~g 186 (337)
.+|...+.++.+.+ +.....+.. ...++||||+++.+|.... .............++.|++.++.++ |+.|
T Consensus 98 ~~E~~~L~~L~~~~-i~~p~~~~~-~~~~lV~E~~~g~~L~~~~----~~~~~~~~~~~~~i~~qi~~~l~~L---H~~g 168 (237)
T smart00090 98 EKEFRNLQRLYEAG-VPVPKPIAW-RRNVLVMEFIGGDGLPAPR----LKDVEPEEEEEFELYDDILEEMRKL---YKEG 168 (237)
T ss_pred HHHHHHHHHHHhcC-CCCCeeeEe-cCceEEEEEecCCcccccc----cccCCcchHHHHHHHHHHHHHHHHH---HhcC
Confidence 67999999997533 222222222 2358999999998887654 2233455566789999999999999 7789
Q ss_pred -eEecCCCCCceeecCCCCeEEecccCcccc
Q 040898 187 -LIHRDIKPANVLIDDDMEARISDFGHGKLM 216 (337)
Q Consensus 187 -i~h~di~~~nil~~~~~~~~l~dfg~~~~~ 216 (337)
++|+||+|+||+++ ++.++|+|||.+...
T Consensus 169 ~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 169 ELVHGDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred CEEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 99999999999999 889999999987643
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=6.6e-18 Score=141.21 Aligned_cols=143 Identities=20% Similarity=0.283 Sum_probs=114.2
Q ss_pred cceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCcccce
Q 040898 46 LKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLL 125 (337)
Q Consensus 46 ~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~ 125 (337)
++.||+|++|.||.+.+ .+..+++|+............. .. ....+.+|+.++..+.|+++....
T Consensus 1 ~~~l~~G~~~~vy~~~~----~~~~~~vK~~~~~~~~~~~~~~--~~---------~~~~~~~E~~~l~~l~~~~i~~p~ 65 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF----LGIKAVIKWRIPKRYRHPELDE--RI---------RRERTRREARIMSRARKAGVNVPA 65 (211)
T ss_pred CcccccCceEEEEEEee----CCCceEEEEeCCcCCcChHHHH--HH---------HHHHHHHHHHHHHHHHHCCCCCCe
Confidence 36799999999999876 6788999987654322111000 00 014677899999999999998888
Q ss_pred eEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCCe
Q 040898 126 AHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEA 205 (337)
Q Consensus 126 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~ 205 (337)
.++......+++|||++|++|.+.+.. . .. ....++.+++.++.++ |+.|++|+|++|.||+++ ++.+
T Consensus 66 ~~~~~~~~~~lv~e~~~G~~L~~~~~~----~---~~-~~~~i~~~i~~~l~~l---H~~~i~H~Dl~p~Nil~~-~~~~ 133 (211)
T PRK14879 66 VYFVDPENFIIVMEYIEGEPLKDLINS----N---GM-EELELSREIGRLVGKL---HSAGIIHGDLTTSNMILS-GGKI 133 (211)
T ss_pred EEEEeCCCCEEEEEEeCCcCHHHHHHh----c---cH-HHHHHHHHHHHHHHHH---HhCCcccCCCCcccEEEE-CCCE
Confidence 888778889999999999999998843 1 11 7789999999999999 777999999999999999 7899
Q ss_pred EEecccCccc
Q 040898 206 RISDFGHGKL 215 (337)
Q Consensus 206 ~l~dfg~~~~ 215 (337)
+++|||.+..
T Consensus 134 ~liDf~~a~~ 143 (211)
T PRK14879 134 YLIDFGLAEF 143 (211)
T ss_pred EEEECCcccC
Confidence 9999998764
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.2e-19 Score=158.22 Aligned_cols=175 Identities=28% Similarity=0.426 Sum_probs=127.8
Q ss_pred CeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCCeEEeccc
Q 040898 132 NCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFG 211 (337)
Q Consensus 132 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~~l~dfg 211 (337)
...|+.|++|...+|.+++... ......++.....+..|++.++.| +|.+|+|++|.||+...++.++|+|||
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr-~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRR-RTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCC-CcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhh
Confidence 3578999999999999999532 234456778889999999999887 589999999999999999999999999
Q ss_pred CccccCCCC----ceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhC-CCCCCCCCCCchhhhHHHHHHh
Q 040898 212 HGKLMPDGH----AQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMG-KFPVDDFFGHTEEMDMVKWMRN 286 (337)
Q Consensus 212 ~~~~~~~~~----~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g-~~pf~~~~~~~~~~~~~~~~~~ 286 (337)
+........ .....+...||..|++||.+.+..|+.++||||||++++|++.- .-+++. ......
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er----------~~t~~d 471 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER----------IATLTD 471 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH----------HHhhhh
Confidence 987765444 22233456799999999999999999999999999999999972 222211 111111
Q ss_pred hhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhh
Q 040898 287 VIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKD 333 (337)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e 333 (337)
+-....+.... . .++. -..|+.+|+.+.|.+||++.+
T Consensus 472 ~r~g~ip~~~~-----~-d~p~----e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 472 IRDGIIPPEFL-----Q-DYPE----EYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred hhcCCCChHHh-----h-cCcH----HHHHHHHhcCCCcccCchHHH
Confidence 11111111111 1 1111 346777899999999996654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.75 E-value=2e-18 Score=164.65 Aligned_cols=212 Identities=22% Similarity=0.279 Sum_probs=143.2
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
...+|+.++.|..|+||-||.+.|.. +.+.+|.| +.++.. +.|- ++.....
T Consensus 81 ~e~df~~IklisngAygavylvrh~~--trqrfa~k-iNkq~l------------------------ilRn--ilt~a~n 131 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKE--TRQRFAMK-INKQNL------------------------ILRN--ILTFAGN 131 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccc--cccchhhc-ccccch------------------------hhhc--cccccCC
Confidence 56789999999999999999999876 88999984 433221 1110 2222233
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|.++ |+=...+ ..-++++... +.+++|+ |+.|++|+|++|+|.+
T Consensus 132 pfvv---------------------gDc~tll----k~~g~lPvdm--------vla~Eyl---h~ygivhrdlkpdnll 175 (1205)
T KOG0606|consen 132 PFVV---------------------GDCATLL----KNIGPLPVDM--------VLAVEYL---HSYGIVHRDLKPDNLL 175 (1205)
T ss_pred ccee---------------------chhhhhc----ccCCCCcchh--------hHHhHhh---ccCCeecCCCCCCcce
Confidence 3333 2222223 2222333222 6789999 8889999999999999
Q ss_pred ecCCCCeEEecccCccccCCCC-------------ceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCC
Q 040898 199 IDDDMEARISDFGHGKLMPDGH-------------AQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGK 265 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~-------------~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~ 265 (337)
|+.-|++|++|||++..--... .....+..++||.|.|||++....|...+|.|++|+|+|+++-|.
T Consensus 176 IT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgc 255 (1205)
T KOG0606|consen 176 ITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGC 255 (1205)
T ss_pred eeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheee
Confidence 9999999999999876431110 011122357999999999999999999999999999999999999
Q ss_pred CCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCC
Q 040898 266 FPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPS 330 (337)
Q Consensus 266 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps 330 (337)
.||.+. +...-+...+.....- .+..+....+..+++.++|+.+|.+|.-
T Consensus 256 vpffGd---tpeelfg~visd~i~w------------pE~dea~p~Ea~dli~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 256 VPFFGD---TPEELFGQVISDDIEW------------PEEDEALPPEAQDLIEQLLRQNPLCRLG 305 (1205)
T ss_pred eeccCC---CHHHHHhhhhhhhccc------------cccCcCCCHHHHHHHHHHHHhChHhhcc
Confidence 998542 2222233333221110 0111222234788899999999999964
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.3e-17 Score=136.67 Aligned_cols=137 Identities=19% Similarity=0.320 Sum_probs=107.7
Q ss_pred eeccCcceEEEEeEEecCCCCceEEEEEecccCcchH-HHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCccccee
Q 040898 48 KIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSA-AELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLLA 126 (337)
Q Consensus 48 ~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~ 126 (337)
.||+|++|.||++.. ++..+++|.......... .... .....+.+|+.++..+.|+++.....
T Consensus 1 ~ig~G~~~~vy~~~~----~~~~~viK~~~~~~~~~~~~~~~------------~~~~~~~~E~~~l~~l~~~~i~~p~~ 64 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF----LGLKAVIKERVPKSYRHPELDER------------IRRERTRNEARLLSRARKAGVNTPVV 64 (199)
T ss_pred CCCCCceEEEEEeec----CCccEEEEEecCCcCcCchHHHH------------HHHHHHHHHHHHHHHHHHCCCCCCEE
Confidence 489999999999874 678899998665432111 0000 01156778999999999988777666
Q ss_pred EEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCCeE
Q 040898 127 HMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEAR 206 (337)
Q Consensus 127 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~~ 206 (337)
++......+++|||++|++|.+.+.. ... .++.+++.++.++ |+.|++|+|++|.||+++ ++.++
T Consensus 65 ~~~~~~~~~lv~e~~~g~~l~~~~~~----~~~-------~~~~~i~~~l~~l---H~~gi~H~Dl~~~Nil~~-~~~~~ 129 (199)
T TIGR03724 65 YDVDPDNKTIVMEYIEGKPLKDVIEE----GND-------ELLREIGRLVGKL---HKAGIVHGDLTTSNIIVR-DDKLY 129 (199)
T ss_pred EEEECCCCEEEEEEECCccHHHHHhh----cHH-------HHHHHHHHHHHHH---HHCCeecCCCCcceEEEE-CCcEE
Confidence 66677778999999999999988732 111 7899999999999 778999999999999999 88999
Q ss_pred EecccCccc
Q 040898 207 ISDFGHGKL 215 (337)
Q Consensus 207 l~dfg~~~~ 215 (337)
++|||.+..
T Consensus 130 liDfg~a~~ 138 (199)
T TIGR03724 130 LIDFGLGKY 138 (199)
T ss_pred EEECCCCcC
Confidence 999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.6e-17 Score=154.29 Aligned_cols=145 Identities=19% Similarity=0.292 Sum_probs=111.9
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
...|...+.||+|+||.||++.. .+..+++|+...+...... . ... .....+.+|+.+++.++|+
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~----~~~~~v~k~~~~~~~~~~~-~-~~~---------~~~~~~~~E~~~l~~l~~~ 396 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEY----LGRDAVIKERVPKGYRHPE-L-DER---------LRTERTRAEARLLSEARRA 396 (535)
T ss_pred ccccCccceeccCCcEEEEEEee----cCccceeEEEecccccchh-H-HHH---------HHHHHHHHHHHHHHhhccc
Confidence 34456789999999999999776 3445555554332111100 0 000 0115678899999999999
Q ss_pred CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceee
Q 040898 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI 199 (337)
Q Consensus 120 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~ 199 (337)
+++....+.......++||||+++++|.+++. ....++.+++.++.++ |+.|++|+|++|+||++
T Consensus 397 ~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~l---H~~giiHrDlkp~NILl 461 (535)
T PRK09605 397 GVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKL---HKAGIVHGDLTTSNFIV 461 (535)
T ss_pred CCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHH---HhCCCccCCCChHHEEE
Confidence 99988888777778899999999999999883 3467899999999999 77899999999999999
Q ss_pred cCCCCeEEecccCccc
Q 040898 200 DDDMEARISDFGHGKL 215 (337)
Q Consensus 200 ~~~~~~~l~dfg~~~~ 215 (337)
.++.++|+|||++..
T Consensus 462 -~~~~~~liDFGla~~ 476 (535)
T PRK09605 462 -RDDRLYLIDFGLGKY 476 (535)
T ss_pred -ECCcEEEEeCccccc
Confidence 678999999998765
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.2e-16 Score=132.06 Aligned_cols=156 Identities=17% Similarity=0.158 Sum_probs=108.9
Q ss_pred cccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHH-hhhhh--hhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 42 CFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIK-QDIDE--YSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
.|.+.+.||+|++|.||.+... +|+.||||++............. +.... .............+|..++..+.+
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 92 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP---DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYE 92 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC---CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHH
Confidence 4888999999999999988663 79999999976544211110000 00000 000001111346778888988877
Q ss_pred CC--cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 040898 119 RN--ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPAN 196 (337)
Q Consensus 119 pn--iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~n 196 (337)
++ +...++ ....+++|||+++++|..... . .....++.+++.++.++ |+.|++|+||+|.|
T Consensus 93 ~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~----~------~~~~~~~~~i~~~l~~l---h~~gi~H~Dl~p~N 155 (198)
T cd05144 93 EGFPVPKPID----WNRHAVVMEYIDGVELYRVRV----L------EDPEEVLDEILEEIVKA---YKHGIIHGDLSEFN 155 (198)
T ss_pred cCCCCCceee----cCCceEEEEEeCCcchhhccc----c------ccHHHHHHHHHHHHHHH---HHCCCCcCCCCccc
Confidence 74 333332 245589999999999876541 0 23567889999999999 66899999999999
Q ss_pred eeecCCCCeEEecccCccccC
Q 040898 197 VLIDDDMEARISDFGHGKLMP 217 (337)
Q Consensus 197 il~~~~~~~~l~dfg~~~~~~ 217 (337)
|+++.++.++|+|||.+....
T Consensus 156 ill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 156 ILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred EEEcCCCcEEEEECCccccCC
Confidence 999999999999999886543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.69 E-value=4.7e-18 Score=160.82 Aligned_cols=262 Identities=21% Similarity=0.322 Sum_probs=192.5
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC-
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR- 117 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~- 117 (337)
....|.+.+.||+|+++.|-.... ...+...++.|.+......... ...+..|..+-+.+.
T Consensus 18 ~~~~~~~~~~ig~gs~~~~~~~~~-~~~~~~~~a~~~~s~~~~~~~~-----------------~~~i~~e~~~~~~~s~ 79 (601)
T KOG0590|consen 18 PNSQYKLSRSIGKGSFSSSALASN-SRDPESSSATKPISIPPKSEDS-----------------SEHIDTETDIQKKLSK 79 (601)
T ss_pred ccccccccccccccccchhhhhhh-cCCCcceeeccCCCCCCCccch-----------------hhhcCccccccccccc
Confidence 466799999999999999944433 2345566777766554311110 034555777777776
Q ss_pred CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCC-CCCeEecCCCCCc
Q 040898 118 HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCH-RPRLIHRDIKPAN 196 (337)
Q Consensus 118 hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h-~~gi~h~di~~~n 196 (337)
|+|++.+++........++.+++..++++.+.+.. ......+.......+.|+..++.|+ | ..++.|+|++|+|
T Consensus 80 h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~--~~~~~~~~~~~~~~~~ql~s~l~~~---H~~~~~~h~~ikP~n 154 (601)
T KOG0590|consen 80 HSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISH--PDSTGTSSSSASRYLPQLNSGLSYL---HPENGVTHRDIKPSN 154 (601)
T ss_pred cccccccCCccCCCcccccccCccccccccccccc--CCccCCCCcchhhhhhhhccCcccc---CcccccccCCCCCcc
Confidence 99999999999999999999999999999887731 2222456667788999999999999 6 7899999999999
Q ss_pred eeecCCC-CeEEecccCccccCC-CCceeeeecccC-CCCccCccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCC
Q 040898 197 VLIDDDM-EARISDFGHGKLMPD-GHAQITVKCMVG-TMGYMAPESLQTE-TISDKCDIYSFGVLLAVLVMGKFPVDDFF 272 (337)
Q Consensus 197 il~~~~~-~~~l~dfg~~~~~~~-~~~~~~~~~~~~-~~~~~~PE~~~~~-~~~~~~DiwslG~i~~~ll~g~~pf~~~~ 272 (337)
.+++.++ .+++.|||++..+.. ...........| ++.|.+||...+. ......|+||+|+++..+++|..||+...
T Consensus 155 ~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~ 234 (601)
T KOG0590|consen 155 SLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPS 234 (601)
T ss_pred chhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccc
Confidence 9999999 999999999998877 555555566778 9999999999884 44678899999999999999999986543
Q ss_pred CCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 273 GHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
.... ....+.... .......+........+++.+++..+|..|.+.+++-.
T Consensus 235 ~~~~--~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 235 RKDG--RYSSWKSNK-----------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred cccc--cceeecccc-----------cccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 3221 111111110 00001112222333678888899999999999988753
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.7e-15 Score=128.37 Aligned_cols=148 Identities=18% Similarity=0.221 Sum_probs=102.7
Q ss_pred cceec-cCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCc--c
Q 040898 46 LKKIG-SGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNI--L 122 (337)
Q Consensus 46 ~~~lg-~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpni--v 122 (337)
...|| .||.|+||.+.. .+..+++|++........ ...... .........+.+|+.++..+.|+++ +
T Consensus 36 ~~~lg~~~g~gtv~~v~~----~~~~~vlk~~~r~~~i~k--v~~~~~----~~~~~~~~r~~rE~~ll~~L~~~gi~vP 105 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQT----PGVNWVLRHYRRGGLIGK--LSKDRY----LFTGLERTRAFAEFRLLAQLYEAGLPVP 105 (239)
T ss_pred CceeecCCCCccEEEEEe----CCceEEEEEeeEcchHHh--hhhhcc----cccchhhhHHHHHHHHHHHHHhCCCCCc
Confidence 34576 788888877655 578899998854321100 000000 0000112578889999999998875 6
Q ss_pred cceeEEEcC-Ce---eEEEEEeccC-CCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCce
Q 040898 123 PLLAHMVRP-NC---HLLVYEFMKN-GSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANV 197 (337)
Q Consensus 123 ~~~~~~~~~-~~---~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ni 197 (337)
..+++.... .. .++|+|++++ .+|.+++.. .+++.. .+.+++.++.++ |+.|++|+||+|.||
T Consensus 106 ~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~l---H~~GI~HrDlkp~NI 173 (239)
T PRK01723 106 RPIAARVVRHGLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARF---HDAGVYHADLNAHNI 173 (239)
T ss_pred eeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHH---HHCCCCCCCCCchhE
Confidence 666654332 22 2599999997 689988732 234433 357899999999 778999999999999
Q ss_pred eecCCCCeEEecccCccc
Q 040898 198 LIDDDMEARISDFGHGKL 215 (337)
Q Consensus 198 l~~~~~~~~l~dfg~~~~ 215 (337)
+++.++.++|+|||.+..
T Consensus 174 Lv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 174 LLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred EEcCCCCEEEEECCCccc
Confidence 999989999999998765
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.64 E-value=3e-15 Score=117.89 Aligned_cols=135 Identities=19% Similarity=0.226 Sum_probs=109.3
Q ss_pred ccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC--CCcc
Q 040898 45 SLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH--RNIL 122 (337)
Q Consensus 45 ~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--pniv 122 (337)
+.+.||.|.++.||.+.. .+..+++|....... . ..+.+|...+..+.+ ++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~----~~~~~~iK~~~~~~~--~-------------------~~~~~e~~~~~~l~~~~~~~p 56 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGT----KDEDYVLKINPSREK--G-------------------ADREREVAILQLLARKGLPVP 56 (155)
T ss_pred cceecccccccceEEEEe----cCCeEEEEecCCCCc--h-------------------hHHHHHHHHHHHHHHcCCCCC
Confidence 567899999999998887 447899998755432 0 356678888888866 5888
Q ss_pred cceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCC
Q 040898 123 PLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDD 202 (337)
Q Consensus 123 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~ 202 (337)
+++.+...++..++++||+++.++..+ +......++.+++.++..+|..+..+++|+|++|.||+++..
T Consensus 57 ~~~~~~~~~~~~~~v~e~~~g~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~ 125 (155)
T cd05120 57 KVLASGESDGWSYLLMEWIEGETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDG 125 (155)
T ss_pred eEEEEcCCCCccEEEEEecCCeecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECC
Confidence 888888888889999999988766533 345567788999999999965545689999999999999998
Q ss_pred CCeEEecccCccc
Q 040898 203 MEARISDFGHGKL 215 (337)
Q Consensus 203 ~~~~l~dfg~~~~ 215 (337)
+.++++||+.+..
T Consensus 126 ~~~~l~Df~~~~~ 138 (155)
T cd05120 126 KILGIIDWEYAGY 138 (155)
T ss_pred cEEEEEecccccC
Confidence 9999999997653
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.63 E-value=5.7e-16 Score=130.67 Aligned_cols=205 Identities=21% Similarity=0.293 Sum_probs=144.8
Q ss_pred HHHHhcCCCCcccceeEEEcCC-----eeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCC
Q 040898 111 ITANQTRHRNILPLLAHMVRPN-----CHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRP 185 (337)
Q Consensus 111 ~~l~~l~hpniv~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~ 185 (337)
.-+-++.|.|+++++.+|.+.+ ...+++||+..|+|..+|+........+......+|+.||+.||.|||+| +.
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CC
Confidence 4566678999999999987654 47899999999999999998777777889999999999999999999986 67
Q ss_pred CeEecCCCCCceeecCCCCeEEecccCcc--ccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh
Q 040898 186 RLIHRDIKPANVLIDDDMEARISDFGHGK--LMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM 263 (337)
Q Consensus 186 gi~h~di~~~nil~~~~~~~~l~dfg~~~--~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~ 263 (337)
.++|+++..+.|++..+|-++++--.-.. ..-............+-++|.+||.-..-..+-++|||++|+...+|-.
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 89999999999999999988876422111 1000111111112346778999997666666778999999999999887
Q ss_pred CCCCCCCCCCCchhhh-HHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 264 GKFPVDDFFGHTEEMD-MVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 264 g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
+..--.. ++... ....+...... .....-..++..|++..|+.||++++++.|
T Consensus 278 lEiq~tn----seS~~~~ee~ia~~i~~-----------------len~lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 278 LEIQSTN----SESKVEVEENIANVIIG-----------------LENGLQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred heeccCC----Ccceeehhhhhhhheee-----------------ccCccccCcCcccccCCCCCCcchhhhhcC
Confidence 7633111 11100 00000000000 000113567889999999999999999876
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.63 E-value=4.2e-15 Score=121.80 Aligned_cols=156 Identities=19% Similarity=0.171 Sum_probs=98.3
Q ss_pred ccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHH---hhhh--hhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 45 SLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIK---QDID--EYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 45 ~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~---~~~~--~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
+.+.||+|+||.||.+.+. +++.||+|++............. +... ...............|...+..+.+.
T Consensus 1 ~~~~lg~G~~g~Vy~a~~~---~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~ 77 (187)
T cd05119 1 VGGPIGTGKEADVYLALDG---DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEA 77 (187)
T ss_pred CCcccccccceeEEEEECC---CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHc
Confidence 3578999999999998764 78999999987643322111100 0000 00000001111223456666666443
Q ss_pred C--cccceeEEEcCCeeEEEEEeccCCCHHH-HHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCC-CCeEecCCCCC
Q 040898 120 N--ILPLLAHMVRPNCHLLVYEFMKNGSLQD-ILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHR-PRLIHRDIKPA 195 (337)
Q Consensus 120 n--iv~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~-~gi~h~di~~~ 195 (337)
. +.+.++. ...+++|||++++++.. .+.... .. .....++.+++.++.++ |. .|++|+||+|+
T Consensus 78 ~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~l---h~~~~ivH~Dl~p~ 144 (187)
T cd05119 78 GVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKL---YREAGLVHGDLSEY 144 (187)
T ss_pred CCCCCceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHH---hhccCcCcCCCChh
Confidence 3 3333332 23589999999854321 111100 11 55788999999999999 66 89999999999
Q ss_pred ceeecCCCCeEEecccCccccC
Q 040898 196 NVLIDDDMEARISDFGHGKLMP 217 (337)
Q Consensus 196 nil~~~~~~~~l~dfg~~~~~~ 217 (337)
||+++ ++.++++|||.+....
T Consensus 145 Nili~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 145 NILVD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred hEEEE-CCcEEEEECccccccc
Confidence 99999 8999999999886543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.52 E-value=3e-14 Score=129.69 Aligned_cols=257 Identities=20% Similarity=0.199 Sum_probs=183.4
Q ss_pred ccccccccceecc--CcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc
Q 040898 39 KEDCFDSLKKIGS--GGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT 116 (337)
Q Consensus 39 ~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 116 (337)
....+.+.+.+|. |.+|.||.......+++..+|+|+-+......... .+-.+|...-+.+
T Consensus 112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~-----------------~~k~~~~~s~~~i 174 (524)
T KOG0601|consen 112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDS-----------------KRKLREFLSHHKI 174 (524)
T ss_pred hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCcccc-----------------ccccchhhccccc
Confidence 4456889999999 99999999888556689999999854443321111 1223355555555
Q ss_pred -CCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHH----HHHHHhhCCCCCeEecC
Q 040898 117 -RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIAS----GLEYLHMCHRPRLIHRD 191 (337)
Q Consensus 117 -~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~----~l~~l~~~h~~gi~h~d 191 (337)
.|+|.++.+..++..+..++-+|+|. .+|..+..+ ...-++....+..+.+... |+.++ |..+++|-|
T Consensus 175 ~~~~~~v~~~~~~e~~~~lfiqtE~~~-~sl~~~~~~---~~~~~p~~~l~~~~~~~~~~~~~al~~~---hs~~~~~~~ 247 (524)
T KOG0601|consen 175 DSHENPVRDSPAWEGSGILFIQTELCG-ESLQSYCHT---PCNFLPDNLLWNSLRDWLSRDVTALSHL---HSNNIVHDD 247 (524)
T ss_pred CccccccccCcccccCCcceeeecccc-chhHHhhhc---ccccCCchhhhhHHhhhhhccccccccc---CCCcccccc
Confidence 68999999999999999999999996 578777643 2333677788888888888 99999 888999999
Q ss_pred CCCCceeecCC-CCeEEecccCccccCCCCceeeee---cccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCC
Q 040898 192 IKPANVLIDDD-MEARISDFGHGKLMPDGHAQITVK---CMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFP 267 (337)
Q Consensus 192 i~~~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~---~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~p 267 (337)
++|.||+...+ ...+++||+++..+.......... ...+...|++||..++. ++...|++++|.++.+..++..+
T Consensus 248 ~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~ 326 (524)
T KOG0601|consen 248 LKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHL 326 (524)
T ss_pred cchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhccc
Confidence 99999999999 889999999998877654332222 22577789999998765 57789999999999999998766
Q ss_pred CCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 268 VDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 268 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
+....... +.+.......... .......+...+.+|++.+|..|++...++.|
T Consensus 327 ~~~g~~~~-------------W~~~r~~~ip~e~----~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 327 PSVGKNSS-------------WSQLRQGYIPLEF----CEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred ccCCCCCC-------------ccccccccCchhh----hcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 42210000 0000000011111 11112235558889999999999999988754
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.48 E-value=5.1e-13 Score=122.88 Aligned_cols=159 Identities=21% Similarity=0.257 Sum_probs=99.9
Q ss_pred cceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHH---HHH-------------------hhhhhhhhhhHHhH
Q 040898 46 LKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAE---LIK-------------------QDIDEYSDLLHWKI 103 (337)
Q Consensus 46 ~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~---~~~-------------------~~~~~~~~~~~~~~ 103 (337)
.+.||.|++|.||++... +|+.||||+..+........ ... ..+.........+
T Consensus 122 ~~plasaSigQVh~A~l~---~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~E- 197 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLV---DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRE- 197 (437)
T ss_pred CcceeeeehhheEEEEec---CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHH-
Confidence 367999999999998764 79999999987654221110 000 0000111111111
Q ss_pred HhHHHHHHHHHhcC-----CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHH-HHH
Q 040898 104 GAIRSEIITANQTR-----HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIAS-GLE 177 (337)
Q Consensus 104 ~~~~~e~~~l~~l~-----hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~-~l~ 177 (337)
-.+.+|...+.++. +|++.-..-+.......++||||++|++|.+....... .. ....++..++. .+.
T Consensus 198 ldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~---~~---~~~~ia~~~~~~~l~ 271 (437)
T TIGR01982 198 LDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA---GL---DRKALAENLARSFLN 271 (437)
T ss_pred HCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc---CC---CHHHHHHHHHHHHHH
Confidence 13455665555552 34433233333344567999999999999887643111 11 23445555555 355
Q ss_pred HHhhCCCCCeEecCCCCCceeecCCCCeEEecccCccccC
Q 040898 178 YLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMP 217 (337)
Q Consensus 178 ~l~~~h~~gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~ 217 (337)
.+ |..|++|+|++|.||+++.++.++++|||++..+.
T Consensus 272 ql---~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 272 QV---LRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HH---HhCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 66 67899999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.5e-12 Score=120.02 Aligned_cols=165 Identities=18% Similarity=0.207 Sum_probs=124.9
Q ss_pred CCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCcccceeEEEcCCeeEEEEEeccCCCH
Q 040898 67 NGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSL 146 (337)
Q Consensus 67 ~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L 146 (337)
++.+|.|..+....... .+.+.+.++.++.++||||++++..++.....|+|+|.+ ..|
T Consensus 36 ~~~~vsVF~~~~~~~~~-------------------~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl 94 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNGEV-------------------TELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPL 94 (690)
T ss_pred cCCceEEEEEeCCCchh-------------------hHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccH
Confidence 77888888776554311 145677889999999999999999999999999999976 477
Q ss_pred HHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCCeEEecccCccccCCCCceeeee
Q 040898 147 QDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVK 226 (337)
Q Consensus 147 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 226 (337)
..++.+ +....+..-+.||+.||.+|| ++.+++|+++....|+++..|..+|++|.++........ ...
T Consensus 95 ~~~lk~-------l~~~~v~~Gl~qIl~AL~FL~--~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~ 163 (690)
T KOG1243|consen 95 ETVLKE-------LGKEEVCLGLFQILAALSFLN--DDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAK 163 (690)
T ss_pred HHHHHH-------hHHHHHHHHHHHHHHHHHHHh--ccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccc
Confidence 777754 335677888999999999997 567899999999999999999999999988765433221 111
Q ss_pred cccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCC
Q 040898 227 CMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGK 265 (337)
Q Consensus 227 ~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~ 265 (337)
....-..|..|+.+.... -..|.|.||+++++++.|.
T Consensus 164 ~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 164 SLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred cchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCcc
Confidence 111222355666543222 3569999999999999993
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.44 E-value=3.5e-13 Score=125.56 Aligned_cols=163 Identities=17% Similarity=0.179 Sum_probs=95.0
Q ss_pred cccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHH---HH-------HHhhhhh-----hhhhhHHhHHhH
Q 040898 42 CFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAA---EL-------IKQDIDE-----YSDLLHWKIGAI 106 (337)
Q Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~---~~-------~~~~~~~-----~~~~~~~~~~~~ 106 (337)
.|+. +.||+|++|.||.+.... +|+.||||+..+....... .. ....... ......+....+
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~--~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKD--NGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECC--CCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 4666 899999999999988864 6999999999865322100 00 0000000 000111111233
Q ss_pred HHHHHH------HHhc----CCCCcccceeEE-EcCCeeEEEEEeccCCCHHHHHHHhcCCc---ccCChHHHHHHHHHH
Q 040898 107 RSEIIT------ANQT----RHRNILPLLAHM-VRPNCHLLVYEFMKNGSLQDILYDVSQGR---RELDWPARHRIARGI 172 (337)
Q Consensus 107 ~~e~~~------l~~l----~hpniv~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~---~~~~~~~~~~i~~~i 172 (337)
.+|+.. +.++ .+.+.+.+-.++ +-....++||||++|+.+.++-.- ...+ ..+....+..++.|+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l-~~~g~d~~~la~~~v~~~~~Qi 276 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAAL-RAAGTDMKLLAERGVEVFFTQV 276 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHH-HhcCCCHHHHHHHHHHHHHHHH
Confidence 333333 3333 122223322222 234556799999999999875311 1111 122333333333333
Q ss_pred HHHHHHHhhCCCCCeEecCCCCCceeecCCC----CeEEecccCccccCC
Q 040898 173 ASGLEYLHMCHRPRLIHRDIKPANVLIDDDM----EARISDFGHGKLMPD 218 (337)
Q Consensus 173 ~~~l~~l~~~h~~gi~h~di~~~nil~~~~~----~~~l~dfg~~~~~~~ 218 (337)
...|++|+|++|.||+++.++ .++++|||++..++.
T Consensus 277 ----------f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 ----------FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ----------HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 456999999999999999887 999999999877654
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.42 E-value=7.8e-12 Score=109.56 Aligned_cols=259 Identities=16% Similarity=0.169 Sum_probs=160.9
Q ss_pred ccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHh-cCCCCc
Q 040898 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQ-TRHRNI 121 (337)
Q Consensus 43 y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~-l~hpni 121 (337)
....+.||+|+.+.+|-.... ...+.|+++........ ..+..|.. -.||-+
T Consensus 13 i~~gr~LgqGgea~ly~l~e~-----~d~VAKIYh~Pppa~~a----------------------qk~a~la~~p~~p~~ 65 (637)
T COG4248 13 IPPGRPLGQGGEADLYTLGEV-----RDQVAKIYHAPPPAAQA----------------------QKVAELAATPDAPLL 65 (637)
T ss_pred cCCCccccCCccceeeecchh-----hchhheeecCCCchHHH----------------------HHHHHhccCCCCcch
Confidence 456788999999999854332 23456777655432211 12222332 356543
Q ss_pred ccceeE-------EEcCCeeEEEEEeccCC-CHHHHHH--HhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 040898 122 LPLLAH-------MVRPNCHLLVYEFMKNG-SLQDILY--DVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRD 191 (337)
Q Consensus 122 v~~~~~-------~~~~~~~~lv~e~~~~~-~L~~~l~--~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~d 191 (337)
-.-+.| -..+....++|..+.+. ...+++. +.+++....+|.....+.+.++.+.+.| |.+|.+-+|
T Consensus 66 ~~rvaWPqa~L~G~~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~l---H~~Gh~vGD 142 (637)
T COG4248 66 NYRVAWPQATLHGGRRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATL---HEHGHVVGD 142 (637)
T ss_pred hhhhcccHHHhhCCCccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHH---HhcCCcccc
Confidence 331221 01223367888888764 2333332 2344556689999999999999999999 778999999
Q ss_pred CCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccc-----cCCCCCcccchhhhHHHHHHHhC-C
Q 040898 192 IKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQ-----TETISDKCDIYSFGVLLAVLVMG-K 265 (337)
Q Consensus 192 i~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~-----~~~~~~~~DiwslG~i~~~ll~g-~ 265 (337)
++++|+++++++.|.|.|-+....... .....+.++...|+|||... +..-+...|.|.||+++++++.| .
T Consensus 143 Vn~~~~lVsd~~~V~LVdsDsfqi~~n---g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggr 219 (637)
T COG4248 143 VNQNSFLVSDDSKVVLVDSDSFQINAN---GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGR 219 (637)
T ss_pred cCccceeeecCceEEEEcccceeeccC---CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCC
Confidence 999999999999999999765443322 22345678999999999864 33346778999999999999986 8
Q ss_pred CCCCCCCCCchhhhHHH-HHHhhhccCC--cchhhhhcccCCchHHHHHHHHHHHhhhccC--CCCCCCChhhh
Q 040898 266 FPVDDFFGHTEEMDMVK-WMRNVIFSEN--PNRAINSKLLGNGYEEQMLLVLKLACFCTLK--DPDERPSSKDV 334 (337)
Q Consensus 266 ~pf~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~--dP~~Rps~~el 334 (337)
+||.+.........-.+ .+....+... ......+....-..+....++..|..+|+.. ++.-|||++-.
T Consensus 220 HPysGI~~~~~ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW 293 (637)
T COG4248 220 HPYSGIPLISDAPNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAW 293 (637)
T ss_pred CCCCcccccCCCCCcchhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHH
Confidence 99987544332221111 1211111111 1111111112222334444577777788875 46689998754
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.40 E-value=6.5e-12 Score=102.07 Aligned_cols=160 Identities=15% Similarity=0.073 Sum_probs=102.5
Q ss_pred cceeccCcceEEEEeEEecCC----CCceEEEEEecccCc--chHHHHHHhhhhhh-----hhhhHHhHHhHHHHHHHHH
Q 040898 46 LKKIGSGGWGEVFYKAELPGS----NGKMIAIRKLIVDAP--MSAAELIKQDIDEY-----SDLLHWKIGAIRSEIITAN 114 (337)
Q Consensus 46 ~~~lg~G~~g~V~~~~~~~~~----~~~~vavK~~~~~~~--~~~~~~~~~~~~~~-----~~~~~~~~~~~~~e~~~l~ 114 (337)
...||.|--+.||.+...... .+..+|+|+...... .......++..... ............+|...|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 457999999999998764211 357899998875432 11222221111100 0111111134558999999
Q ss_pred hcCCC--CcccceeEEEcCCeeEEEEEeccCCCHHH-HHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 040898 115 QTRHR--NILPLLAHMVRPNCHLLVYEFMKNGSLQD-ILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRD 191 (337)
Q Consensus 115 ~l~hp--niv~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~d 191 (337)
++... ++..++.+ ...++||||+.+..+.. .+. ...++......+..+++.++..++ |+.|++|+|
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk-----d~~~~~~~~~~i~~~i~~~l~~l~--H~~glVHGD 150 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK-----DAKLNDEEMKNAYYQVLSMMKQLY--KECNLVHAD 150 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh-----ccccCHHHHHHHHHHHHHHHHHHH--HhCCeecCC
Confidence 88543 45555543 45689999997654322 221 122444556778889999998884 567999999
Q ss_pred CCCCceeecCCCCeEEecccCccccC
Q 040898 192 IKPANVLIDDDMEARISDFGHGKLMP 217 (337)
Q Consensus 192 i~~~nil~~~~~~~~l~dfg~~~~~~ 217 (337)
+++.||+++ ++.++++|||.+....
T Consensus 151 Ls~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 151 LSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CCHHHEEEE-CCcEEEEECCCceeCC
Confidence 999999997 4689999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.40 E-value=4.2e-13 Score=122.25 Aligned_cols=247 Identities=20% Similarity=0.215 Sum_probs=175.0
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc-C
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT-R 117 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~ 117 (337)
...+|..+..||.|.|+.|+.+. +...++..|++|-+........++ ..-..|+.+...+ .
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~-~r~~~~~~Y~~ke~~~~l~~~~~d-----------------i~sl~ev~l~~~l~~ 324 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVS-KRPEGDCIYAAKELLNGLATFASD-----------------IFSLGEVILEAILGS 324 (524)
T ss_pred ecCCcceeEEccCCccccceeee-ecCCCCceEeChhhhccccchHhh-----------------hcchhhhhHhhHhhc
Confidence 55679999999999999997655 544688999999887765544433 2334456555555 6
Q ss_pred CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCce
Q 040898 118 HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANV 197 (337)
Q Consensus 118 hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ni 197 (337)
|.+++..+..|....+.|+-.|||+++++...+. -...+++...+.+..|++.++.++ |+..++|.|++|+||
T Consensus 325 ~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~----~~~~~d~~~~~~~~~q~~~~l~~i---~s~~~~~~d~~psni 397 (524)
T KOG0601|consen 325 HLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSV----TSQMLDEDPRLRLTAQILTALNVI---HSKLFVHLDVKPSNI 397 (524)
T ss_pred ccccCCCCCCccccccccCchhhhcCcchhhhhH----HHHhcCcchhhhhHHHHHhccccc---cchhhhcccccccce
Confidence 8899998888888888889999999998887762 234577788999999999999999 788999999999999
Q ss_pred eecCC-CCeEEecccCccccCCCCceeeeecccCCCCcc--CccccccCCCCCcccchhhhHHHHHHHhCCCC-CCCCCC
Q 040898 198 LIDDD-MEARISDFGHGKLMPDGHAQITVKCMVGTMGYM--APESLQTETISDKCDIYSFGVLLAVLVMGKFP-VDDFFG 273 (337)
Q Consensus 198 l~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~--~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~p-f~~~~~ 273 (337)
++.++ +..+++||+....+..... .....-++. +|.......+..+.|+++||..+.+..++..- ......
T Consensus 398 ~i~~~~~~~~~~~~~~~t~~~~~~~-----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~ 472 (524)
T KOG0601|consen 398 LISNDGFFSKLGDFGCWTRLAFSSG-----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS 472 (524)
T ss_pred eeccchhhhhccccccccccceecc-----cccccccccccchhhccccccccccccccccccccccccCcccCcccccc
Confidence 99986 6778999998764222111 112233333 55555666778899999999999999988632 111000
Q ss_pred CchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 274 HTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
..++. ... ...+.....+..+...+...++..||++.++..|
T Consensus 473 --------~~i~~---~~~-----------p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~ 514 (524)
T KOG0601|consen 473 --------LTIRS---GDT-----------PNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLH 514 (524)
T ss_pred --------eeeec---ccc-----------cCCCchHHhhhhhhhhhcCCccccchhhhhhccc
Confidence 00000 000 0111112446777788999999999999887654
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.37 E-value=2.2e-11 Score=95.76 Aligned_cols=137 Identities=20% Similarity=0.304 Sum_probs=102.7
Q ss_pred ceeccCcceEEEEeEEecCCCCceEEEEEecccCc--chHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCcccc
Q 040898 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAP--MSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPL 124 (337)
Q Consensus 47 ~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~ 124 (337)
..+++|+-+.+|.+.. -|.++++|.-.++.= ..-+..+ . -.+-.+|..++..+.--.|...
T Consensus 2 ~~i~~GAEa~i~~~~~----~g~~av~K~Ri~K~YR~p~LD~kl----r---------r~Rt~~Earil~~a~~~GV~~P 64 (204)
T COG3642 2 DLIKQGAEAIIYLTDF----LGLPAVVKERIPKRYRHPELDEKL----R---------RERTRREARILAKAREAGVPVP 64 (204)
T ss_pred chhhCCcceeEEeeec----cCcceEEEeecCcccCChHHHHHH----H---------HHHHHHHHHHHHHHHHcCCCCC
Confidence 4678999999987655 355566665433321 1111111 1 1567789999999987788778
Q ss_pred eeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCC
Q 040898 125 LAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDME 204 (337)
Q Consensus 125 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~ 204 (337)
.-+..+.+...++|||.+|..|.+.+... ...++..+-.-+.-| |..|++|+|++++||++.+.+
T Consensus 65 ~v~dvD~~~~~I~me~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~l---H~~givHGDLTtsNiIl~~~~- 129 (204)
T COG3642 65 IVYDVDPDNGLIVMEYIEGELLKDALEEA-----------RPDLLREVGRLVGKL---HKAGIVHGDLTTSNIILSGGR- 129 (204)
T ss_pred eEEEEcCCCCEEEEEEeCChhHHHHHHhc-----------chHHHHHHHHHHHHH---HhcCeecCCCccceEEEeCCc-
Confidence 88888888889999999999999988541 245667777777788 888999999999999998765
Q ss_pred eEEecccCccc
Q 040898 205 ARISDFGHGKL 215 (337)
Q Consensus 205 ~~l~dfg~~~~ 215 (337)
+.++|||++..
T Consensus 130 i~~IDfGLg~~ 140 (204)
T COG3642 130 IYFIDFGLGEF 140 (204)
T ss_pred EEEEECCcccc
Confidence 99999999764
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.35 E-value=6.3e-12 Score=101.18 Aligned_cols=130 Identities=18% Similarity=0.159 Sum_probs=90.7
Q ss_pred cceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCcc-cc
Q 040898 46 LKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNIL-PL 124 (337)
Q Consensus 46 ~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv-~~ 124 (337)
++.|+.|.++.||.+.. .+..|++|......... ....+|+..++.+.+.+++ ++
T Consensus 3 ~~~l~~G~~~~vy~~~~----~~~~~~lK~~~~~~~~~--------------------~~~~~E~~~l~~l~~~~~~P~~ 58 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV----ANKKYVVRIPGNGTELL--------------------INRENEAENSKLAAEAGIGPKL 58 (170)
T ss_pred eeecCCcccCceEEEEE----CCeEEEEEeCCCCcccc--------------------cCHHHHHHHHHHHHHhCCCCce
Confidence 56789999999998776 57889999875443210 2345677777777554443 34
Q ss_pred eeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCC--CCCeEecCCCCCceeecCC
Q 040898 125 LAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCH--RPRLIHRDIKPANVLIDDD 202 (337)
Q Consensus 125 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h--~~gi~h~di~~~nil~~~~ 202 (337)
+... ....++||||++|.++...- . .....+.+++.++..||... ..+++|+|++|.||+++ +
T Consensus 59 ~~~~--~~~~~lv~e~i~G~~l~~~~---------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~ 123 (170)
T cd05151 59 YYFD--PETGVLITEFIEGSELLTED---------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-D 123 (170)
T ss_pred EEEe--CCCCeEEEEecCCCcccccc---------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-C
Confidence 4432 33458999999998765420 1 11345678999999995432 22369999999999999 6
Q ss_pred CCeEEecccCcc
Q 040898 203 MEARISDFGHGK 214 (337)
Q Consensus 203 ~~~~l~dfg~~~ 214 (337)
+.++++||+.+.
T Consensus 124 ~~~~liDf~~a~ 135 (170)
T cd05151 124 GRLWLIDWEYAG 135 (170)
T ss_pred CeEEEEeccccc
Confidence 789999999765
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.27 E-value=2e-10 Score=90.16 Aligned_cols=151 Identities=19% Similarity=0.249 Sum_probs=109.3
Q ss_pred ccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCcccc
Q 040898 45 SLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPL 124 (337)
Q Consensus 45 ~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~ 124 (337)
.+..+-+|+-+.|+.+.+ .|+...||.-..+.=..+ . ....+.+ .+...|.+++.++.--.|.-.
T Consensus 11 ~l~likQGAEArv~~~~~----~Ge~~iIK~Rf~K~YRHP-~-LD~kLtr---------~Rt~~Ear~l~k~~~~GI~~P 75 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF----SGEAAIIKERFSKRYRHP-A-LDQKLTR---------KRTKQEARLLAKCRALGIPAP 75 (229)
T ss_pred cceeeeccceeeEeeecc----CCceeEEeecccccccch-H-HHHHHHH---------HHHHHHHHHHHHHHHhCCCCc
Confidence 788899999999987777 788888886543321110 0 0001111 566778888888866677666
Q ss_pred eeEEEcCCeeEEEEEeccC-CCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCC
Q 040898 125 LAHMVRPNCHLLVYEFMKN-GSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDM 203 (337)
Q Consensus 125 ~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~ 203 (337)
.-++.+...-.++|||++| .++.+++.... ..+........++..|-+.+.-| |..+++||||+.+||++..++
T Consensus 76 ~l~~~D~~~~~i~ME~~~g~~~vk~~i~~~~--~~~~~d~~~~~~~~~iG~~igkl---H~ndiiHGDLTTSNill~~~~ 150 (229)
T KOG3087|consen 76 RLIFIDTYGGQIYMEFIDGASTVKDFILSTM--EDESEDEGLAELARRIGELIGKL---HDNDIIHGDLTTSNILLRSDG 150 (229)
T ss_pred eEEEEecCCCeEEEEeccchhHHHHHHHHHc--cCcccchhHHHHHHHHHHHHHHh---hhCCeecccccccceEEecCC
Confidence 6677777778899999977 47888886522 22333344478899999999999 888999999999999997554
Q ss_pred ---CeEEecccCccc
Q 040898 204 ---EARISDFGHGKL 215 (337)
Q Consensus 204 ---~~~l~dfg~~~~ 215 (337)
.+.++|||++..
T Consensus 151 ~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 151 NQITPILIDFGLSSV 165 (229)
T ss_pred CcCceEEEeecchhc
Confidence 358999998764
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.1e-10 Score=104.79 Aligned_cols=215 Identities=15% Similarity=0.197 Sum_probs=149.3
Q ss_pred eEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCcccceeEEE----c
Q 040898 55 GEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLLAHMV----R 130 (337)
Q Consensus 55 g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~----~ 130 (337)
.+.|++.... +|..|++|+++-...... .....-+++++++.|+|+|.+.++|. .
T Consensus 290 ~Ttyk~~s~~--DG~~YvLkRlhg~r~~~~-------------------nk~t~lve~wkkl~h~NvV~frevf~t~tF~ 348 (655)
T KOG3741|consen 290 ITTYKATSNV--DGNAYVLKRLHGDRDQST-------------------NKDTSLVEAWKKLCHTNVVPFREVFLTYTFG 348 (655)
T ss_pred ceeEeeeecc--CCceeeeeeeccccccCc-------------------ccchHHHHHHHHhccCceeehhhhhhhhccC
Confidence 5567776665 999999999955444332 23344678899999999999999886 3
Q ss_pred CCeeEEEEEeccC-CCHHHHHHHhc-----------CCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 131 PNCHLLVYEFMKN-GSLQDILYDVS-----------QGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 131 ~~~~~lv~e~~~~-~~L~~~l~~~~-----------~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
+..+++|++|.++ ++|.++.-.-. .++..+++..+|.++.|+..||.++ |+.|+...-+.|.+|+
T Consensus 349 D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sI---HssGLAck~L~~~kIl 425 (655)
T KOG3741|consen 349 DLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSI---HSSGLACKTLDLKKIL 425 (655)
T ss_pred cceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHH---HhcCceeecccHhHeE
Confidence 4568999999986 56777543211 1344577899999999999999999 7889999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhh
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEM 278 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~ 278 (337)
++++.+++|..+|.......... +.+.+ ..+-|.=.||.++..|.||..-= .. .+.
T Consensus 426 v~G~~RIriS~C~i~Dvl~~d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns---~~--~d~ 481 (655)
T KOG3741|consen 426 VTGKMRIRISGCGIMDVLQEDPT----------------EPLES---QQQNDLRDLGLLLLALATGTENS---NR--TDS 481 (655)
T ss_pred eeCcceEEEecccceeeecCCCC----------------cchhH---HhhhhHHHHHHHHHHHhhccccc---cc--ccc
Confidence 99999999999997765543320 11111 23568999999999999996320 00 000
Q ss_pred hHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 279 DMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
......+ ...+....++.+++......++++ -++.+++.
T Consensus 482 ~~~s~~~------------------~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp 520 (655)
T KOG3741|consen 482 TQSSHLT------------------RITTTYSTDLRNVVEYLESLNFRE-KSIQDLLP 520 (655)
T ss_pred hHHHHHH------------------HhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHH
Confidence 1100011 112344455777777777778876 67776654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.15 E-value=1e-11 Score=119.49 Aligned_cols=255 Identities=22% Similarity=0.213 Sum_probs=170.1
Q ss_pred cccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC
Q 040898 38 KKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR 117 (337)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 117 (337)
...+.+.+.+.+.+|+++.++.+.-.. +|...++|.......... ..+..+..+-.++..-.
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~--sgh~~~~~v~~~ap~i~~----------------~~~~s~r~~s~~~i~p~ 862 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAG--SGHTRPSKVHGLAPKIRT----------------NDYESIRSKSNILITPR 862 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccc--cccccchhhhccchhhcc----------------ccccccCCccCccccCC
Confidence 466778899999999999998765543 554444443322111000 00122333333333345
Q ss_pred CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCce
Q 040898 118 HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANV 197 (337)
Q Consensus 118 hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ni 197 (337)
+|.+++....+......+++++|+.+++|...+.+ .+..+..........+.+++.+| |...+.|+|++|.|+
T Consensus 863 ~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~----~~~~saepaRs~i~~~vqs~e~L---~s~~r~h~~~~p~~~ 935 (1205)
T KOG0606|consen 863 SPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHN----SGCLSAEPARSPILERVQSLESL---HSSLRKHRDLKPDSL 935 (1205)
T ss_pred CCceecccCCCCCCCCcchhhHHhccCCchhhhhc----CCCcccccccchhHHHHhhhhcc---ccchhhcccccccch
Confidence 67777666666666778999999999999998843 33455555666677788899999 777799999999999
Q ss_pred eecCCCCeEEecccCccccCC------C---------------Cc--e------eeeecccCCCCccCccccccCCCCCc
Q 040898 198 LIDDDMEARISDFGHGKLMPD------G---------------HA--Q------ITVKCMVGTMGYMAPESLQTETISDK 248 (337)
Q Consensus 198 l~~~~~~~~l~dfg~~~~~~~------~---------------~~--~------~~~~~~~~~~~~~~PE~~~~~~~~~~ 248 (337)
+...++...+.+|+....... . .. . .......+|+.|.+||...+......
T Consensus 936 l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ 1015 (1205)
T KOG0606|consen 936 LIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSA 1015 (1205)
T ss_pred hhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCc
Confidence 999999999999973322110 0 00 0 11123468999999999999999999
Q ss_pred ccchhhhHHHHHHHhCCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCC
Q 040898 249 CDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDER 328 (337)
Q Consensus 249 ~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 328 (337)
+|.|+.|+++++.++|.+||+.......- +.+.....+ +............+++...+..+|.+|
T Consensus 1016 ad~~~~g~~l~e~l~g~pp~na~tpq~~f-------~ni~~~~~~--------~p~g~~~~s~~aq~~~~~ll~~~~~qr 1080 (1205)
T KOG0606|consen 1016 ADWWSSGVCLFEVLTGIPPFNAETPQQIF-------ENILNRDIP--------WPEGPEEGSYEAQDLINRLLTEEPTQR 1080 (1205)
T ss_pred chhhhhhhhhhhhhcCCCCCCCcchhhhh-------hccccCCCC--------CCCCccccChhhhhhhhhhhccCchhc
Confidence 99999999999999999998754332111 111111111 112222333447888888999999999
Q ss_pred CChh
Q 040898 329 PSSK 332 (337)
Q Consensus 329 ps~~ 332 (337)
..+.
T Consensus 1081 ~~a~ 1084 (1205)
T KOG0606|consen 1081 LGAK 1084 (1205)
T ss_pred cCcc
Confidence 8876
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.13 E-value=6.4e-10 Score=93.47 Aligned_cols=143 Identities=22% Similarity=0.285 Sum_probs=98.4
Q ss_pred cceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC--CCccc
Q 040898 46 LKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH--RNILP 123 (337)
Q Consensus 46 ~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--pniv~ 123 (337)
.+.|+.|..+.||++... +|..+++|.......... ...+.+|..++..+.+ .++.+
T Consensus 3 ~~~l~~G~~n~~~~v~~~---~g~~~ilK~~~~~~~~~~------------------~~~~~~E~~~~~~l~~~~~~vp~ 61 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAG---GGRRLVLRRPPPGALLPS------------------AHDVAREYRVLRALAGTGVPVPK 61 (223)
T ss_pred ceecCCCccceEEEEEec---CCcceEEEeCCCcccCcc------------------cccHHHHHHHHHHhhCCCCCCCC
Confidence 467899999999988763 468899998754432100 0356678888888865 34566
Q ss_pred ceeEEEcC---CeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhC------------------
Q 040898 124 LLAHMVRP---NCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMC------------------ 182 (337)
Q Consensus 124 ~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~------------------ 182 (337)
++.+.... +..++||||++|.++.+.+. . ..++......++.+++.++..||+.
T Consensus 62 ~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~----~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~ 136 (223)
T cd05154 62 VLALCEDPSVLGTPFYVMERVDGRVLRDRLL----R-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLE 136 (223)
T ss_pred EEEECCCCCccCCceEEEEEeCCEecCCCCC----C-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHH
Confidence 67765553 25689999999987765431 0 2344455555566666666666531
Q ss_pred -----------------------------------CCCCeEecCCCCCceeecC--CCCeEEecccCcc
Q 040898 183 -----------------------------------HRPRLIHRDIKPANVLIDD--DMEARISDFGHGK 214 (337)
Q Consensus 183 -----------------------------------h~~gi~h~di~~~nil~~~--~~~~~l~dfg~~~ 214 (337)
....++|+|+++.||+++. ++.+.++||+.+.
T Consensus 137 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 137 RQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 1245899999999999998 5668999998765
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=7.6e-10 Score=92.38 Aligned_cols=155 Identities=19% Similarity=0.224 Sum_probs=103.4
Q ss_pred cccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHH--Hhhh--hhhhhhhHHhHHhHHHHHHHHHhcC
Q 040898 42 CFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELI--KQDI--DEYSDLLHWKIGAIRSEIITANQTR 117 (337)
Q Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~--~~~~--~~~~~~~~~~~~~~~~e~~~l~~l~ 117 (337)
-..++.+||-|--|.||.+.+- .|.++++|.-..-. .+..... .+.. ........-....+.+|.++|..|.
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~---~g~~~~vKfHR~Gr-tsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~ 167 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDP---KGRKVAVKFHRLGR-TSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLY 167 (304)
T ss_pred HHhhccccccCccceEEEEECC---CCCEEEEEEeecCc-hhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhh
Confidence 4567899999999999988774 79999999544322 1211110 0000 0111222223357888999999986
Q ss_pred CC--CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCC
Q 040898 118 HR--NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPA 195 (337)
Q Consensus 118 hp--niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ 195 (337)
.. .+.+.+++ +...+|||+.+|-.|...- ++......++..|+.-+..+ -..|++|||+++-
T Consensus 168 ~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~---~~~GiVHGDlSef 231 (304)
T COG0478 168 PEGVKVPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKA---YRRGIVHGDLSEF 231 (304)
T ss_pred hcCCCCCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHH---HHcCccccCCchh
Confidence 55 56666553 4567999999986554321 13334455566666666666 4459999999999
Q ss_pred ceeecCCCCeEEecccCcccc
Q 040898 196 NVLIDDDMEARISDFGHGKLM 216 (337)
Q Consensus 196 nil~~~~~~~~l~dfg~~~~~ 216 (337)
||+++++|.++++||..+...
T Consensus 232 NIlV~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 232 NILVTEDGDIVVIDWPQAVPI 252 (304)
T ss_pred eEEEecCCCEEEEeCcccccC
Confidence 999999999999999876543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.10 E-value=3.1e-09 Score=86.08 Aligned_cols=145 Identities=14% Similarity=0.169 Sum_probs=84.2
Q ss_pred EEEEeEEecCCCCceEEEEEecccCcc-hHHHHHHhhhhh------hhhhhHHhHHhHHHHHHHHHhcCCC--Cccccee
Q 040898 56 EVFYKAELPGSNGKMIAIRKLIVDAPM-SAAELIKQDIDE------YSDLLHWKIGAIRSEIITANQTRHR--NILPLLA 126 (337)
Q Consensus 56 ~V~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~------~~~~~~~~~~~~~~e~~~l~~l~hp--niv~~~~ 126 (337)
.||.+... +|..+|+|........ +..........+ .............+|...|..+..- ++.+++.
T Consensus 1 ~Vy~~~~~---~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~ 77 (188)
T PF01163_consen 1 DVYHAIDP---DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYD 77 (188)
T ss_dssp EEEEEEEC---TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEE
T ss_pred CEEEEECC---CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEE
Confidence 37777664 7889999988764321 111111111111 0112222235788899999999776 4555554
Q ss_pred EEEcCCeeEEEEEecc--CCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCC
Q 040898 127 HMVRPNCHLLVYEFMK--NGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDME 204 (337)
Q Consensus 127 ~~~~~~~~~lv~e~~~--~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~ 204 (337)
+. ...+||||++ |..+..+... .++......++.+++..+..+. |..|++|||+++.||+++++ .
T Consensus 78 ~~----~~~ivME~I~~~G~~~~~l~~~------~~~~~~~~~~~~~il~~~~~~~--~~~givHGDLs~~NIlv~~~-~ 144 (188)
T PF01163_consen 78 YN----RNVIVMEYIGEDGVPLPRLKDV------DLSPEEPKELLEEILEEIIKML--HKAGIVHGDLSEYNILVDDG-K 144 (188)
T ss_dssp EE----TTEEEEE--EETTEEGGCHHHC------GGGGSTHHHHHHHHHHHHHHHH--HCTTEEESS-STTSEEEETT-C
T ss_pred Ee----CCEEEEEecCCCccchhhHHhc------cccchhHHHHHHHHHHHHHHHH--HhcCceecCCChhhEEeecc-e
Confidence 32 3469999998 6555443321 1113455667777777555543 67799999999999999977 9
Q ss_pred eEEecccCcccc
Q 040898 205 ARISDFGHGKLM 216 (337)
Q Consensus 205 ~~l~dfg~~~~~ 216 (337)
+.++|||.+...
T Consensus 145 ~~iIDf~qav~~ 156 (188)
T PF01163_consen 145 VYIIDFGQAVDS 156 (188)
T ss_dssp EEE--GTTEEET
T ss_pred EEEEecCcceec
Confidence 999999977654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.02 E-value=8.5e-09 Score=88.56 Aligned_cols=105 Identities=16% Similarity=0.179 Sum_probs=78.8
Q ss_pred hHHHHHHHHHhcCCCCccc--ceeEEEc-----CCeeEEEEEeccCC-CHHHHHHHhcCCcccCChHHHHHHHHHHHHHH
Q 040898 105 AIRSEIITANQTRHRNILP--LLAHMVR-----PNCHLLVYEFMKNG-SLQDILYDVSQGRRELDWPARHRIARGIASGL 176 (337)
Q Consensus 105 ~~~~e~~~l~~l~hpniv~--~~~~~~~-----~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l 176 (337)
.+.+|...+..+..-+|.. +..+.+. ....++|+|++++. +|.+++.... ..+.+......++.+++..+
T Consensus 74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i 151 (268)
T PRK15123 74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMV 151 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHH
Confidence 4677888887774444433 3444433 23568999999886 8999985321 23455667789999999999
Q ss_pred HHHhhCCCCCeEecCCCCCceeecC-------CCCeEEecccCcc
Q 040898 177 EYLHMCHRPRLIHRDIKPANVLIDD-------DMEARISDFGHGK 214 (337)
Q Consensus 177 ~~l~~~h~~gi~h~di~~~nil~~~-------~~~~~l~dfg~~~ 214 (337)
..| |..|++|+|++++||+++. +..+.++||+.+.
T Consensus 152 ~~L---H~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 152 RDM---HAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred HHH---HHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 999 7889999999999999975 4678999999765
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.94 E-value=4.7e-10 Score=104.21 Aligned_cols=149 Identities=18% Similarity=0.231 Sum_probs=99.1
Q ss_pred HHHHHHHHHhhCCCCCeEecCCCCCceeecCCCCeEEecccCccccCCCCceeee--------ecccCCCCccCcccccc
Q 040898 171 GIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITV--------KCMVGTMGYMAPESLQT 242 (337)
Q Consensus 171 ~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~--------~~~~~~~~~~~PE~~~~ 242 (337)
+++.|+.++| .+.++||++|.|++|++++++..||+.|+.+........ .+. ........|.+||.+.+
T Consensus 107 ~v~dgl~flh--~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~-~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 107 NVADGLAFLH--RSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTE-YPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred cccchhhhhc--cCcceeecccchhheeeccCcceeeccchhhhccCCCCc-cccccCCCCCChhhccCcccccchhhcc
Confidence 3348899997 467899999999999999999999999998765433111 111 11235667999999999
Q ss_pred CCCCCcccchhhhHHHHHHHhC-CCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhc
Q 040898 243 ETISDKCDIYSFGVLLAVLVMG-KFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCT 321 (337)
Q Consensus 243 ~~~~~~~DiwslG~i~~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 321 (337)
...+.++|+||+|+++|.+..| +.-+..... .....+........ ......+.+.++.+-+.+++
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~-~~~~~~~~~~~~~~-------------~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGG-LLSYSFSRNLLNAG-------------AFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCC-cchhhhhhcccccc-------------cccccccCcHHHHHHHHHHh
Confidence 8889999999999999999854 444432211 11111111110000 00111233344777777899
Q ss_pred cCCCCCCCChhhhhc
Q 040898 322 LKDPDERPSSKDVRS 336 (337)
Q Consensus 322 ~~dP~~Rps~~ell~ 336 (337)
..++.-||++.++++
T Consensus 250 ~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLS 264 (700)
T ss_pred cCCcccCcchhhhhc
Confidence 999999998877654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.92 E-value=2e-08 Score=81.93 Aligned_cols=143 Identities=15% Similarity=0.133 Sum_probs=98.5
Q ss_pred ccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC--cccceeE
Q 040898 50 GSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN--ILPLLAH 127 (337)
Q Consensus 50 g~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn--iv~~~~~ 127 (337)
|+||.+.|+.... .|..+-+|+-......+.. . ...-..+.+|...+.++..-+ +.++. +
T Consensus 27 ~rgG~SgV~r~~~----~g~~~ylKrq~nhl~~s~r------------~-P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f 88 (216)
T PRK09902 27 RRNGMSGVQCVER----NGKKLYVKRMTHHLFHSVR------------Y-PFGRPTIVREVAVIKELERAGVIVPKIV-F 88 (216)
T ss_pred CCCCcceEEEEEe----CCcEEEEEeccCccccccc------------C-CCCchHHHHHHHHHHHHHHcCCCCCccc-e
Confidence 6789999987655 4557888886422211110 0 001157888998888884332 34443 2
Q ss_pred EE---c--CCeeEEEEEeccC-CCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecC
Q 040898 128 MV---R--PNCHLLVYEFMKN-GSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDD 201 (337)
Q Consensus 128 ~~---~--~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~ 201 (337)
+. . ....+||+|-+++ -+|.+++.. ..-.+.+......++.+++.++.-| |+.|+.|+|+.+.||+++.
T Consensus 89 ~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~--~~~~~~~~~~k~~il~~va~~ia~L---H~~Gv~Hgdly~khIll~~ 163 (216)
T PRK09902 89 GEAVKIEGEWRALLVTEDMAGFISIADWYAQ--HAVSPYSDEVRQAMLKAVALAFKKM---HSVNRQHGCCYVRHIYVKT 163 (216)
T ss_pred eeeeccCCceEEEEEEEeCCCCccHHHHHhc--CCcCCcchHHHHHHHHHHHHHHHHH---HHCCCcCCCCCHhheeecC
Confidence 22 1 1235799997753 589888743 2233456777889999999999999 8889999999999999987
Q ss_pred CCC--eEEecccCccc
Q 040898 202 DME--ARISDFGHGKL 215 (337)
Q Consensus 202 ~~~--~~l~dfg~~~~ 215 (337)
++. +.++||.-++.
T Consensus 164 ~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 164 EGKAEAGFLDLEKSRR 179 (216)
T ss_pred CCCeeEEEEEhhccch
Confidence 777 89999986543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.87 E-value=2.5e-08 Score=82.77 Aligned_cols=105 Identities=23% Similarity=0.315 Sum_probs=79.4
Q ss_pred HhHHHHHHHHHhcCCCC--cccceeEEEcC----CeeEEEEEeccCC-CHHHHHHHhcCCcccCChHHHHHHHHHHHHHH
Q 040898 104 GAIRSEIITANQTRHRN--ILPLLAHMVRP----NCHLLVYEFMKNG-SLQDILYDVSQGRRELDWPARHRIARGIASGL 176 (337)
Q Consensus 104 ~~~~~e~~~l~~l~hpn--iv~~~~~~~~~----~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l 176 (337)
..+.+|...+..+..-. +...+++.+.. ...++|+|++++. +|.+++.... ..+......++.+++..+
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARLI 131 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHHH
Confidence 45677777777764333 34445554442 2458999999874 7999885421 255667789999999999
Q ss_pred HHHhhCCCCCeEecCCCCCceeecCCC---CeEEecccCccc
Q 040898 177 EYLHMCHRPRLIHRDIKPANVLIDDDM---EARISDFGHGKL 215 (337)
Q Consensus 177 ~~l~~~h~~gi~h~di~~~nil~~~~~---~~~l~dfg~~~~ 215 (337)
.-| |..|++|+|+++.|||++.++ .+.++||+-+..
T Consensus 132 ~~l---H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 132 AKL---HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHH---HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999 788999999999999999887 899999997654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.80 E-value=2.9e-08 Score=92.33 Aligned_cols=160 Identities=19% Similarity=0.209 Sum_probs=100.0
Q ss_pred ceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHH---HH-------------------HHhhhhhhhhhhHHhHH
Q 040898 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAA---EL-------------------IKQDIDEYSDLLHWKIG 104 (337)
Q Consensus 47 ~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~---~~-------------------~~~~~~~~~~~~~~~~~ 104 (337)
+.|+.++-|.||.+.-. +|+.||||+.++.....-. .. ....+....+...+++
T Consensus 131 ~PiAsASIaQVH~A~L~---sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~El- 206 (517)
T COG0661 131 EPIASASIAQVHRAVLK---SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREEL- 206 (517)
T ss_pred CchhhhhHhhheeEEec---CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHh-
Confidence 67999999999888775 6999999998875432110 00 0011111111111221
Q ss_pred hHHHHHHHHHhc-----CCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHH
Q 040898 105 AIRSEIITANQT-----RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYL 179 (337)
Q Consensus 105 ~~~~e~~~l~~l-----~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l 179 (337)
.+.+|..-+.++ +.|++.-..-+++-...-.++|||++|-.+.+...... ...+.+.+.....++. +..+
T Consensus 207 Dy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~---~g~d~k~ia~~~~~~f--~~q~ 281 (517)
T COG0661 207 DYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS---AGIDRKELAELLVRAF--LRQL 281 (517)
T ss_pred CHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh---cCCCHHHHHHHHHHHH--HHHH
Confidence 234455445444 34555545555566677789999999988888743211 2344333222222221 3333
Q ss_pred hhCCCCCeEecCCCCCceeecCCCCeEEecccCccccCC
Q 040898 180 HMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPD 218 (337)
Q Consensus 180 ~~~h~~gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~~ 218 (337)
-..|++|+|.+|.||+++.+|.+.+.|||+......
T Consensus 282 ---~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 282 ---LRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ---HhcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 346999999999999999999999999999877654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.74 E-value=2.7e-07 Score=75.67 Aligned_cols=146 Identities=16% Similarity=0.197 Sum_probs=92.7
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc--
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT-- 116 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-- 116 (337)
..++|.+.+.+-......|-+..- +|..+++|........ ....++..+.. +...+.+..+..+
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei----~~~kyIlK~pr~~~~r-~er~~~sf~kg---------~~~~~l~~~~~~i~~ 94 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI----DGKKYILKEPREENRR-PERRFKSFFKG---------SEYSRLINNTDKIRN 94 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE----CCcEEEEeccchhhhh-HHHHHHHHhcc---------HHHHHHHHHHHHHHH
Confidence 677888889988888888854443 7899999988776543 22222222211 2233333333333
Q ss_pred -CCCCcccceeEE-----EcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 040898 117 -RHRNILPLLAHM-----VRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHR 190 (337)
Q Consensus 117 -~hpniv~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~ 190 (337)
.......++.+. .-....+++|||++|..|.+... +++ .+...+.+++.-+ |+.|++|+
T Consensus 95 ~g~~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikql---H~~G~~HG 159 (229)
T PF06176_consen 95 EGFTEPADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQL---HKHGFYHG 159 (229)
T ss_pred cCccccccceeeeeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHH---HHcCCccC
Confidence 333333333322 22345578999999987766531 222 2345566778888 78899999
Q ss_pred CCCCCceeecCCCCeEEecccCcc
Q 040898 191 DIKPANVLIDDDMEARISDFGHGK 214 (337)
Q Consensus 191 di~~~nil~~~~~~~~l~dfg~~~ 214 (337)
|.+|.|++++++ .++++|++...
T Consensus 160 D~hpgNFlv~~~-~i~iID~~~k~ 182 (229)
T PF06176_consen 160 DPHPGNFLVSNN-GIRIIDTQGKR 182 (229)
T ss_pred CCCcCcEEEECC-cEEEEECcccc
Confidence 999999999955 59999998543
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.60 E-value=5.7e-07 Score=74.65 Aligned_cols=155 Identities=18% Similarity=0.227 Sum_probs=92.8
Q ss_pred eeccCcceEEEEeEEecCCCCceEEEEEecccCcchHH--HHHHhhhh---hhhhhhHHhHHhHHHHHHHHHhcCC--CC
Q 040898 48 KIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAA--ELIKQDID---EYSDLLHWKIGAIRSEIITANQTRH--RN 120 (337)
Q Consensus 48 ~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~~~~~---~~~~~~~~~~~~~~~e~~~l~~l~h--pn 120 (337)
.|++|--+.||++... ++..+|+|++......-.. ........ .........-....+|..-|.++.- =.
T Consensus 55 ~istGKEA~Vy~a~~~---~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 55 CISTGKEANVYLAETG---DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred eecCCcceEEEeeccC---CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 5667777889987763 7899999998765432111 00000000 0001111122345667777777633 34
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHH-HHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceee
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQD-ILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI 199 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~ 199 (337)
+.+.+.+..+ .+||||+....... .| +.-++.......+..++++.+.-|. ...|+||+||+.=|||+
T Consensus 132 vP~Pi~~~~n----VLvMEfIg~~g~pAP~L-----kDv~~e~~e~~~~~~~~v~~~~~l~--~~a~LVHgDLSEyNiL~ 200 (268)
T COG1718 132 VPEPIAFRNN----VLVMEFIGDDGLPAPRL-----KDVPLELEEAEGLYEDVVEYMRRLY--KEAGLVHGDLSEYNILV 200 (268)
T ss_pred CCCceeecCC----eEEEEeccCCCCCCCCc-----ccCCcCchhHHHHHHHHHHHHHHHH--HhcCcccccchhhheEE
Confidence 4455554332 59999985531100 11 1122223346666777777777774 33699999999999999
Q ss_pred cCCCCeEEecccCccccC
Q 040898 200 DDDMEARISDFGHGKLMP 217 (337)
Q Consensus 200 ~~~~~~~l~dfg~~~~~~ 217 (337)
. ++.++++|++.+....
T Consensus 201 ~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 201 H-DGEPYIIDVSQAVTID 217 (268)
T ss_pred E-CCeEEEEECccccccC
Confidence 9 8899999999876543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.55 E-value=2.4e-06 Score=71.83 Aligned_cols=140 Identities=12% Similarity=0.154 Sum_probs=80.9
Q ss_pred ceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC--Ccccc
Q 040898 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR--NILPL 124 (337)
Q Consensus 47 ~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp--niv~~ 124 (337)
.+||+|..+.||.. .+..+++|........ ....+|.+.++.+..- .+.+.
T Consensus 7 ~~i~~G~t~~~y~~------~~~~~VlR~~~~~~~~---------------------~~i~~E~~~l~~l~~~glpvP~~ 59 (226)
T TIGR02172 7 TQTGEGGNGESYTH------KTGKWMLKLYNPGFDK---------------------ETIKREFDASRKVFSLGIPTPHP 59 (226)
T ss_pred eeecCCCCcceeEe------cCCCEEEEeCCCCCCH---------------------HHHHHHHHHHHHHHHcCCCCCce
Confidence 68999999999962 3446778877543211 3456688888877533 24666
Q ss_pred eeEEEcCCeeEEEEEeccCCC-HHHHH--------------HH----hcC-CcccCChHHHH-HHHH----------HHH
Q 040898 125 LAHMVRPNCHLLVYEFMKNGS-LQDIL--------------YD----VSQ-GRRELDWPARH-RIAR----------GIA 173 (337)
Q Consensus 125 ~~~~~~~~~~~lv~e~~~~~~-L~~~l--------------~~----~~~-~~~~~~~~~~~-~i~~----------~i~ 173 (337)
+.+...++...+|||+++|.+ +...+ -. .-. .....+..... .+.. .+.
T Consensus 60 ~~~~~~~~~~glv~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~ 139 (226)
T TIGR02172 60 FDLVEDGGRLGLIYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYK 139 (226)
T ss_pred EEEEecCCeeeeeeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHH
Confidence 777777778889999999863 21111 00 000 00001100000 0000 000
Q ss_pred HH-HHHHhh-CCCCCeEecCCCCCceeecCCCCeEEecccCcc
Q 040898 174 SG-LEYLHM-CHRPRLIHRDIKPANVLIDDDMEARISDFGHGK 214 (337)
Q Consensus 174 ~~-l~~l~~-~h~~gi~h~di~~~nil~~~~~~~~l~dfg~~~ 214 (337)
.. ..++.. .....++|+|+.|.||++++++ +.++||+.+.
T Consensus 140 ~~l~~~l~~~~~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 140 EKARAFIKEVPDTSTCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred HHHHHHHHhCCCCCceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 11 111110 1234579999999999999888 9999998654
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.32 E-value=3.2e-05 Score=62.96 Aligned_cols=105 Identities=22% Similarity=0.215 Sum_probs=80.1
Q ss_pred HHHHHHHhcCC-CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCC
Q 040898 108 SEIITANQTRH-RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPR 186 (337)
Q Consensus 108 ~e~~~l~~l~h-pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~g 186 (337)
.|.-+++.+++ +++.+++|+|-. +++.||.+.+++...... ..+-...+|..+.+++.++++.+.+++......
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~-l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRP-LSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccc-cccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 37778888865 699999998843 688999987655321000 011234789999999999999999997544456
Q ss_pred eEecCCCCCceeecCCCCeEEecccCccccC
Q 040898 187 LIHRDIKPANVLIDDDMEARISDFGHGKLMP 217 (337)
Q Consensus 187 i~h~di~~~nil~~~~~~~~l~dfg~~~~~~ 217 (337)
+..+|++++|+-+++++.++++|.+.+....
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVED 113 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence 8889999999999999999999998765543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.27 E-value=2.2e-05 Score=66.25 Aligned_cols=78 Identities=17% Similarity=0.196 Sum_probs=51.2
Q ss_pred cceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC--Cccc
Q 040898 46 LKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR--NILP 123 (337)
Q Consensus 46 ~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp--niv~ 123 (337)
++.|+.|..+.||.+.. ++..+++|..... ... ..+.+|..+++.+... .+.+
T Consensus 2 i~~l~~G~~n~~~~v~~----~~~~~vlK~~~~~---~~~------------------~~~~~e~~~~~~l~~~~~pvP~ 56 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTT----DDGRYVLKFYRPP---DAA------------------ERLRREAAVLRQLAEHGIPVPR 56 (239)
T ss_dssp EEEEEESSSSEEEEEEE----TTSEEEEEEESSH---HHH------------------HHHHHHHHHHHHHHHTTSBS--
T ss_pred CccCCCCCeeeEEEEEE----CCcEEEEEEeCCC---CCH------------------HHHHHHHHHHHHHHhcCCCCce
Confidence 57899999999998877 4468999986443 111 3455666676666322 3455
Q ss_pred ceeEE---EcCCeeEEEEEeccCCCHHH
Q 040898 124 LLAHM---VRPNCHLLVYEFMKNGSLQD 148 (337)
Q Consensus 124 ~~~~~---~~~~~~~lv~e~~~~~~L~~ 148 (337)
++... ......+++|++++|.++..
T Consensus 57 ~~~~~~~~~~~~~~~~~~~~i~g~~~~~ 84 (239)
T PF01636_consen 57 VLAFDTSDEFNGFPYLLMEYIPGRPLDD 84 (239)
T ss_dssp EEEEEEETEETSEEEEEEEEESSEEHHH
T ss_pred EEeecccccccccceEEEEEeccccccc
Confidence 55533 22345789999999987777
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.27 E-value=2.4e-05 Score=66.79 Aligned_cols=142 Identities=11% Similarity=0.033 Sum_probs=80.2
Q ss_pred ceeccCcc-eEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC-CCCcccc
Q 040898 47 KKIGSGGW-GEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR-HRNILPL 124 (337)
Q Consensus 47 ~~lg~G~~-g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~ 124 (337)
+.|..|.+ +.||++.. .+..+++|+..... . ..+.+|+.+++.+. +--+.++
T Consensus 4 ~~~~~g~~~~~v~~~~~----~~~~~~vk~~~~~~---~-------------------~~~~~E~~~l~~l~~~~~vP~v 57 (244)
T cd05150 4 ERVTEGQSGATVYRLDG----KNPGLYLKIAPSGP---T-------------------YELEREAERLRWLAGKLPVPEV 57 (244)
T ss_pred eecCCCCCcCeEEEEcC----CCCcEEEEecCCCc---c-------------------cchHHHHHHHHHHHhcCCCCeE
Confidence 45556666 77887644 34678888764332 0 23445777776663 3335566
Q ss_pred eeEEEcCCeeEEEEEeccCCCHHHHHH----------------HhcCC---cccCChH--HHHHH---------------
Q 040898 125 LAHMVRPNCHLLVYEFMKNGSLQDILY----------------DVSQG---RRELDWP--ARHRI--------------- 168 (337)
Q Consensus 125 ~~~~~~~~~~~lv~e~~~~~~L~~~l~----------------~~~~~---~~~~~~~--~~~~i--------------- 168 (337)
+.+...++..++||++++|.+|..... ....- ..+.... .....
T Consensus 58 ~~~~~~~~~~~lv~e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 137 (244)
T cd05150 58 IDYGSDDGRAWLLTSAVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDF 137 (244)
T ss_pred EEEEecCCccEEEEEeeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhC
Confidence 776666667899999999977764320 00000 0011100 00000
Q ss_pred --------HHHHHHHHHHHh-hCCCCCeEecCCCCCceeecCCCCeEEecccCcc
Q 040898 169 --------ARGIASGLEYLH-MCHRPRLIHRDIKPANVLIDDDMEARISDFGHGK 214 (337)
Q Consensus 169 --------~~~i~~~l~~l~-~~h~~gi~h~di~~~nil~~~~~~~~l~dfg~~~ 214 (337)
..++...+.... ......++|+|+.|.||++++++.+.|+||+.+.
T Consensus 138 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 138 DDERRGWSAEELYAELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred cHhhcCCCHHHHHHHHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 111122111110 0123459999999999999997777899998654
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.1e-05 Score=63.47 Aligned_cols=137 Identities=15% Similarity=0.170 Sum_probs=94.6
Q ss_pred cccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHh
Q 040898 36 FLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQ 115 (337)
Q Consensus 36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~ 115 (337)
+......-+..+.|+.|++|.||++.+ .|..+|+|+-..+++. ..+..|.+++..
T Consensus 17 ~~~~~~~~~v~~~L~KG~~s~Vyl~~~----~~~~~a~Kvrr~ds~r---------------------~~l~kEakiLei 71 (201)
T COG2112 17 VEEGKYELRVEKELAKGTTSVVYLGEW----RGGEVALKVRRRDSPR---------------------RNLEKEAKILEI 71 (201)
T ss_pred eeccchhhhhhhhhhcccccEEEEeec----cCceEEEEEecCCcch---------------------hhHHHHHHHHHH
Confidence 333555567788999999999999888 6778999987665442 456778998888
Q ss_pred cCCCCccc-ceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCC-
Q 040898 116 TRHRNILP-LLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIK- 193 (337)
Q Consensus 116 l~hpniv~-~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~- 193 (337)
++-.++.. ++.+..+ ++.|||++|-+|.+.-.. .+. +-+..+++...-| ...||-|+.|+
T Consensus 72 l~g~~~~p~vy~yg~~----~i~me~i~G~~L~~~~~~-------~~r----k~l~~vlE~a~~L---D~~GI~H~El~~ 133 (201)
T COG2112 72 LAGEGVTPEVYFYGED----FIRMEYIDGRPLGKLEIG-------GDR----KHLLRVLEKAYKL---DRLGIEHGELSR 133 (201)
T ss_pred hhhcCCCceEEEechh----hhhhhhhcCcchhhhhhc-------ccH----HHHHHHHHHHHHH---HHhccchhhhcC
Confidence 87665543 3333322 355999999888776521 122 2334455555666 66799999996
Q ss_pred CCceeecCCCCeEEecccCccc
Q 040898 194 PANVLIDDDMEARISDFGHGKL 215 (337)
Q Consensus 194 ~~nil~~~~~~~~l~dfg~~~~ 215 (337)
|...++.+++.+.|+||..++.
T Consensus 134 ~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 134 PWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred CceeEEecCCcEEEEEccchhh
Confidence 4555555566999999998764
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.25 E-value=2.9e-05 Score=63.57 Aligned_cols=149 Identities=17% Similarity=0.200 Sum_probs=93.7
Q ss_pred ccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC------C
Q 040898 45 SLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR------H 118 (337)
Q Consensus 45 ~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~------h 118 (337)
-...||+|+.-.||. + .......||+..... .......+.....+... .......+|+.....+. +
T Consensus 5 ~~~~i~~G~~R~cy~---H--P~dp~~cIKV~~~~~-~~~~~~~~~~~k~~~~~--~~~~~~~~E~~~y~~l~~~~~~~~ 76 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQ---H--PDDPNLCIKVMRPDR-GERRRPFKRWLKRLRPK--SRYRQNRRELRYYKQLSLRRGVDW 76 (199)
T ss_pred CCcccccCCCceEEE---C--CCCCCeEEEEEcccc-ccccccchhHHHhhccc--chhHHHHHHHHHHHHHhhccCCcc
Confidence 356799999999984 2 256677888887766 11111111111111110 11145556666655555 7
Q ss_pred CCcccceeEEEcCCeeEEEEEeccC------CCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKN------GSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDI 192 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~------~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di 192 (337)
.+|.+++|+.+++....+|+|.... -+|.+++. ...++. ...+.+.++ ..+| -...|+.+|+
T Consensus 77 ~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~-----~~~~~~-~~~~~L~~f---~~~l---~~~~Iv~~dl 144 (199)
T PF10707_consen 77 SHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLK-----EGGLTE-ELRQALDEF---KRYL---LDHHIVIRDL 144 (199)
T ss_pred cccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHH-----cCCccH-HHHHHHHHH---HHHH---HHcCCeecCC
Confidence 8999999999999999999998743 36777772 233554 344444444 4555 4557999999
Q ss_pred CCCceeecCCC----CeEEec-ccCc
Q 040898 193 KPANVLIDDDM----EARISD-FGHG 213 (337)
Q Consensus 193 ~~~nil~~~~~----~~~l~d-fg~~ 213 (337)
+|.||++..+. .+.|+| ||..
T Consensus 145 ~~~NIv~~~~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 145 NPHNIVVQRRDSGEFRLVLIDGLGEK 170 (199)
T ss_pred CcccEEEEecCCCceEEEEEeCCCCc
Confidence 99999996432 577887 6643
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.15 E-value=4.7e-05 Score=61.89 Aligned_cols=145 Identities=18% Similarity=0.256 Sum_probs=89.9
Q ss_pred ccccccccceeccCcc-eEEEEeEEecCCCCceEEEEE---ecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHH
Q 040898 39 KEDCFDSLKKIGSGGW-GEVFYKAELPGSNGKMIAIRK---LIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITAN 114 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~-g~V~~~~~~~~~~~~~vavK~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~ 114 (337)
.+.+++.++.||.|+. |.||++.. .|+.||+|. .....+............... -.....+.|..|++..-
T Consensus 35 h~~~I~flefLg~g~~~~~V~kv~I----~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~-~~~~y~~PF~~ECRAfg 109 (207)
T PF13095_consen 35 HGDDIEFLEFLGHGSHDGYVFKVEI----DGRIYALKLFRFWDYTEPDYTRERFAGHETSLS-TPAHYADPFNCECRAFG 109 (207)
T ss_pred CCCcEeeeeecCCCCceeEEEEEEE----CCeEEEEEEeeccccCCCccccccccccccccc-hhhhhcChHHHHHHhhH
Confidence 5589999999999999 99998877 889999999 222222111000000000000 01223457778887766
Q ss_pred hc---CCCCc--ccceeEEEcC------------------CeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHH
Q 040898 115 QT---RHRNI--LPLLAHMVRP------------------NCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARG 171 (337)
Q Consensus 115 ~l---~hpni--v~~~~~~~~~------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~ 171 (337)
+| .+.++ ++.+||..-. ....||-||.+... .+....+. +
T Consensus 110 RLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~~~~~----~ 172 (207)
T PF13095_consen 110 RLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQIRDIP----Q 172 (207)
T ss_pred HHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccchhHHH----H
Confidence 66 44555 8888886322 12357777765542 12333333 3
Q ss_pred HHHHHHHHhhCCCCCeEecCCCCCceeecCCCCeEEecccCc
Q 040898 172 IASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHG 213 (337)
Q Consensus 172 i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~~l~dfg~~ 213 (337)
+..-+..+ |..||+-+|+++.|.. .-+|+|||.+
T Consensus 173 ~~~dl~~~---~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 173 MLRDLKIL---HKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHHHH---HHCCeeeccCcccccc-----CCEEEecccC
Confidence 33444555 7779999999999997 3488899853
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.09 E-value=7.2e-05 Score=75.00 Aligned_cols=83 Identities=14% Similarity=0.196 Sum_probs=54.7
Q ss_pred ccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC-CCCc--
Q 040898 45 SLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR-HRNI-- 121 (337)
Q Consensus 45 ~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-hpni-- 121 (337)
.++.++.|.++.+|+...........+++|+.......... ..+.+|..+++.+. |+++
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~------------------~~~~rE~~~l~~L~~~~~vpV 103 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSA------------------HAVEREYQVLRALGEHTDVPV 103 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccH------------------HHHHHHHHHHHHHhhcCCCCC
Confidence 46788999999999876542111246777775433211111 35667999998885 6655
Q ss_pred ccceeEEEcC---CeeEEEEEeccCCC
Q 040898 122 LPLLAHMVRP---NCHLLVYEFMKNGS 145 (337)
Q Consensus 122 v~~~~~~~~~---~~~~lv~e~~~~~~ 145 (337)
.+.+.++.+. +..|+||||++|..
T Consensus 104 P~v~~~~~d~~v~G~~flVME~v~G~~ 130 (822)
T PLN02876 104 PKVYCLCTDASVIGTAFYIMEYLEGRI 130 (822)
T ss_pred CcEEEEecCCCcCCCceEEEEecCCcc
Confidence 6667766554 45789999998854
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.07 E-value=1.2e-06 Score=81.30 Aligned_cols=193 Identities=18% Similarity=0.140 Sum_probs=130.7
Q ss_pred ccccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHH
Q 040898 35 AFLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITAN 114 (337)
Q Consensus 35 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~ 114 (337)
+.-++..-+.....+++|+++.+++++... +. ....+.+... ....-++++|.
T Consensus 236 ~lkDk~kws~~fh~fvK~altknpKkRpta--ek-lL~h~fvs~~------------------------l~~rl~~eLLd 288 (829)
T KOG0576|consen 236 TLKDKTKWSEFFHNFVKGALTKNPKKRPTA--EK-LLQHPFVSQT------------------------LSRRLAIELLD 288 (829)
T ss_pred cccCCccchHHHHHHHHHHhcCCCccCCCh--hh-heeceeeccc------------------------hhhHHHHHHHH
Confidence 333466667778889999999998766643 22 2224433222 12344789999
Q ss_pred hcCCCC-cccceeEEEcCCeeEEEEEeccCC-CHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 040898 115 QTRHRN-ILPLLAHMVRPNCHLLVYEFMKNG-SLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDI 192 (337)
Q Consensus 115 ~l~hpn-iv~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di 192 (337)
+.+||| .+..++-++.+...++.++++.++ +...... .....+..-.....++.-..+++++ |+.--+|+|
T Consensus 289 K~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l---~~~~~~~~d- 361 (829)
T KOG0576|consen 289 KVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMT---VSEIALEQYQFAYPLRKETRPLAEL---HSSYKVHRD- 361 (829)
T ss_pred HccCCCCcccccccCCcccccchhhhhhcCCccccccCC---hhhHhhhhhhhhhhhhhhccccccc---ccccccCcc-
Confidence 999999 667777677778889999999776 2211110 1111233334455556666677888 443346777
Q ss_pred CCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCC
Q 040898 193 KPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPV 268 (337)
Q Consensus 193 ~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf 268 (337)
||+.++ +..+.++|+....+.... ..+...+++.+++||+.....+....|.|++|.-..++--|.+|-
T Consensus 362 ---~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 362 ---NILGSE-EEVKLLDFAVPPQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred ---cccccc-cccccccccCCcccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 666554 688999999887766543 224467899999999999999999999999998777777777663
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.05 E-value=4.9e-05 Score=70.97 Aligned_cols=160 Identities=14% Similarity=0.161 Sum_probs=89.0
Q ss_pred ceeccCcceEEEEeEEecCCCCceEEEEEecccCcch--HHHHHHhhh----hhh------hhhhHHhHHhHHHHHHHHH
Q 040898 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMS--AAELIKQDI----DEY------SDLLHWKIGAIRSEIITAN 114 (337)
Q Consensus 47 ~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~----~~~------~~~~~~~~~~~~~e~~~l~ 114 (337)
+.||..+.|.|+.++-. +|+.||||+-++.-... .+-...+.+ ... .-+.++-...+..|+..++
T Consensus 167 ~piaaASlaQVhrA~L~---~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~ 243 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLK---NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTK 243 (538)
T ss_pred chhhhcchhheEEEEec---CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHH
Confidence 67999999999877765 69999999877643221 100000000 000 0001111122222322222
Q ss_pred ----------hcCCCCccc---cee-EEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHH-HHH
Q 040898 115 ----------QTRHRNILP---LLA-HMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGL-EYL 179 (337)
Q Consensus 115 ----------~l~hpniv~---~~~-~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l-~~l 179 (337)
.+.|-+... .=. ++.-.....|+|||++|..+.+.-.- ....++.. .++..+.++. ..+
T Consensus 244 EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i---~~~gi~~~---~i~~~l~~~~~~qI 317 (538)
T KOG1235|consen 244 EAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI---DKRGISPH---DILNKLVEAYLEQI 317 (538)
T ss_pred HHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH---HHcCCCHH---HHHHHHHHHHHHHH
Confidence 223333111 111 12334456899999999877665321 12234444 3444444432 222
Q ss_pred hhCCCCCeEecCCCCCceeec----CCCCeEEecccCccccCC
Q 040898 180 HMCHRPRLIHRDIKPANVLID----DDMEARISDFGHGKLMPD 218 (337)
Q Consensus 180 ~~~h~~gi~h~di~~~nil~~----~~~~~~l~dfg~~~~~~~ 218 (337)
-..|++|+|=+|.||++. .++.+.+.|||+......
T Consensus 318 ---f~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 318 ---FKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred ---HhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 456899999999999998 467899999999876543
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.03 E-value=2.5e-05 Score=77.51 Aligned_cols=198 Identities=20% Similarity=0.206 Sum_probs=130.9
Q ss_pred HHhHHHHHHHHHhcCCCCcccceeEEEcCCee----EEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHH
Q 040898 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCH----LLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEY 178 (337)
Q Consensus 103 ~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~ 178 (337)
+.....|...+....|+|++.++.+....... ....++|...++...+ ..-...+......+..++.+++.+
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~----q~v~~i~~~~~r~~~~~~~~GL~~ 301 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL----QSVGSIPLETLRILHQKLLEGLAY 301 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH----hhccccCHHHHHHHHHHHhhhHHH
Confidence 34555678888889999999999987655332 3456778888888877 345568888999999999999999
Q ss_pred HhhCCCCCeEecCCCCC---ceeecCCCCeEEe--cccCccccCCCCceeeeecccCCCCccCccccccCCCCC--cccc
Q 040898 179 LHMCHRPRLIHRDIKPA---NVLIDDDMEARIS--DFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISD--KCDI 251 (337)
Q Consensus 179 l~~~h~~gi~h~di~~~---nil~~~~~~~~l~--dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~--~~Di 251 (337)
+|. ..+.|.-+..+ +--.+..+.+..+ ||+.+.......... ....+..+.+||.......+. ..|+
T Consensus 302 ~h~---~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL 375 (1351)
T KOG1035|consen 302 LHS---LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDL 375 (1351)
T ss_pred HHH---hccceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHH
Confidence 954 33444434433 3334455666666 888776654433221 123455577888776655544 4699
Q ss_pred hhhhHHHHHHHhCCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCCh
Q 040898 252 YSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSS 331 (337)
Q Consensus 252 wslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~ 331 (337)
|.+|.....+..|..+-..... ..... ...... .+.+...+|+..++++|+++
T Consensus 376 ~~lgll~~~~~~~~~i~~~~~~----------~~~~l-------------~~~~~~----~~~d~~~~~~~~~~~~Rl~~ 428 (1351)
T KOG1035|consen 376 WCLGLLLLQLSQGEDISEKSAV----------PVSLL-------------DVLSTS----ELLDALPKCLDEDSEERLSA 428 (1351)
T ss_pred HHHHHHHhhhhhcCcccccccc----------hhhhh-------------ccccch----hhhhhhhhhcchhhhhccch
Confidence 9999999998887755211000 00000 000000 26788889999999999999
Q ss_pred hhhhcC
Q 040898 332 KDVRSM 337 (337)
Q Consensus 332 ~ell~~ 337 (337)
.+++.|
T Consensus 429 ~~ll~~ 434 (1351)
T KOG1035|consen 429 LELLTH 434 (1351)
T ss_pred hhhhhc
Confidence 999876
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.01 E-value=7.1e-05 Score=63.50 Aligned_cols=31 Identities=32% Similarity=0.564 Sum_probs=25.7
Q ss_pred CCCeEecCCCCCceeecCCCCeEEecccCcc
Q 040898 184 RPRLIHRDIKPANVLIDDDMEARISDFGHGK 214 (337)
Q Consensus 184 ~~gi~h~di~~~nil~~~~~~~~l~dfg~~~ 214 (337)
..+++|+|+++.|+++++++..-|+||+.+.
T Consensus 163 ~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 163 PPVWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred CceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 4569999999999999876555799999654
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00024 Score=62.44 Aligned_cols=79 Identities=10% Similarity=0.075 Sum_probs=53.2
Q ss_pred ccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC---C
Q 040898 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH---R 119 (337)
Q Consensus 43 y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h---p 119 (337)
..-.+.||.|..+.||.... .+..+++|........ ..+..|...++.+.- -
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~----~~~~~~~k~~~~~~~~---------------------~~~~~Ea~~L~~L~~~~~v 70 (297)
T PRK10593 16 LSRVECISEQPYAALWALYD----SQGNPMPLMARSFSTP---------------------GVAQQEAWKLSMLARSGTV 70 (297)
T ss_pred hheeeecCCccceeEEEEEc----CCCCEEEEEecccccc---------------------hHHHHHHHHHHHHccCCCC
Confidence 44567899999999997755 2335666764321111 356678888887743 3
Q ss_pred CcccceeEEEc---CCeeEEEEEeccCCCH
Q 040898 120 NILPLLAHMVR---PNCHLLVYEFMKNGSL 146 (337)
Q Consensus 120 niv~~~~~~~~---~~~~~lv~e~~~~~~L 146 (337)
.+.++++++.. .+..++|||++++.++
T Consensus 71 pVP~V~~~~~~~~~~g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 71 RMPTVYGVMTHEQSPGPDVLLLERLRGVSV 100 (297)
T ss_pred CcCcEEEEeccCCcCCCeEEEEeccCCEec
Confidence 56777776654 3668999999998754
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.83 E-value=2.6e-05 Score=67.36 Aligned_cols=169 Identities=17% Similarity=0.166 Sum_probs=101.5
Q ss_pred ccccccccccc-ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHH-Hh-hhhhhh--hhhHHh
Q 040898 28 LVEKQDLAFLK-KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELI-KQ-DIDEYS--DLLHWK 102 (337)
Q Consensus 28 ~~~~~~~~~~~-~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~-~~-~~~~~~--~~~~~~ 102 (337)
.++.=.+..+. ...-+.+++.||-|.-+.||.+.+. .|++.++|.-..-.. +.+..- ++ ...... .+....
T Consensus 78 GyDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~---~G~~~~lK~HRLGRt-SFR~Vk~kRDY~r~r~~~sWlyLS 153 (465)
T KOG2268|consen 78 GYDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADE---EGNPLILKLHRLGRT-SFRNVKNKRDYLRKRKSGSWLYLS 153 (465)
T ss_pred cchHHHHHHHHhcchhhhhccccccccccceEEEecC---CCCchhHHHHhhhhh-hHHHhhhhhhhHhcCCccchhhhH
Confidence 33333444444 4446789999999999999988875 688888885433211 111000 00 000000 011111
Q ss_pred HHhHHHHHHHHHhcCCC--CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHh
Q 040898 103 IGAIRSEIITANQTRHR--NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLH 180 (337)
Q Consensus 103 ~~~~~~e~~~l~~l~hp--niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~ 180 (337)
--+..+|...|+.|... -+.+.+ +.+..+.|||++.+-.|...-. ..+ ...+...+...+.-|
T Consensus 154 Rlaa~kEfafmkaL~e~gfpVPkpi----D~~RH~Vvmelv~g~Pl~~v~~-------v~d---~~~ly~~lm~~Iv~l- 218 (465)
T KOG2268|consen 154 RLAATKEFAFMKALYERGFPVPKPI----DHNRHCVVMELVDGYPLRQVRH-------VED---PPTLYDDLMGLIVRL- 218 (465)
T ss_pred HHHHHHHHHHHHHHHHcCCCCCCcc----cccceeeHHHhhcccceeeeee-------cCC---hHHHHHHHHHHHHHH-
Confidence 12566788888777321 122222 3456789999998877655421 122 233444455555666
Q ss_pred hCCCCCeEecCCCCCceeecCCCCeEEecccCccccC
Q 040898 181 MCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMP 217 (337)
Q Consensus 181 ~~h~~gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~ 217 (337)
..+|++|||++-=||++..++.++++||..+....
T Consensus 219 --a~~GlIHgDFNEFNimv~dd~~i~vIDFPQmvS~s 253 (465)
T KOG2268|consen 219 --ANHGLIHGDFNEFNIMVKDDDKIVVIDFPQMVSTS 253 (465)
T ss_pred --HHcCceecccchheeEEecCCCEEEeechHhhccC
Confidence 77899999999999999999999999998654443
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00094 Score=58.71 Aligned_cols=31 Identities=32% Similarity=0.378 Sum_probs=27.0
Q ss_pred CCCeEecCCCCCceeecCCCCeEEecccCcc
Q 040898 184 RPRLIHRDIKPANVLIDDDMEARISDFGHGK 214 (337)
Q Consensus 184 ~~gi~h~di~~~nil~~~~~~~~l~dfg~~~ 214 (337)
..+++|+|++|.|+++++++.+.|+||+.+.
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 3579999999999999987777899998654
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.0017 Score=57.38 Aligned_cols=31 Identities=35% Similarity=0.469 Sum_probs=27.4
Q ss_pred CCCeEecCCCCCceeecCCCCeEEecccCcc
Q 040898 184 RPRLIHRDIKPANVLIDDDMEARISDFGHGK 214 (337)
Q Consensus 184 ~~gi~h~di~~~nil~~~~~~~~l~dfg~~~ 214 (337)
..+++|+|+++.|+++++++.+.++||+.+.
T Consensus 186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 5789999999999999988767899999754
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.0014 Score=56.39 Aligned_cols=30 Identities=13% Similarity=0.224 Sum_probs=25.8
Q ss_pred CCeEecCCCCCceeecCCCCeEEecccCccc
Q 040898 185 PRLIHRDIKPANVLIDDDMEARISDFGHGKL 215 (337)
Q Consensus 185 ~gi~h~di~~~nil~~~~~~~~l~dfg~~~~ 215 (337)
..++|+|+.|.||++++++ +.++||..+..
T Consensus 146 ~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 146 LAPLHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CeeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 4689999999999999877 78999987653
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.0038 Score=52.79 Aligned_cols=31 Identities=13% Similarity=0.309 Sum_probs=26.9
Q ss_pred CCCeEecCCCCCceeecC-CCCeEEecccCcc
Q 040898 184 RPRLIHRDIKPANVLIDD-DMEARISDFGHGK 214 (337)
Q Consensus 184 ~~gi~h~di~~~nil~~~-~~~~~l~dfg~~~ 214 (337)
..+++|+|+.+.||++++ ++.+.++||..+.
T Consensus 169 ~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 169 PIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred CEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 357999999999999998 5789999998764
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.0044 Score=56.40 Aligned_cols=82 Identities=13% Similarity=0.170 Sum_probs=49.7
Q ss_pred cceeccCcceEEEEeEEecCCCC-ceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc---CCCCc
Q 040898 46 LKKIGSGGWGEVFYKAELPGSNG-KMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT---RHRNI 121 (337)
Q Consensus 46 ~~~lg~G~~g~V~~~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l---~hpni 121 (337)
.+.||.|-...||++... +| +.++||+-.+........+ . ...++...|...|..+ ...++
T Consensus 31 ~~elggGn~N~VyrV~~~---~g~~svIVKqa~p~~r~~g~~w-p-----------l~~eR~~~Eae~L~~l~~~~p~~V 95 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDT---EGGKSVIVKQALPYVRVVGESW-P-----------LTLDRARIEAEALKIQAKYVPDLV 95 (401)
T ss_pred eeEcCCCceEEEEEEEeC---CCCeEEEEEecCcccccccccc-c-----------ccHHHHHHHHHHHHHHHhhCCCCC
Confidence 467999999999988874 44 5899998643211100000 0 0013455566666665 23456
Q ss_pred ccceeEEEcCCeeEEEEEeccCC
Q 040898 122 LPLLAHMVRPNCHLLVYEFMKNG 144 (337)
Q Consensus 122 v~~~~~~~~~~~~~lv~e~~~~~ 144 (337)
.+++.+ +....++|||++++.
T Consensus 96 PkV~~~--D~~~~~lVME~L~~~ 116 (401)
T PRK09550 96 PKVYHY--DEELAVTVMEDLSDH 116 (401)
T ss_pred CeEEEE--CCCCCEEEEecCCCc
Confidence 666665 445578999999763
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.0018 Score=57.34 Aligned_cols=160 Identities=18% Similarity=0.186 Sum_probs=93.8
Q ss_pred cccceeccCcceEEEEeEEecCCCCceEEEEEecccCcc-h-HHHHHHhhhhh---hhhhhHHhH--HhHHHHHHHHHhc
Q 040898 44 DSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPM-S-AAELIKQDIDE---YSDLLHWKI--GAIRSEIITANQT 116 (337)
Q Consensus 44 ~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~-~-~~~~~~~~~~~---~~~~~~~~~--~~~~~e~~~l~~l 116 (337)
++-.+|..|--+.||.+... +|..+|||++.-.... + ....+..+... ++.-....+ -.+..|++-|.++
T Consensus 147 ~inGCiSTGKEANVYHat~~---dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl 223 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEE---DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRL 223 (520)
T ss_pred ecccccccCccceeEeeecC---CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHH
Confidence 45567888999999976554 7888999988653221 1 11111111110 111111111 2334466667776
Q ss_pred CCCCcccceeEEEcCCeeEEEEEeccCCCHHH-HHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCC
Q 040898 117 RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQD-ILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPA 195 (337)
Q Consensus 117 ~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ 195 (337)
....|.-..-+... ...|||+++....-.. .| +.-.++...+..+-.+++..+.-|. +.-++||.||+-=
T Consensus 224 ~~aGIP~PePIlLk--~hVLVM~FlGrdgw~aPkL-----Kd~~ls~~ka~~~Y~~~v~~MR~lY--~~c~LVHADLSEf 294 (520)
T KOG2270|consen 224 NNAGIPCPEPILLK--NHVLVMEFLGRDGWAAPKL-----KDASLSTSKARELYQQCVRIMRRLY--QKCRLVHADLSEF 294 (520)
T ss_pred HhcCCCCCCceeee--cceEeeeeccCCCCcCccc-----ccccCChHHHHHHHHHHHHHHHHHH--HHhceeccchhhh
Confidence 55554433333322 3469999985422111 11 2334555566667777777777665 4458999999999
Q ss_pred ceeecCCCCeEEecccCcccc
Q 040898 196 NVLIDDDMEARISDFGHGKLM 216 (337)
Q Consensus 196 nil~~~~~~~~l~dfg~~~~~ 216 (337)
|+|+. +|.++++|-+.+.-.
T Consensus 295 N~Lyh-dG~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 295 NLLYH-DGKLYIIDVSQSVEH 314 (520)
T ss_pred hheEE-CCEEEEEEccccccC
Confidence 99987 678999998866543
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0043 Score=53.92 Aligned_cols=32 Identities=31% Similarity=0.670 Sum_probs=25.8
Q ss_pred CCCeEecCCCCCceeecCCCCe-EEecccCccc
Q 040898 184 RPRLIHRDIKPANVLIDDDMEA-RISDFGHGKL 215 (337)
Q Consensus 184 ~~gi~h~di~~~nil~~~~~~~-~l~dfg~~~~ 215 (337)
...++|+|++|.||++++++.+ -|+||+.+..
T Consensus 184 ~~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 184 HTVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CCeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 3458999999999999975654 6999997653
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.017 Score=51.31 Aligned_cols=31 Identities=29% Similarity=0.337 Sum_probs=26.2
Q ss_pred CCCeEecCCCCCceeecCCCCeEEecccCcc
Q 040898 184 RPRLIHRDIKPANVLIDDDMEARISDFGHGK 214 (337)
Q Consensus 184 ~~gi~h~di~~~nil~~~~~~~~l~dfg~~~ 214 (337)
..|++|+|++|.||+++++...-++||+.+.
T Consensus 186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred CcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 3589999999999999966556899999764
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.011 Score=52.10 Aligned_cols=32 Identities=31% Similarity=0.591 Sum_probs=28.2
Q ss_pred CCCeEecCCCCCceeecCCCCeEEecccCccc
Q 040898 184 RPRLIHRDIKPANVLIDDDMEARISDFGHGKL 215 (337)
Q Consensus 184 ~~gi~h~di~~~nil~~~~~~~~l~dfg~~~~ 215 (337)
...++|+|+++.|++++.++-+-+.||+.+..
T Consensus 197 ~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 197 PPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred CceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 34589999999999999988899999998764
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.014 Score=51.53 Aligned_cols=31 Identities=19% Similarity=0.320 Sum_probs=27.2
Q ss_pred CCCeEecCCCCCceeecCC----CCeEEecccCcc
Q 040898 184 RPRLIHRDIKPANVLIDDD----MEARISDFGHGK 214 (337)
Q Consensus 184 ~~gi~h~di~~~nil~~~~----~~~~l~dfg~~~ 214 (337)
..+++|+|+.+.||+++++ +.+.++||..+.
T Consensus 178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 4579999999999999985 889999999764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.0078 Score=52.47 Aligned_cols=76 Identities=13% Similarity=0.177 Sum_probs=46.6
Q ss_pred ccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc---CCC
Q 040898 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT---RHR 119 (337)
Q Consensus 43 y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l---~hp 119 (337)
.+-.+.++.|....+|.... +++.+.+|.-..... ..+..|..-|+.| ..-
T Consensus 19 i~~~~~v~GG~i~~a~~~~~----~~~~~FvK~~~~~~~----------------------~~f~~Ea~gL~~L~~~~~~ 72 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLDT----DGGSYFVKVNSESGR----------------------DMFEGEAEGLKALAEANPI 72 (288)
T ss_dssp --EEEEE--SSSSEEEEEET----TS-EEEEEEEEGGGC----------------------CHHHHHHHHHHHHCHTTTS
T ss_pred eeeeEecCCCChhheEEEEC----CCccEEEEecChhhH----------------------HHHHHHHHHHHHHHhcCCC
Confidence 45667899999999987663 888999998752221 3456677777766 344
Q ss_pred CcccceeEEEcCCeeEEEEEeccCC
Q 040898 120 NILPLLAHMVRPNCHLLVYEFMKNG 144 (337)
Q Consensus 120 niv~~~~~~~~~~~~~lv~e~~~~~ 144 (337)
.+.+.+++...++..++++||++.+
T Consensus 73 ~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 73 RVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp BS--EEEEEE-SSCCEEEEE-----
T ss_pred CCCeEEEEEeecCCceEEEEeecCC
Confidence 6778888888777889999999765
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.00045 Score=70.95 Aligned_cols=170 Identities=11% Similarity=0.008 Sum_probs=121.8
Q ss_pred hhhHHhHHhHHHHHHHHHhcCCCCcccceeEEE--cCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHH
Q 040898 97 DLLHWKIGAIRSEIITANQTRHRNILPLLAHMV--RPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIAS 174 (337)
Q Consensus 97 ~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~ 174 (337)
.+.++..+....|...++...|+++.....-.. ++..-+..++++.+|.+.+.+.+...+..+.+...+.....+.+.
T Consensus 1267 ~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl 1346 (2724)
T KOG1826|consen 1267 NLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVL 1346 (2724)
T ss_pred HHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHh
Confidence 344444466666777777789998877665443 234568899999999999998775555566666555555555344
Q ss_pred HHHHHhhCC--CCCeEecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccch
Q 040898 175 GLEYLHMCH--RPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIY 252 (337)
Q Consensus 175 ~l~~l~~~h--~~gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Diw 252 (337)
...-+|... +.--+|.++++.|.++..+-.++++++|+.+...... .......+++-|+.|++.+...++.++|+|
T Consensus 1347 ~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~--sf~Gl~l~sp~~v~qli~N~ik~t~rsdil 1424 (2724)
T KOG1826|consen 1347 NRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL--SFFGLELCSPIYVLQLIKNEIKFTKRSDIL 1424 (2724)
T ss_pred ccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchH--hhhhhhhCCHHHHHHHHHHHHhhhhHHHHH
Confidence 444443222 2337899999999999999999999999987332221 112334677888999998888889889999
Q ss_pred hhhHHHHHHHhCCCCC
Q 040898 253 SFGVLLAVLVMGKFPV 268 (337)
Q Consensus 253 slG~i~~~ll~g~~pf 268 (337)
..|+.+|..-.|..+|
T Consensus 1425 r~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1425 RRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred HHHHHHHHHhcccHHH
Confidence 9999999988888776
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.021 Score=51.99 Aligned_cols=81 Identities=9% Similarity=0.123 Sum_probs=48.2
Q ss_pred ccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC---CCCc
Q 040898 45 SLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR---HRNI 121 (337)
Q Consensus 45 ~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~---hpni 121 (337)
..+.||.|-...||++.+ .+..++||+-..........+ . . ...+...|...|+.+. ..++
T Consensus 36 ~~~eiggGn~N~VyrV~~----~~~svVVKqa~p~~r~vga~w-p--l---------~~~R~~~Ea~aL~~~~~~~p~~V 99 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVS----SSGSFVIKQALPYIRCIGESW-P--M---------TKERAYFEATALREHGRLCPDHV 99 (418)
T ss_pred eEEEcCCCceeeEEEEEc----CCccEEEEeCCccccCCCccc-c--C---------CccHHHHHHHHHHHhhhcCCCCC
Confidence 467889999999998776 345688998763322111000 0 0 0023344555555442 3467
Q ss_pred ccceeEEEcCCeeEEEEEeccC
Q 040898 122 LPLLAHMVRPNCHLLVYEFMKN 143 (337)
Q Consensus 122 v~~~~~~~~~~~~~lv~e~~~~ 143 (337)
.+++.++. ...+++||++++
T Consensus 100 PkVy~~de--d~~vlvME~L~~ 119 (418)
T PLN02756 100 PEVYHFDR--TMALIGMRYLEP 119 (418)
T ss_pred CeEEEECC--CCCEEEEeecCC
Confidence 77777666 446788999966
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.046 Score=48.35 Aligned_cols=30 Identities=27% Similarity=0.350 Sum_probs=25.9
Q ss_pred CCCeEecCCCCCceeecCCCCeEEecccCcc
Q 040898 184 RPRLIHRDIKPANVLIDDDMEARISDFGHGK 214 (337)
Q Consensus 184 ~~gi~h~di~~~nil~~~~~~~~l~dfg~~~ 214 (337)
..+++|+|+++.|++++. +.+.++||+.+.
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 468999999999999987 678999998654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.51 E-value=0.018 Score=53.28 Aligned_cols=166 Identities=19% Similarity=0.167 Sum_probs=92.3
Q ss_pred HhHHHHHHHHHhcCCCCcccceeEEEcC-CeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhC
Q 040898 104 GAIRSEIITANQTRHRNILPLLAHMVRP-NCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMC 182 (337)
Q Consensus 104 ~~~~~e~~~l~~l~hpniv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~ 182 (337)
..+.....+++.+.|+|....+.+-... ....+|+|++. .||++.+.... .... ++
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~~~-----l~~~-------s~---------- 83 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKTGN-----LKDE-------SL---------- 83 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHhcc-----cchh-------hh----------
Confidence 3456678899999999999988876543 45788999994 49999884411 1100 00
Q ss_pred CCCCeEecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHH
Q 040898 183 HRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLV 262 (337)
Q Consensus 183 h~~gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll 262 (337)
-.+|+.|- |+ ++.+| .+... . |-. ..+++|||++|.++.++.
T Consensus 84 ~~~~~~~~-----~~-------~~~td-~~~t~---~-----------------~~~-----~~pKsdVwsl~~i~~el~ 125 (725)
T KOG1093|consen 84 LAHGVLHL-----NI-------IYITD-HFLTK---Y-----------------PSP-----IGPKSDVWSLGFIILELY 125 (725)
T ss_pred ccccccee-----hh-------hhccc-ccccc---C-----------------CCC-----CCcchhhhhHHHHHHHHH
Confidence 01133321 22 22223 11000 0 000 113899999999999998
Q ss_pred hCCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 263 MGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 263 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
-|..-+... ...+....+...-..+......... ....-.+.+...++...|+...|..||...++.+
T Consensus 126 L~~~l~~~~----~~s~~l~~i~k~~~~d~~~~~~a~e--~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k 193 (725)
T KOG1093|consen 126 LGISLEAEL----TESEYLEILLKYYTDDQELLSTAME--HLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSK 193 (725)
T ss_pred HhhHHHHHH----HHHHHHHHHHHhccCchhHHHHHHH--HHHHHhhhHhHHHHhccCCccccccccchhHHhc
Confidence 887554332 1112222222222222221111110 0122344455788999999999999998777655
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.047 Score=48.92 Aligned_cols=31 Identities=16% Similarity=0.403 Sum_probs=25.3
Q ss_pred CCCCeEecCCCCCceeecCCCCeEEecccCcc
Q 040898 183 HRPRLIHRDIKPANVLIDDDMEARISDFGHGK 214 (337)
Q Consensus 183 h~~gi~h~di~~~nil~~~~~~~~l~dfg~~~ 214 (337)
..+.++|||+.+.||+++.+ .++++||..+.
T Consensus 190 ~~~~llHGDl~~gNi~~~~~-~~~~iD~e~~~ 220 (370)
T TIGR01767 190 SAETLLHGDLHSGSIFVSEH-ETKVIDPEFAF 220 (370)
T ss_pred CcceeeeccCCcccEEEcCC-CCEEEcCcccc
Confidence 45678999999999999865 47799997654
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.27 E-value=0.044 Score=45.56 Aligned_cols=80 Identities=11% Similarity=0.155 Sum_probs=53.9
Q ss_pred cccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC---C
Q 040898 42 CFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR---H 118 (337)
Q Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h 118 (337)
+.+..+.+.-|.--..|.+.+ ...++.+|+-.... ...|..|+.-|+.+. .
T Consensus 17 ~i~er~~v~gG~inea~~v~d----g~~~~FvK~n~~~~----------------------~~~f~AEa~gL~~la~s~t 70 (286)
T COG3001 17 EIKEREEVSGGDINEAWRLRD----GTDPFFVKCNQREQ----------------------LSMFTAEADGLELLARSNT 70 (286)
T ss_pred hhhcccccCCccccceeEeec----CCcceEEEecchhh----------------------HHHHHHHHHHHHHHHhcCC
Confidence 344455666677777777666 67788888743221 145566666666653 3
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHH
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQ 147 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~ 147 (337)
-.+.+.+.+.......|+|+||++.+.+.
T Consensus 71 i~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 71 ITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred ccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 45677788788889999999999876554
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.00 E-value=0.14 Score=46.11 Aligned_cols=33 Identities=21% Similarity=0.401 Sum_probs=27.3
Q ss_pred CCCCeEecCCCCCceeecC-CCCeEEecccCccc
Q 040898 183 HRPRLIHRDIKPANVLIDD-DMEARISDFGHGKL 215 (337)
Q Consensus 183 h~~gi~h~di~~~nil~~~-~~~~~l~dfg~~~~ 215 (337)
+...++|+|+++.||++++ ++.+.++||..+..
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 3457899999999999986 46799999987653
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.90 E-value=0.18 Score=44.66 Aligned_cols=31 Identities=19% Similarity=0.368 Sum_probs=27.8
Q ss_pred CCCeEecCCCCCceeecCCCCeEEecccCcc
Q 040898 184 RPRLIHRDIKPANVLIDDDMEARISDFGHGK 214 (337)
Q Consensus 184 ~~gi~h~di~~~nil~~~~~~~~l~dfg~~~ 214 (337)
..+++|+|+.++|+++++++.+.++||..+.
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 4589999999999999999999999998764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.73 E-value=0.047 Score=49.50 Aligned_cols=86 Identities=15% Similarity=0.096 Sum_probs=50.9
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC--
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR-- 117 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-- 117 (337)
.+.+. .+.||.|--..||++.+.. .+..++||+-.+......+. ....++...|...|+...
T Consensus 29 ~~~~~-~~eigdGnlN~VfrV~~~~--~~~svIVKQAlp~vRv~~sw-------------pL~~~R~~~E~~aL~~~~~~ 92 (409)
T PRK12396 29 AKGLQ-CKEIGDGNLNYVFRVWDEQ--KNISVIVKQAGDTARISDEF-------------KLSTNRIRIESDVLQLEEEL 92 (409)
T ss_pred cccce-eeEcCCCceEEEEEEeeCC--CCceEEEEeccHhhccCCCC-------------CCChHHHHHHHHHHHHHHhh
Confidence 34444 6788999999999988732 35679999865433211100 001145555666666552
Q ss_pred CC-CcccceeEEEcCCeeEEEEEeccC
Q 040898 118 HR-NILPLLAHMVRPNCHLLVYEFMKN 143 (337)
Q Consensus 118 hp-niv~~~~~~~~~~~~~lv~e~~~~ 143 (337)
.| .+.+++. .+.....+|||+++.
T Consensus 93 ~P~~VP~vy~--~D~e~~~~vMEdL~~ 117 (409)
T PRK12396 93 APGLVPKVYL--FDSVMNCCVMEDLSD 117 (409)
T ss_pred CCCcCCeEEE--ECcHHhhHHHHhCcc
Confidence 23 4555554 455566788998853
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.71 E-value=0.72 Score=41.15 Aligned_cols=29 Identities=28% Similarity=0.485 Sum_probs=24.4
Q ss_pred CCCeEecCCCCCceeecCCCCeEEecccCcc
Q 040898 184 RPRLIHRDIKPANVLIDDDMEARISDFGHGK 214 (337)
Q Consensus 184 ~~gi~h~di~~~nil~~~~~~~~l~dfg~~~ 214 (337)
..+++|+|+.+.||+++ + .+.++||+-+.
T Consensus 195 ~~~liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 195 RLLRLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred CccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 46799999999999995 3 57899999654
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.16 E-value=0.46 Score=42.46 Aligned_cols=30 Identities=20% Similarity=0.444 Sum_probs=25.7
Q ss_pred CeEecCCCCCceeecC-CCCeEEecccCccc
Q 040898 186 RLIHRDIKPANVLIDD-DMEARISDFGHGKL 215 (337)
Q Consensus 186 gi~h~di~~~nil~~~-~~~~~l~dfg~~~~ 215 (337)
.++|+|+.+.||++++ ++.++++||..+..
T Consensus 183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 4799999999999975 57899999997654
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.12 E-value=0.076 Score=48.02 Aligned_cols=60 Identities=20% Similarity=0.215 Sum_probs=39.3
Q ss_pred eEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 134 HLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 134 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
..++=+|..|.++..++.. ...++....+++.-.+.|+-.+- --.+++|.|++|.||++-
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~-----~~~pe~l~kkva~lg~~AllkMl--~vDNFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKW-----KSQPEALVKKVAKLGVNALLKML--IVDNFVHADLHPGNVLIR 379 (565)
T ss_pred ceeeeeccccccHHhhhhc-----ccChHHHHHHHHHHHHHHHHHHH--HhhcceecccCCCcEEEE
Confidence 3566667788888888843 22333455555555555533322 446899999999999995
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.23 E-value=0.049 Score=45.08 Aligned_cols=85 Identities=14% Similarity=0.029 Sum_probs=53.8
Q ss_pred HHHHHHHHHhcCCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCC
Q 040898 106 IRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRP 185 (337)
Q Consensus 106 ~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~ 185 (337)
+..+..++.++ -.|+++.. .+...+.+++|+|-.... .. ..++..-+++|.-.|+. +.
T Consensus 105 y~nky~v~Arm--hGilrL~N--Dn~~~yGvIlE~Cy~~~i----------------~~-~N~i~agi~~L~~fH~~-~~ 162 (308)
T PF07387_consen 105 YFNKYRVFARM--HGILRLKN--DNNYKYGVILERCYKIKI----------------NF-SNFITAGIKDLMDFHSE-NQ 162 (308)
T ss_pred hhhhhhHHHHh--hheeEeec--CCCceeEEEEeeccCccc----------------ch-hHHHHHhHHHHHHhhcc-CC
Confidence 44455555543 24555553 244556788998844210 01 11122223556777663 56
Q ss_pred CeEecCCCCCceeecCCCCeEEecccC
Q 040898 186 RLIHRDIKPANVLIDDDMEARISDFGH 212 (337)
Q Consensus 186 gi~h~di~~~nil~~~~~~~~l~dfg~ 212 (337)
+.+|||.+|+||+.++.|-+||.|.+.
T Consensus 163 ~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 163 HCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred CeecCCCChhheeecCCCCEEecChhh
Confidence 899999999999999999999999874
|
The function of this family is unknown. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.15 E-value=0.24 Score=44.30 Aligned_cols=73 Identities=18% Similarity=0.191 Sum_probs=52.7
Q ss_pred CeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCCeEEeccc
Q 040898 132 NCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFG 211 (337)
Q Consensus 132 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~~l~dfg 211 (337)
...|+++++- |+++.- + ....+++...++++.+..++-+. -+-..-|+|+...||+++ +|+|.|+||-
T Consensus 299 ~y~yl~~kdh-gt~is~-i-------k~~~~~e~lsff~s~~sil~~le--kkf~fehrnlt~~niLId-~GnvtLIDfk 366 (488)
T COG5072 299 LYLYLHFKDH-GTPISI-I-------KADRSEEELSFFWSCISILDILE--KKFPFEHRNLTLDNILID-EGNVTLIDFK 366 (488)
T ss_pred eEEEEEEecC-Cceeee-e-------ecccHHHHHHHHHHHHHHHhhhh--hcCCcccccccccceeee-cCceEEEEee
Confidence 3456677654 333321 2 22456778888888887777763 245688999999999999 9999999999
Q ss_pred Ccccc
Q 040898 212 HGKLM 216 (337)
Q Consensus 212 ~~~~~ 216 (337)
+++..
T Consensus 367 lsRl~ 371 (488)
T COG5072 367 LSRLS 371 (488)
T ss_pred eeecc
Confidence 98843
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=93.68 E-value=0.14 Score=44.22 Aligned_cols=31 Identities=26% Similarity=0.363 Sum_probs=27.7
Q ss_pred CCeEecCCCCCceeecCCCCeEEecccCccc
Q 040898 185 PRLIHRDIKPANVLIDDDMEARISDFGHGKL 215 (337)
Q Consensus 185 ~gi~h~di~~~nil~~~~~~~~l~dfg~~~~ 215 (337)
.-++|+|+.|.|++.++.+.++|+||..|..
T Consensus 153 ~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 153 LVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred eeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence 3689999999999999999999999987653
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.44 E-value=0.065 Score=43.34 Aligned_cols=29 Identities=17% Similarity=0.243 Sum_probs=25.2
Q ss_pred CeEecCCCCCceeecCCCCeEEecccCccc
Q 040898 186 RLIHRDIKPANVLIDDDMEARISDFGHGKL 215 (337)
Q Consensus 186 gi~h~di~~~nil~~~~~~~~l~dfg~~~~ 215 (337)
..+|+|+.|.|+++++++ ++++||+.+..
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 469999999999998877 89999997653
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=93.38 E-value=0.026 Score=51.94 Aligned_cols=76 Identities=14% Similarity=0.279 Sum_probs=59.9
Q ss_pred cccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHh
Q 040898 36 FLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQ 115 (337)
Q Consensus 36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~ 115 (337)
.-+.-.+|+.+..+|.|+||+|+.+.... ++-.+|||++........+ .+..++..-+..
T Consensus 44 ~sr~a~~~e~~~~~~~~g~~~~~~~~n~~--d~~~~avkritlkn~e~s~------------------~rvl~~~~s~a~ 103 (516)
T KOG1033|consen 44 TSREANDFEPGQCLGRGGFGVVFSAQNKA--DENKYAVKRITLKNREESR------------------SRVLREVSSLAE 103 (516)
T ss_pred hhhhhccccccccccccCccccCCccccc--cchhhHHHHhcccchhhhh------------------hhhhccccchhh
Confidence 34455679999999999999999888765 7778999999776543332 456778888999
Q ss_pred cCCCCcccceeEEEcC
Q 040898 116 TRHRNILPLLAHMVRP 131 (337)
Q Consensus 116 l~hpniv~~~~~~~~~ 131 (337)
+.|++++++...|...
T Consensus 104 feh~g~~~~~ha~~~~ 119 (516)
T KOG1033|consen 104 FEHPGIKRYFHAWYER 119 (516)
T ss_pred hcccchhhheeceecC
Confidence 9999999998877643
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=92.11 E-value=5.5 Score=34.75 Aligned_cols=29 Identities=28% Similarity=0.375 Sum_probs=23.9
Q ss_pred CeEecCCCCCceeecCC--C---CeEEecccCcc
Q 040898 186 RLIHRDIKPANVLIDDD--M---EARISDFGHGK 214 (337)
Q Consensus 186 gi~h~di~~~nil~~~~--~---~~~l~dfg~~~ 214 (337)
-++|||++.+||++..+ | .+++.||-.+.
T Consensus 216 vl~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~ 249 (294)
T PF02958_consen 216 VLCHGDFWTNNILFKYDDDGKPIDVVLIDFQLAR 249 (294)
T ss_pred EEEcCccCHHhEeEccccccccccceeecccccc
Confidence 48999999999999654 3 58999998654
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 337 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 8e-40 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-39 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-28 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-28 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-28 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 8e-27 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-20 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-20 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-20 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-20 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-20 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-19 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-19 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 8e-18 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-17 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-17 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-17 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-17 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-17 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-17 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-17 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-17 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-17 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-17 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-17 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-17 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-16 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-16 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-16 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-16 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-16 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-16 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-16 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-16 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-16 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-16 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-16 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-16 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-16 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-16 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 7e-16 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 8e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 8e-16 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 9e-16 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 9e-16 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 9e-16 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-16 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 9e-16 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-15 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-15 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-15 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-15 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-15 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-15 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-15 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-15 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-15 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-15 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-15 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-15 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-15 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-15 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-15 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-15 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-15 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-15 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-15 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-15 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-15 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-15 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-15 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-15 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-15 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-15 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-15 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-15 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-15 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-15 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-15 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-15 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-15 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-15 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 7e-15 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-15 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 8e-15 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-15 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-15 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 8e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 9e-15 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-15 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-14 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-14 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-14 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-14 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-14 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-14 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-14 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-14 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-14 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-14 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-14 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-14 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-14 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-14 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-14 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-14 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 6e-14 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-14 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 6e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-14 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-14 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 6e-14 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 6e-14 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 7e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 7e-14 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-14 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 7e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 7e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-14 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 8e-14 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 9e-14 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-14 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-14 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 9e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 9e-14 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-14 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 9e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 9e-14 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 9e-14 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-13 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-13 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-13 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-13 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-13 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-13 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-13 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-13 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-13 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-13 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-13 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-13 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-13 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-13 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-13 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-13 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-13 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-13 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-13 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-13 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-13 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-13 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-13 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-13 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-13 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-13 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-13 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-13 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-13 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-13 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-13 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-13 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-13 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-13 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-13 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-13 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-13 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-13 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-13 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-13 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-13 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 6e-13 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 7e-13 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 7e-13 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 8e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 8e-13 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 8e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 8e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-13 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 9e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-12 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-12 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-12 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-12 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-12 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-12 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-12 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-12 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-12 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-12 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-12 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-12 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-12 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-12 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-12 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-12 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-12 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-12 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-12 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-12 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-12 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-12 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-12 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-12 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-12 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-12 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-12 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-12 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-12 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-12 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-12 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 6e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 6e-12 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 6e-12 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 7e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 7e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-11 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-11 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-11 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-11 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-11 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-11 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-11 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-11 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-11 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-11 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-11 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-11 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-11 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-11 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-11 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-11 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-11 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-11 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-11 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-11 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-11 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-11 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-11 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-11 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-11 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-11 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-11 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-11 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-11 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-11 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-11 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-11 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-11 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-11 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-11 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-11 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-11 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-11 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-11 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 5e-11 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-11 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 6e-11 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-11 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-11 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 6e-11 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 7e-11 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 7e-11 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-11 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 7e-11 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 7e-11 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-11 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 8e-11 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-11 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 8e-11 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 8e-11 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 8e-11 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 9e-11 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 9e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 9e-11 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 9e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 9e-11 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 9e-11 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 9e-11 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 9e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-10 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-10 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-10 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-10 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-10 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-10 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-10 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-10 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-10 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-10 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-10 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-10 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-10 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-10 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-10 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-10 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-10 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-10 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-10 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-10 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-10 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-10 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 4e-10 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 4e-10 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-10 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-10 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-10 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 5e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-10 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 5e-10 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-10 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 5e-10 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 5e-10 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 5e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-10 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-10 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 5e-10 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 5e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-10 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-10 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-10 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 6e-10 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 6e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-10 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 6e-10 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 6e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 6e-10 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 6e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 6e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 7e-10 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 7e-10 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 7e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 7e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 7e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 7e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-10 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 8e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 8e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 9e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 9e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 9e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-09 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-09 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-09 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-09 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-09 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-09 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-09 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-09 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-09 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-09 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-09 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-09 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-09 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 6e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 6e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 7e-09 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 7e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 7e-09 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 7e-09 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 7e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-09 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 8e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 8e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 9e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 9e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 9e-09 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 9e-09 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 9e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-08 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-08 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-08 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-08 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-08 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-08 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-08 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-08 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-08 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-08 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-08 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-08 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-08 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-08 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-08 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-08 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-08 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-08 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-08 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-08 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-08 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-08 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-08 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-08 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-08 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-08 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-08 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-08 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-08 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-08 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-08 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-08 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-08 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-08 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-08 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-08 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-08 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-08 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-08 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-08 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-08 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-08 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-08 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-08 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-08 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-08 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-08 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-08 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-08 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-08 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-08 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 4e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-08 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-08 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-08 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 5e-08 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-08 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-08 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-08 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 5e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 5e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 5e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 5e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-08 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 6e-08 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 6e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 6e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-08 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 6e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 6e-08 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 6e-08 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 7e-08 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 7e-08 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 7e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 7e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-08 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 8e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 8e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 8e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 8e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 9e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-08 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 9e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 9e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 9e-08 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 9e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 9e-08 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 9e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-07 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-07 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-07 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-07 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-07 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-07 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-07 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-07 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-07 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-07 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-07 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-07 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-07 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-07 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-07 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-07 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-07 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-07 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-07 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-07 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-07 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-07 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-07 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-07 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-07 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-07 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-07 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-07 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-07 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-07 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-07 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-07 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-07 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-07 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-07 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-07 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-07 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-07 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-07 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-07 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-07 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-07 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-07 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-07 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-07 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 7e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-07 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 8e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 8e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 8e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 9e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 9e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-06 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-06 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-06 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-06 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-06 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-06 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-06 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 1e-06 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 1e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-06 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-06 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-06 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-06 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 2e-06 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-06 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-06 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-06 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-06 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-06 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-06 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-06 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-06 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-06 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-06 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-06 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-06 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-06 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-06 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 5e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-06 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 249 bits (637), Expect = 4e-81
Identities = 95/299 (31%), Positives = 155/299 (51%), Gaps = 25/299 (8%)
Query: 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVD-APMSAAELIKQDIDEYSDLL 99
D F + +G GG+G+V YK L +G ++A+++L + +
Sbjct: 30 DNFSNKNILGRGGFGKV-YKGRLA--DGTLVAVKRLKEERTQGGELQF------------ 74
Query: 100 HWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRE 159
++E+ + HRN+L L + P LLVY +M NGS+ L + + +
Sbjct: 75 -------QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPP 127
Query: 160 LDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDG 219
LDWP R RIA G A GL YLH P++IHRD+K AN+L+D++ EA + DFG KLM
Sbjct: 128 LDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 187
Query: 220 HAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMD 279
+T GT+G++APE L T S+K D++ +GV+L L+ G+ D ++
Sbjct: 188 DTHVTTAVR-GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 246
Query: 280 M-VKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337
M + W++ ++ + ++ L GN +E++ ++++A CT P ERP +V M
Sbjct: 247 MLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRM 305
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 2e-67
Identities = 91/292 (31%), Positives = 139/292 (47%), Gaps = 31/292 (10%)
Query: 48 KIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIR 107
K+G GG+G V YK + N +A++KL ++ EL +Q +
Sbjct: 38 KMGEGGFGVV-YKGYV---NNTTVAVKKLAAMVDITTEELKQQ----------FD----- 78
Query: 108 SEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHR 167
EI + +H N++ LL + LVY +M NGSL D L G L W R +
Sbjct: 79 QEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC-LDGTPPLSWHMRCK 137
Query: 168 IARGIASGLEYLH-MCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQ-ITV 225
IA+G A+G+ +LH H IHRDIK AN+L+D+ A+ISDFG + +T
Sbjct: 138 IAQGAANGINFLHENHH----IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTS 193
Query: 226 KCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMR 285
+ + GT YMAPE+L I+ K DIYSFGV+L ++ G VD+ H E ++
Sbjct: 194 RIV-GTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDE---HREPQLLLDIKE 248
Query: 286 NVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337
+ E K + + + + +A C + ++RP K V+ +
Sbjct: 249 EIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 5e-66
Identities = 83/297 (27%), Positives = 138/297 (46%), Gaps = 32/297 (10%)
Query: 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLH 100
+ FD IG G +G+V YK L +G +A+++ P S Q I+E+
Sbjct: 39 NNFDHKFLIGHGVFGKV-YKGVLR--DGAKVALKRR---TPES-----SQGIEEF----- 82
Query: 101 WKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRREL 160
+EI T + RH +++ L+ N +L+Y++M+NG+L+ LY +
Sbjct: 83 ------ETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSM 136
Query: 161 DWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDG- 219
W R I G A GL YL H +IHRD+K N+L+D++ +I+DFG K +
Sbjct: 137 SWEQRLEICIGAARGLHYL---HTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELD 193
Query: 220 --HAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEE 277
H VK GT+GY+ PE +++K D+YSFGV+L ++ + + E
Sbjct: 194 QTHLSTVVK---GTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP-REM 249
Query: 278 MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDV 334
+++ +W + + ++ L E + A C ++RPS DV
Sbjct: 250 VNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDV 306
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 2e-55
Identities = 72/322 (22%), Positives = 116/322 (36%), Gaps = 56/322 (17%)
Query: 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLL 99
L+ G +G V +KA+L + +A++ QD +
Sbjct: 23 SMPLQLLEVKARGRFGCV-WKAQL---LNEYVAVKIFP-----------IQDKQSW---- 63
Query: 100 HWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCH----LLVYEFMKNGSLQDILYDVSQ 155
E+ + +H NIL + R L+ F + GSL D L
Sbjct: 64 -----QNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK---- 114
Query: 156 GRRELDWPARHRIARGIASGLEYLHM-------CHRPRLIHRDIKPANVLIDDDMEARIS 208
+ W IA +A GL YLH H+P + HRDIK NVL+ +++ A I+
Sbjct: 115 -ANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173
Query: 209 DFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTE-----TISDKCDIYSFGVLLAVLVM 263
DFG G + VGT YMAPE L+ + D+Y+ G++L L
Sbjct: 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELAS 233
Query: 264 GKFPVDD--------FFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLK 315
D F + ++ M+ V+ + + + M ++ +
Sbjct: 234 RCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKH---AGMAMLCE 290
Query: 316 LACFCTLKDPDERPSSKDVRSM 337
C D + R S+ V
Sbjct: 291 TIEECWDHDAEARLSAGCVGER 312
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 3e-48
Identities = 65/221 (29%), Positives = 113/221 (51%), Gaps = 25/221 (11%)
Query: 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAI 106
+KIG+G +G V ++AE +G +A++ L+ + + ++E+
Sbjct: 43 EKIGAGSFGTV-HRAEW---HGSDVAVKILMEQ------DFHAERVNEF----------- 81
Query: 107 RSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARH 166
E+ + RH NI+ + + +P +V E++ GSL +L+ S R +LD R
Sbjct: 82 LREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-SGAREQLDERRRL 140
Query: 167 RIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVK 226
+A +A G+ YLH P ++HR++K N+L+D ++ DFG +L ++ K
Sbjct: 141 SMAYDVAKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST--FLSSK 197
Query: 227 CMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFP 267
GT +MAPE L+ E ++K D+YSFGV+L L + P
Sbjct: 198 SAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP 238
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 6e-48
Identities = 66/292 (22%), Positives = 117/292 (40%), Gaps = 53/292 (18%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGA 105
+ +G G +G V KA+ K +AI+++ + + +
Sbjct: 13 EEVVGRGAFGVV-CKAKW---RAKDVAIKQIESE----------SERKAF---------- 48
Query: 106 IRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPAR 165
E+ ++ H NI+ L + P C LV E+ + GSL ++L+ ++
Sbjct: 49 -IVELRQLSRVNHPNIVKLYGACLNPVC--LVMEYAEGGSLYNVLHG-AEPLPYYTAAHA 104
Query: 166 HRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDME-ARISDFGHGKLMPDGHAQIT 224
+ G+ YLH LIHRD+KP N+L+ +I DFG + Q
Sbjct: 105 MSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI-----QTH 159
Query: 225 VKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMV--K 282
+ G+ +MAPE + S+KCD++S+G++L ++ + P D+ G +
Sbjct: 160 MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN 219
Query: 283 WMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDV 334
R + P + L C KDP +RPS +++
Sbjct: 220 GTRPPLIKNLPKP-----------------IESLMTRCWSKDPSQRPSMEEI 254
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 3e-47
Identities = 62/258 (24%), Positives = 113/258 (43%), Gaps = 34/258 (13%)
Query: 21 GPTIFSPLVEKQDLAFLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDA 80
G S + + E + K+IG GG+G V +K L + ++AI K ++
Sbjct: 1 GAMGGSEFPKSRLPTLADNE--IEYEKQIGKGGFGLV-HKGRLV-KDKSVVAI-KSLILG 55
Query: 81 PMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEF 140
+ + E+ + E+ + H NI+ L M P +V EF
Sbjct: 56 DSEGETEMIEKFQEF-----------QREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEF 102
Query: 141 MKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200
+ G L L D + W + R+ IA G+EY+ P ++HRD++ N+ +
Sbjct: 103 VPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQ 158
Query: 201 -----DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETI--SDKCDIYS 253
+ A+++DFG + +V ++G +MAPE++ E ++K D YS
Sbjct: 159 SLDENAPVCAKVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYS 213
Query: 254 FGVLLAVLVMGKFPVDDF 271
F ++L ++ G+ P D++
Sbjct: 214 FAMILYTILTGEGPFDEY 231
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 1e-45
Identities = 71/331 (21%), Positives = 115/331 (34%), Gaps = 65/331 (19%)
Query: 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLH 100
D L+ IG G +G V YK L + + +A++ + ++
Sbjct: 13 DNLKLLELIGRGRYGAV-YKGSL---DERPVAVKVF--------------SFANRQNFIN 54
Query: 101 WKIGAIRSEIITANQTRHRNILPLLAHMVRPNCH-----LLVYEFMKNGSLQDILYDVSQ 155
I H NI + R LLV E+ NGSL L
Sbjct: 55 ------EKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS---- 104
Query: 156 GRRELDWPARHRIARGIASGLEYLHM------CHRPRLIHRDIKPANVLIDDDMEARISD 209
DW + R+A + GL YLH ++P + HRD+ NVL+ +D ISD
Sbjct: 105 -LHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163
Query: 210 FG------HGKLMPDGHAQITVKCMVGTMGYMAPESLQ-------TETISDKCDIYSFGV 256
FG +L+ G VGT+ YMAPE L+ E+ + D+Y+ G+
Sbjct: 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGL 223
Query: 257 LLAVLVMGKFPVDDFFGHTEEM----DMVKW------MRNVIFSENPNRAINSKLLGNGY 306
+ + M + E V M+ ++ E N
Sbjct: 224 IYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKEN-- 281
Query: 307 EEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337
+ + + C +D + R +++
Sbjct: 282 SLAVRSLKETIEDCWDQDAEARLTAQXAEER 312
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 2e-45
Identities = 61/229 (26%), Positives = 97/229 (42%), Gaps = 36/229 (15%)
Query: 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAI 106
+ IG GG+G+V Y+A G +A++ D ++ I+ +
Sbjct: 13 EIIGIGGFGKV-YRAFW---IGDEVAVKAARHDPDEDISQTIEN---------------V 53
Query: 107 RSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARH 166
R E +H NI+ L ++ LV EF + G L +L + +
Sbjct: 54 RQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS-----GKRIPPDILV 108
Query: 167 RIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEAR--------ISDFGHGKLMPD 218
A IA G+ YLH +IHRD+K +N+LI +E I+DFG +
Sbjct: 109 NWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW-- 166
Query: 219 GHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFP 267
+ T G +MAPE ++ S D++S+GVLL L+ G+ P
Sbjct: 167 --HRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 3e-43
Identities = 56/231 (24%), Positives = 91/231 (39%), Gaps = 36/231 (15%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGA 105
L K+ GE+ +K G I ++ L V + + ++
Sbjct: 15 LTKLNENHSGEL-WKGRW---QGNDIVVKVLKVR------DWSTRKSRDF---------- 54
Query: 106 IRSEIITANQTRHRNILPLL-AHMVRPNCHL-LVYEFMKNGSLQDILYDVSQGRRELDWP 163
E H N+LP+L A P H L+ +M GSL ++L++ +D
Sbjct: 55 -NEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHE--GTNFVVDQS 111
Query: 164 ARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQI 223
+ A +A G+ +LH P + + +V+ID+DM ARIS
Sbjct: 112 QAVKFALDMARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPG--- 167
Query: 224 TVKCMVGTMGYMAPESLQTE---TISDKCDIYSFGVLLAVLVMGKFPVDDF 271
+ ++APE+LQ + T D++SF VLL LV + P D
Sbjct: 168 ----RMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL 214
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 5e-43
Identities = 66/316 (20%), Positives = 117/316 (37%), Gaps = 56/316 (17%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGA 105
+K+IG G +GEV + + G+ +A++ + +
Sbjct: 42 VKQIGKGRYGEV-WMGKW---RGEKVAVKVFF-----------TTEEASW---------F 77
Query: 106 IRSEIITANQTRHRNILPLLAHMVRPNC----HLLVYEFMKNGSLQDILYDVSQGRRELD 161
+EI RH NIL +A ++ L+ ++ +NGSL D L LD
Sbjct: 78 RETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLK-----STTLD 132
Query: 162 WPARHRIARGIASGLEYLHM-----CHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLM 216
+ ++A SGL +LH +P + HRD+K N+L+ + I+D G
Sbjct: 133 AKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKF 192
Query: 217 PDGHAQITVKCM--VGTMGYMAPESLQTETISD------KCDIYSFGVLLAVLVMGKFPV 268
++ + VGT YM PE L + D+YSFG++L +
Sbjct: 193 ISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG 252
Query: 269 DD-------FFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCT 321
+ + MR ++ + + ++ + QM KL C
Sbjct: 253 GIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMG---KLMTECW 309
Query: 322 LKDPDERPSSKDVRSM 337
+P R ++ V+
Sbjct: 310 AHNPASRLTALRVKKT 325
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 5e-43
Identities = 60/308 (19%), Positives = 114/308 (37%), Gaps = 64/308 (20%)
Query: 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAI 106
+ +G G +G+ K + G+++ +++LI +
Sbjct: 16 EVLGKGCFGQA-IKVTHRET-GEVMVMKELIRFDEETQRT-------------------F 54
Query: 107 RSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARH 166
E+ H N+L + + + + E++K G+L+ I+ + W R
Sbjct: 55 LKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS---MDSQYPWSQRV 111
Query: 167 RIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDG------- 219
A+ IASG+ YLH + +IHRD+ N L+ ++ ++DFG +LM D
Sbjct: 112 SFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGL 168
Query: 220 -----HAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGH 274
+ +VG +MAPE + + +K D++SFG++L ++ D+
Sbjct: 169 RSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYL-- 226
Query: 275 TEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQM-----LLVLKLACFCTLKDPDERP 329
R + F N + + C DP++RP
Sbjct: 227 ---------PRTMDFGLNVRG---------FLDRYCPPNCPPSFFPITVRCCDLDPEKRP 268
Query: 330 SSKDVRSM 337
S +
Sbjct: 269 SFVKLEHW 276
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-41
Identities = 70/316 (22%), Positives = 122/316 (38%), Gaps = 56/316 (17%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGA 105
L+ +G G +GEV ++ G+ +A++ ++ K E
Sbjct: 13 LECVGKGRYGEV-WRGSW---QGENVAVKIF-------SSRDEKSWFRE----------- 50
Query: 106 IRSEIITANQTRHRNILPLLA----HMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELD 161
+E+ RH NIL +A L+ + + GSL D L LD
Sbjct: 51 --TELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLD 103
Query: 162 WPARHRIARGIASGLEYLHM-----CHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLM 216
+ RI IASGL +LH+ +P + HRD+K N+L+ + + I+D G +
Sbjct: 104 TVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMH 163
Query: 217 PDGHAQITVKCM--VGTMGYMAPESLQTETISD------KCDIYSFGVLLAVLVMGKFPV 268
Q+ V VGT YMAPE L D + DI++FG++L +
Sbjct: 164 SQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSN 223
Query: 269 DD-------FFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCT 321
F+ + MR V+ + I ++ + + ++K C
Sbjct: 224 GIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKE---CW 280
Query: 322 LKDPDERPSSKDVRSM 337
++P R ++ ++
Sbjct: 281 YQNPSARLTALRIKKT 296
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 5e-41
Identities = 73/297 (24%), Positives = 123/297 (41%), Gaps = 62/297 (20%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGA 105
++IGSG +G V YK + +G +A++ L V AP A
Sbjct: 29 GQRIGSGSFGTV-YKGKW---HGD-VAVKMLNVTAPTPQQLQ-----------------A 66
Query: 106 IRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPAR 165
++E+ +TRH NIL + + P +V ++ + SL L+ + +
Sbjct: 67 FKNEVGVLRKTRHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHA---SETKFEMKKL 122
Query: 166 HRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITV 225
IAR A G++YLH +IHRD+K N+ + +D +I DFG
Sbjct: 123 IDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQF 179
Query: 226 KCMVGTMGYMAPESLQTETI---SDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVK 282
+ + G++ +MAPE ++ + S + D+Y+FG++L L+ G+ P + + D +
Sbjct: 180 EQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP----YSNINNRDQII 235
Query: 283 WMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLAC---------FCTLKDPDERPS 330
M +G G L ++ C C K DERPS
Sbjct: 236 EM-----------------VGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPS 275
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-40
Identities = 66/316 (20%), Positives = 117/316 (37%), Gaps = 56/316 (17%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGA 105
+ IG G +GEV ++ + G+ +A++ ++ + E
Sbjct: 47 QESIGKGRFGEV-WRGKW---RGEEVAVKIF-------SSREERSWFRE----------- 84
Query: 106 IRSEIITANQTRHRNILPLLAHMVRPN----CHLLVYEFMKNGSLQDILYDVSQGRRELD 161
+EI RH NIL +A + N LV ++ ++GSL D L R +
Sbjct: 85 --AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVT 137
Query: 162 WPARHRIARGIASGLEYLHM-----CHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLM 216
++A ASGL +LHM +P + HRD+K N+L+ + I+D G
Sbjct: 138 VEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 197
Query: 217 PDGHAQITVKC--MVGTMGYMAPESLQTETISD------KCDIYSFGVLLAVLVMGKFPV 268
I + VGT YMAPE L + DIY+ G++ +
Sbjct: 198 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG 257
Query: 269 DD-------FFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCT 321
++ V+ MR V+ + I ++ M +++ C
Sbjct: 258 GIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRE---CW 314
Query: 322 LKDPDERPSSKDVRSM 337
+ R ++ ++
Sbjct: 315 YANGAARLTALRIKKT 330
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-38
Identities = 49/234 (20%), Positives = 98/234 (41%), Gaps = 41/234 (17%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGA 105
+ IG G +G+V Y +G+ +AIR + ++ + + +
Sbjct: 38 GELIGKGRFGQV-YHGRW---HGE-VAIRLIDIE------RDNEDQLKAF---------- 76
Query: 106 IRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPAR 165
+ E++ QTRH N++ + + P ++ K +L ++ D + LD
Sbjct: 77 -KREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRD---AKIVLDVNKT 132
Query: 166 HRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITV 225
+IA+ I G+ YL H ++H+D+K NV D+ + I+DFG + A
Sbjct: 133 RQIAQEIVKGMGYL---HAKGILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRRE 188
Query: 226 KCM---VGTMGYMAPESLQTETI---------SDKCDIYSFGVLLAVLVMGKFP 267
+ G + ++APE ++ + S D+++ G + L ++P
Sbjct: 189 DKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 9e-36
Identities = 63/306 (20%), Positives = 113/306 (36%), Gaps = 53/306 (17%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
+ ++K+G GG+ V E +G A+++++ E +++ D +
Sbjct: 31 YLFIQKLGEGGFSYV-DLVE-GLHDGHFYALKRILC-HEQQDREEAQREADMHRLF---- 83
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCH----LLVYEFMKNGSLQDILYDVSQGRR 158
H NIL L+A+ +R L+ F K G+L + + +
Sbjct: 84 --------------NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGN 129
Query: 159 ELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFG---HGKL 215
L + GI GLE H HRD+KP N+L+ D+ + + D G +
Sbjct: 130 FLTEDQILWLLLGICRGLEA---IHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACI 186
Query: 216 MPDGHAQITV----KCMVGTMGYMAPESLQTE---TISDKCDIYSFGVLLAVLVMGKFPV 268
+G Q T+ Y APE + I ++ D++S G +L ++ G+ P
Sbjct: 187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP- 245
Query: 269 DDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDER 328
+ ++ D V S + +S L +L DP +R
Sbjct: 246 --YDMVFQKGDSVALAVQNQLSIPQSPRHSSAL------------WQLLNSMMTVDPHQR 291
Query: 329 PSSKDV 334
P +
Sbjct: 292 PHIPLL 297
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-34
Identities = 64/292 (21%), Positives = 113/292 (38%), Gaps = 49/292 (16%)
Query: 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAI 106
+IG G + V YK L +A + D ++ +E +
Sbjct: 32 IEIGRGSFKTV-YKG-LDTETTVEVAW-CELQDRKLTKSERQR----------------F 72
Query: 107 RSEIITANQTRHRNILPLL---AHMVRPNCHLLVY-EFMKNGSLQDILYDVSQGRRELDW 162
+ E +H NI+ V+ +++ E M +G+L+ L + + +
Sbjct: 73 KEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL----KRFKVMKI 128
Query: 163 PARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID-DDMEARISDFGHGKLMPDGHA 221
R I GL++LH P +IHRD+K N+ I +I D G L A
Sbjct: 129 KVLRSWCRQILKGLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA 187
Query: 222 QITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMV 281
K ++GT +MAPE + E + D+Y+FG+ + + ++P ++E +
Sbjct: 188 ----KAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYP------YSECQNAA 236
Query: 282 KWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKD 333
+ R V S + + E ++ C ++ DER S KD
Sbjct: 237 QIYRRVT-SGVKPASFDKVA----IPEVKEIIEG----CIRQNKDERYSIKD 279
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-33
Identities = 65/318 (20%), Positives = 122/318 (38%), Gaps = 70/318 (22%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
F+ + +G G +G+V KA + + AI K I ++ +
Sbjct: 8 FEEIAVLGQGAFGQV-VKAR-NALDSRYYAI-KKI--------RHTEEKLST-------- 48
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHL-------------LVYEFMKNGSLQDI 149
I SE++ H+ ++ A + + + E+ +NG+L D+
Sbjct: 49 ---ILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDL 105
Query: 150 LYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISD 209
+ R+ R I L Y H +IHRD+KP N+ ID+ +I D
Sbjct: 106 I---HSENLNQQRDEYWRLFRQILEALSY---IHSQGIIHRDLKPMNIFIDESRNVKIGD 159
Query: 210 FGHGKLMPDGHAQITVKC------------MVGTMGYMAPESLQ-TETISDKCDIYSFGV 256
FG K + + + +GT Y+A E L T ++K D+YS G+
Sbjct: 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGI 219
Query: 257 LLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKL 316
+ ++ F E ++++K +R+V P+ N + + ++ L
Sbjct: 220 IFFEMIYP------FSTGMERVNILKKLRSVSIEFPPD------FDDNKMKVEKKIIRLL 267
Query: 317 ACFCTLKDPDERPSSKDV 334
DP++RP ++ +
Sbjct: 268 ID----HDPNKRPGARTL 281
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-33
Identities = 56/229 (24%), Positives = 101/229 (44%), Gaps = 28/229 (12%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
F +G G + V+ + G +AI K+I M A ++++
Sbjct: 13 FKVGNLLGKGSFAGVYRAESI--HTGLEVAI-KMIDKKAMYKAGMVQR------------ 57
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDW 162
+++E+ Q +H +IL L + N LV E NG + L ++ + +
Sbjct: 58 ---VQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYL--KNRVKPFSEN 112
Query: 163 PARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFG-HGKLMPDGHA 221
ARH + I +G+ Y H ++HRD+ +N+L+ +M +I+DFG +L
Sbjct: 113 EARHFM-HQIITGMLY---LHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK 168
Query: 222 QITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDD 270
T+ C GT Y++PE + D++S G + L++G+ P D
Sbjct: 169 HYTL-C--GTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDT 214
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 7e-33
Identities = 53/229 (23%), Positives = 101/229 (44%), Gaps = 29/229 (12%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
+ + +G GG+ + F ++ ++ A K++ + + ++
Sbjct: 43 YVRGRFLGKGGFAKCFEISDA--DTKEVFAG-KIVPKSLLLKPHQREK------------ 87
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDW 162
+ EI H++++ + +V E + SL ++ + L
Sbjct: 88 ---MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELH--KRRKA--LTE 140
Query: 163 PARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFG-HGKLMPDGHA 221
P R I G +Y HR R+IHRD+K N+ +++D+E +I DFG K+ DG
Sbjct: 141 PEARYYLRQIVLGCQY---LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 197
Query: 222 QITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDD 270
+ + C GT Y+APE L + S + D++S G ++ L++GK P +
Sbjct: 198 KKVL-C--GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 243
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 8e-33
Identities = 52/229 (22%), Positives = 101/229 (44%), Gaps = 29/229 (12%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
+ + +G GG+ + ++ + ++ A K++ + + ++
Sbjct: 17 YVRGRFLGKGGFAKC-FEISDADT-KEVFAG-KIVPKSLLLKPHQREK------------ 61
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDW 162
+ EI H++++ + +V E + SL ++ + L
Sbjct: 62 ---MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELH--KRRKA--LTE 114
Query: 163 PARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFG-HGKLMPDGHA 221
P R I G +Y HR R+IHRD+K N+ +++D+E +I DFG K+ DG
Sbjct: 115 PEARYYLRQIVLGCQY---LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 171
Query: 222 QITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDD 270
+ + C GT Y+APE L + S + D++S G ++ L++GK P +
Sbjct: 172 KKVL-C--GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 217
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-32
Identities = 64/314 (20%), Positives = 117/314 (37%), Gaps = 65/314 (20%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
F+ ++ +G GG+G V ++A+ + AI K I + EL ++ +
Sbjct: 7 FEPIQCLGRGGFGVV-FEAKN-KVDDCNYAI-KRI---RLPNRELAREKV---------- 50
Query: 103 IGAIRSEIITANQTRHRNIL---------PLLAHMVRPNCHLLVY---EFMKNGSLQDIL 150
E+ + H I+ + + + +Y + + +L+D +
Sbjct: 51 ----MREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM 106
Query: 151 YDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDF 210
+ E + I IA +E+ H L+HRD+KP+N+ D ++ DF
Sbjct: 107 -NGRCTIEERERSVCLHIFLQIAEAVEF---LHSKGLMHRDLKPSNIFFTMDDVVKVGDF 162
Query: 211 GHGKLM----------PDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAV 260
G M A VGT YM+PE + + S K DI+S G++L
Sbjct: 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222
Query: 261 LVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFC 320
L+ F E + + +RN+ F + Y + ++V
Sbjct: 223 LLYP------FSTQMERVRTLTDVRNLKFPPLFTQK---------YPCEYVMVQD----M 263
Query: 321 TLKDPDERPSSKDV 334
P ERP + ++
Sbjct: 264 LSPSPMERPEAINI 277
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 4e-32
Identities = 58/313 (18%), Positives = 115/313 (36%), Gaps = 42/313 (13%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAI---RKLIVDAPMSAAELIKQDIDEYSDLL 99
+ ++ + G + ++ E + K A+ K +++ + I S
Sbjct: 33 YRIIRTLNQGKFNKI-ILCE---KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88
Query: 100 HWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDIL-----YDVS 154
++E+ ++ L + + ++YE+M+N S+ D +
Sbjct: 89 D-----FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN 143
Query: 155 QGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGK 214
+ I + + + Y+H + + HRD+KP+N+L+D + ++SDFG +
Sbjct: 144 YTCFIPIQVIK-CIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESE 200
Query: 215 LMPDGHAQITVKCMVGTMGYMAPESLQTETISD--KCDIYSFGVLLAVLVMGKFPVDDFF 272
M D +K GT +M PE E+ + K DI+S G+ L V+ P F
Sbjct: 201 YMVDKK----IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP---FS 253
Query: 273 GHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQML---------LVLKLACFCTLK 323
+++ +R +R L N + K
Sbjct: 254 LKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLR----K 309
Query: 324 DPDERPSSKDVRS 336
+P ER +S+D
Sbjct: 310 NPAERITSEDALK 322
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 4e-32
Identities = 65/305 (21%), Positives = 119/305 (39%), Gaps = 59/305 (19%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGA 105
LK+IGSGG +V ++ ++ AI K + ++ D + + +
Sbjct: 14 LKQIGSGGSSKV-FQVL--NEKKQIYAI-KYV----------NLEEADNQT------LDS 53
Query: 106 IRSEIITANQTRH--RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWP 163
R+EI N+ + I+ L + + +V E N L L + ++ +D
Sbjct: 54 YRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL----KKKKSIDPW 108
Query: 164 ARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQI 223
R + + + H+ ++H D+KPAN LI D M ++ DFG M +
Sbjct: 109 ERKSYWKNMLEAVHT---IHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSV 164
Query: 224 TVKCMVGTMGYMAPESLQ-----------TETISDKCDIYSFGVLLAVLVMGKFPVDDFF 272
VGT+ YM PE+++ IS K D++S G +L + GK P
Sbjct: 165 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 224
Query: 273 GHTEEM-DMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSS 331
++ ++ + F + P + + L C +DP +R S
Sbjct: 225 NQISKLHAIIDPNHEIEFPDIPEKDLQDVLKC----------------CLKRDPKQRISI 268
Query: 332 KDVRS 336
++ +
Sbjct: 269 PELLA 273
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 9e-32
Identities = 39/302 (12%), Positives = 75/302 (24%), Gaps = 33/302 (10%)
Query: 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAEL--IKQDIDEYSDLLHWKIG 104
+ + G V + + A++ + A S +EL + + + LL
Sbjct: 68 EPLRVGDRSVV-FLVRDVER-LEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPE 125
Query: 105 AIRS--------EIITANQTRHRNILPLLAHMVRPNCHLLVYEFMK--NGSLQDILYDVS 154
R + + L +LL+ L L V
Sbjct: 126 EARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVY 185
Query: 155 QGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGK 214
R + A H + + L+H P N+ I D + D
Sbjct: 186 VFRGDEGILALHILTAQLIRLAAN---LQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALW 242
Query: 215 LMPDGHAQITVKCMVGTMGYMAPESLQTETI--SDKCDIYSFGVLLAVLVMGKFPVDDFF 272
+ + Y E L T + + + G+ + + P F
Sbjct: 243 KVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP----F 293
Query: 273 GHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSK 332
G W R + ++ + L+ + D R
Sbjct: 294 GLVTPGIKGSWKRPSLRVPGT-DSLAFGSCTPLPDFVKTLIGRFLN----FDRRRRLLPL 348
Query: 333 DV 334
+
Sbjct: 349 EA 350
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 9e-32
Identities = 59/228 (25%), Positives = 99/228 (43%), Gaps = 29/228 (12%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
F+ + +G G +G V+ E + ++A+ K++ A + A + Q
Sbjct: 11 FEIGRPLGKGKFGNVYLAREK--QSKFILAL-KVLFKAQLEKAGVEHQ------------ 55
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDW 162
+R E+ + RH NIL L + L+ E+ G++ L + D
Sbjct: 56 ---LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSK--FDE 108
Query: 163 PARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQ 222
+A+ L Y CH R+IHRDIKP N+L+ E +I+DFG P
Sbjct: 109 QRTATYITELANALSY---CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--- 162
Query: 223 ITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDD 270
+ GT+ Y+ PE ++ +K D++S GVL ++GK P +
Sbjct: 163 -RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 209
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-31
Identities = 71/304 (23%), Positives = 124/304 (40%), Gaps = 57/304 (18%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGA 105
LK+IGSGG +V ++ ++ AI K + ++ D + + +
Sbjct: 33 LKQIGSGGSSKV-FQVL--NEKKQIYAI-KYV----------NLEEADNQT------LDS 72
Query: 106 IRSEIITANQTRHRN--ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWP 163
R+EI N+ + + I+ L + + +V E N L L + ++ +D
Sbjct: 73 YRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL----KKKKSIDPW 127
Query: 164 ARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQI 223
R + + + H+ ++H D+KPAN LI D M ++ DFG M +
Sbjct: 128 ERKSYWKNMLEAVHT---IHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSV 183
Query: 224 TVKCMVGTMGYMAPESLQ-----------TETISDKCDIYSFGVLLAVLVMGKFPVDDFF 272
VGT+ YM PE+++ IS K D++S G +L + GK P F
Sbjct: 184 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP----F 239
Query: 273 GHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSK 332
+ +I +PN I + E+ + VLK C +DP +R S
Sbjct: 240 QQIINQISK--LHAII---DPNHEIE---FPDIPEKDLQDVLK-CCLK--RDPKQRISIP 288
Query: 333 DVRS 336
++ +
Sbjct: 289 ELLA 292
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-31
Identities = 65/299 (21%), Positives = 118/299 (39%), Gaps = 44/299 (14%)
Query: 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDL 98
K D + + ++G G +G V K S G+++A++++ + + D+D
Sbjct: 5 KADDLEPIMELGRGAYGVV-EKMRHVPS-GQIMAVKRIRATVNSQEQKRLLMDLD----- 57
Query: 99 LHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRR 158
I+ + + R + E M + SL V +
Sbjct: 58 ------------ISMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQ 104
Query: 159 ELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPD 218
+ +IA I LE+LH +IHRD+KP+NVLI+ + ++ DFG + D
Sbjct: 105 TIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162
Query: 219 GHAQITVKCMVGTMGYMAPESLQTETISD----KCDIYSFGVLLAVLVMGKFPVDDFFGH 274
A+ G YMAPE + E K DI+S G+ + L + +FP D +
Sbjct: 163 DVAKDID---AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP 219
Query: 275 TEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKD 333
+++ V + +P +L + + + + C K+ ERP+ +
Sbjct: 220 FQQLKQV------VEEPSP------QLPADKFSAEFVDFTSQ---CLKKNSKERPTYPE 263
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 2e-31
Identities = 56/246 (22%), Positives = 98/246 (39%), Gaps = 42/246 (17%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGA 105
LK+IGSGG +V ++ ++ AI K + ++ D + + +
Sbjct: 61 LKQIGSGGSSKV-FQVL--NEKKQIYAI-KYVN----------LEEADNQT------LDS 100
Query: 106 IRSEIITANQTRH--RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWP 163
R+EI N+ + I+ L + + +V E N L L ++ +D
Sbjct: 101 YRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKK----KKSIDPW 155
Query: 164 ARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQI 223
R + + + H+ ++H D+KPAN LI D M ++ DFG M +
Sbjct: 156 ERKSYWKNMLEAVHT---IHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSV 211
Query: 224 TVKCMVGTMGYMAPESLQ-----------TETISDKCDIYSFGVLLAVLVMGKFPVDDFF 272
VG + YM PE+++ IS K D++S G +L + GK P
Sbjct: 212 VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 271
Query: 273 GHTEEM 278
++
Sbjct: 272 NQISKL 277
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-31
Identities = 74/332 (22%), Positives = 122/332 (36%), Gaps = 57/332 (17%)
Query: 28 LVEKQDLAFLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAEL 87
L +KQ + LK +D F+ + ++G+G G V +K S G ++A KLI +
Sbjct: 21 LTQKQKVGELKDDD-FEKISELGAGNGGVV-FKVSHKPS-GLVMAR-KLI---HLEIKPA 73
Query: 88 IKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQ 147
I+ I E+ ++ I+ + E M GSL
Sbjct: 74 IRNQI--------------IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD 119
Query: 148 DILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARI 207
+L GR + ++ + GL YL H+ ++HRD+KP+N+L++ E ++
Sbjct: 120 QVLKKA--GRIPEQILGK--VSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKL 173
Query: 208 SDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFP 267
DFG + D A VGT YM+PE LQ S + DI+S G+ L + +G++P
Sbjct: 174 CDFGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229
Query: 268 --VDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACF------ 319
D P + + +L +
Sbjct: 230 IPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPP 289
Query: 320 ------------------CTLKDPDERPSSKD 333
C +K+P ER K
Sbjct: 290 PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 321
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-31
Identities = 43/322 (13%), Positives = 91/322 (28%), Gaps = 73/322 (22%)
Query: 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAI 106
+G +A + G+ + + + IKQ +E L + I
Sbjct: 79 TVLGQEDPYAY-LEATDQET-GESFEV-HVPYFTERPPSNAIKQMKEEVLRLRLLR--GI 133
Query: 107 RSEIITANQTRHRNILPLLAHMVRPNCH--------------LLVYEFMK--NGSLQDIL 150
+++ R L+ + +Y M+ + ++L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 151 YDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDF 210
S + L AR ++ + L H L+H ++P ++++D ++ F
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLAS---LHHYGLVHTYLRPVDIVLDQRGGVFLTGF 250
Query: 211 GHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISD-----------KCDIYSFGVLLA 259
H L+ DG ++ + G+ PE D ++ G+++
Sbjct: 251 EH--LVRDGARVVS----SVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304
Query: 260 VLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPN-----RAINSKLLGNGYEEQMLLVL 314
+ P + +W IF N RA+ L
Sbjct: 305 WIWCADLP----ITKDAALGGSEW----IFRSCKNIPQPVRALLEGFLR----------- 345
Query: 315 KLACFCTLKDPDERPSSKDVRS 336
++R
Sbjct: 346 --------YPKEDRLLPLQAME 359
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-30
Identities = 65/341 (19%), Positives = 126/341 (36%), Gaps = 74/341 (21%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
F+ ++ +G GG+G V ++A+ + AI+++ + A E + +++ + L H
Sbjct: 8 FEPIQCMGRGGFGVV-FEAKNK-VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 103 IGAIRS---------------------------------------EIITANQTRHRNILP 123
I + +I + +N +
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 124 LLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCH 183
L + + + +L+D + + + + I IA +E+LH
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWM-NRRCSLEDREHGVCLHIFIQIAEAVEFLH--- 181
Query: 184 RPRLIHRDIKPANVLIDDDMEARISDFG----------HGKLMPDGHAQITVKCMVGTMG 233
L+HRD+KP+N+ D ++ DFG ++ A T VGT
Sbjct: 182 SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241
Query: 234 YMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENP 293
YM+PE + S K DI+S G++L L+ F E + ++ +RN+ F
Sbjct: 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYS------FSTQMERVRIITDVRNLKFPLLF 295
Query: 294 NRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDV 334
+ Y ++ ++V + P ERP + D+
Sbjct: 296 TQ---------KYPQEHMMVQDMLS----PSPTERPEATDI 323
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-30
Identities = 62/303 (20%), Positives = 105/303 (34%), Gaps = 58/303 (19%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
F +G G G + Y+ + + +A+ K I+ +
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMF---DNRDVAV-KRIL----------PECFS--------- 62
Query: 103 IGAIRSEI-ITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELD 161
E+ + H N++ + E +LQ+ + L+
Sbjct: 63 --FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLE 119
Query: 162 WPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI-----DDDMEARISDFGHGK-L 215
+ + SGL +LH ++HRD+KP N+LI ++A ISDFG K L
Sbjct: 120 ---PITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173
Query: 216 MPDGHAQITVKCMVGTMGYMAPESLQTETI---SDKCDIYSFGVLLA-VLVMGKFPVDDF 271
H+ + GT G++APE L + + DI+S G + V+ G P
Sbjct: 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHP---- 229
Query: 272 FGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSS 331
FG + + + + L+ K DP +RPS+
Sbjct: 230 FGKSLQRQANILLGACSLDCLHPEKHEDVIARE-------LIEK----MIAMDPQKRPSA 278
Query: 332 KDV 334
K V
Sbjct: 279 KHV 281
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-30
Identities = 63/228 (27%), Positives = 98/228 (42%), Gaps = 29/228 (12%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
FD + +G G +G V+ E N ++A+ K++ + + + Q
Sbjct: 16 FDIGRPLGKGKFGNVYLAREK--QNKFIMAL-KVLFKSQLEKEGVEHQ------------ 60
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDW 162
+R EI + RH NIL + + L+ EF G L L GR D
Sbjct: 61 ---LRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL--QKHGR--FDE 113
Query: 163 PARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQ 222
+A L Y CH ++IHRDIKP N+L+ E +I+DFG P +
Sbjct: 114 QRSATFMEELADALHY---CHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR 170
Query: 223 ITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDD 270
C GT+ Y+ PE ++ +T +K D++ GVL ++G P D
Sbjct: 171 TM--C--GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS 214
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-30
Identities = 42/315 (13%), Positives = 89/315 (28%), Gaps = 64/315 (20%)
Query: 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAI 106
+G +A G+ + + + IKQ +E L + I
Sbjct: 84 TVLGQEDPYAY-LEATDQ-ETGESFEV-HVPYFTERPPSNAIKQMKEEVLRLRLLR--GI 138
Query: 107 RSEIITANQTRHRNILPLLAHMVRPNCH--------------LLVYEFMK--NGSLQDIL 150
+++ R L+ + +Y M+ + ++L
Sbjct: 139 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 198
Query: 151 YDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDF 210
S + L AR ++ + L H L+H ++P ++++D ++ F
Sbjct: 199 LSHSSTHKSLVHHARLQLTLQVIRLLAS---LHHYGLVHTYLRPVDIVLDQRGGVFLTGF 255
Query: 211 GHGKLMPDGHAQITVKCM-VGTMGYMAPESL-----QTETISDKCDIYSFGVLLAVLVMG 264
H L+ DG + ++ A L ++ D ++ G+ + +
Sbjct: 256 EH--LVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA 313
Query: 265 KFPVDDFFGHTEEMDMVKWMRNVIFSENPN-----RAINSKLLGNGYEEQMLLVLKLACF 319
P + +W IF N RA+ L
Sbjct: 314 DLP----NTDDAALGGSEW----IFRSCKNIPQPVRALLEGFLR---------------- 349
Query: 320 CTLKDPDERPSSKDV 334
++R
Sbjct: 350 ---YPKEDRLLPLQA 361
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 4e-30
Identities = 54/299 (18%), Positives = 92/299 (30%), Gaps = 56/299 (18%)
Query: 40 EDCFDSLKKIGSGGWGEVF---YKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYS 96
+ F L ++G G +GEVF K +G++ A+ K + + +
Sbjct: 56 QQSFQRLSRLGHGSYGEVFKVRSK-----EDGRLYAV-KRSMSPFRGPKDRAR------- 102
Query: 97 DLLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQG 156
+ +H + L L E SLQ
Sbjct: 103 --------KLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGAS 153
Query: 157 RRELD-WPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKL 215
E W R L +LH L+H D+KPAN+ + ++ DFG
Sbjct: 154 LPEAQVW----GYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVE 206
Query: 216 MPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHT 275
+ A G YMAPE LQ + D++S G+ + +
Sbjct: 207 LGTAGAGEV---QEGDPRYMAPELLQ-GSYGTAADVFSLGLTILEVACNMEL---PH--- 256
Query: 276 EEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDV 334
+ + +R G ++ VL + DP R +++ +
Sbjct: 257 -GGEGWQQLRQGYLPPE---------FTAGLSSELRSVLVM---MLEPDPKLRATAEAL 302
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-30
Identities = 75/310 (24%), Positives = 124/310 (40%), Gaps = 37/310 (11%)
Query: 25 FSPLVEKQDLAFLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSA 84
F P + F KKIG G + EV Y+A +G +A++K+ + M A
Sbjct: 16 FQPQKALRPDMGYNTLANFRIEKKIGRGQFSEV-YRA-ACLLDGVPVALKKVQIFDLMDA 73
Query: 85 AELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNG 144
+ D EI Q H N++ A + N +V E G
Sbjct: 74 KA--RADC--------------IKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAG 117
Query: 145 SLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDME 204
L ++ + +R + + + S LE++H R++HRDIKPANV I
Sbjct: 118 DLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGV 174
Query: 205 ARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMG 264
++ D G G+ +VGT YM+PE + + K DI+S G LL +
Sbjct: 175 VKLGDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAAL 232
Query: 265 KFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKD 324
+ P F+G + + + + + P L + Y E++ ++ + C D
Sbjct: 233 QSP---FYGDKMNLYSL--CKKIEQCDYP------PLPSDHYSEELRQLVNM---CINPD 278
Query: 325 PDERPSSKDV 334
P++RP V
Sbjct: 279 PEKRPDVTYV 288
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-29
Identities = 45/245 (18%), Positives = 86/245 (35%), Gaps = 42/245 (17%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGA 105
+ + GG+ V Y+A+ +G+ A+++L+ + I Q++ L
Sbjct: 33 RRVLAEGGFAFV-YEAQ-DVGSGREYALKRLLSNE-EEKNRAIIQEVCFMKKLSG----- 84
Query: 106 IRSEIITANQTRHRNILPLLAH-------MVRPNCHLLVYEFMKNGSLQDILYDVSQGRR 158
H NI+ + L+ + G L + L +
Sbjct: 85 ------------HPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGP 132
Query: 159 ELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPD 218
L +I ++++H +P +IHRD+K N+L+ + ++ DFG +
Sbjct: 133 -LSCDTVLKIFYQTCRAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISH 190
Query: 219 GHAQITVKC----------MVGTMGYMAPE---SLQTETISDKCDIYSFGVLLAVLVMGK 265
T Y PE I +K DI++ G +L +L +
Sbjct: 191 YPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250
Query: 266 FPVDD 270
P +D
Sbjct: 251 HPFED 255
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-29
Identities = 61/307 (19%), Positives = 106/307 (34%), Gaps = 60/307 (19%)
Query: 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLH 100
+ L +IG G +G V K S G+++A++++ + + D+D
Sbjct: 22 EDLKDLGEIGRGAYGSV-NKMVHKPS-GQIMAVKRIRSTVDEKEQKQLLMDLD------- 72
Query: 101 WKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGR-RE 159
+ + I+ + R + E M + S V
Sbjct: 73 ----------VVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDV 121
Query: 160 LDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFG-HGKLMPD 218
+ +I L +L + +IHRDIKP+N+L+D ++ DFG G+L+
Sbjct: 122 IPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLV-- 177
Query: 219 GHAQITVKCMVGTMGYMAPESLQTETISD----KCDIYSFGVLLAVLVMGKFPVDDFFGH 274
I G YMAPE + + D++S G+ L L G+FP +
Sbjct: 178 --DSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV 235
Query: 275 TEEMDMV--------KWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPD 326
+++ V FS + +N C KD
Sbjct: 236 FDQLTQVVKGDPPQLSNSEEREFSPSFINFVNL--------------------CLTKDES 275
Query: 327 ERPSSKD 333
+RP K+
Sbjct: 276 KRPKYKE 282
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-29
Identities = 50/226 (22%), Positives = 87/226 (38%), Gaps = 33/226 (14%)
Query: 40 EDCFDSLKKIGSG--GWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSD 97
C++ L IG G V P G+ + +R++ L + +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKP--TGEYVTVRRI---------NLEACSNEMVTF 72
Query: 98 LLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGR 157
++ E+ + H NI+P A + N +V FM GS +D++
Sbjct: 73 --------LQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDG 124
Query: 158 RELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGH-GKLM 216
A I +G+ L+Y+H +HR +K +++LI D + +S ++
Sbjct: 125 MNELAIAY--ILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179
Query: 217 PDGHAQITVKCM----VGTMGYMAPESLQTETI--SDKCDIYSFGV 256
G Q V V + +++PE LQ K DIYS G+
Sbjct: 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGI 225
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 7e-29
Identities = 69/302 (22%), Positives = 124/302 (41%), Gaps = 50/302 (16%)
Query: 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLH 100
+ ++ L IG+G +G K S+GK++ K + M+ AE
Sbjct: 6 EDYEVLYTIGTGSYGRC-QKIRRK-SDGKILVW-KELDYGSMTEAEKQM----------- 51
Query: 101 WKIGAIRSEIITANQTRHRNILPLLAHMV-RPNCHL-LVYEFMKNGSLQDILYDVSQGRR 158
+ SE+ + +H NI+ ++ R N L +V E+ + G L ++ ++ R+
Sbjct: 52 -----LVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQ 106
Query: 159 ELD----WPARHRIARGIASGLEYLHMCHRP--RLIHRDIKPANVLIDDDMEARISDFGH 212
LD R+ + L+ H ++HRD+KPANV +D ++ DFG
Sbjct: 107 YLDEEFVL----RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162
Query: 213 GKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFF 272
+++ H K VGT YM+PE + + ++K DI+S G LL L P F
Sbjct: 163 ARIL--NHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP---FT 217
Query: 273 GHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSK 332
+++ K I R + Y +++ ++ RPS +
Sbjct: 218 AFSQKELAGK-----IREGKFRR------IPYRYSDELNEIITR---MLNLKDYHRPSVE 263
Query: 333 DV 334
++
Sbjct: 264 EI 265
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 2e-28
Identities = 57/250 (22%), Positives = 96/250 (38%), Gaps = 44/250 (17%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGA 105
+++G+GG+G V G+ +AI K EL ++ +
Sbjct: 19 KERLGTGGFGYVLRWIHQ--DTGEQVAI-KQC------RQELSPKNRE-----------R 58
Query: 106 IRSEIITANQTRHRNILPLLA------HMVRPNCHLLVYEFMKNGSLQDILYDVSQGR-- 157
EI + H N++ + + LL E+ + G L+ L
Sbjct: 59 WCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYL--NQFENCC 116
Query: 158 --RELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEAR---ISDFGH 212
+E R + I+S L Y H R+IHRD+KP N+++ + I D G+
Sbjct: 117 GLKEGP--IRT-LLSDISSALRY---LHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170
Query: 213 GKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFF 272
K + G VGT+ Y+APE L+ + + D +SFG L + G P +
Sbjct: 171 AKELDQGELCTE---FVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW 227
Query: 273 GHTEEMDMVK 282
+ V+
Sbjct: 228 QPVQWHGKVR 237
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-28
Identities = 57/326 (17%), Positives = 110/326 (33%), Gaps = 54/326 (16%)
Query: 13 VRGGSRDRGPTIFSPLVEKQDLAFLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIA 72
+ + D + + ++ D + ++ ++G G +GEV ++ G A
Sbjct: 30 LGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEV-HRM-KDKQTGFQCA 87
Query: 73 IRKLIVDAPMSAAELIKQ-DIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLLAHMVRP 131
+ K+ ++ + E++ I+PL +
Sbjct: 88 V---------------KKVRLEVFRV----------EELVACAGLSSPRIVPLYGAVREG 122
Query: 132 NCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRD 191
+ E ++ GSL ++ + L GLEYLH R++H D
Sbjct: 123 PWVNIFMELLEGGSLGQLI----KQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGD 175
Query: 192 IKPANVLIDDD-MEARISDFGHGKLMPDGHAQITV---KCMVGTMGYMAPESLQTETISD 247
+K NVL+ D A + DFGH + ++ + GT +MAPE + +
Sbjct: 176 VKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDA 235
Query: 248 KCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYE 307
K DI+S ++ ++ G P + + P R I
Sbjct: 236 KVDIWSSCCMMLHMLNGCHP----WTQYFRG---PLCLKIASEPPPIREIPPSC-----A 283
Query: 308 EQMLLVLKLACFCTLKDPDERPSSKD 333
++ K+P R S+ +
Sbjct: 284 PLTAQAIQE-GLR--KEPVHRASAME 306
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 5e-28
Identities = 61/302 (20%), Positives = 108/302 (35%), Gaps = 59/302 (19%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
++L ++GSG G+V +K + G +IA++++ + I D+D
Sbjct: 27 LENLGEMGSGTCGQV-WKMRFRKT-GHVIAVKQMRRSGNKEENKRILMDLD--------- 75
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDW 162
+ I+ + + E M + + L QG
Sbjct: 76 --------VVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCA--EKLKKRMQGPIPERI 125
Query: 163 PARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQ 222
+ + I L YL H +IHRD+KP+N+L+D+ + ++ DFG + D A+
Sbjct: 126 LGK--MTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK 181
Query: 223 ITVKCMVGTMGYMAPESLQTETISD-----KCDIYSFGVLLAVLVMGKFPVDDFFGHTEE 277
G YMAPE + + + D++S G+ L L G+FP + E
Sbjct: 182 DR---SAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV 238
Query: 278 MDMV------KWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSS 331
+ V ++ FS + + C KD +RP
Sbjct: 239 LTKVLQEEPPLLPGHMGFSGDFQSFVKD--------------------CLTKDHRKRPKY 278
Query: 332 KD 333
Sbjct: 279 NK 280
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 5e-28
Identities = 57/294 (19%), Positives = 109/294 (37%), Gaps = 43/294 (14%)
Query: 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLH 100
+ + L+KIG G +G+ + +G+ I K I + MS+ E +
Sbjct: 24 EKYVRLQKIGEGSFGKA-ILVK-STEDGRQYVI-KEINISRMSSKEREE----------- 69
Query: 101 WKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRREL 160
R E+ +H NI+ +V ++ + G L + Q
Sbjct: 70 -----SRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINA--QKGVLF 122
Query: 161 DWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGH 220
I L++ H +++HRDIK N+ + D ++ DFG +++
Sbjct: 123 QEDQILDWFVQICLALKH---VHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179
Query: 221 AQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDM 280
+ +GT Y++PE + + ++K DI++ G +L L K F M
Sbjct: 180 EL--ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA---FEAG----SM 230
Query: 281 VKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDV 334
+ +I P + Y + ++ F ++P +RPS +
Sbjct: 231 KNLVLKIISGSFPP-------VSLHYSYDLRSLVS-QLFK--RNPRDRPSVNSI 274
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 5e-28
Identities = 50/171 (29%), Positives = 81/171 (47%), Gaps = 17/171 (9%)
Query: 106 IRSEIITANQTRHRNILPLLAHMVRPN-CHL-LVYEFMKNGSLQDILYDVSQGR-RELDW 162
+ EI + H N++ L+ + PN HL +V+E + G + ++ + E
Sbjct: 83 VYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV---PTLKPLSEDQ- 138
Query: 163 PARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQ 222
AR + + G+EY H ++IHRDIKP+N+L+ +D +I+DFG A
Sbjct: 139 -AR-FYFQDLIKGIEY---LHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL 193
Query: 223 ITVKCMVGTMGYMAPESLQTETIS---DKCDIYSFGVLLAVLVMGKFPVDD 270
++ GT +MAPESL D+++ GV L V G+ P D
Sbjct: 194 LSNTV--GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 9e-28
Identities = 75/302 (24%), Positives = 130/302 (43%), Gaps = 62/302 (20%)
Query: 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLL 99
+ + +KIG G G V Y A + + G+ +AIR++ + + +
Sbjct: 19 KKKYTRFEKIGQGASGTV-YTA-MDVATGQEVAIRQMNLQQ--------QPKKEL----- 63
Query: 100 HWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRE 159
I +EI+ + ++ NI+ L + + +V E++ GSL D+ V++ +
Sbjct: 64 ------IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV---VTETCMD 114
Query: 160 LDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGH-GKLMPD 218
A + R LE+LH IHRDIK N+L+ D +++DFG ++ P+
Sbjct: 115 EGQIAA--VCRECLQALEFLHSNQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169
Query: 219 GHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEM 278
+ T MVGT +MAPE + + K DI+S G++ ++ G+ P
Sbjct: 170 QSKRST---MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP----------- 215
Query: 279 DMVKWMRNVIFSENPNRAINSKLLG-NG---YEEQMLLVLKLACF---CTLKDPDERPSS 331
+ENP RA+ L+ NG + L F C D ++R S+
Sbjct: 216 ---------YLNENPLRAL--YLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSA 264
Query: 332 KD 333
K+
Sbjct: 265 KE 266
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-27
Identities = 76/305 (24%), Positives = 127/305 (41%), Gaps = 68/305 (22%)
Query: 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLL 99
E+ FD L+K+G G +G V+ G+++AI+++ V+ D+ E
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHK--ETGQIVAIKQVPVE----------SDLQE----- 70
Query: 100 HWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRE 159
I EI Q +++ + +V E+ GS+ DI+ ++ E
Sbjct: 71 ------IIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTE 124
Query: 160 LDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDG 219
D A I + GLEYLH + IHRDIK N+L++ + A+++DFG
Sbjct: 125 -DEIAT--ILQSTLKGLEYLHFMRK---IHRDIKAGNILLNTEGHAKLADFGVA------ 172
Query: 220 HAQITV-----KCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGH 274
Q+T ++GT +MAPE +Q + DI+S G+ + GK P D H
Sbjct: 173 -GQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADI--H 229
Query: 275 TEEMDMVKWMRNVIF---SENPNRAINSKLLGNGYEEQMLLVLKLACF---CTLKDPDER 328
MR IF + P +L + + + F C +K P++R
Sbjct: 230 P--------MR-AIFMIPTNPPPTFRKPELWSDNFTD----------FVKQCLVKSPEQR 270
Query: 329 PSSKD 333
++
Sbjct: 271 ATATQ 275
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-27
Identities = 74/317 (23%), Positives = 126/317 (39%), Gaps = 49/317 (15%)
Query: 30 EKQDLAFLKKEDCFDSLKKIGSGGWGEVFYKA-ELPGSNGKMIAIRKLIVDAPMSAAELI 88
+ L + D ++ + IGSG V A P + +AI K I
Sbjct: 4 DSSALPWSINRDDYELQEVIGSGATAVV-QAAYCAP--KKEKVAI-KRI----------- 48
Query: 89 KQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQD 148
++++ + + EI +Q H NI+ V + LV + + GS+ D
Sbjct: 49 --NLEKCQT----SMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLD 102
Query: 149 ILYDVSQGRRELDWPARHR----IARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDME 204
I+ + I R + GLEYLH + IHRD+K N+L+ +D
Sbjct: 103 IIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGS 159
Query: 205 ARISDFG-HGKLMPDGHAQITVK--CMVGTMGYMAPESLQTETISD-KCDIYSFGVLLAV 260
+I+DFG L G VGT +MAPE ++ D K DI+SFG+
Sbjct: 160 VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIE 219
Query: 261 LVMGKFPVDDFFGHTEEMDMVKWMRNVIF--SENPNRAINSKLLGNGYEEQMLLVLK--L 316
L G P + M+ V+ +N ++ + + ++ + +
Sbjct: 220 LATGAAPYHKY--PP--------MK-VLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMI 268
Query: 317 ACFCTLKDPDERPSSKD 333
+ C KDP++RP++ +
Sbjct: 269 SL-CLQKDPEKRPTAAE 284
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 2e-27
Identities = 74/318 (23%), Positives = 133/318 (41%), Gaps = 81/318 (25%)
Query: 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLL 99
F+ ++ +G+G +G+V YK G++ AI K++ ++ + +E
Sbjct: 23 AGIFELVELVGNGTYGQV-YKG-RHVKTGQLAAI-KVM--------DVTGDEEEE----- 66
Query: 100 HWKIGAIRSEI-ITANQTRHRNILPLLAHMVRPNCHL------LVYEFMKNGSLQDILYD 152
I+ EI + + HRNI ++ N LV EF GS+ D++ +
Sbjct: 67 ------IKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN 120
Query: 153 VSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGH 212
+ +W A I R I GL +LH + ++IHRDIK NVL+ ++ E ++ DFG
Sbjct: 121 TKGNTLKEEWIAY--ICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGV 175
Query: 213 GKLMPDGHAQITV-----KCMVGTMGYMAPESLQTETISD-----KCDIYSFGVLLAVLV 262
AQ+ +GT +MAPE + + D K D++S G+ +
Sbjct: 176 S-------AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMA 228
Query: 263 MGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAI-----NS--KLLGNGYEEQMLLVLK 315
G P+ D +P RA+ N +L + ++ ++
Sbjct: 229 EGAPPLCD--------------------MHPMRALFLIPRNPAPRLKSKKWSKKFQSFIE 268
Query: 316 LACFCTLKDPDERPSSKD 333
C +K+ +RP+++
Sbjct: 269 S---CLVKNHSQRPATEQ 283
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-27
Identities = 55/220 (25%), Positives = 85/220 (38%), Gaps = 40/220 (18%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGA 105
++IG G +GEV + L N +A+ K + D + L
Sbjct: 119 GEQIGRGNFGEV-FSGRLRADNTL-VAV-KSCRETLPP---------DLKAKFLQ----- 161
Query: 106 IRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPAR 165
E Q H NI+ L+ + +V E ++ G L L
Sbjct: 162 ---EARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL---RTEGARLRVKTL 215
Query: 166 HRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPD------- 218
++ A+G+EYL IHRD+ N L+ + +ISDFG + D
Sbjct: 216 LQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASG 272
Query: 219 GHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
G Q+ VK + APE+L S + D++SFG+LL
Sbjct: 273 GLRQVPVK-------WTAPEALNYGRYSSESDVWSFGILL 305
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-27
Identities = 73/308 (23%), Positives = 131/308 (42%), Gaps = 74/308 (24%)
Query: 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLL 99
DS KIG G G V A +G+ +A++ + + +Q +
Sbjct: 44 RLLLDSYVKIGEGSTGIV-CLA-REKHSGRQVAVKMMDLRK--------QQRREL----- 88
Query: 100 HWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRE 159
+ +E++ +H N++ + + ++ EF++ G+L DI VSQ R
Sbjct: 89 ------LFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDI---VSQVRLN 139
Query: 160 LDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDG 219
+ A + + L YLH IHRDIK ++L+ D ++SDFG
Sbjct: 140 EEQIAT--VCEAVLQALAYLHAQGV---IHRDIKSDSILLTLDGRVKLSDFGFC------ 188
Query: 220 HAQITV-----KCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGH 274
AQI+ K +VGT +MAPE + + + DI+S G+++ +V G+ P
Sbjct: 189 -AQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP------- 240
Query: 275 TEEMDMVKWMRNVIFSENPNRAI-----NS--KLLGNGYEEQMLLVLK--LACFCTLKDP 325
FS++P +A+ + KL + ++ VL+ L ++DP
Sbjct: 241 -------------YFSDSPVQAMKRLRDSPPPKLKNS---HKVSPVLRDFLER-MLVRDP 283
Query: 326 DERPSSKD 333
ER ++++
Sbjct: 284 QERATAQE 291
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-27
Identities = 50/287 (17%), Positives = 91/287 (31%), Gaps = 52/287 (18%)
Query: 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLL 99
+ +G G V ++ G + AI K+ D+
Sbjct: 8 NHLWLLSDILGQGATANV-FRGRHK-KTGDLFAI-KVF----------NNISFLRPVDVQ 54
Query: 100 HWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHL--LVYEFMKNGSLQDILYDVSQGR 157
E + H+NI+ L A L+ EF GSL +L
Sbjct: 55 -------MREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVL--EEPSN 105
Query: 158 ----RELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI----DDDMEARISD 209
E + + R + G+ + ++HR+IKP N++ D +++D
Sbjct: 106 AYGLPESE--FL-IVLRDVVGGMNH---LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTD 159
Query: 210 FGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISD--------KCDIYSFGVLLAVL 261
FG + + D ++ + GT Y+ P+ + + D++S GV
Sbjct: 160 FGAARELEDDEQFVS---LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHA 216
Query: 262 VMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEE 308
G P F + M +I + + NG +
Sbjct: 217 ATGSLP---FRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPID 260
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 3e-27
Identities = 62/309 (20%), Positives = 124/309 (40%), Gaps = 73/309 (23%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
F ++ IGSGG+G+V +KA+ +GK I++ +K + ++
Sbjct: 13 FKEIELIGSGGFGQV-FKAKHR-IDGKTYVIKR------------VKYNNEK-------- 50
Query: 103 IGAIRSEIITANQTRHRNI---------------LPLLAHMVRPNCHL-LVYEFMKNGSL 146
E+ + H NI L + EF G+L
Sbjct: 51 ---AEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTL 107
Query: 147 QDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEAR 206
+ + + +LD + I G++Y H +LI+RD+KP+N+ + D + +
Sbjct: 108 EQWIEK--RRGEKLDKVLALELFEQITKGVDY---IHSKKLINRDLKPSNIFLVDTKQVK 162
Query: 207 ISDFGHGK-LMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGK 265
I DFG L DG GT+ YM+PE + ++ + D+Y+ G++LA L+
Sbjct: 163 IGDFGLVTSLKNDGKR----TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVC 218
Query: 266 FPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDP 325
+ K+ + + ++ + ++++ +L+ K P
Sbjct: 219 DTA---------FETSKFFTD----------LRDGIISDIFDKKEKTLLQ-KLLS--KKP 256
Query: 326 DERPSSKDV 334
++RP++ ++
Sbjct: 257 EDRPNTSEI 265
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-27
Identities = 59/315 (18%), Positives = 104/315 (33%), Gaps = 67/315 (21%)
Query: 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLL 99
F L+KIGSG +G V +K + +G + AI K + +
Sbjct: 10 TTEFHELEKIGSGEFGSV-FKC-VKRLDGCIYAI-KRSKKPLAGSVDEQN---------- 56
Query: 100 HWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRE 159
A+R A +H +++ + + L+ E+ GSL D + + +
Sbjct: 57 -----ALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSY 111
Query: 160 LDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDD----------------- 202
+ + GL Y+H L+H DIKP+N+ I
Sbjct: 112 FKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS 168
Query: 203 --MEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQ-TETISDKCDIYSFGVLLA 259
+ +I D GH + G ++A E LQ T K DI++ + +
Sbjct: 169 NKVMFKIGDLGHVTRISSPQV------EEGDSRFLANEVLQENYTHLPKADIFALALTVV 222
Query: 260 VLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACF 319
+ + D +R P ++ +LK+
Sbjct: 223 CAAGAEPLPRN-------GDQWHEIRQGRLPRIP----------QVLSQEFTELLKV--- 262
Query: 320 CTLKDPDERPSSKDV 334
DP+ RPS+ +
Sbjct: 263 MIHPDPERRPSAMAL 277
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-27
Identities = 50/283 (17%), Positives = 92/283 (32%), Gaps = 44/283 (15%)
Query: 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLL 99
+ +G G V ++ G + AI K+ D+
Sbjct: 8 NHLWLLSDILGQGATANV-FRGRHK-KTGDLFAI-KVF----------NNISFLRPVDVQ 54
Query: 100 HWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHL--LVYEFMKNGSLQDILYDVSQGR 157
E + H+NI+ L A L+ EF GSL +L + S
Sbjct: 55 -------MREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAY 107
Query: 158 RELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI----DDDMEARISDFGHG 213
+ + R + G+ + ++HR+IKP N++ D +++DFG
Sbjct: 108 GLPESEFLI-VLRDVVGGMNH---LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163
Query: 214 KLMPDGHAQITVKCMVGTMGYMAPESLQTETISD--------KCDIYSFGVLLAVLVMGK 265
+ + D ++ + GT Y+ P+ + + D++S GV G
Sbjct: 164 RELEDDEQFVS---LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
Query: 266 FPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEE 308
P F + M +I + + NG +
Sbjct: 221 LP---FRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPID 260
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 5e-27
Identities = 37/279 (13%), Positives = 82/279 (29%), Gaps = 46/279 (16%)
Query: 40 EDCFDSLKKIGSGGWGEVFYKAELPGSN----GKMIAIRKLIVDAPMSAAELIKQDIDEY 95
+G G + +V Y+A N + + K+ A
Sbjct: 64 SKLVYVHHLLGEGAFAQV-YEATQGDLNDAKNKQKFVL-KVQKPANP------------- 108
Query: 96 SDLLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDV-S 154
W+ + + + + + N +LV E G+L + + +
Sbjct: 109 -----WEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKN 163
Query: 155 QGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEA--------- 205
+ + A + +E +H C +IH DIKP N ++ +
Sbjct: 164 TPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSA 220
Query: 206 --RISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM 263
+ D G M T G+ E L + + + D + + ++
Sbjct: 221 GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLF 280
Query: 264 GKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLL 302
G + + + + +F P+ + ++
Sbjct: 281 GTYM---KVKN----EGGECKPEGLFRRLPHLDMWNEFF 312
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-26
Identities = 85/298 (28%), Positives = 133/298 (44%), Gaps = 55/298 (18%)
Query: 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLL 99
E+ F L+KIG G +GEV +K + K++AI K+I D++E D
Sbjct: 21 EELFTKLEKIGKGSFGEV-FKG-IDNRTQKVVAI-KII-------------DLEEAED-- 62
Query: 100 HWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRE 159
+I I+ EI +Q + ++ ++ E++ GS D+L G +
Sbjct: 63 --EIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLD 117
Query: 160 LDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFG-HGKLMPD 218
A I R I GL+YLH + IHRDIK ANVL+ + E +++DFG G+L
Sbjct: 118 ETQIAT--ILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172
Query: 219 GHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEM 278
+ T VGT +MAPE ++ K DI+S G+ L G+ P + H
Sbjct: 173 QIKRNT---FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL--HP--- 224
Query: 279 DMVKWMRNVIF---SENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKD 333
M+ V+F NP L Y + + ++ C K+P RP++K+
Sbjct: 225 -----MK-VLFLIPKNNPPT------LEGNYSKPLKEFVEA---CLNKEPSFRPTAKE 267
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 66/322 (20%), Positives = 120/322 (37%), Gaps = 69/322 (21%)
Query: 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLL 99
++ S K +G G G V ++ G+ +A++++++D
Sbjct: 14 KNLVVSEKILGYGSSGTVVFQGSF---QGRPVAVKRMLID-------------------- 50
Query: 100 HWKIGAIRSEI-ITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDIL---YDVSQ 155
EI + H N++ + E N +LQD++ +
Sbjct: 51 --FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDE 107
Query: 156 GRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID-------------DD 202
+ + R IASG+ + H ++IHRD+KP N+L+ ++
Sbjct: 108 NLKLQKEYNPISLLRQIASGVAH---LHSLKIIHRDLKPQNILVSTSSRFTADQQTGAEN 164
Query: 203 MEARISDFGHGKLMPDGHA--QITVKCMVGTMGYMAPESLQTETISD-------KCDIYS 253
+ ISDFG K + G + + + GT G+ APE L+ DI+S
Sbjct: 165 LRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFS 224
Query: 254 FGVLL-AVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLL 312
G + +L GK P F + IFS + + ++ + L E L
Sbjct: 225 MGCVFYYILSKGKHP---FGDKYSRESNII---RGIFSLDEMKCLHDRSLI---AEATDL 275
Query: 313 VLKLACFCTLKDPDERPSSKDV 334
+ ++ DP +RP++ V
Sbjct: 276 ISQMID----HDPLKRPTAMKV 293
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 59/215 (27%), Positives = 94/215 (43%), Gaps = 32/215 (14%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGA 105
K+G G +GEV Y+ + +A++ L D M E +K
Sbjct: 225 KHKLGGGQYGEV-YEGVWKKYSLT-VAVKTLKEDT-MEVEEFLK---------------- 265
Query: 106 IRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPAR 165
E + +H N++ LL R ++ EFM G+L D L R+E+
Sbjct: 266 ---EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVL 320
Query: 166 HRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDG--HAQI 223
+A I+S +EYL + IHR++ N L+ ++ +++DFG +LM A
Sbjct: 321 LYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 377
Query: 224 TVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
K + + APESL S K D+++FGVLL
Sbjct: 378 GAKFPI---KWTAPESLAYNKFSIKSDVWAFGVLL 409
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 48/237 (20%), Positives = 93/237 (39%), Gaps = 42/237 (17%)
Query: 31 KQDLAFLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKM-IAIRKLIVDAPMSAAELIK 89
K FLK+++ + ++G G +G V + ++ +AI+ L + E
Sbjct: 326 KDKKLFLKRDNLLIADIELGCGNFGSV-RQGVYRMRKKQIDVAIKVLKQGTEKADTE--- 381
Query: 90 QDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDI 149
+++ E +Q + I+ L+ + + +LV E G L
Sbjct: 382 -------EMM--------REAQIMHQLDNPYIVRLIG-VCQAEALMLVMEMAGGGPLHKF 425
Query: 150 LYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISD 209
L R E+ + ++ G++YL +HR++ NVL+ + A+ISD
Sbjct: 426 L---VGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISD 479
Query: 210 FGHGKLMPD--------GHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
FG K + + +K + APE + S + D++S+GV +
Sbjct: 480 FGLSKALGADDSYYTARSAGKWPLK-------WYAPECINFRKFSSRSDVWSYGVTM 529
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-26
Identities = 55/233 (23%), Positives = 91/233 (39%), Gaps = 46/233 (19%)
Query: 39 KEDCFDSLKKIGSGGWGEVFYKAE---LPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEY 95
+E + ++G G +G V L + G ++A+++L P + +
Sbjct: 21 EERHLKYISQLGKGNFGSV-ELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQR------ 73
Query: 96 SDLLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCH--LLVYEFMKNGSLQDILYDV 153
EI I+ P LV E++ +G L+D L
Sbjct: 74 -------------EIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--- 117
Query: 154 SQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHG 213
+ R LD + I G+EYL R +HRD+ N+L++ + +I+DFG
Sbjct: 118 QRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLA 174
Query: 214 KLMPD--------GHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
KL+P Q + + APESL S + D++SFGV+L
Sbjct: 175 KLLPLDKDYYVVREPGQSPIF-------WYAPESLSDNIFSRQSDVWSFGVVL 220
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 58/224 (25%), Positives = 99/224 (44%), Gaps = 42/224 (18%)
Query: 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLH 100
+ K+G G +GEV + G+ +AI+ L MS ++
Sbjct: 267 ESLRLEVKLGQGCFGEV-WMGTWNGT--TRVAIKTLKPGT-MSPEAFLQ----------- 311
Query: 101 WKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRREL 160
E + RH ++ L A +V +V E+M GSL D L + + L
Sbjct: 312 --------EAQVMKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLK--GETGKYL 360
Query: 161 DWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDG- 219
P +A IASG+ Y+ R +HRD++ AN+L+ +++ +++DFG +L+ D
Sbjct: 361 RLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417
Query: 220 -----HAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
A+ +K + APE+ + K D++SFG+LL
Sbjct: 418 YTARQGAKFPIK-------WTAPEAALYGRFTIKSDVWSFGILL 454
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 71/304 (23%), Positives = 135/304 (44%), Gaps = 48/304 (15%)
Query: 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNG----KMIAIRKLIVDAPMSAAELIKQDIDEY 95
+ + ++K+GSG +GEV + + K+I + + I++ +E
Sbjct: 35 GESYFKVRKLGSGAYGEV-LLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEE- 92
Query: 96 SDLLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQ 155
I +EI H NI+ L LV EF + G L + + +++
Sbjct: 93 ----------IYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI--INR 140
Query: 156 GR-RELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI---DDDMEARISDFG 211
+ E D A + I + I SG+ Y H+ ++HRDIKP N+L+ + + +I DFG
Sbjct: 141 HKFDECD--AAN-IMKQILSGICY---LHKHNIVHRDIKPENILLENKNSLLNIKIVDFG 194
Query: 212 HGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDF 271
+ ++ +GT Y+APE L+ + ++KCD++S GV++ +L+ G P F
Sbjct: 195 LSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPP---F 247
Query: 272 FGHTEEMDMVKWMRNVI-FSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPS 330
G ++ + K + F N + I+ +E L+ + D ++R +
Sbjct: 248 GGQNDQDIIKKVEKGKYYFDFNDWKNIS--------DEAKELIKLMLT----YDYNKRCT 295
Query: 331 SKDV 334
+++
Sbjct: 296 AEEA 299
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-26
Identities = 47/228 (20%), Positives = 85/228 (37%), Gaps = 49/228 (21%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGK---MIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
++ +G G +G+V +A++ L ++ + DL
Sbjct: 26 IRDLGEGHFGKV-ELCRYDPEGDNTGEQVAVKSLKPESGGNHIA----------DLK--- 71
Query: 103 IGAIRSEIITANQTRHRNILPLLA----HMVRPNCHLLVYEFMKNGSLQDILYDVSQGRR 158
EI H NI+ L+ EF+ +GSL++ L + +
Sbjct: 72 -----KEIEILRNLYHENIVKYKGICTEDGGNGIK--LIMEFLPSGSLKEYL---PKNKN 121
Query: 159 ELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPD 218
+++ + + A I G++YL + +HRD+ NVL++ + + +I DFG K +
Sbjct: 122 KINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 178
Query: 219 G--------HAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
V + APE L D++SFGV L
Sbjct: 179 DKEYYTVKDDRDSPVF-------WYAPECLMQSKFYIASDVWSFGVTL 219
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 7e-26
Identities = 55/228 (24%), Positives = 92/228 (40%), Gaps = 50/228 (21%)
Query: 46 LKKIGSGGWGEVFYKAE---LPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
L+++G G +G V L + G+++A++KL + D
Sbjct: 15 LQQLGKGNFGSV-EMCRYDPLQDNTGEVVAVKKLQHSTE-----------EHLRDFE--- 59
Query: 103 IGAIRSEIITANQTRHRNILPLLA----HMVRPNCHLLVYEFMKNGSLQDILYDVSQGRR 158
EI +H NI+ R L+ E++ GSL+D L + +
Sbjct: 60 -----REIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYL---QKHKE 109
Query: 159 ELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPD 218
+D + I G+EYL R IHRD+ N+L++++ +I DFG K++P
Sbjct: 110 RIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166
Query: 219 --------GHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
+ + + APESL S D++SFGV+L
Sbjct: 167 DKEFFKVKEPGESPIF-------WYAPESLTESKFSVASDVWSFGVVL 207
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-26
Identities = 60/222 (27%), Positives = 95/222 (42%), Gaps = 40/222 (18%)
Query: 46 LKKIGSGGWGEVFY-KAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIG 104
K IGSG GEV Y + +PG +AI+ L D L
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRR----------DFL----- 98
Query: 105 AIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPA 164
SE Q H NI+ L + R ++V E+M+NGSL L +
Sbjct: 99 ---SEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL---RTHDGQFTIMQ 152
Query: 165 RHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPD------ 218
+ RG+ +G+ YL +HRD+ NVL+D ++ ++SDFG +++ D
Sbjct: 153 LVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAY 209
Query: 219 --GHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
+I ++ + APE++ T S D++SFGV++
Sbjct: 210 TTTGGKIPIR-------WTAPEAIAFRTFSSASDVWSFGVVM 244
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 8e-26
Identities = 54/221 (24%), Positives = 87/221 (39%), Gaps = 42/221 (19%)
Query: 47 KKIGSGGWGEVFYKAELPGSNGKM-IAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGA 105
K++GSG +G V K +A++ L +A D +LL
Sbjct: 23 KELGSGNFGTV-KKGYYQMKKVVKTVAVKILKNEAN---------DPALKDELL------ 66
Query: 106 IRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPAR 165
+E Q + I+ ++ + +LV E + G L L Q R +
Sbjct: 67 --AEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYL----QQNRHVKDKNI 119
Query: 166 HRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDG------ 219
+ ++ G++YL +HRD+ NVL+ A+ISDFG K +
Sbjct: 120 IELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 176
Query: 220 --HAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
H + VK + APE + S K D++SFGVL+
Sbjct: 177 QTHGKWPVK-------WYAPECINYYKFSSKSDVWSFGVLM 210
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 8e-26
Identities = 69/308 (22%), Positives = 121/308 (39%), Gaps = 67/308 (21%)
Query: 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLL 99
+ ++ + ++G G +G+V YKA G + A K+I E ++
Sbjct: 18 NEVWEIVGELGDGAFGKV-YKA-KNKETGALAAA-KVI--------ETKSEE-------- 58
Query: 100 HWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRE 159
++ EI H I+ LL ++ EF G++ I+ ++ +G E
Sbjct: 59 --ELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTE 116
Query: 160 LDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFG-HGKLMPD 218
+ R + L +LH IHRD+K NVL+ + + R++DFG K +
Sbjct: 117 -PQIQV--VCRQMLEALNFLHSKRI---IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT 170
Query: 219 GHAQITVKCMVGTMGYMAPESLQTETISD-----KCDIYSFGVLLAVLVMGKFPVDDFFG 273
+ + +GT +MAPE + ET+ D K DI+S G+ L + + P
Sbjct: 171 LQKRDS---FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP------ 221
Query: 274 HTEEMDMVKWMRNVIFSENPNRAI-----NS--KLL-GNGYEEQMLLVLKLACFCTLKDP 325
NP R + + LL + + + LK+ K+P
Sbjct: 222 --------------HHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKI---ALDKNP 264
Query: 326 DERPSSKD 333
+ RPS+
Sbjct: 265 ETRPSAAQ 272
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 8e-26
Identities = 74/305 (24%), Positives = 117/305 (38%), Gaps = 66/305 (21%)
Query: 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLL 99
E F L++IG G +G V Y A N +++AI+K+ KQ +++ D
Sbjct: 53 EKLFSDLREIGHGSFGAV-YFA-RDVRNSEVVAIKKMSYSG--------KQSNEKWQD-- 100
Query: 100 HWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRE 159
I E+ + RH N + +R + LV E+ GS D+L + +E
Sbjct: 101 ------IIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQE 153
Query: 160 LDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDG 219
A + G GL YLH + IHRD+K N+L+ + ++ DFG
Sbjct: 154 -VEIAA--VTHGALQGLAYLHSHNM---IHRDVKAGNILLSEPGLVKLGDFGSA------ 201
Query: 220 HAQITVK-CMVGTMGYMAPESLQTETISD---KCDIYSFGVLLAVLVMGKFPVDDFFGHT 275
+ + VGT +MAPE + K D++S G+ L K P
Sbjct: 202 -SIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP-------- 252
Query: 276 EEMDMVKWMRNVIFSENPNRAI-----NS--KLLGNGYEEQMLLVLKLACFCTLKDPDER 328
+F+ N A+ N L + E + C K P +R
Sbjct: 253 ------------LFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS---CLQKIPQDR 297
Query: 329 PSSKD 333
P+S+
Sbjct: 298 PTSEV 302
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 9e-26
Identities = 45/220 (20%), Positives = 85/220 (38%), Gaps = 42/220 (19%)
Query: 48 KIGSGGWGEVFYKAELPGSNGKM-IAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAI 106
++G G +G V + ++ +AI+ L + E +++
Sbjct: 17 ELGCGNFGSV-RQGVYRMRKKQIDVAIKVLKQGTEKADTE----------EMM------- 58
Query: 107 RSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARH 166
E +Q + I+ L+ + + +LV E G L L R E+
Sbjct: 59 -REAQIMHQLDNPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFL---VGKREEIPVSNVA 113
Query: 167 RIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPD-------- 218
+ ++ G++YL +HRD+ NVL+ + A+ISDFG K +
Sbjct: 114 ELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 170
Query: 219 GHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
+ +K + APE + S + D++S+GV +
Sbjct: 171 SAGKWPLK-------WYAPECINFRKFSSRSDVWSYGVTM 203
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 9e-26
Identities = 54/226 (23%), Positives = 91/226 (40%), Gaps = 46/226 (20%)
Query: 46 LKKIGSGGWGEVFYKAE---LPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
L+++G G +G V L + G+++A++KL + D
Sbjct: 46 LQQLGKGNFGSV-EMCRYDPLQDNTGEVVAVKKLQHSTE-----------EHLRDFE--- 90
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCH--LLVYEFMKNGSLQDILYDVSQGRREL 160
EI +H NI+ L+ E++ GSL+D L + + +
Sbjct: 91 -----REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERI 142
Query: 161 DWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPD-- 218
D + I G+EYL R IHRD+ N+L++++ +I DFG K++P
Sbjct: 143 DHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 199
Query: 219 ------GHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
+ + + APESL S D++SFGV+L
Sbjct: 200 EYYKVKEPGESPIF-------WYAPESLTESKFSVASDVWSFGVVL 238
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 1e-25
Identities = 57/231 (24%), Positives = 95/231 (41%), Gaps = 25/231 (10%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
+ ++ +GSG +G V+ + K + ++ + K+ + E + K
Sbjct: 26 YSTMSPLGSGAFGFVWTAVDKE--KNKEVVVK--FIK---------KEKVLEDCWIEDPK 72
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGS-LQDILYDVSQGRRELD 161
+G + EI ++ H NI+ +L LV E +G L + R LD
Sbjct: 73 LGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFA--FIDRHPR--LD 128
Query: 162 WPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHA 221
P I R + S + Y +IHRDIK N++I +D ++ DFG + G
Sbjct: 129 EPLASYIFRQLVSAVGY---LRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL 185
Query: 222 QITVKCMVGTMGYMAPESLQTET-ISDKCDIYSFGVLLAVLVMGKFPVDDF 271
T GT+ Y APE L + +++S GV L LV + P +
Sbjct: 186 FYTF---CGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCEL 233
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 30/218 (13%)
Query: 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLH 100
+ K+G G +GEV + G+ +AI+ L MS ++
Sbjct: 184 ESLRLEVKLGQGCFGEV-WMGTWNGT--TRVAIKTLKPGT-MSPEAFLQ----------- 228
Query: 101 WKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRREL 160
E + RH ++ L A +V +V E+M GSL D L + + L
Sbjct: 229 --------EAQVMKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLK--GETGKYL 277
Query: 161 DWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGH 220
P +A IASG+ Y+ R +HRD++ AN+L+ +++ +++DFG +L+ D
Sbjct: 278 RLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334
Query: 221 AQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
+ + APE+ + K D++SFG+LL
Sbjct: 335 YTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILL 371
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 56/233 (24%), Positives = 97/233 (41%), Gaps = 37/233 (15%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGA 105
+GSGG+G V+ + S+ +AI+ V+ K I ++ +L +
Sbjct: 48 GPLLGSGGFGSVYSGIRV--SDNLPVAIK--HVE---------KDRISDWGELPN--GTR 92
Query: 106 IRSEIITANQTRHR--NILPLLAHMVRPNCHLLVYEFMKN-GSLQDILYDVSQGR---RE 159
+ E++ + ++ LL RP+ +L+ E + L D + +G
Sbjct: 93 VPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFD--FITERGALQEEL 150
Query: 160 LDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID-DDMEARISDFGHGKLMPD 218
AR + + + CH ++HRDIK N+LID + E ++ DFG G L+ D
Sbjct: 151 ----AR-SFFWQVLEAVRH---CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD 202
Query: 219 GHAQITVKCMVGTMGYMAPESLQTET-ISDKCDIYSFGVLLAVLVMGKFPVDD 270
T GT Y PE ++ ++S G+LL +V G P +
Sbjct: 203 TV--YTDFD--GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 251
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-25
Identities = 57/241 (23%), Positives = 98/241 (40%), Gaps = 45/241 (18%)
Query: 30 EKQDLAFLK--KEDCFDSLKKIGSGGWGEVFYKAEL--PGSNGKM-IAIRKLIVDAPMSA 84
E + A L+ KE F +K +GSG +G V YK G K+ +AI++L A
Sbjct: 2 EAPNQALLRILKETEFKKIKVLGSGAFGTV-YKGLWIPEGEKVKIPVAIKELREATSPKA 60
Query: 85 AELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNG 144
+ ++L E + ++ LL + + L+ + M G
Sbjct: 61 NK----------EIL--------DEAYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFG 101
Query: 145 SLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDME 204
L D + + + + IA G+ YL RL+HRD+ NVL+
Sbjct: 102 CLLDYV---REHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQH 155
Query: 205 ARISDFGHGKLMPDG-------HAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVL 257
+I+DFG KL+ ++ +K +MA ES+ + + D++S+GV
Sbjct: 156 VKITDFGLAKLLGAEEKEYHAEGGKVPIK-------WMALESILHRIYTHQSDVWSYGVT 208
Query: 258 L 258
+
Sbjct: 209 V 209
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-25
Identities = 56/223 (25%), Positives = 97/223 (43%), Gaps = 42/223 (18%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGKMI--AIRKLIVDAPMSAAELIKQDIDEYSDLLHWKI 103
K +G+G +GEV L + K I AI+ L V D L
Sbjct: 50 DKVVGAGEFGEV-CSGRLKLPSKKEISVAIKTLKVGYTEKQRR----------DFL---- 94
Query: 104 GAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWP 163
E Q H NI+ L + + ++V E+M+NGSL L + +
Sbjct: 95 ----GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL---RKHDAQFTVI 147
Query: 164 ARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDG---- 219
+ RGIASG++YL +HRD+ N+LI+ ++ ++SDFG G+++ D
Sbjct: 148 QLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAA 204
Query: 220 ----HAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
+I ++ + +PE++ + D++S+G++L
Sbjct: 205 YTTRGGKIPIR-------WTSPEAIAYRKFTSASDVWSYGIVL 240
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-25
Identities = 56/224 (25%), Positives = 100/224 (44%), Gaps = 43/224 (19%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGKM---IAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
K IG+G +GEV YK L S+GK +AI+ L D L
Sbjct: 49 QKVIGAGEFGEV-YKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV----------DFL--- 94
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDW 162
E Q H NI+ L + + +++ E+M+NG+L L + E
Sbjct: 95 -----GEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFL---REKDGEFSV 146
Query: 163 PARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGH-- 220
+ RGIA+G++YL + +HRD+ N+L++ ++ ++SDFG +++ D
Sbjct: 147 LQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 203
Query: 221 ------AQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
+I ++ + APE++ + D++SFG+++
Sbjct: 204 TYTTSGGKIPIR-------WTAPEAISYRKFTSASDVWSFGIVM 240
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-25
Identities = 59/219 (26%), Positives = 94/219 (42%), Gaps = 40/219 (18%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGA 105
K+G G +GEV Y+ + +A++ L D M E +
Sbjct: 18 KHKLGGGQYGEV-YEGVWKKYSLT-VAVKTLKEDT-MEVEEFL----------------- 57
Query: 106 IRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPAR 165
E + +H N++ LL R ++ EFM G+L D L R+E+
Sbjct: 58 --KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVL 113
Query: 166 HRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPD------G 219
+A I+S +EYL + IHRD+ N L+ ++ +++DFG +LM
Sbjct: 114 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 170
Query: 220 HAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
A+ +K + APESL S K D+++FGVLL
Sbjct: 171 GAKFPIK-------WTAPESLAYNKFSIKSDVWAFGVLL 202
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 53/224 (23%), Positives = 96/224 (42%), Gaps = 42/224 (18%)
Query: 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLH 100
+ KK+G+G +GEV + A +A++ + + MS +
Sbjct: 188 ESLKLEKKLGAGQFGEV-WMATYNKH--TKVAVKTMKPGS-MSVEAFLA----------- 232
Query: 101 WKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRREL 160
E +H ++ L A +V ++ EFM GSL D L S +
Sbjct: 233 --------EANVMKTLQHDKLVKLHA-VVTKEPIYIITEFMAKGSLLDFLK--SDEGSKQ 281
Query: 161 DWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPD-- 218
P + IA G+ ++ + IHRD++ AN+L+ + +I+DFG +++ D
Sbjct: 282 PLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338
Query: 219 ----GHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
A+ +K + APE++ + + K D++SFG+LL
Sbjct: 339 YTAREGAKFPIK-------WTAPEAINFGSFTIKSDVWSFGILL 375
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 3e-25
Identities = 61/241 (25%), Positives = 102/241 (42%), Gaps = 35/241 (14%)
Query: 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAI 106
K +GSG GEV A K +AI ++I + + D +
Sbjct: 141 KTLGSGACGEV-KLAFER-KTCKKVAI-RIISKRKFAIGSAREADPAL----------NV 187
Query: 107 RSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGR-RELDWPAR 165
+EI + H I+ + + ++ V E M+ G L D V R +E +
Sbjct: 188 ETEIEILKKLNHPCIIKIKNFFDAEDYYI-VLELMEGGELFD--KVVGNKRLKEAT--CK 242
Query: 166 HRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI---DDDMEARISDFGHGKLMPDGHAQ 222
+ ++Y H +IHRD+KP NVL+ ++D +I+DFGH K++ +
Sbjct: 243 L-YFYQMLLAVQY---LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM 298
Query: 223 ITVKCMVGTMGYMAPESLQTETI---SDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMD 279
T + GT Y+APE L + + D +S GV+L + + G P F H ++
Sbjct: 299 RT---LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP---FSEHRTQVS 352
Query: 280 M 280
+
Sbjct: 353 L 353
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-25
Identities = 57/212 (26%), Positives = 83/212 (39%), Gaps = 30/212 (14%)
Query: 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAI 106
+G G +G V Y SN IAI K I P + + +
Sbjct: 28 VVLGKGTYGIV-YAG-RDLSNQVRIAI-KEI---PERDSRYSQP---------------L 66
Query: 107 RSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARH 166
EI +H+NI+ L + E + GSL +L G + +
Sbjct: 67 HEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRS-KWGPLKDNEQTIG 125
Query: 167 RIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDM-EARISDFGHGKLMPDGHAQITV 225
+ I GL+YLH +++HRDIK NVLI+ +ISDFG K + +
Sbjct: 126 FYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC--T 180
Query: 226 KCMVGTMGYMAPESLQTETI--SDKCDIYSFG 255
+ GT+ YMAPE + DI+S G
Sbjct: 181 ETFTGTLQYMAPEIIDKGPRGYGKAADIWSLG 212
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 5e-25
Identities = 54/167 (32%), Positives = 79/167 (47%), Gaps = 13/167 (7%)
Query: 106 IRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGR-RELDWPA 164
+ E+ H NI+ L + L+ E+ G + D Y V+ GR +E + A
Sbjct: 61 LFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFD--YLVAHGRMKEKE--A 116
Query: 165 RHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQIT 224
R R I S ++Y CH+ R++HRD+K N+L+D DM +I+DFG G
Sbjct: 117 R-SKFRQIVSAVQY---CHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA 172
Query: 225 VKCMVGTMGYMAPESLQTET-ISDKCDIYSFGVLLAVLVMGKFPVDD 270
C G Y APE Q + + D++S GV+L LV G P D
Sbjct: 173 F-C--GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 216
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 5e-25
Identities = 71/226 (31%), Positives = 107/226 (47%), Gaps = 31/226 (13%)
Query: 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAI 106
+G G +G+V G +A++ I++ +Q I + I
Sbjct: 17 DTLGVGTFGKVKIGEHQL--TGHKVAVK--ILN---------RQKIRSLDVVGK-----I 58
Query: 107 RSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGR-RELDWPAR 165
+ EI RH +I+ L + P +V E++ G L D Y GR E++ AR
Sbjct: 59 KREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFD--YICKHGRVEEME--AR 114
Query: 166 HRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITV 225
R+ + I S ++Y CHR ++HRD+KP NVL+D M A+I+DFG +M DG T
Sbjct: 115 -RLFQQILSAVDY---CHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS 170
Query: 226 KCMVGTMGYMAPESLQTET-ISDKCDIYSFGVLLAVLVMGKFPVDD 270
C G+ Y APE + + DI+S GV+L L+ G P DD
Sbjct: 171 -C--GSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD 213
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 6e-25
Identities = 53/248 (21%), Positives = 92/248 (37%), Gaps = 47/248 (18%)
Query: 21 GPTIFSPLVEKQDLAFLKKE---DCFDSLKKIGSGGWGEVFYKAELPGSNGKM-IAIRKL 76
GP L + E LK++G+G +G V + G+ +AI+ +
Sbjct: 1 GPLGSKNAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVV-KYGKW---RGQYDVAIKMI 56
Query: 77 IVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLL 136
+ MS E I+ E H ++ L + +
Sbjct: 57 KEGS-MSEDEFIE-------------------EAKVMMNLSHEKLVQLYGVCTKQRPIFI 96
Query: 137 VYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPAN 196
+ E+M NG L + L + R + + + +EYL +HRD+ N
Sbjct: 97 ITEYMANGCLLNYL---REMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARN 150
Query: 197 VLIDDDMEARISDFGHGKLMPD------GHAQITVKCMVGTMGYMAPESLQTETISDKCD 250
L++D ++SDFG + + D ++ V+ + PE L S K D
Sbjct: 151 CLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR-------WSPPEVLMYSKFSSKSD 203
Query: 251 IYSFGVLL 258
I++FGVL+
Sbjct: 204 IWAFGVLM 211
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 7e-25
Identities = 51/219 (23%), Positives = 86/219 (39%), Gaps = 42/219 (19%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGA 105
+++IGSG +G V + + +AI+ + A MS + I+
Sbjct: 13 VQEIGSGQFGLV-HLGYWLNKD--KVAIKTIREGA-MSEEDFIE---------------- 52
Query: 106 IRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPAR 165
E + H ++ L + LV EFM++G L D L R
Sbjct: 53 ---EAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYL---RTQRGLFAAETL 106
Query: 166 HRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPD------G 219
+ + G+ YL +IHRD+ N L+ ++ ++SDFG + + D
Sbjct: 107 LGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 163
Query: 220 HAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
+ VK + +PE S K D++SFGVL+
Sbjct: 164 GTKFPVK-------WASPEVFSFSRYSSKSDVWSFGVLM 195
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 8e-25
Identities = 54/232 (23%), Positives = 88/232 (37%), Gaps = 33/232 (14%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGA 105
+G GG+G VF L ++ +AI+ ++ + + +S L
Sbjct: 36 GPLLGKGGFGTVFAGHRL--TDRLQVAIK--VIP---------RNRVLGWSPLS--DSVT 80
Query: 106 IRSEI----ITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGS-LQDILYDVSQGRREL 160
E+ H ++ LL +LV E L D Y +G L
Sbjct: 81 CPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFD--YITEKGP--L 136
Query: 161 DWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDM-EARISDFGHGKLMPDG 219
+ + +++ CH ++HRDIK N+LID A++ DFG G L+ D
Sbjct: 137 GEGPSRCFFGQVVAAIQH---CHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE 193
Query: 220 HAQITVKCMVGTMGYMAPESLQTET-ISDKCDIYSFGVLLAVLVMGKFPVDD 270
T GT Y PE + + ++S G+LL +V G P +
Sbjct: 194 P--YTDFD--GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 9e-25
Identities = 65/248 (26%), Positives = 97/248 (39%), Gaps = 44/248 (17%)
Query: 21 GPTIFSPLVEKQDLAFLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMI--AIRKLIV 78
G PL Q L L E L+K+G G +G V + E +GK + A+ K +
Sbjct: 1 GSAGEGPL---QSLTCLIGEKDLRLLEKLGDGSFGVV-RRGEWDAPSGKTVSVAV-KCLK 55
Query: 79 DAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVY 138
+S E + D + E+ + HRN++ L +V +V
Sbjct: 56 PDVLSQPEAMD-------DFI--------REVNAMHSLDHRNLIRLYG-VVLTPPMKMVT 99
Query: 139 EFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198
E GSL D L + + R A +A G+ YL IHRD+ N+L
Sbjct: 100 ELAPLGSLLDRL---RKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLL 153
Query: 199 IDDDMEARISDFGHGKLMPDG--------HAQITVKCMVGTMGYMAPESLQTETISDKCD 250
+ +I DFG + +P H ++ + APESL+T T S D
Sbjct: 154 LATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA-------WCAPESLKTRTFSHASD 206
Query: 251 IYSFGVLL 258
+ FGV L
Sbjct: 207 TWMFGVTL 214
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 9e-25
Identities = 56/219 (25%), Positives = 101/219 (46%), Gaps = 42/219 (19%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGA 105
++++G+G +GEV + G +A++ L + MS +
Sbjct: 18 VERLGAGQFGEV-WMGYYNGHT--KVAVKSLKQGS-MSPDAFLA---------------- 57
Query: 106 IRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPAR 165
E Q +H+ ++ L A +V ++ E+M+NGSL D L + +L
Sbjct: 58 ---EANLMKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLK--TPSGIKLTINKL 111
Query: 166 HRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPD------G 219
+A IA G+ ++ IHRD++ AN+L+ D + +I+DFG +L+ D
Sbjct: 112 LDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE 168
Query: 220 HAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
A+ +K + APE++ T + K D++SFG+LL
Sbjct: 169 GAKFPIK-------WTAPEAINYGTFTIKSDVWSFGILL 200
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-24
Identities = 58/227 (25%), Positives = 88/227 (38%), Gaps = 49/227 (21%)
Query: 46 LKKIGSGGWGEVFYKAELPGSN---GKMIAIRKLIVDA-PMSAAELIKQDIDEYSDLLHW 101
++ +G G +G+V +N G+M+A++ L DA P + +
Sbjct: 36 IRDLGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQ------------ 82
Query: 102 KIGAIRSEIITANQTRHRNILPLLA--HMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRE 159
EI H +I+ LV E++ GSL+D L R
Sbjct: 83 -------EIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP-----RHS 130
Query: 160 LDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDG 219
+ A+ I G+ YLH IHRD+ NVL+D+D +I DFG K +P+G
Sbjct: 131 IGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187
Query: 220 --------HAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
V + APE L+ D++SFGV L
Sbjct: 188 HEYYRVREDGDSPVF-------WYAPECLKEYKFYYASDVWSFGVTL 227
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-24
Identities = 50/221 (22%), Positives = 86/221 (38%), Gaps = 41/221 (18%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGKMI--AIRKLIVDAPMSAAELIKQDIDEYSDLLHWKI 103
+ IG G +G+V ++ + AI+ S E L
Sbjct: 20 GRCIGEGQFGDV-HQGIYMSPENPALAVAIKTCKNCTSDSVRE----------KFL---- 64
Query: 104 GAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWP 163
E +T Q H +I+ L+ ++ N ++ E G L+ L + LD
Sbjct: 65 ----QEALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFL---QVRKYSLDLA 116
Query: 164 ARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPD----- 218
+ A +++ L YL R +HRDI NVL+ + ++ DFG + M D
Sbjct: 117 SLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK 173
Query: 219 -GHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
++ +K +MAPES+ + D++ FGV +
Sbjct: 174 ASKGKLPIK-------WMAPESINFRRFTSASDVWMFGVCM 207
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 2e-24
Identities = 48/167 (28%), Positives = 77/167 (46%), Gaps = 10/167 (5%)
Query: 106 IRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGR-RELDWPA 164
I+ EI H N++ H N L E+ G L D E D A
Sbjct: 52 IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD--RIEPDIGMPEPD--A 107
Query: 165 RHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQIT 224
+ R + +G+ Y H + HRDIKP N+L+D+ +ISDFG + + +
Sbjct: 108 Q-RFFHQLMAGVVY---LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163
Query: 225 VKCMVGTMGYMAPESLQTET-ISDKCDIYSFGVLLAVLVMGKFPVDD 270
+ M GT+ Y+APE L+ ++ D++S G++L ++ G+ P D
Sbjct: 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 77/301 (25%), Positives = 121/301 (40%), Gaps = 52/301 (17%)
Query: 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLL 99
D + + +G G +GEV + G+ A+ K+I + +
Sbjct: 25 SDRYKGQRVLGKGSFGEV-ILCKDK-ITGQECAV-KVISKRQVKQKTDKES--------- 72
Query: 100 HWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGR-R 158
+ E+ Q H NI+ L LV E G L D + +S+ R
Sbjct: 73 ------LLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI--ISRKRFS 124
Query: 159 ELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI---DDDMEARISDFGHGKL 215
E+D A I R + SG+ Y H+ +++HRD+KP N+L+ D RI DFG
Sbjct: 125 EVD--AAR-IIRQVLSGITY---MHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178
Query: 216 MPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHT 275
+K +GT Y+APE L T +KCD++S GV+L +L+ G P F G
Sbjct: 179 FEASK---KMKDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPP---FNGAN 231
Query: 276 EE--MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKD 333
E + V+ F + ++ E L+ K+ P R S++D
Sbjct: 232 EYDILKKVE-KGKYTFELPQWKKVS--------ESAKDLIRKMLT----YVPSMRISARD 278
Query: 334 V 334
Sbjct: 279 A 279
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-24
Identities = 63/241 (26%), Positives = 102/241 (42%), Gaps = 35/241 (14%)
Query: 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAI 106
K +GSG GEV A K +AI K+I K+ S +
Sbjct: 16 KTLGSGACGEV-KLAFE-RKTCKKVAI-KIIS----------KRKFAIGSAREADPALNV 62
Query: 107 RSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGR-RELDWPAR 165
+EI + H I+ + + ++ V E M+ G L D V R +E +
Sbjct: 63 ETEIEILKKLNHPCIIKIKNFFDAEDYYI-VLELMEGGELFD--KVVGNKRLKEAT--CK 117
Query: 166 HRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI---DDDMEARISDFGHGKLMPDGHAQ 222
+ ++Y H +IHRD+KP NVL+ ++D +I+DFGH K++ +
Sbjct: 118 L-YFYQMLLAVQY---LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM 173
Query: 223 ITVKCMVGTMGYMAPESLQTETI---SDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMD 279
T + GT Y+APE L + + D +S GV+L + + G P F H ++
Sbjct: 174 RT---LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP---FSEHRTQVS 227
Query: 280 M 280
+
Sbjct: 228 L 228
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 62/216 (28%), Positives = 96/216 (44%), Gaps = 40/216 (18%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGA 105
L+ IG G +G+V + G +A++ + K D L
Sbjct: 198 LQTIGKGEFGDV-MLGDY---RGNKVAVKCI------------KNDATA-QAFL------ 234
Query: 106 IRSEIITANQTRHRNILPLLAHMVRPNCHL-LVYEFMKNGSLQDILYDVSQGRRELDWPA 164
+E Q RH N++ LL +V L +V E+M GSL D L S+GR L
Sbjct: 235 --AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDC 290
Query: 165 RHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLM--PDGHAQ 222
+ + + +EYL +HRD+ NVL+ +D A++SDFG K +
Sbjct: 291 LLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK 347
Query: 223 ITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
+ VK + APE+L+ + S K D++SFG+LL
Sbjct: 348 LPVK-------WTAPEALREKKFSTKSDVWSFGILL 376
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-24
Identities = 46/166 (27%), Positives = 75/166 (45%), Gaps = 8/166 (4%)
Query: 106 IRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPAR 165
I+ EI H N++ H N L E+ G L D + P
Sbjct: 52 IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD--RIEPDIG--MPEPDA 107
Query: 166 HRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITV 225
R + +G+ Y H + HRDIKP N+L+D+ +ISDFG + + + +
Sbjct: 108 QRFFHQLMAGVVY---LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164
Query: 226 KCMVGTMGYMAPESLQTET-ISDKCDIYSFGVLLAVLVMGKFPVDD 270
M GT+ Y+APE L+ ++ D++S G++L ++ G+ P D
Sbjct: 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 3e-24
Identities = 42/228 (18%), Positives = 82/228 (35%), Gaps = 41/228 (17%)
Query: 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMI--AIRKLIVDAPMSAAELIKQDIDEYS 96
+ + +G G +GEV Y+ G+ I A++ D + E
Sbjct: 10 AREDVVLNRILGEGFFGEV-YEGVYTNHKGEKINVAVKTCKKDCTLDNKE---------- 58
Query: 97 DLLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQG 156
+ SE + H +I+ L+ ++ ++ E G L L +
Sbjct: 59 KFM--------SEAVIMKNLDHPHIVKLIG-IIEEEPTWIIMELYPYGELGHYL---ERN 106
Query: 157 RRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLM 216
+ L + I + YL + +HRDI N+L+ ++ DFG + +
Sbjct: 107 KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI 163
Query: 217 PD------GHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
D ++ +K +M+PES+ + D++ F V +
Sbjct: 164 EDEDYYKASVTRLPIK-------WMSPESINFRRFTTASDVWMFAVCM 204
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 72/300 (24%), Positives = 125/300 (41%), Gaps = 51/300 (17%)
Query: 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLL 99
+ + +KK+GSG +GEV AI K+I + +
Sbjct: 36 SEMYQRVKKLGSGAYGEV-LLCRDK-VTHVERAI-KII-----RKTSVSTSSNSK----- 82
Query: 100 HWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGR-R 158
+ E+ H NI+ L + LV E K G L D + + + +
Sbjct: 83 ------LLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEI--IHRMKFN 134
Query: 159 ELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI---DDDMEARISDFGHGKL 215
E+D A I + + SG+ Y H+ ++HRD+KP N+L+ + D +I DFG +
Sbjct: 135 EVD--AAV-IIKQVLSGVTY---LHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188
Query: 216 MPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHT 275
+ +K +GT Y+APE L+ + +KCD++S GV+L +L+ G P F G T
Sbjct: 189 FENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPP---FGGQT 241
Query: 276 EEMDMVKWMRNVI-FSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDV 334
++ + K + F + ++ E L+ ++ D R S++
Sbjct: 242 DQEILRKVEKGKYTFDSPEWKNVS--------EGAKDLIKQMLQ----FDSQRRISAQQA 289
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 4e-24
Identities = 50/220 (22%), Positives = 89/220 (40%), Gaps = 44/220 (20%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGKM-IAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIG 104
LK++GSG +G V + G+ +A+ K+I + MS E +
Sbjct: 13 LKELGSGQFGVV-KLGKW---KGQYDVAV-KMIKEGSMSEDEFFQ--------------- 52
Query: 105 AIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPA 164
E T + H ++ + +V E++ NG L + L + L+
Sbjct: 53 ----EAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYL---RSHGKGLEPSQ 105
Query: 165 RHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPD------ 218
+ + G+ +L + IHRD+ N L+D D+ ++SDFG + + D
Sbjct: 106 LLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS 162
Query: 219 GHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
+ VK + APE S K D+++FG+L+
Sbjct: 163 VGTKFPVK-------WSAPEVFHYFKYSSKSDVWAFGILM 195
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 5e-24
Identities = 56/237 (23%), Positives = 96/237 (40%), Gaps = 43/237 (18%)
Query: 32 QDLAFLKKEDCFDSLKKIGSGGWGEVFYKAEL--PGSNGKM-IAIRKLIVDAPMSAAELI 88
Q L + KE F +K +GSG +G V YK G K+ +AI++L A +
Sbjct: 6 QALLRILKETEFKKIKVLGSGAFGTV-YKGLWIPEGEKVKIPVAIKELREATSPKANK-- 62
Query: 89 KQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQD 148
++L E + ++ LL + + L+ + M G L D
Sbjct: 63 --------EIL--------DEAYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLD 105
Query: 149 ILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARIS 208
+ + + + IA G+ YL RL+HRD+ NVL+ +I+
Sbjct: 106 YV---REHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKIT 159
Query: 209 DFGHGKLMPDG-------HAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
DFG KL+ ++ +K +MA ES+ + + D++S+GV +
Sbjct: 160 DFGLAKLLGAEEKEYHAEGGKVPIK-------WMALESILHRIYTHQSDVWSYGVTV 209
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 64/306 (20%), Positives = 113/306 (36%), Gaps = 64/306 (20%)
Query: 40 EDCFDSLKKIGSGGWGEVFYKAELPGSN----GKMIAIRKLIVDAPMSAAELIKQDIDEY 95
D +D +++G+G +G V ++ + K + D +
Sbjct: 156 LDHYDIHEELGTGAFGVV-HRVTERATGNNFAAKFVMTPHE-------------SDKET- 200
Query: 96 SDLLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQ 155
+R EI T + RH ++ L N +++YEFM G L + + D
Sbjct: 201 ----------VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN 250
Query: 156 GRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARI--SDFGHG 213
E + A R + GL + H +H D+KP N++ + DFG
Sbjct: 251 KMSEDE--AVE-YMRQVCKGLCH---MHENNYVHLDLKPENIMFTTKRSNELKLIDFGLT 304
Query: 214 KLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFG 273
+ +VK GT + APE + + + D++S GVL +L+ G P F G
Sbjct: 305 AHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP---FGG 358
Query: 274 HTEEMDMVKWMRNVI-----FSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDER 328
++ + +RNV ++ I+ E+ + KL DP+ R
Sbjct: 359 ENDD----ETLRNVKSCDWNMDDSAFSGIS--------EDGKDFIRKLLL----ADPNTR 402
Query: 329 PSSKDV 334
+
Sbjct: 403 MTIHQA 408
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 7e-24
Identities = 49/212 (23%), Positives = 86/212 (40%), Gaps = 44/212 (20%)
Query: 132 NCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRD 191
+V E++ +L+DI+ + + L + H+ +IHRD
Sbjct: 89 PLPYIVMEYVDGVTLRDIV----HTEGPMTPKRAIEVIADACQALNF---SHQNGIIHRD 141
Query: 192 IKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMV-GTMGYMAPESLQTETISDKCD 250
+KPAN++I ++ DFG + + D +T V GT Y++PE + +++ + D
Sbjct: 142 VKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSD 201
Query: 251 IYSFGVLLAVLVMGKFPVDDFFG---------HTEEMDMVKWMRNVIFSENPNRAINSKL 301
+YS G +L ++ G+ P F G H E D + P A + L
Sbjct: 202 VYSLGCVLYEVLTGEPP---FTGDSPVSVAYQHVRE-DPI-----------PPSARHEGL 246
Query: 302 LGNGYEEQML--LVLKLACFCTLKDPDERPSS 331
L +VLK K+P+ R +
Sbjct: 247 ------SADLDAVVLK----ALAKNPENRYQT 268
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 9e-24
Identities = 58/247 (23%), Positives = 96/247 (38%), Gaps = 42/247 (17%)
Query: 40 EDCFDSLKKIGSGGWGEVFYKAELPGSN----GKMIAIRKLIVDAPMSAAELIKQDIDEY 95
ED +D +++GSG + V K + K I R+ E
Sbjct: 11 EDFYDIGEELGSGQFAIV-KKCREKSTGLEYAAKFIKKRQSRASRRGVCRE--------- 60
Query: 96 SDLLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQ 155
I E+ Q H NI+ L +L+ E + G L D L +
Sbjct: 61 ---------EIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFL--AQK 109
Query: 156 GR-RELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI----DDDMEARISDF 210
E + A + I G+ Y H ++ H D+KP N+++ ++ DF
Sbjct: 110 ESLSEEE--ATS-FIKQILDGVNY---LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163
Query: 211 GHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDD 270
G + DG K + GT ++APE + E + + D++S GV+ +L+ G P
Sbjct: 164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP--- 217
Query: 271 FFGHTEE 277
F G T++
Sbjct: 218 FLGDTKQ 224
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 9e-24
Identities = 56/224 (25%), Positives = 88/224 (39%), Gaps = 44/224 (19%)
Query: 47 KKIGSGGWGEVFYKAELPGSNGKMI--AIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIG 104
+ IG G +G V Y E I AI+ L M + L
Sbjct: 27 RVIGKGHFGVV-YHGEYIDQAQNRIQCAIKSLSRITEMQ----------QVEAFL----- 70
Query: 105 AIRSEIITANQTRHRNILPLLAHMVRPNCHLL-VYEFMKNGSLQDILYDVSQGRRELDWP 163
E + H N+L L+ M+ P + +M +G L + +R
Sbjct: 71 ---REGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS---PQRNPTVK 124
Query: 164 ARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPD----- 218
+A G+EYL + +HRD+ N ++D+ +++DFG + + D
Sbjct: 125 DLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYS 181
Query: 219 ----GHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
HA++ VK + A ESLQT + K D++SFGVLL
Sbjct: 182 VQQHRHARLPVK-------WTALESLQTYRFTTKSDVWSFGVLL 218
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 9e-24
Identities = 53/229 (23%), Positives = 89/229 (38%), Gaps = 44/229 (19%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGKMI--AIRKLIVDAPMSAAELIKQDIDEYSDLLHWKI 103
K +G G +G V + L +G + A++ + +D E + L
Sbjct: 39 GKILGEGEFGSV-MEGNLKQEDGTSLKVAVKTMKLDN---------SSQREIEEFL---- 84
Query: 104 GAIRSEIITANQTRHRNILPLLA-----HMVRPNCHLLVYEFMKNGSLQDIL--YDVSQG 156
SE H N++ LL +++ FMK G L L + G
Sbjct: 85 ----SEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETG 140
Query: 157 RRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLM 216
+ + + IA G+EYL +HRD+ N ++ DDM ++DFG K +
Sbjct: 141 PKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKI 197
Query: 217 PD-------GHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
A++ VK ++A ESL + K D+++FGV +
Sbjct: 198 YSGDYYRQGRIAKMPVK-------WIAIESLADRVYTSKSDVWAFGVTM 239
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 9e-24
Identities = 59/247 (23%), Positives = 101/247 (40%), Gaps = 42/247 (17%)
Query: 40 EDCFDSLKKIGSGGWGEVFYKAELPGSN----GKMIAIRKLIVDAPMSAAELIKQDIDEY 95
ED ++ +++GSG + V K G+ K I R+L +E
Sbjct: 4 EDHYEMGEELGSGQFAIV-RKCRQKGTGKEYAAKFIKKRRLSSSRR-------GVSREE- 54
Query: 96 SDLLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQ 155
I E+ + RH NI+ L +L+ E + G L D L +
Sbjct: 55 ----------IEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL--AEK 102
Query: 156 GR-RELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI----DDDMEARISDF 210
E + A + I G+ Y H R+ H D+KP N+++ + ++ DF
Sbjct: 103 ESLTEDE--ATQ-FLKQILDGVHY---LHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDF 156
Query: 211 GHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDD 270
G + G+ K + GT ++APE + E + + D++S GV+ +L+ G P
Sbjct: 157 GIAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP--- 210
Query: 271 FFGHTEE 277
F G T++
Sbjct: 211 FLGETKQ 217
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 9e-24
Identities = 54/238 (22%), Positives = 97/238 (40%), Gaps = 45/238 (18%)
Query: 32 QDLAFLKKEDCFDSLKKIGSGGWGEVFYKAEL--PGSNGKM-IAIRKLIVDA-PMSAAEL 87
+ LA + KE LK +GSG +G V +K G + K+ + I+ + + S +
Sbjct: 4 KVLARIFKETELRKLKVLGSGVFGTV-HKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAV 62
Query: 88 IKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQ 147
++ H +I+ LL + + LV +++ GSL
Sbjct: 63 T-------------------DHMLAIGSLDHAHIVRLLG-LCPGSSLQLVTQYLPLGSLL 102
Query: 148 DILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARI 207
D + Q R L IA G+ YL ++HR++ NVL+ + ++
Sbjct: 103 DHVR---QHRGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQV 156
Query: 208 SDFGHGKLMPDG-------HAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
+DFG L+P A+ +K +MA ES+ + + D++S+GV +
Sbjct: 157 ADFGVADLLPPDDKQLLYSEAKTPIK-------WMALESIHFGKYTHQSDVWSYGVTV 207
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 1e-23
Identities = 58/221 (26%), Positives = 93/221 (42%), Gaps = 36/221 (16%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGKMI--AIRKLIVDAPMSAAELIKQDIDEYSDLLHWKI 103
+ IG G +G V Y L ++GK I A++ L + E S L
Sbjct: 94 NEVIGRGHFGCV-YHGTLLDNDGKKIHCAVKSLNRITDIG----------EVSQFL---- 138
Query: 104 GAIRSEIITANQTRHRNILPLLAHMVRPNC-HLLVYEFMKNGSLQDILYDVSQGRRELDW 162
+E I H N+L LL +R L+V +MK+G L++ + +
Sbjct: 139 ----TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTV 191
Query: 163 PARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQ 222
+A G+++L +HRD+ N ++D+ +++DFG + M D
Sbjct: 192 KDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 248
Query: 223 ITVKCMVGTMG-----YMAPESLQTETISDKCDIYSFGVLL 258
T +MA ESLQT+ + K D++SFGVLL
Sbjct: 249 SVHN---KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 286
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 1e-23
Identities = 52/202 (25%), Positives = 94/202 (46%), Gaps = 25/202 (12%)
Query: 132 NCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRD 191
+C+ LV E+++ +L + + + L I G+++ H R++HRD
Sbjct: 84 DCYYLVMEYIEGPTLSEYI----ESHGPLSVDTAINFTNQILDGIKH---AHDMRIVHRD 136
Query: 192 IKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDI 251
IKP N+LID + +I DFG K + + T ++GT+ Y +PE + E + DI
Sbjct: 137 IKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNH-VLGTVQYFSPEQAKGEATDECTDI 195
Query: 252 YSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQML 311
YS G++L +++G+ P F G T +K +++ + N + + Q L
Sbjct: 196 YSIGIVLYEMLVGEPP---FNGETAVSIAIKHIQDSV--PNVTTDVRKDI------PQSL 244
Query: 312 --LVLKLACFCTLKDPDERPSS 331
++L+ T KD R +
Sbjct: 245 SNVILR----ATEKDKANRYKT 262
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 73/301 (24%), Positives = 126/301 (41%), Gaps = 53/301 (17%)
Query: 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLL 99
+ ++ + +G G +GEV K + + A+ K+I + A +D
Sbjct: 21 AERYNIVCMLGKGSFGEV-LKCKDR-ITQQEYAV-KVI-----NKASAKNKDTST----- 67
Query: 100 HWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGR-R 158
I E+ + H NI+ L + + +V E G L D + + + R
Sbjct: 68 ------ILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI--IKRKRFS 119
Query: 159 ELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI---DDDMEARISDFGHGKL 215
E D A I + + SG+ Y H+ ++HRD+KP N+L+ + D + +I DFG
Sbjct: 120 EHD--AAR-IIKQVFSGITY---MHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173
Query: 216 MPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHT 275
+K +GT Y+APE L+ T +KCD++S GV+L +L+ G P F+G
Sbjct: 174 FQQNT---KMKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPP---FYGKN 226
Query: 276 EE--MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKD 333
E + V+ F R I+ ++ L+ K+ P R ++
Sbjct: 227 EYDILKRVE-TGKYAFDLPQWRTIS--------DDAKDLIRKMLT----FHPSLRITATQ 273
Query: 334 V 334
Sbjct: 274 C 274
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 39/196 (19%), Positives = 73/196 (37%), Gaps = 41/196 (20%)
Query: 136 LVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPA 195
+V E++ SL+ ++L I L YLH L++ D+KP
Sbjct: 161 IVMEYVGGQSLKRSK------GQKLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPE 211
Query: 196 NVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFG 255
N+++ ++ + ++ D G + + GT G+ APE ++T + DIY+ G
Sbjct: 212 NIMLTEE-QLKLIDLGAVSRINSFGY------LYGTPGFQAPEIVRTGP-TVATDIYTVG 263
Query: 256 VLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLK 315
LA L + G V + ++P Y+ L+ +
Sbjct: 264 RTLAALTLDLPT---RNG-----RYVDGLP----EDDPVLKT--------YDSYGRLLRR 303
Query: 316 LACFCTLKDPDERPSS 331
DP +R ++
Sbjct: 304 ----AIDPDPRQRFTT 315
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 1e-23
Identities = 61/253 (24%), Positives = 105/253 (41%), Gaps = 37/253 (14%)
Query: 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLL 99
+D IG G V + + G A+ K++ + +++ E
Sbjct: 93 YQKYDPKDVIGRGVSSVV-RRCVHR-ATGHEFAV-KIMEVTAERLSPEQLEEVRE----- 144
Query: 100 HWKIGAIRSEI-ITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGR- 157
A R E I H +I+ L+ + LV++ M+ G L D Y +
Sbjct: 145 -----ATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFD--YLTEKVAL 197
Query: 158 RELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMP 217
E + R I R + + + H ++HRD+KP N+L+DD+M+ R+SDFG +
Sbjct: 198 SEKE--TRS-IMRSLLEAVSF---LHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251
Query: 218 DGHAQITVKCMVGTMGYMAPESLQTETISD------KCDIYSFGVLLAVLVMGKFPVDDF 271
G + GT GY+APE L+ + D+++ GV+L L+ G P F
Sbjct: 252 PGEKLREL---CGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP---F 305
Query: 272 FGHTEE--MDMVK 282
+ + + M+
Sbjct: 306 WHRRQILMLRMIM 318
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-23
Identities = 57/247 (23%), Positives = 97/247 (39%), Gaps = 42/247 (17%)
Query: 40 EDCFDSLKKIGSGGWGEVFYKAELPGSN----GKMIAIRKLIVDAPMSAAELIKQDIDEY 95
ED +D +++GSG + V K + K I R+ + E
Sbjct: 11 EDFYDIGEELGSGQFAIV-KKCREKSTGLEYAAKFIKKRQSRASRRGVSRE--------- 60
Query: 96 SDLLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQ 155
I E+ Q H N++ L +L+ E + G L D L +
Sbjct: 61 ---------EIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL--AQK 109
Query: 156 GR-RELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI----DDDMEARISDF 210
E + A + I G+ Y H ++ H D+KP N+++ ++ DF
Sbjct: 110 ESLSEEE--ATS-FIKQILDGVNY---LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163
Query: 211 GHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDD 270
G + DG K + GT ++APE + E + + D++S GV+ +L+ G P
Sbjct: 164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP--- 217
Query: 271 FFGHTEE 277
F G T++
Sbjct: 218 FLGDTKQ 224
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 1e-23
Identities = 61/225 (27%), Positives = 97/225 (43%), Gaps = 44/225 (19%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGKMI--AIRKLIVDAPMSAAELIKQDIDEYSDLLHWKI 103
+ IG G +G V Y L ++GK I A++ L + E S L
Sbjct: 30 NEVIGRGHFGCV-YHGTLLDNDGKKIHCAVKSLNRITDIG----------EVSQFL---- 74
Query: 104 GAIRSEIITANQTRHRNILPLLAHMVRP-NCHLLVYEFMKNGSLQDILYDVSQGRRELDW 162
+E I H N+L LL +R L+V +MK+G L++ + +
Sbjct: 75 ----TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTV 127
Query: 163 PARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDG--- 219
+A G++YL +HRD+ N ++D+ +++DFG + M D
Sbjct: 128 KDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY 184
Query: 220 ------HAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
A++ VK +MA ESLQT+ + K D++SFGVLL
Sbjct: 185 SVHNKTGAKLPVK-------WMALESLQTQKFTTKSDVWSFGVLL 222
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 1e-23
Identities = 49/230 (21%), Positives = 89/230 (38%), Gaps = 45/230 (19%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGKMI--AIRKLIVDAPMSAAELIKQDIDEYSDLLHWKI 103
+ +G G +G V +A+L +G + A++ L D + + L
Sbjct: 28 GRMLGKGEFGSV-REAQLKQEDGSFVKVAVKMLKADII---------ASSDIEEFL---- 73
Query: 104 GAIRSEIITANQTRHRNILPLLA------HMVRPNCHLLVYEFMKNGSLQDIL--YDVSQ 155
E + H ++ L+ R +++ FMK+G L L + +
Sbjct: 74 ----REAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGE 129
Query: 156 GRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKL 215
L R IA G+EYL IHRD+ N ++ +DM ++DFG +
Sbjct: 130 NPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRK 186
Query: 216 MPD-------GHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
+ +++ VK ++A ESL + D+++FGV +
Sbjct: 187 IYSGDYYRQGCASKLPVK-------WLALESLADNLYTVHSDVWAFGVTM 229
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-23
Identities = 57/246 (23%), Positives = 100/246 (40%), Gaps = 34/246 (13%)
Query: 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLL 99
+ ++ + +G G V + K A+ K+I + ++ +
Sbjct: 16 YENYEPKEILGRGVSSVV-RRCIHK-PTCKEYAV-KII---------DVTGGGSFSAEEV 63
Query: 100 HWKIGAIRSEI-ITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGR- 157
A E+ I + H NI+ L LV++ MK G L D L +
Sbjct: 64 QELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTL 121
Query: 158 RELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMP 217
E + R I R + + H+ ++HRD+KP N+L+DDDM +++DFG +
Sbjct: 122 SEKE--TRK-IMRALLEVICA---LHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 175
Query: 218 DGHAQITVKCMVGTMGYMAPESLQTETISD------KCDIYSFGVLLAVLVMGKFPVDDF 271
G V GT Y+APE ++ + + D++S GV++ L+ G P F
Sbjct: 176 PGEKLREV---CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP---F 229
Query: 272 FGHTEE 277
+ +
Sbjct: 230 WHRKQM 235
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 49/221 (22%), Positives = 85/221 (38%), Gaps = 41/221 (18%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGKMI--AIRKLIVDAPMSAAELIKQDIDEYSDLLHWKI 103
+ IG G +G+V ++ + AI+ S E L
Sbjct: 395 GRCIGEGQFGDV-HQGIYMSPENPAMAVAIKTCKNCTSDSVRE----------KFL---- 439
Query: 104 GAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWP 163
E +T Q H +I+ L+ ++ N ++ E G L+ L + LD
Sbjct: 440 ----QEALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQ---VRKFSLDLA 491
Query: 164 ARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPD----- 218
+ A +++ L YL +HRDI NVL+ + ++ DFG + M D
Sbjct: 492 SLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK 548
Query: 219 -GHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
++ +K +MAPES+ + D++ FGV +
Sbjct: 549 ASKGKLPIK-------WMAPESINFRRFTSASDVWMFGVCM 582
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 2e-23
Identities = 72/226 (31%), Positives = 108/226 (47%), Gaps = 31/226 (13%)
Query: 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAI 106
+G G +G+V G +A++ I++ +Q I + I
Sbjct: 22 DTLGVGTFGKVKVGKHEL--TGHKVAVK--ILN---------RQKIRSLDVVGK-----I 63
Query: 107 RSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGR-RELDWPAR 165
R EI RH +I+ L + P+ +V E++ G L D Y GR E + +R
Sbjct: 64 RREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFD--YICKNGRLDEKE--SR 119
Query: 166 HRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITV 225
R+ + I SG++Y CHR ++HRD+KP NVL+D M A+I+DFG +M DG T
Sbjct: 120 -RLFQQILSGVDY---CHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS 175
Query: 226 KCMVGTMGYMAPESLQTET-ISDKCDIYSFGVLLAVLVMGKFPVDD 270
C G+ Y APE + + DI+S GV+L L+ G P DD
Sbjct: 176 -C--GSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD 218
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 3e-23
Identities = 54/237 (22%), Positives = 89/237 (37%), Gaps = 61/237 (25%)
Query: 47 KKIGSGGWGEVFYKAELPGSNGKM-IAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGA 105
IG G +G+V KA + +M AI+++ A ++ D
Sbjct: 31 DVIGEGNFGQV-LKARIKKDGLRMDAAIKRMKEYASKD----------DHRDFA------ 73
Query: 106 IRSEI-ITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDIL------------YD 152
E+ + H NI+ LL L E+ +G+L D L
Sbjct: 74 --GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 131
Query: 153 VSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFG- 211
+ L A +A G++YL + + IHRD+ N+L+ ++ A+I+DFG
Sbjct: 132 ANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGL 188
Query: 212 ----------HGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
+P V+ +MA ESL + D++S+GVLL
Sbjct: 189 SRGQEVYVKKTMGRLP-------VR-------WMAIESLNYSVYTTNSDVWSYGVLL 231
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 3e-23
Identities = 62/305 (20%), Positives = 115/305 (37%), Gaps = 55/305 (18%)
Query: 40 EDCFDSLKKIGSGGWGEVFYKAELPGSN----GKMIAIRKLIVDAPMSAAELIKQDIDEY 95
+D +D+ +++GSG + V K + K I R+ + E
Sbjct: 10 DDYYDTGEELGSGQFAVV-KKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE--------- 59
Query: 96 SDLLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQ 155
I E+ + +H N++ L +L+ E + G L D L +
Sbjct: 60 ---------DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEK 108
Query: 156 GR-RELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI----DDDMEARISDF 210
E + A + I +G+ Y H ++ H D+KP N+++ +I DF
Sbjct: 109 ESLTEEE--AT-EFLKQILNGVYY---LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 162
Query: 211 GHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDD 270
G + G+ K + GT ++APE + E + + D++S GV+ +L+ G P
Sbjct: 163 GLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP--- 216
Query: 271 FFGHTEEMDMVKWMRNVI-FSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERP 329
F G T++ + F + + + +L KDP +R
Sbjct: 217 FLGDTKQETLANVSAVNYEFEDEYFSNTS--------ALAKDFIRRLLV----KDPKKRM 264
Query: 330 SSKDV 334
+ +D
Sbjct: 265 TIQDS 269
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 3e-23
Identities = 62/216 (28%), Positives = 96/216 (44%), Gaps = 40/216 (18%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGA 105
L+ IG G +G+V + G +A++ + K D L
Sbjct: 26 LQTIGKGEFGDV-MLGDY---RGNKVAVKCI------------KNDATA-QAFL------ 62
Query: 106 IRSEIITANQTRHRNILPLLAHMVRPNCHL-LVYEFMKNGSLQDILYDVSQGRRELDWPA 164
+E Q RH N++ LL +V L +V E+M GSL D L S+GR L
Sbjct: 63 --AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDC 118
Query: 165 RHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLM--PDGHAQ 222
+ + + +EYL +HRD+ NVL+ +D A++SDFG K +
Sbjct: 119 LLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK 175
Query: 223 ITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
+ VK + APE+L+ + S K D++SFG+LL
Sbjct: 176 LPVK-------WTAPEALREKKFSTKSDVWSFGILL 204
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 4e-23
Identities = 49/230 (21%), Positives = 90/230 (39%), Gaps = 46/230 (20%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGK----MIAIRKLIVDAPMSAAELIKQDIDEYSDLLHW 101
+++G G +G V Y+ G +AI+ + A M E + L
Sbjct: 30 SRELGQGSFGMV-YEGVAKGVVKDEPETRVAIKTVNEAASMR----------ERIEFL-- 76
Query: 102 KIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDIL------YDVSQ 155
+E + +++ LL + + L++ E M G L+ L +
Sbjct: 77 ------NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNP 130
Query: 156 GRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKL 215
++A IA G+ YL+ +HRD+ N ++ +D +I DFG +
Sbjct: 131 VLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRD 187
Query: 216 M-------PDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
+ G + V+ +M+PESL+ + D++SFGV+L
Sbjct: 188 IYETDYYRKGGKGLLPVR-------WMSPESLKDGVFTTYSDVWSFGVVL 230
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 5e-23
Identities = 80/291 (27%), Positives = 122/291 (41%), Gaps = 46/291 (15%)
Query: 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLH 100
+ F + +G GG+GEV ++ + GKM A +KL K+ I +
Sbjct: 184 NTFRQYRVLGKGGFGEVC-ACQVRAT-GKMYACKKLE-----------KKRIKKRKGEAM 230
Query: 101 WKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRREL 160
+E + R ++ L + LV M G L+ +Y + G+
Sbjct: 231 -----ALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM--GQAGF 283
Query: 161 DWP-ARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDG 219
A A I GLE LH R R+++RD+KP N+L+DD RISD G +P+G
Sbjct: 284 PEARAVFYAAE-ICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339
Query: 220 HAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGK--FPVDDFFGHTEE 277
T+K VGT+GYMAPE ++ E + D ++ G LL ++ G+ F EE
Sbjct: 340 Q---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE 396
Query: 278 MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDER 328
++ + +SE + S LL KDP ER
Sbjct: 397 VERLVKEVPEEYSERFSPQARSLC-------SQLLC---------KDPAER 431
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 8e-23
Identities = 72/253 (28%), Positives = 110/253 (43%), Gaps = 30/253 (11%)
Query: 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLH 100
D F + +G GG+GEVF ++ + GK+ A +KL K+ + +
Sbjct: 185 DWFLDFRVLGRGGFGEVF-ACQMKAT-GKLYACKKLN-----------KKRLKKRKGYQG 231
Query: 101 WKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHL-LVYEFMKNGSLQDILYDVSQGRRE 159
E + R I+ L L LV M G ++ +Y+V +
Sbjct: 232 -----AMVEKKILAKVHSRFIVSLAYAFETKT-DLCLVMTIMNGGDIRYHIYNVDEDNPG 285
Query: 160 LDWP-ARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPD 218
P A A+ I SGLE+LH + +I+RD+KP NVL+DDD RISD G +
Sbjct: 286 FQEPRAIFYTAQ-IVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341
Query: 219 GHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEM 278
G Q K GT G+MAPE L E D ++ GV L ++ + P F E++
Sbjct: 342 G--QTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP---FRARGEKV 396
Query: 279 DMVKWMRNVIFSE 291
+ + + V+
Sbjct: 397 ENKELKQRVLEQA 409
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 1e-22
Identities = 63/302 (20%), Positives = 110/302 (36%), Gaps = 56/302 (18%)
Query: 40 EDCFDSLKKIGSGGWGEVFYKAELPGSN----GKMIAIRKLIVDAPMSAAELIKQDIDEY 95
D +D L+++GSG +G V ++ + K I D
Sbjct: 50 YDYYDILEELGSGAFGVV-HRCVEKATGRVFVAKFINTPYP-------------LDKYT- 94
Query: 96 SDLLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQ 155
+++EI NQ H ++ L +L+ EF+ G L D +
Sbjct: 95 ----------VKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY 144
Query: 156 GRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARI--SDFGHG 213
E + + R GL++ H ++H DIKP N++ + + + DFG
Sbjct: 145 KMSEAE--VIN-YMRQACEGLKH---MHEHSIVHLDIKPENIMCETKKASSVKIIDFGLA 198
Query: 214 KLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFG 273
+ VK T + APE + E + D+++ GVL VL+ G P F G
Sbjct: 199 TKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP---FAG 252
Query: 274 HTEEMDMVKWMR-NVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSK 332
+ + R + F E+ +++ E + L K+P +R +
Sbjct: 253 EDDLETLQNVKRCDWEFDEDAFSSVS--------PEAKDFIKNLLQ----KEPRKRLTVH 300
Query: 333 DV 334
D
Sbjct: 301 DA 302
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 95.3 bits (237), Expect = 2e-22
Identities = 69/339 (20%), Positives = 101/339 (29%), Gaps = 79/339 (23%)
Query: 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLL 99
+ + IG G +G V A + AI K++ + +
Sbjct: 25 QKKYHLKGAIGQGSYGVV-RVAIEN-QTRAIRAI-KIMNKNKIRQINPKDVE-------- 73
Query: 100 HWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRE 159
I++E+ + H NI L LV E G L D L
Sbjct: 74 -----RIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTG 128
Query: 160 LDWPARH------------------------------------RIARGIASGLEYLHMCH 183
I R I S L Y H
Sbjct: 129 KCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY---LH 185
Query: 184 RPRLIHRDIKPANVLIDDDMEAR--ISDFGHGKLMPDGHAQITVKC--MVGTMGYMAPES 239
+ HRDIKP N L + + DFG K + GT ++APE
Sbjct: 186 NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEV 245
Query: 240 LQ--TETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEE--MDMVKWMRNVIFSENPNR 295
L E+ KCD +S GVLL +L+MG P F G + + V + + F
Sbjct: 246 LNTTNESYGPKCDAWSAGVLLHLLLMGAVP---FPGVNDADTISQVL-NKKLCFENPNYN 301
Query: 296 AINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDV 334
++ L+ L ++ DER +
Sbjct: 302 VLS--------PLARDLLSNLLN----RNVDERFDAMRA 328
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 2e-22
Identities = 61/244 (25%), Positives = 102/244 (41%), Gaps = 39/244 (15%)
Query: 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLL 99
+D F +K+GSG +G+V + E S G I K I + + +++
Sbjct: 21 DDLFIFKRKLGSGAFGDV-HLVEERSS-GLERVI-KTI------NKDRSQVPMEQ----- 66
Query: 100 HWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQD-ILYDVSQGRR 158
I +EI H NI+ + + +V E + G L + I+ ++G+
Sbjct: 67 ------IEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKA 120
Query: 159 --ELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI---DDDMEARISDFGHG 213
E + + + + L Y H ++H+D+KP N+L +I DFG
Sbjct: 121 LSEGY--VA-ELMKQMMNALAY---FHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA 174
Query: 214 KLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFG 273
+L GT YMAPE + ++ KCDI+S GV++ L+ G P F G
Sbjct: 175 ELFKSDEHSTNA---AGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLP---FTG 227
Query: 274 HTEE 277
+ E
Sbjct: 228 TSLE 231
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-22
Identities = 47/235 (20%), Positives = 88/235 (37%), Gaps = 52/235 (22%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGK----MIAIRKLIVDAPMSAAELIKQDIDEYSDLLHW 101
++G G +G+V + AE + ++A+ K + +A D
Sbjct: 46 KWELGEGAFGKV-FLAECHNLLPEQDKMLVAV-KALKEASE----------SARQDFQ-- 91
Query: 102 KIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDIL----------- 150
E +H++I+ L+V+E+M++G L L
Sbjct: 92 ------REAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLA 145
Query: 151 YDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDF 210
L +A +A+G+ YL H +HRD+ N L+ + +I DF
Sbjct: 146 GGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDF 202
Query: 211 GHGKLMPD-------GHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
G + + G + ++ +M PES+ + + D++SFGV+L
Sbjct: 203 GMSRDIYSTDYYRVGGRTMLPIR-------WMPPESILYRKFTTESDVWSFGVVL 250
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 3e-22
Identities = 44/197 (22%), Positives = 77/197 (39%), Gaps = 25/197 (12%)
Query: 136 LVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPA 195
+ + L +L + + L P I R I S L+ H HRD+KP
Sbjct: 111 VDMRLINGVDLAAML----RRQGPLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPE 163
Query: 196 NVLIDDDMEARISDFGHGKLMPDGHAQIT-VKCMVGTMGYMAPESLQTETISDKCDIYSF 254
N+L+ D A + DFG D ++T + VGT+ YMAPE + + DIY+
Sbjct: 164 NILVSADDFAYLVDFGIASATTD--EKLTQLGNTVGTLYYMAPERFSESHATYRADIYAL 221
Query: 255 GVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVL 314
+L + G P + G + M + I + + ++ ++
Sbjct: 222 TCVLYECLTGSPP---YQGDQLSV-MGAHINQAI---PRPSTVRPG-IPVAFDA---VIA 270
Query: 315 KLACFCTLKDPDERPSS 331
+ K+P++R +
Sbjct: 271 R----GMAKNPEDRYVT 283
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 4e-22
Identities = 67/299 (22%), Positives = 118/299 (39%), Gaps = 56/299 (18%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSN----GKMIAIRKLIVDAPMSAAELIKQDIDEYSDL 98
+ +G G +G+V +K E + K+I R + +D +E
Sbjct: 91 VSKTEILGGGRFGQV-HKCEETATGLKLAAKIIKTRGM-------------KDKEE---- 132
Query: 99 LHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRR 158
+++EI NQ H N++ L N +LV E++ G L D + D S
Sbjct: 133 -------VKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLT 185
Query: 159 ELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARI--SDFGHGKLM 216
ELD + I G+ + H+ ++H D+KP N+L + +I DFG +
Sbjct: 186 ELD--TI-LFMKQICEGIRH---MHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY 239
Query: 217 PDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTE 276
+K GT ++APE + + +S D++S GV+ +L+ G P F G +
Sbjct: 240 KPRE---KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP---FLGDND 293
Query: 277 EMDMVKWMR-NVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDV 334
+ + + + I+ EE + KL K+ R S+ +
Sbjct: 294 AETLNNILACRWDLEDEEFQDIS--------EEAKEFISKLLI----KEKSWRISASEA 340
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 6e-22
Identities = 66/255 (25%), Positives = 98/255 (38%), Gaps = 37/255 (14%)
Query: 41 DCFDSLKKIGSGGWGEVF---YKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSD 97
+ F + IG GG+GEV+ GKM A++ L K+ I
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKAD-----TGKMYAMKCLD-----------KKRIKMKQG 232
Query: 98 LLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGR 157
R + + I+ + P+ + + M G D+ Y +SQ
Sbjct: 233 ETLAL--NERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGG---DLHYHLSQHG 287
Query: 158 RELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMP 217
+ R A I GLE++H +++RD+KPAN+L+D+ RISD G
Sbjct: 288 VFSEADMRFYAAE-IILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 343
Query: 218 DGHAQITVKCMVGTMGYMAPESLQTETISDKC-DIYSFGVLLAVLVMGKFPVDDFFGHTE 276
VGT GYMAPE LQ D D +S G +L L+ G P F +
Sbjct: 344 KK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP----FRQHK 395
Query: 277 EMDMVKWMRNVIFSE 291
D + R +
Sbjct: 396 TKDKHEIDRMTLTMA 410
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 7e-22
Identities = 73/295 (24%), Positives = 106/295 (35%), Gaps = 53/295 (17%)
Query: 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAI 106
IG G WGEV A G+ A K I + +
Sbjct: 15 NTIGRGSWGEV-KIAVQKGT-RIRRAA-KKIPKYFVEDVD------------------RF 53
Query: 107 RSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGR-RELDWPAR 165
+ EI H NI+ L LV E G L + V + RE D A
Sbjct: 54 KQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFE--RVVHKRVFRESD--AA 109
Query: 166 HRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI---DDDMEARISDFGHGKLMPDGHAQ 222
I + + S + Y CH+ + HRD+KP N L D ++ DFG G
Sbjct: 110 R-IMKDVLSAVAY---CHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM 165
Query: 223 ITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVK 282
T VGT Y++P+ L+ +CD +S GV++ VL+ G P F T+ M+K
Sbjct: 166 RTK---VGTPYYVSPQVLE-GLYGPECDEWSAGVMMYVLLCGYPP---FSAPTDSEVMLK 218
Query: 283 WMRNVI-FSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336
F E ++ + L+ +L K P +R +S
Sbjct: 219 IREGTFTFPEKDWLNVS--------PQAESLIRRLLT----KSPKQRITSLQALE 261
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 7e-22
Identities = 59/249 (23%), Positives = 108/249 (43%), Gaps = 39/249 (15%)
Query: 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLL 99
D +D +++G G + V + + G A K+I + +L +D
Sbjct: 5 SDNYDVKEELGKGAFSVV-RRCVHK-TTGLEFAA-KII-----NTKKLSARDFQ------ 50
Query: 100 HWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGR-R 158
+ E + +H NI+ L + + H LV++ + G L + + V++
Sbjct: 51 -----KLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI--VAREFYS 103
Query: 159 ELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI---DDDMEARISDFGHGKL 215
E D A H + I + Y CH ++HR++KP N+L+ +++DFG
Sbjct: 104 EAD--ASH-CIQQILESIAY---CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157
Query: 216 MPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHT 275
+ D A GT GY++PE L+ + S DI++ GV+L +L++G P F+
Sbjct: 158 VNDSEAWHGF---AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP---FWDED 211
Query: 276 EE--MDMVK 282
+ +K
Sbjct: 212 QHRLYAQIK 220
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 7e-22
Identities = 53/236 (22%), Positives = 95/236 (40%), Gaps = 53/236 (22%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGK----MIAIRKLIVDAPMSAAELIKQDIDEYSDLLHW 101
+++G G +G+V + AE + ++A+ K + D ++ D
Sbjct: 20 KRELGEGAFGKV-FLAECYNLSPTKDKMLVAV-KALKDPTLA----------ARKDFQ-- 65
Query: 102 KIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDIL----------- 150
E +H +I+ + ++V+E+MK+G L L
Sbjct: 66 ------REAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILV 119
Query: 151 -YDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISD 209
Q + EL IA IASG+ YL H +HRD+ N L+ ++ +I D
Sbjct: 120 DGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGD 176
Query: 210 FGHGKLMPD-------GHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
FG + + GH + ++ +M PES+ + + D++SFGV+L
Sbjct: 177 FGMSRDVYSTDYYRVGGHTMLPIR-------WMPPESIMYRKFTTESDVWSFGVIL 225
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 9e-22
Identities = 57/264 (21%), Positives = 100/264 (37%), Gaps = 56/264 (21%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGK----MIAIRKLIVDAPMSAAELIKQDIDEYSDLLHW 101
K +G+G +G+V +A G +A++ L A + E L+
Sbjct: 28 GKTLGAGAFGKV-VEATAYGLIKSDAAMTVAVKMLKPSA----------HLTEREALM-- 74
Query: 102 KIGAIRSEI-ITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDIL---------- 150
SE+ + + H NI+ LL L++ E+ G L + L
Sbjct: 75 ------SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICS 128
Query: 151 ----YDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEAR 206
+ LD + +A G+ +L IHRD+ N+L+ +
Sbjct: 129 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITK 185
Query: 207 ISDFG-------HGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLA 259
I DFG + G+A++ VK +MAPES+ + + D++S+G+ L
Sbjct: 186 ICDFGLARDIKNDSNYVVKGNARLPVK-------WMAPESIFNCVYTFESDVWSYGIFLW 238
Query: 260 VLV-MGKFPVDDFFGHTEEMDMVK 282
L +G P ++ M+K
Sbjct: 239 ELFSLGSSPYPGMPVDSKFYKMIK 262
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 9e-22
Identities = 62/226 (27%), Positives = 110/226 (48%), Gaps = 32/226 (14%)
Query: 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAI 106
+ +G G +G+V + +A++ + +Q + + + +
Sbjct: 15 ETLGEGSFGKVKLATHYK--TQQKVALK--FIS---------RQLLKKSDMHMR-----V 56
Query: 107 RSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGR-RELDWPAR 165
EI RH +I+ L + P ++V E+ G L D Y V + R E + R
Sbjct: 57 EREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFD--YIVEKKRMTEDE--GR 111
Query: 166 HRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITV 225
R + I +EY CHR +++HRD+KP N+L+DD++ +I+DFG +M DG+ T
Sbjct: 112 -RFFQQIICAIEY---CHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS 167
Query: 226 KCMVGTMGYMAPESLQTET-ISDKCDIYSFGVLLAVLVMGKFPVDD 270
C G+ Y APE + + + D++S G++L V+++G+ P DD
Sbjct: 168 -C--GSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDD 210
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 1e-21
Identities = 72/301 (23%), Positives = 123/301 (40%), Gaps = 53/301 (17%)
Query: 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLL 99
+ ++ + +G G +GEV K + + A+ K+I + A +D
Sbjct: 21 AERYNIVCMLGKGSFGEV-LKCK-DRITQQEYAV-KVI-----NKASAKNKDTS------ 66
Query: 100 HWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQD-ILYDVSQGR- 157
I E+ + H NI+ L + + +V E G L D I + + R
Sbjct: 67 -----TILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI---IKRKRF 118
Query: 158 RELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI---DDDMEARISDFGHGK 214
E D A I + + SG+ Y H+ ++HRD+KP N+L+ + D + +I DFG
Sbjct: 119 SEHD--AAR-IIKQVFSGITY---MHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLST 172
Query: 215 LMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGH 274
+GT Y+APE L+ T +KCD++S GV+L +L+ G P F+G
Sbjct: 173 CFQQNTKMKDR---IGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPP---FYGK 225
Query: 275 TEEMDMVKWMRNVI-FSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKD 333
E + + F R I+ ++ L+ K+ P R ++
Sbjct: 226 NEYDILKRVETGKYAFDLPQWRTIS--------DDAKDLIRKMLT----FHPSLRITATQ 273
Query: 334 V 334
Sbjct: 274 C 274
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-21
Identities = 55/238 (23%), Positives = 98/238 (41%), Gaps = 53/238 (22%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQ-----DIDEYSDLLH 100
K +G G +G+V AE G I K ++ A +K + SDL+
Sbjct: 40 GKPLGEGAFGQV-VMAEAVG-------IDKDKPKEAVTVA--VKMLKDDATEKDLSDLV- 88
Query: 101 WKIGAIRSEI-ITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDIL--------- 150
SE+ + +H+NI+ LL + ++ E+ G+L++ L
Sbjct: 89 -------SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGME 141
Query: 151 ---YDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARI 207
++ + +A G+EYL IHRD+ NVL+ ++ +I
Sbjct: 142 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKI 198
Query: 208 SDFGHGKLM-------PDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
+DFG + + + ++ VK +MAPE+L + + D++SFGVL+
Sbjct: 199 ADFGLARDINNIDYYKKTTNGRLPVK-------WMAPEALFDRVYTHQSDVWSFGVLM 249
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-21
Identities = 55/189 (29%), Positives = 85/189 (44%), Gaps = 19/189 (10%)
Query: 106 IRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGR-RELDWPA 164
++ EII RH NI+ ++ P ++ E+ G L + + GR E + A
Sbjct: 63 VQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYE--RICNAGRFSEDE--A 118
Query: 165 RHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEAR--ISDFGHGKLMPDGHAQ 222
R + + SG+ Y CH ++ HRD+K N L+D R I DFG+ K
Sbjct: 119 R-FFFQQLLSGVSY---CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 174
Query: 223 ITVKCMVGTMGYMAPESLQTET-ISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMV 281
+ VGT Y+APE L + D++S GV L V+++G +P +D EE
Sbjct: 175 KST---VGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFED----PEEPRDY 227
Query: 282 KWMRNVIFS 290
+ I S
Sbjct: 228 RKTIQRILS 236
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 2e-21
Identities = 55/235 (23%), Positives = 96/235 (40%), Gaps = 51/235 (21%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGK----MIAIRKLIVDAPMSAAELIKQDIDEYSDLLHW 101
K +G+G +G+V +A G + +A++ L A DE L+
Sbjct: 51 GKTLGAGAFGKV-VEATAFGLGKEDAVLKVAVKMLKSTA----------HADEKEALM-- 97
Query: 102 KIGAIRSEI-ITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDIL---------- 150
SE+ I ++ +H NI+ LL L++ E+ G L + L
Sbjct: 98 ------SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETD 151
Query: 151 YDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDF 210
+ + +A G+ +L IHRD+ NVL+ + A+I DF
Sbjct: 152 PAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDF 208
Query: 211 GHGKLM-------PDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
G + + G+A++ VK +MAPES+ + + D++S+G+LL
Sbjct: 209 GLARDIMNDSNYIVKGNARLPVK-------WMAPESIFDCVYTVQSDVWSYGILL 256
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-21
Identities = 62/274 (22%), Positives = 103/274 (37%), Gaps = 44/274 (16%)
Query: 15 GGSRDRGPTIFSPLVEKQDLAFLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNG----KM 70
G G + D+ F ED ++ + IG G + V + + K+
Sbjct: 1 GSPGISGGGGGILDMADDDVLF---EDVYELCEVIGKGPFSVV-RRCINRETGQQFAVKI 56
Query: 71 IAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLLAHMVR 130
+ + K +S ++ E + +H +I+ LL
Sbjct: 57 VDVAKFTSSPGLS-------------------TEDLKREASICHMLKHPHIVELLETYSS 97
Query: 131 PNCHLLVYEFMKNGSLQD-ILYDVSQGRR--ELDWPARHRIARGIASGLEYLHMCHRPRL 187
+V+EFM L I+ G E A H R I L Y CH +
Sbjct: 98 DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAV--ASH-YMRQILEALRY---CHDNNI 151
Query: 188 IHRDIKPANVLI---DDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTET 244
IHRD+KP VL+ ++ ++ FG + + + VGT +MAPE ++ E
Sbjct: 152 IHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES--GLVAGGRVGTPHFMAPEVVKREP 209
Query: 245 ISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEM 278
D++ GV+L +L+ G P F+G E +
Sbjct: 210 YGKPVDVWGCGVILFILLSGCLP---FYGTKERL 240
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-21
Identities = 53/239 (22%), Positives = 89/239 (37%), Gaps = 49/239 (20%)
Query: 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAI 106
+G G +G+V K L A++ I+ K+ + + +
Sbjct: 11 DLLGEGSYGKV--KEVLDSETLCRRAVK--ILK---------KKKLRRIPNGE----ANV 53
Query: 107 RSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDIL----YDVSQGRREL-D 161
+ EI + RH+N++ L + + N Q + Y G +E+ D
Sbjct: 54 KKEIQLLRRLRHKNVIQL-------------VDVLYNEEKQKMYMVMEY-CVCGMQEMLD 99
Query: 162 WPARHRI----ARG----IASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHG 213
R A G + GLEY H ++H+DIKP N+L+ +IS G
Sbjct: 100 SVPEKRFPVCQAHGYFCQLIDGLEY---LHSQGIVHKDIKPGNLLLTTGGTLKISALGVA 156
Query: 214 KLMPDGHAQITVKCMVGTMGYMAPESLQTETISD--KCDIYSFGVLLAVLVMGKFPVDD 270
+ + A T + G+ + PE K DI+S GV L + G +P +
Sbjct: 157 EALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG 215
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-21
Identities = 57/306 (18%), Positives = 111/306 (36%), Gaps = 65/306 (21%)
Query: 40 EDCFDSLKKIGSGGWGEVFYKAELPGSN----GKMIAIRKLIVDAPMSAAELIKQDIDEY 95
+ + + +G G +G V ++ S K + ++ D
Sbjct: 4 YEKYMIAEDLGRGEFGIV-HRCVETSSKKTYMAKFVKVKG--------------TDQVL- 47
Query: 96 SDLLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQ 155
++ EI N RHRNIL L ++++EF+ + + + +
Sbjct: 48 ----------VKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAF 97
Query: 156 GRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEA--RISDFGHG 213
E + + L++ H + H DI+P N++ + +I +FG
Sbjct: 98 ELNERE--IVS-YVHQVCEALQF---LHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQA 151
Query: 214 KLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFG 273
+ + G + + Y APE Q + +S D++S G L+ VL+ G P F
Sbjct: 152 RQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP---FLA 205
Query: 274 HTEEMDMVKWMRNVI-----FSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDER 328
T + + + N++ F E + I+ E M V +L K+ R
Sbjct: 206 ETNQ----QIIENIMNAEYTFDEEAFKEIS--------IEAMDFVDRLLV----KERKSR 249
Query: 329 PSSKDV 334
++ +
Sbjct: 250 MTASEA 255
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-21
Identities = 59/249 (23%), Positives = 108/249 (43%), Gaps = 39/249 (15%)
Query: 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLL 99
D +D +++G G + V + + G A K+I + +L +D
Sbjct: 28 SDNYDVKEELGKGAFSVV-RRCVHK-TTGLEFAA-KII-----NTKKLSARDFQ------ 73
Query: 100 HWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGR-R 158
+ E + +H NI+ L + + H LV++ + G L + + V++
Sbjct: 74 -----KLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI--VAREFYS 126
Query: 159 ELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI---DDDMEARISDFGHGKL 215
E D A H + I + Y CH ++HR++KP N+L+ +++DFG
Sbjct: 127 EAD--ASH-CIQQILESIAY---CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180
Query: 216 MPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHT 275
+ D A GT GY++PE L+ + S DI++ GV+L +L++G P F+
Sbjct: 181 VNDSEAWHGF---AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP---FWDED 234
Query: 276 EE--MDMVK 282
+ +K
Sbjct: 235 QHRLYAQIK 243
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-21
Identities = 57/238 (23%), Positives = 98/238 (41%), Gaps = 54/238 (22%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGK----MIAIRKLIVDAPMSAAELIKQDIDEYSDLLHW 101
K +G G +G+V +A+ G + +A++ L A E+ L+
Sbjct: 32 GKPLGRGAFGQV-IEADAFGIDKTATCRTVAVKMLKEGA----------THSEHRALM-- 78
Query: 102 KIGAIRSEI-ITANQTRHRNILPLLAHMVRPNCHLLV-YEFMKNGSLQDIL--------- 150
SE+ I + H N++ LL +P L+V EF K G+L L
Sbjct: 79 ------SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 132
Query: 151 ---YDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARI 207
+ L + +A G+E+L + IHRD+ N+L+ + +I
Sbjct: 133 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKI 189
Query: 208 SDFGHGKLM-------PDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
DFG + + G A++ +K +MAPE++ + + D++SFGVLL
Sbjct: 190 CDFGLARDIYKDPDYVRKGDARLPLK-------WMAPETIFDRVYTIQSDVWSFGVLL 240
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 4e-21
Identities = 63/243 (25%), Positives = 108/243 (44%), Gaps = 42/243 (17%)
Query: 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLL 99
F ++ +GSG + EV + + GK+ A+ K I +P ++ +I +L
Sbjct: 8 RKTFIFMEVLGSGAFSEV-FLVK-QRLTGKLFAL-KCIKKSPAFRDSSLENEIA----VL 60
Query: 100 HWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQD-ILYDVSQGR- 157
+ +H NI+ L + LV + + G L D I + +G
Sbjct: 61 K--------------KIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRI---LERGVY 103
Query: 158 RELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI---DDDMEARISDFGHGK 214
E D A + + + S ++Y H ++HRD+KP N+L +++ + I+DFG K
Sbjct: 104 TEKD--ASL-VIQQVLSAVKY---LHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK 157
Query: 215 LMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGH 274
+ +G + GT GY+APE L + S D +S GV+ +L+ G P F+
Sbjct: 158 MEQNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP---FYEE 210
Query: 275 TEE 277
TE
Sbjct: 211 TES 213
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 5e-21
Identities = 51/236 (21%), Positives = 98/236 (41%), Gaps = 52/236 (22%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGK----MIAIRKLIVDAPMSAAELIKQDIDEYSDLLHW 101
++++G +G+V YK L G +AI+ L A +
Sbjct: 14 MEELGEDRFGKV-YKGHLFGPAPGEQTQAVAIKTLKDKAEG----------PLREEFR-- 60
Query: 102 KIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDIL----------- 150
E + + +H N++ LL + + +++ + +G L + L
Sbjct: 61 ------HEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGS 114
Query: 151 -YDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISD 209
D + L+ P + IA+G+EYL H ++H+D+ NVL+ D + +ISD
Sbjct: 115 TDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISD 171
Query: 210 FGHGKLMPD-------GHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
G + + G++ + ++ +MAPE++ S DI+S+GV+L
Sbjct: 172 LGLFREVYAADYYKLLGNSLLPIR-------WMAPEAIMYGKFSIDSDIWSYGVVL 220
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 6e-21
Identities = 55/238 (23%), Positives = 98/238 (41%), Gaps = 53/238 (22%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQ-----DIDEYSDLLH 100
K +G G +G+V AE G I K ++ A +K + SDL+
Sbjct: 86 GKPLGEGCFGQV-VMAEAVG-------IDKDKPKEAVTVA--VKMLKDDATEKDLSDLV- 134
Query: 101 WKIGAIRSEI-ITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDIL--------- 150
SE+ + +H+NI+ LL + ++ E+ G+L++ L
Sbjct: 135 -------SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGME 187
Query: 151 ---YDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARI 207
++ + +A G+EYL IHRD+ NVL+ ++ +I
Sbjct: 188 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKI 244
Query: 208 SDFGHGKLM-------PDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
+DFG + + + ++ VK +MAPE+L + + D++SFGVL+
Sbjct: 245 ADFGLARDINNIDYYKKTTNGRLPVK-------WMAPEALFDRVYTHQSDVWSFGVLM 295
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 7e-21
Identities = 59/320 (18%), Positives = 126/320 (39%), Gaps = 55/320 (17%)
Query: 26 SPLVEKQDLAFLKKEDCFD----SLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAP 81
+ ++L F E+ + + K++G G + V + S G+ A K +
Sbjct: 10 GVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVV-RQCI-SKSTGQEYAA-KFL---- 62
Query: 82 MSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR-NILPLLAHMVRPNCHLLVYEF 140
+ E I EI + ++ L + +L+ E+
Sbjct: 63 -KKRRRGQDCRAE-----------ILHEIAVLELAKSCPRVINLHEVYENTSEIILILEY 110
Query: 141 MKNGSLQD-ILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI 199
G + L ++++ E D + + I G+ Y H+ ++H D+KP N+L+
Sbjct: 111 AAGGEIFSLCLPELAEMVSEND--VIR-LIKQILEGVYY---LHQNNIVHLDLKPQNILL 164
Query: 200 ---DDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGV 256
+ +I DFG + + ++ ++GT Y+APE L + I+ D+++ G+
Sbjct: 165 SSIYPLGDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGI 221
Query: 257 LLAVLVMGKFPVDDFFGHTEE--MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVL 314
+ +L+ P F G + + + NV +SE +++ + +
Sbjct: 222 IAYMLLTHTSP---FVGEDNQETYLNISQV-NVDYSEETFSSVS--------QLATDFIQ 269
Query: 315 KLACFCTLKDPDERPSSKDV 334
L K+P++RP+++
Sbjct: 270 SLLV----KNPEKRPTAEIC 285
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 1e-20
Identities = 56/230 (24%), Positives = 90/230 (39%), Gaps = 46/230 (20%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGK----MIAIRKLIVDAPMSAAELIKQDIDEYSDLLHW 101
++ +G G +GEV Y+ ++ G +A++ L + D L
Sbjct: 35 IRGLGHGAFGEV-YEGQVSGMPNDPSPLQVAVKTLPEVCSE----------QDELDFL-- 81
Query: 102 KIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYD---VSQGRR 158
E + ++ H+NI+ + ++ ++ E M G L+ L +
Sbjct: 82 ------MEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPS 135
Query: 159 ELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID---DDMEARISDFGHGKL 215
L +AR IA G +YL H IHRDI N L+ A+I DFG +
Sbjct: 136 SLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 192
Query: 216 MPD-------GHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
+ G A + VK +M PE+ + K D +SFGVLL
Sbjct: 193 IYRASYYRKGGCAMLPVK-------WMPPEAFMEGIFTSKTDTWSFGVLL 235
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-20
Identities = 52/183 (28%), Positives = 81/183 (44%), Gaps = 23/183 (12%)
Query: 108 SEIITANQTRH----RNILPLLAH--MVR-------PNCHLLVYEFMKNGSLQDILYDVS 154
II N+ + R+++ L H V+ + KNG L L +
Sbjct: 66 RHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL---LKYIR 122
Query: 155 QGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGK 214
+ + R A I S LEYLH +IHRD+KP N+L+++DM +I+DFG K
Sbjct: 123 KIGSFDETCTRFYTAE-IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAK 178
Query: 215 LMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGH 274
++ Q VGT Y++PE L ++ D+++ G ++ LV G P F
Sbjct: 179 VLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP---FRAG 235
Query: 275 TEE 277
E
Sbjct: 236 NEY 238
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-20
Identities = 50/181 (27%), Positives = 79/181 (43%), Gaps = 20/181 (11%)
Query: 102 KIGAIRSEI-ITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQD-ILYDVSQGR-R 158
+ EI H NI+ L LV E + G L + I +
Sbjct: 48 MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERI---KKKKHFS 104
Query: 159 ELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI---DDDMEARISDFGHGKL 215
E + A + I R + S + + H ++HRD+KP N+L +D++E +I DFG +L
Sbjct: 105 ETE--ASY-IMRKLVSAVSH---MHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL 158
Query: 216 MPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHT 275
P + + C T+ Y APE L + CD++S GV+L ++ G+ P F H
Sbjct: 159 KPPDNQPLKTPC--FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVP---FQSHD 213
Query: 276 E 276
Sbjct: 214 R 214
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 1e-20
Identities = 59/239 (24%), Positives = 99/239 (41%), Gaps = 55/239 (23%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGK------MIAIRKLIVDAPMSAAELIKQDIDEYSDLL 99
K +G G +G+V AE G + +A++ L DA + SDL+
Sbjct: 74 GKPLGEGAFGQV-VLAEAIGLDKDKPNRVTKVAVKMLKSDATEK----------DLSDLI 122
Query: 100 HWKIGAIRSEI-ITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDIL-------- 150
SE+ + +H+NI+ LL + ++ E+ G+L++ L
Sbjct: 123 --------SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 174
Query: 151 ----YDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEAR 206
+L A +A G+EYL IHRD+ NVL+ +D +
Sbjct: 175 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMK 231
Query: 207 ISDFGHGKLM-------PDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
I+DFG + + + ++ VK +MAPE+L + + D++SFGVLL
Sbjct: 232 IADFGLARDIHHIDYYKKTTNGRLPVK-------WMAPEALFDRIYTHQSDVWSFGVLL 283
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 1e-20
Identities = 56/230 (24%), Positives = 90/230 (39%), Gaps = 46/230 (20%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGK----MIAIRKLIVDAPMSAAELIKQDIDEYSDLLHW 101
++ +G G +GEV Y+ ++ G +A++ L + D L
Sbjct: 76 IRGLGHGAFGEV-YEGQVSGMPNDPSPLQVAVKTLPEVCSE----------QDELDFL-- 122
Query: 102 KIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYD---VSQGRR 158
E + ++ H+NI+ + ++ ++ E M G L+ L +
Sbjct: 123 ------MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS 176
Query: 159 ELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID---DDMEARISDFGHGKL 215
L +AR IA G +YL H IHRDI N L+ A+I DFG +
Sbjct: 177 SLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 233
Query: 216 MPD-------GHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
+ G A + VK +M PE+ + K D +SFGVLL
Sbjct: 234 IYRAGYYRKGGCAMLPVK-------WMPPEAFMEGIFTSKTDTWSFGVLL 276
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-20
Identities = 64/246 (26%), Positives = 97/246 (39%), Gaps = 43/246 (17%)
Query: 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLL 99
D F+ ++G G V Y+ + K A++ L D
Sbjct: 52 SDFFEVESELGRGATSIV-YRCK-QKGTQKPYALKVL----------KKTVDKK------ 93
Query: 100 HWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQD-ILYDVSQGR- 157
+R+EI + H NI+ L P LV E + G L D I V +G
Sbjct: 94 -----IVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRI---VEKGYY 145
Query: 158 RELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI---DDDMEARISDFGHGK 214
E D A + I + Y H ++HRD+KP N+L D +I+DFG K
Sbjct: 146 SERD--AAD-AVKQILEAVAY---LHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSK 199
Query: 215 LMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGH 274
++ TV GT GY APE L+ + D++S G++ +L+ G P F+
Sbjct: 200 IVEHQVLMKTV---CGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEP---FYDE 253
Query: 275 TEEMDM 280
+ M
Sbjct: 254 RGDQFM 259
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 7e-20
Identities = 56/261 (21%), Positives = 98/261 (37%), Gaps = 47/261 (18%)
Query: 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAI 106
+G G V L + A+ K+I P + ++++ + ++
Sbjct: 19 DVLGEGAHARVQTCINL--ITSQEYAV-KIIEKQPGHIRSRVFREVE-----MLYQCQG- 69
Query: 107 RSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQD-ILYDVSQGR-RELDWPA 164
HRN+L L+ + LV+E M+ GS+ I + EL+ A
Sbjct: 70 -----------HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHI---HKRRHFNELE--A 113
Query: 165 RHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI---DDDMEARISDFGHGKLMPDGHA 221
+ + +AS L++ H + HRD+KP N+L + +I DF G +
Sbjct: 114 SV-VVQDVASALDF---LHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD 169
Query: 222 QITVKC-----MVGTMGYMAPESLQTETISDK-----CDIYSFGVLLAVLVMGKFPVDDF 271
+ G+ YMAPE ++ + CD++S GV+L +L+ G P F
Sbjct: 170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP---F 226
Query: 272 FGHTEEMDMVKWMRNVIFSEN 292
G +N
Sbjct: 227 VGRCGSDCGWDRGEACPACQN 247
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 1e-19
Identities = 60/249 (24%), Positives = 102/249 (40%), Gaps = 46/249 (18%)
Query: 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAI 106
+ +G G G+V G+ A+ KL+ D+P +Q++D HW+
Sbjct: 35 QVLGLGVNGKVLECFHR--RTGQKCAL-KLLYDSPK-----ARQEVD-----HHWQAS-- 79
Query: 107 RSEIITANQTRHRNILPLLA----HMVRPNCHLLVYEFMKNGSLQD-ILYDVSQGRRELD 161
+I+ +L C L++ E M+ G L I Q E +
Sbjct: 80 ----------GGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTERE 129
Query: 162 WPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI---DDDMEARISDFGHGKLMPD 218
A I R I + +++ H + HRD+KP N+L + D +++DFG K
Sbjct: 130 --AAE-IMRDIGTAIQF---LHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ 183
Query: 219 GHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEM 278
++ T Y+APE L E CD++S GV++ +L+ G P F+ +T +
Sbjct: 184 N----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP---FYSNTGQA 236
Query: 279 DMVKWMRNV 287
R +
Sbjct: 237 ISPGMKRRI 245
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 1e-19
Identities = 52/171 (30%), Positives = 76/171 (44%), Gaps = 24/171 (14%)
Query: 117 RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQD-ILYDVSQGR---RELDWPARHRIARGI 172
+H NI+ L +V E MK G L D I + Q RE A + I
Sbjct: 74 QHPNIITLKDVYDDGKYVYVVTELMKGGELLDKI---LRQKFFSERE----ASA-VLFTI 125
Query: 173 ASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEA----RISDFGHGKLMPDGHAQITVKCM 228
+EYLH ++HRD+KP+N+L D+ RI DFG K + + + C
Sbjct: 126 TKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC- 181
Query: 229 VGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMD 279
T ++APE L+ + CDI+S GVLL ++ G P F ++
Sbjct: 182 -YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP---FANGPDDTP 228
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-19
Identities = 58/244 (23%), Positives = 94/244 (38%), Gaps = 60/244 (24%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGK----MIAIRKLIVDAPMSAAELIKQDIDEYSDLLHW 101
K +GSG +G+V A G + +A++ L A D E L+
Sbjct: 50 GKVLGSGAFGKV-MNATAYGISKTGVSIQVAVKMLKEKA----------DSSEREALM-- 96
Query: 102 KIGAIRSEI-ITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDIL---------- 150
SE+ + H NI+ LL L++E+ G L + L
Sbjct: 97 ------SELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSED 150
Query: 151 ---------YDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDD 201
+ + L + A +A G+E+L +HRD+ NVL+
Sbjct: 151 EIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTH 207
Query: 202 DMEARISDFGHGKLMPD-------GHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSF 254
+I DFG + + G+A++ VK +MAPESL + K D++S+
Sbjct: 208 GKVVKICDFGLARDIMSDSNYVVRGNARLPVK-------WMAPESLFEGIYTIKSDVWSY 260
Query: 255 GVLL 258
G+LL
Sbjct: 261 GILL 264
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-19
Identities = 39/227 (17%), Positives = 86/227 (37%), Gaps = 45/227 (19%)
Query: 46 LKKIGSGGWGEVFY-KAELPGSNGKMIAIR---KLIVDAPMSAAELIKQDIDEYSDLLHW 101
+ +G G + ++F G G++ K++ A + +E
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSE----------SFF-- 60
Query: 102 KIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELD 161
++ H++++ V + ++LV EF+K GSL L + ++
Sbjct: 61 ------EAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK---NKNCIN 111
Query: 162 WPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEAR--------ISDFGHG 213
+ +A+ +A+ + +L LIH ++ N+L+ + + + +SD G
Sbjct: 112 ILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS 168
Query: 214 KLM-PDGHAQITVKCMVGTMGYMAPESLQTETI-SDKCDIYSFGVLL 258
+ P Q + ++ PE ++ + D +SFG L
Sbjct: 169 ITVLPKDILQERIP-------WVPPECIENPKNLNLATDKWSFGTTL 208
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 4e-19
Identities = 55/244 (22%), Positives = 97/244 (39%), Gaps = 60/244 (24%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGK----MIAIRKLIVDAPMSAAELIKQDIDEYSDLLHW 101
++ IG G +G V ++A PG M+A++ L +A +D
Sbjct: 52 VRDIGEGAFGRV-FQARAPGLLPYEPFTMVAVKMLKEEASAD----------MQADFQ-- 98
Query: 102 KIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDIL----------- 150
E + + NI+ LL L++E+M G L + L
Sbjct: 99 ------REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSL 152
Query: 151 ---------YDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDD 201
S G L + IAR +A+G+ YL +HRD+ N L+ +
Sbjct: 153 SHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGE 209
Query: 202 DMEARISDFGHGKLM-------PDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSF 254
+M +I+DFG + + DG+ I ++ +M PES+ + + D++++
Sbjct: 210 NMVVKIADFGLSRNIYSADYYKADGNDAIPIR-------WMPPESIFYNRYTTESDVWAY 262
Query: 255 GVLL 258
GV+L
Sbjct: 263 GVVL 266
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 5e-19
Identities = 61/244 (25%), Positives = 95/244 (38%), Gaps = 60/244 (24%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGK----MIAIRKLIVDAPMSAAELIKQDIDEYSDLLHW 101
K +G G +G+V KA G+ +A++ L +A E DLL
Sbjct: 28 GKTLGEGEFGKV-VKATAFHLKGRAGYTTVAVKMLKENA----------SPSELRDLL-- 74
Query: 102 KIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDIL----------- 150
SE Q H +++ L + LL+ E+ K GSL+ L
Sbjct: 75 ------SEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYL 128
Query: 151 ---------YDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDD 201
R L A I+ G++YL +L+HRD+ N+L+ +
Sbjct: 129 GSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAE 185
Query: 202 DMEARISDFGHGKLM-------PDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSF 254
+ +ISDFG + + +I VK +MA ESL + + D++SF
Sbjct: 186 GRKMKISDFGLSRDVYEEDSYVKRSQGRIPVK-------WMAIESLFDHIYTTQSDVWSF 238
Query: 255 GVLL 258
GVLL
Sbjct: 239 GVLL 242
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 5e-19
Identities = 51/250 (20%), Positives = 101/250 (40%), Gaps = 40/250 (16%)
Query: 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLL 99
+ + +++G G + V + G+ A +I +SA +
Sbjct: 10 TEEYQLFEELGKGAFSVV-RRCV-KVLAGQEYAA-MIINTKKLSARD------------- 53
Query: 100 HWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQD-ILYDVSQGR- 157
+ E +H NI+ L + H L+++ + G L + I V++
Sbjct: 54 ---HQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDI---VAREYY 107
Query: 158 RELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI---DDDMEARISDFGHGK 214
E D A H + I + + CH+ ++HR++KP N+L+ +++DFG
Sbjct: 108 SEAD--ASH-CIQQILEAVLH---CHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161
Query: 215 LMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGH 274
+ GT GY++PE L+ + D+++ GV+L +L++G P F+
Sbjct: 162 EVEGEQQAWFGFA--GTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP---FWDE 216
Query: 275 TEE--MDMVK 282
+ +K
Sbjct: 217 DQHRLYQQIK 226
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 8e-19
Identities = 56/257 (21%), Positives = 95/257 (36%), Gaps = 68/257 (26%)
Query: 41 DCFDSLKKIGSGGWGEVF---YKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSD 97
D F+ L+ IG G +G+V KM A++ + KQ
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKN-----DTKKMYAMK-----------YMNKQ------- 51
Query: 98 LLHWKIGAIRSEIITANQTRH----RNILPLLAH--MVR--------PNCHLLVYEFMKN 143
+ + N+ R+ I+ L H +V + + V + +
Sbjct: 52 -----------KCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFM-VVDLLLG 99
Query: 144 GSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDM 203
G D+ Y + Q + + I + L+YL +IHRD+KP N+L+D+
Sbjct: 100 G---DLRYHLQQNVHFKEETVKLFICE-LVMALDYLQNQR---IIHRDMKPDNILLDEHG 152
Query: 204 EARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETIS--DKC-DIYSFGVLLAV 260
I+DF ++P T+ GT YMAPE + + D +S GV
Sbjct: 153 HVHITDFNIAAMLPRETQITTM-A--GTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYE 209
Query: 261 LVMGKFPVDDFFGHTEE 277
L+ G+ P + +
Sbjct: 210 LLRGRRP---YHIRSST 223
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 5e-18
Identities = 41/169 (24%), Positives = 71/169 (42%), Gaps = 24/169 (14%)
Query: 102 KIGAIRSEI-ITANQTRHRNILPLLA----HMVRPNCHLLVYEFMKNGSLQD-ILYDVSQ 155
R E+ + ++ +I+ ++ C L+V E + G L I +
Sbjct: 97 DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI---QDR 153
Query: 156 GRR---ELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI---DDDMEARISD 209
G + E + A I + I ++Y H + HRD+KP N+L + +++D
Sbjct: 154 GDQAFTERE--ASE-IMKSIGEAIQY---LHSINIAHRDVKPENLLYTSKRPNAILKLTD 207
Query: 210 FGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
FG K ++ T T Y+APE L E CD++S GV++
Sbjct: 208 FGFAKETTSHNSLTTP---CYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 5e-18
Identities = 71/292 (24%), Positives = 115/292 (39%), Gaps = 51/292 (17%)
Query: 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLH 100
+ +++L +G G +G V K G+++AI+K + D+
Sbjct: 25 EKYENLGLVGEGSYGMV-MKCR-NKDTGRIVAIKK------------FLESDDDKMV--- 67
Query: 101 WKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRREL 160
K A+R EI Q RH N++ LL + LV+EF+ IL D+ L
Sbjct: 68 -KKIAMR-EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVD----HTILDDLELFPNGL 121
Query: 161 DWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGH 220
D+ + I +G+ + CH +IHRDIKP N+L+ ++ DFG + +
Sbjct: 122 DYQVVQKYLFQIINGIGF---CHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178
Query: 221 AQITVKCMVGTMGYMAPESL-QTETISDKCDIYSFGVLLAVLVMGK--FPVDDFFGHTEE 277
V T Y APE L D+++ G L+ + MG+ FP D +
Sbjct: 179 EVYD--DEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDS------D 230
Query: 278 MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERP 329
+D + I LGN L K F ++ P+ +
Sbjct: 231 IDQLY----HIM----------MCLGNLIPRHQELFNKNPVFAGVRLPEIKE 268
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 7e-18
Identities = 67/252 (26%), Positives = 117/252 (46%), Gaps = 42/252 (16%)
Query: 27 PLVEKQDLAFLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDA-----P 81
+++L F + + L+K+G G +G V YKA+ S G+++A++++ +DA P
Sbjct: 7 HSSGRENLYFQGLMEKYQKLEKVGEGTYGVV-YKAK--DSQGRIVALKRIRLDAEDEGIP 63
Query: 82 MSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFM 141
+A IR EI + H NI+ L+ + C LV+EFM
Sbjct: 64 STA---------------------IR-EISLLKELHHPNIVSLIDVIHSERCLTLVFEFM 101
Query: 142 KNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDD 201
+ +D+ + + + L + G+ + CH+ R++HRD+KP N+LI+
Sbjct: 102 E----KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAH---CHQHRILHRDLKPQNLLINS 154
Query: 202 DMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESL-QTETISDKCDIYSFGVLLAV 260
D +++DFG + T V T+ Y AP+ L ++ S DI+S G + A
Sbjct: 155 DGALKLADFGLARAFGIPVRSYT--HEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAE 212
Query: 261 LVMGK--FPVDD 270
++ GK FP
Sbjct: 213 MITGKPLFPGVT 224
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 2e-17
Identities = 65/271 (23%), Positives = 110/271 (40%), Gaps = 60/271 (22%)
Query: 25 FSPLVEKQDLAFLKKEDCFDSLKKIGSGGWGEVF---YKAELPGSNGKMIAIRKLIVDAP 81
P K L +ED F+ LK IG G +GEV K + K+ A++ L
Sbjct: 59 AKPFTSKVKQMRLHRED-FEILKVIGRGAFGEVAVVKLK-----NADKVFAMKILN---- 108
Query: 82 MSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLLAH--MVRPNC------ 133
K ++ + ++ R E R++L + +
Sbjct: 109 -------KWEMLKRAETAC-----FREE---------RDVLVNGDSKWITTLHYAFQDDN 147
Query: 134 HL-LVYEFMKNGSLQDILYDVSQGRRELDWP-ARHRIARGIASGLEYLHMCHRPRLIHRD 191
+L LV ++ G D+L +S+ L AR +A + ++ +H H +HRD
Sbjct: 148 NLYLVMDYYVGG---DLLTLLSKFEDRLPEEMARFYLAE-MVIAIDSVHQLH---YVHRD 200
Query: 192 IKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDK--- 248
IKP N+L+D + R++DFG + + + VGT Y++PE LQ
Sbjct: 201 IKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS-SVAVGTPDYISPEILQAMEGGKGRYG 259
Query: 249 --CDIYSFGVLLAVLVMGKFPVDDFFGHTEE 277
CD +S GV + ++ G+ P F+ +
Sbjct: 260 PECDWWSLGVCMYEMLYGETP---FYAESLV 287
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 4e-17
Identities = 72/340 (21%), Positives = 127/340 (37%), Gaps = 73/340 (21%)
Query: 30 EKQDLAFLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIK 89
+ + F + ++ L KIG G +GEV +KA G+ +A++K++++ + E
Sbjct: 6 DSVECPFCDEVSKYEKLAKIGQGTFGEV-FKA-RHRKTGQKVALKKVLME---NEKEGFP 60
Query: 90 QDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHL--------LVYEFM 141
I A+R EI +H N++ L+ LV++F
Sbjct: 61 -------------ITALR-EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFC 106
Query: 142 KNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDD 201
+ D+ +S + R+ + + +GL Y HR +++HRD+K ANVLI
Sbjct: 107 E----HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYY---IHRNKILHRDMKAANVLITR 159
Query: 202 DMEARISDFG----HGKLMPDGHAQITVKCMVGTMGYMAPESL-QTETISDKCDIYSFGV 256
D +++DFG + T V T+ Y PE L D++ G
Sbjct: 160 DGVLKLADFGLARAFSLAKNSQPNRYT--NRVVTLWYRPPELLLGERDYGPPIDLWGAGC 217
Query: 257 LLAVLVMGK--FPVDDFFGHTE--------------------EMDMVKWMRNVIFSENPN 294
++A + G+TE +D + + +
Sbjct: 218 IMAEMWTRSPIMQ-----GNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQK 272
Query: 295 RAINSKLLGNGYEEQML-LVLKLACFCTLKDPDERPSSKD 333
R + +L + L L+ KL DP +R S D
Sbjct: 273 RKVKDRLKAYVRDPYALDLIDKLLVL----DPAQRIDSDD 308
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 4e-17
Identities = 61/250 (24%), Positives = 99/250 (39%), Gaps = 56/250 (22%)
Query: 25 FSPLVEKQDLAFLKKEDCFDSLKKIGSGGWGEVF---YKAELPGSNGKMIAIRKLIVDAP 81
+ + K +K ED ++ +K IG G +GEV +K S K+ A++ L
Sbjct: 54 YKDTINKIRDLRMKAED-YEVVKVIGRGAFGEVQLVRHK-----STRKVYAMKLLS---- 103
Query: 82 MSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLLAH--MVR-------PN 132
K ++ + SD E R+I+ +V+
Sbjct: 104 -------KFEMIKRSDSAF-----FWEE---------RDIMAFANSPWVVQLFYAFQDDR 142
Query: 133 CHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDI 192
+V E+M G D++ +S W AR A + L+ +H IHRD+
Sbjct: 143 YLYMVMEYMPGG---DLVNLMSNYDVPEKW-ARFYTAE-VVLALDAIHSMG---FIHRDV 194
Query: 193 KPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDK---- 248
KP N+L+D +++DFG M VGT Y++PE L+++
Sbjct: 195 KPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC-DTAVGTPDYISPEVLKSQGGDGYYGRE 253
Query: 249 CDIYSFGVLL 258
CD +S GV L
Sbjct: 254 CDWWSVGVFL 263
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 5e-17
Identities = 54/241 (22%), Positives = 103/241 (42%), Gaps = 45/241 (18%)
Query: 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDA-----PMSAAELIKQDIDEY 95
++ + +IG G +G+V +KA + G+ +A++++ V P+S I E
Sbjct: 11 QQYECVAEIGEGAYGKV-FKARDLKNGGRFVALKRVRVQTGEEGMPLST-------IREV 62
Query: 96 SDLLHWKIGAIRSEIITANQTRHRNILPLL-----AHMVRPNCHLLVYEFMKNGSLQDI- 149
+ L H + H N++ L + R LV+E + QD+
Sbjct: 63 AVLRHLE------------TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD----QDLT 106
Query: 150 -LYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARIS 208
D + + + GL++ H R++HRD+KP N+L+ + +++
Sbjct: 107 TYLD-KVPEPGVPTETIKDMMFQLLRGLDF---LHSHRVVHRDLKPQNILVTSSGQIKLA 162
Query: 209 DFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGK--F 266
DFG ++ Q+ + +V T+ Y APE L + + D++S G + A + K F
Sbjct: 163 DFGLARIY---SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF 219
Query: 267 P 267
Sbjct: 220 R 220
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 6e-17
Identities = 65/292 (22%), Positives = 113/292 (38%), Gaps = 51/292 (17%)
Query: 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLH 100
+ ++ + KIG G +G V +K G+++AI+K + D+
Sbjct: 3 EKYEKIGKIGEGSYGVV-FKCR-NRDTGQIVAIKK------------FLESEDDPVI--- 45
Query: 101 WKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRREL 160
K A+R EI Q +H N++ LL R LV+E+ +L+++ + +R +
Sbjct: 46 -KKIALR-EIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCD----HTVLHELDRYQRGV 99
Query: 161 DWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGH 220
I + + CH+ IHRD+KP N+LI ++ DFG +L+
Sbjct: 100 PEHLVKSITWQTLQAVNF---CHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156
Query: 221 AQITVKCMVGTMGYMAPESL-QTETISDKCDIYSFGVLLAVLVMGK--FPVDDFFGHTEE 277
V T Y +PE L D+++ G + A L+ G +P +
Sbjct: 157 DYYD--DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKS------D 208
Query: 278 MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERP 329
+D + +I K LG+ + F +K PD
Sbjct: 209 VDQLY----LIR----------KTLGDLIPRHQQVFSTNQYFSGVKIPDPED 246
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 7e-17
Identities = 52/237 (21%), Positives = 97/237 (40%), Gaps = 40/237 (16%)
Query: 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDA----PMSAAELIKQDIDEYS 96
+ + L K+G G + V YK + ++A++++ ++ P +A
Sbjct: 2 ETYIKLDKLGEGTYATV-YKGKSK-LTDNLVALKEIRLEHEEGAPCTA------------ 47
Query: 97 DLLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQG 156
IR E+ +H NI+ L + LV+E++ L+ L D
Sbjct: 48 ---------IR-EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNI 96
Query: 157 RRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLM 216
++ + GL Y CHR +++HRD+KP N+LI++ E +++DFG +
Sbjct: 97 ---INMHNVKLFLFQLLRGLAY---CHRQKVLHRDLKPQNLLINERGELKLADFGLARAK 150
Query: 217 PDGHAQITVKCMVGTMGYMAPESL-QTETISDKCDIYSFGVLLAVLVMGK--FPVDD 270
V T+ Y P+ L + S + D++ G + + G+ FP
Sbjct: 151 SIPTKTYD--NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST 205
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 1e-16
Identities = 65/242 (26%), Positives = 107/242 (44%), Gaps = 45/242 (18%)
Query: 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDA----PMSAAELIKQDIDEYS 96
F L+K+G+G + V YK L + G +A++++ +D+ P +A
Sbjct: 5 SQFKQLEKLGNGTYATV-YKG-LNKTTGVYVALKEVKLDSEEGTPSTA------------ 50
Query: 97 DLLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQG 156
IR EI + +H NI+ L + N LV+EFM + L+ + + G
Sbjct: 51 ---------IR-EISLMKELKHENIVRLYDVIHTENKLTLVFEFM-DNDLKKYMDSRTVG 99
Query: 157 RRELDWPARH--RIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGK 214
+ GL + CH +++HRD+KP N+LI+ + ++ DFG +
Sbjct: 100 NTPRGLELNLVKYFQWQLLQGLAF---CHENKILHRDLKPQNLLINKRGQLKLGDFGLAR 156
Query: 215 LMPDGHAQITVKCM---VGTMGYMAPESL-QTETISDKCDIYSFGVLLAVLVMGK--FPV 268
I V V T+ Y AP+ L + T S DI+S G +LA ++ GK FP
Sbjct: 157 AF-----GIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPG 211
Query: 269 DD 270
+
Sbjct: 212 TN 213
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 3e-16
Identities = 65/274 (23%), Positives = 110/274 (40%), Gaps = 64/274 (23%)
Query: 25 FSPLVEKQDLAFLKKEDCFDSLKKIGSGGWGEVF---YKAELPGSNGKMIAIRKLIVDAP 81
P+V + L+++D F+ LK IG G + EV K G++ A++ +
Sbjct: 46 AEPIVVRLKEVRLQRDD-FEILKVIGRGAFSEVAVVKMK-----QTGQVYAMKIMN---- 95
Query: 82 MSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLLAH--MVRPNC------ 133
K D+ + ++ R E R++L + + +
Sbjct: 96 -------KWDMLKRGEVSC-----FREE---------RDVLVNGDRRWITQLHFAFQDEN 134
Query: 134 HL-LVYEFMKNGSLQDILYDVSQGRRELDWP-ARHRIARGIASGLEYLHMCHRPRLIHRD 191
+L LV E+ G D+L +S+ + AR +A I ++ +H +HRD
Sbjct: 135 YLYLVMEYYVGG---DLLTLLSKFGERIPAEMARFYLAE-IVMAIDSVHRLG---YVHRD 187
Query: 192 IKPANVLIDDDMEARISDFGHGK-LMPDGHAQITVKCMVGTMGYMAPESLQTETISDK-- 248
IKP N+L+D R++DFG L DG + V GT Y++PE LQ
Sbjct: 188 IKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV--GTPDYLSPEILQAVGGGPGTG 245
Query: 249 -----CDIYSFGVLLAVLVMGKFPVDDFFGHTEE 277
CD ++ GV + G+ P F+ +
Sbjct: 246 SYGPECDWWALGVFAYEMFYGQTP---FYADSTA 276
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 3e-16
Identities = 63/241 (26%), Positives = 107/241 (44%), Gaps = 48/241 (19%)
Query: 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDA-----PMSAAELIKQDIDEY 95
+ + L+KIG G +G V YKA+ + G+ A++K+ ++ P +
Sbjct: 2 EKYHGLEKIGEGTYGVV-YKAQ--NNYGETFALKKIRLEKEDEGIPSTT----------- 47
Query: 96 SDLLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQ 155
IR EI + +H NI+ L + +LV+E + QD+ +
Sbjct: 48 ----------IR-EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD----QDLKKLLDV 92
Query: 156 GRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKL 215
L+ + +G+ Y CH R++HRD+KP N+LI+ + E +I+DFG +
Sbjct: 93 CEGGLESVTAKSFLLQLLNGIAY---CHDRRVLHRDLKPQNLLINREGELKIADFGLARA 149
Query: 216 MPDGHAQITVKCM---VGTMGYMAPESL-QTETISDKCDIYSFGVLLAVLVMGK--FPVD 269
I V+ + T+ Y AP+ L ++ S DI+S G + A +V G FP
Sbjct: 150 F-----GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204
Query: 270 D 270
Sbjct: 205 S 205
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 5e-16
Identities = 61/245 (24%), Positives = 105/245 (42%), Gaps = 47/245 (19%)
Query: 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDA-----PMSAAELIKQDIDEY 95
++ L+KIG G +G V +KA +++A++++ +D P SA
Sbjct: 2 QKYEKLEKIGEGTYGTV-FKA-KNRETHEIVALKRVRLDDDDEGVPSSA----------- 48
Query: 96 SDLLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQ 155
+R EI + +H+NI+ L + LV+EF QD+
Sbjct: 49 ----------LR-EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD----QDLKKYFDS 93
Query: 156 GRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKL 215
+LD + GL + CH ++HRD+KP N+LI+ + E ++++FG +
Sbjct: 94 CNGDLDPEIVKSFLFQLLKGLGF---CHSRNVLHRDLKPQNLLINRNGELKLANFGLARA 150
Query: 216 MPDGHAQITVKCM---VGTMGYMAPESL-QTETISDKCDIYSFGVLLAVLVMGKFPVDDF 271
I V+C V T+ Y P+ L + S D++S G + A L P+ F
Sbjct: 151 F-----GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL--F 203
Query: 272 FGHTE 276
G+
Sbjct: 204 PGNDV 208
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 7e-16
Identities = 39/289 (13%), Positives = 80/289 (27%), Gaps = 73/289 (25%)
Query: 46 LKKIGSGGWGEVFYKAE---LPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
L G + ++A L + +A+ VD + + Q
Sbjct: 36 LIFHGGVPPLQF-WQALDTAL----DRQVALT--FVDPQGVLPDDVLQ------------ 76
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDW 162
S + ++ + +L + L+V E+++ GSLQ++
Sbjct: 77 --ETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA------DTSPSP 128
Query: 163 PARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQ 222
R + +A+ + H R + P+ V + DG
Sbjct: 129 VGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVS----------------IDGDV- 168
Query: 223 ITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVK 282
++ M + Q DI G L L++ ++P +
Sbjct: 169 -----VLAYPATMPDANPQD-------DIRGIGASLYALLVNRWP---LPEAGVRSGLAP 213
Query: 283 WMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSS 331
R+ I+ + + +A D R +S
Sbjct: 214 AERDTAGQPIEPADIDRDIPFQ--------ISAVAARSVQGDGGIRSAS 254
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 1e-15
Identities = 62/241 (25%), Positives = 105/241 (43%), Gaps = 37/241 (15%)
Query: 41 DCFDSLKKIGSGGWGEVF---YKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSD 97
+ F+ LK +G G +G+V KA G+ A++ L K+ I +
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKA-----TGRYYAMKILK-----------KEVIVAKDE 191
Query: 98 LLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGR 157
+ H +E +RH + L + V E+ G ++ + +S+ R
Sbjct: 192 VAH-----TLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG---ELFFHLSRER 243
Query: 158 RELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKL-M 216
+ AR A I S L+YLH +++RD+K N+++D D +I+DFG K +
Sbjct: 244 VFSEDRARFYGAE-IVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300
Query: 217 PDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTE 276
DG T+K GT Y+APE L+ D + GV++ ++ G+ P F+
Sbjct: 301 KDGA---TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP---FYNQDH 354
Query: 277 E 277
E
Sbjct: 355 E 355
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 5e-15
Identities = 61/230 (26%), Positives = 100/230 (43%), Gaps = 28/230 (12%)
Query: 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLH 100
++ L +G G + V YKA + +++AI+K+ + A + I
Sbjct: 10 KRYEKLDFLGEGQFATV-YKARDK-NTNQIVAIKKIKLGHRSEAKDGIN----------- 56
Query: 101 WKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRREL 160
A+R EI + H NI+ LL + LV++FM+ L+ I+ D S L
Sbjct: 57 --RTALR-EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLV---L 109
Query: 161 DWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGH 220
GLEY H+ ++HRD+KP N+L+D++ +++DFG K +
Sbjct: 110 TPSHIKAYMLMTLQGLEY---LHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 166
Query: 221 AQITVKCMVGTMGYMAPESL-QTETISDKCDIYSFGVLLAVLVMGK--FP 267
T V T Y APE L D+++ G +LA L++ P
Sbjct: 167 RAYT--HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLP 214
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 7e-15
Identities = 56/246 (22%), Positives = 100/246 (40%), Gaps = 53/246 (21%)
Query: 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDA-----PMSAAELIKQDIDEY 95
D + + K+G G +GEV YKA + +AI+++ ++ P +A
Sbjct: 34 DRYRRITKLGEGTYGEV-YKAI-DTVTNETVAIKRIRLEHEEEGVPGTA----------- 80
Query: 96 SDLLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQ 155
IR E+ + +HRNI+ L + + + L++E+ + D L
Sbjct: 81 ----------IR-EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE----ND-LKKYMD 124
Query: 156 GRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEAR-----ISDF 210
++ + +G+ + CH R +HRD+KP N+L+ + I DF
Sbjct: 125 KNPDVSMRVIKSFLYQLINGVNF---CHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDF 181
Query: 211 GHGKLMPDGHAQITVKCM---VGTMGYMAPESL-QTETISDKCDIYSFGVLLAVLVMGK- 265
G + I ++ + T+ Y PE L + S DI+S + A ++M
Sbjct: 182 GLARAF-----GIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTP 236
Query: 266 -FPVDD 270
FP D
Sbjct: 237 LFPGDS 242
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 8e-15
Identities = 54/237 (22%), Positives = 96/237 (40%), Gaps = 35/237 (14%)
Query: 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLH 100
++ + +IG G +G V YKA +G +A++ + V L
Sbjct: 9 SRYEPVAEIGVGAYGTV-YKA-RDPHSGHFVALKSVRVPNG-----------GGGGGGLP 55
Query: 101 WKIGAIRSEIIT---ANQTRHRNILPLL--AHMVRPNCHL---LVYEFMKNGSLQDILYD 152
I +R E+ H N++ L+ R + + LV+E + L+ L
Sbjct: 56 --ISTVR-EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDK 111
Query: 153 VSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGH 212
L + R GL++ H ++HRD+KP N+L+ +++DFG
Sbjct: 112 APP--PGLPAETIKDLMRQFLRGLDF---LHANCIVHRDLKPENILVTSGGTVKLADFGL 166
Query: 213 GKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGK--FP 267
++ Q+ + +V T+ Y APE L T + D++S G + A + K F
Sbjct: 167 ARIY---SYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFC 220
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 2e-14
Identities = 63/242 (26%), Positives = 102/242 (42%), Gaps = 50/242 (20%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
+ +LK IGSG G V A + +AI+KL + + H K
Sbjct: 27 YQNLKPIGSGAQGIV-CAAYDAIL-ERNVAIKKLS---------------RPFQNQTHAK 69
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHL-------LVYEFMKNGSLQDILYDVSQ 155
A R E++ H+NI+ LL ++ P L +V E M + +L ++
Sbjct: 70 -RAYR-ELVLMKCVNHKNIIGLL-NVFTPQKSLEEFQDVYIVMELM-DANLCQVI----- 120
Query: 156 GRRELDWPARHR-IARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGK 214
+ ELD R + + G+++LH +IHRD+KP+N+++ D +I DFG +
Sbjct: 121 -QMELD-HERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 175
Query: 215 LMPDGHAQITVKCM---VGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGK--FPVD 269
M V T Y APE + + DI+S G ++ ++ G FP
Sbjct: 176 TAGTSFM------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 229
Query: 270 DF 271
D
Sbjct: 230 DH 231
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 6e-14
Identities = 56/258 (21%), Positives = 101/258 (39%), Gaps = 43/258 (16%)
Query: 30 EKQDLAFLKKEDCFDSLK-KIGSGGWGEVFYKA-ELPGSNGKMIAIRKL-IVDAPMSAAE 86
K + ED F+ K+G G +G V YKA G + K A++++ MSA
Sbjct: 9 VKLSSERERVEDLFEYEGCKVGRGTYGHV-YKAKRKDGKDDKDYALKQIEGTGISMSA-- 65
Query: 87 LIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLL-AHMVRPNCHL-LVYEFMKN- 143
R EI + +H N++ L + + + L++++ ++
Sbjct: 66 -------------------CR-EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHD 105
Query: 144 -GSLQDILYDVSQGRRELDWPARHR--IARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200
+ ++ + P + I G+ Y H ++HRD+KPAN+L+
Sbjct: 106 LWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY---LHANWVLHRDLKPANILVM 162
Query: 201 DDMEAR----ISDFGHGKLMPDGHAQIT-VKCMVGTMGYMAPESL-QTETISDKCDIYSF 254
+ R I+D G +L + + +V T Y APE L + DI++
Sbjct: 163 GEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAI 222
Query: 255 GVLLAVLVMGK--FPVDD 270
G + A L+ + F
Sbjct: 223 GCIFAELLTSEPIFHCRQ 240
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 71.2 bits (174), Expect = 8e-14
Identities = 62/239 (25%), Positives = 105/239 (43%), Gaps = 33/239 (13%)
Query: 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLH 100
F+ L +G G +G+V +E G+ ++ A++ L K + + D+
Sbjct: 341 TDFNFLMVLGKGSFGKVM-LSERKGT-DELYAVKILK-----------KDVVIQDDDVEC 387
Query: 101 WKIGAIRSE-IITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRE 159
E + A + + L + + V E++ G D++Y + Q R
Sbjct: 388 -----TMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGG---DLMYHIQQVGRF 439
Query: 160 LDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKL-MPD 218
+ A A IA GL +L +I+RD+K NV++D + +I+DFG K + D
Sbjct: 440 KEPHAVFYAAE-IAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 495
Query: 219 GHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEE 277
G T K GT Y+APE + + D ++FGVLL ++ G+ P F G E+
Sbjct: 496 GV---TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP---FEGEDED 548
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 8e-14
Identities = 61/242 (25%), Positives = 98/242 (40%), Gaps = 50/242 (20%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
+ +LK IGSG G + A + +AI+KL + + H K
Sbjct: 64 YQNLKPIGSGAQG-IVCAA-YDAVLDRNVAIKKLS---------------RPFQNQTHAK 106
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHL-------LVYEFMKNGSLQDILYDVSQ 155
A R E++ H+NI+ LL ++ P L LV E M ++ Q
Sbjct: 107 -RAYR-ELVLMKCVNHKNIISLL-NVFTPQKTLEEFQDVYLVMELMD--------ANLCQ 155
Query: 156 GRRELDWPARHR-IARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGK 214
+ R + + G+++LH +IHRD+KP+N+++ D +I DFG +
Sbjct: 156 VIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 212
Query: 215 LMPDGHAQITVKCM---VGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGK--FPVD 269
M V T Y APE + + DI+S G ++ +V K FP
Sbjct: 213 TAGTSFM------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 266
Query: 270 DF 271
D+
Sbjct: 267 DY 268
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 2e-13
Identities = 56/269 (20%), Positives = 93/269 (34%), Gaps = 54/269 (20%)
Query: 21 GPTIFSPLVEKQDLAFLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDA 80
G + D K+ D F + G G +G V + S G +AI+K
Sbjct: 3 GSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTV-QLGKEK-STGMSVAIKK----- 55
Query: 81 PMSAAELIKQDIDEYSDLLHWKIGAIR--SEIITANQTRHRNILPLLAHMVRPN------ 132
+ QD R + H NI+ L ++
Sbjct: 56 -------VIQD----------PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRD 98
Query: 133 -CHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHR------IARGIASGLEYLHMCHRP 185
+V E++ +L + + + P + R I LH
Sbjct: 99 IYLNVVMEYV-PDTLHRCCRNYYRRQVAP--PPILIKVFLFQLIRSIG----CLH-LPSV 150
Query: 186 RLIHRDIKPANVLID-DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTET 244
+ HRDIKP NVL++ D ++ DFG K + + C + Y APE +
Sbjct: 151 NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYIC---SRYYRAPELIFGNQ 207
Query: 245 I-SDKCDIYSFGVLLAVLVMGK--FPVDD 270
+ DI+S G + A +++G+ F D+
Sbjct: 208 HYTTAVDIWSVGCIFAEMMLGEPIFRGDN 236
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 2e-13
Identities = 59/242 (24%), Positives = 99/242 (40%), Gaps = 46/242 (19%)
Query: 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLH 100
D + ++K+G G + EVF + N + + ++ L P+ +
Sbjct: 36 DDYQLVRKLGRGKYSEVFEAINIT--NNEKVVVKIL---KPVKKKK-------------- 76
Query: 101 WKIGAIRSEI-ITANQTRHRNILPLLAHMVRPNCH---LLVYEFMKNGSLQDILYDVSQG 156
R EI I N NI+ L +V+ LV+E + N + + ++
Sbjct: 77 ----IKR-EIKILENLRGGPNIITLA-DIVKDPVSRTPALVFEHVNNTDFKQLYQTLT-- 128
Query: 157 RRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID-DDMEARISDFGHGKL 215
D+ R + I L+Y CH ++HRD+KP NV+ID + + R+ D+G L
Sbjct: 129 ----DYDIRFYM-YEILKALDY---CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWG---L 177
Query: 216 MPDGHAQITVKCMVGTMGYMAPESLQTETISDKC-DIYSFGVLLAVLVMGKFPVDDFFGH 274
H V + + PE L + D D++S G +LA ++ K P F GH
Sbjct: 178 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF--FHGH 235
Query: 275 TE 276
Sbjct: 236 DN 237
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 3e-13
Identities = 65/239 (27%), Positives = 106/239 (44%), Gaps = 33/239 (13%)
Query: 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLH 100
D F+ ++ +G G +G+V A + + G + A+ K+ L K I + D+
Sbjct: 23 DNFEFIRVLGKGSFGKVM-LARVKET-GDLYAV-KV----------LKKDVILQDDDVEC 69
Query: 101 WKIGAIRSE-IITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRE 159
+E I + H + L P+ V EF+ G D+++ + + RR
Sbjct: 70 -----TMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGG---DLMFHIQKSRRF 121
Query: 160 LDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKL-MPD 218
+ AR A I S L +LH +I+RD+K NVL+D + +++DFG K + +
Sbjct: 122 DEARARFYAAE-IISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN 177
Query: 219 GHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEE 277
G T GT Y+APE LQ D ++ GVLL ++ G P F E+
Sbjct: 178 GV---TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP---FEAENED 230
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 3e-13
Identities = 62/250 (24%), Positives = 110/250 (44%), Gaps = 56/250 (22%)
Query: 38 KKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSD 97
+E + K IG+G +G V Y+A+L S G+++AI+K++ D EL
Sbjct: 51 PQEVSYTDTKVIGNGSFGVV-YQAKLCDS-GELVAIKKVLQDKRFKNREL---------Q 99
Query: 98 LLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHL-------LVYEFMKNGSLQDIL 150
++ + H NI+ L + + LV +++ ++ +
Sbjct: 100 IMR--------------KLDHCNIVRLR-YFFYSSGEKKDEVYLNLVLDYVPE-TVYRVA 143
Query: 151 YDVSQGRRELDWPARH------RIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDME 204
S+ ++ L P + ++ R +A Y H + HRDIKP N+L+D D
Sbjct: 144 RHYSRAKQTL--PVIYVKLYMYQLFRSLA----Y---IHSFGICHRDIKPQNLLLDPDTA 194
Query: 205 A-RISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETI-SDKCDIYSFGVLLAVLV 262
++ DFG K + G ++ C + Y APE + T + D++S G +LA L+
Sbjct: 195 VLKLCDFGSAKQLVRGEPNVSYIC---SRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 251
Query: 263 MGK--FPVDD 270
+G+ FP D
Sbjct: 252 LGQPIFPGDS 261
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 4e-13
Identities = 36/122 (29%), Positives = 56/122 (45%), Gaps = 9/122 (7%)
Query: 172 IASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGT 231
I LE+LH +I+RDIK N+L+D + ++DFG K + GT
Sbjct: 168 IVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERA-YDFCGT 223
Query: 232 MGYMAPESLQTETI--SDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIF 289
+ YMAP+ ++ D +S GVL+ L+ G P F E+ + R ++
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP---FTVDGEKNSQAEISRRILK 280
Query: 290 SE 291
SE
Sbjct: 281 SE 282
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 4e-13
Identities = 64/247 (25%), Positives = 104/247 (42%), Gaps = 50/247 (20%)
Query: 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLH 100
+ FD LK +G G +G+V + G+ A+ K+ L K+ I ++ H
Sbjct: 5 NDFDYLKLLGKGTFGKVI-LVREKAT-GRYYAM-KI----------LRKEVIIAKDEVAH 51
Query: 101 WKIGAIRSEIITANQTRHRNILPLLAH--MVRPNC------HL-LVYEFMKNGSLQDILY 151
+E +L H + L V E+ G ++ +
Sbjct: 52 -----TVTE---------SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG---ELFF 94
Query: 152 DVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFG 211
+S+ R + AR A I S LEYLH +++RDIK N+++D D +I+DFG
Sbjct: 95 HLSRERVFTEERARFYGAE-IVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFG 150
Query: 212 HGKL-MPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDD 270
K + DG T+K GT Y+APE L+ D + GV++ ++ G+ P
Sbjct: 151 LCKEGISDGA---TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--- 204
Query: 271 FFGHTEE 277
F+ E
Sbjct: 205 FYNQDHE 211
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 5e-13
Identities = 54/221 (24%), Positives = 90/221 (40%), Gaps = 36/221 (16%)
Query: 41 DCFDSLKKIGSGGWGEVF---YKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSD 97
D FD +K +G+G +G V +K +G A++ L KQ + +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHK-----ESGNHYAMKI-----------LDKQKVVKLKQ 84
Query: 98 LLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGR 157
+ H +E ++ L + +V E++ G + L GR
Sbjct: 85 IEH-----TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR--IGR 137
Query: 158 RELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMP 217
AR A+ I EYLH LI+RD+KP N+LID +++DFG K +
Sbjct: 138 FSEPH-ARFYAAQ-IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192
Query: 218 DGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
+ GT +APE + ++ + D ++ GVL+
Sbjct: 193 G-----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLI 228
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 9e-13
Identities = 64/239 (26%), Positives = 100/239 (41%), Gaps = 33/239 (13%)
Query: 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLH 100
+ F K +G G +G+VF AE + + AI K L K + D+
Sbjct: 17 EDFILHKMLGKGSFGKVF-LAEFKKT-NQFFAI-KA----------LKKDVVLMDDDVEC 63
Query: 101 WKIGAIRSE-IITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRE 159
E + + H + + V E++ G D++Y + +
Sbjct: 64 -----TMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGG---DLMYHIQSCHKF 115
Query: 160 LDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKL-MPD 218
A A I GL++LH +++RD+K N+L+D D +I+DFG K M
Sbjct: 116 DLSRATFYAAE-IILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 171
Query: 219 GHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEE 277
T C GT Y+APE L + + D +SFGVLL +++G+ P F G EE
Sbjct: 172 DAKTNTF-C--GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP---FHGQDEE 224
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 1e-12
Identities = 64/248 (25%), Positives = 107/248 (43%), Gaps = 51/248 (20%)
Query: 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLH 100
F+ L +G G +G+V +E G+ ++ A+ K+ L K + + D+
Sbjct: 20 TDFNFLMVLGKGSFGKVM-LSERKGT-DELYAV-KI----------LKKDVVIQDDDVEC 66
Query: 101 WKIGAIRSEIITANQTRHRNILPLLAH---MVRPNC------HL-LVYEFMKNGSLQDIL 150
E + +L L + + + L V E++ G D++
Sbjct: 67 -----TMVE---------KRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGG---DLM 109
Query: 151 YDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDF 210
Y + Q R + A A IA GL +L +I+RD+K NV++D + +I+DF
Sbjct: 110 YHIQQVGRFKEPHAVFYAAE-IAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADF 165
Query: 211 GHGKL-MPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVD 269
G K + DG T K GT Y+APE + + D ++FGVLL ++ G+ P
Sbjct: 166 GMCKENIWDGV---TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP-- 220
Query: 270 DFFGHTEE 277
F G E+
Sbjct: 221 -FEGEDED 227
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 66.5 bits (162), Expect = 2e-12
Identities = 35/152 (23%), Positives = 67/152 (44%), Gaps = 21/152 (13%)
Query: 127 HMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARH---RIARGIASGLEYLHMCH 183
+ + F++ SL D+ + + D+ + +A G+E+L
Sbjct: 154 DSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA--- 210
Query: 184 RPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPD-------GHAQITVKCMVGTMGYMA 236
+ IHRD+ N+L+ + +I DFG + + G A++ +K +MA
Sbjct: 211 SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK-------WMA 263
Query: 237 PESLQTETISDKCDIYSFGVLL-AVLVMGKFP 267
PE++ + + D++SFGVLL + +G P
Sbjct: 264 PETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 66.4 bits (163), Expect = 2e-12
Identities = 59/251 (23%), Positives = 108/251 (43%), Gaps = 54/251 (21%)
Query: 41 DCFDSLKKIGSGGWGEVFY-KAELPGSNGKMIAI---RKLIVDAPMSAAELIKQDIDEYS 96
+CF+ L+ +G GG+G+VF + + GK+ A+ +K +I ++ +
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKK----------AMIVRNAKD-- 64
Query: 97 DLLHWKIGAIRSEIITANQTRHRNILPLLAH--MVRPNC------HL-LVYEFMKNGSLQ 147
++E RNIL + H +V L L+ E++ G
Sbjct: 65 ------TAHTKAE---------RNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGG--- 106
Query: 148 DILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARI 207
++ + + ++ A +A I+ L +LH +I+RD+KP N++++ ++
Sbjct: 107 ELFMQLEREGIFMEDTACFYLAE-ISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKL 162
Query: 208 SDFGHGKL-MPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKF 266
+DFG K + DG GT+ YMAPE L + D +S G L+ ++ G
Sbjct: 163 TDFGLCKESIHDGT---VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAP 219
Query: 267 PVDDFFGHTEE 277
P F G +
Sbjct: 220 P---FTGENRK 227
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 3e-12
Identities = 34/109 (31%), Positives = 56/109 (51%), Gaps = 11/109 (10%)
Query: 172 IASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKL-MPDGHAQITVKCMVG 230
+A L++LH +I+RD+KP N+L+D++ +++DFG K + G
Sbjct: 135 LALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK---KAYSFCG 188
Query: 231 TMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGH-TEEM 278
T+ YMAPE + + D +SFGVL+ ++ G P F G +E
Sbjct: 189 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP---FQGKDRKET 234
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 4e-12
Identities = 56/243 (23%), Positives = 89/243 (36%), Gaps = 39/243 (16%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
+ + I SG +G V S G +AI+++ + ++ SD K
Sbjct: 24 YTVQRFISSGSYGAVC-AGV--DSEGIPVAIKRV------FNTVSDGRTVNILSDSFLCK 74
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHL------LVYEFMKNGSLQDILYDVSQG 156
+R EI N H NIL L + LV E M+ L +++
Sbjct: 75 -RVLR-EIRLLNHFHHPNILGLR-DIFVHFEEPAMHKLYLVTELMRT-DLAQVIH---DQ 127
Query: 157 RRELDWPARHR-IARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKL 215
R + P + I GL LH ++HRD+ P N+L+ D+ + I DF +
Sbjct: 128 RIVIS-PQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLARE 183
Query: 216 MPDGHAQITVKCM---VGTMGYMAPESLQTETISDKC-DIYSFGVLLAVLVMGK--FPVD 269
V Y APE + K D++S G ++A + K F
Sbjct: 184 DTADAN------KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGS 237
Query: 270 DFF 272
F+
Sbjct: 238 TFY 240
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 65.2 bits (160), Expect = 4e-12
Identities = 32/87 (36%), Positives = 50/87 (57%), Gaps = 8/87 (9%)
Query: 172 IASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGT 231
+ LEYLH +I+RD+KP N+L+D + +I+DFG K +PD + GT
Sbjct: 115 VCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGT 166
Query: 232 MGYMAPESLQTETISDKCDIYSFGVLL 258
Y+APE + T+ + D +SFG+L+
Sbjct: 167 PDYIAPEVVSTKPYNKSIDWWSFGILI 193
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 5e-12
Identities = 58/249 (23%), Positives = 104/249 (41%), Gaps = 57/249 (22%)
Query: 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDL 98
+E + + K IG+G +G V ++A+L S+ +AI+K + QD
Sbjct: 38 REIAYTNCKVIGNGSFGVV-FQAKLVESD--EVAIKK------------VLQDKRF---- 78
Query: 99 LHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHL-------LVYEFMKNGSLQDILY 151
R E+ +H N++ L N LV E++ ++
Sbjct: 79 ------KNR-ELQIMRIVKHPNVVDLK-AFFYSNGDKKDEVFLNLVLEYVPE-TVYRASR 129
Query: 152 DVSQGRRELDWPARH------RIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDM-E 204
++ ++ + P ++ R +A Y H + HRDIKP N+L+D
Sbjct: 130 HYAKLKQTM--PMLLIKLYMYQLLRSLA----Y---IHSIGICHRDIKPQNLLLDPPSGV 180
Query: 205 ARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETI-SDKCDIYSFGVLLAVLVM 263
++ DFG K++ G ++ C + Y APE + T + DI+S G ++A L+
Sbjct: 181 LKLIDFGSAKILIAGEPNVSYIC---SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQ 237
Query: 264 GK--FPVDD 270
G+ FP +
Sbjct: 238 GQPLFPGES 246
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 5e-12
Identities = 53/220 (24%), Positives = 101/220 (45%), Gaps = 30/220 (13%)
Query: 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLH 100
FD L+ IG G + +V L + ++ A+ K+ + K+ +++ D+
Sbjct: 9 QDFDLLRVIGRGSYAKVL-LVRLKKT-DRIYAM-KV----------VKKELVNDDEDIDW 55
Query: 101 WKIGAIRSE-IITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRE 159
+++E + + H ++ L + + V E++ G D+++ + + R+
Sbjct: 56 -----VQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG---DLMFHMQRQRKL 107
Query: 160 LDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKL-MPD 218
+ AR A I+ L YLH +I+RD+K NVL+D + +++D+G K +
Sbjct: 108 PEEHARFYSAE-ISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163
Query: 219 GHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
G T GT Y+APE L+ E D ++ GVL+
Sbjct: 164 GD---TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLM 200
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 6e-12
Identities = 52/220 (23%), Positives = 101/220 (45%), Gaps = 30/220 (13%)
Query: 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLH 100
FD L+ IG G + +V L + ++ A+ ++ + K+ +++ D+
Sbjct: 52 QDFDLLRVIGRGSYAKVL-LVRLKKT-DRIYAM-RV----------VKKELVNDDEDIDW 98
Query: 101 WKIGAIRSE-IITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRE 159
+++E + + H ++ L + + V E++ G D+++ + + R+
Sbjct: 99 -----VQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG---DLMFHMQRQRKL 150
Query: 160 LDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKL-MPD 218
+ AR A I+ L YLH +I+RD+K NVL+D + +++D+G K +
Sbjct: 151 PEEHARFYSAE-ISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 206
Query: 219 GHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
G T GT Y+APE L+ E D ++ GVL+
Sbjct: 207 GD---TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLM 243
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 64.5 bits (156), Expect = 6e-12
Identities = 31/225 (13%), Positives = 64/225 (28%), Gaps = 37/225 (16%)
Query: 30 EKQDLAFLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIK 89
+ + +KIG G +GEV ++ + +AI+ + ++ P +
Sbjct: 9 GPVPFSHCLPTEKLQRCEKIGEGVFGEV-FQTIA---DHTPVAIKIIAIEGPDLVNGSHQ 64
Query: 90 QDIDEYSD--LLHWKIGAIRSEIITANQTRHRNILPLLAHMV----RPNCHLLVYEFM-- 141
+ +E ++ ++ + E R + L + P L ++
Sbjct: 65 KTFEEILPEIIISKELSLLSGE----VCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNS 120
Query: 142 KNGSLQDILYDVSQ-------------------GRRELDWPARHRIARGIASGLEYLHMC 182
GS D + I + + L
Sbjct: 121 TKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAE-- 178
Query: 183 HRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKC 227
R HRD+ NVL+ ++ +GK + V
Sbjct: 179 ASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSI 223
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 7e-12
Identities = 62/242 (25%), Positives = 103/242 (42%), Gaps = 51/242 (21%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
+ S +GSG +G V + +G+ +AI+KL + + K
Sbjct: 26 YVSPTHVGSGAYGSVCSAIDKR--SGEKVAIKKLS---------------RPFQSEIFAK 68
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHL-------LVYEFMKNGSLQDILYDVSQ 155
A R E++ +H N++ LL + P L LV FM LQ I+
Sbjct: 69 -RAYR-ELLLLKHMQHENVIGLL-DVFTPASSLRNFYDFYLVMPFM-QTDLQKIM----- 119
Query: 156 GRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKL 215
+ + + GL+Y+H ++HRD+KP N+ +++D E +I DFG L
Sbjct: 120 -GLKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFG---L 172
Query: 216 MPDGHAQITVKCM---VGTMGYMAPESLQTETISDKC-DIYSFGVLLAVLVMGK--FPVD 269
A+ M V T Y APE + + ++ DI+S G ++A ++ GK F
Sbjct: 173 -----ARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 227
Query: 270 DF 271
D+
Sbjct: 228 DY 229
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 9e-12
Identities = 57/259 (22%), Positives = 96/259 (37%), Gaps = 73/259 (28%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
F +G G +G V P G+++AI+K I+ + L
Sbjct: 13 FQLKSLLGEGAYGVVCSATHKP--TGEIVAIKK----------------IEPFDKPLFAL 54
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHL------LVYEFM--------KNGSLQD 148
+R EI +H NI+ + ++ RP+ ++ E M L D
Sbjct: 55 -RTLR-EIKILKHFKHENIITIF-NIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSD 111
Query: 149 -----ILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDM 203
+Y Q ++ LH + +IHRD+KP+N+LI+ +
Sbjct: 112 DHIQYFIY---Q----------------TLRAVKVLHGSN---VIHRDLKPSNLLINSNC 149
Query: 204 EARISDFG-----HGKLMPDGHAQITVKCM---VGTMGYMAPESLQTETISDKC-DIYSF 254
+ ++ DFG + M V T Y APE + T + D++S
Sbjct: 150 DLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSC 209
Query: 255 GVLLAVLVMGK--FPVDDF 271
G +LA L + + FP D+
Sbjct: 210 GCILAELFLRRPIFPGRDY 228
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 1e-11
Identities = 65/243 (26%), Positives = 105/243 (43%), Gaps = 52/243 (21%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
+ +L +GSG +G V + G +A++KL + ++H K
Sbjct: 31 YQNLSPVGSGAYGSVCAAFDTK--TGLRVAVKKLS---------------RPFQSIIHAK 73
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHL-------LVYEFMKNGSLQDILYDVSQ 155
R E+ +H N++ LL + P L LV M L +I+ Q
Sbjct: 74 -RTYR-ELRLLKHMKHENVIGLL-DVFTPARSLEEFNDVYLVTHLM-GADLNNIVK--CQ 127
Query: 156 GRRELDWPARHR-IARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGK 214
+L + + I GL+Y+H +IHRD+KP+N+ +++D E +I DFG
Sbjct: 128 ---KLT-DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFG--- 177
Query: 215 LMPDGHAQITVKCM---VGTMGYMAPESLQTETISDKC-DIYSFGVLLAVLVMGK--FPV 268
L A+ T M V T Y APE + ++ DI+S G ++A L+ G+ FP
Sbjct: 178 L-----ARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 232
Query: 269 DDF 271
D
Sbjct: 233 TDH 235
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 1e-11
Identities = 65/242 (26%), Positives = 100/242 (41%), Gaps = 50/242 (20%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
+ L+ +GSG +G V + + G G +AI+KL + L K
Sbjct: 27 YRDLQPVGSGAYGAVC--SAVDGRTGAKVAIKKLY---------------RPFQSELFAK 69
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHL-------LVYEFMKNGSLQDILYDVSQ 155
A R E+ RH N++ LL + P+ L LV FM L ++
Sbjct: 70 -RAYR-ELRLLKHMRHENVIGLL-DVFTPDETLDDFTDFYLVMPFM-GTDLGKLMK---- 121
Query: 156 GRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKL 215
+L + + GL Y+H +IHRD+KP N+ +++D E +I DFG L
Sbjct: 122 -HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG---L 174
Query: 216 MPDGHAQITVKCM---VGTMGYMAPESLQTETISDKC-DIYSFGVLLAVLVMGK--FPVD 269
A+ M V T Y APE + + DI+S G ++A ++ GK F
Sbjct: 175 -----ARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 229
Query: 270 DF 271
D
Sbjct: 230 DH 231
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 2e-11
Identities = 35/109 (32%), Positives = 52/109 (47%), Gaps = 11/109 (10%)
Query: 172 IASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKL-MPDGHAQITVKCMVG 230
IAS L YLH + +++RD+KP N+L+D ++DFG K + T G
Sbjct: 148 IASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS---TTSTFCG 201
Query: 231 TMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGH-TEEM 278
T Y+APE L + D + G +L ++ G P F+ T EM
Sbjct: 202 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP---FYSRNTAEM 247
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 3e-11
Identities = 59/250 (23%), Positives = 97/250 (38%), Gaps = 70/250 (28%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
+ +L IG G +G V A N +AI+K I + + +
Sbjct: 29 YTNLSYIGEGAYGMV-CSA-YDNLNKVRVAIKK----------------ISPFEHQTYCQ 70
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHL------LVYEFM--------KNGSLQD 148
+R EI + RH NI+ + ++R +V + M K L +
Sbjct: 71 -RTLR-EIKILLRFRHENIIGIN-DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN 127
Query: 149 -----ILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDM 203
LY Q I GL+Y+H + ++HRD+KP+N+L++
Sbjct: 128 DHICYFLY---Q----------------ILRGLKYIHSAN---VLHRDLKPSNLLLNTTC 165
Query: 204 EARISDFGHGKLMPDGHAQITVKCM---VGTMGYMAPESLQTETISDKC-DIYSFGVLLA 259
+ +I DFG ++ H + V T Y APE + K DI+S G +LA
Sbjct: 166 DLKICDFGLARVADPDHDHTGF--LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILA 223
Query: 260 VLVMGK--FP 267
++ + FP
Sbjct: 224 EMLSNRPIFP 233
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 3e-11
Identities = 51/253 (20%), Positives = 97/253 (38%), Gaps = 40/253 (15%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAEL----------IKQDI 92
+ K +G+G +G V + S GK A++K++ D EL I + +
Sbjct: 9 YSLGKTLGTGSFGIV-CEVFDIES-GKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLV 66
Query: 93 DEYSDLLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHL-----LVYEFMKNGSLQ 147
D + + + N + V N ++ E++ + +L
Sbjct: 67 DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLH 125
Query: 148 DILYDVSQGRRELDWPARH------RIARGIASGLEYLHMCHRPRLIHRDIKPANVLID- 200
+L + R + P ++ R + ++H + HRDIKP N+L++
Sbjct: 126 KVLKSFIRSGRSI--PMNLISIYIYQLFRAVG----FIHSL---GICHRDIKPQNLLVNS 176
Query: 201 DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETI-SDKCDIYSFGVLLA 259
D ++ DFG K + + C + Y APE + T + D++S G +
Sbjct: 177 KDNTLKLCDFGSAKKLIPSEPSVAYIC---SRFYRAPELMLGATEYTPSIDLWSIGCVFG 233
Query: 260 VLVMGK--FPVDD 270
L++GK F +
Sbjct: 234 ELILGKPLFSGET 246
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 8e-11
Identities = 40/189 (21%), Positives = 73/189 (38%), Gaps = 62/189 (32%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
++ IG+G +G V +A +++AI+K+ + + DL+ K
Sbjct: 55 YEIRHLIGTGSYGHV-CEA-YDKLEKRVVAIKKI---------------LRVFEDLIDCK 97
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHL------LVYEFM---------KNGSLQ 147
+R EI N+ H +++ +L +V P +V E L
Sbjct: 98 -RILR-EIAILNRLNHDHVVKVL-DIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLT 154
Query: 148 D-----ILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDD 202
+ +LY + G++Y H ++HRD+KPAN L++ D
Sbjct: 155 ELHIKTLLY---N----------------LLVGVKY---VHSAGILHRDLKPANCLVNQD 192
Query: 203 MEARISDFG 211
++ DFG
Sbjct: 193 CSVKVCDFG 201
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 8e-11
Identities = 58/249 (23%), Positives = 102/249 (40%), Gaps = 59/249 (23%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
+ LK +G GG G VF A + K +AI+K+++ P S K
Sbjct: 13 YMDLKPLGCGGNGLVF-SA-VDNDCDKRVAIKKIVLTDPQSV----KH------------ 54
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRREL-- 160
A+R EI + H NI+ + ++ P+ L + L + Y V E
Sbjct: 55 --ALR-EIKIIRRLDHDNIVKVF-EILGPSGSQLTDDVGSLTELNSV-YIVQ----EYME 105
Query: 161 -DWPARHRIARG--------------IASGLEYLHMCHRPRLIHRDIKPANVLID-DDME 204
D + + GL+Y+H + ++HRD+KPAN+ I+ +D+
Sbjct: 106 TDL---ANVLEQGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLV 159
Query: 205 ARISDFGHGKLMPDGHAQITVKCM---VGTMGYMAPE-SLQTETISDKCDIYSFGVLLAV 260
+I DFG ++M ++ + + T Y +P L + D+++ G + A
Sbjct: 160 LKIGDFGLARIMDPHYSHKGH--LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAE 217
Query: 261 LVMGK--FP 267
++ GK F
Sbjct: 218 MLTGKTLFA 226
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 7e-10
Identities = 52/267 (19%), Positives = 101/267 (37%), Gaps = 73/267 (27%)
Query: 21 GPTIFSPLVEKQDLAFLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDA 80
GP + S L K++ A + + +G G G+V + + A+ K++ D
Sbjct: 1 GPHVKSGLQIKKN-AIIDDYKVTS--QVLGLGINGKV-LQIFNK-RTQEKFAL-KMLQDC 54
Query: 81 PMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLLA----HMVRPNCHLL 136
+++++ LHW+ ++ +I+ ++ C L+
Sbjct: 55 -----PKARREVE-----LHWRA------------SQCPHIVRIVDVYENLYAGRKCLLI 92
Query: 137 VYEFMKNGSLQDILYDVSQGRR---ELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIK 193
V E + G L + +G + E + A I + I ++Y H + HRD+K
Sbjct: 93 VMECLDGGELFSRI--QDRGDQAFTERE--ASE-IMKSIGEAIQY---LHSINIAHRDVK 144
Query: 194 PANVLI---DDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCD 250
P N+L + +++DFG A E+ E CD
Sbjct: 145 PENLLYTSKRPNAILKLTDFG-----------------------FAKETTG-EKYDKSCD 180
Query: 251 IYSFGVLLAVLVMGKFPVDDFFGHTEE 277
++S GV++ +L+ G P F+ +
Sbjct: 181 MWSLGVIMYILLCGYPP---FYSNHGL 204
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 3e-09
Identities = 41/179 (22%), Positives = 76/179 (42%), Gaps = 22/179 (12%)
Query: 118 HRNILPLL---AHMVRPNCHL-LVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIA 173
+IL LL H H+ +V+E + +L ++ R + +I++ +
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKK--YEHRGIPLIYVKQISKQLL 141
Query: 174 SGLEYLHMCHRPRLIHRDIKPANVLIDD------DMEARISDFGHGKLMPDGHAQITVKC 227
GL+Y+H +IH DIKP NVL++ ++ +I+D G+ + +
Sbjct: 142 LGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 199
Query: 228 MVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGK--FPVDDFFGHTEEMDMVKWM 284
Y +PE L DI+S L+ L+ G F D+ +T++ D + +
Sbjct: 200 E-----YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 253
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 3e-09
Identities = 59/264 (22%), Positives = 92/264 (34%), Gaps = 83/264 (31%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
+ IG G +G V Y A + K +AI+K + + DL+ K
Sbjct: 28 YIIKHLIGRGSYGYV-YLAYDK-NTEKNVAIKK-VNRM--------------FEDLIDCK 70
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHL------LVYEFM---------KNGSLQ 147
+R EI N+ + I+ L ++ P+ L +V E L
Sbjct: 71 -RILR-EITILNRLKSDYIIRLY-DLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLT 127
Query: 148 D-----ILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDD 202
+ ILY + G ++H +IHRD+KPAN L++ D
Sbjct: 128 EEHIKTILY---N----------------LLLGENFIHESG---IIHRDLKPANCLLNQD 165
Query: 203 MEARISDFG-----------------HGKLMPDGHAQITVKCM---VGTMGYMAPESLQT 242
++ DFG P H + K + V T Y APE +
Sbjct: 166 CSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILL 225
Query: 243 ETISDKC-DIYSFGVLLAVLVMGK 265
+ K DI+S G + A L+
Sbjct: 226 QENYTKSIDIWSTGCIFAELLNML 249
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 1e-08
Identities = 28/213 (13%), Positives = 62/213 (29%), Gaps = 49/213 (23%)
Query: 47 KKIGSGGWGEVF------YKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLH 100
G ++ G + +++ D + + Q + +
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNK 107
Query: 101 WKIGAIRSEIITANQTRHRNILPLLAHMVRPNCH----------LLVYEFMKNG-SLQDI 149
WK T I P C LV + G SLQ
Sbjct: 108 WK---------KLYSTPLLAI---------PTCMGFGVHQDKYRFLVLPSL--GRSLQSA 147
Query: 150 LYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARI-- 207
L + L + ++A + LE+LH +H ++ N+ +D + ++++
Sbjct: 148 LDV--SPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTL 202
Query: 208 SDFGHGKLMPDGHAQI-----TVKCMVGTMGYM 235
+ +G + + G + ++
Sbjct: 203 AGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFI 235
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 3e-08
Identities = 37/156 (23%), Positives = 56/156 (35%), Gaps = 29/156 (18%)
Query: 137 VYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPAN 196
+YE +K Q P + A I L+ LH R+IH D+KP N
Sbjct: 185 LYELIKKNKFQG-----------FSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPEN 230
Query: 197 VLI--DDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSF 254
+L+ ++ DFG + Y APE + D++S
Sbjct: 231 ILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQ-----SRFYRAPEVILGARYGMPIDMWSL 285
Query: 255 GVLLAVLVMGK--FPVDDFFGHTEEMDMVKWMRNVI 288
G +LA L+ G P G E D + M ++
Sbjct: 286 GCILAELLTGYPLLP-----GED-EGDQLACMIELL 315
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 6e-08
Identities = 55/267 (20%), Positives = 105/267 (39%), Gaps = 87/267 (32%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
++ +KK+G G +G V+ K+ + G+++A++K + + ++ E L
Sbjct: 11 YELVKKLGKGAYGIVW-KS-IDRRTGEVVAVKK--IFDAFQNSTDAQRTFREIMILTELS 66
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHL---LVYEFM--------KNGSLQD--- 148
H NI+ LL +++R + LV+++M + L+
Sbjct: 67 --------------GHENIVNLL-NVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHK 111
Query: 149 --ILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEAR 206
++Y Q + ++YLH L+HRD+KP+N+L++ + +
Sbjct: 112 QYVVY---Q----------------LIKVIKYLHSGG---LLHRDMKPSNILLNAECHVK 149
Query: 207 ISDFG----------------HGKLMPDGHAQITVKCM---VGTMGYMAPESLQ-----T 242
++DFG + + V T Y APE L T
Sbjct: 150 VADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYT 209
Query: 243 ETISDKCDIYSFGVLLAVLVMGK--FP 267
+ I D++S G +L ++ GK FP
Sbjct: 210 KGI----DMWSLGCILGEILCGKPIFP 232
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 1e-07
Identities = 38/158 (24%), Positives = 65/158 (41%), Gaps = 24/158 (15%)
Query: 134 HL-LVYEFMKNGSLQDILYDVSQ--GRRELDWPARHRIARGIASGLEYLHMCHRPRLIHR 190
HL LV+E L LYD+ + R + + A+ + + L +L +IH
Sbjct: 130 HLCLVFE-----MLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT-PELSIIHC 183
Query: 191 DIKPANVLIDDDMEA--RISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDK 248
D+KP N+L+ + + +I DFG + Q + Y +PE L
Sbjct: 184 DLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQ-----SRFYRSPEVLLGMPYDLA 238
Query: 249 CDIYSFGVLLAVLVMGK--FPVDDFFGHTEEMDMVKWM 284
D++S G +L + G+ F G E+D + +
Sbjct: 239 IDMWSLGCILVEMHTGEPLFS-----GAN-EVDQMNKI 270
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 3e-07
Identities = 41/210 (19%), Positives = 73/210 (34%), Gaps = 53/210 (25%)
Query: 118 HRNILPLLAH--MVRPN-CHL-LVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIA 173
++ LL + N H+ +V+E + + L + S + L P +I + +
Sbjct: 100 REMVVQLLDDFKISGVNGTHICMVFEVLGH-HLLKWI-IKSNYQG-LPLPCVKKIIQQVL 156
Query: 174 SGLEYLHMCHRPRLIHRDIKPANVLIDDD------------------------------- 202
GL+YLH + R+IH DIKP N+L+ +
Sbjct: 157 QGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAP 214
Query: 203 ----------MEARISDFGHGKLMPDGHAQITVKC---MVGTMGYMAPESLQTETISDKC 249
+E + ++ K+ G+A K + T Y + E L +
Sbjct: 215 ATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPA 274
Query: 250 DIYSFGVLLAVLVMGKFPVDDFFGHTEEMD 279
DI+S + L G + + G D
Sbjct: 275 DIWSTACMAFELATGDYLFEPHSGEEYTRD 304
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 4e-06
Identities = 18/76 (23%), Positives = 31/76 (40%), Gaps = 10/76 (13%)
Query: 167 RIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARI--SDFGHGK--LMPDGHAQ 222
++ + LEY+H +H DIK AN+L+ ++ +D+G H Q
Sbjct: 155 QLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQ 211
Query: 223 I---TVKCMVGTMGYM 235
K GT+ +
Sbjct: 212 YQENPRKGHNGTIEFT 227
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 5e-06
Identities = 33/208 (15%), Positives = 61/208 (29%), Gaps = 39/208 (18%)
Query: 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAI 106
IG GG+G + Y A++ S ++ P E
Sbjct: 41 LPIGQGGFGCI-YLADMNSSESVGSDAPCVVKVEPSDN----GPLFTELKFYQRAAKPEQ 95
Query: 107 RSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNG------------SLQDILYDVS 154
+ I + ++ + P LQ I +
Sbjct: 96 IQKWIRTRKLKYLGV---------PKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIY--EA 144
Query: 155 QGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARI--SDFGH 212
+R +++ I LEY+H +H DIK +N+L++ ++ D+G
Sbjct: 145 NAKR-FSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGL 200
Query: 213 GK--LMPDGHAQIT---VKCMVGTMGYM 235
H +C GT+ +
Sbjct: 201 AYRYCPEGVHKAYAADPKRCHDGTIEFT 228
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 30/109 (27%), Positives = 45/109 (41%), Gaps = 11/109 (10%)
Query: 167 RIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEAR---ISDFGHGKL--MPDGHA 221
+A + + +E++H +HRDIKP N L+ A I DFG K H
Sbjct: 107 MLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163
Query: 222 QI---TVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFP 267
I K + GT Y + + S + D+ S G +L + G P
Sbjct: 164 HIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 4e-05
Identities = 36/173 (20%), Positives = 58/173 (33%), Gaps = 46/173 (26%)
Query: 137 VYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPAN 196
+EF+K + P +A + L +LH +L H D+KP N
Sbjct: 108 TFEFLKEN-----------NFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPEN 153
Query: 197 VLIDDDMEA-------------------RISDFGHGKLMPDGHAQITVKCMVGTMGYMAP 237
+L + R++DFG D T+ V T Y P
Sbjct: 154 ILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA--TFDHEHHTTI---VATRHYRPP 208
Query: 238 ESLQTETISDKCDIYSFGVLLAVLVMGK--FPVDDFFGHTEEMDMVKWMRNVI 288
E + + CD++S G +L G F H E + + M ++
Sbjct: 209 EVILELGWAQPCDVWSIGCILFEYYRGFTLFQ-----TH-ENREHLVMMEKIL 255
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 5e-05
Identities = 31/109 (28%), Positives = 46/109 (42%), Gaps = 11/109 (10%)
Query: 167 RIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEA---RISDFGHGK--LMPDGHA 221
+A + S +EY+H + IHRD+KP N L+ + I DFG K H
Sbjct: 109 LLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 165
Query: 222 QI---TVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFP 267
I K + GT Y + + S + D+ S G +L +G P
Sbjct: 166 HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 5e-05
Identities = 35/180 (19%), Positives = 49/180 (27%), Gaps = 54/180 (30%)
Query: 137 VYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPAN 196
+YE + I L YL L H D+KP N
Sbjct: 122 LYEIITR-----------NNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPEN 167
Query: 197 VLIDDDMEARISDFGHGKLMPDGHAQITVK------------CMVG--------TMGYMA 236
+L+DD + K T Y A
Sbjct: 168 ILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRA 227
Query: 237 PESLQTETI------SDKCDIYSFGVLLAVLVMGK--FPVDDFFGHTEEMDMVKWMRNVI 288
PE + D++SFG +LA L G F H E M+ + M ++I
Sbjct: 228 PE------VILNLGWDVSSDMWSFGCVLAELYTGSLLFR-----TH-EHMEHLAMMESII 275
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 8e-05
Identities = 27/111 (24%), Positives = 44/111 (39%), Gaps = 13/111 (11%)
Query: 167 RIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEAR-----ISDFGHGK--LMPDG 219
A+ + + ++ +H L++RDIKP N LI + DFG K P
Sbjct: 110 MAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 166
Query: 220 HAQI---TVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFP 267
I K + GT YM+ + S + D+ + G + + G P
Sbjct: 167 KQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 8e-05
Identities = 37/179 (20%), Positives = 61/179 (34%), Gaps = 58/179 (32%)
Query: 137 VYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPAN 196
Y+F+K G ++A I + +LH +L H D+KP N
Sbjct: 103 TYDFIKE-----------NGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPEN 148
Query: 197 VLIDD-------------------DMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAP 237
+L + + ++ DFG D T+ V T Y AP
Sbjct: 149 ILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA--TYDDEHHSTL---VSTRHYRAP 203
Query: 238 ESLQTETI------SDKCDIYSFGVLLAVLVMGK--FPVDDFFGHTEEMDMVKWMRNVI 288
E + S CD++S G +L +G FP H + + + M ++
Sbjct: 204 E------VILALGWSQPCDVWSIGCILIEYYLGFTVFP-----TH-DSKEHLAMMERIL 250
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 31/111 (27%), Positives = 48/111 (43%), Gaps = 13/111 (11%)
Query: 167 RIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEAR-----ISDFGHGK--LMPDG 219
IA + S +EY+H + LI+RD+KP N LI I DF K + P+
Sbjct: 109 MIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPET 165
Query: 220 HAQI---TVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFP 267
I K + GT YM+ + + S + D+ + G + + G P
Sbjct: 166 KKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 40.6 bits (94), Expect = 7e-04
Identities = 41/355 (11%), Positives = 92/355 (25%), Gaps = 126/355 (35%)
Query: 17 SRDR-------GPTIFSPLVEKQDLAFLKKEDCFDSLKKIGSGGWGEVFYKA------EL 63
+R + T ++ + E + K +L
Sbjct: 272 TRFKQVTDFLSAATTTHISLDHHSMTLTPDE----VK---------SLLLKYLDCRPQDL 318
Query: 64 PGSNGKMIAIRKLIVDAPMSAAELIKQDI---DEYSDLLHWKIGAIRS---EIITANQTR 117
P ++ + AE I+ + D + + K+ I ++ + R
Sbjct: 319 PRE---VLTTNPRRLS---IIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYR 372
Query: 118 HRNILPLLAHMVRPNCHLLVYE----FMKNGSLQDILYDVSQGRRELDWPARHRIARGIA 173
++ F + + L W +
Sbjct: 373 KM------------------FDRLSVFPPS-------AHIPTILLSLIWFDVIKS----- 402
Query: 174 SGLEYLHMCHRPRLIHRDIKPANVLIDD---DMEARISDFGHGKLMPDGHAQITVKCMVG 230
+ ++ H+ L+ + K + + I +++ ++ + H I V
Sbjct: 403 DVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLEN------EYALHRSI-VDH--- 452
Query: 231 TMGYMAPESLQTETISDKC-DIYSFGVLLAVLVMGKFPVDDFFGH-------TEEMDM-- 280
Y P++ ++ + D Y + GH E M +
Sbjct: 453 ---YNIPKTFDSDDLIPPYLDQYFY---------------SHIGHHLKNIEHPERMTLFR 494
Query: 281 -----VKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKL-ACFCTLKDPD-ER 328
+++ I R ++ +G L LK + DP ER
Sbjct: 495 MVFLDFRFLEQKI------RHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYER 543
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 337 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.89 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.81 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.69 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.4 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.12 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.08 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.74 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.64 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.63 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.44 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.42 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.39 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.18 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.03 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.02 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.96 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.76 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.57 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.57 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.48 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.39 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.19 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.96 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.8 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.69 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.6 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.42 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.31 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.68 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.57 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 87.67 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 86.88 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 85.03 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 82.2 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-58 Score=405.55 Aligned_cols=259 Identities=19% Similarity=0.314 Sum_probs=206.4
Q ss_pred cccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHh
Q 040898 36 FLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQ 115 (337)
Q Consensus 36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~ 115 (337)
++..-++|++++.||+|+||.||++.+.. +|+.||||++......... .+.+.+|+.++++
T Consensus 19 ~f~sme~Y~~~~~lG~G~fg~V~~a~~~~--~~~~vAiK~i~~~~~~~~~-----------------~~~~~~E~~il~~ 79 (350)
T 4b9d_A 19 YFQSMEKYVRLQKIGEGSFGKAILVKSTE--DGRQYVIKEINISRMSSKE-----------------REESRREVAVLAN 79 (350)
T ss_dssp BCSCCCCEEEEEEC------CEEEEEETT--TCCEEEEEEEECTTSCHHH-----------------HHHHHHHHHHHHH
T ss_pred CCCcccceEEeEEEecCCCeEEEEEEECC--CCCEEEEEEEehHHCCHHH-----------------HHHHHHHHHHHHH
Confidence 44556789999999999999999999976 8999999999765432211 1578899999999
Q ss_pred cCCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCC
Q 040898 116 TRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPA 195 (337)
Q Consensus 116 l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ 195 (337)
++|||||++++++++++.+|+|||||+||+|.+++.. ..+..+++..++.++.||+.||.|| |++||+||||||+
T Consensus 80 l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~--~~~~~~~e~~~~~~~~qi~~aL~yl---H~~~IiHRDlKp~ 154 (350)
T 4b9d_A 80 MKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINA--QKGVLFQEDQILDWFVQICLALKHV---HDRKILHRDIKSQ 154 (350)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHH---HHTTCEETTCCGG
T ss_pred CCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHH--cCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeccCCHH
Confidence 9999999999999999999999999999999999965 3455678999999999999999999 6779999999999
Q ss_pred ceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCc
Q 040898 196 NVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHT 275 (337)
Q Consensus 196 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~ 275 (337)
|||++.+|.+||+|||++........ .....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||....
T Consensus 155 NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~--- 229 (350)
T 4b9d_A 155 NIFLTKDGTVQLGDFGIARVLNSTVE--LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS--- 229 (350)
T ss_dssp GEEECTTCCEEECSTTEESCCCHHHH--HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS---
T ss_pred HEEECCCCCEEEcccccceeecCCcc--cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC---
Confidence 99999999999999999987643211 1234579999999999999999999999999999999999999996431
Q ss_pred hhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 276 EEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
...+ ...+.....+. .+...+..+.+|+.+||+.||++|||+.|+|+|
T Consensus 230 -~~~~---~~~i~~~~~~~----------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 230 -MKNL---VLKIISGSFPP----------VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp -HHHH---HHHHHHTCCCC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -HHHH---HHHHHcCCCCC----------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1222 22222111110 011223458999999999999999999999987
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-57 Score=400.55 Aligned_cols=253 Identities=23% Similarity=0.372 Sum_probs=209.1
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..+.|+++++||+|+||.||++.+.. +|+.||||++........ +.+.+|+.++++++|
T Consensus 72 p~~~y~~~~~iG~G~fG~V~~a~~~~--tg~~vAiK~i~~~~~~~~-------------------~~~~~Ei~il~~l~H 130 (346)
T 4fih_A 72 PRSYLDNFIKIGEGSTGIVCIATVRS--SGKLVAVKKMDLRKQQRR-------------------ELLFNEVVIMRDYQH 130 (346)
T ss_dssp GGGTEEEEEEEEECSSCEEEEEEETT--TCCEEEEEEEEGGGCSSG-------------------GGGHHHHHHHHHCCC
T ss_pred hhHhcEEeEEeecCcCeEEEEEEECC--CCCEEEEEEEecCchhHH-------------------HHHHHHHHHHHhCCC
Confidence 34679999999999999999999976 999999999865432211 467889999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
||||++++++.+++.+|+|||||++|+|.+++.. ..+++..+..++.||+.||.|| |++||+||||||+|||
T Consensus 131 pnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~yl---H~~~IiHRDlKp~NIL 202 (346)
T 4fih_A 131 ENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVL---HAQGVIHRDIKSDSIL 202 (346)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEE
T ss_pred CCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHH---HHCCcccccCCHHHEE
Confidence 9999999999999999999999999999999853 3599999999999999999999 6779999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhh
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEM 278 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~ 278 (337)
++.+|.+||+|||++......... ....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+. ...
T Consensus 203 l~~~g~vKl~DFGla~~~~~~~~~--~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~----~~~ 276 (346)
T 4fih_A 203 LTHDGRVKLSDFGFCAQVSKEVPR--RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE----PPL 276 (346)
T ss_dssp ECTTCCEEECCCTTCEECCSSSCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS----CHH
T ss_pred ECCCCCEEEecCcCceecCCCCCc--ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc----CHH
Confidence 999999999999999876543322 23468999999999999999999999999999999999999999642 122
Q ss_pred hHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 279 DMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.....+... ..+. ...+...+..+.+|+.+||+.||++|||+.|+|+|
T Consensus 277 ~~~~~i~~~---~~~~--------~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 277 KAMKMIRDN---LPPR--------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp HHHHHHHHS---SCCC--------CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHHcC---CCCC--------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 222222221 1110 01112234458999999999999999999999987
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-58 Score=399.70 Aligned_cols=254 Identities=24% Similarity=0.332 Sum_probs=209.1
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++++.||+|+||+||++.+.. +++.||+|++........ .....+.+|+.++++++|
T Consensus 30 ~~~dy~i~~~lG~G~fg~V~~a~~~~--~~~~~AiK~i~k~~~~~~----------------~~~~~~~~E~~il~~l~H 91 (311)
T 4aw0_A 30 RPEDFKFGKILGEGSFSTVVLARELA--TSREYAIKILEKRHIIKE----------------NKVPYVTRERDVMSRLDH 91 (311)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEEHHHHHHT----------------TCHHHHHHHHHHHTTCCC
T ss_pred CccccEEEEEEecccCeEEEEEEECC--CCCEEEEEEEEHHHCCCH----------------HHHHHHHHHHHHHHhCCC
Confidence 45689999999999999999999976 999999999864321111 112578899999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++++++++.+|+|||||+||+|.+++.. .+.+++..+..++.||+.||.|| |++||+||||||+|||
T Consensus 92 pnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~yl---H~~~IiHRDlKPeNIL 164 (311)
T 4aw0_A 92 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYL---HGKGIIHRDLKPENIL 164 (311)
T ss_dssp TTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEE
T ss_pred CCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCCccCCCCHHHeE
Confidence 9999999999999999999999999999999954 35699999999999999999999 6779999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhh
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEM 278 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~ 278 (337)
++.++.+||+|||++..+............+||+.|+|||++.+..|+.++|+|||||++|+|++|.+||... ...
T Consensus 165 l~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~----~~~ 240 (311)
T 4aw0_A 165 LNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG----NEG 240 (311)
T ss_dssp ECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS----SHH
T ss_pred EcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC----CHH
Confidence 9999999999999998876544433445578999999999999999999999999999999999999999642 122
Q ss_pred hHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhh
Q 040898 279 DMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVR 335 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 335 (337)
.+...+.. ..... +...+..+.+|+.+||+.||++|||++|++
T Consensus 241 ~~~~~i~~---~~~~~-----------p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 241 LIFAKIIK---LEYDF-----------PEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp HHHHHHHH---TCCCC-----------CTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred HHHHHHHc---CCCCC-----------CcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 22222211 11110 011233488999999999999999999864
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-56 Score=401.93 Aligned_cols=253 Identities=23% Similarity=0.375 Sum_probs=209.1
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..+.|+++++||+|+||.||++.+.. +|+.||||++........ +.+.+|+.+|+.++|
T Consensus 149 p~~~y~~~~~iG~G~fG~V~~a~~~~--tg~~vAiK~i~~~~~~~~-------------------~~~~~Ei~il~~l~H 207 (423)
T 4fie_A 149 PRSYLDNFIKIGEGSTGIVCIATVRS--SGKLVAVKKMDLRKQQRR-------------------ELLFNEVVIMRDYQH 207 (423)
T ss_dssp GGGTEEEEEEEEECSSCEEEEEEETT--TCCEEEEEEEESTTCSSG-------------------GGHHHHHHHHHHCCC
T ss_pred hhHhcEeeeEeccCcCcEEEEEEECC--CCCEEEEEEEeccchhHH-------------------HHHHHHHHHHHhCCC
Confidence 45679999999999999999999976 999999999965433211 567889999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
||||++++++.+++.+|+|||||+||+|.+++.. ..+++..+..++.||+.||.|| |++||+||||||+|||
T Consensus 208 pnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~yl---H~~~IiHRDiKp~NIL 279 (423)
T 4fie_A 208 ENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVL---HAQGVIHRDIKSDSIL 279 (423)
T ss_dssp TTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSTTTEE
T ss_pred CCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHH---HHCCeecccCCHHHEE
Confidence 9999999999999999999999999999999853 3589999999999999999999 6779999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhh
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEM 278 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~ 278 (337)
++.+|.+||+|||++..+...... ....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+. ...
T Consensus 280 l~~~g~vKl~DFGla~~~~~~~~~--~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~----~~~ 353 (423)
T 4fie_A 280 LTHDGRVKLSDFGFCAQVSKEVPR--RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE----PPL 353 (423)
T ss_dssp ECTTCCEEECCCTTCEECCSSCCC--BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS----CHH
T ss_pred EcCCCCEEEecCccceECCCCCcc--ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc----CHH
Confidence 999999999999999876543222 23467999999999999999999999999999999999999999642 122
Q ss_pred hHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 279 DMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.....+... ..+.. ......+..+.+|+.+||+.||++|||+.|+|+|
T Consensus 354 ~~~~~i~~~---~~~~~--------~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 354 KAMKMIRDN---LPPRL--------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp HHHHHHHHS---CCCCC--------SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHHcC---CCCCC--------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 222222221 11100 1111233458999999999999999999999997
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-56 Score=384.21 Aligned_cols=252 Identities=23% Similarity=0.372 Sum_probs=200.3
Q ss_pred cccc-cccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 40 EDCF-DSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 40 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
.++| ++.++||+|+||.||++.+.. ++..||+|++......... .+.+.+|+.++++++|
T Consensus 24 ~gr~~~~~~~iG~G~fg~Vy~a~~~~--~~~~vAiK~i~~~~~~~~~-----------------~~~~~~E~~il~~l~H 84 (290)
T 3fpq_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTE--TTVEVAWCELQDRKLTKSE-----------------RQRFKEEAEMLKGLQH 84 (290)
T ss_dssp TSSEEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEEGGGSCHHH-----------------HHHHHHHHHHHHTCCC
T ss_pred CCceEEeeeEEecCcCcEEEEEEECC--CCeEEEEEEEchhhCCHHH-----------------HHHHHHHHHHHHhCCC
Confidence 4556 677889999999999999876 8999999999755432221 1578899999999999
Q ss_pred CCcccceeEEEc----CCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCC--eEecCC
Q 040898 119 RNILPLLAHMVR----PNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPR--LIHRDI 192 (337)
Q Consensus 119 pniv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~g--i~h~di 192 (337)
||||++++++.+ +..+|+|||||++|+|.+++.. ...+++..+..++.||+.||.|| |++| |+||||
T Consensus 85 pnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~yl---H~~~~~IiHRDl 157 (290)
T 3fpq_A 85 PNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFL---HTRTPPIIHRDL 157 (290)
T ss_dssp TTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HTSSSCCCCCCC
T ss_pred CCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCCCEEeccc
Confidence 999999999865 3568999999999999999954 45689999999999999999999 5556 999999
Q ss_pred CCCceeecC-CCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCC
Q 040898 193 KPANVLIDD-DMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDF 271 (337)
Q Consensus 193 ~~~nil~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~ 271 (337)
||+|||+++ ++.+||+|||+|....... ....+||+.|+|||++.+ .|+.++|||||||++|+|+||.+||.+.
T Consensus 158 Kp~NILl~~~~g~vKl~DFGla~~~~~~~----~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~ 232 (290)
T 3fpq_A 158 KCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC 232 (290)
T ss_dssp CGGGEEESSTTSCEEECCTTGGGGCCTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ChhheeEECCCCCEEEEeCcCCEeCCCCc----cCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 999999985 7899999999998654332 234679999999999875 5999999999999999999999999643
Q ss_pred CCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 272 FGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.. ...+.. .......+. ... ...+.++.+|+.+||+.||++|||++|+|+|
T Consensus 233 ~~---~~~~~~---~i~~~~~~~-~~~--------~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 233 QN---AAQIYR---RVTSGVKPA-SFD--------KVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp SS---HHHHHH---HHTTTCCCG-GGG--------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred Cc---HHHHHH---HHHcCCCCC-CCC--------ccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 22 122222 222111111 111 1112348899999999999999999999997
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-56 Score=384.72 Aligned_cols=251 Identities=25% Similarity=0.396 Sum_probs=191.5
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
-++|++++.||+|+||.||++.+.. +|+.||+|++.......... ...+.+|+.++++++||
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~--~~~~vAiK~i~~~~~~~~~~----------------~~~~~~Ei~il~~l~Hp 73 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTT--TGQKVALKIINKKVLAKSDM----------------QGRIEREISYLRLLRHP 73 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTT--TCCEEEEEEEECC------C----------------HHHHHHHHHHHHHCCCT
T ss_pred eeCeEEEEEEecCcCeEEEEEEECC--CCCEEEEEEEeHHHcCCHHH----------------HHHHHHHHHHHHHCCCC
Confidence 4689999999999999999999876 89999999997654322211 15688999999999999
Q ss_pred CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceee
Q 040898 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI 199 (337)
Q Consensus 120 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~ 199 (337)
||+++++++.+++.+|+||||+ +|+|.+++.. ...+++..+..++.||+.||.|| |++||+||||||+||++
T Consensus 74 nIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~yl---H~~~IiHRDiKP~NILl 145 (275)
T 3hyh_A 74 HIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYC---HRHKIVHRDLKPENLLL 145 (275)
T ss_dssp TBCCEEEEEECSSEEEEEEECC-CEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCTTTEEE
T ss_pred CCCeEEEEEEECCEEEEEEeCC-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCcccccCChHHeEE
Confidence 9999999999999999999999 6799998843 45699999999999999999999 67799999999999999
Q ss_pred cCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCC-CCcccchhhhHHHHHHHhCCCCCCCCCCCchhh
Q 040898 200 DDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETI-SDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEM 278 (337)
Q Consensus 200 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~ 278 (337)
+.++.+||+|||++....... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||... ...
T Consensus 146 ~~~~~vkl~DFGla~~~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~----~~~ 218 (275)
T 3hyh_A 146 DEHLNVKIADFGLSNIMTDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE----SIP 218 (275)
T ss_dssp CTTCCEEECCSSCC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS----SHH
T ss_pred CCCCCEEEeecCCCeecCCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC----CHH
Confidence 999999999999998754432 2234679999999999998876 57899999999999999999999642 122
Q ss_pred hHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 279 DMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.+...+.. ..... +...+..+.+|+.+||+.||++|||++|+++|
T Consensus 219 ~~~~~i~~---~~~~~-----------p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 219 VLFKNISN---GVYTL-----------PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp HHHHHHHH---TCCCC-----------CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred HHHHHHHc---CCCCC-----------CCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 22222221 11111 01123458899999999999999999999987
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-56 Score=394.98 Aligned_cols=257 Identities=23% Similarity=0.318 Sum_probs=205.4
Q ss_pred ccccccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHH
Q 040898 33 DLAFLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIIT 112 (337)
Q Consensus 33 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 112 (337)
+.++....+.|++.++||+|+||.||++.+.. +|+.||||++..+. ...+|+.+
T Consensus 50 ~~~~~~~~~~~~~~~~lG~G~fG~Vy~a~~~~--~g~~vAiK~i~~~~------------------------~~~~E~~i 103 (336)
T 4g3f_A 50 DYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQ--TGFQCAVKKVRLEV------------------------FRVEELVA 103 (336)
T ss_dssp TTBCCBTTTEEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEETTT------------------------CCTHHHHT
T ss_pred chhhhcchhheEeCcEeccCCCeEEEEEEECC--CCCEEEEEEECHHH------------------------hHHHHHHH
Confidence 33444556779999999999999999999976 99999999986432 22459999
Q ss_pred HHhcCCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 040898 113 ANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDI 192 (337)
Q Consensus 113 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di 192 (337)
++.++|||||++++++.+++.+|+|||||+||+|.+++.. .+.+++..+..++.||+.||.|| |++||+||||
T Consensus 104 l~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~yl---H~~~IiHRDl 176 (336)
T 4g3f_A 104 CAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYL---HTRRILHGDV 176 (336)
T ss_dssp TTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HTTTEECSCC
T ss_pred HHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCceeccc
Confidence 9999999999999999999999999999999999999954 35699999999999999999999 7789999999
Q ss_pred CCCceeecCCC-CeEEecccCccccCCCCce---eeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCC
Q 040898 193 KPANVLIDDDM-EARISDFGHGKLMPDGHAQ---ITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPV 268 (337)
Q Consensus 193 ~~~nil~~~~~-~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf 268 (337)
||+|||++.+| .+||+|||++......... ......+||+.|+|||++.+..|+.++|||||||++|+|++|.+||
T Consensus 177 Kp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf 256 (336)
T 4g3f_A 177 KADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPW 256 (336)
T ss_dssp CGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred CHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCC
Confidence 99999999987 6999999999876543221 1122357999999999999999999999999999999999999999
Q ss_pred CCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 269 DDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.......... ... ....+.. ..++..+..+.+|+.+||+.||++|||+.|+++|
T Consensus 257 ~~~~~~~~~~---~i~----~~~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~ 310 (336)
T 4g3f_A 257 TQYFRGPLCL---KIA----SEPPPIR--------EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRK 310 (336)
T ss_dssp TTTCCSCCHH---HHH----HSCCGGG--------GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHH---HHH----cCCCCch--------hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 7643322111 111 1111111 1112334558899999999999999999998753
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-55 Score=384.50 Aligned_cols=258 Identities=21% Similarity=0.337 Sum_probs=204.5
Q ss_pred cccccccceeccCcceEEEEeEEec---CCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELP---GSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT 116 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 116 (337)
.++|.+.++||+|+||.||++.+.. ..++..||||++....... .+.+.+|+.+++++
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~-------------------~~~f~~E~~il~~l 72 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNA-------------------RKDFHREAELLTNL 72 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHH-------------------HHHHHHHHHHHTTC
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHH-------------------HHHHHHHHHHHHhC
Confidence 3579999999999999999998752 2368899999986432111 15688999999999
Q ss_pred CCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhc---------CCcccCChHHHHHHHHHHHHHHHHHhhCCCCCe
Q 040898 117 RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVS---------QGRRELDWPARHRIARGIASGLEYLHMCHRPRL 187 (337)
Q Consensus 117 ~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi 187 (337)
+|||||++++++.+++..++|||||++|+|.+++.... .....+++..+..++.||+.||.|| |++++
T Consensus 73 ~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yL---H~~~i 149 (299)
T 4asz_A 73 QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYL---ASQHF 149 (299)
T ss_dssp CCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHH---HHTTC
T ss_pred CCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHH---HhCCc
Confidence 99999999999999999999999999999999997532 2345689999999999999999999 66799
Q ss_pred EecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCC
Q 040898 188 IHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKF 266 (337)
Q Consensus 188 ~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~ 266 (337)
+||||||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+| |+.
T Consensus 150 iHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~ 229 (299)
T 4asz_A 150 VHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ 229 (299)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCC
Confidence 9999999999999999999999999987654433333334568999999999999999999999999999999999 899
Q ss_pred CCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 267 PVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 267 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
||.+... .++...+....... .+...+..+.+|+.+||+.||++|||+++|++
T Consensus 230 Pf~~~~~----~~~~~~i~~~~~~~-------------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~ 282 (299)
T 4asz_A 230 PWYQLSN----NEVIECITQGRVLQ-------------RPRTCPQEVYELMLGCWQREPHMRKNIKGIHT 282 (299)
T ss_dssp TTTTSCH----HHHHHHHHHTCCCC-------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCH----HHHHHHHHcCCCCC-------------CCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9975422 22222222211111 11123345899999999999999999999864
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-54 Score=383.97 Aligned_cols=258 Identities=21% Similarity=0.314 Sum_probs=198.1
Q ss_pred cccccccceeccCcceEEEEeEEec---CCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELP---GSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT 116 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 116 (337)
.++|.+.++||+|+||.||++.+.. ..+++.||||++....... .+.|.+|+.+++++
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~-------------------~~~f~~E~~il~~l 100 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESA-------------------RQDFQREAELLTML 100 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHH-------------------HHHHHHHHHHHTTC
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHH-------------------HHHHHHHHHHHHhC
Confidence 4679999999999999999998642 3478999999986432111 15688999999999
Q ss_pred CCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcC-----------CcccCChHHHHHHHHHHHHHHHHHhhCCCC
Q 040898 117 RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQ-----------GRRELDWPARHRIARGIASGLEYLHMCHRP 185 (337)
Q Consensus 117 ~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~ 185 (337)
+|||||++++++.+++..++|||||++|+|.+++..... ...++++..+..++.||+.||.|| |++
T Consensus 101 ~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yL---H~~ 177 (329)
T 4aoj_A 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGL 177 (329)
T ss_dssp CCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHH---HHT
T ss_pred CCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHH---hcC
Confidence 999999999999999999999999999999999965322 235689999999999999999999 667
Q ss_pred CeEecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-C
Q 040898 186 RLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-G 264 (337)
Q Consensus 186 gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g 264 (337)
+|+||||||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+| |
T Consensus 178 ~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G 257 (329)
T 4aoj_A 178 HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYG 257 (329)
T ss_dssp TCCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred CeecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCC
Confidence 999999999999999999999999999987654433333345679999999999999999999999999999999999 8
Q ss_pred CCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 265 KFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 265 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
+.||..... ......+........ +...+..+.+|+.+||+.||++|||+.||++
T Consensus 258 ~~Pf~~~~~----~~~~~~i~~g~~~~~-------------p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 312 (329)
T 4aoj_A 258 KQPWYQLSN----TEAIDCITQGRELER-------------PRACPPEVYAIMRGCWQREPQQRHSIKDVHA 312 (329)
T ss_dssp CCTTCSSCH----HHHHHHHHHTCCCCC-------------CTTCCHHHHHHHHHHCCSSTTTSCCHHHHHH
T ss_pred CCCCCCCCH----HHHHHHHHcCCCCCC-------------cccccHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 999965422 222222222111111 1123345899999999999999999999975
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-55 Score=382.87 Aligned_cols=259 Identities=24% Similarity=0.373 Sum_probs=205.9
Q ss_pred cccccccceeccCcceEEEEeEEe---cCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAEL---PGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT 116 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 116 (337)
.+++++.++||+|+||+||++... ...+++.||||++......... +.|.+|+.+++++
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~------------------~~f~~E~~il~~l 86 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLR------------------EEFRHEAMLRARL 86 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CH------------------HHHHHHHHHHHHC
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHH------------------HHHHHHHHHHHhC
Confidence 356889999999999999998763 2346789999999755432211 5688999999999
Q ss_pred CCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcC------------CcccCChHHHHHHHHHHHHHHHHHhhCCC
Q 040898 117 RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQ------------GRRELDWPARHRIARGIASGLEYLHMCHR 184 (337)
Q Consensus 117 ~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~l~~~h~ 184 (337)
+|||||++++++.+++..++|||||++|+|.+++..... ....+++..+..++.||+.||.|| |+
T Consensus 87 ~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yL---H~ 163 (308)
T 4gt4_A 87 QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL---SS 163 (308)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHH---HH
T ss_pred CCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHH---Hh
Confidence 999999999999999999999999999999999965321 134689999999999999999999 66
Q ss_pred CCeEecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-
Q 040898 185 PRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM- 263 (337)
Q Consensus 185 ~gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~- 263 (337)
++++||||||+|||+++++.+||+|||+++...............||+.|+|||++.+..++.++||||+||++|||+|
T Consensus 164 ~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~ 243 (308)
T 4gt4_A 164 HHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSY 243 (308)
T ss_dssp TTCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred CCCCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhC
Confidence 7999999999999999999999999999986644333323344678999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 264 GKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 264 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
|..||.+.. ..++...+... ... +.++.++..+.+|+.+||+.||++|||+.||++
T Consensus 244 g~~Pf~~~~----~~~~~~~i~~~---~~~----------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~ 299 (308)
T 4gt4_A 244 GLQPYCGYS----NQDVVEMIRNR---QVL----------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHS 299 (308)
T ss_dssp TCCTTTTCC----HHHHHHHHHTT---CCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCC----HHHHHHHHHcC---CCC----------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 899996542 22232222221 111 111223455889999999999999999999976
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-54 Score=379.20 Aligned_cols=257 Identities=26% Similarity=0.394 Sum_probs=195.8
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..+++++.++||+|+||+||++... ..||||++......... .+.+.+|+.++++++|
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~-----~~vAvK~~~~~~~~~~~-----------------~~~f~~E~~il~~l~H 91 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWH-----GDVAVKILKVVDPTPEQ-----------------FQAFRNEVAVLRKTRH 91 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESS-----SEEEEEECCCSSCCHHH-----------------HHHHHHHHHHHTTCCC
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEEC-----CcEEEEEEEecCCCHHH-----------------HHHHHHHHHHHHhCCC
Confidence 4567999999999999999998653 25999998654332211 1578899999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
||||++++++.+ +.+++|||||++|+|.+++.. ....+++..+..++.||+.||.|| |+++|+||||||+|||
T Consensus 92 pNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~---~~~~l~~~~~~~i~~qia~gL~yL---H~~~IiHRDlKp~NIL 164 (307)
T 3omv_A 92 VNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHV---QETKFQMFQLIDIARQTAQGMDYL---HAKNIIHRDMKSNNIF 164 (307)
T ss_dssp TTBCCEEEEECS-SSCEEEEECCSSCBHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHH---HHTTCBCSCCCSSSEE
T ss_pred CCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHH---HHCCccCCccCHHHEE
Confidence 999999998754 568999999999999999853 345699999999999999999999 6679999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccC---CCCCcccchhhhHHHHHHHhCCCCCCCCCCCc
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTE---TISDKCDIYSFGVLLAVLVMGKFPVDDFFGHT 275 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~---~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~ 275 (337)
+++++.+||+|||++................||+.|+|||++.+. .++.++|||||||++|||+||+.||.+....
T Consensus 165 l~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~- 243 (307)
T 3omv_A 165 LHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR- 243 (307)
T ss_dssp EETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-
T ss_pred ECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH-
Confidence 999999999999999876544333333456899999999999643 5888999999999999999999999754321
Q ss_pred hhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 276 EEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
......+......+.. ...++..+..+.+|+.+||+.||++|||+.||++
T Consensus 244 --~~~~~~~~~~~~~p~~---------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~ 293 (307)
T 3omv_A 244 --DQIIFMVGRGYASPDL---------SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILS 293 (307)
T ss_dssp --HHHHHHHHTTCCCCCS---------TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred --HHHHHHHhcCCCCCCc---------ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 1121112111111100 1112233455899999999999999999999875
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-56 Score=386.61 Aligned_cols=254 Identities=21% Similarity=0.308 Sum_probs=199.3
Q ss_pred cccccccceeccCcceEEEEeEEec-CCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELP-GSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
.++|++++.||+|+||.||++.+.. ..+++.||+|++......... ...+.+|+.++++++|
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~-----------------~~~~~~E~~il~~l~H 85 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-----------------RVRTKMERDILVEVNH 85 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE-----------------CC------CCCCCCCC
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH-----------------HHHHHHHHHHHHHCCC
Confidence 3679999999999999999998854 347899999998654322110 0356789999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++++++++.+|+|||||+||+|.+++.. ...+++..+..++.||+.||.|| |++||+||||||+|||
T Consensus 86 pnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~yl---H~~~IiHRDlKp~NIL 158 (304)
T 3ubd_A 86 PFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHL---HSLGIIYRDLKPENIL 158 (304)
T ss_dssp TTEECEEEEEEETTEEEEEECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSSCCGGGEE
T ss_pred CCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCCcCCCCCHHHeE
Confidence 9999999999999999999999999999999954 45699999999999999999999 6779999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhh
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEM 278 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~ 278 (337)
++.+|.+||+|||++........ .....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.... ..
T Consensus 159 l~~~g~vKl~DFGla~~~~~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~----~~ 232 (304)
T 3ubd_A 159 LDEEGHIKLTDFGLSKESIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD----RK 232 (304)
T ss_dssp ECTTSCEEEESSEEEEC-----C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS----HH
T ss_pred EcCCCCEEecccccceeccCCCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC----HH
Confidence 99999999999999986543222 1234679999999999999999999999999999999999999996431 12
Q ss_pred hHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCCh-----hhhhcC
Q 040898 279 DMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSS-----KDVRSM 337 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~ell~~ 337 (337)
.....+.. ..... +...+.++.+|+.+||+.||++|||+ +|+++|
T Consensus 233 ~~~~~i~~---~~~~~-----------p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 233 ETMTMILK---AKLGM-----------PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp HHHHHHHH---CCCCC-----------CTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred HHHHHHHc---CCCCC-----------CCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 22222211 11110 11123458899999999999999994 789887
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-53 Score=372.93 Aligned_cols=254 Identities=23% Similarity=0.355 Sum_probs=189.9
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
++|++++.||+|+||.||++.+.. +|+.||||++......... +.+.+|+.++++++|||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~--~~~~vAiK~i~~~~~~~~~------------------~~~~~E~~il~~l~Hpn 64 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKV--DDCNYAIKRIRLPNRELAR------------------EKVMREVKALAKLEHPG 64 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETT--TCCEEEEEEEEECSSHHHH------------------HHHHHHHHHHTTCCCTT
T ss_pred hhCEEeeEEecCCCeEEEEEEECC--CCCEEEEEEEeccCCHHHH------------------HHHHHHHHHHHhCCCCC
Confidence 469999999999999999999876 8999999998755432111 56889999999999999
Q ss_pred cccceeEEEcCC------------eeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeE
Q 040898 121 ILPLLAHMVRPN------------CHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLI 188 (337)
Q Consensus 121 iv~~~~~~~~~~------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~ 188 (337)
||++++++.+.+ .+|+|||||++|+|.+++.... .....++..++.++.||+.||.|| |++||+
T Consensus 65 IV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~yl---H~~~Ii 140 (299)
T 4g31_A 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFL---HSKGLM 140 (299)
T ss_dssp BCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHH---HHTTCC
T ss_pred CCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHH---HHCcCc
Confidence 999999987544 3699999999999999995421 223345667889999999999999 677999
Q ss_pred ecCCCCCceeecCCCCeEEecccCccccCCCCce----------eeeecccCCCCccCccccccCCCCCcccchhhhHHH
Q 040898 189 HRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQ----------ITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258 (337)
Q Consensus 189 h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~----------~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~ 258 (337)
||||||+|||++.++.+||+|||++......... ...+..+||+.|+|||++.+..|+.++|||||||++
T Consensus 141 HRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvil 220 (299)
T 4g31_A 141 HRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLIL 220 (299)
T ss_dssp CCCCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHH
T ss_pred cccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHH
Confidence 9999999999999999999999999876543221 112335799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 259 AVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 259 ~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
|+|++ ||... .+....+........+ +..+.......+|+.+||+.||++|||+.|+++|
T Consensus 221 yell~---Pf~~~------~~~~~~~~~~~~~~~p----------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 221 FELLY---PFSTQ------MERVRTLTDVRNLKFP----------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HHHHS---CCSSH------HHHHHHHHHHHTTCCC----------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHcc---CCCCc------cHHHHHHHHHhcCCCC----------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 99996 76421 1111112222111111 1122333446789999999999999999999987
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-53 Score=378.43 Aligned_cols=262 Identities=21% Similarity=0.290 Sum_probs=209.3
Q ss_pred ccccccccceeccCcceEEEEeEEecC---CCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHh
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPG---SNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQ 115 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~ 115 (337)
..++|++++.||+|+||.||++.+... .+++.||||.+......... ..+.+|+.++.+
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~------------------~~~~~E~~il~~ 123 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH------------------RALMSELKILIH 123 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHH------------------HHHHHHHHHHHH
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHH------------------HHHHHHHHHHHH
Confidence 457899999999999999999987641 24578999998765432211 568889999999
Q ss_pred cCC-CCcccceeEEEc-CCeeEEEEEeccCCCHHHHHHHhcC------------CcccCChHHHHHHHHHHHHHHHHHhh
Q 040898 116 TRH-RNILPLLAHMVR-PNCHLLVYEFMKNGSLQDILYDVSQ------------GRRELDWPARHRIARGIASGLEYLHM 181 (337)
Q Consensus 116 l~h-pniv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~l~~ 181 (337)
+.| ||||++++++.+ ++.+++|||||++|+|.++++.... ....+++..+..++.||+.||.||
T Consensus 124 l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yL-- 201 (353)
T 4ase_A 124 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL-- 201 (353)
T ss_dssp HCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHH--
T ss_pred cCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhH--
Confidence 976 899999999866 4578999999999999999976432 134588999999999999999999
Q ss_pred CCCCCeEecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHH
Q 040898 182 CHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVL 261 (337)
Q Consensus 182 ~h~~gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~l 261 (337)
|+++++||||||+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||
T Consensus 202 -H~~~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El 280 (353)
T 4ase_A 202 -ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 280 (353)
T ss_dssp -HHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred -hhCCeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHH
Confidence 6679999999999999999999999999999876555444444456789999999999999999999999999999999
Q ss_pred Hh-CCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 262 VM-GKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 262 l~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
+| |..||.+..... .+...+........ ++..+..+.+++.+||+.||++|||+.||++|
T Consensus 281 ~t~G~~Pf~~~~~~~---~~~~~i~~g~~~~~-------------p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 281 FSLGASPYPGVKIDE---EFCRRLKEGTRMRA-------------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp TTTSCCSSTTCCCSH---HHHHHHHHTCCCCC-------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhCCCCCCCCCCHHH---HHHHHHHcCCCCCC-------------CccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 98 899997643322 22222222111111 11223458899999999999999999999875
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-53 Score=382.14 Aligned_cols=268 Identities=21% Similarity=0.292 Sum_probs=204.1
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++++.||+|+||.||++.+.. +|+.||||++......... ...+.+|+.+|+.++|
T Consensus 52 i~~~Y~~~~~lG~G~fG~V~~a~~~~--t~~~vAiK~i~~~~~~~~~-----------------~~~~~~Ei~il~~l~H 112 (398)
T 4b99_A 52 VGDEYEIIETIGNGAYGVVSSARRRL--TGQQVAIKKIPNAFDVVTN-----------------AKRTLRELKILKHFKH 112 (398)
T ss_dssp CCSSEEEEEEEEECSSCEEEEEEETT--TCCEEEEEEETTTTSSHHH-----------------HHHHHHHHHHHHHCCC
T ss_pred CCCCeEEEEEEecccCeEEEEEEECC--CCCEEEEEEECccccchHH-----------------HHHHHHHHHHHHhcCC
Confidence 34689999999999999999999976 9999999999655432221 1567889999999999
Q ss_pred CCcccceeEEEc------CCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 040898 119 RNILPLLAHMVR------PNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDI 192 (337)
Q Consensus 119 pniv~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di 192 (337)
|||+++++++.. .+.+|+|||||+ |+|.+++ .....+++..+..++.||+.||.|| |++||+||||
T Consensus 113 pnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i----~~~~~l~~~~~~~~~~qil~al~yl---H~~~iiHRDl 184 (398)
T 4b99_A 113 DNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQII----HSSQPLTLEHVRYFLYQLLRGLKYM---HSAQVIHRDL 184 (398)
T ss_dssp TTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHHH----TSSSCCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCC
T ss_pred CCcceEeeeeecccccccCCEEEEEEeCCC-CCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHH---HHCcCcCCCc
Confidence 999999998754 367899999996 5799988 4567899999999999999999999 6779999999
Q ss_pred CCCceeecCCCCeEEecccCccccCCCCc--eeeeecccCCCCccCccccccCC-CCCcccchhhhHHHHHHHhCCCCCC
Q 040898 193 KPANVLIDDDMEARISDFGHGKLMPDGHA--QITVKCMVGTMGYMAPESLQTET-ISDKCDIYSFGVLLAVLVMGKFPVD 269 (337)
Q Consensus 193 ~~~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~~~~PE~~~~~~-~~~~~DiwslG~i~~~ll~g~~pf~ 269 (337)
||+|||++.++.+||+|||++..+..... .......+||+.|+|||++.+.. ++.++||||+||++|+|++|.+||.
T Consensus 185 KP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~ 264 (398)
T 4b99_A 185 KPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFP 264 (398)
T ss_dssp CGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSC
T ss_pred CccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCC
Confidence 99999999999999999999987643321 12233568999999999988754 6899999999999999999999996
Q ss_pred CCCCCchhhhHHHHHHhhhccCCcchh----------hh-------hcccCCchHHHHHHHHHHHhhhccCCCCCCCChh
Q 040898 270 DFFGHTEEMDMVKWMRNVIFSENPNRA----------IN-------SKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSK 332 (337)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~-------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ 332 (337)
+.. ..+....+............ .. +.......+..+..+.+|+.+||..||++|||+.
T Consensus 265 g~~----~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~ 340 (398)
T 4b99_A 265 GKN----YVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAA 340 (398)
T ss_dssp CSS----HHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred CCC----HHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHH
Confidence 532 12222222221111111000 00 0000001112345688999999999999999999
Q ss_pred hhhcC
Q 040898 333 DVRSM 337 (337)
Q Consensus 333 ell~~ 337 (337)
|+|+|
T Consensus 341 e~L~H 345 (398)
T 4b99_A 341 AALRH 345 (398)
T ss_dssp HHTTS
T ss_pred HHhcC
Confidence 99998
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-51 Score=367.18 Aligned_cols=265 Identities=21% Similarity=0.297 Sum_probs=199.2
Q ss_pred ccccccccceeccCcceEEEEeEEec-CCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc-
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELP-GSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT- 116 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l- 116 (337)
-.++|++.++||+|+||+||++.+.. ..+++.||+|++...... ..+.+|+.+++.+
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~---------------------~~~~~E~~~l~~~~ 77 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHP---------------------IRIAAELQCLTVAG 77 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCH---------------------HHHHHHHHHHHHTC
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCH---------------------HHHHHHHHHHHHhc
Confidence 45779999999999999999998753 347889999998654321 3567799999998
Q ss_pred CCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 040898 117 RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPAN 196 (337)
Q Consensus 117 ~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~n 196 (337)
.||||+++++++.+++.+|+||||+++|+|.+++. .+++..+..++.||+.||.|| |++||+||||||+|
T Consensus 78 ~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~yl---H~~gIiHRDiKPeN 147 (361)
T 4f9c_A 78 GQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRI---HQFGIVHRDVKPSN 147 (361)
T ss_dssp SBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGG
T ss_pred CCCCCceEEEEEEECCEEEEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHH---HHCCeEeCcCCHHH
Confidence 69999999999999999999999999999999982 388999999999999999999 67799999999999
Q ss_pred eeecCC-CCeEEecccCccccCCCCc--------------------------eeeeecccCCCCccCccccccC-CCCCc
Q 040898 197 VLIDDD-MEARISDFGHGKLMPDGHA--------------------------QITVKCMVGTMGYMAPESLQTE-TISDK 248 (337)
Q Consensus 197 il~~~~-~~~~l~dfg~~~~~~~~~~--------------------------~~~~~~~~~~~~~~~PE~~~~~-~~~~~ 248 (337)
||++.+ +.+||+|||+|+....... .......+||+.|+|||++.+. .++.+
T Consensus 148 iLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~ 227 (361)
T 4f9c_A 148 FLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTA 227 (361)
T ss_dssp EEEETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTH
T ss_pred eEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCc
Confidence 999876 7999999999976543211 0112335799999999999775 48999
Q ss_pred ccchhhhHHHHHHHhCCCCCCCCCCCchhhhHHHHHHhhhcc------------------CCcc---hhhh---------
Q 040898 249 CDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFS------------------ENPN---RAIN--------- 298 (337)
Q Consensus 249 ~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~------------------~~~~---~~~~--------- 298 (337)
+||||+||++|+|++|+.||..... ....+.. +...... ..+. ....
T Consensus 228 ~DiWSlG~il~ell~G~~Pf~~~~~--~~~~l~~-I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 304 (361)
T 4f9c_A 228 IDMWSAGVIFLSLLSGRYPFYKASD--DLTALAQ-IMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSS 304 (361)
T ss_dssp HHHHHHHHHHHHHHHTCSSSSCCSS--HHHHHHH-HHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC-----
T ss_pred cchhhhHHHHHHHHHCCCCCCCCCC--HHHHHHH-HHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccc
Confidence 9999999999999999999854222 1111111 1110000 0000 0000
Q ss_pred -h---------cccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 299 -S---------KLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 299 -~---------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
+ ..........+++..+|+.+||+.||++|||++|+|+|
T Consensus 305 ~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~H 353 (361)
T 4f9c_A 305 TPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLH 353 (361)
T ss_dssp -----------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred ccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0 00001112234568899999999999999999999998
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-51 Score=359.13 Aligned_cols=263 Identities=24% Similarity=0.282 Sum_probs=192.7
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
.+|.+.++||+|+||+||++.+ +|+.||||++..... .. .....|+..+.+++|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~----~g~~VAvK~l~~~~~---~~-----------------~~~e~Ei~~~~~l~HpN 58 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW----RGEEVAVKIFSSREE---RS-----------------WFREAEIYQTVMLRHEN 58 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE----TTEEEEEEEECGGGH---HH-----------------HHHHHHHHTSTTCCCTT
T ss_pred cEEEEEEEEeeCCCeEEEEEEE----CCEEEEEEEECccch---hh-----------------HHHHHHHHHHhcCCCCC
Confidence 4689999999999999999976 789999999854321 00 12334677778899999
Q ss_pred cccceeEEEcCC----eeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhC-----CCCCeEecC
Q 040898 121 ILPLLAHMVRPN----CHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMC-----HRPRLIHRD 191 (337)
Q Consensus 121 iv~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~-----h~~gi~h~d 191 (337)
|+++++++.+++ .+|+||||+++|+|.+++.. .++++..+..++.|++.||.|||+. |..+|+|||
T Consensus 59 Iv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRD 133 (303)
T 3hmm_A 59 ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRD 133 (303)
T ss_dssp BCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSC
T ss_pred CCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeecc
Confidence 999999987653 57999999999999999954 3589999999999999999999643 345999999
Q ss_pred CCCCceeecCCCCeEEecccCccccCCCCcee--eeecccCCCCccCccccccC------CCCCcccchhhhHHHHHHHh
Q 040898 192 IKPANVLIDDDMEARISDFGHGKLMPDGHAQI--TVKCMVGTMGYMAPESLQTE------TISDKCDIYSFGVLLAVLVM 263 (337)
Q Consensus 192 i~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~------~~~~~~DiwslG~i~~~ll~ 263 (337)
|||+|||++.++.+||+|||++.......... ......||+.|+|||++.+. .++.++|||||||++|||+|
T Consensus 134 lKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~t 213 (303)
T 3hmm_A 134 LKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR 213 (303)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHH
Confidence 99999999999999999999998765433221 12235799999999999764 35678999999999999999
Q ss_pred CCCCCCCCCCCc--------hhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhh
Q 040898 264 GKFPVDDFFGHT--------EEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVR 335 (337)
Q Consensus 264 g~~pf~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 335 (337)
|.+||....... ................. ...... ..........+.+|+.+||+.||++|||+.||+
T Consensus 214 g~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-rp~~p~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~ 289 (303)
T 3hmm_A 214 RCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKL-RPNIPN---RWQSCEALRVMAKIMRECWYANGAARLTALRIK 289 (303)
T ss_dssp TBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCC-CCCCCG---GGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHH
T ss_pred CCCCCCccccccccchhcccccchHHHHHHHHhcccC-CCCCCc---cccchHHHHHHHHHHHHHcccCHhHCcCHHHHH
Confidence 988764321110 00111111111111110 000000 011224556789999999999999999999997
Q ss_pred c
Q 040898 336 S 336 (337)
Q Consensus 336 ~ 336 (337)
+
T Consensus 290 ~ 290 (303)
T 3hmm_A 290 K 290 (303)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-50 Score=380.51 Aligned_cols=258 Identities=24% Similarity=0.268 Sum_probs=203.8
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
.-++|++++.||+|+||.||++.+.. +|+.||+|++.......... .........++.+++.++|
T Consensus 187 slddf~i~k~LG~G~fG~V~la~~~~--tg~~~AiK~i~K~~i~~~~~-------------~~~~~~E~~~l~ll~~~~H 251 (689)
T 3v5w_A 187 TMNDFSVHRIIGRGGFGEVYGCRKAD--TGKMYAMKCLDKKRIKMKQG-------------ETLALNERIMLSLVSTGDC 251 (689)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEEHHHHHHTTC-------------HHHHHHHHHHHHHHSSSCC
T ss_pred chHHeEEEEEEecccCeEEEEEEECC--CCCEEEEEEEeHHHcchhhh-------------HHHHHHHHHHHHHHhhCCC
Confidence 45789999999999999999999976 99999999986532111000 0000222345677888899
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++++++.+.+|+||||++||+|.+++.. .+.+++..+..++.||+.||.|| |++||+||||||+|||
T Consensus 252 P~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yL---H~~gIiHRDLKPeNIL 324 (689)
T 3v5w_A 252 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHM---HNRFVVYRDLKPANIL 324 (689)
T ss_dssp TTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCSGGGEE
T ss_pred CCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCchHHeE
Confidence 9999999999999999999999999999999954 45699999999999999999999 7789999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccc-cCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchh
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQ-TETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEE 277 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~-~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~ 277 (337)
++.+|.+||+|||++....... ....+||+.|+|||++. +..|+.++|+|||||++|+|++|.+||.......
T Consensus 325 ld~~G~vKL~DFGlA~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~-- 398 (689)
T 3v5w_A 325 LDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-- 398 (689)
T ss_dssp ECTTSCEEECCCTTCEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC--
T ss_pred EeCCCCEEecccceeeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--
Confidence 9999999999999998765432 23468999999999996 5679999999999999999999999996533221
Q ss_pred hhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCC-----hhhhhcC
Q 040898 278 MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPS-----SKDVRSM 337 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~~ 337 (337)
............... +...+..+.+|+.+||+.||++|++ ++||++|
T Consensus 399 --~~~i~~~i~~~~~~~-----------p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 399 --KHEIDRMTLTMAVEL-----------PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp --HHHHHHHHHHCCCCC-----------CTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred --HHHHHHhhcCCCCCC-----------CccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 111122211111110 1112344899999999999999998 7999987
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-50 Score=380.99 Aligned_cols=254 Identities=22% Similarity=0.341 Sum_probs=208.0
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
-++|++++.||+|+||.||++.+.. +|+.||+|.+........ +.+.+|+.+|+.++||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~--tg~~~AiK~i~~~~~~~~-------------------~~~~~Ei~il~~l~hp 214 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERA--TGNNFAAKFVMTPHESDK-------------------ETVRKEIQTMSVLRHP 214 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEECCSHHHH-------------------HHHHHHHHHHHHTCCT
T ss_pred ccccEEEEEEeeccCeEEEEEEECC--CCCEEEEEEEeccchhhH-------------------HHHHHHHHHHHhCCCC
Confidence 3689999999999999999999976 999999999865432111 4678899999999999
Q ss_pred CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceee
Q 040898 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI 199 (337)
Q Consensus 120 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~ 199 (337)
||+++++++.+++.+|+|||||+||+|.+++.. ....+++..+..++.||+.||.|| |++||+||||||+||++
T Consensus 215 nIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~yl---H~~~iiHRDlKp~Nill 288 (573)
T 3uto_A 215 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHM---HENNYVHLDLKPENIMF 288 (573)
T ss_dssp TBCCEEEEEECSSEEEEEEECCCCCBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEE
T ss_pred CCCeEEEEEEECCEEEEEEeecCCCcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeccCChhhccc
Confidence 999999999999999999999999999998842 345689999999999999999999 67799999999999999
Q ss_pred cCC--CCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchh
Q 040898 200 DDD--MEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEE 277 (337)
Q Consensus 200 ~~~--~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~ 277 (337)
+.+ +.+||+|||++..+..... ....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.. .
T Consensus 289 ~~~~~~~vKl~DFG~a~~~~~~~~---~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~----~ 361 (573)
T 3uto_A 289 TTKRSNELKLIDFGLTAHLDPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN----D 361 (573)
T ss_dssp SSSSCCCEEECCCSSCEECCTTSE---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS----H
T ss_pred cCCCCCCEEEeeccceeEccCCCc---eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC----H
Confidence 854 8999999999988765432 234579999999999999999999999999999999999999996432 1
Q ss_pred hhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 278 MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
......+.. ...... ...++..+..+.+|+.+||+.||++|||+.|+|+|
T Consensus 362 ~~~~~~i~~---~~~~~~-------~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 362 DETLRNVKS---CDWNMD-------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp HHHHHHHHT---TCCCCC-------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHh---CCCCCC-------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 222222211 111100 11112234458899999999999999999999987
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=335.46 Aligned_cols=256 Identities=25% Similarity=0.373 Sum_probs=208.5
Q ss_pred cccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHh
Q 040898 36 FLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQ 115 (337)
Q Consensus 36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~ 115 (337)
..+..++|++.+.||+|+||+||++.+.. +++.||+|++........ +.+.+|+.++++
T Consensus 15 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~-------------------~~~~~E~~~l~~ 73 (297)
T 3fxz_A 15 VGDPKKKYTRFEKIGQGASGTVYTAMDVA--TGQEVAIRQMNLQQQPKK-------------------ELIINEILVMRE 73 (297)
T ss_dssp SSCGGGTBCCCEEEEEETTEEEEEEEBTT--TCCEEEEEEEEGGGCSCH-------------------HHHHHHHHHHHH
T ss_pred cCChhhceeeeeeeccCCCeEEEEEEECC--CCcEEEEEEeecccccHH-------------------HHHHHHHHHHhc
Confidence 34467889999999999999999998866 899999999865443222 457789999999
Q ss_pred cCCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCC
Q 040898 116 TRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPA 195 (337)
Q Consensus 116 l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ 195 (337)
++||||+++++++..++..++||||+++++|.+++.. ..+++..++.++.|++.||.|| |++|++|+||+|+
T Consensus 74 l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~Dlkp~ 145 (297)
T 3fxz_A 74 NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFL---HSNQVIHRDIKSD 145 (297)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGG
T ss_pred CCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHH---HhCCceeCCCCHH
Confidence 9999999999999999999999999999999999854 3588999999999999999999 6679999999999
Q ss_pred ceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCc
Q 040898 196 NVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHT 275 (337)
Q Consensus 196 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~ 275 (337)
||+++.++.++|+|||++......... .....+|+.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 146 Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-- 221 (297)
T 3fxz_A 146 NILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-- 221 (297)
T ss_dssp GEEECTTCCEEECCCTTCEECCSTTCC--BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--
T ss_pred HEEECCCCCEEEeeCCCceecCCcccc--cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--
Confidence 999999999999999998776543322 2345799999999999999999999999999999999999999864321
Q ss_pred hhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 276 EEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.......... ..... ..+...+..+.+++.+||+.||++|||+.|+++|
T Consensus 222 -~~~~~~~~~~-~~~~~-----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 222 -LRALYLIATN-GTPEL-----------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp -HHHHHHHHHH-CSCCC-----------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -HHHHHHHHhC-CCCCC-----------CCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1111111111 00000 1112233458899999999999999999999987
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=339.09 Aligned_cols=252 Identities=23% Similarity=0.344 Sum_probs=206.0
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++++.||+|+||.||++.+.. +|+.||+|++......... ...+.+|+.+++.++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~--~~~~vaiK~~~~~~~~~~~-----------------~~~~~~E~~~l~~l~h 73 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHIL--TGREVAIKIIDKTQLNPTS-----------------LQKLFREVRIMKILNH 73 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEEGGGSCHHH-----------------HHHHHHHHHHHHHCCC
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECC--CCCEEEEEEEEhhcCCHHH-----------------HHHHHHHHHHHHhCCC
Confidence 45679999999999999999999876 9999999998655332211 1567889999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++++.+.+..|+||||+++++|.+++.. ...+++..+..++.|++.||.|| |++|++|+||||+||+
T Consensus 74 pnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~l---H~~~ivHrDlkp~NIl 146 (328)
T 3fe3_A 74 PNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYC---HQKRIVHRDLKAENLL 146 (328)
T ss_dssp TTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEE
T ss_pred CCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCEeccCCCHHHEE
Confidence 9999999999999999999999999999999854 34589999999999999999999 6679999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCC-CcccchhhhHHHHHHHhCCCCCCCCCCCchh
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETIS-DKCDIYSFGVLLAVLVMGKFPVDDFFGHTEE 277 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~-~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~ 277 (337)
++.++.++|+|||++........ .....||+.|+|||++.+..++ .++||||||+++|+|++|..||.... .
T Consensus 147 l~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~----~ 219 (328)
T 3fe3_A 147 LDADMNIKIADFGFSNEFTVGGK---LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN----L 219 (328)
T ss_dssp ECTTSCEEECSTTCCGGGSSSCG---GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS----H
T ss_pred EcCCCCEEEeeccCceecCCCCc---cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC----H
Confidence 99999999999999976654322 2345799999999999888765 78999999999999999999996532 1
Q ss_pred hhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 278 MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
......+.. ..... +...+..+.+|+.+||+.||.+|||++|+++|
T Consensus 220 ~~~~~~i~~---~~~~~-----------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 220 KELRERVLR---GKYRI-----------PFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp HHHHHHHHH---CCCCC-----------CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred HHHHHHHHh---CCCCC-----------CCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 222222211 11110 01123348899999999999999999999987
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=338.79 Aligned_cols=279 Identities=32% Similarity=0.598 Sum_probs=223.7
Q ss_pred ccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc
Q 040898 37 LKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT 116 (337)
Q Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 116 (337)
....++|++.+.||+|+||.||++.+. +++.||+|++......... ..+.+|+.+++.+
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~------------------~~~~~e~~~l~~l 84 (326)
T 3uim_A 26 QVASDNFSNKNILGRGGFGKVYKGRLA---DGTLVAVKRLKEERTQGGE------------------LQFQTEVEMISMA 84 (326)
T ss_dssp HTTTTSSCSTTEEECCSSSEEEEECCS---SSCCEEEEECCC-----CC------------------CHHHHHHHGGGTC
T ss_pred HHHhhccccceeEecCCCcEEEEEEec---CCCEEEEEEeccccCchHH------------------HHHHHHHHHHHhc
Confidence 337789999999999999999998643 7899999998654321110 3577899999999
Q ss_pred CCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 040898 117 RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPAN 196 (337)
Q Consensus 117 ~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~n 196 (337)
+||||+++++++.++...++||||+++++|.+++........++++..++.++.|++.||.|||+.+..|++|+||+|+|
T Consensus 85 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~N 164 (326)
T 3uim_A 85 VHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAAN 164 (326)
T ss_dssp CCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGG
T ss_pred cCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhh
Confidence 99999999999999999999999999999999997655556679999999999999999999965444499999999999
Q ss_pred eeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCC-CCc
Q 040898 197 VLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFF-GHT 275 (337)
Q Consensus 197 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~-~~~ 275 (337)
|+++.++.++|+|||++.......... .....+|+.|+|||.+.+..++.++||||||+++|+|++|..||+... ...
T Consensus 165 il~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 243 (326)
T 3uim_A 165 ILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND 243 (326)
T ss_dssp EEECTTCCEEECCCSSCEECCSSSSCE-ECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTT
T ss_pred EEECCCCCEEeccCccccccCcccccc-cccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccc
Confidence 999999999999999998765443322 234569999999999988889999999999999999999999995311 111
Q ss_pred hhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 276 EEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.......+.......................+.....+.+++.+||+.||.+|||+.++++|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 305 (326)
T 3uim_A 244 DDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRM 305 (326)
T ss_dssp SCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred cchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHH
Confidence 22234444444444444444444444556667788889999999999999999999999874
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=336.32 Aligned_cols=277 Identities=26% Similarity=0.450 Sum_probs=220.0
Q ss_pred ccccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHH
Q 040898 35 AFLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITAN 114 (337)
Q Consensus 35 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~ 114 (337)
+.....++|++.+.||+|+||.||++.+. +++.||+|++........ +.+.+|+.+++
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~-------------------~~~~~E~~~l~ 90 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLR---DGAKVALKRRTPESSQGI-------------------EEFETEIETLS 90 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEECT---TCCEEEEEECCSCCSSHH-------------------HHHHHHHHGGG
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEEC---CCCEEEEEEecccChHHH-------------------HHHHHHHHHHH
Confidence 34457889999999999999999998853 689999998866533211 56788999999
Q ss_pred hcCCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCC
Q 040898 115 QTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKP 194 (337)
Q Consensus 115 ~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~ 194 (337)
.++||||+++++++.+++..++||||+++++|.+++.........+++..++.++.|++.||.|| |++|++|+||+|
T Consensus 91 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l---H~~~ivH~dlkp 167 (321)
T 2qkw_B 91 FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYL---HTRAIIHRDVKS 167 (321)
T ss_dssp SCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCS
T ss_pred hCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHh---cCCCeecCCCCH
Confidence 99999999999999999999999999999999998854333344689999999999999999999 667999999999
Q ss_pred CceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCC
Q 040898 195 ANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGH 274 (337)
Q Consensus 195 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~ 274 (337)
+||+++.++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++|..||......
T Consensus 168 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~ 247 (321)
T 2qkw_B 168 INILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR 247 (321)
T ss_dssp TTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSS
T ss_pred HHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcH
Confidence 99999999999999999987654332222223345899999999998888999999999999999999999999754332
Q ss_pred chhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 275 TEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
. ......+..............++.......+.....+.+++.+||+.||++|||+.+++++
T Consensus 248 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 309 (321)
T 2qkw_B 248 E-MVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK 309 (321)
T ss_dssp S-CCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred H-HHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 2 2223333222222222223333333444567788889999999999999999999999864
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-47 Score=335.69 Aligned_cols=256 Identities=24% Similarity=0.430 Sum_probs=204.7
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
.++|++.+.||+|+||.||++.+.. +++.||+|++......... +.+.+|+.+++.++||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~------------------~~~~~E~~~l~~l~hp 65 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRV--TEEAVAVKIVDMKRAVDCP------------------ENIKKEICINKMLNHE 65 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEECC-------------------------CHHHHHHHHHHCCCT
T ss_pred hhhceeeeEEecCCCEEEEEEEECC--CCcEEEEEEEEcccccchH------------------HHHHHHHHHHHhCCCC
Confidence 4679999999999999999998876 8999999998654332211 4677899999999999
Q ss_pred CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceee
Q 040898 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI 199 (337)
Q Consensus 120 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~ 199 (337)
||+++++++.+++..++||||+++++|.+++ .....+++..++.++.|++.||.|| |+.|++|+||+|+||++
T Consensus 66 nIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~aL~~L---H~~givH~Dlkp~NIll 138 (323)
T 3tki_A 66 NVVKFYGHRREGNIQYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYL---HGIGITHRDIKPENLLL 138 (323)
T ss_dssp TBCCEEEEEECSSEEEEEEECCTTEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEE
T ss_pred CCCeEEEEEecCCeEEEEEEcCCCCcHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHH---HHCCccccccchHHEEE
Confidence 9999999999999999999999999999888 4556699999999999999999999 66799999999999999
Q ss_pred cCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCC-CCcccchhhhHHHHHHHhCCCCCCCCCCCchhh
Q 040898 200 DDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETI-SDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEM 278 (337)
Q Consensus 200 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~ 278 (337)
+.++.++|+|||++................||+.|+|||++.+..+ +.++||||||+++|+|++|..||........
T Consensus 139 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-- 216 (323)
T 3tki_A 139 DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-- 216 (323)
T ss_dssp CTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH--
T ss_pred eCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH--
Confidence 9999999999999976544333333345679999999999987765 6789999999999999999999975433211
Q ss_pred hHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 279 DMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
....+..... .. .........+.+|+.+||+.||++|||+.|+++|
T Consensus 217 ~~~~~~~~~~-~~------------~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 217 EYSDWKEKKT-YL------------NPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp HHHHHHTTCT-TS------------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHhcccc-cC------------CccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 1111111100 00 0111223447899999999999999999999986
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-47 Score=341.14 Aligned_cols=260 Identities=22% Similarity=0.300 Sum_probs=208.2
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
-.++|++++.||+|+||.||++.+.. +|+.||+|.+........... ...+.+.+|+.++++++|
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~--~~~~~avK~i~~~~~~~~~~~-------------~~~~~~~~E~~il~~l~h 74 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKS--TGLEYAAKFIKKRQSRASRRG-------------VCREEIEREVSILRQVLH 74 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEEBCSSTTCSSS-------------BCHHHHHHHHHHHTTCCC
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECC--CCCEEEEEEEEccccccccch-------------hHHHHHHHHHHHHHhCCC
Confidence 45679999999999999999999876 899999999976543221000 001467889999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++++.+....++||||+++++|.+++ .....+++..++.++.||+.||.|| |+.|++|+||+|+||+
T Consensus 75 pnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l----~~~~~l~~~~~~~i~~qi~~aL~~L---H~~givHrDlkp~NIl 147 (361)
T 2yab_A 75 PNIITLHDVYENRTDVVLILELVSGGELFDFL----AQKESLSEEEATSFIKQILDGVNYL---HTKKIAHFDLKPENIM 147 (361)
T ss_dssp TTBCCEEEEEECSSEEEEEEECCCSCBHHHHH----TTCSCCBHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEE
T ss_pred cCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEE
Confidence 99999999999999999999999999999999 4456799999999999999999999 6679999999999999
Q ss_pred ecCCC----CeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCC
Q 040898 199 IDDDM----EARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGH 274 (337)
Q Consensus 199 ~~~~~----~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~ 274 (337)
++.++ .++|+|||++........ .....||+.|+|||++.+..++.++|+||||+++|+|++|.+||....
T Consensus 148 l~~~~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~-- 222 (361)
T 2yab_A 148 LLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT-- 222 (361)
T ss_dssp ESCTTSSSCCEEECCCSSCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS--
T ss_pred EeCCCCCccCEEEEecCCceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC--
Confidence 98877 799999999987654322 234579999999999999899999999999999999999999986431
Q ss_pred chhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 275 TEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.......+.. ....... ..++..+..+.+|+.+||..||++|||+.|+++|
T Consensus 223 --~~~~~~~i~~---~~~~~~~-------~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 223 --KQETLANITA---VSYDFDE-------EFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp --HHHHHHHHHT---TCCCCCH-------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred --HHHHHHHHHh---cCCCCCc-------hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1122221211 1111000 0011223458899999999999999999999987
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=337.98 Aligned_cols=261 Identities=24% Similarity=0.379 Sum_probs=199.0
Q ss_pred ccccccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHH
Q 040898 33 DLAFLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIIT 112 (337)
Q Consensus 33 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 112 (337)
++......++|++++.||+|+||.||++.+.. +++.||+|++....... ..+.+|+.+
T Consensus 12 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~--------------------~~~~~E~~~ 69 (361)
T 3uc3_A 12 DMPIMHDSDRYDFVKDIGSGNFGVARLMRDKL--TKELVAVKYIERGAAID--------------------ENVQREIIN 69 (361)
T ss_dssp CCCCCCCTTTEEEEEEESSSTTSSEEEEEETT--TCCEEEEEEEESSTTSC--------------------HHHHHHHHH
T ss_pred CccCCCCCCcEEEEEEeccCCCEEEEEEEECC--CCcEEEEEEEecCcccc--------------------HHHHHHHHH
Confidence 45556677899999999999999999999876 89999999986543221 356789999
Q ss_pred HHhcCCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 040898 113 ANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDI 192 (337)
Q Consensus 113 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di 192 (337)
++.++||||+++++++.++...++||||+++++|.+++.. ...+++..++.++.|++.||.|| |++|++|+||
T Consensus 70 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~L---H~~~ivH~Dl 142 (361)
T 3uc3_A 70 HRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYC---HSMQICHRDL 142 (361)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HHTTCCSCCC
T ss_pred HHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCC
Confidence 9999999999999999999999999999999999999854 34589999999999999999999 6679999999
Q ss_pred CCCceeecCCCC--eEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCc-ccchhhhHHHHHHHhCCCCCC
Q 040898 193 KPANVLIDDDME--ARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDK-CDIYSFGVLLAVLVMGKFPVD 269 (337)
Q Consensus 193 ~~~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~-~DiwslG~i~~~ll~g~~pf~ 269 (337)
||+||+++.++. ++|+|||++....... ......+|+.|+|||++.+..++.+ +||||||+++|+|++|..||.
T Consensus 143 kp~Nill~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~ 219 (361)
T 3uc3_A 143 KLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFE 219 (361)
T ss_dssp CGGGEEECSSSSCCEEECCCCCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CHHHEEEcCCCCceEEEeecCccccccccC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCC
Confidence 999999987765 9999999987433222 1233569999999999988777655 899999999999999999997
Q ss_pred CCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 270 DFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
............. ........... ....+..+.+|+.+||+.||++|||+.|+++|
T Consensus 220 ~~~~~~~~~~~~~---~~~~~~~~~~~---------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 220 DPEEPRDYRKTIQ---RILSVKYSIPD---------DIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp ----CCCHHHHHH---HHHTTCCCCCT---------TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCccHHHHHHHHH---HHhcCCCCCCC---------cCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 6433322222222 22111111000 00122348899999999999999999999987
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=339.71 Aligned_cols=281 Identities=22% Similarity=0.329 Sum_probs=210.5
Q ss_pred ccccccccccccccceeccC--cceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHH
Q 040898 33 DLAFLKKEDCFDSLKKIGSG--GWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEI 110 (337)
Q Consensus 33 ~~~~~~~~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~ 110 (337)
.-.+....++|++++.||+| +||.||++.+.. +++.||+|++......... ...+.+|+
T Consensus 17 ~s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~-----------------~~~~~~E~ 77 (389)
T 3gni_B 17 MSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKP--TGEYVTVRRINLEACSNEM-----------------VTFLQGEL 77 (389)
T ss_dssp -CCCCCCGGGEEEEEEEEEETTTTEEEEEEEETT--TCCEEEEEEEEGGGSCHHH-----------------HHHHHHHH
T ss_pred hhcccCCCCcEEEEecccCCcCCceEEEEEEEcC--CCCEEEEEEecccccChHH-----------------HHHHHHHH
Confidence 45567788999999999999 999999999976 8999999999765432211 15778899
Q ss_pred HHHHhcCCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 040898 111 ITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHR 190 (337)
Q Consensus 111 ~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~ 190 (337)
.+++.++||||+++++++.+++..++||||+++++|.+++.. .....+++..+..++.||+.||.|| |++|++|+
T Consensus 78 ~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~qi~~~l~~L---H~~~ivHr 152 (389)
T 3gni_B 78 HVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICT--HFMDGMNELAIAYILQGVLKALDYI---HHMGYVHR 152 (389)
T ss_dssp HHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH--TCTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECC
T ss_pred HHHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhh--hcccCCCHHHHHHHHHHHHHHHHHH---HhCCeecC
Confidence 999999999999999999999999999999999999999965 3335689999999999999999999 66799999
Q ss_pred CCCCCceeecCCCCeEEecccCccccCCCCce-----eeeecccCCCCccCcccccc--CCCCCcccchhhhHHHHHHHh
Q 040898 191 DIKPANVLIDDDMEARISDFGHGKLMPDGHAQ-----ITVKCMVGTMGYMAPESLQT--ETISDKCDIYSFGVLLAVLVM 263 (337)
Q Consensus 191 di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~~~~PE~~~~--~~~~~~~DiwslG~i~~~ll~ 263 (337)
||||+||+++.++.++|+|||.+......... .......+|+.|+|||++.+ ..++.++||||||+++|+|++
T Consensus 153 Dlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~ 232 (389)
T 3gni_B 153 SVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELAN 232 (389)
T ss_dssp CCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHH
Confidence 99999999999999999999987654221111 11122468889999999987 578999999999999999999
Q ss_pred CCCCCCCCCCCchhhhHHHHHHh-hhcc---------------------------CCcchhhhhcccCCchHHHHHHHHH
Q 040898 264 GKFPVDDFFGHTEEMDMVKWMRN-VIFS---------------------------ENPNRAINSKLLGNGYEEQMLLVLK 315 (337)
Q Consensus 264 g~~pf~~~~~~~~~~~~~~~~~~-~~~~---------------------------~~~~~~~~~~~~~~~~~~~~~~l~~ 315 (337)
|..||.................. .... ......................+.+
T Consensus 233 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 312 (389)
T 3gni_B 233 GHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHH 312 (389)
T ss_dssp SSCTTTTCCSTTHHHHC--------------------------------------------------------CCHHHHH
T ss_pred CCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHH
Confidence 99999764332222111100000 0000 0000000000001122233456899
Q ss_pred HHhhhccCCCCCCCChhhhhcC
Q 040898 316 LACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 316 li~~~l~~dP~~Rps~~ell~~ 337 (337)
|+.+||+.||++|||+.|+|+|
T Consensus 313 li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 313 FVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp HHHHHTCSCTTTSCCHHHHTTS
T ss_pred HHHHHhhcCcccCCCHHHHhcC
Confidence 9999999999999999999987
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=330.85 Aligned_cols=270 Identities=23% Similarity=0.348 Sum_probs=203.2
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
-.++|++++.||+|+||+||++.+. +++.||+|++........ ....+.+|+.++++++|
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~-----------------~~~~~~~E~~~l~~l~h 78 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDS---QGRIVALKRIRLDAEDEG-----------------IPSTAIREISLLKELHH 78 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEET---TSCEEEEEEEC------C-----------------HHHHHHHHHHHHHHCCC
T ss_pred hHhhhHhhhhccCCCCeEEEEEEEC---CCCEEEEEEEecccccch-----------------hhHHHHHHHHHHHHcCC
Confidence 4577999999999999999999884 689999999865432111 01467789999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++++.++...++||||+++ +|.+++.. ....+++..++.++.|++.||.|| |+.|++|+||||+||+
T Consensus 79 p~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~L---H~~~ivH~Dikp~NIl 151 (311)
T 3niz_A 79 PNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHC---HQHRILHRDLKPQNLL 151 (311)
T ss_dssp TTBCCEEEEECCSSCEEEEEECCSE-EHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEE
T ss_pred CCEeeeeeEEccCCEEEEEEcCCCC-CHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCchHhEE
Confidence 9999999999999999999999986 78777743 445689999999999999999999 6679999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCcccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchh
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQT-ETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEE 277 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~ 277 (337)
++.++.++|+|||++......... .....+|+.|+|||++.+ ..++.++||||||+++|+|++|..||.........
T Consensus 152 ~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 229 (311)
T 3niz_A 152 INSDGALKLADFGLARAFGIPVRS--YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQL 229 (311)
T ss_dssp ECTTCCEEECCCTTCEETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHH
T ss_pred ECCCCCEEEccCcCceecCCCccc--ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 999999999999999876433222 233568999999999876 56899999999999999999999999765444333
Q ss_pred hhHHHHHHhhhccCCcchh------------hhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 278 MDMVKWMRNVIFSENPNRA------------INSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
..+............+... ..........+.....+.+|+.+||+.||++|||+.|+|+|
T Consensus 230 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 230 PKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp HHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 3332222111100000000 00000000111223468899999999999999999999987
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=328.83 Aligned_cols=272 Identities=19% Similarity=0.255 Sum_probs=211.0
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
.+++|++.+.||+|+||.||++.+.. +++.||+|++........ .+.+.+|+.++++++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~------------------~~~~~~E~~~l~~l~h 66 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKK--TGDLFAIKVFNNISFLRP------------------VDVQMREFEVLKKLNH 66 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEECGGGGGSC------------------HHHHHHHHHHHHHCCC
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECC--CCcEEEEEEeccccccch------------------HHHHHHHHHHHHhcCC
Confidence 46789999999999999999999876 899999999865432211 1456789999999999
Q ss_pred CCcccceeEEEcCC--eeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 040898 119 RNILPLLAHMVRPN--CHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPAN 196 (337)
Q Consensus 119 pniv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~n 196 (337)
|||+++++++.... ..++||||+++++|.+++.... ....+++..++.++.|++.||.|| |+.|++|+||||+|
T Consensus 67 ~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dlkp~N 142 (319)
T 4euu_A 67 KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHL---RENGIVHRNIKPGN 142 (319)
T ss_dssp TTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGG
T ss_pred CCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHH---HHCCEecCCCCHHH
Confidence 99999999987665 7799999999999999996422 223389999999999999999999 66799999999999
Q ss_pred eee----cCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccc--------cCCCCCcccchhhhHHHHHHHhC
Q 040898 197 VLI----DDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQ--------TETISDKCDIYSFGVLLAVLVMG 264 (337)
Q Consensus 197 il~----~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~--------~~~~~~~~DiwslG~i~~~ll~g 264 (337)
|++ +.++.++|+|||++......... ....+|+.|+|||++. +..++.++||||||+++|+|++|
T Consensus 143 Ill~~~~~~~~~~kL~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g 219 (319)
T 4euu_A 143 IMRVIGEDGQSVYKLTDFGAARELEDDEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219 (319)
T ss_dssp EEEEECTTSCEEEEECCCTTCEECCTTCCB---CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHS
T ss_pred EEEeccCCCCceEEEccCCCceecCCCCce---eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhC
Confidence 999 77888999999999876544322 2356899999999986 46788999999999999999999
Q ss_pred CCCCCCCCCCchhhhHHHHHHhhhccCCcchh---------h--hhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhh
Q 040898 265 KFPVDDFFGHTEEMDMVKWMRNVIFSENPNRA---------I--NSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKD 333 (337)
Q Consensus 265 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~--~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e 333 (337)
..||...............+............ . ...............+.+++.+||+.||++|||++|
T Consensus 220 ~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~e 299 (319)
T 4euu_A 220 SLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQ 299 (319)
T ss_dssp SCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHH
T ss_pred CCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHH
Confidence 99997655443333333222221111100000 0 000111334667778999999999999999999999
Q ss_pred hhcC
Q 040898 334 VRSM 337 (337)
Q Consensus 334 ll~~ 337 (337)
+|+|
T Consensus 300 ll~h 303 (319)
T 4euu_A 300 FFAE 303 (319)
T ss_dssp HHHH
T ss_pred hhhc
Confidence 9975
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=332.99 Aligned_cols=253 Identities=26% Similarity=0.333 Sum_probs=204.3
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
.++|++++.||+|+||.||++.+.. +++.||+|++....... ......+.+|+.+++.++||
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~--~~~~vaiK~~~~~~~~~----------------~~~~~~~~~E~~~l~~l~hp 65 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKA--TGRYYAMKILRKEVIIA----------------KDEVAHTVTESRVLQNTRHP 65 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEEHHHHHH----------------TTCHHHHHHHHHHHHSCCCT
T ss_pred hHHeEEEEEEecCCCeEEEEEEECC--CCCEEEEEEEeHHHhhh----------------hhHHHHHHHHHHHHHhCCCC
Confidence 4679999999999999999998876 89999999986432110 01125678899999999999
Q ss_pred CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceee
Q 040898 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI 199 (337)
Q Consensus 120 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~ 199 (337)
||+++++++.+.+..|+||||+++|+|.+++.. ...+++..+..++.||+.||.|| |++|++|+||||+||++
T Consensus 66 ~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~NIll 138 (337)
T 1o6l_A 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYL---HSRDVVYRDIKLENLML 138 (337)
T ss_dssp TBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEE
T ss_pred cCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCcCCHHHEEE
Confidence 999999999999999999999999999999853 34689999999999999999999 66799999999999999
Q ss_pred cCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhh
Q 040898 200 DDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMD 279 (337)
Q Consensus 200 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~ 279 (337)
+.++.++|+|||++........ ......||+.|+|||++.+..++.++|+||||+++|+|++|..||.... ...
T Consensus 139 ~~~g~vkL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~----~~~ 212 (337)
T 1o6l_A 139 DKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD----HER 212 (337)
T ss_dssp CTTSCEEECCCTTCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS----HHH
T ss_pred CCCCCEEEeeccchhhcccCCC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC----HHH
Confidence 9999999999999876432221 1234578999999999999999999999999999999999999986421 112
Q ss_pred HHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCC-----ChhhhhcC
Q 040898 280 MVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERP-----SSKDVRSM 337 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 337 (337)
....+ ....... +...+..+.+|+.+||+.||++|| ++.++++|
T Consensus 213 ~~~~i---~~~~~~~-----------p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 213 LFELI---LMEEIRF-----------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHHHH---HHCCCCC-----------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHHH---HcCCCCC-----------CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 22111 1111110 011234489999999999999999 89999987
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=345.53 Aligned_cols=257 Identities=17% Similarity=0.277 Sum_probs=205.9
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
-.++|++.+.||+|+||.||++.+.. +|+.+|+|++......... ...+.+|+.+++.++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~--~~~~~a~K~i~~~~~~~~~-----------------~~~~~~E~~il~~l~h 69 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVL--AGQEYAAMIINTKKLSARD-----------------HQKLEREARICRLLKH 69 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETT--TTEEEEEEEEESCSCHHHH-----------------HHHHHHHHHHHHHCCB
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECC--CCcEEEEEEEEcccCCHHH-----------------HHHHHHHHHHHHhCCC
Confidence 45679999999999999999998876 9999999998765432211 1567889999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++++.+++..|+||||+++|+|.+.+.. ...+++..+..++.||+.||.|| |++|++|+||||+||+
T Consensus 70 pnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~l---H~~givHrDlKp~NIl 142 (444)
T 3soa_A 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHC---HQMGVVHRNLKPENLL 142 (444)
T ss_dssp TTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCSSTTEE
T ss_pred cCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHEE
Confidence 9999999999999999999999999999999854 35689999999999999999999 6679999999999999
Q ss_pred ec---CCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCc
Q 040898 199 ID---DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHT 275 (337)
Q Consensus 199 ~~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~ 275 (337)
++ .++.++|+|||++......... .....||+.|+|||++.+..++.++||||||+++|+|++|.+||....
T Consensus 143 l~~~~~~~~vkL~DFG~a~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~--- 217 (444)
T 3soa_A 143 LASKLKGAAVKLADFGLAIEVEGEQQA--WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED--- 217 (444)
T ss_dssp ESBSSTTCCEEECCCSSCBCCCTTCCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS---
T ss_pred EeccCCCCcEEEccCceeEEecCCCce--eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc---
Confidence 98 4678999999999776543222 234579999999999999899999999999999999999999985421
Q ss_pred hhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 276 EEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.......+........ . ...+..+..+.+|+.+||+.||++|||+.|+|+|
T Consensus 218 -~~~~~~~i~~~~~~~~-~---------~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 218 -QHRLYQQIKAGAYDFP-S---------PEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp -HHHHHHHHHHTCCCCC-T---------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -HHHHHHHHHhCCCCCC-c---------cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 2222222221111100 0 1111223458899999999999999999999987
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=326.27 Aligned_cols=266 Identities=21% Similarity=0.282 Sum_probs=202.9
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
++|++++.||+|+||+||++.+.. +++.||+|++......... ...+.+|+.++++++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~~ 62 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRE--THEIVALKRVRLDDDDEGV-----------------PSSALREICLLKELKHKN 62 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETT--TCCEEEEEEEESSCSSTTH-----------------HHHHHHHHHHHTTCCCTT
T ss_pred CCceeeeEecCCCCeEEEEEEECC--CCceEEEEeeeccCCcCCc-----------------chHHHHHHHHHhcCCCCC
Confidence 579999999999999999999876 8999999999765432221 146778999999999999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
|+++++++.+++..++||||+++ +|.+.+.. ....+++..++.++.|++.||.|| |++|++|+||||+||+++
T Consensus 63 iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~l---H~~~ivH~dikp~Nil~~ 135 (292)
T 3o0g_A 63 IVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFC---HSRNVLHRDLKPQNLLIN 135 (292)
T ss_dssp BCCEEEEEEETTEEEEEEECCSE-EHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEC
T ss_pred EeeEEeEEEeCCEEEEEEecCCC-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEc
Confidence 99999999999999999999986 56555533 345699999999999999999999 667999999999999999
Q ss_pred CCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCC-CCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhh
Q 040898 201 DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTET-ISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMD 279 (337)
Q Consensus 201 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~ 279 (337)
.++.++|+|||++......... .....+|+.|+|||++.+.. ++.++||||||+++|+|++|..||... ......
T Consensus 136 ~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~--~~~~~~ 211 (292)
T 3o0g_A 136 RNGELKLANFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG--NDVDDQ 211 (292)
T ss_dssp TTSCEEECCCTTCEECCSCCSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCC--SSHHHH
T ss_pred CCCCEEEeecccceecCCcccc--ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCC--CCHHHH
Confidence 9999999999999876433221 23456899999999997765 799999999999999999988885322 112222
Q ss_pred HHHHHHhhhccCCcchh--hh-------------hcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 280 MVKWMRNVIFSENPNRA--IN-------------SKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~~--~~-------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
+.. +............ .. ........+.....+.+|+.+||+.||++|||++|+++|
T Consensus 212 ~~~-i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 212 LKR-IFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp HHH-HHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHH-HHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 222 2111111110000 00 000011122344568899999999999999999999987
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=336.35 Aligned_cols=262 Identities=21% Similarity=0.296 Sum_probs=206.7
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
.++|++.+.||+|+||.||++.+.. +++.||+|++......... ....+.+.+|+.+++.++||
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~--------------~~~~~~~~~E~~~l~~l~hp 86 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRE--TGQQFAVKIVDVAKFTSSP--------------GLSTEDLKREASICHMLKHP 86 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEEHHHHHTSS--------------SCCHHHHHHHHHHHHHCCCT
T ss_pred ccceEEeeEEeeCCCEEEEEEEECC--CCCEEEEEEEEhhhccccc--------------cchHHHHHHHHHHHHhCCCC
Confidence 4569999999999999999998876 8999999998543211000 00015678899999999999
Q ss_pred CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceee
Q 040898 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI 199 (337)
Q Consensus 120 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~ 199 (337)
||+++++++.+++..|+||||+++++|.+.+......+..+++..++.++.||+.||.|| |++|++|+||||+||++
T Consensus 87 nIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~l---H~~~ivHrDlkp~NIl~ 163 (351)
T 3c0i_A 87 HIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYC---HDNNIIHRDVKPHCVLL 163 (351)
T ss_dssp TBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEE
T ss_pred CCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHH---HHCCceeccCChHHeEE
Confidence 999999999999999999999999999998876555556689999999999999999999 66799999999999999
Q ss_pred cCCCC---eEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCch
Q 040898 200 DDDME---ARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTE 276 (337)
Q Consensus 200 ~~~~~---~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~ 276 (337)
+.++. ++|+|||++......... .....+|+.|+|||++.+..++.++||||||+++|+|++|..||... .
T Consensus 164 ~~~~~~~~vkl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~----~ 237 (351)
T 3c0i_A 164 ASKENSAPVKLGGFGVAIQLGESGLV--AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT----K 237 (351)
T ss_dssp CSSSTTCCEEECCCTTCEECCTTSCB--CCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS----H
T ss_pred ecCCCCCcEEEecCcceeEecCCCee--ecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc----H
Confidence 86654 999999999876543321 23457999999999999999999999999999999999999998652 1
Q ss_pred hhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 277 EMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
......+.. ....... ...+..+..+.+|+.+||+.||++|||+.++++|
T Consensus 238 -~~~~~~i~~---~~~~~~~-------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 238 -ERLFEGIIK---GKYKMNP-------RQWSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp -HHHHHHHHH---TCCCCCH-------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -HHHHHHHHc---CCCCCCc-------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 111111111 1111000 0011223458999999999999999999999987
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=333.20 Aligned_cols=253 Identities=21% Similarity=0.317 Sum_probs=205.4
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
.++|++.+.||+|+||.||++.+.. +++.||+|.+...... ...+.+|+.+++.++||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~~~~~a~K~~~~~~~~--------------------~~~~~~E~~~l~~l~hp 61 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETS--SKKTYMAKFVKVKGTD--------------------QVLVKKEISILNIARHR 61 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT--TTEEEEEEEECCCTHH--------------------HHHHHHHHHHHHHSCCT
T ss_pred hhceEeeeEEecCCCeEEEEEEECC--CCcEEEEEEEecCccc--------------------HHHHHHHHHHHHhCCCC
Confidence 5789999999999999999999876 8999999998643211 04577899999999999
Q ss_pred CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceee
Q 040898 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI 199 (337)
Q Consensus 120 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~ 199 (337)
||+++++++.+.+..++||||+++++|.+++.. ....+++..++.++.|++.||.|| |++|++|+||+|+||++
T Consensus 62 nIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~l---H~~givH~Dlkp~NIl~ 135 (321)
T 1tki_A 62 NILHLHESFESMEELVMIFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFL---HSHNIGHFDIRPENIIY 135 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEE
T ss_pred CCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH---HHCCCCcCCCCHHHEEE
Confidence 999999999999999999999999999999842 334689999999999999999999 66799999999999999
Q ss_pred cC--CCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchh
Q 040898 200 DD--DMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEE 277 (337)
Q Consensus 200 ~~--~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~ 277 (337)
+. ++.++|+|||++........ .....+|+.|+|||++.+..++.++|+||||+++|+|++|..||.... .
T Consensus 136 ~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~ 208 (321)
T 1tki_A 136 QTRRSSTIKIIEFGQARQLKPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET----N 208 (321)
T ss_dssp SSSSCCCEEECCCTTCEECCTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS----H
T ss_pred ccCCCCCEEEEECCCCeECCCCCc---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC----H
Confidence 87 78999999999987654432 234568999999999998888999999999999999999999986532 1
Q ss_pred hhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 278 MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
......+.. ....... ...+..+..+.+|+.+||+.||++|||+.|+|+|
T Consensus 209 ~~~~~~i~~---~~~~~~~-------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 209 QQIIENIMN---AEYTFDE-------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHHHHHHHH---TCCCCCH-------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHc---CCCCCCh-------hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 122111111 1111000 0011223458999999999999999999999987
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=335.65 Aligned_cols=255 Identities=21% Similarity=0.346 Sum_probs=206.1
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
.++|++.+.||+|+||.||++.+.. +++.||+|++......... ...+.+|+.+++.++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~--~~~~~avK~~~~~~~~~~~-----------------~~~~~~E~~il~~l~hp 88 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKT--TGLEFAAKIINTKKLSARD-----------------FQKLEREARICRKLQHP 88 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEETTTCCHHH-----------------HHHHHHHHHHHHHCCCT
T ss_pred ccCeEEeeEEecCCCeEEEEEEECC--CCCEEEEEEEEcccCCHHH-----------------HHHHHHHHHHHHhCCCC
Confidence 4679999999999999999998865 8999999999765432211 15678899999999999
Q ss_pred CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceee
Q 040898 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI 199 (337)
Q Consensus 120 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~ 199 (337)
||+++++++.+++..|+||||+++++|.+.+ .....+++..++.++.||+.||.|| |++|++|+||+|+||++
T Consensus 89 nIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l----~~~~~~~~~~~~~~~~qi~~al~~l---H~~~ivH~Dlkp~NIll 161 (362)
T 2bdw_A 89 NIVRLHDSIQEESFHYLVFDLVTGGELFEDI----VAREFYSEADASHCIQQILESIAYC---HSNGIVHRNLKPENLLL 161 (362)
T ss_dssp TBCCEEEEEECSSEEEEEECCCCSCBHHHHH----TTCSCCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCSGGGEEE
T ss_pred CCCeEEEEEEeCCEEEEEEecCCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHH---HHCCeEeccCchHHEEE
Confidence 9999999999999999999999999999988 4456789999999999999999999 66799999999999999
Q ss_pred cCCC---CeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCch
Q 040898 200 DDDM---EARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTE 276 (337)
Q Consensus 200 ~~~~---~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~ 276 (337)
+.++ .++|+|||++........ .....||+.|+|||++.+..++.++||||||+++|+|++|.+||....
T Consensus 162 ~~~~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~---- 234 (362)
T 2bdw_A 162 ASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED---- 234 (362)
T ss_dssp SCSSTTCCEEECCCTTCBCCTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS----
T ss_pred ecCCCCCCEEEeecCcceEecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC----
Confidence 8654 599999999987654322 234579999999999999899999999999999999999999986431
Q ss_pred hhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 277 EMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.......+....... +. ......+..+.+|+.+||+.||++|||+.++|+|
T Consensus 235 ~~~~~~~i~~~~~~~-~~---------~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 235 QHRLYAQIKAGAYDY-PS---------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp HHHHHHHHHHTCCCC-CT---------TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHHHhCCCCC-Cc---------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 122222222111110 00 1112233458999999999999999999999987
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-46 Score=335.43 Aligned_cols=255 Identities=23% Similarity=0.326 Sum_probs=204.8
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
.++|++++.||+|+||.||++.+.. +++.||+|.+........ .....+.+|+.+++.++||
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~--~~~~~AiK~~~~~~~~~~----------------~~~~~~~~E~~il~~l~hp 75 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKND--TKKMYAMKYMNKQKCVER----------------NEVRNVFKELQIMQGLEHP 75 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETT--TCCEEEEEEEEHHHHHHT----------------TCHHHHHHHHHHHHTCCCT
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECC--CCCEEEEEEEehhhcccH----------------HHHHHHHHHHHHHHhCCCC
Confidence 4679999999999999999998876 899999999864321110 1125678899999999999
Q ss_pred CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceee
Q 040898 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI 199 (337)
Q Consensus 120 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~ 199 (337)
||+++++++.+....|+||||+++|+|.+++. ....+++..+..++.||+.||.|| |+.|++|+||||+||++
T Consensus 76 ~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~L---H~~givHrDlkp~NIll 148 (384)
T 4fr4_A 76 FLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQ----QNVHFKEETVKLFICELVMALDYL---QNQRIIHRDMKPDNILL 148 (384)
T ss_dssp TBCCEEEEEECSSEEEEEECCCTTEEHHHHHH----TTCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEE
T ss_pred CCCcEEEEEEeCCEEEEEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHH---HHCCceeccCcHHHeEE
Confidence 99999999999999999999999999999984 455699999999999999999999 66799999999999999
Q ss_pred cCCCCeEEecccCccccCCCCceeeeecccCCCCccCcccccc---CCCCCcccchhhhHHHHHHHhCCCCCCCCCCCch
Q 040898 200 DDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQT---ETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTE 276 (337)
Q Consensus 200 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~---~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~ 276 (337)
+.++.++|+|||++........ .....||+.|+|||++.+ ..++.++|+||||+++|+|++|..||........
T Consensus 149 ~~~g~vkL~DFG~a~~~~~~~~---~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~ 225 (384)
T 4fr4_A 149 DEHGHVHITDFNIAAMLPRETQ---ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS 225 (384)
T ss_dssp CTTSCEEECCCTTCEECCTTCC---BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCH
T ss_pred CCCCCEEEeccceeeeccCCCc---eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccH
Confidence 9999999999999987654322 234679999999999864 4588999999999999999999999975433222
Q ss_pred hhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCC-hhhhhcC
Q 040898 277 EMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPS-SKDVRSM 337 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-~~ell~~ 337 (337)
. .....+.. .... .+...+..+.+|+.+||+.||.+||+ ++++++|
T Consensus 226 ~-~~~~~~~~---~~~~-----------~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~h 272 (384)
T 4fr4_A 226 K-EIVHTFET---TVVT-----------YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNF 272 (384)
T ss_dssp H-HHHHHHHH---CCCC-----------CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred H-HHHHHHhh---cccC-----------CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence 1 12111111 1111 01112344899999999999999999 8888876
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=329.92 Aligned_cols=269 Identities=24% Similarity=0.345 Sum_probs=190.7
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++++.||+|+||.||++.+.. +++.||+|++......... ..+.+|+.++++++|
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~------------------~~~~~E~~~l~~l~h 62 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKT--TGVYVALKEVKLDSEEGTP------------------STAIREISLMKELKH 62 (317)
T ss_dssp ----------------CEEEEEECSS--SCCEEEEEEEECCSTTCSC------------------HHHHHHHHHHTTCCB
T ss_pred cccceeEeeEECCCCCEEEEEEEECC--CCcEEEEEEeecccccccH------------------HHHHHHHHHHHhcCC
Confidence 45789999999999999999998866 8999999998655422110 456789999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcC--CcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQ--GRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPAN 196 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~n 196 (337)
|||+++++++.+++..++||||+++ +|.+++..... ....+++..+..++.||+.||.|| |+.|++|+||||+|
T Consensus 63 p~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~l---H~~~ivH~Dlkp~N 138 (317)
T 2pmi_A 63 ENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC---HENKILHRDLKPQN 138 (317)
T ss_dssp TTBCCEEEEECCTTEEEEEEECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGG
T ss_pred CCcceEEEEEEECCeEEEEEEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHH---HHCCeeeCCCChHH
Confidence 9999999999999999999999985 99999865432 234588999999999999999999 66799999999999
Q ss_pred eeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCCCc
Q 040898 197 VLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTE-TISDKCDIYSFGVLLAVLVMGKFPVDDFFGHT 275 (337)
Q Consensus 197 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~ 275 (337)
|+++.++.++|+|||++........ ......+|+.|+|||++.+. .++.++||||||+++|+|++|..||......
T Consensus 139 Il~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~- 215 (317)
T 2pmi_A 139 LLINKRGQLKLGDFGLARAFGIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE- 215 (317)
T ss_dssp EEECTTCCEEECCCSSCEETTSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-
T ss_pred eEEcCCCCEEECcCccceecCCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-
Confidence 9999999999999999987643221 12235689999999999764 5899999999999999999999999653221
Q ss_pred hhhhHHHHHHhhhccCCc----chh----------------hhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhh
Q 040898 276 EEMDMVKWMRNVIFSENP----NRA----------------INSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVR 335 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~----~~~----------------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 335 (337)
.....+......... ... ................+.+|+.+||+.||++|||+.|+|
T Consensus 216 ---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l 292 (317)
T 2pmi_A 216 ---EQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQAL 292 (317)
T ss_dssp ---HHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred ---HHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHh
Confidence 111111111111000 000 000000000112234689999999999999999999999
Q ss_pred cC
Q 040898 336 SM 337 (337)
Q Consensus 336 ~~ 337 (337)
+|
T Consensus 293 ~h 294 (317)
T 2pmi_A 293 HH 294 (317)
T ss_dssp TS
T ss_pred CC
Confidence 87
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-47 Score=336.30 Aligned_cols=252 Identities=24% Similarity=0.381 Sum_probs=202.1
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++.+.||+|+||.||++.+.. +++.||+|++........ .....+.+|+.+++.++|
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~--~~~~vaiK~~~~~~~~~~----------------~~~~~~~~E~~~l~~l~h 68 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYK--TQQKVALKFISRQLLKKS----------------DMHMRVEREISYLKLLRH 68 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEEHHHHHHT----------------TCSHHHHHHHHHHTTCCC
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECC--CCCEEEEEEEehHHccch----------------hHHHHHHHHHHHHHhCCC
Confidence 45789999999999999999999876 899999999854321100 001467889999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++++.++...++||||+ +|+|.+++.. ...+++..++.++.|++.||.|| |+.|++|+||+|+||+
T Consensus 69 pnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~L---H~~givH~Dlkp~NIl 140 (336)
T 3h4j_B 69 PHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYC---HRHKIVHRDLKPENLL 140 (336)
T ss_dssp TTBCCEEEEEECSSEEEEEECCC-CEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHH---HHHTCCCCCCSTTTEE
T ss_pred CCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCchhhEE
Confidence 99999999999999999999999 6789888844 34689999999999999999999 6669999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCC-CCcccchhhhHHHHHHHhCCCCCCCCCCCchh
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETI-SDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEE 277 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~ 277 (337)
++.++.++|+|||++......... ....||+.|+|||++.+..+ +.++||||||+++|+|++|..||.........
T Consensus 141 l~~~~~~kl~DFG~s~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~ 217 (336)
T 3h4j_B 141 LDDNLNVKIADFGLSNIMTDGNFL---KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF 217 (336)
T ss_dssp ECTTCCEEECCSSCTBTTTTSBTT---CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB
T ss_pred EcCCCCEEEEEeccceeccCCccc---ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH
Confidence 999999999999999876543322 33579999999999988776 67899999999999999999999653221100
Q ss_pred hhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 278 MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.. ..... ...+...+..+.+|+.+||+.||.+|||+.|+++|
T Consensus 218 ~~-------i~~~~-----------~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 218 KK-------VNSCV-----------YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp CC-------CCSSC-----------CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred HH-------HHcCC-----------CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 00 00000 00111223458899999999999999999999987
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=333.20 Aligned_cols=260 Identities=23% Similarity=0.325 Sum_probs=207.2
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++.+.||+|+||.||++.+.. +++.||+|.+........... ...+.+.+|+.+++.++|
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~--~~~~~avK~~~~~~~~~~~~~-------------~~~~~~~~E~~~l~~l~h 73 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKS--TGLQYAAKFIKKRRTKSSRRG-------------VSREDIEREVSILKEIQH 73 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETT--TCCEEEEEEEEBCCSTTCSSS-------------BCHHHHHHHHHHHHHCCC
T ss_pred cccceEeceEEeeCCCeEEEEEEECC--CCcEEEEEEEEccccccccch-------------hhHHHHHHHHHHHHhCCC
Confidence 45679999999999999999999876 899999999876543221000 001567889999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++++.++...++||||+++++|.+++ .....+++..++.++.|++.||.|| |+.|++|+||+|+||+
T Consensus 74 p~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~al~~l---H~~~ivH~Dlkp~NIl 146 (326)
T 2y0a_A 74 PNVITLHEVYENKTDVILILELVAGGELFDFL----AEKESLTEEEATEFLKQILNGVYYL---HSLQIAHFDLKPENIM 146 (326)
T ss_dssp TTBCCEEEEEECSSEEEEEEECCCSCBHHHHH----TTSSCCBHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEE
T ss_pred CCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHH----HhcCCcCHHHHHHHHHHHHHHHHHH---HHCCeEcCCCCHHHEE
Confidence 99999999999999999999999999999998 4456789999999999999999999 6679999999999999
Q ss_pred ecCCC----CeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCC
Q 040898 199 IDDDM----EARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGH 274 (337)
Q Consensus 199 ~~~~~----~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~ 274 (337)
++.++ .++|+|||++........ .....+|+.|+|||++.+..++.++|+||||+++|+|++|..||.....
T Consensus 147 l~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~- 222 (326)
T 2y0a_A 147 LLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK- 222 (326)
T ss_dssp ESCSSSSSCCEEECCCTTCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-
T ss_pred EecCCCCCCCEEEEECCCCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH-
Confidence 99877 799999999987654322 2335699999999999988999999999999999999999999854311
Q ss_pred chhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 275 TEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
......+...... .+.. ..+..+..+.+|+.+||+.||++|||+.++|+|
T Consensus 223 ---~~~~~~~~~~~~~-~~~~---------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 223 ---QETLANVSAVNYE-FEDE---------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp ---HHHHHHHHHTCCC-CCHH---------HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ---HHHHHHHHhcCCC-cCcc---------ccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1111111111110 0000 011223458899999999999999999999987
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-46 Score=327.19 Aligned_cols=254 Identities=23% Similarity=0.416 Sum_probs=203.6
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++.+.||+|+||.||++.+.. +++.||+|.+....... ...+.+|+.++++++|
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~--~~~~va~K~~~~~~~~~-------------------~~~~~~E~~~l~~l~h 66 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRE--TGEVMVMKELIRFDEET-------------------QRTFLKEVKVMRCLEH 66 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETT--TCCEEEEEEESCCCHHH-------------------HHHHHHHHHHHTTCCC
T ss_pred ChhHeeccceecCCCCEEEEEEEECC--CCcEEEEEEeccCCHHH-------------------HHHHHHHHHHHHhCCC
Confidence 46789999999999999999999876 89999999885432111 1578889999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++++.+++..++||||+++++|.+++.. ....+++..+..++.|++.||.|| |+.|++|+||+|+||+
T Consensus 67 p~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~l---H~~~ivH~dlkp~Nil 140 (310)
T 3s95_A 67 PNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYL---HSMNIIHRDLNSHNCL 140 (310)
T ss_dssp TTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH---CCTTSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSTTSEE
T ss_pred cCcccEEEEEecCCeeEEEEEecCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHH---HhCCccCCCCCcCeEE
Confidence 9999999999999999999999999999999964 345689999999999999999999 6679999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceee------------eecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCC
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQIT------------VKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKF 266 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~------------~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~ 266 (337)
++.++.++|+|||++........... .....||+.|+|||++.+..++.++||||||+++|+|++|..
T Consensus 141 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~ 220 (310)
T 3s95_A 141 VRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVN 220 (310)
T ss_dssp ECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCC
T ss_pred ECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCC
Confidence 99999999999999987644322110 113568999999999999999999999999999999999999
Q ss_pred CCCCCCCCchhh--hHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 267 PVDDFFGHTEEM--DMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 267 pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
||.......... .......... ++..+..+.+++.+||+.||++|||+.++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 221 ADPDYLPRTMDFGLNVRGFLDRYC-----------------PPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp SSTTTSCBCTTSSBCHHHHHHHTC-----------------CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCcchhhhHHHHhhhhhccccccC-----------------CCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 987543322111 1111111110 0111123889999999999999999999875
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=336.33 Aligned_cols=253 Identities=25% Similarity=0.311 Sum_probs=200.2
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc-CC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT-RH 118 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h 118 (337)
.++|++++.||+|+||.||++.+.. +++.||+|++........ .....+.+|..++..+ +|
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~--~~~~~AvK~~~~~~~~~~----------------~~~~~~~~E~~il~~~~~h 83 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKE--TGDLYAVKVLKKDVILQD----------------DDVECTMTEKRILSLARNH 83 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEEHHHHHHH----------------TTHHHHHHHHHHHHHTTTC
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcC--CCCEEEEEEEEHHHhcch----------------hHHHHHHHHHHHHHhccCC
Confidence 4679999999999999999999876 899999999864321111 1125677899999988 79
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++++.+.+..|+||||+++|+|.+++.. ...+++..++.++.||+.||.|| |++|++|+||||+||+
T Consensus 84 p~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~L---H~~givHrDlkp~NIL 156 (353)
T 3txo_A 84 PFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFL---HDKGIIYRDLKLDNVL 156 (353)
T ss_dssp TTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEE
T ss_pred CceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCCcccCCCHHHEE
Confidence 9999999999999999999999999999999854 34589999999999999999999 6679999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhh
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEM 278 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~ 278 (337)
++.++.++|+|||++........ ......||+.|+|||++.+..++.++|+||||+++|+|++|..||.... ..
T Consensus 157 l~~~g~ikL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~----~~ 230 (353)
T 3txo_A 157 LDHEGHCKLADFGMCKEGICNGV--TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN----ED 230 (353)
T ss_dssp ECTTSCEEECCCTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS----HH
T ss_pred ECCCCCEEEccccceeecccCCc--cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC----HH
Confidence 99999999999999875432221 2234579999999999998889999999999999999999999996432 12
Q ss_pred hHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCCh------hhhhcC
Q 040898 279 DMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSS------KDVRSM 337 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~------~ell~~ 337 (337)
.....+.. ..... +......+.+|+.+||+.||++||++ .++++|
T Consensus 231 ~~~~~i~~---~~~~~-----------p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 231 DLFEAILN---DEVVY-----------PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp HHHHHHHH---CCCCC-----------CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred HHHHHHHc---CCCCC-----------CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 22222211 11111 01123348899999999999999998 888887
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-46 Score=336.15 Aligned_cols=261 Identities=22% Similarity=0.284 Sum_probs=203.8
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc-C
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT-R 117 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~ 117 (337)
..++|++++.||+|+||.||++.+.. +++.||+|++.......... ...+.+|..++.++ +
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~--~~~~~AvK~~~k~~~~~~~~----------------~~~~~~E~~il~~~~~ 111 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKK--TDRIYAMRVVKKELVNDDED----------------IDWVQTEKHVFEQASN 111 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT--TTEEEEEEEEEGGGTC--------------------CCHHHHHHHHHHHHTT
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECC--CCCEEEEEEEEhhhccCHHH----------------HHHHHHHHHHHHhcCC
Confidence 45689999999999999999999876 89999999997654322211 14577788888887 8
Q ss_pred CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCce
Q 040898 118 HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANV 197 (337)
Q Consensus 118 hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ni 197 (337)
||||+++++++.+....|+||||+++|+|..++.. ...+++..+..++.||+.||.|| |++|++||||||+||
T Consensus 112 hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~L---H~~givHrDLKp~NI 184 (396)
T 4dc2_A 112 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYL---HERGIIYRDLKLDNV 184 (396)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGE
T ss_pred CCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCEEeccCCHHHE
Confidence 99999999999999999999999999999999854 34689999999999999999999 667999999999999
Q ss_pred eecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchh
Q 040898 198 LIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEE 277 (337)
Q Consensus 198 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~ 277 (337)
+++.++.++|+|||++........ ......||+.|+|||++.+..++.++|+||||+++|+|++|..||.........
T Consensus 185 Ll~~~g~ikL~DFGla~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~ 262 (396)
T 4dc2_A 185 LLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP 262 (396)
T ss_dssp EECTTSCEEECCCTTCBCCCCTTC--CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC----
T ss_pred EECCCCCEEEeecceeeecccCCC--ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccccccc
Confidence 999999999999999875322211 223467999999999999999999999999999999999999999643221111
Q ss_pred -h-hHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCCh------hhhhcC
Q 040898 278 -M-DMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSS------KDVRSM 337 (337)
Q Consensus 278 -~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~------~ell~~ 337 (337)
. ............... .+...+..+.+|+.+||+.||++||++ .|+++|
T Consensus 263 ~~~~~~~~~~~i~~~~~~-----------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 263 DQNTEDYLFQVILEKQIR-----------IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp --CCHHHHHHHHHHCCCC-----------CCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred chhhHHHHHHHHhccccC-----------CCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 0 111111111111111 011123448899999999999999995 688876
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=330.08 Aligned_cols=250 Identities=24% Similarity=0.388 Sum_probs=204.0
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
.++|++++.||+|+||.||++.+.. +|+.||+|++........ ...+.+.+|..+++.++||
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~----------------~~~~~~~~E~~~l~~l~hp 66 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRH--NGRYYAMKVLKKEIVVRL----------------KQVEHTNDERLMLSIVTHP 66 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT--TCCEEEEEEEEHHHHHHT----------------TCHHHHHHHHHHHHSCCBT
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECC--CCCEEEEEEEEHHHhhhh----------------hHHHHHHHHHHHHhhCCCC
Confidence 4679999999999999999998876 899999999864321110 1125677899999999999
Q ss_pred CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceee
Q 040898 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI 199 (337)
Q Consensus 120 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~ 199 (337)
||+++++++.+....|+||||+++++|.+++.. ...+++..+..++.||+.||.|| |++|++|+||+|+||++
T Consensus 67 ~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~NIll 139 (318)
T 1fot_A 67 FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYL---HSKDIIYRDLKPENILL 139 (318)
T ss_dssp TBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCCGGGEEE
T ss_pred CCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCChheEEE
Confidence 999999999999999999999999999999954 34689999999999999999999 77899999999999999
Q ss_pred cCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhh
Q 040898 200 DDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMD 279 (337)
Q Consensus 200 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~ 279 (337)
+.++.++|+|||++...... .....||+.|+|||++.+..++.++|+||||+++|+|++|..||.... . ..
T Consensus 140 ~~~g~~kL~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~-~~ 210 (318)
T 1fot_A 140 DKNGHIKITDFGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN---T-MK 210 (318)
T ss_dssp CTTSCEEECCCSSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS---H-HH
T ss_pred cCCCCEEEeecCcceecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC---H-HH
Confidence 99999999999999865432 123579999999999999999999999999999999999999986431 1 11
Q ss_pred HHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCC-----ChhhhhcC
Q 040898 280 MVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERP-----SSKDVRSM 337 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 337 (337)
.. ..+....... ++.....+.+++.+||+.||++|| +++++++|
T Consensus 211 ~~---~~i~~~~~~~-----------p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 211 TY---EKILNAELRF-----------PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp HH---HHHHHCCCCC-----------CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HH---HHHHhCCCCC-----------CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 11 1111111110 011234488999999999999999 89999987
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=328.91 Aligned_cols=260 Identities=22% Similarity=0.282 Sum_probs=204.7
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc-CC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT-RH 118 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h 118 (337)
.++|++++.||+|+||.||++.+.. +++.||+|++.......... ...+.+|..++.++ +|
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~----------------~~~~~~E~~~l~~~~~h 69 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKK--TDRIYAMKVVKKELVNDDED----------------IDWVQTEKHVFEQASNH 69 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT--TTEEEEEEEEEGGGSCSHHH----------------HHHHHHHHHHHHHTTTC
T ss_pred hhheEEEEEEEecCCeEEEEEEECC--CCCEEEEEEEEhHHhcchHH----------------HHHHHHHHHHHHhcCCC
Confidence 4679999999999999999999876 89999999997654332221 15677899999887 89
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++++.+....|+||||+++|+|.+++.. ...+++..++.++.||+.||.|| |++|++|+||||+||+
T Consensus 70 p~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~NIl 142 (345)
T 3a8x_A 70 PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYL---HERGIIYRDLKLDNVL 142 (345)
T ss_dssp TTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEE
T ss_pred CccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCceecCCCHHHEE
Confidence 9999999999999999999999999999999854 34689999999999999999999 6679999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchh-
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEE- 277 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~- 277 (337)
++.++.++|+|||++........ ......||+.|+|||++.+..++.++|+||||+++|+|++|..||.........
T Consensus 143 l~~~g~~kL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~ 220 (345)
T 3a8x_A 143 LDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 220 (345)
T ss_dssp ECTTSCEEECCGGGCBCSCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-----
T ss_pred ECCCCCEEEEeccccccccCCCC--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccc
Confidence 99999999999999875432221 123457999999999999999999999999999999999999999653221110
Q ss_pred -hhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCCh------hhhhcC
Q 040898 278 -MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSS------KDVRSM 337 (337)
Q Consensus 278 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~------~ell~~ 337 (337)
................ .+...+..+.+|+.+||+.||++|||+ .++++|
T Consensus 221 ~~~~~~~~~~i~~~~~~-----------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 221 QNTEDYLFQVILEKQIR-----------IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp --CHHHHHHHHHHCCCC-----------CCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred cccHHHHHHHHHcCCCC-----------CCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 0111111111111111 011223448899999999999999996 788876
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-46 Score=326.52 Aligned_cols=255 Identities=26% Similarity=0.398 Sum_probs=195.3
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++.+.||+|+||.||++.+ +++.||+|++......... ...+.+|+.++++++|
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~----~~~~vavK~~~~~~~~~~~-----------------~~~~~~E~~~l~~l~h 93 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW----HGSDVAVKILMEQDFHAER-----------------VNEFLREVAIMKRLRH 93 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE----TTEEEEEEEECCCCCSHHH-----------------HHHHHHHHHHHHHCCC
T ss_pred ChhHceeeeEeecCCCeEEEEEEE----CCCcEEEEEecCCCCCHHH-----------------HHHHHHHHHHHHhCCC
Confidence 467899999999999999999876 7889999998765432221 1567889999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCC--eEecCCCCCc
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPR--LIHRDIKPAN 196 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~g--i~h~di~~~n 196 (337)
|||+++++++.+....++||||+++++|.+++.... ....+++..++.++.|++.||.|| |++| ++|+||+|+|
T Consensus 94 p~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~L---H~~~~~ivH~Dikp~N 169 (309)
T 3p86_A 94 PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYL---HNRNPPIVHRNLKSPN 169 (309)
T ss_dssp TTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHH---HTSSSCCCCTTCCGGG
T ss_pred CCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHH---HcCCCCEECCCCChhh
Confidence 999999999999999999999999999999985311 123489999999999999999999 6678 9999999999
Q ss_pred eeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCch
Q 040898 197 VLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTE 276 (337)
Q Consensus 197 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~ 276 (337)
|+++.++.++|+|||++........ ......+|+.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 170 Ill~~~~~~kL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~--- 244 (309)
T 3p86_A 170 LLVDKKYTVKVCDFGLSRLKASTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP--- 244 (309)
T ss_dssp EEECTTCCEEECCCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH---
T ss_pred EEEeCCCcEEECCCCCCcccccccc--ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---
Confidence 9999999999999999875433221 12345689999999999999999999999999999999999999965322
Q ss_pred hhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 277 EMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
......... ..... ..+...+..+.+++.+||+.||.+|||+.++++
T Consensus 245 -~~~~~~~~~---~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 291 (309)
T 3p86_A 245 -AQVVAAVGF---KCKRL---------EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMD 291 (309)
T ss_dssp -HHHHHHHHH---SCCCC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -HHHHHHHHh---cCCCC---------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 111111111 10000 011122334889999999999999999999985
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=325.52 Aligned_cols=265 Identities=23% Similarity=0.316 Sum_probs=198.9
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
++|++++.||+|+||.||++.+ . +++.||+|++........ ....+.+|+.+++.++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~--~~~~~aiK~~~~~~~~~~-----------------~~~~~~~E~~~l~~l~h~~ 61 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-N--YGETFALKKIRLEKEDEG-----------------IPSTTIREISILKELKHSN 61 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-T--TSCEEEEEEECCSSGGGC-----------------CCHHHHHHHHGGGGCCCTT
T ss_pred ccchhhhhcccCCCEEEEEEEc-C--CCCEEEEEEEeccccccc-----------------cchhHHHHHHHHHhcCCCC
Confidence 5799999999999999999987 3 789999999865532211 0145778999999999999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
|+++++++.+++..++||||+++ +|.+++.. ....+++..+..++.|++.||.|| |++|++|+||+|+||+++
T Consensus 62 iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nil~~ 134 (288)
T 1ob3_A 62 IVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYC---HDRRVLHRDLKPQNLLIN 134 (288)
T ss_dssp BCCEEEEEECSSCEEEEEECCSE-EHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEEC
T ss_pred EeeeeeEEccCCeEEEEEEecCC-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEEc
Confidence 99999999999999999999986 89888853 335688999999999999999999 667999999999999999
Q ss_pred CCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhh
Q 040898 201 DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTE-TISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMD 279 (337)
Q Consensus 201 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~ 279 (337)
.++.++|+|||++........ ......+|+.|+|||++.+. .++.++|+||||+++|+|++|..||..... ...
T Consensus 135 ~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~ 209 (288)
T 1ob3_A 135 REGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE---ADQ 209 (288)
T ss_dssp TTSCEEECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHH
T ss_pred CCCCEEEeECccccccCcccc--ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHH
Confidence 999999999999876543221 12234689999999999764 589999999999999999999999965422 111
Q ss_pred HHHHHHhhhccC---Ccchh----h-------hhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 280 MVKWMRNVIFSE---NPNRA----I-------NSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 280 ~~~~~~~~~~~~---~~~~~----~-------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
............ .+... . .+..........+..+.+|+.+||+.||++|||+.|+++|
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 210 LMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp HHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 222111111000 00000 0 0000001111234558899999999999999999999987
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=326.60 Aligned_cols=258 Identities=23% Similarity=0.398 Sum_probs=199.4
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
-.++|++++.||+|+||.||++.+.. +++.||+|.+.......... ...+.+|+.++++++|
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~----------------~~~~~~e~~~l~~l~h 70 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTI--LNIKVAIKAIFIPPREKEET----------------LKRFEREVHNSSQLSH 70 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETT--TCSEEEEEEEECCSSCCHHH----------------HHHHHHHHHHHTTCCB
T ss_pred hhccEEEEEEEccCCCEEEEEEEECC--CCCeEEEEEeccCccccHHH----------------HHHHHHHHHHHhcCCC
Confidence 35789999999999999999998876 89999999986654433221 1578889999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++++.+++..++||||+++++|.+++.. ..++++..++.++.|++.||.|| |++|++|+||+|+||+
T Consensus 71 p~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~Dlkp~Nil 143 (294)
T 4eqm_A 71 QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHA---HDMRIVHRDIKPQNIL 143 (294)
T ss_dssp TTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEE
T ss_pred CCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEE
Confidence 9999999999999999999999999999999954 34689999999999999999999 6679999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhh
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEM 278 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~ 278 (337)
++.++.++|+|||++......... ......+|+.|+|||.+.+..++.++|+||||+++|+|++|..||..... ..
T Consensus 144 ~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~---~~ 219 (294)
T 4eqm_A 144 IDSNKTLKIFDFGIAKALSETSLT-QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA---VS 219 (294)
T ss_dssp ECTTSCEEECCCSSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH---HH
T ss_pred ECCCCCEEEEeCCCcccccccccc-ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh---HH
Confidence 999999999999999876443222 22335689999999999999999999999999999999999999965321 11
Q ss_pred hHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCC-Chhhhh
Q 040898 279 DMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERP-SSKDVR 335 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-s~~ell 335 (337)
.... ......+... .. ..+..+..+.+++.+||+.||.+|| ++.++.
T Consensus 220 ~~~~----~~~~~~~~~~--~~----~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~ 267 (294)
T 4eqm_A 220 IAIK----HIQDSVPNVT--TD----VRKDIPQSLSNVILRATEKDKANRYKTIQEMK 267 (294)
T ss_dssp HHHH----HHSSCCCCHH--HH----SCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHH
T ss_pred HHHH----HhhccCCCcc--hh----cccCCCHHHHHHHHHHhcCCHhHccccHHHHH
Confidence 1111 1111111110 00 0112234588999999999999999 565554
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=333.46 Aligned_cols=260 Identities=22% Similarity=0.323 Sum_probs=206.6
Q ss_pred ccccccccceeccCcceEEEEeEEec-----CCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHH
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELP-----GSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITA 113 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l 113 (337)
..++|++.+.||+|+||.||++.+.. ..++..||+|.+........ ...+.+|+.++
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~------------------~~~~~~E~~~l 140 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD------------------LSDLVSEMEMM 140 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHH------------------HHHHHHHHHHH
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHH------------------HHHHHHHHHHH
Confidence 56789999999999999999998752 23567899999865532211 15688899999
Q ss_pred Hhc-CCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcC------------CcccCChHHHHHHHHHHHHHHHHHh
Q 040898 114 NQT-RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQ------------GRRELDWPARHRIARGIASGLEYLH 180 (337)
Q Consensus 114 ~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~l~ 180 (337)
+.+ +||||+++++++.+++..|+||||+++|+|.+++..... ....+++..++.++.||+.||.||
T Consensus 141 ~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L- 219 (370)
T 2psq_A 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL- 219 (370)
T ss_dssp HHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHH-
T ss_pred HHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHH-
Confidence 999 899999999999999999999999999999999976332 123578899999999999999999
Q ss_pred hCCCCCeEecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHH
Q 040898 181 MCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAV 260 (337)
Q Consensus 181 ~~h~~gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ 260 (337)
|++|++|+||||+||+++.++.++|+|||++................+++.|+|||++.+..++.++||||||+++|+
T Consensus 220 --H~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~e 297 (370)
T 2psq_A 220 --ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE 297 (370)
T ss_dssp --HHTTEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHH
T ss_pred --HhCCeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHH
Confidence 667999999999999999999999999999986654332222233456788999999999899999999999999999
Q ss_pred HHh-CCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 261 LVM-GKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 261 ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
|++ |..||..... ......+....... .+......+.+++.+||+.||++|||+.|+++
T Consensus 298 llt~g~~p~~~~~~----~~~~~~~~~~~~~~-------------~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 357 (370)
T 2psq_A 298 IFTLGGSPYPGIPV----EELFKLLKEGHRMD-------------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 357 (370)
T ss_dssp HHTTSCCSSTTCCG----GGHHHHHHTTCCCC-------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHcCCCCCCCCCCH----HHHHHHHhcCCCCC-------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 999 9999865422 22222222111111 11122345899999999999999999999986
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-46 Score=327.19 Aligned_cols=265 Identities=23% Similarity=0.312 Sum_probs=199.7
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
++|++++.||+|+||.||++.+.. +++.||+|++......... ...+.+|+.++++++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~~ 63 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRD--TGQIVAIKKFLESEDDPVI-----------------KKIALREIRMLKQLKHPN 63 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEECCCCC-HHH-----------------HHHHHHHHHHHHHCCCTT
T ss_pred ccceEeeEEeecCCeEEEEEEeCC--CCcEEEEEEeeccccchHH-----------------HHHHHHHHHHHHhCCCCC
Confidence 579999999999999999999876 8999999998665432211 156778999999999999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
|+++++++.+++..++||||+++++|.+++. ....+++..+..++.|++.||.|| |+.|++|+||+|+||+++
T Consensus 64 i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~i~~~l~~~l~~l---H~~~ivH~dlkp~Nil~~ 136 (311)
T 4agu_A 64 LVNLLEVFRRKRRLHLVFEYCDHTVLHELDR----YQRGVPEHLVKSITWQTLQAVNFC---HKHNCIHRDVKPENILIT 136 (311)
T ss_dssp BCCEEEEEEETTEEEEEEECCSEEHHHHHHH----TSSCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEC
T ss_pred ccchhheeecCCeEEEEEEeCCCchHHHHHh----hhcCCCHHHHHHHHHHHHHHHHHH---HHCCCcCCCCChhhEEEc
Confidence 9999999999999999999999999998873 445689999999999999999999 667999999999999999
Q ss_pred CCCCeEEecccCccccCCCCceeeeecccCCCCccCcccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhh
Q 040898 201 DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQT-ETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMD 279 (337)
Q Consensus 201 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~ 279 (337)
.++.++|+|||.+......... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...........
T Consensus 137 ~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~ 214 (311)
T 4agu_A 137 KHSVIKLCDFGFARLLTGPSDY--YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYL 214 (311)
T ss_dssp TTSCEEECCCTTCEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred CCCCEEEeeCCCchhccCcccc--cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9999999999999876533221 223468999999999876 5679999999999999999999999965432211111
Q ss_pred HHHHHHhhhccCCcch--------------hhhhc---ccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 280 MVKWMRNVIFSENPNR--------------AINSK---LLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~--------------~~~~~---~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
+........+.. ..... ......+..+..+.+|+.+||+.||++|||++|+++|
T Consensus 215 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 215 ----IRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp ----HHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ----HHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 111111000000 00000 0000012234458899999999999999999999987
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-45 Score=322.13 Aligned_cols=250 Identities=24% Similarity=0.392 Sum_probs=203.3
Q ss_pred cccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCc
Q 040898 42 CFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNI 121 (337)
Q Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpni 121 (337)
.|...+.||+|+||.||++.+.. +|+.||||++........ +.+.+|+.+++.++||||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~--~g~~vavK~~~~~~~~~~-------------------~~~~~E~~~l~~l~h~ni 104 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKH--SGRQVAVKMMDLRKQQRR-------------------ELLFNEVVIMRDYQHFNV 104 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEETTTCCSH-------------------HHHHHHHHHHTTCCCTTB
T ss_pred hhhccEEeccCCCeEEEEEEECC--CCcEEEEEEEeccchhHH-------------------HHHHHHHHHHHhCCCCCc
Confidence 48888999999999999998865 899999999865443221 457789999999999999
Q ss_pred ccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecC
Q 040898 122 LPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDD 201 (337)
Q Consensus 122 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~ 201 (337)
+++++++...+..++||||+++++|.+++. ...+++..+..++.|++.||.|| |+.|++|+||+|+||+++.
T Consensus 105 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-----~~~l~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dlkp~NIll~~ 176 (321)
T 2c30_A 105 VEMYKSYLVGEELWVLMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYL---HAQGVIHRDIKSDSILLTL 176 (321)
T ss_dssp CCEEEEEEETTEEEEEECCCCSCBHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECT
T ss_pred ceEEEEEEECCEEEEEEecCCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECC
Confidence 999999999999999999999999999983 24589999999999999999999 6679999999999999999
Q ss_pred CCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHH
Q 040898 202 DMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMV 281 (337)
Q Consensus 202 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~ 281 (337)
++.++|+|||++......... .....||+.|+|||.+.+..++.++|+||||+++|+|++|..||..... ....
T Consensus 177 ~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~----~~~~ 250 (321)
T 2c30_A 177 DGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP----VQAM 250 (321)
T ss_dssp TCCEEECCCTTCEECCSSSCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----HHHH
T ss_pred CCcEEEeeeeeeeecccCccc--cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHH
Confidence 999999999998776543221 2345799999999999998999999999999999999999999864311 1121
Q ss_pred HHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 282 KWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
..+.. ...+... .....+..+.+++.+||+.||++|||+.++++|
T Consensus 251 ~~~~~---~~~~~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 251 KRLRD---SPPPKLK--------NSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHHHH---SSCCCCT--------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHhc---CCCCCcC--------ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 21211 1111100 011223448899999999999999999999986
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=331.41 Aligned_cols=254 Identities=24% Similarity=0.341 Sum_probs=203.5
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc-C
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT-R 117 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~ 117 (337)
..++|++.+.||+|+||.||++.+.. +++.||+|++........ .....+..|..++..+ +
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~--~~~~vaiK~~~~~~~~~~----------------~~~~~~~~E~~il~~~~~ 76 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKK--TNQFFAIKALKKDVVLMD----------------DDVECTMVEKRVLSLAWE 76 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETT--TTEEEEEEEEEHHHHHHT----------------TCHHHHHHHHHHHHHHTT
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECC--CCCEEEEEEEEhHHhhhh----------------hhHHHHHHHHHHHHhcCC
Confidence 56789999999999999999999876 899999999864321100 1114567788888876 9
Q ss_pred CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCce
Q 040898 118 HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANV 197 (337)
Q Consensus 118 hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ni 197 (337)
||||+++++++.+....|+||||+++|+|.+++.. ...+++..+..++.||+.||.|| |++|++|+||||+||
T Consensus 77 hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~NI 149 (345)
T 1xjd_A 77 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFL---HSKGIVYRDLKLDNI 149 (345)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGE
T ss_pred CCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeEeCCCChhhE
Confidence 99999999999999999999999999999999954 34589999999999999999999 667999999999999
Q ss_pred eecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchh
Q 040898 198 LIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEE 277 (337)
Q Consensus 198 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~ 277 (337)
+++.++.++|+|||++........ ......||+.|+|||++.+..++.++|+||||+++|+|++|..||.... .
T Consensus 150 ll~~~g~vkL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~----~ 223 (345)
T 1xjd_A 150 LLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD----E 223 (345)
T ss_dssp EECTTSCEEECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----H
T ss_pred EECCCCCEEEeEChhhhhcccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC----H
Confidence 999999999999999876432221 1234579999999999999999999999999999999999999986432 1
Q ss_pred hhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChh-hhhcC
Q 040898 278 MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSK-DVRSM 337 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~-ell~~ 337 (337)
......+.. ..... +...+..+.+|+.+||+.||++|||+. ++++|
T Consensus 224 ~~~~~~i~~---~~~~~-----------p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 224 EELFHSIRM---DNPFY-----------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp HHHHHHHHH---CCCCC-----------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred HHHHHHHHh---CCCCC-----------CcccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence 222222211 11110 011234488999999999999999998 88876
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=340.51 Aligned_cols=258 Identities=21% Similarity=0.293 Sum_probs=204.9
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++++.||+|+||.||++.+.. +++.||+|++........ .....+.+|..++..++|
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~--~~~~~AiK~~~k~~~~~~----------------~~~~~~~~E~~il~~l~h 128 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKS--TRKVYAMKLLSKFEMIKR----------------SDSAFFWEERDIMAFANS 128 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEEHHHHHHT----------------CCCSTHHHHHHHHHHCCC
T ss_pred CccccEEEEEEEcCCCEEEEEEEECC--CCcEEEEEEEehhhhhhh----------------HHHHHHHHHHHHHHhCCC
Confidence 66789999999999999999999876 899999999854211100 011457789999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++++.++...|+||||+++|+|.+++.. ..+++..+..++.||+.||.|| |++|++||||||+||+
T Consensus 129 p~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~L---H~~givHrDLKp~NIL 200 (410)
T 3v8s_A 129 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAI---HSMGFIHRDVKPDNML 200 (410)
T ss_dssp TTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEE
T ss_pred CCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHH---HHCCeEeccCCHHHee
Confidence 9999999999999999999999999999999853 3488999999999999999999 6679999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCC----CCCcccchhhhHHHHHHHhCCCCCCCCCCC
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTET----ISDKCDIYSFGVLLAVLVMGKFPVDDFFGH 274 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~----~~~~~DiwslG~i~~~ll~g~~pf~~~~~~ 274 (337)
++.++.++|+|||++........ .......||+.|+|||++.+.. ++.++|+||||+++|+|++|..||....
T Consensus 201 l~~~g~ikL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-- 277 (410)
T 3v8s_A 201 LDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS-- 277 (410)
T ss_dssp ECTTSCEEECCCTTCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS--
T ss_pred ECCCCCEEEeccceeEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC--
Confidence 99999999999999987654432 2223567999999999997665 7889999999999999999999986432
Q ss_pred chhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCC--CCChhhhhcC
Q 040898 275 TEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDE--RPSSKDVRSM 337 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~ell~~ 337 (337)
.................+. ....+..+.+|+.+||+.+|.+ ||+++||++|
T Consensus 278 -~~~~~~~i~~~~~~~~~p~-----------~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 278 -LVGTYSKIMNHKNSLTFPD-----------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp -HHHHHHHHHTHHHHCCCCT-----------TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred -hhhHHHHHHhccccccCCC-----------cccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 1111222111111111110 0112234899999999999998 9999999987
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-46 Score=328.70 Aligned_cols=252 Identities=23% Similarity=0.351 Sum_probs=181.7
Q ss_pred cceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC-CCCcccc
Q 040898 46 LKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR-HRNILPL 124 (337)
Q Consensus 46 ~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~ 124 (337)
.+.||+|+||.||++.+.. +++.||+|++..... ..+.+|+.+++.+. ||||+++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~----------------------~~~~~e~~~l~~l~~h~niv~~ 71 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKK--SNQAFAVKIISKRME----------------------ANTQKEITALKLCEGHPNIVKL 71 (325)
T ss_dssp SCCSEEETTEEEEEEEETT--TCCEEEEEEEEGGGH----------------------HHHHHHHHHHHHTTTCTTBCCE
T ss_pred CCccccCCCeEEEEEEECC--CCCEEEEEEEChhhh----------------------hhHHHHHHHHHHhcCCCCeeEE
Confidence 3789999999999999876 899999999854311 45667999999996 9999999
Q ss_pred eeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCC-
Q 040898 125 LAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDM- 203 (337)
Q Consensus 125 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~- 203 (337)
++++.++...|+||||+++++|.+++.. ...+++..++.++.|++.||.|| |++|++|+||+|+||+++.++
T Consensus 72 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~L---H~~~ivH~Dlkp~NIll~~~~~ 144 (325)
T 3kn6_A 72 HEVFHDQLHTFLVMELLNGGELFERIKK----KKHFSETEASYIMRKLVSAVSHM---HDVGVVHRDLKPENLLFTDEND 144 (325)
T ss_dssp EEEEECSSEEEEEECCCCSCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEEEC---
T ss_pred EEEEEcCCEEEEEEEccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCCeecCCCHHHEEEecCCC
Confidence 9999999999999999999999999954 35689999999999999999999 667999999999999998765
Q ss_pred --CeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHH
Q 040898 204 --EARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMV 281 (337)
Q Consensus 204 --~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~ 281 (337)
.++|+|||++........ ......+|+.|+|||++.+..++.++||||||+++|+|++|..||.............
T Consensus 145 ~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~ 222 (325)
T 3kn6_A 145 NLEIKIIDFGFARLKPPDNQ--PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAV 222 (325)
T ss_dssp -CEEEECCCTTCEECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHH
T ss_pred cccEEEeccccceecCCCCC--cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHH
Confidence 799999999986544322 2234568999999999999999999999999999999999999997643322222222
Q ss_pred HHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 282 KWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.............. .......+..+.+|+.+||+.||++|||+.++++|
T Consensus 223 ~~~~~i~~~~~~~~-------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 223 EIMKKIKKGDFSFE-------GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHHHHHTTTCCCCC-------SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred HHHHHHHcCCCCCC-------cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 22332222211110 11112334568999999999999999999999987
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=332.41 Aligned_cols=251 Identities=22% Similarity=0.259 Sum_probs=204.8
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++++.||+|+||.||++.+.. +++.||+|++........ .....+.+|+.+++.++|
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~----------------~~~~~~~~E~~~l~~l~h 100 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKE--SGNHYAMKILDKQKVVKL----------------KQIEHTLNEKRILQAVNF 100 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT--TCCEEEEEEEEHHHHHHT----------------TCHHHHHHHHHHHTTCCC
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECC--CCCEEEEEEEEhHHhccH----------------HHHHHHHHHHHHHHhCCC
Confidence 45789999999999999999999876 899999999854321110 112567889999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++++.++...|+||||+++++|.+++.. ...+++..++.++.||+.||.|| |++|++|+||||+||+
T Consensus 101 p~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~NIl 173 (350)
T 1rdq_E 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYL---HSLDLIYRDLKPENLL 173 (350)
T ss_dssp TTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEE
T ss_pred CCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCcccccCccceEE
Confidence 9999999999999999999999999999999954 24589999999999999999999 6679999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhh
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEM 278 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~ 278 (337)
++.++.++|+|||++....... ....||+.|+|||++.+..++.++|+||||+++|+|++|..||.... ..
T Consensus 174 l~~~g~~kL~DFg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~----~~ 244 (350)
T 1rdq_E 174 IDQQGYIQVTDFGFAKRVKGRT-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ----PI 244 (350)
T ss_dssp ECTTSCEEECCCTTCEECSSCB-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----HH
T ss_pred ECCCCCEEEcccccceeccCCc-----ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC----HH
Confidence 9999999999999998764332 23468999999999999999999999999999999999999986431 11
Q ss_pred hHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCC-----hhhhhcC
Q 040898 279 DMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPS-----SKDVRSM 337 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~~ 337 (337)
.....+.. ..... +...+..+.+++.+||+.||++||+ ++++++|
T Consensus 245 ~~~~~i~~---~~~~~-----------p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 245 QIYEKIVS---GKVRF-----------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp HHHHHHHH---CCCCC-----------CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHHHHHc---CCCCC-----------CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 22221111 11110 0112344899999999999999999 9999887
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=318.78 Aligned_cols=255 Identities=20% Similarity=0.336 Sum_probs=205.0
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
.++|++.+.||+|+||.||++.+.. +++.||+|++......... ...+.+|+.++++++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~-----------------~~~~~~e~~~l~~l~h~ 65 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKT--TGLEFAAKIINTKKLSARD-----------------FQKLEREARICRKLQHP 65 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEEGGGCCHHH-----------------HHHHHHHHHHHHHCCCT
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcC--CCceEEEEEeecccCCHHH-----------------HHHHHHHHHHHHHcCCC
Confidence 5789999999999999999998876 8999999998765432211 15678899999999999
Q ss_pred CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceee
Q 040898 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI 199 (337)
Q Consensus 120 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~ 199 (337)
||+++++++.+++..++||||+++++|.+.+.. ...+++..++.++.|++.||.|| |+.|++|+||+|+||++
T Consensus 66 ~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dikp~Nil~ 138 (284)
T 3kk8_A 66 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYC---HSNGIVHRNLKPENLLL 138 (284)
T ss_dssp TBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEE
T ss_pred CcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCcCcCCCCHHHEEE
Confidence 999999999999999999999999999998854 34589999999999999999999 66799999999999999
Q ss_pred cCCCC---eEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCch
Q 040898 200 DDDME---ARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTE 276 (337)
Q Consensus 200 ~~~~~---~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~ 276 (337)
+.++. ++|+|||.+........ .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||....
T Consensus 139 ~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~---- 211 (284)
T 3kk8_A 139 ASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED---- 211 (284)
T ss_dssp SSSSTTCCEEECCCTTCEECCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----
T ss_pred ecCCCCCcEEEeeceeeEEcccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc----
Confidence 86655 99999999976654332 233568999999999999999999999999999999999999985432
Q ss_pred hhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 277 EMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.......+......... ......+..+.+++.+||+.||++|||+.|+++|
T Consensus 212 ~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 212 QHRLYAQIKAGAYDYPS----------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp HHHHHHHHHHTCCCCCT----------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hhHHHHHHHhccccCCc----------hhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 12222222111111000 0111223448899999999999999999999987
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=330.23 Aligned_cols=270 Identities=24% Similarity=0.303 Sum_probs=203.7
Q ss_pred ccccccccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHH
Q 040898 31 KQDLAFLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEI 110 (337)
Q Consensus 31 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~ 110 (337)
....++.=..++|++.+.||+|+||.||++.+ .++.||+|++....... ....+|+
T Consensus 14 ~~~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~----~~~~vavK~~~~~~~~~--------------------~~~~~E~ 69 (322)
T 3soc_A 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL----LNEYVAVKIFPIQDKQS--------------------WQNEYEV 69 (322)
T ss_dssp CCCCCEEETTEEEEEEEEEECSTTCEEEEEEE----TTEEEEEEEECGGGHHH--------------------HHHHHHH
T ss_pred cCccccccchhhchhhheecccCceEEEEEEE----CCCEEEEEEeecCchHH--------------------HHHHHHH
Confidence 33445555677899999999999999999977 58999999985432111 3445588
Q ss_pred HHHHhcCCCCcccceeEEEcCC----eeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCC-
Q 040898 111 ITANQTRHRNILPLLAHMVRPN----CHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRP- 185 (337)
Q Consensus 111 ~~l~~l~hpniv~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~- 185 (337)
.++++++||||+++++++.... ..++||||+++|+|.+++.. ..+++..++.++.|++.||.|| |+.
T Consensus 70 ~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~L---H~~~ 141 (322)
T 3soc_A 70 YSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYL---HEDI 141 (322)
T ss_dssp HTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHH---TCCE
T ss_pred HHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHH---Hhhc
Confidence 9999999999999999988754 36999999999999999954 3489999999999999999999 777
Q ss_pred ---------CeEecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccC-----CCCCcccc
Q 040898 186 ---------RLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTE-----TISDKCDI 251 (337)
Q Consensus 186 ---------gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-----~~~~~~Di 251 (337)
|++|+||||+||+++.++.++|+|||++................+|+.|+|||++.+. .++.++||
T Consensus 142 ~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Di 221 (322)
T 3soc_A 142 PGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDM 221 (322)
T ss_dssp EEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHH
T ss_pred cccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchh
Confidence 9999999999999999999999999999876554433333345789999999999863 45567899
Q ss_pred hhhhHHHHHHHhCCCCCCCCCCCchhh---------hHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhcc
Q 040898 252 YSFGVLLAVLVMGKFPVDDFFGHTEEM---------DMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTL 322 (337)
Q Consensus 252 wslG~i~~~ll~g~~pf~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 322 (337)
||||+++|+|++|..||.......... .......... ............ ........+.+|+.+||+
T Consensus 222 wslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~ 297 (322)
T 3soc_A 222 YAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVV-HKKKRPVLRDYW---QKHAGMAMLCETIEECWD 297 (322)
T ss_dssp HHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHT-TSCCCCCCCGGG---GSSHHHHHHHHHHHHHTC
T ss_pred HHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhh-cccCCCCccccc---cccchHHHHHHHHHHHcc
Confidence 999999999999999997543221110 1111111111 111111111100 112345669999999999
Q ss_pred CCCCCCCChhhhhc
Q 040898 323 KDPDERPSSKDVRS 336 (337)
Q Consensus 323 ~dP~~Rps~~ell~ 336 (337)
.||++|||+.++++
T Consensus 298 ~dP~~Rps~~ell~ 311 (322)
T 3soc_A 298 HDAEARLSAGCVGE 311 (322)
T ss_dssp SSGGGSCCHHHHHH
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999986
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=332.55 Aligned_cols=262 Identities=22% Similarity=0.325 Sum_probs=206.5
Q ss_pred ccccccccceeccCcceEEEEeEEe---cCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHh
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAEL---PGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQ 115 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~ 115 (337)
..++|++.+.||+|+||.||++.+. ...+++.||+|++........ ...+.+|+.++.+
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~------------------~~~~~~E~~~l~~ 81 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE------------------HRALMSELKILIH 81 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHH------------------HHHHHHHHHHHHH
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHH------------------HHHHHHHHHHHHh
Confidence 6788999999999999999999854 234779999999965433221 1567889999999
Q ss_pred c-CCCCcccceeEEEcCC-eeEEEEEeccCCCHHHHHHHhcCC-------------------------------------
Q 040898 116 T-RHRNILPLLAHMVRPN-CHLLVYEFMKNGSLQDILYDVSQG------------------------------------- 156 (337)
Q Consensus 116 l-~hpniv~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~------------------------------------- 156 (337)
+ .||||+++++++.+.+ ..++||||+++|+|.+++......
T Consensus 82 l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (359)
T 3vhe_A 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQS 161 (359)
T ss_dssp HCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------
T ss_pred hcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccc
Confidence 9 7899999999987755 489999999999999999753321
Q ss_pred -------------------------cccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCCeEEeccc
Q 040898 157 -------------------------RRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFG 211 (337)
Q Consensus 157 -------------------------~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~~l~dfg 211 (337)
...+++..++.++.|++.||.|| |++|++|+||||+||+++.++.++|+|||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~L---H~~~ivH~Dikp~NIll~~~~~~kl~Dfg 238 (359)
T 3vhe_A 162 SASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFG 238 (359)
T ss_dssp ----------------------CTTTTCBCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECGGGCEEECCCG
T ss_pred ccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHH---HHCCcccCCCChhhEEEcCCCcEEEEecc
Confidence 12288899999999999999999 66799999999999999999999999999
Q ss_pred CccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCchhhhHHHHHHhhhcc
Q 040898 212 HGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHTEEMDMVKWMRNVIFS 290 (337)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 290 (337)
++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||....... ............
T Consensus 239 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~~~~~~~~~ 315 (359)
T 3vhe_A 239 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---EFCRRLKEGTRM 315 (359)
T ss_dssp GGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH---HHHHHHHHTCCC
T ss_pred ceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH---HHHHHHHcCCCC
Confidence 9987655444444445668899999999999899999999999999999998 999997543322 222222211111
Q ss_pred CCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 291 ENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
..+ ......+.+++.+||+.||.+|||+.++++|
T Consensus 316 ~~~-------------~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 316 RAP-------------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp CCC-------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCC-------------CCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 111 1122348899999999999999999999875
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=326.16 Aligned_cols=271 Identities=20% Similarity=0.268 Sum_probs=198.7
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc--
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT-- 116 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-- 116 (337)
..++|++.+.||+|+||+||++.+.. +++.||+|++............ ...+.+|+.+++.+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~--------------~~~~~~e~~~l~~l~~ 70 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPH--SGHFVALKSVRVPNGGGGGGGL--------------PISTVREVALLRRLEA 70 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTT--TCCEEEEEEEEEECCCTTSSCC--------------CHHHHHHHHHHHHHHH
T ss_pred cccceEEEEEEecCCCeEEEEEEECC--CCcEEEEEEEeccccccccccc--------------chhHHHHHHHHHHHhh
Confidence 35789999999999999999998866 8999999998754422110000 02344566655555
Q ss_pred -CCCCcccceeEEEcCC-----eeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 040898 117 -RHRNILPLLAHMVRPN-----CHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHR 190 (337)
Q Consensus 117 -~hpniv~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~ 190 (337)
+||||+++++++.... ..++|+||+++ +|.+++.. .....+++..++.++.|++.||.|| |++|++|+
T Consensus 71 ~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~--~~~~~~~~~~~~~i~~qi~~al~~l---H~~~ivH~ 144 (308)
T 3g33_A 71 FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDK--APPPGLPAETIKDLMRQFLRGLDFL---HANCIVHR 144 (308)
T ss_dssp HCCTTBCCEEEEEEECCSSSEEEEEEEEECCCC-BHHHHHHT--CCTTCSCHHHHHHHHHHHHHHHHHH---HHTTCCCS
T ss_pred cCCCCeEEeeeeeeccCCCCceeEEEEehhhhc-CHHHHHhh--ccCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccC
Confidence 5999999999987755 57999999975 99999864 3334489999999999999999999 66799999
Q ss_pred CCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCC
Q 040898 191 DIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDD 270 (337)
Q Consensus 191 di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~ 270 (337)
||||+||+++.++.++|+|||++........ .....+|+.|+|||++.+..++.++||||||+++|+|++|.+||..
T Consensus 145 Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 221 (308)
T 3g33_A 145 DLKPENILVTSGGTVKLADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCG 221 (308)
T ss_dssp CCCTTTEEECTTSCEEECSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCC
T ss_pred CCCHHHEEEcCCCCEEEeeCccccccCCCcc---cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999986643322 2345789999999999999999999999999999999999999865
Q ss_pred CCCCchhhhHHHHHHhhhccC---Ccchh------hh---hcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 271 FFGHTEEMDMVKWMRNVIFSE---NPNRA------IN---SKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~---~~~~~------~~---~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
... ............... .+... .. ........+.....+.+|+.+||+.||++|||+.|+|+|
T Consensus 222 ~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 222 NSE---ADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp SSH---HHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCH---HHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 322 222222111111000 00000 00 000000112234568899999999999999999999987
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=331.00 Aligned_cols=281 Identities=22% Similarity=0.324 Sum_probs=208.5
Q ss_pred ccccccccccccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhH
Q 040898 27 PLVEKQDLAFLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAI 106 (337)
Q Consensus 27 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 106 (337)
...+...+.++...++|++++.||+|+||.||++.+.. +++.||+|++......... ...+
T Consensus 3 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~-----------------~~~~ 63 (351)
T 3mi9_A 3 KQYDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRK--TGQKVALKKVLMENEKEGF-----------------PITA 63 (351)
T ss_dssp -----CCCTTSCBGGGEEEEEECSSCSTTSEEEEEETT--TCCEEEEEECCCSSCSSSS-----------------CHHH
T ss_pred cccccccccccccccceeEEEEEecCCCcEEEEEEECC--CCCEEEEEEEecccccccc-----------------hHHH
Confidence 34455578888889999999999999999999999876 8999999998665432210 0456
Q ss_pred HHHHHHHHhcCCCCcccceeEEEc--------CCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHH
Q 040898 107 RSEIITANQTRHRNILPLLAHMVR--------PNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEY 178 (337)
Q Consensus 107 ~~e~~~l~~l~hpniv~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~ 178 (337)
.+|+.+++.++||||+++++++.. .+..++||||+++ +|.+.+.. ....+++..++.++.|++.||.|
T Consensus 64 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~ 139 (351)
T 3mi9_A 64 LREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYY 139 (351)
T ss_dssp HHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCSE-EHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEeccCC-CHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHH
Confidence 789999999999999999999876 4568999999986 77776643 34568999999999999999999
Q ss_pred HhhCCCCCeEecCCCCCceeecCCCCeEEecccCccccCCCCc--eeeeecccCCCCccCcccccc-CCCCCcccchhhh
Q 040898 179 LHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHA--QITVKCMVGTMGYMAPESLQT-ETISDKCDIYSFG 255 (337)
Q Consensus 179 l~~~h~~gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG 255 (337)
| |+.|++|+||+|+||+++.++.++|+|||++........ ........+|+.|+|||++.+ ..++.++||||||
T Consensus 140 L---H~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG 216 (351)
T 3mi9_A 140 I---HRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAG 216 (351)
T ss_dssp H---HHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHH
T ss_pred H---HHCCeeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHH
Confidence 9 667999999999999999999999999999987643221 122234568999999999876 4579999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCchhhhHHHHHHhhhccCCcch--hhhh-cc---------cCCchHH------HHHHHHHHH
Q 040898 256 VLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNR--AINS-KL---------LGNGYEE------QMLLVLKLA 317 (337)
Q Consensus 256 ~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~-~~---------~~~~~~~------~~~~l~~li 317 (337)
+++|+|++|.+||...... .....+........+.. .... .. ....... ....+.+|+
T Consensus 217 ~il~ell~g~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 292 (351)
T 3mi9_A 217 CIMAEMWTRSPIMQGNTEQ----HQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLI 292 (351)
T ss_dssp HHHHHHHHSSCSCCCSSHH----HHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHH
T ss_pred HHHHHHHhCCCCCCCCChH----HHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHH
Confidence 9999999999998753221 22222222111111100 0000 00 0000000 134588999
Q ss_pred hhhccCCCCCCCChhhhhcC
Q 040898 318 CFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 318 ~~~l~~dP~~Rps~~ell~~ 337 (337)
.+||+.||++|||+.|+|+|
T Consensus 293 ~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 293 DKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp HHHSCSSGGGSCCHHHHHTS
T ss_pred HHHhcCChhhCCCHHHHhCC
Confidence 99999999999999999987
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=332.03 Aligned_cols=257 Identities=21% Similarity=0.318 Sum_probs=206.5
Q ss_pred ccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc
Q 040898 37 LKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT 116 (337)
Q Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 116 (337)
....++|++++.||+|+||.||++.+.. +++.||+|.+........ ..+.+|+.+++.+
T Consensus 47 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~--~~~~~a~K~~~~~~~~~~-------------------~~~~~E~~il~~l 105 (387)
T 1kob_A 47 GSVYDYYDILEELGSGAFGVVHRCVEKA--TGRVFVAKFINTPYPLDK-------------------YTVKNEISIMNQL 105 (387)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEECCSHHHH-------------------HHHHHHHHHHTTC
T ss_pred CccccceEEEEEEecCCCEEEEEEEECC--CCCEEEEEEecccchhhH-------------------HHHHHHHHHHHhC
Confidence 3455789999999999999999998876 899999999865432111 4577899999999
Q ss_pred CCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 040898 117 RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPAN 196 (337)
Q Consensus 117 ~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~n 196 (337)
+||||+++++++.+....++||||+++++|.+++.. ....+++..++.++.||+.||.|| |+.|++|+||+|+|
T Consensus 106 ~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~L---H~~givHrDlkp~N 179 (387)
T 1kob_A 106 HHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHM---HEHSIVHLDIKPEN 179 (387)
T ss_dssp CSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGG
T ss_pred CCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHH---HhCCeeecccchHH
Confidence 999999999999999999999999999999998842 344689999999999999999999 66799999999999
Q ss_pred eeecC--CCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCC
Q 040898 197 VLIDD--DMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGH 274 (337)
Q Consensus 197 il~~~--~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~ 274 (337)
|+++. ++.++|+|||++......... ....+|+.|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 180 Ill~~~~~~~vkL~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~-- 254 (387)
T 1kob_A 180 IMCETKKASSVKIIDFGLATKLNPDEIV---KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED-- 254 (387)
T ss_dssp EEESSTTCCCEEECCCTTCEECCTTSCE---EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS--
T ss_pred eEEecCCCCceEEEecccceecCCCcce---eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC--
Confidence 99974 578999999999876544322 23469999999999999889999999999999999999999986532
Q ss_pred chhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 275 TEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.......+... .... ........+..+.+|+.+||+.||++|||+.++|+|
T Consensus 255 --~~~~~~~i~~~---~~~~-------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 255 --DLETLQNVKRC---DWEF-------DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp --HHHHHHHHHHC---CCCC-------CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred --HHHHHHHHHhC---CCCC-------CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 11111111111 1100 011112233458999999999999999999999987
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=320.13 Aligned_cols=270 Identities=22% Similarity=0.318 Sum_probs=198.1
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHh-------hhhhhhhhhHHhHHhHHHHHHH
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQ-------DIDEYSDLLHWKIGAIRSEIIT 112 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~e~~~ 112 (337)
.++|++.+.||+|+||.||++.+.. +++.||+|++.............. .............+.+.+|+.+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNEN--DNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETT--TTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECC--CCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 4679999999999999999998876 899999999976543221100000 0000000001112568899999
Q ss_pred HHhcCCCCcccceeEEEc--CCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 040898 113 ANQTRHRNILPLLAHMVR--PNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHR 190 (337)
Q Consensus 113 l~~l~hpniv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~ 190 (337)
+++++||||+++++++.+ ....++||||+++++|.+++ ....+++..++.++.|++.||.|| |++|++|+
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~ 161 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-----TLKPLSEDQARFYFQDLIKGIEYL---HYQKIIHR 161 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-----CSSCCCHHHHHHHHHHHHHHHHHH---HHTTEECC
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHH---HHCCeecc
Confidence 999999999999999986 56889999999999987754 345799999999999999999999 66799999
Q ss_pred CCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCC---CCCcccchhhhHHHHHHHhCCCC
Q 040898 191 DIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTET---ISDKCDIYSFGVLLAVLVMGKFP 267 (337)
Q Consensus 191 di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~---~~~~~DiwslG~i~~~ll~g~~p 267 (337)
||+|+||+++.++.++|+|||++......... .....+|+.|+|||.+.+.. ++.++|+||||+++|+|++|..|
T Consensus 162 Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p 239 (298)
T 2zv2_A 162 DIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL--LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239 (298)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCEECSSSSCE--ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCS
T ss_pred CCCHHHEEECCCCCEEEecCCCcccccccccc--ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCC
Confidence 99999999999999999999999876543322 23457999999999997665 36789999999999999999999
Q ss_pred CCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 268 VDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 268 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
|.... .......+.. ...... ..+.....+.+++.+||+.||++|||+.|+++|
T Consensus 240 f~~~~----~~~~~~~~~~---~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 240 FMDER----IMCLHSKIKS---QALEFP---------DQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp SCCSS----HHHHHHHHHH---CCCCCC---------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred CCCcc----HHHHHHHHhc---ccCCCC---------CccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 86431 1112111111 111000 011223448999999999999999999999987
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=341.72 Aligned_cols=253 Identities=30% Similarity=0.426 Sum_probs=205.9
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|.+++.||+|+||.||++.+.. +|+.||+|++........ .....+.+|+.+++.++|
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~--~g~~vAvK~i~~~~~~~~----------------~~~~~~~~Ei~~l~~l~H 75 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHEL--TGHKVAVKILNRQKIRSL----------------DVVGKIRREIQNLKLFRH 75 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETT--TCCEEEEEEEEHHHHHHT----------------TTHHHHHHHHHHHTTCCC
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECC--CCCEEEEEEEEhhhccCH----------------HHHHHHHHHHHHHHhCCC
Confidence 45779999999999999999999876 899999999864321100 011578899999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++++.+.+..++||||+++++|.+++ .....+++..++.++.||+.||.|| |+.|++|+||||+||+
T Consensus 76 pnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l----~~~~~l~~~~~~~i~~qi~~aL~~L---H~~givHrDLkp~NIl 148 (476)
T 2y94_A 76 PHIIKLYQVISTPSDIFMVMEYVSGGELFDYI----CKNGRLDEKESRRLFQQILSGVDYC---HRHMVVHRDLKPENVL 148 (476)
T ss_dssp TTBCCEEEEEECSSEEEEEEECCSSEEHHHHT----TSSSSCCHHHHHHHHHHHHHHHHHH---HTTTEECSCCSGGGEE
T ss_pred CCCCcEEEEEEECCEEEEEEeCCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHH---HHCCCCcccccHHHEE
Confidence 99999999999999999999999999999998 4556799999999999999999999 7789999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCC-CCcccchhhhHHHHHHHhCCCCCCCCCCCchh
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETI-SDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEE 277 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~ 277 (337)
++.++.++|+|||++........ .....||+.|+|||++.+..+ +.++||||||+++|+|++|..||.....
T Consensus 149 l~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~---- 221 (476)
T 2y94_A 149 LDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV---- 221 (476)
T ss_dssp ECTTCCEEECCCSSCEECCTTCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS----
T ss_pred EecCCCeEEEeccchhhcccccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH----
Confidence 99999999999999987654322 234579999999999988765 6789999999999999999999965322
Q ss_pred hhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 278 MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
......+... .... +......+.+|+.+||+.||++|||+.++++|
T Consensus 222 ~~~~~~i~~~---~~~~-----------p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 222 PTLFKKICDG---IFYT-----------PQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp HHHHHHHHTT---CCCC-----------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred HHHHHHHhcC---CcCC-----------CccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 1222211111 1100 01122348899999999999999999999987
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=327.99 Aligned_cols=274 Identities=24% Similarity=0.388 Sum_probs=203.7
Q ss_pred cccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHh
Q 040898 36 FLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQ 115 (337)
Q Consensus 36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~ 115 (337)
++...++|++++.||+|+||.||++.+.. +++.||+|++.......... ..+.+|+.++++
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~-----------------~~~~~E~~~l~~ 80 (331)
T 4aaa_A 20 YFQSMEKYENLGLVGEGSYGMVMKCRNKD--TGRIVAIKKFLESDDDKMVK-----------------KIAMREIKLLKQ 80 (331)
T ss_dssp CCBCGGGEEEEEEGGGGTTSSEEEEEETT--TCCEEEEEEEESCSSCHHHH-----------------HHHHHHHHHHHH
T ss_pred hhhhhhhheeeeEEeecCCEEEEEEEECC--CCceEEEEEEecCCCchHHH-----------------HHHHHHHHHHhh
Confidence 34456789999999999999999999876 89999999986654332211 467789999999
Q ss_pred cCCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCC
Q 040898 116 TRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPA 195 (337)
Q Consensus 116 l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ 195 (337)
++||||+++++++.+.+..++||||+++++|.+++ .....+++..++.++.|++.||.+| |+.|++|+||+|+
T Consensus 81 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~qi~~~l~~L---H~~~ivH~dlkp~ 153 (331)
T 4aaa_A 81 LRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLE----LFPNGLDYQVVQKYLFQIINGIGFC---HSHNIIHRDIKPE 153 (331)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHH----HSTTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGG
T ss_pred CCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHH----hhccCCCHHHHHHHHHHHHHHHHHH---HHCCEEccCcChh
Confidence 99999999999999999999999999999888876 3445689999999999999999999 6679999999999
Q ss_pred ceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCCC
Q 040898 196 NVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTE-TISDKCDIYSFGVLLAVLVMGKFPVDDFFGH 274 (337)
Q Consensus 196 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~ 274 (337)
||+++.++.++|+|||.+........ ......+++.|+|||.+.+. .++.++||||||+++|+|++|..||......
T Consensus 154 Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 231 (331)
T 4aaa_A 154 NILVSQSGVVKLCDFGFARTLAAPGE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDI 231 (331)
T ss_dssp GEEECTTSCEEECCCTTC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred eEEEcCCCcEEEEeCCCceeecCCcc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcH
Confidence 99999999999999999876543222 12345689999999999775 6889999999999999999999998654221
Q ss_pred chhhhHHHHHHhh------------hccCCc-chhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 275 TEEMDMVKWMRNV------------IFSENP-NRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 275 ~~~~~~~~~~~~~------------~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
............. ...... .............+..+..+.+|+.+||+.||++|||+.|+|+|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 232 DQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp HHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred HHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1111111100000 000000 00000000001112335669999999999999999999999987
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=325.87 Aligned_cols=255 Identities=22% Similarity=0.326 Sum_probs=198.3
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
.++|++.+.||+|+||.||++.+.. +++.||||++......... +.+.+|+.++++++||
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~--~~~~vavK~~~~~~~~~~~------------------~~~~~E~~~l~~l~hp 64 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKV--DDCNYAIKRIRLPNRELAR------------------EKVMREVKALAKLEHP 64 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETT--TCCEEEEEEEECCSTTTHH------------------HHHHHHHHHHTSCCCT
T ss_pred hhcCceeeEecCCCCeEEEEEEEcC--CCcEEEEEEeecCCchhHH------------------HHHHHHHHHHHhCCCC
Confidence 3579999999999999999999876 8999999999754432211 5688899999999999
Q ss_pred CcccceeEEEcCC---------------------------------------------------------eeEEEEEecc
Q 040898 120 NILPLLAHMVRPN---------------------------------------------------------CHLLVYEFMK 142 (337)
Q Consensus 120 niv~~~~~~~~~~---------------------------------------------------------~~~lv~e~~~ 142 (337)
||+++++++.+.. ..++||||++
T Consensus 65 niv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~ 144 (332)
T 3qd2_B 65 GIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCR 144 (332)
T ss_dssp TBCCEEEEEEECCSCHHHHHHHC--------------------------------------------CCCEEEEEEECCC
T ss_pred CEeeEEEEEEEeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecC
Confidence 9999999885543 3799999999
Q ss_pred CCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCCeEEecccCccccCCCCce
Q 040898 143 NGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQ 222 (337)
Q Consensus 143 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 222 (337)
+++|.+++.... .....++..++.++.|++.||.|| |++|++|+||||+||+++.++.++|+|||++.........
T Consensus 145 ~~~L~~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~ 220 (332)
T 3qd2_B 145 KENLKDWMNRRC-SLEDREHGVCLHIFIQIAEAVEFL---HSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE 220 (332)
T ss_dssp SSCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC---
T ss_pred CCCHHHHHhccc-CccchhhHHHHHHHHHHHHHHHHH---HhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhh
Confidence 999999996522 234456667899999999999999 6679999999999999999999999999999876544221
Q ss_pred ----------eeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHHHHHHhhhccCC
Q 040898 223 ----------ITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSEN 292 (337)
Q Consensus 223 ----------~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 292 (337)
.......+|+.|+|||.+.+..++.++|+||||+++|+|++|..|+.. .............
T Consensus 221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~---------~~~~~~~~~~~~~ 291 (332)
T 3qd2_B 221 QTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME---------RVRIITDVRNLKF 291 (332)
T ss_dssp -----------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH---------HHHHHHHHHTTCC
T ss_pred ccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH---------HHHHHHHhhccCC
Confidence 112234689999999999999999999999999999999998877421 1111111111111
Q ss_pred cchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 293 PNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
+ .........+.+++.+||+.||++|||+.|+++|
T Consensus 292 ~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 292 P----------LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp C----------HHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred C----------cccccCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 1 1123334457899999999999999999999987
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=324.64 Aligned_cols=267 Identities=24% Similarity=0.336 Sum_probs=211.1
Q ss_pred ccccccccccccccceeccCcceEEEEeEEec---CCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHH
Q 040898 33 DLAFLKKEDCFDSLKKIGSGGWGEVFYKAELP---GSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSE 109 (337)
Q Consensus 33 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e 109 (337)
+.++.-..++|++.+.||+|+||.||++.+.. ..++..||+|.+........ ...+.+|
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~------------------~~~~~~E 76 (314)
T 2ivs_A 15 DPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSE------------------LRDLLSE 76 (314)
T ss_dssp CTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHH------------------HHHHHHH
T ss_pred CcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHH------------------HHHHHHH
Confidence 33444467889999999999999999998743 23668999999875432211 1567889
Q ss_pred HHHHHhcCCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcC--------------------CcccCChHHHHHHH
Q 040898 110 IITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQ--------------------GRRELDWPARHRIA 169 (337)
Q Consensus 110 ~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------------~~~~~~~~~~~~i~ 169 (337)
+.+++.++||||+++++++.+++..++||||+++++|.+++..... ....+++..++.++
T Consensus 77 ~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 156 (314)
T 2ivs_A 77 FNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFA 156 (314)
T ss_dssp HHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHH
T ss_pred HHHHhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHH
Confidence 9999999999999999999999999999999999999999976432 12348889999999
Q ss_pred HHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcc
Q 040898 170 RGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKC 249 (337)
Q Consensus 170 ~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~ 249 (337)
.|++.||.|| |++|++|+||+|+||+++.++.++|+|||++................+++.|+|||.+.+..++.++
T Consensus 157 ~qi~~~l~~l---H~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 233 (314)
T 2ivs_A 157 WQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQS 233 (314)
T ss_dssp HHHHHHHHHH---HHTTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHH
T ss_pred HHHHHHHHHH---HHCCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchh
Confidence 9999999999 6679999999999999999999999999999876554443333345678889999999988899999
Q ss_pred cchhhhHHHHHHHh-CCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCC
Q 040898 250 DIYSFGVLLAVLVM-GKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDER 328 (337)
Q Consensus 250 DiwslG~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 328 (337)
||||||+++|+|++ |..||..... ......+....... .+...+..+.+++.+||+.||++|
T Consensus 234 Di~slG~il~el~t~g~~p~~~~~~----~~~~~~~~~~~~~~-------------~~~~~~~~~~~li~~~l~~dp~~R 296 (314)
T 2ivs_A 234 DVWSFGVLLWEIVTLGGNPYPGIPP----ERLFNLLKTGHRME-------------RPDNCSEEMYRLMLQCWKQEPDKR 296 (314)
T ss_dssp HHHHHHHHHHHHHTTSCCSSTTCCG----GGHHHHHHTTCCCC-------------CCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred hHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHhhcCCcCC-------------CCccCCHHHHHHHHHHccCChhhC
Confidence 99999999999999 9999865422 12222222111111 111223458999999999999999
Q ss_pred CChhhhhcC
Q 040898 329 PSSKDVRSM 337 (337)
Q Consensus 329 ps~~ell~~ 337 (337)
||+.+++++
T Consensus 297 ps~~~l~~~ 305 (314)
T 2ivs_A 297 PVFADISKD 305 (314)
T ss_dssp CCHHHHHHH
T ss_pred cCHHHHHHH
Confidence 999999863
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=338.20 Aligned_cols=261 Identities=22% Similarity=0.248 Sum_probs=205.8
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++++.||+|+||.||++.+.. +++.||+|++........ .....+.+|..++..++|
T Consensus 72 ~~~~y~~~~~LG~G~fG~V~~~~~~~--~~~~vAvK~~~~~~~~~~----------------~~~~~~~~E~~il~~~~h 133 (437)
T 4aw2_A 72 HREDFEILKVIGRGAFGEVAVVKLKN--ADKVFAMKILNKWEMLKR----------------AETACFREERDVLVNGDS 133 (437)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT--TTEEEEEEEEEHHHHHHT----------------TTTCCHHHHHHHHHHSCT
T ss_pred ChhheEEEEEEEeCCCEEEEEEEEcC--CCcEEEEEEEEHHHhhhH----------------HHHHHHHHHHHHHHhCCC
Confidence 56789999999999999999999876 899999999864211100 011457889999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++++.+++..|+||||+++|+|.+++.. ....+++..+..++.|++.||.|| |+.|++||||||+||+
T Consensus 134 p~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~L---H~~giiHrDLKp~NIL 207 (437)
T 4aw2_A 134 KWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSV---HQLHYVHRDIKPDNIL 207 (437)
T ss_dssp TTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEE
T ss_pred CCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHH---HhCCeEecccCHHHee
Confidence 9999999999999999999999999999999954 245699999999999999999999 6679999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccc-----cCCCCCcccchhhhHHHHHHHhCCCCCCCCCC
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQ-----TETISDKCDIYSFGVLLAVLVMGKFPVDDFFG 273 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~-----~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~ 273 (337)
++.++.+||+|||++......... ......||+.|+|||++. ...++.++|+||||+++|+|++|..||....
T Consensus 208 l~~~g~vkL~DFGla~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~- 285 (437)
T 4aw2_A 208 MDMNGHIRLADFGSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES- 285 (437)
T ss_dssp ECTTSCEEECCCTTCEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS-
T ss_pred EcCCCCEEEcchhhhhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC-
Confidence 999999999999999766543322 223457999999999986 4568999999999999999999999996432
Q ss_pred CchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCC--CCChhhhhcC
Q 040898 274 HTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDE--RPSSKDVRSM 337 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~ell~~ 337 (337)
.................+. .....+..+.+|+.+||..+|++ ||+++|+++|
T Consensus 286 --~~~~~~~i~~~~~~~~~p~----------~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 286 --LVETYGKIMNHKERFQFPT----------QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp --HHHHHHHHHTHHHHCCCCS----------SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred --hhHHHHhhhhccccccCCc----------ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 1111222111111111110 00112344889999999988888 9999999987
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=315.85 Aligned_cols=256 Identities=24% Similarity=0.434 Sum_probs=205.2
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
.++|++.+.||+|+||.||++.+.. +++.||+|.+......... +.+.+|+.+++.++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~------------------~~~~~e~~~l~~l~h~ 65 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRV--TEEAVAVKIVDMKRAVDCP------------------ENIKKEICINKMLNHE 65 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETT--TCCEEEEEEEEGGGCTTHH------------------HHHHHHHHHHHTCCCT
T ss_pred ecceEEEEEeecCCCcEEEEEEECC--CCcEEEEEEeeeccchhhh------------------HHHHHHHHHHHhcCCC
Confidence 3579999999999999999998865 8999999998654332211 5677899999999999
Q ss_pred CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceee
Q 040898 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI 199 (337)
Q Consensus 120 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~ 199 (337)
||+++++++.+++..++|+||+++++|.+++ .....+++..++.++.|++.||.+| |+.|++|+||+|+||++
T Consensus 66 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~Nil~ 138 (276)
T 2yex_A 66 NVVKFYGHRREGNIQYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYL---HGIGITHRDIKPENLLL 138 (276)
T ss_dssp TBCCEEEEEEETTEEEEEEECCTTEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEE
T ss_pred CceeeeeEEEcCCEEEEEEEecCCCcHHHHH----hhccCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCChHHEEE
Confidence 9999999999999999999999999999887 4456789999999999999999999 66799999999999999
Q ss_pred cCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCC-CCcccchhhhHHHHHHHhCCCCCCCCCCCchhh
Q 040898 200 DDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETI-SDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEM 278 (337)
Q Consensus 200 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~ 278 (337)
+.++.++|+|||.+................+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||........
T Consensus 139 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-- 216 (276)
T 2yex_A 139 DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-- 216 (276)
T ss_dssp CTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH--
T ss_pred ccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH--
Confidence 9999999999999876543332222334578999999999987665 6789999999999999999999976433221
Q ss_pred hHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 279 DMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
....+... .... ......+..+.+++.+||+.||++|||+.++++|
T Consensus 217 ~~~~~~~~----~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 217 EYSDWKEK----KTYL---------NPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp HHHHHHTT----CTTS---------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHhhhc----cccc---------CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 11111111 0000 0111223458899999999999999999999987
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=332.03 Aligned_cols=266 Identities=22% Similarity=0.325 Sum_probs=191.4
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC-C
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR-H 118 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h 118 (337)
.++|++++.||+|+||.||++.+.. +++.||+|++......... ...+.+|+.+++.+. |
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~--~~~~vaiK~i~~~~~~~~~-----------------~~~~~~E~~~l~~l~~h 68 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRR--TGEVVAVKKIFDAFQNSTD-----------------AQRTFREIMILTELSGH 68 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETT--TCCEEEEEEECC--CCHHH-----------------HHHHHHHHHHHHHTTTC
T ss_pred cCceEEEEEeeeCCCeEEEEEEECC--CCCEEEEEEecccccChHH-----------------HHHHHHHHHHHHhccCC
Confidence 4679999999999999999998876 8999999998654322221 156778999999997 9
Q ss_pred CCcccceeEEEcCC--eeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 040898 119 RNILPLLAHMVRPN--CHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPAN 196 (337)
Q Consensus 119 pniv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~n 196 (337)
|||+++++++...+ .+|+||||+++ +|.+++.. ..+++..+..++.||+.||.|| |+.|++|+||||+|
T Consensus 69 ~niv~l~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~L---H~~~ivHrDlkp~N 139 (388)
T 3oz6_A 69 ENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRA-----NILEPVHKQYVVYQLIKVIKYL---HSGGLLHRDMKPSN 139 (388)
T ss_dssp TTBCCEEEEEECTTSSCEEEEEECCSE-EHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGG
T ss_pred CCCCeeeeEEecCCCCEEEEEecccCc-CHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHH---HhCCEEeCCCCHHH
Confidence 99999999987543 78999999975 89998854 3588899999999999999999 66799999999999
Q ss_pred eeecCCCCeEEecccCccccCCCC-------------------ceeeeecccCCCCccCcccccc-CCCCCcccchhhhH
Q 040898 197 VLIDDDMEARISDFGHGKLMPDGH-------------------AQITVKCMVGTMGYMAPESLQT-ETISDKCDIYSFGV 256 (337)
Q Consensus 197 il~~~~~~~~l~dfg~~~~~~~~~-------------------~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~ 256 (337)
|+++.++.++|+|||++....... .........+|+.|+|||++.+ ..++.++|||||||
T Consensus 140 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~ 219 (388)
T 3oz6_A 140 ILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGC 219 (388)
T ss_dssp EEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHH
T ss_pred eEEcCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHH
Confidence 999999999999999997653211 1112234579999999999976 67899999999999
Q ss_pred HHHHHHhCCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhh--------------------hcccCCchH---------
Q 040898 257 LLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAIN--------------------SKLLGNGYE--------- 307 (337)
Q Consensus 257 i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~--------- 307 (337)
++|+|++|.+||.+.. ....+.... ............. ........+
T Consensus 220 il~ell~g~~pf~~~~---~~~~~~~i~-~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (388)
T 3oz6_A 220 ILGEILCGKPIFPGSS---TMNQLERII-GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKI 295 (388)
T ss_dssp HHHHHHHSSCSCCCSS---HHHHHHHHH-HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCCCCC---HHHHHHHHH-HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccc
Confidence 9999999999996532 222222221 1111111000000 000000011
Q ss_pred ----HHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 308 ----EQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 308 ----~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.....+.+|+.+||+.||++|||++|+|+|
T Consensus 296 ~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 296 NPKADCNEEALDLLDKLLQFNPNKRISANDALKH 329 (388)
T ss_dssp CTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred cccccCCHHHHHHHHHhhccCcccCCCHHHHhCC
Confidence 223468899999999999999999999987
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=321.64 Aligned_cols=268 Identities=21% Similarity=0.300 Sum_probs=211.6
Q ss_pred ccccccccccccccceeccCcceEEEEeEEe---cCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHH
Q 040898 33 DLAFLKKEDCFDSLKKIGSGGWGEVFYKAEL---PGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSE 109 (337)
Q Consensus 33 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e 109 (337)
+-.+.-..++|++.+.||+|+||.||++.+. ...+++.||+|.+......... +.+.+|
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~------------------~~~~~E 76 (313)
T 1t46_A 15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER------------------EALMSE 76 (313)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHH------------------HHHHHH
T ss_pred ccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHH------------------HHHHHH
Confidence 3334446678999999999999999999863 2357889999999755432211 567889
Q ss_pred HHHHHhc-CCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcC--------------CcccCChHHHHHHHHHHHH
Q 040898 110 IITANQT-RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQ--------------GRRELDWPARHRIARGIAS 174 (337)
Q Consensus 110 ~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~~~i~~~i~~ 174 (337)
+.+++++ +||||+++++++.+++..++||||+++++|.+++..... ....+++..++.++.|++.
T Consensus 77 ~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~ 156 (313)
T 1t46_A 77 LKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAK 156 (313)
T ss_dssp HHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHH
T ss_pred HHHHhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHH
Confidence 9999999 999999999999999999999999999999999976322 1235899999999999999
Q ss_pred HHHHHhhCCCCCeEecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhh
Q 040898 175 GLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSF 254 (337)
Q Consensus 175 ~l~~l~~~h~~gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Diwsl 254 (337)
||.|| |++|++|+||+|+||+++.++.++|+|||++................+++.|+|||.+.+..++.++|||||
T Consensus 157 ~l~~l---H~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 233 (313)
T 1t46_A 157 GMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSY 233 (313)
T ss_dssp HHHHH---HHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred HHHHH---HHCCeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHH
Confidence 99999 667999999999999999999999999999987765544333334557788999999988889999999999
Q ss_pred hHHHHHHHh-CCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhh
Q 040898 255 GVLLAVLVM-GKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKD 333 (337)
Q Consensus 255 G~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e 333 (337)
|+++|+|++ |..||........ ............. +...+..+.+++.+||+.||.+|||+.+
T Consensus 234 G~il~ellt~g~~p~~~~~~~~~---~~~~~~~~~~~~~-------------~~~~~~~l~~li~~~l~~dp~~Rps~~e 297 (313)
T 1t46_A 234 GIFLWELFSLGSSPYPGMPVDSK---FYKMIKEGFRMLS-------------PEHAPAEMYDIMKTCWDADPLKRPTFKQ 297 (313)
T ss_dssp HHHHHHHHTTTCCSSTTCCSSHH---HHHHHHHTCCCCC-------------CTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHHhCCCCCCCcccchhH---HHHHhccCCCCCC-------------cccCCHHHHHHHHHHcCCCchhCcCHHH
Confidence 999999999 9999876433221 2222221111110 1122345899999999999999999999
Q ss_pred hhcC
Q 040898 334 VRSM 337 (337)
Q Consensus 334 ll~~ 337 (337)
++++
T Consensus 298 ll~~ 301 (313)
T 1t46_A 298 IVQL 301 (313)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9863
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=317.05 Aligned_cols=252 Identities=21% Similarity=0.318 Sum_probs=202.9
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++.+.||+|+||.||++.+. ++..||+|++....... +.+.+|+.++.+++|
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~--------------------~~~~~E~~~l~~l~h 62 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK---GQYDVAVKMIKEGSMSE--------------------DEFFQEAQTMMKLSH 62 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET---TTEEEEEEEECBTTBCH--------------------HHHHHHHHHHHHCCC
T ss_pred chhheeeeeeeccCCCceEEEEEec---CceeEEEEEeccCCCcH--------------------HHHHHHHHHHHhCCC
Confidence 5678999999999999999998664 67789999986544321 457789999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++++.++...++||||+++++|.+++.. .+..+++..++.++.|++.||.+| |+.|++|+||+|+||+
T Consensus 63 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dikp~Nil 136 (268)
T 3sxs_A 63 PKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRS---HGKGLEPSQLLEMCYDVCEGMAFL---ESHQFIHRDLAARNCL 136 (268)
T ss_dssp TTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHH---HHTTEEESSCSGGGEE
T ss_pred CCEeeEEEEEccCCceEEEEEccCCCcHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCcCcceEE
Confidence 9999999999999999999999999999999965 234589999999999999999999 6679999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCchh
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHTEE 277 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~ 277 (337)
++.++.++|+|||.+......... ......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.....
T Consensus 137 ~~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---- 211 (268)
T 3sxs_A 137 VDRDLCVKVSDFGMTRYVLDDQYV-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN---- 211 (268)
T ss_dssp ECTTCCEEECCTTCEEECCTTCEE-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH----
T ss_pred ECCCCCEEEccCccceecchhhhh-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh----
Confidence 999999999999999876554322 2233456778999999998889999999999999999999 9999865322
Q ss_pred hhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 278 MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
...............+ ...+..+.+++.+||+.||++|||+.+++++
T Consensus 212 ~~~~~~~~~~~~~~~~-------------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 212 SEVVLKVSQGHRLYRP-------------HLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HHHHHHHHTTCCCCCC-------------TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCCCCCC-------------CcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1111111111100000 1112348899999999999999999999864
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=318.93 Aligned_cols=257 Identities=25% Similarity=0.368 Sum_probs=200.8
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++.+.||+|+||.||++.+.. ++..+|+|++......... +.+.+|+.++++++|
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~------------------~~~~~E~~~l~~l~h 79 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERS--SGLERVIKTINKDRSQVPM------------------EQIEAEIEVLKSLDH 79 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETT--TCCEEEEEEEEGGGCCSCH------------------HHHHHHHHHHHTCCC
T ss_pred hhhheeecceeccCCCeEEEEEEEcc--CCceEEEEEeeccccchhH------------------HHHHHHHHHHHhCCC
Confidence 45679999999999999999998876 8999999998765432211 567889999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++++.+....++||||+++++|.+++......+..+++..++.++.|++.||.|| |+.|++|+||+|+||+
T Consensus 80 p~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~L---H~~~ivH~dikp~NIl 156 (285)
T 3is5_A 80 PNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF---HSQHVVHKDLKPENIL 156 (285)
T ss_dssp TTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCSGGGEE
T ss_pred chHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHH---HhCCEEECCCCHHHEE
Confidence 9999999999999999999999999999999876555556799999999999999999999 6679999999999999
Q ss_pred e---cCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCc
Q 040898 199 I---DDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHT 275 (337)
Q Consensus 199 ~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~ 275 (337)
+ +.++.++|+|||++........ .....+++.|+|||.+.+ .++.++|+||||+++|+|++|..||.....
T Consensus 157 ~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~il~~ll~g~~pf~~~~~-- 230 (285)
T 3is5_A 157 FQDTSPHSPIKIIDFGLAELFKSDEH---STNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSL-- 230 (285)
T ss_dssp ESSSSTTCCEEECCCCCCCC-------------CTTGGGCCHHHHTT-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--
T ss_pred EecCCCCCCEEEEeeecceecCCccc---CcCcccccCcCChHHhcc-CCCcccCeehHHHHHHHHHhCCCCCCCCCH--
Confidence 9 4567899999999976543321 234568999999999864 578899999999999999999999865321
Q ss_pred hhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 276 EEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
....... ........... ......+.+|+.+||+.||++|||+.|+|+|
T Consensus 231 --~~~~~~~---~~~~~~~~~~~--------~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 231 --EEVQQKA---TYKEPNYAVEC--------RPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp --HHHHHHH---HHCCCCCCC----------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred --HHHHhhh---ccCCccccccc--------CcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111111 11111110000 0012348899999999999999999999987
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=316.60 Aligned_cols=252 Identities=25% Similarity=0.352 Sum_probs=201.4
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
+.++|++.+.||+|+||.||++.+.. ++..||+|++........ .....+.+|+.+++.++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~----------------~~~~~~~~e~~~l~~l~h 68 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQ--SKFILALKVLFKAQLEKA----------------GVEHQLRREVEIQSHLRH 68 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEEHHHHHHH----------------TCHHHHHHHHHHHTTCCC
T ss_pred ecccEEEeeEEecCCCeEEEEEEEcc--CCcEEEEEEEeccccchh----------------hHHHHHHHHHHHHHcCCC
Confidence 45779999999999999999998876 889999999854321110 001567889999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++++.+....++||||+++++|.+++.. ...+++..++.++.|++.||.|| |+.|++|+||+|+||+
T Consensus 69 ~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~L---H~~~i~H~dlkp~Nil 141 (279)
T 3fdn_A 69 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYC---HSKRVIHRDIKPENLL 141 (279)
T ss_dssp TTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HTTTCEECCCCGGGEE
T ss_pred CCCcchhheEecCCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HhCCEecccCChHhEE
Confidence 9999999999999999999999999999999854 24589999999999999999999 6789999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhh
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEM 278 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~ 278 (337)
++.++.++|+|||++....... .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||..... .
T Consensus 142 i~~~~~~~l~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~ 213 (279)
T 3fdn_A 142 LGSAGELKIADFGWSVHAPSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY----Q 213 (279)
T ss_dssp ECTTSCEEECSCCEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH----H
T ss_pred EcCCCCEEEEeccccccCCccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH----H
Confidence 9999999999999886543322 2335689999999999999899999999999999999999999864321 1
Q ss_pred hHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 279 DMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.....+.... .. .+......+.+|+.+||+.||++|||+.|+++|
T Consensus 214 ~~~~~~~~~~---~~-----------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 214 ETYKRISRVE---FT-----------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp HHHHHHHHTC---CC-----------CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred HHHHHHHhCC---CC-----------CCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 1211111111 11 011123348899999999999999999999987
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=341.07 Aligned_cols=262 Identities=27% Similarity=0.351 Sum_probs=210.0
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++.+.||+|+||.||++.+.. +|+.||+|++........ .....+.+|..+++.++|
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~--tg~~vAiK~l~k~~~~~~----------------~~~~~~~~E~~iL~~l~h 244 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKA--TGKLYACKKLNKKRLKKR----------------KGYQGAMVEKKILAKVHS 244 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETT--TCCEEEEEEEEHHHHHHT----------------TCHHHHHHHHHHHHHCCC
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECC--CCcEEEEEEEEhHHhhhh----------------HHHHHHHHHHHHHHhcCC
Confidence 45789999999999999999999865 899999999854321110 112567889999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++++.+....|+||||++||+|.+++.........+++..++.++.||+.||.|| |++|++|+||||+||+
T Consensus 245 p~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~L---H~~gIvHrDLKP~NIL 321 (543)
T 3c4z_A 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHL---HQRNIIYRDLKPENVL 321 (543)
T ss_dssp TTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEE
T ss_pred CCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHH---HHcCCcccCCChHHEE
Confidence 9999999999999999999999999999999976444456799999999999999999999 6679999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhh
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEM 278 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~ 278 (337)
++.+|.++|+|||++......... .....||+.|+|||++.+..++.++|+||||+++|+|++|..||..........
T Consensus 322 l~~~g~vkL~DFGla~~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~ 399 (543)
T 3c4z_A 322 LDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK 399 (543)
T ss_dssp ECTTSCEEECCCTTCEECCTTCCC--BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHH
T ss_pred EeCCCCEEEeecceeeeccCCCcc--cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHH
Confidence 999999999999999876543321 223579999999999999999999999999999999999999997643322222
Q ss_pred hHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCCh-----hhhhcC
Q 040898 279 DMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSS-----KDVRSM 337 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~ell~~ 337 (337)
.+...+.. ..... ++..+..+.+|+.+||+.||++||++ .++++|
T Consensus 400 ~~~~~i~~---~~~~~-----------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 400 ELKQRVLE---QAVTY-----------PDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp HHHHHHHH---CCCCC-----------CTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred HHHHHHhh---cccCC-----------CcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 22222211 11110 11223448899999999999999964 778876
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=328.62 Aligned_cols=265 Identities=23% Similarity=0.325 Sum_probs=209.7
Q ss_pred ccccccccccccceeccCcceEEEEeEEec-----CCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHH
Q 040898 35 AFLKKEDCFDSLKKIGSGGWGEVFYKAELP-----GSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSE 109 (337)
Q Consensus 35 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e 109 (337)
.+.-..++|++.+.||+|+||.||++.+.. ...+..||+|++........ ...+.+|
T Consensus 63 ~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~------------------~~~~~~E 124 (382)
T 3tt0_A 63 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD------------------LSDLISE 124 (382)
T ss_dssp TTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHH------------------HHHHHHH
T ss_pred ccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHH------------------HHHHHHH
Confidence 334466789999999999999999998753 12456899999875533221 1567889
Q ss_pred HHHHHhc-CCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcC------------CcccCChHHHHHHHHHHHHHH
Q 040898 110 IITANQT-RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQ------------GRRELDWPARHRIARGIASGL 176 (337)
Q Consensus 110 ~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l 176 (337)
+.+++.+ +||||+++++++.+++..++||||+++++|.+++..... ....+++..++.++.|++.||
T Consensus 125 ~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL 204 (382)
T 3tt0_A 125 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGM 204 (382)
T ss_dssp HHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHH
Confidence 9999999 999999999999999999999999999999999976432 124589999999999999999
Q ss_pred HHHhhCCCCCeEecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhH
Q 040898 177 EYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGV 256 (337)
Q Consensus 177 ~~l~~~h~~gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~ 256 (337)
.|| |+.|++|+||||+||+++.++.++|+|||++................+++.|+|||++.+..++.++||||||+
T Consensus 205 ~~L---H~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~ 281 (382)
T 3tt0_A 205 EYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGV 281 (382)
T ss_dssp HHH---HHTTCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHH
T ss_pred HHH---HhCCEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHH
Confidence 999 66799999999999999999999999999998765443322333445788899999999999999999999999
Q ss_pred HHHHHHh-CCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhh
Q 040898 257 LLAVLVM-GKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVR 335 (337)
Q Consensus 257 i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 335 (337)
++|+|++ |..||.... .......+........+ ......+.+++.+||+.||++|||+.+++
T Consensus 282 il~ellt~g~~p~~~~~----~~~~~~~~~~~~~~~~~-------------~~~~~~l~~li~~~l~~dP~~Rps~~ell 344 (382)
T 3tt0_A 282 LLWEIFTLGGSPYPGVP----VEELFKLLKEGHRMDKP-------------SNCTNELYMMMRDCWHAVPSQRPTFKQLV 344 (382)
T ss_dssp HHHHHHTTSCCSSTTCC----HHHHHHHHHTTCCCCCC-------------SSCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHhCCCCCCCCCC----HHHHHHHHHcCCCCCCC-------------ccCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 9999999 999986532 22222222221111111 11234588999999999999999999998
Q ss_pred cC
Q 040898 336 SM 337 (337)
Q Consensus 336 ~~ 337 (337)
++
T Consensus 345 ~~ 346 (382)
T 3tt0_A 345 ED 346 (382)
T ss_dssp HH
T ss_pred HH
Confidence 63
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=342.82 Aligned_cols=259 Identities=29% Similarity=0.402 Sum_probs=209.6
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++.+.||+|+||.||++.+.. +|+.||+|++........ .....+.+|+.++..++|
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~--tg~~vAvK~l~k~~~~~~----------------~~~~~~~~E~~iL~~l~h 243 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRA--TGKMYACKKLEKKRIKKR----------------KGEAMALNEKQILEKVNS 243 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEEHHHHHHT----------------TCHHHHHHHHHHHHHCCC
T ss_pred cccceEEEEEEeeCCCEEEEEEEECC--CCCEEEEEEEEhHhhhhh----------------HHHHHHHHHHHHHHHcCC
Confidence 45779999999999999999999876 899999999854321110 011567889999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++++.+.+..|+||||+++|+|.+++.. .....+++..++.++.||+.||.|| |++|++|+||||+||+
T Consensus 244 p~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~--~~~~~l~e~~~~~i~~qIl~aL~yL---H~~gIvHrDLKPeNIL 318 (576)
T 2acx_A 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYH--MGQAGFPEARAVFYAAEICCGLEDL---HRERIVYRDLKPENIL 318 (576)
T ss_dssp TTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHS--SSSCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEE
T ss_pred CCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHH---HHCCEeccCCchheEE
Confidence 9999999999999999999999999999999854 2334589999999999999999999 6679999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhh
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEM 278 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~ 278 (337)
++.++.++|+|||++........ .....||+.|+|||++.+..++.++|+||||+++|+|++|..||..........
T Consensus 319 ld~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~ 395 (576)
T 2acx_A 319 LDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE 395 (576)
T ss_dssp ECTTSCEEECCCTTCEECCTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHH
T ss_pred EeCCCCeEEEecccceecccCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHH
Confidence 99999999999999987654432 234579999999999999889999999999999999999999997643322222
Q ss_pred hHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCC-----ChhhhhcC
Q 040898 279 DMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERP-----SSKDVRSM 337 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 337 (337)
.+...+...... . +...+..+.+|+.+||+.||++|| |+.|+++|
T Consensus 396 ~i~~~i~~~~~~-~-------------p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 396 EVERLVKEVPEE-Y-------------SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp HHHHHHHHCCCC-C-------------CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred HHHHHhhccccc-C-------------CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 333322221110 0 111234489999999999999999 78999987
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=326.94 Aligned_cols=268 Identities=24% Similarity=0.300 Sum_probs=208.9
Q ss_pred ccccccccccccccceeccCcceEEEEeEEec---CCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHH
Q 040898 33 DLAFLKKEDCFDSLKKIGSGGWGEVFYKAELP---GSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSE 109 (337)
Q Consensus 33 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e 109 (337)
+..+.-..++|++.+.||+|+||.||++.+.. ..++..||+|.+........ .+.+.+|
T Consensus 37 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~------------------~~~~~~E 98 (344)
T 1rjb_A 37 DLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSE------------------REALMSE 98 (344)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------------------------CHHHHHH
T ss_pred CcCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHH------------------HHHHHHH
Confidence 44455577899999999999999999998742 23677899999875432111 1568889
Q ss_pred HHHHHhc-CCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCC-------------------cccCChHHHHHHH
Q 040898 110 IITANQT-RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQG-------------------RRELDWPARHRIA 169 (337)
Q Consensus 110 ~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------------------~~~~~~~~~~~i~ 169 (337)
+.++.++ +||||+++++++..++..++||||+++++|.+++...... ...+++..++.++
T Consensus 99 ~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~ 178 (344)
T 1rjb_A 99 LKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFA 178 (344)
T ss_dssp HHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHH
T ss_pred HHHHHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHH
Confidence 9999999 9999999999999999999999999999999999653211 1347889999999
Q ss_pred HHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcc
Q 040898 170 RGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKC 249 (337)
Q Consensus 170 ~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~ 249 (337)
.||+.||.|| |++|++|+||+|+||+++.++.++|+|||++................+|+.|+|||.+.+..++.++
T Consensus 179 ~qi~~aL~~L---H~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~ 255 (344)
T 1rjb_A 179 YQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKS 255 (344)
T ss_dssp HHHHHHHHHH---HHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHH
T ss_pred HHHHHHHHHH---HhCCcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhH
Confidence 9999999999 6679999999999999999999999999999876544333333445678899999999888899999
Q ss_pred cchhhhHHHHHHHh-CCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCC
Q 040898 250 DIYSFGVLLAVLVM-GKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDER 328 (337)
Q Consensus 250 DiwslG~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 328 (337)
||||||+++|+|++ |..||....... .............. +...+..+.+++.+||+.||.+|
T Consensus 256 Di~slG~il~el~t~g~~p~~~~~~~~---~~~~~~~~~~~~~~-------------~~~~~~~l~~li~~~l~~dp~~R 319 (344)
T 1rjb_A 256 DVWSYGILLWEIFSLGVNPYPGIPVDA---NFYKLIQNGFKMDQ-------------PFYATEEIYIIMQSCWAFDSRKR 319 (344)
T ss_dssp HHHHHHHHHHHHTTTSCCSSTTCCCSH---HHHHHHHTTCCCCC-------------CTTCCHHHHHHHHHHTCSSGGGS
T ss_pred hHHHHHHHHHHHHcCCCCCcccCCcHH---HHHHHHhcCCCCCC-------------CCCCCHHHHHHHHHHcCCCchhC
Confidence 99999999999998 999997653322 22222221111111 11123458999999999999999
Q ss_pred CChhhhhcC
Q 040898 329 PSSKDVRSM 337 (337)
Q Consensus 329 ps~~ell~~ 337 (337)
||+.+++++
T Consensus 320 ps~~~l~~~ 328 (344)
T 1rjb_A 320 PSFPNLTSF 328 (344)
T ss_dssp CCHHHHHHH
T ss_pred cCHHHHHHH
Confidence 999999864
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=325.31 Aligned_cols=257 Identities=26% Similarity=0.342 Sum_probs=202.0
Q ss_pred ccccccccceeccCcceEEEEeEEecC-CCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPG-SNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR 117 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 117 (337)
..++|++.+.||+|+||.||++.+... ..+..||||.+......... ..+.+|+.++++++
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~------------------~~~~~E~~~l~~l~ 108 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR------------------RDFLSEASIMGQFD 108 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHH------------------HHHHHHHHHHTTCC
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHH------------------HHHHHHHHHHHhCC
Confidence 467899999999999999999988641 24456999998754332211 56788999999999
Q ss_pred CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCce
Q 040898 118 HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANV 197 (337)
Q Consensus 118 hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ni 197 (337)
||||+++++++.+++..++||||+++++|.+++.. ....+++..++.++.|++.||.|| |+.|++|+||+|+||
T Consensus 109 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dlkp~NI 182 (325)
T 3kul_A 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYL---SDLGYVHRDLAARNV 182 (325)
T ss_dssp CTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGE
T ss_pred CCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHH---HHCCeeCCCCCcceE
Confidence 99999999999999999999999999999999853 345689999999999999999999 667999999999999
Q ss_pred eecCCCCeEEecccCccccCCCCce-eeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCc
Q 040898 198 LIDDDMEARISDFGHGKLMPDGHAQ-ITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHT 275 (337)
Q Consensus 198 l~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~ 275 (337)
+++.++.++|+|||++......... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 183 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-- 260 (325)
T 3kul_A 183 LVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN-- 260 (325)
T ss_dssp EECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH--
T ss_pred EECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH--
Confidence 9999999999999999876543221 22223346778999999998889999999999999999999 9999865322
Q ss_pred hhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 276 EEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
......+....... .+...+..+.+++.+||+.||++|||+.++++
T Consensus 261 --~~~~~~~~~~~~~~-------------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 261 --RDVISSVEEGYRLP-------------APMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp --HHHHHHHHTTCCCC-------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --HHHHHHHHcCCCCC-------------CCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 12222221111111 11122345899999999999999999999985
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=326.53 Aligned_cols=254 Identities=23% Similarity=0.304 Sum_probs=200.7
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc-C
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT-R 117 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~ 117 (337)
-.++|++.+.||+|+||.||++.+.. +++.||+|++..... ...+|+.++.++ +
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~--~~~~~avK~~~~~~~-----------------------~~~~E~~~l~~~~~ 74 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKA--TNMEFAVKIIDKSKR-----------------------DPTEEIEILLRYGQ 74 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT--TTEEEEEEEEETTTC-----------------------CCHHHHHHHHHHTT
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECC--CCCEEEEEEEEcccC-----------------------ChHHHHHHHHHhcC
Confidence 35679999999999999999999876 899999999865432 233577777777 7
Q ss_pred CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCce
Q 040898 118 HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANV 197 (337)
Q Consensus 118 hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ni 197 (337)
||||+++++++.++...|+||||+++|+|.+++. ....+++..+..++.||+.||.|| |++|++|+||||+||
T Consensus 75 hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~----~~~~~~~~~~~~~~~qi~~al~~l---H~~givHrDlkp~NI 147 (342)
T 2qr7_A 75 HPNIITLKDVYDDGKYVYVVTELMKGGELLDKIL----RQKFFSEREASAVLFTITKTVEYL---HAQGVVHRDLKPSNI 147 (342)
T ss_dssp STTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH----TCTTCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGE
T ss_pred CCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHH---HHCCcEeccCCHHHE
Confidence 9999999999999999999999999999999984 345689999999999999999999 667999999999999
Q ss_pred eecCC----CCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCC
Q 040898 198 LIDDD----MEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFG 273 (337)
Q Consensus 198 l~~~~----~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~ 273 (337)
++..+ +.++|+|||++......... .....+|+.|+|||++.+..++.++|+||||+++|+|++|..||.....
T Consensus 148 l~~~~~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 225 (342)
T 2qr7_A 148 LYVDESGNPESIRICDFGFAKQLRAENGL--LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD 225 (342)
T ss_dssp EESSSSCSGGGEEECCCTTCEECBCTTCC--BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT
T ss_pred EEecCCCCcCeEEEEECCCcccCcCCCCc--eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc
Confidence 98543 35999999999875443221 2345789999999999888888999999999999999999999975432
Q ss_pred CchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 274 HTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.. ...+...+.. ..... ....++..+..+.+|+.+||+.||++|||+.++++|
T Consensus 226 ~~-~~~~~~~i~~---~~~~~-------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 226 DT-PEEILARIGS---GKFSL-------SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp SC-HHHHHHHHHH---CCCCC-------CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred CC-HHHHHHHHcc---CCccc-------CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 22 2222222221 11110 011112234458999999999999999999999987
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=328.60 Aligned_cols=263 Identities=19% Similarity=0.277 Sum_probs=196.2
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
++|++++.||+|+||.||++.+.. +++.||+|++......... ..+.+|+.+++.++|||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~------------------~~~~~E~~~l~~l~h~~ 61 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKL--TDNLVALKEIRLEHEEGAP------------------CTAIREVSLLKDLKHAN 61 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEECC------C------------------CCCCCCHHHHSCCCCTT
T ss_pred CceEEEEEEcCCCCEEEEEEEECC--CCcEEEEEEEecccccccc------------------hhHHHHHHHHHhcCCCC
Confidence 579999999999999999999876 8999999998654321110 24456999999999999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
|+++++++.+++..++||||+++ +|.+++.. .+..+++..++.++.|++.||.|| |+.|++|+||+|+||+++
T Consensus 62 iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~L---H~~~ivH~Dikp~NIl~~ 134 (324)
T 3mtl_A 62 IVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDD---CGNIINMHNVKLFLFQLLRGLAYC---HRQKVLHRDLKPQNLLIN 134 (324)
T ss_dssp BCCEEEEEECSSCEEEEEECCSE-EHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHH---HHTTEEESSCCGGGEEEC
T ss_pred CCeeeeEEeeCCEEEEEeccccc-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH---HHCCccCCCcCHHHEEEC
Confidence 99999999999999999999975 89888854 345689999999999999999999 667999999999999999
Q ss_pred CCCCeEEecccCccccCCCCceeeeecccCCCCccCcccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhh
Q 040898 201 DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQT-ETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMD 279 (337)
Q Consensus 201 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~ 279 (337)
.++.++|+|||++........ ......+|+.|+|||++.+ ..++.++||||||+++|+|++|..||..... .+
T Consensus 135 ~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----~~ 208 (324)
T 3mtl_A 135 ERGELKLADFGLARAKSIPTK--TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV----EE 208 (324)
T ss_dssp TTCCEEECSSSEEECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HH
T ss_pred CCCCEEEccCcccccccCCcc--ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HH
Confidence 999999999999876543221 2233468999999999876 5689999999999999999999999965422 12
Q ss_pred HHHHHHhhhccCCcchhhhhcc-----------------cCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 280 MVKWMRNVIFSENPNRAINSKL-----------------LGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
....+.......... ...... .....+.....+.+|+.+||+.||++|||++|+|+|
T Consensus 209 ~~~~i~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 209 QLHFIFRILGTPTEE-TWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp HHHHHHHHHCCCCTT-TSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHHhCCCChH-hchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 222222211111110 000000 000111234568899999999999999999999987
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=327.29 Aligned_cols=253 Identities=25% Similarity=0.337 Sum_probs=191.2
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++.+.||+|+||.||++.+.. +++.||+|++...... +.+.+|+.++++++|
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~---------------------~~~~~E~~~l~~l~h 107 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKG--TQKPYALKVLKKTVDK---------------------KIVRTEIGVLLRLSH 107 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEEC-------------------------------CHHHHHCCC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECC--CCcEEEEEEeccchhH---------------------HHHHHHHHHHHhCCC
Confidence 45779999999999999999999875 8899999998643210 456789999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++++.++...++||||+++++|.+++ .....+++..++.++.|++.||.|| |+.|++|+||+|+||+
T Consensus 108 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dikp~NIl 180 (349)
T 2w4o_A 108 PNIIKLKEIFETPTEISLVLELVTGGELFDRI----VEKGYYSERDAADAVKQILEAVAYL---HENGIVHRDLKPENLL 180 (349)
T ss_dssp TTBCCEEEEEECSSEEEEEECCCCSCBHHHHH----TTCSSCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEE
T ss_pred CCCcceeeeEecCCeEEEEEEeCCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCcccEE
Confidence 99999999999999999999999999999998 4455689999999999999999999 6679999999999999
Q ss_pred ecC---CCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCc
Q 040898 199 IDD---DMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHT 275 (337)
Q Consensus 199 ~~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~ 275 (337)
++. ++.++|+|||++........ .....+|+.|+|||++.+..++.++||||||+++|+|++|..||......
T Consensus 181 l~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~- 256 (349)
T 2w4o_A 181 YATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD- 256 (349)
T ss_dssp ESSSSTTCCEEECCCC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH-
T ss_pred EecCCCCCCEEEccCccccccCcccc---cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc-
Confidence 975 88999999999876543321 23356899999999999989999999999999999999999998653221
Q ss_pred hhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 276 EEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
......+ ....... .....+..+..+.+|+.+||+.||++|||+.++++|
T Consensus 257 --~~~~~~i---~~~~~~~-------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 257 --QFMFRRI---LNCEYYF-------ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp --HHHHHHH---HTTCCCC-------CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --HHHHHHH---HhCCCcc-------CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111111 1111100 001112233458899999999999999999999987
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=327.22 Aligned_cols=254 Identities=22% Similarity=0.288 Sum_probs=203.0
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc-C
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT-R 117 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~ 117 (337)
..++|++++.||+|+||.||++.+.. +++.||+|++........ .....+..|..++..+ .
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~--~~~~~AiK~~~~~~~~~~----------------~~~~~~~~E~~~l~~~~~ 79 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKG--TDELYAVKILKKDVVIQD----------------DDVECTMVEKRVLALPGK 79 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETT--EEEEEEEEEEEHHHHHHT----------------TCHHHHHHHHHHHTCTTC
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECC--CCCEEEEEEEEHHHhhcc----------------hHHHHHHHHHHHHHhcCC
Confidence 45789999999999999999999875 899999999864321110 1125677899999887 8
Q ss_pred CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCce
Q 040898 118 HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANV 197 (337)
Q Consensus 118 hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ni 197 (337)
||||+++++++.+.+..|+||||+++|+|.+++.. ...+++..++.++.||+.||.|| |++|++|+||||+||
T Consensus 80 hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~L---H~~givHrDlkp~NI 152 (353)
T 2i0e_A 80 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFL---QSKGIIYRDLKLDNV 152 (353)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGE
T ss_pred CCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCEEeccCCHHHE
Confidence 99999999999999999999999999999999954 34589999999999999999999 667999999999999
Q ss_pred eecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchh
Q 040898 198 LIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEE 277 (337)
Q Consensus 198 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~ 277 (337)
+++.++.++|+|||++........ ......||+.|+|||++.+..++.++|+||||+++|+|++|..||.... .
T Consensus 153 ll~~~g~vkL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~----~ 226 (353)
T 2i0e_A 153 MLDSEGHIKIADFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED----E 226 (353)
T ss_dssp EECTTSCEEECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS----H
T ss_pred EEcCCCcEEEEeCCcccccccCCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC----H
Confidence 999999999999999876432221 2234579999999999999999999999999999999999999986431 1
Q ss_pred hhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCC-----hhhhhcC
Q 040898 278 MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPS-----SKDVRSM 337 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~~ 337 (337)
......+ ....... +...+..+.+|+.+||+.||.+||+ ++++++|
T Consensus 227 ~~~~~~i---~~~~~~~-----------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 227 DELFQSI---MEHNVAY-----------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp HHHHHHH---HHCCCCC-----------CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred HHHHHHH---HhCCCCC-----------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1222211 1111110 0122345899999999999999995 5888876
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=333.40 Aligned_cols=260 Identities=23% Similarity=0.272 Sum_probs=203.6
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++++.||+|+||.||++.+.. +++.||+|++....... ......+.+|..++..++|
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~--~~~~vAiK~l~k~~~~~----------------~~~~~~~~~E~~il~~~~h 120 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQ--TGQVYAMKIMNKWDMLK----------------RGEVSCFREERDVLVNGDR 120 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT--TCCEEEEEEEEHHHHHH----------------HGGGCCHHHHHHHHHHSCT
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECC--CCCEEEEEEEeHHHhhh----------------HHHHHHHHHHHHHHHhcCC
Confidence 56889999999999999999999876 89999999985421111 0112567889999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++++.+.+..|+||||+++|+|.+++... +..+++..+..++.||+.||.|| |+.|++|+||||+||+
T Consensus 121 p~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~L---H~~giiHrDLKp~NIL 194 (412)
T 2vd5_A 121 RWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSV---HRLGYVHRDIKPDNIL 194 (412)
T ss_dssp TTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEE
T ss_pred CCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecccCHHHee
Confidence 99999999999999999999999999999999642 24689999999999999999999 6679999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccc-------cCCCCCcccchhhhHHHHHHHhCCCCCCCC
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQ-------TETISDKCDIYSFGVLLAVLVMGKFPVDDF 271 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~-------~~~~~~~~DiwslG~i~~~ll~g~~pf~~~ 271 (337)
++.++.++|+|||++......... ......||+.|+|||++. ...++.++|+||||+++|+|++|..||...
T Consensus 195 ld~~g~vkL~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 273 (412)
T 2vd5_A 195 LDRCGHIRLADFGSCLKLRADGTV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD 273 (412)
T ss_dssp ECTTSCEEECCCTTCEECCTTSCE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred ecCCCCEEEeechhheeccCCCcc-ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCC
Confidence 999999999999999876543322 223457999999999987 356889999999999999999999999653
Q ss_pred CCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCC---CChhhhhcC
Q 040898 272 FGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDER---PSSKDVRSM 337 (337)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R---ps~~ell~~ 337 (337)
.. ................+ ......+..+.+|+.+||. +|.+| |+++|+++|
T Consensus 274 ~~---~~~~~~i~~~~~~~~~p----------~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 274 ST---AETYGKIVHYKEHLSLP----------LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp SH---HHHHHHHHTHHHHCCCC--------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred CH---HHHHHHHHhcccCcCCC----------ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 21 11111111110000000 0011223458999999999 99998 599999987
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=316.22 Aligned_cols=253 Identities=23% Similarity=0.316 Sum_probs=203.7
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++.+.||+|+||.||++.+.. ++..+|+|++........ +.+.+|+.++++++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~~a~k~~~~~~~~~~-------------------~~~~~E~~~l~~l~h 65 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKG--TRIRRAAKKIPKYFVEDV-------------------DRFKQEIEIMKSLDH 65 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEEGGGCSCH-------------------HHHHHHHHHHHTCCC
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCC--CCcEEEEEeehhhccchH-------------------HHHHHHHHHHHhCCC
Confidence 45679999999999999999998876 889999999865433221 567789999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++++.++...++||||+++++|.+++.. ...+++..++.++.|++.||.+| |++|++|+||+|+||+
T Consensus 66 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~l---H~~~i~H~dlkp~Nil 138 (277)
T 3f3z_A 66 PNIIRLYETFEDNTDIYLVMELCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYC---HKLNVAHRDLKPENFL 138 (277)
T ss_dssp TTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEE
T ss_pred CCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCccCCCCCHHHEE
Confidence 9999999999999999999999999999998854 34589999999999999999999 6679999999999999
Q ss_pred e---cCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCc
Q 040898 199 I---DDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHT 275 (337)
Q Consensus 199 ~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~ 275 (337)
+ +.++.++|+|||.+........ .....+|+.|+|||.+.+. ++.++|+||||+++|+|++|..||.....
T Consensus 139 ~~~~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~-- 212 (277)
T 3f3z_A 139 FLTDSPDSPLKLIDFGLAARFKPGKM---MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTD-- 212 (277)
T ss_dssp ESSSSTTCCEEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSH--
T ss_pred EecCCCCCcEEEEecccceeccCccc---hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCH--
Confidence 9 7889999999999877654332 2335689999999998765 89999999999999999999999865321
Q ss_pred hhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 276 EEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
......+.. ........ .....+..+.+++.+||+.||++|||+.++++|
T Consensus 213 --~~~~~~~~~---~~~~~~~~-------~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 213 --SEVMLKIRE---GTFTFPEK-------DWLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp --HHHHHHHHH---CCCCCCHH-------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred --HHHHHHHHh---CCCCCCch-------hhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 112111111 11110000 001123458999999999999999999999987
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=316.38 Aligned_cols=256 Identities=22% Similarity=0.347 Sum_probs=185.1
Q ss_pred cccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC
Q 040898 38 KKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR 117 (337)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 117 (337)
...++|++.+.||+|+||.||++.+.. +++.||+|.+........ .....+.+|+.++++++
T Consensus 8 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~----------------~~~~~~~~e~~~l~~l~ 69 (278)
T 3cok_A 8 EKIEDFKVGNLLGKGSFAGVYRAESIH--TGLEVAIKMIDKKAMYKA----------------GMVQRVQNEVKIHCQLK 69 (278)
T ss_dssp SSGGGEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEEHHHHHHT----------------TCHHHHHHHHHHHTTBC
T ss_pred cccccceeeeeecCCCceEEEEEEEcc--CCceEEEEEeehhhhhhh----------------hHHHHHHHHHHHHHhCC
Confidence 356789999999999999999998865 899999999854321100 01156788999999999
Q ss_pred CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCce
Q 040898 118 HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANV 197 (337)
Q Consensus 118 hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ni 197 (337)
||||+++++++.+.+..++|+||+++++|.+++.. ....+++..++.++.|++.||.|| |+.|++|+||+|+||
T Consensus 70 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~Ni 143 (278)
T 3cok_A 70 HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYL---HSHGILHRDLTLSNL 143 (278)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHH---HHTTEECSSCCGGGE
T ss_pred CCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHE
Confidence 99999999999999999999999999999999853 345689999999999999999999 667999999999999
Q ss_pred eecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchh
Q 040898 198 LIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEE 277 (337)
Q Consensus 198 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~ 277 (337)
+++.++.++|+|||.+......... .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||........
T Consensus 144 li~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~- 220 (278)
T 3cok_A 144 LLTRNMNIKIADFGLATQLKMPHEK--HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT- 220 (278)
T ss_dssp EECTTCCEEECCCTTCEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---
T ss_pred EEcCCCCEEEEeecceeeccCCCCc--ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-
Confidence 9999999999999998876432221 1234689999999999988899999999999999999999999965332110
Q ss_pred hhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 278 MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.......... .+...+..+.+++.+||+.||++|||+.++++|
T Consensus 221 ------~~~~~~~~~~-----------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 221 ------LNKVVLADYE-----------MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp ---------CCSSCCC-----------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ------HHHHhhcccC-----------CccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 0111100000 011123458899999999999999999999987
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=330.21 Aligned_cols=255 Identities=23% Similarity=0.332 Sum_probs=193.6
Q ss_pred cccccccc-ceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHH-Hhc
Q 040898 39 KEDCFDSL-KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITA-NQT 116 (337)
Q Consensus 39 ~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l-~~l 116 (337)
..++|.+. +.||+|+||.||++.+.. +++.||+|++... ..+.+|+.++ +..
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~--~~~~vAiK~~~~~------------------------~~~~~E~~~~~~~~ 112 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKR--TQEKFALKMLQDC------------------------PKARREVELHWRAS 112 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEECS------------------------HHHHHHHHHHHHHT
T ss_pred ccccceeccceeeeccCeEEEEEEECC--CCCEEEEEEeCcc------------------------hhHHHHHHHHHHhc
Confidence 45668877 789999999999999876 8999999998532 2455677776 445
Q ss_pred CCCCcccceeEEEc----CCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 040898 117 RHRNILPLLAHMVR----PNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDI 192 (337)
Q Consensus 117 ~hpniv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di 192 (337)
+||||+++++++.. ...+|+||||+++|+|.+++.. .....+++..+..++.||+.||.|| |+.|++|+||
T Consensus 113 ~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~L---H~~~ivHrDl 187 (400)
T 1nxk_A 113 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYL---HSINIAHRDV 187 (400)
T ss_dssp TSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHC--C---CCBHHHHHHHHHHHHHHHHHH---HHTTEECCCC
T ss_pred CCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCc
Confidence 89999999998875 5678999999999999999954 2334689999999999999999999 6679999999
Q ss_pred CCCceeecC---CCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCC
Q 040898 193 KPANVLIDD---DMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVD 269 (337)
Q Consensus 193 ~~~nil~~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~ 269 (337)
||+||+++. ++.++|+|||++....... ......+|+.|+|||++.+..++.++||||||+++|+|++|..||.
T Consensus 188 kp~Nill~~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 264 (400)
T 1nxk_A 188 KPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY 264 (400)
T ss_dssp CGGGEEESSSSTTCCEEECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CcceEEEecCCCCccEEEEecccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Confidence 999999997 7899999999998654322 1234568999999999999999999999999999999999999997
Q ss_pred CCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 270 DFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
..............+....... + ..........+.+|+.+||+.||++|||+.++++|
T Consensus 265 ~~~~~~~~~~~~~~i~~~~~~~-~---------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 265 SNHGLAISPGMKTRIRMGQYEF-P---------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp CCTTCSSCCSHHHHHHHTCCCC-C---------TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCccccccHHHHHHHHcCcccC-C---------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 6543322222222222111100 0 00112233458999999999999999999999987
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=318.37 Aligned_cols=254 Identities=22% Similarity=0.332 Sum_probs=203.5
Q ss_pred ccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc
Q 040898 37 LKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT 116 (337)
Q Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 116 (337)
.-..++|++.+.||+|+||.||++.+. +++.||+|++....... +.+.+|+.+++++
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~--------------------~~~~~E~~~l~~l 62 (269)
T 4hcu_A 6 VIDPSELTFVQEIGSGQFGLVHLGYWL---NKDKVAIKTIREGAMSE--------------------EDFIEEAEVMMKL 62 (269)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEET---TTEEEEEEEECTTSBCH--------------------HHHHHHHHHHHTC
T ss_pred EeChhhceeeheecCCCccEEEEEEec---CCCeEEEEEecccccCH--------------------HHHHHHHHHHHhC
Confidence 335678999999999999999999875 57789999987554322 4577899999999
Q ss_pred CCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 040898 117 RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPAN 196 (337)
Q Consensus 117 ~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~n 196 (337)
+||||+++++++.++...++||||+++++|.+++.. ....+++..++.++.|++.||.+| |+.|++|+||+|+|
T Consensus 63 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~l---H~~~i~H~dikp~N 136 (269)
T 4hcu_A 63 SHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYL---EEACVIHRDLAARN 136 (269)
T ss_dssp CCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGG
T ss_pred CCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHH---HhCCeecCCcchhe
Confidence 999999999999999999999999999999999854 345689999999999999999999 66799999999999
Q ss_pred eeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCc
Q 040898 197 VLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHT 275 (337)
Q Consensus 197 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~ 275 (337)
|+++.++.++|+|||++......... ......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.....
T Consensus 137 il~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~-- 213 (269)
T 4hcu_A 137 CLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-- 213 (269)
T ss_dssp EEECGGGCEEECCTTGGGGBCCHHHH-STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--
T ss_pred EEEcCCCCEEeccccccccccccccc-cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH--
Confidence 99999999999999998765433211 1123456778999999998889999999999999999999 9999865321
Q ss_pred hhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 276 EEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
......+........ +...+..+.+++.+||+.||++|||+.+++++
T Consensus 214 --~~~~~~~~~~~~~~~-------------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 214 --SEVVEDISTGFRLYK-------------PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp --HHHHHHHHTTCCCCC-------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --HHHHHHHhcCccCCC-------------CCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 122221111111100 11123448899999999999999999999874
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=331.16 Aligned_cols=258 Identities=23% Similarity=0.304 Sum_probs=204.1
Q ss_pred cccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHh
Q 040898 36 FLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQ 115 (337)
Q Consensus 36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~ 115 (337)
|.-..++|++.+.||+|+||.||++.+.. +++.||+|.+........ ...+.+|+.++++
T Consensus 109 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~------------------~~~~~~E~~~l~~ 168 (377)
T 3cbl_A 109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRA--DNTLVAVKSCRETLPPDL------------------KAKFLQEARILKQ 168 (377)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETT--TCCEEEEEECCTTSCHHH------------------HTTTTHHHHHHTT
T ss_pred cEEchHHeEEeeEeccCCCCeEEEEEEec--CCeEEEEEEccccCCHHH------------------HHHHHHHHHHHHh
Confidence 33456789999999999999999999865 899999999865432111 1467889999999
Q ss_pred cCCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCC
Q 040898 116 TRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPA 195 (337)
Q Consensus 116 l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ 195 (337)
++||||+++++++.++...++||||+++|+|.+++.. .+..+++..+..++.|++.||.|| |++|++|+||+|+
T Consensus 169 l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~L---H~~~ivHrDlkp~ 242 (377)
T 3cbl_A 169 YSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYL---ESKCCIHRDLAAR 242 (377)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGG
T ss_pred CCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH---HHCCcCCcccCHH
Confidence 9999999999999999999999999999999999964 234589999999999999999999 6679999999999
Q ss_pred ceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCC
Q 040898 196 NVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGH 274 (337)
Q Consensus 196 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~ 274 (337)
||+++.++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 243 Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~- 321 (377)
T 3cbl_A 243 NCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN- 321 (377)
T ss_dssp GEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH-
T ss_pred HEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-
Confidence 99999999999999999876543321111111234677999999998889999999999999999998 9999865422
Q ss_pred chhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 275 TEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
......+....... .+...+..+.+++.+||+.||++|||+.++++
T Consensus 322 ---~~~~~~~~~~~~~~-------------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 322 ---QQTREFVEKGGRLP-------------CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp ---HHHHHHHHTTCCCC-------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---HHHHHHHHcCCCCC-------------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 11222221111000 11122345889999999999999999999975
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=331.41 Aligned_cols=261 Identities=21% Similarity=0.313 Sum_probs=203.0
Q ss_pred ccccccccceeccCcceEEEEeEEec---CCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHh
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELP---GSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQ 115 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~ 115 (337)
..++|++++.||+|+||.||++.+.. ..+++.||+|++......... ..+.+|+.++++
T Consensus 69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~------------------~~~~~E~~~l~~ 130 (367)
T 3l9p_A 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE------------------LDFLMEALIISK 130 (367)
T ss_dssp CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHH------------------HHHHHHHHHHHH
T ss_pred CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhH------------------HHHHHHHHHHHh
Confidence 45789999999999999999998542 237889999998644322211 457789999999
Q ss_pred cCCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcC---CcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 040898 116 TRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQ---GRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDI 192 (337)
Q Consensus 116 l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di 192 (337)
++||||+++++++.++...++||||+++|+|.+++..... ....+++..++.++.||+.||.|| |++|++|+||
T Consensus 131 l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDl 207 (367)
T 3l9p_A 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL---EENHFIHRDI 207 (367)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCC
T ss_pred CCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHH---HhCCeeCCCC
Confidence 9999999999999999999999999999999999976442 224588999999999999999999 6679999999
Q ss_pred CCCceeecCCC---CeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCC
Q 040898 193 KPANVLIDDDM---EARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPV 268 (337)
Q Consensus 193 ~~~nil~~~~~---~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf 268 (337)
||+||+++.++ .++|+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||
T Consensus 208 kp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf 287 (367)
T 3l9p_A 208 AARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 287 (367)
T ss_dssp CGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred ChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 99999999555 599999999875432222122234567899999999998889999999999999999998 99998
Q ss_pred CCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 269 DDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.... .......+........ +...+..+.+|+.+||+.||++|||+.+++++
T Consensus 288 ~~~~----~~~~~~~i~~~~~~~~-------------~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 339 (367)
T 3l9p_A 288 PSKS----NQEVLEFVTSGGRMDP-------------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILER 339 (367)
T ss_dssp TTCC----HHHHHHHHHTTCCCCC-------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCC----HHHHHHHHHcCCCCCC-------------CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 6532 2222222221111111 11122348899999999999999999999864
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=325.32 Aligned_cols=260 Identities=22% Similarity=0.314 Sum_probs=206.9
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++.+.||+|+||.||++.+.. +++.||+|.+........... ...+.+.+|+.++++++|
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~-------------~~~~~~~~E~~~l~~l~h 74 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKS--TGLEYAAKFIKKRQSRASRRG-------------VSREEIEREVSILRQVLH 74 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEEBCSSSSCSSS-------------BCHHHHHHHHHHHHHCCC
T ss_pred hhccEEEeeEeeecCCEEEEEEEECC--CCeEEEEEEEecccccccccc-------------hhHHHHHHHHHHHHhCCC
Confidence 45679999999999999999999876 899999999976543221000 001567889999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++++.+....++||||+++++|.+++. ....+++..++.++.|++.||.|| |+.|++|+||+|+||+
T Consensus 75 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~l---H~~~ivH~dikp~NIl 147 (321)
T 2a2a_A 75 HNVITLHDVYENRTDVVLILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYL---HTKKIAHFDLKPENIM 147 (321)
T ss_dssp TTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH----TCSCEEHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEE
T ss_pred CCcceEEEEEecCCEEEEEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCChHHEE
Confidence 999999999999999999999999999999994 345689999999999999999999 6679999999999999
Q ss_pred ecCCC----CeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCC
Q 040898 199 IDDDM----EARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGH 274 (337)
Q Consensus 199 ~~~~~----~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~ 274 (337)
++.++ .++|+|||++........ .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||....
T Consensus 148 ~~~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-- 222 (321)
T 2a2a_A 148 LLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT-- 222 (321)
T ss_dssp ESCTTSSSCCEEECCCTTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS--
T ss_pred EecCCCCcCCEEEccCccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC--
Confidence 99887 799999999987654322 233568999999999999899999999999999999999999986432
Q ss_pred chhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 275 TEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.......+...... .+.. .....+..+.+++.+||+.||++|||+.++++|
T Consensus 223 --~~~~~~~i~~~~~~-~~~~---------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 223 --KQETLANITSVSYD-FDEE---------FFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp --HHHHHHHHHTTCCC-CCHH---------HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred --HHHHHHHHHhcccc-cChh---------hhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11121111111110 0000 011223458999999999999999999999987
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=325.71 Aligned_cols=252 Identities=26% Similarity=0.428 Sum_probs=202.0
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++.+.||+|+||.||++.+.. +++.||+|++.......... ...+.+|+.++++++|
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~a~~~~--~~~~vaiK~~~~~~~~~~~~----------------~~~~~~E~~~l~~l~h 113 (348)
T 1u5q_A 52 PEKLFSDLREIGHGSFGAVYFARDVR--NSEVVAIKKMSYSGKQSNEK----------------WQDIIKEVRFLQKLRH 113 (348)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT--TTEEEEEEEEESCSSCHHHH----------------HHHHHHHHHHHHHCCC
T ss_pred hhhheeeeeEEccCCCEEEEEEEEcc--CCeEEEEEEEccccccchHH----------------HHHHHHHHHHHHhCCC
Confidence 55679999999999999999999876 89999999987654332221 1568889999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++++.+++..++||||+. |+|.+++.. ....+++..++.++.|++.||.|| |+.|++|+||+|+||+
T Consensus 114 pniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dlkp~NIl 186 (348)
T 1u5q_A 114 PNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYL---HSHNMIHRDVKAGNIL 186 (348)
T ss_dssp TTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCSGGGEE
T ss_pred CCEeeEEEEEEECCeEEEEEecCC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCCHHHEE
Confidence 999999999999999999999997 588887754 235689999999999999999999 6679999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccc---cCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCc
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQ---TETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHT 275 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~ 275 (337)
++.++.++|+|||++...... ....+|+.|+|||++. ...++.++||||||+++|+|++|..||.....
T Consensus 187 l~~~~~~kL~DfG~a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~-- 258 (348)
T 1u5q_A 187 LSEPGLVKLGDFGSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-- 258 (348)
T ss_dssp EETTTEEEECCCTTCBSSSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--
T ss_pred ECCCCCEEEeeccCceecCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh--
Confidence 999999999999998765432 2356899999999984 55688999999999999999999999864321
Q ss_pred hhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 276 EEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
...... ......+.. .....+..+.+++.+||+.||++|||+.++++|
T Consensus 259 -~~~~~~----~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 259 -MSALYH----IAQNESPAL---------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp -HHHHHH----HHHSCCCCC---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred -HHHHHH----HHhcCCCCC---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 111111 111111100 001123448899999999999999999999986
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=327.37 Aligned_cols=268 Identities=21% Similarity=0.295 Sum_probs=195.7
Q ss_pred cccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC
Q 040898 38 KKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR 117 (337)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 117 (337)
...++|++++.||+|+||.||++.+.. +++.||+|++......... ...+.+|+.++++++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~-----------------~~~~~~E~~~l~~l~ 91 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTV--TNETVAIKRIRLEHEEEGV-----------------PGTAIREVSLLKELQ 91 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETT--TTEEEEEEECCCCC-------------------------CHHHHHHGGGCC
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECC--CCceEEEEEEccccccccc-----------------chhHHHHHHHHHHcC
Confidence 355679999999999999999998876 8999999999655432211 146778999999999
Q ss_pred CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCce
Q 040898 118 HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANV 197 (337)
Q Consensus 118 hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ni 197 (337)
||||+++++++.++...++||||+++ +|.+++.. ...+++..++.++.||+.||.|| |+.|++|+||||+||
T Consensus 92 h~~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~L---H~~~ivH~Dlkp~NI 163 (329)
T 3gbz_A 92 HRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDK----NPDVSMRVIKSFLYQLINGVNFC---HSRRCLHRDLKPQNL 163 (329)
T ss_dssp CTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGE
T ss_pred CCCcceEEEEEecCCEEEEEEecCCC-CHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHH---HhCCEECCCCCHHHE
Confidence 99999999999999999999999985 99999853 34589999999999999999999 667999999999999
Q ss_pred eec-----CCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCC
Q 040898 198 LID-----DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTE-TISDKCDIYSFGVLLAVLVMGKFPVDDF 271 (337)
Q Consensus 198 l~~-----~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~i~~~ll~g~~pf~~~ 271 (337)
+++ .++.++|+|||++......... .....+|+.|+|||++.+. .++.++||||||+++|+|++|..||...
T Consensus 164 ll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 241 (329)
T 3gbz_A 164 LLSVSDASETPVLKIGDFGLARAFGIPIRQ--FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGD 241 (329)
T ss_dssp EEEC-----CCEEEECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEecCCCCccceEEECcCCCccccCCcccc--cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCC
Confidence 994 4456999999999776433221 2334679999999999874 4799999999999999999999998653
Q ss_pred CCCchhhhHHHHHHhhhccCCcc---hh-------hhhcccCCch-----HHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 272 FGHTEEMDMVKWMRNVIFSENPN---RA-------INSKLLGNGY-----EEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~---~~-------~~~~~~~~~~-----~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
.. ...+.............. .. ..+....... ......+.+|+.+||+.||++|||+.|+|+
T Consensus 242 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 242 SE---IDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp SH---HHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CH---HHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 22 222222221111110000 00 0000000000 112356889999999999999999999998
Q ss_pred C
Q 040898 337 M 337 (337)
Q Consensus 337 ~ 337 (337)
|
T Consensus 319 h 319 (329)
T 3gbz_A 319 H 319 (329)
T ss_dssp S
T ss_pred C
Confidence 7
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=315.43 Aligned_cols=273 Identities=32% Similarity=0.488 Sum_probs=211.7
Q ss_pred cccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC
Q 040898 38 KKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR 117 (337)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 117 (337)
.....|...+.||+|+||.||++.+ +++.||+|++.......... ....+.+|+.++++++
T Consensus 28 ~~~~~~~~~~~lg~G~~g~Vy~~~~----~~~~vavK~~~~~~~~~~~~---------------~~~~~~~E~~~l~~l~ 88 (307)
T 2nru_A 28 DERPISVGGNKMGEGGFGVVYKGYV----NNTTVAVKKLAAMVDITTEE---------------LKQQFDQEIKVMAKCQ 88 (307)
T ss_dssp CCSBTTTTCCEEEECSSEEEEEEES----SSCEEEEEEECCCTTSCTTT---------------HHHHHHHHHHHHHHCC
T ss_pred ccccccccCCccccCCCeEEEEEEE----CCceEEEEEEecccCcchHH---------------HHHHHHHHHHHHHhcC
Confidence 3444466669999999999998876 68899999986543221110 0156888999999999
Q ss_pred CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCce
Q 040898 118 HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANV 197 (337)
Q Consensus 118 hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ni 197 (337)
||||+++++++.+++..++||||+++++|.+++.... ...++++..++.++.|++.||.|| |++|++|+||+|+||
T Consensus 89 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~l---H~~~i~H~dlkp~Ni 164 (307)
T 2nru_A 89 HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFL---HENHHIHRDIKSANI 164 (307)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGE
T ss_pred CCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHE
Confidence 9999999999999999999999999999999986432 235689999999999999999999 667999999999999
Q ss_pred eecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchh
Q 040898 198 LIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEE 277 (337)
Q Consensus 198 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~ 277 (337)
+++.++.++|+|||++................+++.|+|||.+.+. ++.++|+||||+++|+|++|..||.........
T Consensus 165 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~ 243 (307)
T 2nru_A 165 LLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL 243 (307)
T ss_dssp EECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTTE-ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBT
T ss_pred EEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcCC-CCccchhHHHHHHHHHHHHCCCCcccCcchHHH
Confidence 9999999999999998876554333333445789999999998764 788999999999999999999999765443333
Q ss_pred hhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 278 MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
........ ........................+.+++.+||+.||++|||+.+++++
T Consensus 244 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 244 LDIKEEIE---DEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp THHHHHHH---TTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHhh---hhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 23222211 1111111111122234456677889999999999999999999999863
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=328.54 Aligned_cols=261 Identities=22% Similarity=0.295 Sum_probs=202.4
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC-
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR- 117 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~- 117 (337)
..++|+++++||+|+||.||++.+.. +++.||+|++..... . ...+..|+.+++.+.
T Consensus 33 ~~~~y~~~~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~--~------------------~~~~~~e~~~l~~l~~ 90 (360)
T 3llt_A 33 LNNAFLVIRKMGDGTFGRVLLCQHID--NKKYYAVKVVRNIKK--Y------------------TRSAKIEADILKKIQN 90 (360)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEECSCHH--H------------------HHHHHHHHHHHHHTCC
T ss_pred ecCEEEEEEEEcccCCeEEEEEEECC--CCeEEEEEEeccchh--h------------------hhhhHHHHHHHHHhcc
Confidence 46789999999999999999999876 899999999853211 0 145666888888886
Q ss_pred ----CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCC
Q 040898 118 ----HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIK 193 (337)
Q Consensus 118 ----hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~ 193 (337)
||||+++++++...+..++||||+ +++|.+++.. .....+++..+..++.||+.||.|| |+.|++|+|||
T Consensus 91 ~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlk 164 (360)
T 3llt_A 91 DDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITR--NNYNGFHIEDIKLYCIEILKALNYL---RKMSLTHTDLK 164 (360)
T ss_dssp CSTTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCS
T ss_pred cCCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeCCCC
Confidence 999999999999999999999999 8899999965 3334589999999999999999999 66799999999
Q ss_pred CCceeecC-------------------------CCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCc
Q 040898 194 PANVLIDD-------------------------DMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDK 248 (337)
Q Consensus 194 ~~nil~~~-------------------------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~ 248 (337)
|+||+++. ++.++|+|||++....... ....+|+.|+|||++.+..++.+
T Consensus 165 p~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~ 239 (360)
T 3llt_A 165 PENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVS 239 (360)
T ss_dssp GGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTT
T ss_pred cccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCc
Confidence 99999975 7899999999998654322 23568999999999999999999
Q ss_pred ccchhhhHHHHHHHhCCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcc-----------------c---------
Q 040898 249 CDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKL-----------------L--------- 302 (337)
Q Consensus 249 ~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~--------- 302 (337)
+||||||+++|+|++|..||..... ......+......... ....... .
T Consensus 240 ~DiwslG~il~ell~g~~pf~~~~~----~~~~~~~~~~~~~~p~-~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 314 (360)
T 3llt_A 240 SDMWSFGCVLAELYTGSLLFRTHEH----MEHLAMMESIIQPIPK-NMLYEATKTNGSKYVNKDELKLAWPENASSINSI 314 (360)
T ss_dssp HHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHHTCCCCH-HHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHH
T ss_pred cchHHHHHHHHHHHHCCCCCCCCcH----HHHHHHHHHhcCCCCH-HHHhhhhhccCccccCcccceecCcccccchhhh
Confidence 9999999999999999999965322 1222222221111110 0000000 0
Q ss_pred -------CCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 303 -------GNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 303 -------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
..........+.+|+.+||+.||++|||+.|+|+|
T Consensus 315 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 315 KHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp HHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred hhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00000111567899999999999999999999987
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=331.70 Aligned_cols=263 Identities=24% Similarity=0.284 Sum_probs=196.1
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++++.||+|+||.||++.+.. +++.||||++......... ...+.+|+.+++.++|
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~--~~~~vAiK~~~~~~~~~~~-----------------~~~~~~E~~~l~~l~h 120 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAV--LDRNVAIKKLSRPFQNQTH-----------------AKRAYRELVLMKCVNH 120 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETT--TTEEEEEEEEESGGGSHHH-----------------HHHHHHHHHHHHHCCC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECC--CCCEEEEEEECccccChHH-----------------HHHHHHHHHHHHhCCC
Confidence 45789999999999999999999876 8999999998654222111 1567889999999999
Q ss_pred CCcccceeEEEcC------CeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 040898 119 RNILPLLAHMVRP------NCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDI 192 (337)
Q Consensus 119 pniv~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di 192 (337)
|||+++++++... ...|+||||+++ +|.+.+. ..+++..+..++.||+.||.|| |++|++||||
T Consensus 121 pnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~------~~l~~~~~~~~~~qil~aL~~l---H~~~iiHrDl 190 (464)
T 3ttj_A 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHL---HSAGIIHRDL 190 (464)
T ss_dssp TTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHT------SCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCC
T ss_pred CCCCcEEEEEccCCccccCCeEEEEEeCCCC-CHHHHHh------hcCCHHHHHHHHHHHHHHHHHH---HHCCcccCCC
Confidence 9999999998654 457999999977 5666652 2388899999999999999999 6679999999
Q ss_pred CCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCC
Q 040898 193 KPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFF 272 (337)
Q Consensus 193 ~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~ 272 (337)
||+||+++.++.++|+|||++........ .....+|+.|+|||++.+..++.++||||||+++|+|++|..||.+..
T Consensus 191 kp~NIll~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~ 267 (464)
T 3ttj_A 191 KPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 267 (464)
T ss_dssp CGGGEEECTTSCEEECCCCCC-----CCC---C----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ChHhEEEeCCCCEEEEEEEeeeecCCCcc---cCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999987644321 234578999999999999999999999999999999999999996532
Q ss_pred CCchhhhHHHHHHhhhccCCcc------------------------hhh-hhccc---CCchHHHHHHHHHHHhhhccCC
Q 040898 273 GHTEEMDMVKWMRNVIFSENPN------------------------RAI-NSKLL---GNGYEEQMLLVLKLACFCTLKD 324 (337)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~------------------------~~~-~~~~~---~~~~~~~~~~l~~li~~~l~~d 324 (337)
. ...+..... ......+. ... ..... ..........+.+|+.+||+.|
T Consensus 268 ~---~~~~~~i~~-~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~d 343 (464)
T 3ttj_A 268 Y---IDQWNKVIE-QLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 343 (464)
T ss_dssp H---HHHHHHHHH-HHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSS
T ss_pred H---HHHHHHHHH-hcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCC
Confidence 1 111111111 11100000 000 00000 0011122567899999999999
Q ss_pred CCCCCChhhhhcC
Q 040898 325 PDERPSSKDVRSM 337 (337)
Q Consensus 325 P~~Rps~~ell~~ 337 (337)
|++|||++|+|+|
T Consensus 344 P~~R~ta~e~L~H 356 (464)
T 3ttj_A 344 PAKRISVDDALQH 356 (464)
T ss_dssp TTTSCCHHHHHTS
T ss_pred hhhCCCHHHHhcC
Confidence 9999999999987
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=324.15 Aligned_cols=257 Identities=21% Similarity=0.304 Sum_probs=195.9
Q ss_pred ccccccccceeccCcceEEEEeEEec-CCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELP-GSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR 117 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 117 (337)
..++|++.+.||+|+||.||++.+.. ..+++.||+|++.......... ....+.+|+.+++.++
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~---------------~~~~~~~E~~~l~~l~ 79 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAK---------------DTAHTKAERNILEEVK 79 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC-----------------------------HHHHHHHCC
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhh---------------HHHHHHHHHHHHHhCC
Confidence 45789999999999999999988752 2489999999987653221110 0145778999999999
Q ss_pred CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCce
Q 040898 118 HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANV 197 (337)
Q Consensus 118 hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ni 197 (337)
||||+++++++.+++..|+||||+++++|.+++.. ...+++..+..++.||+.||.|| |++|++|+||+|+||
T Consensus 80 hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~l---H~~~ivH~Dlkp~Ni 152 (327)
T 3a62_A 80 HPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHL---HQKGIIYRDLKPENI 152 (327)
T ss_dssp CTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCTTTE
T ss_pred CCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHH---HhCCEEcccCCHHHe
Confidence 99999999999999999999999999999999854 34588899999999999999999 667999999999999
Q ss_pred eecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchh
Q 040898 198 LIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEE 277 (337)
Q Consensus 198 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~ 277 (337)
+++.++.++|+|||++........ ......||+.|+|||++.+..++.++|+||||+++|+|++|..||.....
T Consensus 153 ll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---- 226 (327)
T 3a62_A 153 MLNHQGHVKLTDFGLCKESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR---- 226 (327)
T ss_dssp EECTTSCEEECCCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----
T ss_pred EECCCCcEEEEeCCcccccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH----
Confidence 999999999999999875432211 12345789999999999998899999999999999999999999964321
Q ss_pred hhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCC-----ChhhhhcC
Q 040898 278 MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERP-----SSKDVRSM 337 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 337 (337)
......+ ...... .++.....+.+++.+||+.||++|| ++.++++|
T Consensus 227 ~~~~~~i---~~~~~~-----------~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 227 KKTIDKI---LKCKLN-----------LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp HHHHHHH---HHTCCC-----------CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred HHHHHHH---HhCCCC-----------CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 1111111 111111 0111234489999999999999999 78899887
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=316.50 Aligned_cols=255 Identities=22% Similarity=0.351 Sum_probs=206.7
Q ss_pred cccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC
Q 040898 38 KKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR 117 (337)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 117 (337)
...++|++.+.||+|+||.||++.+.. +++.+|+|.+.......... .+.+.+|+.+++.++
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~--~~~~~a~K~~~~~~~~~~~~----------------~~~~~~e~~~l~~l~ 73 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDAD--TKEVFAGKIVPKSLLLKPHQ----------------REKMSMEISIHRSLA 73 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEEGGGCCSHHH----------------HHHHHHHHHHHHTCC
T ss_pred CcccceEEEEEEeecCCEEEEEEEECC--CCceEEEEEechhhccCHHH----------------HHHHHHHHHHHHhCC
Confidence 366789999999999999999999876 89999999986654322211 156788999999999
Q ss_pred CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCce
Q 040898 118 HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANV 197 (337)
Q Consensus 118 hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ni 197 (337)
||||+++++++.+++..++||||+++++|.+++.. ...+++..++.++.|++.||.|| |+.|++|+||+|+||
T Consensus 74 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dl~p~Ni 146 (294)
T 2rku_A 74 HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYL---HRNRVIHRDLKLGNL 146 (294)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGE
T ss_pred CCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCChHhE
Confidence 99999999999999999999999999999998853 34689999999999999999999 667999999999999
Q ss_pred eecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchh
Q 040898 198 LIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEE 277 (337)
Q Consensus 198 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~ 277 (337)
+++.++.++|+|||.+......... .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||.....
T Consensus 147 l~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---- 220 (294)
T 2rku_A 147 FLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL---- 220 (294)
T ss_dssp EECTTCCEEECCCTTCEECCSTTCC--BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH----
T ss_pred EEcCCCCEEEEeccCceecccCccc--cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----
Confidence 9999999999999998876433221 2335689999999999998899999999999999999999999865321
Q ss_pred hhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 278 MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
..... ......... +......+.+++.+||+.||++|||+.++++|
T Consensus 221 ~~~~~---~~~~~~~~~-----------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 221 KETYL---RIKKNEYSI-----------PKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp HHHHH---HHHTTCCCC-----------CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred HHHHH---HHhhccCCC-----------ccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11111 111111110 01122348899999999999999999999986
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=323.53 Aligned_cols=255 Identities=24% Similarity=0.367 Sum_probs=194.4
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++++.||+|+||.||++.+. +++.||+|++......... .+.+.+|+.++..++|
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~-----------------~~~~~~E~~~l~~l~~ 66 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNE---KKQIYAIKYVNLEEADNQT-----------------LDSYRNEIAYLNKLQQ 66 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECT---TSCEEEEEEEECTTCCHHH-----------------HHHHHHHHHHHHHHTT
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeC---CCCEEEEEEeeccccchHH-----------------HHHHHHHHHHHHhhhh
Confidence 4677999999999999999998773 7899999998755432211 1568889999999987
Q ss_pred --CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 040898 119 --RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPAN 196 (337)
Q Consensus 119 --pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~n 196 (337)
|||+++++++.++...++|||+ .+++|.+++.. ...+++..+..++.|++.||.|| |++|++|+||||+|
T Consensus 67 ~~~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~l---H~~~iiHrDikp~N 138 (343)
T 3dbq_A 67 HSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTI---HQHGIVHSDLKPAN 138 (343)
T ss_dssp TCTTBCCEEEEEECSSEEEEEECC-CSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGG
T ss_pred cCCceEEEeeeEeeCCEEEEEEeC-CCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCcce
Confidence 9999999999999999999994 57799999954 45688999999999999999999 66799999999999
Q ss_pred eeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCcccccc-----------CCCCCcccchhhhHHHHHHHhCC
Q 040898 197 VLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQT-----------ETISDKCDIYSFGVLLAVLVMGK 265 (337)
Q Consensus 197 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-----------~~~~~~~DiwslG~i~~~ll~g~ 265 (337)
|+++ ++.++|+|||++................||+.|+|||++.+ ..++.++||||||+++|+|++|.
T Consensus 139 Ill~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~ 217 (343)
T 3dbq_A 139 FLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217 (343)
T ss_dssp EEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSS
T ss_pred EEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCC
Confidence 9997 67899999999987654433333345679999999999865 56788999999999999999999
Q ss_pred CCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 266 FPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 266 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.||..... ......... ...... ..+......+.+|+.+||+.||.+|||+.++++|
T Consensus 218 ~pf~~~~~--~~~~~~~~~----~~~~~~---------~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 218 TPFQQIIN--QISKLHAII----DPNHEI---------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp CTTTTCCS--HHHHHHHHH----CTTSCC---------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred Ccchhhhh--HHHHHHHHh----cCCccc---------CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 99965322 111111111 111100 0001112348899999999999999999999987
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=324.60 Aligned_cols=260 Identities=20% Similarity=0.302 Sum_probs=196.5
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
-.++|++.+.||+|+||.||++.+.. +++.||+|++.......... ...+.+|+.++.+++|
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~----------------~~~~~~E~~~l~~l~h 71 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLR--DHRDVAVKVLRADLARDPSF----------------YLRFRREAQNAAALNH 71 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETT--TTEEEEEEEECTTTTTSHHH----------------HHHHHHHHTTCCCCCC
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECC--CCceEEEEEeCccccCCHHH----------------HHHHHHHHHHHHcCCC
Confidence 45789999999999999999999876 89999999997654433221 1567889999999999
Q ss_pred CCcccceeEEEcCCe----eEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCC
Q 040898 119 RNILPLLAHMVRPNC----HLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKP 194 (337)
Q Consensus 119 pniv~~~~~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~ 194 (337)
|||+++++++..... .|+||||+++++|.+++.. ...+++..++.++.|++.||.|| |++|++|+||+|
T Consensus 72 p~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp 144 (311)
T 3ork_A 72 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFS---HQNGIIHRDVKP 144 (311)
T ss_dssp TTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCG
T ss_pred CCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCCCcCCCCH
Confidence 999999999876543 4999999999999999954 34689999999999999999999 667999999999
Q ss_pred CceeecCCCCeEEecccCccccCCCCce-eeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCC
Q 040898 195 ANVLIDDDMEARISDFGHGKLMPDGHAQ-ITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFG 273 (337)
Q Consensus 195 ~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~ 273 (337)
+||+++.++.++|+|||++......... .......||+.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 145 ~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~ 224 (311)
T 3ork_A 145 ANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224 (311)
T ss_dssp GGEEEETTSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred HHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 9999999999999999999766543222 122335689999999999998999999999999999999999999965321
Q ss_pred CchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 274 HTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
........ .....+.... ....+..+.+++.+||+.||++||++.+++.+
T Consensus 225 ---~~~~~~~~---~~~~~~~~~~--------~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~ 274 (311)
T 3ork_A 225 ---VSVAYQHV---REDPIPPSAR--------HEGLSADLDAVVLKALAKNPENRYQTAAEMRA 274 (311)
T ss_dssp ---HHHHHHHH---HCCCCCHHHH--------STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred ---HHHHHHHh---cCCCCCcccc--------cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHH
Confidence 11111111 1111111100 01123458899999999999999998888753
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=322.46 Aligned_cols=255 Identities=22% Similarity=0.359 Sum_probs=207.0
Q ss_pred cccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC
Q 040898 38 KKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR 117 (337)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 117 (337)
...++|.+.+.||+|+||.||++.+.. +++.||+|.+.......... .+.+.+|+.+++.++
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~--~~~~~a~K~~~~~~~~~~~~----------------~~~~~~E~~~l~~l~ 99 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDAD--TKEVFAGKIVPKSLLLKPHQ----------------REKMSMEISIHRSLA 99 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEEGGGCCSHHH----------------HHHHHHHHHHHHTCC
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECC--CCCEEEEEEechhhhcCHHH----------------HHHHHHHHHHHHhCC
Confidence 367889999999999999999998876 89999999987554322211 156788999999999
Q ss_pred CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCce
Q 040898 118 HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANV 197 (337)
Q Consensus 118 hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ni 197 (337)
||||+++++++.+.+..++||||+++++|.+++.. ...+++..++.++.|++.||.|| |++|++|+||+|+||
T Consensus 100 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~dlkp~NI 172 (335)
T 2owb_A 100 HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYL---HRNRVIHRDLKLGNL 172 (335)
T ss_dssp CTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGE
T ss_pred CCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHH---HHCCCEecCCCchhE
Confidence 99999999999999999999999999999998854 34689999999999999999999 667999999999999
Q ss_pred eecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchh
Q 040898 198 LIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEE 277 (337)
Q Consensus 198 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~ 277 (337)
+++.++.++|+|||++......... .....+++.|+|||++.+..++.++|+||||+++|+|++|..||.....
T Consensus 173 l~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---- 246 (335)
T 2owb_A 173 FLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL---- 246 (335)
T ss_dssp EECTTCCEEECCCTTCEECCSTTCC--BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH----
T ss_pred EEcCCCCEEEeeccCceecccCccc--ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH----
Confidence 9999999999999999876433221 2335689999999999988899999999999999999999999865321
Q ss_pred hhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 278 MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
......+.. ..... +......+.+++.+||+.||++|||+.++++|
T Consensus 247 ~~~~~~~~~---~~~~~-----------~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 247 KETYLRIKK---NEYSI-----------PKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp HHHHHHHHH---TCCCC-----------CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred HHHHHHHhc---CCCCC-----------CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111111111 11100 01122348899999999999999999999986
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=324.56 Aligned_cols=265 Identities=23% Similarity=0.320 Sum_probs=199.0
Q ss_pred ccccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHH
Q 040898 35 AFLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITAN 114 (337)
Q Consensus 35 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~ 114 (337)
..+...++|++++.||+|+||.||++.+.. +|+.||+|++......... ...+.+|+.+++
T Consensus 19 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~--~~~~vaiK~~~~~~~~~~~-----------------~~~~~~E~~~l~ 79 (367)
T 1cm8_A 19 TAWEVRAVYRDLQPVGSGAYGAVCSAVDGR--TGAKVAIKKLYRPFQSELF-----------------AKRAYRELRLLK 79 (367)
T ss_dssp SEECCBSSEEEEEEC------CEEEEEETT--TCCEEEEEECSSTTSSHHH-----------------HHHHHHHHHHHH
T ss_pred ceeeecceEEEeEEeeecCCeEEEEEEECC--CCCEEEEEEeCccccCHHH-----------------HHHHHHHHHHHH
Confidence 445567889999999999999999999876 8999999998654322111 156788999999
Q ss_pred hcCCCCcccceeEEEcCC------eeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeE
Q 040898 115 QTRHRNILPLLAHMVRPN------CHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLI 188 (337)
Q Consensus 115 ~l~hpniv~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~ 188 (337)
.++||||+++++++.... .+|+||||+ +++|.+++.. ..+++..+..++.|++.||.|| |+.|++
T Consensus 80 ~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~L---H~~~iv 150 (367)
T 1cm8_A 80 HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYI---HAAGII 150 (367)
T ss_dssp HCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHH---HHTTEE
T ss_pred hCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHH---HHCCcc
Confidence 999999999999987653 469999999 7799999854 3588999999999999999999 667999
Q ss_pred ecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCcccccc-CCCCCcccchhhhHHHHHHHhCCCC
Q 040898 189 HRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQT-ETISDKCDIYSFGVLLAVLVMGKFP 267 (337)
Q Consensus 189 h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~i~~~ll~g~~p 267 (337)
|+||||+||+++.++.++|+|||++...... .....+|+.|+|||++.+ ..++.++|+||+||++|+|++|..|
T Consensus 151 H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p 225 (367)
T 1cm8_A 151 HRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL 225 (367)
T ss_dssp CCCCCGGGEEECTTCCEEECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred ccCcCHHHEEEcCCCCEEEEeeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999875432 234568999999999877 6789999999999999999999999
Q ss_pred CCCCCCCchhhhHHHHHHhhhccCCcchhh------------------hhcccCCchHHHHHHHHHHHhhhccCCCCCCC
Q 040898 268 VDDFFGHTEEMDMVKWMRNVIFSENPNRAI------------------NSKLLGNGYEEQMLLVLKLACFCTLKDPDERP 329 (337)
Q Consensus 268 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp 329 (337)
|.+... . +....+........ .... .........+.....+.+|+.+||+.||++||
T Consensus 226 f~~~~~---~-~~l~~i~~~~g~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~ 300 (367)
T 1cm8_A 226 FKGSDH---L-DQLKEIMKVTGTPP-AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV 300 (367)
T ss_dssp SCCSSH---H-HHHHHHHHHHCCCC-HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSC
T ss_pred CCCCCH---H-HHHHHHHHhcCCCC-HHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCC
Confidence 965322 1 11111111111100 0000 00001111223345689999999999999999
Q ss_pred ChhhhhcC
Q 040898 330 SSKDVRSM 337 (337)
Q Consensus 330 s~~ell~~ 337 (337)
|+.++|+|
T Consensus 301 t~~e~l~h 308 (367)
T 1cm8_A 301 TAGEALAH 308 (367)
T ss_dssp CHHHHHHS
T ss_pred CHHHHhcC
Confidence 99999987
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=324.47 Aligned_cols=272 Identities=25% Similarity=0.284 Sum_probs=203.6
Q ss_pred ccccccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHH
Q 040898 33 DLAFLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIIT 112 (337)
Q Consensus 33 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 112 (337)
--......++|++.+.||+|+||.||++.+.. ++..||+|++........ .....+.+.+|+.+
T Consensus 18 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~--------------~~~~~~~~~~E~~~ 81 (345)
T 3hko_A 18 GGSLLELQKKYHLKGAIGQGSYGVVRVAIENQ--TRAIRAIKIMNKNKIRQI--------------NPKDVERIKTEVRL 81 (345)
T ss_dssp CBCHHHHHHHEEEEEEEEECSSCEEEEEEETT--TCCEEEEEEEEHHHHHC-----------------CHHHHHHHHHHH
T ss_pred CchhhhhhhheeecceeeecCCeEEEEEEECC--CCceEEEeehhhhhhccc--------------CHHHHHHHHHHHHH
Confidence 33445567789999999999999999998865 899999999864321110 01112578889999
Q ss_pred HHhcCCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcC------------------------------------C
Q 040898 113 ANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQ------------------------------------G 156 (337)
Q Consensus 113 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------------------------------------~ 156 (337)
++.++||||+++++++.+.+..++||||+++++|.+++..... .
T Consensus 82 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (345)
T 3hko_A 82 MKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESL 161 (345)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEEC
T ss_pred HHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999999999999999999999999998842111 1
Q ss_pred cccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCC--CeEEecccCccccCCCC--ceeeeecccCCC
Q 040898 157 RRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDM--EARISDFGHGKLMPDGH--AQITVKCMVGTM 232 (337)
Q Consensus 157 ~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~--~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~ 232 (337)
...+++..++.++.|++.||.|| |+.|++|+||+|+||+++.++ .++|+|||++....... .........+|+
T Consensus 162 ~~~~~~~~~~~i~~qi~~~l~~L---H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~ 238 (345)
T 3hko_A 162 DFVQREKLISNIMRQIFSALHYL---HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTP 238 (345)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCG
T ss_pred cccccHHHHHHHHHHHHHHHHHH---HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCc
Confidence 22345678889999999999999 667999999999999998776 89999999987653321 111233457999
Q ss_pred CccCcccccc--CCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHH
Q 040898 233 GYMAPESLQT--ETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQM 310 (337)
Q Consensus 233 ~~~~PE~~~~--~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (337)
.|+|||++.+ ..++.++||||||+++|+|++|..||..... ......... ...... ........
T Consensus 239 ~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~~~~----~~~~~~-------~~~~~~~~ 304 (345)
T 3hko_A 239 YFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVND---ADTISQVLN----KKLCFE-------NPNYNVLS 304 (345)
T ss_dssp GGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHH----CCCCTT-------SGGGGGSC
T ss_pred cccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCh---HHHHHHHHh----cccccC-------CcccccCC
Confidence 9999999975 6688999999999999999999999865322 111111111 111100 00111223
Q ss_pred HHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 311 LLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 311 ~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
..+.+|+.+||+.||.+|||+.++++|
T Consensus 305 ~~~~~li~~~l~~~p~~Rps~~~~l~h 331 (345)
T 3hko_A 305 PLARDLLSNLLNRNVDERFDAMRALQH 331 (345)
T ss_dssp HHHHHHHHHHSCSCTTTSCCHHHHHHS
T ss_pred HHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 458999999999999999999999987
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=324.00 Aligned_cols=260 Identities=23% Similarity=0.363 Sum_probs=205.8
Q ss_pred ccccccccceeccCcceEEEEeEEecC---CCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHh
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPG---SNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQ 115 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~ 115 (337)
..++|++.+.||+|+||.||++.+... .+++.||+|.+........ ...+.+|+.+++.
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~------------------~~~~~~E~~~l~~ 106 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM------------------QADFQREAALMAE 106 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHH------------------HHHHHHHHHHHHT
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHH------------------HHHHHHHHHHHHh
Confidence 678899999999999999999988632 3568999999875533211 1568889999999
Q ss_pred cCCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCC--------------------cccCChHHHHHHHHHHHHH
Q 040898 116 TRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQG--------------------RRELDWPARHRIARGIASG 175 (337)
Q Consensus 116 l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--------------------~~~~~~~~~~~i~~~i~~~ 175 (337)
++||||+++++++.+++..++||||+++++|.+++...... ...+++..++.++.||+.|
T Consensus 107 l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~ 186 (343)
T 1luf_A 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAG 186 (343)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHH
T ss_pred CCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999999999763221 2568999999999999999
Q ss_pred HHHHhhCCCCCeEecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhh
Q 040898 176 LEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFG 255 (337)
Q Consensus 176 l~~l~~~h~~gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG 255 (337)
|.|| |++|++|+||+|+||+++.++.++|+|||++................+++.|+|||.+.+..++.++|+||||
T Consensus 187 l~~L---H~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG 263 (343)
T 1luf_A 187 MAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYG 263 (343)
T ss_dssp HHHH---HHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred HHHH---HhCCeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHH
Confidence 9999 6679999999999999999999999999998765433322223345678899999999988899999999999
Q ss_pred HHHHHHHh-CCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhh
Q 040898 256 VLLAVLVM-GKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDV 334 (337)
Q Consensus 256 ~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el 334 (337)
+++|+|++ |..||..... ......+.. .... ..+...+..+.+++.+||+.||++|||+.++
T Consensus 264 ~il~el~t~g~~p~~~~~~----~~~~~~~~~---~~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~ 326 (343)
T 1luf_A 264 VVLWEIFSYGLQPYYGMAH----EEVIYYVRD---GNIL----------ACPENCPLELYNLMRLCWSKLPADRPSFCSI 326 (343)
T ss_dssp HHHHHHHTTTCCTTTTSCH----HHHHHHHHT---TCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHhcCCCcCCCCCh----HHHHHHHhC---CCcC----------CCCCCCCHHHHHHHHHHcccCcccCCCHHHH
Confidence 99999999 9999865321 122221111 1110 0111223458999999999999999999999
Q ss_pred hc
Q 040898 335 RS 336 (337)
Q Consensus 335 l~ 336 (337)
++
T Consensus 327 ~~ 328 (343)
T 1luf_A 327 HR 328 (343)
T ss_dssp HH
T ss_pred HH
Confidence 86
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=316.19 Aligned_cols=253 Identities=28% Similarity=0.446 Sum_probs=206.1
Q ss_pred cccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC
Q 040898 38 KKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR 117 (337)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 117 (337)
...++|++.+.||+|+||.||++.+.. +++.||+|.+........ ...+.+|+.+++.++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~------------------~~~~~~e~~~l~~l~ 78 (303)
T 3a7i_A 19 DPEELFTKLEKIGKGSFGEVFKGIDNR--TQKVVAIKIIDLEEAEDE------------------IEDIQQEITVLSQCD 78 (303)
T ss_dssp CGGGTEEEEEEEEECSSSEEEEEEETT--TCCEEEEEEEETTTCSTT------------------HHHHHHHHHHHHHCC
T ss_pred ChHHHHHHhhhhcccCCeEEEEEEECC--CCcEEEEEEecccccHHH------------------HHHHHHHHHHHHhCC
Confidence 466779999999999999999998865 899999999865543221 156788999999999
Q ss_pred CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCce
Q 040898 118 HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANV 197 (337)
Q Consensus 118 hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ni 197 (337)
||||+++++++.++...++||||+++++|.+++. ...+++..++.++.|++.||.+| |+.|++|+||+|+||
T Consensus 79 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~Ni 150 (303)
T 3a7i_A 79 SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYL---HSEKKIHRDIKAANV 150 (303)
T ss_dssp CTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGE
T ss_pred CCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHH---HHCCCccCCCChheE
Confidence 9999999999999999999999999999999983 34689999999999999999999 667999999999999
Q ss_pred eecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchh
Q 040898 198 LIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEE 277 (337)
Q Consensus 198 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~ 277 (337)
+++.++.++|+|||.+........ ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||.....
T Consensus 151 l~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---- 224 (303)
T 3a7i_A 151 LLSEHGEVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP---- 224 (303)
T ss_dssp EECTTSCEEECCCTTCEECBTTBC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----
T ss_pred EECCCCCEEEeecccceecCcccc--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH----
Confidence 999999999999999877544322 12345689999999999998899999999999999999999999865321
Q ss_pred hhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 278 MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
......+... ..+. .....+..+.+++.+||+.||++|||+.++++|
T Consensus 225 ~~~~~~~~~~---~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 225 MKVLFLIPKN---NPPT----------LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp HHHHHHHHHS---CCCC----------CCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred HHHHHHhhcC---CCCC----------CccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 1111111111 1100 011122348899999999999999999999986
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=340.50 Aligned_cols=254 Identities=24% Similarity=0.319 Sum_probs=196.9
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++++.||+|+||.||++.+.. +++.||+|++......... ....+.+|+.+++.++|
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~----------------~~~~~~~e~~~l~~l~h 207 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKA--TGRYYAMKILKKEVIVAKD----------------EVAHTLTENRVLQNSRH 207 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEEHHHHC-----------------------------CCCCCSC
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcC--CCCEEEEEEEEhhhhhhhH----------------HHHHHHHHHHHHHhCCC
Confidence 45679999999999999999999876 8999999998643221111 11466789999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCC-CCeEecCCCCCce
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHR-PRLIHRDIKPANV 197 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~-~gi~h~di~~~ni 197 (337)
|||+++++++.+.+..++||||+++++|.+++.. ...+++..+..++.||+.||.|| |+ .|++|+||||+||
T Consensus 208 ~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~L---H~~~giiHrDlkp~NI 280 (446)
T 4ejn_A 208 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYL---HSEKNVVYRDLKLENL 280 (446)
T ss_dssp TTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHH---HHHTCCCCCCCCGGGE
T ss_pred CeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---hhcCCEEECCCCHHHE
Confidence 9999999999999999999999999999999854 34689999999999999999999 54 7999999999999
Q ss_pred eecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchh
Q 040898 198 LIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEE 277 (337)
Q Consensus 198 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~ 277 (337)
+++.++.++|+|||++........ ......||+.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 281 ll~~~~~~kl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---- 354 (446)
T 4ejn_A 281 MLDKDGHIKITDFGLCKEGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---- 354 (446)
T ss_dssp EECSSSCEEECCCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----
T ss_pred EECCCCCEEEccCCCceeccCCCc--ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH----
Confidence 999999999999999875433221 22346799999999999999999999999999999999999999864321
Q ss_pred hhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCC-----ChhhhhcC
Q 040898 278 MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERP-----SSKDVRSM 337 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 337 (337)
......+. ...... +......+.+|+.+||+.||++|| |+.|+++|
T Consensus 355 ~~~~~~i~---~~~~~~-----------p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 355 EKLFELIL---MEEIRF-----------PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp HHHHHHHH---HCCCCC-----------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHHHHHH---hCCCCC-----------CccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 11211111 111110 011224488999999999999999 99999987
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=322.43 Aligned_cols=267 Identities=21% Similarity=0.324 Sum_probs=207.8
Q ss_pred cccccccccccccccceeccCcceEEEEeEEec-----CCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhH
Q 040898 32 QDLAFLKKEDCFDSLKKIGSGGWGEVFYKAELP-----GSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAI 106 (337)
Q Consensus 32 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 106 (337)
+...+.-..++|++.+.||+|+||.||++.+.. ..++..||+|++........ ...+
T Consensus 26 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~------------------~~~~ 87 (334)
T 2pvf_A 26 EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD------------------LSDL 87 (334)
T ss_dssp CCTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHH------------------HHHH
T ss_pred CCccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHH------------------HHHH
Confidence 344444477899999999999999999998752 23678899999875532211 1567
Q ss_pred HHHHHHHHhc-CCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCC------------cccCChHHHHHHHHHHH
Q 040898 107 RSEIITANQT-RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQG------------RRELDWPARHRIARGIA 173 (337)
Q Consensus 107 ~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------------~~~~~~~~~~~i~~~i~ 173 (337)
.+|+.+++.+ +||||+++++++.+++..++||||+++++|.+++...... ...+++..++.++.|++
T Consensus 88 ~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~ 167 (334)
T 2pvf_A 88 VSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLA 167 (334)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHH
Confidence 8899999999 9999999999999999999999999999999999653221 23488899999999999
Q ss_pred HHHHHHhhCCCCCeEecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchh
Q 040898 174 SGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYS 253 (337)
Q Consensus 174 ~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Diws 253 (337)
.||.|| |+.|++|+||+|+||+++.++.++|+|||++................+++.|+|||++.+..++.++||||
T Consensus 168 ~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 244 (334)
T 2pvf_A 168 RGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 244 (334)
T ss_dssp HHHHHH---HHTTEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHH
T ss_pred HHHHHH---HhCCeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHH
Confidence 999999 66799999999999999999999999999998766544333333445778899999998888999999999
Q ss_pred hhHHHHHHHh-CCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChh
Q 040898 254 FGVLLAVLVM-GKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSK 332 (337)
Q Consensus 254 lG~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ 332 (337)
||+++|+|++ |..||.... .......+........ +......+.+++.+||+.||++|||+.
T Consensus 245 lG~il~ellt~g~~p~~~~~----~~~~~~~~~~~~~~~~-------------~~~~~~~l~~li~~~l~~dp~~Rps~~ 307 (334)
T 2pvf_A 245 FGVLMWEIFTLGGSPYPGIP----VEELFKLLKEGHRMDK-------------PANCTNELYMMMRDCWHAVPSQRPTFK 307 (334)
T ss_dssp HHHHHHHHHTTSCCSSTTCC----HHHHHHHHHHTCCCCC-------------CTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHHHHHHHHhCCCCCcCcCC----HHHHHHHHhcCCCCCC-------------CccCCHHHHHHHHHHccCChhhCcCHH
Confidence 9999999999 999986532 1222222221111110 112234488999999999999999999
Q ss_pred hhhc
Q 040898 333 DVRS 336 (337)
Q Consensus 333 ell~ 336 (337)
++++
T Consensus 308 ell~ 311 (334)
T 2pvf_A 308 QLVE 311 (334)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9986
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=310.83 Aligned_cols=259 Identities=23% Similarity=0.362 Sum_probs=203.5
Q ss_pred ccccccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHH
Q 040898 33 DLAFLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIIT 112 (337)
Q Consensus 33 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 112 (337)
...+......|++.+.||+|+||.||++.+.. ++..||+|.+......... ...+.+|+.+
T Consensus 18 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~~va~k~~~~~~~~~~~-----------------~~~~~~e~~~ 78 (290)
T 1t4h_A 18 AVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTE--TTVEVAWCELQDRKLTKSE-----------------RQRFKEEAEM 78 (290)
T ss_dssp CCEECTTSCEEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEEGGGSCHHH-----------------HHHHHHHHHH
T ss_pred hhhcccCceeEEeeeeccCCCCeEEEEeEecC--CceEEEEEEecchhhCHHH-----------------HHHHHHHHHH
Confidence 33444566779999999999999999998876 8999999998755432221 1578889999
Q ss_pred HHhcCCCCcccceeEEEc----CCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCC--
Q 040898 113 ANQTRHRNILPLLAHMVR----PNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPR-- 186 (337)
Q Consensus 113 l~~l~hpniv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~g-- 186 (337)
++.++||||+++++++.. ....++||||+++++|.+++.. ...+++..++.++.|++.||.|| |+.|
T Consensus 79 l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~l---H~~~~~ 151 (290)
T 1t4h_A 79 LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFL---HTRTPP 151 (290)
T ss_dssp HTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HTSSSC
T ss_pred HHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHH---HcCCCC
Confidence 999999999999998865 4568999999999999999954 34588999999999999999999 6667
Q ss_pred eEecCCCCCceeec-CCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCC
Q 040898 187 LIHRDIKPANVLID-DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGK 265 (337)
Q Consensus 187 i~h~di~~~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~ 265 (337)
++|+||+|+||+++ .++.++|+|||++........ ....+++.|+|||.+.+ .++.++|+||||+++|+|++|.
T Consensus 152 i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~ 226 (290)
T 1t4h_A 152 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA----KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSE 226 (290)
T ss_dssp CCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTSB----EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSS
T ss_pred EEECCCCHHHEEEECCCCCEEEeeCCCccccccccc----ccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCC
Confidence 99999999999998 789999999999876544322 23468999999998875 4899999999999999999999
Q ss_pred CCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 266 FPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 266 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.||..... .... .........+. ... ......+.+++.+||+.||++|||+.++++|
T Consensus 227 ~pf~~~~~---~~~~---~~~~~~~~~~~-~~~--------~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 227 YPYSECQN---AAQI---YRRVTSGVKPA-SFD--------KVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp CTTTTCSS---HHHH---HHHHTTTCCCG-GGG--------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCCCcCc---HHHH---HHHHhccCCcc-ccC--------CCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 99965322 1111 11111111111 111 1112348999999999999999999999987
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=317.69 Aligned_cols=258 Identities=23% Similarity=0.362 Sum_probs=204.8
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++.+.||+|+||.||++.+.. +++.||+|.+......... .+.+.+|+.++++++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~-----------------~~~~~~e~~~l~~l~h 64 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKS--DGKILVWKELDYGSMTEAE-----------------KQMLVSEVNLLRELKH 64 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETT--TCCEEEEEEEECTTCCHHH-----------------HHHHHHHHHHHHHCCC
T ss_pred chhheeeehhccCCCCcEEEEEEECC--CCcEEEEEEEEcccCCHHH-----------------HHHHHHHHHHHHhcCC
Confidence 46789999999999999999998876 8999999999765432221 1578889999999999
Q ss_pred CCcccceeEEE--cCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCC-----eEecC
Q 040898 119 RNILPLLAHMV--RPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPR-----LIHRD 191 (337)
Q Consensus 119 pniv~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~g-----i~h~d 191 (337)
|||+++++++. .+...++||||+++++|.+++.........+++..++.++.|++.||.||| +.| ++|+|
T Consensus 65 ~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~d 141 (279)
T 2w5a_A 65 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRD 141 (279)
T ss_dssp TTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCC
T ss_pred CCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEec
Confidence 99999999874 467899999999999999999775555666999999999999999999994 456 99999
Q ss_pred CCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCC
Q 040898 192 IKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDF 271 (337)
Q Consensus 192 i~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~ 271 (337)
|+|+||+++.++.++|+|||.+......... .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||...
T Consensus 142 l~p~NIl~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 219 (279)
T 2w5a_A 142 LKPANVFLDGKQNVKLGDFGLARILNHDTSF--AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF 219 (279)
T ss_dssp CSGGGEEECSSSCEEECCCCHHHHC---CHH--HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cchhhEEEcCCCCEEEecCchheeecccccc--ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCccc
Confidence 9999999999999999999998775433211 12346899999999999888999999999999999999999998654
Q ss_pred CCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 272 FGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
. .......+........ +...+..+.+++.+||+.||++|||+.++++|
T Consensus 220 ~----~~~~~~~i~~~~~~~~-------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 268 (279)
T 2w5a_A 220 S----QKELAGKIREGKFRRI-------------PYRYSDELNEIITRMLNLKDYHRPSVEEILEN 268 (279)
T ss_dssp S----HHHHHHHHHHTCCCCC-------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred C----HHHHHHHHhhcccccC-------------CcccCHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 2 1222222222111111 11223458999999999999999999999986
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=331.84 Aligned_cols=210 Identities=24% Similarity=0.316 Sum_probs=172.0
Q ss_pred cccccccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHH
Q 040898 32 QDLAFLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEII 111 (337)
Q Consensus 32 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~ 111 (337)
|.+..+...++|++++.||+|+||.||++.+.. +++.||||++......... ...+.+|+.
T Consensus 17 Q~~~~~~i~~~y~~~~~lG~G~~g~V~~a~~~~--~~~~vAiK~~~~~~~~~~~-----------------~~~~~~E~~ 77 (432)
T 3n9x_A 17 QGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKN--TEKNVAIKKVNRMFEDLID-----------------CKRILREIT 77 (432)
T ss_dssp TCGGGCCCCTTEEEEEEEEEETTEEEEEEEETT--TTEEEEEEEECSTTTSHHH-----------------HHHHHHHHH
T ss_pred cCCCcceecCCEEEEEEEeecCCEEEEEEEECC--CCcEEEEEEeCchhcChHH-----------------HHHHHHHHH
Confidence 345566678899999999999999999999876 8999999999654322211 157889999
Q ss_pred HHHhcCCCCcccceeEEEcC-----CeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCC
Q 040898 112 TANQTRHRNILPLLAHMVRP-----NCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPR 186 (337)
Q Consensus 112 ~l~~l~hpniv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~g 186 (337)
+++.++||||+++++++... ...|+||||+++ +|.+++. ....+++..+..++.||+.||.|| |+.|
T Consensus 78 ~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~----~~~~l~~~~~~~i~~qil~aL~~L---H~~g 149 (432)
T 3n9x_A 78 ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFK----TPIFLTEEHIKTILYNLLLGENFI---HESG 149 (432)
T ss_dssp HHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCSE-EHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHH---HHTT
T ss_pred HHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCCc-CHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHH---HHCC
Confidence 99999999999999998766 578999999965 9999983 455699999999999999999999 6679
Q ss_pred eEecCCCCCceeecCCCCeEEecccCccccCCCCce--------------------eeeecccCCCCccCcccc-ccCCC
Q 040898 187 LIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQ--------------------ITVKCMVGTMGYMAPESL-QTETI 245 (337)
Q Consensus 187 i~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~--------------------~~~~~~~~~~~~~~PE~~-~~~~~ 245 (337)
++|+||||+||+++.++.++|+|||++......... .......+|+.|+|||++ .+..+
T Consensus 150 ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~ 229 (432)
T 3n9x_A 150 IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENY 229 (432)
T ss_dssp EECCCCCGGGEEECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCC
T ss_pred CCCCCCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCC
Confidence 999999999999999999999999999876533211 122456789999999986 56678
Q ss_pred CCcccchhhhHHHHHHHhCCCCC
Q 040898 246 SDKCDIYSFGVLLAVLVMGKFPV 268 (337)
Q Consensus 246 ~~~~DiwslG~i~~~ll~g~~pf 268 (337)
+.++|||||||++|+|++|..||
T Consensus 230 ~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 230 TKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp CTHHHHHHHHHHHHHHHTTCTTT
T ss_pred CcccccchHHHHHHHHHhccccc
Confidence 99999999999999999865554
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=314.12 Aligned_cols=258 Identities=23% Similarity=0.369 Sum_probs=193.3
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++.+.||+|+||.||++.+.. +++.||+|++......... ...+.++...++.++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~h 65 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVP--SGQIMAVKRIRATVNSQEQ-----------------KRLLMDLDISMRTVDC 65 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT--TTEEEEEEEEC---CHHHH-----------------HHHHHHHHHHHTTCCC
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecC--CCeEEEEEEeecccCcHHH-----------------HHHHHHHHHHHHhCCC
Confidence 45789999999999999999999876 8999999998654332211 0344555666888999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCC-CeEecCCCCCce
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRP-RLIHRDIKPANV 197 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~-gi~h~di~~~ni 197 (337)
|||+++++++.+++..++||||+++ +|.+++......+..+++..++.++.|++.||.|| |++ |++|+||+|+||
T Consensus 66 ~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~~i~H~dlkp~Ni 141 (290)
T 3fme_A 66 PFTVTFYGALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL---HSKLSVIHRDVKPSNV 141 (290)
T ss_dssp TTBCCEEEEEECSSSEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH---HHHSCCCCCCCSGGGC
T ss_pred CeEEEEeeeeeccCCEEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---hhcCCeecCCCCHHHE
Confidence 9999999999999999999999975 99888876666677899999999999999999999 666 999999999999
Q ss_pred eecCCCCeEEecccCccccCCCCceeeeecccCCCCccCcccc----ccCCCCCcccchhhhHHHHHHHhCCCCCCCCCC
Q 040898 198 LIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESL----QTETISDKCDIYSFGVLLAVLVMGKFPVDDFFG 273 (337)
Q Consensus 198 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~----~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~ 273 (337)
+++.++.++|+|||++........ .....+++.|+|||.+ .+..++.++|+||||+++|+|++|..||.....
T Consensus 142 l~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 218 (290)
T 3fme_A 142 LINALGQVKMCDFGISGYLVDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT 218 (290)
T ss_dssp EECTTCCEEBCCC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC
T ss_pred EECCCCCEEEeecCCccccccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc
Confidence 999999999999999876544322 2234689999999996 455688899999999999999999999965322
Q ss_pred CchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 274 HTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
........... ..+... ....+..+.+++.+||+.||++|||+.++++|
T Consensus 219 --~~~~~~~~~~~----~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 219 --PFQQLKQVVEE----PSPQLP---------ADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp --HHHHHHHHHHS----CCCCCC---------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred --hHHHHHHHhcc----CCCCcc---------cccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 11122221111 111100 01123448999999999999999999999987
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=314.93 Aligned_cols=261 Identities=26% Similarity=0.371 Sum_probs=197.5
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++.+.||+|+||.||++.+.. +++.||+|++.......... ...+.+|+.+++.++|
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~----------------~~~~~~E~~~l~~l~h 91 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLL--DGVPVALKKVQIFDLMDAKA----------------RADCIKEIDLLKQLNH 91 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETT--TCCEEEEEEECTTSSCCHHH----------------HHHHHHHHHHHHTCCC
T ss_pred cccceEEEEeecCCCCceEEEEEEcC--CCceEEEEeeehhhccCHHH----------------HHHHHHHHHHHHhCCC
Confidence 55679999999999999999998876 89999999987543322211 1567889999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++++..++..++||||+++++|.+++.........+++..++.++.|++.||.+| |+.|++|+||+|+||+
T Consensus 92 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~L---H~~~i~H~dl~p~NIl 168 (310)
T 2wqm_A 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM---HSRRVMHRDIKPANVF 168 (310)
T ss_dssp TTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEE
T ss_pred CCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHH---hhCCeeCCCCcHHHEE
Confidence 9999999999999999999999999999999976655667799999999999999999999 6679999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhh
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEM 278 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~ 278 (337)
++.++.++|+|||++......... .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||...... ..
T Consensus 169 ~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~ 244 (310)
T 2wqm_A 169 ITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LY 244 (310)
T ss_dssp ECTTSCEEECCC--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC--HH
T ss_pred EcCCCCEEEEeccceeeecCCCcc--ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh--HH
Confidence 999999999999998765433211 12346899999999999988999999999999999999999998643221 11
Q ss_pred hHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 279 DMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
.....+......... ....+..+.+++.+||+.||++|||+.++++
T Consensus 245 ~~~~~~~~~~~~~~~------------~~~~~~~l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 245 SLCKKIEQCDYPPLP------------SDHYSEELRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp HHHHHHHTTCSCCCC------------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhhcccCCCCc------------ccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 222222111111100 0122345889999999999999999999986
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=325.09 Aligned_cols=272 Identities=23% Similarity=0.297 Sum_probs=197.8
Q ss_pred cccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC
Q 040898 38 KKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR 117 (337)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 117 (337)
...++|++.+.||+|+||.||++.+.. +|+.||+|++............ ...+.+|+.+++.++
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~--------------~~~~~~E~~~l~~l~ 70 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKN--TNQIVAIKKIKLGHRSEAKDGI--------------NRTALREIKLLQELS 70 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSS--CCSEEEEEEC--------------------------CTHHHHHHHHHHHCC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECC--CCcEEEEEEEecCCcchhhhhh--------------hHHHHHHHHHHhhCC
Confidence 456789999999999999999998876 8999999998654332211100 145778999999999
Q ss_pred CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCce
Q 040898 118 HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANV 197 (337)
Q Consensus 118 hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ni 197 (337)
||||+++++++.+....++||||+++ +|.+++.. ....+++..++.++.|++.||.|| |+.|++|+||+|+||
T Consensus 71 h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dlkp~Ni 143 (346)
T 1ua2_A 71 HPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYL---HQHWILHRDLKPNNL 143 (346)
T ss_dssp CTTBCCEEEEECCTTCCEEEEECCSE-EHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGE
T ss_pred CCCCCeEEEEEeeCCceEEEEEcCCC-CHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHH---HHCCEECCCCCHHHE
Confidence 99999999999999999999999986 88888743 345688999999999999999999 667999999999999
Q ss_pred eecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCCCch
Q 040898 198 LIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTE-TISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTE 276 (337)
Q Consensus 198 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~ 276 (337)
+++.++.++|+|||++......... .....+|+.|+|||++.+. .++.++||||||+++|+|++|.+||.... .
T Consensus 144 l~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~---~ 218 (346)
T 1ua2_A 144 LLDENGVLKLADFGLAKSFGSPNRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS---D 218 (346)
T ss_dssp EECTTCCEEECCCGGGSTTTSCCCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS---H
T ss_pred EEcCCCCEEEEecccceeccCCccc--CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCC---H
Confidence 9999999999999999876433221 2345689999999999764 47889999999999999999999986532 2
Q ss_pred hhhHHHHHHhhhccCC---cch-hhhh----cccCC-----chHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 277 EMDMVKWMRNVIFSEN---PNR-AINS----KLLGN-----GYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~---~~~-~~~~----~~~~~-----~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
...+............ +.. .... ..... ........+.+|+.+||+.||++|||+.|+|+|
T Consensus 219 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 219 LDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp HHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 2222222211111000 000 0000 00000 012234568999999999999999999999987
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=334.20 Aligned_cols=273 Identities=19% Similarity=0.265 Sum_probs=189.2
Q ss_pred cccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC
Q 040898 38 KKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR 117 (337)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 117 (337)
...++|++++.||+|+||.||++.+.. +++.||||++......... ...+.+|+.+++.++
T Consensus 50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~--~~~~vaiK~i~~~~~~~~~-----------------~~~~~~E~~~l~~l~ 110 (458)
T 3rp9_A 50 QIPDRYEIRHLIGTGSYGHVCEAYDKL--EKRVVAIKKILRVFEDLID-----------------CKRILREIAILNRLN 110 (458)
T ss_dssp CSCTTEEECCC-------CEEEEEECC----CEEEEEEECSTTSSHHH-----------------HHHHHHHHHHHHHCC
T ss_pred ccCCCeEEeeEeeecCCeEEEEEEECC--CCcEEEEEEechhhcCHHH-----------------HHHHHHHHHHHHhCC
Confidence 456789999999999999999999876 8999999998654322211 157889999999999
Q ss_pred CCCcccceeEEEc-----CCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 040898 118 HRNILPLLAHMVR-----PNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDI 192 (337)
Q Consensus 118 hpniv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di 192 (337)
||||+++++++.. ...+|+||||+. ++|.+++. ....+++..+..++.||+.||.|| |+.|++||||
T Consensus 111 h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~l~~~~~~~~~~qi~~aL~~L---H~~~iiHrDl 182 (458)
T 3rp9_A 111 HDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLFR----TPVYLTELHIKTLLYNLLVGVKYV---HSAGILHRDL 182 (458)
T ss_dssp CTTBCCEEEECCCSCTTTCCCEEEEECCCS-EEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCC
T ss_pred CCCCCceEEEEecCCcccCceEEEEEeccc-cchhhhcc----cCCCCCHHHHHHHHHHHHHHHHHH---HhCCcCCCCC
Confidence 9999999999843 357899999985 58998883 455699999999999999999999 6679999999
Q ss_pred CCCceeecCCCCeEEecccCccccCCCCce-------------------------eeeecccCCCCccCcccc-ccCCCC
Q 040898 193 KPANVLIDDDMEARISDFGHGKLMPDGHAQ-------------------------ITVKCMVGTMGYMAPESL-QTETIS 246 (337)
Q Consensus 193 ~~~nil~~~~~~~~l~dfg~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~PE~~-~~~~~~ 246 (337)
||+||+++.++.++|+|||++......... .......+|+.|+|||++ .+..++
T Consensus 183 Kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ 262 (458)
T 3rp9_A 183 KPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYT 262 (458)
T ss_dssp CGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCC
T ss_pred ChhhEEECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCC
Confidence 999999999999999999999876422110 122345789999999986 566799
Q ss_pred CcccchhhhHHHHHHHh-----------CCCCCCCCCCC----------------chhhhHHHHHHhhhccCCcchh---
Q 040898 247 DKCDIYSFGVLLAVLVM-----------GKFPVDDFFGH----------------TEEMDMVKWMRNVIFSENPNRA--- 296 (337)
Q Consensus 247 ~~~DiwslG~i~~~ll~-----------g~~pf~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~--- 296 (337)
.++|||||||++|+|++ |.++|.+.... ....+....+............
T Consensus 263 ~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~ 342 (458)
T 3rp9_A 263 EAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEAL 342 (458)
T ss_dssp THHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTS
T ss_pred cHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhc
Confidence 99999999999999999 56666432110 0001111111111111110000
Q ss_pred --------------hhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 297 --------------INSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 297 --------------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
..........+.....+.+|+.+||+.||++|||++|+|+|
T Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H 397 (458)
T 3rp9_A 343 EKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAH 397 (458)
T ss_dssp SCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00000011122335568999999999999999999999987
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=317.46 Aligned_cols=264 Identities=23% Similarity=0.340 Sum_probs=197.5
Q ss_pred cccccccc-ceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc-
Q 040898 39 KEDCFDSL-KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT- 116 (337)
Q Consensus 39 ~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l- 116 (337)
-.++|++. +.||+|+||.||++.+.. +++.||+|++........ ..+.+|+.++.++
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~-------------------~~~~~E~~~l~~~~ 68 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLI--TSQEYAVKIIEKQPGHIR-------------------SRVFREVEMLYQCQ 68 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSS--SCCEEEEEEEECCSSCCH-------------------HHHHHHHHHHHHTC
T ss_pred cceeEEecCceecCCceEEEEEEEEcC--CCcEEEEEEEeeCcchhH-------------------HHHHHHHHHHHHhc
Confidence 35679885 789999999999998876 899999999865532211 4677899999885
Q ss_pred CCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 040898 117 RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPAN 196 (337)
Q Consensus 117 ~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~n 196 (337)
+||||+++++++.+++..++||||+++++|.+++.. ...+++..++.++.|++.||.|| |++|++|+||+|+|
T Consensus 69 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~dlkp~N 141 (316)
T 2ac3_A 69 GHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFL---HNKGIAHRDLKPEN 141 (316)
T ss_dssp CCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGG
T ss_pred CCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHH---HhCCceeCCCCHHH
Confidence 799999999999999999999999999999999954 34689999999999999999999 66799999999999
Q ss_pred eeecCCCC---eEEecccCccccCCCCc-----eeeeecccCCCCccCcccccc-----CCCCCcccchhhhHHHHHHHh
Q 040898 197 VLIDDDME---ARISDFGHGKLMPDGHA-----QITVKCMVGTMGYMAPESLQT-----ETISDKCDIYSFGVLLAVLVM 263 (337)
Q Consensus 197 il~~~~~~---~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~~~~PE~~~~-----~~~~~~~DiwslG~i~~~ll~ 263 (337)
|+++.++. ++|+|||++........ ........+|+.|+|||++.+ ..++.++||||||+++|+|++
T Consensus 142 il~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~ 221 (316)
T 2ac3_A 142 ILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLS 221 (316)
T ss_dssp EEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHH
T ss_pred EEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHH
Confidence 99998776 99999999876542211 111123458999999999875 457889999999999999999
Q ss_pred CCCCCCCCCCCchhhh--------HHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhh
Q 040898 264 GKFPVDDFFGHTEEMD--------MVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVR 335 (337)
Q Consensus 264 g~~pf~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 335 (337)
|..||........... ................. ......+..+.+|+.+||+.||++|||+.|++
T Consensus 222 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 294 (316)
T 2ac3_A 222 GYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPD-------KDWAHISCAAKDLISKLLVRDAKQRLSAAQVL 294 (316)
T ss_dssp SSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCH-------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred CCCCCcccccccccccccccchhHHHHHHHHHhccCcccCc-------hhcccCCHHHHHHHHHHhhCChhhCCCHHHHh
Confidence 9999976433221100 01111111111111000 00011234589999999999999999999999
Q ss_pred cC
Q 040898 336 SM 337 (337)
Q Consensus 336 ~~ 337 (337)
+|
T Consensus 295 ~h 296 (316)
T 2ac3_A 295 QH 296 (316)
T ss_dssp HS
T ss_pred cC
Confidence 87
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=329.16 Aligned_cols=254 Identities=24% Similarity=0.296 Sum_probs=195.7
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHH-HHhcC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIIT-ANQTR 117 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-l~~l~ 117 (337)
..++|++++.||+|+||.||++.+.. +++.||+|++........... ..+.+|..+ ++.++
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~--~~~~~AiK~~~~~~~~~~~~~----------------~~~~~e~~~ll~~~~ 97 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKA--EEVFYAVKVLQKKAILKKKEE----------------KHIMSERNVLLKNVK 97 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETT--TCCEEEEEEEEGGGBC-----------------------------CCBCCCC
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcC--CCCEEEEEEEEHHHhhhhHHH----------------HHHHHHHHHHHHhCC
Confidence 55789999999999999999999876 899999999976543322111 345556665 56789
Q ss_pred CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCce
Q 040898 118 HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANV 197 (337)
Q Consensus 118 hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ni 197 (337)
||||+++++++.+.+..|+||||+++|+|.+++.. ...+++..++.++.||+.||.|| |++|++|+||||+||
T Consensus 98 hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~L---H~~givHrDlkp~NI 170 (373)
T 2r5t_A 98 HPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYL---HSLNIVYRDLKPENI 170 (373)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGE
T ss_pred CCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCceecCCCHHHE
Confidence 99999999999999999999999999999999854 34588899999999999999999 667999999999999
Q ss_pred eecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchh
Q 040898 198 LIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEE 277 (337)
Q Consensus 198 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~ 277 (337)
+++.++.++|+|||++........ ......||+.|+|||++.+..++.++|+||||+++|+|++|..||.... .
T Consensus 171 ll~~~g~ikL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~----~ 244 (373)
T 2r5t_A 171 LLDSQGHIVLTDFGLCKENIEHNS--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN----T 244 (373)
T ss_dssp EECTTSCEEECCCCBCGGGBCCCC--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB----H
T ss_pred EECCCCCEEEeeCccccccccCCC--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC----H
Confidence 999999999999999875332211 2234579999999999999999999999999999999999999986421 1
Q ss_pred hhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCCh----hhhhcC
Q 040898 278 MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSS----KDVRSM 337 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~----~ell~~ 337 (337)
......+ ....... ++.....+.+|+.+||+.||++||++ .++++|
T Consensus 245 ~~~~~~i---~~~~~~~-----------~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h 294 (373)
T 2r5t_A 245 AEMYDNI---LNKPLQL-----------KPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSH 294 (373)
T ss_dssp HHHHHHH---HHSCCCC-----------CSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTS
T ss_pred HHHHHHH---HhcccCC-----------CCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCC
Confidence 1222111 1111100 01122348899999999999999997 467665
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=322.76 Aligned_cols=264 Identities=21% Similarity=0.296 Sum_probs=206.5
Q ss_pred cccccccccccceeccCcceEEEEeEEecC---CCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHH
Q 040898 36 FLKKEDCFDSLKKIGSGGWGEVFYKAELPG---SNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIIT 112 (337)
Q Consensus 36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 112 (337)
+.-..++|++.+.||+|+||.||++.+... .....||+|.+......... ..+.+|+.+
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~------------------~~~~~E~~~ 102 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK------------------EALMSELKI 102 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHH------------------HHHHHHHHH
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHH------------------HHHHHHHHH
Confidence 333567899999999999999999988641 12347999998655432211 567889999
Q ss_pred HHhc-CCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcC----------CcccCChHHHHHHHHHHHHHHHHHhh
Q 040898 113 ANQT-RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQ----------GRRELDWPARHRIARGIASGLEYLHM 181 (337)
Q Consensus 113 l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----------~~~~~~~~~~~~i~~~i~~~l~~l~~ 181 (337)
++.+ +||||+++++++.+++..++||||+++++|.+++..... ....+++..++.++.|++.||.||
T Consensus 103 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l-- 180 (333)
T 2i1m_A 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFL-- 180 (333)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHH--
T ss_pred HHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHH--
Confidence 9999 899999999999999999999999999999999965321 134578999999999999999999
Q ss_pred CCCCCeEecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHH
Q 040898 182 CHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVL 261 (337)
Q Consensus 182 ~h~~gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~l 261 (337)
|++|++|+||+|+||+++.++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|
T Consensus 181 -H~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 259 (333)
T 2i1m_A 181 -ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 259 (333)
T ss_dssp -HHTTEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred -hcCCcccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHH
Confidence 6679999999999999999999999999999865443333333344567889999999988899999999999999999
Q ss_pred Hh-CCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 262 VM-GKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 262 l~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
++ |..||........ ............. +...+..+.+++.+||+.||.+|||+.++++
T Consensus 260 ~t~g~~p~~~~~~~~~---~~~~~~~~~~~~~-------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 260 FSLGLNPYPGILVNSK---FYKLVKDGYQMAQ-------------PAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp TTTSCCSSTTCCSSHH---HHHHHHHTCCCCC-------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HcCCCCCCcccchhHH---HHHHHhcCCCCCC-------------CCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 99 8999876433222 1222221111110 0111234889999999999999999999986
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=312.45 Aligned_cols=258 Identities=20% Similarity=0.221 Sum_probs=205.5
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc-C
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT-R 117 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~ 117 (337)
..++|++.+.||+|+||.||++.+.. +++.||+|++...... ..+.+|+..+..+ .
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~---------------------~~~~~e~~~~~~l~~ 64 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLL--NNQQVAIKFEPRRSDA---------------------PQLRDEYRTYKLLAG 64 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETT--TTEEEEEEEEECCTTS---------------------CCHHHHHHHHHHTTT
T ss_pred cccceEEEEEEeecCCEEEEEEEECC--CCcEEEEEEeccCCcc---------------------HHHHHHHHHHHHHhc
Confidence 45679999999999999999999865 8999999988544321 3567799999999 8
Q ss_pred CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCce
Q 040898 118 HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANV 197 (337)
Q Consensus 118 hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ni 197 (337)
|||++++++++.++...++||||+ +++|.+++.. .+..+++..++.++.|++.||.|| |++|++|+||+|+||
T Consensus 65 ~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~Dlkp~NI 137 (298)
T 1csn_A 65 CTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSI---HEKSLVYRDIKPDNF 137 (298)
T ss_dssp CTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCCGGGE
T ss_pred CCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHE
Confidence 999999999999999999999999 8899999964 234589999999999999999999 778999999999999
Q ss_pred eecCCCC-----eEEecccCccccCCCCce-----eeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCC
Q 040898 198 LIDDDME-----ARISDFGHGKLMPDGHAQ-----ITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFP 267 (337)
Q Consensus 198 l~~~~~~-----~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~p 267 (337)
+++.++. ++|+|||++......... .......+|+.|+|||.+.+..++.++||||||+++|+|++|..|
T Consensus 138 l~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 217 (298)
T 1csn_A 138 LIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217 (298)
T ss_dssp EECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred EeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCC
Confidence 9987766 999999999876543221 112345699999999999999999999999999999999999999
Q ss_pred CCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 268 VDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 268 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
|.................... ....... .+..+..+.+++.+||+.||++|||+.++++
T Consensus 218 f~~~~~~~~~~~~~~~~~~~~-~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 218 WQGLKAATNKQKYERIGEKKQ-STPLREL---------CAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp TSSCCSCCHHHHHHHHHHHHH-HSCHHHH---------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred cchhhccccHHHHHHHHhhcc-CccHHHH---------HhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 987544333322222221111 1111000 0112345899999999999999999999875
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=316.11 Aligned_cols=252 Identities=26% Similarity=0.334 Sum_probs=203.8
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++.+.||+|+||.||++.+.. ++..||+|.+........ .....+.+|+.+++.++|
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~----------------~~~~~~~~e~~~l~~l~h 73 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQ--NKFIMALKVLFKSQLEKE----------------GVEHQLRREIEIQSHLRH 73 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT--TTEEEEEEEEEHHHHHHT----------------TCHHHHHHHHHHHHTCCC
T ss_pred hhhhceeeheecCCCCeEEEEEEEcC--CCcEEEEEEEcccccchH----------------HHHHHHHHHHHHHhcCCC
Confidence 34679999999999999999998865 889999999864321110 001467889999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++++.+.+..++||||+++++|.+++.. ...+++..++.++.|++.||.+| |+.|++|+||+|+||+
T Consensus 74 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~Nil 146 (284)
T 2vgo_A 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYC---HERKVIHRDIKPENLL 146 (284)
T ss_dssp TTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCSGGGEE
T ss_pred CCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCceecCCCHHHEE
Confidence 9999999999999999999999999999999854 34589999999999999999999 7789999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhh
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEM 278 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~ 278 (337)
++.++.++|+|||.+....... .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||..... .
T Consensus 147 ~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~ 218 (284)
T 2vgo_A 147 MGYKGELKIADFGWSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH----T 218 (284)
T ss_dssp ECTTCCEEECCCTTCEECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH----H
T ss_pred EcCCCCEEEecccccccCcccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH----h
Confidence 9999999999999987654322 1235689999999999998899999999999999999999999865321 1
Q ss_pred hHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 279 DMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.... ........ .++..+..+.+++.+||+.||++|||+.++++|
T Consensus 219 ~~~~---~~~~~~~~-----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 219 ETHR---RIVNVDLK-----------FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp HHHH---HHHTTCCC-----------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred HHHH---HHhccccC-----------CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 1111 11111110 011123448899999999999999999999987
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=315.18 Aligned_cols=251 Identities=22% Similarity=0.284 Sum_probs=200.4
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc-C
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT-R 117 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~ 117 (337)
-.++|++.+.||+|+||.||++.+.. +++.||+|.+.......... ..+.+|+..+..+ +
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~-----------------~~~~~e~~~~~~l~~ 69 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRL--DGCIYAIKRSKKPLAGSVDE-----------------QNALREVYAHAVLGQ 69 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEECCCTTSHHH-----------------HHHHHHHHHHHHSCS
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcC--CCceEEEEEecccccccHHH-----------------HHHHHHHHHHHHhCC
Confidence 35679999999999999999999876 89999999987654332211 4677899999998 9
Q ss_pred CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCce
Q 040898 118 HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANV 197 (337)
Q Consensus 118 hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ni 197 (337)
||||+++++++.+++..++||||+++++|.+++.........+++..++.++.||+.||.|| |++|++|+||+|+||
T Consensus 70 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~l---H~~~ivH~Dikp~NI 146 (289)
T 1x8b_A 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI---HSMSLVHMDIKPSNI 146 (289)
T ss_dssp CTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGE
T ss_pred CCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHH---HhCCEeecCCCHHHE
Confidence 99999999999999999999999999999999976544446689999999999999999999 667999999999999
Q ss_pred eecCC-------------------CCeEEecccCccccCCCCceeeeecccCCCCccCccccccC-CCCCcccchhhhHH
Q 040898 198 LIDDD-------------------MEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTE-TISDKCDIYSFGVL 257 (337)
Q Consensus 198 l~~~~-------------------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~i 257 (337)
+++.+ ..++|+|||.+....... ...+++.|+|||.+.+. .++.++||||||++
T Consensus 147 l~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~i 220 (289)
T 1x8b_A 147 FISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALT 220 (289)
T ss_dssp EEC--------------------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHH
T ss_pred EEcCCCCCcccccccccccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHH
Confidence 99844 479999999988765432 23589999999999765 55679999999999
Q ss_pred HHHHHhCCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 258 LAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 258 ~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
+|+|++|.+|+... ... ..+....... .+...+..+.+++.+||+.||++|||+.++++|
T Consensus 221 l~~l~~~~~~~~~~------~~~-~~~~~~~~~~-------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 221 VVCAAGAEPLPRNG------DQW-HEIRQGRLPR-------------IPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp HHHHTTCCCCCSSS------HHH-HHHHTTCCCC-------------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred HHHHhcCCCCCcch------hHH-HHHHcCCCCC-------------CCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 99999998876321 111 1111111110 011123458999999999999999999999987
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=317.93 Aligned_cols=248 Identities=20% Similarity=0.230 Sum_probs=192.1
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHh-cCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQ-TRHR 119 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~-l~hp 119 (337)
++|++.++||+|+||+||++.+.. +++.||||++.......... .....|+..+.. ..||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~-----------------~~~~~e~~~~~~~~~h~ 117 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKE--DGRLYAVKRSMSPFRGPKDR-----------------ARKLAEVGSHEKVGQHP 117 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETT--TSCEEEEEEESSSCCSHHHH-----------------HHHHHHHHHHHHHCCCT
T ss_pred hheeeeheeccCCCeEEEEEEECC--CCeEEEEEEecccccChHHH-----------------HHHHHHHHHHHHhcCCC
Confidence 679999999999999999999876 89999999886554332211 233445544444 4999
Q ss_pred CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceee
Q 040898 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI 199 (337)
Q Consensus 120 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~ 199 (337)
||+++++++.+++..++||||+ +++|.+++... +..+++..++.++.|++.||.|| |+.|++|+||||+||++
T Consensus 118 ~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dikp~NIll 190 (311)
T 3p1a_A 118 CCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHL---HSQGLVHLDVKPANIFL 190 (311)
T ss_dssp TBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEE
T ss_pred cEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHH---HHCCEecCCCCHHHEEE
Confidence 9999999999999999999999 56999888652 34699999999999999999999 66799999999999999
Q ss_pred cCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhh
Q 040898 200 DDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMD 279 (337)
Q Consensus 200 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~ 279 (337)
+.++.++|+|||++........ .....||+.|+|||++.+ .++.++||||||+++|+|++|..|+... ..
T Consensus 191 ~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~------~~ 260 (311)
T 3p1a_A 191 GPRGRCKLGDFGLLVELGTAGA---GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG------EG 260 (311)
T ss_dssp CGGGCEEECCCTTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH------HH
T ss_pred CCCCCEEEccceeeeecccCCC---CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc------cH
Confidence 9999999999999876644322 233568999999999876 6899999999999999999997665321 11
Q ss_pred HHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 280 MVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
. ........+. . ........+.+++.+||+.||++|||+.++++|
T Consensus 261 ~----~~~~~~~~~~-~--------~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 261 W----QQLRQGYLPP-E--------FTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp H----HHHTTTCCCH-H--------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred H----HHHhccCCCc-c--------cccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 1 1111111111 0 011223458999999999999999999999987
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=320.88 Aligned_cols=260 Identities=23% Similarity=0.331 Sum_probs=186.6
Q ss_pred cccccccccceeccCcceEEEEeEEecCCCC---ceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHH
Q 040898 38 KKEDCFDSLKKIGSGGWGEVFYKAELPGSNG---KMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITAN 114 (337)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~ 114 (337)
-..++|++.+.||+|+||.||++.+.. ++ ..||+|.+......... .+.+.+|+.+++
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~--~~~~~~~vavK~~~~~~~~~~~-----------------~~~~~~E~~~l~ 80 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQ--EDGSFVKVAVKMLKADIIASSD-----------------IEEFLREAACMK 80 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC---------CEEEEEEC------CHH-----------------HHHHHHHHHHHT
T ss_pred cChhHeEEeceecccCCeEEEEEEEcc--cCCcceeEEEEEecccccCHHH-----------------HHHHHHHHHHHH
Confidence 356789999999999999999998865 33 38999998654322211 157889999999
Q ss_pred hcCCCCcccceeEEEcCCee------EEEEEeccCCCHHHHHHHhcC--CcccCChHHHHHHHHHHHHHHHHHhhCCCCC
Q 040898 115 QTRHRNILPLLAHMVRPNCH------LLVYEFMKNGSLQDILYDVSQ--GRRELDWPARHRIARGIASGLEYLHMCHRPR 186 (337)
Q Consensus 115 ~l~hpniv~~~~~~~~~~~~------~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~g 186 (337)
+++||||+++++++...... ++|+||+++++|.+++..... ....+++..++.++.|++.||.|| |++|
T Consensus 81 ~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~L---H~~~ 157 (323)
T 3qup_A 81 EFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYL---SSRN 157 (323)
T ss_dssp TCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHH---HHTT
T ss_pred HCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHH---HcCC
Confidence 99999999999999877655 999999999999999965432 223589999999999999999999 6679
Q ss_pred eEecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CC
Q 040898 187 LIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GK 265 (337)
Q Consensus 187 i~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~ 265 (337)
++|+||||+||+++.++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |.
T Consensus 158 ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~ 237 (323)
T 3qup_A 158 FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQ 237 (323)
T ss_dssp CCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred cccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCC
Confidence 99999999999999999999999999987654433333334456788999999999889999999999999999999 89
Q ss_pred CCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 266 FPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 266 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
.||...... .....+....... ..+..+..+.+++.+||+.||++|||+.++++
T Consensus 238 ~p~~~~~~~----~~~~~~~~~~~~~-------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 291 (323)
T 3qup_A 238 TPYAGIENA----EIYNYLIGGNRLK-------------QPPECMEEVYDLMYQCWSADPKQRPSFTCLRM 291 (323)
T ss_dssp CTTTTCCGG----GHHHHHHTTCCCC-------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred CCccccChH----HHHHHHhcCCCCC-------------CCCccCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 998654321 1211111111000 11122345899999999999999999777764
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=326.61 Aligned_cols=249 Identities=22% Similarity=0.311 Sum_probs=195.0
Q ss_pred ccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCcccc
Q 040898 45 SLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPL 124 (337)
Q Consensus 45 ~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~ 124 (337)
..+.||+|+||.||++.+.. +|+.||+|++........ +.+.+|+.++++++||||+++
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~--~g~~vavK~~~~~~~~~~-------------------~~~~~E~~~l~~l~hpnIv~~ 151 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETA--TGLKLAAKIIKTRGMKDK-------------------EEVKNEISVMNQLDHANLIQL 151 (373)
T ss_dssp EEEECC-----CEEEEEETT--TCCEEEEEEEECCSHHHH-------------------HHHHHHHHHHTTCCCTTBCCE
T ss_pred cceEEecCcCEEEEEEEEcC--CCcEEEEEEEcccccccH-------------------HHHHHHHHHHHhCCCCCCCeE
Confidence 36789999999999998876 899999999875432111 567889999999999999999
Q ss_pred eeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceee--cCC
Q 040898 125 LAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI--DDD 202 (337)
Q Consensus 125 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~--~~~ 202 (337)
++++.+.+..++||||+++++|.+++.. ....+++..++.++.||+.||.|| |+.|++|+||+|+||++ +.+
T Consensus 152 ~~~~~~~~~~~lv~E~~~~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~ 225 (373)
T 2x4f_A 152 YDAFESKNDIVLVMEYVDGGELFDRIID---ESYNLTELDTILFMKQICEGIRHM---HQMYILHLDLKPENILCVNRDA 225 (373)
T ss_dssp EEEEECSSEEEEEEECCTTCEEHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEEEETTT
T ss_pred EEEEEECCEEEEEEeCCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccccCCHHHEEEecCCC
Confidence 9999999999999999999999998854 345689999999999999999999 66799999999999999 567
Q ss_pred CCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHHH
Q 040898 203 MEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVK 282 (337)
Q Consensus 203 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~ 282 (337)
+.++|+|||++........ .....+|+.|+|||++.+..++.++||||||+++|+|++|..||..... ...+..
T Consensus 226 ~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---~~~~~~ 299 (373)
T 2x4f_A 226 KQIKIIDFGLARRYKPREK---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND---AETLNN 299 (373)
T ss_dssp TEEEECCCSSCEECCTTCB---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHH
T ss_pred CcEEEEeCCCceecCCccc---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHH
Confidence 8899999999987654332 2234699999999999988899999999999999999999999865321 111111
Q ss_pred HHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 283 WMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.... ..... ....+.....+.+|+.+||+.||.+|||+.|+++|
T Consensus 300 i~~~-~~~~~----------~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 300 ILAC-RWDLE----------DEEFQDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp HHHT-CCCSC----------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHhc-cCCCC----------hhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1111 11100 01111233458999999999999999999999987
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=314.13 Aligned_cols=261 Identities=26% Similarity=0.363 Sum_probs=196.0
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHh--c
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQ--T 116 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~--l 116 (337)
..++|++.+.||+|+||.||++.+ +++.||+|++..... ..+.+|.+++.. +
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~----~~~~vavK~~~~~~~----------------------~~~~~e~~~~~~~~l 59 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW----QGENVAVKIFSSRDE----------------------KSWFRETELYNTVML 59 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE----TTEEEEEEEECGGGH----------------------HHHHHHHHHHHHTCC
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE----CCEEEEEEEeccccc----------------------hhhHHHHHHHHHhhc
Confidence 457899999999999999999877 789999999854321 234445555555 7
Q ss_pred CCCCcccceeEEEc----CCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhC-----CCCCe
Q 040898 117 RHRNILPLLAHMVR----PNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMC-----HRPRL 187 (337)
Q Consensus 117 ~hpniv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~-----h~~gi 187 (337)
+||||+++++++.. ....++||||+++|+|.+++. ...+++..++.++.|++.||.|||.. ++.|+
T Consensus 60 ~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~i 134 (301)
T 3q4u_A 60 RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAI 134 (301)
T ss_dssp CCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEE
T ss_pred cCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCe
Confidence 99999999998644 356899999999999999993 34689999999999999999999521 17899
Q ss_pred EecCCCCCceeecCCCCeEEecccCccccCCCCceee--eecccCCCCccCccccccC------CCCCcccchhhhHHHH
Q 040898 188 IHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQIT--VKCMVGTMGYMAPESLQTE------TISDKCDIYSFGVLLA 259 (337)
Q Consensus 188 ~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~------~~~~~~DiwslG~i~~ 259 (337)
+|+||||+||+++.++.++|+|||++........... .....+|+.|+|||.+.+. .++.++||||||+++|
T Consensus 135 vH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~ 214 (301)
T 3q4u_A 135 AHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLW 214 (301)
T ss_dssp ECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHH
T ss_pred ecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHH
Confidence 9999999999999999999999999876544333221 2234789999999999876 3456899999999999
Q ss_pred HHHhC----------CCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCC
Q 040898 260 VLVMG----------KFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERP 329 (337)
Q Consensus 260 ~ll~g----------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp 329 (337)
+|++| ..||................ .. .......... ..........+.+++.+||+.||++||
T Consensus 215 el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~--~~-~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rp 288 (301)
T 3q4u_A 215 EVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKV--VC-VDQQRPNIPN---RWFSDPTLTSLAKLMKECWYQNPSARL 288 (301)
T ss_dssp HHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHH--HT-TSCCCCCCCG---GGGGSHHHHHHHHHHHHHCCSSGGGSC
T ss_pred HHHhhhcCccccccccccccccCCCCcchhhhhHH--Hh-ccCCCCCCCh---hhccCccHHHHHHHHHHHhhcChhhCC
Confidence 99999 88886544433222221111 11 1111000000 011234566799999999999999999
Q ss_pred Chhhhhc
Q 040898 330 SSKDVRS 336 (337)
Q Consensus 330 s~~ell~ 336 (337)
|+.++++
T Consensus 289 s~~~i~~ 295 (301)
T 3q4u_A 289 TALRIKK 295 (301)
T ss_dssp CHHHHHH
T ss_pred CHHHHHH
Confidence 9999986
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=322.42 Aligned_cols=252 Identities=23% Similarity=0.332 Sum_probs=203.1
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
-.++|++.+.||+|+||.||++.+.. +++.||+|.+........... .......+.+|+.+++.++|
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~--~~~~vavK~~~~~~~~~~~~~-----------~~~~~~~~~~E~~~l~~l~h 88 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKE--KNKEVVVKFIKKEKVLEDCWI-----------EDPKLGKVTLEIAILSRVEH 88 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETT--TTEEEEEEEEESTTSCTTSEE-----------EETTTEEEEHHHHHHTTCCC
T ss_pred cccceEEEeEEEecCCEEEEEEEECC--CCcEEEEEEEehhhccccccc-----------chHHHHHHHHHHHHHHhCCC
Confidence 45789999999999999999998876 899999999876543211000 00011467789999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCC-CHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCce
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNG-SLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANV 197 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ni 197 (337)
|||+++++++.+.+..++||||+.+| +|.+++. ....+++..++.++.|++.||.|| |++|++|+||||+||
T Consensus 89 ~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~----~~~~l~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dlkp~NI 161 (335)
T 3dls_A 89 ANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFID----RHPRLDEPLASYIFRQLVSAVGYL---RLKDIIHRDIKDENI 161 (335)
T ss_dssp TTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHH----TCCCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGE
T ss_pred CCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHH---HhCCeEEeccCHHHE
Confidence 99999999999999999999998766 9999984 445699999999999999999999 667999999999999
Q ss_pred eecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCC-CCcccchhhhHHHHHHHhCCCCCCCCCCCch
Q 040898 198 LIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETI-SDKCDIYSFGVLLAVLVMGKFPVDDFFGHTE 276 (337)
Q Consensus 198 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~ 276 (337)
+++.++.++|+|||++......... ....+|+.|+|||++.+..+ +.++||||||+++|+|++|..||.....
T Consensus 162 ll~~~~~~kL~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--- 235 (335)
T 3dls_A 162 VIAEDFTIKLIDFGSAAYLERGKLF---YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE--- 235 (335)
T ss_dssp EECTTSCEEECCCTTCEECCTTCCB---CEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG---
T ss_pred EEcCCCcEEEeecccceECCCCCce---eccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH---
Confidence 9999999999999999876544322 23568999999999988776 7789999999999999999999864211
Q ss_pred hhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 277 EMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
....... .+...+..+.+|+.+||+.||++|||+.++++|
T Consensus 236 ----------~~~~~~~-----------~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 236 ----------TVEAAIH-----------PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ----------GTTTCCC-----------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ----------HHhhccC-----------CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000 000123348999999999999999999999986
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=324.49 Aligned_cols=254 Identities=24% Similarity=0.356 Sum_probs=194.7
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCce----EEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHH
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKM----IAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITAN 114 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~ 114 (337)
..++|++.+.||+|+||.||++.+.. +++. ||+|.+........ ...+.+|+.+++
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~--~~~~~~~~vaiK~~~~~~~~~~------------------~~~~~~E~~~l~ 72 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIP--EGEKVKIPVAIKELREATSPKA------------------NKEILDEAYVMA 72 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC------CCEEEEEEEC-------C------------------HHHHHHHHHHHH
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcC--CCceEEEEEEEeecccccCHHH------------------HHHHHHHHHHHH
Confidence 45679999999999999999998865 5544 57777654322111 156788999999
Q ss_pred hcCCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCC
Q 040898 115 QTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKP 194 (337)
Q Consensus 115 ~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~ 194 (337)
+++||||+++++++.++. .+++++++++|+|.+++.. ....+++..++.++.|++.||.|| |++|++|+||||
T Consensus 73 ~l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~L---H~~~ivH~Dikp 145 (327)
T 3poz_A 73 SVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYL---EDRRLVHRDLAA 145 (327)
T ss_dssp HCCBTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHH---STTSCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCG
T ss_pred hCCCCCEeEEEEEEecCC-eEEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH---hhCCeeCCCCCh
Confidence 999999999999998764 7899999999999999864 345689999999999999999999 667999999999
Q ss_pred CceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCC
Q 040898 195 ANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFG 273 (337)
Q Consensus 195 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~ 273 (337)
+||+++.++.++|+|||++................+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 146 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 225 (327)
T 3poz_A 146 RNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 225 (327)
T ss_dssp GGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred heEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH
Confidence 999999999999999999987655444333344557889999999999999999999999999999999 9999975432
Q ss_pred CchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 274 HTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
. .....+........ ++.....+.+++.+||+.||++|||+.++++
T Consensus 226 ~----~~~~~~~~~~~~~~-------------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~ 271 (327)
T 3poz_A 226 S----EISSILEKGERLPQ-------------PPICTIDVYMIMVKCWMIDADSRPKFRELII 271 (327)
T ss_dssp G----GHHHHHHTTCCCCC-------------CTTBCHHHHHHHHHHTCSCGGGSCCHHHHHH
T ss_pred H----HHHHHHHcCCCCCC-------------CccCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 1 22222222111111 1122334889999999999999999999985
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=317.78 Aligned_cols=257 Identities=23% Similarity=0.247 Sum_probs=204.2
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc-C
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT-R 117 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~ 117 (337)
-.++|++.+.||+|+||.||++.+.. +++.||+|.+...... ..+.+|+.+++.+ .
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~---------------------~~~~~E~~~l~~l~~ 63 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLY--TNEYVAIKLEPMKSRA---------------------PQLHLEYRFYKQLGS 63 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETT--TTEEEEEEEEETTCSS---------------------CCHHHHHHHHHHHCS
T ss_pred EcCCeEEEEEeeccCCceEEEEEECC--CCcEEEEEEeccccch---------------------HHHHHHHHHHHHhhC
Confidence 35789999999999999999999866 8999999998654321 3577899999999 9
Q ss_pred CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCce
Q 040898 118 HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANV 197 (337)
Q Consensus 118 hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ni 197 (337)
||||+++++++.+++..++||||+ +++|.+++... ...+++..++.++.|++.||.|| |+.|++|+||||+||
T Consensus 64 h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~L---H~~~iiHrDlkp~Ni 136 (330)
T 2izr_A 64 GDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYV---HSKNLIYRDVKPENF 136 (330)
T ss_dssp CTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGE
T ss_pred CCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHe
Confidence 999999999999999999999999 88999999652 45699999999999999999999 667999999999999
Q ss_pred eecCCCC-----eEEecccCccccCCCCcee-----eeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCC
Q 040898 198 LIDDDME-----ARISDFGHGKLMPDGHAQI-----TVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFP 267 (337)
Q Consensus 198 l~~~~~~-----~~l~dfg~~~~~~~~~~~~-----~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~p 267 (337)
+++.++. ++|+|||++.......... ......||+.|+|||++.+..++.++|+||||+++|+|++|..|
T Consensus 137 ll~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~P 216 (330)
T 2izr_A 137 LIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216 (330)
T ss_dssp EECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred eeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCC
Confidence 9998887 9999999998754332211 12345799999999999999999999999999999999999999
Q ss_pred CCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 268 VDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 268 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
|.............. +........... .... .+ .+.+++..||+.||.+|||+.+|++
T Consensus 217 f~~~~~~~~~~~~~~-i~~~~~~~~~~~-----~~~~----~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 217 WQGLKADTLKERYQK-IGDTKRATPIEV-----LCEN----FP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp TTTCCCSSHHHHHHH-HHHHHHHSCHHH-----HTTT----CH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ccccccccHHHHHHH-HHhhhccCCHHH-----Hhcc----Ch-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 987544332222222 211111111100 0000 11 4899999999999999999999875
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-45 Score=323.12 Aligned_cols=255 Identities=23% Similarity=0.348 Sum_probs=198.8
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCce----EEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHH
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKM----IAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITAN 114 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~ 114 (337)
..++|++.+.||+|+||.||++.+.. +++. |++|.+........ ...+.+|+.++.
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~--~~~~~~~kv~~K~~~~~~~~~~------------------~~~~~~e~~~l~ 70 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWIP--EGESIKIPVCIKVIEDKSGRQS------------------FQAVTDHMLAIG 70 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEECC--TTCSCCEEEEEEEECCTTSCSC------------------BCSCCHHHHHHH
T ss_pred CHhHceeeeeeeecCCceEEEEEEcC--CCceEEEEEEEEeccccccHHH------------------HHHHHHHHHHHh
Confidence 56779999999999999999998875 5554 77777644322111 045667999999
Q ss_pred hcCCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCC
Q 040898 115 QTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKP 194 (337)
Q Consensus 115 ~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~ 194 (337)
+++||||+++++++. +...++|+||+++++|.+++.. ....+++..++.++.|++.||.|| |+.|++|+||||
T Consensus 71 ~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dikp 143 (325)
T 3kex_A 71 SLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYL---EEHGMVHRNLAA 143 (325)
T ss_dssp TCCCTTBCCEEEEEC-BSSEEEEEECCTTCBSHHHHHS---SGGGSCTTHHHHHHHHHHHHHHHH---HHTTCCCSCCSS
T ss_pred cCCCCCcCeEEEEEc-CCccEEEEEeCCCCCHHHHHHH---ccccCCHHHHHHHHHHHHHHHHHH---HhCCCCCCccch
Confidence 999999999999886 5668999999999999999853 345789999999999999999999 667999999999
Q ss_pred CceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCC
Q 040898 195 ANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFG 273 (337)
Q Consensus 195 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~ 273 (337)
+||+++.++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 144 ~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 223 (325)
T 3kex_A 144 RNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL 223 (325)
T ss_dssp TTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT
T ss_pred heEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH
Confidence 999999999999999999988765544433445568889999999998889999999999999999999 9999976433
Q ss_pred CchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 274 HTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
. .....+........+.. ....+.+++.+||+.||++|||+.+++++
T Consensus 224 ~----~~~~~~~~~~~~~~~~~-------------~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 224 A----EVPDLLEKGERLAQPQI-------------CTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp T----HHHHHHHTTCBCCCCTT-------------BCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred H----HHHHHHHcCCCCCCCCc-------------CcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2 22222222111111110 11227889999999999999999999863
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-45 Score=316.78 Aligned_cols=254 Identities=22% Similarity=0.336 Sum_probs=200.6
Q ss_pred ccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc
Q 040898 37 LKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT 116 (337)
Q Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 116 (337)
.-..++|++++.||+|+||.||++.+. ++..||+|++....... +.+.+|+.++.++
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~--------------------~~~~~E~~~l~~l 76 (283)
T 3gen_A 20 EIDPKDLTFLKELGTGQFGVVKYGKWR---GQYDVAIKMIKEGSMSE--------------------DEFIEEAKVMMNL 76 (283)
T ss_dssp BCCGGGEEEEEECC---CEEEEEEEET---TTEEEEEEEECTTSBCH--------------------HHHHHHHHHHHTC
T ss_pred cCCHHHHHhHhhcCCCCCceEEEEEEc---CCCeEEEEEecCCCCCH--------------------HHHHHHHHHHhcC
Confidence 336778999999999999999998764 67789999987554321 4577899999999
Q ss_pred CCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 040898 117 RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPAN 196 (337)
Q Consensus 117 ~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~n 196 (337)
+||||+++++++.+++..++||||+++++|.+++.. ....+++..++.++.|++.||.+| |++|++|+||+|+|
T Consensus 77 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dikp~N 150 (283)
T 3gen_A 77 SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHRDLAARN 150 (283)
T ss_dssp CCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHC---GGGCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSSCSGGG
T ss_pred CCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHH---HHCCccCCCCccce
Confidence 999999999999999999999999999999999854 245689999999999999999999 66799999999999
Q ss_pred eeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCc
Q 040898 197 VLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHT 275 (337)
Q Consensus 197 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~ 275 (337)
|+++.++.++|+|||.+......... ......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.....
T Consensus 151 ili~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~-- 227 (283)
T 3gen_A 151 CLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-- 227 (283)
T ss_dssp EEECTTSCEEECSTTGGGGBCCHHHH-STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH--
T ss_pred EEEcCCCCEEEccccccccccccccc-cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh--
Confidence 99999999999999998765432211 1122346778999999998889999999999999999998 9999865422
Q ss_pred hhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 276 EEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
......+........+ ......+.+++.+||+.||.+|||+.+++++
T Consensus 228 --~~~~~~~~~~~~~~~~-------------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 228 --SETAEHIAQGLRLYRP-------------HLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp --HHHHHHHHTTCCCCCC-------------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred --hHHHHHHhcccCCCCC-------------CcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 1222222211111111 1112348899999999999999999999864
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=324.59 Aligned_cols=255 Identities=24% Similarity=0.373 Sum_probs=194.9
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC-
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR- 117 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~- 117 (337)
...+|++++.||+|+||.||++.+. +++.||||++......... .+.+.+|+.+++.++
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~---~~~~vaiK~~~~~~~~~~~-----------------~~~~~~Ei~~l~~l~~ 113 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNE---KKQIYAIKYVNLEEADNQT-----------------LDSYRNEIAYLNKLQQ 113 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECT---TCCEEEEEEEECTTCCHHH-----------------HHHHHHHHHHHHHHTT
T ss_pred cCCceEEEEEEccCCCeEEEEEEcC---CCCEEEEEEEecccccHHH-----------------HHHHHHHHHHHHHccc
Confidence 4456999999999999999998764 5889999998765432211 157888999999996
Q ss_pred -CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 040898 118 -HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPAN 196 (337)
Q Consensus 118 -hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~n 196 (337)
||||+++++++..++..|+||| +.+++|.+++.. ...+++..+..++.||+.||.|| |++|++|+||||+|
T Consensus 114 ~~~~iv~~~~~~~~~~~~~lv~E-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~l---H~~~ivHrDlkp~N 185 (390)
T 2zmd_A 114 HSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTI---HQHGIVHSDLKPAN 185 (390)
T ss_dssp TCTTBCCEEEEEECSSEEEEEEE-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHH---HTTTCCCCCCCGGG
T ss_pred CCCeEEEEEEEEecCCEEEEEEe-cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCHHH
Confidence 5999999999999999999999 567899999854 34688889999999999999999 77799999999999
Q ss_pred eeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCcccccc-----------CCCCCcccchhhhHHHHHHHhCC
Q 040898 197 VLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQT-----------ETISDKCDIYSFGVLLAVLVMGK 265 (337)
Q Consensus 197 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-----------~~~~~~~DiwslG~i~~~ll~g~ 265 (337)
|+++ ++.++|+|||++................||+.|+|||++.+ ..++.++||||||+++|+|++|.
T Consensus 186 Ill~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~ 264 (390)
T 2zmd_A 186 FLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264 (390)
T ss_dssp EEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSS
T ss_pred EEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCC
Confidence 9995 58999999999987654433222344679999999999865 35788999999999999999999
Q ss_pred CCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 266 FPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 266 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.||...... ... ............ .+......+.+|+.+||+.||++|||+.|+|+|
T Consensus 265 ~Pf~~~~~~--~~~----~~~~~~~~~~~~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 265 TPFQQIINQ--ISK----LHAIIDPNHEIE---------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp CTTTTCCCH--HHH----HHHHHCTTSCCC---------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CcchhhhHH--HHH----HHHHhCccccCC---------CCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 999653221 111 111111111100 000112348899999999999999999999987
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=325.41 Aligned_cols=259 Identities=24% Similarity=0.400 Sum_probs=202.8
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++.+.||+|+||.||++.+.. ++..||+|++......... ..+.+|+.+++.++|
T Consensus 31 ~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~va~K~~~~~~~~~~~------------------~~~~~E~~~l~~l~h 90 (360)
T 3eqc_A 31 KDDDFEKISELGAGNGGVVFKVSHKP--SGLVMARKLIHLEIKPAIR------------------NQIIRELQVLHECNS 90 (360)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT--TCCEEEEEEEECCCCHHHH------------------HHHHHHHGGGGGCCC
T ss_pred ccccceeeeeecCCCCeEEEEEEECC--CCcEEEEEEeccccCHHHH------------------HHHHHHHHHHHHCCC
Confidence 45789999999999999999999876 8999999998765322111 567889999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCC-CeEecCCCCCce
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRP-RLIHRDIKPANV 197 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~-gi~h~di~~~ni 197 (337)
|||+++++++.+++..++||||+++++|.+++.. ...+++..+..++.|++.||.|| |+. |++|+||+|+||
T Consensus 91 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~l---h~~~~i~H~dlkp~Ni 163 (360)
T 3eqc_A 91 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYL---REKHKIMHRDVKPSNI 163 (360)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HHHHCCCCSCCSGGGE
T ss_pred CCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHhCCEEcCCccHHHE
Confidence 9999999999999999999999999999999954 34588999999999999999999 543 899999999999
Q ss_pred eecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchh
Q 040898 198 LIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEE 277 (337)
Q Consensus 198 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~ 277 (337)
+++.++.++|+|||++...... ......+++.|+|||++.+..++.++||||||+++|+|++|..||.........
T Consensus 164 l~~~~~~~kl~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 239 (360)
T 3eqc_A 164 LVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE 239 (360)
T ss_dssp EECTTCCEEECCCCCCHHHHHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHH
T ss_pred EECCCCCEEEEECCCCcccccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9999999999999988654221 122356899999999999999999999999999999999999999653221100
Q ss_pred hhH-----------------------------------HHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhcc
Q 040898 278 MDM-----------------------------------VKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTL 322 (337)
Q Consensus 278 ~~~-----------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 322 (337)
... ............ ........+..+.+|+.+||+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~li~~~L~ 310 (360)
T 3eqc_A 240 LMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPP---------PKLPSGVFSLEFQDFVNKCLI 310 (360)
T ss_dssp HHHC------------------------------CCCHHHHHHHHHHSCC---------CCCCTTTSCHHHHHHHHHHHC
T ss_pred HHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCC---------CCCCcccccHHHHHHHHHHhh
Confidence 000 000000000000 000011123458999999999
Q ss_pred CCCCCCCChhhhhcC
Q 040898 323 KDPDERPSSKDVRSM 337 (337)
Q Consensus 323 ~dP~~Rps~~ell~~ 337 (337)
.||++|||+.++|+|
T Consensus 311 ~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 311 KNPAERADLKQLMVH 325 (360)
T ss_dssp SSTTTSCCHHHHHTS
T ss_pred cChhhCCCHHHHhhC
Confidence 999999999999987
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=328.11 Aligned_cols=263 Identities=20% Similarity=0.291 Sum_probs=200.6
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++++.||+|+||.||++.+.. +++.||+|++.... ....+|+.+++.++|
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~--~~~~vAiK~~~~~~-----------------------~~~~~E~~il~~l~h 59 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIE--SGKRFALKKVLQDP-----------------------RYKNRELDIMKVLDH 59 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETT--TCCEEEEEEEECCT-----------------------TSCCHHHHHHTTCCC
T ss_pred ccceEEEEEEEEeccCEEEEEEEECC--CCCEEEEEEEecCc-----------------------chHHHHHHHHHHcCC
Confidence 46789999999999999999999876 89999999986442 223469999999999
Q ss_pred CCcccceeEEEc--------------------------------------CCeeEEEEEeccCCCHHHHHHHhcCCcccC
Q 040898 119 RNILPLLAHMVR--------------------------------------PNCHLLVYEFMKNGSLQDILYDVSQGRREL 160 (337)
Q Consensus 119 pniv~~~~~~~~--------------------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 160 (337)
|||+++++++.. ....++||||+++ +|.+.+......+..+
T Consensus 60 pnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l 138 (383)
T 3eb0_A 60 VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSI 138 (383)
T ss_dssp TTBCCEEEEEEEC-------------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCC
T ss_pred CCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCC
Confidence 999999999843 3348899999985 8888887666677789
Q ss_pred ChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec-CCCCeEEecccCccccCCCCceeeeecccCCCCccCccc
Q 040898 161 DWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID-DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPES 239 (337)
Q Consensus 161 ~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~ 239 (337)
++..++.++.||+.||.|| |+.|++|+||||+||+++ .++.++|+|||++......... ....+|+.|+|||+
T Consensus 139 ~~~~~~~i~~qi~~aL~~L---H~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~ 212 (383)
T 3eb0_A 139 PMNLISIYIYQLFRAVGFI---HSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS---VAYICSRFYRAPEL 212 (383)
T ss_dssp CHHHHHHHHHHHHHHHHHH---HTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC---CCCCCCSSCCCHHH
T ss_pred CHHHHHHHHHHHHHHHHHH---HHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC---cCcccCCCccCHHH
Confidence 9999999999999999999 778999999999999997 6889999999999876443322 23568999999999
Q ss_pred cccCC-CCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHHHHHHhhhccCCcchhh----------hhcccCC----
Q 040898 240 LQTET-ISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAI----------NSKLLGN---- 304 (337)
Q Consensus 240 ~~~~~-~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~---- 304 (337)
+.+.. ++.++||||+|+++|+|++|..||..... ...+...+.. .......... .+.....
T Consensus 213 ~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~i~~~-~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (383)
T 3eb0_A 213 MLGATEYTPSIDLWSIGCVFGELILGKPLFSGETS---IDQLVRIIQI-MGTPTKEQMIRMNPHYTEVRFPTLKAKDWRK 288 (383)
T ss_dssp HTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHH-HCCCCHHHHHHHCTTC--CCCCCCCCCCHHH
T ss_pred hcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHH-hCCCCHHHHHHhCcccccccCCccCcccHHh
Confidence 87654 89999999999999999999999965322 2222222111 1111000000 0000000
Q ss_pred -chHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 305 -GYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 305 -~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.+...+..+.+|+.+||+.||++|||+.|+++|
T Consensus 289 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (383)
T 3eb0_A 289 ILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAH 322 (383)
T ss_dssp HSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111234558999999999999999999999987
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=317.93 Aligned_cols=254 Identities=25% Similarity=0.417 Sum_probs=202.8
Q ss_pred cccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC
Q 040898 38 KKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR 117 (337)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 117 (337)
...++|++.+.||+|+||.||++.+.. +++.||+|.+........ ..+.+|+.+++.++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~-------------------~~~~~e~~~l~~l~ 64 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQRL--TGKLFALKCIKKSPAFRD-------------------SSLENEIAVLKKIK 64 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEECC-------------------------HHHHHHHHHHHCC
T ss_pred chhccceeeeeccCCCCceEEEEEECC--CCCEEEEEEEecccccch-------------------HHHHHHHHHHHhCC
Confidence 345789999999999999999999876 899999999875432111 45778999999999
Q ss_pred CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCce
Q 040898 118 HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANV 197 (337)
Q Consensus 118 hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ni 197 (337)
||||+++++++.+....++||||+++++|.+++.. ...+++..++.++.|++.||.|| |+.|++|+||+|+||
T Consensus 65 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dikp~NI 137 (304)
T 2jam_A 65 HENIVTLEDIYESTTHYYLVMQLVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYL---HENGIVHRDLKPENL 137 (304)
T ss_dssp CTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCSCCGGGC
T ss_pred CCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHE
Confidence 99999999999999999999999999999999854 34588999999999999999999 667999999999999
Q ss_pred ee---cCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCC
Q 040898 198 LI---DDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGH 274 (337)
Q Consensus 198 l~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~ 274 (337)
++ +.++.++|+|||.+....... .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||....
T Consensus 138 l~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-- 211 (304)
T 2jam_A 138 LYLTPEENSKIMITDFGLSKMEQNGI----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET-- 211 (304)
T ss_dssp EESSSSTTCCEEBCSCSTTCCCCCBT----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC--
T ss_pred EEecCCCCCCEEEccCCcceecCCCc----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC--
Confidence 99 778899999999987543321 123468999999999999889999999999999999999999986532
Q ss_pred chhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 275 TEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.......+........ .......+..+.+++.+||+.||++|||+.++++|
T Consensus 212 --~~~~~~~i~~~~~~~~----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 212 --ESKLFEKIKEGYYEFE----------SPFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp --HHHHHHHHHHCCCCCC----------TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred --HHHHHHHHHcCCCCCC----------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1122222211110000 01111233458999999999999999999999986
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=339.01 Aligned_cols=255 Identities=24% Similarity=0.386 Sum_probs=202.1
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
-.++|++.+.||+|+||+||++.+.. +++.||+|++........ ....+.+|+.++++++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~-----------------~~~~~~~E~~~l~~l~h 80 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRI--TQQEYAVKVINKASAKNK-----------------DTSTILREVELLKKLDH 80 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETT--TCCEEEEEEEEHHHHBCS-----------------CHHHHHHHHHHHHHCCC
T ss_pred hhcceEEeEEEeecCCEEEEEEEECC--CCCEEEEEEEecccccch-----------------HHHHHHHHHHHHHhCCC
Confidence 45679999999999999999999876 899999999854321110 11567889999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++++.+....++||||+.+++|.+.+.. ...+++..++.++.||+.||.|| |++|++|+||||+||+
T Consensus 81 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~l---H~~~ivH~Dlkp~Nil 153 (486)
T 3mwu_A 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYM---HKHNIVHRDLKPENIL 153 (486)
T ss_dssp TTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEE
T ss_pred CCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeEeccCchHHEE
Confidence 9999999999999999999999999999998854 34689999999999999999999 6679999999999999
Q ss_pred ec---CCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCc
Q 040898 199 ID---DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHT 275 (337)
Q Consensus 199 ~~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~ 275 (337)
++ .++.++|+|||++....... ......+|+.|+|||++.+ .++.++||||||+++|+|++|.+||....
T Consensus 154 ~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~--- 226 (486)
T 3mwu_A 154 LESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN--- 226 (486)
T ss_dssp ESSSSTTCCEEECSCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS---
T ss_pred EecCCCCCCEEEEECCcCeECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC---
Confidence 95 45679999999997664432 2234579999999999976 48899999999999999999999986432
Q ss_pred hhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 276 EEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.......+......... +.+...+..+.+|+.+||+.||++|||+.++|+|
T Consensus 227 -~~~~~~~i~~~~~~~~~----------~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 227 -EYDILKRVETGKYAFDL----------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp -HHHHHHHHHHTCCCSCS----------GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred -HHHHHHHHHhCCCCCCC----------cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 12222222211111100 1112233458999999999999999999999987
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=337.90 Aligned_cols=254 Identities=24% Similarity=0.392 Sum_probs=198.3
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
.++|++++.||+|+||.||++.+.. ++..||+|++......... ...+.+|+.+++.++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~-----------------~~~~~~E~~~l~~l~hp 96 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKV--THVERAIKIIRKTSVSTSS-----------------NSKLLEEVAVLKLLDHP 96 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETT--TCCEEEEEEEEC-----CT-----------------THHHHHHHHHHTTCCCT
T ss_pred hcCeEEeeEEecCCCEEEEEEEECC--CCcEEEEEEEeccccCchH-----------------HHHHHHHHHHHHhCCCC
Confidence 3479999999999999999999876 8999999998754321110 15678899999999999
Q ss_pred CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceee
Q 040898 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI 199 (337)
Q Consensus 120 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~ 199 (337)
||+++++++.+....++||||+++|+|.+.+.. ...+++..++.++.||+.||.|| |+.|++|+||||+||++
T Consensus 97 niv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~Dlkp~Nil~ 169 (494)
T 3lij_A 97 NIMKLYDFFEDKRNYYLVMECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYL---HKHNIVHRDLKPENLLL 169 (494)
T ss_dssp TBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEE
T ss_pred CCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCceeccCChhhEEE
Confidence 999999999999999999999999999998854 34589999999999999999999 66799999999999999
Q ss_pred cCC---CCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCch
Q 040898 200 DDD---MEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTE 276 (337)
Q Consensus 200 ~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~ 276 (337)
+.. +.++|+|||++........ .....+|+.|+|||++.+ .++.++||||+|+++|+|++|.+||....
T Consensus 170 ~~~~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~---- 241 (494)
T 3lij_A 170 ESKEKDALIKIVDFGLSAVFENQKK---MKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQT---- 241 (494)
T ss_dssp SCSSTTCCEEECCCTTCEECBTTBC---BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSS----
T ss_pred eCCCCCCcEEEEECCCCeECCCCcc---ccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCC----
Confidence 764 4599999999887654322 234579999999999864 58999999999999999999999996532
Q ss_pred hhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 277 EMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.......+......... +.....+..+.+|+.+||+.||++|||+.++|+|
T Consensus 242 ~~~~~~~i~~~~~~~~~----------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 242 DQEILRKVEKGKYTFDS----------PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp HHHHHHHHHHTCCCCCS----------GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred HHHHHHHHHhCCCCCCc----------hhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 12222222221111110 0111233458899999999999999999999987
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=318.71 Aligned_cols=263 Identities=21% Similarity=0.306 Sum_probs=206.5
Q ss_pred cccccccccceeccCcceEEEEeEEec---CCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHH
Q 040898 38 KKEDCFDSLKKIGSGGWGEVFYKAELP---GSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITAN 114 (337)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~ 114 (337)
-..++|++.+.||+|+||.||++.+.. ..+++.||+|++......... ..+.+|+.++.
T Consensus 24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~------------------~~~~~E~~~l~ 85 (316)
T 2xir_A 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH------------------RALMSELKILI 85 (316)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHH------------------HHHHHHHHHHH
T ss_pred cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHH------------------HHHHHHHHHHH
Confidence 367889999999999999999998642 347899999998755432211 46788999999
Q ss_pred hc-CCCCcccceeEEEcCC-eeEEEEEeccCCCHHHHHHHhcCC------------cccCChHHHHHHHHHHHHHHHHHh
Q 040898 115 QT-RHRNILPLLAHMVRPN-CHLLVYEFMKNGSLQDILYDVSQG------------RRELDWPARHRIARGIASGLEYLH 180 (337)
Q Consensus 115 ~l-~hpniv~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~------------~~~~~~~~~~~i~~~i~~~l~~l~ 180 (337)
++ .||||+++++++...+ ..++|+||+++++|.+++...... ...+++..++.++.|++.||.||
T Consensus 86 ~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~l- 164 (316)
T 2xir_A 86 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL- 164 (316)
T ss_dssp HHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHH-
T ss_pred hcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHH-
Confidence 99 7899999999987654 589999999999999999653221 12278899999999999999999
Q ss_pred hCCCCCeEecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHH
Q 040898 181 MCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAV 260 (337)
Q Consensus 181 ~~h~~gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ 260 (337)
|++|++|+||+|+||+++.++.++|+|||++................+++.|+|||++.+..++.++|+||||+++|+
T Consensus 165 --H~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~ 242 (316)
T 2xir_A 165 --ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE 242 (316)
T ss_dssp --HHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred --HhCCcccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHH
Confidence 667999999999999999999999999999987655444334344567889999999998889999999999999999
Q ss_pred HHh-CCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 261 LVM-GKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 261 ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
|++ |..||....... .....+........ +......+.+++.+||+.||.+|||+.++++|
T Consensus 243 l~t~g~~p~~~~~~~~---~~~~~~~~~~~~~~-------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 243 IFSLGASPYPGVKIDE---EFCRRLKEGTRMRA-------------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHTTSCCSSTTCCCSH---HHHHHHHHTCCCCC-------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhCCCCCCcccchhH---HHHHHhccCccCCC-------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 998 999997643322 12222211111110 01122348899999999999999999999874
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=318.11 Aligned_cols=265 Identities=19% Similarity=0.313 Sum_probs=207.0
Q ss_pred ccccccccccccceeccCcceEEEEeEEec---CCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHH
Q 040898 35 AFLKKEDCFDSLKKIGSGGWGEVFYKAELP---GSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEII 111 (337)
Q Consensus 35 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~ 111 (337)
++.-..++|++.+.||+|+||.||++.+.. ..+++.||+|.+......... ..+.+|+.
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~------------------~~~~~E~~ 80 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER------------------IEFLNEAS 80 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHH------------------HHHHHHHH
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHH------------------HHHHHHHH
Confidence 344467889999999999999999987752 236788999998754332211 46788999
Q ss_pred HHHhcCCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcC------CcccCChHHHHHHHHHHHHHHHHHhhCCCC
Q 040898 112 TANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQ------GRRELDWPARHRIARGIASGLEYLHMCHRP 185 (337)
Q Consensus 112 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~ 185 (337)
+++.++||||+++++++.+++..++||||+++++|.+++..... ....+++..++.++.|++.||.+| |++
T Consensus 81 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~ 157 (322)
T 1p4o_A 81 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL---NAN 157 (322)
T ss_dssp HGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHH---HHT
T ss_pred HHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHH---HHC
Confidence 99999999999999999999999999999999999999965321 124568899999999999999999 667
Q ss_pred CeEecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-C
Q 040898 186 RLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-G 264 (337)
Q Consensus 186 gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g 264 (337)
|++|+||+|+||+++.++.++|+|||++................+++.|+|||.+.+..++.++|+||||+++|+|++ |
T Consensus 158 ~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g 237 (322)
T 1p4o_A 158 KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 237 (322)
T ss_dssp TCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTS
T ss_pred CCccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcC
Confidence 999999999999999999999999999876543332222223456888999999998889999999999999999999 8
Q ss_pred CCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 265 KFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 265 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
..||..... ......+.. .... ..+...+..+.+++.+||+.||++|||+.+++++
T Consensus 238 ~~p~~~~~~----~~~~~~~~~---~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 238 EQPYQGLSN----EQVLRFVME---GGLL----------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp CCTTTTSCH----HHHHHHHHT---TCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCccccCCH----HHHHHHHHc---CCcC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 899865321 112111111 1110 0111223458899999999999999999999863
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=315.70 Aligned_cols=265 Identities=20% Similarity=0.295 Sum_probs=203.4
Q ss_pred cccccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHH
Q 040898 34 LAFLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITA 113 (337)
Q Consensus 34 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l 113 (337)
...+...++|++.+.||+|+||.||++.+.. +++.||+|++..... ..+.+|+.++
T Consensus 29 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~----------------------~~~~~E~~~l 84 (330)
T 3nsz_A 29 VVEWGNQDDYQLVRKLGRGKYSEVFEAINIT--NNEKVVVKILKPVKK----------------------KKIKREIKIL 84 (330)
T ss_dssp CCCCEEGGGEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEECSCCH----------------------HHHHHHHHHH
T ss_pred hhcccCCCceEEEEEecccCCeEEEEEEECC--CCcEEEEEEecccch----------------------HHHHHHHHHH
Confidence 3334467889999999999999999998876 899999999864321 4577899999
Q ss_pred HhcC-CCCcccceeEEEc--CCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 040898 114 NQTR-HRNILPLLAHMVR--PNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHR 190 (337)
Q Consensus 114 ~~l~-hpniv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~ 190 (337)
++++ ||||+++++++.+ ....++||||+++++|.+++. .+++..+..++.|++.||.|| |++|++|+
T Consensus 85 ~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~ 154 (330)
T 3nsz_A 85 ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYC---HSMGIMHR 154 (330)
T ss_dssp HHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHH---HHTTEECC
T ss_pred HHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHH---HhCCeeeC
Confidence 9997 9999999999987 667899999999999999873 388889999999999999999 66799999
Q ss_pred CCCCCceeecCCC-CeEEecccCccccCCCCceeeeecccCCCCccCcccccc-CCCCCcccchhhhHHHHHHHhCCCCC
Q 040898 191 DIKPANVLIDDDM-EARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQT-ETISDKCDIYSFGVLLAVLVMGKFPV 268 (337)
Q Consensus 191 di~~~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~i~~~ll~g~~pf 268 (337)
||+|+||+++.++ .++|+|||++........ .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||
T Consensus 155 Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~ 231 (330)
T 3nsz_A 155 DVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231 (330)
T ss_dssp CCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred CCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCc
Confidence 9999999999776 899999999987654332 234568999999999977 66899999999999999999999998
Q ss_pred CCCCCCchhhhHHHHHH------------hhhccCCc----------chhhhhcccCCchHHHHHHHHHHHhhhccCCCC
Q 040898 269 DDFFGHTEEMDMVKWMR------------NVIFSENP----------NRAINSKLLGNGYEEQMLLVLKLACFCTLKDPD 326 (337)
Q Consensus 269 ~~~~~~~~~~~~~~~~~------------~~~~~~~~----------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~ 326 (337)
...... ...+..... .......+ ...................+.+|+.+||+.||+
T Consensus 232 ~~~~~~--~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 309 (330)
T 3nsz_A 232 FHGHDN--YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQ 309 (330)
T ss_dssp SCCSSH--HHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGG
T ss_pred ccCCch--HHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcc
Confidence 543221 111111111 00000000 000000011111122345689999999999999
Q ss_pred CCCChhhhhcC
Q 040898 327 ERPSSKDVRSM 337 (337)
Q Consensus 327 ~Rps~~ell~~ 337 (337)
+|||++|+|+|
T Consensus 310 ~Rpta~e~l~h 320 (330)
T 3nsz_A 310 SRLTAREAMEH 320 (330)
T ss_dssp GSCCHHHHHTS
T ss_pred cCCCHHHHhcC
Confidence 99999999987
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=340.66 Aligned_cols=255 Identities=27% Similarity=0.410 Sum_probs=205.1
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
.++|++.+.||+|+||.||++.+.. +++.||+|++......... ....+.+|+.++++++||
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~~avK~~~~~~~~~~~----------------~~~~~~~E~~~l~~l~hp 86 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKI--TGQECAVKVISKRQVKQKT----------------DKESLLREVQLLKQLDHP 86 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEETTTCCBSS----------------CHHHHHHHHHHHTTCCCT
T ss_pred cCceEEeeEEecCCCEEEEEEEECC--CCCEEEEEEEEhhhcccch----------------HHHHHHHHHHHHHhCCCC
Confidence 4679999999999999999999876 8999999998654322111 015688899999999999
Q ss_pred CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceee
Q 040898 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI 199 (337)
Q Consensus 120 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~ 199 (337)
||+++++++.+.+..++|+||+.+++|.+++. ....+++..++.++.||+.||.|| |++|++|+||||+||++
T Consensus 87 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~Dlkp~Nil~ 159 (484)
T 3nyv_A 87 NIMKLYEFFEDKGYFYLVGEVYTGGELFDEII----SRKRFSEVDAARIIRQVLSGITYM---HKNKIVHRDLKPENLLL 159 (484)
T ss_dssp TBCCEEEEEECSSEEEEEECCCCSCBHHHHHH----TCSCCBHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEE
T ss_pred CCCcEEEEEEeCCEEEEEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeCCCCHHHEEE
Confidence 99999999999999999999999999999884 445689999999999999999999 66799999999999999
Q ss_pred ---cCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCch
Q 040898 200 ---DDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTE 276 (337)
Q Consensus 200 ---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~ 276 (337)
+.++.++|+|||++........ .....+|+.|+|||++.+ .++.++||||||+++|+|++|.+||....
T Consensus 160 ~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~---- 231 (484)
T 3nyv_A 160 ESKSKDANIRIIDFGLSTHFEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN---- 231 (484)
T ss_dssp SSSSTTCCEEECCTTHHHHBCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS----
T ss_pred ecCCCCCcEEEEeeeeeEEcccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC----
Confidence 5678999999999987654432 234579999999999976 58999999999999999999999996532
Q ss_pred hhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 277 EMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.......+.. ...... .+.+...+..+.+|+.+||+.||++|||+.++|+|
T Consensus 232 ~~~~~~~i~~---~~~~~~-------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 232 EYDILKKVEK---GKYTFE-------LPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp HHHHHHHHHH---CCCCCC-------SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHc---CCCCCC-------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 1222222221 111100 01112234458999999999999999999999987
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=309.74 Aligned_cols=252 Identities=27% Similarity=0.359 Sum_probs=189.0
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++.+.||+|+||.||++.+ +++.||+|++.......... ..+.+.+|+.+++.++|
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~----~~~~vavK~~~~~~~~~~~~---------------~~~~~~~e~~~l~~l~h 65 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFW----IGDEVAVKAARHDPDEDISQ---------------TIENVRQEAKLFAMLKH 65 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEE----TTEEEEEEEC-------------------------CHHHHHHHHHHHHHCCC
T ss_pred chhheeeeeeeccCCCeEEEEEEE----cCCeEEEEEEecCCcccHHH---------------HHHHHHHHHHHHHhcCC
Confidence 356899999999999999999887 68899999986543322111 11567889999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCC---eEecCCCCC
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPR---LIHRDIKPA 195 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~g---i~h~di~~~ 195 (337)
|||+++++++.+++..++||||+++++|.+++. +..+++..++.++.|++.||.|| |++| ++|+||+|+
T Consensus 66 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~l---H~~~~~~i~H~dikp~ 137 (271)
T 3dtc_A 66 PNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYL---HDEAIVPIIHRDLKSS 137 (271)
T ss_dssp TTBCCEEEEECCC--CEEEEECCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHH---HHSSSSCCCCSCCSGG
T ss_pred CCEeeEEEEEecCCceEEEEEcCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHH---HhCCCCceeecCCchH
Confidence 999999999999999999999999999999983 34689999999999999999999 4556 999999999
Q ss_pred ceeecC--------CCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCC
Q 040898 196 NVLIDD--------DMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFP 267 (337)
Q Consensus 196 nil~~~--------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~p 267 (337)
||+++. ++.++|+|||.+........ ....+++.|+|||.+.+..++.++|+||||+++|+|++|..|
T Consensus 138 Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p 213 (271)
T 3dtc_A 138 NILILQKVENGDLSNKILKITDFGLAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213 (271)
T ss_dssp GEEESSCCSSSCCSSCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCT
T ss_pred HEEEecccccccccCcceEEccCCcccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 999986 77899999999876543321 234689999999999988899999999999999999999999
Q ss_pred CCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 268 VDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 268 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
|..... ..... ......... ..+...+..+.+++.+||+.||.+|||+.+++++
T Consensus 214 ~~~~~~---~~~~~----~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 214 FRGIDG---LAVAY----GVAMNKLAL---------PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp TTTSCH---HHHHH----HHHTSCCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCH---HHHHH----hhhcCCCCC---------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 965321 11111 111111100 0111223458999999999999999999999874
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=313.45 Aligned_cols=256 Identities=23% Similarity=0.318 Sum_probs=191.0
Q ss_pred cccccccccceeccCcceEEEEeEEecC-CCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc
Q 040898 38 KKEDCFDSLKKIGSGGWGEVFYKAELPG-SNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT 116 (337)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 116 (337)
-..++|++.+.||+|+||.||++.+... ..+..||+|.+........ .+.+.+|+.+++++
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~------------------~~~~~~e~~~l~~l 73 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV------------------REKFLQEALTMRQF 73 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHH------------------HHHHHHHHHHHHTC
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHH------------------HHHHHHHHHHHHhC
Confidence 3567899999999999999999988642 2466799998865432211 15678899999999
Q ss_pred CCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 040898 117 RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPAN 196 (337)
Q Consensus 117 ~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~n 196 (337)
+||||+++++++. ++..++||||+++++|.+++.. ....+++..++.++.|++.||.|| |+.|++|+||+|+|
T Consensus 74 ~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~N 146 (281)
T 1mp8_A 74 DHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYL---ESKRFVHRDIAARN 146 (281)
T ss_dssp CCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGG
T ss_pred CCCccceEEEEEc-cCccEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH---HhCCeecccccHHH
Confidence 9999999999874 5678999999999999999964 344689999999999999999999 66799999999999
Q ss_pred eeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCc
Q 040898 197 VLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHT 275 (337)
Q Consensus 197 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~ 275 (337)
|+++.++.++|+|||++......... ......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||......
T Consensus 147 il~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~- 224 (281)
T 1mp8_A 147 VLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN- 224 (281)
T ss_dssp EEEEETTEEEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-
T ss_pred EEECCCCCEEECccccccccCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH-
Confidence 99999999999999998876443221 1123456788999999998889999999999999999997 99998754322
Q ss_pred hhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 276 EEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
.....+....... .++..+..+.+++.+||+.||++|||+.++++
T Consensus 225 ---~~~~~i~~~~~~~-------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 269 (281)
T 1mp8_A 225 ---DVIGRIENGERLP-------------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 269 (281)
T ss_dssp ---GHHHHHHTTCCCC-------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---HHHHHHHcCCCCC-------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1222121111000 11123345889999999999999999999986
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=315.07 Aligned_cols=258 Identities=23% Similarity=0.329 Sum_probs=202.1
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
++|++.+.||+|+||.||++.+.. +++.||+|.+........... ...+.+.+|+.++++++|||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~--~~~~~avK~~~~~~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~ 69 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKG--TGKEYAAKFIKKRRLSSSRRG-------------VSREEIEREVNILREIRHPN 69 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEEBCSSTTCSSS-------------BCHHHHHHHHHHHHHCCCTT
T ss_pred hhhhhHHhhcccCceEEEEEEEcC--CCCeeehHHhhhccccccccc-------------hHHHHHHHHHHHHHhCCCCC
Confidence 579999999999999999999876 899999999876543221000 00156788999999999999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
|+++++++.++...++||||+++++|.+++.. ...+++..++.++.|++.||.+| |+.|++|+||+|+||+++
T Consensus 70 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~Nil~~ 142 (283)
T 3bhy_A 70 IITLHDIFENKTDVVLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYL---HSKRIAHFDLKPENIMLL 142 (283)
T ss_dssp BCCEEEEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEES
T ss_pred eeehhheecCCCeEEEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HhCCccCCCCChHHEEEe
Confidence 99999999999999999999999999999954 34689999999999999999999 667999999999999998
Q ss_pred CCC----CeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCch
Q 040898 201 DDM----EARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTE 276 (337)
Q Consensus 201 ~~~----~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~ 276 (337)
.++ .++|+|||.+........ .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||.....
T Consensus 143 ~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--- 216 (283)
T 3bhy_A 143 DKNVPNPRIKLIDFGIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK--- 216 (283)
T ss_dssp CSSSSSCCEEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH---
T ss_pred cCCCCCCceEEEecccceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch---
Confidence 877 899999999887644321 2335689999999999988899999999999999999999999865321
Q ss_pred hhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 277 EMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
......+...... .+.. ..+..+..+.+++.+||+.||++|||+.++++|
T Consensus 217 -~~~~~~~~~~~~~-~~~~---------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 217 -QETLTNISAVNYD-FDEE---------YFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp -HHHHHHHHTTCCC-CCHH---------HHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred -HHHHHHhHhcccC-Ccch---------hcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 1111111111100 0000 011223458999999999999999999999986
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=310.36 Aligned_cols=253 Identities=27% Similarity=0.414 Sum_probs=199.5
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++.+.||+|+||.||++.+.. +|+.||+|.+...... ..+.+|+.+++.++|
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~---------------------~~~~~e~~~l~~l~h 83 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKE--TGQIVAIKQVPVESDL---------------------QEIIKEISIMQQCDS 83 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETT--TCCEEEEEEEETTSCC---------------------HHHHHHHHHHHTCCC
T ss_pred chhhhhhheeeccCCCeEEEEEEECC--CCCEEEEEecCchHHH---------------------HHHHHHHHHHHhCCC
Confidence 67789999999999999999998865 8999999998654321 457789999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++++..++..++||||+++++|.+++.. ....+++..++.++.|++.||.+| |+.|++|+||+|+||+
T Consensus 84 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~l---H~~~i~H~dl~p~Nil 157 (314)
T 3com_A 84 PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYL---HFMRKIHRDIKAGNIL 157 (314)
T ss_dssp TTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEE
T ss_pred CCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH---HhCCCcCCCcCHHHEE
Confidence 9999999999999999999999999999999853 245689999999999999999999 6679999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhh
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEM 278 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~ 278 (337)
++.++.++|+|||.+......... .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||..... .
T Consensus 158 ~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~ 231 (314)
T 3com_A 158 LNTEGHAKLADFGVAGQLTDTMAK--RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP----M 231 (314)
T ss_dssp ECTTCCEEECCCTTCEECBTTBSC--BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH----H
T ss_pred ECCCCCEEEeecccchhhhhhccc--cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh----H
Confidence 999999999999998765433221 2235689999999999998899999999999999999999999865321 1
Q ss_pred hHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 279 DMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
...... .....+.. ......+..+.+++.+||+.||++|||+.++++|
T Consensus 232 ~~~~~~---~~~~~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 232 RAIFMI---PTNPPPTF--------RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp HHHHHH---HHSCCCCC--------SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred HHHHHH---hcCCCccc--------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 111111 11111100 0111223458999999999999999999999986
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-44 Score=314.50 Aligned_cols=262 Identities=23% Similarity=0.345 Sum_probs=194.8
Q ss_pred ccccccccceeccCcceEEEEeEEec-CCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELP-GSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR 117 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 117 (337)
..++|++.+.||+|+||.||++.+.. ..++..||+|.+......... .+.+.+|+.++++++
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~-----------------~~~~~~e~~~l~~l~ 94 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQRE-----------------IEEFLSEAACMKDFS 94 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHH-----------------HHHHHHHHHHHHTCC
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhH-----------------HHHHHHHHHHHhcCC
Confidence 66789999999999999999987764 235678999998755432211 156788999999999
Q ss_pred CCCcccceeEEEcCC-----eeEEEEEeccCCCHHHHHHHhc--CCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 040898 118 HRNILPLLAHMVRPN-----CHLLVYEFMKNGSLQDILYDVS--QGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHR 190 (337)
Q Consensus 118 hpniv~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~ 190 (337)
||||+++++++.+.. ..++|+||+++++|.+++.... .....+++..++.++.|++.||.|| |++|++|+
T Consensus 95 h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~ 171 (313)
T 3brb_A 95 HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL---SNRNFLHR 171 (313)
T ss_dssp CTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHH---HTTTCCCC
T ss_pred CCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHH---HhCCcccC
Confidence 999999999987754 3599999999999999985432 2345689999999999999999999 77799999
Q ss_pred CCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCC
Q 040898 191 DIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVD 269 (337)
Q Consensus 191 di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~ 269 (337)
||+|+||+++.++.++|+|||++................+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.
T Consensus 172 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~ 251 (313)
T 3brb_A 172 DLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYP 251 (313)
T ss_dssp CCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred CCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCc
Confidence 9999999999999999999999877654332222233457888999999999889999999999999999999 889986
Q ss_pred CCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 270 DFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
..... ............. .+...+..+.+++.+||+.||++|||+.+++++
T Consensus 252 ~~~~~----~~~~~~~~~~~~~-------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 252 GVQNH----EMYDYLLHGHRLK-------------QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp TCCGG----GHHHHHHTTCCCC-------------CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred cCCHH----HHHHHHHcCCCCC-------------CCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 54221 2222111111111 111223458999999999999999999999863
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=336.00 Aligned_cols=266 Identities=24% Similarity=0.366 Sum_probs=202.1
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|+++++||+|+||+||++.+.. +++.||+|++............. ........+.+.+|+.++++++|
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~------~~~~~~~~~~~~~E~~~l~~l~h 105 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKN--GHSEKAIKVIKKSQFDKGRYSDD------NKNIEKFHEEIYNEISLLKSLDH 105 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETT--TCCEEEEEEEEC----------------------CTHHHHHHHHHHHHTCCC
T ss_pred cccceEEEeEecccCCeEEEEEEECC--CCcEEEEEEEEhhhccccccccc------chhhHHHHHHHHHHHHHHHhCCC
Confidence 56789999999999999999999876 89999999987654321100000 00000112578899999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++++.++...++||||+++|+|.+++.. ...+++..++.++.||+.||.|| |+.|++|+||+|+||+
T Consensus 106 pniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~Dlkp~Nil 178 (504)
T 3q5i_A 106 PNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYL---HKHNIVHRDIKPENIL 178 (504)
T ss_dssp TTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEE
T ss_pred CCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeEeCCCcHHHEE
Confidence 9999999999999999999999999999998854 34589999999999999999999 6679999999999999
Q ss_pred ecCCC---CeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCc
Q 040898 199 IDDDM---EARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHT 275 (337)
Q Consensus 199 ~~~~~---~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~ 275 (337)
++.++ .++|+|||++........ .....||+.|+|||++.+ .++.++||||+|+++|+|++|.+||....
T Consensus 179 ~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~--- 251 (504)
T 3q5i_A 179 LENKNSLLNIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQN--- 251 (504)
T ss_dssp ESSTTCCSSEEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSS---
T ss_pred EecCCCCccEEEEECCCCEEcCCCCc---cccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCC---
Confidence 98776 699999999987654322 234579999999999875 58999999999999999999999996532
Q ss_pred hhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 276 EEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.......+.. ........ .+...+..+.+|+.+||+.||.+|||+.|+|+|
T Consensus 252 -~~~~~~~i~~---~~~~~~~~-------~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 252 -DQDIIKKVEK---GKYYFDFN-------DWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp -HHHHHHHHHH---CCCCCCHH-------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -HHHHHHHHHc---CCCCCCcc-------ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 1222222221 11110000 011223458999999999999999999999987
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=313.97 Aligned_cols=253 Identities=26% Similarity=0.364 Sum_probs=207.2
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++.+.||+|+||.||++.+.. ++..||+|.+...... .+.+.+|+.++++++|
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~--------------------~~~~~~E~~~l~~l~h 68 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKK--YSLTVAVKTLKEDTME--------------------VEEFLKEAAVMKEIKH 68 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGG--GTEEEEEEEECSCSTH--------------------HHHHHHHHHHHHHCCC
T ss_pred cccceeEEeecCCCCceeEEEeEecC--CCEEEEEEecCcCHHH--------------------HHHHHHHHHHHHhCCC
Confidence 67789999999999999999999976 8999999998654321 1567789999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++++.+++..++||||+++++|.+++.. .....+++..++.++.|++.||.+| |+.|++|+||+|+||+
T Consensus 69 ~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~l---H~~~i~H~dikp~Nil 143 (288)
T 3kfa_A 69 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYL---EKKNFIHRDLAARNCL 143 (288)
T ss_dssp TTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHH--CCTTTSCHHHHHHHHHHHHHHHHHH---HHHTCCCSCCSGGGEE
T ss_pred CCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHh--cccCCccHhHHHHHHHHHHHHHHHH---HHCCccCCCCCcceEE
Confidence 9999999999999999999999999999999965 3445689999999999999999999 6679999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCchh
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHTEE 277 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~ 277 (337)
++.++.++|+|||.+......... ......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.....
T Consensus 144 ~~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~---- 218 (288)
T 3kfa_A 144 VGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---- 218 (288)
T ss_dssp ECGGGCEEECCCCGGGTSCSSSSE-EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG----
T ss_pred EcCCCCEEEccCccceeccCCccc-cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH----
Confidence 999999999999999876544322 2233456788999999998889999999999999999999 9999865422
Q ss_pred hhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 278 MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
......+........ +...+..+.+++.+||+.||.+|||+.++++
T Consensus 219 ~~~~~~~~~~~~~~~-------------~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 219 SQVYELLEKDYRMER-------------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp GGHHHHHHTTCCCCC-------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhccCCCCC-------------CCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 122222222111111 1122345899999999999999999999975
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=313.68 Aligned_cols=263 Identities=23% Similarity=0.311 Sum_probs=197.0
Q ss_pred ccccccccceeccCcceEEEEeEEe--cCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAEL--PGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT 116 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 116 (337)
..++|++++.||+|+||.||++... ...+++.||+|++....... ...+.+|+.+++++
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~-------------------~~~~~~E~~~l~~l 68 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH-------------------LRDFEREIEILKSL 68 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHH-------------------HHHHHHHHHHHHTC
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHH-------------------HHHHHHHHHHHHhC
Confidence 3577999999999999999998742 23489999999986542211 15678899999999
Q ss_pred CCCCcccceeEEEc--CCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCC
Q 040898 117 RHRNILPLLAHMVR--PNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKP 194 (337)
Q Consensus 117 ~hpniv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~ 194 (337)
+||||+++++++.. ....++||||+++++|.+++.. ....+++..++.++.|++.||.|| |+.|++|+||+|
T Consensus 69 ~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dikp 142 (295)
T 3ugc_A 69 QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLAT 142 (295)
T ss_dssp CCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHH---CGGGCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSG
T ss_pred CCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHh---cccccCHHHHHHHHHHHHHHHHHH---hcCCcccCCCCH
Confidence 99999999999855 3568999999999999999965 344689999999999999999999 667999999999
Q ss_pred CceeecCCCCeEEecccCccccCCCCce-eeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCC
Q 040898 195 ANVLIDDDMEARISDFGHGKLMPDGHAQ-ITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFG 273 (337)
Q Consensus 195 ~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~ 273 (337)
+||+++.++.++|+|||++......... .......++..|+|||.+.+..++.++||||||+++|+|++|..||.....
T Consensus 143 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~ 222 (295)
T 3ugc_A 143 RNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA 222 (295)
T ss_dssp GGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHH
T ss_pred hhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChH
Confidence 9999999999999999999876543221 112234467779999999998999999999999999999999999754210
Q ss_pred C---------chhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 274 H---------TEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 274 ~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
. ................. ....+...+..+.+++.+||+.||++|||+.++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 223 EFMRMIGNDKQGQMIVFHLIELLKNNG----------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHHCTTCCTHHHHHHHHHHHHTTC----------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHhhhcCccccchhHHHHHHHHhccC----------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0 00000001111111110 01112233455899999999999999999999975
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=319.20 Aligned_cols=272 Identities=21% Similarity=0.260 Sum_probs=204.7
Q ss_pred ccccccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHH
Q 040898 33 DLAFLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIIT 112 (337)
Q Consensus 33 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 112 (337)
..+.++..++|++++.||+|+||.||++.+.. +++.||+|++........ ...+.+|+.+
T Consensus 19 ~g~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~------------------~~~~~~E~~~ 78 (364)
T 3qyz_A 19 RGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTY------------------CQRTLREIKI 78 (364)
T ss_dssp C-CBCCCTTTEEEEEEEEECSSEEEEEEEETT--TTEEEEEEEECCTTCHHH------------------HHHHHHHHHH
T ss_pred ccEeccccccEEEEEEeecCCCeEEEEEEECC--CCeEEEEEEeccccCcHH------------------HHHHHHHHHH
Confidence 34556667889999999999999999998876 899999999864332111 1567889999
Q ss_pred HHhcCCCCcccceeEEEcC-----CeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCe
Q 040898 113 ANQTRHRNILPLLAHMVRP-----NCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRL 187 (337)
Q Consensus 113 l~~l~hpniv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi 187 (337)
+++++||||+++++++... ...++|+||+++ +|.+++.. ..+++..++.++.|++.||.|| |+.|+
T Consensus 79 l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~~-~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~L---H~~~i 149 (364)
T 3qyz_A 79 LLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKT-----QHLSNDHICYFLYQILRGLKYI---HSANV 149 (364)
T ss_dssp HHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCSE-EHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHH---HHTTE
T ss_pred HHhcCCCCCccceeEEecCCccccceEEEEEcccCc-CHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHH---HHCCe
Confidence 9999999999999998655 468999999975 89998853 3589999999999999999999 66799
Q ss_pred EecCCCCCceeecCCCCeEEecccCccccCCCCcee-eeecccCCCCccCccccc-cCCCCCcccchhhhHHHHHHHhCC
Q 040898 188 IHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQI-TVKCMVGTMGYMAPESLQ-TETISDKCDIYSFGVLLAVLVMGK 265 (337)
Q Consensus 188 ~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~-~~~~~~~~DiwslG~i~~~ll~g~ 265 (337)
+|+||+|+||+++.++.++|+|||++.......... ......+|+.|+|||++. +..++.++||||||+++|+|++|.
T Consensus 150 vH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~ 229 (364)
T 3qyz_A 150 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229 (364)
T ss_dssp ECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSS
T ss_pred ecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCC
Confidence 999999999999999999999999998764332211 123357899999999865 445899999999999999999999
Q ss_pred CCCCCCCCCchhhhHHHHHHhhhccCCcchhh-----------------hhcccCCchHHHHHHHHHHHhhhccCCCCCC
Q 040898 266 FPVDDFFGHTEEMDMVKWMRNVIFSENPNRAI-----------------NSKLLGNGYEEQMLLVLKLACFCTLKDPDER 328 (337)
Q Consensus 266 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 328 (337)
.||...........+.. ........... .........+.....+.+|+.+||+.||++|
T Consensus 230 ~pf~~~~~~~~~~~i~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 305 (364)
T 3qyz_A 230 PIFPGKHYLDQLNHILG----ILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKR 305 (364)
T ss_dssp CSSCCSSGGGHHHHHHH----HHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTS
T ss_pred CCCCCCChHHHHHHHHH----HhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhC
Confidence 99965433222222211 11111000000 0000000011223458899999999999999
Q ss_pred CChhhhhcC
Q 040898 329 PSSKDVRSM 337 (337)
Q Consensus 329 ps~~ell~~ 337 (337)
||+.|+|+|
T Consensus 306 ~t~~e~l~h 314 (364)
T 3qyz_A 306 IEVEQALAH 314 (364)
T ss_dssp CCHHHHHTS
T ss_pred CCHHHHhcC
Confidence 999999987
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=311.46 Aligned_cols=258 Identities=21% Similarity=0.296 Sum_probs=202.5
Q ss_pred cccccccccc-eeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc
Q 040898 38 KKEDCFDSLK-KIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT 116 (337)
Q Consensus 38 ~~~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 116 (337)
-..++|.+.+ .||+|+||.||++.+....++..||+|++........ ...+.+|+.+++++
T Consensus 6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~------------------~~~~~~E~~~l~~l 67 (287)
T 1u59_A 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD------------------TEEMMREAQIMHQL 67 (287)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHH------------------HHHHHHHHHHHHHC
T ss_pred ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhH------------------HHHHHHHHHHHHhC
Confidence 3556788877 9999999999999876555788999999976532211 15678899999999
Q ss_pred CCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 040898 117 RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPAN 196 (337)
Q Consensus 117 ~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~n 196 (337)
+||||+++++++ ..+..++||||+++++|.+++.. ....+++..++.++.|++.||.+| |+.|++|+||+|+|
T Consensus 68 ~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~N 140 (287)
T 1u59_A 68 DNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYL---EEKNFVHRDLAARN 140 (287)
T ss_dssp CCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGG
T ss_pred CCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHH---HHCCEeeCCCchhe
Confidence 999999999998 45678999999999999999843 445689999999999999999999 66799999999999
Q ss_pred eeecCCCCeEEecccCccccCCCCceee-eecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCC
Q 040898 197 VLIDDDMEARISDFGHGKLMPDGHAQIT-VKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGH 274 (337)
Q Consensus 197 il~~~~~~~~l~dfg~~~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~ 274 (337)
|+++.++.++|+|||++........... .....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.....
T Consensus 141 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~- 219 (287)
T 1u59_A 141 VLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG- 219 (287)
T ss_dssp EEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-
T ss_pred EEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH-
Confidence 9999999999999999987654332211 223346788999999988889999999999999999998 9999965432
Q ss_pred chhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 275 TEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
......+...... ..++..+..+.+++.+||+.||++|||+.+++++
T Consensus 220 ---~~~~~~i~~~~~~-------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 266 (287)
T 1u59_A 220 ---PEVMAFIEQGKRM-------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQR 266 (287)
T ss_dssp ---HHHHHHHHTTCCC-------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ---HHHHHHHhcCCcC-------------CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1222222111110 0111233458999999999999999999999864
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=325.76 Aligned_cols=271 Identities=19% Similarity=0.261 Sum_probs=207.2
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
.+++|++.+.||+|+||.||++.+.. +++.||+|++........ .+.+.+|+.++++++|
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~------------------~~~~~~E~~~l~~l~h 66 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKK--TGDLFAIKVFNNISFLRP------------------VDVQMREFEVLKKLNH 66 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEECGGGGGSC------------------HHHHHHHHHHHHHCCC
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECC--CCcEEEEEEeccccccch------------------HHHHHHHHHHHHhcCC
Confidence 46789999999999999999999876 899999999865432211 1456789999999999
Q ss_pred CCcccceeEEEcCC--eeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 040898 119 RNILPLLAHMVRPN--CHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPAN 196 (337)
Q Consensus 119 pniv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~n 196 (337)
|||+++++++.... ..++||||+++++|.+++.... ....+++..++.++.|++.||.|| |+.|++|+||||+|
T Consensus 67 pnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dlkp~N 142 (396)
T 4eut_A 67 KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHL---RENGIVHRNIKPGN 142 (396)
T ss_dssp TTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGG
T ss_pred CCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHH---HHCCEEECCcCHHH
Confidence 99999999988765 6799999999999999985422 122389999999999999999999 66799999999999
Q ss_pred eee----cCCCCeEEecccCccccCCCCceeeeecccCCCCccCcccccc--------CCCCCcccchhhhHHHHHHHhC
Q 040898 197 VLI----DDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQT--------ETISDKCDIYSFGVLLAVLVMG 264 (337)
Q Consensus 197 il~----~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~--------~~~~~~~DiwslG~i~~~ll~g 264 (337)
|++ +.++.++|+|||++........ .....+|+.|+|||++.+ ..++.++||||||+++|+|++|
T Consensus 143 Ill~~~~~~~~~~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg 219 (396)
T 4eut_A 143 IMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219 (396)
T ss_dssp EEEEECTTSCEEEEECCGGGCEECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHS
T ss_pred EEEeecCCCceeEEEecCCCceEccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHC
Confidence 999 7778899999999987654322 123568999999999865 4567889999999999999999
Q ss_pred CCCCCCCCCCchhhhHHHHHHhhhccCCcchh---------h--hhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhh
Q 040898 265 KFPVDDFFGHTEEMDMVKWMRNVIFSENPNRA---------I--NSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKD 333 (337)
Q Consensus 265 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~--~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e 333 (337)
..||...............+............ . ...............+.+++.+||+.||++|||+.+
T Consensus 220 ~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e 299 (396)
T 4eut_A 220 SLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQ 299 (396)
T ss_dssp SCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHH
T ss_pred CCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHH
Confidence 99997654433333322222111111000000 0 000111233667778999999999999999999999
Q ss_pred hhc
Q 040898 334 VRS 336 (337)
Q Consensus 334 ll~ 336 (337)
+++
T Consensus 300 ~l~ 302 (396)
T 4eut_A 300 FFA 302 (396)
T ss_dssp HHH
T ss_pred HHH
Confidence 875
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=311.64 Aligned_cols=257 Identities=25% Similarity=0.400 Sum_probs=189.0
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++.++||+|+||.||++.+. ..+|+|.+......... ...+.+|+.++++++|
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~-----~~vavK~~~~~~~~~~~-----------------~~~~~~E~~~l~~l~h 79 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWH-----GDVAVKMLNVTAPTPQQ-----------------LQAFKNEVGVLRKTRH 79 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESS-----SEEEEEEESCSSCCHHH-----------------HHHHHHHHHHHTTCCC
T ss_pred CccceeeeeEecCCCCeEEEEEEEc-----CceEEEEEeccCCCHHH-----------------HHHHHHHHHHHHhCCC
Confidence 4678999999999999999988653 35999998765443221 1568889999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||++++++ ......++||||+++++|.+++.. ....+++..++.++.|++.||.|| |+.|++|+||+|+||+
T Consensus 80 ~~iv~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~l---H~~~i~H~Dlkp~Nil 152 (289)
T 3og7_A 80 VNILLFMGY-STAPQLAIVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYL---HAKSIIHRDLKSNNIF 152 (289)
T ss_dssp TTBCCEEEE-ECSSSCEEEEECCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEE
T ss_pred CcEEEEEee-ccCCccEEEEEecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHH---HhCCcccccCccceEE
Confidence 999999995 456678999999999999999843 445689999999999999999999 6679999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccc---cCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCc
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQ---TETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHT 275 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~ 275 (337)
++.++.++|+|||++................+++.|+|||.+. +..++.++||||||+++|+|++|..||......
T Consensus 153 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~- 231 (289)
T 3og7_A 153 LHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR- 231 (289)
T ss_dssp EETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH-
T ss_pred ECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH-
Confidence 9999999999999987655433333334457899999999986 556788999999999999999999999754332
Q ss_pred hhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 276 EEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
................ .......+..+.+++.+||+.||++|||+.++++
T Consensus 232 --~~~~~~~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 232 --DQIIEMVGRGSLSPDL---------SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp --HHHHHHHHHTSCCCCT---------TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --HHHHHHhcccccCcch---------hhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 1222222221111111 0111223345899999999999999999999986
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=313.09 Aligned_cols=256 Identities=25% Similarity=0.395 Sum_probs=196.8
Q ss_pred ccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc
Q 040898 37 LKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT 116 (337)
Q Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 116 (337)
....++|++.+.||+|+||.||++.+.. +++.||+|++....... ..+.+|+.+++++
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~--------------------~~~~~e~~~l~~l 77 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVK--TGQLAAIKVMDVTGDEE--------------------EEIKQEINMLKKY 77 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEECCSSTT--------------------HHHHHHHHHHHHH
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECC--CCCeEEEEEEecCcccH--------------------HHHHHHHHHHHhc
Confidence 3478899999999999999999999876 89999999986543211 4577899999998
Q ss_pred -CCCCcccceeEEEc------CCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEe
Q 040898 117 -RHRNILPLLAHMVR------PNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIH 189 (337)
Q Consensus 117 -~hpniv~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h 189 (337)
.||||+++++++.. ....++||||+++++|.+++.. .....+++..++.++.||+.||.|| |+.|++|
T Consensus 78 ~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~ivH 152 (326)
T 2x7f_A 78 SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN--TKGNTLKEEWIAYICREILRGLSHL---HQHKVIH 152 (326)
T ss_dssp CCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHH--SGGGCCCHHHHHHHHHHHHHHHHHH---HHTTCCC
T ss_pred cCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHh--cccCCCCHHHHHHHHHHHHHHHHHH---HHCCccc
Confidence 89999999999876 4678999999999999999965 2345689999999999999999999 6679999
Q ss_pred cCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccc-----cCCCCCcccchhhhHHHHHHHhC
Q 040898 190 RDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQ-----TETISDKCDIYSFGVLLAVLVMG 264 (337)
Q Consensus 190 ~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~-----~~~~~~~~DiwslG~i~~~ll~g 264 (337)
+||+|+||+++.++.++|+|||++........ ......+++.|+|||++. +..++.++||||||+++|+|++|
T Consensus 153 ~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g 230 (326)
T 2x7f_A 153 RDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230 (326)
T ss_dssp CCCSGGGEEECTTCCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHS
T ss_pred cCCcHHHEEEcCCCCEEEeeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhC
Confidence 99999999999999999999999876543221 122346899999999987 45688999999999999999999
Q ss_pred CCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 265 KFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 265 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
..||..... ......+ .....+.. .....+..+.+++.+||+.||.+|||+.++++|
T Consensus 231 ~~p~~~~~~----~~~~~~~---~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 231 APPLCDMHP----MRALFLI---PRNPAPRL---------KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp SCTTTTSCH----HHHHHHH---HHSCCCCC---------SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCCCCCCcH----HHHHHHh---hcCccccC---------CccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 999864321 1111111 11111100 001122348899999999999999999999987
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=319.55 Aligned_cols=274 Identities=26% Similarity=0.395 Sum_probs=188.3
Q ss_pred ccccccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHH
Q 040898 33 DLAFLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIIT 112 (337)
Q Consensus 33 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 112 (337)
.+.+.-..++|++.+.||+|+||.||++.+.. +++.||+|.+........ .+.+.+|+.+
T Consensus 7 ~~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~------------------~~~~~~e~~~ 66 (303)
T 2vwi_A 7 ALPWSINRDDYELQEVIGSGATAVVQAAYCAP--KKEKVAIKRINLEKCQTS------------------MDELLKEIQA 66 (303)
T ss_dssp ------CCCCCEEEEECC---CCCEEEEEC------CEEEEECCC----------------------------------C
T ss_pred ccccccchhhhhhhheeccccceEEEEEEECC--CCcEEEEEEEEhhhcchh------------------HHHHHHHHHH
Confidence 44455567889999999999999999998876 889999999865432111 1467789999
Q ss_pred HHhcCCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcC----CcccCChHHHHHHHHHHHHHHHHHhhCCCCCeE
Q 040898 113 ANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQ----GRRELDWPARHRIARGIASGLEYLHMCHRPRLI 188 (337)
Q Consensus 113 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~ 188 (337)
+++++||||+++++++..++..++||||+++++|.+++..... ....+++..++.++.|++.||.|| |+.|++
T Consensus 67 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~ 143 (303)
T 2vwi_A 67 MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYL---HKNGQI 143 (303)
T ss_dssp CCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHH---HHTTCC
T ss_pred HhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHH---HhCCCC
Confidence 9999999999999999999999999999999999999865322 245689999999999999999999 667999
Q ss_pred ecCCCCCceeecCCCCeEEecccCccccCCCCc---eeeeecccCCCCccCcccccc-CCCCCcccchhhhHHHHHHHhC
Q 040898 189 HRDIKPANVLIDDDMEARISDFGHGKLMPDGHA---QITVKCMVGTMGYMAPESLQT-ETISDKCDIYSFGVLLAVLVMG 264 (337)
Q Consensus 189 h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~i~~~ll~g 264 (337)
|+||+|+||+++.++.++|+|||.+........ ........+++.|+|||.+.+ ..++.++|+||||+++|+|++|
T Consensus 144 H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g 223 (303)
T 2vwi_A 144 HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATG 223 (303)
T ss_dssp CCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHS
T ss_pred CCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhC
Confidence 999999999999999999999999876543221 111223568999999999865 5678999999999999999999
Q ss_pred CCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 265 KFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 265 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
..||....... ......... ........... .........+.+++.+||+.||.+|||+.++++|
T Consensus 224 ~~pf~~~~~~~---~~~~~~~~~-~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 224 AAPYHKYPPMK---VLMLTLQND-PPSLETGVQDK----EMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp SCTTTTSCGGG---HHHHHHTSS-CCCTTC---------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCCCccCchhh---HHHHHhccC-CCccccccccc----hhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 99997643221 111111110 00000000000 1111223458899999999999999999999987
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=321.63 Aligned_cols=262 Identities=25% Similarity=0.392 Sum_probs=204.4
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc-C
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT-R 117 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~ 117 (337)
-.++|++.+.||+|++|.||++.+.. +|+.||||++............ ......+.+|+.+++++ +
T Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~a~~~~--~g~~vavK~~~~~~~~~~~~~~-----------~~~~~~~~~E~~~l~~l~~ 158 (365)
T 2y7j_A 92 FYQKYDPKDVIGRGVSSVVRRCVHRA--TGHEFAVKIMEVTAERLSPEQL-----------EEVREATRRETHILRQVAG 158 (365)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEETTSSCCCHHHH-----------HHHHHHHHHHHHHHHHHTT
T ss_pred hhhhcccceEEecCCCEEEEEEEECC--CCcEEEEEEEEccccccCHHHH-----------HHHHHHHHHHHHHHHHhcC
Confidence 34679999999999999999998865 8999999998765432111100 01115678899999999 8
Q ss_pred CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCce
Q 040898 118 HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANV 197 (337)
Q Consensus 118 hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ni 197 (337)
||||+++++++......++||||+++++|.+++.. ...+++..+..++.||+.||.|| |+.|++|+||+|+||
T Consensus 159 hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~L---H~~gi~H~Dlkp~NI 231 (365)
T 2y7j_A 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFL---HANNIVHRDLKPENI 231 (365)
T ss_dssp CTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGE
T ss_pred CCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHE
Confidence 99999999999999999999999999999999853 34689999999999999999999 667999999999999
Q ss_pred eecCCCCeEEecccCccccCCCCceeeeecccCCCCccCcccccc------CCCCCcccchhhhHHHHHHHhCCCCCCCC
Q 040898 198 LIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQT------ETISDKCDIYSFGVLLAVLVMGKFPVDDF 271 (337)
Q Consensus 198 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~------~~~~~~~DiwslG~i~~~ll~g~~pf~~~ 271 (337)
+++.++.++|+|||++........ .....+|+.|+|||++.+ ..++.++||||||+++|+|++|..||...
T Consensus 232 l~~~~~~ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~ 308 (365)
T 2y7j_A 232 LLDDNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR 308 (365)
T ss_dssp EECTTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EECCCCCEEEEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCC
Confidence 999999999999999887654322 234579999999999863 35788999999999999999999998642
Q ss_pred CCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 272 FGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
. .......+.. ........ .....+..+.+++.+||+.||++|||+.++++|
T Consensus 309 ~----~~~~~~~i~~---~~~~~~~~-------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 309 R----QILMLRMIME---GQYQFSSP-------EWDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp S----HHHHHHHHHH---TCCCCCHH-------HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred C----HHHHHHHHHh---CCCCCCCc-------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1 1111111111 11110000 001123448899999999999999999999987
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=322.39 Aligned_cols=265 Identities=18% Similarity=0.273 Sum_probs=202.8
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC--
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR-- 117 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-- 117 (337)
.++|++.+.||+|+||.||++.+.. +++.||+|++..... . ...+.+|+.+++.++
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~--~------------------~~~~~~E~~~l~~l~~~ 93 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQ--GKKFVAMKVVKSAEH--Y------------------TETALDEIRLLKSVRNS 93 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT--TTEEEEEEEECSCHH--H------------------HHHHHHHHHHHHHHHHS
T ss_pred CCeEEEEEEeeecCCeeEEEEEecC--CCeEEEEEEEecCCc--c------------------hHHHHHHHHHHHHHhhc
Confidence 4789999999999999999998876 899999999863311 0 146777888888885
Q ss_pred ------CCCcccceeEEE----cCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCC-C
Q 040898 118 ------HRNILPLLAHMV----RPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRP-R 186 (337)
Q Consensus 118 ------hpniv~~~~~~~----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~-g 186 (337)
||||+++++++. +....++||||+ +++|.+.+.. .....+++..++.++.||+.||.|| |++ |
T Consensus 94 ~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~l---H~~~g 167 (397)
T 1wak_A 94 DPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIK--SNYQGLPLPCVKKIIQQVLQGLDYL---HTKCR 167 (397)
T ss_dssp CTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHH---HHTTC
T ss_pred CCCCCCcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHh--cccCCCCHHHHHHHHHHHHHHHHHH---HHhCC
Confidence 788999999987 566889999999 5566666644 3335689999999999999999999 666 9
Q ss_pred eEecCCCCCceeecCCC-------------------------------------------------CeEEecccCccccC
Q 040898 187 LIHRDIKPANVLIDDDM-------------------------------------------------EARISDFGHGKLMP 217 (337)
Q Consensus 187 i~h~di~~~nil~~~~~-------------------------------------------------~~~l~dfg~~~~~~ 217 (337)
++|+||||+||+++.++ .++|+|||.+....
T Consensus 168 ivHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~ 247 (397)
T 1wak_A 168 IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH 247 (397)
T ss_dssp EECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETT
T ss_pred EecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccc
Confidence 99999999999998775 79999999998754
Q ss_pred CCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchh--hhHHHHHHhhhccCCcch
Q 040898 218 DGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEE--MDMVKWMRNVIFSENPNR 295 (337)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 295 (337)
.. .....+|+.|+|||++.+..++.++||||||+++|+|++|..||......... ......+...........
T Consensus 248 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 322 (397)
T 1wak_A 248 KH-----FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKL 322 (397)
T ss_dssp BC-----SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHH
T ss_pred cc-----CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHH
Confidence 33 23346899999999999999999999999999999999999999765443321 111222222111111000
Q ss_pred hhhhc----------------------------ccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 296 AINSK----------------------------LLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 296 ~~~~~----------------------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
..... ............+.+|+.+||+.||++|||+.|+|+|
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 323 IVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp HHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred hhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 00000 0012245667789999999999999999999999987
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=315.99 Aligned_cols=260 Identities=22% Similarity=0.313 Sum_probs=200.2
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++.+.||+|+||.||++.+.. +++.||+|++....... ...+.+|+.+++.++|
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~-------------------~~~~~~E~~~l~~l~h 85 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLH--DGHFYALKRILCHEQQD-------------------REEAQREADMHRLFNH 85 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETT--TCCEEEEEEEEESSHHH-------------------HHHHHHHHHHHHTCCC
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecC--CCcEEEEEEEecCCHHH-------------------HHHHHHHHHHHhhcCC
Confidence 55789999999999999999999866 89999999986532211 1567889999999999
Q ss_pred CCcccceeEEE----cCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCC
Q 040898 119 RNILPLLAHMV----RPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKP 194 (337)
Q Consensus 119 pniv~~~~~~~----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~ 194 (337)
|||+++++++. .....++|+||+++++|.+++......+..+++..++.++.|++.||.|| |+.|++|+||+|
T Consensus 86 ~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~L---H~~~ivH~dlkp 162 (317)
T 2buj_A 86 PNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAI---HAKGYAHRDLKP 162 (317)
T ss_dssp TTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCG
T ss_pred CCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCH
Confidence 99999999986 34578999999999999999987666677899999999999999999999 667999999999
Q ss_pred CceeecCCCCeEEecccCccccCCCCcee-------eeecccCCCCccCccccccCC---CCCcccchhhhHHHHHHHhC
Q 040898 195 ANVLIDDDMEARISDFGHGKLMPDGHAQI-------TVKCMVGTMGYMAPESLQTET---ISDKCDIYSFGVLLAVLVMG 264 (337)
Q Consensus 195 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~-------~~~~~~~~~~~~~PE~~~~~~---~~~~~DiwslG~i~~~ll~g 264 (337)
+||+++.++.++|+|||.+.......... ......+++.|+|||.+.+.. ++.++||||||+++|+|++|
T Consensus 163 ~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g 242 (317)
T 2buj_A 163 TNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFG 242 (317)
T ss_dssp GGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHS
T ss_pred HHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhC
Confidence 99999999999999999877543211000 001234699999999987654 68899999999999999999
Q ss_pred CCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 265 KFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 265 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
..||........ ........... ....+..+..+.+++.+||+.||++|||+.+++++
T Consensus 243 ~~p~~~~~~~~~--~~~~~~~~~~~-------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 243 EGPYDMVFQKGD--SVALAVQNQLS-------------IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp SCTTHHHHHTTS--CHHHHHHCC---------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCChhhhhcccc--hhhHHhhccCC-------------CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 999853211100 11111111000 00111223458999999999999999999999863
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=311.07 Aligned_cols=263 Identities=21% Similarity=0.297 Sum_probs=200.7
Q ss_pred cccccccceeccCcceEEEEeEEe--cCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAEL--PGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR 117 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 117 (337)
..+|++++.||+|+||.||++... ...+++.||+|++........ ...+.+|+.+++.++
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~------------------~~~~~~E~~~l~~l~ 81 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH------------------IADLKKEIEILRNLY 81 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CC------------------HHHHHHHHHHHHTCC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchh------------------HHHHHHHHHHHHhCC
Confidence 456999999999999999998832 233899999999875432211 156788999999999
Q ss_pred CCCcccceeEEEcC--CeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCC
Q 040898 118 HRNILPLLAHMVRP--NCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPA 195 (337)
Q Consensus 118 hpniv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ 195 (337)
||||+++++++... ...++||||+++++|.+++.. ....+++..++.++.|++.||.+| |++|++|+||+|+
T Consensus 82 h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dikp~ 155 (302)
T 4e5w_A 82 HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYL---GSRQYVHRDLAAR 155 (302)
T ss_dssp CTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGG
T ss_pred CCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHh---hcCCcccCCCchh
Confidence 99999999999876 678999999999999999954 234589999999999999999999 6679999999999
Q ss_pred ceeecCCCCeEEecccCccccCCCCce-eeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCC--
Q 040898 196 NVLIDDDMEARISDFGHGKLMPDGHAQ-ITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFF-- 272 (337)
Q Consensus 196 nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~-- 272 (337)
||+++.++.++|+|||++......... .......+|..|+|||.+.+..++.++|+||||+++|+|++|..|+....
T Consensus 156 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 235 (302)
T 4e5w_A 156 NVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMAL 235 (302)
T ss_dssp GEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH
T ss_pred eEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhH
Confidence 999999999999999999877654332 22234567888999999998888999999999999999999998864321
Q ss_pred ------CCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 273 ------GHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 273 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
.................... ...++..+..+.+++.+||+.||.+|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 236 FLKMIGPTHGQMTVTRLVNTLKEGKR----------LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHHCSCCGGGHHHHHHHHHHTTCC----------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HhhccCCcccccCHHHHHHHHhccCC----------CCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 00011111111111111110 1111233455899999999999999999999985
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=323.64 Aligned_cols=265 Identities=23% Similarity=0.342 Sum_probs=187.3
Q ss_pred ccccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHH
Q 040898 35 AFLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITAN 114 (337)
Q Consensus 35 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~ 114 (337)
..+...++|++++.||+|+||.||++.+.. +|+.||||++......... ...+.+|+.+++
T Consensus 23 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~--~~~~vaiK~~~~~~~~~~~-----------------~~~~~~E~~~l~ 83 (367)
T 2fst_X 23 TIWEVPERYQNLSPVGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIH-----------------AKRTYRELRLLK 83 (367)
T ss_dssp EEEEEETTEEEEEECC----CCEEEEEETT--TTEEEEEEECSSTTSSHHH-----------------HHHHHHHHHHHH
T ss_pred cccCCCCceEEeeEEeecCCeEEEEEEECC--CCCEEEEEEeCccccCHHH-----------------HHHHHHHHHHHH
Confidence 344566889999999999999999998876 8999999998654322111 156788999999
Q ss_pred hcCCCCcccceeEEEcC------CeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeE
Q 040898 115 QTRHRNILPLLAHMVRP------NCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLI 188 (337)
Q Consensus 115 ~l~hpniv~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~ 188 (337)
.++||||+++++++... ...|+++|++ +++|.+++.. ..+++..+..++.||+.||.|| |+.|++
T Consensus 84 ~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~L---H~~giv 154 (367)
T 2fst_X 84 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYI---HSADII 154 (367)
T ss_dssp HCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHH---HHTTCC
T ss_pred hCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHH---HHCCee
Confidence 99999999999998654 5679999999 6799888732 4689999999999999999999 667999
Q ss_pred ecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCcccccc-CCCCCcccchhhhHHHHHHHhCCCC
Q 040898 189 HRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQT-ETISDKCDIYSFGVLLAVLVMGKFP 267 (337)
Q Consensus 189 h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~i~~~ll~g~~p 267 (337)
|+||||+||+++.++.++|+|||++...... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|..|
T Consensus 155 H~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p 229 (367)
T 2fst_X 155 HRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 229 (367)
T ss_dssp CCCCCGGGEEECTTCCEEECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred eCCCCHhhEEECCCCCEEEeecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999998765432 234578999999999877 6789999999999999999999999
Q ss_pred CCCCCCCchhhhHHHHHHhhhccCCcchhhh------------------hcccCCchHHHHHHHHHHHhhhccCCCCCCC
Q 040898 268 VDDFFGHTEEMDMVKWMRNVIFSENPNRAIN------------------SKLLGNGYEEQMLLVLKLACFCTLKDPDERP 329 (337)
Q Consensus 268 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp 329 (337)
|.+... ......+......... .... ........+.....+.+|+.+||+.||++||
T Consensus 230 f~~~~~----~~~l~~i~~~~g~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~ 304 (367)
T 2fst_X 230 FPGTDH----IDQLKLILRLVGTPGA-ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 304 (367)
T ss_dssp CCCSSH----HHHHHHHHHHHCSCCH-HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSC
T ss_pred CCCCCH----HHHHHHHHHHhCCCCH-HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCc
Confidence 965322 1111112111111100 0000 0000000112235689999999999999999
Q ss_pred ChhhhhcC
Q 040898 330 SSKDVRSM 337 (337)
Q Consensus 330 s~~ell~~ 337 (337)
|+.++|+|
T Consensus 305 t~~e~L~h 312 (367)
T 2fst_X 305 TAAQALAH 312 (367)
T ss_dssp CHHHHHTS
T ss_pred CHHHHhcC
Confidence 99999987
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=330.73 Aligned_cols=253 Identities=13% Similarity=0.132 Sum_probs=191.7
Q ss_pred ccccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHH---H
Q 040898 35 AFLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEI---I 111 (337)
Q Consensus 35 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~---~ 111 (337)
++....++|++.+.||+|+||.||++.+.. +|+.||||++.......... .+.+.+|+ .
T Consensus 67 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~--~~~~vavK~~~~~~~~~~~~----------------~~~~~~E~~~l~ 128 (377)
T 3byv_A 67 ELGERPRTLVRGTVLGQEDPYAYLEATDQE--TGESFEVHVPYFTERPPSNA----------------IKQMKEEVLRLR 128 (377)
T ss_dssp SSSCCCEEEEEEEEEEEETTEEEEEEEC-C--CCCEEEEEEEEECC-CCTTH----------------HHHHHHHHHGGG
T ss_pred ecCCCCceEEEcceeecCCCEEEEEEEECC--CCcEEEEEEEeeccccchHH----------------HHHHHHHHHHHH
Confidence 344567889999999999999999999865 89999999997543322111 15677888 5
Q ss_pred HHHhcCCCCcccce-------eEEEcCC-----------------eeEEEEEeccCCCHHHHHHHhcC---CcccCChHH
Q 040898 112 TANQTRHRNILPLL-------AHMVRPN-----------------CHLLVYEFMKNGSLQDILYDVSQ---GRRELDWPA 164 (337)
Q Consensus 112 ~l~~l~hpniv~~~-------~~~~~~~-----------------~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~ 164 (337)
++++++||||++++ +++.+.+ ..|++|||+ +|+|.+++..... ....+++..
T Consensus 129 ~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~ 207 (377)
T 3byv_A 129 LLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHA 207 (377)
T ss_dssp GSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHH
T ss_pred hccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHH
Confidence 56666899999998 6665543 278999999 5799999965321 122344588
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccC-
Q 040898 165 RHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTE- 243 (337)
Q Consensus 165 ~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~- 243 (337)
++.++.||+.||.|| |++|++|+||||+||+++.++.++|+|||++..... ......| +.|+|||++.+.
T Consensus 208 ~~~i~~qi~~aL~~L---H~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~ 278 (377)
T 3byv_A 208 RLQLTLQVIRLLASL---HHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRA 278 (377)
T ss_dssp HHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHT
T ss_pred HHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccc
Confidence 889999999999999 667999999999999999999999999999886332 2234567 999999999887
Q ss_pred ----------CCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHH
Q 040898 244 ----------TISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLV 313 (337)
Q Consensus 244 ----------~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 313 (337)
.++.++||||||+++|+|++|..||.......... ... .. .+..+..+
T Consensus 279 ~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~-------~~~-~~--------------~~~~~~~~ 336 (377)
T 3byv_A 279 TISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSE-------WIF-RS--------------CKNIPQPV 336 (377)
T ss_dssp STHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSG-------GGG-SS--------------CCCCCHHH
T ss_pred cccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchh-------hhh-hh--------------ccCCCHHH
Confidence 78999999999999999999999986432211000 000 00 01123448
Q ss_pred HHHHhhhccCCCCCCCChhhhhcC
Q 040898 314 LKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 314 ~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.+|+.+||+.||++|||+.++++|
T Consensus 337 ~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 337 RALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp HHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred HHHHHHHcCCCchhCCCHHHHhhC
Confidence 899999999999999999999987
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=320.84 Aligned_cols=257 Identities=24% Similarity=0.353 Sum_probs=192.4
Q ss_pred ccccccccceeccCcceEEEEeEEec-CCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELP-GSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR 117 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 117 (337)
..++|++.+.||+|+||.||++.+.. ..++..||+|.+........ ...+.+|+.++.+++
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~------------------~~~~~~E~~~l~~l~ 104 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ------------------RRDFLGEASIMGQFD 104 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHH------------------HHHHHHHHHHHTTCC
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHH------------------HHHHHHHHHHHHhCC
Confidence 55789999999999999999987752 23678899999865432211 156888999999999
Q ss_pred CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCce
Q 040898 118 HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANV 197 (337)
Q Consensus 118 hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ni 197 (337)
||||+++++++.+++..++||||+++++|.+++.. .+..+++..++.++.|++.||.|| |+.|++|+||+|+||
T Consensus 105 h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dlkp~NI 178 (373)
T 2qol_A 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNI 178 (373)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGE
T ss_pred CCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeCCCCCcceE
Confidence 99999999999999999999999999999999953 345689999999999999999999 667999999999999
Q ss_pred eecCCCCeEEecccCccccCCCCce-eeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCc
Q 040898 198 LIDDDMEARISDFGHGKLMPDGHAQ-ITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHT 275 (337)
Q Consensus 198 l~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~ 275 (337)
+++.++.++|+|||++......... .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 179 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~-- 256 (373)
T 2qol_A 179 LINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-- 256 (373)
T ss_dssp EECTTCCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH--
T ss_pred EEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence 9999999999999998876543221 11122335678999999998889999999999999999998 9999865321
Q ss_pred hhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 276 EEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
......+....... .+...+..+.+++.+||+.||++|||+.++++
T Consensus 257 --~~~~~~i~~~~~~~-------------~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 257 --QDVIKAVDEGYRLP-------------PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp --HHHHHHHHTTEECC-------------CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --HHHHHHHHcCCCCC-------------CCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 22222222111111 11122345899999999999999999999875
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=312.43 Aligned_cols=253 Identities=29% Similarity=0.430 Sum_probs=195.3
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++.+.||+|+||.||.+.+.. +++.||+|.+........ .....+.+|+.+++.++|
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~----------------~~~~~~~~e~~~l~~l~h 70 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQL--TGHKVAVKILNRQKIRSL----------------DVVGKIKREIQNLKLFRH 70 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEEHHHHHHT----------------TCHHHHHHHHHHHHTCCC
T ss_pred eeccEEEEeeecCCCCeEEEEEEECC--CCceEEEEEeccccccch----------------hHHHHHHHHHHHHhcCCC
Confidence 45689999999999999999998865 899999999854321100 011567889999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++++.+++..++|+||+++++|.+++.. ...+++..++.++.|++.||.+| |++|++|+||+|+||+
T Consensus 71 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~Nil 143 (276)
T 2h6d_A 71 PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYC---HRHMVVHRDLKPENVL 143 (276)
T ss_dssp TTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHH---HHHCSSCCCCCGGGEE
T ss_pred CCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHH---HHCCCccCCCChhhEE
Confidence 9999999999999999999999999999999954 34588999999999999999999 6679999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCC-CCcccchhhhHHHHHHHhCCCCCCCCCCCchh
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETI-SDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEE 277 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~ 277 (337)
++.++.++|+|||.+........ .....+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||.... .
T Consensus 144 ~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~----~ 216 (276)
T 2h6d_A 144 LDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH----V 216 (276)
T ss_dssp ECTTSCEEECCCCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS----H
T ss_pred ECCCCCEEEeecccccccCCCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc----H
Confidence 99999999999999887644321 123468999999999987765 578999999999999999999986531 1
Q ss_pred hhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 278 MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
......+.. ..... +......+.+++.+||+.||++|||+.++++|
T Consensus 217 ~~~~~~~~~---~~~~~-----------~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 217 PTLFKKIRG---GVFYI-----------PEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp HHHHHHHHH---CCCCC-----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHHhhc---CcccC-----------chhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 122222211 11100 01122348899999999999999999999987
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=310.68 Aligned_cols=259 Identities=20% Similarity=0.256 Sum_probs=193.0
Q ss_pred ccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc
Q 040898 37 LKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT 116 (337)
Q Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 116 (337)
....++|++.+.||+|+||.||++.+.. +++.||+|++.......... ...+.+|+.+++.+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~----------------~~~~~~e~~~l~~l 91 (309)
T 2h34_A 30 GTQFGPYRLRRLVGRGGMGDVYEAEDTV--RERIVALKLMSETLSSDPVF----------------RTRMQREARTAGRL 91 (309)
T ss_dssp ----CCEEEEEEEEECSSSEEEEEEETT--TTEEEEEEECGGGGGGSHHH----------------HHHHHHHHHHHTTC
T ss_pred CcEeccEEEEEEEcCCCCeeEEEEEEcC--CCeEEEEEecCcccccCHHH----------------HHHHHHHHHHHhhc
Confidence 3456789999999999999999999876 89999999986553322211 15678899999999
Q ss_pred CCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 040898 117 RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPAN 196 (337)
Q Consensus 117 ~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~n 196 (337)
+||||+++++++..++..++|+||+++++|.+++.. ...+++..++.++.|++.||.|| |+.|++|+||+|+|
T Consensus 92 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dlkp~N 164 (309)
T 2h34_A 92 QEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAA---HAAGATHRDVKPEN 164 (309)
T ss_dssp CCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGG
T ss_pred CCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCcCCcCCCChHH
Confidence 999999999999999999999999999999999954 34689999999999999999999 66799999999999
Q ss_pred eeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCch
Q 040898 197 VLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTE 276 (337)
Q Consensus 197 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~ 276 (337)
|+++.++.++|+|||++......... ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||....
T Consensus 165 Il~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---- 239 (309)
T 2h34_A 165 ILVSADDFAYLVDFGIASATTDEKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ---- 239 (309)
T ss_dssp EEECTTSCEEECSCCC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH----
T ss_pred EEEcCCCCEEEecCccCccccccccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch----
Confidence 99999999999999998765443221 1234568999999999999889999999999999999999999986421
Q ss_pred hhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCC-Chhhhhc
Q 040898 277 EMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERP-SSKDVRS 336 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-s~~ell~ 336 (337)
...+...+. ........ ..+..+..+.+++.+||+.||++|| |++++++
T Consensus 240 ~~~~~~~~~---~~~~~~~~--------~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 240 LSVMGAHIN---QAIPRPST--------VRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHHHHHHHH---SCCCCGGG--------TSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHHHHHhc---cCCCCccc--------cCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 111111111 11111111 1112233488999999999999999 8888764
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=318.34 Aligned_cols=254 Identities=24% Similarity=0.356 Sum_probs=193.3
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCce----EEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHH
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKM----IAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITAN 114 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~ 114 (337)
..++|++++.||+|+||.||++.+.. +++. |++|.+......... ..+.+|+.+++
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~--~~~~~~~kv~iK~~~~~~~~~~~------------------~~~~~E~~~l~ 72 (327)
T 3lzb_A 13 KETEFKKIKVLGSGAFGTVYKGLWIP--EGEKVKIPVAIKELREATSPKAN------------------KEILDEAYVMA 72 (327)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECC--TTCSCCEEEEEEEECCCSSCCCH------------------HHHHHHHHHHT
T ss_pred CHhHceEEEEeeeCCCeEEEEEEEcC--CCceEEEEEEEEeeccccCHHHH------------------HHHHHHHHHHH
Confidence 56779999999999999999999875 5554 467766543322211 56788999999
Q ss_pred hcCCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCC
Q 040898 115 QTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKP 194 (337)
Q Consensus 115 ~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~ 194 (337)
.++||||+++++++..+. .+++++++.+++|.+++.. ....+++..++.++.|++.||.|| |++|++|+||||
T Consensus 73 ~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dikp 145 (327)
T 3lzb_A 73 SVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYL---EDRRLVHRDLAA 145 (327)
T ss_dssp TCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCG
T ss_pred hCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH---hhCCCcCCCCCH
Confidence 999999999999988765 7899999999999999865 345689999999999999999999 667999999999
Q ss_pred CceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCC
Q 040898 195 ANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFG 273 (337)
Q Consensus 195 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~ 273 (337)
+||+++.++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 146 ~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~ 225 (327)
T 3lzb_A 146 RNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 225 (327)
T ss_dssp GGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred HHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH
Confidence 999999999999999999987654443333334557888999999999999999999999999999999 9999975432
Q ss_pred CchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 274 HTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
. .....+........ ++.....+.+++.+||+.||.+|||+.++++
T Consensus 226 ~----~~~~~~~~~~~~~~-------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 226 S----EISSILEKGERLPQ-------------PPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp G----GHHHHHHTTCCCCC-------------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred H----HHHHHHHcCCCCCC-------------CccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 2 22222222111111 1112334889999999999999999999985
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=317.24 Aligned_cols=264 Identities=22% Similarity=0.255 Sum_probs=193.4
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++++.||+|+||.||++.+.. +++.||+|++......... ...+.+|+.+++.++|
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~-----------------~~~~~~E~~~l~~l~h 83 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAI--LERNVAIKKLSRPFQNQTH-----------------AKRAYRELVLMKCVNH 83 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETT--TTEEEEEEEEECTTSSHHH-----------------HHHHHHHHHHHHHCCC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECC--CCceEEEEEeccccCChHH-----------------HHHHHHHHHHHHhcCC
Confidence 45789999999999999999998876 8999999998754322111 1567789999999999
Q ss_pred CCcccceeEEEcCC------eeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 040898 119 RNILPLLAHMVRPN------CHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDI 192 (337)
Q Consensus 119 pniv~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di 192 (337)
|||+++++++.... ..++||||+++ +|.+.+. ..+++..+..++.|++.||.|| |++|++|+||
T Consensus 84 pniv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~i~~qi~~al~~l---H~~~ivH~Dl 153 (371)
T 2xrw_A 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHL---HSAGIIHRDL 153 (371)
T ss_dssp TTBCCEEEEECSCCSTTTCCEEEEEEECCSE-EHHHHHH------SCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCC
T ss_pred CCccceEEeeccccccccccceEEEEEcCCC-CHHHHHh------hccCHHHHHHHHHHHHHHHHHH---HHCCeecccC
Confidence 99999999987664 78999999976 7888773 2488899999999999999999 6679999999
Q ss_pred CCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCC
Q 040898 193 KPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFF 272 (337)
Q Consensus 193 ~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~ 272 (337)
+|+||+++.++.++|+|||++....... ......+|+.|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 154 kp~NIl~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 230 (371)
T 2xrw_A 154 KPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 230 (371)
T ss_dssp CGGGEEECTTSCEEECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CHHHEEEcCCCCEEEEEeeccccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999987654322 1233568999999999999999999999999999999999999996532
Q ss_pred CCchhhhHHHHHHhhh------------------ccCCc-----chh-hhhccc---CCchHHHHHHHHHHHhhhccCCC
Q 040898 273 GHTEEMDMVKWMRNVI------------------FSENP-----NRA-INSKLL---GNGYEEQMLLVLKLACFCTLKDP 325 (337)
Q Consensus 273 ~~~~~~~~~~~~~~~~------------------~~~~~-----~~~-~~~~~~---~~~~~~~~~~l~~li~~~l~~dP 325 (337)
. ............ ..... ... ...... ..........+.+|+.+||+.||
T Consensus 231 ~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP 307 (371)
T 2xrw_A 231 H---IDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA 307 (371)
T ss_dssp H---HHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSG
T ss_pred H---HHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCCh
Confidence 1 111111111000 00000 000 000000 00112335679999999999999
Q ss_pred CCCCChhhhhcC
Q 040898 326 DERPSSKDVRSM 337 (337)
Q Consensus 326 ~~Rps~~ell~~ 337 (337)
++|||++|+|+|
T Consensus 308 ~~R~t~~e~l~h 319 (371)
T 2xrw_A 308 SKRISVDEALQH 319 (371)
T ss_dssp GGSCCHHHHHHS
T ss_pred hhCCCHHHHhCC
Confidence 999999999987
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=329.03 Aligned_cols=262 Identities=24% Similarity=0.330 Sum_probs=194.6
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|.+.+.||+|+||.||++.+.. +++.||+|++............ ......+.+|+.++++++|
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~--~~~~vavK~~~~~~~~~~~~~~-----------~~~~~~~~~E~~~l~~l~h 199 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERK--TCKKVAIRIISKRKFAIGSARE-----------ADPALNVETEIEILKKLNH 199 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETT--TCCEEEEEEEEGGGGTTC-------------------CCHHHHHHHHHHCCC
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECC--CCcEEEEEEEEechhccccccc-----------chhHHHHHHHHHHHHhCCC
Confidence 35789999999999999999998876 8999999998764321110000 0011457889999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++++.. +..++||||+++++|.+++ .....+++..++.++.|++.||.|| |++|++|+||||+||+
T Consensus 200 pniv~l~~~~~~-~~~~lv~e~~~~g~L~~~l----~~~~~~~~~~~~~i~~qi~~~l~~L---H~~~ivHrDlkp~NIl 271 (419)
T 3i6u_A 200 PCIIKIKNFFDA-EDYYIVLELMEGGELFDKV----VGNKRLKEATCKLYFYQMLLAVQYL---HENGIIHRDLKPENVL 271 (419)
T ss_dssp TTBCCCCEEEES-SEEEEEEECCTTCBGGGGT----SSSCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEE
T ss_pred CCEeeEEEEEec-CceEEEEEcCCCCcHHHHH----hccCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCChHhEE
Confidence 999999998754 5579999999999998887 4556799999999999999999999 6679999999999999
Q ss_pred ecCCC---CeEEecccCccccCCCCceeeeecccCCCCccCcccccc---CCCCCcccchhhhHHHHHHHhCCCCCCCCC
Q 040898 199 IDDDM---EARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQT---ETISDKCDIYSFGVLLAVLVMGKFPVDDFF 272 (337)
Q Consensus 199 ~~~~~---~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~---~~~~~~~DiwslG~i~~~ll~g~~pf~~~~ 272 (337)
++.++ .++|+|||++....... ......||+.|+|||++.+ ..++.++|+||||+++|+|++|..||....
T Consensus 272 l~~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~ 348 (419)
T 3i6u_A 272 LSSQEEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 348 (419)
T ss_dssp ESSSSSSCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCS
T ss_pred EecCCCcceEEEeecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCc
Confidence 97554 59999999998765432 2234568999999999854 557789999999999999999999997543
Q ss_pred CCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 273 GHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
... .+...+........+ ......+..+.+|+.+||+.||++|||+.++|+|
T Consensus 349 ~~~---~~~~~i~~~~~~~~~----------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 349 TQV---SLKDQITSGKYNFIP----------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp SSC---CHHHHHHTTCCCCCH----------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred chH---HHHHHHhcCCCCCCc----------hhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 221 122222111111100 0011223458999999999999999999999987
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=319.11 Aligned_cols=257 Identities=19% Similarity=0.285 Sum_probs=200.4
Q ss_pred ccccccc-ceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc-C
Q 040898 40 EDCFDSL-KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT-R 117 (337)
Q Consensus 40 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~ 117 (337)
.++|.+. +.||+|+||.||++.+.. +++.||+|++......... ...+.+|+.++..+ .
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~-----------------~~~~~~e~~~l~~l~~ 87 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKS--TGQEYAAKFLKKRRRGQDC-----------------RAEILHEIAVLELAKS 87 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEESEETTEEC-----------------HHHHHHHHHHHHHTTT
T ss_pred hhEEeeccceeCCCCCeEEEEEEECC--CCCEEEEEEEehhhcchHH-----------------HHHHHHHHHHHHhccC
Confidence 4568787 899999999999998876 8999999998754322110 14677899999999 5
Q ss_pred CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCce
Q 040898 118 HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANV 197 (337)
Q Consensus 118 hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ni 197 (337)
||||+++++++.++...++||||+++++|.+++.. .....+++..++.++.|++.||.|| |+.|++|+||+|+||
T Consensus 88 ~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~L---H~~givH~Dikp~NI 162 (327)
T 3lm5_A 88 CPRVINLHEVYENTSEIILILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYL---HQNNIVHLDLKPQNI 162 (327)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGE
T ss_pred CCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHH---HHCCeecCcCChHHE
Confidence 69999999999999999999999999999988733 3346689999999999999999999 667999999999999
Q ss_pred eecC---CCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCC
Q 040898 198 LIDD---DMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGH 274 (337)
Q Consensus 198 l~~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~ 274 (337)
+++. ++.++|+|||++........ .....+++.|+|||++.+..++.++|+||||+++|+|++|..||.....
T Consensus 163 l~~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~- 238 (327)
T 3lm5_A 163 LLSSIYPLGDIKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN- 238 (327)
T ss_dssp EESCBTTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-
T ss_pred EEecCCCCCcEEEeeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-
Confidence 9987 78999999999987643322 2235689999999999999999999999999999999999999865321
Q ss_pred chhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 275 TEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
......+........ ..........+.+++.+||+.||++|||++++|+|
T Consensus 239 ---~~~~~~i~~~~~~~~----------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 239 ---QETYLNISQVNVDYS----------EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp ---HHHHHHHHHTCCCCC----------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred ---hHHHHHHHhcccccC----------chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 111111111111110 11112233458899999999999999999999987
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=309.93 Aligned_cols=263 Identities=23% Similarity=0.334 Sum_probs=205.4
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC-
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR- 117 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~- 117 (337)
-.++|++.+.||+|++|.||++.+.. +++.||+|.+............ . ....+.+.+|+.+++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~---~-------~~~~~~~~~e~~~l~~l~~ 82 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKP--TCKEYAVKIIDVTGGGSFSAEE---V-------QELREATLKEVDILRKVSG 82 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETT--TTEEEEEEEEETTCSTTCCHHH---H-------HHHHHHHHHHHHHHHHHTT
T ss_pred hhhccceeeeecCCCceEEEEEEEcC--cCceEEEEEEecccccccCHHH---H-------HHHHHHHHHHHHHHHHhcC
Confidence 45789999999999999999999876 8999999999765422110000 0 011156788999999995
Q ss_pred CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCce
Q 040898 118 HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANV 197 (337)
Q Consensus 118 hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ni 197 (337)
||||+++++++..+...++||||+++++|.+++.. ...+++..++.++.|++.||.+| |+.|++|+||+|+||
T Consensus 83 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~Ni 155 (298)
T 1phk_A 83 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICAL---HKLNIVHRDLKPENI 155 (298)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGE
T ss_pred CCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCcceE
Confidence 99999999999999999999999999999999954 34689999999999999999999 667999999999999
Q ss_pred eecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccc------cCCCCCcccchhhhHHHHHHHhCCCCCCCC
Q 040898 198 LIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQ------TETISDKCDIYSFGVLLAVLVMGKFPVDDF 271 (337)
Q Consensus 198 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~------~~~~~~~~DiwslG~i~~~ll~g~~pf~~~ 271 (337)
+++.++.++|+|||.+........ .....+++.|+|||++. ...++.++|+||||+++|+|++|..||...
T Consensus 156 l~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 232 (298)
T 1phk_A 156 LLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR 232 (298)
T ss_dssp EECTTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEcCCCcEEEecccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCc
Confidence 999999999999999887654322 23356899999999985 445788999999999999999999998543
Q ss_pred CCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 272 FGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
. .......+... ..... .......+..+.+++.+||+.||++|||+.++++|
T Consensus 233 ~----~~~~~~~~~~~---~~~~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 233 K----QMLMLRMIMSG---NYQFG-------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp S----HHHHHHHHHHT---CCCCC-------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred c----HHHHHHHHhcC---CcccC-------cccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 2 11111111111 11100 01112233458999999999999999999999987
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=318.66 Aligned_cols=277 Identities=15% Similarity=0.204 Sum_probs=203.2
Q ss_pred cccccccccceeccCcceEEEEeEEecCC---CCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHH
Q 040898 38 KKEDCFDSLKKIGSGGWGEVFYKAELPGS---NGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITAN 114 (337)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~ 114 (337)
...++|++.+.||+|+||.||++.+.... .++.||+|++........ .++.....+ .......|+..++
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----~e~~~~~~~---~~~~~~~e~~~~~ 103 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLF-----TELKFYQRA---AKPEQIQKWIRTR 103 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHH-----HHHHHHHHH---CCHHHHHHHHHHT
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHH-----HHHHHHHhh---hhhHHHHHHHHHh
Confidence 36678999999999999999999886422 368999999866543211 112222221 1145667888899
Q ss_pred hcCCCCcccceeEEEcC----CeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 040898 115 QTRHRNILPLLAHMVRP----NCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHR 190 (337)
Q Consensus 115 ~l~hpniv~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~ 190 (337)
.++||||+++++++... ...++||||+ +++|.+++.. ....+++..++.++.||+.||.|| |++|++|+
T Consensus 104 ~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~l---H~~~iiHr 176 (364)
T 3op5_A 104 KLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYI---HEHEYVHG 176 (364)
T ss_dssp TCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHH---HHTTEECC
T ss_pred hccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHH---HHCCeEEe
Confidence 99999999999998764 4589999999 8899999864 345699999999999999999999 66799999
Q ss_pred CCCCCceeec--CCCCeEEecccCccccCCCCce-----eeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh
Q 040898 191 DIKPANVLID--DDMEARISDFGHGKLMPDGHAQ-----ITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM 263 (337)
Q Consensus 191 di~~~nil~~--~~~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~ 263 (337)
||||+||+++ .++.++|+|||++......... .......||+.|+|||.+.+..++.++||||||+++|+|++
T Consensus 177 Dlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~ 256 (364)
T 3op5_A 177 DIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLT 256 (364)
T ss_dssp CCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHh
Confidence 9999999999 8899999999999765432211 11123459999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 264 GKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 264 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
|..||............. .... ........+..+.. ...+..+.+++..||+.||++|||+.+|++
T Consensus 257 g~~Pf~~~~~~~~~~~~~---~~~~-~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 257 GHLPWEDNLKDPKYVRDS---KIRY-RENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp SCCTTGGGTTCHHHHHHH---HHHH-HHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred CCCCccccccCHHHHHHH---HHHh-hhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 999997543322211111 1110 00111111110000 112345889999999999999999999875
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=312.22 Aligned_cols=247 Identities=17% Similarity=0.287 Sum_probs=195.1
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCC-------ceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHH
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNG-------KMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEII 111 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~ 111 (337)
..++|++.+.||+|+||.||++.+.. ++ ..||+|.+........ +.+.+|+.
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~~~~~~~~va~K~~~~~~~~~~-------------------~~~~~E~~ 64 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRRE--VGDYGQLHETEVLLKVLDKAHRNYS-------------------ESFFEAAS 64 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEE--ECGGGCEEEEEEEEEEECGGGGGGH-------------------HHHHHHHH
T ss_pred chhHeeeeeeeccCCCceEEEEEEec--ccccccccchhhhhhhcccccHHHH-------------------HHHHHHHH
Confidence 46789999999999999999998875 44 5799999854322111 56788999
Q ss_pred HHHhcCCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 040898 112 TANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRD 191 (337)
Q Consensus 112 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~d 191 (337)
++++++||||+++++++.+++..++||||+++++|.+++.. ....+++..++.++.|++.||.|| |++|++|+|
T Consensus 65 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~L---H~~~ivH~D 138 (289)
T 4fvq_A 65 MMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFL---EENTLIHGN 138 (289)
T ss_dssp HHHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHH---HHTTCCCCC
T ss_pred HHHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHH---hhCCeECCC
Confidence 99999999999999999999999999999999999999964 344589999999999999999999 667999999
Q ss_pred CCCCceeecCCCC--------eEEecccCccccCCCCceeeeecccCCCCccCcccccc-CCCCCcccchhhhHHHHHHH
Q 040898 192 IKPANVLIDDDME--------ARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQT-ETISDKCDIYSFGVLLAVLV 262 (337)
Q Consensus 192 i~~~nil~~~~~~--------~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~i~~~ll 262 (337)
|+|+||+++.++. ++|+|||.+...... ....+++.|+|||.+.+ ..++.++||||||+++|+|+
T Consensus 139 lkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~ 212 (289)
T 4fvq_A 139 VCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEIC 212 (289)
T ss_dssp CCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHH
T ss_pred cCcceEEEecCCcccccccceeeeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHH
Confidence 9999999998877 999999998654322 22457889999999987 66899999999999999999
Q ss_pred hCC-CCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 263 MGK-FPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 263 ~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
+|. +||... . .......... ....... ....+.+++.+||+.||++|||+.+++++
T Consensus 213 ~g~~~~~~~~-~---~~~~~~~~~~---~~~~~~~------------~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 213 SGGDKPLSAL-D---SQRKLQFYED---RHQLPAP------------KAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp TTTCCTTTTS-C---HHHHHHHHHT---TCCCCCC------------SSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred cCCCCCcccc-c---hHHHHHHhhc---cCCCCCC------------CCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 965 554332 1 1111111111 1000000 01228899999999999999999999864
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=306.09 Aligned_cols=257 Identities=26% Similarity=0.474 Sum_probs=200.1
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++.+.||+|+||.||++.+.. +++.||+|++............ .....+.+|+.++++++|
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~------------~~~~~~~~E~~~l~~l~h 82 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVK--DKSVVAIKSLILGDSEGETEMI------------EKFQEFQREVFIMSNLNH 82 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETT--TCCEEEEEECCCCTTTCCHHHH------------CCSHHHHHHHHHHTTCCC
T ss_pred hhccceehhccccCCceeEEEEEEcC--CceEEEEEEeeccccccchhHH------------HHHHHHHHHHHHHHhCCC
Confidence 45779999999999999999999876 8999999998765443222110 011467889999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCC--eEecCCCCCc
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPR--LIHRDIKPAN 196 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~g--i~h~di~~~n 196 (337)
|||+++++++.+.. ++||||+++++|.+++.. ....+++..++.++.|++.||.|| |++| ++|+||+|+|
T Consensus 83 ~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~l---H~~~~~ivH~dikp~N 154 (287)
T 4f0f_A 83 PNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYM---QNQNPPIVHRDLRSPN 154 (287)
T ss_dssp TTBCCEEEEETTTT--EEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHH---HTSSSCCBCSCCSGGG
T ss_pred CCchhhheeecCCC--eEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHH---HhCCCCeecCCCCcce
Confidence 99999999987665 699999999999888743 445789999999999999999999 6678 9999999999
Q ss_pred eeecCCCC-----eEEecccCccccCCCCceeeeecccCCCCccCccccc--cCCCCCcccchhhhHHHHHHHhCCCCCC
Q 040898 197 VLIDDDME-----ARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQ--TETISDKCDIYSFGVLLAVLVMGKFPVD 269 (337)
Q Consensus 197 il~~~~~~-----~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~--~~~~~~~~DiwslG~i~~~ll~g~~pf~ 269 (337)
|+++.++. ++|+|||++...... .....+++.|+|||.+. ...++.++|+||||+++|+|++|..||.
T Consensus 155 il~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 229 (287)
T 4f0f_A 155 IFLQSLDENAPVCAKVADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229 (287)
T ss_dssp EEESCCCTTCSCCEEECCCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred EEEeccCCCCceeEEeCCCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCc
Confidence 99988776 999999998754332 23457899999999984 4557889999999999999999999997
Q ss_pred CCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 270 DFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
....... ........ ..... ..+...+..+.+++.+||+.||++|||+.++++
T Consensus 230 ~~~~~~~--~~~~~~~~---~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 230 EYSYGKI--KFINMIRE---EGLRP---------TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp TCCCCHH--HHHHHHHH---SCCCC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccccHH--HHHHHHhc---cCCCC---------CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 6433221 11111111 11100 011122345899999999999999999999986
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=306.75 Aligned_cols=249 Identities=24% Similarity=0.276 Sum_probs=197.7
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++.+.||+|+||.||++.+ +++.||+|++.......... ..+.+|+.++++++|
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~----~~~~~avK~~~~~~~~~~~~-----------------~~~~~E~~~l~~l~h 66 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRW----QGNDIVVKVLKVRDWSTRKS-----------------RDFNEECPRLRIFSH 66 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEE----TTEEEEEEEECCTTCCHHHH-----------------HHHHHHGGGGCCCSC
T ss_pred CHHHhHHHHHhcCCCcceEEEEEE----CCeeEEEEEecccccCHHHH-----------------HHHHHHHHHHHhcCC
Confidence 456799999999999999999987 68999999997654332211 568889999999999
Q ss_pred CCcccceeEEEcC--CeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCC--eEecCCCC
Q 040898 119 RNILPLLAHMVRP--NCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPR--LIHRDIKP 194 (337)
Q Consensus 119 pniv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~g--i~h~di~~ 194 (337)
|||+++++++.+. ...++||||+++++|.+++.. .....+++..++.++.|++.||.|| |+.| ++|+||+|
T Consensus 67 ~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~~~i~H~dikp 141 (271)
T 3kmu_A 67 PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHE--GTNFVVDQSQAVKFALDMARGMAFL---HTLEPLIPRHALNS 141 (271)
T ss_dssp TTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHS--CSSCCCCHHHHHHHHHHHHHHHHHH---TTSSSCCTTCCCSG
T ss_pred CchhheEEEEccCCCCCeEeeecccCCCcHHHHHhh--cccCCCCHHHHHHHHHHHHHHHHHH---hcCCCceecCCCcc
Confidence 9999999999887 788999999999999999954 3334689999999999999999999 7778 99999999
Q ss_pred CceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCC---cccchhhhHHHHHHHhCCCCCCCC
Q 040898 195 ANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISD---KCDIYSFGVLLAVLVMGKFPVDDF 271 (337)
Q Consensus 195 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~---~~DiwslG~i~~~ll~g~~pf~~~ 271 (337)
+||+++.++.+++.|||+....... ...+|+.|+|||.+.+..++. ++||||||+++|+|++|..||...
T Consensus 142 ~Nil~~~~~~~~l~~~~~~~~~~~~-------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 214 (271)
T 3kmu_A 142 RSVMIDEDMTARISMADVKFSFQSP-------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL 214 (271)
T ss_dssp GGEEECTTSCEEEEGGGSCCTTSCT-------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTS
T ss_pred ceEEEcCCcceeEEeccceeeeccc-------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 9999999999999998876543222 246889999999998765554 799999999999999999999653
Q ss_pred CCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 272 FGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
.. ......... ..... ..+...+..+.+++.+||+.||++|||+.++++
T Consensus 215 ~~---~~~~~~~~~----~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 215 SN---MEIGMKVAL----EGLRP---------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp CH---HHHHHHHHH----SCCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred Ch---HHHHHHHHh----cCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 22 111111111 11110 011122344899999999999999999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=312.20 Aligned_cols=257 Identities=21% Similarity=0.236 Sum_probs=199.0
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
.++|++.+.||+|+||.||++.+.. +++.||+|++........ ......+.+|+.++++++||
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~--~~~~~avK~~~~~~~~~~---------------~~~~~~~~~E~~~l~~l~h~ 66 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSE--TLCRRAVKILKKKKLRRI---------------PNGEANVKKEIQLLRRLRHK 66 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTT--TCCEEEEEEECHHHHHHS---------------TTHHHHHHHHHHHHTTCCCT
T ss_pred ccceeEeeEEecCCCeEEEEEEECC--CCcEEEEEEecccccccc---------------chhHHHHHHHHHHHHhcCCC
Confidence 3679999999999999999998865 899999999865321110 00115788899999999999
Q ss_pred CcccceeEE--EcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCce
Q 040898 120 NILPLLAHM--VRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANV 197 (337)
Q Consensus 120 niv~~~~~~--~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ni 197 (337)
||+++++++ .+....++||||++++ |.+++.. .....+++..++.++.|++.||.|| |++|++|+||+|+||
T Consensus 67 ~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~L---H~~~i~H~dlkp~NI 140 (305)
T 2wtk_C 67 NVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDS--VPEKRFPVCQAHGYFCQLIDGLEYL---HSQGIVHKDIKPGNL 140 (305)
T ss_dssp TBCCEEEEEECC---CEEEEEECCSEE-HHHHHHH--STTCSCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGE
T ss_pred CeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHh--CcccccCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCcccE
Confidence 999999998 4456789999999875 7777755 3345689999999999999999999 667999999999999
Q ss_pred eecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCC--CCCcccchhhhHHHHHHHhCCCCCCCCCCCc
Q 040898 198 LIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTET--ISDKCDIYSFGVLLAVLVMGKFPVDDFFGHT 275 (337)
Q Consensus 198 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~--~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~ 275 (337)
+++.++.++|+|||.+................+++.|+|||++.+.. ++.++|+||||+++|+|++|..||....
T Consensus 141 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--- 217 (305)
T 2wtk_C 141 LLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN--- 217 (305)
T ss_dssp EECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS---
T ss_pred EEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch---
Confidence 99999999999999998765433333334567899999999997654 3678999999999999999999986431
Q ss_pred hhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 276 EEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.......+.. .... .+......+.+++.+||+.||++|||+.++++|
T Consensus 218 -~~~~~~~i~~---~~~~-----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 218 -IYKLFENIGK---GSYA-----------IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp -HHHHHHHHHH---CCCC-----------CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -HHHHHHHHhc---CCCC-----------CCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1122221111 1110 001123348899999999999999999999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=321.50 Aligned_cols=261 Identities=24% Similarity=0.351 Sum_probs=202.2
Q ss_pred cccccccceeccCcceEEEEeEEec-CCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc-C
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELP-GSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT-R 117 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~ 117 (337)
.++|++++.||+|+||.||++.+.. ..+++.||+|++.......... ....+.+|+.+++.+ .
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~---------------~~~~~~~E~~~l~~l~~ 117 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAK---------------TTEHTRTERQVLEHIRQ 117 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEES---------------SGGGCCCHHHHHHHHHT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhh---------------HHHHHHHHHHHHHHccC
Confidence 3789999999999999999998853 3489999999986543211000 004566789999999 6
Q ss_pred CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCce
Q 040898 118 HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANV 197 (337)
Q Consensus 118 hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ni 197 (337)
||||+++++++......++||||+++++|.+++.. ...+++..++.++.|++.||.|| |++|++|+||||+||
T Consensus 118 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~L---H~~~ivH~Dlkp~NI 190 (355)
T 1vzo_A 118 SPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHL---HKLGIIYRDIKLENI 190 (355)
T ss_dssp CTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGE
T ss_pred CCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHE
Confidence 99999999999999999999999999999999954 34589999999999999999999 667999999999999
Q ss_pred eecCCCCeEEecccCccccCCCCceeeeecccCCCCccCcccccc--CCCCCcccchhhhHHHHHHHhCCCCCCCCCCCc
Q 040898 198 LIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQT--ETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHT 275 (337)
Q Consensus 198 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~ 275 (337)
+++.++.++|+|||++......... ......+|+.|+|||++.+ ..++.++||||||+++|+|++|..||.......
T Consensus 191 ll~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~ 269 (355)
T 1vzo_A 191 LLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN 269 (355)
T ss_dssp EECTTSCEEESCSSEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC
T ss_pred EECCCCcEEEeeCCCCeecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc
Confidence 9999999999999998765432221 1223569999999999985 347889999999999999999999997543322
Q ss_pred hhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCC-----ChhhhhcC
Q 040898 276 EEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERP-----SSKDVRSM 337 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 337 (337)
....+.... .....+ .+......+.+|+.+||+.||++|| |+.++++|
T Consensus 270 ~~~~~~~~~---~~~~~~-----------~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 270 SQAEISRRI---LKSEPP-----------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp CHHHHHHHH---HHCCCC-----------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred hHHHHHHHH---hccCCC-----------CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 222222221 111111 1112234488999999999999999 99999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=311.53 Aligned_cols=257 Identities=22% Similarity=0.343 Sum_probs=198.9
Q ss_pred ccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc
Q 040898 37 LKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT 116 (337)
Q Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 116 (337)
....++|++.+.||+|+||.||++.+.. +++.||+|.+....... ...+.+|+.++..+
T Consensus 15 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~-------------------~~~~~~e~~~l~~l 73 (302)
T 2j7t_A 15 LDPNEVWEIVGELGDGAFGKVYKAKNKE--TGALAAAKVIETKSEEE-------------------LEDYIVEIEILATC 73 (302)
T ss_dssp SCGGGTEEEEEEEECSTTCCEEEEEETT--TCCEEEEEEEC----CC-------------------HHHHHHHHHHHHHC
T ss_pred cCCccceeecceeccCCCeEEEEEEEcC--CCcEEEEEEecCCCHHH-------------------HHHHHHHHHHHhcC
Confidence 3467889999999999999999999875 89999999986543221 15677899999999
Q ss_pred CCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 040898 117 RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPAN 196 (337)
Q Consensus 117 ~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~n 196 (337)
+||||+++++++..++..++||||+++++|.+++.. ....+++..++.++.|++.||.|| |+.|++|+||+|+|
T Consensus 74 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~N 147 (302)
T 2j7t_A 74 DHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLE---LDRGLTEPQIQVVCRQMLEALNFL---HSKRIIHRDLKAGN 147 (302)
T ss_dssp CCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCSGGG
T ss_pred CCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHH---hcCCcccCCCCHHH
Confidence 999999999999999999999999999999998854 234589999999999999999999 66799999999999
Q ss_pred eeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCcccc-----ccCCCCCcccchhhhHHHHHHHhCCCCCCCC
Q 040898 197 VLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESL-----QTETISDKCDIYSFGVLLAVLVMGKFPVDDF 271 (337)
Q Consensus 197 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~-----~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~ 271 (337)
|+++.++.++|+|||++....... .......+++.|+|||.+ .+..++.++|+||||+++|+|++|..||...
T Consensus 148 il~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 225 (302)
T 2j7t_A 148 VLMTLEGDIRLADFGVSAKNLKTL--QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 225 (302)
T ss_dssp EEECTTSCEEECCCHHHHHHHHHH--HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred EEECCCCCEEEEECCCCccccccc--cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccC
Confidence 999999999999999865321110 011234689999999998 4667889999999999999999999998653
Q ss_pred CCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 272 FGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.. ... .........+.. ......+..+.+++.+||+.||++|||+.++++|
T Consensus 226 ~~---~~~----~~~~~~~~~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 226 NP---MRV----LLKIAKSDPPTL--------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp CH---HHH----HHHHHHSCCCCC--------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred CH---HHH----HHHHhccCCccc--------CCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 22 111 111111111110 0111223458899999999999999999999987
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=334.11 Aligned_cols=253 Identities=25% Similarity=0.351 Sum_probs=205.6
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++.+.||+|+||.||++.+.. ++..||||.+....... +.+.+|+.++++++|
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~--~~~~vavK~~~~~~~~~--------------------~~~~~E~~~l~~l~h 275 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKK--YSLTVAVKTLKEDTMEV--------------------EEFLKEAAVMKEIKH 275 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGG--GTEEEEEEECCSSSSCH--------------------HHHHHHHHHHHHCCC
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcC--CCeEEEEEEecCcccch--------------------HHHHHHHHHHHhcCC
Confidence 56779999999999999999999876 78999999986543211 567889999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++++.+....++||||+++|+|.+++.. .....+++..++.++.||+.||.|| |++|++|+||+|+||+
T Consensus 276 pniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~L~~L---H~~~ivHrDlkp~NIl 350 (495)
T 1opk_A 276 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYL---EKKNFIHRNLAARNCL 350 (495)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHH--SCTTTSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEE
T ss_pred CCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHh--cCcCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCChhhEE
Confidence 9999999999999999999999999999999965 3445689999999999999999999 6679999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCchh
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHTEE 277 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~ 277 (337)
++.++.++|+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......
T Consensus 351 l~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~--- 426 (495)
T 1opk_A 351 VGENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--- 426 (495)
T ss_dssp ECGGGCEEECCTTCEECCTTCCE-ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---
T ss_pred ECCCCcEEEeecccceeccCCce-eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH---
Confidence 99999999999999987644321 12223346778999999998889999999999999999999 99998754321
Q ss_pred hhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 278 MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
.....+...... ..+...+..+.+|+.+||+.||++|||+.++++
T Consensus 427 -~~~~~~~~~~~~-------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 427 -QVYELLEKDYRM-------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp -GHHHHHHTTCCC-------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -HHHHHHHcCCCC-------------CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 222222211111 111123345889999999999999999999975
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-44 Score=322.48 Aligned_cols=261 Identities=12% Similarity=0.037 Sum_probs=184.6
Q ss_pred ccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHH---HHH
Q 040898 37 LKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEI---ITA 113 (337)
Q Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~---~~l 113 (337)
.....+|++.+.||+|+||.||++.+.. +++.||+|++........... ..+.+|+ ..+
T Consensus 58 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~----------------~~~~~E~~~~~~l 119 (371)
T 3q60_A 58 SQGERKLKLVEPLRVGDRSVVFLVRDVE--RLEDFALKVFTMGAENSRSEL----------------ERLHEATFAAARL 119 (371)
T ss_dssp TCCEEEEEEEEEEEECSSEEEEEEEETT--TTEEEEEEEEECCSTTHHHHH----------------HHHHHHHHHHHHH
T ss_pred CCCceeeeeeeeccCCCCEEEEEEEECC--CCceeEEEEEEecccccccHH----------------HHHHHHHHHHHHh
Confidence 3355569999999999999999999876 899999999987654322211 4566674 455
Q ss_pred HhcCCCCcccce-------eEEEcC-----------------CeeEEEEEeccCCCHHHHHHHhcCCcccCChHHH----
Q 040898 114 NQTRHRNILPLL-------AHMVRP-----------------NCHLLVYEFMKNGSLQDILYDVSQGRRELDWPAR---- 165 (337)
Q Consensus 114 ~~l~hpniv~~~-------~~~~~~-----------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~---- 165 (337)
+. +||||++++ +++..+ ...|+||||++ ++|.+++... +..+++..+
T Consensus 120 ~~-~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~ 194 (371)
T 3q60_A 120 LG-ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---DFVYVFRGDEGIL 194 (371)
T ss_dssp HC-----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---HHSCCCCHHHHHH
T ss_pred cc-cChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---ccccchhhhhhhh
Confidence 55 799987754 444332 33799999998 7999999753 233455556
Q ss_pred --HHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCcccccc-
Q 040898 166 --HRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQT- 242 (337)
Q Consensus 166 --~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~- 242 (337)
..++.||+.||.|| |++|++|+||||+||+++.++.++|+|||++...... .....+++.|+|||++.+
T Consensus 195 vk~~i~~qi~~aL~~L---H~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~ 266 (371)
T 3q60_A 195 ALHILTAQLIRLAANL---QSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNAS 266 (371)
T ss_dssp HHHHHHHHHHHHHHHH---HHTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCS
T ss_pred hHHHHHHHHHHHHHHH---HHCCCccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCC
Confidence 78889999999999 6679999999999999999999999999999865322 124467799999999987
Q ss_pred -CCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhc
Q 040898 243 -ETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCT 321 (337)
Q Consensus 243 -~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 321 (337)
..++.++||||||+++|+|++|..||.......... ...................+..+..+.+|+.+||
T Consensus 267 ~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 337 (371)
T 3q60_A 267 TATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGS---------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFL 337 (371)
T ss_dssp EEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTC---------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHT
T ss_pred CCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccc---------hhhhhhhhccccccchhhccCCCHHHHHHHHHHc
Confidence 678999999999999999999999997643211000 0000000000000001111233456899999999
Q ss_pred cCCCCCCCChhhhhcC
Q 040898 322 LKDPDERPSSKDVRSM 337 (337)
Q Consensus 322 ~~dP~~Rps~~ell~~ 337 (337)
+.||++|||+.++++|
T Consensus 338 ~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 338 NFDRRRRLLPLEAMET 353 (371)
T ss_dssp CSSTTTCCCHHHHTTS
T ss_pred CCChhhCCCHHHHhcC
Confidence 9999999999999987
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=314.69 Aligned_cols=202 Identities=22% Similarity=0.317 Sum_probs=169.0
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC-
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR- 117 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~- 117 (337)
..++|++.+.||+|+||.||++.+.. +++.||||++...... ...+.+|+.++..++
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~--------------------~~~~~~e~~~l~~l~~ 109 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRV--EQEWVAIKIIKNKKAF--------------------LNQAQIEVRLLELMNK 109 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETT--TTEEEEEEEECSSHHH--------------------HHHHHHHHHHHHHHHH
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcC--CCcEEEEEEEeccHHH--------------------HHHHHHHHHHHHHHHh
Confidence 35789999999999999999998876 8999999998643110 034556777777764
Q ss_pred CC-----CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 040898 118 HR-----NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDI 192 (337)
Q Consensus 118 hp-----niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di 192 (337)
|+ +|+++++++...+..++||||+++ +|.+++.. .....+++..+..++.|++.||.|||. |+.|++|+||
T Consensus 110 ~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~--~~~~~~~~~~~~~i~~qi~~al~~lH~-~~~~ivHrDl 185 (382)
T 2vx3_A 110 HDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRN--TNFRGVSLNLTRKFAQQMCTALLFLAT-PELSIIHCDL 185 (382)
T ss_dssp CSSGGGGGBCCEEEEEEETTEEEEEEECCCC-BHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHTS-TTTCEECCCC
T ss_pred cccccceeEEEeeeeeccCCceEEEEecCCC-CHHHHHhh--cCcCCCCHHHHHHHHHHHHHHHHHhcc-CCCCEEcCCC
Confidence 44 499999999999999999999965 99999865 333458999999999999999999954 3679999999
Q ss_pred CCCceeec--CCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCC
Q 040898 193 KPANVLID--DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDD 270 (337)
Q Consensus 193 ~~~nil~~--~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~ 270 (337)
||+||+++ .++.++|+|||++....... ....+|+.|+|||++.+..++.++||||||+++|+|++|..||..
T Consensus 186 kp~NIll~~~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~ 260 (382)
T 2vx3_A 186 KPENILLCNPKRSAIKIVDFGSSCQLGQRI-----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG 260 (382)
T ss_dssp SGGGEEESSTTSCCEEECCCTTCEETTCCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CcccEEEecCCCCcEEEEeccCceeccccc-----ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999995 47789999999998764322 245789999999999999999999999999999999999999975
Q ss_pred C
Q 040898 271 F 271 (337)
Q Consensus 271 ~ 271 (337)
.
T Consensus 261 ~ 261 (382)
T 2vx3_A 261 A 261 (382)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=314.45 Aligned_cols=261 Identities=25% Similarity=0.346 Sum_probs=198.3
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
.++|++.+.||+|+||.||++.+.. +++.||+|.+............ ......+.+|+.++++++||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~-----------~~~~~~~~~E~~~l~~l~h~ 75 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERK--TCKKVAIKIISKRKFAIGSARE-----------ADPALNVETEIEILKKLNHP 75 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT--TTEEEEEEEECC--------------------------CHHHHHHHHHHCCCT
T ss_pred hhceeEeeEEecCCCEEEEEEEEcC--CCcEEEEEEeehhhhhhccccc-----------chhhhhHHHHHHHHHhCCCC
Confidence 4679999999999999999998876 8999999998654321110000 00114678899999999999
Q ss_pred CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceee
Q 040898 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI 199 (337)
Q Consensus 120 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~ 199 (337)
||+++++++..+. .++||||+++++|.+++ .....+++..++.++.||+.||.|| |++|++|+||+|+||++
T Consensus 76 ~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~----~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~NIl~ 147 (322)
T 2ycf_A 76 CIIKIKNFFDAED-YYIVLELMEGGELFDKV----VGNKRLKEATCKLYFYQMLLAVQYL---HENGIIHRDLKPENVLL 147 (322)
T ss_dssp TBCCEEEEEESSS-EEEEEECCTTEETHHHH----STTCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEE
T ss_pred CCceEeeEEcCCc-eEEEEecCCCCcHHHHH----hccCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHEEE
Confidence 9999999987665 89999999999999988 4556789999999999999999999 66799999999999999
Q ss_pred cCCCC---eEEecccCccccCCCCceeeeecccCCCCccCccccc---cCCCCCcccchhhhHHHHHHHhCCCCCCCCCC
Q 040898 200 DDDME---ARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQ---TETISDKCDIYSFGVLLAVLVMGKFPVDDFFG 273 (337)
Q Consensus 200 ~~~~~---~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~ 273 (337)
+.++. ++|+|||++........ .....+++.|+|||++. ...++.++|+||||+++|+|++|..||.....
T Consensus 148 ~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 224 (322)
T 2ycf_A 148 SSQEEDCLIKITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 224 (322)
T ss_dssp SSSSSSCCEEECCCTTCEECCCCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTC
T ss_pred ecCCCCCeEEEccCccceecccccc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch
Confidence 87664 99999999887644321 12346899999999974 45678999999999999999999999975433
Q ss_pred CchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 274 HTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
... +...+........+ ......+..+.+++.+||+.||++|||+.++++|
T Consensus 225 ~~~---~~~~~~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 225 QVS---LKDQITSGKYNFIP----------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp SSC---HHHHHHHTCCCCCH----------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHH---HHHHHHhCccccCc----------hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 221 11112111110000 0011223458999999999999999999999987
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=309.24 Aligned_cols=252 Identities=23% Similarity=0.327 Sum_probs=201.7
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++.+.||+|+||.||++.+. +++.||+|.+....... +.+.+|+.++++++|
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~~~~--------------------~~~~~e~~~l~~l~h 62 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWL---NKDKVAIKTIREGAMSE--------------------EDFIEEAEVMMKLSH 62 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET---TTEEEEEEEECTTTBCH--------------------HHHHHHHHHHHTCCC
T ss_pred chhheeeeeEecCCCceeEEEEEec---CCCeEEEEEccccCCCH--------------------HHHHHHHHHHHhCCC
Confidence 4578999999999999999998875 67889999987654321 457789999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++++.+++..++||||+++++|.+++.. ....+++..++.++.|++.||.+| |+.|++|+||+|+||+
T Consensus 63 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~Nil 136 (267)
T 3t9t_A 63 PKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYL---EEACVIHRDLAARNCL 136 (267)
T ss_dssp TTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSSCCGGGEE
T ss_pred CCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhh---CcccCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCchheEE
Confidence 9999999999999999999999999999999964 335688999999999999999999 6679999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCchh
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHTEE 277 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~ 277 (337)
++.++.++|+|||.+......... ......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.....
T Consensus 137 i~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---- 211 (267)
T 3t9t_A 137 VGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---- 211 (267)
T ss_dssp ECGGGCEEECCTTGGGGBCCHHHH-STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----
T ss_pred ECCCCCEEEccccccccccccccc-ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH----
Confidence 999999999999998765432111 1123456778999999998889999999999999999999 8999865321
Q ss_pred hhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 278 MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
......+.. ..... .+...+..+.+++.+||+.||++|||+.+++++
T Consensus 212 ~~~~~~i~~---~~~~~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 212 SEVVEDIST---GFRLY----------KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HHHHHHHHT---TCCCC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhc---CCcCC----------CCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 111111111 11100 011123448899999999999999999999863
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=323.85 Aligned_cols=200 Identities=22% Similarity=0.339 Sum_probs=169.3
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc--
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT-- 116 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-- 116 (337)
...+|++++.||+|+||.||++.+.. +++.||||++....... ..+.+|+.+++.+
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~--~~~~vAvK~~~~~~~~~--------------------~~~~~E~~~l~~l~~ 152 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHK--VHQHVALKMVRNEKRFH--------------------RQAAEEIRILEHLRK 152 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETT--TTEEEEEEEECSCHHHH--------------------HHHHHHHHHHHHHHT
T ss_pred ccCcEEEEEEcccCccEEEEEEEECC--CCcEEEEEEECCccchH--------------------HHHHHHHHHHHHHhh
Confidence 56789999999999999999998876 89999999986432110 3445566666665
Q ss_pred ----CCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 040898 117 ----RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDI 192 (337)
Q Consensus 117 ----~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di 192 (337)
.||||+++++.+......++||||+. ++|.+++.. .....+++..+..++.||+.||.|| |+.|++|+||
T Consensus 153 ~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDl 226 (429)
T 3kvw_A 153 QDKDNTMNVIHMLENFTFRNHICMTFELLS-MNLYELIKK--NKFQGFSLPLVRKFAHSILQCLDAL---HKNRIIHCDL 226 (429)
T ss_dssp TCTTSCSCBCCEEEEEEETTEEEEEECCCC-CBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHH---HHHTEECSCC
T ss_pred ccccCCcCEEEEEeecccCCeEEEEEeccC-CCHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCC
Confidence 67899999999999999999999996 589998865 3334589999999999999999999 5669999999
Q ss_pred CCCceeecCCCC--eEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCC
Q 040898 193 KPANVLIDDDME--ARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDD 270 (337)
Q Consensus 193 ~~~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~ 270 (337)
||+||+++.++. ++|+|||++....... ....+|+.|+|||++.+..++.++|||||||++|+|++|.+||..
T Consensus 227 Kp~NILl~~~~~~~vkL~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~ 301 (429)
T 3kvw_A 227 KPENILLKQQGRSGIKVIDFGSSCYEHQRV-----YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPG 301 (429)
T ss_dssp SGGGEEESSTTSCCEEECCCTTCEETTCCC-----CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CHHHeEEccCCCcceEEeecccceecCCcc-----cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCC
Confidence 999999999887 9999999987654322 235789999999999999999999999999999999999999865
Q ss_pred C
Q 040898 271 F 271 (337)
Q Consensus 271 ~ 271 (337)
.
T Consensus 302 ~ 302 (429)
T 3kvw_A 302 E 302 (429)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=325.22 Aligned_cols=247 Identities=27% Similarity=0.393 Sum_probs=198.4
Q ss_pred cccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC
Q 040898 38 KKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR 117 (337)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 117 (337)
-..++|++.+.||+|+||.||++.+ +++.||||.+...... ..+.+|+.++++++
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~----~~~~vavK~~~~~~~~---------------------~~~~~E~~~l~~l~ 244 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDY----RGNKVAVKCIKNDATA---------------------QAFLAEASVMTQLR 244 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE----TTEEEEEEEESSCTTS---------------------HHHHHHHHHHHTCC
T ss_pred cChHHeEEEeeecCcCCeeEEEEEe----cCCeEEEEEeCCchHH---------------------HHHHHHHHHHHhcc
Confidence 3567899999999999999999877 5789999998654311 56788999999999
Q ss_pred CCCcccceeEEEcCC-eeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 040898 118 HRNILPLLAHMVRPN-CHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPAN 196 (337)
Q Consensus 118 hpniv~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~n 196 (337)
||||+++++++.... ..++||||+++|+|.+++... ....+++..++.++.|++.||.|| |++|++|+||+|+|
T Consensus 245 h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~L---H~~~ivHrDlkp~N 319 (450)
T 1k9a_A 245 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVHRDLAARN 319 (450)
T ss_dssp CTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGG
T ss_pred CCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCCHhh
Confidence 999999999987665 789999999999999999752 333478899999999999999999 66799999999999
Q ss_pred eeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCc
Q 040898 197 VLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHT 275 (337)
Q Consensus 197 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~ 275 (337)
|+++.++.++|+|||++....... ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus 320 ill~~~~~~kl~DfG~a~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~ 394 (450)
T 1k9a_A 320 VLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 394 (450)
T ss_dssp EEECTTSCEEECCCTTCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT
T ss_pred EEECCCCCEEEeeCCCcccccccc-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999999987543221 22357889999999999999999999999999999998 999997653322
Q ss_pred hhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 276 EEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
....+...... ..+...+..+.+++.+||+.||++|||+.++++
T Consensus 395 ----~~~~i~~~~~~-------------~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 395 ----VVPRVEKGYKM-------------DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp ----HHHHHHTTCCC-------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----HHHHHHcCCCC-------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 11111111100 011123345889999999999999999999875
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=309.41 Aligned_cols=249 Identities=24% Similarity=0.364 Sum_probs=190.6
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
.++|++.+.||+|+||.||++.+ .++.||+|++..... ...+.+|+.++++++||
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~----~~~~vavK~~~~~~~---------------------~~~~~~E~~~l~~l~hp 61 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW----RAKDVAIKQIESESE---------------------RKAFIVELRQLSRVNHP 61 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE----TTEEEEEEECSSTTH---------------------HHHHHHHHHHHHHCCCT
T ss_pred HhHeeeeeEeecCCCceEEEEEE----CCeeEEEEEecChhH---------------------HHHHHHHHHHHhcCCCC
Confidence 46799999999999999999877 678999999853311 14678899999999999
Q ss_pred CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceee
Q 040898 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI 199 (337)
Q Consensus 120 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~ 199 (337)
||+++++++.+ ..++||||+++++|.+++.... ....++...++.++.|++.||.|||+.+.+|++|+||+|+||++
T Consensus 62 ~iv~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll 138 (307)
T 2eva_A 62 NIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLL 138 (307)
T ss_dssp TBCCEEEBCTT--TTEEEEECCTTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEE
T ss_pred CcCeEEEEEcC--CcEEEEEcCCCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEE
Confidence 99999998764 4789999999999999995411 22346888999999999999999976555899999999999999
Q ss_pred cCCCC-eEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhh
Q 040898 200 DDDME-ARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEM 278 (337)
Q Consensus 200 ~~~~~-~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~ 278 (337)
+.++. ++|+|||++....... ....+++.|+|||.+.+..++.++||||||+++|+|++|..||........
T Consensus 139 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-- 211 (307)
T 2eva_A 139 VAGGTVLKICDFGTACDIQTHM-----TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF-- 211 (307)
T ss_dssp ETTTTEEEECCCCC-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH--
T ss_pred eCCCCEEEEccccccccccccc-----ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH--
Confidence 98886 7999999987543321 234589999999999998999999999999999999999999975433211
Q ss_pred hHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 279 DMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
....... ....+ ......+..+.+++.+||+.||++|||+.++++
T Consensus 212 ~~~~~~~---~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 212 RIMWAVH---NGTRP----------PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp HHHHHHH---TTCCC----------CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHh---cCCCC----------CcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 1111111 11111 001122334889999999999999999999986
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=306.98 Aligned_cols=256 Identities=22% Similarity=0.276 Sum_probs=199.9
Q ss_pred ccccccccc-eeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC
Q 040898 39 KEDCFDSLK-KIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR 117 (337)
Q Consensus 39 ~~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 117 (337)
..++|++.+ .||+|+||.||++.+....+++.||+|++......... .+.+.+|+.+++.++
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~-----------------~~~~~~e~~~l~~l~ 76 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPAL-----------------KDELLAEANVMQQLD 76 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHH-----------------HHHHHHHHHHHHTCC
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHH-----------------HHHHHHHHHHHHhCC
Confidence 356799998 99999999999997665558899999998654322111 156888999999999
Q ss_pred CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCce
Q 040898 118 HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANV 197 (337)
Q Consensus 118 hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ni 197 (337)
||||+++++++ ..+..++||||+++++|.+++.. ...+++..++.++.|++.||.+| |+.|++|+||+|+||
T Consensus 77 h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~L---H~~~i~H~dikp~Ni 148 (291)
T 1xbb_A 77 NPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYL---EESNFVHRDLAARNV 148 (291)
T ss_dssp CTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGE
T ss_pred CCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHH---HhCCeEcCCCCcceE
Confidence 99999999998 56678999999999999999954 34589999999999999999999 667999999999999
Q ss_pred eecCCCCeEEecccCccccCCCCcee-eeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCc
Q 040898 198 LIDDDMEARISDFGHGKLMPDGHAQI-TVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHT 275 (337)
Q Consensus 198 l~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~ 275 (337)
+++.++.++|+|||++.......... ......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.....
T Consensus 149 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-- 226 (291)
T 1xbb_A 149 LLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-- 226 (291)
T ss_dssp EEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--
T ss_pred EEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH--
Confidence 99999999999999998765443322 1222346788999999988888999999999999999999 9999865322
Q ss_pred hhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 276 EEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
......+....... .+...+..+.+++.+||+.||++|||+.++++
T Consensus 227 --~~~~~~~~~~~~~~-------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 227 --SEVTAMLEKGERMG-------------CPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp --HHHHHHHHTTCCCC-------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred --HHHHHHHHcCCCCC-------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 12222221111110 11123345899999999999999999999975
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=316.55 Aligned_cols=272 Identities=19% Similarity=0.226 Sum_probs=194.0
Q ss_pred ccccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHH
Q 040898 35 AFLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITAN 114 (337)
Q Consensus 35 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~ 114 (337)
......++|++.+.||+|+||.||++.+.. +++.||||++....... ....+++..+.
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~--------------------~~~~~~~~~l~ 74 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKS--TGMSVAIKKVIQDPRFR--------------------NRELQIMQDLA 74 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETT--TCCEEEEEEEECCTTCC--------------------CHHHHHHHHHH
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECC--CCCEEEEEEEecCcccc--------------------HHHHHHHHHHH
Confidence 344567789999999999999999999876 89999999886543221 24456778888
Q ss_pred hcCCCCcccceeEEEcCCe-------eEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCe
Q 040898 115 QTRHRNILPLLAHMVRPNC-------HLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRL 187 (337)
Q Consensus 115 ~l~hpniv~~~~~~~~~~~-------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi 187 (337)
.++||||+++++++..... .++||||+++ +|...+.........+++..++.++.|++.|+.|||. |+.|+
T Consensus 75 ~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~i 152 (360)
T 3e3p_A 75 VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHL-PSVNV 152 (360)
T ss_dssp HHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTS-TTTCC
T ss_pred hcCCCCcccHHHhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhC-CCCCe
Confidence 8999999999999865433 7899999986 6666665555567778999999999999999999942 38999
Q ss_pred EecCCCCCceeecC-CCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCC-CCCcccchhhhHHHHHHHhCC
Q 040898 188 IHRDIKPANVLIDD-DMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTET-ISDKCDIYSFGVLLAVLVMGK 265 (337)
Q Consensus 188 ~h~di~~~nil~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~DiwslG~i~~~ll~g~ 265 (337)
+|+||||+||+++. ++.++|+|||++......... ....+|+.|+|||++.+.. ++.++||||||+++|+|++|.
T Consensus 153 vH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~ 229 (360)
T 3e3p_A 153 CHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN---VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229 (360)
T ss_dssp BCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSCC---CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSS
T ss_pred ecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCCc---ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 99999999999996 899999999999876543322 2356899999999986654 899999999999999999999
Q ss_pred CCCCCCCCCchhhhHHHHHHhhhccCCcc------------hhh------hhcccCCchHHHHHHHHHHHhhhccCCCCC
Q 040898 266 FPVDDFFGHTEEMDMVKWMRNVIFSENPN------------RAI------NSKLLGNGYEEQMLLVLKLACFCTLKDPDE 327 (337)
Q Consensus 266 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~ 327 (337)
.||..... ...+....+... ..... ... ...............+.+|+.+||+.||.+
T Consensus 230 ~pf~~~~~---~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 305 (360)
T 3e3p_A 230 PIFRGDNS---AGQLHEIVRVLG-CPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEE 305 (360)
T ss_dssp CSSCCSSH---HHHHHHHHHHHC-CCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGG
T ss_pred CCcCCCCh---HHHHHHHHHHcC-CCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccc
Confidence 99965322 222222221110 00000 000 000001111124566999999999999999
Q ss_pred CCChhhhhcC
Q 040898 328 RPSSKDVRSM 337 (337)
Q Consensus 328 Rps~~ell~~ 337 (337)
|||+.|+|+|
T Consensus 306 Rpt~~e~l~h 315 (360)
T 3e3p_A 306 RMKPYEALCH 315 (360)
T ss_dssp SCCHHHHTTS
T ss_pred cCCHHHHhcC
Confidence 9999999987
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=307.81 Aligned_cols=256 Identities=18% Similarity=0.256 Sum_probs=198.3
Q ss_pred ccccccccceeccCcceEEEEeEEecC-CCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPG-SNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR 117 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 117 (337)
..++|++.+.||+|+||.||++.+... .++..||+|.+......... +.+.+|+.+++.++
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~------------------~~~~~E~~~l~~l~ 71 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK------------------EKFMSEAVIMKNLD 71 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHH------------------HHHHHHHHHHHHHC
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHH------------------HHHHHHHHHHHhCC
Confidence 567899999999999999999987642 24567999998765332111 56788999999999
Q ss_pred CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCce
Q 040898 118 HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANV 197 (337)
Q Consensus 118 hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ni 197 (337)
||||+++++++.+ +..++||||+++++|.+++.. ....+++..++.++.|++.||.+| |++|++|+||+|+||
T Consensus 72 h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~Ni 144 (281)
T 3cc6_A 72 HPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYL---ESINCVHRDIAVRNI 144 (281)
T ss_dssp CTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCSGGGE
T ss_pred CCCcceEEEEEcC-CCCEEEEecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCccceE
Confidence 9999999998765 456899999999999999964 234588999999999999999999 667999999999999
Q ss_pred eecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCch
Q 040898 198 LIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHTE 276 (337)
Q Consensus 198 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~ 276 (337)
+++.++.++|+|||.+......... ......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||......
T Consensus 145 l~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~-- 221 (281)
T 3cc6_A 145 LVASPECVKLGDFGLSRYIEDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK-- 221 (281)
T ss_dssp EEEETTEEEECCCCGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG--
T ss_pred EECCCCcEEeCccCCCccccccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH--
Confidence 9999999999999998876543221 1223456788999999988889999999999999999998 99998643222
Q ss_pred hhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 277 EMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.....+........ +...+..+.+++.+||+.||++|||+.+++++
T Consensus 222 --~~~~~~~~~~~~~~-------------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 222 --DVIGVLEKGDRLPK-------------PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp --GHHHHHHHTCCCCC-------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --HHHHHHhcCCCCCC-------------CCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 12222211111110 11123448899999999999999999999863
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=321.86 Aligned_cols=264 Identities=21% Similarity=0.280 Sum_probs=198.5
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
...+|++.+.||+|+||.||++.+.. +++.||||++.... ....+|+.+++.++|
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~--~~~~vaiK~~~~~~-----------------------~~~~~E~~il~~l~h 106 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCD--SGELVAIKKVLQDK-----------------------RFKNRELQIMRKLDH 106 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEECCT-----------------------TSCCHHHHHHHTCCC
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECC--CCcEEEEEEecccc-----------------------hhHHHHHHHHHHcCC
Confidence 34479999999999999999999976 89999999986432 123469999999999
Q ss_pred CCcccceeEEEcC------CeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 040898 119 RNILPLLAHMVRP------NCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDI 192 (337)
Q Consensus 119 pniv~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di 192 (337)
|||+++++++... ...++||||+++ +|.+.+.........+++..++.++.||+.||.|| |++|++|+||
T Consensus 107 pniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~L---H~~~ivHrDl 182 (420)
T 1j1b_A 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI---HSFGICHRDI 182 (420)
T ss_dssp TTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH---HTTTEECSCC
T ss_pred CCccceeeEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCC
Confidence 9999999987532 236799999976 77777765555667799999999999999999999 7789999999
Q ss_pred CCCceeecCC-CCeEEecccCccccCCCCceeeeecccCCCCccCccccccC-CCCCcccchhhhHHHHHHHhCCCCCCC
Q 040898 193 KPANVLIDDD-MEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTE-TISDKCDIYSFGVLLAVLVMGKFPVDD 270 (337)
Q Consensus 193 ~~~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~i~~~ll~g~~pf~~ 270 (337)
||+||+++.+ +.+||+|||++........ .....+|+.|+|||++.+. .++.++|||||||++|+|++|+.||..
T Consensus 183 kp~NILl~~~~~~~kl~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~ 259 (420)
T 1j1b_A 183 KPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 259 (420)
T ss_dssp SGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ChhhEEEeCCCCeEEeccchhhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 9999999965 5689999999987644322 1235789999999998765 689999999999999999999999965
Q ss_pred CCCCchhhhHHHHHHhhhccCC---------cchhhhhcccCCc-----hHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 271 FFGHTEEMDMVKWMRNVIFSEN---------PNRAINSKLLGNG-----YEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
... ...+.+.+.....+.. ......+...... .+.....+.+|+.+||+.||++|||+.|+++
T Consensus 260 ~~~---~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 260 DSG---VDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp SSH---HHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCH---HHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 322 2222222221100000 0000000000000 1122456899999999999999999999998
Q ss_pred C
Q 040898 337 M 337 (337)
Q Consensus 337 ~ 337 (337)
|
T Consensus 337 h 337 (420)
T 1j1b_A 337 H 337 (420)
T ss_dssp S
T ss_pred C
Confidence 7
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=306.31 Aligned_cols=243 Identities=23% Similarity=0.383 Sum_probs=197.5
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
.++|++.+.||+|+||.||++.+.. +++.||+|.+.... ..+.+|+.+++.++||
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~-----------------------~~~~~e~~~l~~l~h~ 64 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRI--DGKTYVIKRVKYNN-----------------------EKAEREVKALAKLDHV 64 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETT--TCCEEEEEEEECCS-----------------------GGGHHHHHHHHHCCCT
T ss_pred ccccceeeeeccCCceEEEEEEEcC--CCeEEEEEEecccc-----------------------HHHHHHHHHHHhCCCC
Confidence 4679999999999999999999865 89999999986542 3456799999999999
Q ss_pred CcccceeEEEc----------------CCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCC
Q 040898 120 NILPLLAHMVR----------------PNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCH 183 (337)
Q Consensus 120 niv~~~~~~~~----------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h 183 (337)
||+++++++.. ....++||||+++++|.+++... ....+++..++.++.|++.||.|| |
T Consensus 65 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~l---H 139 (284)
T 2a19_B 65 NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYI---H 139 (284)
T ss_dssp TBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHH---H
T ss_pred CEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHH---H
Confidence 99999998754 45589999999999999999652 335689999999999999999999 6
Q ss_pred CCCeEecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh
Q 040898 184 RPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM 263 (337)
Q Consensus 184 ~~gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~ 263 (337)
+.|++|+||+|+||+++.++.++|+|||.+........ .....+++.|+|||.+.+..++.++|+||||+++|+|++
T Consensus 140 ~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 216 (284)
T 2a19_B 140 SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLH 216 (284)
T ss_dssp HTTEECSCCSGGGEEEEETTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHS
T ss_pred hCCeeeccCCHHHEEEcCCCCEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHh
Confidence 67999999999999999999999999999887654332 123468999999999999889999999999999999999
Q ss_pred CCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 264 GKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 264 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
|..||.. .... ......... . ...+..+.+++.+||+.||++|||+.+++++
T Consensus 217 ~~~~~~~------~~~~---~~~~~~~~~-~------------~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 268 (284)
T 2a19_B 217 VCDTAFE------TSKF---FTDLRDGII-S------------DIFDKKEKTLLQKLLSKKPEDRPNTSEILRT 268 (284)
T ss_dssp CCSSHHH------HHHH---HHHHHTTCC-C------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCcchh------HHHH---HHHhhcccc-c------------ccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9988631 1111 111111110 0 1112347899999999999999999999864
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=308.57 Aligned_cols=263 Identities=23% Similarity=0.300 Sum_probs=200.1
Q ss_pred ccccccccccccccceeccCcceEEEEeEEecC-CCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHH
Q 040898 33 DLAFLKKEDCFDSLKKIGSGGWGEVFYKAELPG-SNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEII 111 (337)
Q Consensus 33 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~ 111 (337)
...+.....+|++.+.||+|+||.||++.+... .+...+|+|.+........ ...+.+|+.
T Consensus 17 ~~~i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~------------------~~~~~~E~~ 78 (298)
T 3f66_A 17 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE------------------VSQFLTEGI 78 (298)
T ss_dssp GGBCCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHH------------------HHHHHHHHH
T ss_pred heecCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHH------------------HHHHHHHHH
Confidence 455556778899999999999999999987542 2344689998865332211 156788999
Q ss_pred HHHhcCCCCcccceeEE-EcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 040898 112 TANQTRHRNILPLLAHM-VRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHR 190 (337)
Q Consensus 112 ~l~~l~hpniv~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~ 190 (337)
++++++||||+++++++ ..++..++||||+++++|.+++.. ....+++..++.++.|++.||.+| |++|++|+
T Consensus 79 ~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~l---H~~~i~H~ 152 (298)
T 3f66_A 79 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYL---ASKKFVHR 152 (298)
T ss_dssp HHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCS
T ss_pred HHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHH---HhCCccCC
Confidence 99999999999999985 456688999999999999999953 445688999999999999999999 66799999
Q ss_pred CCCCCceeecCCCCeEEecccCccccCCCCce--eeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCC
Q 040898 191 DIKPANVLIDDDMEARISDFGHGKLMPDGHAQ--ITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFP 267 (337)
Q Consensus 191 di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~p 267 (337)
||+|+||+++.++.++|+|||++......... .......+++.|+|||.+.+..++.++|+||||+++|+|++ +.+|
T Consensus 153 dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~ 232 (298)
T 3f66_A 153 DLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232 (298)
T ss_dssp CCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred CCchheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999866443221 12233457788999999999889999999999999999999 5666
Q ss_pred CCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 268 VDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 268 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
|....... ............. +...+..+.+++.+||+.||++|||+.++++
T Consensus 233 ~~~~~~~~----~~~~~~~~~~~~~-------------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 233 YPDVNTFD----ITVYLLQGRRLLQ-------------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp STTSCTTT----HHHHHHTTCCCCC-------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CccCCHHH----HHHHHhcCCCCCC-------------CccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 65433221 1111111111100 0112234899999999999999999999985
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=313.31 Aligned_cols=273 Identities=21% Similarity=0.331 Sum_probs=202.5
Q ss_pred ccccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHH
Q 040898 35 AFLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITAN 114 (337)
Q Consensus 35 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~ 114 (337)
...+..++|++.+.||+|+||.||++.+.. .+++.||+|++......... ...+.+|+.+++
T Consensus 5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~vavK~~~~~~~~~~~-----------------~~~~~~e~~~l~ 66 (326)
T 1blx_A 5 GLCRADQQYECVAEIGEGAYGKVFKARDLK-NGGRFVALKRVRVQTGEEGM-----------------PLSTIREVAVLR 66 (326)
T ss_dssp CCCCGGGTEEEEEEEEEETTEEEEEEEETT-TTTEEEEEEEEEEEBCTTSC-----------------BCTHHHHHHHHH
T ss_pred cccCchhceeeeeeecccccEEEEEEEecC-CCCEEEEEEEeccCcccccC-----------------CchhhHHHHHHH
Confidence 345677899999999999999999998842 27899999998754322110 023455666666
Q ss_pred hc---CCCCcccceeEEE-----cCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCC
Q 040898 115 QT---RHRNILPLLAHMV-----RPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPR 186 (337)
Q Consensus 115 ~l---~hpniv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~g 186 (337)
.+ .||||+++++++. .....++|+||++ ++|.+++.. .....+++..++.++.|++.||.|| |+.|
T Consensus 67 ~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~--~~~~~~~~~~~~~~~~qi~~~l~~l---H~~g 140 (326)
T 1blx_A 67 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFL---HSHR 140 (326)
T ss_dssp HHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHH---HHTT
T ss_pred hhhccCCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHh--cccCCCCHHHHHHHHHHHHHHHHHH---HHCC
Confidence 55 8999999999987 5677899999998 599999865 3334589999999999999999999 6679
Q ss_pred eEecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCC
Q 040898 187 LIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKF 266 (337)
Q Consensus 187 i~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~ 266 (337)
++|+||+|+||+++.++.++|+|||.+....... ......+++.|+|||++.+..++.++|+||||+++|+|++|..
T Consensus 141 i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 217 (326)
T 1blx_A 141 VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 217 (326)
T ss_dssp CCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ceeccCCHHHeEEcCCCCEEEecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCC
Confidence 9999999999999999999999999987654322 1233568999999999998889999999999999999999999
Q ss_pred CCCCCCCCchhhhHHHHHHhhhccC---Ccc------hhhh---hcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhh
Q 040898 267 PVDDFFGHTEEMDMVKWMRNVIFSE---NPN------RAIN---SKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDV 334 (337)
Q Consensus 267 pf~~~~~~~~~~~~~~~~~~~~~~~---~~~------~~~~---~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el 334 (337)
||..... ............... .+. .... ........+..+..+.+|+.+||+.||++|||+.++
T Consensus 218 pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~ 294 (326)
T 1blx_A 218 LFRGSSD---VDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 294 (326)
T ss_dssp SCCCSSH---HHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred CCCCCCH---HHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHH
Confidence 9865322 111212111110000 000 0000 000001112234568899999999999999999999
Q ss_pred hcC
Q 040898 335 RSM 337 (337)
Q Consensus 335 l~~ 337 (337)
++|
T Consensus 295 l~h 297 (326)
T 1blx_A 295 LSH 297 (326)
T ss_dssp HTS
T ss_pred hcC
Confidence 987
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=310.10 Aligned_cols=262 Identities=24% Similarity=0.368 Sum_probs=193.3
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHh--c
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQ--T 116 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~--l 116 (337)
..++|++.+.||+|+||.||++.+ +++.||+|++..... ....+|..++.. +
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~----~~~~vavK~~~~~~~----------------------~~~~~e~~~~~~~~~ 88 (337)
T 3mdy_A 35 IAKQIQMVKQIGKGRYGEVWMGKW----RGEKVAVKVFFTTEE----------------------ASWFRETEIYQTVLM 88 (337)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEE----TTEEEEEEEEEGGGH----------------------HHHHHHHHHHTSTTC
T ss_pred cccceEEEeEeecCCCeEEEEEEE----CCceEEEEEEecccc----------------------chhhhHHHHHHHHhh
Confidence 346899999999999999999877 689999999853321 223334444444 4
Q ss_pred CCCCcccceeEEEcC----CeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhC-----CCCCe
Q 040898 117 RHRNILPLLAHMVRP----NCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMC-----HRPRL 187 (337)
Q Consensus 117 ~hpniv~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~-----h~~gi 187 (337)
+||||+++++++... ...++||||+++++|.+++.. ..+++..++.++.|++.||.|||+. +..|+
T Consensus 89 ~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~i 163 (337)
T 3mdy_A 89 RHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAI 163 (337)
T ss_dssp CCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCE
T ss_pred cCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCE
Confidence 999999999998877 788999999999999999954 3589999999999999999999431 12299
Q ss_pred EecCCCCCceeecCCCCeEEecccCccccCCCCcee--eeecccCCCCccCccccccCCCCCc------ccchhhhHHHH
Q 040898 188 IHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQI--TVKCMVGTMGYMAPESLQTETISDK------CDIYSFGVLLA 259 (337)
Q Consensus 188 ~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~------~DiwslG~i~~ 259 (337)
+|+||||+||+++.++.++|+|||++.......... ......+|+.|+|||++.+...+.. +||||||+++|
T Consensus 164 vH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~ 243 (337)
T 3mdy_A 164 AHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILW 243 (337)
T ss_dssp ECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHH
T ss_pred EecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHH
Confidence 999999999999999999999999997654332221 1224579999999999988776665 89999999999
Q ss_pred HHHhC----------CCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCC
Q 040898 260 VLVMG----------KFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERP 329 (337)
Q Consensus 260 ~ll~g----------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp 329 (337)
+|++| ..||.................. .......... ..........+.+++.+||+.||++||
T Consensus 244 el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rp 317 (337)
T 3mdy_A 244 EVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVC---IKKLRPSFPN---RWSSDECLRQMGKLMTECWAHNPASRL 317 (337)
T ss_dssp HHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHT---TSCCCCCCCG---GGGGSHHHHHHHHHHHHHSCSSGGGSC
T ss_pred HHHhccCcccccccccccHhhhcCCCCchhhhHHHHh---hhccCccccc---cchhhHHHHHHHHHHHHhhhhChhhCC
Confidence 99999 6676554333222221111111 1110000000 011235667799999999999999999
Q ss_pred ChhhhhcC
Q 040898 330 SSKDVRSM 337 (337)
Q Consensus 330 s~~ell~~ 337 (337)
|+.+++++
T Consensus 318 s~~ell~~ 325 (337)
T 3mdy_A 318 TALRVKKT 325 (337)
T ss_dssp CHHHHHHH
T ss_pred CHHHHHHH
Confidence 99999864
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=314.29 Aligned_cols=275 Identities=16% Similarity=0.199 Sum_probs=198.3
Q ss_pred ccccccccceeccCcceEEEEeEEec-CCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELP-GSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR 117 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 117 (337)
..++|++.+.||+|+||.||++.+.. ..++..+|+|+.......... +...... .....+.+|+..++.++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~-----e~~~~~~---~~~~~~~~e~~~~~~l~ 106 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFS-----ELKFYQR---VAKKDCIKKWIERKQLD 106 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHH-----HHHHHHH---HCCHHHHHHHHHHHTCS
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHH-----HHHHHHH---HhhhHHHHHHHhhcccc
Confidence 46789999999999999999998853 226788999998765432211 1111111 11146778999999999
Q ss_pred CCCcccceeEEEc----CCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCC
Q 040898 118 HRNILPLLAHMVR----PNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIK 193 (337)
Q Consensus 118 hpniv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~ 193 (337)
||||+++++++.. ....++||||+ +++|.+++. ....+++..++.++.||+.||.|| |++|++|+||+
T Consensus 107 h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dlk 178 (345)
T 2v62_A 107 YLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISG----QNGTFKKSTVLQLGIRMLDVLEYI---HENEYVHGDIK 178 (345)
T ss_dssp CCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCB----GGGBCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCS
T ss_pred ccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCcC
Confidence 9999999999887 77899999999 889999984 334799999999999999999999 66799999999
Q ss_pred CCceeecCCC--CeEEecccCccccCCCCce-----eeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCC
Q 040898 194 PANVLIDDDM--EARISDFGHGKLMPDGHAQ-----ITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKF 266 (337)
Q Consensus 194 ~~nil~~~~~--~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~ 266 (337)
|+||+++.++ .++|+|||++......... .......+|+.|+|||++.+..++.++||||||+++|+|++|..
T Consensus 179 p~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~ 258 (345)
T 2v62_A 179 AANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKL 258 (345)
T ss_dssp GGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred HHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 9999998877 9999999999765432111 11133568999999999999889999999999999999999999
Q ss_pred CCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 267 PVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 267 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
||......... ......... ...+....... . ....+..+.+++.+||+.||++|||+.++++
T Consensus 259 pf~~~~~~~~~--~~~~~~~~~-~~~~~~~~~~~-~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 259 PWEQNLKDPVA--VQTAKTNLL-DELPQSVLKWA-P---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp TTGGGTTCHHH--HHHHHHHHH-HTTTHHHHHHS-C---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred CccccccccHH--HHHHHHhhc-ccccHHHHhhc-c---ccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 99643222211 111111111 11111110000 0 0022345899999999999999999999975
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=318.93 Aligned_cols=264 Identities=23% Similarity=0.307 Sum_probs=203.0
Q ss_pred ccccccccceeccCcceEEEEeEEe--cCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAEL--PGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT 116 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 116 (337)
..++|++.+.||+|+||.||++... ...+++.||+|++........ +.+.+|+.+++++
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~-------------------~~~~~E~~~l~~l 81 (327)
T 3lxl_A 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ-------------------RDFQREIQILKAL 81 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHH-------------------HHHHHHHHHHHTC
T ss_pred chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHH-------------------HHHHHHHHHHHhc
Confidence 4567999999999999999998842 234899999999865432111 4678899999999
Q ss_pred CCCCcccceeEEE--cCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCC
Q 040898 117 RHRNILPLLAHMV--RPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKP 194 (337)
Q Consensus 117 ~hpniv~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~ 194 (337)
+||||+++++++. +....++||||+++++|.+++... ...+++..++.++.|++.||.|| |+.|++|+||+|
T Consensus 82 ~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~l---H~~~ivH~Dikp 155 (327)
T 3lxl_A 82 HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYL---GSRRCVHRDLAA 155 (327)
T ss_dssp CCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSG
T ss_pred CCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHH---HhCCccCCCCCh
Confidence 9999999999886 456789999999999999999652 34589999999999999999999 667999999999
Q ss_pred CceeecCCCCeEEecccCccccCCCCcee-eeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCC
Q 040898 195 ANVLIDDDMEARISDFGHGKLMPDGHAQI-TVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFG 273 (337)
Q Consensus 195 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~ 273 (337)
+||+++.++.++|+|||++.......... ......+++.|+|||.+.+..++.++||||||+++|+|++|..||.....
T Consensus 156 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~ 235 (327)
T 3lxl_A 156 RNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSA 235 (327)
T ss_dssp GGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH
T ss_pred hhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccc
Confidence 99999999999999999998765443322 22234578889999999988889999999999999999999999754211
Q ss_pred C--------chhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 274 H--------TEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 274 ~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
. .............. ... ....++..+..+.+++.+||+.||++|||+.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~-~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 236 EFLRMMGCERDVPALSRLLELLE-EGQ---------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHHHCC----CCHHHHHHHHHH-TTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhhhhcccccccccHHHHHHHhh-ccc---------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 00000011111110 000 111122334558999999999999999999999763
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=323.46 Aligned_cols=262 Identities=20% Similarity=0.268 Sum_probs=194.5
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
...+|++.+.||+|+||.||++.+.. + ..+|+|++..... ...+|+.+++.++|
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~--~-~~~aikk~~~~~~-----------------------~~~~E~~il~~l~h 91 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVE--S-DEVAIKKVLQDKR-----------------------FKNRELQIMRIVKH 91 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETT--T-EEEEEEEEECCTT-----------------------SCCHHHHHHHTCCC
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECC--C-CeEEEEEEecCcc-----------------------hHHHHHHHHHhCCC
Confidence 45679999999999999999998864 4 4489988865422 22358999999999
Q ss_pred CCcccceeEEEcCCe------eEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 040898 119 RNILPLLAHMVRPNC------HLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDI 192 (337)
Q Consensus 119 pniv~~~~~~~~~~~------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di 192 (337)
|||+++++++..... .++||||+++ ++...+.........+++..++.++.||+.||.|| |++|++|+||
T Consensus 92 ~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDl 167 (394)
T 4e7w_A 92 PNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYI---HSIGICHRDI 167 (394)
T ss_dssp TTBCCEEEEEEEESSSSSCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCC
T ss_pred CCcceEEEEEEecCCCCCceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH---HHCCccCCCC
Confidence 999999999855433 7899999987 45444444334566799999999999999999999 6679999999
Q ss_pred CCCceeec-CCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccC-CCCCcccchhhhHHHHHHHhCCCCCCC
Q 040898 193 KPANVLID-DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTE-TISDKCDIYSFGVLLAVLVMGKFPVDD 270 (337)
Q Consensus 193 ~~~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~i~~~ll~g~~pf~~ 270 (337)
||+||+++ .++.++|+|||++......... ....+|+.|+|||++.+. .++.++||||+|+++|+|++|..||..
T Consensus 168 kp~Nill~~~~~~~kL~DFG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 244 (394)
T 4e7w_A 168 KPQNLLLDPPSGVLKLIDFGSAKILIAGEPN---VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPG 244 (394)
T ss_dssp SGGGEEEETTTTEEEECCCTTCEECCTTCCC---CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CHHHEEEcCCCCcEEEeeCCCcccccCCCCC---cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999 7999999999999876443322 235689999999998765 589999999999999999999999965
Q ss_pred CCCCchhhhHHHHHHhhhccCCcchh----------hhhcccCC-----chHHHHHHHHHHHhhhccCCCCCCCChhhhh
Q 040898 271 FFGHTEEMDMVKWMRNVIFSENPNRA----------INSKLLGN-----GYEEQMLLVLKLACFCTLKDPDERPSSKDVR 335 (337)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~-----~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 335 (337)
... ...+........ ....... ..+..... ..+.....+.+|+.+||+.||++|||+.|++
T Consensus 245 ~~~---~~~l~~i~~~~g-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 320 (394)
T 4e7w_A 245 ESG---IDQLVEIIKVLG-TPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEAL 320 (394)
T ss_dssp SSH---HHHHHHHHHHHC-CCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred CCH---HHHHHHHHHHhC-CCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHh
Confidence 422 222222221110 0000000 00000000 0112345689999999999999999999999
Q ss_pred cC
Q 040898 336 SM 337 (337)
Q Consensus 336 ~~ 337 (337)
+|
T Consensus 321 ~h 322 (394)
T 4e7w_A 321 CH 322 (394)
T ss_dssp TS
T ss_pred cC
Confidence 87
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=313.78 Aligned_cols=261 Identities=21% Similarity=0.318 Sum_probs=197.8
Q ss_pred ccccccccceeccCcceEEEEeEEe---cCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHh
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAEL---PGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQ 115 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~ 115 (337)
..++|++.+.||+|+||.||++.+. ...++..||+|.+......... ..+.+|+.++++
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~------------------~~~~~E~~~l~~ 89 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE------------------LDFLMEALIISK 89 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHH------------------HHHHHHHHHHHH
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhH------------------HHHHHHHHHHhh
Confidence 4578999999999999999998843 2237889999998644322111 467789999999
Q ss_pred cCCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCC---cccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 040898 116 TRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQG---RRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDI 192 (337)
Q Consensus 116 l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di 192 (337)
++||||+++++++.++...++||||+++++|.+++...... ...+++..++.++.|++.||.|| |+.|++|+||
T Consensus 90 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~L---H~~~i~H~dl 166 (327)
T 2yfx_A 90 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL---EENHFIHRDI 166 (327)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCC
T ss_pred CCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHH---hhCCeecCcC
Confidence 99999999999999999999999999999999999764321 24588899999999999999999 6679999999
Q ss_pred CCCceeecC---CCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCC
Q 040898 193 KPANVLIDD---DMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPV 268 (337)
Q Consensus 193 ~~~nil~~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf 268 (337)
+|+||+++. +..++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||
T Consensus 167 kp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~ 246 (327)
T 2yfx_A 167 AARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 246 (327)
T ss_dssp CGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred CHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCC
Confidence 999999984 44699999999876543332223334567889999999988889999999999999999998 99998
Q ss_pred CCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 269 DDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.... .......+........ ....+..+.+++.+||+.||++|||+.+++++
T Consensus 247 ~~~~----~~~~~~~~~~~~~~~~-------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 298 (327)
T 2yfx_A 247 PSKS----NQEVLEFVTSGGRMDP-------------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILER 298 (327)
T ss_dssp TTCC----HHHHHHHHHTTCCCCC-------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCcC----HHHHHHHHhcCCCCCC-------------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 6532 1222222221111100 11123348899999999999999999999864
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=339.08 Aligned_cols=254 Identities=22% Similarity=0.294 Sum_probs=204.5
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc-C
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT-R 117 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~ 117 (337)
..++|++++.||+|+||.||++.+.. +++.||||++........ .....+..|..++..+ .
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~--~~~~vAvK~l~~~~~~~~----------------~~~~~~~~E~~~l~~~~~ 400 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKG--TDELYAVKILKKDVVIQD----------------DDVECTMVEKRVLALPGK 400 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESS--SCCEEEEEEEEHHHHHHT----------------TTTHHHHHHHHHHTCTTC
T ss_pred cccceEEEEEEccCCCEEEEEEEECC--CCcEEEEEEEeccccccH----------------HHHHHHHHHHHHHHhccC
Confidence 45689999999999999999999876 899999999864321110 1125677788999887 7
Q ss_pred CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCce
Q 040898 118 HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANV 197 (337)
Q Consensus 118 hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ni 197 (337)
||+|+.+++++.+.+.+|+||||+++|+|.+++.. ...+++..+..++.||+.||.|| |++||+||||||+||
T Consensus 401 ~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~L---H~~gIiHrDLKp~NI 473 (674)
T 3pfq_A 401 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFL---QSKGIIYRDLKLDNV 473 (674)
T ss_dssp CTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HHTSEECCCCCSTTE
T ss_pred CCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HhCCeEeccCChhhE
Confidence 99999999999999999999999999999999954 34589999999999999999999 667999999999999
Q ss_pred eecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchh
Q 040898 198 LIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEE 277 (337)
Q Consensus 198 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~ 277 (337)
|++.++.++|+|||++........ ......||+.|+|||++.+..++.++|+||||+++|+|++|..||.... .
T Consensus 474 Ll~~~g~ikL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~----~ 547 (674)
T 3pfq_A 474 MLDSEGHIKIADFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED----E 547 (674)
T ss_dssp EECSSSCEEECCCTTCEECCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS----H
T ss_pred EEcCCCcEEEeecceeeccccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC----H
Confidence 999999999999999876432222 2234679999999999999999999999999999999999999996531 1
Q ss_pred hhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCCh-----hhhhcC
Q 040898 278 MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSS-----KDVRSM 337 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~ell~~ 337 (337)
..+.. .+....... +......+.+|+.+||+.||++||++ +||++|
T Consensus 548 ~~~~~---~i~~~~~~~-----------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 548 DELFQ---SIMEHNVAY-----------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp HHHHH---HHHSSCCCC-----------CTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred HHHHH---HHHhCCCCC-----------CccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 22222 222111111 11223458999999999999999998 889876
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=312.50 Aligned_cols=255 Identities=24% Similarity=0.287 Sum_probs=198.3
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceE--EEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc-
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMI--AIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT- 116 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~v--avK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l- 116 (337)
.++|++.+.||+|+||.||++.+.. ++..+ ++|.+........ ...+.+|+.+++++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~--~~~~~~v~iK~~~~~~~~~~------------------~~~~~~E~~~l~~l~ 83 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKK--DGLRMDAAIKRMKEYASKDD------------------HRDFAGELEVLCKLG 83 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEE--TTEEEEEEEEEEECC------------------------CHHHHHHHHHTTCC
T ss_pred HHHccceeeeecCCCceEEEEEEcc--CCcccceeeeeeccccchHH------------------HHHHHHHHHHHHhcc
Confidence 3679999999999999999999876 66654 8898864322111 14678899999999
Q ss_pred CCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhc------------CCcccCChHHHHHHHHHHHHHHHHHhhCCC
Q 040898 117 RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVS------------QGRRELDWPARHRIARGIASGLEYLHMCHR 184 (337)
Q Consensus 117 ~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~ 184 (337)
+||||+++++++.+.+..++||||+++++|.+++.... .....+++..++.++.|++.||.|| |+
T Consensus 84 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~ 160 (327)
T 1fvr_A 84 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQ 160 (327)
T ss_dssp CCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHH---HH
T ss_pred CCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHH---Hh
Confidence 99999999999999999999999999999999996532 2234689999999999999999999 66
Q ss_pred CCeEecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-
Q 040898 185 PRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM- 263 (337)
Q Consensus 185 ~gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~- 263 (337)
+|++|+||+|+||+++.++.++|+|||++....... ......+++.|+|||.+.+..++.++|+||||+++|+|++
T Consensus 161 ~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~ 237 (327)
T 1fvr_A 161 KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL 237 (327)
T ss_dssp TTEECSCCSGGGEEECGGGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred CCccCCCCccceEEEcCCCeEEEcccCcCccccccc---cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcC
Confidence 799999999999999999999999999987432211 1123456888999999988888999999999999999998
Q ss_pred CCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 264 GKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 264 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
|..||..... ......+ ...... ..+...+..+.+++.+||+.||++|||+.+++++
T Consensus 238 g~~pf~~~~~----~~~~~~~---~~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 238 GGTPYCGMTC----AELYEKL---PQGYRL----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp SCCTTTTCCH----HHHHHHG---GGTCCC----------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCcH----HHHHHHh---hcCCCC----------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999865321 1121111 111110 0111223458999999999999999999999863
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=319.90 Aligned_cols=273 Identities=21% Similarity=0.264 Sum_probs=186.5
Q ss_pred ccccccc-cceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC
Q 040898 39 KEDCFDS-LKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR 117 (337)
Q Consensus 39 ~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 117 (337)
-.+.|++ .++||+|+||.||++.+....+++.||+|++...... ..+.+|+.+++.++
T Consensus 18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~---------------------~~~~~E~~~l~~l~ 76 (405)
T 3rgf_A 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS---------------------MSACREIALLRELK 76 (405)
T ss_dssp HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC---------------------HHHHHHHHHHHHCC
T ss_pred hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC---------------------HHHHHHHHHHHhcC
Confidence 4455777 5589999999999999765558899999998654321 35678999999999
Q ss_pred CCCcccceeEEE--cCCeeEEEEEeccCCCHHHHHHHhcC-----CcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 040898 118 HRNILPLLAHMV--RPNCHLLVYEFMKNGSLQDILYDVSQ-----GRRELDWPARHRIARGIASGLEYLHMCHRPRLIHR 190 (337)
Q Consensus 118 hpniv~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~ 190 (337)
||||+++++++. .+...++||||+.+ +|.+++..... ....+++..++.++.||+.||.|| |+.|++|+
T Consensus 77 hpniv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~L---H~~~ivH~ 152 (405)
T 3rgf_A 77 HPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL---HANWVLHR 152 (405)
T ss_dssp CTTBCCCCEEEEETTTTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHH---HHTTCCCC
T ss_pred CCCeeeEeeEEecCCCCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHH---HhCCEeCC
Confidence 999999999995 46789999999975 88887753221 223589999999999999999999 66799999
Q ss_pred CCCCCceee----cCCCCeEEecccCccccCCCCce-eeeecccCCCCccCccccccC-CCCCcccchhhhHHHHHHHhC
Q 040898 191 DIKPANVLI----DDDMEARISDFGHGKLMPDGHAQ-ITVKCMVGTMGYMAPESLQTE-TISDKCDIYSFGVLLAVLVMG 264 (337)
Q Consensus 191 di~~~nil~----~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~i~~~ll~g 264 (337)
||||+||++ +.++.++|+|||++......... .......+|+.|+|||++.+. .++.++|||||||++|+|++|
T Consensus 153 Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g 232 (405)
T 3rgf_A 153 DLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 232 (405)
T ss_dssp CCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHS
T ss_pred CcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhC
Confidence 999999999 67789999999999876533211 222345789999999999874 489999999999999999999
Q ss_pred CCCCCCCCCCc-----hhhhHHHHHHhhhccCCcchhhhhc------------c----cCCch---------HHHHHHHH
Q 040898 265 KFPVDDFFGHT-----EEMDMVKWMRNVIFSENPNRAINSK------------L----LGNGY---------EEQMLLVL 314 (337)
Q Consensus 265 ~~pf~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~------------~----~~~~~---------~~~~~~l~ 314 (337)
.+||....... ...+....+.......... .+... . ..... ......+.
T Consensus 233 ~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (405)
T 3rgf_A 233 EPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADK-DWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAF 311 (405)
T ss_dssp SCTTCCCC------CCCCHHHHHHHHHHHCCCCTT-TCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHH
T ss_pred CCCCCCccccccccccchHHHHHHHHHhhCCCChh-hcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHH
Confidence 99996533210 0011111111111111100 00000 0 00000 00134578
Q ss_pred HHHhhhccCCCCCCCChhhhhcC
Q 040898 315 KLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 315 ~li~~~l~~dP~~Rps~~ell~~ 337 (337)
+|+.+||+.||.+|||++|+|+|
T Consensus 312 ~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 312 HLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHccCCcccCCCHHHHhcC
Confidence 99999999999999999999987
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=303.96 Aligned_cols=258 Identities=21% Similarity=0.317 Sum_probs=198.6
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++.+.||+|+||.||++.+.. +++.||+|++...... ..+.+|+.+++.++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~---------------------~~~~~e~~~l~~l~~ 63 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIA--AGEEVAIKLECVKTKH---------------------PQLHIESKIYKMMQG 63 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETT--TTEEEEEEEEEC---C---------------------CCHHHHHHHHHHHTT
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcC--CCceEEEEeecccccc---------------------hHHHHHHHHHHHhcC
Confidence 45789999999999999999999876 8999999986543221 356779999999998
Q ss_pred CCcccceeEE-EcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCce
Q 040898 119 RNILPLLAHM-VRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANV 197 (337)
Q Consensus 119 pniv~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ni 197 (337)
++++..+..+ ..+...++||||+ +++|.+++.. ....+++..++.++.|++.||.|| |++|++|+||+|+||
T Consensus 64 ~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~L---H~~~ivH~Dlkp~NI 136 (296)
T 4hgt_A 64 GVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYI---HSKNFIHRDVKPDNF 136 (296)
T ss_dssp STTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGE
T ss_pred CCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHe
Confidence 8877776665 6677889999999 8899999864 344689999999999999999999 667999999999999
Q ss_pred ee---cCCCCeEEecccCccccCCCCce-----eeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCC
Q 040898 198 LI---DDDMEARISDFGHGKLMPDGHAQ-----ITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVD 269 (337)
Q Consensus 198 l~---~~~~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~ 269 (337)
++ +.++.++|+|||++......... .......+|+.|+|||.+.+..++.++||||||+++|+|++|..||.
T Consensus 137 l~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 216 (296)
T 4hgt_A 137 LMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQ 216 (296)
T ss_dssp EECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred eeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCc
Confidence 99 78899999999999876543221 11234578999999999999999999999999999999999999998
Q ss_pred CCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 270 DFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
..................... ... .. ....+..+.+++.+||+.||++|||+.++++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~-~~~-~~--------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 217 GLKAATKRQKYERISEKKMST-PIE-VL--------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp SCCCSSSSSHHHHHHHHHHHS-CHH-HH--------TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred ccchhhhhhhhhhhhcccccc-hhh-hh--------hccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 654433333332222221111 100 00 0111245899999999999999999999975
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=312.16 Aligned_cols=261 Identities=20% Similarity=0.319 Sum_probs=200.4
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
.++|++.+.||+|+||.||++.+.. .+++.||+|++..... . .+.+.+|+.++..++|+
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~vavK~~~~~~~--~------------------~~~~~~e~~~l~~l~~~ 71 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHK-AGGRHVAVKIVKNVDR--Y------------------CEAARSEIQVLEHLNTT 71 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETT-TTTEEEEEEEECSSHH--H------------------HHHHHHHHHHHHHHHHH
T ss_pred cCceEEEEEEecCCCeEEEEEEecC-CCCcEEEEEEEecCCc--h------------------hHHHHHHHHHHHHhhhc
Confidence 4689999999999999999988732 3789999999853211 0 14566788888877655
Q ss_pred ------CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCC
Q 040898 120 ------NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIK 193 (337)
Q Consensus 120 ------niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~ 193 (337)
+++++++++.+.+..++||||+ +++|.+++.. ....++++..++.++.|++.||.|| |++|++|+||+
T Consensus 72 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~--~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dlk 145 (339)
T 1z57_A 72 DPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKE--NGFLPFRLDHIRKMAYQICKSVNFL---HSNKLTHTDLK 145 (339)
T ss_dssp CTTCTTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCC
T ss_pred CCCCceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHh--cCCCCCcHHHHHHHHHHHHHHHHHH---HHCCCcCCCCC
Confidence 4999999999999999999999 7899999865 3334688999999999999999999 66799999999
Q ss_pred CCceeecC-------------------CCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhh
Q 040898 194 PANVLIDD-------------------DMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSF 254 (337)
Q Consensus 194 ~~nil~~~-------------------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Diwsl 254 (337)
|+||+++. ++.++|+|||.+....... ....+|+.|+|||++.+..++.++|+|||
T Consensus 146 p~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 220 (339)
T 1z57_A 146 PENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILALGWSQPCDVWSI 220 (339)
T ss_dssp GGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTSCCCTHHHHHHH
T ss_pred HHHEEEeccccccccCCccccccccccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCCCCCcchhhHHH
Confidence 99999987 6689999999987654322 23568999999999999999999999999
Q ss_pred hHHHHHHHhCCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhh-------------------------------hcccC
Q 040898 255 GVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAIN-------------------------------SKLLG 303 (337)
Q Consensus 255 G~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~ 303 (337)
|+++|+|++|..||...... .....+....... +..... .....
T Consensus 221 G~il~el~~g~~pf~~~~~~----~~~~~~~~~~~~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (339)
T 1z57_A 221 GCILIEYYLGFTVFPTHDSK----EHLAMMERILGPL-PKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFM 295 (339)
T ss_dssp HHHHHHHHHSSCSCCCSCHH----HHHHHHHHHHCSC-CHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGC
T ss_pred HHHHHHHHhCCCCCCCCChH----HHHHHHHHHhCCC-CHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhc
Confidence 99999999999999653221 1112222211111 100000 00001
Q ss_pred CchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 304 NGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 304 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.........+.+|+.+||+.||++|||+.|+++|
T Consensus 296 ~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 296 LSQDVEHERLFDLIQKMLEYDPAKRITLREALKH 329 (339)
T ss_dssp SCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ccchhhHHHHHHHHHHHhCcCcccccCHHHHhcC
Confidence 1223456779999999999999999999999987
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=306.96 Aligned_cols=255 Identities=24% Similarity=0.407 Sum_probs=200.5
Q ss_pred ccccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHH
Q 040898 35 AFLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITAN 114 (337)
Q Consensus 35 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~ 114 (337)
+|.-..++|++.+.||+|+||.||++.+. ++..||+|.+....... +.+.+|+.+++
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~--------------------~~~~~E~~~l~ 63 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN---GHTKVAVKSLKQGSMSP--------------------DAFLAEANLMK 63 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET---TTEEEEEEEECTTSSCH--------------------HHHHHHHHHHH
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEc---CCcEEEEEEecCCcccH--------------------HHHHHHHHHHH
Confidence 44446788999999999999999998864 67789999986543211 46778999999
Q ss_pred hcCCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCC
Q 040898 115 QTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKP 194 (337)
Q Consensus 115 ~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~ 194 (337)
.++||||+++++++. ++..++||||+++++|.+++... .+..+++..++.++.|++.||.+| |++|++|+||+|
T Consensus 64 ~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dikp 137 (279)
T 1qpc_A 64 QLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFI---EERNYIHRDLRA 137 (279)
T ss_dssp HCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSG
T ss_pred hCCCcCcceEEEEEc-CCCcEEEEecCCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCH
Confidence 999999999999876 45689999999999999998431 123689999999999999999999 667999999999
Q ss_pred CceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCC
Q 040898 195 ANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFG 273 (337)
Q Consensus 195 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~ 273 (337)
+||+++.++.++|+|||.+......... ......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.....
T Consensus 138 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 216 (279)
T 1qpc_A 138 ANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 216 (279)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSSCEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred hhEEEcCCCCEEECCCcccccccCcccc-cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH
Confidence 9999999999999999999876543221 1223456788999999988888999999999999999999 8999865321
Q ss_pred CchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 274 HTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
......+... ... ..+...+..+.+++.+||+.||++|||+.++++
T Consensus 217 ----~~~~~~~~~~---~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 217 ----PEVIQNLERG---YRM----------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp ----HHHHHHHHTT---CCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----HHHHHHHhcc---cCC----------CCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1121111111 110 001122345899999999999999999999875
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=313.26 Aligned_cols=263 Identities=22% Similarity=0.300 Sum_probs=198.6
Q ss_pred cccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHh
Q 040898 36 FLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQ 115 (337)
Q Consensus 36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~ 115 (337)
-+.-.++|.+.+.||+|+||.||++.+.. +|+.||+|++......... ...+.+|+.+++.
T Consensus 37 ~~~l~~~y~~~~~lG~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~-----------------~~~~~~E~~~l~~ 97 (371)
T 4exu_A 37 AWELPKTYVSPTHVGSGAYGSVCSAIDKR--SGEKVAIKKLSRPFQSEIF-----------------AKRAYRELLLLKH 97 (371)
T ss_dssp EEEEETTEEEEEEEEECSSEEEEEEEETT--TTEEEEEEEECSTTSSHHH-----------------HHHHHHHHHHHHH
T ss_pred eecccccEEEEeEEecCCCeEEEEEEECC--CCCEEEEEEecccccchhH-----------------HHHHHHHHHHHHh
Confidence 34456789999999999999999999876 8999999998754332211 1567889999999
Q ss_pred cCCCCcccceeEEEcCCee------EEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEe
Q 040898 116 TRHRNILPLLAHMVRPNCH------LLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIH 189 (337)
Q Consensus 116 l~hpniv~~~~~~~~~~~~------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h 189 (337)
++||||+++++++...... ++||||++ ++|.+.+ . ..+++..+..++.|++.||.|| |+.|++|
T Consensus 98 l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~----~--~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH 167 (371)
T 4exu_A 98 MQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIM----G--MEFSEEKIQYLVYQMLKGLKYI---HSAGVVH 167 (371)
T ss_dssp CCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHT----T--SCCCHHHHHHHHHHHHHHHHHH---HHTTCCC
T ss_pred cCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHHHh----h--cCCCHHHHHHHHHHHHHHHHHH---HHCCCcC
Confidence 9999999999999877655 99999997 4887776 2 2389999999999999999999 6679999
Q ss_pred cCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCcccccc-CCCCCcccchhhhHHHHHHHhCCCCC
Q 040898 190 RDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQT-ETISDKCDIYSFGVLLAVLVMGKFPV 268 (337)
Q Consensus 190 ~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~i~~~ll~g~~pf 268 (337)
+||+|+||+++.++.++|+|||++...... .....+|+.|+|||++.+ ..++.++||||||+++|+|++|..||
T Consensus 168 ~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf 242 (371)
T 4exu_A 168 RDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF 242 (371)
T ss_dssp SCCCGGGEEECTTCCEEECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred CCcCHHHeEECCCCCEEEEecCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999998765332 234568999999999977 67899999999999999999999999
Q ss_pred CCCCCCchhhhHHHHHHhhhccCCcchhhh-----------h---cccC----CchHHHHHHHHHHHhhhccCCCCCCCC
Q 040898 269 DDFFGHTEEMDMVKWMRNVIFSENPNRAIN-----------S---KLLG----NGYEEQMLLVLKLACFCTLKDPDERPS 330 (337)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~---~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps 330 (337)
..... ...+..... ....... .... . .... ...+.....+.+|+.+||+.||++|||
T Consensus 243 ~~~~~---~~~~~~i~~-~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 317 (371)
T 4exu_A 243 KGKDY---LDQLTQILK-VTGVPGT-EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLT 317 (371)
T ss_dssp CCSSH---HHHHHHHHH-HHCCCCH-HHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCC
T ss_pred CCCCh---HHHHHHHHH-HhCCCcH-HHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCC
Confidence 65322 111111111 1100000 0000 0 0000 001123456899999999999999999
Q ss_pred hhhhhcC
Q 040898 331 SKDVRSM 337 (337)
Q Consensus 331 ~~ell~~ 337 (337)
+.|+|+|
T Consensus 318 ~~ell~h 324 (371)
T 4exu_A 318 AAQALTH 324 (371)
T ss_dssp HHHHHTS
T ss_pred HHHHhcC
Confidence 9999987
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=305.67 Aligned_cols=263 Identities=23% Similarity=0.326 Sum_probs=201.7
Q ss_pred ccccccccccccccceeccCcceEEEEeEEecC-CCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHH
Q 040898 33 DLAFLKKEDCFDSLKKIGSGGWGEVFYKAELPG-SNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEII 111 (337)
Q Consensus 33 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~ 111 (337)
+..+-...-.|.+.+.||+|+||.||++.+... .++..+|+|.+........ .+.+.+|+.
T Consensus 13 ~~~i~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~------------------~~~~~~E~~ 74 (298)
T 3pls_A 13 DVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQ------------------VEAFLREGL 74 (298)
T ss_dssp GGBCCGGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHH------------------HHHHHHHHH
T ss_pred heEccccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHH------------------HHHHHHHHH
Confidence 444555666788899999999999999987642 2344799999865332211 156788999
Q ss_pred HHHhcCCCCcccceeEEEcCCee-EEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 040898 112 TANQTRHRNILPLLAHMVRPNCH-LLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHR 190 (337)
Q Consensus 112 ~l~~l~hpniv~~~~~~~~~~~~-~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~ 190 (337)
+++.++||||+++++++.+.+.. ++++||+.+++|.+++.. ....+++..++.++.|++.||.|| |+.|++|+
T Consensus 75 ~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~L---H~~~i~H~ 148 (298)
T 3pls_A 75 LMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYL---AEQKFVHR 148 (298)
T ss_dssp HHHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHH---HHTTCCCS
T ss_pred HHHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHH---HhCCcccC
Confidence 99999999999999999776655 999999999999999853 345688899999999999999999 66799999
Q ss_pred CCCCCceeecCCCCeEEecccCccccCCCCc--eeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCC-
Q 040898 191 DIKPANVLIDDDMEARISDFGHGKLMPDGHA--QITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFP- 267 (337)
Q Consensus 191 di~~~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~p- 267 (337)
||+|+||+++.++.++|+|||++........ ........+++.|+|||.+.+..++.++|+||||+++|+|++|..|
T Consensus 149 dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~ 228 (298)
T 3pls_A 149 DLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228 (298)
T ss_dssp CCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCT
T ss_pred CCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCC
Confidence 9999999999999999999999976543221 1122234578899999999999999999999999999999996555
Q ss_pred CCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 268 VDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 268 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
|... ................. +...+..+.+++.+||+.||.+|||+.++++
T Consensus 229 ~~~~----~~~~~~~~~~~~~~~~~-------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 229 YRHI----DPFDLTHFLAQGRRLPQ-------------PEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp TTTS----CGGGHHHHHHTTCCCCC-------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CccC----CHHHHHHHhhcCCCCCC-------------CccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 4332 12222222222111111 1112245899999999999999999999985
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=303.89 Aligned_cols=257 Identities=26% Similarity=0.368 Sum_probs=199.0
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
.-++|.....||+|+||.||++.+.. +++.||+|.+........ ..+.+|+.+++.++|
T Consensus 20 ~~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~-------------------~~~~~e~~~l~~l~h 78 (295)
T 2clq_A 20 EYDENGDRVVLGKGTYGIVYAGRDLS--NQVRIAIKEIPERDSRYS-------------------QPLHEEIALHKHLKH 78 (295)
T ss_dssp CBCTTSSBCEEEECSSSEEEEEEETT--TCCEEEEEEEECCCC----------------------HHHHHHHHHHHTCCC
T ss_pred cccCCCCcEEEeecCcEEEEEEEECC--CCeEEEEEEccCCchHHH-------------------HHHHHHHHHHHhCCC
Confidence 44456666799999999999999876 899999999865432111 467789999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++++...+..++||||+++++|.+++.... .....++..++.++.|++.||.|| |+.|++|+||+|+||+
T Consensus 79 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~Nil 154 (295)
T 2clq_A 79 KNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYL---HDNQIVHRDIKGDNVL 154 (295)
T ss_dssp TTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEE
T ss_pred CCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHH---HhCCEEccCCChhhEE
Confidence 999999999999999999999999999999996522 233567888999999999999999 6679999999999999
Q ss_pred ecC-CCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCC--CCCcccchhhhHHHHHHHhCCCCCCCCCCCc
Q 040898 199 IDD-DMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTET--ISDKCDIYSFGVLLAVLVMGKFPVDDFFGHT 275 (337)
Q Consensus 199 ~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~--~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~ 275 (337)
++. ++.++|+|||.+........ ......+++.|+|||++.+.. ++.++|+||||+++|+|++|..||.......
T Consensus 155 ~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 232 (295)
T 2clq_A 155 INTYSGVLKISDFGTSKRLAGINP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ 232 (295)
T ss_dssp EETTTCCEEECCTTTCEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH
T ss_pred EECCCCCEEEeecccccccCCCCC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh
Confidence 987 89999999999877643321 122456899999999997643 7889999999999999999999996532211
Q ss_pred hhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 276 EEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
...... ......+ ..+...+..+.+++.+||+.||++|||+.++++|
T Consensus 233 --~~~~~~---~~~~~~~----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 233 --AAMFKV---GMFKVHP----------EIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp --HHHHHH---HHHCCCC----------CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred --HHHHhh---ccccccc----------cccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111111 0001000 1111223458899999999999999999999986
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=312.71 Aligned_cols=257 Identities=23% Similarity=0.368 Sum_probs=196.3
Q ss_pred ccccccccceeccCcceEEEEeEEecC--CCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPG--SNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT 116 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 116 (337)
..++|++.+.||+|+||.||++.+... ..+..||+|.+......... ..+.+|+.+++++
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~------------------~~~~~E~~~l~~l 103 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR------------------VDFLGEAGIMGQF 103 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHH------------------HHHHHHHHHHHTC
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHH------------------HHHHHHHHHHHhC
Confidence 567899999999999999999987642 12456999998654322111 4678899999999
Q ss_pred CCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 040898 117 RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPAN 196 (337)
Q Consensus 117 ~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~n 196 (337)
+||||+++++++.+.+..++||||+++++|.+++.. ....+++..++.++.|++.||.+| |++|++|+||+|+|
T Consensus 104 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dikp~N 177 (333)
T 1mqb_A 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYL---ANMNYVHRDLAARN 177 (333)
T ss_dssp CCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGG
T ss_pred CCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCChhe
Confidence 999999999999999999999999999999999864 345689999999999999999999 66799999999999
Q ss_pred eeecCCCCeEEecccCccccCCCCce-eeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCC
Q 040898 197 VLIDDDMEARISDFGHGKLMPDGHAQ-ITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGH 274 (337)
Q Consensus 197 il~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~ 274 (337)
|+++.++.++|+|||++......... .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 178 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~- 256 (333)
T 1mqb_A 178 ILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN- 256 (333)
T ss_dssp EEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-
T ss_pred EEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH-
Confidence 99999999999999998876543221 11122346778999999998889999999999999999999 9999865321
Q ss_pred chhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 275 TEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
......+... .... .+...+..+.+++.+||+.||++|||+.++++
T Consensus 257 ---~~~~~~~~~~---~~~~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 302 (333)
T 1mqb_A 257 ---HEVMKAINDG---FRLP----------TPMDCPSAIYQLMMQCWQQERARRPKFADIVS 302 (333)
T ss_dssp ---HHHHHHHHTT---CCCC----------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ---HHHHHHHHCC---CcCC----------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1222222111 1100 01122345889999999999999999999975
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=315.87 Aligned_cols=265 Identities=22% Similarity=0.321 Sum_probs=198.7
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC-
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR- 117 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~- 117 (337)
..++|++.+.||+|+||.||++.+.. +++.||+|++..... . ...+.+|+.+++++.
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~--~------------------~~~~~~e~~~l~~l~~ 74 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMV--NNTHVAMKIVRGDKV--Y------------------TEAAEDEIKLLQRVND 74 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETT--TTEEEEEEEECSCHH--H------------------HHHHHHHHHHHHHHHH
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecC--CCcEEEEEEecCCcc--c------------------hhhhhHHHHHHHHhhc
Confidence 45789999999999999999999876 899999999864311 0 045666777777775
Q ss_pred ----------CCCcccceeEEEcCC----eeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCC
Q 040898 118 ----------HRNILPLLAHMVRPN----CHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCH 183 (337)
Q Consensus 118 ----------hpniv~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h 183 (337)
||||+++++++.... ..++++|++ +++|.+++.. .....+++..++.++.||+.||.|| |
T Consensus 75 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~l---H 148 (373)
T 1q8y_A 75 ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKK--YEHRGIPLIYVKQISKQLLLGLDYM---H 148 (373)
T ss_dssp TCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHH---H
T ss_pred ccccchhccccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHH--hhccCCcHHHHHHHHHHHHHHHHHH---H
Confidence 899999999987654 789999999 8899999965 2344589999999999999999999 6
Q ss_pred CC-CeEecCCCCCceeec------CCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhH
Q 040898 184 RP-RLIHRDIKPANVLID------DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGV 256 (337)
Q Consensus 184 ~~-gi~h~di~~~nil~~------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~ 256 (337)
++ |++|+||+|+||+++ ..+.++|+|||++....... ....+|+.|+|||++.+..++.++||||||+
T Consensus 149 ~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~ 223 (373)
T 1q8y_A 149 RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTAC 223 (373)
T ss_dssp HTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHH
T ss_pred hcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCCC-----CCCCCCccccCcHHHhCCCCCchHhHHHHHH
Confidence 66 999999999999994 44479999999997764321 2346899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCchhh--hHHHHHHhhhccCCcchhhh-----------------------------hcccCCc
Q 040898 257 LLAVLVMGKFPVDDFFGHTEEM--DMVKWMRNVIFSENPNRAIN-----------------------------SKLLGNG 305 (337)
Q Consensus 257 i~~~ll~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~ 305 (337)
++|+|++|..||.......... .....+....... +..... .......
T Consensus 224 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (373)
T 1q8y_A 224 LIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGEL-PSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKF 302 (373)
T ss_dssp HHHHHHHSSCCC---------CHHHHHHHHHHHHCSC-CHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCC
T ss_pred HHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCC-CHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccC
Confidence 9999999999997544322111 1111111111111 000000 0001123
Q ss_pred hHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 306 YEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 306 ~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.......+.+|+.+||+.||++|||+.|+|+|
T Consensus 303 ~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 334 (373)
T 1q8y_A 303 SKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 334 (373)
T ss_dssp CHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred CcchHHHHHHHHHHHhccCccccCCHHHHhhC
Confidence 45677889999999999999999999999987
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=328.93 Aligned_cols=254 Identities=22% Similarity=0.384 Sum_probs=200.9
Q ss_pred cccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHh
Q 040898 36 FLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQ 115 (337)
Q Consensus 36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~ 115 (337)
+.-..++|++.+.||+|+||.||++.+. ++..||||.+...... .+.+.+|+.++++
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~---~~~~vavK~~~~~~~~--------------------~~~~~~E~~~l~~ 239 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYN---KHTKVAVKTMKPGSMS--------------------VEAFLAEANVMKT 239 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEET---TTEEEEEEEECTTSBC--------------------HHHHHHHHHHHTT
T ss_pred eeechHHeEEEEEcccCCceEEEEEEEC---CccEEEEEEecCCCcc--------------------HHHHHHHHHHHhh
Confidence 3446788999999999999999998874 5788999998754321 1568889999999
Q ss_pred cCCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCC
Q 040898 116 TRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPA 195 (337)
Q Consensus 116 l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ 195 (337)
++||||+++++++. ....++||||+++|+|.+++... ....+++..++.++.||+.||.|| |++|++|+||+|+
T Consensus 240 l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~L---H~~~ivHrDlkp~ 313 (454)
T 1qcf_A 240 LQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFI---EQRNYIHRDLRAA 313 (454)
T ss_dssp CCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSH--HHHTCCHHHHHHHHHHHHHHHHHH---HHTTCCCSSCSGG
T ss_pred CCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHH---HhCCccCCCCCHH
Confidence 99999999999876 66789999999999999999542 223578889999999999999999 6679999999999
Q ss_pred ceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCC
Q 040898 196 NVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGH 274 (337)
Q Consensus 196 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~ 274 (337)
||+++.++.++|+|||++......... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus 314 Nill~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~- 391 (454)
T 1qcf_A 314 NILVSASLVCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN- 391 (454)
T ss_dssp GEEECTTCCEEECSTTGGGGBCCHHHH-TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-
T ss_pred HEEECCCCcEEEeeCCCceEcCCCcee-ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH-
Confidence 999999999999999999875432111 1122346778999999998889999999999999999999 9999965322
Q ss_pred chhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 275 TEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
......+....... .+...+..+.+++.+||+.||++|||+.+|++
T Consensus 392 ---~~~~~~i~~~~~~~-------------~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 392 ---PEVIRALERGYRMP-------------RPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp ---HHHHHHHHHTCCCC-------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---HHHHHHHHcCCCCC-------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 12222221111110 11123345899999999999999999999875
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=301.93 Aligned_cols=258 Identities=21% Similarity=0.317 Sum_probs=201.6
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++.+.||+|+||.||++.+.. +++.||+|++...... ..+.+|+.+++.++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~---------------------~~~~~e~~~l~~l~~ 63 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIA--AGEEVAIKLECVKTKH---------------------PQLHIESKIYKMMQG 63 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETT--TTEEEEEEEEESCSSC---------------------CHHHHHHHHHHHHTT
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcC--CCcEEEEEEecCCcch---------------------hHHHHHHHHHHHhhc
Confidence 46789999999999999999999866 8999999988654321 346779999999999
Q ss_pred CCcccceeEE-EcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCce
Q 040898 119 RNILPLLAHM-VRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANV 197 (337)
Q Consensus 119 pniv~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ni 197 (337)
++++..+..+ ..+...++||||+ +++|.+++.. ....+++..++.++.|++.||.|| |++|++|+||+|+||
T Consensus 64 ~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~dlkp~NI 136 (296)
T 3uzp_A 64 GVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYI---HSKNFIHRDVKPDNF 136 (296)
T ss_dssp STTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGE
T ss_pred CCCCCccccccCCCCceEEEEEec-CCCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCCHHHe
Confidence 8877766655 6677889999999 8899999964 334689999999999999999999 667999999999999
Q ss_pred eec---CCCCeEEecccCccccCCCCcee-----eeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCC
Q 040898 198 LID---DDMEARISDFGHGKLMPDGHAQI-----TVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVD 269 (337)
Q Consensus 198 l~~---~~~~~~l~dfg~~~~~~~~~~~~-----~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~ 269 (337)
+++ .++.++|+|||++.......... ......+++.|+|||.+.+..++.++||||||+++|+|++|..||.
T Consensus 137 l~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 216 (296)
T 3uzp_A 137 LMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQ 216 (296)
T ss_dssp EECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred EEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 994 78899999999998765433211 1234578999999999999999999999999999999999999998
Q ss_pred CCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 270 DFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
..................... ... .. ....+..+.+++.+||+.||++|||+.++++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~-~~~-~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 217 GLKAATKRQKYERISEKKMST-PIE-VL--------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp SCCCSSSSSHHHHHHHHHHHS-CHH-HH--------TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred CcCchhhhhhhhhhcccccCC-chH-HH--------HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 654433322222222211111 100 00 0112244899999999999999999999875
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=314.57 Aligned_cols=258 Identities=24% Similarity=0.322 Sum_probs=197.6
Q ss_pred ccccceeccCcceEEEEeEEe--cCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 43 FDSLKKIGSGGWGEVFYKAEL--PGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 43 y~~~~~lg~G~~g~V~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
|++++.||+|+||.||++... ...+++.||+|++......... ..+.+|+.+++.++|||
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~------------------~~~~~E~~~l~~l~h~~ 94 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHR------------------SGWKQEIDILRTLYHEH 94 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHH------------------HHHHHHHHHHHHCCCTT
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHH------------------HHHHHHHHHHHhCCCcc
Confidence 499999999999999876542 2338899999999765332211 56788999999999999
Q ss_pred cccceeEEEc--CCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 121 ILPLLAHMVR--PNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 121 iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|+++++++.+ ....++||||+++++|.+++.. ..+++..++.++.|++.||.+| |+.|++|+||+|+||+
T Consensus 95 iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~L---H~~~ivH~Dikp~Nil 166 (318)
T 3lxp_A 95 IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYL---HAQHYIHRDLAARNVL 166 (318)
T ss_dssp BCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEE
T ss_pred hhhEEEEEecCCCceEEEEEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHH---HhCCccCCCCchheEE
Confidence 9999999987 4678999999999999999843 3489999999999999999999 6679999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCcee-eeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCC---
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQI-TVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGH--- 274 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~--- 274 (337)
++.++.++|+|||++.......... ......+++.|+|||.+.+..++.++||||||+++|+|++|..||......
T Consensus 167 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~ 246 (318)
T 3lxp_A 167 LDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLE 246 (318)
T ss_dssp ECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH
T ss_pred EcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhh
Confidence 9999999999999998776543322 223345788899999999888899999999999999999999998542110
Q ss_pred -----chhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 275 -----TEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 275 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
.............. ... ....+...+..+.+|+.+||+.||++|||+.++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~-~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 247 LIGIAQGQMTVLRLTELLE-RGE---------RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHCSCCHHHHHHHHHHHHH-TTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhcccccchhHHHHHHHHh-ccc---------CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 00011111111111 110 01111223345899999999999999999999985
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=306.37 Aligned_cols=250 Identities=28% Similarity=0.394 Sum_probs=192.9
Q ss_pred ccccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHH
Q 040898 35 AFLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITAN 114 (337)
Q Consensus 35 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~ 114 (337)
.+.-..++|++.+.||+|+||.||++.+ +++.||+|.+..... .+.+.+|+.+++
T Consensus 15 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~----~~~~vavK~~~~~~~---------------------~~~~~~E~~~l~ 69 (278)
T 1byg_A 15 GWALNMKELKLLQTIGKGEFGDVMLGDY----RGNKVAVKCIKNDAT---------------------AQAFLAEASVMT 69 (278)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEE----TTEEEEEEECCCCC-----------------------HHHHHTHHHHT
T ss_pred cccCChhhceEEeEEecCCCceEEEEEE----cCCEEEEEEecchhH---------------------HHHHHHHHHHHH
Confidence 3334567899999999999999999876 688999999865421 146778999999
Q ss_pred hcCCCCcccceeEEEcC-CeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCC
Q 040898 115 QTRHRNILPLLAHMVRP-NCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIK 193 (337)
Q Consensus 115 ~l~hpniv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~ 193 (337)
+++||||+++++++.+. +..++|+||+++++|.+++... ....+++..++.++.|++.||.+| |++|++|+||+
T Consensus 70 ~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlk 144 (278)
T 1byg_A 70 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVHRDLA 144 (278)
T ss_dssp TCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCS
T ss_pred hCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHH---HhCCccccCCC
Confidence 99999999999986544 5789999999999999999652 223478899999999999999999 66799999999
Q ss_pred CCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCC
Q 040898 194 PANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFF 272 (337)
Q Consensus 194 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~ 272 (337)
|+||+++.++.++|+|||++....... ....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||....
T Consensus 145 p~Nil~~~~~~~~l~Dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 219 (278)
T 1byg_A 145 ARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 219 (278)
T ss_dssp GGGEEECTTSCEEECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC
T ss_pred cceEEEeCCCcEEEeeccccccccccc-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999987543321 22357889999999998889999999999999999998 999986542
Q ss_pred CCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 273 GHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
. ......+...... ..+...+..+.+++.+||+.||++|||+.++++
T Consensus 220 ~----~~~~~~~~~~~~~-------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 220 L----KDVVPRVEKGYKM-------------DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp G----GGHHHHHTTTCCC-------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred H----HHHHHHHhcCCCC-------------CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 2 1222211111000 011122345889999999999999999999875
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=315.20 Aligned_cols=267 Identities=21% Similarity=0.287 Sum_probs=198.9
Q ss_pred cccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC
Q 040898 38 KKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR 117 (337)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 117 (337)
...++|++.+.||+|+||.||++.+.. +|+.||||++........ ...+.+|+.+++.++
T Consensus 8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~------------------~~~~~~E~~~l~~l~ 67 (353)
T 2b9h_A 8 NISSDFQLKSLLGEGAYGVVCSATHKP--TGEIVAIKKIEPFDKPLF------------------ALRTLREIKILKHFK 67 (353)
T ss_dssp CSCTTEEEEEEEEECSSEEEEEEEETT--TTEEEEEEEECCCSSHHH------------------HHHHHHHHHHHHHCC
T ss_pred ccccceEEeeEEcCCCCeEEEEEEECC--CCcEEEEEeecccccchH------------------HHHHHHHHHHHHhCc
Confidence 356789999999999999999998865 899999999864332111 146778999999999
Q ss_pred CCCcccceeEEEcC-----CeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 040898 118 HRNILPLLAHMVRP-----NCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDI 192 (337)
Q Consensus 118 hpniv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di 192 (337)
||||+++++++... ...++|+||+. ++|.+++.. ..+++..+..++.|++.||.|| |+.|++|+||
T Consensus 68 h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~L---H~~~ivH~Dl 138 (353)
T 2b9h_A 68 HENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVL---HGSNVIHRDL 138 (353)
T ss_dssp CTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCC
T ss_pred CCCcCCeeeeecccccCccceEEEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCC
Confidence 99999999987654 67899999997 489998854 3589999999999999999999 6679999999
Q ss_pred CCCceeecCCCCeEEecccCccccCCCCcee--------eeecccCCCCccCcccccc-CCCCCcccchhhhHHHHHHHh
Q 040898 193 KPANVLIDDDMEARISDFGHGKLMPDGHAQI--------TVKCMVGTMGYMAPESLQT-ETISDKCDIYSFGVLLAVLVM 263 (337)
Q Consensus 193 ~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~--------~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~i~~~ll~ 263 (337)
+|+||+++.++.++|+|||++.......... ......+|+.|+|||++.+ ..++.++|+||||+++|+|++
T Consensus 139 kp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 218 (353)
T 2b9h_A 139 KPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL 218 (353)
T ss_dssp CGGGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHH
T ss_pred CHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHh
Confidence 9999999999999999999998765332111 1123468999999998754 678899999999999999999
Q ss_pred CCCCCCCCCCCchhhhHHHHHHhhhccCCcchhh------------h------hcccCCchHHHHHHHHHHHhhhccCCC
Q 040898 264 GKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAI------------N------SKLLGNGYEEQMLLVLKLACFCTLKDP 325 (337)
Q Consensus 264 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~------~~~~~~~~~~~~~~l~~li~~~l~~dP 325 (337)
|..||...... .... .+............. . ........+.....+.+|+.+||+.||
T Consensus 219 g~~pf~~~~~~---~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 294 (353)
T 2b9h_A 219 RRPIFPGRDYR---HQLL-LIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDP 294 (353)
T ss_dssp SSCSCCCSSHH---HHHH-HHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSG
T ss_pred CCCCCCCCCcH---HHHH-HHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCc
Confidence 99999653221 1111 111111110000000 0 000000012234568899999999999
Q ss_pred CCCCChhhhhcC
Q 040898 326 DERPSSKDVRSM 337 (337)
Q Consensus 326 ~~Rps~~ell~~ 337 (337)
++|||+.++++|
T Consensus 295 ~~Rpt~~ell~h 306 (353)
T 2b9h_A 295 AKRITAKEALEH 306 (353)
T ss_dssp GGSCCHHHHHTS
T ss_pred ccCCCHHHHhcC
Confidence 999999999987
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=311.44 Aligned_cols=248 Identities=14% Similarity=0.128 Sum_probs=194.9
Q ss_pred ccccccccceeccCcceEEEEeEEe---cCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHh
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAEL---PGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQ 115 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~ 115 (337)
..++|++.+.||+|+||.||++.+. ...+++.||+|++..... ..+.+|..++..
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~----------------------~~~~~e~~~~~~ 120 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP----------------------WEFYIGTQLMER 120 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH----------------------HHHHHHHHHHHH
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh----------------------hHHHHHHHHHHH
Confidence 5678999999999999999999421 123899999999865432 345566777777
Q ss_pred cC---CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcC-CcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 040898 116 TR---HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQ-GRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRD 191 (337)
Q Consensus 116 l~---hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~d 191 (337)
+. |+||+.+++++..++..++||||+++|+|.+++..... ....+++..++.++.||+.||.|| |++|++|+|
T Consensus 121 l~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~l---H~~~ivHrD 197 (365)
T 3e7e_A 121 LKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQV---HDCEIIHGD 197 (365)
T ss_dssp SCGGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHH---HTTTEECCC
T ss_pred hhhhhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHH---hhCCeecCC
Confidence 65 99999999999999999999999999999999975433 356699999999999999999999 677999999
Q ss_pred CCCCceeecC-----------CCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHH
Q 040898 192 IKPANVLIDD-----------DMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAV 260 (337)
Q Consensus 192 i~~~nil~~~-----------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ 260 (337)
|||+||+++. ++.++|+|||++................||+.|+|||++.+..++.++||||||+++|+
T Consensus 198 iKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 277 (365)
T 3e7e_A 198 IKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYC 277 (365)
T ss_dssp CSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHH
T ss_pred CCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHH
Confidence 9999999998 89999999999976543333334455679999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhh
Q 040898 261 LVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKD 333 (337)
Q Consensus 261 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e 333 (337)
|++|..||......... .... . ... ...+.+.+++..||+.+|.+|++..+
T Consensus 278 lltg~~pf~~~~~~~~~------------~~~~---~----~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~ 328 (365)
T 3e7e_A 278 MLFGTYMKVKNEGGECK------------PEGL---F----RRL---PHLDMWNEFFHVMLNIPDCHHLPSLD 328 (365)
T ss_dssp HHHSSCCCEEEETTEEE------------ECSC---C----TTC---SSHHHHHHHHHHHHCCCCTTCCCCHH
T ss_pred HHhCCCccccCCCCcee------------echh---c----ccc---CcHHHHHHHHHHHcCCCCCCcchHHH
Confidence 99999998532221000 0000 0 000 11334778899999999999966433
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=306.89 Aligned_cols=255 Identities=23% Similarity=0.371 Sum_probs=201.1
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
-.++|++.+.||+|+||.||++.+.. +++.||+|++........ ....+.+|+.++++++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~--~~~~valK~~~~~~~~~~-----------------~~~~~~~e~~~l~~l~h 80 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRI--TQQEYAVKVINKASAKNK-----------------DTSTILREVELLKKLDH 80 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEEGGGBSSS-----------------CHHHHHHHHHHHHTCCC
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcC--CCcEEEEEEecccccchH-----------------HHHHHHHHHHHHHhccC
Confidence 45679999999999999999998865 899999999865432211 01567889999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++++.+....++|+||+++++|.+++.. ...+++..++.++.|++.||.+| |+.|++|+||+|+||+
T Consensus 81 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~L---H~~~i~H~dl~p~NIl 153 (287)
T 2wei_A 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYM---HKHNIVHRDLKPENIL 153 (287)
T ss_dssp TTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEE
T ss_pred CCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCChhhEE
Confidence 9999999999999999999999999999998854 34589999999999999999999 6679999999999999
Q ss_pred ecCC---CCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCc
Q 040898 199 IDDD---MEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHT 275 (337)
Q Consensus 199 ~~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~ 275 (337)
++.+ +.++|+|||++......... ....+++.|+|||.+.+. ++.++|+||||+++|+|++|..||....
T Consensus 154 v~~~~~~~~~kL~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~--- 226 (287)
T 2wei_A 154 LESKEKDCDIKIIDFGLSTCFQQNTKM---KDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKN--- 226 (287)
T ss_dssp ESCSSTTCCEEECSTTGGGTBCCCSSC---SCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSS---
T ss_pred EecCCCcccEEEeccCcceeecCCCcc---ccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCC---
Confidence 9754 46999999998765443221 223578899999998764 8899999999999999999999986532
Q ss_pred hhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 276 EEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.......+.. ....... ......+..+.+++.+||+.||++|||+.++++|
T Consensus 227 -~~~~~~~~~~---~~~~~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 227 -EYDILKRVET---GKYAFDL-------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp -HHHHHHHHHH---CCCCCCS-------GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -HHHHHHHHHc---CCCCCCc-------hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 1122222211 1111000 0011223458899999999999999999999986
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=307.18 Aligned_cols=266 Identities=22% Similarity=0.312 Sum_probs=192.3
Q ss_pred cccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC
Q 040898 38 KKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR 117 (337)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 117 (337)
.-.++|++++.||+|+||.||++.+.. +++.||+|++....... ...+.+|+.++++++
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~-------------------~~~~~~e~~~l~~l~ 66 (320)
T 2i6l_A 8 DLGSRYMDLKPLGCGGNGLVFSAVDND--CDKRVAIKKIVLTDPQS-------------------VKHALREIKIIRRLD 66 (320)
T ss_dssp EETTTEEEEEECC-----CEEEEEETT--TTEEEEEEEEECCSHHH-------------------HHHHHHHHHHHHTCC
T ss_pred ccCCceeEEEEeccCCCeEEEEEEECC--CCeEEEEEEEecCChHH-------------------HHHHHHHHHHHHhcC
Confidence 356789999999999999999999875 89999999986543211 156788999999999
Q ss_pred CCCcccceeEEE--------------cCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCC
Q 040898 118 HRNILPLLAHMV--------------RPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCH 183 (337)
Q Consensus 118 hpniv~~~~~~~--------------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h 183 (337)
||||+++++++. +....++||||++ ++|.+++. ..++++..++.++.|++.||.|| |
T Consensus 67 h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~l---H 137 (320)
T 2i6l_A 67 HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLE-----QGPLLEEHARLFMYQLLRGLKYI---H 137 (320)
T ss_dssp CTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHH---H
T ss_pred CCCeeEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHhh-----cCCccHHHHHHHHHHHHHHHHHH---H
Confidence 999999999873 3467899999998 59999883 34688999999999999999999 6
Q ss_pred CCCeEecCCCCCceeec-CCCCeEEecccCccccCCCCc-eeeeecccCCCCccCcccccc-CCCCCcccchhhhHHHHH
Q 040898 184 RPRLIHRDIKPANVLID-DDMEARISDFGHGKLMPDGHA-QITVKCMVGTMGYMAPESLQT-ETISDKCDIYSFGVLLAV 260 (337)
Q Consensus 184 ~~gi~h~di~~~nil~~-~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~i~~~ 260 (337)
++|++|+||+|+||+++ .++.++|+|||++........ ........+++.|+|||.+.+ ..++.++|+||||+++|+
T Consensus 138 ~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~e 217 (320)
T 2i6l_A 138 SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAE 217 (320)
T ss_dssp HTTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHH
T ss_pred hCCEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHH
Confidence 67999999999999997 567999999999887543211 111233457899999998865 678889999999999999
Q ss_pred HHhCCCCCCCCCCCchhhhHHHHHHhhhccCCcch----------hhhhcc--c----CCchHHHHHHHHHHHhhhccCC
Q 040898 261 LVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNR----------AINSKL--L----GNGYEEQMLLVLKLACFCTLKD 324 (337)
Q Consensus 261 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~--~----~~~~~~~~~~l~~li~~~l~~d 324 (337)
|++|..||..... ............ ...... ...... . ....+..+..+.+++.+||+.|
T Consensus 218 l~~g~~pf~~~~~---~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 293 (320)
T 2i6l_A 218 MLTGKTLFAGAHE---LEQMQLILESIP-VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFS 293 (320)
T ss_dssp HHHSSCSSCCSSH---HHHHHHHHHHSC-CCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSS
T ss_pred HHhCCCCCCCCCH---HHHHHHHHHhcC-CCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCC
Confidence 9999999965422 111111111100 000000 000000 0 0001123456899999999999
Q ss_pred CCCCCChhhhhcC
Q 040898 325 PDERPSSKDVRSM 337 (337)
Q Consensus 325 P~~Rps~~ell~~ 337 (337)
|++|||+.++++|
T Consensus 294 P~~Rpt~~ell~h 306 (320)
T 2i6l_A 294 PMDRLTAEEALSH 306 (320)
T ss_dssp GGGSCCHHHHHTS
T ss_pred ccccCCHHHHhCC
Confidence 9999999999987
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=309.17 Aligned_cols=265 Identities=22% Similarity=0.352 Sum_probs=183.4
Q ss_pred cccccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHH-H
Q 040898 34 LAFLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEII-T 112 (337)
Q Consensus 34 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~ 112 (337)
..+.-..++|++.+.||+|+||.||++.+.. +++.||+|++......... ..+..|+. +
T Consensus 15 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~------------------~~~~~e~~~~ 74 (327)
T 3aln_A 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKP--SGQIMAVKRIRSTVDEKEQ------------------KQLLMDLDVV 74 (327)
T ss_dssp EEECCCSCSEEC-CEEEECSSEEEEEEEETT--TTEEEEEEEEECCCCHHHH------------------HHHHHHHHHH
T ss_pred HhcccCHHHhhehheeccCCCEEEEEEEEcC--CCCEEEEEEeecccCchHH------------------HHHHHHHHHH
Confidence 3344466889999999999999999998866 8999999999765432211 23444554 7
Q ss_pred HHhcCCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhc-CCcccCChHHHHHHHHHHHHHHHHHhhCCCC-CeEec
Q 040898 113 ANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVS-QGRRELDWPARHRIARGIASGLEYLHMCHRP-RLIHR 190 (337)
Q Consensus 113 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~-gi~h~ 190 (337)
++.++||||+++++++.+++..++||||+++ +|.+++.... .....+++..++.++.|++.||.+| |+. |++|+
T Consensus 75 ~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~l---H~~~~ivH~ 150 (327)
T 3aln_A 75 MRSSDCPYIVQFYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHL---KENLKIIHR 150 (327)
T ss_dssp HSSCCCTTBCCEEEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHH---HHHHSCCCS
T ss_pred HHcCCCCcEeeeeeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHH---hccCCEeEC
Confidence 7788999999999999999999999999986 8888775422 2356789999999999999999999 666 99999
Q ss_pred CCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCcccc----ccCCCCCcccchhhhHHHHHHHhCCC
Q 040898 191 DIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESL----QTETISDKCDIYSFGVLLAVLVMGKF 266 (337)
Q Consensus 191 di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~----~~~~~~~~~DiwslG~i~~~ll~g~~ 266 (337)
||+|+||+++.++.++|+|||++........ .....+++.|+|||.+ .+..++.++|+||||+++|+|++|..
T Consensus 151 dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~ 227 (327)
T 3aln_A 151 DIKPSNILLDRSGNIKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRF 227 (327)
T ss_dssp CCCGGGEEEETTTEEEECCCSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCC
T ss_pred CCCHHHEEEcCCCCEEEccCCCceecccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCC
Confidence 9999999999999999999999876543321 1234689999999998 45668899999999999999999999
Q ss_pred CCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 267 PVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 267 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
||...... ............+ .............+.+|+.+||+.||++|||+.++++|
T Consensus 228 pf~~~~~~------~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 228 PYPKWNSV------FDQLTQVVKGDPP------QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CSSCC-------------CCCCCSCCC------CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCCCcchH------HHHHHHHhcCCCC------CCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 99653211 0111111111110 00011111223458999999999999999999999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=305.26 Aligned_cols=255 Identities=24% Similarity=0.372 Sum_probs=192.8
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC-
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR- 117 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~- 117 (337)
..++|++++.||+|+||.||++.+. +++.||+|++......... .+.+.+|+.++.+++
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~-----------------~~~~~~E~~~l~~l~~ 85 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNE---KKQIYAIKYVNLEEADNQT-----------------LDSYRNEIAYLNKLQQ 85 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECT---TCCEEEEEEEECSSCCHHH-----------------HHHHHHHHHHHHHHGG
T ss_pred ccceEEEEEEecCCCCEEEEEEEcC---CCcEEEEEEeccccccccc-----------------hHHHHHHHHHHHhccc
Confidence 5667999999999999999998774 6889999998765432211 156788999999997
Q ss_pred -CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 040898 118 -HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPAN 196 (337)
Q Consensus 118 -hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~n 196 (337)
||||+++++++.+++..++||| +.+++|.+++.. ...+++..++.++.|++.||.|| |+.|++|+||+|+|
T Consensus 86 ~~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~dlkp~N 157 (313)
T 3cek_A 86 HSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTI---HQHGIVHSDLKPAN 157 (313)
T ss_dssp GCTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGG
T ss_pred cCCceEEEEEEeecCCEEEEEEe-cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCceecCCCccc
Confidence 5999999999999999999999 557799999954 34688999999999999999999 66799999999999
Q ss_pred eeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCcccccc-----------CCCCCcccchhhhHHHHHHHhCC
Q 040898 197 VLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQT-----------ETISDKCDIYSFGVLLAVLVMGK 265 (337)
Q Consensus 197 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-----------~~~~~~~DiwslG~i~~~ll~g~ 265 (337)
|+++ ++.++|+|||++................+++.|+|||.+.+ ..++.++||||||+++|+|++|.
T Consensus 158 Il~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~ 236 (313)
T 3cek_A 158 FLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236 (313)
T ss_dssp EEEE-TTEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSS
T ss_pred EEEE-CCeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCC
Confidence 9996 48999999999987654433222234568999999999875 35778999999999999999999
Q ss_pred CCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 266 FPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 266 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.||...... ..... .......... .+......+.+++.+||+.||++|||+.++++|
T Consensus 237 ~pf~~~~~~--~~~~~----~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 237 TPFQQIINQ--ISKLH----AIIDPNHEIE---------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp CTTTTCCSH--HHHHH----HHHCTTSCCC---------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CchhhHHHH--HHHHH----HHHhcccccC---------CcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 999654221 11111 1111111000 000112348899999999999999999999986
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=316.41 Aligned_cols=260 Identities=23% Similarity=0.305 Sum_probs=190.9
Q ss_pred cccccccccccceeccCcceEEEEeEEecCC-CCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHH
Q 040898 36 FLKKEDCFDSLKKIGSGGWGEVFYKAELPGS-NGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITAN 114 (337)
Q Consensus 36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~ 114 (337)
+......|++.+.||+|+||.||++.+.... .+..||+|.+........ ...+.+|+.+++
T Consensus 84 i~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~------------------~~~~~~E~~il~ 145 (373)
T 3c1x_A 84 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE------------------VSQFLTEGIIMK 145 (373)
T ss_dssp CCSTTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHH------------------HHHHHHHHTTST
T ss_pred cChhhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHH------------------HHHHHHHHHHHH
Confidence 3335556889999999999999999876421 235689998864332211 156888999999
Q ss_pred hcCCCCcccceeEEE-cCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCC
Q 040898 115 QTRHRNILPLLAHMV-RPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIK 193 (337)
Q Consensus 115 ~l~hpniv~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~ 193 (337)
+++||||+++++++. .++..++||||+++++|.+++.. ....+++..++.++.|++.||.|| |++|++|+||+
T Consensus 146 ~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlk 219 (373)
T 3c1x_A 146 DFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLA 219 (373)
T ss_dssp TCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHH---HHTTCCCSCCC
T ss_pred hCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHH---HHCCEecCccc
Confidence 999999999999865 45678999999999999999953 345578899999999999999999 66799999999
Q ss_pred CCceeecCCCCeEEecccCccccCCCCce--eeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCC
Q 040898 194 PANVLIDDDMEARISDFGHGKLMPDGHAQ--ITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDD 270 (337)
Q Consensus 194 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~ 270 (337)
|+||+++.++.++|+|||++......... .......+++.|+|||.+.+..++.++||||||+++|+|++ |.+||..
T Consensus 220 p~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~ 299 (373)
T 3c1x_A 220 ARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 299 (373)
T ss_dssp GGGEEECTTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT
T ss_pred hheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCC
Confidence 99999999999999999999765433211 11123456788999999999899999999999999999999 6788865
Q ss_pred CCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 271 FFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
..... ....+........ +...+..+.+++.+||+.||++|||+.++++
T Consensus 300 ~~~~~----~~~~~~~~~~~~~-------------p~~~~~~l~~li~~cl~~dp~~RPs~~ell~ 348 (373)
T 3c1x_A 300 VNTFD----ITVYLLQGRRLLQ-------------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 348 (373)
T ss_dssp SCSSC----HHHHHHTTCCCCC-------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHH----HHHHHHcCCCCCC-------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 43322 1111111111000 1112334889999999999999999999986
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=318.07 Aligned_cols=275 Identities=20% Similarity=0.230 Sum_probs=194.7
Q ss_pred cccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC
Q 040898 38 KKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR 117 (337)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 117 (337)
...++|++.+.||+|+||.||++.+. ++..||+|++............ . ........+.+|+.++++++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~---~-----~~~~~~~~~~~E~~~l~~l~ 87 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDS---EGIPVAIKRVFNTVSDGRTVNI---L-----SDSFLCKRVLREIRLLNHFH 87 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECT---TSCEEEEEEECEECCTTSCEEG---G-----GSHHHHHHHHHHHHHHHHCC
T ss_pred HhccceEEeEEeccCCCEEEEEEECC---CCCeEEEEeccccCCccchhhh---h-----hhhhHHHHHHHHHHHHHhCC
Confidence 36788999999999999999998774 5999999998765432210000 0 00011257889999999999
Q ss_pred CCCcccceeEEEc-----CCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 040898 118 HRNILPLLAHMVR-----PNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDI 192 (337)
Q Consensus 118 hpniv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di 192 (337)
||||+++++++.. ....++||||+++ +|.+++. .....+++..++.++.||+.||.|| |+.|++|+||
T Consensus 88 h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dl 160 (362)
T 3pg1_A 88 HPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIH---DQRIVISPQHIQYFMYHILLGLHVL---HEAGVVHRDL 160 (362)
T ss_dssp CTTBCCCSEEEEECCTTTCCEEEEEEECCSE-EHHHHHH---CTTSCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCC
T ss_pred CcCccceeeeEEeccCCCcceEEEEEccCCC-CHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHH---HHCcCEecCC
Confidence 9999999999843 3468999999984 8888774 3445689999999999999999999 6679999999
Q ss_pred CCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCcccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCC
Q 040898 193 KPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQT-ETISDKCDIYSFGVLLAVLVMGKFPVDDF 271 (337)
Q Consensus 193 ~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~i~~~ll~g~~pf~~~ 271 (337)
+|+||+++.++.++|+|||++....... ......+++.|+|||++.+ ..++.++|+||||+++|+|++|..||...
T Consensus 161 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 237 (362)
T 3pg1_A 161 HPGNILLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGS 237 (362)
T ss_dssp CGGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ChHHEEEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999987543322 1233568899999999876 67899999999999999999999999653
Q ss_pred CCCchhhhHHHHHHhhhccCCcchh------------------hhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhh
Q 040898 272 FGHTEEMDMVKWMRNVIFSENPNRA------------------INSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKD 333 (337)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e 333 (337)
... .....+............ ..........+.....+.+|+.+||+.||++|||+.|
T Consensus 238 ~~~----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 313 (362)
T 3pg1_A 238 TFY----NQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQ 313 (362)
T ss_dssp SHH----HHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CHH----HHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHH
Confidence 221 111111111111000000 0000000011122355889999999999999999999
Q ss_pred hhcC
Q 040898 334 VRSM 337 (337)
Q Consensus 334 ll~~ 337 (337)
+++|
T Consensus 314 ll~h 317 (362)
T 3pg1_A 314 ALRH 317 (362)
T ss_dssp HHTS
T ss_pred HHcC
Confidence 9987
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=314.82 Aligned_cols=261 Identities=14% Similarity=0.163 Sum_probs=196.9
Q ss_pred ccccccccceeccCcceEEEEeEEecCC------CCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHH
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGS------NGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIIT 112 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 112 (337)
..++|++.+.||+|+||.||++.+.... .++.||+|.+... ..+.+|+.+
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------------------------~~~~~E~~~ 95 (352)
T 2jii_A 40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------------------------GRLFNEQNF 95 (352)
T ss_dssp TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------------------------STHHHHHHH
T ss_pred cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------------------------chHHHHHHH
Confidence 4688999999999999999999886511 3889999998643 246678888
Q ss_pred HHhcCCCCccc---------------ceeEEEc-CCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHH
Q 040898 113 ANQTRHRNILP---------------LLAHMVR-PNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGL 176 (337)
Q Consensus 113 l~~l~hpniv~---------------~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l 176 (337)
+++++||||++ +++++.. +...++||||+ +++|.+++.. .....+++..++.++.||+.||
T Consensus 96 l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~~L 172 (352)
T 2jii_A 96 FQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDV--SPKHVLSERSVLQVACRLLDAL 172 (352)
T ss_dssp HHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHH--SGGGCCCHHHHHHHHHHHHHHH
T ss_pred HHHhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHh--CCcCCCCHHHHHHHHHHHHHHH
Confidence 88888888887 5666665 77889999999 8999999965 2246799999999999999999
Q ss_pred HHHhhCCCCCeEecCCCCCceeecCCC--CeEEecccCccccCCCCcee-----eeecccCCCCccCccccccCCCCCcc
Q 040898 177 EYLHMCHRPRLIHRDIKPANVLIDDDM--EARISDFGHGKLMPDGHAQI-----TVKCMVGTMGYMAPESLQTETISDKC 249 (337)
Q Consensus 177 ~~l~~~h~~gi~h~di~~~nil~~~~~--~~~l~dfg~~~~~~~~~~~~-----~~~~~~~~~~~~~PE~~~~~~~~~~~ 249 (337)
.|| |++|++|+||+|+||+++.++ .++|+|||++.......... ......+|+.|+|||++.+..++.++
T Consensus 173 ~~L---H~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 249 (352)
T 2jii_A 173 EFL---HENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRS 249 (352)
T ss_dssp HHH---HHTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHH
T ss_pred HHH---HhCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchh
Confidence 999 667999999999999999988 89999999997654322111 11234789999999999998899999
Q ss_pred cchhhhHHHHHHHhCCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCC
Q 040898 250 DIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERP 329 (337)
Q Consensus 250 DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp 329 (337)
||||||+++|+|++|..||....... .................... . ......+..+.+++.+||+.||++||
T Consensus 250 Di~slG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~--~---~~~~~~~~~l~~li~~~l~~dp~~Rp 322 (352)
T 2jii_A 250 DLQSLGYCMLKWLYGFLPWTNCLPNT--EDIMKQKQKFVDKPGPFVGP--C---GHWIRPSETLQKYLKVVMALTYEEKP 322 (352)
T ss_dssp HHHHHHHHHHHHHHSCCTTGGGTTCH--HHHHHHHHHHHHSCCCEECT--T---SCEECCCHHHHHHHHHHHTCCTTCCC
T ss_pred hHHHHHHHHHHHHhCCCCcccCCcCH--HHHHHHHHhccCChhhhhhh--c---cccCCCcHHHHHHHHHHHhCChhhCC
Confidence 99999999999999999997653222 12222222211111110000 0 00011224489999999999999999
Q ss_pred Chhhhhc
Q 040898 330 SSKDVRS 336 (337)
Q Consensus 330 s~~ell~ 336 (337)
|+.++++
T Consensus 323 s~~~l~~ 329 (352)
T 2jii_A 323 PYAMLRN 329 (352)
T ss_dssp CHHHHHH
T ss_pred CHHHHHH
Confidence 9999975
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=325.33 Aligned_cols=252 Identities=26% Similarity=0.414 Sum_probs=195.2
Q ss_pred cccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC
Q 040898 38 KKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR 117 (337)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 117 (337)
-..++|++.+.||+|+||.||++.+. .+..||||.+....... +.+.+|+.++++++
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~--------------------~~~~~E~~~l~~l~ 237 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWN---GTTRVAIKTLKPGTMSP--------------------EAFLQEAQVMKKLR 237 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET---TTEEEEEEECCTTSSCH--------------------HHHHHHHHHHHHCC
T ss_pred cChhHceeeeeecCCCCeEEEEEEEC---CCceEEEEEeccCCCCH--------------------HHHHHHHHHHHhCC
Confidence 35678999999999999999998875 45679999987543211 46788999999999
Q ss_pred CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCce
Q 040898 118 HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANV 197 (337)
Q Consensus 118 hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ni 197 (337)
||||+++++++.+ +..++||||+++|+|.+++... .+..+++..+..++.|++.||.|| |++|++|+||+|+||
T Consensus 238 hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~L---H~~~ivHrDlkp~Ni 311 (452)
T 1fmk_A 238 HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANI 311 (452)
T ss_dssp CTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGE
T ss_pred CCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCChhhE
Confidence 9999999998876 6789999999999999999542 234588999999999999999999 667999999999999
Q ss_pred eecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCch
Q 040898 198 LIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHTE 276 (337)
Q Consensus 198 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~ 276 (337)
+++.++.++|+|||++......... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 312 ll~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~--- 387 (452)
T 1fmk_A 312 LVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--- 387 (452)
T ss_dssp EECGGGCEEECCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH---
T ss_pred EECCCCCEEECCCccceecCCCcee-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH---
Confidence 9999999999999999876433211 1123456788999999998889999999999999999999 9999865322
Q ss_pred hhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 277 EMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
......+.. .... ..++..+..+.+++.+||+.||++|||+.++++
T Consensus 388 -~~~~~~i~~---~~~~----------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 388 -REVLDQVER---GYRM----------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp -HHHHHHHHT---TCCC----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -HHHHHHHHc---CCCC----------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 112221111 1100 111223345889999999999999999999875
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=311.40 Aligned_cols=256 Identities=24% Similarity=0.341 Sum_probs=173.7
Q ss_pred cccccccccc-eeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc
Q 040898 38 KKEDCFDSLK-KIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT 116 (337)
Q Consensus 38 ~~~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 116 (337)
.-.++|++.+ .||+|+||.||++.+.. +++.||+|++.... ....+....++.+
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~-----------------------~~~~e~~~~~~~~ 79 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRR--TGQKCALKLLYDSP-----------------------KARQEVDHHWQAS 79 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEESSH-----------------------HHHHHHHHHHHHT
T ss_pred cccceeEecceeeeeCCCeEEEEEEECC--CCCEEEEEEecCcH-----------------------HHHHHHHHHHHhc
Confidence 3456799966 59999999999999876 89999999985421 1111223345667
Q ss_pred CCCCcccceeEEEc----CCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 040898 117 RHRNILPLLAHMVR----PNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDI 192 (337)
Q Consensus 117 ~hpniv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di 192 (337)
.||||+++++++.. +...++||||+++++|.+++.. .....+++..++.++.|++.||.|| |+.|++|+||
T Consensus 80 ~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~ql~~~l~~L---H~~~ivH~dl 154 (336)
T 3fhr_A 80 GGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQE--RGDQAFTEREAAEIMRDIGTAIQFL---HSHNIAHRDV 154 (336)
T ss_dssp TSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHT--C-CCCCBHHHHHHHHHHHHHHHHHH---HHTTEECSCC
T ss_pred CCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCC
Confidence 99999999999876 4568999999999999999964 3335689999999999999999999 6679999999
Q ss_pred CCCceeecC---CCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCC
Q 040898 193 KPANVLIDD---DMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVD 269 (337)
Q Consensus 193 ~~~nil~~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~ 269 (337)
+|+||+++. ++.++|+|||++....... .....+|+.|+|||++.+..++.++||||||+++|+|++|..||.
T Consensus 155 kp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 230 (336)
T 3fhr_A 155 KPENLLYTSKEKDAVLKLTDFGFAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFY 230 (336)
T ss_dssp SGGGEEESCSSTTCCEEECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-
T ss_pred CHHHEEEEecCCCceEEEeccccceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 999999986 4559999999987654322 223468999999999988888999999999999999999999996
Q ss_pred CCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 270 DFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
..............+...... .+ .......+..+.+|+.+||+.||++|||+.++++|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~-~~---------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 231 SNTGQAISPGMKRRIRLGQYG-FP---------NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp --------------------C-CC---------TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CccchhhhhhHHHhhhccccc-cC---------chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 543322111111111110000 00 01112233458899999999999999999999987
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=312.79 Aligned_cols=262 Identities=22% Similarity=0.311 Sum_probs=197.2
Q ss_pred cccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC
Q 040898 38 KKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR 117 (337)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 117 (337)
+-.++|.+.+.||+|+||.||++.+.. +|+.||||++......... ...+.+|+.+++.++
T Consensus 21 ~l~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~-----------------~~~~~~E~~~l~~l~ 81 (353)
T 3coi_A 21 ELPKTYVSPTHVGSGAYGSVCSAIDKR--SGEKVAIKKLSRPFQSEIF-----------------AKRAYRELLLLKHMQ 81 (353)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETT--TTEEEEEEEESSTTSSHHH-----------------HHHHHHHHHHHHHCC
T ss_pred ccCceEEEeeeEecCCCeEEEEEEECC--CCCEEEEEEecccccchHH-----------------HHHHHHHHHHHHhcC
Confidence 346789999999999999999998876 8999999998654332211 156788999999999
Q ss_pred CCCcccceeEEEcCCe------eEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 040898 118 HRNILPLLAHMVRPNC------HLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRD 191 (337)
Q Consensus 118 hpniv~~~~~~~~~~~------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~d 191 (337)
||||+++++++..... .++||||+++ +|.+++ . ..+++..++.++.||+.||.|| |++|++|+|
T Consensus 82 h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~----~--~~~~~~~~~~i~~qi~~al~~L---H~~~ivH~d 151 (353)
T 3coi_A 82 HENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIM----G--LKFSEEKIQYLVYQMLKGLKYI---HSAGVVHRD 151 (353)
T ss_dssp CTTBCCCSEEECSCSSGGGCCCCEEEEECCSE-EGGGTT----T--SCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSS
T ss_pred CCCcccHhheEecccccccceeEEEEeccccC-CHHHHh----c--CCCCHHHHHHHHHHHHHHHHHH---HHCCcccCC
Confidence 9999999999987654 4999999974 777665 2 2489999999999999999999 667999999
Q ss_pred CCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCcccccc-CCCCCcccchhhhHHHHHHHhCCCCCCC
Q 040898 192 IKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQT-ETISDKCDIYSFGVLLAVLVMGKFPVDD 270 (337)
Q Consensus 192 i~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~i~~~ll~g~~pf~~ 270 (337)
|+|+||+++.++.++|+|||++...... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||..
T Consensus 152 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 226 (353)
T 3coi_A 152 LKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 226 (353)
T ss_dssp CCGGGEEECTTCCEEECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBS
T ss_pred CCHHHEeECCCCcEEEeecccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999998764332 223568999999999876 6789999999999999999999999965
Q ss_pred CCCCchhhhHHHHHHhhhccCCcc-------h----------hhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhh
Q 040898 271 FFGHTEEMDMVKWMRNVIFSENPN-------R----------AINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKD 333 (337)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~-------~----------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e 333 (337)
.... ..+..... ........ . ...........+.....+.+|+.+||+.||++|||+.+
T Consensus 227 ~~~~---~~~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e 302 (353)
T 3coi_A 227 KDYL---DQLTQILK-VTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQ 302 (353)
T ss_dssp SCHH---HHHHHHHH-HHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHH
T ss_pred CCHH---HHHHHHHH-HhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHH
Confidence 3221 11111111 10000000 0 00000011122334556899999999999999999999
Q ss_pred hhcC
Q 040898 334 VRSM 337 (337)
Q Consensus 334 ll~~ 337 (337)
+++|
T Consensus 303 ~l~h 306 (353)
T 3coi_A 303 ALTH 306 (353)
T ss_dssp HHTS
T ss_pred HhcC
Confidence 9987
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=310.50 Aligned_cols=253 Identities=23% Similarity=0.327 Sum_probs=181.3
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC-
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR- 117 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~- 117 (337)
...+|++.+.||+|+||.||++.+.. +++.||+|++........ ..+.+|+.++.++.
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~-------------------~~~~~e~~~l~~l~~ 84 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVG--SGREYALKRLLSNEEEKN-------------------RAIIQEVCFMKKLSG 84 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETT--TCCEEEEEEEEESSHHHH-------------------HHHHHHHHHHHHHTT
T ss_pred cCceEEEEEEEccCCceEEEEEEECC--CCcEEEEEEecCCchHHH-------------------HHHHHHHHHHHHhcc
Confidence 45689999999999999999999876 899999999855432111 46778999999995
Q ss_pred CCCcccceeEEE--------cCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCC--e
Q 040898 118 HRNILPLLAHMV--------RPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPR--L 187 (337)
Q Consensus 118 hpniv~~~~~~~--------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~g--i 187 (337)
||||+++++++. ....+++++||++ |+|.+++.... ....+++..++.++.||+.||.|| |+.| +
T Consensus 85 h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~L---H~~~~~i 159 (337)
T 3ll6_A 85 HPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHM---HRQKPPI 159 (337)
T ss_dssp STTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHH---HTSSSCC
T ss_pred CCChhhccccccccccccccCCceEEEEEEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHH---HhCCCCE
Confidence 999999999984 3455899999996 59999886543 344699999999999999999999 6668 9
Q ss_pred EecCCCCCceeecCCCCeEEecccCccccCCCCcee----------eeecccCCCCccCcccc---ccCCCCCcccchhh
Q 040898 188 IHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQI----------TVKCMVGTMGYMAPESL---QTETISDKCDIYSF 254 (337)
Q Consensus 188 ~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~----------~~~~~~~~~~~~~PE~~---~~~~~~~~~Diwsl 254 (337)
+|+||+|+||+++.++.++|+|||++.......... ......+++.|+|||++ .+..++.++|||||
T Consensus 160 vH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~sl 239 (337)
T 3ll6_A 160 IHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWAL 239 (337)
T ss_dssp BCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHH
T ss_pred EEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHH
Confidence 999999999999999999999999998765432211 11134589999999998 56668889999999
Q ss_pred hHHHHHHHhCCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhh
Q 040898 255 GVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDV 334 (337)
Q Consensus 255 G~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el 334 (337)
|+++|+|++|..||...... ....... ..... ......+.+++.+||+.||++|||+.++
T Consensus 240 G~il~el~~g~~p~~~~~~~-------~~~~~~~-~~~~~------------~~~~~~~~~li~~~l~~~p~~Rps~~e~ 299 (337)
T 3ll6_A 240 GCILYLLCFRQHPFEDGAKL-------RIVNGKY-SIPPH------------DTQYTVFHSLIRAMLQVNPEERLSIAEV 299 (337)
T ss_dssp HHHHHHHHHSSCCC-------------------C-CCCTT------------CCSSGGGHHHHHHHSCSSGGGSCCHHHH
T ss_pred HHHHHHHHhCCCCCcchhHH-------HhhcCcc-cCCcc------------cccchHHHHHHHHHccCChhhCcCHHHH
Confidence 99999999999998642211 1111100 00000 0111227899999999999999999999
Q ss_pred hcC
Q 040898 335 RSM 337 (337)
Q Consensus 335 l~~ 337 (337)
+++
T Consensus 300 l~~ 302 (337)
T 3ll6_A 300 VHQ 302 (337)
T ss_dssp HHH
T ss_pred HHH
Confidence 864
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=307.99 Aligned_cols=262 Identities=24% Similarity=0.318 Sum_probs=199.0
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHh--c
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQ--T 116 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~--l 116 (337)
..++|++.+.||+|+||.||++.+ +++.||+|++..... ..+.+|..++.. +
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~----~~~~vavK~~~~~~~----------------------~~~~~e~~~~~~~~l 93 (342)
T 1b6c_B 40 IARTIVLQESIGKGRFGEVWRGKW----RGEEVAVKIFSSREE----------------------RSWFREAEIYQTVML 93 (342)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEE----TTEEEEEEEECGGGH----------------------HHHHHHHHHHHHSCC
T ss_pred ccccEEEEeeecCCCCcEEEEEEE----cCccEEEEEeCchhH----------------------HHHHHHHHHHHHhhc
Confidence 457899999999999999999877 689999999853311 345667888777 7
Q ss_pred CCCCcccceeEEEcCC----eeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhC-----CCCCe
Q 040898 117 RHRNILPLLAHMVRPN----CHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMC-----HRPRL 187 (337)
Q Consensus 117 ~hpniv~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~-----h~~gi 187 (337)
+||||+++++++.... ..++||||+++++|.+++.. ..+++..++.++.|++.||.|||.. ++.|+
T Consensus 94 ~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~i 168 (342)
T 1b6c_B 94 RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAI 168 (342)
T ss_dssp CCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEE
T ss_pred CCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCe
Confidence 9999999999998776 78999999999999999954 3588999999999999999999521 17899
Q ss_pred EecCCCCCceeecCCCCeEEecccCccccCCCCcee--eeecccCCCCccCccccccCC------CCCcccchhhhHHHH
Q 040898 188 IHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQI--TVKCMVGTMGYMAPESLQTET------ISDKCDIYSFGVLLA 259 (337)
Q Consensus 188 ~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~------~~~~~DiwslG~i~~ 259 (337)
+|+||+|+||+++.++.++|+|||++.......... ......+++.|+|||++.+.. ++.++||||||+++|
T Consensus 169 vH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ 248 (342)
T 1b6c_B 169 AHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 248 (342)
T ss_dssp ECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHH
T ss_pred eeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHH
Confidence 999999999999999999999999987765443221 223457899999999997653 336799999999999
Q ss_pred HHHhC----------CCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCC
Q 040898 260 VLVMG----------KFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERP 329 (337)
Q Consensus 260 ~ll~g----------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp 329 (337)
+|++| ..||.......... .............. ..... -........+.+|+.+||+.||++||
T Consensus 249 el~tg~~~~~~~~~~~~p~~~~~~~~~~~--~~~~~~~~~~~~~~-~~~~~---~~~~~~~~~l~~li~~cl~~dp~~Rp 322 (342)
T 1b6c_B 249 EIARRCSIGGIHEDYQLPYYDLVPSDPSV--EEMRKVVCEQKLRP-NIPNR---WQSCEALRVMAKIMRECWYANGAARL 322 (342)
T ss_dssp HHHTTBCBTTBCCCCCCTTTTTSCSSCCH--HHHHHHHTTSCCCC-CCCGG---GGTSHHHHHHHHHHHHHCCSSGGGSC
T ss_pred HHHhccCcCCcccccccCccccCcCcccH--HHHHHHHHHHHhCC-CCccc---ccchhHHHHHHHHHHHHhccChhhCC
Confidence 99999 77876543322111 11111111111100 00000 01235566799999999999999999
Q ss_pred ChhhhhcC
Q 040898 330 SSKDVRSM 337 (337)
Q Consensus 330 s~~ell~~ 337 (337)
|+.+++++
T Consensus 323 s~~~i~~~ 330 (342)
T 1b6c_B 323 TALRIKKT 330 (342)
T ss_dssp CHHHHHHH
T ss_pred CHHHHHHH
Confidence 99999864
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=302.31 Aligned_cols=261 Identities=25% Similarity=0.340 Sum_probs=192.6
Q ss_pred ccccccccccceeccCcceEEEEeEEec-CCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHh
Q 040898 37 LKKEDCFDSLKKIGSGGWGEVFYKAELP-GSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQ 115 (337)
Q Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~ 115 (337)
.-..++|++.+.||+|+||.||++.+.. ...+..||+|++......... ..+.+.+|+.++++
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~----------------~~~~~~~e~~~l~~ 77 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPE----------------AMDDFIREVNAMHS 77 (291)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CH----------------HHHHHHHHHHHHHH
T ss_pred ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHH----------------HHHHHHHHHHHHHh
Confidence 3356789999999999999999998653 123346899988654322111 11578889999999
Q ss_pred cCCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCC
Q 040898 116 TRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPA 195 (337)
Q Consensus 116 l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ 195 (337)
++||||+++++++.++. .++|+||+++++|.+++... ...+++..++.++.|++.||.+| |++|++|+||+|+
T Consensus 78 l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dikp~ 150 (291)
T 1u46_A 78 LDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYL---ESKRFIHRDLAAR 150 (291)
T ss_dssp CCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGG
T ss_pred CCCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHH---HhCCcccCCCchh
Confidence 99999999999987765 89999999999999998652 35689999999999999999999 6679999999999
Q ss_pred ceeecCCCCeEEecccCccccCCCCcee-eeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCC
Q 040898 196 NVLIDDDMEARISDFGHGKLMPDGHAQI-TVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFG 273 (337)
Q Consensus 196 nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~ 273 (337)
||+++.++.++|+|||++.......... ......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.....
T Consensus 151 Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 230 (291)
T 1u46_A 151 NLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG 230 (291)
T ss_dssp GEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred eEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH
Confidence 9999999999999999998765443322 2223457778999999988888999999999999999999 9999865321
Q ss_pred CchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 274 HTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
... ........... ......+..+.+++.+||+.||++|||+.++++
T Consensus 231 ----~~~---~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 231 ----SQI---LHKIDKEGERL---------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp ----HHH---HHHHHTSCCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----HHH---HHHHHccCCCC---------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 111 11111111110 011123345899999999999999999999986
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=308.85 Aligned_cols=260 Identities=18% Similarity=0.294 Sum_probs=197.9
Q ss_pred cccccccceeccCcceEEEEeEEecCCCC-ceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNG-KMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
.++|++.+.||+|+||.||++.+.. ++ +.||+|++..... . ...+.+|+.+++.+.|
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~~vavK~~~~~~~--~------------------~~~~~~E~~~l~~l~~ 75 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHA--RGKSQVALKIIRNVGK--Y------------------REAARLEINVLKKIKE 75 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETT--TTTEEEEEEEECSCHH--H------------------HHHHHHHHHHHHHHHH
T ss_pred cccEEEEEEeeccCCeEEEEEEecC--CCceEEEEEEEccccc--c------------------hhHHHHHHHHHHHHhh
Confidence 5789999999999999999998864 55 7899999853211 0 0456678888888876
Q ss_pred CC------cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 040898 119 RN------ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDI 192 (337)
Q Consensus 119 pn------iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di 192 (337)
++ ++.+.+++...+..++||||+ +++|.+++.. .....+++..++.++.||+.||.|| |++|++|+||
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~--~~~~~~~~~~~~~i~~qi~~~L~~l---H~~~ivH~Dl 149 (355)
T 2eu9_A 76 KDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKE--NNFQPYPLPHVRHMAYQLCHALRFL---HENQLTHTDL 149 (355)
T ss_dssp HCTTSCSCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHH---HTTTEECCCC
T ss_pred cCCCCceeEEEeeeeeeeCCeEEEEEecc-CCChHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCC
Confidence 55 899999999999999999999 5577777654 3335689999999999999999999 7779999999
Q ss_pred CCCceee-------------------cCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchh
Q 040898 193 KPANVLI-------------------DDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYS 253 (337)
Q Consensus 193 ~~~nil~-------------------~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Diws 253 (337)
+|+||++ +.++.++|+|||++....... ....+|+.|+|||++.+..++.++|+||
T Consensus 150 kp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~s 224 (355)
T 2eu9_A 150 KPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWS 224 (355)
T ss_dssp CGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHH
T ss_pred CHHHEEEecccccccccccccccccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHH
Confidence 9999999 567899999999987644322 2356899999999999999999999999
Q ss_pred hhHHHHHHHhCCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhh-------------------------------ccc
Q 040898 254 FGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINS-------------------------------KLL 302 (337)
Q Consensus 254 lG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------------------~~~ 302 (337)
||+++|+|++|..||...... .....+...... .+...... ...
T Consensus 225 lG~il~el~~g~~pf~~~~~~----~~~~~~~~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (355)
T 2eu9_A 225 IGCILFEYYRGFTLFQTHENR----EHLVMMEKILGP-IPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSY 299 (355)
T ss_dssp HHHHHHHHHHSSCSCCCSSHH----HHHHHHHHHHCC-CCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGG
T ss_pred HHHHHHHHHhCCCCCCCCCHH----HHHHHHHHHcCC-CcHHHhhhccchhhhcccccccccccchhccccccCCccccc
Confidence 999999999999999753221 111111111111 11000000 000
Q ss_pred CCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 303 GNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 303 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
..........+.+|+.+||+.||++|||+.|+++|
T Consensus 300 ~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 334 (355)
T 2eu9_A 300 MLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLH 334 (355)
T ss_dssp CSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 01122345578999999999999999999999987
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=303.45 Aligned_cols=254 Identities=24% Similarity=0.430 Sum_probs=191.3
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
.++|++.+.||+|+||.||++.+.. +++.||+|++.... . ....+.+|+.++++++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~----~----------------~~~~~~~E~~~l~~l~h~ 62 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNAL--DSRYYAIKKIRHTE----E----------------KLSTILSEVMLLASLNHQ 62 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEEEEH----H----------------HHHHHHHHHHHHTTCCCT
T ss_pred cccchhhheeccCCcEEEEEEEEcC--CCeEEEEEEEeccH----H----------------HHHHHHHHHHHHHhcCch
Confidence 4679999999999999999998866 89999999985321 0 115678899999999999
Q ss_pred CcccceeEEEc-------------CCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCC
Q 040898 120 NILPLLAHMVR-------------PNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPR 186 (337)
Q Consensus 120 niv~~~~~~~~-------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~g 186 (337)
||+++++++.+ ....++||||+++++|.+++.. ....+++..++.++.|++.||.|| |++|
T Consensus 63 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~L---H~~~ 136 (303)
T 1zy4_A 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYI---HSQG 136 (303)
T ss_dssp TBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHH---HHTT
T ss_pred HHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHH---HhCC
Confidence 99999998754 4568999999999999999964 345678889999999999999999 6679
Q ss_pred eEecCCCCCceeecCCCCeEEecccCccccCCCCc------------eeeeecccCCCCccCccccccC-CCCCcccchh
Q 040898 187 LIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHA------------QITVKCMVGTMGYMAPESLQTE-TISDKCDIYS 253 (337)
Q Consensus 187 i~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~------------~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Diws 253 (337)
++|+||+|+||+++.++.++|+|||.+........ ........+++.|+|||.+.+. .++.++|+||
T Consensus 137 i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s 216 (303)
T 1zy4_A 137 IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYS 216 (303)
T ss_dssp CCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHH
T ss_pred eecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHH
Confidence 99999999999999999999999999876543211 1112335689999999999764 6889999999
Q ss_pred hhHHHHHHHhCCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhh
Q 040898 254 FGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKD 333 (337)
Q Consensus 254 lG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e 333 (337)
||+++|+|++ ||... .........+...... . ...........+.+++.+||+.||.+|||+.+
T Consensus 217 lG~il~~l~~---p~~~~---~~~~~~~~~~~~~~~~-~---------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ 280 (303)
T 1zy4_A 217 LGIIFFEMIY---PFSTG---MERVNILKKLRSVSIE-F---------PPDFDDNKMKVEKKIIRLLIDHDPNKRPGART 280 (303)
T ss_dssp HHHHHHHHHS---CCSSH---HHHHHHHHHHHSTTCC-C---------CTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHHHh---ccCCc---hhHHHHHHhccccccc-c---------CccccccchHHHHHHHHHHHhcCcccCcCHHH
Confidence 9999999998 54321 1111222211111100 0 01111223345889999999999999999999
Q ss_pred hhcC
Q 040898 334 VRSM 337 (337)
Q Consensus 334 ll~~ 337 (337)
+++|
T Consensus 281 ll~h 284 (303)
T 1zy4_A 281 LLNS 284 (303)
T ss_dssp HHHS
T ss_pred HhCC
Confidence 9986
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=329.34 Aligned_cols=256 Identities=21% Similarity=0.295 Sum_probs=198.2
Q ss_pred ccccccccc-eeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC
Q 040898 39 KEDCFDSLK-KIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR 117 (337)
Q Consensus 39 ~~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 117 (337)
..+++.+.+ .||+|+||.||++.+....++..||||++......... +.+.+|+.++++++
T Consensus 333 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~------------------~~~~~E~~il~~l~ 394 (613)
T 2ozo_A 333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT------------------EEMMREAQIMHQLD 394 (613)
T ss_dssp CTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTH------------------HHHHHHHHHHTTCC
T ss_pred cccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHH------------------HHHHHHHHHHHhCC
Confidence 445566666 89999999999998876557788999999765322111 56888999999999
Q ss_pred CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCce
Q 040898 118 HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANV 197 (337)
Q Consensus 118 hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ni 197 (337)
||||+++++++.. +..++||||+++|+|.+++.. ....+++..+..++.||+.||.|| |++|++|+||+|+||
T Consensus 395 hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~L---H~~~iiHrDlkp~NI 467 (613)
T 2ozo_A 395 NPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYL---EEKNFVHRNLAARNV 467 (613)
T ss_dssp CTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGE
T ss_pred CCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHH---HHCCEEcCcCCHHHE
Confidence 9999999999876 568999999999999999843 345689999999999999999999 667999999999999
Q ss_pred eecCCCCeEEecccCccccCCCCcee-eeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCc
Q 040898 198 LIDDDMEARISDFGHGKLMPDGHAQI-TVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHT 275 (337)
Q Consensus 198 l~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~ 275 (337)
+++.++.++|+|||++.......... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 468 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~- 546 (613)
T 2ozo_A 468 LLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP- 546 (613)
T ss_dssp EEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH-
T ss_pred EEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH-
Confidence 99999999999999998764332211 1122345688999999998899999999999999999998 99999764331
Q ss_pred hhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 276 EEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
+....+...... ..++..+..+.+++.+||+.||++|||+.++++
T Consensus 547 ---~~~~~i~~~~~~-------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 547 ---EVMAFIEQGKRM-------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp ---HHHHHHHTTCCC-------------CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred ---HHHHHHHcCCCC-------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 222222211110 111123345899999999999999999999875
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=309.37 Aligned_cols=281 Identities=19% Similarity=0.303 Sum_probs=204.1
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++.+.||+|+||.||++.+ +++.||+|.+............. ..............+.+|+.++++++|
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~----~~~~vavK~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~E~~~l~~l~h 102 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK----DNKFYALKKYEKSLLEKKRDFTK--SNNDKISIKSKYDDFKNELQIITDIKN 102 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE----TTEEEEEEEEEHHHHSSCEEECC--CSSSSCCEEEHHHHHHHHHHHHTTCCC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc----CCceEEEEEeecccccchhhhcc--ccchhhhHHhHHHHHHHHHHHHHhCCC
Confidence 356899999999999999999988 79999999986542211000000 000000000001467889999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHH------HHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCC-CCeEecC
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDI------LYDVSQGRRELDWPARHRIARGIASGLEYLHMCHR-PRLIHRD 191 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~------l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~-~gi~h~d 191 (337)
|||+++++++.+++..++||||+++++|.++ +.. .....+++..++.++.|++.||.|| |+ .|++|+|
T Consensus 103 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~~i~H~d 177 (348)
T 2pml_X 103 EYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK--NYTCFIPIQVIKCIIKSVLNSFSYI---HNEKNICHRD 177 (348)
T ss_dssp TTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCS--SSCCCCCHHHHHHHHHHHHHHHHHH---HHTSCEECCC
T ss_pred CCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh--ccccCCCHHHHHHHHHHHHHHHHHH---hccCCEeecC
Confidence 9999999999999999999999999999988 421 2256799999999999999999999 55 7999999
Q ss_pred CCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccC-CCCC-cccchhhhHHHHHHHhCCCCCC
Q 040898 192 IKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTE-TISD-KCDIYSFGVLLAVLVMGKFPVD 269 (337)
Q Consensus 192 i~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~-~~DiwslG~i~~~ll~g~~pf~ 269 (337)
|+|+||+++.++.++|+|||.+...... ......+++.|+|||.+.+. .++. ++|+||||+++|+|++|..||.
T Consensus 178 l~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 253 (348)
T 2pml_X 178 VKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS 253 (348)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999998875433 23445789999999999877 5555 8999999999999999999997
Q ss_pred CCCCCchhhhHHHHHHhhhccCCcc-hhh----hhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 270 DFFGHTEEMDMVKWMRNVIFSENPN-RAI----NSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~----~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
..... ......+.......... ... ............+..+.+|+.+||+.||.+|||+.++++|
T Consensus 254 ~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 254 LKISL---VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp CSSCS---HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCCcH---HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 54331 12222221111000000 000 0000000112334568999999999999999999999987
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=304.33 Aligned_cols=264 Identities=23% Similarity=0.322 Sum_probs=199.9
Q ss_pred ccccccccceeccCcceEEEEeEEe--cCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAEL--PGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT 116 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 116 (337)
..++|++++.||+|+||.||++... ...+++.||+|++....... ...+.+|+.+++++
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~-------------------~~~~~~E~~~l~~l 99 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH-------------------LRDFEREIEILKSL 99 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHH-------------------HHHHHHHHHHHHTC
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHH-------------------HHHHHHHHHHHHhC
Confidence 4567999999999999999998742 23489999999987543211 15678899999999
Q ss_pred CCCCcccceeEEEcCC--eeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCC
Q 040898 117 RHRNILPLLAHMVRPN--CHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKP 194 (337)
Q Consensus 117 ~hpniv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~ 194 (337)
+||||+++++++.... ..++||||+++++|.+++.. ....+++..++.++.|++.||.+| |+.|++|+||+|
T Consensus 100 ~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~dikp 173 (326)
T 2w1i_A 100 QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLAT 173 (326)
T ss_dssp CCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHH---STTSSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCG
T ss_pred CCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHH---HhCCEeccCCCc
Confidence 9999999999886543 78999999999999999965 334589999999999999999999 667999999999
Q ss_pred CceeecCCCCeEEecccCccccCCCCceee-eecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCC
Q 040898 195 ANVLIDDDMEARISDFGHGKLMPDGHAQIT-VKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFG 273 (337)
Q Consensus 195 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~ 273 (337)
+||+++.++.++|+|||++........... .....++..|+|||.+.+..++.++||||||+++|+|++|..||.....
T Consensus 174 ~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~ 253 (326)
T 2w1i_A 174 RNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA 253 (326)
T ss_dssp GGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH
T ss_pred ceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH
Confidence 999999999999999999987655433222 1223467789999999888889999999999999999999998753200
Q ss_pred -------C-chhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 274 -------H-TEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 274 -------~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
. .........+......... ...+...+..+.+++.+||+.||++|||+.++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 254 EFMRMIGNDKQGQMIVFHLIELLKNNGR---------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHHCTTCCTHHHHHHHHHHHHTTCC---------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHhhccccchhhhHHHHHHHhhcCCC---------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0 0000000001111111000 0111223455899999999999999999999975
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=310.55 Aligned_cols=264 Identities=24% Similarity=0.324 Sum_probs=187.7
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++++.||+|+||.||++.+ +++.||+|++....... .....++..+..++|
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~----~~~~vavK~~~~~~~~~--------------------~~~e~~~~~~~~~~h 66 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL----DERPVAVKVFSFANRQN--------------------FINEKNIYRVPLMEH 66 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE----TTEEEEEEEEEGGGHHH--------------------HHHHHHHHTSTTCCC
T ss_pred ChHHhheeeecccCCCeEEEEEEE----CCeEEEEEEeeccchhh--------------------HHHHHHHHHHHhccC
Confidence 457899999999999999999866 78999999985432110 111234444556899
Q ss_pred CCcccceeEEEc-----CCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCC--------
Q 040898 119 RNILPLLAHMVR-----PNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRP-------- 185 (337)
Q Consensus 119 pniv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~-------- 185 (337)
|||+++++.+.. ...+++||||+++|+|.+++.. ...++..++.++.|++.||.|| |+.
T Consensus 67 ~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~L---H~~~~~~~~~~ 138 (336)
T 3g2f_A 67 DNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYL---HTELPRGDHYK 138 (336)
T ss_dssp TTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHH---HCCBCCGGGCB
T ss_pred cchhhheecccccccCCCceEEEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHH---Hhhhccccccc
Confidence 999999975432 3367899999999999999954 2357888999999999999999 566
Q ss_pred -CeEecCCCCCceeecCCCCeEEecccCccccCCCCc------eeeeecccCCCCccCcccccc-------CCCCCcccc
Q 040898 186 -RLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHA------QITVKCMVGTMGYMAPESLQT-------ETISDKCDI 251 (337)
Q Consensus 186 -gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~------~~~~~~~~~~~~~~~PE~~~~-------~~~~~~~Di 251 (337)
|++|+||||+||+++.++.++|+|||++........ ........||+.|+|||++.+ ..++.++||
T Consensus 139 ~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Di 218 (336)
T 3g2f_A 139 PAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDM 218 (336)
T ss_dssp CCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHH
T ss_pred cceeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccch
Confidence 999999999999999999999999999987653221 112223569999999999976 345678999
Q ss_pred hhhhHHHHHHHhCCCCCCCCCCCchh-hhHH---------HHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhc
Q 040898 252 YSFGVLLAVLVMGKFPVDDFFGHTEE-MDMV---------KWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCT 321 (337)
Q Consensus 252 wslG~i~~~ll~g~~pf~~~~~~~~~-~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 321 (337)
||||+++|+|++|..||......... .... .................. ...........+.+|+.+||
T Consensus 219 wslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl 296 (336)
T 3g2f_A 219 YALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPE--AWKENSLAVRSLKETIEDCW 296 (336)
T ss_dssp HHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCT--TCCCCSHHHHHHHHHHHHHS
T ss_pred HHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCc--ccccccchHHHHHHHHHHHh
Confidence 99999999999997665332211110 0000 000111111110000000 01122345667999999999
Q ss_pred cCCCCCCCChhhhhc
Q 040898 322 LKDPDERPSSKDVRS 336 (337)
Q Consensus 322 ~~dP~~Rps~~ell~ 336 (337)
+.||++|||+.|+++
T Consensus 297 ~~dP~~Rps~~e~l~ 311 (336)
T 3g2f_A 297 DQDAEARLTAQXAEE 311 (336)
T ss_dssp CSSGGGSCCHHHHHH
T ss_pred cCChhhCcchHHHHH
Confidence 999999999999975
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=314.39 Aligned_cols=256 Identities=24% Similarity=0.389 Sum_probs=186.2
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc-CC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT-RH 118 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h 118 (337)
.+.|.+.+.||+|+||+||++... +|+.||||++..+.. +.+.+|+.++.++ +|
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~~~~---~g~~vAvK~~~~~~~----------------------~~~~~E~~~l~~l~~H 68 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQGSF---QGRPVAVKRMLIDFC----------------------DIALMEIKLLTESDDH 68 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEEEES---SSSEEEEEEEEGGGH----------------------HHHHHHHHHHHHHTTS
T ss_pred hheeeccCeEeeCCCeEEEEEEEE---CCeEEEEEEEcHHHH----------------------HHHHHHHHHHHhccCC
Confidence 455777899999999999875443 799999999854321 3456799999876 89
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCccc---CChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCC
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRE---LDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPA 195 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~---~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ 195 (337)
|||+++++++.+++..++||||++ |+|.+++......... .++..++.++.||+.||.|| |++|++|+||||+
T Consensus 69 pnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDLkp~ 144 (434)
T 2rio_A 69 PNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL---HSLKIIHRDLKPQ 144 (434)
T ss_dssp TTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHH---HHTTEECCCCSGG
T ss_pred CCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHH---HHCCccccCCChH
Confidence 999999999999999999999996 5999999642221111 13345678999999999999 6679999999999
Q ss_pred ceeecCC-------------CCeEEecccCccccCCCCcee--eeecccCCCCccCcccccc-------CCCCCcccchh
Q 040898 196 NVLIDDD-------------MEARISDFGHGKLMPDGHAQI--TVKCMVGTMGYMAPESLQT-------ETISDKCDIYS 253 (337)
Q Consensus 196 nil~~~~-------------~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~-------~~~~~~~Diws 253 (337)
||+++.+ +.++|+|||++.......... ......||+.|+|||++.+ ..++.++||||
T Consensus 145 NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwS 224 (434)
T 2rio_A 145 NILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFS 224 (434)
T ss_dssp GEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHH
T ss_pred hEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHh
Confidence 9999754 489999999998765433211 1234579999999999976 56889999999
Q ss_pred hhHHHHHHHh-CCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChh
Q 040898 254 FGVLLAVLVM-GKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSK 332 (337)
Q Consensus 254 lG~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ 332 (337)
||+++|+|++ |..||...... . ............ ............+.+|+.+||+.||++|||+.
T Consensus 225 lG~il~ellt~g~~Pf~~~~~~--~---~~i~~~~~~~~~--------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ 291 (434)
T 2rio_A 225 MGCVFYYILSKGKHPFGDKYSR--E---SNIIRGIFSLDE--------MKCLHDRSLIAEATDLISQMIDHDPLKRPTAM 291 (434)
T ss_dssp HHHHHHHHHTTSCCTTCSTTTH--H---HHHHHTCCCCCC--------CTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHHHHHHHHhCCCCCCCCchhh--H---HHHhcCCCCccc--------ccccccccchHHHHHHHHHHhhCChhhCCCHH
Confidence 9999999999 99998653221 1 111111110000 01112345566799999999999999999999
Q ss_pred hhhcC
Q 040898 333 DVRSM 337 (337)
Q Consensus 333 ell~~ 337 (337)
++++|
T Consensus 292 eil~h 296 (434)
T 2rio_A 292 KVLRH 296 (434)
T ss_dssp HHHTS
T ss_pred HHHhC
Confidence 99987
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=298.67 Aligned_cols=259 Identities=20% Similarity=0.339 Sum_probs=183.7
Q ss_pred cccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHh
Q 040898 36 FLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQ 115 (337)
Q Consensus 36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~ 115 (337)
+....++|++++.||+|+||.||++.+.. +++.||+|++.......... ..+..+..+++.
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~-----------------~~~~~~~~~~~~ 80 (318)
T 2dyl_A 20 YQAEINDLENLGEMGSGTCGQVWKMRFRK--TGHVIAVKQMRRSGNKEENK-----------------RILMDLDVVLKS 80 (318)
T ss_dssp EECCGGGEEEEEEC------CEEEEEETT--TCCEEEEEEEETTSCHHHHH-----------------HHHHHHHHHHHT
T ss_pred hhhhhccccccceeeecCCeeEEEEEEec--CCeEEEEEEecccccchHHH-----------------HHHHHHHHHHHh
Confidence 33456789999999999999999999876 89999999987654322110 334445567888
Q ss_pred cCCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCC-CeEecCCCC
Q 040898 116 TRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRP-RLIHRDIKP 194 (337)
Q Consensus 116 l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~-gi~h~di~~ 194 (337)
++||||+++++++.++...++||||+ ++.+..+... ....+++..++.++.|++.||.|| |++ |++|+||+|
T Consensus 81 ~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~l---H~~~~i~H~dlkp 153 (318)
T 2dyl_A 81 HDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYL---KEKHGVIHRDVKP 153 (318)
T ss_dssp TTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHH---HHHHCCCCCCCCG
T ss_pred cCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHH---HhhCCEEeCCCCH
Confidence 89999999999999999999999999 5566665533 235689999999999999999999 553 999999999
Q ss_pred CceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccc-----cCCCCCcccchhhhHHHHHHHhCCCCCC
Q 040898 195 ANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQ-----TETISDKCDIYSFGVLLAVLVMGKFPVD 269 (337)
Q Consensus 195 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~-----~~~~~~~~DiwslG~i~~~ll~g~~pf~ 269 (337)
+||+++.++.++|+|||++........ .....+++.|+|||.+. ...++.++||||||+++|+|++|..||.
T Consensus 154 ~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 230 (318)
T 2dyl_A 154 SNILLDERGQIKLCDFGISGRLVDDKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYK 230 (318)
T ss_dssp GGEEECTTSCEEECCCTTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred HHEEECCCCCEEEEECCCchhccCCcc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCC
Confidence 999999999999999999876543321 22346899999999984 4567889999999999999999999996
Q ss_pred CCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 270 DFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.... ..... ........+... .....+..+.+++.+||+.||.+|||+.++++|
T Consensus 231 ~~~~---~~~~~---~~~~~~~~~~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 231 NCKT---DFEVL---TKVLQEEPPLLP--------GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp TCCS---HHHHH---HHHHHSCCCCCC--------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CCCc---cHHHH---HHHhccCCCCCC--------ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 5322 11111 111111111100 001122348899999999999999999999987
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=306.30 Aligned_cols=249 Identities=23% Similarity=0.361 Sum_probs=198.7
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC-
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR- 117 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~- 117 (337)
-.++|++.+.||+|+||.||++.+.. +++.||+|.+........... .....+.+|+.+++.+.
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~-------------~~~~~~~~E~~~l~~l~~ 105 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVS--DNLPVAIKHVEKDRISDWGEL-------------PNGTRVPMEVVLLKKVSS 105 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETT--TTEEEEEEEEEGGGCCCEEEC-------------TTCCEEEHHHHHHHHHCS
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECC--CCcEEEEEEEecccchhhhhh-------------hhhhHHHHHHHHHHhhcc
Confidence 46779999999999999999998876 899999999876533211000 00035667999999996
Q ss_pred -CCCcccceeEEEcCCeeEEEEEeccC-CCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCC
Q 040898 118 -HRNILPLLAHMVRPNCHLLVYEFMKN-GSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPA 195 (337)
Q Consensus 118 -hpniv~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ 195 (337)
||||+++++++..++..++|+|++.+ ++|.+++.. ...+++..++.++.|++.||.|| |+.|++|+||+|+
T Consensus 106 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dlkp~ 178 (320)
T 3a99_A 106 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHC---HNCGVLHRDIKDE 178 (320)
T ss_dssp SSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGG
T ss_pred CCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHH---HHCCcEeCCCCHH
Confidence 59999999999999999999999976 899999854 35689999999999999999999 6679999999999
Q ss_pred ceeec-CCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCC-CCcccchhhhHHHHHHHhCCCCCCCCCC
Q 040898 196 NVLID-DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETI-SDKCDIYSFGVLLAVLVMGKFPVDDFFG 273 (337)
Q Consensus 196 nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~DiwslG~i~~~ll~g~~pf~~~~~ 273 (337)
||+++ .++.++|+|||++....... .....+++.|+|||++.+..+ +.++|+||||+++|+|++|..||....
T Consensus 179 NIll~~~~~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~- 253 (320)
T 3a99_A 179 NILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE- 253 (320)
T ss_dssp GEEEETTTTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-
T ss_pred HEEEeCCCCCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-
Confidence 99999 78899999999988765432 223468999999999977665 678899999999999999999985420
Q ss_pred CchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 274 HTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
..... .... ....+..+.+++.+||+.||++|||+.++++|
T Consensus 254 --------~~~~~----~~~~-----------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 254 --------EIIRG----QVFF-----------RQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp --------HHHHC----CCCC-----------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --------hhhcc----cccc-----------cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11110 0000 01122348899999999999999999999986
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=328.68 Aligned_cols=248 Identities=23% Similarity=0.285 Sum_probs=192.5
Q ss_pred ceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCccccee
Q 040898 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLLA 126 (337)
Q Consensus 47 ~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~ 126 (337)
+.||+|+||.||++.+....+++.||||++........ ..+.+.+|+.++++++||||+++++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~-----------------~~~~~~~E~~il~~l~hpnIv~l~~ 437 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA-----------------LKDELLAEANVMQQLDNPYIVRMIG 437 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGG-----------------GHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHH-----------------HHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 47999999999999776556789999999865432211 1157888999999999999999999
Q ss_pred EEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCCeE
Q 040898 127 HMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEAR 206 (337)
Q Consensus 127 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~~ 206 (337)
++.. +..++||||+++|+|.+++.. ...+++..++.++.||+.||.|| |++|++|+||||+||+++.++.++
T Consensus 438 ~~~~-~~~~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yL---H~~~iiHrDLkp~NILl~~~~~~k 509 (635)
T 4fl3_A 438 ICEA-ESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAK 509 (635)
T ss_dssp EEES-SSEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEEEETTEEE
T ss_pred EEec-CCEEEEEEccCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHH---HHCCEeCCCCChHhEEEeCCCCEE
Confidence 8865 468899999999999999943 35689999999999999999999 667999999999999999999999
Q ss_pred EecccCccccCCCCce-eeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCchhhhHHHHH
Q 040898 207 ISDFGHGKLMPDGHAQ-ITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHTEEMDMVKWM 284 (337)
Q Consensus 207 l~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~ 284 (337)
|+|||++......... .......+++.|+|||++.+..++.++||||||+++|+|++ |..||..... ......+
T Consensus 510 L~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~----~~~~~~i 585 (635)
T 4fl3_A 510 ISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG----SEVTAML 585 (635)
T ss_dssp ECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH----HHHHHHH
T ss_pred EEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHH
Confidence 9999999876543321 11223346788999999999899999999999999999998 9999965422 1222222
Q ss_pred HhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 285 RNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
....... .+...+..+.+++.+||+.||++|||+.+|++
T Consensus 586 ~~~~~~~-------------~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 586 EKGERMG-------------CPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp HTTCCCC-------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HcCCCCC-------------CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 2111111 11123345899999999999999999999975
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=302.74 Aligned_cols=249 Identities=23% Similarity=0.295 Sum_probs=191.3
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc--
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT-- 116 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-- 116 (337)
-.++|++.+.||+|+||.||++.+.. +++.||+|++............ ....+.+|+.++.++
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~-------------~~~~~~~e~~~l~~l~~ 93 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRLT--DRLQVAIKVIPRNRVLGWSPLS-------------DSVTCPLEVALLWKVGA 93 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECTT--TCCEEEEEECCSTTTC---------------------CCCCHHHHHHHHHHS
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEcc--CCeEEEEEEEecccccccccch-------------hhHHHHHHHHHHHhhcc
Confidence 45679999999999999999998865 8999999999765433221110 014566788888888
Q ss_pred --CCCCcccceeEEEcCCeeEEEEEe-ccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCC
Q 040898 117 --RHRNILPLLAHMVRPNCHLLVYEF-MKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIK 193 (337)
Q Consensus 117 --~hpniv~~~~~~~~~~~~~lv~e~-~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~ 193 (337)
+||||+++++++...+..++|+|+ +.+++|.+++.. ...+++..++.++.|++.||.|| |+.|++|+||+
T Consensus 94 ~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlk 166 (312)
T 2iwi_A 94 GGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHC---HSRGVVHRDIK 166 (312)
T ss_dssp SCCCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHH---HHHTEECCCCS
T ss_pred cCCCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCC
Confidence 899999999999999999999999 788999999954 34589999999999999999999 66699999999
Q ss_pred CCceeec-CCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCC-CcccchhhhHHHHHHHhCCCCCCCC
Q 040898 194 PANVLID-DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETIS-DKCDIYSFGVLLAVLVMGKFPVDDF 271 (337)
Q Consensus 194 ~~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~-~~~DiwslG~i~~~ll~g~~pf~~~ 271 (337)
|+||+++ .++.++|+|||++....... .....+++.|+|||.+.+..+. .++|+||||+++|+|++|..||...
T Consensus 167 p~Nil~~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 242 (312)
T 2iwi_A 167 DENILIDLRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD 242 (312)
T ss_dssp GGGEEEETTTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred hhhEEEeCCCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh
Confidence 9999999 88999999999988765432 2345689999999998776654 4899999999999999999998542
Q ss_pred CCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 272 FGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
. ..... ... ........+.+++.+||+.||++|||+.++++|
T Consensus 243 ------~---~~~~~----~~~-----------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 243 ------Q---EILEA----ELH-----------FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp ------H---HHHHT----CCC-----------CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ------H---HHhhh----ccC-----------CcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 11110 000 011123348899999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=313.69 Aligned_cols=252 Identities=22% Similarity=0.337 Sum_probs=187.1
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc-C
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT-R 117 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~ 117 (337)
...+|.+.+.||+|+||+||+.... +++.||||++..... ..+.+|+.+++++ +
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~~~~---~~~~vAvK~~~~~~~----------------------~~~~~E~~~l~~l~~ 76 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYRGMF---DNRDVAVKRILPECF----------------------SFADREVQLLRESDE 76 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEEEES---SSSEEEEEEECTTTE----------------------EECHHHHHHHHHSCC
T ss_pred ccEEEecCCeeecCcCEEEEEEEEe---CCeEEEEEEECHHHH----------------------HHHHHHHHHHHhccC
Confidence 5567999999999999998754433 799999999865432 2455799999999 8
Q ss_pred CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCce
Q 040898 118 HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANV 197 (337)
Q Consensus 118 hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ni 197 (337)
||||+++++++.+....|+||||+++ +|.+++.. .........++.++.||+.||.|| |++|++|+||||+||
T Consensus 77 HpnIv~l~~~~~~~~~~~lv~E~~~g-~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlKp~NI 149 (432)
T 3p23_A 77 HPNVIRYFCTEKDRQFQYIAIELCAA-TLQEYVEQ---KDFAHLGLEPITLLQQTTSGLAHL---HSLNIVHRDLKPHNI 149 (432)
T ss_dssp CTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHS---SSCCCCSSCHHHHHHHHHHHHHHH---HHTTCCCCCCSTTSE
T ss_pred CCCcCeEEEEEecCCEEEEEEECCCC-CHHHHHHh---cCCCccchhHHHHHHHHHHHHHHH---HHCcCEeCCCCHHHE
Confidence 99999999999999999999999964 99999854 333455556789999999999999 667999999999999
Q ss_pred eecC-----CCCeEEecccCccccCCCCce-eeeecccCCCCccCccccc---cCCCCCcccchhhhHHHHHHHh-CCCC
Q 040898 198 LIDD-----DMEARISDFGHGKLMPDGHAQ-ITVKCMVGTMGYMAPESLQ---TETISDKCDIYSFGVLLAVLVM-GKFP 267 (337)
Q Consensus 198 l~~~-----~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~---~~~~~~~~DiwslG~i~~~ll~-g~~p 267 (337)
+++. ...++|+|||++......... .......||+.|+|||++. ...++.++|||||||++|+|++ |..|
T Consensus 150 ll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~p 229 (432)
T 3p23_A 150 LISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHP 229 (432)
T ss_dssp EECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBT
T ss_pred EEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCC
Confidence 9953 335789999999876533211 1223457999999999997 4557789999999999999999 8999
Q ss_pred CCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 268 VDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 268 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
|...... .. .. .. ....... ..........+.+|+.+||+.||++|||+.++++|
T Consensus 230 f~~~~~~----~~-~~---~~-~~~~~~~------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 230 FGKSLQR----QA-NI---LL-GACSLDC------LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp TBSTTTH----HH-HH---HT-TCCCCTT------SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cchhhHH----HH-HH---Hh-ccCCccc------cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 8543221 11 11 11 1100000 00112334457899999999999999999999987
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=310.68 Aligned_cols=258 Identities=21% Similarity=0.283 Sum_probs=201.7
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|+++++||+|+||.||++.+.. +++.||||++...... ..+.+|+.+++.++|
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~--~~~~vAvK~~~~~~~~---------------------~~~~~E~~il~~L~~ 61 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQ--TNEEVAIKLENVKTKH---------------------PQLLYESKIYRILQG 61 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETT--TCCEEEEEEEETTCSS---------------------CCHHHHHHHHHHTTT
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECC--CCcEEEEEEecccccc---------------------HHHHHHHHHHHHhcC
Confidence 45789999999999999999999876 8999999987544321 356779999999987
Q ss_pred C-CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCce
Q 040898 119 R-NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANV 197 (337)
Q Consensus 119 p-niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ni 197 (337)
+ ++..+..++......++||||+ +++|.+++.. ....+++..++.++.||+.||.|| |++|++|+||||+||
T Consensus 62 ~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~---~~~~l~~~~~~~i~~qi~~aL~yL---H~~gIvHrDIKP~NI 134 (483)
T 3sv0_A 62 GTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFV---HSKSFLHRDIKPDNF 134 (483)
T ss_dssp STTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGE
T ss_pred CCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHH---HHCCEeecccCcceE
Confidence 4 5555666667788899999999 8899999964 244699999999999999999999 667999999999999
Q ss_pred ee---cCCCCeEEecccCccccCCCCce-----eeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCC
Q 040898 198 LI---DDDMEARISDFGHGKLMPDGHAQ-----ITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVD 269 (337)
Q Consensus 198 l~---~~~~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~ 269 (337)
|+ +.++.++|+|||++......... .......+|+.|+|||.+.+..++.++||||||+++|+|++|..||.
T Consensus 135 Ll~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~ 214 (483)
T 3sv0_A 135 LMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQ 214 (483)
T ss_dssp EECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred EEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCc
Confidence 99 57899999999999876543321 11224579999999999999999999999999999999999999998
Q ss_pred CCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 270 DFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
..........+........ ....... ....+..+.+++..||+.||++||++.+|++
T Consensus 215 ~~~~~~~~~~~~~i~~~~~-~~~~~~l---------~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 215 GLKAGTKKQKYEKISEKKV-ATSIEAL---------CRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp SCCCSSHHHHHHHHHHHHH-HSCHHHH---------HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred cccchhHHHHHHHHhhccc-cccHHHH---------hcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 7655433333332222211 1111100 0112345899999999999999999999875
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=326.56 Aligned_cols=252 Identities=26% Similarity=0.412 Sum_probs=199.2
Q ss_pred cccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC
Q 040898 38 KKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR 117 (337)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 117 (337)
-..++|++.+.||+|+||.||++.+. .+..||||++....... +.+.+|+.++++++
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~--------------------~~~~~E~~~l~~l~ 320 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWN---GTTRVAIKTLKPGTMSP--------------------EAFLQEAQVMKKLR 320 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET---TTEEEEEEEECTTSSCH--------------------HHHHHHHHHHHHCC
T ss_pred cchhhhhhheecccCCCeEEEEEEEC---CCceEEEEEeCCCCCCH--------------------HHHHHHHHHHHhCC
Confidence 35678999999999999999998875 45779999987543211 46788999999999
Q ss_pred CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCce
Q 040898 118 HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANV 197 (337)
Q Consensus 118 hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ni 197 (337)
||||+++++++.+ +..++||||+++|+|.+++... .+..+++..++.++.||+.||.|| |++|++|+||+|+||
T Consensus 321 hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~L---H~~~ivHrDlkp~NI 394 (535)
T 2h8h_A 321 HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANI 394 (535)
T ss_dssp CTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGE
T ss_pred CCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCCHhhE
Confidence 9999999998876 6789999999999999999542 224588999999999999999999 667999999999999
Q ss_pred eecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCch
Q 040898 198 LIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHTE 276 (337)
Q Consensus 198 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~ 276 (337)
+++.++.++|+|||++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 395 ll~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~--- 470 (535)
T 2h8h_A 395 LVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--- 470 (535)
T ss_dssp EECGGGCEEECCTTSTTTCCCHHHH-TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH---
T ss_pred EEcCCCcEEEcccccceecCCCcee-cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---
Confidence 9999999999999999765432111 1122346778999999998889999999999999999999 8999865321
Q ss_pred hhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 277 EMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
.+....+.... .. ..+......+.+|+.+||+.||++|||+.+|++
T Consensus 471 -~~~~~~i~~~~---~~----------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 471 -REVLDQVERGY---RM----------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 516 (535)
T ss_dssp -HHHHHHHHTTC---CC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -HHHHHHHHcCC---CC----------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 12222221111 00 011123345889999999999999999999875
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=324.65 Aligned_cols=271 Identities=20% Similarity=0.267 Sum_probs=198.4
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
.++|++.+.||+|+||.||++.+.. +|+.||+|++........ ...+.+|+.+++.++||
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~--tg~~VAVKvi~~~~~~~~------------------~~~~~~Ei~iL~~L~Hp 72 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQD--TGEQVAIKQCRQELSPKN------------------RERWCLEIQIMKKLNHP 72 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTT--TTCCEEECCCCSCCCHHH------------------HHHHHHHHHHHHHCCBT
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECC--CCcEEEEEEecccCCHHH------------------HHHHHHHHHHHHhCCCC
Confidence 4789999999999999999988865 899999999865432211 15678899999999999
Q ss_pred CcccceeEEEc------CCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCC
Q 040898 120 NILPLLAHMVR------PNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIK 193 (337)
Q Consensus 120 niv~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~ 193 (337)
||+++++++.. ++..++||||+++++|.+++.... ....+++..++.++.|++.||.|| |+.|++|+||+
T Consensus 73 nIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yL---Hs~gIVHrDLK 148 (676)
T 3qa8_A 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYL---HENRIIHRDLK 148 (676)
T ss_dssp TBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHH---HHTTBCCCCCC
T ss_pred CCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHH---HHCCCccCCCC
Confidence 99999998765 677899999999999999986422 233588999999999999999999 66799999999
Q ss_pred CCceeecCCCC---eEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCC
Q 040898 194 PANVLIDDDME---ARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDD 270 (337)
Q Consensus 194 ~~nil~~~~~~---~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~ 270 (337)
|+||+++.++. ++|+|||.+........ .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||..
T Consensus 149 P~NILl~~~g~~~~vKL~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~ 225 (676)
T 3qa8_A 149 PENIVLQPGPQRLIHKIIDLGYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225 (676)
T ss_dssp STTEEEECCSSSCEEEECSCCCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HHHeEeecCCCceeEEEcccccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 99999997765 89999999987654432 2345789999999999999999999999999999999999999864
Q ss_pred CCCCchhhh-H-HHHHHhhhccCCcch----hhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 271 FFGHTEEMD-M-VKWMRNVIFSENPNR----AINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 271 ~~~~~~~~~-~-~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
......... . ............... ...........+.....+.+++.+||+.||++|||+.++++|
T Consensus 226 ~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~h 298 (676)
T 3qa8_A 226 NWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNV 298 (676)
T ss_dssp SCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCC
T ss_pred ccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcC
Confidence 211000000 0 000000000000000 000000112233456779999999999999999999999876
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=323.61 Aligned_cols=255 Identities=23% Similarity=0.317 Sum_probs=197.4
Q ss_pred ccccccccceeccCcceEEEEeEEecC-CCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPG-SNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR 117 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 117 (337)
..++|++.+.||+|+||.||++.+... ..+..||+|.+........ .+.+.+|+.++++++
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~------------------~~~~~~E~~~l~~l~ 449 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSV------------------REKFLQEALTMRQFD 449 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHH------------------HHHHHHHHHHHHHCC
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHH------------------HHHHHHHHHHHHhCC
Confidence 457799999999999999999988642 2467899998865432211 156788999999999
Q ss_pred CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCce
Q 040898 118 HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANV 197 (337)
Q Consensus 118 hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ni 197 (337)
||||+++++++. ++..++||||+++|+|.+++.. .+..+++..++.++.|++.||.|| |++|++|+||+|+||
T Consensus 450 HpnIv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~L---H~~givHrDikp~NI 522 (656)
T 2j0j_A 450 HPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYL---ESKRFVHRDIAARNV 522 (656)
T ss_dssp CTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGE
T ss_pred CCCCCeEEEEEe-cCceEEEEEcCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHH---HhCCccccccchHhE
Confidence 999999999885 4568999999999999999964 344688999999999999999999 667999999999999
Q ss_pred eecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCch
Q 040898 198 LIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHTE 276 (337)
Q Consensus 198 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~ 276 (337)
+++.++.++|+|||++......... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 523 Ll~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~--- 598 (656)
T 2j0j_A 523 LVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--- 598 (656)
T ss_dssp EEEETTEEEECCCCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---
T ss_pred EEeCCCCEEEEecCCCeecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH---
Confidence 9999999999999999876543222 1223456788999999998889999999999999999997 9999865322
Q ss_pred hhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 277 EMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
.+....+....... .++..+..+.+++.+||+.||++|||+.++++
T Consensus 599 -~~~~~~i~~~~~~~-------------~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 599 -NDVIGRIENGERLP-------------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp -HHHHHHHHHTCCCC-------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -HHHHHHHHcCCCCC-------------CCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 12222221111000 11122345889999999999999999999975
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=297.64 Aligned_cols=253 Identities=21% Similarity=0.332 Sum_probs=190.2
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++.+.||+|+||.||++.+. ..+|+|.+......... ...+.+|+.++++++|
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~avk~~~~~~~~~~~-----------------~~~~~~e~~~l~~l~h 88 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWH-----GEVAIRLIDIERDNEDQ-----------------LKAFKREVMAYRQTRH 88 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEES-----SSEEEEECCCCSCCCCC-----------------CCCCCTTGGGGTTCCC
T ss_pred CHHHeEEeeEeccCCceEEEEEEEc-----CeEEEEEeecCCCCHHH-----------------HHHHHHHHHHHhcCCC
Confidence 5678999999999999999998773 24999998654322110 1456678999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++++.+....++|+||+++++|.+++.. .+..+++..++.++.|++.||.|| |+.|++|+||+|+||+
T Consensus 89 ~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~l---H~~~i~H~dlkp~NIl 162 (319)
T 2y4i_B 89 ENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYL---HAKGILHKDLKSKNVF 162 (319)
T ss_dssp TTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHH---HHTTCCCCCCCSTTEE
T ss_pred CCEeEEEEEEecCCceEEEeecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH---HhCCccccCCChhhEE
Confidence 9999999999999999999999999999999843 344689999999999999999999 6679999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCc---eeeeecccCCCCccCcccccc---------CCCCCcccchhhhHHHHHHHhCCC
Q 040898 199 IDDDMEARISDFGHGKLMPDGHA---QITVKCMVGTMGYMAPESLQT---------ETISDKCDIYSFGVLLAVLVMGKF 266 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~~~~PE~~~~---------~~~~~~~DiwslG~i~~~ll~g~~ 266 (337)
++ ++.++|+|||++........ ........+++.|+|||++.+ ..++.++||||||+++|+|++|..
T Consensus 163 ~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~ 241 (319)
T 2y4i_B 163 YD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREW 241 (319)
T ss_dssp EC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred Ee-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCC
Confidence 98 67999999998765432111 111223458899999999875 346788999999999999999999
Q ss_pred CCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 267 PVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 267 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
||..... ......+........... ..+..+.+++.+||+.||++|||+.++++
T Consensus 242 p~~~~~~----~~~~~~~~~~~~~~~~~~------------~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 242 PFKTQPA----EAIIWQMGTGMKPNLSQI------------GMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp SSSSCCH----HHHHHHHHTTCCCCCCCS------------SCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred CCCCCCH----HHHHHHhccCCCCCCCcC------------CCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 9865321 111111111111111000 01123889999999999999999999985
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=288.90 Aligned_cols=236 Identities=21% Similarity=0.320 Sum_probs=179.8
Q ss_pred cccccccccc-ceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHH-H
Q 040898 37 LKKEDCFDSL-KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITA-N 114 (337)
Q Consensus 37 ~~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l-~ 114 (337)
....++|.+. +.||+|+||.||++.+.. +++.||+|.+... ..+.+|+.++ +
T Consensus 13 ~~~~~~y~~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~------------------------~~~~~e~~~~~~ 66 (299)
T 3m2w_A 13 NAIIDDYKVTSQVLGLGINGKVLQIFNKR--TQEKFALKMLQDC------------------------PKARREVELHWR 66 (299)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEECS------------------------HHHHHHHHHHHH
T ss_pred cccccchhhcCcccccCCCeEEEEEEEcC--CCcEEEEEEeccc------------------------HHHHHHHHHHHH
Confidence 3455668888 789999999999999876 8999999998532 3455677777 5
Q ss_pred hcCCCCcccceeEEEc----CCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 040898 115 QTRHRNILPLLAHMVR----PNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHR 190 (337)
Q Consensus 115 ~l~hpniv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~ 190 (337)
.++||||+++++++.. ....++||||+++++|.+++.. .....+++..++.++.|++.||.|| |++|++|+
T Consensus 67 ~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~ 141 (299)
T 3m2w_A 67 ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYL---HSINIAHR 141 (299)
T ss_dssp HTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHH--CTTCCCBHHHHHHHHHHHHHHHHHH---HHTTEECC
T ss_pred hccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHH---HhCCcccC
Confidence 5699999999999876 6788999999999999999965 3345689999999999999999999 66799999
Q ss_pred CCCCCceeecC---CCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCC
Q 040898 191 DIKPANVLIDD---DMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFP 267 (337)
Q Consensus 191 di~~~nil~~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~p 267 (337)
||+|+||+++. ++.++|+|||++.... +..++.++|+||||+++|+|++|..|
T Consensus 142 dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~p 197 (299)
T 3m2w_A 142 DVKPENLLYTSKRPNAILKLTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPP 197 (299)
T ss_dssp CCSGGGEEESSSSTTCCEEECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCS
T ss_pred CCCHHHEEEecCCCCCcEEEeccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCC
Confidence 99999999998 7889999999875432 23357789999999999999999999
Q ss_pred CCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 268 VDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 268 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
|............. ......... .........+..+.+++.+||+.||++|||+.|+++|
T Consensus 198 f~~~~~~~~~~~~~---~~~~~~~~~-------~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 198 FYSNHGLAISPGMK---TRIRMGQYE-------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp CCC-------CCSC---CSSCTTCCS-------SCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCcchhhhHHHH---HHHhhcccc-------CCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 96532211000000 000000000 0000011234568999999999999999999999987
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=281.42 Aligned_cols=229 Identities=14% Similarity=0.104 Sum_probs=177.0
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
.++|++.+.||+|+||.||++.+.. +++.||+|.+.......... ...+.+|+..+.+++||
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~--~~~~vavK~~~~~~~~~~~~----------------~~~~~~e~~~l~~l~hp 91 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTA--LDRQVALTFVDPQGVLPDDV----------------LQETLSRTLRLSRIDKP 91 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETT--TTEEEEEEESCTTCCSCHHH----------------HHHHHHHHHHHHTCCCT
T ss_pred cCcEEEEEEEcccCCeEEEEEEecC--CCceEEEEEECcccccCHHH----------------HHHHHHHHHHHhcCCCC
Confidence 3679999999999999999999865 89999999997665433221 15678899999999999
Q ss_pred CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceee
Q 040898 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI 199 (337)
Q Consensus 120 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~ 199 (337)
||+++++++.+++..|+||||+++++|.+++.. + .....+..++.|++.||.|| |++|++|+||||+||++
T Consensus 92 ~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~----~--~~~~~~~~i~~ql~~aL~~l---H~~givH~Dikp~NIll 162 (286)
T 3uqc_A 92 GVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT----S--PSPVGAIRAMQSLAAAADAA---HRAGVALSIDHPSRVRV 162 (286)
T ss_dssp TBCCEEEEEEETTEEEEEEECCCEEEHHHHHTT----C--CCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCSGGGEEE
T ss_pred CcceeeEEEEECCcEEEEEEecCCCCHHHHHhc----C--CChHHHHHHHHHHHHHHHHH---HHCCCccCCCCcccEEE
Confidence 999999999999999999999999999999832 2 34556888999999999999 66799999999999999
Q ss_pred cCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhh
Q 040898 200 DDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMD 279 (337)
Q Consensus 200 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~ 279 (337)
+.++.++|++++. ++ .++.++||||||+++|+|++|..||...........
T Consensus 163 ~~~g~~kl~~~~~----------------------~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~ 213 (286)
T 3uqc_A 163 SIDGDVVLAYPAT----------------------MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP 213 (286)
T ss_dssp ETTSCEEECSCCC----------------------CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE
T ss_pred cCCCCEEEEeccc----------------------cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH
Confidence 9999999985542 22 257889999999999999999999975432110000
Q ss_pred HHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 280 MVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
.. ........... ...+..+..+.+++.+||+.||++| |+.++++
T Consensus 214 ~~---~~~~~~~~~~~--------~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 214 AE---RDTAGQPIEPA--------DIDRDIPFQISAVAARSVQGDGGIR-SASTLLN 258 (286)
T ss_dssp CC---BCTTSCBCCHH--------HHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred HH---HHhccCCCChh--------hcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence 00 00000000000 0011233458999999999999999 9999975
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=314.47 Aligned_cols=237 Identities=20% Similarity=0.283 Sum_probs=188.6
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
.++|++.+.||+|+||.||++.+.. .+++.||||++......... ..+.+|+.++.+++||
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~-~~~~~vaiK~~~~~~~~~~~------------------~~~~~E~~~l~~l~hp 139 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRN-VNGRPVVLKGLVHSGDAEAQ------------------AMAMAERQFLAEVVHP 139 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGG-GTTEEEEEEESCSSCCHHHH------------------HHHHHHHGGGGGCCCT
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcC-CCCcEEEEEEeCccCCHHHH------------------HHHHHHHHHHHhcCCC
Confidence 4789999999999999999998853 25889999988654322111 4677899999999999
Q ss_pred CcccceeEEEcCCe-----eEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCC
Q 040898 120 NILPLLAHMVRPNC-----HLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKP 194 (337)
Q Consensus 120 niv~~~~~~~~~~~-----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~ 194 (337)
||+++++++...+. .|+||||+++++|.+++. . .+++..++.++.||+.+|.|| |++|++|+||||
T Consensus 140 ~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~----~--~l~~~~~~~~~~qi~~aL~~l---H~~giiHrDlkp 210 (681)
T 2pzi_A 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG----Q--KLPVAEAIAYLLEILPALSYL---HSIGLVYNDLKP 210 (681)
T ss_dssp TBCCEEEEEEEECTTSCEEEEEEEECCCCEECC--------C--CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSG
T ss_pred CcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHh----C--CCCHHHHHHHHHHHHHHHHHH---HHCCCeecccCh
Confidence 99999999987665 799999999999988762 2 689999999999999999999 667999999999
Q ss_pred CceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCC
Q 040898 195 ANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGH 274 (337)
Q Consensus 195 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~ 274 (337)
+||+++.+ .++|+|||++...... ....||+.|+|||++.+.. +.++||||||+++|+|++|.+||......
T Consensus 211 ~NIll~~~-~~kl~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~ 282 (681)
T 2pzi_A 211 ENIMLTEE-QLKLIDLGAVSRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD 282 (681)
T ss_dssp GGEEECSS-CEEECCCTTCEETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS
T ss_pred HHeEEeCC-cEEEEecccchhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc
Confidence 99999975 8999999999876443 2356999999999987654 88999999999999999999887542211
Q ss_pred chhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 275 TEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
. .+. ..........+.+++.+||+.||++||+..+.+.
T Consensus 283 ~----------------~~~--------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~ 320 (681)
T 2pzi_A 283 G----------------LPE--------DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMS 320 (681)
T ss_dssp S----------------CCT--------TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred c----------------ccc--------cccccccCHHHHHHHhhhccCChhhCCCHHHHHH
Confidence 0 000 0011122345889999999999999998776653
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=296.13 Aligned_cols=249 Identities=14% Similarity=0.160 Sum_probs=181.8
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
...+|...+.||+|+||.||++.+.. +|+.||||++.......... .+.+.+|+.+++.+.|
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~--~g~~vAvK~~~~~~~~~~~~----------------~~~~~~E~~~~~~l~~ 137 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQE--TGESFEVHVPYFTERPPSNA----------------IKQMKEEVLRLRLLRG 137 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEECCSCC----C----------------CHHHHHHHHGGGGSTT
T ss_pred CceeEEEecccccCCCEEEEEEEecC--CCCceEEEEEecCCCccHHH----------------HHHHHHHHHHHHhhcc
Confidence 44568899999999999999999876 89999999887443322111 1567788888888876
Q ss_pred -CCccc---------------------ceeEEEc-----CCeeEEEEEeccCCCHHHHHHHh---cCCcccCChHHHHHH
Q 040898 119 -RNILP---------------------LLAHMVR-----PNCHLLVYEFMKNGSLQDILYDV---SQGRRELDWPARHRI 168 (337)
Q Consensus 119 -pniv~---------------------~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i 168 (337)
+|... +..++.. ....+++++++ +++|.+++... ...+..+++..++.+
T Consensus 138 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i 216 (413)
T 3dzo_A 138 IKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQL 216 (413)
T ss_dssp CCSHHHHHHHTCBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHH
T ss_pred CCCHHHHHHhcccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHH
Confidence 22111 1111111 12356777765 56999988543 234566888899999
Q ss_pred HHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCcccc--------
Q 040898 169 ARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESL-------- 240 (337)
Q Consensus 169 ~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~-------- 240 (337)
+.|++.||.|| |++|++|+||||+||+++.++.+||+|||++...... .....| +.|+|||++
T Consensus 217 ~~qi~~aL~~L---H~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~ 287 (413)
T 3dzo_A 217 TLQVIRLLASL---HHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFG 287 (413)
T ss_dssp HHHHHHHHHHH---HHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTG
T ss_pred HHHHHHHHHHH---HhCCcccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccc
Confidence 99999999999 6779999999999999999999999999998764332 234567 999999999
Q ss_pred --ccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHh
Q 040898 241 --QTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLAC 318 (337)
Q Consensus 241 --~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 318 (337)
.+..++.++||||||+++|+|++|..||......... ... .... ...+..+.+|+.
T Consensus 288 ~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~-------~~~-~~~~--------------~~~~~~~~~li~ 345 (413)
T 3dzo_A 288 QHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGS-------EWI-FRSC--------------KNIPQPVRALLE 345 (413)
T ss_dssp GGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCS-------GGG-GSSC--------------CCCCHHHHHHHH
T ss_pred cccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhH-------HHH-Hhhc--------------ccCCHHHHHHHH
Confidence 5556788999999999999999999999653211100 000 0000 011245899999
Q ss_pred hhccCCCCCCCChhhhhcC
Q 040898 319 FCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 319 ~~l~~dP~~Rps~~ell~~ 337 (337)
+||+.||++|||+.++++|
T Consensus 346 ~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 346 GFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp HHTCSSGGGSCCHHHHTTS
T ss_pred HHccCChhhCcCHHHHHhC
Confidence 9999999999999999876
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=289.68 Aligned_cols=252 Identities=17% Similarity=0.176 Sum_probs=182.2
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC-
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR- 117 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~- 117 (337)
..++|++++.||+|+||.||++.+ +|+.||+|++........... .......+.+|+.+++.++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~----~~~~vAvK~~~~~~~~~~~~~-----------~~~~~~~~~~E~~~l~~l~~ 82 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA----DHTPVAIKIIAIEGPDLVNGS-----------HQKTFEEILPEIIISKELSL 82 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE----TTEEEEEEEEEESCSSCBTTB-----------CCBCHHHHHHHHHHHHHHHH
T ss_pred ccccchheeeecccCceEEEEEEe----CCceEEEEEEecCCccccccc-----------cchhHHHHHHHHHHHHHHHH
Confidence 457899999999999999999987 789999999976643210000 0000145667777777775
Q ss_pred --------CCCcccceeE-----------------EEc-------------CCeeEEEEEeccCCCHHHHHHHhcCCccc
Q 040898 118 --------HRNILPLLAH-----------------MVR-------------PNCHLLVYEFMKNGSLQDILYDVSQGRRE 159 (337)
Q Consensus 118 --------hpniv~~~~~-----------------~~~-------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 159 (337)
||||+++.++ +.+ ....|+||||+++|++.+.+. +..
T Consensus 83 l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-----~~~ 157 (336)
T 2vuw_A 83 LSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-----TKL 157 (336)
T ss_dssp GGGCSSSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-----TTC
T ss_pred hhccccccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH-----hcC
Confidence 5555555554 433 678999999999986655552 245
Q ss_pred CChHHHHHHHHHHHHHHHHHhhCC-CCCeEecCCCCCceeecCCC--------------------CeEEecccCccccCC
Q 040898 160 LDWPARHRIARGIASGLEYLHMCH-RPRLIHRDIKPANVLIDDDM--------------------EARISDFGHGKLMPD 218 (337)
Q Consensus 160 ~~~~~~~~i~~~i~~~l~~l~~~h-~~gi~h~di~~~nil~~~~~--------------------~~~l~dfg~~~~~~~ 218 (337)
+++..++.++.||+.||.|| | +.|++||||||+||+++.++ .+||+|||++.....
T Consensus 158 ~~~~~~~~i~~qi~~aL~~l---H~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~ 234 (336)
T 2vuw_A 158 SSLATAKSILHQLTASLAVA---EASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD 234 (336)
T ss_dssp CCHHHHHHHHHHHHHHHHHH---HHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET
T ss_pred CCHHHHHHHHHHHHHHHHHH---HHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC
Confidence 89999999999999999999 5 67999999999999999887 899999999986543
Q ss_pred CCceeeeecccCCCCccCccccccCCCCCcccchhhhHH-HHHHHhCCCCCCCCCCCchhhhHHHHHH-hhhccCCcchh
Q 040898 219 GHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVL-LAVLVMGKFPVDDFFGHTEEMDMVKWMR-NVIFSENPNRA 296 (337)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i-~~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 296 (337)
. ...||+.|+|||++.+.. +.++||||++++ .+++++|..||.... ........+. .......
T Consensus 235 ~-------~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~---- 299 (336)
T 2vuw_A 235 G-------IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL---WLHYLTDKMLKQMTFKTK---- 299 (336)
T ss_dssp T-------EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH---HHHHHHHHHHHTCCCSSC----
T ss_pred C-------cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh---hhhHHHHhhhhhhccCcc----
Confidence 2 236999999999998776 889999998776 778888999973210 0000111111 1111111
Q ss_pred hhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhh-cC
Q 040898 297 INSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVR-SM 337 (337)
Q Consensus 297 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell-~~ 337 (337)
......+..+..+.+|+.+||+.| |+.|+| +|
T Consensus 300 ----~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 300 ----CNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp ----CCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred ----cchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcC
Confidence 111224466778999999999977 999999 77
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-32 Score=257.28 Aligned_cols=194 Identities=20% Similarity=0.130 Sum_probs=130.6
Q ss_pred ccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc-CCCCcccceeEE
Q 040898 50 GSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT-RHRNILPLLAHM 128 (337)
Q Consensus 50 g~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~ 128 (337)
+.|+.|.+..+.... .|+.+++|.+............+. +...+.+.+|+.+|+++ .|+||+++++++
T Consensus 243 ~~~~~~~h~~~rr~~--fg~~~~~K~~~~~~~~~~~~~~~~---------~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ 311 (569)
T 4azs_A 243 YAGAGLAHKRSRRYF--FGEDYVCKFFYYDMPHGILTAEES---------QRNKYELHNEIKFLTQPPAGFDAPAVLAHG 311 (569)
T ss_dssp C--------CCEEEE--ECSSEEEEEEESSCSTTCSCHHHH---------HHHHHHHHHHHHHHHSCCTTCCCCCEEEEE
T ss_pred ccCCccccccccccc--ccceeEEEEEecccccccchhhhh---------HHHHHHHHHHHHHHHhcCCCCCeeEEEEEE
Confidence 445555554444444 789999999976543211100000 11126789999999999 799999999999
Q ss_pred EcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCCeEEe
Q 040898 129 VRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARIS 208 (337)
Q Consensus 129 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~~l~ 208 (337)
++++..||||||++|++|.+++. .+++++.. .++.||+.||.|+ |++||+||||||+|||++.+|.+||+
T Consensus 312 ed~~~~yLVMEyv~G~~L~d~i~----~~~~l~~~---~I~~QIl~AL~yl---H~~GIIHRDIKPeNILL~~dg~vKL~ 381 (569)
T 4azs_A 312 ENAQSGWLVMEKLPGRLLSDMLA----AGEEIDRE---KILGSLLRSLAAL---EKQGFWHDDVRPWNVMVDARQHARLI 381 (569)
T ss_dssp ECSSEEEEEEECCCSEEHHHHHH----TTCCCCHH---HHHHHHHHHHHHH---HHTTCEESCCCGGGEEECTTSCEEEC
T ss_pred EECCEEEEEEecCCCCcHHHHHH----hCCCCCHH---HHHHHHHHHHHHH---HHCCceeccCchHhEEECCCCCEEEe
Confidence 99999999999999999999994 44556553 5889999999999 77899999999999999999999999
Q ss_pred cccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCC
Q 040898 209 DFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFP 267 (337)
Q Consensus 209 dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~p 267 (337)
|||+++....... .....+||+.|++||++.+. +..++|+||+|++.+++.++..|
T Consensus 382 DFGlAr~~~~~~~--~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 382 DFGSIVTTPQDCS--WPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp CCTTEESCC---C--CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred ecccCeeCCCCCc--cccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 9999987654322 12346799999999999765 56789999999998877665544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-27 Score=224.68 Aligned_cols=193 Identities=17% Similarity=0.137 Sum_probs=145.2
Q ss_pred cccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCccc
Q 040898 44 DSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILP 123 (337)
Q Consensus 44 ~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~ 123 (337)
...+.||+|+||.||++.. .+..+++|+...+........ . ....+.+.+|+.++++++||||+.
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~----~~~~~~~k~~~~~~~~~~~~~-~----------~~~~~~~~~E~~il~~l~h~nIv~ 403 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY----LDFDVIIKERVKKGYRDERLD-E----------NIRKSRTAREARYLALVKDFGIPA 403 (540)
T ss_dssp ---------CCEEEEEEEC----SSCEEEEEEECCCTTSCHHHH-H----------HHHHHHHHHHHHHHHHGGGGTCCC
T ss_pred CCCCEEeeCCCEEEEEEEE----CCCeEEEEEEecccccchhhh-h----------HHHHHHHHHHHHHHHhcCCCCcCc
Confidence 4567999999999998843 688899998765433221100 0 001157889999999999999997
Q ss_pred ceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCC
Q 040898 124 LLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDM 203 (337)
Q Consensus 124 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~ 203 (337)
+..++......|+||||+++++|.+++.. +..++.|++.+|.|| |++|++|+||||+||+++.
T Consensus 404 ~~~~~~~~~~~~lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~L---H~~gIiHrDiKp~NILl~~-- 466 (540)
T 3en9_A 404 PYIFDVDLDNKRIMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKL---HKNDVIHNDLTTSNFIFDK-- 466 (540)
T ss_dssp CCEEEEETTTTEEEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHH---HHTTEECTTCCTTSEEESS--
T ss_pred eEEEEEeCCccEEEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHH---HHCcCccCCCCHHHEEECC--
Confidence 77777777888999999999999999832 568999999999999 6679999999999999998
Q ss_pred CeEEecccCccccCCCCcee-----eeecccCCCCccCcccccc--CCCCCcccchhhhHHHHHHHhCCCCC
Q 040898 204 EARISDFGHGKLMPDGHAQI-----TVKCMVGTMGYMAPESLQT--ETISDKCDIYSFGVLLAVLVMGKFPV 268 (337)
Q Consensus 204 ~~~l~dfg~~~~~~~~~~~~-----~~~~~~~~~~~~~PE~~~~--~~~~~~~DiwslG~i~~~ll~g~~pf 268 (337)
.++|+|||++.......... ......||+.|+|||++.. ..|+..+|+|+...-..+-+.++.+|
T Consensus 467 ~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 467 DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 99999999998775432111 1124578999999999976 55778889999988888877777665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=9.2e-24 Score=183.07 Aligned_cols=164 Identities=14% Similarity=0.058 Sum_probs=116.7
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHH-HHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAE-LIKQDIDEYSDLLHWKIGAIRSEIITANQTR 117 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 117 (337)
....|.+.+.||+|+||.||++.+ . +|+.||+|.+.......... ...... ...........+.+|+.+++.++
T Consensus 88 ~~~~~~~~~~iG~G~~g~Vy~~~~-~--~g~~valK~~~~~~~~~~~~~~~~~~~--~~~w~~~~~~~~~~E~~~l~~l~ 162 (282)
T 1zar_A 88 SGKVDAIGKLMGEGKESAVFNCYS-E--KFGECVVKFHKVGHTSFKKVKEKRDYG--DLHFSVLAIRSARNEFRALQKLQ 162 (282)
T ss_dssp TTSCSEEEEEEEECSSEEEEEEEE-T--TTEEEEEEEECC------CCCC---------CHHHHHHHHHHHHHHHHHHTT
T ss_pred CCeEEEecCEeccCCCceEEEEEe-C--CCCEEEEEEEECCCCchhhhhhhhhhc--chhhHHHHHHHHHHHHHHHHhcc
Confidence 445566679999999999999988 4 89999999986543211000 000000 00000011257889999999999
Q ss_pred CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCce
Q 040898 118 HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANV 197 (337)
Q Consensus 118 hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ni 197 (337)
| +++.+++.. +..++||||+++++|.+ + . ......++.|++.|+.+| |+.|++|+||||+||
T Consensus 163 --~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l----~------~~~~~~i~~qi~~~l~~l---H~~giiHrDlkp~NI 224 (282)
T 1zar_A 163 --G-LAVPKVYAW-EGNAVLMELIDAKELYR-V----R------VENPDEVLDMILEEVAKF---YHRGIVHGDLSQYNV 224 (282)
T ss_dssp --T-SSSCCEEEE-ETTEEEEECCCCEEGGG-C----C------CSCHHHHHHHHHHHHHHH---HHTTEECSCCSTTSE
T ss_pred --C-CCcCeEEec-cceEEEEEecCCCcHHH-c----c------hhhHHHHHHHHHHHHHHH---HHCCCEeCCCCHHHE
Confidence 5 666665544 56699999999999987 4 1 123457999999999999 677999999999999
Q ss_pred eecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccc
Q 040898 198 LIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQ 241 (337)
Q Consensus 198 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~ 241 (337)
+++ ++.++|+|||++.. +..+.+||.+.
T Consensus 225 Ll~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~ 252 (282)
T 1zar_A 225 LVS-EEGIWIIDFPQSVE---------------VGEEGWREILE 252 (282)
T ss_dssp EEE-TTEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred EEE-CCcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence 999 99999999998753 23357888764
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=1.3e-19 Score=155.00 Aligned_cols=160 Identities=15% Similarity=0.182 Sum_probs=109.5
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCce--EEEEEecccCcchHHHHHHhhhh---hhh----hhhHHhHHhHHHH
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKM--IAIRKLIVDAPMSAAELIKQDID---EYS----DLLHWKIGAIRSE 109 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~--vavK~~~~~~~~~~~~~~~~~~~---~~~----~~~~~~~~~~~~e 109 (337)
...-|++.+.||+|+||.||++.+.. +|+. ||||++......... . ...+. ... .........+.+|
T Consensus 45 ~~~~~~i~~~ig~G~~g~Vy~a~~~~--~g~~~~vAvK~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~~~E 120 (258)
T 1zth_A 45 KGYITAMGGVISTGKEANVFYADGVF--DGKPVAMAVKIYRIETSEFDK-M-DEYLYGDERFDMRRISPKEKVFIWTEKE 120 (258)
T ss_dssp TTSEEEEEEEEEECSSEEEEEEEEEE--TTEEEEEEEEEECCC---------GGGTTTCTTSCC----CHHHHHHHHHHH
T ss_pred CCCchhhCCEEeecceEEEEEEEEcC--CCcEeeEEEEEEECCccchhh-H-HHhhcccchhhhhccChHHHHHHHHHHH
Confidence 33447889999999999999998855 7888 999987554211000 0 00000 000 0000111467889
Q ss_pred HHHHHhcCCCCcccceeEEEcCCeeEEEEEeccC-C----CHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCC-
Q 040898 110 IITANQTRHRNILPLLAHMVRPNCHLLVYEFMKN-G----SLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCH- 183 (337)
Q Consensus 110 ~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h- 183 (337)
+..+..+.|+++....-+.. ...++||||+.+ | +|.+.... .++..+..++.|++.++.++ |
T Consensus 121 ~~~l~~l~~~~i~~p~~~~~--~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~l---H~ 188 (258)
T 1zth_A 121 FRNLERAKEAGVSVPQPYTY--MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRL---YQ 188 (258)
T ss_dssp HHHHHHHHHTTCCCCCEEEE--ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHH---HH
T ss_pred HHHHHHHHhCCCCCCeEEEc--CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHH---HH
Confidence 99999998886533222222 356899999942 3 67766421 23456788999999999999 6
Q ss_pred CCCeEecCCCCCceeecCCCCeEEecccCcccc
Q 040898 184 RPRLIHRDIKPANVLIDDDMEARISDFGHGKLM 216 (337)
Q Consensus 184 ~~gi~h~di~~~nil~~~~~~~~l~dfg~~~~~ 216 (337)
+.|++|+||+|+||+++. .++|+|||++...
T Consensus 189 ~~givHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 189 EAELVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TSCEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred HCCEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 779999999999999998 8999999998653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.69 E-value=3.9e-17 Score=145.52 Aligned_cols=162 Identities=15% Similarity=0.127 Sum_probs=103.2
Q ss_pred cccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHH-HHHHhhhhhhhhhh--HHhHHhHHHHHHHHH
Q 040898 38 KKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAA-ELIKQDIDEYSDLL--HWKIGAIRSEIITAN 114 (337)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~~~~~~~~~--~~~~~~~~~e~~~l~ 114 (337)
+...-|.++++||+|++|.||++.+. +|+.||||++......... .............. ...--...+|...+.
T Consensus 92 ~rg~iY~I~~~IG~Gk~a~VY~a~d~---~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~ 168 (397)
T 4gyi_A 92 ARKDVYSVGSRIGVGKESDIMIVADE---KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMK 168 (397)
T ss_dssp HTTSCSEEEEEEEECSSEEEEEEECT---TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred HCCCEEEecCEeeeCCceEEEEEECC---CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHH
Confidence 34555999999999999999998874 7999999987643211000 00000000000000 000012345677777
Q ss_pred hcCCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCC
Q 040898 115 QTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKP 194 (337)
Q Consensus 115 ~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~ 194 (337)
++.++++.-..-+... ..++||||++|++|..+. .......++.|++.++.++ |+.|++||||||
T Consensus 169 rL~~~gv~vp~p~~~~--~~~LVME~i~G~~L~~l~----------~~~~~~~l~~qll~~l~~l---H~~gIVHrDLKp 233 (397)
T 4gyi_A 169 ALYEEGFPVPEPIAQS--RHTIVMSLVDALPMRQVS----------SVPDPASLYADLIALILRL---AKHGLIHGDFNE 233 (397)
T ss_dssp HHHHTTCSCCCEEEEE--TTEEEEECCSCEEGGGCC----------CCSCHHHHHHHHHHHHHHH---HHTTEECSCCST
T ss_pred HHHhcCCCCCeeeecc--CceEEEEecCCccHhhhc----------ccHHHHHHHHHHHHHHHHH---HHCCCcCCCCCH
Confidence 7755444322222222 347999999998775432 1123467889999999999 566999999999
Q ss_pred CceeecCCC----------CeEEecccCccccC
Q 040898 195 ANVLIDDDM----------EARISDFGHGKLMP 217 (337)
Q Consensus 195 ~nil~~~~~----------~~~l~dfg~~~~~~ 217 (337)
.|||++.++ .+.|+||+.+....
T Consensus 234 ~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 234 FNILIREEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp TSEEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred HHEEEeCCCCcccccccccceEEEEeCCcccCC
Confidence 999998776 38999999765543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=1.2e-12 Score=111.88 Aligned_cols=142 Identities=11% Similarity=0.068 Sum_probs=108.6
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC-CC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR-HR 119 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp 119 (337)
+.|++...++.|+.+.||++.. .++.+++|.......... ..+.+|..+++.+. +.
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~----~~~~~vlK~~~~~~~~~~-------------------~~~~~E~~~l~~l~~~~ 70 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG----ENENLYLKMTDSRYKGTT-------------------YDVEREKDMMLWLEGKL 70 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC----SSCEEEEEEECGGGTTST-------------------TCHHHHHHHHHHHTTTS
T ss_pred ccceeEeeccCCCCCeEEEEEC----CCCcEEEEeCCcccCCCH-------------------HHHHHHHHHHHHHhcCC
Confidence 4588999999999999998764 578899998864321110 35677888888884 67
Q ss_pred CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhC-----------------
Q 040898 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMC----------------- 182 (337)
Q Consensus 120 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~----------------- 182 (337)
.+.+++++..+.+..|+|||+++|.+|.+.+ . +......++.+++.++..||..
T Consensus 71 ~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~----~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~ 141 (263)
T 3tm0_A 71 PVPKVLHFERHDGWSNLLMSEADGVLCSEEY----E-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAE 141 (263)
T ss_dssp CCCCEEEEEEETTEEEEEEECCSSEEHHHHC----C-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHH
T ss_pred CCCeEEEEEecCCceEEEEEecCCeehhhcc----C-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHH
Confidence 7888999988888999999999999988753 1 1223457788899999999861
Q ss_pred ---------------------------------------CCCCeEecCCCCCceeecCCCCeEEecccCcc
Q 040898 183 ---------------------------------------HRPRLIHRDIKPANVLIDDDMEARISDFGHGK 214 (337)
Q Consensus 183 ---------------------------------------h~~gi~h~di~~~nil~~~~~~~~l~dfg~~~ 214 (337)
...+++|+|++|.||++++++.+.|+||+.+.
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 142 LDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 11459999999999999876556799998653
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.12 E-value=4.2e-10 Score=95.64 Aligned_cols=138 Identities=13% Similarity=0.092 Sum_probs=93.6
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
-..+.+....+.|+.+.||++.. .+|..+++|....... ..+.+|..+++.+.+.
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~---~~g~~~vlK~~~~~~~----------------------~~~~~E~~~l~~l~~~ 73 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSA---QGRPVLFVKTDLSGAL----------------------NELQDEAARLSWLATT 73 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEEC---TTSCCEEEEEECSCTT----------------------SCHHHHHHHHHHHHTT
T ss_pred cCCCceEecccCCCCceEEEEec---CCCCeEEEEeCCcccc----------------------hhhhHHHHHHHHHHhC
Confidence 34455544445666799998754 2677899998654311 3456688888877543
Q ss_pred C--cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCC--------------
Q 040898 120 N--ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCH-------------- 183 (337)
Q Consensus 120 n--iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h-------------- 183 (337)
+ +.+++.+...++..++||||++|.+|. . .. . ....++.+++..+..||...
T Consensus 74 ~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~----~~---~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~ 141 (264)
T 1nd4_A 74 GVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--S----SH---L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRI 141 (264)
T ss_dssp TCCBCCEEEEEECSSCEEEEEECCSSEETT--T----SC---C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHH
T ss_pred CCCCCeEEEeccCCCCCEEEEEecCCcccC--c----Cc---C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHH
Confidence 3 566888888878889999999998773 2 11 1 12245566666666665321
Q ss_pred -----------------------------------------CCCeEecCCCCCceeecCCCCeEEecccCcc
Q 040898 184 -----------------------------------------RPRLIHRDIKPANVLIDDDMEARISDFGHGK 214 (337)
Q Consensus 184 -----------------------------------------~~gi~h~di~~~nil~~~~~~~~l~dfg~~~ 214 (337)
..+++|+|++|.||++++++.+.|+||+.+.
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 142 ERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1239999999999999876666799999754
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.08 E-value=3.8e-10 Score=100.85 Aligned_cols=145 Identities=15% Similarity=0.167 Sum_probs=103.2
Q ss_pred ccccceeccCcceEEEEeEEecCCCCceEEEEEec--ccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC--C
Q 040898 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLI--VDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR--H 118 (337)
Q Consensus 43 y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h 118 (337)
....+.|+.|.++.||++.. .+..+++|+.. ........ ..+.+|..+++.+. +
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~----~~~~~vlr~~~~p~~~~~~~~------------------~~~~~E~~~l~~L~~~~ 97 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVT----PGQTYVMRAKPGPKSKLLPSA------------------HAIEREYRVMDALAGTD 97 (359)
T ss_dssp CCEEEECCC-CCSCEEEEEC----SSCEEEEECCCC----------------------------CHHHHHHHHHHHTTSS
T ss_pred CceEEEcCCcccceEEEEEE----CCceEEEEeCCCCCCCCCCcH------------------HHHHHHHHHHHHhhcCC
Confidence 44578899999999998765 45678888765 22111110 45677888888886 3
Q ss_pred CCcccceeEEEcC---CeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCC------------
Q 040898 119 RNILPLLAHMVRP---NCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCH------------ 183 (337)
Q Consensus 119 pniv~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h------------ 183 (337)
..+.+++.++.+. +..|+||||++|..+.+. .-..++......++.+++..|..||...
T Consensus 98 vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~------~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~ 171 (359)
T 3dxp_A 98 VPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQ------SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKP 171 (359)
T ss_dssp SCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCT------TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCC
T ss_pred CCCCcEEEECCCCCccCCeEEEEEecCCeecCCC------ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCC
Confidence 4577888877766 458999999998766431 1123567777888999999999998631
Q ss_pred -------------------------------------------CCCeEecCCCCCceeecCCCC--eEEecccCccc
Q 040898 184 -------------------------------------------RPRLIHRDIKPANVLIDDDME--ARISDFGHGKL 215 (337)
Q Consensus 184 -------------------------------------------~~gi~h~di~~~nil~~~~~~--~~l~dfg~~~~ 215 (337)
..+++|+|+++.||+++.++. +.|+||+.+..
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 172 GNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp SCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 257999999999999997653 58999998754
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.74 E-value=6.3e-09 Score=90.67 Aligned_cols=184 Identities=16% Similarity=0.174 Sum_probs=111.6
Q ss_pred ccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc-CCCC--c
Q 040898 45 SLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT-RHRN--I 121 (337)
Q Consensus 45 ~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~hpn--i 121 (337)
.++.++.|....||.+. ..+++|..... .. ...+.+|...++.+ .+.. +
T Consensus 24 ~i~~~~~G~~n~v~~v~-------~~~vlR~~~~~---~~------------------~~~~~~E~~~l~~l~~~~~v~v 75 (304)
T 3sg8_A 24 TIEISGEGNDCIAYEIN-------RDFIFKFPKHS---RG------------------STNLFNEVNILKRIHNKLPLPI 75 (304)
T ss_dssp CCCEEEECSSEEEEEST-------TSEEEEEESSH---HH------------------HHHHHHHHHHHHHHTTSSSSCC
T ss_pred eeEecCCCCcceEEEEC-------CEEEEEecCCc---ch------------------HHHHHHHHHHHHHHHhcCCCCC
Confidence 34568999999998742 46888875322 00 14677788888887 3333 3
Q ss_pred ccceeEEEcCC---eeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhC----------------
Q 040898 122 LPLLAHMVRPN---CHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMC---------------- 182 (337)
Q Consensus 122 v~~~~~~~~~~---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~---------------- 182 (337)
.+.+....... ..|+||++++|.+|.+... ..++......++.+++..+..||..
T Consensus 76 P~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~ 149 (304)
T 3sg8_A 76 PEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREK 149 (304)
T ss_dssp CCEEEECCCCSSCSCSCEEEECCCCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHH
T ss_pred CceEeecCCCCCCCcceEEEcccCCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHH
Confidence 34444333332 3489999999987765321 1244555566666666666666531
Q ss_pred ---------------------------------------CCCCeEecCCCCCceeecC--CCCeEEecccCccccCCCCc
Q 040898 183 ---------------------------------------HRPRLIHRDIKPANVLIDD--DMEARISDFGHGKLMPDGHA 221 (337)
Q Consensus 183 ---------------------------------------h~~gi~h~di~~~nil~~~--~~~~~l~dfg~~~~~~~~~~ 221 (337)
....++|+|++|.||++++ ...+.++||+.+..-....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~- 228 (304)
T 3sg8_A 150 INEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN- 228 (304)
T ss_dssp HHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH-
T ss_pred HHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH-
Confidence 1245899999999999998 4567899999875432110
Q ss_pred eeeeecccCCCCc---cCccccc----cCC----------CCCcccchhhhHHHHHHHhCCCCC
Q 040898 222 QITVKCMVGTMGY---MAPESLQ----TET----------ISDKCDIYSFGVLLAVLVMGKFPV 268 (337)
Q Consensus 222 ~~~~~~~~~~~~~---~~PE~~~----~~~----------~~~~~DiwslG~i~~~ll~g~~pf 268 (337)
.. ...... ..|+... ... .....+.|+++.++|.+.+|..+|
T Consensus 229 Dl-----~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 229 DF-----ISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HH-----HTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HH-----HHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 00 000011 1222211 000 011258999999999999998775
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.63 E-value=3.4e-07 Score=78.08 Aligned_cols=135 Identities=16% Similarity=0.164 Sum_probs=90.8
Q ss_pred eeccCcce-EEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC-CCCcccce
Q 040898 48 KIGSGGWG-EVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR-HRNILPLL 125 (337)
Q Consensus 48 ~lg~G~~g-~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~ 125 (337)
.+..|..| .||...... .+..+++|+-.... . ..+.+|...++.+. +--+.+++
T Consensus 31 ~~~~G~S~~~v~rl~~~~--~~~~~~lk~~~~~~---~-------------------~~~~~E~~~l~~l~~~vPVP~v~ 86 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKP--NAPELFLKHGKGSV---A-------------------NDVTDEMVRLNWLTAFMPLPTIK 86 (272)
T ss_dssp EEECSSSSCEEEEEECCT--TCCCEEEEEEETHH---H-------------------HHHHHHHHHHHHHTTTSCCCCEE
T ss_pred EccCCCcCCeEEEEEecC--CCeEEEEEECCCCC---H-------------------hHHHHHHHHHHHhccCCCcCeEE
Confidence 44455555 688766543 56788899754221 0 34566888887773 22367788
Q ss_pred eEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhC-----------------------
Q 040898 126 AHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMC----------------------- 182 (337)
Q Consensus 126 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~----------------------- 182 (337)
.++.+++..++|||+++|.++.+.... .......+..++...|..||..
T Consensus 87 ~~~~~~~~~~lvme~l~G~~~~~~~~~--------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (272)
T 4gkh_A 87 HFIRTPDDAWLLTTAIPGKTAFQVLEE--------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMN 158 (272)
T ss_dssp EEEEETTEEEEEEECCCSEEHHHHHHH--------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHH
T ss_pred EEEEECCeEEEEEEeeCCccccccccC--------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHH
Confidence 888888999999999999888776532 1122334555566666666532
Q ss_pred --------------------------------CCCCeEecCCCCCceeecCCCCeEEecccCcc
Q 040898 183 --------------------------------HRPRLIHRDIKPANVLIDDDMEARISDFGHGK 214 (337)
Q Consensus 183 --------------------------------h~~gi~h~di~~~nil~~~~~~~~l~dfg~~~ 214 (337)
+...++|+|+++.||++++++.+-|+||+.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 159 NGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp TTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 01137999999999999987767799999764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.39 E-value=5.7e-06 Score=71.94 Aligned_cols=137 Identities=20% Similarity=0.177 Sum_probs=85.4
Q ss_pred ccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC---Cc
Q 040898 45 SLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR---NI 121 (337)
Q Consensus 45 ~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp---ni 121 (337)
..+.++.|....||.+ +..+++|+.... .. ...+.+|..+++.+.+. .+
T Consensus 23 ~v~~l~~G~~n~v~~v-------g~~~VlR~~~~~---~~------------------~~~~~~E~~~L~~L~~~~~v~V 74 (306)
T 3tdw_A 23 SVESLGEGFRNYAILV-------NGDWVFRFPKSQ---QG------------------ADELNKEIQLLPLLVGCVKVNI 74 (306)
T ss_dssp CEEEEEECSSEEEEEE-------TTTEEEEEESSH---HH------------------HHHHHHHHHHHHHHTTTCSSBC
T ss_pred eeeecCCCcceeEEEE-------CCEEEEEecCCc---hH------------------HHHHHHHHHHHHHHHhcCCCCC
Confidence 3566888999999875 456888874211 00 14677899999988642 35
Q ss_pred ccceeEEE-cCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhC------------------
Q 040898 122 LPLLAHMV-RPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMC------------------ 182 (337)
Q Consensus 122 v~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~------------------ 182 (337)
.+.+.+.. ..+..+++|++++|.++.+.... .++......++.++...|..||+.
T Consensus 75 P~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~~------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~ 148 (306)
T 3tdw_A 75 PQYVYIGKRSDGNPFVGYRKVQGQILGEDGMA------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNK 148 (306)
T ss_dssp CCEEEEEECTTSCEEEEEECCCSEECHHHHHT------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHH
T ss_pred CCeEeecccCCCceEEEEeccCCeECchhhhh------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHH
Confidence 56666553 44567899999999877653110 012222222233333333332221
Q ss_pred ---------------------------------------CCCCeEecCCCCCceeecC---CCCe-EEecccCccc
Q 040898 183 ---------------------------------------HRPRLIHRDIKPANVLIDD---DMEA-RISDFGHGKL 215 (337)
Q Consensus 183 ---------------------------------------h~~gi~h~di~~~nil~~~---~~~~-~l~dfg~~~~ 215 (337)
....++|+|++|.||+++. ++.+ .|+||+.+..
T Consensus 149 ~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 149 ILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3446899999999999987 4555 7999997653
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.18 E-value=2.9e-06 Score=75.41 Aligned_cols=85 Identities=4% Similarity=-0.077 Sum_probs=50.9
Q ss_pred ccccee-ccCcceEEEEeEEecCC----CCceEEEEEecccCc--chHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc
Q 040898 44 DSLKKI-GSGGWGEVFYKAELPGS----NGKMIAIRKLIVDAP--MSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT 116 (337)
Q Consensus 44 ~~~~~l-g~G~~g~V~~~~~~~~~----~~~~vavK~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 116 (337)
...+.| +.|....+|++...... ++..+++|....... .... ..+.+|..+++.+
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~------------------~~~~~E~~~l~~L 84 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPT------------------YRLDHQFEVIRLV 84 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSC------------------CCHHHHHHHHHHH
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCch------------------hHHHHHHHHHHHH
Confidence 345678 88889999977552000 166788887643220 0000 2345566666666
Q ss_pred C-C--CCcccceeEEEcC---CeeEEEEEeccCCCH
Q 040898 117 R-H--RNILPLLAHMVRP---NCHLLVYEFMKNGSL 146 (337)
Q Consensus 117 ~-h--pniv~~~~~~~~~---~~~~lv~e~~~~~~L 146 (337)
. + -.+.+++.+..+. ...++|||+++|.++
T Consensus 85 ~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 85 GELTDVPVPRVRWIETTGDVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp HHHCCSCCCCEEEEECSSTTTSSCEEEEECCCCBCC
T ss_pred hhcCCCCCCcEEEEccCCCccCCceEEEEecCCCCh
Confidence 3 2 3466677766554 356899999988554
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.03 E-value=2.4e-05 Score=68.82 Aligned_cols=31 Identities=23% Similarity=0.422 Sum_probs=27.7
Q ss_pred CCCeEecCCCCCceeecCCCCeEEecccCcc
Q 040898 184 RPRLIHRDIKPANVLIDDDMEARISDFGHGK 214 (337)
Q Consensus 184 ~~gi~h~di~~~nil~~~~~~~~l~dfg~~~ 214 (337)
..+++|+|+++.||+++.++.+.++||+.+.
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp SCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred cCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 5789999999999999888899999999654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.02 E-value=1.7e-05 Score=71.45 Aligned_cols=84 Identities=14% Similarity=0.146 Sum_probs=47.2
Q ss_pred ccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC--C-Cc
Q 040898 45 SLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH--R-NI 121 (337)
Q Consensus 45 ~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--p-ni 121 (337)
..+.||.|..+.||++.... +++.+++|............. . ...+.+..|..+++.+.. | .+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~--~~~~~vvK~~~~~~r~~~~~~---~---------~~~~r~~~E~~~L~~l~~~~~~~v 99 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQE--HDRALIIKQAVPYAKVVGESW---P---------LTIDRARIESSALIRQGEHVPHLV 99 (397)
T ss_dssp EEEECCSSSSEEEEEEEC------CEEEEEEECCC-------C---C---------CCTTHHHHHHHHHHHHHTTCGGGS
T ss_pred EEEECCCCceEEEEEEEECC--CCcEEEEEecchhhcccCCCC---c---------CcHHHHHHHHHHHHHhhhhCCCCc
Confidence 46789999999999886543 567899998653221000000 0 000345567777776632 3 33
Q ss_pred ccceeEEEcCCeeEEEEEeccCC
Q 040898 122 LPLLAHMVRPNCHLLVYEFMKNG 144 (337)
Q Consensus 122 v~~~~~~~~~~~~~lv~e~~~~~ 144 (337)
.+++.+ +....++|||++++.
T Consensus 100 P~~~~~--d~~~~~lvmE~l~g~ 120 (397)
T 2olc_A 100 PRVFYS--DTEMAVTVMEDLSHL 120 (397)
T ss_dssp CCEEEE--ETTTTEEEECCCTTS
T ss_pred CeEEEE--cCCccEEEEEeCCCc
Confidence 445443 344568999999763
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.96 E-value=7e-05 Score=65.06 Aligned_cols=78 Identities=12% Similarity=0.077 Sum_probs=57.7
Q ss_pred ccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC---CC
Q 040898 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR---HR 119 (337)
Q Consensus 43 y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~---hp 119 (337)
..-.+.|+.|....+|++.. ++..+++|+..... . ..+.+|...|+.|. ..
T Consensus 38 i~~~~~l~gG~~n~~y~v~~----~~~~~vlK~~~~~~----~------------------~~~~~E~~~L~~L~~~~~v 91 (312)
T 3jr1_A 38 IKHKEKLYSGEMNEIWLIND----EVQTVFVKINERSY----R------------------SMFRAEADQLALLAKTNSI 91 (312)
T ss_dssp CCEEEEECCSSSSEEEEEES----SSCEEEEEEEEGGG----H------------------HHHHHHHHHHHHHHHTTSS
T ss_pred eeeeEEeCCccceeeeEEEE----CCCeEEEEeCCccc----H------------------HHHHHHHHHHHHHHhhCCC
Confidence 34567899999999998765 56788898765321 0 45666777777762 35
Q ss_pred CcccceeEEEcCCeeEEEEEeccCCCH
Q 040898 120 NILPLLAHMVRPNCHLLVYEFMKNGSL 146 (337)
Q Consensus 120 niv~~~~~~~~~~~~~lv~e~~~~~~L 146 (337)
.+.+++.+....+..++|||++++..+
T Consensus 92 ~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 92 NVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp BCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred CcceEEEEeecCCceEEEEEeccCCCC
Confidence 678888888878889999999998653
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.76 E-value=5.7e-05 Score=61.03 Aligned_cols=103 Identities=15% Similarity=0.049 Sum_probs=66.7
Q ss_pred CCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCCeEEecccCccccCCCCcee
Q 040898 144 GSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQI 223 (337)
Q Consensus 144 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 223 (337)
.||.+.|.. .+.++++.++|.++.|.+.+|.-.-.. ... ...=+.|..|++..+|.|.+.+ ..+.
T Consensus 33 vSL~eIL~~---~~~PlsEEqaWALc~Qc~~~L~~~~~~-~~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 33 LSLEEILRL---YNQPINEEQAWAVCYQCCGSLRAAARR-RQP-RHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT-TCC-CCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred ccHHHHHHH---cCCCcCHHHHHHHHHHHHHHHHhhhhc-ccC-CceecCCcceEEecCCceeccc-cccc---------
Confidence 479999865 567899999999999999998776210 111 1333456889999999888774 1110
Q ss_pred eeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCC
Q 040898 224 TVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFP 267 (337)
Q Consensus 224 ~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~p 267 (337)
.....+.|||... ...+.+.=|||||+++|..+--..|
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1223356888763 2345677899999999998876555
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.57 E-value=0.00056 Score=58.59 Aligned_cols=78 Identities=14% Similarity=0.184 Sum_probs=52.3
Q ss_pred cccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC--
Q 040898 42 CFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR-- 119 (337)
Q Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp-- 119 (337)
...-.+.+|.|..+.||++... +|+.|++|+......... ..+.+|...|+.|...
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~---DG~~~~vK~~~~~~~~~~-------------------~~~~~Ea~~L~~L~~~~~ 73 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELA---DGTPLFVKALPDDAPALD-------------------GLFRAEALGLDWLGRSFG 73 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEET---TSCEEEEEECCTTCCCCT-------------------THHHHHHHHHHHHTCSTT
T ss_pred CeEEEEecCCCCCeEEEEEEEC---CCCEEEEEEeCCCCcchh-------------------hHHHHHHHHHHHHHhhCC
Confidence 4566788999999999987653 789999998654432211 3466788888877422
Q ss_pred -CcccceeEEEcCCeeEEEEEeccCCC
Q 040898 120 -NILPLLAHMVRPNCHLLVYEFMKNGS 145 (337)
Q Consensus 120 -niv~~~~~~~~~~~~~lv~e~~~~~~ 145 (337)
.+.+.+++ . ..++|||+++++.
T Consensus 74 vpvP~v~~~--~--~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 74 SPVPQVAGW--D--DRTLAMEWVDERP 96 (288)
T ss_dssp CCSCCEEEE--E--TTEEEEECCCCCC
T ss_pred CCcceEEec--c--CceEEEEeecccC
Confidence 23444443 2 2478999997654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.57 E-value=0.00025 Score=64.33 Aligned_cols=32 Identities=22% Similarity=0.374 Sum_probs=28.0
Q ss_pred CCCCeEecCCCCCceeecCCCCeEEecccCccc
Q 040898 183 HRPRLIHRDIKPANVLIDDDMEARISDFGHGKL 215 (337)
Q Consensus 183 h~~gi~h~di~~~nil~~~~~~~~l~dfg~~~~ 215 (337)
+...++|+|+++.||+++.++ +.++||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 467899999999999998776 99999987764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00075 Score=58.17 Aligned_cols=31 Identities=23% Similarity=0.151 Sum_probs=25.8
Q ss_pred CCCeEecCCCCCceeecCCCCeEEecccCccc
Q 040898 184 RPRLIHRDIKPANVLIDDDMEARISDFGHGKL 215 (337)
Q Consensus 184 ~~gi~h~di~~~nil~~~~~~~~l~dfg~~~~ 215 (337)
...++|+|+.+.||+ ..++.+.++||..+..
T Consensus 172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 172 PLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred CceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 456899999999999 5567889999987653
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.39 E-value=0.00095 Score=58.38 Aligned_cols=33 Identities=27% Similarity=0.413 Sum_probs=27.9
Q ss_pred CCCCeEecCCCCCceeecCC----CCeEEecccCccc
Q 040898 183 HRPRLIHRDIKPANVLIDDD----MEARISDFGHGKL 215 (337)
Q Consensus 183 h~~gi~h~di~~~nil~~~~----~~~~l~dfg~~~~ 215 (337)
+..+++|+|+++.||+++.+ +.+.++||+.+..
T Consensus 181 ~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 181 GDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp SCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 35689999999999999874 6789999997654
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.19 E-value=0.0045 Score=53.68 Aligned_cols=31 Identities=26% Similarity=0.280 Sum_probs=26.2
Q ss_pred CCCeEecCCCCCceeecCCCCeEEecccCcc
Q 040898 184 RPRLIHRDIKPANVLIDDDMEARISDFGHGK 214 (337)
Q Consensus 184 ~~gi~h~di~~~nil~~~~~~~~l~dfg~~~ 214 (337)
..+++|+|+++.||++++++.+.++||+.+.
T Consensus 186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 186 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 4579999999999999987656899998654
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.96 E-value=0.012 Score=51.04 Aligned_cols=29 Identities=21% Similarity=0.325 Sum_probs=25.0
Q ss_pred CCCeEecCCCCCceeecCCCCeEEecccCcc
Q 040898 184 RPRLIHRDIKPANVLIDDDMEARISDFGHGK 214 (337)
Q Consensus 184 ~~gi~h~di~~~nil~~~~~~~~l~dfg~~~ 214 (337)
...++|+|+++.||+++ + .+.++||+.+.
T Consensus 194 ~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 194 TVLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp CCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred CeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 45689999999999999 4 89999998654
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.80 E-value=0.0071 Score=54.89 Aligned_cols=74 Identities=11% Similarity=0.102 Sum_probs=43.7
Q ss_pred ccceeccCcceEEEEeEEecC-----CCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 45 SLKKIGSGGWGEVFYKAELPG-----SNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 45 ~~~~lg~G~~g~V~~~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
-.+.|+.|....||++..... ..+..+++|+...... . +.+.+|..+++.+...
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~-------------------~~li~E~~~l~~L~~~ 135 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--E-------------------SHLVAESVIFTLLSER 135 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--H-------------------HHHHHHHHHHHHHHHT
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--H-------------------HHHHHHHHHHHHHHhC
Confidence 456788898999998765310 1257888888743211 0 1222466666666322
Q ss_pred Cc-ccceeEEEcCCeeEEEEEeccC
Q 040898 120 NI-LPLLAHMVRPNCHLLVYEFMKN 143 (337)
Q Consensus 120 ni-v~~~~~~~~~~~~~lv~e~~~~ 143 (337)
++ .++++.+.+ .+|+||++|
T Consensus 136 g~~P~l~~~~~~----g~v~e~l~G 156 (429)
T 1nw1_A 136 HLGPKLYGIFSG----GRLEEYIPS 156 (429)
T ss_dssp TSSSCEEEEETT----EEEECCCCE
T ss_pred CCCCcEEEEeCC----CEEEEEeCC
Confidence 33 455655432 288999876
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.69 E-value=0.0076 Score=53.66 Aligned_cols=145 Identities=12% Similarity=0.097 Sum_probs=75.3
Q ss_pred cceeccCcceEEEEeEEec-----CCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC-CC
Q 040898 46 LKKIGSGGWGEVFYKAELP-----GSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR-HR 119 (337)
Q Consensus 46 ~~~lg~G~~g~V~~~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp 119 (337)
.+.|..|-...+|++.... ..++..+++|+.-.... .. ....+|..+++.+. +.
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~-~~-------------------~~~~rE~~vl~~L~~~g 114 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQ-GV-------------------DSLVLESVMFAILAERS 114 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---C-CH-------------------HHHHHHHHHHHHHHHTT
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccc-hH-------------------HHHHHHHHHHHHHHhcC
Confidence 4677778888888876531 11347888888532111 11 23446777777663 22
Q ss_pred CcccceeEEEcCCeeEEEEEeccCCCHH--------------HHHHHhcCC----cccCC--hHHHHHHHHHHHH-----
Q 040898 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQ--------------DILYDVSQG----RRELD--WPARHRIARGIAS----- 174 (337)
Q Consensus 120 niv~~~~~~~~~~~~~lv~e~~~~~~L~--------------~~l~~~~~~----~~~~~--~~~~~~i~~~i~~----- 174 (337)
-..++++.+.+ .+|+||++|.+|. +.+...-.. ..... +..+..+..++-.
T Consensus 115 v~P~ll~~~~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~ 190 (379)
T 3feg_A 115 LGPQLYGVFPE----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTG 190 (379)
T ss_dssp SSCCEEEEETT----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCS
T ss_pred CCCeEEEEcCC----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcc
Confidence 23455655443 2899999874432 111111111 11111 2333444433311
Q ss_pred --------------HHHH----Hhh-CCCCCeEecCCCCCceeecCC----CCeEEecccCcc
Q 040898 175 --------------GLEY----LHM-CHRPRLIHRDIKPANVLIDDD----MEARISDFGHGK 214 (337)
Q Consensus 175 --------------~l~~----l~~-~h~~gi~h~di~~~nil~~~~----~~~~l~dfg~~~ 214 (337)
.+.. |.. .....++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 191 ~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 191 LPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp CCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred cchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 1111 211 123569999999999999876 789999999764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.60 E-value=0.024 Score=51.75 Aligned_cols=74 Identities=15% Similarity=0.043 Sum_probs=43.4
Q ss_pred ccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCc-cc
Q 040898 45 SLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNI-LP 123 (337)
Q Consensus 45 ~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpni-v~ 123 (337)
-++.|+.|-...+|++.... .+..+++|+........ ..-.+|..+++.|...++ .+
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~--~~~~~vLRi~g~~~~~~--------------------idR~~E~~vl~~L~~~gl~P~ 169 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMS--KQAKYLIRLYGPKTDEI--------------------INREREKKISCILYNKNIAKK 169 (458)
T ss_dssp EEEEECC--CEEEEEEEETT--TTEEEEEEEECC-CCSC--------------------SCHHHHHHHHHHHTTSSSBCC
T ss_pred EEEEcCCCeEeEEEEEEECC--CCceEEEEECCCChhhh--------------------cCHHHHHHHHHHHHhcCCCCC
Confidence 35678888889999876621 24788888764321100 011357777777754444 45
Q ss_pred ceeEEEcCCeeEEEEEeccCC
Q 040898 124 LLAHMVRPNCHLLVYEFMKNG 144 (337)
Q Consensus 124 ~~~~~~~~~~~~lv~e~~~~~ 144 (337)
+++.+. + ..|+||++|.
T Consensus 170 ll~~~~--~--G~v~e~I~G~ 186 (458)
T 2qg7_A 170 IYVFFT--N--GRIEEFMDGY 186 (458)
T ss_dssp EEEEET--T--EEEEECCCSE
T ss_pred EEEEeC--C--eEEEEeeCCc
Confidence 666552 2 2599999873
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.42 E-value=0.053 Score=47.38 Aligned_cols=32 Identities=31% Similarity=0.452 Sum_probs=27.6
Q ss_pred CCCeEecCCCCCceeecCCCCeEEecccCccc
Q 040898 184 RPRLIHRDIKPANVLIDDDMEARISDFGHGKL 215 (337)
Q Consensus 184 ~~gi~h~di~~~nil~~~~~~~~l~dfg~~~~ 215 (337)
..+++|+|+.+.||+++.++.+.++||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 35799999999999999888899999986543
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.31 E-value=0.014 Score=51.72 Aligned_cols=30 Identities=20% Similarity=0.355 Sum_probs=24.7
Q ss_pred CCCeEecCCCCCceeecCCCCeEEecccCcc
Q 040898 184 RPRLIHRDIKPANVLIDDDMEARISDFGHGK 214 (337)
Q Consensus 184 ~~gi~h~di~~~nil~~~~~~~~l~dfg~~~ 214 (337)
..+++|+|+.+.||++++++ +.++||..+.
T Consensus 211 ~~~l~HgDl~~~Nil~~~~~-~~lID~e~a~ 240 (369)
T 3c5i_A 211 TIVFCHNDLQENNIINTNKC-LRLIDFEYSG 240 (369)
T ss_dssp CEEEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred CeEEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence 35699999999999998654 8999998764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.57 E-value=0.19 Score=45.26 Aligned_cols=30 Identities=20% Similarity=0.398 Sum_probs=26.2
Q ss_pred CCeEecCCCCCceeecCCCCeEEecccCccc
Q 040898 185 PRLIHRDIKPANVLIDDDMEARISDFGHGKL 215 (337)
Q Consensus 185 ~gi~h~di~~~nil~~~~~~~~l~dfg~~~~ 215 (337)
..++|+|+.+.||+ +.++.+.++||..+..
T Consensus 262 ~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 262 LVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp EEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred ceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 46899999999999 7788999999997653
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=87.67 E-value=0.77 Score=36.92 Aligned_cols=115 Identities=11% Similarity=0.116 Sum_probs=77.1
Q ss_pred CCCCcccceeEEEcCCeeEEEEEeccCC-CHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCC
Q 040898 117 RHRNILPLLAHMVRPNCHLLVYEFMKNG-SLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPA 195 (337)
Q Consensus 117 ~hpniv~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ 195 (337)
.||+.+.. .+-.+.+.+.+.++.-+.+ ++.. -...+....+.++.+|+....++ ..-+|--++|+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~--------ik~~~~~eKlr~l~ni~~l~~~~-----~~r~tf~L~P~ 108 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN--------IKSFTKNEKLRYLLNIKNLEEVN-----RTRYTFVLAPD 108 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG--------GGGSCHHHHHHHHHHGGGGGGGG-----GSSEECCCSGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH--------HHhcCHHHHHHHHHHHHHHHHHh-----cCceEEEEecc
Confidence 67877766 4566666766666654422 2222 23477788899999988866544 23578899999
Q ss_pred ceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccch-hhhHHHHHHHhCCCCCCC
Q 040898 196 NVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIY-SFGVLLAVLVMGKFPVDD 270 (337)
Q Consensus 196 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Diw-slG~i~~~ll~g~~pf~~ 270 (337)
|++++.++.+++..-|+-.. ++|.. .+ ..|.| .+=+++..+++++..|+.
T Consensus 109 NL~f~~~~~p~i~~RGik~~-------------------l~P~~-----~~-ee~fL~qyKAliiall~~K~~Fe~ 159 (215)
T 4ann_A 109 ELFFTRDGLPIAKTRGLQNV-------------------VDPLP-----VS-EAEFLTRYKALVICAFNEKQSFDA 159 (215)
T ss_dssp GEEECTTSCEEESCCEETTT-------------------BSCCC-----CC-HHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred eEEEcCCCCEEEEEccCccC-------------------CCCCC-----CC-HHHHHHHHHHHHHHHHcCCCCHHH
Confidence 99999999999998775322 12221 11 22333 467888899999999854
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=86.88 E-value=2.5 Score=34.06 Aligned_cols=115 Identities=16% Similarity=0.186 Sum_probs=77.5
Q ss_pred CCCCcccceeEEEcCCeeEEEEEeccCC-CHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCC
Q 040898 117 RHRNILPLLAHMVRPNCHLLVYEFMKNG-SLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPA 195 (337)
Q Consensus 117 ~hpniv~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ 195 (337)
.||++ -..+-.+.+.+.+.++.-+++ ++. .++ ..+....++++.+|+.... .|...-+|.-++|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~-~i~-------~~~~~eKlrll~nl~~L~~----~~~~~r~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFA-AIR-------KTTLLSRIRAAIHLVSKVK----HHSARRLIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHH-HHH-------TSCHHHHHHHHHHHHHHHS----SCCSSSEECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHH-HHH-------hcCHHHHHHHHHHHHHHHH----HhhhCceeEEEeCc
Confidence 67777 455557777877777766443 344 332 3777888999988877544 13345688999999
Q ss_pred ceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccch-hhhHHHHHHHhCCCCCCC
Q 040898 196 NVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIY-SFGVLLAVLVMGKFPVDD 270 (337)
Q Consensus 196 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Diw-slG~i~~~ll~g~~pf~~ 270 (337)
|++++.++.+++...|+-.. ++|..+ ...|.| ++=+++..++.++..|+.
T Consensus 114 NL~f~~~~~p~i~hRGi~~~-------------------lpP~e~------~ee~fl~qyKali~all~~K~~Fe~ 164 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKES-------------------LPPDEW------DDERLLREVKATVLALTEGEYRFDE 164 (219)
T ss_dssp GEEECTTCCEEESCCEETTT-------------------BSSCSC------CHHHHHHHHHHHHHHHTTCSSCHHH
T ss_pred eEEEeCCCcEEEEEcCCccc-------------------CCCCCC------CHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 99999999999998885322 222211 122443 466888888989888743
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=85.03 E-value=0.12 Score=47.27 Aligned_cols=64 Identities=5% Similarity=-0.003 Sum_probs=18.5
Q ss_pred cccceeccCcceEEEEeEEecCCCCceEEE------EEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC
Q 040898 44 DSLKKIGSGGWGEVFYKAELPGSNGKMIAI------RKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR 117 (337)
Q Consensus 44 ~~~~~lg~G~~g~V~~~~~~~~~~~~~vav------K~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 117 (337)
.+.+.|| ||.||++.... ...+||+ |........ ......+.++..+++.++
T Consensus 145 ~l~~~lG---fG~v~~g~~~~--~~~~Vav~~~~~~K~~~~~~~~-----------------~e~~~~~~rea~l~~~~~ 202 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYK--KHMPVLKETHDERDSTGQDGVS-----------------EKRLTSLVRRATLKENEQ 202 (463)
T ss_dssp CSTTTSS---BCCC-----------CCBGGGC------------------------------------------------
T ss_pred cccccCC---chhhhcccccc--cCCchhhhhccCcccccccccc-----------------cccccccccccccccccc
Confidence 4566776 99999887753 3457777 544322111 111245777888889999
Q ss_pred CCCcccceeEEE
Q 040898 118 HRNILPLLAHMV 129 (337)
Q Consensus 118 hpniv~~~~~~~ 129 (337)
|||+++.+++..
T Consensus 203 H~niv~~h~f~~ 214 (463)
T 3cxl_A 203 IPKYEKIHNFKV 214 (463)
T ss_dssp ----CBCCCEEE
T ss_pred ccccCCCcceEE
Confidence 999999998754
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=82.20 E-value=0.68 Score=41.31 Aligned_cols=30 Identities=20% Similarity=0.392 Sum_probs=24.9
Q ss_pred CeEecCCCCCceee------cCCCCeEEecccCccc
Q 040898 186 RLIHRDIKPANVLI------DDDMEARISDFGHGKL 215 (337)
Q Consensus 186 gi~h~di~~~nil~------~~~~~~~l~dfg~~~~ 215 (337)
.++|+|+.+.||++ +.+..+.++||.++..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46799999999999 3467799999997653
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 337 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-52 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-51 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 8e-50 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-48 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 9e-48 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-47 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-47 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-47 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 8e-47 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 9e-47 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-46 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-46 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 9e-46 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 9e-46 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-45 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-45 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-45 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 8e-45 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 8e-45 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-44 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-44 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-43 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-43 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-43 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 8e-43 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-42 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-41 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-41 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-40 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-40 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-40 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-40 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-40 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-39 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-39 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-38 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-38 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-38 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-38 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-37 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-36 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-36 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-35 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-35 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-35 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-35 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-33 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-33 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-31 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-31 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-31 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-31 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-31 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-30 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-30 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-29 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-28 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-28 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-27 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-25 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-24 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-23 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-12 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 1e-52
Identities = 68/300 (22%), Positives = 128/300 (42%), Gaps = 44/300 (14%)
Query: 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLH 100
++IGSG +G V YK + G +A++ L V A Q +
Sbjct: 8 GQITVGQRIGSGSFGTV-YKGKWHGD----VAVKMLNVTA------PTPQQLQA------ 50
Query: 101 WKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRREL 160
++E+ +TRH NIL + + P +V ++ + SL L+ + +
Sbjct: 51 -----FKNEVGVLRKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHII---ETKF 101
Query: 161 DWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGH 220
+ IAR A G++YLH +IHRD+K N+ + +D+ +I DFG +
Sbjct: 102 EMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158
Query: 221 AQITVKCMVGTMGYMAPESLQTET---ISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEE 277
+ + G++ +MAPE ++ + S + D+Y+FG++L L+ G+ P +
Sbjct: 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP---YSNINNR 215
Query: 278 MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337
++ + S + ++ + + + M +L C K DERP + +
Sbjct: 216 DQIIFMVGRGYLSPDLSK------VRSNCPKAM---KRLMAECLKKKRDERPLFPQILAS 266
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 5e-51
Identities = 64/322 (19%), Positives = 117/322 (36%), Gaps = 56/322 (17%)
Query: 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDL 98
K+D F+ + ++G+G G V +K +G ++A + I +I
Sbjct: 4 KDDDFEKISELGAGNGGVV-FKVSHK-PSGLVMARKL------------IHLEIKP---- 45
Query: 99 LHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRR 158
I E+ ++ I+ + E M GSL +L
Sbjct: 46 --AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AG 99
Query: 159 ELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPD 218
+ +++ + GL YL + +++HRD+KP+N+L++ E ++ DFG + D
Sbjct: 100 RIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157
Query: 219 GHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEM 278
A VGT YM+PE LQ S + DI+S G+ L + +G++P+ E+
Sbjct: 158 SMA----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 213
Query: 279 DMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACF------------------- 319
+ P + L + + +
Sbjct: 214 MFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLE 273
Query: 320 -------CTLKDPDERPSSKDV 334
C +K+P ER K +
Sbjct: 274 FQDFVNKCLIKNPAERADLKQL 295
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 8e-50
Identities = 62/301 (20%), Positives = 120/301 (39%), Gaps = 43/301 (14%)
Query: 38 KKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSD 97
+ ED ++ L IG+G +G K S+GK++ ++L +Y
Sbjct: 2 RAED-YEVLYTIGTGSYGRC-QKIRRK-SDGKILVWKEL-----------------DYGS 41
Query: 98 LLHWKIGAIRSEIITANQTRHRNILPLLAHMVRP--NCHLLVYEFMKNGSLQDILYDVSQ 155
+ + + SE+ + +H NI+ ++ +V E+ + G L ++ ++
Sbjct: 42 MTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTK 101
Query: 156 GRRELDWPARHRIARGIASGLEYLHM--CHRPRLIHRDIKPANVLIDDDMEARISDFGHG 213
R+ LD R+ + L+ H ++HRD+KPANV +D ++ DFG
Sbjct: 102 ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161
Query: 214 KLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFG 273
+++ + T YM+PE + + ++K DI+S G LL L P F
Sbjct: 162 RILNHDTSFAKAFVG--TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP----FT 215
Query: 274 HTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKD 333
+ ++ +R F P R + + ++ RPS ++
Sbjct: 216 AFSQKELAGKIREGKFRRIPYRYSDE-------------LNEIITRMLNLKDYHRPSVEE 262
Query: 334 V 334
+
Sbjct: 263 I 263
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 2e-48
Identities = 66/295 (22%), Positives = 120/295 (40%), Gaps = 43/295 (14%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
+D ++ +G G +GEV A + +A++ + + + E IK+
Sbjct: 7 WDLVQTLGEGAYGEV-QLAVNR-VTEEAVAVKIVDMKRAVDCPENIKK------------ 52
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDW 162
EI H N++ H N L E+ G L D + + +
Sbjct: 53 ------EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI----EPDIGMPE 102
Query: 163 PARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQ 222
P R + +G+ YLH + HRDIKP N+L+D+ +ISDFG + + +
Sbjct: 103 PDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159
Query: 223 ITVKCMVGTMGYMAPESLQTETISD-KCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMV 281
+ M GT+ Y+APE L+ D++S G++L ++ G+ P + ++
Sbjct: 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP---WDQPSDSCQEY 216
Query: 282 KWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336
+ NP + I+S L L+ K +++P R + D++
Sbjct: 217 SDWKEKKTYLNPWKKIDSAPLA--------LLHK----ILVENPSARITIPDIKK 259
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 9e-48
Identities = 69/346 (19%), Positives = 122/346 (35%), Gaps = 61/346 (17%)
Query: 16 GSRDRGPTIFSPLVEKQDLAFLKKEDCFDSLKKIGSGGWGEVFYKAELPGSN----GKMI 71
GS D + DL + + + K +GSG +G+V A G + +
Sbjct: 12 GSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKV-MNATAYGISKTGVSIQV 70
Query: 72 AIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLLAHMVRP 131
A++ L A S E + ++ + H NI+ LL
Sbjct: 71 AVKMLKEKADSSEREALMSELK-----------------MMTQLGSHENIVNLLGACTLS 113
Query: 132 NCHLLVYEFMKNGSLQDILY-------------------DVSQGRRELDWPARHRIARGI 172
L++E+ G L + L + + L + A +
Sbjct: 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQV 173
Query: 173 ASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTM 232
A G+E+L +HRD+ NVL+ +I DFG + + + +
Sbjct: 174 AKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPV 230
Query: 233 GYMAPESLQTETISDKCDIYSFGVLLAVLV-MGKFPVDDFFGHTEEMDMVKWMRNVIFSE 291
+MAPESL + K D++S+G+LL + +G P + G + + K ++N +
Sbjct: 231 KWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP---YPGIPVDANFYKLIQNGFKMD 287
Query: 292 NPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337
P A + + C D +RPS ++ S
Sbjct: 288 QPFYATEE-------------IYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 3e-47
Identities = 70/292 (23%), Positives = 117/292 (40%), Gaps = 47/292 (16%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
F+ + +G G +G V Y A + ++A+ K++ A + A + Q
Sbjct: 8 FEIGRPLGKGKFGNV-YLAREK-QSKFILAL-KVLFKAQLEKAGVEHQ------------ 52
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDW 162
+R E+ + RH NIL L + L+ E+ G++ L Q + D
Sbjct: 53 ---LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDE 105
Query: 163 PARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQ 222
+A+ L Y CH R+IHRDIKP N+L+ E +I+DFG P
Sbjct: 106 QRTATYITELANALSY---CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT 162
Query: 223 ITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVK 282
+ GT+ Y+ PE ++ +K D++S GVL ++GK P F + K
Sbjct: 163 ----TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYK 214
Query: 283 WMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDV 334
+ V F+ ++ L +P +RP ++V
Sbjct: 215 RISRVEFTFPDFVTEGAR--------------DLISRLLKHNPSQRPMLREV 252
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 4e-47
Identities = 65/303 (21%), Positives = 124/303 (40%), Gaps = 49/303 (16%)
Query: 37 LKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYS 96
L ED ++ + ++G G +G+V YKA+ + A + + + ++++++
Sbjct: 8 LNPEDFWEIIGELGDGAFGKV-YKAQNK-ETSVLAAAKVIDTKS--------EEELED-- 55
Query: 97 DLLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQG 156
EI H NI+ LL N ++ EF G++ ++ +
Sbjct: 56 ---------YMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE---L 103
Query: 157 RRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLM 216
R L + + L YLH ++IHRD+K N+L D + +++DFG
Sbjct: 104 ERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKN 160
Query: 217 PDGHAQITVKCMVGTMGYMAPESLQTETISD-----KCDIYSFGVLLAVLVMGKFPVDDF 271
+ +GT +MAPE + ET D K D++S G+ L + + P +
Sbjct: 161 TRTIQRRD--SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHE- 217
Query: 272 FGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSS 331
++ ++ + + SE P A S+ N + + K C K+ D R ++
Sbjct: 218 ------LNPMRVLLKIAKSEPPTLAQPSRWSSNFKD----FLKK----CLEKNVDARWTT 263
Query: 332 KDV 334
+
Sbjct: 264 SQL 266
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 6e-47
Identities = 61/297 (20%), Positives = 124/297 (41%), Gaps = 46/297 (15%)
Query: 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLH 100
+ ++++G+G +GEV + G +A++ L D
Sbjct: 13 ETLKLVERLGAGQFGEV-WMGYYNG--HTKVAVKSLKQG---------SMSPDA------ 54
Query: 101 WKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRREL 160
+E Q +H+ ++ L A + + ++ + E+M+NGSL D L +L
Sbjct: 55 -----FLAEANLMKQLQHQRLVRLYAVVTQEPIYI-ITEYMENGSLVDFLKT--PSGIKL 106
Query: 161 DWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGH 220
+A IA G+ ++ + IHRD++ AN+L+ D + +I+DFG +L+ D
Sbjct: 107 TINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163
Query: 221 AQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDM 280
+ + + APE++ T + K D++SFG+LL +V + ++
Sbjct: 164 YTAR-EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRI---PYPGMTNPEV 219
Query: 281 VKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337
++ + P+ + +L C + P++RP+ +RS+
Sbjct: 220 IQNLERGYRMVRPDNCPEE-------------LYQLMRLCWKERPEDRPTFDYLRSV 263
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 158 bits (401), Expect = 8e-47
Identities = 68/298 (22%), Positives = 109/298 (36%), Gaps = 50/298 (16%)
Query: 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLL 99
E F L++IG G +G V Y A N +++AI+K+ S
Sbjct: 14 EKLFSDLREIGHGSFGAV-YFARDV-RNSEVVAIKKMSYSGKQSNE-------------- 57
Query: 100 HWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRE 159
K I E+ + RH N + +R + LV E+ + + ++
Sbjct: 58 --KWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH----KKP 111
Query: 160 LDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDG 219
L + G GL YLH +IHRD+K N+L+ + ++ DFG +M
Sbjct: 112 LQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168
Query: 220 HAQITVKCMVGTMGYMAPESLQTET---ISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTE 276
+ VGT +MAPE + K D++S G+ L K P F
Sbjct: 169 N------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP---LFNMNA 219
Query: 277 EMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDV 334
+ +N + G+ E V C K P +RP+S+ +
Sbjct: 220 MSALYHIAQNESPALQS---------GHWSEYFRNFVDS----CLQKIPQDRPTSEVL 264
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 9e-47
Identities = 60/293 (20%), Positives = 111/293 (37%), Gaps = 49/293 (16%)
Query: 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAI 106
+IG G + V YK +A +L +L K +
Sbjct: 15 IEIGRGSFKTV-YKGLDTE-TTVEVAWCEL------QDRKLTKSERQR-----------F 55
Query: 107 RSEIITANQTRHRNILPLLAHMV----RPNCHLLVYEFMKNGSLQDILYDVSQGRRELDW 162
+ E +H NI+ C +LV E M +G+L+ L + + +
Sbjct: 56 KEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL----KRFKVMKI 111
Query: 163 PARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDD-DMEARISDFGHGKLMPDGHA 221
R I GL++LH P +IHRD+K N+ I +I D G L A
Sbjct: 112 KVLRSWCRQILKGLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA 170
Query: 222 QITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMV 281
K ++GT +MAPE + + + D+Y+FG+ + + ++P + +
Sbjct: 171 ----KAVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSEYP---YSECQNAAQIY 222
Query: 282 KWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDV 334
+ + + + + ++ ++ ++ C ++ DER S KD+
Sbjct: 223 RRVTSGVKPASFDKVAIPEV------------KEIIEGCIRQNKDERYSIKDL 263
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 2e-46
Identities = 71/296 (23%), Positives = 114/296 (38%), Gaps = 52/296 (17%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
L+ IG G +G+V + G +A++ + DA
Sbjct: 9 LKLLQTIGKGEFGDV-MLGDY---RGNKVAVKCIKNDA---------------------T 43
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHL-LVYEFMKNGSLQDILYDVSQGRRELD 161
A +E Q RH N++ LL +V L +V E+M GSL D L S+GR L
Sbjct: 44 AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLG 101
Query: 162 WPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHA 221
+ + + +EYL +HRD+ NVL+ +D A++SDFG K
Sbjct: 102 GDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS--- 155
Query: 222 QITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMV 281
T + + APE+L+ + S K D++SFG+LL + + D+V
Sbjct: 156 --TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV---PYPRIPLKDVV 210
Query: 282 KWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337
+ + P+ + V ++ C D RPS +R
Sbjct: 211 PRVEKGYKMDAPDGCPPA-------------VYEVMKNCWHLDAAMRPSFLQLREQ 253
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 156 bits (395), Expect = 4e-46
Identities = 62/321 (19%), Positives = 117/321 (36%), Gaps = 62/321 (19%)
Query: 41 DCFDSLKKIGSGGWGEVFYKAELPG----SNGKMIAIRKLIVDAPMSAAELIKQDIDEYS 96
+ + ++ IG G +G V ++A PG M+A++ L +A
Sbjct: 13 NNIEYVRDIGEGAFGRV-FQARAPGLLPYEPFTMVAVKMLKEEASADMQA---------- 61
Query: 97 DLLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYD---- 152
+ E + + NI+ LL L++E+M G L + L
Sbjct: 62 --------DFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPH 113
Query: 153 ----------------VSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPAN 196
S G L + IAR +A+G+ YL + +HRD+ N
Sbjct: 114 TVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRN 170
Query: 197 VLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGV 256
L+ ++M +I+DFG + + + +M PES+ + + D++++GV
Sbjct: 171 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGV 230
Query: 257 LLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKL 316
+L + + +++ ++R+ P E L + L
Sbjct: 231 VLWEIFSYGLQ---PYYGMAHEEVIYYVRDGNILACP-------------ENCPLELYNL 274
Query: 317 ACFCTLKDPDERPSSKDVRSM 337
C K P +RPS + +
Sbjct: 275 MRLCWSKLPADRPSFCSIHRI 295
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 9e-46
Identities = 62/297 (20%), Positives = 117/297 (39%), Gaps = 46/297 (15%)
Query: 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLH 100
+ K+G G +GEV + G +AI+ L +
Sbjct: 17 ESLRLEVKLGQGCFGEV-WMGTWNG--TTRVAIKTLKPG---------TMSPEA------ 58
Query: 101 WKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRREL 160
E + RH ++ L A + ++ V E+M GSL D + + + L
Sbjct: 59 -----FLQEAQVMKKLRHEKLVQLYAVVSEEPIYI-VTEYMSKGSLLD--FLKGETGKYL 110
Query: 161 DWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGH 220
P +A IASG+ Y+ + +HRD++ AN+L+ +++ +++DFG +L+ D
Sbjct: 111 RLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 167
Query: 221 AQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDM 280
+ + + APE+ + K D++SFG+LL L + ++
Sbjct: 168 YTAR-QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV---PYPGMVNREV 223
Query: 281 VKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337
+ + P S + L C C K+P+ERP+ + +++
Sbjct: 224 LDQVERGYRMPCPPECPES-------------LHDLMCQCWRKEPEERPTFEYLQAF 267
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 9e-46
Identities = 67/316 (21%), Positives = 116/316 (36%), Gaps = 56/316 (17%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGA 105
+ IG G +GEV ++ + G+ +A++ E
Sbjct: 8 QESIGKGRFGEV-WRGKW---RGEEVAVKIF--------------SSREERSWF------ 43
Query: 106 IRSEIITANQTRHRNILPLLAHMVRPNCHL----LVYEFMKNGSLQDILYDVSQGRRELD 161
+EI RH NIL +A + N LV ++ ++GSL D L R +
Sbjct: 44 REAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVT 98
Query: 162 WPARHRIARGIASGLEYLHM-----CHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLM 216
++A ASGL +LHM +P + HRD+K N+L+ + I+D G
Sbjct: 99 VEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158
Query: 217 PDGHAQITVKC--MVGTMGYMAPESLQTE------TISDKCDIYSFGVLLAVLVMGKFPV 268
I + VGT YMAPE L + DIY+ G++ +
Sbjct: 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG 218
Query: 269 DD-------FFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCT 321
++ V+ MR V+ + I ++ E + ++ K+ C
Sbjct: 219 GIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQS---CEALRVMAKIMRECW 275
Query: 322 LKDPDERPSSKDVRSM 337
+ R ++ ++
Sbjct: 276 YANGAARLTALRIKKT 291
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 154 bits (390), Expect = 2e-45
Identities = 63/297 (21%), Positives = 110/297 (37%), Gaps = 44/297 (14%)
Query: 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLH 100
K+G G +GEV Y+ +A++ L D +++E
Sbjct: 17 TDITMKHKLGGGQYGEV-YEGVWKK-YSLTVAVKTLKED---------TMEVEE------ 59
Query: 101 WKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRREL 160
E + +H N++ LL R ++ EFM G+L D L + R+E+
Sbjct: 60 -----FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEV 112
Query: 161 DWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGH 220
+A I+S + + IHRD+ N L+ ++ +++DFG +LM
Sbjct: 113 SAVVLLYMATQISSAM---EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169
Query: 221 AQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDM 280
+ + APESL S K D+++FGVLL + + + +
Sbjct: 170 YTAHAGA-KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS---PYPGIDLSQV 225
Query: 281 VKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337
+ + E P E V +L C +P +RPS ++
Sbjct: 226 YELLEKDYRMERP-------------EGCPEKVYELMRACWQWNPSDRPSFAEIHQA 269
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 2e-45
Identities = 63/292 (21%), Positives = 119/292 (40%), Gaps = 46/292 (15%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
+ +KIG G G V Y A + G+ +AIR++ +
Sbjct: 22 YTRFEKIGQGASGTV-YTAMDV-ATGQEVAIRQMNLQQQPKKEL---------------- 63
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDW 162
I +EI+ + ++ NI+ L + + +V E++ GSL D++ +D
Sbjct: 64 ---IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDE 115
Query: 163 PARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQ 222
+ R LE+LH ++IHRDIK N+L+ D +++DFG + ++
Sbjct: 116 GQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172
Query: 223 ITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVK 282
+ MVGT +MAPE + + K DI+S G++ ++ G+ P + +
Sbjct: 173 RS--TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP---YLNENPLRALYL 227
Query: 283 WMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDV 334
N +++ + + C D ++R S+K++
Sbjct: 228 IATNGTPELQNPEKLSAIFRD--------FLNR----CLDMDVEKRGSAKEL 267
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 4e-45
Identities = 54/297 (18%), Positives = 106/297 (35%), Gaps = 46/297 (15%)
Query: 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLH 100
+++IGSG +G V + N +AI K I + MS + I+
Sbjct: 5 SELTFVQEIGSGQFGLV-HLGYWL--NKDKVAI-KTIREGAMSEEDFIE----------- 49
Query: 101 WKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRREL 160
E + H ++ L + LV+EFM++G L D + R
Sbjct: 50 --------EAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY---LRTQRGLF 98
Query: 161 DWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGH 220
+ + G+ +IHRD+ N L+ ++ ++SDFG + + D
Sbjct: 99 AAETLLGMCLDVCEGM---AYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155
Query: 221 AQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDM 280
+ + + +PE S K D++SFGVL+ + + ++E ++
Sbjct: 156 YTSS-TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED 214
Query: 281 VKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337
+ + + V ++ C + P++RP+ +
Sbjct: 215 ISTGFRLYKPRLASTH----------------VYQIMNHCWKERPEDRPAFSRLLRQ 255
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 153 bits (387), Expect = 8e-45
Identities = 63/303 (20%), Positives = 122/303 (40%), Gaps = 48/303 (15%)
Query: 41 DCFDSLKKIGSGGWGEVFYKAEL--PGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDL 98
C + IG+G +GEV L PG +AI+ L + ++ +
Sbjct: 26 SCVKIEQVIGAGEFGEV-CSGHLKLPGKREIFVAIKTL-------KSGYTEKQRRD---- 73
Query: 99 LHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRR 158
SE Q H N++ L + + +++ EFM+NGSL L Q
Sbjct: 74 -------FLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR---QNDG 123
Query: 159 ELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPD 218
+ + RGIA+G++YL + +HRD+ N+L++ ++ ++SDFG + + D
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 219 GHAQIT---VKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGH 274
+ T + + APE++Q + D++S+G+++ ++ G+ P +
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP----YWD 236
Query: 275 TEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDV 334
D++ + P + + +L C KD + RP +
Sbjct: 237 MTNQDVINAIEQDYRLPPP-------------MDCPSALHQLMLDCWQKDRNHRPKFGQI 283
Query: 335 RSM 337
+
Sbjct: 284 VNT 286
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 8e-45
Identities = 64/296 (21%), Positives = 111/296 (37%), Gaps = 48/296 (16%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
LK++G+G +G V + G +AI K+I + MS E I+
Sbjct: 6 LTFLKELGTGQFGVV-KYGKWRG--QYDVAI-KMIKEGSMSEDEFIE------------- 48
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDW 162
E H ++ L + ++ E+M NG L + L + R
Sbjct: 49 ------EAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR---EMRHRFQT 99
Query: 163 PARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQ 222
+ + + +EYL +HRD+ N L++D ++SDFG + + D
Sbjct: 100 QQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156
Query: 223 ITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL-AVLVMGKFPVDDFFGHTEEMDMV 281
+V + + PE L S K DI++FGVL+ + +GK P + +
Sbjct: 157 SSV-GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP----YERFTNSETA 211
Query: 282 KWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337
+ + + P+ A V + C + DERP+ K + S
Sbjct: 212 EHIAQGLRLYRPHLASEK-------------VYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 1e-44
Identities = 62/298 (20%), Positives = 122/298 (40%), Gaps = 39/298 (13%)
Query: 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLH 100
C K IG+G +GEV YK L S+GK +++ V A + +K E
Sbjct: 7 SCVTRQKVIGAGEFGEV-YKGMLKTSSGK----KEVPV-----AIKTLKAGYTE------ 50
Query: 101 WKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRREL 160
+ E Q H NI+ L + + +++ E+M+NG+L L + E
Sbjct: 51 KQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEF 107
Query: 161 DWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGH 220
+ RGIA+G++Y +HRD+ N+L++ ++ ++SDFG +++ D
Sbjct: 108 SVLQLVGMLRGIAAGMKY---LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 164
Query: 221 AQITVKC-MVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMD 279
+ + APE++ + D++SFG+++ ++ + +
Sbjct: 165 EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER---PYWELSNHE 221
Query: 280 MVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337
++K + + P + + +L C ++ RP D+ S+
Sbjct: 222 VMKAINDGFRLPTP-------------MDCPSAIYQLMMQCWQQERARRPKFADIVSI 266
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 3e-44
Identities = 56/310 (18%), Positives = 109/310 (35%), Gaps = 54/310 (17%)
Query: 46 LKKIGSGGWGEVFYKAELPG----SNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHW 101
K +G+G +G+V +A G +A++ L A ++ E + ++
Sbjct: 28 GKTLGAGAFGKV-VEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK-------- 78
Query: 102 KIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYD--------- 152
+ + H NI+ LL L++ E+ G L + L
Sbjct: 79 ---------VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSK 129
Query: 153 -----VSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARI 207
+ LD + +A G+ +L IHRD+ N+L+ +I
Sbjct: 130 TSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKI 186
Query: 208 SDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFP 267
DFG + + + + + +MAPES+ + + D++S+G+ L L
Sbjct: 187 CDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS 246
Query: 268 VDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDE 327
+ G + K ++ +P A + + C DP +
Sbjct: 247 --PYPGMPVDSKFYKMIKEGFRMLSPEHAPAE-------------MYDIMKTCWDADPLK 291
Query: 328 RPSSKDVRSM 337
RP+ K + +
Sbjct: 292 RPTFKQIVQL 301
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 1e-43
Identities = 62/294 (21%), Positives = 110/294 (37%), Gaps = 42/294 (14%)
Query: 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAI 106
+ IG G +G V Y L ++GK I A + + + D ++
Sbjct: 33 EVIGRGHFGCV-YHGTLLDNDGKKIHC----------AVKSLNRITDI------GEVSQF 75
Query: 107 RSEIITANQTRHRNILPLLAHMVR-PNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPAR 165
+E I H N+L LL +R L+V +MK+G L++ +
Sbjct: 76 LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDL 132
Query: 166 HRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITV 225
+A G+ + +HRD+ N ++D+ +++DFG + M D
Sbjct: 133 IGFGLQVAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH 189
Query: 226 KC--MVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKW 283
+ +MA ESLQT+ + K D++SFGVLL L+ P + D+ +
Sbjct: 190 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP---PYPDVNTFDITVY 246
Query: 284 MRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337
+ P + + ++ C + RPS ++ S
Sbjct: 247 LLQGRRLLQPEYCPDP-------------LYEVMLKCWHPKAEMRPSFSELVSR 287
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 2e-43
Identities = 64/300 (21%), Positives = 107/300 (35%), Gaps = 45/300 (15%)
Query: 38 KKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSD 97
K+ + F K +G G + V A + + AI+ L +IK++ Y
Sbjct: 5 KRPEDFKFGKILGEGSFSTV-VLAREL-ATSREYAIKIL------EKRHIIKENKVPY-- 54
Query: 98 LLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGR 157
+ E ++ H + L + KNG L +
Sbjct: 55 --------VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK----I 102
Query: 158 RELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMP 217
D I S L H +IHRD+KP N+L+++DM +I+DFG K++
Sbjct: 103 GSFDETCTRFYTAEIVSAL---EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 159
Query: 218 DGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEE 277
Q VGT Y++PE L ++ D+++ G ++ LV G P F E
Sbjct: 160 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP---FRAGNEY 216
Query: 278 MDMVKWMR-NVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336
+ K ++ F E LV K + D +R +++
Sbjct: 217 LIFQKIIKLEYDFPEKFFPKARD------------LVEK----LLVLDATKRLGCEEMEG 260
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 4e-43
Identities = 57/304 (18%), Positives = 112/304 (36%), Gaps = 44/304 (14%)
Query: 36 FLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEY 95
FLK+++ + ++G G +G V + ++ A +++KQ ++
Sbjct: 4 FLKRDNLLIADIELGCGNFGSV-RQGVYRMRKKQIDV-----------AIKVLKQGTEK- 50
Query: 96 SDLLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQ 155
+ E +Q + I+ L+ +LV E G L L
Sbjct: 51 -----ADTEEMMREAQIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVG--- 101
Query: 156 GRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKL 215
R E+ + ++ G++YL +HRD+ NVL+ + A+ISDFG K
Sbjct: 102 KREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKA 158
Query: 216 MPDGHAQITVK-CMVGTMGYMAPESLQTETISDKCDIYSFGVLLA-VLVMGKFPVDDFFG 273
+ + T + + + APE + S + D++S+GV + L G+ P +
Sbjct: 159 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP----YK 214
Query: 274 HTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKD 333
+ +++ ++ E P + L C + ++RP
Sbjct: 215 KMKGPEVMAFIEQGKRMECPPECPPE-------------LYALMSDCWIYKWEDRPDFLT 261
Query: 334 VRSM 337
V
Sbjct: 262 VEQR 265
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 8e-43
Identities = 68/329 (20%), Positives = 117/329 (35%), Gaps = 63/329 (19%)
Query: 22 PTIFSPLVEKQDLAFLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKM-IAIRKLIVDA 80
PTI+ P+++ D+ F IG G +G+V KA + +M AI+++ A
Sbjct: 1 PTIY-PVLDWNDIKFQDV---------IGEGNFGQV-LKARIKKDGLRMDAAIKRMKEYA 49
Query: 81 PMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEF 140
+++ L H H NI+ LL L E+
Sbjct: 50 SKDDHRDFAGELEVLCKLGH-----------------HPNIINLLGACEHRGYLYLAIEY 92
Query: 141 MKNGSLQDILYD------------VSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLI 188
+G+L D L + L A +A G++Y + + I
Sbjct: 93 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDY---LSQKQFI 149
Query: 189 HRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDK 248
HRD+ N+L+ ++ A+I+DFG + + + +MA ESL +
Sbjct: 150 HRDLAARNILVGENYVAKIADFGLSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTN 206
Query: 249 CDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEE 308
D++S+GVLL +V + ++ + + E P +
Sbjct: 207 SDVWSYGVLLWEIVSLGGT---PYCGMTCAELYEKLPQGYRLEKPLNCDDE--------- 254
Query: 309 QMLLVLKLACFCTLKDPDERPSSKDVRSM 337
V L C + P ERPS +
Sbjct: 255 ----VYDLMRQCWREKPYERPSFAQILVS 279
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 3e-42
Identities = 58/305 (19%), Positives = 105/305 (34%), Gaps = 46/305 (15%)
Query: 36 FLKKEDCFDSLKKIGSGGWGEVFYKAELPGSN-GKMIAIRKLIVDAPMSAAELIKQDIDE 94
+L ++ K++GSG +G V K K +A++ L + L +
Sbjct: 2 YLDRKLLTLEDKELGSGNFGTV-KKGYYQMKKVVKTVAVKIL--KNEANDPALKDE---- 54
Query: 95 YSDLLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVS 154
+ +E Q + I+ ++ + +LV E + G L L
Sbjct: 55 -----------LLAEANVMQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQ-- 100
Query: 155 QGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGK 214
R + + ++ G++YL + +HRD+ NVL+ A+ISDFG K
Sbjct: 101 --NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSK 155
Query: 215 LMPDGHAQITVK-CMVGTMGYMAPESLQTETISDKCDIYSFGVLL-AVLVMGKFPVDDFF 272
+ + + + APE + S K D++SFGVL+ G+ P +
Sbjct: 156 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP----Y 211
Query: 273 GHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSK 332
+ ++ + P + L C D + RP
Sbjct: 212 RGMKGSEVTAMLEKGERMGCPAGCPRE-------------MYDLMNLCWTYDVENRPGFA 258
Query: 333 DVRSM 337
V
Sbjct: 259 AVELR 263
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 2e-41
Identities = 64/318 (20%), Positives = 117/318 (36%), Gaps = 43/318 (13%)
Query: 32 QDLAFLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQD 91
+D + D K +G G +G+V AE G K R V M ++ ++D
Sbjct: 4 EDPRWELPRDRLVLGKPLGEGAFGQV-VLAEAIGL-DKDKPNRVTKVAVKMLKSDATEKD 61
Query: 92 IDEYSDLLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILY 151
+ + I + +H+NI+ LL + ++ E+ G+L++ L
Sbjct: 62 LSDL----------ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQ 111
Query: 152 ------------DVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI 199
+L A +A G+EYL + IHRD+ NVL+
Sbjct: 112 ARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV 168
Query: 200 DDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLA 259
+D +I+DFG + + + +MAPE+L + + D++SFGVLL
Sbjct: 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLW 228
Query: 260 VLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACF 319
+ + ++ K ++ + P+ N + +
Sbjct: 229 EIFTLGGS---PYPGVPVEELFKLLKEGHRMDKPSNCTNE-------------LYMMMRD 272
Query: 320 CTLKDPDERPSSKDVRSM 337
C P +RP+ K +
Sbjct: 273 CWHAVPSQRPTFKQLVED 290
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 5e-41
Identities = 59/305 (19%), Positives = 108/305 (35%), Gaps = 41/305 (13%)
Query: 35 AFLK--KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDI 92
A L+ KE F +K +GSG +G V YK G+ + I I + + + ++I
Sbjct: 1 ALLRILKETEFKKIKVLGSGAFGTV-YKGLWI-PEGEKVKIPVAIKELREATSPKANKEI 58
Query: 93 DEYSDLLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYD 152
E + ++ LL + L + + M G L D +
Sbjct: 59 --------------LDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVR- 102
Query: 153 VSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGH 212
+ + + IA G+ YL L+HRD+ NVL+ +I+DFG
Sbjct: 103 --EHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGL 157
Query: 213 GKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFF 272
KL+ + + + +MA ES+ + + D++S+GV + L+ +
Sbjct: 158 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK---PY 214
Query: 273 GHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSK 332
++ + P V + C + D D RP +
Sbjct: 215 DGIPASEISSILEKGERLPQPPICTID-------------VYMIMVKCWMIDADSRPKFR 261
Query: 333 DVRSM 337
++
Sbjct: 262 ELIIE 266
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 143 bits (362), Expect = 1e-40
Identities = 56/294 (19%), Positives = 114/294 (38%), Gaps = 46/294 (15%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
+D +++G+G +G V ++ + G A + ++
Sbjct: 28 YDIHEELGTGAFGVV-HRVTER-ATGNNFAAKFVMTPHESDKET---------------- 69
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDW 162
+R EI T + RH ++ L N +++YEFM G L + + D ++
Sbjct: 70 ---VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD---EHNKMSE 123
Query: 163 PARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI--DDDMEARISDFGHGKLMPDGH 220
R + GL ++H + +H D+KP N++ E ++ DFG +
Sbjct: 124 DEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180
Query: 221 AQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDM 280
+ GT + APE + + + D++S GVL +L+ G P FG + +
Sbjct: 181 SVKV---TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP----FGGENDDET 233
Query: 281 VKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDV 334
++ +++ ++ ++ E+ + K L DP+ R +
Sbjct: 234 LRNVKSCDWN------MDDSAFSGISEDGKDFIRK----LLLADPNTRMTIHQA 277
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 141 bits (356), Expect = 1e-40
Identities = 65/301 (21%), Positives = 122/301 (40%), Gaps = 43/301 (14%)
Query: 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLH 100
+ ++ + +G G V + K A++ + V S + Q++ E
Sbjct: 3 ENYEPKEILGRGVSSVV-RRCIHK-PTCKEYAVKIIDVTGGGSFSAEEVQELRE------ 54
Query: 101 WKIGAIRSEI-ITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRE 159
A E+ I + H NI+ L LV++ MK G L D L +
Sbjct: 55 ----ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL----TEKVT 106
Query: 160 LDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDG 219
L +I R + + LH + ++HRD+KP N+L+DDDM +++DFG + G
Sbjct: 107 LSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG 163
Query: 220 HAQITVKCMVGTMGYMAPESLQTET------ISDKCDIYSFGVLLAVLVMGKFPVDDFFG 273
++ + GT Y+APE ++ + D++S GV++ L+ G P F+
Sbjct: 164 E---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP---FWH 217
Query: 274 HTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKD 333
+ + + M +P S + + LV + + P +R ++++
Sbjct: 218 RKQMLMLRMIMSGNYQFGSPEWDDYSDTVKD-------LVSR----FLVVQPQKRYTAEE 266
Query: 334 V 334
Sbjct: 267 A 267
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 2e-40
Identities = 64/295 (21%), Positives = 114/295 (38%), Gaps = 48/295 (16%)
Query: 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLH 100
+ F K +G G +G+V + AE + AI+ L D + ++
Sbjct: 2 EDFILHKMLGKGSFGKV-FLAEFK-KTNQFFAIKALKKDVVLMDDDVEC----------- 48
Query: 101 WKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRREL 160
+ + + + H + + V E++ G L + Q +
Sbjct: 49 ----TMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI----QSCHKF 100
Query: 161 DWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGH 220
D A I GL++LH +++RD+K N+L+D D +I+DFG K G
Sbjct: 101 DLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 157
Query: 221 AQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEE--M 278
A+ GT Y+APE L + + D +SFGVLL +++G+ P F G EE
Sbjct: 158 AKTN--TFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP---FHGQDEEELF 212
Query: 279 DMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKD 333
++ A + L++K +++P++R +
Sbjct: 213 HSIRMDNPFYPRWLEKEAKD-------------LLVK----LFVREPEKRLGVRG 250
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 4e-40
Identities = 67/301 (22%), Positives = 112/301 (37%), Gaps = 40/301 (13%)
Query: 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDL 98
E L+K+G G +G V + E +GK +++ A + +K D+ +
Sbjct: 6 GEKDLRLLEKLGDGSFGVV-RRGEWDAPSGKTVSV----------AVKCLKPDVLSQPEA 54
Query: 99 LHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRR 158
+ E+ + HRN++ L ++ P + V E GSL D L +
Sbjct: 55 MD----DFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRK---HQG 106
Query: 159 ELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPD 218
R A +A G+ YL R IHRD+ N+L+ +I DFG + +P
Sbjct: 107 HFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163
Query: 219 GHAQITVK-CMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHTE 276
++ + APESL+T T S D + FGV L + G+ P + G
Sbjct: 164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP---WIGLNG 220
Query: 277 EMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336
+ K + P + + C P++RP+ +R
Sbjct: 221 SQILHKIDKEGERLPRPEDCPQD-------------IYNVMVQCWAHKPEDRPTFVALRD 267
Query: 337 M 337
Sbjct: 268 F 268
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 142 bits (358), Expect = 5e-40
Identities = 60/297 (20%), Positives = 114/297 (38%), Gaps = 48/297 (16%)
Query: 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLH 100
D +D L+++GSG +G V ++ + G++ + + P+
Sbjct: 29 DYYDILEELGSGAFGVV-HRCVEK-ATGRVFVAKFINTPYPLDKYT-------------- 72
Query: 101 WKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRREL 160
+++EI NQ H ++ L +L+ EF+ G L D + + ++
Sbjct: 73 -----VKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI---AAEDYKM 124
Query: 161 DWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID--DDMEARISDFGHGKLMPD 218
R GL+++H ++H DIKP N++ + +I DFG +
Sbjct: 125 SEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181
Query: 219 GHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEM 278
VK T + APE + E + D+++ GVL VL+ G P F G +
Sbjct: 182 DE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP---FAGEDDLE 235
Query: 279 DMVKWMR-NVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDV 334
+ R + F E+ +++ + + K+P +R + D
Sbjct: 236 TLQNVKRCDWEFDEDAFSSVSPEAKD--------FIKN----LLQKEPRKRLTVHDA 280
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 1e-39
Identities = 50/306 (16%), Positives = 109/306 (35%), Gaps = 46/306 (15%)
Query: 41 DCFDSLKKIGSGGWGEVF---YKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSD 97
+ +++G G +G V+ K + +AI+ + A M
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI----------- 68
Query: 98 LLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQG- 156
+E + +++ LL + + L++ E M G L+ L +
Sbjct: 69 -------EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAM 121
Query: 157 -----RRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFG 211
++A IA G+ + + +HRD+ N ++ +D +I DFG
Sbjct: 122 ANNPVLAPPSLSKMIQMAGEIADGM---AYLNANKFVHRDLAARNCMVAEDFTVKIGDFG 178
Query: 212 HGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDF 271
+ + + + + +M+PESL+ + D++SFGV+L +
Sbjct: 179 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ---P 235
Query: 272 FGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSS 331
+ +++++ + P+ + + +L C +P RPS
Sbjct: 236 YQGLSNEQVLRFVMEGGLLDKPDNCPDM-------------LFELMRMCWQYNPKMRPSF 282
Query: 332 KDVRSM 337
++ S
Sbjct: 283 LEIISS 288
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 139 bits (351), Expect = 2e-39
Identities = 69/298 (23%), Positives = 120/298 (40%), Gaps = 47/298 (15%)
Query: 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLL 99
D +D +G+G + EV AE K++AI+ + A L
Sbjct: 8 RDIYDFRDVLGTGAFSEV-ILAEDK-RTQKLVAIKCIAKKA------------------L 47
Query: 100 HWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRE 159
K G++ +EI ++ +H NI+ L L+ + + G L D + + +
Sbjct: 48 EGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVE----KGF 103
Query: 160 LDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI---DDDMEARISDFGHGKLM 216
R+ + ++YLH ++HRD+KP N+L D+D + ISDFG K+
Sbjct: 104 YTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160
Query: 217 PDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTE 276
G T GT GY+APE L + S D +S GV+ +L+ G P F+ +
Sbjct: 161 DPGSVLSTA---CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP---FYDEND 214
Query: 277 EMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDV 334
+ ++ ++P S + + KDP++R + +
Sbjct: 215 AKLFEQILKAEYEFDSPYWDDISDSAKD-------FIRH----LMEKDPEKRFTCEQA 261
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 2e-38
Identities = 53/297 (17%), Positives = 102/297 (34%), Gaps = 41/297 (13%)
Query: 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLH 100
+ + + IG G +G+V ++ +A+ S + K
Sbjct: 7 ERIELGRCIGEGQFGDV-HQGIYMSPENPALAVAIKTCKNCTSDSVREK----------- 54
Query: 101 WKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRREL 160
E +T Q H +I+ L+ + N ++ E G L+ L + L
Sbjct: 55 -----FLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQ---VRKYSL 105
Query: 161 DWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGH 220
D + A +++ L R +HRDI NVL+ + ++ DFG + M D
Sbjct: 106 DLASLILYAYQLSTAL---AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 162
Query: 221 AQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDM 280
+ +MAPES+ + D++ FGV + ++M + + +
Sbjct: 163 YYKA-SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR 221
Query: 281 VKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337
++ + N + L C DP RP ++++
Sbjct: 222 IENGERLPMPPNCPPTL----------------YSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (342), Expect = 4e-38
Identities = 56/292 (19%), Positives = 107/292 (36%), Gaps = 49/292 (16%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGA 105
+ +G G +G V ++ S+ K + + V
Sbjct: 10 AEDLGRGEFGIV-HRCVET-SSKKTYMAKFVKVKGTDQVL-------------------- 47
Query: 106 IRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPAR 165
++ EI N RHRNIL L ++++EF+ + + + + EL+
Sbjct: 48 VKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERI---NTSAFELNEREI 104
Query: 166 HRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEAR--ISDFGHGKLMPDGHAQI 223
+ L++LH + + H DI+P N++ + I +FG + + G
Sbjct: 105 VSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR 161
Query: 224 TVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKW 283
+ Y APE Q + +S D++S G L+ VL+ G P F T + +
Sbjct: 162 L---LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP---FLAETNQQIIENI 215
Query: 284 MR-NVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDV 334
M F E + I+ + + V + +K+ R ++ +
Sbjct: 216 MNAEYTFDEEAFKEISIEAMD--------FVDR----LLVKERKSRMTASEA 255
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 4e-38
Identities = 57/314 (18%), Positives = 113/314 (35%), Gaps = 53/314 (16%)
Query: 41 DCFDSLKKIGSGGWGEVFYKAELPG----SNGKMIAIRKLIVDAPMSAAELIKQDIDEYS 96
D K +G G +G+V +A+ G + + +A++ L A S +
Sbjct: 13 DRLKLGKPLGRGAFGQV-IEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL-------- 63
Query: 97 DLLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHL-LVYEFMKNGSLQDILYD--- 152
+ I + H N++ LL +P L ++ EF K G+L L
Sbjct: 64 ---------MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRN 114
Query: 153 ---------VSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDM 203
+ L + +A G+E+L + IHRD+ N+L+ +
Sbjct: 115 EFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKN 171
Query: 204 EARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM 263
+I DFG + + + + +MAPE++ + + D++SFGVLL +
Sbjct: 172 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 231
Query: 264 GKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLK 323
+ G + + + ++ P+ + + C
Sbjct: 232 LGAS--PYPGVKIDEEFCRRLKEGTRMRAPDYTTPE-------------MYQTMLDCWHG 276
Query: 324 DPDERPSSKDVRSM 337
+P +RP+ ++
Sbjct: 277 EPSQRPTFSELVEH 290
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 6e-38
Identities = 64/316 (20%), Positives = 128/316 (40%), Gaps = 52/316 (16%)
Query: 23 TIFSPLVEKQDLAFLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPM 82
T+F ++++ +D +D+ +++GSG + V K S G A + +
Sbjct: 1 TVFR----QENV-----DDYYDTGEELGSGQFAVV-KKCREK-STGLQYAAKFIKKRRTK 49
Query: 83 SAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMK 142
S+ + ++ I E+ + +H N++ L +L+ E +
Sbjct: 50 SSRRGVSRE-------------DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVA 96
Query: 143 NGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDD 202
G L D L + + L + I +G+ + H ++ H D+KP N+++ D
Sbjct: 97 GGELFDFLAE----KESLTEEEATEFLKQILNGV---YYLHSLQIAHFDLKPENIMLLDR 149
Query: 203 MEAR----ISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLL 258
+ I DFG + G+ K + GT ++APE + E + + D++S GV+
Sbjct: 150 NVPKPRIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 206
Query: 259 AVLVMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLAC 318
+L+ G P F G T++ + E+ + S L + + +
Sbjct: 207 YILLSGASP---FLGDTKQETLANVSAVNYEFEDEYFSNTSALAKD-------FIRR--- 253
Query: 319 FCTLKDPDERPSSKDV 334
+KDP +R + +D
Sbjct: 254 -LLVKDPKKRMTIQDS 268
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 132 bits (333), Expect = 3e-37
Identities = 59/296 (19%), Positives = 115/296 (38%), Gaps = 44/296 (14%)
Query: 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLH 100
D ++ + +G GG EV + A + +A++ L D + ++
Sbjct: 7 DRYELGEILGFGGMSEV-HLARDL-RLHRDVAVKVLRADLARDPSFYLR----------- 53
Query: 101 WKIGAIRSEIITANQTRHRNILPLLAHMVRPN----CHLLVYEFMKNGSLQDILYDVSQG 156
R E A H I+ + +V E++ +L+DI++
Sbjct: 54 -----FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT---- 104
Query: 157 RRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLM 216
+ + L + H + +IHRD+KPAN++I ++ DFG + +
Sbjct: 105 EGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAI 161
Query: 217 PDGHAQITV-KCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHT 275
D +T ++GT Y++PE + +++ + D+YS G +L ++ G+ P F G +
Sbjct: 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP---FTGDS 218
Query: 276 EEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSS 331
+ +R + S L +VLK K+P+ R +
Sbjct: 219 PVSVAYQHVREDPIPPSARHEGLSADLDA-------VVLK----ALAKNPENRYQT 263
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 1e-36
Identities = 62/304 (20%), Positives = 110/304 (36%), Gaps = 44/304 (14%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGA 105
L +G G + V YKA + +++AI+K+ + A + I +
Sbjct: 3 LDFLGEGQFATV-YKARDK-NTNQIVAIKKIKLGHRSEAKDGINRTA------------- 47
Query: 106 IRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPAR 165
EI + H NI+ LL + LV++FM+ I L
Sbjct: 48 -LREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVII----KDNSLVLTPSHI 102
Query: 166 HRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITV 225
GLEYLH +HRD+KP N+L+D++ +++DFG K + T
Sbjct: 103 KAYMLMTLQGLEYLHQHWI---LHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT- 158
Query: 226 KCMVGTMGYMAPESLQTETISD-KCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVKWM 284
V T Y APE L + D+++ G +LA L++ ++D + +
Sbjct: 159 -HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPF----LPGDSDLDQLTRI 213
Query: 285 RNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACF--------------CTLKDPDERPS 330
+ + + + L + + + L L +P R +
Sbjct: 214 FETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARIT 273
Query: 331 SKDV 334
+
Sbjct: 274 ATQA 277
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 4e-36
Identities = 52/311 (16%), Positives = 115/311 (36%), Gaps = 38/311 (12%)
Query: 38 KKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSD 97
+ + ++ + +IG G +G+V +KA + G+ +A++++ + +
Sbjct: 4 RADQQYECVAEIGEGAYGKV-FKARDLKNGGRFVALKRV--------------RVQTGEE 48
Query: 98 LLHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQ--DILYDVSQ 155
+ + + H N++ L + + Y
Sbjct: 49 GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV 108
Query: 156 GRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKL 215
+ + + GL++LH ++HRD+KP N+L+ + +++DFG ++
Sbjct: 109 PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARI 165
Query: 216 MPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHT 275
A + +V T+ Y APE L + + D++S G + A + K F G +
Sbjct: 166 YSFQMALTS---VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL---FRGSS 219
Query: 276 EEMDMVK------------WMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLK 323
+ + K W R+V + +++ + + L L C
Sbjct: 220 DVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTF 279
Query: 324 DPDERPSSKDV 334
+P +R S+
Sbjct: 280 NPAKRISAYSA 290
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 130 bits (328), Expect = 1e-35
Identities = 66/290 (22%), Positives = 102/290 (35%), Gaps = 42/290 (14%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
F + IG GG+GEV Y GKM A+ K + + + ++E
Sbjct: 6 FSVHRIIGRGGFGEV-YGCRKA-DTGKMYAM-KCLDKKRIKMKQGETLALNE-------- 54
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDW 162
R + + I+ + P+ + + M G L L
Sbjct: 55 ----RIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ----HGVFSE 106
Query: 163 PARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQ 222
A I GLE++H +++RD+KPAN+L+D+ RISD G
Sbjct: 107 ADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 163
Query: 223 ITVKCMVGTMGYMAPESLQTETISD-KCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMV 281
VGT GYMAPE LQ D D +S G +L L+ G P F H +
Sbjct: 164 ----ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP---FRQHKTKDKHE 216
Query: 282 KWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSS 331
+ + + + +L L+ +D + R
Sbjct: 217 IDRMTLTMAVELPDSFSPELRS--------LLEG----LLQRDVNRRLGC 254
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 129 bits (324), Expect = 2e-35
Identities = 57/289 (19%), Positives = 109/289 (37%), Gaps = 48/289 (16%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
F L+ +G+G +G V + NG+ A+ K++ + + ++
Sbjct: 6 FQILRTLGTGSFGRV-HLIRSR-HNGRYYAM-KVLKKEIVVRLKQVEH------------ 50
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDW 162
E + + H I+ + ++ ++++ G L +L +
Sbjct: 51 ---TNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK----SQRFPN 103
Query: 163 PARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQ 222
P A + L H +I+RD+KP N+L+D + +I+DFG K +PD
Sbjct: 104 PVAKFYAAEVC---LALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-- 158
Query: 223 ITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVK 282
+ GT Y+APE + T+ + D +SFG+L+ ++ G P F + M +
Sbjct: 159 ---YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP----FYDSNTMKTYE 211
Query: 283 WMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSS 331
+ N P N + L +D +R +
Sbjct: 212 KILNAELRFPPF--FNEDV------------KDLLSRLITRDLSQRLGN 246
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 4e-35
Identities = 59/296 (19%), Positives = 109/296 (36%), Gaps = 52/296 (17%)
Query: 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAI 106
+ +G G G+V + + A+ K++ D P
Sbjct: 18 QVLGLGINGKV-LQIFNK-RTQEKFAL-KMLQDCPK-----------------------A 51
Query: 107 RSEI-ITANQTRHRNILPLL----AHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELD 161
R E+ + ++ +I+ ++ C L+V E + G L + D +G +
Sbjct: 52 RREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD--RGDQAFT 109
Query: 162 WPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDME---ARISDFGHGKLMPD 218
I + I ++YLH + + HRD+KP N+L +++DFG K
Sbjct: 110 EREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 166
Query: 219 GHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEM 278
++ T T Y+APE L E CD++S GV++ +L+ G P F +
Sbjct: 167 HNSLTTPCY---TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP----FYSNHGL 219
Query: 279 DMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDV 334
+ M+ I + EE +L+ +P +R + +
Sbjct: 220 AISPGMKTRIRMGQYE--FPNPEWSEVSEEVKMLIRN----LLKTEPTQRMTITEF 269
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 5e-35
Identities = 64/299 (21%), Positives = 112/299 (37%), Gaps = 49/299 (16%)
Query: 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLL 99
E + +GSGG+G V Y S+ +AI+ + K I ++ +L
Sbjct: 3 ESQYQVGPLLGSGGFGSV-YSGIRV-SDNLPVAIKHVE-----------KDRISDWGELP 49
Query: 100 HWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRE 159
+ + ++ + ++ LL RP+ +L+ E + L+D R
Sbjct: 50 NGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQD---LFDFITERGA 106
Query: 160 LDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID-DDMEARISDFGHGKLMPD 218
L + + + H C ++HRDIK N+LID + E ++ DFG G L+ D
Sbjct: 107 LQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKD 163
Query: 219 GHAQITVKCMVGTMGYMAPESLQTETISDK-CDIYSFGVLLAVLVMGKFPVDDFFGHTEE 277
GT Y PE ++ + ++S G+LL +V G P F H EE
Sbjct: 164 TVY----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP----FEHDEE 215
Query: 278 MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336
+ + S I C P +RP+ +++++
Sbjct: 216 IIRGQVFFRQRVSSECQHLIRW--------------------CLALRPSDRPTFEEIQN 254
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 2e-33
Identities = 57/310 (18%), Positives = 101/310 (32%), Gaps = 45/310 (14%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
+ +L IG G +G V A N +AI+K+ + +
Sbjct: 10 YTNLSYIGEGAYGMV-CSAYDN-VNKVRVAIKKISPFEHQTYCQ---------------- 51
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDW 162
EI + RH NI+ + + P + ++ + LY + + + L
Sbjct: 52 --RTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSN 108
Query: 163 PARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQ 222
I GL H ++HRD+KP+N+L++ + +I DFG ++ H
Sbjct: 109 DHICYFLYQILRGL---KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 165
Query: 223 ITVKC-MVGTMGYMAPESLQTETISD-KCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDM 280
V T Y APE + DI+S G +LA ++ + F G +
Sbjct: 166 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI---FPGKHYLDQL 222
Query: 281 VKWMRNVIFSENPNRAINSKLLGNGYEEQML----------------LVLKLACFCTLKD 324
+ + + L Y + L L +
Sbjct: 223 NHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFN 282
Query: 325 PDERPSSKDV 334
P +R +
Sbjct: 283 PHKRIEVEQA 292
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 121 bits (305), Expect = 6e-33
Identities = 56/301 (18%), Positives = 99/301 (32%), Gaps = 49/301 (16%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGA 105
+KIGSG +G++ Y + G+ +AI+ V K
Sbjct: 12 GRKIGSGSFGDI-YLGTDI-AAGEEVAIKLECVKT---------------------KHPQ 48
Query: 106 IRSEIITANQTRHRNILPLL-AHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPA 164
+ E + +P + + +++V E + + R+
Sbjct: 49 LHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFC----SRKFSLKT 104
Query: 165 RHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI---DDDMEARISDFGHGKLMPDGHA 221
+A + S +EY+H IHRD+KP N L+ I DFG K D
Sbjct: 105 VLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161
Query: 222 QITV-----KCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTE 276
+ K + GT Y + + S + D+ S G +L +G P T+
Sbjct: 162 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK 221
Query: 277 EMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336
+ + ++L GY + L C D++P +R
Sbjct: 222 RQKYERISE-------KKMSTPIEVLCKGYPSEFATYLNF---CRSLRFDDKPDYSYLRQ 271
Query: 337 M 337
+
Sbjct: 272 L 272
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 1e-31
Identities = 60/322 (18%), Positives = 112/322 (34%), Gaps = 65/322 (20%)
Query: 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDL 98
+E + K IG+G +G V Y+A+L +G+++AI+K++ D
Sbjct: 18 QEVSYTDTKVIGNGSFGVV-YQAKLC-DSGELVAIKKVLQDKRF---------------- 59
Query: 99 LHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCH------LLVYEFMKNGSLQDILYD 152
E+ + H NI+ L LV +++ +
Sbjct: 60 -------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR-H 111
Query: 153 VSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDD-MEARISDFG 211
S+ ++ L + L Y+H + HRDIKP N+L+D D ++ DFG
Sbjct: 112 YSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFG 168
Query: 212 HGKLMPDGHAQITVKCMVGTMGYMAP-ESLQTETISDKCDIYSFGVLLAVLVMGKFPVDD 270
K + G ++ + + Y AP + D++S G +LA L++G+
Sbjct: 169 SAKQLVRGEPNVS---YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI--- 222
Query: 271 FFGHTEEMDMVKWMR------------------NVIFSENPNRAINSKLLGNGYEEQMLL 312
F G + +V+ ++ F + E + L
Sbjct: 223 FPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIAL 282
Query: 313 VLKLACFCTLKDPDERPSSKDV 334
+ P R + +
Sbjct: 283 CSR----LLEYTPTARLTPLEA 300
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 1e-31
Identities = 63/292 (21%), Positives = 103/292 (35%), Gaps = 45/292 (15%)
Query: 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLH 100
+ FD LK +G G +G+V + G+ A+ K++ + A + +
Sbjct: 5 NDFDYLKLLGKGTFGKV-ILVREK-ATGRYYAM-KILRKEVIIAKDEVAH---------- 51
Query: 101 WKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRREL 160
+E TRH + L + V E+ G L L R
Sbjct: 52 -----TVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL----SRERVF 102
Query: 161 DWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGH 220
I S L H +++RDIK N+++D D +I+DFG K
Sbjct: 103 TEERARFYGAEIVSAL---EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159
Query: 221 AQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDM 280
A T+K GT Y+APE L+ D + GV++ ++ G+ P F+ E
Sbjct: 160 A--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP---FYNQDHERLF 214
Query: 281 VKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSK 332
+ I R ++ + L+ KDP +R
Sbjct: 215 ELILMEEI---RFPRTLSPEAKS--------LLAG----LLKKDPKQRLGGG 251
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 117 bits (294), Expect = 2e-31
Identities = 46/302 (15%), Positives = 95/302 (31%), Gaps = 49/302 (16%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGA 105
++IG G +G + ++ N + +AI+ S A ++ + Y L
Sbjct: 10 GRRIGEGSFGVI-FEGTNL-LNNQQVAIKFEPRR---SDAPQLRDEYRTYKLLAG----- 59
Query: 106 IRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPAR 165
I + ++LV + + + R+
Sbjct: 60 ------------CTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLL----DLCGRKFSVKTV 103
Query: 166 HRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDME-----ARISDFGHGKLMPDGH 220
A+ + + ++ +H L++RDIKP N LI + DFG K D
Sbjct: 104 AMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 160
Query: 221 AQITVKC-----MVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHT 275
+ + + GT YM+ + S + D+ + G + + G P T
Sbjct: 161 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT 220
Query: 276 EEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVR 335
+ + ++ + L G+ E+ + D P ++
Sbjct: 221 NKQKYERIGEK-------KQSTPLRELCAGFPEEFYKYMHY---ARNLAFDATPDYDYLQ 270
Query: 336 SM 337
+
Sbjct: 271 GL 272
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 3e-31
Identities = 66/309 (21%), Positives = 116/309 (37%), Gaps = 45/309 (14%)
Query: 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLH 100
+ F ++KIG G +G V YKA G+++A++K+ +D + +
Sbjct: 2 ENFQKVEKIGEGTYGVV-YKARNK-LTGEVVALKKIRLDT-------ETEGVPS------ 46
Query: 101 WKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRREL 160
EI + H NI+ LL + N LV+EF+ + + + +
Sbjct: 47 ----TAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMD---ASALTGI 99
Query: 161 DWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGH 220
P + GL + H ++HRD+KP N+LI+ + +++DFG +
Sbjct: 100 PLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156
Query: 221 AQITVKCMVGTMGYMAPESL-QTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMD 279
T V T+ Y APE L + S DI+S G + A +V + F G +E
Sbjct: 157 RTYT--HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRAL---FPGDSEIDQ 211
Query: 280 MVKWMRNVIFSENPNRAINSKL--------------LGNGYEEQMLLVLKLACFCTLKDP 325
+ + R + + + + L DP
Sbjct: 212 LFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDP 271
Query: 326 DERPSSKDV 334
++R S+K
Sbjct: 272 NKRISAKAA 280
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 117 bits (294), Expect = 5e-31
Identities = 58/291 (19%), Positives = 104/291 (35%), Gaps = 48/291 (16%)
Query: 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLH 100
D FD +K +G+G +G V + +G A++ L KQ + + + H
Sbjct: 41 DQFDRIKTLGTGSFGRV-MLVKHK-ESGNHYAMKILD-----------KQKVVKLKQIEH 87
Query: 101 WKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRREL 160
+E ++ L + +V E++ G + L
Sbjct: 88 -----TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR----IGRF 138
Query: 161 DWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGH 220
P A I EYLH LI+RD+KP N+LID +++DFG K +
Sbjct: 139 SEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195
Query: 221 AQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDM 280
+ GT +APE + ++ + D ++ GVL+ + G P F + + +
Sbjct: 196 -----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQI 246
Query: 281 VKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSS 331
+ + + + +S L L D +R +
Sbjct: 247 YEKIVSGKVRFPSH--FSSDL------------KDLLRNLLQVDLTKRFGN 283
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 3e-30
Identities = 61/323 (18%), Positives = 117/323 (36%), Gaps = 63/323 (19%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
++ L KIG G +GEV +KA G+ +A++K++++ +
Sbjct: 12 YEKLAKIGQGTFGEV-FKARHR-KTGQKVALKKVLMENEKEGFPI--------------- 54
Query: 103 IGAIRSEIITANQTRHRNILPLL--------AHMVRPNCHLLVYEFMKNGSLQDILYDVS 154
EI +H N++ L+ + LV++F ++ +
Sbjct: 55 --TALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV-- 110
Query: 155 QGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGK 214
+ R+ + + L L+ HR +++HRD+K ANVLI D +++DFG +
Sbjct: 111 --LVKFTLSEIKRVMQML---LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 165
Query: 215 LMPDGHAQITVKC--MVGTMGYMAPESLQTET-ISDKCDIYSFGVLLAVLVMGKFPVDDF 271
+ V T+ Y PE L E D++ G ++A +
Sbjct: 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI---M 222
Query: 272 FGHTEE--------------------MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQML 311
G+TE+ +D + + + R + +L + L
Sbjct: 223 QGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYAL 282
Query: 312 LVLKLACFCTLKDPDERPSSKDV 334
++ + DP +R S D
Sbjct: 283 DLIDK---LLVLDPAQRIDSDDA 302
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 113 bits (283), Expect = 6e-30
Identities = 68/307 (22%), Positives = 123/307 (40%), Gaps = 47/307 (15%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
+ L+KIG G +G V YKA+ G+ A++K+ ++ K+D S +
Sbjct: 4 YHGLEKIGEGTYGVV-YKAQNN--YGETFALKKIRLE---------KEDEGIPSTTIR-- 49
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDW 162
EI + +H NI+ L + +LV+E + + + L+
Sbjct: 50 ------EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC----EGGLES 99
Query: 163 PARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQ 222
+ +G+ Y H R++HRD+KP N+LI+ + E +I+DFG +
Sbjct: 100 VTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP--V 154
Query: 223 ITVKCMVGTMGYMAPESLQ-TETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMV 281
+ T+ Y AP+ L ++ S DI+S G + A +V G F G +E ++
Sbjct: 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPL---FPGVSEADQLM 211
Query: 282 KWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACF--------------CTLKDPDE 327
+ R + + N ++L + L F DP++
Sbjct: 212 RIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQ 271
Query: 328 RPSSKDV 334
R ++K
Sbjct: 272 RITAKQA 278
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 2e-29
Identities = 60/308 (19%), Positives = 118/308 (38%), Gaps = 47/308 (15%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
++ L+KIG G +G V +KA+ +++A+++ ++ D D+
Sbjct: 4 YEKLEKIGEGTYGTV-FKAKNR-ETHEIVALKR------------VRLDDDDEGVPSS-- 47
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDW 162
EI + +H+NI+ L + LV+EF QD+ +LD
Sbjct: 48 ---ALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD----QDLKKYFDSCNGDLDP 100
Query: 163 PARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQ 222
+ GL + H + ++HRD+KP N+LI+ + E ++++FG +
Sbjct: 101 EIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157
Query: 223 ITVKCMVGTMGYMAPESLQTETISD-KCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMV 281
+ V T+ Y P+ L + D++S G + A L P F + D +
Sbjct: 158 YS--AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP---LFPGNDVDDQL 212
Query: 282 KWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLK---------------LACFCTLKDPD 326
K + ++ + + + L + M L +P
Sbjct: 213 KRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPV 272
Query: 327 ERPSSKDV 334
+R S+++
Sbjct: 273 QRISAEEA 280
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 1e-28
Identities = 62/313 (19%), Positives = 107/313 (34%), Gaps = 49/313 (15%)
Query: 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLL 99
+ L+ +GSG +G V A G +AI+KL P + K+
Sbjct: 17 RAVYRDLQPVGSGAYGAV-CSAVDG-RTGAKVAIKKL--YRPFQSELFAKR--------- 63
Query: 100 HWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRE 159
E+ RH N++ LL +F +
Sbjct: 64 ------AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK 117
Query: 160 LDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDG 219
L + + GL Y+H HRD+KP N+ +++D E +I DFG +
Sbjct: 118 LGEDRIQFLVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLAR----- 169
Query: 220 HAQITVKCMVGTMGYMAPES-LQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEM 278
A + V T Y APE L + DI+S G ++A ++ GK F ++ +
Sbjct: 170 QADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL----FKGSDHL 225
Query: 279 DMVKWMRNVIFSENPNRA-----------------INSKLLGNGYEEQMLLVLKLACFCT 321
D +K + V + + K + L + L
Sbjct: 226 DQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKML 285
Query: 322 LKDPDERPSSKDV 334
+ D ++R ++ +
Sbjct: 286 VLDAEQRVTAGEA 298
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 2e-28
Identities = 67/296 (22%), Positives = 114/296 (38%), Gaps = 43/296 (14%)
Query: 41 DCFDSLKKIGSGGWGEVFYKAELPGSN--GKMIAIRKLIVDAPMSAAELIKQDIDEYSDL 98
+ F+ LK +G+G +G+V + + GK+ A++ L + A+ +
Sbjct: 24 ENFELLKVLGTGAYGKV-FLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEH-------- 74
Query: 99 LHWKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHL-LVYEFMKNGSLQDILYDVSQGR 157
R+E R L L + + L L+ +++ G L L R
Sbjct: 75 -------TRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ----R 123
Query: 158 RELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMP 217
I LE+LH + +I+RDIK N+L+D + ++DFG K
Sbjct: 124 ERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180
Query: 218 DGHAQITVKCMVGTMGYMAPESLQT--ETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHT 275
+ GT+ YMAP+ ++ D +S GVL+ L+ G P F
Sbjct: 181 ADETERA-YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP---FTVDG 236
Query: 276 EEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSS 331
E+ + R ++ SE P S L + L+ + +KDP +R
Sbjct: 237 EKNSQAEISRRILKSEPPYPQEMSALAKD-------LIQR----LLMKDPKKRLGC 281
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 108 bits (269), Expect = 1e-27
Identities = 63/333 (18%), Positives = 120/333 (36%), Gaps = 67/333 (20%)
Query: 29 VEKQDLAFLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELI 88
E + + ++D + ++K+G G + EV ++A +N + + ++ L + I
Sbjct: 24 YESHVVEWGNQDD-YQLVRKLGRGKYSEV-FEAINI-TNNEKVVVKIL----KPVKKKKI 76
Query: 89 KQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLLAHMVRP--NCHLLVYEFMKNGSL 146
K++I I N NI+ L + P LV+E + N
Sbjct: 77 KREIK-----------------ILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF 119
Query: 147 QDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID-DDMEA 205
+ + + L I L+Y H ++HRD+KP NV+ID + +
Sbjct: 120 KQLY-------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKL 169
Query: 206 RISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISD-KCDIYSFGVLLAVLVMG 264
R+ D+G + G V + + PE L + D D++S G +LA ++
Sbjct: 170 RLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFR 226
Query: 265 KFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLL------------ 312
K P FF + D + + V+ +E+ I+ + +L
Sbjct: 227 KEP---FFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFV 283
Query: 313 -----------VLKLACFCTLKDPDERPSSKDV 334
L D R ++++
Sbjct: 284 HSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 101 bits (252), Expect = 5e-25
Identities = 53/271 (19%), Positives = 102/271 (37%), Gaps = 17/271 (6%)
Query: 46 LKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGA 105
++K+G G + V + A+ N +A++ IV E + +I +
Sbjct: 18 VRKLGWGHFSTV-WLAKDM-VNNTHVAMK--IVRGDKVYTEAAEDEIKLLQRVND----- 68
Query: 106 IRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDV-SQGRRELDWPA 164
++ + +IL LL H + + + +++L + R +
Sbjct: 69 --ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIY 126
Query: 165 RHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID-DDMEARISDFGHGKLMPDGHAQI 223
+I++ + GL+Y+ R +IH DIKP NVL++ D + L
Sbjct: 127 VKQISKQLLLGLDYM--HRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE 184
Query: 224 TVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGK--FPVDDFFGHTEEMDMV 281
+ T Y +PE L DI+S L+ L+ G F D+ +T++ D +
Sbjct: 185 HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244
Query: 282 KWMRNVIFSENPNRAINSKLLGNGYEEQMLL 312
+ ++ N K + + LL
Sbjct: 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLL 275
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 1e-24
Identities = 57/257 (22%), Positives = 94/257 (36%), Gaps = 42/257 (16%)
Query: 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
+ +LK IGSG G V A + +AI+K + + +
Sbjct: 19 YQNLKPIGSGAQGIV-CAAYDA-VLDRNVAIKK------------LSRPFQNQTHAKR-- 62
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNC------HLLVYEFMKNGSLQDILYDVSQG 156
E++ H+NI+ LL LV E M Q I
Sbjct: 63 ---AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI------- 112
Query: 157 RRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLM 216
+ ELD + + G+++LH IHRD+KP+N+++ D +I DFG +
Sbjct: 113 QMELDHERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTA 169
Query: 217 PDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTE 276
+ V T Y APE + + DI+S G ++ +V K F +
Sbjct: 170 GTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKIL----FPGRD 222
Query: 277 EMDMVKWMRNVIFSENP 293
+D + + + P
Sbjct: 223 YIDQWNKVIEQLGTPCP 239
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.3 bits (236), Expect = 7e-23
Identities = 57/310 (18%), Positives = 101/310 (32%), Gaps = 45/310 (14%)
Query: 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLH 100
+ + +L +GSG +G V A G +A++KL P + K+
Sbjct: 18 ERYQNLSPVGSGAYGSV-CAAFDT-KTGLRVAVKKL--SRPFQSIIHAKR---------- 63
Query: 101 WKIGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRREL 160
E+ +H N++ LL + L + ++L
Sbjct: 64 -----TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 118
Query: 161 DWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGH 220
+ I GL H +IHRD+KP+N+ +++D E +I DFG + D
Sbjct: 119 TDDHVQFLIYQILRGL---KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM 175
Query: 221 AQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDM 280
+ L + DI+S G ++A L+ G+ F G +
Sbjct: 176 TG----YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL---FPGTDHIDQL 228
Query: 281 VKWMRNVIFSENPNRAINSKLLGNGYEEQML----------------LVLKLACFCTLKD 324
+R V S Y + + L + L + D
Sbjct: 229 KLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 288
Query: 325 PDERPSSKDV 334
D+R ++
Sbjct: 289 SDKRITAAQA 298
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 62.1 bits (150), Expect = 4e-12
Identities = 21/169 (12%), Positives = 49/169 (28%), Gaps = 24/169 (14%)
Query: 44 DSL-KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWK 102
D++ K +G G V + ++ ++ + + +
Sbjct: 2 DAIGKLMGEGKESAV-FNCYSE--KFGECVVKFH---------KVGHTSFKKVKEKRDYG 49
Query: 103 IGAIRSEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDW 162
I + + R + L + VY + N L + ++ +
Sbjct: 50 DLHFSVLAIRSARNEFRALQKL-----QGLAVPKVYAWEGNAVLME--LIDAKELYRVRV 102
Query: 163 PARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFG 211
+ I + + ++H D+ NVL+ + I DF
Sbjct: 103 ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLV-SEEGIWIIDFP 147
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 337 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.71 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.13 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.96 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.69 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.57 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.12 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-57 Score=387.81 Aligned_cols=255 Identities=24% Similarity=0.422 Sum_probs=206.3
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
++|++++.||+|+||+||++.+.. +|+.||+|++........ .+.+.+|+.++++++|||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~--~~~~vAiK~i~~~~~~~~------------------~~~~~~Ei~~l~~l~Hpn 64 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRV--TEEAVAVKIVDMKRAVDC------------------PENIKKEICINKMLNHEN 64 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEECC-------------------------CHHHHHHHHHTCCCTT
T ss_pred cceEEEEEEecCcCeEEEEEEECC--CCCEEEEEEEehhhcchH------------------HHHHHHHHHHHHhCCCCC
Confidence 579999999999999999999976 899999999865432211 146788999999999999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
|+++++++.+++..|+|||||++|+|.+++ .....+++..+..++.||+.||.|| |++|++||||||+||+++
T Consensus 65 Iv~~~~~~~~~~~~~ivmEy~~gg~L~~~l----~~~~~l~e~~~~~i~~qi~~al~yl---H~~~IiHrDiKp~NILl~ 137 (271)
T d1nvra_ 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYL---HGIGITHRDIKPENLLLD 137 (271)
T ss_dssp BCCEEEEEEETTEEEEEEECCTTEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEEC
T ss_pred EeeEeeeeccCceeEEEEeccCCCcHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHH---HHcCCccCcccHHHEEEC
Confidence 999999999999999999999999999988 4556799999999999999999999 667999999999999999
Q ss_pred CCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCC-CCcccchhhhHHHHHHHhCCCCCCCCCCCchhhh
Q 040898 201 DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETI-SDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMD 279 (337)
Q Consensus 201 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~ 279 (337)
.++.+||+|||++................||+.|+|||++.+..+ +.++|||||||++|+|++|.+||....... ..
T Consensus 138 ~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~--~~ 215 (271)
T d1nvra_ 138 ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC--QE 215 (271)
T ss_dssp TTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS--HH
T ss_pred CCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH--HH
Confidence 999999999999987654443333445679999999999988776 578999999999999999999997543221 11
Q ss_pred HHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 280 MVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
..... ...... ......+..+.+|+.+||+.||++|||++|+|+|
T Consensus 216 ~~~~~-~~~~~~------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 216 YSDWK-EKKTYL------------NPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp HHHHH-TTCTTS------------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHh-cCCCCC------------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11111 110000 0111223457899999999999999999999987
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-56 Score=383.45 Aligned_cols=253 Identities=25% Similarity=0.397 Sum_probs=207.8
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|+++++||+|+||+||++.+.. +|+.||+|++........ +.+.+|+.++++++|
T Consensus 18 p~~~Y~~~~~iG~G~fg~Vy~a~~~~--~~~~vAvK~~~~~~~~~~-------------------~~~~~E~~il~~l~H 76 (293)
T d1yhwa1 18 PKKKYTRFEKIGQGASGTVYTAMDVA--TGQEVAIRQMNLQQQPKK-------------------ELIINEILVMRENKN 76 (293)
T ss_dssp TTTTBCSCEECCCSSSCEEEEEEBTT--TCCEEEEEEEEGGGCSCH-------------------HHHHHHHHHHHHCCC
T ss_pred cccccEEEEEEecCcCcEEEEEEECC--CCCEEEEEEEecccChHH-------------------HHHHHHHHHHHhCCC
Confidence 45689999999999999999999876 899999999865433221 467889999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++++.+++.+|+|||||++|+|.+++.. ..+++..+..++.||+.||.|| |++|++||||||+||+
T Consensus 77 pnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yL---H~~~iiHrDiKp~NIL 148 (293)
T d1yhwa1 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFL---HSNQVIHRDIKSDNIL 148 (293)
T ss_dssp TTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEE
T ss_pred CCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHH---HHCCCcccCCcHHHeE
Confidence 9999999999999999999999999999998743 3589999999999999999999 6679999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhh
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEM 278 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~ 278 (337)
++.++.+||+|||++......... .....||+.|+|||++.+..++.++|||||||++|+|++|.+||.... ...
T Consensus 149 l~~~~~vkl~DFG~a~~~~~~~~~--~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~---~~~ 223 (293)
T d1yhwa1 149 LGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN---PLR 223 (293)
T ss_dssp ECTTCCEEECCCTTCEECCSTTCC--BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHH
T ss_pred ECCCCcEeeccchhheeecccccc--ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC---HHH
Confidence 999999999999999876543322 234579999999999999999999999999999999999999996432 111
Q ss_pred hHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 279 DMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.+...... ..+.. ..++..+..+.+|+.+||+.||++|||+.|+|+|
T Consensus 224 ~~~~~~~~----~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 224 ALYLIATN----GTPEL--------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp HHHHHHHH----CSCCC--------SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred HHHHHHhC----CCCCC--------CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 12111111 11100 1112233458999999999999999999999987
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-56 Score=380.13 Aligned_cols=250 Identities=25% Similarity=0.366 Sum_probs=206.0
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
++|++++.||+|+||.||++.+.. +++.||+|++........ .....+.+|+.+++.++|||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~--~~~~vAiK~i~~~~~~~~----------------~~~~~~~~E~~il~~l~hpn 67 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQ--SKFILALKVLFKAQLEKA----------------GVEHQLRREVEIQSHLRHPN 67 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEEHHHHHHT----------------TCHHHHHHHHHHHHTCCCTT
T ss_pred hHeEEEEEEecCCCcEEEEEEECC--CCcEEEEEEEchHHccCh----------------HHHHHHHHHHHHHHhcCCCC
Confidence 579999999999999999999976 899999999864321110 01156788999999999999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
|+++++++.+++..|+|||||++|+|.+++.. ...+++..+..++.||+.||.|| |++|++||||||+||+++
T Consensus 68 Iv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~l---H~~~ivHrDiKp~Nill~ 140 (263)
T d2j4za1 68 ILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYC---HSKRVIHRDIKPENLLLG 140 (263)
T ss_dssp BCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEEC
T ss_pred CCeEEEEEEECCEEEEEEeecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeeeeccccceec
Confidence 99999999999999999999999999999953 34689999999999999999999 667999999999999999
Q ss_pred CCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhH
Q 040898 201 DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDM 280 (337)
Q Consensus 201 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~ 280 (337)
.++.+||+|||++....... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ....
T Consensus 141 ~~~~~kl~DFG~a~~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~----~~~~ 212 (263)
T d2j4za1 141 SAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT----YQET 212 (263)
T ss_dssp TTSCEEECCCCSCSCCCCCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS----HHHH
T ss_pred CCCCEeecccceeeecCCCc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC----HHHH
Confidence 99999999999997765432 234579999999999999999999999999999999999999996421 1122
Q ss_pred HHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 281 VKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.. ......... +...++.+.+|+.+||+.||++|||++|+|+|
T Consensus 213 ~~---~i~~~~~~~-----------p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 213 YK---RISRVEFTF-----------PDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp HH---HHHTTCCCC-----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred HH---HHHcCCCCC-----------CccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 22 111111110 11123458899999999999999999999997
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-56 Score=381.04 Aligned_cols=260 Identities=23% Similarity=0.341 Sum_probs=198.9
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
.++|++++.||+|+||.||++.+.. +|+.||+|.+......... .+.+.+|+.++++++||
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~--~~~~vAvK~i~~~~~~~~~-----------------~~~~~~E~~il~~l~Hp 63 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKS--DGKILVWKELDYGSMTEAE-----------------KQMLVSEVNLLRELKHP 63 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEECCTTSCHHH-----------------HHHHHHHHHHTTSCCCT
T ss_pred chhCEEeEEEecCCCeEEEEEEECC--CCCEEEEEEEChhhCCHHH-----------------HHHHHHHHHHHHHCCCC
Confidence 4789999999999999999999876 8999999998765432221 15688899999999999
Q ss_pred CcccceeEEEc--CCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCC--CCCeEecCCCCC
Q 040898 120 NILPLLAHMVR--PNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCH--RPRLIHRDIKPA 195 (337)
Q Consensus 120 niv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h--~~gi~h~di~~~ 195 (337)
||+++++++.+ ++.+|+|||||++|+|.+++......+..+++..++.++.||+.||.|||+.. ..+++||||||+
T Consensus 64 nIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~ 143 (269)
T d2java1 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPA 143 (269)
T ss_dssp TBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGG
T ss_pred CEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchh
Confidence 99999998864 46689999999999999999765555677999999999999999999996532 245999999999
Q ss_pred ceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCc
Q 040898 196 NVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHT 275 (337)
Q Consensus 196 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~ 275 (337)
||+++.++.+||+|||++......... .....||+.|+|||++.+..++.++|||||||++|+|++|.+||.....
T Consensus 144 NIll~~~~~vkl~DFG~a~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~-- 219 (269)
T d2java1 144 NVFLDGKQNVKLGDFGLARILNHDTSF--AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-- 219 (269)
T ss_dssp GEEECTTSCEEECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--
T ss_pred hcCcCCCCcEEEeeccceeecccCCCc--cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH--
Confidence 999999999999999999876543222 2345799999999999999999999999999999999999999965321
Q ss_pred hhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 276 EEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.++...+........ +...++.+.+|+.+||+.||++|||+.|+++|
T Consensus 220 --~~~~~~i~~~~~~~~-------------~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 220 --KELAGKIREGKFRRI-------------PYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp --HHHHHHHHHTCCCCC-------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --HHHHHHHHcCCCCCC-------------CcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 222222222111111 11123458999999999999999999999997
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-55 Score=377.10 Aligned_cols=255 Identities=22% Similarity=0.314 Sum_probs=205.3
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..+.|++++.||+|+||.||++.+.. +++.||+|++....... .+.+.+|+.++++++|
T Consensus 10 p~d~Y~i~~~iG~G~fg~Vy~~~~~~--~~~~vAvK~i~~~~~~~-------------------~~~~~~E~~il~~l~H 68 (288)
T d2jfla1 10 PEDFWEIIGELGDGAFGKVYKAQNKE--TSVLAAAKVIDTKSEEE-------------------LEDYMVEIDILASCDH 68 (288)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEECSSSGG-------------------GGGTHHHHHHHHHCCC
T ss_pred cccCeEEeEEEeeCCCcEEEEEEECC--CCeEEEEEEECcCCHHH-------------------HHHHHHHHHHHHhCCC
Confidence 44679999999999999999999876 89999999986543221 1567889999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++++.+++..++|||||++|+|.+++.. ...++++..+..++.||+.||.|| |++|++||||||+||+
T Consensus 69 pnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~---~~~~l~e~~~~~i~~qi~~gL~yl---H~~~ivHrDiKp~NIl 142 (288)
T d2jfla1 69 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE---LERPLTESQIQVVCKQTLDALNYL---HDNKIIHRDLKAGNIL 142 (288)
T ss_dssp TTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEE
T ss_pred CCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH---HHCCEEEeecChhhee
Confidence 9999999999999999999999999999998754 234699999999999999999999 6679999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccc-----cCCCCCcccchhhhHHHHHHHhCCCCCCCCCC
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQ-----TETISDKCDIYSFGVLLAVLVMGKFPVDDFFG 273 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~-----~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~ 273 (337)
++.++.+||+|||++........ ......||+.|+|||++. +..++.++|||||||++|+|++|..||.+...
T Consensus 143 l~~~~~~Kl~DFG~a~~~~~~~~--~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~ 220 (288)
T d2jfla1 143 FTLDGDIKLADFGVSAKNTRTIQ--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP 220 (288)
T ss_dssp ECTTSCEEECCCTTCEECHHHHH--HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG
T ss_pred ECCCCCEEEEechhhhccCCCcc--cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH
Confidence 99999999999999865432211 122457999999999984 45578999999999999999999999965422
Q ss_pred CchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 274 HTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
. ..+.... ....+.. ..++..+..+.+|+.+||+.||++|||+.|+++|
T Consensus 221 ~---~~~~~i~----~~~~~~~--------~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 221 M---RVLLKIA----KSEPPTL--------AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp G---GHHHHHH----HSCCCCC--------SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred H---HHHHHHH----cCCCCCC--------CccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1 1111111 1111110 1112234458999999999999999999999987
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-55 Score=380.70 Aligned_cols=255 Identities=24% Similarity=0.336 Sum_probs=203.3
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++++.||+|+||.||++.+.. +++.||||++........ ...+.+.+|+.++++++|
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~--~~~~vAvK~i~~~~~~~~----------------~~~~~~~~E~~il~~l~H 67 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLARELA--TSREYAIKILEKRHIIKE----------------NKVPYVTRERDVMSRLDH 67 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT--TCCEEEEEEEEHHHHHHT----------------TCHHHHHHHHHHHHHCCS
T ss_pred CCCCCEEEEEEeeCCCeEEEEEEECC--CCCEEEEEEEehHHccCH----------------HHHHHHHHHHHHHHHcCC
Confidence 34679999999999999999999976 899999999864321110 112578899999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++++.+++..|+||||+++|+|.+++.. .+.+++..+..++.|++.||.|| |++|++||||||+||+
T Consensus 68 pnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~yl---H~~~iiHrDiKp~NIl 140 (288)
T d1uu3a_ 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYL---HGKGIIHRDLKPENIL 140 (288)
T ss_dssp TTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEE
T ss_pred CCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhh---ccccEEcCcCCccccc
Confidence 9999999999999999999999999999998843 45699999999999999999999 6679999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhh
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEM 278 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~ 278 (337)
++.++.++|+|||++................||+.|+|||++.+..++.++|||||||++|+|++|..||.... ..
T Consensus 141 l~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----~~ 216 (288)
T d1uu3a_ 141 LNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN----EY 216 (288)
T ss_dssp ECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS----HH
T ss_pred cCCCceEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC----HH
Confidence 99999999999999988765444434445679999999999999999999999999999999999999996431 12
Q ss_pred hHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 279 DMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
.....+ ....... +...+..+.+|+.+||+.||++|||++|+++
T Consensus 217 ~~~~~i---~~~~~~~-----------p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 217 LIFQKI---IKLEYDF-----------PEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp HHHHHH---HTTCCCC-----------CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred HHHHHH---HcCCCCC-----------CccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 222211 1111110 0112344889999999999999999999753
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-55 Score=389.46 Aligned_cols=269 Identities=23% Similarity=0.373 Sum_probs=205.2
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
++++|+++++||+|+||+||++.+.. +|+.||+|++......... ..+.+|+.++++++|
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~--~~~~vAiK~i~~~~~~~~~------------------~~~~~Ei~il~~l~H 63 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKP--SGLVMARKLIHLEIKPAIR------------------NQIIRELQVLHECNS 63 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETT--TTEEEEEEEEECCCCTTHH------------------HHHHHHGGGGGGCCC
T ss_pred CccCCEEEEEEecCCCeEEEEEEECC--CCcEEEEEEEChhhCHHHH------------------HHHHHHHHHHHhCCC
Confidence 46789999999999999999999876 8999999998765432221 467889999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++++.+++.+|+||||+++|+|.+++.. ...+++..+..++.|++.||.|||+ .+||+||||||+||+
T Consensus 64 pnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NIL 137 (322)
T d1s9ja_ 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNIL 137 (322)
T ss_dssp TTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEE
T ss_pred CCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHee
Confidence 9999999999999999999999999999999954 3468999999999999999999952 248999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhh
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEM 278 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~ 278 (337)
++.++.+||+|||+|....... .....||+.|+|||++.+..++.++||||+||++|+|++|+.||..........
T Consensus 138 l~~~~~vkl~DFGla~~~~~~~----~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~ 213 (322)
T d1s9ja_ 138 VNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 213 (322)
T ss_dssp ECTTCCEEECCCCCCHHHHHHT----C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHH
T ss_pred ECCCCCEEEeeCCCccccCCCc----cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 9999999999999998653321 234579999999999999999999999999999999999999996533221110
Q ss_pred hHHHHHHhhhcc------------------CCc----chhhh----hcccCCchHHHHHHHHHHHhhhccCCCCCCCChh
Q 040898 279 DMVKWMRNVIFS------------------ENP----NRAIN----SKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSK 332 (337)
Q Consensus 279 ~~~~~~~~~~~~------------------~~~----~~~~~----~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ 332 (337)
............ ..+ ..... ...........+.++.+|+.+||+.||++|||++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ 293 (322)
T d1s9ja_ 214 MFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 293 (322)
T ss_dssp HC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHH
Confidence 000000000000 000 00000 0000000001234588999999999999999999
Q ss_pred hhhcC
Q 040898 333 DVRSM 337 (337)
Q Consensus 333 ell~~ 337 (337)
|+|+|
T Consensus 294 e~L~H 298 (322)
T d1s9ja_ 294 QLMVH 298 (322)
T ss_dssp HHHTS
T ss_pred HHhhC
Confidence 99997
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-54 Score=368.11 Aligned_cols=252 Identities=23% Similarity=0.374 Sum_probs=199.0
Q ss_pred cccc-cccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 40 EDCF-DSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 40 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
+++| ++.++||+|+||+||++.+.. ++..||+|.+......... .+.+.+|+.++++++|
T Consensus 7 ~gry~~~~~~iG~G~fg~Vy~~~~~~--~~~~va~K~i~~~~~~~~~-----------------~~~~~~E~~il~~l~H 67 (270)
T d1t4ha_ 7 DGRFLKFDIEIGRGSFKTVYKGLDTE--TTVEVAWCELQDRKLTKSE-----------------RQRFKEEAEMLKGLQH 67 (270)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEEGGGSCHHH-----------------HHHHHHHHHHHTTCCC
T ss_pred CCCEEEeeeEEecCcCcEEEEEEECC--CCeEEEEEEEchhhCCHHH-----------------HHHHHHHHHHHHhCCC
Confidence 3455 677889999999999999876 8999999998765432211 1568899999999999
Q ss_pred CCcccceeEEEc----CCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCC--eEecCC
Q 040898 119 RNILPLLAHMVR----PNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPR--LIHRDI 192 (337)
Q Consensus 119 pniv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~g--i~h~di 192 (337)
|||+++++++.+ +..+|+||||+++|+|.+++.. ...+++..+..++.||+.||.|| |+++ ++||||
T Consensus 68 pnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yL---H~~~~~IiHrDi 140 (270)
T d1t4ha_ 68 PNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFL---HTRTPPIIHRDL 140 (270)
T ss_dssp TTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HTSSSCCCCSCC
T ss_pred CCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHH---HHCCCCEEeCCc
Confidence 999999999865 4568999999999999999954 35689999999999999999999 5566 999999
Q ss_pred CCCceeec-CCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCC
Q 040898 193 KPANVLID-DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDF 271 (337)
Q Consensus 193 ~~~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~ 271 (337)
||+||+++ .++.+||+|||++........ ....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.
T Consensus 141 Kp~NILl~~~~~~~Kl~DFGla~~~~~~~~----~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~ 215 (270)
T d1t4ha_ 141 KCDNIFITGPTGSVKIGDLGLATLKRASFA----KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC 215 (270)
T ss_dssp CGGGEEESSTTSCEEECCTTGGGGCCTTSB----EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ChhhceeeCCCCCEEEeecCcceeccCCcc----CCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCc
Confidence 99999997 478999999999986544322 34579999999999876 5899999999999999999999999643
Q ss_pred CCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 272 FGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.. ...+.. .......+. ... ......+.+|+.+||+.||++|||++|+|+|
T Consensus 216 ~~---~~~~~~---~i~~~~~~~-~~~--------~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 216 QN---AAQIYR---RVTSGVKPA-SFD--------KVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp SS---HHHHHH---HHTTTCCCG-GGG--------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cc---HHHHHH---HHHcCCCCc-ccC--------ccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 22 122222 221111111 111 1112348899999999999999999999997
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.9e-54 Score=377.06 Aligned_cols=252 Identities=25% Similarity=0.404 Sum_probs=204.1
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..+.|+.++.||+|+||.||++.+.. +++.||||++.......... ...+.+|+.++++++|
T Consensus 13 p~~~y~~l~~lG~G~fg~Vy~a~~~~--~~~~vAvK~i~~~~~~~~~~----------------~~~~~~Ei~il~~l~H 74 (309)
T d1u5ra_ 13 PEKLFSDLREIGHGSFGAVYFARDVR--NSEVVAIKKMSYSGKQSNEK----------------WQDIIKEVRFLQKLRH 74 (309)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETT--TTEEEEEEEEECCSSCHHHH----------------HHHHHHHHHHHTTCCC
T ss_pred cHHhcEeeEEEecCCCeEEEEEEECC--CCcEEEEEEEchhhccCHHH----------------HHHHHHHHHHHHHCCC
Confidence 34569999999999999999999876 89999999987655433221 1568899999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++++.+++..|+|||||++|+|..++. .+.++++..++.++.||+.||.|| |++|++||||||+|||
T Consensus 75 pnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~----~~~~l~e~~~~~i~~qi~~aL~yL---H~~~iiHrDiKp~NIL 147 (309)
T d1u5ra_ 75 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYL---HSHNMIHRDVKAGNIL 147 (309)
T ss_dssp TTBCCEEEEEEETTEEEEEEECCSEEHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCSGGGEE
T ss_pred CCEeeEEEEEEECCEEEEEEEecCCCchHHHHH----hCCCCCHHHHHHHHHHHHHHHHHH---HhCCEeccCCCcceEE
Confidence 999999999999999999999999999877663 345699999999999999999999 6679999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCcccccc---CCCCCcccchhhhHHHHHHHhCCCCCCCCCCCc
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQT---ETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHT 275 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~---~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~ 275 (337)
++.++.+||+|||++...... ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..
T Consensus 148 l~~~~~~Kl~DFG~a~~~~~~------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~--- 218 (309)
T d1u5ra_ 148 LSEPGLVKLGDFGSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--- 218 (309)
T ss_dssp EETTTEEEECCCTTCBSSSSB------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---
T ss_pred ECCCCCEEEeecccccccCCC------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC---
Confidence 999999999999999865432 23579999999999864 357889999999999999999999986432
Q ss_pred hhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 276 EEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
....+.. ......+.. .....++.+.+|+.+||+.||++|||++|+|+|
T Consensus 219 ~~~~~~~----i~~~~~~~~---------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 219 AMSALYH----IAQNESPAL---------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp HHHHHHH----HHHSCCCCC---------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred HHHHHHH----HHhCCCCCC---------CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 1111111 111111110 001123458999999999999999999999987
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.5e-55 Score=380.01 Aligned_cols=254 Identities=24% Similarity=0.371 Sum_probs=192.2
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
.++|++.+.||+|+||+||++.+.. +++.||||++......... ..+.+|+.++++++||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~--~~~~vAvK~i~~~~~~~~~------------------~~~~~Ei~il~~l~Hp 67 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKR--TQKLVAIKCIAKKALEGKE------------------GSMENEIAVLHKIKHP 67 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETT--TCCEEEEEEEEC----------------------------CHHHHHHHTCCCT
T ss_pred ccceEEEEEEeeccCeEEEEEEECC--CCCEEEEEEEchHHhhhHH------------------HHHHHHHHHHHhCCCC
Confidence 4669999999999999999999876 8999999998755432211 4577899999999999
Q ss_pred CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceee
Q 040898 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI 199 (337)
Q Consensus 120 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~ 199 (337)
||+++++++.+++.+|+|||||+||+|.+++. ....+++..+..++.||+.||.|| |++|++||||||+||++
T Consensus 68 nIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~al~yl---H~~~iiHrDiKp~Nil~ 140 (307)
T d1a06a_ 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIV----EKGFYTERDASRLIFQVLDAVKYL---HDLGIVHRDLKPENLLY 140 (307)
T ss_dssp TBCCEEEEEECSSEEEEEECCCCSCBHHHHHH----TCSCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEE
T ss_pred CCCcEEEEEEECCEEEEEEeccCCCcHHHhhh----cccCCCHHHHHHHHHHHHHHHHhh---hhceeeeEEecccceee
Confidence 99999999999999999999999999999994 456799999999999999999999 66799999999999999
Q ss_pred c---CCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCch
Q 040898 200 D---DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTE 276 (337)
Q Consensus 200 ~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~ 276 (337)
. .++.+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|.+||.+..
T Consensus 141 ~~~~~~~~vkl~DFG~a~~~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---- 213 (307)
T d1a06a_ 141 YSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN---- 213 (307)
T ss_dssp SSSSTTCCEEECCC---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS----
T ss_pred cccCCCceEEEeccceeEEccCCCe---eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC----
Confidence 5 478999999999986544322 234579999999999999999999999999999999999999996432
Q ss_pred hhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 277 EMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.......+.. ...... .+..+..+..+.+|+.+||+.||++|||+.|+++|
T Consensus 214 ~~~~~~~i~~---~~~~~~-------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 214 DAKLFEQILK---AEYEFD-------SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp HHHHHHHHHT---TCCCCC-------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHhc---cCCCCC-------CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 1222222211 111100 11112233458999999999999999999999987
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.4e-53 Score=378.70 Aligned_cols=255 Identities=22% Similarity=0.335 Sum_probs=207.7
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
.-++|++++.||+|+||.||++.+.. +|+.||||++....... .+.+.+|+.++++++|
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~--~g~~vAvK~i~~~~~~~-------------------~~~~~~E~~il~~l~H 82 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERA--TGNNFAAKFVMTPHESD-------------------KETVRKEIQTMSVLRH 82 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETT--TTEEEEEEEECCCSHHH-------------------HHHHHHHHHHHHHTCC
T ss_pred CccCeEEEEEEecCcCeEEEEEEECC--CCCEEEEEEEcccchhh-------------------HHHHHHHHHHHHhCCC
Confidence 34579999999999999999999876 89999999986543211 1567889999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++++.+++.+|+|||||++|+|.+++.. ....+++..+..++.||+.||.|| |++|++||||||+||+
T Consensus 83 pnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~yl---H~~~iiHrDiKp~NIl 156 (350)
T d1koaa2 83 PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHM---HENNYVHLDLKPENIM 156 (350)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEE
T ss_pred CCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHH---HhcCCeeeeechhHee
Confidence 9999999999999999999999999999998842 345699999999999999999999 6679999999999999
Q ss_pred ec--CCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCch
Q 040898 199 ID--DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTE 276 (337)
Q Consensus 199 ~~--~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~ 276 (337)
++ .++.+||+|||++......... ....||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 157 l~~~~~~~vkL~DFG~a~~~~~~~~~---~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~---- 229 (350)
T d1koaa2 157 FTTKRSNELKLIDFGLTAHLDPKQSV---KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN---- 229 (350)
T ss_dssp ESSTTSCCEEECCCTTCEECCTTSCE---EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS----
T ss_pred eccCCCCeEEEeecchheeccccccc---ceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC----
Confidence 96 4678999999999877654332 34579999999999999999999999999999999999999996431
Q ss_pred hhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 277 EMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
..+....+........ ....+..++.+.+|+.+||+.||++|||++|+|+|
T Consensus 230 ~~~~~~~i~~~~~~~~----------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 230 DDETLRNVKSCDWNMD----------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp HHHHHHHHHHTCCCSC----------CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHHhCCCCCC----------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1222222211111111 01112233458999999999999999999999987
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.2e-53 Score=376.75 Aligned_cols=255 Identities=22% Similarity=0.326 Sum_probs=207.8
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++++.||+|+||.||++.+.. +|+.||||++........ ..+.+|+.++++++|
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~--~~~~vAiK~i~~~~~~~~-------------------~~~~~Ei~il~~l~H 85 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKA--TGRVFVAKFINTPYPLDK-------------------YTVKNEISIMNQLHH 85 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEECCSHHHH-------------------HHHHHHHHHHTTCCS
T ss_pred cccceEEEEEEecCCCeEEEEEEECC--CCCEEEEEEECCcchhHH-------------------HHHHHHHHHHHhCCC
Confidence 34579999999999999999999876 899999999865432111 467789999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++++.+++.+|+|||||++|+|.+++. ..+.++++..++.++.||+.||.|| |++|++||||||+|||
T Consensus 86 pnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~---~~~~~l~e~~~~~i~~qi~~aL~yl---H~~~iiHRDiKp~NIL 159 (352)
T d1koba_ 86 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHM---HEHSIVHLDIKPENIM 159 (352)
T ss_dssp TTBCCEEEEEECSSEEEEEEECCCCCBHHHHTT---CTTCCBCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEE
T ss_pred CCCCcEEEEEEECCEEEEEEEcCCCChHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeccccccccc
Confidence 999999999999999999999999999988763 3445699999999999999999999 6679999999999999
Q ss_pred ec--CCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCch
Q 040898 199 ID--DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTE 276 (337)
Q Consensus 199 ~~--~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~ 276 (337)
++ .++.+||+|||++......... ....+|+.|+|||++.+..++.++|||||||++|+|++|..||.+..
T Consensus 160 l~~~~~~~vkL~DFGla~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~---- 232 (352)
T d1koba_ 160 CETKKASSVKIIDFGLATKLNPDEIV---KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED---- 232 (352)
T ss_dssp ESSTTCCCEEECCCTTCEECCTTSCE---EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS----
T ss_pred ccccCCCeEEEeecccceecCCCCce---eeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC----
Confidence 97 6789999999999887654332 33579999999999999999999999999999999999999996432
Q ss_pred hhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 277 EMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.......+... .... .....+..+..+.+|+.+||+.||++|||+.|+|+|
T Consensus 233 ~~~~~~~i~~~---~~~~-------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 233 DLETLQNVKRC---DWEF-------DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp HHHHHHHHHHC---CCCC-------CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHhC---CCCC-------CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 12222222211 1110 011112233458999999999999999999999987
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-53 Score=369.16 Aligned_cols=259 Identities=22% Similarity=0.322 Sum_probs=207.4
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
.++|++++.||+|+||.||++.+.. +|+.||||++........... ...+.+.+|+.++++++||
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~--~~~~~AvK~i~~~~~~~~~~~-------------~~~~~~~~E~~il~~l~Hp 73 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKS--TGLQYAAKFIKKRRTKSSRRG-------------VSREDIEREVSILKEIQHP 73 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEEBCSSTTCSSS-------------BCHHHHHHHHHHHHHCCCT
T ss_pred ccCEEEeEEEecCCCeEEEEEEECC--CCCEEEEEEEEhhhcchhhhh-------------HHHHHHHHHHHHHHhCCCC
Confidence 4679999999999999999999876 899999999876543221100 0015788999999999999
Q ss_pred CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceee
Q 040898 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI 199 (337)
Q Consensus 120 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~ 199 (337)
||+++++++.+++..|+|||||++|+|.+++.. ...+++..++.++.|++.||.|| |++|++||||||+||++
T Consensus 74 nIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yL---H~~~ivHrDiKp~Nill 146 (293)
T d1jksa_ 74 NVITLHEVYENKTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYL---HSLQIAHFDLKPENIML 146 (293)
T ss_dssp TBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEE
T ss_pred CCCcEEEEEEECCEEEEEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhh---hhcceeecccccceEEE
Confidence 999999999999999999999999999999954 34699999999999999999999 67799999999999999
Q ss_pred cCCC----CeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCc
Q 040898 200 DDDM----EARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHT 275 (337)
Q Consensus 200 ~~~~----~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~ 275 (337)
+.++ .+|++|||++........ .....+|+.|+|||++.+..++.++||||+||++|+|++|..||.+..
T Consensus 147 ~~~~~~~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--- 220 (293)
T d1jksa_ 147 LDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--- 220 (293)
T ss_dssp SCSSSSSCCEEECCCTTCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---
T ss_pred ecCCCcccceEecchhhhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC---
Confidence 8776 599999999987654432 234578999999999999999999999999999999999999986432
Q ss_pred hhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 276 EEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
..+....+.. ....... ..++..+..+.+|+.+||+.||++|||++|+|+|
T Consensus 221 -~~~~~~~i~~---~~~~~~~-------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 221 -KQETLANVSA---VNYEFED-------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp -HHHHHHHHHT---TCCCCCH-------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -HHHHHHHHHh---cCCCCCc-------hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1112111111 1111000 0111223458899999999999999999999987
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.2e-53 Score=368.22 Aligned_cols=253 Identities=25% Similarity=0.338 Sum_probs=206.1
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
.++|++.+.||+|+||+||++.+.. +++.||||++..+.... +.+.+|+.++++++||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~--~~~~vAvK~i~~~~~~~--------------------~~~~~E~~il~~l~Hp 73 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKK--YSLTVAVKTLKEDTMEV--------------------EEFLKEAAVMKEIKHP 73 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGG--GTEEEEEEECCTTCSCH--------------------HHHHHHHHHHHHCCCT
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECC--CCeEEEEEEECCccchH--------------------HHHHHHHHHHHhCCCC
Confidence 4679999999999999999999976 89999999986543211 4678899999999999
Q ss_pred CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceee
Q 040898 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI 199 (337)
Q Consensus 120 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~ 199 (337)
||+++++++.+++..++||||+++|+|.+++.. .....+++..+..++.||+.||.|| |++|++||||||+|||+
T Consensus 74 nIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yL---H~~~iiHrDlKp~NILl 148 (287)
T d1opja_ 74 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYL---EKKNFIHRDLAARNCLV 148 (287)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHH--SCTTTSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEE
T ss_pred CEecCCccEeeCCeeEEEeecccCcchHHHhhh--ccccchHHHHHHHHHHHHHHHHHHH---HHCCcccCccccCeEEE
Confidence 999999999999999999999999999999865 4456789999999999999999999 66799999999999999
Q ss_pred cCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhh
Q 040898 200 DDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMD 279 (337)
Q Consensus 200 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~ 279 (337)
+.++.+||+|||++......... ......+++.|+|||++.+..++.++||||+|+++|+|++|..||.... ....
T Consensus 149 ~~~~~~Kl~DFG~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~---~~~~ 224 (287)
T d1opja_ 149 GENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI---DLSQ 224 (287)
T ss_dssp CGGGCEEECCCCCTTTCCSSSSE-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC---CHHH
T ss_pred CCCCcEEEccccceeecCCCCce-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc---hHHH
Confidence 99999999999999876554333 2233458899999999999999999999999999999999776653321 1222
Q ss_pred HHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 280 MVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
..+.+....... .+...+..+.+|+.+||+.||++|||+.++++
T Consensus 225 ~~~~i~~~~~~~-------------~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 225 VYELLEKDYRME-------------RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp HHHHHHTTCCCC-------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhcCCCCC-------------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 222222211111 11123345899999999999999999999875
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-53 Score=365.76 Aligned_cols=258 Identities=25% Similarity=0.389 Sum_probs=196.0
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++.+.||+|+||+||++.. +..||||++......... .+.+.+|+.++++++|
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~-----~~~vAvK~~~~~~~~~~~-----------------~~~~~~E~~~l~~l~H 63 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKW-----HGDVAVKMLNVTAPTPQQ-----------------LQAFKNEVGVLRKTRH 63 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEES-----SSEEEEEECCCSSCCTTH-----------------HHHHHHHHHHHTTCCC
T ss_pred ccccEEEEEEEeeCCCcEEEEEEE-----CCEEEEEEEEcccCCHHH-----------------HHHHHHHHHHHHhCCC
Confidence 357799999999999999998854 235999998655433221 1578899999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++++. ++..++||||+++|+|.+++.. .+..+++..+..++.||+.||.|| |++|++||||||+||+
T Consensus 64 pnIv~~~~~~~-~~~~~lv~Ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yL---H~~~ivHrDlKp~NiL 136 (276)
T d1uwha_ 64 VNILLFMGYST-APQLAIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYL---HAKSIIHRDLKSNNIF 136 (276)
T ss_dssp TTBCCEEEEEC-SSSCEEEEECCCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEE
T ss_pred CCEeeeeEEEe-ccEEEEEEecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHH---hcCCEeccccCHHHEE
Confidence 99999999765 4568999999999999999853 345689999999999999999999 6679999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccC---CCCCcccchhhhHHHHHHHhCCCCCCCCCCCc
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTE---TISDKCDIYSFGVLLAVLVMGKFPVDDFFGHT 275 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~---~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~ 275 (337)
++.++.+||+|||++................||+.|+|||++.+. .++.++||||+|+++|||+||..||.+....
T Consensus 137 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~- 215 (276)
T d1uwha_ 137 LHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR- 215 (276)
T ss_dssp EETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-
T ss_pred EcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH-
Confidence 999999999999999876554443344456799999999998643 4788999999999999999999999754321
Q ss_pred hhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 276 EEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
......+.......... ......+..+.+|+.+||+.||++|||+.+|+++
T Consensus 216 --~~~~~~~~~~~~~p~~~---------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 216 --DQIIFMVGRGYLSPDLS---------KVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp --HHHHHHHHHTSCCCCGG---------GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --HHHHHHHhcCCCCCcch---------hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 12222222211111100 1112233458999999999999999999999863
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-53 Score=371.96 Aligned_cols=262 Identities=24% Similarity=0.296 Sum_probs=205.6
Q ss_pred ccccccccceeccCcceEEEEeEEecCC---CCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHh
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGS---NGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQ 115 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~ 115 (337)
..++|++++.||+|+||+||++.+.... ....||+|.+........ ...+.+|+.++.+
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~------------------~~~~~~E~~~l~~ 96 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSE------------------REALMSELKMMTQ 96 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------------------------CHHHHHHHHHHHH
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHH------------------HHHHHHHHHHHHH
Confidence 4478999999999999999999886411 234689998865433211 1567889999999
Q ss_pred c-CCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcC-------------------CcccCChHHHHHHHHHHHHH
Q 040898 116 T-RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQ-------------------GRRELDWPARHRIARGIASG 175 (337)
Q Consensus 116 l-~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------------------~~~~~~~~~~~~i~~~i~~~ 175 (337)
+ +||||+++++++.+.+..++|||||++|+|.+++..... ....+++..++.++.||+.|
T Consensus 97 l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~g 176 (325)
T d1rjba_ 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKG 176 (325)
T ss_dssp HCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHH
T ss_pred hcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHH
Confidence 8 899999999999999999999999999999999965321 12458899999999999999
Q ss_pred HHHHhhCCCCCeEecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhh
Q 040898 176 LEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFG 255 (337)
Q Consensus 176 l~~l~~~h~~gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG 255 (337)
|.|| |++||+||||||+||+++.++.+||+|||++................+|+.|+|||++.+..++.++||||||
T Consensus 177 l~yL---H~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~G 253 (325)
T d1rjba_ 177 MEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYG 253 (325)
T ss_dssp HHHH---HHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred HHHH---HhCCeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchh
Confidence 9999 6679999999999999999999999999999876554444444455689999999999999999999999999
Q ss_pred HHHHHHHh-CCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhh
Q 040898 256 VLLAVLVM-GKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDV 334 (337)
Q Consensus 256 ~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el 334 (337)
|++|||+| |.+||.+..... .+...+....... .+...++.+.+|+.+||+.||++|||++||
T Consensus 254 vil~emlt~g~~Pf~~~~~~~---~~~~~~~~~~~~~-------------~p~~~~~~l~~li~~cl~~dP~~RPt~~ei 317 (325)
T d1rjba_ 254 ILLWEIFSLGVNPYPGIPVDA---NFYKLIQNGFKMD-------------QPFYATEEIYIIMQSCWAFDSRKRPSFPNL 317 (325)
T ss_dssp HHHHHHTTTSCCSSTTCCCSH---HHHHHHHTTCCCC-------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHhCCCCCCCCCCHHH---HHHHHHhcCCCCC-------------CCCcCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 99999998 899997643322 2222222211111 111223458999999999999999999999
Q ss_pred hcC
Q 040898 335 RSM 337 (337)
Q Consensus 335 l~~ 337 (337)
++|
T Consensus 318 ~~~ 320 (325)
T d1rjba_ 318 TSF 320 (325)
T ss_dssp HHH
T ss_pred HHH
Confidence 875
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-52 Score=369.78 Aligned_cols=253 Identities=26% Similarity=0.320 Sum_probs=206.4
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
-++|++++.||+|+||.||++.+.. +|+.||+|++........ .....+.+|+.+++.++||
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~--~~~~~AiK~i~k~~~~~~----------------~~~~~~~~E~~il~~l~hp 65 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKA--TGRYYAMKILRKEVIIAK----------------DEVAHTVTESRVLQNTRHP 65 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEEHHHHHHT----------------TCHHHHHHHHHHHHSCCCT
T ss_pred hHhcEEEEEEecCcCeEEEEEEECC--CCCEEEEEEEchhhccCH----------------HHHHHHHHHHHHHHhCCCC
Confidence 3579999999999999999999876 999999999864321110 1125688899999999999
Q ss_pred CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceee
Q 040898 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI 199 (337)
Q Consensus 120 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~ 199 (337)
||+++++++.+++.+|+||||+++|+|.+++.. ...+++..++.++.||+.||.|+ |++|++||||||+||++
T Consensus 66 ~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~yl---H~~~iiHRDlKP~NILl 138 (337)
T d1o6la_ 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYL---HSRDVVYRDIKLENLML 138 (337)
T ss_dssp TBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEE
T ss_pred CEEEEEeeeccccccccceeccCCCchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhh---hhcCccccccCHHHeEe
Confidence 999999999999999999999999999999853 45689999999999999999999 67799999999999999
Q ss_pred cCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhh
Q 040898 200 DDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMD 279 (337)
Q Consensus 200 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~ 279 (337)
+.+|.+||+|||++........ ......||+.|+|||++.+..++.++|+|||||++|+|++|.+||.... ...
T Consensus 139 ~~~g~vkl~DFG~a~~~~~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~----~~~ 212 (337)
T d1o6la_ 139 DKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD----HER 212 (337)
T ss_dssp CTTSCEEECCCTTCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS----HHH
T ss_pred cCCCCEEEeecccccccccCCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC----HHH
Confidence 9999999999999986543322 2234579999999999999999999999999999999999999986532 122
Q ss_pred HHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCC-----hhhhhcC
Q 040898 280 MVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPS-----SKDVRSM 337 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~~ 337 (337)
+...+.. ..... +...+..+.+|+.+||+.||++||+ ++|+++|
T Consensus 213 ~~~~i~~---~~~~~-----------p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 213 LFELILM---EEIRF-----------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHHHHHH---CCCCC-----------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHHHhc---CCCCC-----------CccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 2222211 11110 1112334889999999999999995 8999987
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-53 Score=361.32 Aligned_cols=251 Identities=23% Similarity=0.340 Sum_probs=192.9
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
.++|++++.||+|+||+||++.+. +++.||||++....... +.+.+|+.++++++||
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~---~~~~vAvK~i~~~~~~~--------------------~~~~~E~~~l~~l~Hp 60 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWL---NKDKVAIKTIREGAMSE--------------------EDFIEEAEVMMKLSHP 60 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEET---TTEEEEEEECCSSSSCH--------------------HHHHHHHHHHHHCCCT
T ss_pred hHHcEEEEEEeeCCCeEEEEEEEC---CCCEEEEEEECCCcCcH--------------------HHHHHHHHHHHhcCCC
Confidence 457999999999999999999875 67889999986543321 4578899999999999
Q ss_pred CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceee
Q 040898 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI 199 (337)
Q Consensus 120 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~ 199 (337)
||+++++++..++..++||||+++|+|.+++.. ....+++..+..++.|++.||.|+ |+++++||||||+||++
T Consensus 61 nIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~l---H~~~iiHrDlKp~Nill 134 (263)
T d1sm2a_ 61 KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYL---EEACVIHRDLAARNCLV 134 (263)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCTTCSGGGEEE
T ss_pred CcccccceeccCCceEEEEEecCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHhh---hccceeecccchhheee
Confidence 999999999999999999999999999998853 445688999999999999999999 66799999999999999
Q ss_pred cCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhC-CCCCCCCCCCchhh
Q 040898 200 DDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMG-KFPVDDFFGHTEEM 278 (337)
Q Consensus 200 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g-~~pf~~~~~~~~~~ 278 (337)
+.++.+||+|||++.......... .....||+.|+|||++.+..++.++||||+|+++|||+|+ .+||... ...
T Consensus 135 ~~~~~~Kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~----~~~ 209 (263)
T d1sm2a_ 135 GENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR----SNS 209 (263)
T ss_dssp CGGGCEEECSCC-------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC----CHH
T ss_pred cCCCCeEecccchheeccCCCcee-ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC----CHH
Confidence 999999999999998765433222 2335689999999999999999999999999999999995 5554332 222
Q ss_pred hHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 279 DMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.+...+........+ ...+..+.+|+.+||+.||++|||++||++|
T Consensus 210 ~~~~~i~~~~~~~~p-------------~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 210 EVVEDISTGFRLYKP-------------RLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HHHHHHHHTCCCCCC-------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhcCCCCCc-------------cccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 222222221111111 1123458899999999999999999999874
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.8e-52 Score=367.05 Aligned_cols=249 Identities=24% Similarity=0.391 Sum_probs=204.8
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
++|++++.||+|+||+||++.+.. +|+.||||++........ ...+.+.+|+.++++++|||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~--~g~~vAvK~i~~~~~~~~----------------~~~~~~~~E~~il~~l~Hpn 65 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRH--NGRYYAMKVLKKEIVVRL----------------KQVEHTNDERLMLSIVTHPF 65 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT--TCCEEEEEEEEHHHHHHT----------------TCHHHHHHHHHHHHSCCBTT
T ss_pred hHeEEEEEEecCcCcEEEEEEECC--CCCEEEEEEEchHHccCH----------------HHHHHHHHHHHHHHhccCcC
Confidence 579999999999999999999876 899999999864321111 11257889999999999999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
|+++++++.+++..|+||||++||+|..++. .+..+++..+..++.||+.||.|| |++|++||||||+||+++
T Consensus 66 Iv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~----~~~~~~~~~~~~~~~qi~~al~~l---H~~~iiHrDiKp~NILl~ 138 (316)
T d1fota_ 66 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLR----KSQRFPNPVAKFYAAEVCLALEYL---HSKDIIYRDLKPENILLD 138 (316)
T ss_dssp BCCEEEEEECSSEEEEEECCCCSCBHHHHHH----HTSSCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCCGGGEEEC
T ss_pred hhheeeeEeeCCeeeeEeeecCCcccccccc----ccccccccHHHHHHHHHHHhhhhh---ccCcEEccccCchheeEc
Confidence 9999999999999999999999999999884 345578888999999999999999 778999999999999999
Q ss_pred CCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhH
Q 040898 201 DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDM 280 (337)
Q Consensus 201 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~ 280 (337)
.+|.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.... ....
T Consensus 139 ~~g~vkL~DFG~a~~~~~~~-----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~----~~~~ 209 (316)
T d1fota_ 139 KNGHIKITDFGFAKYVPDVT-----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN----TMKT 209 (316)
T ss_dssp TTSCEEECCCSSCEECSSCB-----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS----HHHH
T ss_pred CCCCEEEecCccceEecccc-----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC----HHHH
Confidence 99999999999998765432 34579999999999999999999999999999999999999996531 1122
Q ss_pred HHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCC-----ChhhhhcC
Q 040898 281 VKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERP-----SSKDVRSM 337 (337)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 337 (337)
. ..+....... ++..+..+.+++.+||+.||.+|| |++++++|
T Consensus 210 ~---~~i~~~~~~~-----------p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 210 Y---EKILNAELRF-----------PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp H---HHHHHCCCCC-----------CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred H---HHHHcCCCCC-----------CCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 1 1221111111 111234488999999999999996 89999987
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.4e-52 Score=359.46 Aligned_cols=261 Identities=23% Similarity=0.339 Sum_probs=207.5
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC-CC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR-HR 119 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp 119 (337)
++|++.+.||+|+||+||++.+.. +++.||||++............ .....+.+.+|+.++++++ ||
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~--~~~~~AvK~i~~~~~~~~~~~~----------~~~~~~~~~~E~~~l~~l~~hp 70 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKP--TCKEYAVKIIDVTGGGSFSAEE----------VQELREATLKEVDILRKVSGHP 70 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETT--TTEEEEEEEEETTCSTTCCHHH----------HHHHHHHHHHHHHHHHHHTTCT
T ss_pred ccCEEceEEecCcCeEEEEEEECC--CCCEEEEEEEecccccchhHHH----------HHHHHHHHHHHHHHHHHhcCCC
Confidence 679999999999999999999876 8999999999766543211100 0111257889999999996 99
Q ss_pred CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceee
Q 040898 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI 199 (337)
Q Consensus 120 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~ 199 (337)
||+++++++.+++.+|+||||+++|+|.+++.. ..++++..+..++.||+.||.|| |++|++||||||+||++
T Consensus 71 nIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~l---H~~~ivHrDlkp~Nill 143 (277)
T d1phka_ 71 NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICAL---HKLNIVHRDLKPENILL 143 (277)
T ss_dssp TBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEE
T ss_pred CeEEEEeecccCcceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHcCCcccccccceEEE
Confidence 999999999999999999999999999999953 45699999999999999999999 66799999999999999
Q ss_pred cCCCCeEEecccCccccCCCCceeeeecccCCCCccCcccccc------CCCCCcccchhhhHHHHHHHhCCCCCCCCCC
Q 040898 200 DDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQT------ETISDKCDIYSFGVLLAVLVMGKFPVDDFFG 273 (337)
Q Consensus 200 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~------~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~ 273 (337)
+.++.+||+|||++......... ....||+.|+|||.+.+ ..++.++||||+||++|+|++|..||....
T Consensus 144 ~~~~~~kl~DFG~a~~~~~~~~~---~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~- 219 (277)
T d1phka_ 144 DDDMNIKLTDFGFSCQLDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK- 219 (277)
T ss_dssp CTTCCEEECCCTTCEECCTTCCB---CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-
T ss_pred cCCCCeEEccchheeEccCCCce---eeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC-
Confidence 99999999999999887554322 34579999999999853 346789999999999999999999996532
Q ss_pred CchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 274 HTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.......+.. ..... ..+..+..+..+.+|+.+||+.||++|||+.|+|+|
T Consensus 220 ---~~~~~~~i~~---~~~~~-------~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 220 ---QMLMLRMIMS---GNYQF-------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp ---HHHHHHHHHH---TCCCC-------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred ---HHHHHHHHHh---CCCCC-------CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1222111111 11100 011122334458999999999999999999999987
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.1e-52 Score=361.72 Aligned_cols=256 Identities=23% Similarity=0.353 Sum_probs=193.7
Q ss_pred cccccccceeccCcceEEEEeEEecC-CCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPG-SNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
.++|++.+.||+|+||+||++.+... .....||||.+......... ..+.+|+.++++++|
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~------------------~~~~~E~~~l~~l~H 86 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQR------------------RDFLSEASIMGQFDH 86 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHH------------------HHHHHHHHHHTTCCC
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHH------------------HHHHHHHHHHHhCCC
Confidence 47899999999999999999988641 12346889988654432211 568899999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++++.+++..++||||+++|+|.+++.. ....+++..+..++.||+.||.|| |++|++||||||+|||
T Consensus 87 pnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yL---H~~~iiHrDlKp~NIL 160 (299)
T d1jpaa_ 87 PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYL---ADMNYVHRDLAARNIL 160 (299)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEE
T ss_pred CCCccEEEEEeeCCEEEEEEEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHH---hhCCCccCccccceEE
Confidence 9999999999999999999999999999998853 445689999999999999999999 6679999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceee---eecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCC
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQIT---VKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGH 274 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~ 274 (337)
++.++.+||+|||++........... .....+|+.|+|||.+.+..++.++|||||||++|||+| |.+||.+...
T Consensus 161 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~- 239 (299)
T d1jpaa_ 161 VNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN- 239 (299)
T ss_dssp ECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-
T ss_pred ECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH-
Confidence 99999999999999987654332211 112357889999999999999999999999999999998 8999865322
Q ss_pred chhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 275 TEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
.+....+....... .+...+..+.+|+.+||+.||++|||+.||++
T Consensus 240 ---~~~~~~i~~~~~~~-------------~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~ 285 (299)
T d1jpaa_ 240 ---QDVINAIEQDYRLP-------------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVN 285 (299)
T ss_dssp ---HHHHHHHHTTCCCC-------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ---HHHHHHHHcCCCCC-------------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 22222222211111 11123345899999999999999999999875
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-52 Score=353.41 Aligned_cols=250 Identities=23% Similarity=0.348 Sum_probs=204.9
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
++|+++++||+|+||+||++.+. +++.||||.+....... +.+.+|+.++++++|||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~---~~~~vAvK~l~~~~~~~--------------------~~~~~Ev~~~~~l~Hpn 60 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR---GQYDVAIKMIKEGSMSE--------------------DEFIEEAKVMMNLSHEK 60 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET---TTEEEEEEEEESSSSCH--------------------HHHHHHHHHHHTCCCTT
T ss_pred HHCEEeEEEecCCCeEEEEEEEC---CCCEEEEEEECcCcCCH--------------------HHHHHHHHHHHhcCCCc
Confidence 67999999999999999999873 78899999987654321 46788999999999999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
|+++++++.+++.+++||||+++|+|.+++.. ....+++..++.++.|++.||.|| |+.|++|+||+|+||+++
T Consensus 61 Iv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~L---H~~~iiH~dlk~~Nill~ 134 (258)
T d1k2pa_ 61 LVQLYGVCTKQRPIFIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHRDLAARNCLVN 134 (258)
T ss_dssp BCCEEEEECCSSSEEEEEECCTTEEHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHH---HHTTBCCSCCSGGGEEEC
T ss_pred eeeEEEEEeeCCceEEEEEccCCCcHHHhhhc---cccCCcHHHHHHHHHHHHHHHHHH---hhcCcccccccceeEEEc
Confidence 99999999999999999999999999998743 445688999999999999999999 667999999999999999
Q ss_pred CCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCchhhh
Q 040898 201 DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHTEEMD 279 (337)
Q Consensus 201 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~~~ 279 (337)
.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||+|+++|||+| |..||..... .+
T Consensus 135 ~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~----~~ 209 (258)
T d1k2pa_ 135 DQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN----SE 209 (258)
T ss_dssp TTCCEEECCCSSCCBCSSSSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH----HH
T ss_pred CCCcEEECcchhheeccCCCce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH----HH
Confidence 9999999999999876543322 2233568999999999999999999999999999999998 7999865422 22
Q ss_pred HHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 280 MVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
....+........+ ...+..+.+|+.+||+.||++|||++++++|
T Consensus 210 ~~~~i~~~~~~~~p-------------~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 210 TAEHIAQGLRLYRP-------------HLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp HHHHHHTTCCCCCC-------------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhCCCCCCc-------------ccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 22222221111111 1122458999999999999999999999875
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=356.79 Aligned_cols=256 Identities=21% Similarity=0.295 Sum_probs=202.3
Q ss_pred ccccccccce-eccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC
Q 040898 39 KEDCFDSLKK-IGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR 117 (337)
Q Consensus 39 ~~~~y~~~~~-lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 117 (337)
+.++|.+.+. ||+|+||.||++.+....++..||||.+........ .+.+.+|+.++++++
T Consensus 6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~------------------~~~~~~E~~il~~l~ 67 (285)
T d1u59a_ 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD------------------TEEMMREAQIMHQLD 67 (285)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHH------------------HHHHHHHHHHHHHCC
T ss_pred cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHH------------------HHHHHHHHHHHHhCC
Confidence 3456888884 999999999999876555677899999865433211 157889999999999
Q ss_pred CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCce
Q 040898 118 HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANV 197 (337)
Q Consensus 118 hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ni 197 (337)
||||+++++++.+ +.+|+||||+++|+|.+++.. .+..+++..+..++.||+.||.|| |++|++||||||+||
T Consensus 68 HpnIv~l~g~~~~-~~~~lvmE~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yl---H~~~iiHrDlKp~Ni 140 (285)
T d1u59a_ 68 NPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYL---EEKNFVHRDLAARNV 140 (285)
T ss_dssp CTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGE
T ss_pred CCCEeeEeeeecc-CeEEEEEEeCCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCcCchhhe
Confidence 9999999998865 468999999999999998742 445799999999999999999999 667999999999999
Q ss_pred eecCCCCeEEecccCccccCCCCcee-eeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCc
Q 040898 198 LIDDDMEARISDFGHGKLMPDGHAQI-TVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHT 275 (337)
Q Consensus 198 l~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~ 275 (337)
+++.++.+||+|||++.......... ......+|+.|+|||++.+..++.++||||+|+++|||+| |..||.+...
T Consensus 141 ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~-- 218 (285)
T d1u59a_ 141 LLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-- 218 (285)
T ss_dssp EEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--
T ss_pred eeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH--
Confidence 99999999999999998876543322 2223468899999999998899999999999999999998 8999976432
Q ss_pred hhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 276 EEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
.+....+....... .++..+..+.+|+.+||+.||++|||+.+|++
T Consensus 219 --~~~~~~i~~~~~~~-------------~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~ 264 (285)
T d1u59a_ 219 --PEVMAFIEQGKRME-------------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 264 (285)
T ss_dssp --HHHHHHHHTTCCCC-------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred --HHHHHHHHcCCCCC-------------CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 22222222211111 11223345889999999999999999999864
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-51 Score=366.71 Aligned_cols=249 Identities=22% Similarity=0.269 Sum_probs=204.7
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
++|++++.||+|+||.||++.+.. +|+.||||++........ ...+.+.+|+.+++.++|||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~--~g~~~AvK~i~~~~~~~~----------------~~~~~~~~E~~il~~l~hpn 102 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKE--SGNHYAMKILDKQKVVKL----------------KQIEHTLNEKRILQAVNFPF 102 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT--TCCEEEEEEEEHHHHHHT----------------TCHHHHHHHHHHHTTCCCTT
T ss_pred cCeEEEEEeecCcCcEEEEEEECC--CCCEEEEEEEchHHccCH----------------HHHHHHHHHHHHHHHcCCCc
Confidence 579999999999999999999876 899999999854321110 11256889999999999999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
|+++++++.+....++|+||+.+|+|.+++.. ...+++..+..++.||+.||.|| |++|++||||||+|||++
T Consensus 103 Iv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yL---H~~~iiHRDIKP~NILl~ 175 (350)
T d1rdqe_ 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYL---HSLDLIYRDLKPENLLID 175 (350)
T ss_dssp BCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEC
T ss_pred EeecccccccccccccccccccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHH---HhCCEecCcCCHHHcccC
Confidence 99999999999999999999999999999854 34689999999999999999999 667999999999999999
Q ss_pred CCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhH
Q 040898 201 DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDM 280 (337)
Q Consensus 201 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~ 280 (337)
.++.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||... . ....
T Consensus 176 ~~g~ikL~DFG~a~~~~~~~-----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~---~-~~~~ 246 (350)
T d1rdqe_ 176 QQGYIQVTDFGFAKRVKGRT-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD---Q-PIQI 246 (350)
T ss_dssp TTSCEEECCCTTCEECSSCB-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---S-HHHH
T ss_pred CCCCEEeeeceeeeeccccc-----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc---C-HHHH
Confidence 99999999999998765432 2356999999999999999999999999999999999999999642 1 1222
Q ss_pred HHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCC-----ChhhhhcC
Q 040898 281 VKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERP-----SSKDVRSM 337 (337)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 337 (337)
...+ ....... ++..+..+.+|+.+||+.||.+|+ |++++++|
T Consensus 247 ~~~i---~~~~~~~-----------p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 247 YEKI---VSGKVRF-----------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp HHHH---HHCCCCC-----------CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHH---hcCCCCC-----------CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 2211 1111110 111234488999999999999995 99999987
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-52 Score=357.67 Aligned_cols=251 Identities=24% Similarity=0.378 Sum_probs=198.3
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
.++|++.+.||+|+||.||++.+. +++.||||++....... +.+.+|+.++++++||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~---~~~~vAvK~~~~~~~~~--------------------~~~~~E~~~l~~l~Hp 68 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN---GHTKVAVKSLKQGSMSP--------------------DAFLAEANLMKQLQHQ 68 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET---TTEEEEEEEECTTSSCH--------------------HHHHHHHHHHHHCCCT
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC---CCCEEEEEEEccCcCCH--------------------HHHHHHHHHHHhCCCC
Confidence 467999999999999999999863 67899999986543221 4678899999999999
Q ss_pred CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceee
Q 040898 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI 199 (337)
Q Consensus 120 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~ 199 (337)
||+++++++.+ +..++||||+++|+|.+++.. .....+++..+..++.||+.||.|| |++|++||||||+||++
T Consensus 69 nIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~--~~~~~l~~~~~~~i~~qi~~gl~~l---H~~~ivHrDiKp~NIll 142 (272)
T d1qpca_ 69 RLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFI---EERNYIHRDLRAANILV 142 (272)
T ss_dssp TBCCEEEEECS-SSCEEEEECCTTCBHHHHTTS--HHHHTCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEE
T ss_pred CEeEEEeeecc-CCeEEEEEeCCCCcHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCccchhheee
Confidence 99999997754 567999999999999998743 2334589999999999999999999 66799999999999999
Q ss_pred cCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhh
Q 040898 200 DDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMD 279 (337)
Q Consensus 200 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~ 279 (337)
++++.+||+|||++......... ......+|+.|+|||++.+..++.++||||||+++|||+||..|+.... ....
T Consensus 143 ~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~---~~~~ 218 (272)
T d1qpca_ 143 SDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---TNPE 218 (272)
T ss_dssp CTTSCEEECCCTTCEECSSSCEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC---CHHH
T ss_pred ecccceeeccccceEEccCCccc-cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC---CHHH
Confidence 99999999999999876544322 2234568999999999998889999999999999999999665543221 1222
Q ss_pred HHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 280 MVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
....+........ +...+..+.+|+.+||+.||++|||++++++
T Consensus 219 ~~~~i~~~~~~~~-------------p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~ 262 (272)
T d1qpca_ 219 VIQNLERGYRMVR-------------PDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (272)
T ss_dssp HHHHHHTTCCCCC-------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhcCCCCC-------------cccChHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 2222222111111 1122345899999999999999999999975
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-51 Score=355.43 Aligned_cols=248 Identities=23% Similarity=0.284 Sum_probs=194.5
Q ss_pred ceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCccccee
Q 040898 47 KKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILPLLA 126 (337)
Q Consensus 47 ~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~ 126 (337)
++||+|+||+||++.+....+++.||||++......... .+.+.+|+.++++++||||+++++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~-----------------~~~~~~E~~il~~l~HpnIv~~~g 75 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPAL-----------------KDELLAEANVMQQLDNPYIVRMIG 75 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHH-----------------HHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHH-----------------HHHHHHHHHHHHhCCCCCCceEEE
Confidence 479999999999998766567789999998654322211 157889999999999999999999
Q ss_pred EEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCCCeE
Q 040898 127 HMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDMEAR 206 (337)
Q Consensus 127 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~~~~ 206 (337)
++.+ +..++||||+++|+|.+++. ....+++..+..++.||+.||.|| |++|++||||||+||+++.++.++
T Consensus 76 ~~~~-~~~~lvmE~~~~g~L~~~l~----~~~~l~~~~~~~i~~qi~~gl~yl---H~~~iiHrDlKp~Nill~~~~~~k 147 (277)
T d1xbba_ 76 ICEA-ESWMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAK 147 (277)
T ss_dssp EEES-SSEEEEEECCTTEEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEEETTEEE
T ss_pred Eecc-CCEEEEEEcCCCCcHHHHHh----hccCCCHHHHHHHHHHHHHHHhhH---HhCCcccCCCcchhhcccccCccc
Confidence 9865 45789999999999999984 345689999999999999999999 667999999999999999999999
Q ss_pred EecccCccccCCCCce-eeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCchhhhHHHHH
Q 040898 207 ISDFGHGKLMPDGHAQ-ITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHTEEMDMVKWM 284 (337)
Q Consensus 207 l~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~ 284 (337)
|+|||++......... .......+|+.|+|||.+.+..++.++||||||+++|||+| |.+||.+... .+....+
T Consensus 148 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~----~~~~~~i 223 (277)
T d1xbba_ 148 ISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG----SEVTAML 223 (277)
T ss_dssp ECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH----HHHHHHH
T ss_pred ccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH----HHHHHHH
Confidence 9999999876544332 22234568999999999999999999999999999999998 8999975321 2222222
Q ss_pred HhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 285 RNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
....... .+...+..+.+|+.+||+.||++|||+++|++
T Consensus 224 ~~~~~~~-------------~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~ 262 (277)
T d1xbba_ 224 EKGERMG-------------CPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 262 (277)
T ss_dssp HTTCCCC-------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HcCCCCC-------------CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 2211111 11122345889999999999999999999853
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-51 Score=361.45 Aligned_cols=252 Identities=20% Similarity=0.318 Sum_probs=204.4
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
++|++++.||+|+||+||++.+.. +++.||+|.+..+.... ..+.+|+.+++.++|||
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~--~~~~~AiK~i~~~~~~~--------------------~~~~~Ei~il~~l~Hpn 62 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETS--SKKTYMAKFVKVKGTDQ--------------------VLVKKEISILNIARHRN 62 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETT--TTEEEEEEEECCCTHHH--------------------HHHHHHHHHHHHSCCTT
T ss_pred cceEEEEEEecCCCeEEEEEEECC--CCcEEEEEEEcCCcccH--------------------HHHHHHHHHHHhCCCCC
Confidence 569999999999999999999876 89999999996543211 35678999999999999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
|+++++++.+++.+|+|||||+||+|.+++.. .+..+++..+..++.||+.||.|| |++|++||||||+||+++
T Consensus 63 Iv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yL---H~~~iiHrDlKp~NIll~ 136 (321)
T d1tkia_ 63 ILHLHESFESMEELVMIFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFL---HSHNIGHFDIRPENIIYQ 136 (321)
T ss_dssp BCCEEEEEEETTEEEEEECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEES
T ss_pred CCeEEEEEEECCEEEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH---HHcCCCcccccccceeec
Confidence 99999999999999999999999999999842 344699999999999999999999 677999999999999998
Q ss_pred C--CCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhh
Q 040898 201 D--DMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEM 278 (337)
Q Consensus 201 ~--~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~ 278 (337)
. .+.++|+|||++......... ....+++.|+|||.+.+..++.++|||||||++|+|++|..||.... ..
T Consensus 137 ~~~~~~ikl~DFG~~~~~~~~~~~---~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~----~~ 209 (321)
T d1tkia_ 137 TRRSSTIKIIEFGQARQLKPGDNF---RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET----NQ 209 (321)
T ss_dssp SSSCCCEEECCCTTCEECCTTCEE---EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS----HH
T ss_pred CCCceEEEEcccchhhccccCCcc---cccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCC----HH
Confidence 5 458999999999876544322 33568999999999999999999999999999999999999986532 12
Q ss_pred hHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 279 DMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.....+ ......... ..++..+..+.+|+.+||+.||++|||+.|+++|
T Consensus 210 ~~~~~i---~~~~~~~~~-------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 210 QIIENI---MNAEYTFDE-------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHHHHH---HHTCCCCCH-------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHH---HhCCCCCCh-------hhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 222211 111111100 0011223458999999999999999999999987
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-52 Score=365.62 Aligned_cols=254 Identities=22% Similarity=0.325 Sum_probs=199.7
Q ss_pred cccccccc-eeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHh-cC
Q 040898 40 EDCFDSLK-KIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQ-TR 117 (337)
Q Consensus 40 ~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~-l~ 117 (337)
.++|+++. .||+|+||.||+|.+.. +++.||||++... ..+.+|+.++.+ ++
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~--~~~~vAiK~i~~~------------------------~~~~~E~~~~~~~~~ 63 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKR--TQEKFALKMLQDC------------------------PKARREVELHWRASQ 63 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETT--TCCEEEEEEEECS------------------------HHHHHHHHHHHHHTT
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECC--CCCEEEEEEECCc------------------------HHHHHHHHHHHHhcC
Confidence 46799875 59999999999999976 8999999998532 356678888655 58
Q ss_pred CCCcccceeEEEc----CCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCC
Q 040898 118 HRNILPLLAHMVR----PNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIK 193 (337)
Q Consensus 118 hpniv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~ 193 (337)
||||+++++++++ +..+|+|||||+||+|.+++.. .....+++..++.++.||+.||.|| |++|++|||||
T Consensus 64 hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~--~~~~~l~e~~~~~i~~qi~~al~yl---H~~~iiHRDiK 138 (335)
T d2ozaa1 64 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYL---HSINIAHRDVK 138 (335)
T ss_dssp STTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHS--CSCCCEEHHHHHHHHHHHHHHHHHH---HHTTEECCCCS
T ss_pred CCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHh--cCCCCcCHHHHHHHHHHHHHHHHHH---HHcCCcccccc
Confidence 9999999999875 4678999999999999999954 2345689999999999999999999 67799999999
Q ss_pred CCceeecC---CCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCC
Q 040898 194 PANVLIDD---DMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDD 270 (337)
Q Consensus 194 ~~nil~~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~ 270 (337)
|+||+++. .+.+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|+||.+||.+
T Consensus 139 p~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~ 215 (335)
T d2ozaa1 139 PENLLYTSKRPNAILKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS 215 (335)
T ss_dssp GGGEEESCSSTTCCEEECCCTTCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEE
T ss_pred ccccccccccccccccccccceeeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCC
Confidence 99999985 56799999999987654432 2345799999999999999999999999999999999999999965
Q ss_pred CCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 271 FFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.........+.. ........ ......+..+.++.+|+.+||+.||++|||+.|+++|
T Consensus 216 ~~~~~~~~~~~~---~i~~~~~~-------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 216 NHGLAISPGMKT---RIRMGQYE-------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp TTCC-----------CCCSCSSS-------CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCHHHHHHHHHH---HHhcCCCC-------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 433221111111 11100000 0111223445669999999999999999999999987
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.9e-51 Score=367.17 Aligned_cols=256 Identities=24% Similarity=0.275 Sum_probs=201.0
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
++|++++.||+|+||.||++.+.. +|+.||||++.......... . ........++.+++.++|||
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~--t~~~vAiK~i~~~~~~~~~~------~-------~~~~~e~~~~~~l~~~~hpn 68 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKAD--TGKMYAMKCLDKKRIKMKQG------E-------TLALNERIMLSLVSTGDCPF 68 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETT--TCCEEEEEEEEHHHHHHHTC------H-------HHHHHHHHHHHHHSSSCCTT
T ss_pred HhCeeeeEEecCCCeEEEEEEECC--CCCEEEEEEEchHHcchhhH------H-------HHHHHHHHHHHHHhcCCCCc
Confidence 579999999999999999999876 89999999985432111100 0 00012234577888889999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
|+++++++.+++.+|+||||+++|+|.+++.. ...+++..++.++.||+.||.|| |++|++||||||+|||++
T Consensus 69 Iv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~yl---H~~~iiHrDlKP~NILl~ 141 (364)
T d1omwa3 69 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHM---HNRFVVYRDLKPANILLD 141 (364)
T ss_dssp BCCEEEEEECSSEEEEEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEC
T ss_pred EEEEEEEEEECCEEEEEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHH---HHCCccceeeccceeEEc
Confidence 99999999999999999999999999999954 45688999999999999999999 677999999999999999
Q ss_pred CCCCeEEecccCccccCCCCceeeeecccCCCCccCccccc-cCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhh
Q 040898 201 DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQ-TETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMD 279 (337)
Q Consensus 201 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~-~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~ 279 (337)
.++.+||+|||++....... .....||+.|+|||++. +..++.++|||||||++|+|++|..||.......
T Consensus 142 ~~g~iKl~DFGla~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~---- 213 (364)
T d1omwa3 142 EHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD---- 213 (364)
T ss_dssp SSSCEEECCCTTCEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC----
T ss_pred CCCcEEEeeeceeeecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH----
Confidence 99999999999998765432 23457999999999986 4568999999999999999999999997643322
Q ss_pred HHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCC-----hhhhhcC
Q 040898 280 MVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPS-----SKDVRSM 337 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~~ 337 (337)
............... +...+..+.+|+.+||+.||++||| ++|+++|
T Consensus 214 ~~~~~~~~~~~~~~~-----------~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 214 KHEIDRMTLTMAVEL-----------PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp HHHHHHHSSSCCCCC-----------CSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred HHHHHHhcccCCCCC-----------CCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 111121111111110 1112344899999999999999999 7999987
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-52 Score=361.66 Aligned_cols=265 Identities=22% Similarity=0.258 Sum_probs=198.0
Q ss_pred cccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCccc
Q 040898 44 DSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNILP 123 (337)
Q Consensus 44 ~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~ 123 (337)
+.++.||+|+||+||++.+.. +|+.||||++........... ....+.+|+.++++++||||++
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~--~~~~vAvK~i~~~~~~~~~~~--------------~~~~~~~Ei~il~~l~hpnIv~ 64 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKN--TNQIVAIKKIKLGHRSEAKDG--------------INRTALREIKLLQELSHPNIIG 64 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSS--CCSEEEEEEC--------------------------CTHHHHHHHHHHHCCCTTBCC
T ss_pred CcceEeccCcCeEEEEEEECC--CCcEEEEEEEehhhhhhhhHH--------------HHHHHHHHHHHHHhCCCCCEeE
Confidence 357899999999999999876 899999999865433221111 0146889999999999999999
Q ss_pred ceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCCC
Q 040898 124 LLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDDM 203 (337)
Q Consensus 124 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~~ 203 (337)
+++++.+++..|+||||+.++++..+. ..+..+++..+..++.||+.||+|| |++|++||||||+||+++.++
T Consensus 65 ~~~~~~~~~~~~ivmE~~~~~~~~~~~----~~~~~l~~~~~~~~~~qil~aL~~l---H~~~iiHrDiKp~NIli~~~~ 137 (299)
T d1ua2a_ 65 LLDAFGHKSNISLVFDFMETDLEVIIK----DNSLVLTPSHIKAYMLMTLQGLEYL---HQHWILHRDLKPNNLLLDENG 137 (299)
T ss_dssp EEEEECCTTCCEEEEECCSEEHHHHHT----TCCSSCCSSHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTC
T ss_pred EEeeeccCCceeehhhhhcchHHhhhh----hcccCCCHHHHHHHHHHHHHHHHHh---hccceecccCCcceEEecCCC
Confidence 999999999999999999987766554 4566789999999999999999999 677999999999999999999
Q ss_pred CeEEecccCccccCCCCceeeeecccCCCCccCccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhhHHH
Q 040898 204 EARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTE-TISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMDMVK 282 (337)
Q Consensus 204 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~~~~ 282 (337)
.+||+|||.+......... .....+|+.|+|||++.+. .++.++||||+||++|+|++|.+||.... ..+...
T Consensus 138 ~~KL~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~----~~~~l~ 211 (299)
T d1ua2a_ 138 VLKLADFGLAKSFGSPNRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS----DLDQLT 211 (299)
T ss_dssp CEEECCCGGGSTTTSCCCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHH
T ss_pred ccccccCccccccCCCccc--ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCC----HHHHHH
Confidence 9999999999776543222 2235789999999998654 57899999999999999999999986432 122222
Q ss_pred HHHhhhccCCcchhh----------hhcccC----CchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 283 WMRNVIFSENPNRAI----------NSKLLG----NGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 283 ~~~~~~~~~~~~~~~----------~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.+.+........... ...... ...+....++.+|+.+||+.||++|||++|+|+|
T Consensus 212 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 212 RIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp HHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred HHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 222211111100000 000000 0011234568999999999999999999999987
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-51 Score=361.36 Aligned_cols=252 Identities=24% Similarity=0.344 Sum_probs=201.8
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHH-hcCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITAN-QTRHR 119 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~-~l~hp 119 (337)
++|++++.||+|+||+||++.+.. +++.||||++........ ...+.+.+|..++. .++||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~--t~~~vAvK~i~k~~~~~~----------------~~~~~~~~e~~~l~~~~~hp 63 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKK--TNQFFAIKALKKDVVLMD----------------DDVECTMVEKRVLSLAWEHP 63 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETT--TTEEEEEEEEEHHHHHHT----------------TCHHHHHHHHHHHHHHTTCT
T ss_pred CCeEEeeEEecCCCcEEEEEEECC--CCCEEEEEEEchhhccCh----------------HHHHHHHHHHHHHHHhCCCC
Confidence 579999999999999999999976 999999999864321110 11144556666654 68999
Q ss_pred CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceee
Q 040898 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLI 199 (337)
Q Consensus 120 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~ 199 (337)
||+++++++.+++..|+||||+++|+|.+++.. ...+++..+..++.||+.||.|| |++|++||||||+||++
T Consensus 64 ~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~yl---H~~~iiHrDikp~NiL~ 136 (320)
T d1xjda_ 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFL---HSKGIVYRDLKLDNILL 136 (320)
T ss_dssp TBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEE
T ss_pred cEEEEEEEEccCCceeEEEeecCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHH---HhCCeeeccCcccceee
Confidence 999999999999999999999999999999954 44588999999999999999999 66799999999999999
Q ss_pred cCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhh
Q 040898 200 DDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMD 279 (337)
Q Consensus 200 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~ 279 (337)
+.++.++|+|||++........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ...
T Consensus 137 ~~~~~~kl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~----~~~ 210 (320)
T d1xjda_ 137 DKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD----EEE 210 (320)
T ss_dssp CTTSCEEECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHH
T ss_pred cCCCceeccccchhhhcccccc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC----HHH
Confidence 9999999999999986544322 2234579999999999999999999999999999999999999996431 122
Q ss_pred HHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChh-hhhcC
Q 040898 280 MVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSK-DVRSM 337 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~-ell~~ 337 (337)
+...+. ...... +...+..+.+|+.+||+.||++|||+. ++++|
T Consensus 211 ~~~~i~---~~~~~~-----------p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 211 LFHSIR---MDNPFY-----------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp HHHHHH---HCCCCC-----------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred HHHHHH---cCCCCC-----------CccCCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence 222221 111110 011234489999999999999999996 78876
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.5e-51 Score=352.73 Aligned_cols=257 Identities=20% Similarity=0.318 Sum_probs=195.7
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
.++|++.+.||+|+||.||++.+.. +|+.||||++..+....... ...+.+|+.+++.++||
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~--~~~~vAiK~i~~~~~~~~~~----------------~~~~~~E~~~l~~~~hp 67 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLR--LHRDVAVKVLRADLARDPSF----------------YLRFRREAQNAAALNHP 67 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT--TTEEEEEEEECSTTTTCHHH----------------HHHHHHHHHHHHTCCCT
T ss_pred cceeEEeEEEeeCCCeEEEEEEECC--CCCEEEEEEEchhhccCHHH----------------HHHHHHHHHHHHhcCCC
Confidence 4679999999999999999999976 89999999997654433221 15788999999999999
Q ss_pred CcccceeEEEcCC----eeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCC
Q 040898 120 NILPLLAHMVRPN----CHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPA 195 (337)
Q Consensus 120 niv~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ 195 (337)
||+++++++.... ..|+||||+++++|.+++.. ..++++..+..++.||+.||.|| |++|++||||||+
T Consensus 68 niv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~l---H~~~iiHrDiKP~ 140 (277)
T d1o6ya_ 68 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFS---HQNGIIHRDVKPA 140 (277)
T ss_dssp TBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGG
T ss_pred CCCcccceeeeccCCCceEEEEEECCCCCEehhhhcc----cCCCCHHHHHHHHHHHHHHHHHH---HhCCccCccccCc
Confidence 9999999987643 47999999999999998843 45689999999999999999999 6679999999999
Q ss_pred ceeecCCCCeEEecccCccccCCCCc-eeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCC
Q 040898 196 NVLIDDDMEARISDFGHGKLMPDGHA-QITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGH 274 (337)
Q Consensus 196 nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~ 274 (337)
||+++.++..+++|||.+........ ........||+.|+|||++.+..++.++||||||+++|+|+||.+||....
T Consensus 141 NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-- 218 (277)
T d1o6ya_ 141 NIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS-- 218 (277)
T ss_dssp GEEEETTSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--
T ss_pred ccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC--
Confidence 99999999999999998876543322 222334579999999999999999999999999999999999999996431
Q ss_pred chhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCC-Chhhhh
Q 040898 275 TEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERP-SSKDVR 335 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-s~~ell 335 (337)
....... .......... ...+..+..+.+++.+||+.||++|| |+++++
T Consensus 219 -~~~~~~~----~~~~~~~~~~-------~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~ 268 (277)
T d1o6ya_ 219 -PVSVAYQ----HVREDPIPPS-------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMR 268 (277)
T ss_dssp -HHHHHHH----HHHCCCCCGG-------GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred -HHHHHHH----HHhcCCCCCc-------hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHH
Confidence 1111111 1111111110 01112234588999999999999999 677765
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-50 Score=348.94 Aligned_cols=257 Identities=22% Similarity=0.338 Sum_probs=195.2
Q ss_pred cccccccceeccCcceEEEEeEEecCC--CCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGS--NGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR 117 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 117 (337)
.++|++.+.||+|+||.||++.+.... ....||||++......... ..+.+|+.++++++
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~------------------~~~~~E~~il~~l~ 67 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR------------------VDFLGEAGIMGQFS 67 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHH------------------HHHHHHHHHHHTCC
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHH------------------HHHHHHHHHHHhcC
Confidence 467999999999999999999876411 2357999998654432211 46889999999999
Q ss_pred CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCce
Q 040898 118 HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANV 197 (337)
Q Consensus 118 hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ni 197 (337)
||||+++++++.+.+..++||||+.++++.+++.. ....+++..+..++.||+.|+.|| |+++++||||||+||
T Consensus 68 H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~l---H~~~iiHrDlKp~NI 141 (283)
T d1mqba_ 68 HHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYL---ANMNYVHRDLAARNI 141 (283)
T ss_dssp CTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGE
T ss_pred CCCEeeeeEEEecCCceEEEEEecccCcchhhhhc---ccccccHHHHHHHHHHHHHhhhhc---cccccccCccccceE
Confidence 99999999999999999999999999999998754 445689999999999999999999 667999999999999
Q ss_pred eecCCCCeEEecccCccccCCCCce-eeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCch
Q 040898 198 LIDDDMEARISDFGHGKLMPDGHAQ-ITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTE 276 (337)
Q Consensus 198 l~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~ 276 (337)
|++.++.+||+|||++......... .......||+.|+|||.+.+..++.++||||||+++|||+++..|+.... .
T Consensus 142 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~---~ 218 (283)
T d1mqba_ 142 LVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL---S 218 (283)
T ss_dssp EECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC---C
T ss_pred EECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC---C
Confidence 9999999999999999876543222 12223468999999999999999999999999999999999765543221 1
Q ss_pred hhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 277 EMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
.......+........ +...+..+.+|+.+||+.||++|||+.||++
T Consensus 219 ~~~~~~~i~~~~~~~~-------------~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 219 NHEVMKAINDGFRLPT-------------PMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HHHHHHHHHTTCCCCC-------------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHhccCCCCC-------------chhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 2222222222111111 1122345899999999999999999999975
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-51 Score=355.36 Aligned_cols=267 Identities=24% Similarity=0.316 Sum_probs=200.6
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
++|++++.||+|+||+||++.+.. +|+.||+|++........ ....+.+|+.++++++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~--~~~~vAvK~i~~~~~~~~-----------------~~~~~~~Ei~il~~l~Hp~ 62 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKL--TGEVVALKKIRLDTETEG-----------------VPSTAIREISLLKELNHPN 62 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETT--TCCEEEEEEEC------------------------CCHHHHHHHHHHTTCCCTT
T ss_pred CCCEeccEEecCcCeEEEEEEECC--CCCEEEEEEEehhhcChH-----------------HHHHHHHHHHHHHhCCCCc
Confidence 579999999999999999999976 899999999864422110 1157888999999999999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
|+++++++.++...|+||||+.+ ++.+++.. .....+++..+..++.|++.||.|| |++|++||||||+||+++
T Consensus 63 Iv~~~~~~~~~~~~~iv~e~~~~-~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yL---H~~~IiHrDiKpeNIl~~ 136 (298)
T d1gz8a_ 63 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFC---HSHRVLHRDLKPQNLLIN 136 (298)
T ss_dssp BCCEEEEEEETTEEEEEEECCSE-EHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEEC
T ss_pred EEEeccccccccceeEEEeecCC-chhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHh---hcCCEEccccCchheeec
Confidence 99999999999999999999976 44444433 3456699999999999999999999 677999999999999999
Q ss_pred CCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCC-CCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhh
Q 040898 201 DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTET-ISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMD 279 (337)
Q Consensus 201 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~ 279 (337)
.++.++|+|||.+........ ......+|+.|+|||++.... ++.++|+||+|+++|+|++|+.||.... ....
T Consensus 137 ~~~~~kl~DFG~a~~~~~~~~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~---~~~~ 211 (298)
T d1gz8a_ 137 TEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS---EIDQ 211 (298)
T ss_dssp TTSCEEECSTTHHHHHCCCSB--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHH
T ss_pred ccCcceeccCCcceeccCCcc--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCC---HHHH
Confidence 999999999999987644322 223457999999999987665 4789999999999999999999996432 1222
Q ss_pred HHHHHHhhhccCC-cchhh--hh-------cccCC----chHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 280 MVKWMRNVIFSEN-PNRAI--NS-------KLLGN----GYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 280 ~~~~~~~~~~~~~-~~~~~--~~-------~~~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
+............ ..... .. ..... ..+..+..+.+|+.+||+.||++|||+.|+|+|
T Consensus 212 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 212 LFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp HHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 2221111110000 00000 00 00000 011233568999999999999999999999987
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=355.63 Aligned_cols=254 Identities=24% Similarity=0.345 Sum_probs=196.9
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCc----eEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHh
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGK----MIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQ 115 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~ 115 (337)
.++|++++.||+|+||+||++.+.. +|+ +||+|++........ .+.+.+|+.++++
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~--~~~~~~~~vavK~~~~~~~~~~------------------~~~~~~E~~~l~~ 67 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIP--EGEKVKIPVAIKELREATSPKA------------------NKEILDEAYVMAS 67 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC------CCEEEEEEEECC----CT------------------HHHHHHHHHHHHH
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcC--CCCEEEEEEEEEEeccccCHHH------------------HHHHHHHHHHHHh
Confidence 3569999999999999999998865 444 688888764332211 1568899999999
Q ss_pred cCCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCC
Q 040898 116 TRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPA 195 (337)
Q Consensus 116 l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ 195 (337)
++||||+++++++.++ ..+++++++.+++|.+++.. ....+++..+..++.||+.||.|| |++|++||||||+
T Consensus 68 l~HpnIv~l~g~~~~~-~~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yL---H~~~iiHrDlKp~ 140 (317)
T d1xkka_ 68 VDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYL---EDRRLVHRDLAAR 140 (317)
T ss_dssp CCCTTBCCEEEEEESS-SEEEEEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGG
T ss_pred CCCCCEeeEEEEEecC-CeeEEEEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHH---HHcCcccCcchhh
Confidence 9999999999998865 56788899999999998754 456789999999999999999999 6679999999999
Q ss_pred ceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCC
Q 040898 196 NVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGH 274 (337)
Q Consensus 196 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~ 274 (337)
||+++.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||+| |.+||+....
T Consensus 141 NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~- 219 (317)
T d1xkka_ 141 NVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA- 219 (317)
T ss_dssp GEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG-
T ss_pred cceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH-
Confidence 99999999999999999988765544444444568999999999999999999999999999999999 7899865432
Q ss_pred chhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 275 TEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
..+...+........ ++..+..+.+|+.+||+.||++|||+.|+++|
T Consensus 220 ---~~~~~~i~~~~~~~~-------------p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 220 ---SEISSILEKGERLPQ-------------PPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp ---GGHHHHHHHTCCCCC-------------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---HHHHHHHHcCCCCCC-------------CcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 222222222111111 11233458999999999999999999999864
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-51 Score=350.69 Aligned_cols=259 Identities=24% Similarity=0.360 Sum_probs=197.5
Q ss_pred cccccccccccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHH
Q 040898 28 LVEKQDLAFLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIR 107 (337)
Q Consensus 28 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 107 (337)
..+++|+. .++|++++.||+|+||.||++.+. +++.||||++....... +.+.
T Consensus 8 ~~~~~~i~----~~~~~i~~~iG~G~fg~Vy~~~~~---~~~~vAiK~l~~~~~~~--------------------~~~~ 60 (285)
T d1fmka3 8 AKDAWEIP----RESLRLEVKLGQGCFGEVWMGTWN---GTTRVAIKTLKPGTMSP--------------------EAFL 60 (285)
T ss_dssp STTCSBCC----GGGEEEEEEEEECSSCEEEEEEET---TTEEEEEEECCTTSSCH--------------------HHHH
T ss_pred CCcceEcC----HHHEEEeeEEeeCCCeEEEEEEEC---CCCEEEEEEECcccCCH--------------------HHHH
Confidence 34445654 467999999999999999999875 45679999986543321 4678
Q ss_pred HHHHHHHhcCCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCe
Q 040898 108 SEIITANQTRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRL 187 (337)
Q Consensus 108 ~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi 187 (337)
+|+.++++++||||+++++++. ++..++||||+++|+|..++... ....+++..+..++.||+.||+|| |++|+
T Consensus 61 ~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~~g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~L---H~~~i 134 (285)
T d1fmka3 61 QEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYV---ERMNY 134 (285)
T ss_dssp HHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHH---HHTTC
T ss_pred HHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecCCCchhhhhhhc--ccccchHHHHHHHHHHHHHHHHHH---hhhhe
Confidence 8999999999999999999885 45689999999999999988542 234589999999999999999999 66799
Q ss_pred EecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCC
Q 040898 188 IHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFP 267 (337)
Q Consensus 188 ~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~p 267 (337)
+|+||||+||+++.++.+||+|||++......... ......+|+.|+|||.+....++.++||||+|+++|||++|..|
T Consensus 135 vH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p 213 (285)
T d1fmka3 135 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 213 (285)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ecccccceEEEECCCCcEEEcccchhhhccCCCce-eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCC
Confidence 99999999999999999999999999876443322 22345689999999999999999999999999999999997666
Q ss_pred CCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 268 VDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 268 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
|.... ....+...+....... .++..++.+.+++.+||+.||++|||+.+|++
T Consensus 214 ~~~~~---~~~~~~~~i~~~~~~~-------------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 266 (285)
T d1fmka3 214 PYPGM---VNREVLDQVERGYRMP-------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQA 266 (285)
T ss_dssp SSTTC---CHHHHHHHHHTTCCCC-------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCC---CHHHHHHHHHhcCCCC-------------CCcccCHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 53322 2222323222211111 11223345899999999999999999999875
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-51 Score=352.03 Aligned_cols=248 Identities=23% Similarity=0.362 Sum_probs=197.7
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC--
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR-- 117 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-- 117 (337)
+++|++.+.||+|+||.||++.+.. +|+.||||++........... .....+.+|+.++++++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~--~~~~vAvK~i~~~~~~~~~~~-------------~~~~~~~~E~~il~~l~~~ 67 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVS--DNLPVAIKHVEKDRISDWGEL-------------PNGTRVPMEVVLLKKVSSG 67 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEEGGGCCCEEEC-------------TTCCEEEHHHHHHHHHCSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECC--CCCEEEEEEEehHHccchhhh-------------hHHHHHHHHHHHHHHhccC
Confidence 4689999999999999999999976 899999999875432211000 00034667999999986
Q ss_pred CCCcccceeEEEcCCeeEEEEEeccC-CCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 040898 118 HRNILPLLAHMVRPNCHLLVYEFMKN-GSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPAN 196 (337)
Q Consensus 118 hpniv~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~n 196 (337)
||||+++++++.+++..++||||+.+ +++.+++.. +..+++..++.++.||+.||.|| |++|++||||||+|
T Consensus 68 h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~l---H~~~iiHrDiKp~N 140 (273)
T d1xwsa_ 68 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHC---HNCGVLHRDIKDEN 140 (273)
T ss_dssp SCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGG
T ss_pred CCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHH---HHCCCccccCcccc
Confidence 89999999999999999999999976 678888743 45689999999999999999999 67799999999999
Q ss_pred eeecC-CCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCC-CCcccchhhhHHHHHHHhCCCCCCCCCCC
Q 040898 197 VLIDD-DMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETI-SDKCDIYSFGVLLAVLVMGKFPVDDFFGH 274 (337)
Q Consensus 197 il~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~DiwslG~i~~~ll~g~~pf~~~~~~ 274 (337)
|+++. ++.++|+|||++....... .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||...
T Consensus 141 Ill~~~~~~vkl~DFG~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~--- 213 (273)
T d1xwsa_ 141 ILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD--- 213 (273)
T ss_dssp EEEETTTTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH---
T ss_pred eEEecCCCeEEECccccceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc---
Confidence 99985 4789999999998654432 234579999999999987765 56789999999999999999998642
Q ss_pred chhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 275 TEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.. ..+ ..... .+..+.++.+|+.+||+.||++|||++|+++|
T Consensus 214 ---~~---i~~----~~~~~-----------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 214 ---EE---IIR----GQVFF-----------RQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp ---HH---HHH----CCCCC-----------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---hH---Hhh----cccCC-----------CCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 01 111 11100 01123458999999999999999999999987
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-50 Score=348.22 Aligned_cols=255 Identities=23% Similarity=0.315 Sum_probs=191.9
Q ss_pred cccccccceeccCcceEEEEeEEecC-CCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPG-SNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
.++|++++.||+|+||.||++.+... ..+..||||.+........ ...+.+|+.++++++|
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~------------------~~~~~~E~~~l~~l~H 67 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV------------------REKFLQEALTMRQFDH 67 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHH------------------HHHHHHHHHHHHTCCC
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHH------------------HHHHHHHHHHHHhCCC
Confidence 46799999999999999999987642 2456789998854433211 1568899999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++++. ++..++||||+++|+|.+++.. ....+++..++.++.||+.||.|| |++|++||||||+||+
T Consensus 68 pnIv~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~yl---H~~~iiHrDlKp~NIl 140 (273)
T d1mp8a_ 68 PHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYL---ESKRFVHRDIAARNVL 140 (273)
T ss_dssp TTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEE
T ss_pred CCEeeEEEEEe-cCeEEEEEEeccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhh---cccCeeccccchhhee
Confidence 99999999885 4678999999999999998754 445689999999999999999999 6679999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCchh
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHTEE 277 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~~ 277 (337)
++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|||++ |.+||.....
T Consensus 141 l~~~~~~Kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~---- 215 (273)
T d1mp8a_ 141 VSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---- 215 (273)
T ss_dssp EEETTEEEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG----
T ss_pred ecCCCcEEEccchhheeccCCcce-eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH----
Confidence 999999999999999876543222 2234568899999999999999999999999999999998 8899865432
Q ss_pred hhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 278 MDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.+....+....... .++..++.+.+|+.+||+.||++|||+.||+++
T Consensus 216 ~~~~~~i~~~~~~~-------------~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 216 NDVIGRIENGERLP-------------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp GGHHHHHHTTCCCC-------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCCCC-------------CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 22222222211111 111233458999999999999999999999863
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=355.28 Aligned_cols=271 Identities=20% Similarity=0.309 Sum_probs=200.7
Q ss_pred cccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHh
Q 040898 36 FLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQ 115 (337)
Q Consensus 36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~ 115 (337)
.++.+++|+++++||+|+||+||++.+.. .+++.||||++.......... ..+.+|+.+++.
T Consensus 2 ~c~~~~~Y~i~~~LG~G~fg~V~~a~~~~-~~~~~vAiK~i~~~~~~~~~~-----------------~~~~~E~~~l~~ 63 (305)
T d1blxa_ 2 LCRADQQYECVAEIGEGAYGKVFKARDLK-NGGRFVALKRVRVQTGEEGMP-----------------LSTIREVAVLRH 63 (305)
T ss_dssp CCCGGGTEEEEEEEEEETTEEEEEEEETT-TTTEEEEEEEEEEEBCTTSCB-----------------CTHHHHHHHHHH
T ss_pred CCCCcCCEEEEEEEecccCeEEEEEEEEC-CCCEEEEEEEEehhhccchHH-----------------HHHHHHHHHHHH
Confidence 36778999999999999999999998864 246789999986643321100 244566666665
Q ss_pred c---CCCCcccceeEEEc-----CCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCe
Q 040898 116 T---RHRNILPLLAHMVR-----PNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRL 187 (337)
Q Consensus 116 l---~hpniv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi 187 (337)
+ +||||+++++++.. ....++++|+++++++..... .....+++..++.++.|++.||.|| |++|+
T Consensus 64 l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~---~~~~~~~~~~~~~~~~qi~~aL~yL---H~~~i 137 (305)
T d1blxa_ 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK---VPEPGVPTETIKDMMFQLLRGLDFL---HSHRV 137 (305)
T ss_dssp HHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHH---SCTTCSCHHHHHHHHHHHHHHHHHH---HHTTC
T ss_pred HhhcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhh---ccCCCCCHHHHHHHHHHHHHHHHHH---HhCCE
Confidence 5 89999999998853 356899999998876654432 3556689999999999999999999 67799
Q ss_pred EecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCC
Q 040898 188 IHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFP 267 (337)
Q Consensus 188 ~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~p 267 (337)
+||||||+|||++.++.++|+|||.+....... ......||+.|+|||++.+..++.++||||+||++|+|++|.+|
T Consensus 138 vHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~p 214 (305)
T d1blxa_ 138 VHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL 214 (305)
T ss_dssp CCCCCCGGGEEECTTCCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred EecCCCccEEEEcCCCCeeecchhhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCC
Confidence 999999999999999999999999987654332 22346799999999999999999999999999999999999999
Q ss_pred CCCCCCCchhhhHHHHHHhhhccCCcch----------hh---hhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhh
Q 040898 268 VDDFFGHTEEMDMVKWMRNVIFSENPNR----------AI---NSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDV 334 (337)
Q Consensus 268 f~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~---~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el 334 (337)
|.... ....+..... ......... .. .........+..++.+.+|+.+||+.||++|||+.|+
T Consensus 215 f~~~~---~~~~~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~ 290 (305)
T d1blxa_ 215 FRGSS---DVDQLGKILD-VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290 (305)
T ss_dssp CCCSS---HHHHHHHHHH-HHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred CCCCC---HHHHHHHHHH-hhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHH
Confidence 96532 2222222111 111100000 00 0000001112234568899999999999999999999
Q ss_pred hcC
Q 040898 335 RSM 337 (337)
Q Consensus 335 l~~ 337 (337)
|+|
T Consensus 291 L~H 293 (305)
T d1blxa_ 291 LSH 293 (305)
T ss_dssp HTS
T ss_pred hcC
Confidence 987
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.7e-50 Score=349.60 Aligned_cols=264 Identities=21% Similarity=0.296 Sum_probs=199.8
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
++|+++++||+|+||+||++.+. +|+.||||++........ ....+.+|+.++++++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~---~~~~vAvK~i~~~~~~~~-----------------~~~~~~~E~~il~~l~hpn 61 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN---YGETFALKKIRLEKEDEG-----------------IPSTTIREISILKELKHSN 61 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET---TSCEEEEEEECCSSGGGC-----------------CCHHHHHHHHGGGGCCCTT
T ss_pred CCceeccEEecCCCcEEEEEEeC---CCCEEEEEEEehhhcChH-----------------HHHHHHHHHHHHHhCCCCc
Confidence 58999999999999999999874 789999999966533211 1157888999999999999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
|+++++++.+++..+++++++.++.+..+. .....+++..+..++.||+.||+|| |++||+||||||+||+++
T Consensus 62 Iv~~~~~~~~~~~~~i~~e~~~~~~~~~~~----~~~~~l~~~~~~~i~~qi~~~L~~L---H~~~IvHrDiKp~NIll~ 134 (286)
T d1ob3a_ 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLD----VCEGGLESVTAKSFLLQLLNGIAYC---HDRRVLHRDLKPQNLLIN 134 (286)
T ss_dssp BCCEEEEEECSSCEEEEEECCSEEHHHHHH----TSTTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEEC
T ss_pred EEeeeeecccCCceeEEEEeehhhhHHHHH----hhcCCcchhhhHHHHHHHHHHHHHh---ccCcEEecCCCCceeeEc
Confidence 999999999999999999999887666665 4556799999999999999999999 667999999999999999
Q ss_pred CCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhh
Q 040898 201 DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTE-TISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMD 279 (337)
Q Consensus 201 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~ 279 (337)
.++.+|++|||.+........ ......+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||..... ...
T Consensus 135 ~~~~~kl~DfG~a~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~---~~~ 209 (286)
T d1ob3a_ 135 REGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE---ADQ 209 (286)
T ss_dssp TTSCEEECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHH
T ss_pred CCCCEEecccccceecccCcc--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCH---HHH
Confidence 999999999999887644322 12334689999999998754 468999999999999999999999965322 111
Q ss_pred HHHHHHhhhccCCcc---------------hhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 280 MVKWMRNVIFSENPN---------------RAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
+.... ......... ............+.....+.+|+.+||+.||++|||++|+|+|
T Consensus 210 ~~~i~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 210 LMRIF-RILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp HHHHH-HHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHH-HhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11111 111110000 0000000011112234568899999999999999999999987
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-50 Score=348.80 Aligned_cols=261 Identities=21% Similarity=0.295 Sum_probs=194.1
Q ss_pred cccccccceeccCcceEEEEeEEec---CCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELP---GSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT 116 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 116 (337)
.++|+++++||+|+||.||++.+.. ..+++.||||++......... ..+.+|...+.++
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~------------------~~~~~e~~~l~~~ 73 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH------------------RALMSELKILIHI 73 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHH------------------HHHHHHHHHHHHH
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHH------------------HHHHHHHHHHHhh
Confidence 4679999999999999999998764 225678999998654332211 4566677777776
Q ss_pred -CCCCcccceeEEEc-CCeeEEEEEeccCCCHHHHHHHhcC------------CcccCChHHHHHHHHHHHHHHHHHhhC
Q 040898 117 -RHRNILPLLAHMVR-PNCHLLVYEFMKNGSLQDILYDVSQ------------GRRELDWPARHRIARGIASGLEYLHMC 182 (337)
Q Consensus 117 -~hpniv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~l~~~ 182 (337)
.||||+.+++++.. +...++|||||++|+|.+++..... ....+++..+..++.||+.||.||
T Consensus 74 ~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~yl--- 150 (299)
T d1ywna1 74 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL--- 150 (299)
T ss_dssp CCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHH---
T ss_pred cCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHH---
Confidence 68899999998765 4568999999999999999975332 234588999999999999999999
Q ss_pred CCCCeEecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHH
Q 040898 183 HRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLV 262 (337)
Q Consensus 183 h~~gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll 262 (337)
|++|++||||||+||+++.++.+||+|||++................||+.|+|||++.+..++.++||||+|+++|||+
T Consensus 151 H~~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ell 230 (299)
T d1ywna1 151 ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 230 (299)
T ss_dssp HHTTCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred HhCCCcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHH
Confidence 66799999999999999999999999999998765444433334457999999999999999999999999999999999
Q ss_pred hC-CCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 263 MG-KFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 263 ~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
+| .+||...... ..+...+........+ ...+..+.+++.+||+.||++|||++|+++|
T Consensus 231 t~~~~p~~~~~~~---~~~~~~~~~~~~~~~~-------------~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 231 SLGASPYPGVKID---EEFCRRLKEGTRMRAP-------------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp TTSCCSSTTCCCS---HHHHHHHHHTCCCCCC-------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hCCCCCCCCCCHH---HHHHHHHhcCCCCCCC-------------ccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 96 5677654332 2222222222111111 1123348899999999999999999999975
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-49 Score=347.56 Aligned_cols=260 Identities=23% Similarity=0.365 Sum_probs=205.6
Q ss_pred ccccccccceeccCcceEEEEeEEec---CCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHh
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELP---GSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQ 115 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~ 115 (337)
+.++|++++.||+|+||+||++.+.. ..+++.||||++......... ..+.+|+.++++
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~------------------~~~~~E~~il~~ 72 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ------------------ADFQREAALMAE 72 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHH------------------HHHHHHHHHHHT
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHH------------------HHHHHHHHHHHh
Confidence 46679999999999999999998753 346789999998654432211 568899999999
Q ss_pred cCCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcC--------------------CcccCChHHHHHHHHHHHHH
Q 040898 116 TRHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQ--------------------GRRELDWPARHRIARGIASG 175 (337)
Q Consensus 116 l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------------~~~~~~~~~~~~i~~~i~~~ 175 (337)
++||||+++++++.+....++++||+++|+|.+++..... ....+++..+..++.|++.|
T Consensus 73 l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~g 152 (301)
T d1lufa_ 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAG 152 (301)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHH
T ss_pred cCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999999999965321 23347888999999999999
Q ss_pred HHHHhhCCCCCeEecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhh
Q 040898 176 LEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFG 255 (337)
Q Consensus 176 l~~l~~~h~~gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG 255 (337)
|+|| |+++++||||||+||+++.++.+||+|||++................+++.|+|||.+.+..++.++||||||
T Consensus 153 l~yl---H~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~G 229 (301)
T d1lufa_ 153 MAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYG 229 (301)
T ss_dssp HHHH---HHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred hhhc---ccCCeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccch
Confidence 9999 6679999999999999999999999999999866544433333456788999999999999999999999999
Q ss_pred HHHHHHHhCC-CCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhh
Q 040898 256 VLLAVLVMGK-FPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDV 334 (337)
Q Consensus 256 ~i~~~ll~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el 334 (337)
+++|||++|. +||... ...+....+........ +...+.++.+|+.+||+.||++|||+.||
T Consensus 230 vvl~ell~~~~~p~~~~----~~~e~~~~v~~~~~~~~-------------p~~~~~~~~~li~~cl~~~P~~RPt~~ev 292 (301)
T d1lufa_ 230 VVLWEIFSYGLQPYYGM----AHEEVIYYVRDGNILAC-------------PENCPLELYNLMRLCWSKLPADRPSFCSI 292 (301)
T ss_dssp HHHHHHHTTTCCTTTTS----CHHHHHHHHHTTCCCCC-------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred hhHHHHHccCCCCCCCC----CHHHHHHHHHcCCCCCC-------------CccchHHHHHHHHHHcCCChhHCcCHHHH
Confidence 9999999985 676543 22222222222111111 11223458899999999999999999999
Q ss_pred hc
Q 040898 335 RS 336 (337)
Q Consensus 335 l~ 336 (337)
++
T Consensus 293 ~~ 294 (301)
T d1lufa_ 293 HR 294 (301)
T ss_dssp HH
T ss_pred HH
Confidence 75
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-50 Score=342.19 Aligned_cols=247 Identities=28% Similarity=0.401 Sum_probs=192.0
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|++++.||+|+||.||++.+ +|..||||++..+... +.+.+|+.++++++|
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~----~~~~vAvK~i~~~~~~---------------------~~~~~E~~~l~~l~H 59 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDY----RGNKVAVKCIKNDATA---------------------QAFLAEASVMTQLRH 59 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE----TTEEEEEEECCCCC-----------------------HHHHHTHHHHTTCCC
T ss_pred CHHHeEEeEEEecCCCeEEEEEEE----CCeEEEEEEECcHHHH---------------------HHHHHHHHHHHhCCC
Confidence 346799999999999999999887 6789999998643211 467889999999999
Q ss_pred CCcccceeEEEc-CCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCce
Q 040898 119 RNILPLLAHMVR-PNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANV 197 (337)
Q Consensus 119 pniv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ni 197 (337)
|||+++++++.+ ++.+++||||+++|+|.+++.. .....+++..+..++.||+.||.|| |+.+++|+||+|+||
T Consensus 60 pnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~al~yl---H~~~ivH~dlkp~Ni 134 (262)
T d1byga_ 60 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVHRDLAARNV 134 (262)
T ss_dssp TTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHH--HHHHHCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGE
T ss_pred CCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHhhcccc---ccCceeccccchHhh
Confidence 999999998854 5668999999999999999965 2334589999999999999999999 667999999999999
Q ss_pred eecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCch
Q 040898 198 LIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHTE 276 (337)
Q Consensus 198 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~ 276 (337)
+++.++.++++|||++....... ....+++.|+|||.+.+..++.++||||||+++|||+| |.+||.....
T Consensus 135 l~~~~~~~kl~dfg~s~~~~~~~-----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~--- 206 (262)
T d1byga_ 135 LVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--- 206 (262)
T ss_dssp EECTTSCEEECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG---
T ss_pred eecCCCCEeecccccceecCCCC-----ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH---
Confidence 99999999999999987653322 23457889999999998899999999999999999998 6788765322
Q ss_pred hhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 277 EMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
.+....+........ ++..+..+.+|+.+||+.||++|||+.+++++
T Consensus 207 -~~~~~~i~~~~~~~~-------------~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 207 -KDVVPRVEKGYKMDA-------------PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp -GGHHHHHTTTCCCCC-------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -HHHHHHHHcCCCCCC-------------CccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 222222222111111 11222458899999999999999999999863
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=342.26 Aligned_cols=258 Identities=24% Similarity=0.334 Sum_probs=192.0
Q ss_pred cccccccceeccCcceEEEEeEEec-CCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELP-GSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
.++|++++.||+|+||.||++.... ......||||++.......... .+.+.+|+.++++++|
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~----------------~~~~~~Ei~~l~~l~H 70 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEA----------------MDDFIREVNAMHSLDH 70 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHH----------------HHHHHHHHHHHHHCCC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHH----------------HHHHHHHHHHHHhCCC
Confidence 4679999999999999999997653 2234578999886543322211 1578899999999999
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++++.+ +..++||||++++++.+++.. ....+++..+..++.||+.||.|| |++|++||||||+||+
T Consensus 71 ~nIv~~~g~~~~-~~~~lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~yl---H~~~iiHrDikp~NIl 143 (273)
T d1u46a_ 71 RNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYL---ESKRFIHRDLAARNLL 143 (273)
T ss_dssp TTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEE
T ss_pred CCEEEEEEEEee-cchheeeeeecCcchhhhhhc---ccCCCCHHHHHHHHHHHHHHHHHh---hhCCEeeeeecHHHhc
Confidence 999999999965 467899999999999998764 345699999999999999999999 6679999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeee-ecccCCCCccCccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCCCch
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITV-KCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVM-GKFPVDDFFGHTE 276 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~-~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~-g~~pf~~~~~~~~ 276 (337)
++.++.+||+|||++............ ....++..|+|||.+.+..++.++||||||+++|||+| |.+||.+...
T Consensus 144 l~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~--- 220 (273)
T d1u46a_ 144 LATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG--- 220 (273)
T ss_dssp EEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH---
T ss_pred cccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH---
Confidence 999999999999999987655433322 23457788999999999999999999999999999998 8999864322
Q ss_pred hhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 277 EMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
.+... .+........ .++..+..+.+|+.+||+.||++|||+.+|++
T Consensus 221 -~~~~~---~i~~~~~~~~---------~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 221 -SQILH---KIDKEGERLP---------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp -HHHHH---HHHTSCCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -HHHHH---HHHhCCCCCC---------CcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 12212 2211111110 11122244889999999999999999999875
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-49 Score=346.17 Aligned_cols=267 Identities=22% Similarity=0.309 Sum_probs=210.8
Q ss_pred ccccccccccccccceeccCcceEEEEeEEec---CCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHH
Q 040898 33 DLAFLKKEDCFDSLKKIGSGGWGEVFYKAELP---GSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSE 109 (337)
Q Consensus 33 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e 109 (337)
+.+|.-..++|++.+.||+|+||.||++.+.. ..+++.||||++......... ..+.+|
T Consensus 15 ~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~------------------~~~~~E 76 (311)
T d1t46a_ 15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER------------------EALMSE 76 (311)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHH------------------HHHHHH
T ss_pred cccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHH------------------HHHHHH
Confidence 33443344789999999999999999998642 357889999999765432211 467889
Q ss_pred HHHHHhc-CCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcC--------------CcccCChHHHHHHHHHHHH
Q 040898 110 IITANQT-RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQ--------------GRRELDWPARHRIARGIAS 174 (337)
Q Consensus 110 ~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~~~i~~~i~~ 174 (337)
+.+++.+ +||||+++++++.++...+++||||++|+|.+++..... ....+++..+..++.||+.
T Consensus 77 ~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~ 156 (311)
T d1t46a_ 77 LKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAK 156 (311)
T ss_dssp HHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHH
T ss_pred HHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHH
Confidence 9999999 699999999999999999999999999999999975331 2345889999999999999
Q ss_pred HHHHHhhCCCCCeEecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhh
Q 040898 175 GLEYLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSF 254 (337)
Q Consensus 175 ~l~~l~~~h~~gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Diwsl 254 (337)
|++|| |++|++||||||+||+++.++.++++|||.+................+|+.|+|||.+.+..++.++|||||
T Consensus 157 gl~~L---H~~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~ 233 (311)
T d1t46a_ 157 GMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSY 233 (311)
T ss_dssp HHHHH---HHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred HHHHH---HhCCeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccch
Confidence 99999 677999999999999999999999999999988766554444455678999999999999999999999999
Q ss_pred hHHHHHHHh-CCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhh
Q 040898 255 GVLLAVLVM-GKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKD 333 (337)
Q Consensus 255 G~i~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e 333 (337)
|+++|+|+| |.+||....... .+...+........+ ...+..+.+|+.+||+.||++|||+++
T Consensus 234 G~~l~ellt~g~p~~~~~~~~~---~~~~~i~~~~~~~~~-------------~~~~~~l~~Li~~cl~~dP~~RPs~~~ 297 (311)
T d1t46a_ 234 GIFLWELFSLGSSPYPGMPVDS---KFYKMIKEGFRMLSP-------------EHAPAEMYDIMKTCWDADPLKRPTFKQ 297 (311)
T ss_dssp HHHHHHHHTTTCCSSTTCCSSH---HHHHHHHHTCCCCCC-------------TTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHHhCCCCCCCCCCHHH---HHHHHHhcCCCCCCc-------------ccccHHHHHHHHHHcCCChhHCcCHHH
Confidence 999999999 555554433322 222222222111111 122344899999999999999999999
Q ss_pred hhc
Q 040898 334 VRS 336 (337)
Q Consensus 334 ll~ 336 (337)
|++
T Consensus 298 il~ 300 (311)
T d1t46a_ 298 IVQ 300 (311)
T ss_dssp HHH
T ss_pred HHH
Confidence 985
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-49 Score=346.61 Aligned_cols=275 Identities=22% Similarity=0.288 Sum_probs=203.5
Q ss_pred ccccccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHH
Q 040898 33 DLAFLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIIT 112 (337)
Q Consensus 33 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 112 (337)
|++.++..++|+++++||+|+||+||++.+.. +|+.||||++........ ....+.+|+.+
T Consensus 2 ~~~~~~~~~rY~i~~~LG~G~fg~Vy~a~~~~--~~~~vAvK~i~~~~~~~~-----------------~~~~~~~E~~i 62 (318)
T d3blha1 2 ECPFCDEVSKYEKLAKIGQGTFGEVFKARHRK--TGQKVALKKVLMENEKEG-----------------FPITALREIKI 62 (318)
T ss_dssp CCTTSCBGGGEEEEEEEEECSSSEEEEEEETT--TCCEEEEEEC----CTTS-----------------SCHHHHHHHHH
T ss_pred CCCCCCccCCEEEEEEEecCcCeEEEEEEECC--CCCEEEEEEEehhhcchH-----------------HHHHHHHHHHH
Confidence 56778889999999999999999999999976 899999999865432211 11567889999
Q ss_pred HHhcCCCCcccceeEEEc--------CCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCC
Q 040898 113 ANQTRHRNILPLLAHMVR--------PNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHR 184 (337)
Q Consensus 113 l~~l~hpniv~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~ 184 (337)
++.++||||+++++++.. ....+++|||+.++.+.... .....+++..++.++.|++.||.|| |+
T Consensus 63 l~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~----~~~~~~~~~~~~~i~~qil~~l~~l---H~ 135 (318)
T d3blha1 63 LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS----NVLVKFTLSEIKRVMQMLLNGLYYI---HR 135 (318)
T ss_dssp HHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHT----CTTCCCCHHHHHHHHHHHHHHHHHH---HH
T ss_pred HHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhh----hcccccccHHHHHHHHHHHHHHHHh---cc
Confidence 999999999999998755 34689999999887665443 4556688999999999999999999 66
Q ss_pred CCeEecCCCCCceeecCCCCeEEecccCccccCCCCce--eeeecccCCCCccCccccccC-CCCCcccchhhhHHHHHH
Q 040898 185 PRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQ--ITVKCMVGTMGYMAPESLQTE-TISDKCDIYSFGVLLAVL 261 (337)
Q Consensus 185 ~gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~i~~~l 261 (337)
+|++||||||+||+++.++.++|+|||++......... .......+|+.|+|||++.+. .++.++||||+||++|+|
T Consensus 136 ~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el 215 (318)
T d3blha1 136 NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 215 (318)
T ss_dssp TTEECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred CCEEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeH
Confidence 79999999999999999999999999999766533221 122335689999999998765 688999999999999999
Q ss_pred HhCCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhh-----------hcc-cCCchH------HHHHHHHHHHhhhccC
Q 040898 262 VMGKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAIN-----------SKL-LGNGYE------EQMLLVLKLACFCTLK 323 (337)
Q Consensus 262 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~-~~~~~~------~~~~~l~~li~~~l~~ 323 (337)
++|+.||.+.. .......+.............. ... ...... .....+.+|+.+||+.
T Consensus 216 ~~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~ 291 (318)
T d3blha1 216 WTRSPIMQGNT----EQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVL 291 (318)
T ss_dssp HHSSCSCCCSS----HHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCS
T ss_pred hhCCCCCCCCC----HHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcC
Confidence 99999996532 2222222222221111100000 000 000011 1134578899999999
Q ss_pred CCCCCCChhhhhcC
Q 040898 324 DPDERPSSKDVRSM 337 (337)
Q Consensus 324 dP~~Rps~~ell~~ 337 (337)
||++|||++|+|+|
T Consensus 292 dP~~R~sa~elL~H 305 (318)
T d3blha1 292 DPAQRIDSDDALNH 305 (318)
T ss_dssp STTTSCCHHHHHHS
T ss_pred ChhHCcCHHHHHcC
Confidence 99999999999987
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-49 Score=343.32 Aligned_cols=263 Identities=23% Similarity=0.315 Sum_probs=202.9
Q ss_pred cccccccccccceeccCcceEEEEeEEecC-----CCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHH
Q 040898 36 FLKKEDCFDSLKKIGSGGWGEVFYKAELPG-----SNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEI 110 (337)
Q Consensus 36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~ 110 (337)
|.-..++|++++.||+|+||.||++.+... .++..||||++..+..... ...+.+|.
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~------------------~~~~~~e~ 69 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD------------------LSDLISEM 69 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHH------------------HHHHHHHH
T ss_pred CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHH------------------HHHHHHHH
Confidence 433556899999999999999999987542 2345799999876543222 15677788
Q ss_pred HHHHhc-CCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcC------------CcccCChHHHHHHHHHHHHHHH
Q 040898 111 ITANQT-RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQ------------GRRELDWPARHRIARGIASGLE 177 (337)
Q Consensus 111 ~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~ 177 (337)
..+.++ +||||+++++++.++...++||||+++|+|.+++..... ....+++..++.++.||+.||+
T Consensus 70 ~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ 149 (299)
T d1fgka_ 70 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGME 149 (299)
T ss_dssp HHHHHHCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHhcCCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHH
Confidence 888888 899999999999999999999999999999999965321 2345899999999999999999
Q ss_pred HHhhCCCCCeEecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHH
Q 040898 178 YLHMCHRPRLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVL 257 (337)
Q Consensus 178 ~l~~~h~~gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i 257 (337)
|| |+.|++||||||+||+++.++.+||+|||++................+++.|+|||.+.+..++.++||||||++
T Consensus 150 yl---H~~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvv 226 (299)
T d1fgka_ 150 YL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 226 (299)
T ss_dssp HH---HHTTCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHH
T ss_pred Hh---hhCCEEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHH
Confidence 99 667999999999999999999999999999987655444333345678999999999999999999999999999
Q ss_pred HHHHHh-CCCCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 258 LAVLVM-GKFPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 258 ~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
+|+|++ |.+||.... .......+........ +...+..+.+|+.+||+.||++|||+.||++
T Consensus 227 l~ell~~g~~p~~~~~----~~~~~~~i~~~~~~~~-------------p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 227 LWEIFTLGGSPYPGVP----VEELFKLLKEGHRMDK-------------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHTTSCCSSTTCC----HHHHHHHHHTTCCCCC-------------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhccCCCCCCCCCC----HHHHHHHHHcCCCCCC-------------CccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 999998 688875432 2222222222111111 1122345899999999999999999999986
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-49 Score=345.02 Aligned_cols=254 Identities=23% Similarity=0.282 Sum_probs=198.2
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCc--eEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc-C
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGK--MIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT-R 117 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~ 117 (337)
++|++.++||+|+||.||++.+.. ++. .||||++........ .+.+.+|+.++.++ +
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~--~~~~~~vaiK~~~~~~~~~~------------------~~~~~~E~~~l~~l~~ 69 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKK--DGLRMDAAIKRMKEYASKDD------------------HRDFAGELEVLCKLGH 69 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEE--TTEEEEEEEEEEECC------------------------CHHHHHHHHHTTCCC
T ss_pred HHcEEEEEEeeCCCcEEEEEEECC--CCeEEEEEEEEECcccChHH------------------HHHHHHHHHHHHhccC
Confidence 679999999999999999999876 555 577777654332211 15688999999998 7
Q ss_pred CCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHh------------cCCcccCChHHHHHHHHHHHHHHHHHhhCCCC
Q 040898 118 HRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDV------------SQGRRELDWPARHRIARGIASGLEYLHMCHRP 185 (337)
Q Consensus 118 hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------------~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~ 185 (337)
||||+++++++.+++..++||||+++|+|.+++... ......+++..+..++.||+.|+.|+ |++
T Consensus 70 HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~l---H~~ 146 (309)
T d1fvra_ 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQK 146 (309)
T ss_dssp CTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHH---HHT
T ss_pred CCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhh---hcC
Confidence 999999999999999999999999999999998642 12346789999999999999999999 667
Q ss_pred CeEecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCC
Q 040898 186 RLIHRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGK 265 (337)
Q Consensus 186 gi~h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~ 265 (337)
|++||||||+|||++.++.+||+|||++........ .....+|+.|+|||.+.+..++.++||||||+++|||++|.
T Consensus 147 ~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~ 223 (309)
T d1fvra_ 147 QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG 223 (309)
T ss_dssp TEECSCCSGGGEEECGGGCEEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTS
T ss_pred CccccccccceEEEcCCCceEEcccccccccccccc---ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcC
Confidence 999999999999999999999999999876543221 12346899999999999999999999999999999999976
Q ss_pred -CCCCCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 266 -FPVDDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 266 -~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
+||... ....+...+.. ...+. .+...++.+.+|+.+||+.||++|||+.||+++
T Consensus 224 ~~p~~~~----~~~~~~~~i~~---~~~~~----------~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 224 GTPYCGM----TCAELYEKLPQ---GYRLE----------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp CCTTTTC----CHHHHHHHGGG---TCCCC----------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCC----CHHHHHHHHHh---cCCCC----------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 566432 22222222221 11111 111223458999999999999999999999863
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-48 Score=346.40 Aligned_cols=264 Identities=22% Similarity=0.311 Sum_probs=196.3
Q ss_pred ccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc
Q 040898 37 LKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT 116 (337)
Q Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 116 (337)
++-.++|+++++||+|+||+||++.+.. +|+.||||++......... ...+.+|+.+|+++
T Consensus 14 ~~~~~~Y~~i~~lG~G~fg~V~~~~~~~--~~~~vAiK~i~~~~~~~~~-----------------~~~~~~Ei~il~~l 74 (346)
T d1cm8a_ 14 WEVRAVYRDLQPVGSGAYGAVCSAVDGR--TGAKVAIKKLYRPFQSELF-----------------AKRAYRELRLLKHM 74 (346)
T ss_dssp ECCBSSEEEEEEC------CEEEEEETT--TCCEEEEEECSSTTSSHHH-----------------HHHHHHHHHHHHHC
T ss_pred eecCCcEEEEEEEecCCCeEEEEEEECC--CCCEEEEEEEchhhcChHH-----------------HHHHHHHHHHHHhc
Confidence 4457899999999999999999999876 8999999999654332111 15788899999999
Q ss_pred CCCCcccceeEEEcCC------eeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 040898 117 RHRNILPLLAHMVRPN------CHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHR 190 (337)
Q Consensus 117 ~hpniv~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~ 190 (337)
+||||+++++++...+ .+|+||||+ +.+|..++.. ..+++..++.++.||+.||.|| |++|++|+
T Consensus 75 ~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~L---H~~~IiHr 145 (346)
T d1cm8a_ 75 RHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYI---HAAGIIHR 145 (346)
T ss_dssp CBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHH---HHTTEECC
T ss_pred CCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHH---HhCCCccc
Confidence 9999999999997654 469999999 5578877632 4599999999999999999999 67799999
Q ss_pred CCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccC-CCCCcccchhhhHHHHHHHhCCCCCC
Q 040898 191 DIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTE-TISDKCDIYSFGVLLAVLVMGKFPVD 269 (337)
Q Consensus 191 di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~i~~~ll~g~~pf~ 269 (337)
||||+||+++.++.++++|||.+....... +...+|+.|+|||++.+. .++.++||||+||++|+|++|.+||.
T Consensus 146 DiKp~NIL~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~ 220 (346)
T d1cm8a_ 146 DLKPGNLAVNEDCELKILDFGLARQADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFK 220 (346)
T ss_dssp CCCGGGEEECTTCCEEECCCTTCEECCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccCcchhhcccccccccccccceeccCCcc-----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCC
Confidence 999999999999999999999998765432 345799999999998764 56899999999999999999999986
Q ss_pred CCCCCchhhhHHHHHHhhhccCCcch-----------------hhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChh
Q 040898 270 DFFGHTEEMDMVKWMRNVIFSENPNR-----------------AINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSK 332 (337)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ 332 (337)
.... ...+.. ............ ...........+.....+.+|+.+||..||++|||+.
T Consensus 221 ~~~~---~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~ 296 (346)
T d1cm8a_ 221 GSDH---LDQLKE-IMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAG 296 (346)
T ss_dssp CSSH---HHHHHH-HHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred CCCh---HHHHHH-HHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHH
Confidence 5321 111111 111110000000 0000000111122344588999999999999999999
Q ss_pred hhhcC
Q 040898 333 DVRSM 337 (337)
Q Consensus 333 ell~~ 337 (337)
|+|+|
T Consensus 297 eiL~H 301 (346)
T d1cm8a_ 297 EALAH 301 (346)
T ss_dssp HHHHS
T ss_pred HHhcC
Confidence 99987
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=347.14 Aligned_cols=260 Identities=21% Similarity=0.284 Sum_probs=195.8
Q ss_pred cccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCc
Q 040898 42 CFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNI 121 (337)
Q Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpni 121 (337)
+|+.++.||+|+||+||++.+.. +|+.||||++..... ...+|+.++++++||||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~--~~~~vAiK~i~~~~~-----------------------~~~~Ei~il~~l~h~ni 75 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCD--SGELVAIKKVLQDKR-----------------------FKNRELQIMRKLDHCNI 75 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEECCSS-----------------------SCCHHHHHHHHCCCTTB
T ss_pred CcEeeeEEeeCcCeEEEEEEECC--CCCEEEEEEECccch-----------------------HHHHHHHHHHhcCCCCC
Confidence 69999999999999999999976 899999999865431 23469999999999999
Q ss_pred ccceeEEEcC------CeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCC
Q 040898 122 LPLLAHMVRP------NCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPA 195 (337)
Q Consensus 122 v~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ 195 (337)
+++++++... ..+++||||++++ +.+.+.........+++..+..++.||+.||.|| |++||+||||||+
T Consensus 76 v~~~~~~~~~~~~~~~~~~~lv~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yL---H~~~IiHrDiKp~ 151 (350)
T d1q5ka_ 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI---HSFGICHRDIKPQ 151 (350)
T ss_dssp CCEEEEEEEC--CCSCCEEEEEEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCCGG
T ss_pred CcEEEEEEecCccCCceEEEEEEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHH---HhcCCcccCCCcc
Confidence 9999998543 3478999999875 4444444344566799999999999999999999 7789999999999
Q ss_pred ceeecCCC-CeEEecccCccccCCCCceeeeecccCCCCccCcccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCC
Q 040898 196 NVLIDDDM-EARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQT-ETISDKCDIYSFGVLLAVLVMGKFPVDDFFG 273 (337)
Q Consensus 196 nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~ 273 (337)
||+++.++ .+||+|||++......... ....+++.|+|||.+.+ ..++.++||||+||++|+|++|.+||.....
T Consensus 152 NILl~~~~~~~kl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~ 228 (350)
T d1q5ka_ 152 NLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 228 (350)
T ss_dssp GEEECTTTCCEEECCCTTCEECCTTSCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH
T ss_pred eEEEecCCCceeEecccchhhccCCccc---ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCH
Confidence 99999775 8999999999876544322 33579999999998865 5689999999999999999999999965322
Q ss_pred CchhhhHHHHHHhhhccCCc---------------chhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 274 HTEEMDMVKWMRNVIFSENP---------------NRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
. ..+..... ....... .............+....++.+|+.+||+.||++|||+.|+|+|
T Consensus 229 ~---~~l~~i~~-~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 229 V---DQLVEIIK-VLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp H---HHHHHHHH-HHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred H---HHHHHHHH-HhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1 11111111 1000000 00000000001112234458899999999999999999999987
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-48 Score=335.26 Aligned_cols=266 Identities=21% Similarity=0.258 Sum_probs=205.1
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRN 120 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpn 120 (337)
++|+++++||+|+||+||++.+.. +++.||||++......... ...+.+|+.+++.++|||
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~--~~~~vAvK~i~~~~~~~~~-----------------~~~~~~E~~il~~l~h~n 62 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRE--THEIVALKRVRLDDDDEGV-----------------PSSALREICLLKELKHKN 62 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETT--TCCEEEEEEEESSCSSTTH-----------------HHHHHHHHHHHTTCCCTT
T ss_pred CCCEeeeEEecCcCeEEEEEEECC--CCcEEEEEEEehhhCChHH-----------------HHHHHHHHHHHHhcCcCC
Confidence 579999999999999999999976 8999999999655432211 157888999999999999
Q ss_pred cccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 121 ILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
|+++++++.+....+++++++.+++|..++. ....+++..+..++.|++.||+|| |++|++|+||||+||+++
T Consensus 63 iv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~----~~~~~~~~~~~~~~~q~~~aL~~l---H~~~IvHrDiKP~NIli~ 135 (292)
T d1unla_ 63 IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFC---HSRNVLHRDLKPQNLLIN 135 (292)
T ss_dssp BCCEEEEEECSSEEEEEEECCSEEHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEC
T ss_pred EEeeccccccccceeEEeeeccccccccccc----cccccchhHHHHHHHHHHHHHHHh---hcCCEeeecccCcccccc
Confidence 9999999999999999999999988888773 456688999999999999999999 667999999999999999
Q ss_pred CCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCC-CCCcccchhhhHHHHHHHhCCCCCCCCCCCchhhh
Q 040898 201 DDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTET-ISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEMD 279 (337)
Q Consensus 201 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~~ 279 (337)
.++.++|+|||.+......... .....+++.|.|||.+.+.. ++.++||||+||++|+|++|..||... ......
T Consensus 136 ~~~~~kl~DFG~a~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~--~~~~~~ 211 (292)
T d1unla_ 136 RNGELKLANFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG--NDVDDQ 211 (292)
T ss_dssp TTCCEEECCCTTCEECCSCCSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCC--SSHHHH
T ss_pred cCCceeeeecchhhcccCCCcc--ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCC--CCHHHH
Confidence 9999999999999876543322 12345778899999987665 689999999999999999999997432 222222
Q ss_pred HHHHHHhhhccCCcch---------------hhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 280 MVKWMRNVIFSENPNR---------------AINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
+ ..+........... ...........+.....+.+|+.+||+.||++|||++|+|+|
T Consensus 212 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 212 L-KRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp H-HHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred H-HHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 2 21221111111000 000000111222334568899999999999999999999987
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=341.49 Aligned_cols=270 Identities=20% Similarity=0.256 Sum_probs=197.9
Q ss_pred cccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHh
Q 040898 36 FLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQ 115 (337)
Q Consensus 36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~ 115 (337)
.++.+++|++++.||+|+||+||++.+.. +|+.||||++........ ...+.+|+.++++
T Consensus 3 ~~~i~~rY~~~~~LG~G~fg~Vy~~~~~~--~~~~vAvK~i~~~~~~~~------------------~~~~~~Ei~il~~ 62 (345)
T d1pmea_ 3 VFDVGPRYTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTY------------------CQRTLREIKILLR 62 (345)
T ss_dssp CCCCCTTEEEEEECC---CCCEEEEEETT--TCSEEEEEEECCTTCHHH------------------HHHHHHHHHHHHH
T ss_pred ccCcCCCeEEEEEEeeccCeEEEEEEECC--CCcEEEEEEEehhcChHH------------------HHHHHHHHHHHHH
Confidence 45667789999999999999999999876 899999999865432111 1567889999999
Q ss_pred cCCCCcccceeEEEcCC----eeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecC
Q 040898 116 TRHRNILPLLAHMVRPN----CHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRD 191 (337)
Q Consensus 116 l~hpniv~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~d 191 (337)
++||||+++++++.... ..+++++++.+|+|.+++.. ..+++..+..++.|++.||.|| |++|++|||
T Consensus 63 l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yL---H~~~iiHRD 134 (345)
T d1pmea_ 63 FRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYI---HSANVLHRD 134 (345)
T ss_dssp CCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHH---HHTTEECCC
T ss_pred cCCCCCCcEEEEEeeccccccceEEEEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHH---HHCCCcCCC
Confidence 99999999999986643 23455566778999999853 3589999999999999999999 667999999
Q ss_pred CCCCceeecCCCCeEEecccCccccCCCCce-eeeecccCCCCccCccccc-cCCCCCcccchhhhHHHHHHHhCCCCCC
Q 040898 192 IKPANVLIDDDMEARISDFGHGKLMPDGHAQ-ITVKCMVGTMGYMAPESLQ-TETISDKCDIYSFGVLLAVLVMGKFPVD 269 (337)
Q Consensus 192 i~~~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~-~~~~~~~~DiwslG~i~~~ll~g~~pf~ 269 (337)
|||+||++++++.+||+|||++......... .......+|+.|+|||++. +..++.++||||+|+++|+|++|..||.
T Consensus 135 IKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~ 214 (345)
T d1pmea_ 135 LKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP 214 (345)
T ss_dssp CCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCC
Confidence 9999999999999999999999765433221 1123456899999999984 4567889999999999999999999996
Q ss_pred CCCCCchhhhHHHHHHhhhccCCcchhh-------------hhcc----cCCchHHHHHHHHHHHhhhccCCCCCCCChh
Q 040898 270 DFFGHTEEMDMVKWMRNVIFSENPNRAI-------------NSKL----LGNGYEEQMLLVLKLACFCTLKDPDERPSSK 332 (337)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ 332 (337)
..... +.................. .+.. .....+..+..+.+|+.+||+.||++|||++
T Consensus 215 ~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~ 290 (345)
T d1pmea_ 215 GKHYL----DQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVE 290 (345)
T ss_dssp CSSHH----HHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred CCCHH----HHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHH
Confidence 53221 1111111111111100000 0000 0000112234588999999999999999999
Q ss_pred hhhcC
Q 040898 333 DVRSM 337 (337)
Q Consensus 333 ell~~ 337 (337)
|+|+|
T Consensus 291 e~L~h 295 (345)
T d1pmea_ 291 QALAH 295 (345)
T ss_dssp HHHTS
T ss_pred HHhcC
Confidence 99987
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-48 Score=338.72 Aligned_cols=259 Identities=20% Similarity=0.316 Sum_probs=205.1
Q ss_pred cccccccceeccCcceEEEEeEEec---CCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELP---GSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT 116 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 116 (337)
.++|++.+.||+|+||+||++.+.. ..+++.||||++......... ..+.+|+.+++++
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~------------------~~~~~E~~il~~l 80 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER------------------IEFLNEASVMKEF 80 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHH------------------HHHHHHHHHGGGC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHH------------------HHHHHHHHHHHHc
Confidence 4789999999999999999988742 235688999998654332211 4688999999999
Q ss_pred CCCCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcC------CcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 040898 117 RHRNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQ------GRRELDWPARHRIARGIASGLEYLHMCHRPRLIHR 190 (337)
Q Consensus 117 ~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~ 190 (337)
+||||+++++++..+...++||||+++|+|.+++..... ....+++..+..++.|++.||.|| |+++++||
T Consensus 81 ~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~L---H~~~ivHr 157 (308)
T d1p4oa_ 81 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL---NANKFVHR 157 (308)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHH---HHTTCBCS
T ss_pred CCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHH---hhCCeeec
Confidence 999999999999999999999999999999999864321 223468889999999999999999 56699999
Q ss_pred CCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCC-CCCC
Q 040898 191 DIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGK-FPVD 269 (337)
Q Consensus 191 di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~-~pf~ 269 (337)
||||+|||+++++.+||+|||++................+++.|+|||.+.+..++.++||||+|+++|||+||. +||.
T Consensus 158 Dlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~ 237 (308)
T d1p4oa_ 158 DLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 237 (308)
T ss_dssp CCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTT
T ss_pred eEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999998765544443334456899999999999999999999999999999999984 7775
Q ss_pred CCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 270 DFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
.... ......+.. ..... .++..+..+.+++.+||+.||++|||+++|++
T Consensus 238 ~~~~----~~~~~~i~~---~~~~~----------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 238 GLSN----EQVLRFVME---GGLLD----------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp TSCH----HHHHHHHHT---TCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCH----HHHHHHHHh---CCCCC----------CcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 4311 122222211 11111 11122345999999999999999999999986
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=6.3e-48 Score=341.09 Aligned_cols=262 Identities=20% Similarity=0.302 Sum_probs=198.8
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC-
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR- 117 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~- 117 (337)
..++|+++++||+|+||+||++.+.. +|+.||||++..... ..+.+|+.+++++.
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~--~~~~vAiK~i~~~~~----------------------~~~~~Ei~il~~l~~ 88 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINIT--NNEKVVVKILKPVKK----------------------KKIKREIKILENLRG 88 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT--TTEEEEEEEECSSCH----------------------HHHHHHHHHHHHHTT
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECC--CCCEEEEEEECHHHH----------------------HHHHHHHHHHHhccC
Confidence 45789999999999999999999876 899999999854321 45778999999995
Q ss_pred CCCcccceeEEEc--CCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCC
Q 040898 118 HRNILPLLAHMVR--PNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPA 195 (337)
Q Consensus 118 hpniv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~ 195 (337)
||||+++++++.. ....++||||+++++|..+. ..+++..+..++.||+.||.|| |++||+|+||||+
T Consensus 89 hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~L---H~~gIvHrDiKp~ 158 (328)
T d3bqca1 89 GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYC---HSMGIMHRDVKPH 158 (328)
T ss_dssp STTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGG
T ss_pred CCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHH---hhccccccccccc
Confidence 9999999999874 45689999999999986653 3589999999999999999999 6779999999999
Q ss_pred ceeecCCC-CeEEecccCccccCCCCceeeeecccCCCCccCccccccCC-CCCcccchhhhHHHHHHHhCCCCCCCCCC
Q 040898 196 NVLIDDDM-EARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTET-ISDKCDIYSFGVLLAVLVMGKFPVDDFFG 273 (337)
Q Consensus 196 nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~DiwslG~i~~~ll~g~~pf~~~~~ 273 (337)
|||++.++ .++|+|||++........ .....+|+.|+|||.+.+.. ++.++|+||+|+++|+|++|..||.....
T Consensus 159 NILi~~~~~~vkl~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~ 235 (328)
T d3bqca1 159 NVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 235 (328)
T ss_dssp GEEEETTTTEEEECCGGGCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred ceEEcCCCCeeeecccccceeccCCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCch
Confidence 99998655 589999999987654432 23457899999999987654 78999999999999999999999865433
Q ss_pred Cchhh-hHHHHH---------HhhhccCC----------cchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhh
Q 040898 274 HTEEM-DMVKWM---------RNVIFSEN----------PNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKD 333 (337)
Q Consensus 274 ~~~~~-~~~~~~---------~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e 333 (337)
..... .+.... ........ ...................++.+|+.+||+.||++|||++|
T Consensus 236 ~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e 315 (328)
T d3bqca1 236 NYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 315 (328)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred hHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHH
Confidence 21111 111100 00000000 00000011111122233456899999999999999999999
Q ss_pred hhcC
Q 040898 334 VRSM 337 (337)
Q Consensus 334 ll~~ 337 (337)
+|+|
T Consensus 316 ~L~H 319 (328)
T d3bqca1 316 AMEH 319 (328)
T ss_dssp HHTS
T ss_pred HhcC
Confidence 9997
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-48 Score=338.05 Aligned_cols=255 Identities=23% Similarity=0.316 Sum_probs=194.6
Q ss_pred ccccceeccCcceEEEEeEEecCC-CCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCc
Q 040898 43 FDSLKKIGSGGWGEVFYKAELPGS-NGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNI 121 (337)
Q Consensus 43 y~~~~~lg~G~~g~V~~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpni 121 (337)
+.+.++||+|+||+||++.+.... +...||||++........ .+.+.+|+.++++++||||
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~------------------~~~~~~E~~~l~~l~HpnI 90 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE------------------VSQFLTEGIIMKDFSHPNV 90 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHH------------------HHHHHHHHHHHHTCCCTTB
T ss_pred eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHH------------------HHHHHHHHHHHHhCCCCCE
Confidence 344678999999999999886522 334689999864332211 1578899999999999999
Q ss_pred ccceeEEEc-CCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeec
Q 040898 122 LPLLAHMVR-PNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLID 200 (337)
Q Consensus 122 v~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~ 200 (337)
+++++++.. ++..++||||+++++|.+++.. .....++..+..++.|++.||.|+ |+.+++||||||+||+++
T Consensus 91 v~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~l---H~~~iiHrDLK~~NILl~ 164 (311)
T d1r0pa_ 91 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLD 164 (311)
T ss_dssp CCCCEEEEETTTEEEEEEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEEC
T ss_pred eEEeEEEEecCCceEEEEEEeecCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhh---cccCcccCCccHHhEeEC
Confidence 999999765 5689999999999999998853 445577888999999999999999 667999999999999999
Q ss_pred CCCCeEEecccCccccCCCCcee--eeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCCCchhh
Q 040898 201 DDMEARISDFGHGKLMPDGHAQI--TVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTEEM 278 (337)
Q Consensus 201 ~~~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~~~ 278 (337)
+++.+||+|||++.......... ......+|+.|+|||.+.+..++.++||||||+++|||+||..||...... .
T Consensus 165 ~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~---~ 241 (311)
T d1r0pa_ 165 EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT---F 241 (311)
T ss_dssp TTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------
T ss_pred CCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH---H
Confidence 99999999999998765433221 122346889999999999999999999999999999999988776542211 1
Q ss_pred hHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 279 DMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
+....+........ +...++.+.+|+.+||+.||++|||+.||+++
T Consensus 242 ~~~~~i~~g~~~~~-------------p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 242 DITVYLLQGRRLLQ-------------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp -CHHHHHTTCCCCC-------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCCCCC-------------cccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 11222211111111 11123458899999999999999999999874
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-48 Score=336.00 Aligned_cols=264 Identities=24% Similarity=0.295 Sum_probs=193.9
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCC
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHR 119 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 119 (337)
..+|.+.++||+|+||.||++.. +|+.||||++...... . .....|+..+.+++||
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~----~g~~vAvK~~~~~~~~---~-----------------~~~e~ei~~~~~~~Hp 57 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW----RGEEVAVKIFSSREER---S-----------------WFREAEIYQTVMLRHE 57 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE----TTEEEEEEEECGGGHH---H-----------------HHHHHHHHTSTTCCCT
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE----CCEEEEEEEECccchh---H-----------------HHHHHHHHHHhhCCCC
Confidence 35789999999999999999976 7899999998543210 0 1223466667788999
Q ss_pred CcccceeEEEcCC----eeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhC-----CCCCeEec
Q 040898 120 NILPLLAHMVRPN----CHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMC-----HRPRLIHR 190 (337)
Q Consensus 120 niv~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~-----h~~gi~h~ 190 (337)
||+++++++.+.+ ..++||||+++|+|.++++. ..+++..++.++.|++.|+.|+|+. |++|++|+
T Consensus 58 nIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHr 132 (303)
T d1vjya_ 58 NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHR 132 (303)
T ss_dssp TBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECS
T ss_pred cCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeecc
Confidence 9999999987653 57999999999999999954 3588999999999999999999753 46799999
Q ss_pred CCCCCceeecCCCCeEEecccCccccCCCCce--eeeecccCCCCccCccccccCC------CCCcccchhhhHHHHHHH
Q 040898 191 DIKPANVLIDDDMEARISDFGHGKLMPDGHAQ--ITVKCMVGTMGYMAPESLQTET------ISDKCDIYSFGVLLAVLV 262 (337)
Q Consensus 191 di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~------~~~~~DiwslG~i~~~ll 262 (337)
||||+||+++.++.+||+|||++......... .......||+.|+|||++.+.. ++.++||||||+++|||+
T Consensus 133 DlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~ 212 (303)
T d1vjya_ 133 DLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 212 (303)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHH
T ss_pred ccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHh
Confidence 99999999999999999999999876543322 1233467999999999987653 456899999999999999
Q ss_pred hCCCCCCCCCCCch--------hhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhh
Q 040898 263 MGKFPVDDFFGHTE--------EMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDV 334 (337)
Q Consensus 263 ~g~~pf~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el 334 (337)
||..||........ ....... ..........+.... ..........+.+|+.+||+.||++|||+.||
T Consensus 213 tg~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~p~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei 288 (303)
T d1vjya_ 213 RRCSIGGIHEDYQLPYYDLVPSDPSVEEM-RKVVCEQKLRPNIPN---RWQSCEALRVMAKIMRECWYANGAARLTALRI 288 (303)
T ss_dssp HTBCBTTBCCCCCCTTTTTSCSSCCHHHH-HHHHTTSCCCCCCCG---GGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHH
T ss_pred hCCCCCCcccccccchhhcccccchHHHH-HHHHhccccCCCCCc---ccCChHHHHHHHHHHHHHcccCHhHCcCHHHH
Confidence 99988753221110 0111111 111111111000000 11123345668999999999999999999999
Q ss_pred hc
Q 040898 335 RS 336 (337)
Q Consensus 335 l~ 336 (337)
++
T Consensus 289 ~~ 290 (303)
T d1vjya_ 289 KK 290 (303)
T ss_dssp HH
T ss_pred HH
Confidence 75
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-48 Score=341.12 Aligned_cols=260 Identities=24% Similarity=0.352 Sum_probs=204.1
Q ss_pred ccccccceeccCcceEEEEeEEec-CCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC-
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELP-GSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH- 118 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h- 118 (337)
++|++++.||+|+||+||++.+.. ..+|+.||||.+.......... ..+.+.+|+.++++++|
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~---------------~~~~~~~E~~il~~l~h~ 88 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAK---------------TTEHTRTERQVLEHIRQS 88 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEES---------------SGGGCCCHHHHHHHHHTC
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchH---------------HHHHHHHHHHHHHhccCC
Confidence 569999999999999999998865 4478999999986543221100 01567789999999977
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
|||+++++++.+....++++||+.+|+|.+++.. ....++..+..++.||+.|+.|+ |++|++|+||||+||+
T Consensus 89 pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~l---H~~~ivHrDiKp~Nil 161 (322)
T d1vzoa_ 89 PFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHL---HKLGIIYRDIKLENIL 161 (322)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEE
T ss_pred CeEEEeeeeeccCCceeeeeecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHh---hcCCEEeccCCcccee
Confidence 8999999999999999999999999999999854 34577888999999999999999 6779999999999999
Q ss_pred ecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccC--CCCCcccchhhhHHHHHHHhCCCCCCCCCCCch
Q 040898 199 IDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTE--TISDKCDIYSFGVLLAVLVMGKFPVDDFFGHTE 276 (337)
Q Consensus 199 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~DiwslG~i~~~ll~g~~pf~~~~~~~~ 276 (337)
++.++.++|+|||++.......... .....+++.|++||.+.+. .++.++|||||||++|+|++|..||........
T Consensus 162 l~~~~~vkL~DFG~a~~~~~~~~~~-~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~ 240 (322)
T d1vzoa_ 162 LDSNGHVVLTDFGLSKEFVADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS 240 (322)
T ss_dssp ECTTSCEEESCSSEEEECCGGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC
T ss_pred ecCCCCEEEeeccchhhhccccccc-ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9999999999999998765433222 2345799999999999754 467899999999999999999999976544333
Q ss_pred hhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCC-----ChhhhhcC
Q 040898 277 EMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERP-----SSKDVRSM 337 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 337 (337)
...+..... ....+ .+...+..+.+|+.+||++||++|| |++|+++|
T Consensus 241 ~~~i~~~~~---~~~~~-----------~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 241 QAEISRRIL---KSEPP-----------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp HHHHHHHHH---HCCCC-----------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred HHHHHHhcc---cCCCC-----------CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 322222211 11111 1112334589999999999999999 48999987
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=341.62 Aligned_cols=264 Identities=23% Similarity=0.242 Sum_probs=192.5
Q ss_pred ccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC
Q 040898 39 KEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH 118 (337)
Q Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 118 (337)
..++|+++++||+|+||+||++.+.. +|+.||||++......... ...+.+|+.++++++|
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~--t~~~vAvK~i~~~~~~~~~-----------------~~~~~~Ei~il~~l~h 75 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAV--LDRNVAIKKLSRPFQNQTH-----------------AKRAYRELVLMKCVNH 75 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETT--TTEEEEEEEEESTTSSHHH-----------------HHHHHHHHHHHHHCCC
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECC--CCCEEEEEEEChhhcCHHH-----------------HHHHHHHHHHHHhcCC
Confidence 34679999999999999999999976 8999999999765432211 1567899999999999
Q ss_pred CCcccceeEEEc------CCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCC
Q 040898 119 RNILPLLAHMVR------PNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDI 192 (337)
Q Consensus 119 pniv~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di 192 (337)
|||+++++++.. ....|+||||+.++.+. .+. ..+++..++.++.||+.||.|| |++|++|+||
T Consensus 76 pnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~-~~~------~~~~~~~i~~~~~qil~gl~~L---H~~giiHrDl 145 (355)
T d2b1pa1 76 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQ-VIQ------MELDHERMSYLLYQMLCGIKHL---HSAGIIHRDL 145 (355)
T ss_dssp TTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHH-HHT------SCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCC
T ss_pred CCeeEEEEEEecccccccCceeEEEEeccchHHHH-hhh------cCCCHHHHHHHHHHHHHHHHHh---hhcccccccC
Confidence 999999999853 46789999999775444 331 3488999999999999999999 6779999999
Q ss_pred CCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCC
Q 040898 193 KPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPVDDFF 272 (337)
Q Consensus 193 ~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf~~~~ 272 (337)
||+||+++.++.++++|||++....... ......+|+.|+|||++.+..++.++||||+||++|+|++|++||....
T Consensus 146 KP~Nil~~~~~~~kl~df~~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~ 222 (355)
T d2b1pa1 146 KPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_dssp CGGGEEECTTCCEEECCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred Cccccccccccceeeechhhhhcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCC
Confidence 9999999999999999999887654433 2234578999999999999999999999999999999999999996432
Q ss_pred CCchhhhHHHHHHhhh------------------ccCC-----cch-hhhh---cccCCchHHHHHHHHHHHhhhccCCC
Q 040898 273 GHTEEMDMVKWMRNVI------------------FSEN-----PNR-AINS---KLLGNGYEEQMLLVLKLACFCTLKDP 325 (337)
Q Consensus 273 ~~~~~~~~~~~~~~~~------------------~~~~-----~~~-~~~~---~~~~~~~~~~~~~l~~li~~~l~~dP 325 (337)
............. .... ... .... ..........+..+.+|+.+||..||
T Consensus 223 ---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP 299 (355)
T d2b1pa1 223 ---YIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 299 (355)
T ss_dssp ---HHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSST
T ss_pred ---HHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCCh
Confidence 1111111111110 0000 000 0000 00011223456678999999999999
Q ss_pred CCCCChhhhhcC
Q 040898 326 DERPSSKDVRSM 337 (337)
Q Consensus 326 ~~Rps~~ell~~ 337 (337)
++|||++|+|+|
T Consensus 300 ~~R~ta~elL~H 311 (355)
T d2b1pa1 300 AKRISVDDALQH 311 (355)
T ss_dssp TTSCCHHHHHTS
T ss_pred hHCcCHHHHhcC
Confidence 999999999998
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-47 Score=338.60 Aligned_cols=268 Identities=21% Similarity=0.291 Sum_probs=199.5
Q ss_pred cccccccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHH
Q 040898 34 LAFLKKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITA 113 (337)
Q Consensus 34 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l 113 (337)
.++++..++|+++++||+|+||+||++.+.. +|+.||||++......... ...+.+|+.++
T Consensus 11 ~~~~~~~~rY~i~~~LG~G~fg~Vy~a~~~~--~~~~vAiK~i~~~~~~~~~-----------------~~~~~~Ei~il 71 (348)
T d2gfsa1 11 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIH-----------------AKRTYRELRLL 71 (348)
T ss_dssp SSEEEEETTEEEEEECGGGTTSSEEEEEETT--TTEEEEEEECSCTTSSHHH-----------------HHHHHHHHHHH
T ss_pred CccccCCCCeEEEEEEecCCCeEEEEEEECC--CCCEEEEEEECchhcChHH-----------------HHHHHHHHHHH
Confidence 4567778899999999999999999999876 8999999998755432221 15678899999
Q ss_pred HhcCCCCcccceeEEEcC-----CeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeE
Q 040898 114 NQTRHRNILPLLAHMVRP-----NCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLI 188 (337)
Q Consensus 114 ~~l~hpniv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~ 188 (337)
++++||||+++++++... ...+++++++.+|+|.+++. ...+++..+..++.||+.||.|| |++|++
T Consensus 72 ~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~-----~~~l~e~~~~~i~~qil~aL~~L---H~~gii 143 (348)
T d2gfsa1 72 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI---HSADII 143 (348)
T ss_dssp HHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHH---HHTTCC
T ss_pred HhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhcc-----cccccHHHHHHHHHHHHHHHHHH---HhCCCc
Confidence 999999999999998643 34567778888999999883 24699999999999999999999 677999
Q ss_pred ecCCCCCceeecCCCCeEEecccCccccCCCCceeeeecccCCCCccCccccccC-CCCCcccchhhhHHHHHHHhCCCC
Q 040898 189 HRDIKPANVLIDDDMEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTE-TISDKCDIYSFGVLLAVLVMGKFP 267 (337)
Q Consensus 189 h~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~i~~~ll~g~~p 267 (337)
||||||+||+++.++.++++|||.+...... .....+++.|+|||...+. .++.++|+||||+++|+|++|.+|
T Consensus 144 HrDiKp~NILi~~~~~~kl~dfg~a~~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~p 218 (348)
T d2gfsa1 144 HRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218 (348)
T ss_dssp CCCCCGGGEEECTTCCEEECCC----CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred ccccCCccccccccccccccccchhcccCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCC
Confidence 9999999999999999999999998765332 2335688999999987665 468899999999999999999999
Q ss_pred CCCCCCCchhhhHHHHHHhhhccCCcchh--------h--h---hcccCC----chHHHHHHHHHHHhhhccCCCCCCCC
Q 040898 268 VDDFFGHTEEMDMVKWMRNVIFSENPNRA--------I--N---SKLLGN----GYEEQMLLVLKLACFCTLKDPDERPS 330 (337)
Q Consensus 268 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~--~---~~~~~~----~~~~~~~~l~~li~~~l~~dP~~Rps 330 (337)
|..... .... ..+............ . . ...... ........+.+|+.+||+.||++|||
T Consensus 219 F~~~~~---~~~~-~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t 294 (348)
T d2gfsa1 219 FPGTDH---IDQL-KLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 294 (348)
T ss_dssp CCCSSH---HHHH-HHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCC
T ss_pred CCCCCH---HHHH-HHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcC
Confidence 965322 1111 111111111000000 0 0 000000 01123345889999999999999999
Q ss_pred hhhhhcC
Q 040898 331 SKDVRSM 337 (337)
Q Consensus 331 ~~ell~~ 337 (337)
+.|+|+|
T Consensus 295 a~elL~H 301 (348)
T d2gfsa1 295 AAQALAH 301 (348)
T ss_dssp HHHHHTS
T ss_pred HHHHhcC
Confidence 9999987
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.6e-46 Score=324.85 Aligned_cols=259 Identities=21% Similarity=0.294 Sum_probs=194.0
Q ss_pred cccccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC
Q 040898 38 KKEDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR 117 (337)
Q Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 117 (337)
+-+++|++++.||+|+||.||++.+.. +|+.||||++..+... ..+.+|+.+++.++
T Consensus 4 ~vg~rY~l~~~iG~G~fG~Vy~a~~~~--~~~~vAvK~~~~~~~~---------------------~~~~~E~~i~~~l~ 60 (299)
T d1ckia_ 4 RVGNRYRLGRKIGSGSFGDIYLGTDIA--AGEEVAIKLECVKTKH---------------------PQLHIESKIYKMMQ 60 (299)
T ss_dssp EETTTEEEEEEEEECSSSEEEEEEETT--TTEEEEEEEEESCTTS---------------------CCHHHHHHHHHHST
T ss_pred eECCEEEEeEEEeeCCCcEEEEEEECC--CCCEEEEEEEchhccC---------------------HHHHHHHHHHHHcc
Confidence 345679999999999999999999876 8999999987654321 35677999999998
Q ss_pred CCCcccc-eeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCc
Q 040898 118 HRNILPL-LAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPAN 196 (337)
Q Consensus 118 hpniv~~-~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~n 196 (337)
|+|++.. ..++.++...++||||+. ++|.+.+.. ....+++..+..++.|++.||+|| |++|++||||||+|
T Consensus 61 ~~~~i~~~~~~~~~~~~~~ivme~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~l---H~~~iiHrDiKp~N 133 (299)
T d1ckia_ 61 GGVGIPTIRWCGAEGDYNVMVMELLG-PSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYI---HSKNFIHRDVKPDN 133 (299)
T ss_dssp TSTTCCCEEEEEEETTEEEEEEECCC-CBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGG
T ss_pred CCCcccEEEEEEecCCEEEEEEEEcC-Cchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHH---HHCCeeeccCCHhh
Confidence 7775555 555677888899999995 467666543 445699999999999999999999 66799999999999
Q ss_pred eeecC---CCCeEEecccCccccCCCCce-----eeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCC
Q 040898 197 VLIDD---DMEARISDFGHGKLMPDGHAQ-----ITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPV 268 (337)
Q Consensus 197 il~~~---~~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf 268 (337)
|+++. +..++|+|||++......... .......||+.|+|||.+.+..++.++||||||+++|+|++|..||
T Consensus 134 Il~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~ 213 (299)
T d1ckia_ 134 FLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPW 213 (299)
T ss_dssp EEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred ccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcc
Confidence 99864 457999999999876543321 1223457999999999999999999999999999999999999999
Q ss_pred CCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 269 DDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
...................... .... . .+..+..+.+++..||+.||++||+++++.+
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~-~~~~-~--------~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~ 271 (299)
T d1ckia_ 214 QGLKAATKRQKYERISEKKMST-PIEV-L--------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 271 (299)
T ss_dssp CCCC-------HHHHHHHHHHS-CHHH-H--------TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHH
T ss_pred cccchHHHHHHHHHhhcccCCC-ChhH-h--------ccCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 7654433332222222111111 1000 0 0112344889999999999999999987643
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.2e-45 Score=318.13 Aligned_cols=257 Identities=20% Similarity=0.236 Sum_probs=200.6
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC-
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH- 118 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h- 118 (337)
.++|++++.||+|+||+||++.+.. +|+.||||++...... ..+.+|++.+..+.|
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~--~~~~vAvK~~~~~~~~---------------------~~~~~e~~~~~~l~~~ 60 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLL--NNQQVAIKFEPRRSDA---------------------PQLRDEYRTYKLLAGC 60 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETT--TTEEEEEEEEECCTTS---------------------CCHHHHHHHHHHTTTC
T ss_pred CCceEEEEEEecCCCeEEEEEEECC--CCCEEEEEEEccccCc---------------------HHHHHHHHHHHHhcCC
Confidence 4689999999999999999999876 8999999987544321 345678888888865
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCcee
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVL 198 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil 198 (337)
+|++.+++++..+...++||||+ +++|.+++.. .+..++...+..++.|++.||.|+ |++|++||||||+||+
T Consensus 61 ~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~l---H~~giiHrDiKp~Nil 133 (293)
T d1csna_ 61 TGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSI---HEKSLVYRDIKPDNFL 133 (293)
T ss_dssp TTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCCGGGEE
T ss_pred CCCCEEEEEeecCCccEEEEEec-CCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHH---HHCCceeccCCcccee
Confidence 89999999999999999999999 6799998754 345689999999999999999999 7789999999999999
Q ss_pred ecC-----CCCeEEecccCccccCCCCce-----eeeecccCCCCccCccccccCCCCCcccchhhhHHHHHHHhCCCCC
Q 040898 199 IDD-----DMEARISDFGHGKLMPDGHAQ-----ITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLAVLVMGKFPV 268 (337)
Q Consensus 199 ~~~-----~~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~~ll~g~~pf 268 (337)
++. ++.++|+|||++......... .......||+.|+|||++.+..++.++||||||+++|+|++|..||
T Consensus 134 i~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf 213 (293)
T d1csna_ 134 IGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPW 213 (293)
T ss_dssp ECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred ecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcC
Confidence 974 578999999999876533221 1123457999999999999999999999999999999999999999
Q ss_pred CCCCCCchhhhHHHHHHhhhccCCcchhhhhcccCCchHHHHHHHHHHHhhhccCCCCCCCChhhhhc
Q 040898 269 DDFFGHTEEMDMVKWMRNVIFSENPNRAINSKLLGNGYEEQMLLVLKLACFCTLKDPDERPSSKDVRS 336 (337)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 336 (337)
.............. +.......... .+... .+..+.+++..|++.+|++||+.+.+.+
T Consensus 214 ~~~~~~~~~~~~~~-i~~~~~~~~~~-----~l~~~----~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 214 QGLKAATNKQKYER-IGEKKQSTPLR-----ELCAG----FPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp SSCCSCCHHHHHHH-HHHHHHHSCHH-----HHTTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CCccchhHHHHHHH-HHhccCCCChH-----HhcCC----CCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 76544333322222 11111111111 11111 2234888999999999999999776643
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.2e-41 Score=304.80 Aligned_cols=267 Identities=22% Similarity=0.294 Sum_probs=188.5
Q ss_pred cccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC--
Q 040898 40 EDCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR-- 117 (337)
Q Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-- 117 (337)
+++|+++++||+|+||+||++.+.. +|+.||||++..+.... +.+.+|+.+++.+.
T Consensus 12 ~~rY~i~~~LG~G~fg~Vy~~~~~~--~g~~vAvKvi~~~~~~~--------------------~~~~~Ei~~l~~l~~~ 69 (362)
T d1q8ya_ 12 DARYILVRKLGWGHFSTVWLAKDMV--NNTHVAMKIVRGDKVYT--------------------EAAEDEIKLLQRVNDA 69 (362)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT--TTEEEEEEEECSCHHHH--------------------HHHHHHHHHHHHHHHT
T ss_pred CCcEEEEEEEeeCCCeEEEEEEECC--CCCEEEEEEEeccccch--------------------HHHHHHHHHHHHhcch
Confidence 4679999999999999999999976 89999999986542111 34455666666554
Q ss_pred ---------CCCcccceeEEEc--CCeeEEEEEeccCCC-HHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCC
Q 040898 118 ---------HRNILPLLAHMVR--PNCHLLVYEFMKNGS-LQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRP 185 (337)
Q Consensus 118 ---------hpniv~~~~~~~~--~~~~~lv~e~~~~~~-L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~ 185 (337)
||||+++++++.. ....++++.++..+. ...... .......++..++.++.||+.|+.|||+ ..
T Consensus 70 ~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~i~~qil~al~~lh~--~~ 145 (362)
T d1q8ya_ 70 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIK--KYEHRGIPLIYVKQISKQLLLGLDYMHR--RC 145 (362)
T ss_dssp CCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHH--HTTTSCCCHHHHHHHHHHHHHHHHHHHH--TT
T ss_pred hhhhhhhcCcCceEEEEEEeeeccccceeeeeeecccccccccccc--cccccCCcHHHHHHHHHHHHHHHHHHhh--hc
Confidence 6889999988754 355667777665543 333222 2455678889999999999999999963 47
Q ss_pred CeEecCCCCCceeecCCC------CeEEecccCccccCCCCceeeeecccCCCCccCccccccCCCCCcccchhhhHHHH
Q 040898 186 RLIHRDIKPANVLIDDDM------EARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPESLQTETISDKCDIYSFGVLLA 259 (337)
Q Consensus 186 gi~h~di~~~nil~~~~~------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~i~~ 259 (337)
||+||||||+||+++.++ .++++|||.+....... ....+|+.|+|||++.+..++.++|+||+|++++
T Consensus 146 ~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 220 (362)
T d1q8ya_ 146 GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIF 220 (362)
T ss_dssp CEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHH
T ss_pred CcccccCChhHeeeeccCcccccceeeEeeccccccccccc-----ccccccccccChhhccccCCCccccccchHHHHH
Confidence 999999999999998655 38999999987654322 3456999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCchhhhHHHHHHhhhc-cCCcchhh-----------------------------hhcccCCchHHH
Q 040898 260 VLVMGKFPVDDFFGHTEEMDMVKWMRNVIF-SENPNRAI-----------------------------NSKLLGNGYEEQ 309 (337)
Q Consensus 260 ~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-----------------------------~~~~~~~~~~~~ 309 (337)
+|++|+.||..................... ...+.... ............
T Consensus 221 el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (362)
T d1q8ya_ 221 ELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDE 300 (362)
T ss_dssp HHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHH
T ss_pred HHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCccc
Confidence 999999999754332211111111100000 00000000 000011233566
Q ss_pred HHHHHHHHhhhccCCCCCCCChhhhhcC
Q 040898 310 MLLVLKLACFCTLKDPDERPSSKDVRSM 337 (337)
Q Consensus 310 ~~~l~~li~~~l~~dP~~Rps~~ell~~ 337 (337)
...+.+|+.+||..||.+|||++|+|+|
T Consensus 301 ~~~~~dll~~mL~~dP~~Rpta~e~L~H 328 (362)
T d1q8ya_ 301 AKEISDFLSPMLQLDPRKRADAGGLVNH 328 (362)
T ss_dssp HHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 7789999999999999999999999997
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=1.2e-23 Score=169.98 Aligned_cols=182 Identities=15% Similarity=0.082 Sum_probs=119.8
Q ss_pred ccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCCCCcc
Q 040898 43 FDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRHRNIL 122 (337)
Q Consensus 43 y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv 122 (337)
+-++++||+|+||+||++.+. +|+.||||++................ ..............+|...+.++.|++++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~---~g~~vAvKi~r~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~e~~~l~~l~~~~v~ 77 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE---KFGECVVKFHKVGHTSFKKVKEKRDY-GDLHFSVLAIRSARNEFRALQKLQGLAVP 77 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET---TTEEEEEEEECC------CCCC--------CHHHHHHHHHHHHHHHHHHTTTSSSC
T ss_pred chhCCEeeeCcceEEEEEECC---CCCEEEEEEEecccchhhhhhhhhhh-ccHHHHHHHHHHHHHHHHHHHHccCCCcc
Confidence 357899999999999998874 78999999875432210000000000 00001111124566789999999999998
Q ss_pred cceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhCCCCCeEecCCCCCceeecCC
Q 040898 123 PLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMCHRPRLIHRDIKPANVLIDDD 202 (337)
Q Consensus 123 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~h~~gi~h~di~~~nil~~~~ 202 (337)
..+++.. .+++|||+++..+. .++......++.|++.++.+| |++|++|+||||+||+++++
T Consensus 78 ~~~~~~~----~~lvme~~~~~~~~-----------~l~~~~~~~i~~ql~~~l~~l---H~~giiHrDiKP~NILv~~~ 139 (191)
T d1zara2 78 KVYAWEG----NAVLMELIDAKELY-----------RVRVENPDEVLDMILEEVAKF---YHRGIVHGDLSQYNVLVSEE 139 (191)
T ss_dssp CEEEEET----TEEEEECCCCEEGG-----------GCCCSCHHHHHHHHHHHHHHH---HHTTEECSCCSTTSEEEETT
T ss_pred eEEEecC----CEEEEEeecccccc-----------chhhHHHHHHHHHHHHHHHHH---hhCCEEEccCChhheeeeCC
Confidence 8876432 37999999875432 244556678999999999999 66799999999999999965
Q ss_pred CCeEEecccCccccCCCCceeeeecccCCCCccCcc-----ccccCCCCCcccchhhhHH
Q 040898 203 MEARISDFGHGKLMPDGHAQITVKCMVGTMGYMAPE-----SLQTETISDKCDIYSFGVL 257 (337)
Q Consensus 203 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~PE-----~~~~~~~~~~~DiwslG~i 257 (337)
.++|+|||.+......... .|.... .+....|+.++|+||+.--
T Consensus 140 -~~~liDFG~a~~~~~~~~~----------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 140 -GIWIIDFPQSVEVGEEGWR----------EILERDVRNIITYFSRTYRTEKDINSAIDR 188 (191)
T ss_dssp -EEEECCCTTCEETTSTTHH----------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHH
T ss_pred -CEEEEECCCcccCCCCCcH----------HHHHHHHHHHHHHHcCCCCCcccHHHHHHH
Confidence 5899999998765432211 111110 0113457888999997543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.71 E-value=8.1e-08 Score=79.56 Aligned_cols=142 Identities=11% Similarity=0.057 Sum_probs=91.5
Q ss_pred ccccccceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC-CC
Q 040898 41 DCFDSLKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR-HR 119 (337)
Q Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp 119 (337)
+.|++.+..+.++.+.||++.. +++.+++|+......... ..+.+|...+..+. +=
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~----~~~~~vlk~~~~~~~~~~-------------------~~~~~E~~~l~~l~~~v 70 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVG----ENENLYLKMTDSRYKGTT-------------------YDVEREKDMMLWLEGKL 70 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEEC----SSCEEEEEEECGGGTTST-------------------TCHHHHHHHHHHHTTTS
T ss_pred hceEEEEcCCCCCCCcEEEEEe----CCCeEEEEEcCCCcccch-------------------hhHHHHHHHHHHHhccC
Confidence 4577777666666688987653 667788887754432211 34566777777663 32
Q ss_pred CcccceeEEEcCCeeEEEEEeccCCCHHHHHHHhcCCcccCChHHHHHHHHHHHHHHHHHhhC-----------------
Q 040898 120 NILPLLAHMVRPNCHLLVYEFMKNGSLQDILYDVSQGRRELDWPARHRIARGIASGLEYLHMC----------------- 182 (337)
Q Consensus 120 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l~~~----------------- 182 (337)
-+.+++.+..+++..++||++++|.++.+.... ......++.++...+..||+.
T Consensus 71 pvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~---------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~ 141 (263)
T d1j7la_ 71 PVPKVLHFERHDGWSNLLMSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAE 141 (263)
T ss_dssp CCCCEEEEEEETTEEEEEEECCSSEEHHHHTTT---------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHH
T ss_pred CCCcEEEEEecCCceEEEEEecccccccccccc---------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhh
Confidence 356777777888889999999999877654311 111222334444444444421
Q ss_pred ---------------------------------------CCCCeEecCCCCCceeecCCCCeEEecccCcc
Q 040898 183 ---------------------------------------HRPRLIHRDIKPANVLIDDDMEARISDFGHGK 214 (337)
Q Consensus 183 ---------------------------------------h~~gi~h~di~~~nil~~~~~~~~l~dfg~~~ 214 (337)
....++|+|+.|.||++++++.+.|+||+.+.
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 142 LDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 11237999999999999977666799998654
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.13 E-value=1.1e-05 Score=65.82 Aligned_cols=74 Identities=11% Similarity=0.074 Sum_probs=47.4
Q ss_pred eeccCcc-eEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcCC--CCcccc
Q 040898 48 KIGSGGW-GEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTRH--RNILPL 124 (337)
Q Consensus 48 ~lg~G~~-g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--pniv~~ 124 (337)
.+..|.. +.||++... .+..+++|....... ..+.+|...++.+.. -.+.++
T Consensus 17 ~~~~G~s~~~v~r~~~~---~~~~~vlK~~~~~~~----------------------~~l~~E~~~l~~L~~~gvpvP~v 71 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQ---GRPVLFVKTDLSGAL----------------------NELQDEAARLSWLATTGVPCAAV 71 (255)
T ss_dssp ECSCTTSSCEEEEEECT---TSCCEEEEEECSCTT----------------------SCHHHHHHHHHHHHTTTCCBCCE
T ss_pred EcCCcccCCeEEEEEeC---CCCEEEEEeCCccCH----------------------hHHHHHHHHHHHHHhcCCCCCce
Confidence 4455554 678876552 566788887644322 234456666665532 235667
Q ss_pred eeEEEcCCeeEEEEEeccCCCH
Q 040898 125 LAHMVRPNCHLLVYEFMKNGSL 146 (337)
Q Consensus 125 ~~~~~~~~~~~lv~e~~~~~~L 146 (337)
+.+..+++..++||++++|.++
T Consensus 72 ~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 72 LDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp EEEEECSSCEEEEEECCSSEET
T ss_pred eeecccccceEEEEEeeecccc
Confidence 7777888889999999987543
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.96 E-value=2.6e-05 Score=68.08 Aligned_cols=84 Identities=15% Similarity=0.169 Sum_probs=46.3
Q ss_pred cceeccCcceEEEEeEEecCCCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhc-CC--CCcc
Q 040898 46 LKKIGSGGWGEVFYKAELPGSNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQT-RH--RNIL 122 (337)
Q Consensus 46 ~~~lg~G~~g~V~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h--pniv 122 (337)
.+.||.|....||++.+.. +++.+++|.-.+......... ....++..+|...++.+ .+ ..+.
T Consensus 31 ~~eig~G~~N~vfrV~~~~--~~~svivKqa~p~~r~~g~~~------------~~~~~R~~~E~~~L~~~~~~~p~~vP 96 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQE--HDRALIIKQAVPYAKVVGESW------------PLTIDRARIESSALIRQGEHVPHLVP 96 (392)
T ss_dssp EEECCSSSSEEEEEEEC------CEEEEEEECCGGGC--CCC------------CCCTTHHHHHHHHHHHHHTTCGGGSC
T ss_pred EEEeCCCceEeEEEEEeCC--CCeEEEEecCCchhcccCCCC------------CCCHHHHHHHHHHHHHhhhhCCCCcc
Confidence 5578999999999887643 677899997644211100000 00013344566666655 22 2344
Q ss_pred cceeEEEcCCeeEEEEEeccCCC
Q 040898 123 PLLAHMVRPNCHLLVYEFMKNGS 145 (337)
Q Consensus 123 ~~~~~~~~~~~~~lv~e~~~~~~ 145 (337)
+++. .++...++|||++++..
T Consensus 97 ~v~~--~d~~~~~lvmE~L~~~~ 117 (392)
T d2pula1 97 RVFY--SDTEMAVTVMEDLSHLK 117 (392)
T ss_dssp CEEE--EETTTTEEEECCCTTSE
T ss_pred eEEE--EcCCCCEEEEeccCCcc
Confidence 4544 34556689999997643
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.69 E-value=0.0068 Score=50.35 Aligned_cols=31 Identities=26% Similarity=0.280 Sum_probs=27.4
Q ss_pred CCCeEecCCCCCceeecCCCCeEEecccCcc
Q 040898 184 RPRLIHRDIKPANVLIDDDMEARISDFGHGK 214 (337)
Q Consensus 184 ~~gi~h~di~~~nil~~~~~~~~l~dfg~~~ 214 (337)
..|++|+|+.++|++++++...-++||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 4689999999999999988777899999764
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.57 E-value=0.015 Score=48.55 Aligned_cols=29 Identities=21% Similarity=0.335 Sum_probs=23.5
Q ss_pred CCCeEecCCCCCceeecCCCCeEEecccCcc
Q 040898 184 RPRLIHRDIKPANVLIDDDMEARISDFGHGK 214 (337)
Q Consensus 184 ~~gi~h~di~~~nil~~~~~~~~l~dfg~~~ 214 (337)
..+++|+|+.+.||+++++ ..++||+-+.
T Consensus 191 p~~liHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 191 TVLRLHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp CCEECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred CceeecCCCCcccEEEeCC--ceEEechhcc
Confidence 4579999999999999743 4589998654
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.12 E-value=0.027 Score=48.19 Aligned_cols=75 Identities=9% Similarity=0.029 Sum_probs=42.9
Q ss_pred ccceeccCcceEEEEeEEecC-----CCCceEEEEEecccCcchHHHHHHhhhhhhhhhhHHhHHhHHHHHHHHHhcC-C
Q 040898 45 SLKKIGSGGWGEVFYKAELPG-----SNGKMIAIRKLIVDAPMSAAELIKQDIDEYSDLLHWKIGAIRSEIITANQTR-H 118 (337)
Q Consensus 45 ~~~~lg~G~~g~V~~~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h 118 (337)
.+++|+.|-.-.+|++..... .....|.+++.-.... . ....+|..+++.+. +
T Consensus 46 ~v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~-~--------------------idr~~E~~i~~~ls~~ 104 (395)
T d1nw1a_ 46 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET-E--------------------SHLVAESVIFTLLSER 104 (395)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC-H--------------------HHHHHHHHHHHHHHHT
T ss_pred EEEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcch-h--------------------hHHHHHHHHHHHHHhC
Confidence 356788888889998766431 1335566666542211 1 11234666666653 3
Q ss_pred CCcccceeEEEcCCeeEEEEEeccCC
Q 040898 119 RNILPLLAHMVRPNCHLLVYEFMKNG 144 (337)
Q Consensus 119 pniv~~~~~~~~~~~~~lv~e~~~~~ 144 (337)
.-..++++++.+ .+|+||++|.
T Consensus 105 gl~Pkll~~~~~----g~I~efi~g~ 126 (395)
T d1nw1a_ 105 HLGPKLYGIFSG----GRLEEYIPSR 126 (395)
T ss_dssp TSSSCEEEEETT----EEEECCCCEE
T ss_pred CCCCeEEEEcCC----ceEEEEeccc
Confidence 233466666543 5889998764
|